["integumentary system cancer (DOID:0060122 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin cancer (DOID:4159 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin carcinoma (DOID:3451 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "basal cell carcinoma (DOID:2513 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "keratoacanthoma (DOID:3149 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin squamous cell carcinoma (DOID:3151 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "actinic keratosis (DOID:8866 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "seborrheic keratosis (DOID:6498 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "verrucous carcinoma (DOID:3737 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "infiltrative basal cell carcinoma (DOID:4299 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant syringoma (DOID:5569 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "morpheaform basal cell carcinoma (DOID:4292 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eccrine sweat gland cancer (DOID:4921 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eccrine porocarcinoma (DOID:7566 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sweat gland cancer (DOID:2095 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myoepithelial carcinoma (DOID:4838 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epithelial-myoepithelial carcinoma (DOID:5309 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "integumentary system benign neoplasm (DOID:0060121 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin benign neoplasm (DOID:3165 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sweat gland neoplasm (DOID:2664 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myoepithelioma (DOID:2661 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "apocrine sweat gland neoplasm (DOID:5876 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "syringocystadenoma papilliferum (DOID:5445 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hidrocystoma (DOID:3893 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "syringoma (DOID:2065 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spiradenoma (DOID:5444 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hair follicle neoplasm (DOID:5375 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pilomatrixoma (DOID:5374 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clear cell hidradenoma (DOID:5443 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hidradenoma (DOID:3896 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nodular hidradenoma (DOID:2061 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucoepidermoid carcinoma (DOID:4531 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oral cavity cancer (DOID:8618 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "salivary gland cancer (DOID:8850 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "salivary gland carcinoma (DOID:0050904 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "salivary gland adenoid cystic carcinoma (DOID:4866 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pleomorphic adenoma (DOID:452 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hard palate cancer (DOID:9149 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choroid plexus papilloma (DOID:2626 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papilloma (DOID:2615 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inverted papilloma (DOID:3179 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillary adenoma (DOID:3172 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fibroepithelial basal cell carcinoma (DOID:4291 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyroid hurthle cell adenoma (DOID:8162 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "infundibulocystic basal cell carcinoma (DOID:4279 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acanthoma (DOID:174 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "squamous cell neoplasm (DOID:3168 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "large cell acanthoma (DOID:4321 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nodular basal cell carcinoma (DOID:4280 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillary craniopharyngioma (DOID:3847 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transitional papilloma (DOID:2670 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast adenoma (DOID:1625 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pregnancy adenoma (DOID:7539 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intraneural perineurioma (DOID:4696 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "perineurioma (DOID:4697 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary cutaneous amyloidosis (DOID:0050639 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atypical choroid plexus papilloma (DOID:3544 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ceruminoma (DOID:7549 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paranasal sinus neoplasm (DOID:1350 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "frontal sinus inverted papilloma (DOID:8060 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "frontal sinus neoplasm (DOID:1361 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "signet ring basal cell carcinoma (DOID:4304 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intrahepatic biliary papillomatosis (DOID:8230 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aggressive digital papillary adenocarcinoma (DOID:5590 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign struma ovarii (DOID:5209 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "jaw-winking syndrome (DOID:560 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenosquamous cell lung carcinoma (DOID:4829 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acneiform dermatitis (DOID:4399 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvar melanoma (DOID:2093 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ascending colon cancer (DOID:218 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic serous cystadenoma (DOID:3917 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cecum adenocarcinoma (DOID:3039 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cecum cancer (DOID:1521 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cecum carcinoma (DOID:1519 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant ovarian brenner tumor (DOID:4217 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian benign neoplasm (DOID:0060112 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian brenner tumor (DOID:2636 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenosquamous pancreas carcinoma (DOID:5637 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bronchiolo-alveolar adenocarcinoma (DOID:4926 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nasal cavity cancer (DOID:10811 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nasal cavity carcinoma (DOID:4931 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nasal cavity adenocarcinoma (DOID:4930 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic ductal carcinoma (DOID:3587 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rectum adenocarcinoma (DOID:1996 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rectum cancer (DOID:1993 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anal canal cancer (DOID:0050688 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anal canal carcinoma (DOID:6126 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anal squamous cell carcinoma (DOID:5525 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anal carcinoma (DOID:4908 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anus cancer (DOID:14110 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cloacogenic carcinoma (DOID:7173 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "basosquamous carcinoma (DOID:5063 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenoid squamous cell carcinoma (DOID:5524 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glomus tumor (DOID:2431 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemangiopericytic tumor (DOID:3850 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glomangiosarcoma (DOID:5233 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenomyoma (DOID:2609 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atypical polypoid adenomyoma (DOID:4993 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "microcystic adenoma (DOID:5403 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eyelid carcinoma (DOID:6425 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian mucinous neoplasm (DOID:6067 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric tubular adenocarcinoma (DOID:6595 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucinous intrahepatic cholangiocarcinoma (DOID:7024 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic intraductal papillary-mucinous neoplasm (DOID:7575 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tumor of exocrine pancreas (DOID:1795 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bile duct cystadenocarcinoma (DOID:4075 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "biliary papillomatosis (DOID:5468 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bile duct adenoma (DOID:5381 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "biliary tract neoplasm (DOID:0050625 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast mucoepidermoid carcinoma (DOID:4679 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "compensatory emphysema (DOID:10031 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic ethmoiditis (DOID:9312 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ethmoid sinusitis (DOID:9507 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "appendix cancer (DOID:11239 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudomyxoma peritonei (DOID:3559 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic cystadenoma (DOID:3918 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic mucinous cystadenoma (DOID:7235 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystadenocarcinoma (DOID:3111 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "serous cystadenocarcinoma (DOID:3114 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucinous cystadenocarcinoma (DOID:3603 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystadenoma (DOID:2634 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colloid carcinoma of the pancreas (DOID:7717 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatoblastoma (DOID:6823 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extrahepatic bile duct carcinoma (DOID:4682 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ampulla of vater adenocarcinoma (DOID:3502 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ampulla of vater cancer (DOID:10020 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ampulla of vater carcinoma (DOID:4932 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "duodenum cancer (DOID:10021 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "small intestine cancer (DOID:10154 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "duodenum adenocarcinoma (DOID:10816 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "small intestine adenocarcinoma (DOID:4906 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "small intestine carcinoma (DOID:4907 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillary transitional carcinoma (DOID:4012 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myxopapillary ependymoma (DOID:5075 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "embryoma (DOID:4766 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blastoma (DOID:0070003 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian small cell carcinoma (DOID:6179 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian carcinosarcoma (DOID:6170 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "female reproductive endometrioid cancer (DOID:3001 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rete testis adenocarcinoma (DOID:14544 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rete testis neoplasm (DOID:5639 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant biphasic mesothelioma (DOID:4486 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenomatoid tumor (DOID:746 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant epithelial mesothelioma (DOID:4489 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystic teratoma (DOID:2660 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dermoid cyst (DOID:2658 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant teratoma (DOID:5563 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "monodermal teratoma (DOID:5207 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian germ cell monodermal and highly specialized teratoma (DOID:2641 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "struma ovarii (DOID:2640 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian germ cell teratoma (DOID:5567 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian germ cell cancer (DOID:2156 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant struma ovarii (DOID:5208 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mature teratoma (DOID:5566 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mature teratoma of the ovary (DOID:6231 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian biphasic or triphasic teratoma (DOID:6232 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian cystic teratoma (DOID:5118 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colloid adenoma (DOID:8419 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fetal adenoma (DOID:8102 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian large-cell neuroendocrine carcinoma (DOID:4555 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung acinar adenocarcinoma (DOID:6482 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anus basaloid carcinoma (DOID:7174 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vaginal adenoma (DOID:5402 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vaginal benign neoplasm (DOID:0060114 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vaginal tubulovillous adenoma (DOID:8104 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucinous adenofibroma (DOID:2700 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "jejunal cancer (DOID:13499 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder lymphoma (DOID:11821 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bile duct mucoepidermoid carcinoma (DOID:4681 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "appendiceal neoplasm (DOID:11240 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "appendix adenocarcinoma (DOID:3608 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "appendix carcinoma (DOID:4902 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder diverticulum (DOID:11353 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulva adenocarcinoma (DOID:2098 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulval paget's disease (DOID:2097 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal pelvis transitional cell carcinoma (DOID:5974 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephrogenic adenoma of urinary bladder (DOID:7333 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal pelvis carcinoma (DOID:4919 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "krukenberg carcinoma (DOID:9597 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "immune system organ benign neoplasm (DOID:0060092 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thymus lipoma (DOID:1975 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "merkel cell carcinoma (DOID:3965 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuroendocrine carcinoma (DOID:1800 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "small cell carcinoma (DOID:0050685 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "large cell carcinoma (DOID:4552 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung small cell carcinoma (DOID:5409 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung oat cell carcinoma (DOID:5411 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tubular adenocarcinoma (DOID:4929 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucinous adenocarcinoma (DOID:3030 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "signet ring cell adenocarcinoma (DOID:3493 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenosquamous carcinoma (DOID:4830 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pleomorphic carcinoma (DOID:5662 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary large cell neuroendocrine carcinoma (DOID:6658 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung large cell carcinoma (DOID:4556 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung giant cell carcinoma (DOID:5583 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "basaloid squamous cell carcinoma (DOID:5522 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "keratinizing squamous cell carcinoma (DOID:5521 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphoepithelioma-like carcinoma (DOID:5660 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervix small cell carcinoma (DOID:6740 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "laryngeal small cell carcinoma (DOID:7144 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatocellular fibrolamellar carcinoma (DOID:5015 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acinar cell carcinoma (DOID:3025 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic acinar cell adenocarcinoma (DOID:5742 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillary cystadenocarcinoma (DOID:3110 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sarcomatoid renal cell carcinoma (DOID:4473 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder papillary transitional cell neoplasm (DOID:5432 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urinary tract papillary transitional cell benign neoplasm (DOID:5433 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder transitional cell papilloma (DOID:6933 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "non-invasive bladder papillary urothelial neoplasm (DOID:6239 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal clear cell carcinoma (DOID:4467 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast lobular carcinoma (DOID:0050938 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "invasive lobular carcinoma (DOID:3457 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lobular neoplasia (DOID:3010 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast ductal carcinoma (DOID:3007 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "invasive ductal carcinoma (DOID:3008 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast carcinoma in situ (DOID:8791 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ductal carcinoma in situ (DOID:0060074 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "in situ carcinoma (DOID:8719 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pre-malignant neoplasm (DOID:0060071 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenocarcinoma in situ (DOID:4943 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast benign neoplasm (DOID:0060082 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thoracic benign neoplasm (DOID:0060097 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast fibroadenoma (DOID:1618 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast giant fibroadenoma (DOID:7223 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulva cancer (DOID:1245 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulva carcinoma (DOID:1294 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tongue cancer (DOID:8649 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transitional cell carcinoma (DOID:2671 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder carcinoma (DOID:4007 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urinary bladder cancer (DOID:11054 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder transitional cell carcinoma (DOID:4006 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "invasive bladder transitional cell carcinoma (DOID:6477 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bile duct adenocarcinoma (DOID:4896 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cholangiocarcinoma (DOID:4947 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bile duct cancer (DOID:4606 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bile duct carcinoma (DOID:4897 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "biliary tract cancer (DOID:4607 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intrahepatic cholangiocarcinoma (DOID:4928 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "klatskin's tumor (DOID:4927 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gallbladder adenocarcinoma (DOID:3500 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gallbladder cancer (DOID:3121 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gallbladder carcinoma (DOID:4948 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uterine cancer (DOID:363 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrial cancer (DOID:1380 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrial carcinoma (DOID:2871 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrial adenocarcinoma (DOID:2870 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrial stromal sarcoma (DOID:4226 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrial stromal tumor (DOID:5166 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervical adenocarcinoma (DOID:3702 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervical cancer (DOID:4362 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervix carcinoma (DOID:2893 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervical squamous cell carcinoma (DOID:3744 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate adenocarcinoma (DOID:2526 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate carcinoma (DOID:10286 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "barrett's adenocarcinoma (DOID:7941 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "esophagus adenocarcinoma (DOID:4914 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "esophageal cancer (DOID:5041 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "esophageal carcinoma (DOID:1107 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric adenocarcinoma (DOID:3717 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "stomach carcinoma (DOID:5517 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "stomach cancer (DOID:10534 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric cardia adenocarcinoma (DOID:6271 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric cardia carcinoma (DOID:6270 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric diffuse adenocarcinoma (DOID:6217 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "linitis plastica (DOID:4023 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypopharynx cancer (DOID:8533 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oropharynx cancer (DOID:8557 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pharynx cancer (DOID:0060119 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nasopharynx carcinoma (DOID:9261 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carcinoma of supraglottis (DOID:7763 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "supraglottis cancer (DOID:13476 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "laryngeal carcinoma (DOID:2600 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "larynx cancer (DOID:2596 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "laryngeal squamous cell carcinoma (DOID:2876 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastrointestinal system benign neoplasm (DOID:0050624 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal benign neoplasm (DOID:4610 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colonic benign neoplasm (DOID:235 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rectal neoplasm (DOID:1984 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatoblastoma (DOID:687 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillary carcinoma (DOID:3113 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endocrine organ benign neoplasm (DOID:0060089 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "follicular adenoma (DOID:6204 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyroid adenoma (DOID:2891 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillary thyroid carcinoma (DOID:3969 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyroid cancer (DOID:1781 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyroid carcinoma (DOID:3963 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "follicular thyroid carcinoma (DOID:3962 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyroid medullary carcinoma (DOID:3973 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ganglioneuroblastoma (DOID:4163 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ganglioneuroma (DOID:4817 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuroendocrine tumor (DOID:169 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paraganglioma (DOID:0050773 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phaeochromocytoma (DOID:0050771 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemangioma (DOID:255 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemangioblastoma (DOID:5241 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "von hippel-lindau disease (DOID:14175 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intravenous leiomyomatosis (DOID:5729 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leiomyomatosis (DOID:5138 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leiomyoma (DOID:127 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "female reproductive organ benign neoplasm (DOID:0060086 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "reproductive organ benign neoplasm (DOID:0050622 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uterine benign neoplasm (DOID:0060095 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uterine fibroid (DOID:13223 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "musculoskeletal system benign neoplasm (DOID:0060099 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "muscle benign neoplasm (DOID:461 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myoma (DOID:2691 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "smooth muscle tumor (DOID:4310 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometriosis (DOID:289 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometriosis of ovary (DOID:11432 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast osteosarcoma (DOID:7787 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "idiopathic corneal edema (DOID:11033 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal chordoma (DOID:4153 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "secretory meningioma (DOID:4588 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucinous tubular and spindle renal cell carcinoma (DOID:4472 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chordoma (DOID:3302 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "notochordal cancer (DOID:3303 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skull base chordoma (DOID:4151 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung squamous cell carcinoma (DOID:3907 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenoid basal cell carcinoma (DOID:4294 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrial mucinous adenocarcinoma (DOID:3707 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast scirrhous carcinoma (DOID:7578 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed hepatoblastoma (DOID:5789 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvar syringoma (DOID:2064 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "granulomatous endometritis (DOID:4561 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bartholin's gland adenoma (DOID:5382 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bartholin's gland neoplasm (DOID:2068 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vestibular gland benign neoplasm (DOID:0060088 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvar glandular tumor (DOID:2076 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrium carcinoma in situ (DOID:5172 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervical adenosarcoma (DOID:4111 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervical carcinosarcoma (DOID:4112 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bartholin's gland carcinoma (DOID:3999 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "predominantly cortical thymoma (DOID:6917 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eccrine sweat gland neoplasm (DOID:173 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "deep angioma (DOID:469 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intramuscular hemangioma (DOID:468 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eccrine adenocarcinoma (DOID:4920 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast leiomyosarcoma (DOID:5285 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast myofibroblastoma (DOID:1629 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung leiomyosarcoma (DOID:5265 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polyp of corpus uteri (DOID:9042 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvar leiomyosarcoma (DOID:5286 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvar sarcoma (DOID:2096 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bizarre leiomyoma (DOID:5127 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast malignant phyllodes tumor (DOID:3016 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign breast phyllodes tumor (DOID:1631 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retroperitoneal cancer (DOID:5875 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retroperitoneal sarcoma (DOID:12341 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retroperitoneal leiomyosarcoma (DOID:5284 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "progesterone-receptor positive breast cancer (DOID:0060077 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "apocrine adenocarcinoma (DOID:4933 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "apocrine sweat gland cancer (DOID:4934 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast metaplastic carcinoma (DOID:4680 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast squamous cell carcinoma (DOID:5514 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oncocytic breast carcinoma (DOID:6585 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast adenoid cystic carcinoma (DOID:4877 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracystic papillary adenoma (DOID:2682 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast intraductal proliferative lesion (DOID:6839 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "triple-receptor negative breast cancer (DOID:0060081 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lipid-rich carcinoma (DOID:5658 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "female breast carcinoma (DOID:7843 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrial clear cell adenocarcinoma (DOID:5299 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "microglandular adenosis (DOID:5998 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "microglandular adenosis of breast (DOID:8335 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "comedo carcinoma (DOID:5670 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "her2-receptor positive breast cancer (DOID:0060079 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "toxic optic neuropathy (DOID:13329 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulva basal cell carcinoma (DOID:4301 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "apocrine adenosis of breast (DOID:5999 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast fibrocystic disease (DOID:10354 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "non-proliferative fibrocystic change of the breast (DOID:5997 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast papillary carcinoma (DOID:5592 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intraductal papilloma (DOID:1627 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cribriform carcinoma (DOID:5675 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast adenomyoepithelioma (DOID:1642 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast myoepithelial neoplasm (DOID:3004 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervical clear cell adenocarcinoma (DOID:5303 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uterine body mixed cancer (DOID:4114 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uterine carcinosarcoma (DOID:6171 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uterine corpus cancer (DOID:9460 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastroesophageal junction adenocarcinoma (DOID:4944 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast adenocarcinoma (DOID:3458 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mammary paget's disease (DOID:3443 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inflammatory breast carcinoma (DOID:6263 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast secretory carcinoma (DOID:4922 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycogen-rich clear cell breast carcinoma (DOID:5310 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nosophobia (DOID:0060048 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cancerophobia (DOID:602 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tuberculous salpingitis (DOID:0050166 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "synchronous bilateral breast carcinoma (DOID:6742 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenofibroma (DOID:2683 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystadenofibroma (DOID:5482 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clear cell adenofibroma (DOID:5477 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fallopian tube adenocarcinoma (DOID:3706 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fallopian tube endometrioid adenocarcinoma (DOID:5831 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fallopian tube cancer (DOID:1964 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fallopian tube carcinoma (DOID:1963 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillary adenocarcinoma (DOID:3112 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillary serous adenocarcinoma (DOID:2632 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endosalpingiosis (DOID:11427 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bilateral breast cancer (DOID:6741 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sporadic breast cancer (DOID:8029 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "female breast cancer (DOID:0050671 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "male breast cancer (DOID:1614 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "estrogen-receptor positive breast cancer (DOID:0060075 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "estrogen-receptor negative breast cancer (DOID:0060076 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "progesterone-receptor negative breast cancer (DOID:0060078 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast apocrine carcinoma (DOID:6581 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed lacrimal gland cancer (DOID:296 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate leiomyoma (DOID:2887 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nodular prostate (DOID:13206 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast duct papilloma (DOID:1626 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intraductal papillary breast neoplasm (DOID:1628 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intraductal breast neoplasm (DOID:3013 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate leiomyosarcoma (DOID:5282 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillary hidradenoma (DOID:5439 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "noma (DOID:9672 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ulcerative stomatitis (DOID:9673 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sarcomatoid basal cell carcinoma (DOID:4303 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant acrospiroma (DOID:5570 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant spiradenoma (DOID:7960 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone giant cell sarcoma (DOID:4719 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvar sebaceous carcinoma (DOID:5761 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder urothelial papillary carcinoma (DOID:6975 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung occult squamous cell carcinoma (DOID:6510 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "penis carcinoma in situ (DOID:8872 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epidermal appendage tumor (DOID:2433 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "larynx verrucous carcinoma (DOID:3752 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastrointestinal adenoma (DOID:4147 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucoepidermoid esophageal carcinoma (DOID:4686 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clear cell cystadenofibroma (DOID:5895 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian serous adenofibroma (DOID:5474 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian serous cystadenofibroma (DOID:7320 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prolactin producing pituitary tumor (DOID:5396 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung papillary adenocarcinoma (DOID:5588 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multifocal osteogenic sarcoma (DOID:3360 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "synchronous multifocal osteogenic sarcoma (DOID:6696 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "penis squamous cell carcinoma (DOID:5518 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "verrucous papilloma (DOID:3177 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder squamous cell carcinoma (DOID:3742 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral primitive neuroectodermal tumor (DOID:7398 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pleomorphic adenoma carcinoma (DOID:297 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cardia cancer (DOID:10548 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "maxillary sinus cancer (DOID:1357 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paranasal sinus cancer (DOID:0050619 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "maxillary sinus squamous cell carcinoma (DOID:7910 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrioid ovary carcinoma (DOID:5828 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acral lentiginous melanoma (DOID:6367 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin melanoma (DOID:8923 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nodular malignant melanoma (DOID:10047 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial melanoma (DOID:6846 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conjunctival cancer (DOID:5467 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant conjunctiva melanoma (DOID:1751 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant spindle cell melanoma (DOID:3162 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrial transitional cell carcinoma (DOID:4005 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retroperitoneum carcinoma (DOID:12342 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "early invasive cervical adenocarcinoma (DOID:8307 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvar seborrheic keratosis (DOID:6944 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvar squamous tumor (DOID:2072 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain stem astrocytic neoplasm (DOID:4860 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meningeal melanocytoma (DOID:5900 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "balanoposthitis (DOID:13031 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrial squamous cell carcinoma (DOID:5533 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulva squamous cell carcinoma (DOID:2101 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast papillomatosis (DOID:1634 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conjunctival intraepithelial neoplasm (DOID:5465 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder carcinoma in situ (DOID:9053 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anus neoplasm (DOID:4551 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "balanitis (DOID:13033 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "balanitis xerotica obliterans (DOID:13477 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign meningioma (DOID:4587 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sebaceous adenocarcinoma (DOID:4839 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endocervical carcinoma (DOID:7519 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rectosigmoid cancer (DOID:2781 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rectosigmoid junction cancer (DOID:2782 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sigmoid colon cancer (DOID:12192 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sebaceous carcinoma (DOID:4840 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sebaceous adenoma (DOID:2648 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sebaceous gland neoplasm (DOID:5759 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lynch syndrome (DOID:3883 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "muir-torre syndrome (DOID:0050465 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peutz-jeghers syndrome (DOID:3852 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary breast ovarian cancer (DOID:5683 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "li-fraumeni syndrome (DOID:3012 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dysplastic nevus syndrome (DOID:10041 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial adenomatous polyposis (DOID:0050424 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphohistiocytoid mesothelioma (DOID:7381 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epididymis adenocarcinoma (DOID:10368 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epididymis cancer (DOID:10366 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sarcomatoid mesothelioma (DOID:4488 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant pleural mesothelioma (DOID:7474 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pleural cancer (DOID:5158 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant mesothelioma (DOID:1790 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign mesothelioma (DOID:2645 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peritoneal mesothelioma (DOID:1788 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peritoneum cancer (DOID:1725 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular leukemia (DOID:12286 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebellar angioblastoma (DOID:6500 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fallopian tube squamous cell carcinoma (DOID:5540 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal wilms' tumor (DOID:5176 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peritoneal carcinoma (DOID:1791 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peritoneal serous adenocarcinoma (DOID:4901 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peritoneal serous papillary adenocarcinoma (DOID:6228 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sarcomatoid squamous cell skin carcinoma (DOID:5536 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sclerosing liposarcoma (DOID:5704 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "proliferative fasciitis (DOID:9599 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myxosarcoma (DOID:4136 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "xanthogranulomatous cholecystitis (DOID:9766 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fibrous histiocytoma (DOID:4415 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous fibrous histiocytoma (DOID:4418 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dermis tumor (DOID:2438 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "histiocytoma (DOID:4231 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant fibroxanthoma (DOID:1907 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fibrosarcoma (DOID:3355 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dermatofibrosarcoma protuberans (DOID:3507 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous leiomyosarcoma (DOID:5273 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin sarcoma (DOID:2687 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "granular cell tumor (DOID:2411 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital epulis (DOID:7280 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epulis (DOID:5337 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult xanthogranuloma (DOID:7875 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "reticulohistiocytic granuloma (DOID:4394 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multicentric reticulohistiocytosis (DOID:11824 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "juvenile xanthogranuloma (DOID:4424 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "verruciform xanthoma of skin (DOID:5769 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "balloon cell malignant melanoma (DOID:10044 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "melanomatosis (DOID:7206 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lactocele (DOID:10686 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "axillary lipoma (DOID:10205 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bacterial esophagitis (DOID:13921 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endocervicitis (DOID:5757 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant giant cell tumor of soft parts (DOID:5638 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast signet ring cell adenocarcinoma (DOID:3503 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast cyst (DOID:10350 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fox fordyce disease (DOID:1381 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inflammatory mfh (DOID:6192 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phacolytic glaucoma (DOID:12570 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "indeterminate leprosy (DOID:11851 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenoiditis (DOID:0050145 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cavernous sinus meningioma (DOID:4435 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphoplasmacyte-rich meningioma (DOID:4591 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "enterobiasis (DOID:7457 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "photokeratitis (DOID:13626 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hodgkin's lymphoma (DOID:8567 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hodgkin's lymphoma, nodular sclerosis (DOID:8838 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hodgkin's lymphoma, mixed cellularity (DOID:8654 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hodgkin's lymphoma, lymphocytic depletion (DOID:8628 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dandy-walker syndrome (DOID:2785 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hodgkin's lymphoma, lymphocytic-histiocytic predominance (DOID:8543 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dendritic cell sarcoma (DOID:7849 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "histiocytic and dendritic cell cancer (DOID:5621 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "follicular dendritic cell sarcoma (DOID:6262 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "langerhans cell sarcoma (DOID:7146 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "interdigitating dendritic cell sarcoma (DOID:7848 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "erdheim-chester disease (DOID:4329 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "histiocytosis (DOID:3405 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "langerhans-cell histiocytosis (DOID:2571 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "non-langerhans-cell histiocytosis (DOID:4330 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "niemann-pick disease (DOID:14504 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liver sarcoma (DOID:270 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sarcomatoid transitional cell carcinoma (DOID:4014 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric signet ring cell adenocarcinoma (DOID:8025 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian stromal hyperthecosis (DOID:7347 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chondroid chordoma (DOID:4152 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parotid gland cancer (DOID:9036 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acoustic neuroma (DOID:12689 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nervous system benign neoplasm (DOID:0060115 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurilemmoma (DOID:3192 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuroma (DOID:2001 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant peripheral nerve sheath tumor (DOID:5940 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurofibroma (DOID:962 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peripheral nerve sheath neoplasm (DOID:3193 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plexiform neurofibroma (DOID:5151 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurofibrosarcoma (DOID:3512 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurofibromatosis (DOID:8712 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemangiopericytoma (DOID:264 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spindle cell sarcoma (DOID:4235 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spindle cell carcinoma (DOID:4015 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epithelioid sarcoma (DOID:6193 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mesenchymal cell neoplasm (DOID:3350 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carcinosarcoma (DOID:4236 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed cell type cancer (DOID:154 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenosarcoma (DOID:1974 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leiomyosarcoma (DOID:1967 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "smooth muscle cancer (DOID:4230 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angiosarcoma (DOID:0001816 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sarcoma (DOID:1115 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastrointestinal stromal tumor (DOID:9253 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "biphasic synovial sarcoma (DOID:5492 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "synovial sarcoma (DOID:5485 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "synovium cancer (DOID:2706 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "monophasic synovial sarcoma (DOID:5495 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "embryonal rhabdomyosarcoma (DOID:3246 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "muscle cancer (DOID:4045 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rhabdomyosarcoma (DOID:3247 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skeletal muscle cancer (DOID:4043 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alveolar rhabdomyosarcoma (DOID:4051 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alveolar soft part sarcoma (DOID:4239 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chondrosarcoma (DOID:3371 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extraosseous chondrosarcoma (DOID:4549 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myxoid chondrosarcoma (DOID:5861 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extraskeletal myxoid chondrosarcoma (DOID:6496 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extraskeletal mesenchymal chondrosarcoma (DOID:4548 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mesenchymal chondrosarcoma (DOID:4545 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epithelial predominant wilms' tumor (DOID:5189 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephrogenic adenofibroma (DOID:2698 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal adenoma (DOID:2697 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "metanephric adenoma (DOID:6404 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystic nephroma (DOID:2673 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chromophobe adenocarcinoma (DOID:4471 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillary renal cell carcinoma (DOID:4465 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "collecting duct carcinoma (DOID:4464 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oxyphilic adenoma (DOID:5389 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal oncocytoma (DOID:6245 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney benign neoplasm (DOID:3116 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urinary system benign neoplasm (DOID:731 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cardiovascular cancer (DOID:176 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vascular cancer (DOID:175 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "perivascular tumor (DOID:3316 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "perivascular epithelioid cell tumor (DOID:2643 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angiomyolipoma (DOID:3314 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney angiomyolipoma (DOID:8411 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphangioleiomyomatosis (DOID:3319 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatobiliary benign neoplasm (DOID:3117 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liver neoplasm (DOID:916 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatic angiomyolipoma (DOID:3317 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system mesenchymal non-meningothelial tumor (DOID:502 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ectomesenchymoma (DOID:4055 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extraosseous ewing's sarcoma (DOID:4232 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skeletal muscle neoplasm (DOID:4044 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast rhabdomyosarcoma (DOID:4060 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orbit embryonal rhabdomyosarcoma (DOID:3258 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orbit rhabdomyosarcoma (DOID:3259 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orbit sarcoma (DOID:9987 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "granular cell leiomyosarcoma (DOID:5258 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant triton tumor (DOID:6707 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant mesenchymoma (DOID:5758 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mesenchymoma (DOID:2668 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult fibrosarcoma (DOID:3516 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spindle cell rhabdomyosarcoma (DOID:3260 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "botryoid rhabdomyosarcoma (DOID:3255 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "medullomyoblastoma (DOID:3861 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pleomorphic rhabdomyosarcoma (DOID:3250 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary blastoma (DOID:4765 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pleuropulmonary blastoma (DOID:4769 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital fibrosarcoma (DOID:8418 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pediatric fibrosarcoma (DOID:3520 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cellular congenital mesoblastic nephroma (DOID:8082 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital mesoblastic nephroma (DOID:4773 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mesoblastic nephroma (DOID:4772 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "childhood kidney neoplasm (DOID:3675 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rhabdoid cancer (DOID:3672 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "juvenile astrocytoma (DOID:3079 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney clear cell sarcoma (DOID:4880 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney sarcoma (DOID:4242 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast angiosarcoma (DOID:4511 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovary sarcoma (DOID:2146 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conventional angiosarcoma (DOID:4512 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian angiosarcoma (DOID:4527 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spleen angiosarcoma (DOID:265 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyroid angiosarcoma (DOID:4514 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign peritoneal mesothelioma (DOID:1789 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peritoneal benign neoplasm (DOID:0060117 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyroid sarcoma (DOID:4515 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eccrine mixed tumor of skin (DOID:2079 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed liposarcoma (DOID:5703 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spleen cancer (DOID:672 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glomeruloid hemangioma (DOID:486 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurogenic arthropathy (DOID:14286 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "venous hemangioma (DOID:467 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain sarcoma (DOID:2132 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary artery leiomyosarcoma (DOID:7389 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphangiosarcoma (DOID:2689 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hobnail hemangioma (DOID:505 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angiomyoma (DOID:4265 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "capillary lymphangioma (DOID:2286 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angiokeratoma of fordyce (DOID:664 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myxoid leiomyosarcoma (DOID:5268 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intravascular fasciitis (DOID:9603 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alveoli adenoma (DOID:8003 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "splenic artery aneurysm (DOID:14006 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "senile angioma (DOID:2495 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "histiocytoid hemangioma (DOID:474 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myofibroma (DOID:4386 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angiolipoma (DOID:3616 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pericardium cancer (DOID:116 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pericardial mesothelioma (DOID:6201 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "heart cancer (DOID:117 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemangioma of lung (DOID:490 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary sclerosing hemangioma (DOID:5766 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sclerosing hemangioma (DOID:495 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angiomatous meningioma (DOID:6548 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal microaneurysm (DOID:11295 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meninges sarcoma (DOID:7614 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meninges hemangiopericytoma (DOID:4957 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphangitis (DOID:9317 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angiokeratoma (DOID:479 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "capillary hemangioma (DOID:2725 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin hemangioma (DOID:471 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal cord oligodendroglioma (DOID:3184 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemangioma of orbit (DOID:14459 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dieulafoy lesion (DOID:12070 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ludwig's angina (DOID:4558 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "substernal goiter (DOID:13200 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "asthenopia (DOID:10141 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal hemangioblastoma (DOID:5240 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peroneal nerve paralysis (DOID:6925 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystic lymphangioma (DOID:3081 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphangioma (DOID:1475 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kimura disease (DOID:7365 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "status asthmaticus (DOID:9362 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung adenoma (DOID:5386 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung benign neoplasm (DOID:3683 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "respiratory system benign neoplasm (DOID:0050621 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast sarcoma (DOID:3017 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast fibrosarcoma (DOID:6001 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult mesoblastic nephroma (DOID:2678 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypercalcemic type ovarian small cell carcinoma (DOID:7651 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central epithelioid sarcoma (DOID:7492 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvar proximal-type epithelioid sarcoma (DOID:7491 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "t-cell adult acute lymphocytic leukemia (DOID:5602 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric liposarcoma (DOID:5700 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign fibrous mesothelioma (DOID:2653 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glomangiomyoma (DOID:8020 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mechanical ectropion (DOID:1569 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extracutaneous mastocytoma (DOID:4659 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ischemic fasciitis (DOID:9601 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular fibroma (DOID:7675 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retina lymphoma (DOID:774 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epithelioid neurofibroma (DOID:5149 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pacinian tumor (DOID:2669 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant pineal area germ cell neoplasm (DOID:1660 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pineal region choriocarcinoma (DOID:5553 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eyelid neoplasm (DOID:2173 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cellular neurofibroma (DOID:5152 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate stromal sarcoma (DOID:7152 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trigonitis (DOID:13507 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvar dystrophy (DOID:14292 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bartholin's gland adenocarcinoma (DOID:6316 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung meningioma (DOID:5764 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diffuse cutaneous mastocytosis (DOID:3665 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostatic acinar adenocarcinoma (DOID:3024 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "small intestinal sarcoma (DOID:5272 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "small intestine leiomyosarcoma (DOID:5271 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "frontal sinus cancer (DOID:1360 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "frontal sinus squamous cell carcinoma (DOID:2441 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liver leiomyoma (DOID:917 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung sarcoma (DOID:2784 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "birt-hogg-dube syndrome (DOID:0050676 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney hemangiopericytoma (DOID:262 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute apical periodontitis (DOID:11693 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral artery occlusion (DOID:10127 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fibrosarcoma of bone (DOID:3354 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant fibrous histiocytoma of bone (DOID:3352 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conventional fibrosarcoma (DOID:3517 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "heart sarcoma (DOID:5262 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inflammatory liposarcoma (DOID:8233 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nodular ganglioneuroblastoma (DOID:5193 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atypical lipomatous tumor (DOID:5690 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lipomatous cancer (DOID:3939 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liposarcoma (DOID:3382 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myxoid liposarcoma (DOID:5363 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cellular myxoid liposarcoma (DOID:5692 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pleomorphic liposarcoma (DOID:5702 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spindle cell liposarcoma (DOID:5705 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pleomorphic lipoma (DOID:10192 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "infiltrating lipoma (DOID:7014 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lipoma (DOID:3315 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spindle cell lipoma (DOID:10184 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed-type liposarcoma (DOID:5709 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chondroid lipoma (DOID:10208 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fasciitis (DOID:9598 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "necrotizing fasciitis (DOID:9602 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudosarcomatous fibromatosis (DOID:7327 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uterine inversion (DOID:997 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conventional leiomyosarcoma (DOID:5253 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inflammatory leiomyosarcoma (DOID:5251 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung combined type small cell carcinoma (DOID:5421 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed endometrial stromal and smooth muscle tumor (DOID:8302 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney leiomyosarcoma (DOID:5287 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvar leiomyoma (DOID:5142 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvar benign neoplasm (DOID:0060109 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "morgagni cataract (DOID:13964 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervical mucinous adenocarcinoma (DOID:3701 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervical adenoma malignum (DOID:6627 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cellular leiomyoma (DOID:5139 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrial stromal nodule (DOID:1373 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "optic nerve glioma (DOID:4992 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "optic nerve neoplasm (DOID:3419 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pilomyxoid astrocytoma (DOID:4845 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vagus nerve neoplasm (DOID:12984 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "obsessive-compulsive disorder (DOID:10933 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurofibroma of the esophagus (DOID:961 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult malignant schwannoma (DOID:8369 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulsating exophthalmos (DOID:12364 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subclavian artery aneurysm (DOID:342 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tolosa-hunt syndrome (DOID:1278 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "frey syndrome (DOID:11599 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant glandular tumor of peripheral nerve sheath (DOID:8420 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic polyneuropathy (DOID:5221 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurilemmomatosis (DOID:3204 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal canal and spinal cord meningioma (DOID:1140 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal meningioma (DOID:1138 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choroid cancer (DOID:12759 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain stem glioma (DOID:4202 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain stem cancer (DOID:4203 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal cord ependymoma (DOID:5503 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal cord glioma (DOID:3185 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal cancer (DOID:5612 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal cord astrocytoma (DOID:4863 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "melanotic neurilemmoma (DOID:3205 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plexiform schwannoma (DOID:3206 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cellular schwannoma (DOID:3196 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atypical neurofibroma (DOID:5153 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fibrous meningioma (DOID:7211 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypoglossal nerve neoplasm (DOID:3198 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "schwannoma of twelfth cranial nerve (DOID:3197 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intraventricular meningioma (DOID:3772 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial meningioma (DOID:4586 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "foramen magnum meningioma (DOID:4708 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "small cell sarcoma (DOID:3098 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral convexity meningioma (DOID:6114 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parasagittal meningioma (DOID:6869 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral meningioma (DOID:6112 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meningothelial meningioma (DOID:7212 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arc syndrome (DOID:0050763 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vestibular nystagmus (DOID:14070 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "jaw cancer (DOID:1862 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mandibular cancer (DOID:2338 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sarcomatosis of the meninges (DOID:7613 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain meningioma (DOID:0060106 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system teratoma (DOID:3640 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "protoplasmic astrocytoma (DOID:7008 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ataxic cerebral palsy (DOID:0050670 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "melanotic medulloblastoma (DOID:3868 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "frontal convexity meningioma (DOID:8000 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gliofibroma (DOID:4856 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "supratentorial primitive neuroectodermal tumor (DOID:4791 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracranial primitive neuroectodermal tumor (DOID:4788 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder sarcoma (DOID:11812 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cranial nerve neoplasm (DOID:338 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cranial nerve malignant neoplasm (DOID:2815 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "olfactory nerve neoplasm (DOID:366 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "olfactory neuroblastoma (DOID:369 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extracranial neuroblastoma (DOID:371 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gangliocytoma (DOID:2426 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebrum cancer (DOID:368 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "supratentorial cancer (DOID:1659 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral ventricle cancer (DOID:3541 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choroid plexus cancer (DOID:3540 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choroid plexus carcinoma (DOID:5648 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central neurocytoma (DOID:14174 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system primitive neuroectodermal neoplasm (DOID:0060103 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ependymoblastoma (DOID:4794 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "medulloepithelioma (DOID:4790 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult medulloblastoma (DOID:3864 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric squamous cell carcinoma (DOID:5516 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nodular medulloblastoma (DOID:3873 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebellum cancer (DOID:4205 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebellar medulloblastoma (DOID:0060104 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dysembryoplastic neuroepithelial tumor (DOID:2679 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fibrillary astrocytoma (DOID:6726 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ganglioglioma (DOID:5078 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant giant cell tumor (DOID:2705 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "giant cell glioblastoma (DOID:3074 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pleomorphic xanthoastrocytoma (DOID:4852 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gliomatosis cerebri (DOID:6128 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "astroblastoma (DOID:7305 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "childhood oligodendroglioma (DOID:3183 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clear cell ependymoma (DOID:5507 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tanycytic ependymoma (DOID:5504 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed glioma (DOID:5076 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gemistocytic astrocytoma (DOID:7005 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "childhood pilocytic astrocytoma (DOID:6812 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "juvenile pilocytic astrocytoma (DOID:6811 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pilocytic astrocytoma (DOID:4851 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oligodendroglioma (DOID:3181 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign ependymoma (DOID:4844 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign glioma (DOID:0060101 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subependymal giant cell astrocytoma (DOID:5077 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subependymal glioma (DOID:4843 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tuberous sclerosis (DOID:13515 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multiple mucosal neuroma (DOID:5155 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extrahepatic bile duct adenocarcinoma (DOID:3495 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous ganglioneuroma (DOID:2425 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed testicular germ cell tumor (DOID:4743 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pediatric ovarian dysgerminoma (DOID:7340 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pediatric ovarian germ cell tumor (DOID:6084 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant sertoli cell tumor (DOID:0050617 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carotid body cancer (DOID:8731 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "large cell carcinoma with rhabdoid phenotype (DOID:7480 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital granular cell tumor (DOID:8303 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mongolian spot (DOID:4702 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrial small cell carcinoma (DOID:7139 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric small cell carcinoma (DOID:6552 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "villonodular synovitis (DOID:9898 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral neuroblastoma (DOID:4164 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system melanocytic neoplasm (DOID:4955 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meningeal melanomatosis (DOID:8243 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trilateral retinoblastoma (DOID:4647 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pineal parenchymal tumor of intermediate differentiation (DOID:5030 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenal neuroblastoma (DOID:5718 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "askin's tumor (DOID:0050608 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epithelioid leiomyosarcoma (DOID:5264 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney rhabdoid cancer (DOID:3674 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epithelioid malignant peripheral nerve sheath tumor (DOID:8353 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clear cell sarcoma (DOID:4233 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chordoid meningioma (DOID:8368 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clear cell meningioma (DOID:4210 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parachordoma (DOID:2647 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rhabdoid meningioma (DOID:5058 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "melanotic neuroectodermal tumor (DOID:166 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ossifying fibromyxoid tumor (DOID:2685 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liver leiomyosarcoma (DOID:5296 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "female urethral cancer (DOID:738 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cauda equina neoplasm (DOID:4847 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urinary bladder small cell neuroendocrine carcinoma (DOID:7132 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acinar cell cystadenocarcinoma (DOID:7729 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ureter small cell carcinoma (DOID:6886 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast neuroendocrine neoplasm (DOID:3009 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cellular ependymoma (DOID:5500 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebellar liponeurocytoma (DOID:6458 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillary ependymoma (DOID:5505 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atypical follicular adenoma (DOID:8292 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute thyroiditis (DOID:14353 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic cystadenocarcinoma (DOID:4073 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary neuroendocrine tumor (DOID:5410 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diffuse pulmonary fibrosis (DOID:5641 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chordoid glioma (DOID:3774 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pineal gland cancer (DOID:5032 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pineoblastoma (DOID:1664 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "middle ear adenoma (DOID:5387 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sensory organ benign neoplasm (DOID:0060096 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "auditory system cancer (DOID:833 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "middle ear cancer (DOID:5099 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic somatostatinoma (DOID:4432 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "duodenal somatostatinoma (DOID:7479 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastrinoma (DOID:5577 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vipoma (DOID:5574 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "somatostatinoma (DOID:4430 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic cholera (DOID:6977 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic gastrinoma (DOID:5580 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "duodenal gastrinoma (DOID:7959 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic endocrine carcinoma (DOID:1798 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "non-functioning pancreatic endocrine tumor (DOID:7698 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric leiomyoma (DOID:10087 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary optic atrophy (DOID:10627 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "erythematosquamous dermatosis (DOID:9097 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "abnormality of glucagon secretion (DOID:14427 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed ductal-endocrine carcinoma (DOID:7716 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ampulla of vater neoplasm (DOID:10022 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "duodenal benign neoplasm (DOID:1737 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "small intestine neoplasm (DOID:7505 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "jejunal neoplasm (DOID:3218 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ileal neoplasm (DOID:10156 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric body carcinoma (DOID:6705 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastrin secretion abnormality (DOID:13656 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "haemonchiasis (DOID:3332 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric gastrinoma (DOID:5579 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pylorospasm (DOID:12072 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary hypertrophic osteoarthropathy (DOID:14283 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucinous ovarian cystadenoma (DOID:3267 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian cystadenoma (DOID:3269 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "encapsulated thymoma (DOID:3278 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "jejunal somatostatinoma (DOID:3216 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastrointestinal neuroendocrine benign tumor (DOID:4148 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "shoulder impingement syndrome (DOID:14276 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric leiomyosarcoma (DOID:5280 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic tic disorder (DOID:10600 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial medullary thyroid carcinoma (DOID:0050547 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sipple syndrome (DOID:0050430 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ureteral benign neoplasm (DOID:11885 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ureter leiomyoma (DOID:11887 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eccrine papillary adenocarcinoma (DOID:5591 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subglottis neoplasm (DOID:10069 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "penile neoplasm (DOID:11624 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "supraglottis neoplasm (DOID:8002 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "laryngeal benign neoplasm (DOID:2598 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "penile cancer (DOID:11615 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "penis carcinoma (DOID:3449 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast mucinous carcinoma (DOID:3610 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemangioma of spleen (DOID:256 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "early onset absence epilepsy (DOID:0050708 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign perivascular tumor (DOID:5238 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cardiovascular organ benign neoplasm (DOID:0060091 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glomangioma (DOID:2436 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial glomangioma (DOID:7996 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tonsil cancer (DOID:8858 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ureter inverted papilloma (DOID:6935 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ureter urothelial papilloma (DOID:6936 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inverted follicular keratosis (DOID:6945 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "focal epithelial hyperplasia (DOID:5362 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervix uteri carcinoma in situ (DOID:8991 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervicitis (DOID:2568 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervix disease (DOID:2253 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic cervicitis (DOID:1513 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital aphakia (DOID:11367 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervix endometriosis (DOID:361 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometriosis of uterus (DOID:288 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spermatocele (DOID:11997 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "superficial basal cell carcinoma (DOID:4300 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scrotal carcinoma (DOID:3445 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scrotum neoplasm (DOID:518 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scrotum squamous cell carcinoma (DOID:13159 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal canal intradural extramedullary neoplasm (DOID:5615 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "squamous blepharitis (DOID:13825 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hairy tongue (DOID:13500 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain ependymoma (DOID:7497 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "esophageal basaloid squamous cell carcinoma (DOID:7051 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "esophagus squamous cell carcinoma (DOID:3748 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "granular cell carcinoma (DOID:4903 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cholangiolocellular carcinoma (DOID:7642 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric adenosquamous carcinoma (DOID:5635 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nonpapillary renal cell carcinoma (DOID:0050387 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary conventional renal cell carcinoma (DOID:7192 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scleromalacia perforans (DOID:14230 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cicatricial ectropion (DOID:12782 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillon-lefevre disease (DOID:3389 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anonychia congenita (DOID:0050643 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nail disease (DOID:4123 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervical adenosquamous carcinoma (DOID:5636 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lacrimal gland mucoepidermoid carcinoma (DOID:4685 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous mucoepidermoid carcinoma (DOID:4683 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thymus mucoepidermoid carcinoma (DOID:4678 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "schneiderian carcinoma (DOID:4003 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lipoadenoma (DOID:5398 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "necrotizing sialometaplasia (DOID:12901 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant granular cell myoblastoma (DOID:5042 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spindle cell synovial sarcoma (DOID:5487 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central pontine myelinolysis (DOID:636 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant ovarian cyst (DOID:2145 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tall cell variant papillary carcinoma (DOID:7089 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial renal oncocytoma (DOID:6244 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial renal papillary carcinoma (DOID:6163 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary renal cell carcinoma (DOID:4455 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retroperitoneal hemangiopericytoma (DOID:5373 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uterine corpus sarcoma (DOID:5165 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "baastrup's syndrome (DOID:6643 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cardiovascular syphilis (DOID:9880 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chest wall lipoma (DOID:10200 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "small intestine leiomyoma (DOID:1738 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate neuroendocrine neoplasm (DOID:2992 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parapharyngeal meningioma (DOID:8216 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epicardium cancer (DOID:4699 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rectum squamous cell carcinoma (DOID:5528 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gallbladder small cell carcinoma (DOID:7133 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gallbladder squamous cell carcinoma (DOID:5535 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "n syndrome (DOID:0050769 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colon lymphoma (DOID:1523 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extratemporal epilepsy (DOID:2544 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orbital cancer (DOID:4143 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orbit lymphoma (DOID:9986 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "visual agnosia (DOID:0060155 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pediatric lymphoma (DOID:5823 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary aspergilloma (DOID:0050153 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "non-gestational choriocarcinoma (DOID:4320 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sparganosis (DOID:10080 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dermatomycosis (DOID:1563 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eumycotic mycetoma (DOID:13078 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sternum cancer (DOID:5090 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myoclonic cerebellar dyssynergia (DOID:12707 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cavernous hemangioma (DOID:483 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vascular hemostatic disease (DOID:484 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intussusception (DOID:8446 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pediatric angiosarcoma (DOID:4505 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "middle lobe syndrome (DOID:2810 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucinous stomach adenocarcinoma (DOID:3716 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alveolar periostitis (DOID:13585 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "periostitis (DOID:9957 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute cor pulmonale (DOID:8517 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute pulmonary heart disease (DOID:8514 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney cortex necrosis (DOID:2973 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chest wall lymphoma (DOID:6758 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary alveolar microlithiasis (DOID:12117 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary immaturity (DOID:424 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neonatal respiratory failure (DOID:11161 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary alveolar proteinosis (DOID:12120 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "occult macular dystrophy (DOID:0050578 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pyromania (DOID:12402 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meckel's diverticulum (DOID:9487 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult pleomorphic rhabdomyosarcoma (DOID:8251 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate embryonal rhabdomyosarcoma (DOID:3251 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate rhabdomyosarcoma (DOID:3252 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate sarcoma (DOID:4054 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atrophy of prostate (DOID:2301 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urethral syndrome (DOID:13498 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clear cell adenocarcinoma (DOID:4468 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urethra cancer (DOID:734 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urethra adenocarcinoma (DOID:4910 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urethra clear cell adenocarcinoma (DOID:5307 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian mucinous adenocarcinoma (DOID:3606 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder adenocarcinoma (DOID:3711 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephrogenic adenoma (DOID:7334 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urethral diverticulum (DOID:9341 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic cystitis (DOID:1680 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glandular cystitis (DOID:2392 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenosquamous prostate carcinoma (DOID:5634 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate signet ring cell adenocarcinoma (DOID:3504 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate transitional cell carcinoma (DOID:4011 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate adenoid cystic carcinoma (DOID:4868 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant choroid melanoma (DOID:6438 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "male urethral cancer (DOID:736 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostatic urethral cancer (DOID:6167 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epiglottis cancer (DOID:8133 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephrogenic adenoma of the urethra (DOID:8109 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urethral benign neoplasm (DOID:730 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostatic cyst (DOID:11133 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "balantidiasis (DOID:12386 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "apocrine adenoma (DOID:3895 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic salpingo-oophoritis (DOID:12265 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "salpingo-oophoritis (DOID:10972 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate squamous cell carcinoma (DOID:10287 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "seminal vesicle adenocarcinoma (DOID:14545 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystitis cystica (DOID:7138 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anthracosilicosis (DOID:10324 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate lymphoma (DOID:10290 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gallbladder lymphoma (DOID:8135 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "male reproductive organ benign neoplasm (DOID:0060087 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostatic adenoma (DOID:2883 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "seminal vesicle tumor (DOID:3855 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary systemic sclerosis (DOID:1578 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute salpingo-oophoritis (DOID:10971 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oophoritis (DOID:10974 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acromesomelic dysplasia (DOID:0080049 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acromesomelic dysplasia, maroteaux type (DOID:0080050 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paraphimosis (DOID:5334 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phimosis (DOID:2712 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult spinal muscular atrophy (DOID:0050529 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amyotrophic lateral sclerosis type 8 (DOID:0050752 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "asphyxia neonatorum (DOID:11088 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute vascular insufficiency of intestine (DOID:8590 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aleutian mink disease (DOID:2934 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "louse-borne relapsing fever (DOID:13035 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "relapsing fever (DOID:13034 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tick-borne relapsing fever (DOID:13036 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "optic nerve sheath meningioma (DOID:5632 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pineal region meningioma (DOID:8031 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreas lymphoma (DOID:1792 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uveoparotid fever (DOID:13404 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "loeffler syndrome (DOID:9503 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pneumoconiosis due to talc (DOID:10329 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral sarcoidosis (DOID:13403 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute anterolateral myocardial infarction (DOID:10651 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal artery obstruction (DOID:2972 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chondromalacia patellae (DOID:13357 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fiedler's myocarditis (DOID:10778 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "granulomatous angiitis (DOID:2555 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "focal chorioretinitis (DOID:1979 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuroretinitis (DOID:10176 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "optic papillitis (DOID:10175 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "optic neuritis (DOID:1210 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choroiditis (DOID:11406 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cardiac sarcoidosis (DOID:13405 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cheilitis (DOID:1762 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lip disease (DOID:9297 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "melkersson-rosenthal syndrome (DOID:1761 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "posterior cranial fossa meningioma (DOID:4211 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebellopontine angle meningioma (DOID:6337 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebellopontine angle tumor (DOID:3200 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glossopharyngeal nerve disease (DOID:3418 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glossopharyngeal neuralgia (DOID:14423 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multiple cranial nerve palsy (DOID:13866 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ehrlich tumor carcinoma (DOID:5050 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anti-basement membrane glomerulonephritis (DOID:4780 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tinea profunda (DOID:13368 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dipetalonemiasis (DOID:14422 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "echinostomiasis (DOID:1218 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colorado tick fever (DOID:4885 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plasmodium malariae malaria (DOID:14324 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vesiculitis (DOID:9365 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anal canal squamous cell carcinoma (DOID:7177 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign essential hypertension (DOID:10913 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orthostatic proteinuria (DOID:9617 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "japanese encephalitis (DOID:10844 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "generalized atherosclerosis (DOID:2347 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphocele (DOID:4347 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fuchs' heterochromic uveitis (DOID:9375 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypertensive encephalopathy (DOID:9427 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypertensive retinopathy (DOID:11561 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracranial hypotension (DOID:4723 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arachnoiditis (DOID:12156 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "denture stomatitis (DOID:11875 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute diffuse nephritis (DOID:14066 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diffuse glomerulonephritis (DOID:4781 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ureterocele (DOID:4022 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "astereognosia (DOID:0060150 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "yellow nail syndrome (DOID:0050468 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "third cranial nerve disease (DOID:562 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oculomotor nerve paralysis (DOID:11550 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancoast tumor (DOID:8007 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liver rhabdomyosarcoma (DOID:4047 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucinous cystadenofibroma (DOID:6468 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian gonadoblastoma (DOID:3578 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal pelvis adenocarcinoma (DOID:4918 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pineal region teratoma (DOID:6856 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vaginal yolk sac tumor (DOID:1910 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric teratoma (DOID:5561 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult teratoma (DOID:5565 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "childhood endodermal sinus tumor (DOID:5342 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "corpus luteum cyst (DOID:13050 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian cyst (DOID:5119 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tuberculous epididymitis (DOID:1251 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neonatal myasthenia gravis (DOID:14043 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular infarct (DOID:5104 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ataxia with oculomotor apraxia type 1 (DOID:0050754 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ataxia with oculomotor apraxia type 2 (DOID:0050755 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choriocarcinoma of the testis (DOID:5551 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular germ cell tumor non-seminomatous (DOID:4086 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular trophoblastic tumor (DOID:4084 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular pure germ cell tumor (DOID:4087 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "embryonal testis carcinoma (DOID:5680 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intratubular embryonal carcinoma (DOID:8275 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular cancer (DOID:2998 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular germ cell cancer (DOID:5557 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular malignant germ cell cancer (DOID:5556 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular non-seminomatous germ cell cancer (DOID:5345 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular yolk sac tumor (DOID:5344 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vaginal cancer (DOID:119 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oligohydramnios (DOID:12215 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "potter's syndrome (DOID:12594 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "wagenmann-froboese syndrome (DOID:10016 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choriocarcinoma (DOID:3594 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "placenta cancer (DOID:2021 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gestational choriocarcinoma (DOID:2025 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "placental choriocarcinoma (DOID:2024 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "placental site trophoblastic tumor (DOID:3596 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epithelioid trophoblastic tumor (DOID:3593 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trophoblastic neoplasm (DOID:4085 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gestational trophoblastic neoplasm (DOID:3590 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed germ cell cancer (DOID:3306 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "teratocarcinoma (DOID:3305 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "embryonal cancer (DOID:688 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "embryonal carcinoma (DOID:3308 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "germ cell and embryonal cancer (DOID:3095 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "germ cell cancer (DOID:2994 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "teratoma (DOID:3307 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "seminoma (DOID:4440 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "germinoma (DOID:3304 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spermatocytoma (DOID:5834 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant ovarian germ cell neoplasm (DOID:2155 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian primitive germ cell tumor (DOID:5351 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dysgerminoma of ovary (DOID:5511 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dysgerminoma (DOID:4441 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian endodermal sinus tumor (DOID:5350 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "granulosa cell tumor (DOID:2999 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sex cord-gonadal stromal tumor (DOID:192 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular granulosa cell tumor (DOID:5331 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "juvenile type testicular granulosa cell tumor (DOID:6032 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leydig cell tumor (DOID:2696 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sex cord-stromal neoplasm (DOID:4757 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sertoli-leydig cell tumor (DOID:2997 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sertoli cell tumor (DOID:3577 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "luteoma (DOID:7880 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular leydig cell tumor (DOID:4756 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parovarian cyst (DOID:4333 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gonadoblastoma (DOID:3301 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "androgen insensitivity syndrome (DOID:4674 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hermaphroditism (DOID:3763 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed gonadal dysgenesis (DOID:14449 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gonadal dysgenesis (DOID:14447 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "turner syndrome (DOID:3491 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anovulation (DOID:3781 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polycystic ovary syndrome (DOID:11612 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gonadal disease (DOID:2277 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sex differentiation disease (DOID:1923 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperandrogenism (DOID:11613 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gynecomastia (DOID:12698 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypertrophy of breast (DOID:10688 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "estrogen excess (DOID:14336 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian dysfunction (DOID:1414 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "premature menopause (DOID:10787 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian disease (DOID:1100 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "premature ovarian failure (DOID:5426 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amenorrhea (DOID:13938 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cryptorchidism (DOID:11383 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypospadias (DOID:10892 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostatitis (DOID:14654 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate disease (DOID:47 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostatic hypertrophy (DOID:11132 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "male reproductive system disease (DOID:48 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "male infertility (DOID:12336 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "azoospermia (DOID:14227 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sertoli cell-only syndrome (DOID:0050457 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "infertility (DOID:5223 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oligospermia (DOID:14228 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spermatic cord torsion (DOID:11996 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular disease (DOID:2519 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orchitis (DOID:2518 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choriocarcinoma of ovary (DOID:5550 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "non-gestational ovarian choriocarcinoma (DOID:7665 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fibrosclerosis of breast (DOID:10353 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "freemartinism (DOID:4671 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mobius syndrome (DOID:13501 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blepharophimosis, ptosis, and epicanthus inversus syndrome (DOID:14778 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blepharophimosis (DOID:10348 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rett syndrome (DOID:1206 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angelman syndrome (DOID:1932 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prader-willi syndrome (DOID:11983 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chromosomal disease (DOID:0080014 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "down syndrome (DOID:14250 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "edwards syndrome (DOID:1085 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "patau syndrome (DOID:11665 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "goodpasture syndrome (DOID:9808 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lipoid nephrosis (DOID:10966 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudohermaphroditism (DOID:3765 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "denys-drash syndrome (DOID:3764 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "frasier syndrome (DOID:0050438 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "wagr syndrome (DOID:14515 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial nephrotic syndrome (DOID:2590 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alport syndrome (DOID:10983 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nail-patella syndrome (DOID:9467 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adamantinous craniopharyngioma (DOID:3846 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system organ benign neoplasm (DOID:0060090 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "craniopharyngioma (DOID:3840 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sella turcica neoplasm (DOID:3643 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skull base neoplasm (DOID:3842 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skull cancer (DOID:1863 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypothalamic disease (DOID:1931 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pituitary-dependent cushing's disease (DOID:3946 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chromophobe adenoma (DOID:3828 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "empty sella syndrome (DOID:3642 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sheehan syndrome (DOID:9476 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "necrosis of pituitary (DOID:3646 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pituitary infarct (DOID:1130 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pituitary apoplexy (DOID:1129 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "premenstrual tension (DOID:727 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pituitary carcinoma (DOID:4916 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hormone producing pituitary cancer (DOID:5716 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pituitary cancer (DOID:1785 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nelson syndrome (DOID:4968 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acth-secreting pituitary adenoma (DOID:7004 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "functioning pituitary adenoma (DOID:5395 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prolactinoma (DOID:5394 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pituitary adenoma (DOID:3829 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acromegaly (DOID:2449 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperpituitarism (DOID:2444 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pituitary gland disease (DOID:53 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperprolactinemia (DOID:12700 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypopituitarism (DOID:9406 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "panhypopituitarism (DOID:9410 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "laron syndrome (DOID:9521 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pituitary hypoplasia (DOID:7378 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "growth hormone secreting pituitary adenoma (DOID:6255 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenal carcinoma (DOID:3950 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenal cortex cancer (DOID:660 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenocortical carcinoma (DOID:3948 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenal gland cancer (DOID:3953 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenal adenoma (DOID:656 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conn's syndrome (DOID:12028 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperaldosteronism (DOID:446 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenal cortex disease (DOID:3952 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenal gland disease (DOID:9553 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenal gland hyperfunction (DOID:3947 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cushing's syndrome (DOID:12252 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "addison's disease (DOID:13774 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenal cortical hypofunction (DOID:10493 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "wermer syndrome (DOID:10017 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carney complex (DOID:0050471 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian endometrioid stromal sarcoma (DOID:5169 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "apparent mineralocorticoid excess syndrome (DOID:4367 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "steroid inherited metabolic disorder (DOID:1701 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "suprasellar meningioma (DOID:7634 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endocrine exophthalmos (DOID:12359 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acidophil adenoma (DOID:5392 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bronchus adenoma (DOID:5391 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chiasmal syndrome (DOID:5655 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "basophil adenoma (DOID:4542 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colon neuroendocrine neoplasm (DOID:4118 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "exophthalmic ophthalmoplegia (DOID:13135 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mediastinal lipomatosis (DOID:3926 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "verbal auditory agnosia (DOID:0060154 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atypical depressive disorder (DOID:12294 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant leydig cell tumor (DOID:0050616 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scleredema adultorum (DOID:3140 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subacute glomerulonephritis (DOID:4782 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenal rest tumor (DOID:1786 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital adrenal insufficiency (DOID:0050546 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "waterhouse-friderichsen syndrome (DOID:9931 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast cystic hypersecretory carcinoma (DOID:7537 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multicentric papillary thyroid carcinoma (DOID:7086 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyroid hurthle cell carcinoma (DOID:8161 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucoepidermoid thyroid carcinoma (DOID:4687 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphoepithelioma-like thymic carcinoma (DOID:7599 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subacute lymphocytic thyroiditis (DOID:7187 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "suppurative thyroiditis (DOID:14350 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillary thymic adenocarcinoma (DOID:5595 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thymus adenocarcinoma (DOID:4923 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dyshormonogenic goiter (DOID:12175 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "type 1 diabetes mellitus (DOID:9744 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyroiditis (DOID:7166 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune thyroiditis (DOID:7188 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune disease of endocrine system (DOID:0060005 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "graves' disease (DOID:12361 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperthyroidism (DOID:7998 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endocrine system disease (DOID:28 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyroid gland disease (DOID:50 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypothyroidism (DOID:1459 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "goiter (DOID:12176 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nodular goiter (DOID:13197 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multinodular goiter (DOID:0050489 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital hypothyroidism (DOID:0050328 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subacute thyroiditis (DOID:7165 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nontoxic goiter (DOID:13195 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plummer's disease (DOID:11277 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endemic goiter (DOID:13198 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "toxic diffuse goiter (DOID:10719 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neonatal thyrotoxicosis (DOID:12573 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyrotoxicosis (DOID:7997 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "euthyroid sick syndrome (DOID:2856 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyroid hormone resistance syndrome (DOID:11633 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperthyroxinemia (DOID:2855 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucinoses (DOID:3141 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myxedema (DOID:11634 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "insulinoma (DOID:3892 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "islet cell tumor (DOID:1799 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperinsulinemic hypoglycemia (DOID:13317 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "maturity-onset diabetes of the young (DOID:0050524 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diabetic ketoacidosis (DOID:1837 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "factitious disorder (DOID:1766 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "munchausen by proxy (DOID:0060045 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neonatal diabetes mellitus (DOID:11717 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "silver-russell syndrome (DOID:14681 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "beckwith-wiedemann syndrome (DOID:5572 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign pleural mesothelioma (DOID:5157 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperlipoproteinemia type v (DOID:1171 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aortic valve prolapse (DOID:5232 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transient refractive change (DOID:11850 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "erythrasma (DOID:4131 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alstrom syndrome (DOID:0050473 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune polyendocrine syndrome type 2 (DOID:0050168 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "johanson-blizzard syndrome (DOID:14694 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "reactive cutaneous fibrous lesion (DOID:2053 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin tag (DOID:6873 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypoglycemic coma (DOID:1607 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "reye syndrome (DOID:14525 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arteriolosclerosis (DOID:5162 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nasopharyngeal disease (DOID:9561 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nasopharyngitis (DOID:10460 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed cell adenoma (DOID:5385 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "donohue syndrome (DOID:0050470 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acanthosis nigricans (DOID:3138 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neonatal jaundice (DOID:2383 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pigmentation disease (DOID:10123 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "metabolic syndrome x (DOID:14221 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lipoatrophic diabetes (DOID:11712 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital generalized lipodystrophy (DOID:0050585 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial partial lipodystrophy (DOID:0050440 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lipodystrophy (DOID:811 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multiple symmetrical lipomatosis (DOID:3137 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adiposis dolorosa (DOID:3928 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lipomatosis (DOID:3153 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multiple symmetric lipomatosis (DOID:14116 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fibromyalgia (DOID:631 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "panniculitis (DOID:1526 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nodular nonsuppurative panniculitis (DOID:1525 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spongiotic dermatitis (DOID:4406 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult syndrome (DOID:0050601 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystinuria (DOID:9266 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary hyperoxaluria (DOID:2977 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephrolithiasis (DOID:585 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypokalemia (DOID:4500 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lactic acidosis (DOID:3650 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "metabolic acidosis (DOID:0050758 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fanconi syndrome (DOID:1062 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal tubular acidosis (DOID:14219 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal tubular transport disease (DOID:447 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glucocorticoid-remediable aldosteronism (DOID:14080 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liddle syndrome (DOID:0050477 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudohypoaldosteronism (DOID:4479 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bartter disease (DOID:445 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gitelman syndrome (DOID:0050450 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurohypophyseal diabetes insipidus (DOID:12388 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diabetes insipidus (DOID:9409 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inappropriate adh syndrome (DOID:3401 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "impaired renal function disease (DOID:11705 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephrogenic diabetes insipidus (DOID:12387 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "wolfram syndrome (DOID:10632 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystinosis (DOID:1064 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "balkan nephropathy (DOID:3052 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "interstitial nephritis (DOID:1063 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant essential hypertension (DOID:10823 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant hypertension (DOID:10824 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant renovascular hypertension (DOID:13730 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant secondary hypertension (DOID:13731 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "perinephritis (DOID:2982 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gray zone lymphoma (DOID:5822 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mediastinal gray zone lymphoma (DOID:6867 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mediastinal malignant lymphoma (DOID:6868 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mediastinal cancer (DOID:5559 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epidural neoplasm (DOID:3618 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "heart lymphoma (DOID:6547 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "idiopathic cd4-positive t-lymphocytopenia (DOID:3109 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastrointestinal lymphoma (DOID:903 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular lymphoma (DOID:12253 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyroid lymphoma (DOID:10011 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric lymphoma (DOID:10540 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung lymphoma (DOID:6760 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eye lymphoma (DOID:6903 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intraocular lymphoma (DOID:775 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system lymphoma (DOID:3234 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cll|sll (DOID:6354 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "richter's syndrome (DOID:1703 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphoplasmacytic lymphoma (DOID:0050747 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "composite lymphoma (DOID:5820 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "marginal zone b-cell lymphoma (DOID:0050748 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "splenic marginal zone lymphoma (DOID:0050750 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hairy cell leukemia (DOID:285 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hcl-v (DOID:713 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prolymphocytic leukemia (DOID:1039 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphatic system cancer (DOID:0060073 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "reticulosarcoma (DOID:8538 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphosarcoma (DOID:8675 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "non-secretory myeloma (DOID:9547 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "solitary osseous plasmacytoma (DOID:3722 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cd3zeta deficiency (DOID:0060007 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plasma cell neoplasm (DOID:6536 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "monoclonal gammopathy of uncertain significance (DOID:7442 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plasmacytoma (DOID:3721 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extramedullary plasmacytoma (DOID:3720 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alpha 1-antitrypsin deficiency (DOID:13372 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plasma protein metabolism disease (DOID:2345 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "macroglobulinemia (DOID:9080 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system leukemia (DOID:12969 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aleukemic leukemia (DOID:6004 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aleukemic leukemia cutis (DOID:6003 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myeloid sarcoma (DOID:8683 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gingival hypertrophy (DOID:5338 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant histiocytosis (DOID:8580 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lethal midline granuloma (DOID:9072 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute monocytic leukemia (DOID:8864 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "monocytic leukemia (DOID:8527 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "t-cell large granular lymphocyte leukemia (DOID:0050751 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "natural killer cell leukemia (DOID:1035 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic nk-cell lymphocytosis (DOID:7465 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune lymphoproliferative syndrome (DOID:6688 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast lymphoma (DOID:5826 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult lymphoma (DOID:5825 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thymus large cell carcinoma (DOID:4553 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tracheal lymphoma (DOID:12001 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tracheal cancer (DOID:11920 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "b cell linker protein deficiency (DOID:0060027 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bruton-type agammaglobulinemia (DOID:14179 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cortical thymoma (DOID:6530 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dendritic cell thymoma (DOID:3282 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epithelial malignant thymoma (DOID:7926 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thymoma (DOID:3275 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thymus cancer (DOID:3277 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thymic carcinoma (DOID:3284 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spindle cell thymoma (DOID:3279 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ectopic thymus (DOID:6307 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thymus gland disease (DOID:533 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "type c thymoma (DOID:4554 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extraocular retinoblastoma (DOID:4656 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anal carcinoma in situ (DOID:9087 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "invasive malignant thymoma (DOID:3283 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orbital periostitis (DOID:11231 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary cerebellar degeneration (DOID:9277 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuronitis (DOID:8117 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "syphilitic meningitis (DOID:10073 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ventilation pneumonitis (DOID:11289 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cyclosporiasis (DOID:12750 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "herpetic whitlow (DOID:8607 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "african histoplasmosis (DOID:11315 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adiaspiromycosis (DOID:0050072 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cork-handlers' disease (DOID:840 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "post-vaccinal encephalitis (DOID:13664 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "norwegian scabies (DOID:14374 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coronin-1a deficiency (DOID:0060019 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "granuloma inguinale (DOID:9113 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphocytic gastritis (DOID:4035 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "viral esophagitis (DOID:6297 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lichen nitidus (DOID:8573 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "necrotizing ulcerative gingivitis (DOID:13924 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pericoronitis (DOID:3671 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thymic dysplasia (DOID:7350 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nezelof syndrome (DOID:2012 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "follicular mucinosis (DOID:9905 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymph node tuberculosis (DOID:4889 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute interstitial pneumonia (DOID:2800 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bird fancier's lung (DOID:13891 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cryptogenic organizing pneumonia (DOID:0050157 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bronchiolitis obliterans organizing pneumonia (DOID:2798 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parapsoriasis (DOID:9088 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lip cancer (DOID:8564 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lower lip cancer (DOID:8883 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "maxillary sinus adenoid cystic carcinoma (DOID:7198 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oral tuberculosis (DOID:402 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "splenic tuberculosis (DOID:9305 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "toxicodendron dermatitis (DOID:3819 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute t cell leukemia (DOID:5603 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "indolent myeloma (DOID:9550 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system tuberculosis (DOID:1638 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nasal cavity lymphoma (DOID:10813 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cauda equina syndrome (DOID:11577 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glossitis (DOID:1456 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tongue disease (DOID:10944 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "median rhomboid glossitis (DOID:14111 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fissured tongue (DOID:11514 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "precursor b lymphoblastic lymphoma|leukemia (DOID:7061 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cd45 deficiency (DOID:0060014 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune polyendocrine syndrome (DOID:14040 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune polyendocrine syndrome type 1 (DOID:0050167 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic mucocutaneous candidiasis (DOID:2058 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cd3delta deficiency (DOID:0060016 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cd3gamma deficiency (DOID:0060018 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cd3epsilon deficiency (DOID:0060017 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "digeorge syndrome (DOID:11198 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "t cell deficiency (DOID:11200 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "velocardiofacial syndrome (DOID:12583 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "t lymphocyte deficiency (DOID:613 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast cancer (DOID:1612 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thoracic cancer (DOID:5093 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast carcinoma (DOID:3459 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenocarcinoma (DOID:299 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carcinoma (DOID:305 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cell type cancer (DOID:0050687 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "squamous cell carcinoma (DOID:1749 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "male reproductive organ cancer (DOID:3856 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate cancer (DOID:10283 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "female reproductive organ cancer (DOID:120 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "reproductive organ cancer (DOID:193 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung adenocarcinoma (DOID:3910 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung cancer (DOID:1324 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "respiratory system cancer (DOID:0050615 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung carcinoma (DOID:3905 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "non-small cell lung carcinoma (DOID:3908 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "melanoma (DOID:1909 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatocellular carcinoma (DOID:684 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liver carcinoma (DOID:686 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liver cancer (DOID:3571 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colon adenocarcinoma (DOID:234 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colon carcinoma (DOID:1520 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colon cancer (DOID:219 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colorectal cancer (DOID:9256 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "large intestine cancer (DOID:5672 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal cancer (DOID:10155 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastrointestinal system cancer (DOID:3119 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cell type benign neoplasm (DOID:0060084 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign neoplasm (DOID:0060072 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "organ system benign neoplasm (DOID:0060085 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenoma (DOID:657 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endocrine gland cancer (DOID:170 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic cancer (DOID:1793 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreas adenocarcinoma (DOID:4074 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic carcinoma (DOID:4905 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic ductal adenocarcinoma (DOID:3498 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephroblastoma (DOID:2154 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal carcinoma (DOID:4451 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal cell carcinoma (DOID:4450 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney cancer (DOID:263 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urinary system cancer (DOID:3996 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system cancer (DOID:3620 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain cancer (DOID:1319 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "infratentorial cancer (DOID:4706 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "medulloblastoma (DOID:0050902 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuroectodermal tumor (DOID:171 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nervous system cancer (DOID:3093 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peripheral nervous system neoplasm (DOID:1192 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autonomic nervous system neoplasm (DOID:2621 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuroblastoma (DOID:769 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "astrocytoma (DOID:3069 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glioblastoma multiforme (DOID:3068 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant glioma (DOID:3070 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meningioma (DOID:3565 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal cancer (DOID:4645 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal cell cancer (DOID:771 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinoblastoma (DOID:768 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ocular cancer (DOID:2174 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sensory system cancer (DOID:0060116 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone cancer (DOID:184 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteosarcoma (DOID:3347 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "connective tissue cancer (DOID:201 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "musculoskeletal system cancer (DOID:0060100 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peripheral primitive neuroectodermal tumor (DOID:3369 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian cancer (DOID:2394 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant ovarian surface epithelial-stromal neoplasm (DOID:2151 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian carcinoma (DOID:4001 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovary epithelial cancer (DOID:2152 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovary adenocarcinoma (DOID:3713 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian clear cell adenocarcinoma (DOID:5304 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cancer (DOID:162 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "disease of cellular proliferation (DOID:14566 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "organ system cancer (DOID:0050686 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "disease (DOID:4 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "disease of anatomical entity (DOID:7 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nervous system disease (DOID:863 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system disease (DOID:331 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain disease (DOID:936 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurodegenerative disease (DOID:1289 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autosomal dominant disease (DOID:0050736 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autosomal genetic disease (DOID:0050739 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "monogenic disease (DOID:0050177 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "genetic disease (DOID:630 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autosomal recessive disease (DOID:0050737 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eye and adnexa disease (DOID:1492 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eye disease (DOID:5614 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sensory system disease (DOID:0050155 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal degeneration (DOID:8466 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal disease (DOID:5679 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "globe disease (DOID:1242 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "disease of metabolism (DOID:0014667 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acquired metabolic disease (DOID:0060158 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carbohydrate metabolism disease (DOID:0050013 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glucose metabolism disease (DOID:4194 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diabetes mellitus (DOID:9351 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coronary artery disease (DOID:3393 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myocardial infarction (DOID:5844 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extrinsic cardiomyopathy (DOID:3978 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cardiomyopathy (DOID:0050700 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "heart disease (DOID:114 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "muscle tissue disease (DOID:66 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myopathy (DOID:423 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "muscular disease (DOID:0080000 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "artery disease (DOID:0050828 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cardiovascular system disease (DOID:1287 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vascular disease (DOID:178 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypertension (DOID:10763 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebrovascular disease (DOID:6713 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arteriosclerosis (DOID:2349 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arteriosclerotic cardiovascular disease (DOID:2348 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atherosclerosis (DOID:1936 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peripheral vascular disease (DOID:341 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bacterial infectious disease (DOID:104 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary bacterial infectious disease (DOID:0050338 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "disease by infectious agent (DOID:0050117 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "viral infectious disease (DOID:934 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parasitic infectious disease (DOID:1398 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parasitic protozoa infectious disease (DOID:2789 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malaria (DOID:12365 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone inflammation disease (DOID:3342 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arthritis (DOID:848 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rheumatoid arthritis (DOID:7148 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone disease (DOID:0080001 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "connective tissue disease (DOID:65 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "musculoskeletal system disease (DOID:17 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteoarthritis (DOID:8398 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypersensitivity reaction disease (DOID:0060056 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypersensitivity reaction type ii disease (DOID:417 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lupus erythematosus (DOID:8857 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "systemic lupus erythematosus (DOID:9074 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dermatitis (DOID:2723 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "integumentary system disease (DOID:16 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin disease (DOID:37 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atopic dermatitis (DOID:3310 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "psoriasis (DOID:8893 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "allergic asthma (DOID:9415 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "asthma (DOID:2841 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bronchial disease (DOID:1176 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "obstructive lung disease (DOID:2320 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lower respiratory tract disease (DOID:0050161 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung disease (DOID:850 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "respiratory system disease (DOID:1579 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic obstructive pulmonary disease (DOID:3083 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nose disease (DOID:2825 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nasal cavity disease (DOID:2163 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rhinitis (DOID:4483 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "allergic rhinitis (DOID:4481 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "upper respiratory tract disease (DOID:974 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colitis (DOID:0060180 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ulcerative colitis (DOID:8577 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inflammatory bowel disease (DOID:0050589 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "crohn's disease (DOID:8778 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastrointestinal system disease (DOID:77 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal disease (DOID:5295 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blood platelet disease (DOID:2218 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemorrhagic disease (DOID:2213 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blood coagulation disease (DOID:1247 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thrombocytopenia (DOID:1588 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hematopoietic system disease (DOID:74 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "immune system disease (DOID:2914 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anemia (DOID:2355 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leukocyte disease (DOID:9500 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "agranulocytosis (DOID:12987 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neutropenia (DOID:1227 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leukopenia (DOID:615 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphopenia (DOID:614 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancytopenia (DOID:12450 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune disease of gastrointestinal tract (DOID:0060031 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "celiac disease (DOID:10608 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune hepatitis (DOID:2048 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatobiliary disease (DOID:3118 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liver disease (DOID:409 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liver cirrhosis (DOID:5082 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatitis (DOID:2237 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune disease of urogenital tract (DOID:0060049 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary biliary cirrhosis (DOID:12236 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "viral hepatitis (DOID:1884 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatitis b (DOID:2043 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatitis c (DOID:1883 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acquired immunodeficiency syndrome (DOID:635 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "human immunodeficiency virus infectious disease (DOID:526 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kaposi's sarcoma (DOID:8632 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute leukemia (DOID:12603 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic myeloid leukemia (DOID:8552 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic lymphocytic leukemia (DOID:1040 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic leukemia (DOID:1036 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphoblastic leukemia (DOID:1037 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leukemia (DOID:1240 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hematologic cancer (DOID:2531 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "immune system cancer (DOID:0060083 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myeloid leukemia (DOID:8692 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute myeloid leukemia (DOID:9119 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone marrow cancer (DOID:4960 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myeloma (DOID:0070004 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multiple myeloma (DOID:9538 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "b-cell lymphoma (DOID:707 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "non-hodgkin lymphoma (DOID:0060060 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphoma (DOID:0060058 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mature b-cell neoplasm (DOID:706 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "burkitt lymphoma (DOID:8584 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diffuse large b-cell lymphoma (DOID:0050745 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mantle cell lymphoma (DOID:0050746 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphoid leukemia (DOID:10747 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "t-cell leukemia (DOID:715 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult t-cell leukemia (DOID:0050523 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tropical spastic paraparesis (DOID:321 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anaplastic large cell lymphoma (DOID:0050744 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous t cell lymphoma (DOID:0060061 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peripheral t-cell lymphoma (DOID:0050749 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mature t-cell and nk-cell lymphoma (DOID:0050743 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mycosis fungoides (DOID:8691 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sezary's disease (DOID:8541 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "idiopathic interstitial pneumonia (DOID:2797 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "idiopathic pulmonary fibrosis (DOID:0050156 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pneumonia (DOID:552 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "interstitial lung disease (DOID:3082 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary fibrosis (DOID:3770 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nonspecific interstitial pneumonia (DOID:2801 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bronchiolitis obliterans (DOID:2799 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult respiratory distress syndrome (DOID:11394 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "respiratory failure (DOID:11162 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary edema (DOID:11396 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "newborn respiratory distress syndrome (DOID:12716 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystic fibrosis (DOID:1485 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pneumoconiosis (DOID:10316 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "silicosis (DOID:10325 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "asbestosis (DOID:10320 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anthracosis (DOID:10327 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "periodontitis (DOID:824 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "periodontal disease (DOID:3388 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mouth disease (DOID:403 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tooth disease (DOID:1091 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aggressive periodontitis (DOID:1474 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gingival overgrowth (DOID:3086 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gingival disease (DOID:1483 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gingivitis (DOID:3087 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dental caries (DOID:216 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "teeth hard tissue disease (DOID:214 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "root caries (DOID:14089 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gingival recession (DOID:1134 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "syndrome (DOID:225 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic fatigue syndrome (DOID:8544 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sudden infant death syndrome (DOID:9007 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "collagen disease (DOID:854 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rheumatic disease (DOID:1575 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scleroderma (DOID:419 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "systemic scleroderma (DOID:418 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diffuse scleroderma (DOID:1580 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "limited scleroderma (DOID:1577 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "localized scleroderma (DOID:8472 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed connective tissue disease (DOID:3492 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "childhood type dermatomyositis (DOID:14203 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dermatomyositis (DOID:10223 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myositis (DOID:633 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inclusion body myositis (DOID:3429 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphatic system disease (DOID:75 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymph node disease (DOID:9942 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphadenitis (DOID:1602 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kawasaki disease (DOID:13378 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polyarteritis nodosa (DOID:9810 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vasculitis (DOID:865 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peritonitis (DOID:8283 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "encephalomyelitis (DOID:640 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "demyelinating disease (DOID:3213 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multiple sclerosis (DOID:2377 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "relapsing-remitting multiple sclerosis (DOID:2378 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypersensitivity reaction type iv disease (DOID:2916 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sarcoidosis (DOID:11335 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary sarcoidosis (DOID:13406 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cryoglobulinemia (DOID:2917 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extrapulmonary tuberculosis (DOID:0050598 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pleural tuberculosis (DOID:106 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tuberculosis (DOID:399 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary tuberculosis (DOID:2957 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "behcet's disease (DOID:13241 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune disease of cardiovascular system (DOID:0060051 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system vasculitis (DOID:525 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "temporal arteritis (DOID:13375 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polymyalgia rheumatica (DOID:853 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "juvenile rheumatoid arthritis (DOID:676 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "psoriatic arthritis (DOID:9008 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "wegener's granulomatosis (DOID:12132 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "churg-strauss syndrome (DOID:3049 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "allergic contact dermatitis (DOID:3042 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "contact dermatitis (DOID:2773 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "irritant dermatitis (DOID:2772 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lichen disease (DOID:8574 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lichen planus (DOID:9201 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral malaria (DOID:14069 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plasmodium falciparum malaria (DOID:14067 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "encephalitis (DOID:9588 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "viral encephalitis (DOID:646 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meningoencephalitis (DOID:10554 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bacterial meningitis (DOID:9470 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meningitis (DOID:9471 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aseptic meningitis (DOID:12157 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "viral meningitis (DOID:10310 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lyme disease (DOID:11729 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tick-borne encephalitis (DOID:0050175 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "borderline leprosy (DOID:1023 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leprosy (DOID:1024 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lepromatous leprosy (DOID:10887 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tuberculoid leprosy (DOID:1025 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous leishmaniasis (DOID:9111 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leishmaniasis (DOID:9065 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "visceral leishmaniasis (DOID:9146 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucocutaneous leishmaniasis (DOID:9155 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chagas disease (DOID:12140 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trypanosomiasis (DOID:10113 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sleeping sickness (DOID:10112 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "histoplasmosis (DOID:1731 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary systemic mycosis (DOID:0050292 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paracoccidioidomycosis (DOID:12662 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coccidioidomycosis (DOID:13450 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aspergillosis (DOID:13564 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "invasive aspergillosis (DOID:0050073 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "candidiasis (DOID:1508 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fungal infectious disease (DOID:1564 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "systemic mycosis (DOID:0050136 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "opportunistic mycosis (DOID:2473 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cryptococcosis (DOID:12053 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oral candidiasis (DOID:14262 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pneumocystosis (DOID:11339 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal hypertension (DOID:1073 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "secondary hypertension (DOID:11130 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephrosclerosis (DOID:11664 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal artery disease (DOID:2388 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renovascular hypertension (DOID:1591 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "proteinuria (DOID:576 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephrosis (DOID:2527 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephrotic syndrome (DOID:1184 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glomerulonephritis (DOID:2921 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephritis (DOID:10952 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney disease (DOID:557 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urinary system disease (DOID:18 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney failure (DOID:1074 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic kidney failure (DOID:784 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "end stage renal failure (DOID:783 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "focal segmental glomerulosclerosis (DOID:1312 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glomerulosclerosis (DOID:0050851 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "iga glomerulonephritis (DOID:2986 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "membranous glomerulonephritis (DOID:10976 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "membranoproliferative glomerulonephritis (DOID:2920 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uremia (DOID:4676 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute proliferative glomerulonephritis (DOID:13138 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "crescentic glomerulonephritis (DOID:13139 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rapidly progressive glomerulonephritis (DOID:4776 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "proliferative glomerulonephritis (DOID:4778 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "immune-complex glomerulonephritis (DOID:4784 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mesangial proliferative glomerulonephritis (DOID:4783 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute kidney failure (DOID:3021 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute kidney tubular necrosis (DOID:12556 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatorenal syndrome (DOID:11823 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hydronephrosis (DOID:11111 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urinary tract obstruction (DOID:5200 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ureteral obstruction (DOID:5199 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ureteral disease (DOID:1426 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vesicoureteral reflux (DOID:9620 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diarrhea (DOID:13250 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "secretory diarrhea (DOID:0050129 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cholera (DOID:1498 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tetanus (DOID:11338 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diphtheria (DOID:11405 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pertussis (DOID:1116 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "commensal bacterial infectious disease (DOID:0050339 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "toxic shock syndrome (DOID:14115 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gas gangrene (DOID:9159 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alopecia (DOID:987 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypotrichosis (DOID:4535 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hair disease (DOID:421 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alopecia areata (DOID:986 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alopecia universalis (DOID:0050634 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vitiligo (DOID:12306 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inherited metabolic disorder (DOID:655 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lipid storage disease (DOID:9455 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lysosomal storage disease (DOID:3211 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fatty liver disease (DOID:9452 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "batten disease (DOID:0050756 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuronal ceroid lipofuscinosis (DOID:14503 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nutrition disease (DOID:374 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nutritional deficiency disease (DOID:5113 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "morbid obesity (DOID:11981 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "obesity (DOID:9970 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "overnutrition (DOID:654 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "type 2 diabetes mellitus (DOID:9352 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glucose intolerance (DOID:10603 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperglycemia (DOID:4195 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endocrine pancreas disease (DOID:1428 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperinsulinism (DOID:2018 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypoglycemia (DOID:9993 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreas disease (DOID:26 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatitis (DOID:4989 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute pancreatitis (DOID:2913 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prediabetes syndrome (DOID:11716 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gestational diabetes (DOID:11714 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kwashiorkor (DOID:13579 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "protein-energy malnutrition (DOID:11801 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "marasmus (DOID:12328 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alcoholic hepatitis (DOID:12351 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alcoholic liver cirrhosis (DOID:14018 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bile duct disease (DOID:4138 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "biliary tract disease (DOID:9741 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cholestasis (DOID:13580 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "biliary atresia (DOID:13608 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cholangitis (DOID:9446 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sclerosing cholangitis (DOID:14268 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "obstructive jaundice (DOID:13603 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cholecystitis (DOID:1949 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gallbladder disease (DOID:0000000 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cholelithiasis (DOID:10211 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intrahepatic cholestasis (DOID:1852 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extrahepatic cholestasis (DOID:13619 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "biliary dyskinesia (DOID:4140 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choledocholithiasis (DOID:11755 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "common bile duct disease (DOID:4137 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cholecystolithiasis (DOID:11151 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "funisitis (DOID:0050698 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chorioamnionitis (DOID:0050697 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meconium aspiration syndrome (DOID:11049 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eclampsia (DOID:13593 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hellp syndrome (DOID:13133 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "severe pre-eclampsia (DOID:13129 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pre-eclampsia (DOID:10591 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mild pre-eclampsia (DOID:10590 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "placental abruption (DOID:9667 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "female reproductive system disease (DOID:229 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "reproductive system disease (DOID:15 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uterine disease (DOID:345 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "placenta disease (DOID:780 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "placental insufficiency (DOID:3891 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polyhydramnios (DOID:8488 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "placenta praevia (DOID:11060 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "placenta accreta (DOID:4744 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "allergic conjunctivitis (DOID:11204 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic conjunctivitis (DOID:2475 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conjunctival disease (DOID:4251 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conjunctivitis (DOID:6195 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adnexa disease (DOID:0050815 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eyelid disease (DOID:530 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blepharitis (DOID:9423 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blepharoconjunctivitis (DOID:2456 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "giant papillary conjunctivitis (DOID:2457 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papillary conjunctivitis (DOID:2458 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "egg allergy (DOID:4377 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "food allergy (DOID:3044 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypersensitivity reaction type i disease (DOID:1205 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peanut allergic reaction (DOID:4378 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic eosinophilic pneumonia (DOID:9502 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eosinophilic pneumonia (DOID:5870 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eosinophilia (DOID:999 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary eosinophilia (DOID:9498 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "allergic bronchopulmonary aspergillosis (DOID:13166 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bronchitis (DOID:6132 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bronchiolitis (DOID:2942 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "common cold (DOID:10459 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bronchiectasis (DOID:9563 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paranasal sinus disease (DOID:1352 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sinusitis (DOID:0050127 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic maxillary sinusitis (DOID:10792 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "maxillary sinusitis (DOID:2051 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extrinsic allergic alveolitis (DOID:841 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sick building syndrome (DOID:2710 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "farmer's lung (DOID:14453 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arteriovenous malformation (DOID:11294 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "moyamoya disease (DOID:13099 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amyloidosis (DOID:9120 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral amyloid angiopathy (DOID:9246 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral arterial disease (DOID:3527 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracranial arterial disease (DOID:13089 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracranial arteriosclerosis (DOID:13097 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vascular dementia (DOID:8725 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracranial aneurysm (DOID:10941 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain infarction (DOID:3454 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral infarction (DOID:3526 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain ischemia (DOID:2316 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transient cerebral ischemia (DOID:224 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ischemia (DOID:326 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain edema (DOID:4724 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "occlusion precerebral artery (DOID:5976 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carotid artery occlusion (DOID:807 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal ischemia (DOID:12510 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "abdominal aortic aneurysm (DOID:7693 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aortic aneurysm (DOID:3627 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aortic disease (DOID:520 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thoracic aortic aneurysm (DOID:14004 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coronary restenosis (DOID:4247 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coronary stenosis (DOID:4248 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myocardial stunning (DOID:9767 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "essential hypertension (DOID:10825 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diabetic angiopathy (DOID:11713 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "persistent fetal circulation syndrome (DOID:13042 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary hypertension (DOID:6432 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic pulmonary heart disease (DOID:12326 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary pulmonary hypertension (DOID:14557 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cor pulmonale (DOID:8515 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congestive heart failure (DOID:6000 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "raynaud disease (DOID:10300 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypertensive heart disease (DOID:11516 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "systolic heart failure (DOID:9651 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diastolic heart failure (DOID:9775 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intrinsic cardiomyopathy (DOID:0060036 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dilated cardiomyopathy (DOID:12930 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypertrophic cardiomyopathy (DOID:11984 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peripartum cardiomyopathy (DOID:9997 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polyclonal hypergammaglobulinemia (DOID:2344 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphoid interstitial pneumonia (DOID:0050159 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sjogren's syndrome (DOID:12894 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parotid disease (DOID:10302 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parotitis (DOID:10301 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "salivary gland disease (DOID:10854 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sialadenitis (DOID:10303 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conjunctival degeneration (DOID:10139 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "xerophthalmia (DOID:10138 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dry eye syndrome (DOID:10140 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lacrimal apparatus disease (DOID:1400 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "keratoconjunctivitis sicca (DOID:12895 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "keratoconjunctivitis (DOID:9368 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dacryoadenitis (DOID:950 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "age related macular degeneration (DOID:10871 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "degeneration of macula and posterior pole (DOID:2007 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "macular degeneration (DOID:4448 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kuhnt-junius degeneration (DOID:10873 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinopathy of prematurity (DOID:13025 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystoid macular edema (DOID:4447 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "macular retinal edema (DOID:4449 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal edema (DOID:6929 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "background diabetic retinopathy (DOID:13208 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "severe nonproliferative diabetic retinopathy (DOID:8946 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diabetic macular edema (DOID:9191 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diabetic retinopathy (DOID:8947 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal vascular disease (DOID:2462 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "proliferative diabetic retinopathy (DOID:13207 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "macular holes (DOID:7633 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal detachment (DOID:5327 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal perforation (DOID:12514 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "proliferative vitreoretinopathy (DOID:9719 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vitreous disease (DOID:9720 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vitreous detachment (DOID:9726 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast disease (DOID:3463 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thoracic disease (DOID:0060118 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mastitis (DOID:10690 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "perinatal necrotizing enterocolitis (DOID:8677 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute endometritis (DOID:7528 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrial disease (DOID:1005 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometritis (DOID:1002 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute pyelonephritis (DOID:559 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pyelitis (DOID:2744 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pyelonephritis (DOID:11400 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic pyelonephritis (DOID:1076 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "xanthogranulomatous pyelonephritis (DOID:11401 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pyuria (DOID:1439 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bacteriuria (DOID:1412 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pelvic inflammatory disease (DOID:1003 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvovaginitis (DOID:2273 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvovaginal candidiasis (DOID:2272 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bacterial vaginosis (DOID:3385 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vaginal disease (DOID:121 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vaginitis (DOID:2170 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vaginal discharge (DOID:3767 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trichomoniasis (DOID:1947 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urethritis (DOID:1343 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gonorrhea (DOID:7551 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cholesteatoma (DOID:869 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cholesteatoma of middle ear (DOID:10964 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "middle ear cholesteatoma (DOID:11433 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "middle ear disease (DOID:5100 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "otitis media (DOID:10754 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic purulent otitis media (DOID:14247 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "suppurative otitis media (DOID:11506 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "appendicitis (DOID:8337 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cecal disease (DOID:1518 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aspiration pneumonia (DOID:0050152 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bacterial pneumonia (DOID:874 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bronchopneumonia (DOID:12375 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dysentery (DOID:12384 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal infectious disease (DOID:100 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "shigellosis (DOID:12385 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amebiasis (DOID:9181 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute diarrhea (DOID:0050140 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "giardiasis (DOID:10718 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brucellosis (DOID:11077 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tularemia (DOID:2123 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pneumonic tularemia (DOID:2122 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "melioidosis (DOID:5052 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glanders (DOID:13444 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mycobacterium avium complex disease (DOID:2755 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "listeriosis (DOID:11573 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paratyphoid fever (DOID:3055 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "typhoid fever (DOID:13258 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemorrhoid (DOID:9746 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anus disease (DOID:3128 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pelvic varices (DOID:9742 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "varicocele (DOID:12337 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "varicose veins (DOID:799 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vein disease (DOID:866 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rectal disease (DOID:1285 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "proctitis (DOID:3127 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rectal prolapse (DOID:9307 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin carcinoma in situ (DOID:8687 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trench fever (DOID:11101 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric antral vascular ectasia (DOID:2493 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperlysinemia (DOID:9274 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "loiasis (DOID:13523 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dracunculiasis (DOID:14418 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alcoholic cardiomyopathy (DOID:12935 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alveolar echinococcosis (DOID:12148 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "echinococcosis (DOID:1496 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystic echinococcosis (DOID:1495 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "filariasis (DOID:1080 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "onchocerciasis (DOID:11678 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parasitic helminthiasis infectious disease (DOID:883 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "schistosomiasis (DOID:1395 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal schistosomiasis (DOID:0050597 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cysticercosis (DOID:10079 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "taeniasis (DOID:0050596 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urinary schistosomiasis (DOID:1394 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "opisthorchiasis (DOID:13768 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "toxocariasis (DOID:9790 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trichinosis (DOID:9784 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coccidiosis (DOID:2113 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "toxoplasmosis (DOID:9965 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital toxoplasmosis (DOID:13336 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cryptosporidiosis (DOID:1733 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parasitic ectoparasitic infectious disease (DOID:4110 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lice infestation (DOID:5502 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pthirus pubis infestation (DOID:13760 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mite infestation (DOID:7894 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scabies (DOID:8295 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tick infestation (DOID:4109 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "capillary disease (DOID:1271 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "capillary leak syndrome (DOID:14400 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "henoch-schoenlein purpura (DOID:11123 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypersensitivity vasculitis (DOID:9809 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypersensitivity reaction type iii disease (DOID:1557 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arthus reaction (DOID:1556 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urticaria (DOID:1555 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vascular skin disease (DOID:9540 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angioedema (DOID:1558 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary angioedema (DOID:14735 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "c1 inhibitor deficiency (DOID:0060002 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "complement deficiency (DOID:626 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "c3 deficiency (DOID:8354 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "complement component 5 deficiency (DOID:8158 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "complement factor i deficiency (DOID:0050419 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rheumatic fever (DOID:1586 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute poststreptococcal glomerulonephritis (DOID:14064 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tonsillitis (DOID:10456 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scarlet fever (DOID:8596 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "null-cell leukemia (DOID:9954 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "listeria meningitis (DOID:11572 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sarcoid meningitis (DOID:12055 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tuberculous empyema (DOID:14305 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pericardial tuberculosis (DOID:4962 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bronchus cancer (DOID:1325 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bronchus carcinoma (DOID:3904 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "abdominal tuberculosis (DOID:0050599 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastrointestinal tuberculosis (DOID:404 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal tuberculosis (DOID:13282 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tuberculous peritonitis (DOID:9801 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "miliary tuberculosis (DOID:9861 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pleural disease (DOID:1532 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pneumothorax (DOID:1673 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pleurisy (DOID:10247 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pleural empyema (DOID:3798 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cardiac tamponade (DOID:115 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pericardial effusion (DOID:118 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pericardium disease (DOID:0050829 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pericarditis (DOID:1787 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "constrictive pericarditis (DOID:11481 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endocarditis (DOID:10314 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endocardium disease (DOID:0050825 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "infective endocarditis (DOID:0060000 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subacute bacterial endocarditis (DOID:4562 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal perforation (DOID:2074 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemophagocytic lymphohistiocytosis (DOID:0050120 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dysgammaglobulinemia (DOID:11702 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "selective immunoglobulin deficiency disease (DOID:6025 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "infectious mononucleosis (DOID:8568 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "combined t cell and b cell immunodeficiency (DOID:628 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "severe combined immunodeficiency (DOID:627 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary immunodeficiency disease (DOID:612 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gamma chain deficiency (DOID:0060013 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "agammaglobulinemia (DOID:2583 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blood protein disease (DOID:620 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "b cell deficiency (DOID:2115 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "common variable immunodeficiency (DOID:12177 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "immunoglobulin alpha deficiency (DOID:0060025 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cd40 deficiency (DOID:0060023 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperimmunoglobulin syndrome (DOID:2959 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "job's syndrome (DOID:3261 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "x-linked hyper igm syndrome (DOID:6620 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "reticular dysgenesis (DOID:0060020 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "omenn syndrome (DOID:0060010 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune disease of central nervous system (DOID:0060004 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "exanthema subitum (DOID:0050495 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "common wart (DOID:11165 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mhc class i deficiency (DOID:0060009 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epidermodysplasia verruciformis (DOID:13777 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "molluscum contagiosum (DOID:8867 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eczema herpeticum (DOID:9123 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "genital herpes (DOID:8704 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "herpes simplex (DOID:8566 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anogenital venereal wart (DOID:11168 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dengue disease (DOID:12205 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dengue hemorrhagic fever (DOID:12206 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dengue shock syndrome (DOID:0050125 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "severe acute respiratory syndrome (DOID:2945 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "yellow fever (DOID:9682 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemorrhagic fever with renal syndrome (DOID:11266 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephropathia epidemica (DOID:0050201 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hantavirus pulmonary syndrome (DOID:14472 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "west nile encephalitis (DOID:2365 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ebola hemorrhagic fever (DOID:4325 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "avian influenza (DOID:4492 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "influenza (DOID:8469 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "swine influenza (DOID:0050211 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "measles (DOID:8622 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mumps (DOID:10264 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rubella (DOID:8781 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chickenpox (DOID:8659 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "herpes zoster (DOID:8536 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subacute sclerosing panencephalitis (DOID:8970 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rabies (DOID:11260 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "smoldering myeloma (DOID:9551 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "schnitzler syndrome (DOID:4371 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mevalonic aciduria (DOID:0050452 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial mediterranean fever (DOID:2987 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blau syndrome (DOID:0050678 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult-onset still's disease (DOID:14256 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervical adenitis (DOID:4637 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pharyngitis (DOID:2275 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aphthous stomatitis (DOID:9663 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "stomatitis (DOID:9637 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ecthyma (DOID:11907 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "impetigo (DOID:8504 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pyoderma (DOID:4223 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pyoderma gangrenosum (DOID:8553 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "axillary adenitis (DOID:4640 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "exudative glomerulonephritis (DOID:4777 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute gonococcal salpingitis (DOID:13942 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "israeli tick typhus (DOID:0050043 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "basidiobolomycosis (DOID:0050278 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "buruli ulcer disease (DOID:0050456 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pontiac fever (DOID:0050150 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic inflammatory demyelinating polyneuritis (DOID:2536 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transient hypogammaglobulinemia (DOID:625 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transient hypogammaglobulinemia of infancy (DOID:624 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital hypogammaglobulinemia (DOID:14177 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute salpingitis (DOID:10973 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic gonococcal salpingitis (DOID:12718 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic salpingitis (DOID:5731 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fallopian tube disease (DOID:1962 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "salpingitis (DOID:5733 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult dermatomyositis (DOID:14202 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic orbital inflammation (DOID:1397 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orbital plasma cell granuloma (DOID:9369 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "viral pneumonia (DOID:10533 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myositis fibrosa (DOID:9788 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute cervicitis (DOID:10616 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dentin caries (DOID:10461 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arthropathy (DOID:381 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "articular cartilage disease (DOID:6227 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cartilage disease (DOID:1222 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudogout (DOID:1156 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chondromalacia (DOID:2557 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "relapsing polychondritis (DOID:2556 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spondylitis (DOID:6590 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spondyloarthropathy (DOID:1123 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "reactive arthritis (DOID:6196 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ankylosing spondylitis (DOID:7147 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "septic arthritis (DOID:813 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteomyelitis (DOID:1019 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sapho syndrome (DOID:13677 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "frozen shoulder (DOID:14188 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tendinitis (DOID:971 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tenosynovitis (DOID:970 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peroneal neuropathy (DOID:4201 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rheumatoid lung disease (DOID:849 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "esophageal tuberculosis (DOID:7332 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebritis (DOID:3431 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous lupus erythematosus (DOID:0050169 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pityriasis rosea (DOID:8892 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "granulomatous dermatitis (DOID:4397 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "granuloma annulare (DOID:3777 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "necrobiosis lipoidica (DOID:3486 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin sarcoidosis (DOID:13402 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "whipple disease (DOID:8476 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cat-scratch disease (DOID:11258 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extrapyramidal and movement disease (DOID:13839 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epidemic typhus (DOID:0050480 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multidrug-resistant tuberculosis (DOID:401 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "typhus (DOID:11256 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scrub typhus (DOID:13371 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endemic typhus (DOID:0050481 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leptospirosis (DOID:2297 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rocky mountain spotted fever (DOID:0050052 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spotted fever (DOID:11104 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "boutonneuse fever (DOID:14095 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "flinders island spotted fever (DOID:0050047 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "japanese spotted fever (DOID:0050050 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ehrlichiosis (DOID:10242 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "human granulocytic anaplasmosis (DOID:0050025 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "human monocytic ehrlichiosis (DOID:0050026 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral falx meningioma (DOID:7986 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conjugate gaze palsy (DOID:12445 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital intrinsic factor deficiency (DOID:0050734 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chorea gravidarum (DOID:14483 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "white piedra (DOID:13902 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choreatic disease (DOID:12859 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dysbaric osteonecrosis (DOID:0080018 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone epithelioid hemangioma (DOID:6610 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "femoral neuropathy (DOID:4196 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lemierre's syndrome (DOID:11337 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "qualitative platelet defect (DOID:11125 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemometra (DOID:9958 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vitamin k deficiency hemorrhagic disease (DOID:11249 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracranial sinus thrombosis (DOID:3572 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sagittal sinus thrombosis (DOID:3576 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "antithrombin iii deficiency (DOID:3755 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "protein s deficiency (DOID:2451 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "protein c deficiency (DOID:3756 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "factor xii deficiency (DOID:2231 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "factor xiii deficiency (DOID:2211 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "factor v deficiency (DOID:2216 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "factor viii deficiency (DOID:12134 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "factor vii deficiency (DOID:2215 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "factor x deficiency (DOID:2222 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prothrombin deficiency (DOID:2235 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "factor xi deficiency (DOID:2229 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital afibrinogenemia (DOID:2236 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemophilia b (DOID:12259 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sneddon syndrome (DOID:13096 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "partial motor epilepsy (DOID:3327 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "post-thrombotic syndrome (DOID:2364 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "venous insufficiency (DOID:10128 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blue toe syndrome (DOID:14121 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cholesterol embolism (DOID:1461 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "giant hemangioma (DOID:5774 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal impaction (DOID:8448 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "korean hemorrhagic fever (DOID:0050200 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "marantic endocarditis (DOID:0060068 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phlebitis (DOID:864 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thrombophlebitis (DOID:3875 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracranial embolism (DOID:4372 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "branch retinal artery occlusion (DOID:13094 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central retinal artery occlusion (DOID:13098 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal artery occlusion (DOID:8483 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal vascular occlusion (DOID:1729 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal vein occlusion (DOID:1727 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central retinal vein occlusion (DOID:2450 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anterior ischemic optic neuropathy (DOID:12010 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemarthrosis (DOID:801 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute myocardial infarction (DOID:9408 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intermediate coronary syndrome (DOID:8805 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary embolism (DOID:9477 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "antiphospholipid syndrome (DOID:2988 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "disseminated intravascular coagulation (DOID:11247 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thrombophilia (DOID:2452 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thrombotic thrombocytopenic purpura (DOID:10772 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coronary thrombosis (DOID:11847 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carotid artery thrombosis (DOID:3410 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracranial thrombosis (DOID:4193 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carotid artery disease (DOID:3407 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carotid stenosis (DOID:13001 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bernard-soulier syndrome (DOID:2217 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glanzmann's thrombasthenia (DOID:2219 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inherited blood coagulation disease (DOID:2214 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "von willebrand's disease (DOID:12531 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian hyperstimulation syndrome (DOID:5425 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subendocardial myocardial infarction (DOID:5849 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thromboangiitis obliterans (DOID:12918 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arteriosclerosis obliterans (DOID:5160 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intermittent claudication (DOID:3669 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cavernous sinus thrombosis (DOID:3575 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thalamic disease (DOID:4662 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dic in newborn (DOID:11246 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anterior spinal artery syndrome (DOID:6712 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic monocytic leukemia (DOID:8593 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hilar cholangiocellular carcinoma (DOID:5246 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "binder syndrome (DOID:14683 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant otitis externa (DOID:10516 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "marburg hemorrhagic fever (DOID:4327 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carrion's disease (DOID:0050398 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "taylor's syndrome (DOID:9346 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "avoidant personality disorder (DOID:1509 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phencyclidine abuse (DOID:5062 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subacute myeloid leukemia (DOID:8747 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "megakaryocytic leukemia (DOID:8761 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leukemoid reaction (DOID:3166 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic myeloproliferative disease (DOID:2226 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemorrhagic thrombocythemia (DOID:2224 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myelofibrosis (DOID:4971 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thrombocytosis (DOID:2228 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polycythemia (DOID:8432 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polycythemia vera (DOID:8997 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune disease of blood (DOID:0060050 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary thrombocytopenia (DOID:8925 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune thrombocytopenic purpura (DOID:8924 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune hemolytic anemia (DOID:718 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "evans' syndrome (DOID:8931 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thrombocytopenia due to platelet alloimmunization (DOID:1587 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemolytic-uremic syndrome (DOID:12554 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypersplenism (DOID:6376 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "splenic disease (DOID:2529 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "splenic infarction (DOID:2533 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemoglobinuria (DOID:582 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital hemolytic anemia (DOID:589 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemoglobinopathy (DOID:2860 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemolytic anemia (DOID:583 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "normocytic anemia (DOID:720 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "methemoglobinemia (DOID:10783 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alpha thalassemia (DOID:1099 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "beta thalassemia (DOID:12241 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thalassemia (DOID:10241 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sickle cell anemia (DOID:10923 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary spherocytosis (DOID:12971 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary elliptocytosis (DOID:2373 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital dyserythropoietic anemia (DOID:1338 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "splenic sequestration (DOID:11786 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemoglobin d disease (DOID:5378 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemoglobin c disease (DOID:2859 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemoglobin e disease (DOID:5379 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute chest syndrome (DOID:1584 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary polycythemia (DOID:10780 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ariboflavinosis (DOID:8454 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lateral sinus thrombosis (DOID:3574 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liver lymphoma (DOID:901 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracortical osteogenic sarcoma (DOID:7602 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney osteogenic sarcoma (DOID:5983 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "submandibular adenitis (DOID:4636 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervix erosion (DOID:3456 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acanthocephaliasis (DOID:0050254 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fibrogenesis imperfecta ossium (DOID:0080040 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "afferent loop syndrome (DOID:8438 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "foster-kennedy syndrome (DOID:14555 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "worth's syndrome (DOID:0080037 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blount's disease (DOID:14798 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tooth ankylosis (DOID:12661 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "emphysematous cholecystitis (DOID:9765 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular gonadoblastoma (DOID:3579 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parathyroid transitional clear cell adenoma (DOID:7609 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "axial osteomalacia (DOID:0080039 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uremic neuropathy (DOID:4675 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epstein-barr virus hepatitis (DOID:0050204 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diaper rash (DOID:2770 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "achondrogenesis type ia (DOID:0080054 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian solid teratoma (DOID:6315 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gallbladder sarcoma (DOID:4058 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "combined thymoma (DOID:3281 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian lymphoma (DOID:2150 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "interstitial myocarditis (DOID:817 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sea-blue histiocyte syndrome (DOID:4423 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "descending colon cancer (DOID:12190 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blind loop syndrome (DOID:10606 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "metagonimiasis (DOID:884 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed germ cell-sex cord neoplasm (DOID:2996 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chief cell adenoma (DOID:7607 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "idiopathic juvenile osteoporosis (DOID:12559 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain germinoma (DOID:2127 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system germ cell tumor (DOID:4439 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system germinoma (DOID:4438 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liver inflammatory pseudotumor (DOID:918 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extragonadal seminoma (DOID:5838 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extragonadal germ cell cancer (DOID:4717 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mesenteric vascular occlusion (DOID:13252 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "postcholecystectomy syndrome (DOID:9740 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "infarct of liver (DOID:13738 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatic tuberculosis (DOID:407 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peliosis hepatis (DOID:914 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extraosseous osteosarcoma (DOID:3357 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clear cell chondrosarcoma (DOID:5867 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "periodontosis (DOID:9893 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ascending cholangitis (DOID:14270 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ancylostomiasis (DOID:12841 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gnathomiasis (DOID:11379 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "liver angiosarcoma (DOID:268 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "secondary hypertrophic osteoarthropathy (DOID:10393 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gorham's disease (DOID:4837 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "suppurative cholangitis (DOID:14269 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endodermal sinus tumor (DOID:1911 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurodermatitis (DOID:3309 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urogenital tuberculosis (DOID:2149 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal tuberculosis (DOID:9733 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dirofilariasis (DOID:1082 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "discitis (DOID:10986 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tympanic membrane disease (DOID:5782 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tympanosclerosis (DOID:1214 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pelger-huet anomaly (DOID:9631 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scheuermann's disease (DOID:13300 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral atherosclerosis (DOID:12720 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chondroblastic osteosarcoma (DOID:3372 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myositis ossificans (DOID:668 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blastomycosis (DOID:12663 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "penicilliosis (DOID:0050288 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acalculous cholecystitis (DOID:2828 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myelophthisic anemia (DOID:2354 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bursitis (DOID:2965 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "periarthritis (DOID:2964 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diffuse idiopathic skeletal hyperostosis (DOID:6652 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypervitaminosis a (DOID:9972 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sideroblastic anemia with spinocerebellar ataxia (DOID:0060064 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acrodermatitis enteropathica (DOID:0050605 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acrodermatitis (DOID:2722 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute cholangitis (DOID:14271 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choledochal cyst (DOID:899 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arterial calcification of infancy (DOID:0050644 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudoxanthoma elasticum (DOID:2738 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic cholangitis (DOID:9439 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scurvy (DOID:13724 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cranial nerve palsy (DOID:3817 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastroschisis (DOID:11044 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "actinomycosis (DOID:8478 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "q fever (DOID:11100 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ornithosis (DOID:11262 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mediastinitis (DOID:819 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "quadriplegia (DOID:12835 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "esophageal varix (DOID:112 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatic vascular disease (DOID:272 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "portal hypertension (DOID:10762 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "portal vein thrombosis (DOID:11695 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatic vein thrombosis (DOID:11512 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatic coma (DOID:12550 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatic encephalopathy (DOID:13413 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatopulmonary syndrome (DOID:900 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatitis a (DOID:12549 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatitis e (DOID:4411 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parathyroid carcinoma (DOID:1540 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parathyroid adenoma (DOID:7608 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "x-linked hypophosphatemia (DOID:0050445 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperphosphatemia (DOID:0050459 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phosphorus metabolism disease (DOID:2485 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypophosphatemia (DOID:0050336 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteomalacia (DOID:10573 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rickets (DOID:10609 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "calcinosis (DOID:182 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "calcium metabolism disease (DOID:10575 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mineral metabolism disease (DOID:0050032 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephrocalcinosis (DOID:12679 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "calciphylaxis (DOID:4734 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteitis fibrosa (DOID:3341 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal osteodystrophy (DOID:13068 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypercalcemia (DOID:12678 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperparathyroidism (DOID:13543 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parathyroid gland disease (DOID:11201 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary hyperparathyroidism (DOID:11202 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "secondary hyperparathyroidism (DOID:12466 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypoparathyroidism (DOID:11199 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypervitaminosis d (DOID:9971 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteochondrodysplasia (DOID:2256 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteogenesis imperfecta (DOID:12347 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cleidocranial dysplasia (DOID:13994 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fibrous dysplasia (DOID:0080031 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mccune albright syndrome (DOID:1858 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fibrodysplasia ossificans progressiva (DOID:13374 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone remodeling disease (DOID:0080005 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone resorption disease (DOID:0080011 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteoporosis (DOID:11476 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteosclerosis (DOID:4254 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteopetrosis (DOID:13533 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "camurati-engelmann disease (DOID:4997 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "craniometaphyseal dysplasia (DOID:0080033 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperostosis (DOID:205 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paget's disease of bone (DOID:5408 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sost-related sclerosing bone dysplasia (DOID:0080036 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ankylosis (DOID:227 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "root resorption (DOID:14550 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tooth resorption (DOID:13240 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "otosclerosis (DOID:12185 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ollier disease (DOID:4624 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone osteosarcoma (DOID:3376 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conventional central osteosarcoma (DOID:3378 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "small cell osteogenic sarcoma (DOID:3377 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "telangiectatic osteogenic sarcoma (DOID:6951 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fibrosarcomatous osteosarcoma (DOID:7603 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "juxtacortical osteosarcoma (DOID:3373 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peripheral osteosarcoma (DOID:3374 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "periosteal osteogenic sarcoma (DOID:6489 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chondroblastoma (DOID:2649 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone benign neoplasm (DOID:0060094 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "connective tissue benign neoplasm (DOID:0060123 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteoblastoma (DOID:0060098 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ossifying fibroma (DOID:180 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone giant cell tumor (DOID:4305 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "giant cell tumor (DOID:200 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "giant cell reparative granuloma (DOID:1866 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pycnodysostosis (DOID:0080038 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tenosynovial giant cell tumor (DOID:314 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pigmented villonodular synovitis (DOID:2702 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "synovitis (DOID:2703 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testis seminoma (DOID:5842 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "testicular spermatocytic seminoma (DOID:7891 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tyrosinemia (DOID:9275 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tyrosinemia type i (DOID:0050726 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bilirubin metabolic disorder (DOID:2741 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "crigler-najjar syndrome (DOID:3803 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gilbert syndrome (DOID:2739 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kernicterus (DOID:2382 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fascioliasis (DOID:885 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choline deficiency disease (DOID:8456 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pericholangitis (DOID:14272 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "granulomatous hepatitis (DOID:2239 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatitis d (DOID:2047 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multiple chemical sensitivity (DOID:4661 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "drug-induced hepatitis (DOID:2044 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney hypertrophy (DOID:9622 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dubin-johnson syndrome (DOID:12308 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder tuberculosis (DOID:754 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "squamous papillomatosis (DOID:7532 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "laryngeal tuberculosis (DOID:1583 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder calculus (DOID:11355 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric ulcer (DOID:10808 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rumination disorder (DOID:11507 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neonatal candidiasis (DOID:9577 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fungal esophagitis (DOID:13147 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ischemic neuropathy (DOID:1195 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute laryngitis (DOID:9396 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic intestinal vascular insufficiency (DOID:8633 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "photoallergic dermatitis (DOID:3818 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eosinophilic gastritis (DOID:4030 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lennox-gastaut syndrome (DOID:0050561 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cronkhite-canada syndrome (DOID:6225 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "duodenal obstruction (DOID:3558 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "superior mesenteric artery syndrome (DOID:3557 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "radiation cystitis (DOID:7127 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "granulomatous gastritis (DOID:4038 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pneumatosis cystoides intestinalis (DOID:13249 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric mucosal hypertrophy (DOID:8757 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peptic ulcer perforation (DOID:752 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dyskinesia of esophagus (DOID:9192 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anisakiasis (DOID:7033 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "laryngeal disease (DOID:786 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "laryngitis (DOID:3437 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic laryngitis (DOID:11797 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "toxic megacolon (DOID:1770 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "functional diarrhea (DOID:11371 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "duodenitis (DOID:8643 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastroduodenitis (DOID:8644 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "esophageal candidiasis (DOID:13146 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angiodysplasia (DOID:2494 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "active peptic ulcer disease (DOID:749 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alcoholic pancreatitis (DOID:4988 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "exocrine pancreatic insufficiency (DOID:13316 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "steatorrhea (DOID:10602 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pancreatic steatorrhea (DOID:10610 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "postgastrectomy syndrome (DOID:8439 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dumping syndrome (DOID:14495 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tropical sprue (DOID:10607 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "duodenal disease (DOID:4072 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "duodenogastric reflux (DOID:4071 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "short bowel syndrome (DOID:10605 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastritis (DOID:4029 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "stomach disease (DOID:76 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atrophic gastritis (DOID:8929 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "functional gastric disease (DOID:1159 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dyspepsia (DOID:2321 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastroparesis (DOID:11914 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "esophageal disease (DOID:6050 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "esophagitis (DOID:11963 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eosinophilic esophagitis (DOID:13922 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peptic esophagitis (DOID:13976 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peptic ulcer disease (DOID:750 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "duodenal ulcer (DOID:1724 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastroesophageal reflux disease (DOID:8534 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bile reflux (DOID:12237 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hiatus hernia (DOID:12642 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bowel dysfunction (DOID:9779 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "constipation (DOID:2089 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colonic disease (DOID:5353 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "irritable bowel syndrome (DOID:9778 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "megacolon (DOID:11372 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hirschsprung's disease (DOID:10487 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal obstruction (DOID:8437 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ileus (DOID:8440 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal pseudo-obstruction (DOID:3878 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colonic pseudo-obstruction (DOID:3876 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "functional colonic disease (DOID:3877 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paralytic ileus (DOID:8442 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "achalasia (DOID:9164 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "triple-a syndrome (DOID:0050602 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atypical teratoid rhabdoid tumor (DOID:2129 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "erythema infectiosum (DOID:8743 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "viral exanthem (DOID:8672 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "exanthem (DOID:0050486 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epididymitis (DOID:9402 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epididymo-orchitis (DOID:9401 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "legionellosis (DOID:10458 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "legionnaires' disease (DOID:10457 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "facioscapulohumeral muscular dystrophy (DOID:11727 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "wolf-hirschhorn syndrome (DOID:0050460 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sotos syndrome (DOID:14748 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "progeria (DOID:3911 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mast-cell sarcoma (DOID:355 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mast-cell leukemia (DOID:9254 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sm-ahnmd (DOID:4797 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aggressive systemic mastocytosis (DOID:4798 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mastocytosis (DOID:350 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mast cell neoplasm (DOID:3664 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous mastocytosis (DOID:3663 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "systemic mastocytosis (DOID:349 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "indolent systemic mastocytosis (DOID:4660 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urticaria pigmentosa (DOID:12309 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "loeffler endocarditis (DOID:396 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mansonelliasis (DOID:1081 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "restrictive cardiomyopathy (DOID:397 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endomyocardial fibrosis (DOID:12932 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eosinophilic gastroenteritis (DOID:4031 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastroenteritis (DOID:2326 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "folliculitis (DOID:4409 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cellulitis (DOID:3488 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cholinergic urticaria (DOID:14443 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "physical urticaria (DOID:0060220 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dermatographia (DOID:743 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cough variant asthma (DOID:12323 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic rhinitis (DOID:8252 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hand dermatosis (DOID:3158 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "byssinosis (DOID:10323 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovary transitional cell carcinoma (DOID:4000 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "palindromic rheumatism (DOID:1166 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "monoclonal paraproteinemia (DOID:2346 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orbital granuloma (DOID:10499 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brown induration (DOID:12118 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute transudative otitis media (DOID:3697 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute serous otitis media (DOID:11557 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "non-suppurative otitis media (DOID:11180 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "impetigo herpetiformis (DOID:8503 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ocular hyperemia (DOID:1248 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hydrarthrosis (DOID:528 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aortitis (DOID:519 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "takayasu's arteritis (DOID:2508 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain stem infarction (DOID:3523 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lateral medullary syndrome (DOID:3522 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "podoconiosis (DOID:0050138 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kleine-levin syndrome (DOID:0060165 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "recurrent hypersomnia (DOID:8619 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "narcolepsy (DOID:8986 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "herpes gestationis (DOID:14482 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "felty's syndrome (DOID:11042 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mhc class ii deficiency (DOID:5812 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "berylliosis (DOID:10322 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "septal myocardial infarction (DOID:5846 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "caplan's syndrome (DOID:10326 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "juvenile dermatitis herpetiformis (DOID:8507 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glaucomatocyclitic crisis (DOID:9378 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "posterior scleritis (DOID:13676 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute retinal necrosis syndrome (DOID:3611 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atrophic glossitis (DOID:1453 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "geographic tongue (DOID:1455 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "variola major (DOID:0050508 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pustulosis of palm and sole (DOID:4398 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinitis (DOID:3612 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "stevens-johnson syndrome (DOID:0050426 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal vasculitis (DOID:11563 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anterior scleritis (DOID:13794 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sclerosing keratitis (DOID:14444 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scleritis (DOID:13452 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scleral disease (DOID:11343 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "deep keratitis (DOID:9858 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "interstitial keratitis (DOID:9857 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chorioretinitis (DOID:8886 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intermediate uveitis (DOID:12732 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pars planitis (DOID:12731 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sympathetic ophthalmia (DOID:12029 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vogt-koyanagi-harada disease (DOID:12297 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anterior uveitis (DOID:1407 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "panuveitis (DOID:12030 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uveitis (DOID:13141 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uveal disease (DOID:3480 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "iridocyclitis (DOID:9383 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypopyon (DOID:10443 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "posterior uveitis (DOID:12574 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "iritis (DOID:1406 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteosclerotic myeloma (DOID:9541 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "poems syndrome (DOID:14039 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "precursor lymphoblastic lymphoma|leukemia (DOID:5600 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "precursor t-lymphoblastic lymphoma|leukemia (DOID:5599 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral arteritis (DOID:11390 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperglobulinemic purpura (DOID:3325 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "purpura (DOID:3326 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "selective igg deficiency disease (DOID:14176 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "selective iga deficiency disease (DOID:11701 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "early yaws (DOID:10568 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brill-zinsser disease (DOID:11254 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meningovascular neurosyphilis (DOID:0050491 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic interstitial cystitis (DOID:1678 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transient neonatal neutropenia (DOID:11245 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transient neonatal thrombocytopenia (DOID:9771 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystoisosporiasis (DOID:2112 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cicatricial entropion (DOID:13113 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuroschistosomiasis (DOID:13722 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic follicular conjunctivitis (DOID:13326 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carotenemia (DOID:9969 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vernal conjunctivitis (DOID:2474 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ulcerative blepharitis (DOID:9483 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ritter's disease (DOID:9063 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blepharochalasis (DOID:348 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rhinoscleroma (DOID:11336 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parasitic ichthyosporea infectious disease (DOID:0050291 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rhinosporidiosis (DOID:2409 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cd40 ligand deficiency (DOID:0060022 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "small intestine lymphoma (DOID:13996 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alpha chain disease (DOID:0060126 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "heavy chain disease (DOID:0060125 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gamma heavy chain disease (DOID:0060127 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mu chain disease (DOID:0060128 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "asymptomatic neurosyphilis (DOID:10035 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tertiary neurosyphilis (DOID:9988 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tertiary syphilis (DOID:8200 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tabes dorsalis (DOID:10027 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "syphilis (DOID:4166 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "secondary syphilis (DOID:4157 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary syphilis (DOID:4156 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "latent syphilis (DOID:9531 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital syphilis (DOID:9856 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "late congenital syphilis (DOID:10039 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "yaws (DOID:10371 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transient arthritis (DOID:2092 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pediculus humanus capitis infestation (DOID:5501 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bacterial conjunctivitis (DOID:9700 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ophthalmia neonatorum (DOID:9699 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycogen storage disease xv (DOID:0050579 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trachoma (DOID:11265 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphogranuloma venereum (DOID:13819 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inclusion conjunctivitis (DOID:13800 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "suppurative lymphadenitis (DOID:4639 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute tympanitis (DOID:13790 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvar disease (DOID:2059 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vulvitis (DOID:3901 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thoracic outlet syndrome (DOID:3103 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ulnar neuropathy (DOID:4613 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carpal tunnel syndrome (DOID:12169 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nerve compression syndrome (DOID:573 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lesion of sciatic nerve (DOID:12528 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mononeuritis of lower limb (DOID:9473 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sciatic neuropathy (DOID:11446 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mononeuritis (DOID:1802 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mononeuritis multiplex (DOID:1835 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mononeuritis of upper limb and mononeuritis multiplex (DOID:572 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mononeuropathy (DOID:1188 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuritis (DOID:1803 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "median neuropathy (DOID:571 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ulnar nerve lesion (DOID:12168 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune disease of peripheral nervous system (DOID:0060033 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "guillain-barre syndrome (DOID:12842 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "miller fisher syndrome (DOID:12889 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "demyelinating polyneuropathy (DOID:5214 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peripheral nervous system disease (DOID:574 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polyneuropathy (DOID:1389 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic inflammatory demyelinating polyradiculoneuropathy (DOID:5213 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polyradiculoneuropathy (DOID:4308 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polyradiculopathy (DOID:4307 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "radiculopathy (DOID:4306 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune disease of the nervous system (DOID:438 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myasthenia gravis (DOID:437 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuromuscular junction disease (DOID:439 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lambert-eaton myasthenic syndrome (DOID:0050214 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital myasthenic syndrome (DOID:3635 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute disseminated encephalomyelitis (DOID:639 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute hemorrhagic leukoencephalitis (DOID:10992 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myelitis (DOID:322 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuromyelitis optica (DOID:8869 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tibial nerve palsy (DOID:12529 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "asymmetric motor neuropathy (DOID:7559 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "46 xy gonadal dysgenesis (DOID:14448 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peripheral neuropathy (DOID:0060053 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sensory peripheral neuropathy (DOID:2491 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "axonal neuropathy (DOID:7319 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "motor peripheral neuropathy (DOID:2477 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "charcot-marie-tooth disease (DOID:10595 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "charcot-marie-tooth disease type 2 (DOID:0050539 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "charcot-marie-tooth disease type 3 (DOID:0050540 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "charcot-marie-tooth disease type 1 (DOID:0050538 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "motor neuritis (DOID:683 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "distal hereditary motor neuropathy (DOID:0050582 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amyotrophic neuralgia (DOID:10383 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brachial plexus neuropathy (DOID:3690 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plexopathy (DOID:3688 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brachial plexus lesion (DOID:8443 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vertebrobasilar insufficiency (DOID:13003 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hymenolepiasis (DOID:10074 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "photosensitivity disease (DOID:3159 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phototoxic dermatitis (DOID:4407 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "shwartzman phenomenon (DOID:3825 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leukocyte-adhesion deficiency syndrome (DOID:611 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leukostasis (DOID:12986 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leukocyte adhesion deficiency (DOID:6612 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic granulomatous disease (DOID:3265 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phagocyte bactericidal dysfunction (DOID:3262 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acne (DOID:6543 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sebaceous gland disease (DOID:9098 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "seborrheic dermatitis (DOID:8741 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rosacea (DOID:8881 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anhidrosis (DOID:11156 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hidradenitis (DOID:2282 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hidradenitis suppurativa (DOID:2280 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sweat gland disease (DOID:1383 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypohidrosis (DOID:11155 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "keratosis (DOID:161 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "palmoplantar keratosis (DOID:3390 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nonepidermolytic palmoplantar keratoderma (DOID:0050428 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary mucosal leukokeratosis (DOID:0050448 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pachyonychia congenita (DOID:0050449 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epidermolytic hyperkeratosis (DOID:4603 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "monilethrix (DOID:0050472 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital ichthyosiform erythroderma (DOID:1699 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ichthyosis vulgaris (DOID:1702 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "x-linked ichthyosis (DOID:1700 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "netherton syndrome (DOID:0050474 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "porokeratosis (DOID:3805 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pityriasis rubra pilaris (DOID:9212 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autoimmune disease of skin and connective tissue (DOID:0060039 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bullous skin disease (DOID:8502 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bullous pemphigoid (DOID:8506 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dermatitis herpetiformis (DOID:8505 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cicatricial pemphigoid (DOID:11656 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epidermolysis bullosa acquisita (DOID:4313 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subcorneal pustular dermatosis (DOID:8508 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "erythema multiforme (DOID:0050185 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epidermolysis bullosa (DOID:2730 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vesiculobullous skin disease (DOID:2731 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epidermolysis bullosa simplex (DOID:4644 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epidermolysis bullosa dystrophica (DOID:4959 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "junctional epidermolysis bullosa (DOID:3209 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "keratosis follicularis (DOID:2734 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hailey-hailey disease (DOID:0050429 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acrokeratosis verruciformis (DOID:0050606 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brody myopathy (DOID:0050692 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "croup (DOID:9395 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "jmp syndrome (DOID:0050553 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute hemorrhagic conjunctivitis (DOID:11227 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paralytic poliomyelitis (DOID:0050515 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "poliomyelitis (DOID:4953 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "postpoliomyelitis syndrome (DOID:4952 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "smallpox (DOID:8736 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vaccinia (DOID:3298 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "variola minor (DOID:9153 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "monkeypox (DOID:3292 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cowpox (DOID:8956 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "western equine encephalitis (DOID:10843 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "venezuelan equine encephalitis (DOID:9584 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chikungunya (DOID:0050012 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast medullary carcinoma (DOID:5605 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mikulicz disease (DOID:12900 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute necrotizing encephalitis (DOID:5222 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coronary aneurysm (DOID:3362 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "heart aneurysm (DOID:9768 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "asymptomatic dengue (DOID:0050143 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "borna disease (DOID:5154 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "barth syndrome (DOID:0050476 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neutral lipid storage disease (DOID:0050729 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sjogren-larsson syndrome (DOID:14501 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral palsy (DOID:1969 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spastic cerebral palsy (DOID:0050669 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spastic quadriplegia (DOID:10970 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spastic diplegia (DOID:10965 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spastic hemiplegia (DOID:10967 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mitochondrial metabolism disease (DOID:700 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leigh disease (DOID:3652 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic progressive external ophthalmoplegia (DOID:12558 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kearns-sayre syndrome (DOID:12934 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "melas syndrome (DOID:3687 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mitochondrial encephalomyopathy (DOID:890 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mitochondrial myopathy (DOID:699 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "merrf syndrome (DOID:310 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alpers syndrome (DOID:1442 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cranial nerve disease (DOID:5656 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "optic nerve disease (DOID:1891 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "visual pathway disease (DOID:1393 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "optic atrophy (DOID:5723 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leber hereditary optic neuropathy (DOID:705 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary spastic paraplegia (DOID:2476 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paraplegia (DOID:607 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebellar ataxia (DOID:0050753 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebellar disease (DOID:2786 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dentatorubral-pallidoluysian atrophy (DOID:0060162 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "machado-joseph disease (DOID:1440 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "friedreich ataxia (DOID:12705 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinocerebellar ataxia (DOID:1441 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinocerebellar degeneration (DOID:2478 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "olivopontocerebellar atrophy (DOID:14784 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cortical blindness (DOID:11831 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "visual cortex disease (DOID:5691 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "visual epilepsy (DOID:11832 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "wernicke-korsakoff syndrome (DOID:10915 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "wernicke encephalopathy (DOID:2384 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "beriberi (DOID:13725 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "biotin-responsive basal ganglia disease (DOID:0050659 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "deafness dystonia syndrome (DOID:0050757 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary lymphedema (DOID:0050580 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cranio-facial dystonia (DOID:0050845 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meige syndrome (DOID:3982 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "de quervain disease (DOID:14107 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuroleptic malignant syndrome (DOID:14464 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system hereditary degenerative disease (DOID:481 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dystonia (DOID:543 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "generalized dystonia (DOID:0050835 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blepharospasm (DOID:529 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "focal dystonia (DOID:0050836 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lingual-facial-buccal dyskinesia (DOID:9854 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "motion sickness (DOID:2951 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "space motion sickness (DOID:4796 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amnestic disorder (DOID:10914 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retrograde amnesia (DOID:4543 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anterograde amnesia (DOID:5340 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "basal ganglia disease (DOID:679 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "synucleinopathy (DOID:0050890 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parkinson's disease (DOID:14330 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "toxic encephalopathy (DOID:3602 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alzheimer's disease (DOID:10652 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tauopathy (DOID:680 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dementia (DOID:1307 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amyotrophic lateral sclerosis (DOID:332 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "motor neuron disease (DOID:231 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "huntington's disease (DOID:12858 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "frontotemporal dementia (DOID:9255 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "movement disease (DOID:480 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "progressive supranuclear palsy (DOID:678 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pick's disease (DOID:11870 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lewy body dementia (DOID:12217 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multiple system atrophy (DOID:4752 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "striatonigral degeneration (DOID:4751 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cognitive disorder (DOID:1561 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "psychotic disorder (DOID:2468 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "schizophrenia (DOID:5419 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "developmental disorder of mental health (DOID:0060037 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "specific developmental disorder (DOID:0060038 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "disease of mental health (DOID:150 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intellectual disability (DOID:1059 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autism spectrum disorder (DOID:0060041 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pervasive developmental disorder (DOID:0060040 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autistic disorder (DOID:12849 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tic disorder (DOID:2769 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gilles de la tourette syndrome (DOID:11119 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "attention deficit hyperactivity disorder (DOID:1094 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "agnosia (DOID:4090 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "communication disorder (DOID:2033 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pain agnosia (DOID:0060145 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "apraxia (DOID:0060135 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aphasia (DOID:0060046 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "language disorder (DOID:93 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "essential tremor (DOID:4990 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "agoraphobia (DOID:593 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phobic disorder (DOID:591 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "specific phobia (DOID:599 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anxiety disorder (DOID:2030 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "panic disorder (DOID:594 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "generalized anxiety disorder (DOID:14320 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bipolar disorder (DOID:3312 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mood disorder (DOID:3324 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bipolar i disorder (DOID:14042 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "schizoaffective disorder (DOID:5418 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endogenous depression (DOID:1595 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mental depression (DOID:1596 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "major depressive disorder (DOID:1470 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "melancholia (DOID:2848 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conduct disorder (DOID:12995 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "antisocial personality disorder (DOID:10939 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "personality disorder (DOID:1510 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "borderline personality disorder (DOID:10930 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alcohol abuse (DOID:1574 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "substance abuse (DOID:302 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cocaine abuse (DOID:809 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "substance-related disorder (DOID:303 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "substance dependence (DOID:9973 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alcohol dependence (DOID:0050741 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "drug dependence (DOID:9974 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "opiate dependence (DOID:2559 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "morphine dependence (DOID:2560 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "heroin dependence (DOID:9976 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cocaine dependence (DOID:9975 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nicotine dependence (DOID:0050742 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "withdrawal disorder (DOID:0060001 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eating disorder (DOID:8670 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "impulse control disorder (DOID:10937 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pathological gambling (DOID:12399 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trichotillomania (DOID:0050587 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kleptomania (DOID:12400 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "separation anxiety disorder (DOID:10685 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cyclothymic disorder (DOID:845 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "delusional disorder (DOID:778 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "animal phobia (DOID:600 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "childhood disintegrative disease (DOID:13487 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dysthymic disorder (DOID:12139 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "schizophreniform disorder (DOID:11328 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "somatization disorder (DOID:13918 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adjustment disorder (DOID:507 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cannabis abuse (DOID:9505 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cannabis dependence (DOID:1849 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hallucinogen dependence (DOID:9977 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neonatal abstinence syndrome (DOID:9828 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "communicating hydrocephalus (DOID:1573 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "normal pressure hydrocephalus (DOID:1572 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hydrocephalus (DOID:10908 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracranial hypertension (DOID:9428 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "obstructive hydrocephalus (DOID:14159 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudotumor cerebri (DOID:11459 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "papilledema (DOID:146 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trigeminal nerve disease (DOID:561 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trigeminal neuralgia (DOID:12098 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurotic disorder (DOID:4964 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bell's palsy (DOID:12506 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "facial paralysis (DOID:13934 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "facial nerve disease (DOID:1756 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuroaxonal dystrophy (DOID:2367 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary sensory neuropathy (DOID:0050548 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "riley-day syndrome (DOID:11589 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autonomic nervous system disease (DOID:11465 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autonomic neuropathy (DOID:11504 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diabetic autonomic neuropathy (DOID:11503 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "horner's syndrome (DOID:11486 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diabetic neuropathy (DOID:9743 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diabetic polyneuropathy (DOID:12785 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "complex regional pain syndrome (DOID:3223 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "reflex sympathetic dystrophy (DOID:1811 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "causalgia (DOID:3222 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "burning mouth syndrome (DOID:4331 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vasomotor rhinitis (DOID:4730 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dental pulp disease (DOID:5330 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulpitis (DOID:11121 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dental pulp necrosis (DOID:11623 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "stereotypic movement disorder (DOID:2303 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "opioid abuse (DOID:11206 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute cystitis (DOID:13148 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder disease (DOID:365 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystitis (DOID:1679 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "interstitial cystitis (DOID:13949 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurogenic bladder (DOID:12143 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "body dysmorphic disorder (DOID:0060163 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "somatoform disorder (DOID:4737 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pain disorder (DOID:0060164 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "erythromelalgia (DOID:9240 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dentin sensitivity (DOID:698 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric outlet obstruction (DOID:3122 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pyloric stenosis (DOID:12639 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypertrophic pyloric stenosis (DOID:12638 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polycystic liver disease (DOID:0050770 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epicondylitis (DOID:14087 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plantar fasciitis (DOID:9600 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "temporal lobe epilepsy (DOID:3328 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myofascial pain syndrome (DOID:431 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plasmodium ovale malaria (DOID:12919 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coronary artery vasospasm (DOID:11840 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "priapism (DOID:9286 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "penile disease (DOID:1529 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "impotence (DOID:1875 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sexual dysfunction (DOID:1876 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sexual disorder (DOID:0060043 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vasculogenic impotence (DOID:4762 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peyronie's disease (DOID:8616 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypoactive sexual desire disorder (DOID:13868 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "psychosexual disorder (DOID:10132 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "premature ejaculation (DOID:13709 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder neck obstruction (DOID:13948 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urethral obstruction (DOID:12577 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urethral disease (DOID:732 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urethral stricture (DOID:1829 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urethral intrinsic sphincter deficiency (DOID:13461 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "episodic ataxia (DOID:963 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign familial infantile epilepsy (DOID:0060169 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign familial neonatal epilepsy (DOID:14777 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign neonatal seizures (DOID:14264 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neonatal period electroclinical syndrome (DOID:0050702 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ohtahara syndrome (DOID:0050709 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "early myoclonic encephalopathy (DOID:308 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adolescence-adult electroclinical syndrome (DOID:0050705 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epilepsy with generalized tonic-clonic seizures (DOID:7725 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "juvenile absence epilepsy (DOID:0060172 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "infancy electroclinical syndrome (DOID:0050703 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dravet syndrome (DOID:0060171 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "generalized epilepsy with febrile seizures plus (DOID:0060170 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "idiopathic generalized epilepsy (DOID:1827 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "electroclinical syndrome (DOID:0050701 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epilepsy syndrome (DOID:1826 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "progressive myoclonus epilepsy (DOID:891 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "variable age at onset electroclinical syndrome (DOID:0050706 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lafora disease (DOID:3534 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "unverricht-lundborg syndrome (DOID:3535 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign epilepsy with centrotemporal spikes (DOID:3329 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "childhood electroclinical syndrome (DOID:0050704 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "childhood absence epilepsy (DOID:1825 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "landau-kleffner syndrome (DOID:2538 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "complex partial epilepsy (DOID:12382 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "focal epilepsy (DOID:2234 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial hemiplegic migraine (DOID:0060178 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "migraine with aura (DOID:10024 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "migraine (DOID:6364 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "migraine without aura (DOID:12783 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alternating hemiplegia of childhood (DOID:0050635 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemiplegia (DOID:10969 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alcohol-related neurodevelopmental disorder (DOID:0050667 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fetal alcohol spectrum disorder (DOID:0050696 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fetal alcohol syndrome (DOID:0050665 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "partial fetal alcohol syndrome (DOID:0050666 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sclerosing hepatic carcinoma (DOID:5026 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian embryonal carcinoma (DOID:5681 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dermoid cyst of ovary (DOID:5117 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ileum cancer (DOID:10153 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "necrotizing gastritis (DOID:4037 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conjunctival deposit (DOID:11653 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conjunctival pigmentation (DOID:12304 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parenchymatous neurosyphilis (DOID:0050490 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ostertagiasis (DOID:3985 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brown-sequard syndrome (DOID:606 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "filamentary keratitis (DOID:4664 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dressler's syndrome (DOID:10507 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skull base meningioma (DOID:4437 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "petroclival meningioma (DOID:7818 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "encephalitozoonosis (DOID:4270 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "microsporidiosis (DOID:4271 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "telogen effluvium (DOID:1943 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trichuriasis (DOID:1252 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ascariasis (DOID:456 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute intermittent porphyria (DOID:3890 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute porphyria (DOID:3133 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "porphyria (DOID:13268 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "erythropoietic protoporphyria (DOID:13270 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "porphyria cutanea tarda (DOID:3132 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "variegate porphyria (DOID:4346 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary coproporphyria (DOID:13269 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hepatoerythropoietic porphyria (DOID:5230 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous porphyria (DOID:13271 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pearson syndrome (DOID:0060067 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "x-linked sideroblastic anemia with ataxia (DOID:0050554 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sideroblastic anemia (DOID:8955 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "x-linked sideroblastic anemia (DOID:0060063 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pyridoxine-responsive sideroblastic anemia (DOID:0060066 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "metal metabolism disorder (DOID:896 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemochromatosis (DOID:2352 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "wilson disease (DOID:893 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "menkes disease (DOID:1838 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atransferrinemia (DOID:0050649 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aceruloplasminemia (DOID:0050711 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pantothenate kinase-associated neurodegeneration (DOID:3981 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemosiderosis (DOID:12119 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "iron metabolism disease (DOID:2351 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "siderosis (DOID:10328 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "iron deficiency anemia (DOID:11758 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "microcytic anemia (DOID:11252 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypochromic microcytic anemia (DOID:0050642 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypochromic anemia (DOID:11759 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "folic acid deficiency anemia (DOID:14026 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "deficiency anemia (DOID:13121 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "methylmalonic aciduria and homocystinuria type cblc (DOID:0050715 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vitamin b12 deficiency (DOID:0050731 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vitamin metabolic disorder (DOID:0050718 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "macrocytic anemia (DOID:2361 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "megaloblastic anemia (DOID:13382 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pernicious anemia (DOID:13381 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anemia of prematurity (DOID:11243 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "stress polycythemia (DOID:2838 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acquired polycythemia (DOID:2834 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neonatal anemia (DOID:11244 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "twin-to-twin transfusion syndrome (DOID:13576 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blood group incompatibility (DOID:4176 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rh isoimmunization (DOID:4175 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rh deficiency syndrome (DOID:0050641 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fetal erythroblastosis (DOID:1098 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian cystadenocarcinoma (DOID:3605 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian serous cystadenocarcinoma (DOID:5746 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovary serous adenocarcinoma (DOID:5744 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian mucinous cystadenocarcinoma (DOID:3604 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric papillary adenocarcinoma (DOID:5593 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "purulent acute otitis media (DOID:10435 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "streptococcal meningitis (DOID:11574 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial periodic paralysis (DOID:1029 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypokalemic periodic paralysis (DOID:14452 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperkalemic periodic paralysis (DOID:14451 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thomsen disease (DOID:2106 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myotonic disease (DOID:450 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myotonic dystrophy type 1 (DOID:11722 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myotonic dystrophy type 2 (DOID:0050759 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arrhythmogenic right ventricular cardiomyopathy (DOID:0050431 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "becker muscular dystrophy (DOID:9883 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "muscular dystrophy (DOID:9884 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atrophic muscular disease (DOID:913 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "duchenne muscular dystrophy (DOID:11723 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuropathy (DOID:870 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuromuscular disease (DOID:440 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "limb-girdle muscular dystrophy (DOID:11724 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "muscular atrophy (DOID:767 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "emery-dreifuss muscular dystrophy (DOID:11726 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "distal muscular dystrophy (DOID:11720 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central core myopathy (DOID:3529 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital structural myopathy (DOID:422 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant hyperthermia (DOID:8545 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nemaline myopathy (DOID:3191 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "centronuclear myopathy (DOID:14717 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bethlem myopathy (DOID:0050663 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ullrich congenital muscular dystrophy (DOID:0050558 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital muscular dystrophy (DOID:0050557 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "walker-warburg syndrome (DOID:0050560 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fukuyama congenital muscular dystrophy (DOID:0050559 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "muscular dystrophy-dystroglycanopathy (DOID:0050588 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clubfoot (DOID:11836 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "distal arthrogryposis (DOID:0050646 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atrioventricular block (DOID:0050820 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital heart block (DOID:990 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "heart conduction disease (DOID:10273 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sick sinus syndrome (DOID:13884 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sinoatrial node disease (DOID:0050824 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "right bundle branch block (DOID:13209 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "wolff-parkinson-white syndrome (DOID:384 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial atrial fibrillation (DOID:0050650 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brugada syndrome (DOID:0050451 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "long qt syndrome (DOID:2843 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "timothy syndrome (DOID:0060173 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "jervell-lange nielsen syndrome (DOID:2842 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "andersen-tawil syndrome (DOID:0050434 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aortic valve disease (DOID:62 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aortic valve stenosis (DOID:1712 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "heart valve disease (DOID:4079 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aortic valve insufficiency (DOID:57 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mitral valve disease (DOID:61 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mitral valve insufficiency (DOID:11502 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mitral valve stenosis (DOID:1754 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mitral valve prolapse (DOID:988 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ebstein anomaly (DOID:14289 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tricuspid valve disease (DOID:0050826 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tricuspid valve insufficiency (DOID:4080 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary valve stenosis (DOID:6420 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary valve disease (DOID:5749 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary valve insufficiency (DOID:14265 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atrial heart septal defect (DOID:1882 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "patent foramen ovale (DOID:13620 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital heart disease (DOID:1682 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "heart septal defect (DOID:1681 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ventricular septal defect (DOID:1657 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "double outlet right ventricle (DOID:6406 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tetralogy of fallot (DOID:6419 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "patent ductus arteriosus (DOID:13832 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atrioventricular septal defect (DOID:0050651 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypoplastic left heart syndrome (DOID:9955 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anterolateral myocardial infarction (DOID:5845 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemopneumothorax (DOID:2718 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "silent myocardial infarction (DOID:5854 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endocardial fibroelastosis (DOID:12929 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "posteroinferior myocardial infarction (DOID:5843 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tick paralysis (DOID:11285 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anterior compartment syndrome (DOID:3933 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tricuspid valve prolapse (DOID:5644 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diaphragmatic eventration (DOID:10480 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "compartment syndrome (DOID:682 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous diphtheria (DOID:12275 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atrophic rhinitis (DOID:4731 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conjunctival pterygium (DOID:10526 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pterygium (DOID:0002116 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bruxism (DOID:2846 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic ulcer of skin (DOID:8549 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "decubitus ulcer (DOID:8717 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orbital disease (DOID:930 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myopathy of extraocular muscle (DOID:929 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oculopharyngeal muscular dystrophy (DOID:11719 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "exophthalmos (DOID:9370 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "enophthalmos (DOID:11175 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital disorder of glycosylation (DOID:5212 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital disorder of glycosylation type ii (DOID:0050571 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutis laxa (DOID:3144 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "protein-losing enteropathy (DOID:10611 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital disorder of glycosylation type i (DOID:0050570 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nutmeg liver (DOID:13739 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "geniculate herpes zoster (DOID:9210 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "posterior polar cataract (DOID:0050537 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pasteurellosis (DOID:11055 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic apical periodontitis (DOID:11269 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "periapical granuloma (DOID:4617 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "periapical periodontitis (DOID:823 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "von economo's disease (DOID:5225 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skeletal tuberculosis (DOID:1639 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dubowitz syndrome (DOID:14796 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal glycosuria (DOID:9432 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "laryngotracheitis (DOID:0050148 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plasmodium vivax malaria (DOID:12978 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed malaria (DOID:14325 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "villous adenocarcinoma (DOID:4917 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "psammomatous meningioma (DOID:7210 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nasal cavity neoplasm (DOID:9310 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "internal hemorrhoid (DOID:9749 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult astrocytic tumour (DOID:3076 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spastic entropion (DOID:12395 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "senile ectropion (DOID:13356 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypercementosis (DOID:12733 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "microcystic meningioma (DOID:4594 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nasal cavity squamous cell carcinoma (DOID:5515 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "suppurative periapical periodontitis (DOID:2562 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "middle ear carcinoma (DOID:4893 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "middle ear squamous cell carcinoma (DOID:5526 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lacrimal gland adenocarcinoma (DOID:298 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lacrimal gland adenoid cystic carcinoma (DOID:4870 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lacrimal gland cancer (DOID:294 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lacrimal system cancer (DOID:292 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lacrimal gland carcinoma (DOID:293 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "childhood malignant schwannoma (DOID:7732 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dentine erosion (DOID:13629 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "enamel erosion (DOID:2497 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tooth erosion (DOID:2498 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain glioma (DOID:0060108 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain glioblastoma multiforme (DOID:3073 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endometrial adenosquamous carcinoma (DOID:5631 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "perforated corneal ulcer (DOID:10445 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cornea cancer (DOID:6199 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "corneal ulcer (DOID:8463 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mooren's ulcer (DOID:10439 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conjunctivochalasis (DOID:4250 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic meningitis (DOID:10341 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eosinophilic meningitis (DOID:10361 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angiostrongyliasis (DOID:0050256 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain angioma (DOID:5393 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracranial structure hemangioma (DOID:2517 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral angioma (DOID:6621 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angiokeratoma circumscriptum (DOID:5949 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary emphysema (DOID:9675 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "interstitial emphysema (DOID:10030 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "iris disease (DOID:240 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aniridia (DOID:12271 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "exfoliation syndrome (DOID:13641 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phacogenic glaucoma (DOID:12571 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glaucoma (DOID:1686 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "open-angle glaucoma (DOID:1067 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary open angle glaucoma (DOID:1070 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "low tension glaucoma (DOID:13544 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "borderline glaucoma (DOID:9283 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ocular hypertension (DOID:9282 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute closed-angle glaucoma (DOID:13862 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angle-closure glaucoma (DOID:13550 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary angle-closure glaucoma (DOID:1405 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic closed-angle glaucoma (DOID:14445 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neovascular glaucoma (DOID:1687 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "buphthalmos (DOID:11211 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hydrophthalmos (DOID:11212 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary congenital glaucoma (DOID:0050593 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "juvenile glaucoma (DOID:1068 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "axenfeld-rieger syndrome (DOID:14686 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tyrosinemia type ii (DOID:0050725 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "macular corneal dystrophy (DOID:2565 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lattice corneal dystrophy (DOID:8943 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "corneal granular dystrophy (DOID:12318 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "keratoconus (DOID:10126 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "corneal disease (DOID:10124 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "keratitis (DOID:4677 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "corneal neovascularization (DOID:11382 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bullous keratopathy (DOID:11031 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "keratopathy (DOID:2283 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "corneal edema (DOID:11030 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chandler syndrome (DOID:11554 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fuchs' endothelial dystrophy (DOID:11555 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "corneal dystrophy (DOID:2566 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "corneal degeneration (DOID:1237 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "recurrent corneal erosion (DOID:11541 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "band keratopathy (DOID:11164 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "exocervical carcinoma (DOID:2892 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sennetsu fever (DOID:0050485 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "far eastern spotted fever (DOID:0050046 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "salpingitis isthmica nodosa (DOID:5730 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "squamous cell papilloma (DOID:139 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pyomyositis (DOID:876 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nocardiosis (DOID:2312 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "opportunistic bacterial infectious disease (DOID:0050340 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chancroid (DOID:13778 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sporotrichosis (DOID:14484 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anthrax disease (DOID:7427 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inhalation anthrax (DOID:0050160 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous anthrax (DOID:7426 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic endophthalmitis (DOID:10697 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phlyctenulosis (DOID:11581 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "facial dermatosis (DOID:3134 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "septicemic plague (DOID:3481 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bubonic plague (DOID:10773 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plague (DOID:3482 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pneumonic plague (DOID:10398 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transitional meningioma (DOID:7213 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "2-hydroxyglutaric aciduria (DOID:0050573 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "l-2-hydroxyglutaric aciduria (DOID:0050574 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "d-2-hydroxyglutaric aciduria (DOID:0050575 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acatalasia (DOID:2582 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sulfhemoglobinemia (DOID:12451 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vitreous syneresis (DOID:11816 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "steatitis (DOID:4025 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coronary artery anomaly (DOID:11843 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute maxillary sinusitis (DOID:2050 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "swayback (DOID:5112 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "favism (DOID:13628 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glucosephosphate dehydrogenase deficiency (DOID:2862 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "theileriasis (DOID:3733 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intrinsic asthma (DOID:9360 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "keshan disease (DOID:0050083 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "babesiosis (DOID:9643 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "galactokinase deficiency (DOID:14695 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "galactosemia (DOID:9870 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cataract (DOID:83 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lens disease (DOID:110 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "senile cataract (DOID:9669 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mature cataract (DOID:13717 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diabetic cataract (DOID:13328 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eye carcinoma (DOID:295 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "megakaryocytic tumor (DOID:2225 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "histidine metabolism disease (DOID:9265 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "histidinemia (DOID:0060168 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oral submucous fibrosis (DOID:5773 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amino acid metabolic disorder (DOID:9252 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperhomocysteinemia (DOID:9279 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "homocystinuria (DOID:9263 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypermethioninemia (DOID:0050544 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "methylmalonic acidemia (DOID:14749 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "organic acidemia (DOID:0060159 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "propionic acidemia (DOID:14701 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "isovaleric acidemia (DOID:14753 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "maple syrup urine disease (DOID:9269 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phenylketonuria (DOID:9281 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "3-methylcrotonyl-coa carboxylase deficiency (DOID:0050710 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "biotinidase deficiency (DOID:856 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multiple carboxylase deficiency (DOID:857 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "holocarboxylase synthetase deficiency (DOID:859 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "beta-ketothiolase deficiency (DOID:14723 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "citrullinemia (DOID:9273 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ornithine carbamoyltransferase deficiency (DOID:9271 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urea cycle disorder (DOID:9267 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperargininemia (DOID:9278 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carbamoyl phosphate synthetase i deficiency disease (DOID:9280 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "systemic primary carnitine deficiency disease (DOID:14365 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "psph deficiency (DOID:0050724 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "serine deficiency (DOID:0050721 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycine encephalopathy (DOID:9268 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary fructose intolerance syndrome (DOID:9869 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gamma-amino butyric acid metabolism disorder (DOID:0060176 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "succinic semialdehyde dehydrogenase deficiency (DOID:0060175 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "homocarnosinosis (DOID:0060177 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "stiff-person syndrome (DOID:13366 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chorea-acanthocytosis (DOID:0050766 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neuroacanthocytosis (DOID:0050765 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenosquamous gallbladder carcinoma (DOID:5627 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "megaesophagus (DOID:13186 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pinguecula (DOID:11029 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute frontal sinusitis (DOID:14225 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "baller-gerold syndrome (DOID:0050654 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rapadilino syndrome (DOID:0050774 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rothmund-thomson syndrome (DOID:2732 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "xeroderma pigmentosum (DOID:0050427 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cockayne syndrome (DOID:2962 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "photosensitive trichothiodystrophy (DOID:2960 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "werner syndrome (DOID:5688 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bloom syndrome (DOID:2717 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ataxia telangiectasia (DOID:12704 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nijmegen breakage syndrome (DOID:7400 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dyskeratosis congenita (DOID:2729 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aplastic anemia (DOID:12449 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone marrow disease (DOID:4961 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital hypoplastic anemia (DOID:1342 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fanconi's anemia (DOID:13636 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diamond-blackfan anemia (DOID:1339 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pure red-cell aplasia (DOID:1340 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "recombinase activating gene 1 deficiency (DOID:0060011 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "baylisascariasis (DOID:0050259 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "artemis deficiency (DOID:0060006 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dna ligase iv deficiency (DOID:0060021 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian squamous cell carcinoma (DOID:5531 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute dacryoadenitis (DOID:952 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anaerobic meningitis (DOID:14559 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "granulomatous orchitis (DOID:3089 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "heel spur (DOID:210 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pharyngoconjunctival fever (DOID:13801 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pyosalpinx (DOID:5732 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracranial abscess (DOID:10095 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "calcific tendinitis (DOID:14181 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rheumatic myocarditis (DOID:8481 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anus adenocarcinoma (DOID:3447 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anal gland adenocarcinoma (DOID:7531 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anal canal adenocarcinoma (DOID:3692 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subdural empyema (DOID:11389 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ulceroglandular tularemia (DOID:11990 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anuria (DOID:2983 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ureterolithiasis (DOID:14146 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "herpangina (DOID:10883 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hand, foot and mouth disease (DOID:10881 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute orbital inflammation (DOID:11230 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orbital cellulitis (DOID:11234 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spastic ectropion (DOID:1571 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "female stress incontinence (DOID:724 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gastric dilatation (DOID:3229 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal volvulus (DOID:8445 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alexithymia (DOID:0060131 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "schizoid personality disorder (DOID:10936 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary venoocclusive disease (DOID:5453 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "advanced sleep phase syndrome (DOID:0050628 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central sleep apnea (DOID:9220 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sleep apnea (DOID:0050847 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sleep disorder (DOID:535 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "birk-barel syndrome (DOID:0050675 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung mixed small cell and squamous cell carcinoma (DOID:7081 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fasciolopsiasis (DOID:888 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plantar wart (DOID:13775 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kyasanur forest disease (DOID:11320 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudo-torch syndrome (DOID:0050656 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aicardi-goutieres syndrome (DOID:0050629 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rhinotracheitis (DOID:0050084 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "newcastle disease (DOID:2929 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lassa fever (DOID:9537 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "argentine hemorrhagic fever (DOID:0050194 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bolivian hemorrhagic fever (DOID:0050195 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "venezuelan hemorrhagic fever (DOID:0050196 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphocytic choriomeningitis (DOID:12155 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gallbladder papillomatosis (DOID:3120 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phlebotomus fever (DOID:11360 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "splenic abscess (DOID:2530 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acquired thrombocytopenia (DOID:11126 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "localized pulmonary fibrosis (DOID:5642 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glandular tularemia (DOID:0050382 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oculoglandular tularemia (DOID:13226 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coenurosis (DOID:0050251 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aagenaes syndrome (DOID:6691 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "heterophyiasis (DOID:882 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alcohol-induced mental disorder (DOID:251 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alcoholic psychosis (DOID:252 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "african tick-bite fever (DOID:0050035 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sarcocystosis (DOID:9640 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aspiration pneumonitis (DOID:3240 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lipid pneumonia (DOID:3241 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "crimean-congo hemorrhagic fever (DOID:12287 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute myocarditis (DOID:3951 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myocarditis (DOID:820 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "toxic myocarditis (DOID:9694 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "occupational dermatitis (DOID:4404 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hydrops of gallbladder (DOID:9717 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "toxic pneumonitis (DOID:551 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "campylobacteriosis (DOID:13622 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "la crosse encephalitis (DOID:0050118 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "louping ill (DOID:10250 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "murray valley encephalitis (DOID:10842 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "st. louis encephalitis (DOID:10845 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "west nile fever (DOID:2366 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracranial chondrosarcoma (DOID:7903 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult oligodendroglioma (DOID:3186 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "interval angle-closure glaucoma (DOID:13549 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diffuse infiltrative lymphocytosis syndrome (DOID:6677 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebellar astrocytoma (DOID:4848 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pilocytic astrocytoma of cerebellum (DOID:4853 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "post-traumatic stress disorder (DOID:2055 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "substance-induced psychosis (DOID:8646 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "drug psychosis (DOID:1742 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "drug-induced mental disorder (DOID:1203 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "enamel caries (DOID:217 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "strongyloidiasis (DOID:10955 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spindle cell hemangioma (DOID:496 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gliosarcoma (DOID:3071 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "internuclear ophthalmoplegia (DOID:538 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ophthalmoplegia (DOID:539 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "accommodative spasm (DOID:11637 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "capgras syndrome (DOID:6680 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypodermyiasis (DOID:12926 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "postencephalitic parkinson disease (DOID:14332 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "secondary parkinson disease (DOID:13548 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ocular hypotension (DOID:790 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sphenoorbital meningioma (DOID:7819 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "infiltrating angiolipoma (DOID:3615 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plica syndrome (DOID:12225 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bowen-conradi syndrome (DOID:0050684 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lipoid proteinosis (DOID:14498 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "laurence-moon syndrome (DOID:1930 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudomembranous conjunctivitis (DOID:11190 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "erysipeloid (DOID:0050061 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lobomycosis (DOID:13026 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "erysipelas (DOID:11330 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epithelioid cell synovial sarcoma (DOID:5494 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adamantinoma (DOID:2776 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "long bone adamantinoma (DOID:2775 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tibial adamantinoma (DOID:6322 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mixed type thymoma (DOID:3280 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "water-clear cell adenoma (DOID:5401 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "jaccoud's syndrome (DOID:13080 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "postsurgical hypothyroidism (DOID:1458 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bronchial neoplasm (DOID:3906 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thyroid crisis (DOID:12837 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "albright's hereditary osteodystrophy (DOID:0080053 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudohypoparathyroidism (DOID:4184 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudopseudohypoparathyroidism (DOID:4183 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acrodysostosis (DOID:14669 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "central nervous system origin vertigo (DOID:2479 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone ewing's sarcoma (DOID:3368 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "juxtacortical chondroma (DOID:2601 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chondroma (DOID:2602 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "periosteal chondrosarcoma (DOID:5859 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "extraskeletal chondroma (DOID:3814 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clear cell adenoma (DOID:5390 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dyshidrosis (DOID:9230 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eosinophilic variant of chromophobe renal cell carcinoma (DOID:6606 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "submandibular gland disease (DOID:12897 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ascaridiasis (DOID:3108 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "craniodiaphyseal dysplasia (DOID:0080032 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteopoikilosis (DOID:11991 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "melorheostosis (DOID:4253 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "steroid-induced glaucoma (DOID:9946 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "respiratory bronchiolitis-associated interstitial lung disease (DOID:0050158 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "desquamative interstitial pneumonia (DOID:2796 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous adenocystic carcinoma (DOID:4871 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sweat gland carcinoma (DOID:5667 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transverse colon cancer (DOID:261 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycogen storage disease viii (DOID:2751 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycogen storage disease ix (DOID:0050594 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycogen storage disease vi (DOID:2754 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycogen storage disease i (DOID:2749 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fructose-1,6-bisphosphatase deficiency (DOID:5204 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycogen storage disease iv (DOID:2750 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycogen storage disease iii (DOID:2748 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pyruvate decarboxylase deficiency (DOID:3649 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carbohydrate metabolic disorder (DOID:2978 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycogen metabolism disorder (DOID:0050728 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycogen storage disease (DOID:2747 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycogen storage disease ii (DOID:2752 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycogen storage disease v (DOID:2746 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "danon disease (DOID:0050437 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "x-linked myopathy with excessive autophagy (DOID:0050760 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dihydropyrimidine dehydrogenase deficiency (DOID:14218 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lesch-nyhan syndrome (DOID:1919 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "purine-pyrimidine metabolic disorder (DOID:653 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adenosine deaminase deficiency (DOID:5810 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "purine nucleoside phosphorylase deficiency (DOID:5813 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arts syndrome (DOID:0050647 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperuricemia (DOID:1920 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gout (DOID:13189 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial juvenile hyperuricemic nephropathy (DOID:0060062 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "argininosuccinic aciduria (DOID:14755 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sialuria (DOID:3659 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "canavan disease (DOID:3613 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cherubism (DOID:1856 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "refsum disease (DOID:10582 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peroxisomal disease (DOID:906 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "zellweger syndrome (DOID:905 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "infantile refsum disease (DOID:0050444 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rhizomelic chondrodysplasia punctata (DOID:2580 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenoleukodystrophy (DOID:10588 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral degeneration (DOID:1443 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leukodystrophy (DOID:10579 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "associative agnosia (DOID:0060136 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "apperceptive agnosia (DOID:0060134 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pelizaeus-merzbacher disease (DOID:3210 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "encephalomalacia (DOID:2034 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "periventricular leukomalacia (DOID:13088 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucolipidosis (DOID:3343 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alpha-mannosidosis (DOID:3413 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucopolysaccharidosis i (DOID:12802 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucopolysaccharidosis (DOID:12798 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sly syndrome (DOID:12803 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucopolysaccharidosis iii (DOID:12801 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucopolysaccharidosis ii (DOID:12799 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "metachromatic leukodystrophy (DOID:10581 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucosulfatidosis (DOID:0050441 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucopolysaccharidosis vi (DOID:12800 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fabry disease (DOID:14499 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sphingolipidosis (DOID:1927 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gaucher's disease (DOID:1926 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gangliosidosis (DOID:2368 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gangliosidosis gm2 (DOID:3321 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tay-sachs disease (DOID:3320 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sandhoff disease (DOID:3323 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gangliosidosis gm1 (DOID:3322 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "krabbe disease (DOID:10587 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fucosidosis (DOID:14500 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aspartylglucosaminuria (DOID:0050461 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "beta-mannosidosis (DOID:3633 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alexander disease (DOID:4252 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral lipidosis (DOID:10742 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anal paget's disease (DOID:3446 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "simultanagnosia (DOID:0060148 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "abetalipoproteinemia (DOID:1386 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypolipoproteinemia (DOID:1387 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypobetalipoproteinemia (DOID:1390 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tangier disease (DOID:1388 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "norum disease (DOID:1391 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arcus senilis (DOID:11342 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial lipoprotein lipase deficiency (DOID:14118 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial hypertriglyceridemia (DOID:0050527 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperlipoproteinemia type iii (DOID:3145 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial combined hyperlipidemia (DOID:13809 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial hyperlipidemia (DOID:1168 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lipid metabolism disorder (DOID:3146 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial hypercholesterolemia (DOID:13810 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aortic atherosclerosis (DOID:10230 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebrotendinous xanthomatosis (DOID:4810 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "xanthomatosis (DOID:3345 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "wolman disease (DOID:14497 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cholesterol ester storage disease (DOID:14502 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trachea leiomyoma (DOID:248 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vertebral artery insufficiency (DOID:13095 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital bile acid synthesis defect (DOID:0050674 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anterior cranial fossa meningioma (DOID:4436 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "olfactory groove meningioma (DOID:8057 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "petrous apex meningioma (DOID:7482 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eustachian tube disease (DOID:9739 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "patulous eustachian tube (DOID:12358 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trachea adenoid cystic carcinoma (DOID:4875 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic sphenoidal sinusitis (DOID:10793 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trachea carcinoma (DOID:4876 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sphenoid sinusitis (DOID:10794 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "discrete subaortic stenosis (DOID:5804 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subvalvular aortic stenosis (DOID:5805 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "x-linked nonsyndromic deafness (DOID:0050566 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diffuse interstitial keratitis (DOID:13353 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tracheal disease (DOID:3225 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tracheal stenosis (DOID:3227 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tracheitis (DOID:9392 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endolymphatic hydrops (DOID:9848 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peripheral vertigo (DOID:9847 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meniere's disease (DOID:9849 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "labyrinthine disease (DOID:4539 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vestibular disease (DOID:3426 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "auditory system disease (DOID:2742 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inner ear disease (DOID:2952 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sensorineural hearing loss (DOID:10003 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign paroxysmal positional nystagmus (DOID:13941 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autosomal dominant nonsyndromic deafness (DOID:0050564 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nonsyndromic deafness (DOID:0050563 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autosomal recessive nonsyndromic deafness (DOID:0050565 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "enlarged vestibular aqueduct (DOID:0050332 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "usher syndrome (DOID:0050439 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "labyrinthitis (DOID:1468 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "otitis interna (DOID:3930 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "purulent labyrinthitis (DOID:13534 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "serous labyrinthitis (DOID:1467 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "erythrokeratodermia variabilis (DOID:0050467 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bart-pumphrey syndrome (DOID:0050658 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clouston syndrome (DOID:14693 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant dermis tumor (DOID:5274 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant skin fibrous histiocytoma (DOID:1906 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ciliary body cancer (DOID:4352 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ciliary body disease (DOID:4353 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant ciliary body melanoma (DOID:6524 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "iris cancer (DOID:3478 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant iris melanoma (DOID:6994 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diffuse meningeal melanocytosis (DOID:6379 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gallbladder melanoma (DOID:8167 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "melanoacanthoma (DOID:11684 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epithelioid cell melanoma (DOID:4360 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amelanotic melanoma (DOID:4359 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute conjunctivitis (DOID:11184 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute contagious conjunctivitis (DOID:11213 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amyloid tumor (DOID:6755 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lateral cystocele (DOID:14130 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uveal cancer (DOID:3479 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "uveal melanoma (DOID:6039 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ocular melanoma (DOID:1752 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "posterior uveal melanoma (DOID:6566 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "childhood kidney cell carcinoma (DOID:4454 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myoblastoma (DOID:5039 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cochlear disease (DOID:5463 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "abcd syndrome (DOID:0050600 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "waardenburg's syndrome (DOID:9258 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "piebaldism (DOID:3263 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "platelet storage pool deficiency (DOID:2223 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oculocutaneous albinism (DOID:0050632 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hermansky-pudlak syndrome (DOID:3753 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chediak-higashi syndrome (DOID:2935 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bilateral retinoblastoma (DOID:4650 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "unilateral retinoblastoma (DOID:4651 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leukocoria (DOID:11772 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intraocular retinoblastoma (DOID:4653 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ureter cancer (DOID:11819 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ureter carcinoma (DOID:4939 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subglottis cancer (DOID:11472 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subglottis carcinoma (DOID:7764 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paranasal sinus lymphoma (DOID:1355 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lung adenoid cystic carcinoma (DOID:4872 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dyskinetic cerebral palsy (DOID:0050672 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "contagious pustular dermatitis (DOID:8771 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ureter adenocarcinoma (DOID:4938 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymph node cancer (DOID:10619 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "superficial urinary bladder cancer (DOID:7371 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "periampullary adenocarcinoma (DOID:8110 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "interleukin-7 receptor alpha deficiency (DOID:0060015 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ethmoid sinus adenocarcinoma (DOID:2766 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ethmoid sinus cancer (DOID:1363 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tietze's syndrome (DOID:14021 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "algoneurodystrophy (DOID:14022 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute urate nephropathy (DOID:580 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal disaccharidase deficiency (DOID:9868 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multiple intestinal atresia (DOID:14671 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lactose intolerance (DOID:10604 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fallopian tube gestational choriocarcinoma (DOID:8186 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial retinoblastoma (DOID:4648 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute lymphocytic leukemia (DOID:9952 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adult acute lymphocytic leukemia (DOID:5604 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "childhood leukemia (DOID:7757 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neonatal leukemia (DOID:7756 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenal cortical adenocarcinoma (DOID:3959 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "juvenile myelomonocytic leukemia (DOID:0050458 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myelodysplastic myeloproliferative cancer (DOID:4972 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "noonan syndrome (DOID:3490 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leopard syndrome (DOID:14291 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "costello syndrome (DOID:0050469 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adrenal medulla cancer (DOID:5719 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multilocular clear cell renal cell carcinoma (DOID:4463 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bannayan-riley-ruvalcaba syndrome (DOID:0050657 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cowden disease (DOID:6457 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "olecranon bursitis (DOID:12581 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "specific bursitis often of occupational origin (DOID:12223 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "enthesopathy (DOID:204 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cyclic hematopoiesis (DOID:5339 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "severe congenital neutropenia (DOID:0050590 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thrombocytopenia-absent radius syndrome (DOID:14699 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scirrhous adenocarcinoma (DOID:4024 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "type i ehlers-danlos syndrome (DOID:14720 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "caffey disease (DOID:4257 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucopolysaccharidosis iv (DOID:12804 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amelogenesis imperfecta (DOID:2187 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dental enamel hypoplasia (DOID:693 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dentin dysplasia (DOID:701 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dentinogenesis imperfecta (DOID:4154 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tooth agenesis (DOID:0050591 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypophosphatasia (DOID:14213 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dental fluorosis (DOID:13711 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypermobility syndrome (DOID:13781 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "arterial tortuosity syndrome (DOID:0050645 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervical incompetence (DOID:9681 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ehlers-danlos syndrome (DOID:13359 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "type vi ehlers-danlos syndrome (DOID:14775 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "marfan syndrome (DOID:14323 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "loeys-dietz syndrome (DOID:0050466 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal artery atheroma (DOID:14092 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "achondrogenesis (DOID:0080043 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "achondrogenesis type ib (DOID:0080055 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diastrophic dysplasia (DOID:14687 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "achondrogenesis type ii (DOID:0080056 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypochondrogenesis (DOID:0080044 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kniest dysplasia (DOID:0080045 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spondyloepimetaphyseal dysplasia, strudwick type (DOID:0080028 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spondyloepimetaphyseal dysplasia, sponastrime type (DOID:5684 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spondyloepimetaphyseal dysplasia, missouri type (DOID:0080030 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spondyloepimetaphyseal dysplasia (DOID:0080027 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spondyloepiphyseal dysplasia congenita (DOID:14789 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "weissenbacher-zweym\u00e3\u00bcller syndrome (DOID:4258 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "otospondylomegaepiphyseal dysplasia (DOID:0080026 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vitreoretinal dystrophy (DOID:14251 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "stickler syndrome (DOID:0080046 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "campomelic dysplasia (DOID:0050463 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multiple epiphyseal dysplasia (DOID:12721 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudoachondroplasia (DOID:0080047 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "jansen's metaphyseal chondrodysplasia (DOID:0080020 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "metaphyseal dysplasia (DOID:0080019 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "schmid metaphyseal chondrodysplasia (DOID:0080021 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ischemic bone disease (DOID:0080008 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteonecrosis (DOID:10159 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteochondrosis (DOID:8125 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "legg-calve-perthes disease (DOID:14415 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osteochondritis dissecans (DOID:84 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone deterioration disease (DOID:0080007 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone structure disease (DOID:0080010 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "degenerative disc disease (DOID:90 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal stenosis (DOID:6725 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spondylolisthesis (DOID:6682 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spondylolysis (DOID:2300 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spondylosis (DOID:2247 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cervical keratinizing squamous cell carcinoma (DOID:7483 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "beare-stevenson cutis gyrata syndrome (DOID:0050660 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypertropia (DOID:9837 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pfeiffer syndrome (DOID:14705 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ladd syndrome (DOID:0050331 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "thanatophoric dysplasia (DOID:13481 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "achondroplasia (DOID:4480 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypochondroplasia (DOID:0080041 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dermatosis papulosa nigra (DOID:4400 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alcohol-related birth defect (DOID:0050668 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "radioulnar synostosis (DOID:9827 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "antley-bixler syndrome (DOID:0050462 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "craniofrontonasal syndrome (DOID:14737 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "smith-lemli-opitz syndrome (DOID:14692 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "greig cephalopolysyndactyly syndrome (DOID:14761 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pallister-hall syndrome (DOID:9248 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rubinstein-taybi syndrome (DOID:1933 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nevoid basal cell carcinoma syndrome (DOID:2512 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone development disease (DOID:0080006 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dysostosis (DOID:1934 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "synostosis (DOID:11971 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "syndactyly (DOID:11193 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brachydactyly (DOID:0050581 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "craniosynostosis (DOID:2340 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "crouzon syndrome (DOID:2339 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acrocephalosyndactylia (DOID:12960 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "saethre-chotzen syndrome (DOID:14768 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital nervous system abnormality (DOID:2490 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "microcephaly (DOID:10907 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "physical disorder (DOID:0080015 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lissencephaly (DOID:0050453 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "holoprosencephaly (DOID:4621 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cleft lip (DOID:9296 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orofacial cleft (DOID:0050567 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cleft palate (DOID:674 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acrocapitofemoral dysplasia (DOID:0050604 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acrocallosal syndrome (DOID:9250 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "esophageal atresia (DOID:10485 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vacterl association (DOID:14679 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "imperforate anus (DOID:10488 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "goldenhar syndrome (DOID:2907 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coloboma (DOID:12270 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "microphthalmia (DOID:10629 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choanal atresia (DOID:9574 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypogonadism (DOID:1924 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kallmann syndrome (DOID:3614 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "klinefelter's syndrome (DOID:1921 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypogonadotropism (DOID:7455 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renal agenesis (DOID:14766 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital diaphragmatic hernia (DOID:3827 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diaphragm disease (DOID:10481 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal atresia (DOID:10486 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bamforth-lazarus syndrome (DOID:0050655 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anodontia (DOID:13714 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tooth and nail syndrome (DOID:6678 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypohidrotic ectodermal dysplasia (DOID:14793 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "treacher collins syndrome (DOID:2908 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dextrocardia (DOID:9565 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "situs inversus (DOID:758 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "visceral heterotaxy (DOID:0050545 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary ciliary dyskinesia (DOID:9562 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cystic kidney (DOID:2975 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nephronophthisis (DOID:12712 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polycystic kidney disease (DOID:898 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "senior-loken syndrome (DOID:0050576 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "seckel syndrome (DOID:0050569 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "polydactyly (DOID:1148 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bardet-biedl syndrome (DOID:1935 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sensenbrenner syndrome (DOID:0050577 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "asphyxiating thoracic dystrophy (DOID:0050592 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ellis-van creveld syndrome (DOID:12714 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orofaciodigital syndrome (DOID:4501 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angioma serpiginosum (DOID:4028 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "orbital cyst (DOID:14233 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin atrophy (DOID:2733 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "incontinentia pigmenti achromians (DOID:3156 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "focal dermal hypoplasia (DOID:2120 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aicardi syndrome (DOID:8461 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bloch-sulzberger syndrome (DOID:12305 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "larsen syndrome (DOID:14764 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "telangiectasis (DOID:1272 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary hemorrhagic telangiectasia (DOID:1270 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coats disease (DOID:7765 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal telangiectasia (DOID:7736 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "proteus syndrome (DOID:13482 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "klippel-trenaunay syndrome (DOID:2926 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "exudative vitreoretinopathy (DOID:0050535 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "angioid streaks (DOID:13401 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "elephantiasis (DOID:4976 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lymphedema (DOID:4977 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hydrocele (DOID:9912 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paraneoplastic polyneuropathy (DOID:8681 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "oculocerebrorenal syndrome (DOID:1056 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "renpenning syndrome (DOID:0060179 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "syndromic intellectual disability (DOID:0050888 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "partington syndrome (DOID:14744 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "non-specific x-linked mental retardation (DOID:0050776 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "non-syndromic intellectual disability (DOID:0050889 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coffin-lowry syndrome (DOID:3783 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fg syndrome (DOID:14711 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "wiskott-aldrich syndrome (DOID:9169 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "x-linked disease (DOID:0050735 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fragile x syndrome (DOID:14261 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "charcot-marie-tooth disease type x (DOID:0050542 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "allan-herndon-dudley syndrome (DOID:0050631 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain oligodendroglioma (DOID:3187 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinal drusen (DOID:2569 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "agat deficiency (DOID:0050712 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral creatine deficiency syndrome (DOID:0050798 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ornithine translocase deficiency (DOID:0050720 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choroid disease (DOID:1417 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choroideremia (DOID:9821 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gyrate atrophy (DOID:1415 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "farber lipogranulomatosis (DOID:0050464 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vitelliform macular dystrophy (DOID:0050661 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bestrophinopathy (DOID:0050662 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "night blindness (DOID:8499 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital stationary night blindness (DOID:0050534 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary night blindness (DOID:8498 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fundus albipunctatus (DOID:11105 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinitis pigmentosa (DOID:10584 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cone-rod dystrophy (DOID:0050572 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leber congenital amaurosis (DOID:14791 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fundus dystrophy (DOID:8501 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary retinal dystrophy (DOID:8500 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "achromatopsia (DOID:13911 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "color blindness (DOID:13399 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blue cone monochromacy (DOID:0050679 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blindness (DOID:1432 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "red-green color blindness (DOID:13909 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "red color blindness (DOID:13910 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blue color blindness (DOID:11661 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scotoma (DOID:9335 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chorioretinal scar (DOID:11086 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "solar retinopathy (DOID:11282 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "partial central choroid dystrophy (DOID:9822 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary choroidal atrophy (DOID:9794 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "choroidal sclerosis (DOID:980 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eye degenerative disease (DOID:9799 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "degenerative myopia (DOID:11829 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bullous retinoschisis (DOID:12108 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retinoschisis (DOID:8465 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign mammary dysplasia (DOID:9504 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subclavian steal syndrome (DOID:13002 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "abnormal retinal correspondence (DOID:12668 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "binocular vision disease (DOID:12667 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "expressive language disorder (DOID:11385 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paralytic squint (DOID:10863 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "supine hypotensive syndrome (DOID:10556 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute endophthalmitis (DOID:11752 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "endophthalmitis (DOID:4692 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "purulent endophthalmitis (DOID:9724 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "panophthalmitis (DOID:13732 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "stomach carcinoma in situ (DOID:9138 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tetanus neonatorum (DOID:13521 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemopericardium (DOID:11482 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eye accommodation disease (DOID:10034 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "presbyopia (DOID:11638 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cycloplegia (DOID:10033 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudopterygium (DOID:11028 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leukorrhea (DOID:3766 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "accommodative esotropia (DOID:9839 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "partial third-nerve palsy (DOID:10864 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ametropic amblyopia (DOID:10377 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "disuse amblyopia (DOID:10378 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "suppression amblyopia (DOID:10375 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aniseikonia (DOID:0050304 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tungiasis (DOID:0050266 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epiglottitis (DOID:9398 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "corneal ectasia (DOID:1436 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "esotropia (DOID:9840 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperopia (DOID:9834 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "strabismus (DOID:540 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ocular motility disease (DOID:1279 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "exotropia (DOID:1143 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "refractive error (DOID:9835 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myopia (DOID:11830 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "astigmatism (DOID:11782 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anisometropia (DOID:12273 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amblyopia (DOID:10376 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "duane retraction syndrome (DOID:12557 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "klippel-feil syndrome (DOID:10426 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypotropia (DOID:9841 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dissociated nystagmus (DOID:13174 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital nystagmus (DOID:9649 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pathologic nystagmus (DOID:9650 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ocular albinism (DOID:0050633 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aland island eye disease (DOID:0050630 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary wilms' tumor (DOID:5183 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "good syndrome (DOID:0060028 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal neuroendocrine benign tumor (DOID:4119 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clear cell acanthoma (DOID:172 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spontaneous ocular nystagmus (DOID:11771 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "low compliance bladder (DOID:12144 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "external ear disease (DOID:379 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "otitis externa (DOID:9463 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "otomycosis (DOID:0050147 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "phaeohyphomycosis (DOID:14049 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inflammatory diarrhea (DOID:0050132 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fungal meningitis (DOID:11608 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intracranial vasospasm (DOID:13100 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eastern equine encephalitis (DOID:10841 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epiglottis neoplasm (DOID:7105 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic frontal sinusitis (DOID:10790 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "frontal sinusitis (DOID:10791 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "obsessive-compulsive personality disorder (DOID:10932 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute dacryocystitis (DOID:12996 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dacryocystocele (DOID:9939 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lacrimal duct obstruction (DOID:13929 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "excessive tearing (DOID:13757 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute inflammation of lacrimal passage (DOID:6970 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dacryocystitis (DOID:9938 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic dacryocystitis (DOID:9937 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic inflammation of lacrimal passage (DOID:9935 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lagophthalmos (DOID:12959 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "entropion (DOID:12397 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ectropion (DOID:1570 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colon carcinoma in situ (DOID:8826 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute pericementitis (DOID:10423 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "boomerang dysplasia (DOID:0050680 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atelosteogenesis (DOID:0050648 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "senile entropion (DOID:12836 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pulmonary plasma cell granuloma (DOID:3677 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lower urinary tract calculus (DOID:9590 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "urethral calculus (DOID:9589 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "myiasis (DOID:11080 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudobulbar palsy (DOID:12680 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "periventricular nodular heterotopia (DOID:0050454 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dependent personality disorder (DOID:10931 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "histrionic personality disorder (DOID:334 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "narcissistic personality disorder (DOID:2745 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hydranencephaly (DOID:4626 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "actinobacillosis (DOID:4974 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cerebral lymphoma (DOID:5815 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bietti crystalline corneoretinal dystrophy (DOID:0050664 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tinea unguium (DOID:13074 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tinea cruris (DOID:11917 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurotic excoriation (DOID:9165 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "blackwater fever (DOID:14068 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous mycosis (DOID:0050134 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dermatophytosis (DOID:8913 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tinea capitis (DOID:4337 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tinea pedis (DOID:12403 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tinea corporis (DOID:12179 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pityriasis versicolor (DOID:9060 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "superficial mycosis (DOID:0050133 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vertebral artery occlusion (DOID:11299 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "seborrheic infantile dermatitis (DOID:8941 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trichosporonosis (DOID:0050290 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fusariosis (DOID:0050289 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diencephalic neoplasm (DOID:3843 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypothalamic neoplasm (DOID:3644 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eunuchism (DOID:5003 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder benign neoplasm (DOID:0050623 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bladder leiomyoma (DOID:13109 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tsh producing pituitary tumor (DOID:6275 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "functionless pituitary adenoma (DOID:5715 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fetishism (DOID:1235 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transvestism (DOID:1233 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "voyeurism (DOID:10834 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paraphilia disorder (DOID:0060044 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "exhibitionism (DOID:10236 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gender identity disorder (DOID:1234 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transsexualism (DOID:10919 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal cord melanoma (DOID:14151 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pedophilia (DOID:13351 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "differentiating neuroblastoma (DOID:4160 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hartnup disease (DOID:1060 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osmotic diarrhea (DOID:0050130 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pellagra (DOID:8457 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pyridoxine deficiency anemia (DOID:8455 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic tympanitis (DOID:11217 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tinea nigra (DOID:8912 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "immature cataract (DOID:10997 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atrophy of testis (DOID:11994 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trichostrongyloidiasis (DOID:1255 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trichostrongylosis (DOID:1254 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "allergic urticaria (DOID:10612 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mesenteric lymphadenitis (DOID:10782 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "partial optic atrophy (DOID:10631 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lown-ganong-levine syndrome (DOID:13087 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "progressive bulbar palsy (DOID:681 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "subcutaneous mycosis (DOID:0050135 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chromoblastomycosis (DOID:1562 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate carcinoma in situ (DOID:8634 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "protein-deficiency anemia (DOID:13120 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bagassosis (DOID:12522 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "granulomatous amebic encephalitis (DOID:0050246 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "laryngostenosis (DOID:11527 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "occlusion of gallbladder (DOID:9714 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tinea favosa (DOID:4336 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cercarial dermatitis (DOID:11302 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clonorchiasis (DOID:13767 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paragonimiasis (DOID:10699 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glycogen storage disease vii (DOID:11721 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "congenital nonspherocytic hemolytic anemia (DOID:2861 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diphyllobothriasis (DOID:10075 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "primary amebic meningoencephalitis (DOID:0050242 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dicrocoeliasis (DOID:1219 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "capillariasis (DOID:12474 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "necatoriasis (DOID:2790 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "osgood-schlatter's disease (DOID:7489 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diverticulitis (DOID:7475 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "branchiootorenal syndrome (DOID:14702 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "branchiooculofacial syndrome (DOID:0050691 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "splenic flexure cancer (DOID:12191 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intermediate spinal muscular atrophy (DOID:0050530 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anterior horn cell disease (DOID:4873 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "juvenile spinal muscular atrophy (DOID:12376 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "survival motor neuron spinal muscular atrophy (DOID:0060160 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "werdnig-hoffmann disease (DOID:13137 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal muscular atrophy (DOID:12377 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kennedy's disease (DOID:0060161 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lateral sclerosis (DOID:230 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "progressive muscular atrophy (DOID:318 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal cord disease (DOID:319 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "syringomyelia (DOID:327 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brown-vialetto-van laere syndrome (DOID:0050694 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nonphotosensitive trichothiodystrophy (DOID:0050528 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin papilloma (DOID:3178 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hordeolum (DOID:9909 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "auditory agnosia (DOID:0060137 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tuberculum sellae meningioma (DOID:7713 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paramyloidosis (DOID:0050761 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autonomic peripheral neuropathy (DOID:0060054 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tarsal tunnel syndrome (DOID:12526 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tibial neuropathy (DOID:1187 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transthyretin amyloidosis (DOID:0050638 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "familial visceral amyloidosis (DOID:0050636 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pediatric osteosarcoma (DOID:3361 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "localized osteosarcoma (DOID:3356 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "c-p angle neurinoma (DOID:3199 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "radial neuropathy (DOID:12171 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mucocele of salivary gland (DOID:12904 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brachial plexus neuritis (DOID:3689 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "optic disk drusen (DOID:13561 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sialolithiasis (DOID:12905 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scimitar syndrome (DOID:4297 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cadasil (DOID:13945 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spondylocostal dysostosis (DOID:0050568 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hajdu-cheney syndrome (DOID:2736 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alagille syndrome (DOID:9245 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cascade stomach (DOID:12234 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pseudopapilledema (DOID:1392 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tricuspid valve stenosis (DOID:4078 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "parametritis (DOID:1260 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "detrusor sphincter dyssynergia (DOID:12145 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hemangioma of intra-abdominal structure (DOID:254 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chorioangioma (DOID:277 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "patellar tendinitis (DOID:10471 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lumbosacral lipoma (DOID:7017 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amphetamine abuse (DOID:670 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paranoid schizophrenia (DOID:1229 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "large cell medulloblastoma (DOID:3857 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "childhood medulloblastoma (DOID:3869 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vaginal adenosarcoma (DOID:4117 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vaginal carcinosarcoma (DOID:136 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vaginal carcinoma (DOID:0050918 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hallermann-streiff syndrome (DOID:4534 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant ependymoma (DOID:5074 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pediatric ependymoma (DOID:5509 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate small cell carcinoma (DOID:7141 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal cord primitive neuroectodermal neoplasm (DOID:6872 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "transient global amnesia (DOID:13027 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cri-du-chat syndrome (DOID:12580 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "staphyloenterotoxemia (DOID:96 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "chronic wasting disease (DOID:3530 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kuru (DOID:648 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "creutzfeldt-jakob disease (DOID:11949 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prion disease (DOID:649 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scrapie (DOID:5434 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "variant creutzfeldt-jakob disease (DOID:5435 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fatal familial insomnia (DOID:0050433 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gerstmann-straussler-scheinker syndrome (DOID:4249 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kluver-bucy syndrome (DOID:2510 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "akinetic mutism (DOID:4267 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ideomotor apraxia (DOID:4627 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "writing disorder (DOID:0060047 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dysgraphia (DOID:4540 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gait apraxia (DOID:4260 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gerstmann syndrome (DOID:4969 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "finger agnosia (DOID:0060141 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dyscalculia (DOID:12568 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "articulation disorder (DOID:4186 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mutism (DOID:4189 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "speech disorder (DOID:92 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "learning disability (DOID:8927 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dyslexia (DOID:4428 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "reading disorder (DOID:13365 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "asperger syndrome (DOID:0050432 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "atypical autism (DOID:0060042 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "psat deficiency (DOID:0050723 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "schizotypal personality disorder (DOID:10646 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paranoid personality disorder (DOID:10938 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperlipoproteinemia type iv (DOID:1172 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prosopagnosia (DOID:4970 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acheiropody (DOID:0050603 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spinal cord lymphoma (DOID:14150 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epidermolytic acanthoma (DOID:4323 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "locked-in syndrome (DOID:12697 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alcoholic neuropathy (DOID:14183 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inflammatory and toxic neuropathy (DOID:2537 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "critical illness polyneuropathy (DOID:14402 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "plasmacytic leukemia (DOID:9513 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ethmoid sinus adenoid cystic carcinoma (DOID:2764 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epidemic pleurodynia (DOID:10882 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "periodic limb movement disorder (DOID:9207 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "regular astigmatism (DOID:11781 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "preretinal fibrosis (DOID:2006 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "irregular astigmatism (DOID:13919 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scleral staphyloma (DOID:11595 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "retrocochlear disease (DOID:2889 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vestibulocochlear nerve disease (DOID:12657 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "vestibular neuronitis (DOID:12683 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "epidural abscess (DOID:11387 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rift valley fever (DOID:1328 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurogenic bowel (DOID:13419 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "wound botulism (DOID:0050353 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intestinal botulism (DOID:0050141 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "botulism (DOID:11976 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "foodborne botulism (DOID:0050352 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "infant botulism (DOID:0050354 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "developmental coordination disorder (DOID:9923 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone carcinoma (DOID:2762 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anauxetic dysplasia (DOID:0050640 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cartilage-hair hypoplasia (DOID:14773 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bone lymphoma (DOID:6759 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "refractory hairy cell leukemia (DOID:711 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "refractory hematologic cancer (DOID:712 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eosinophilia-myalgia syndrome (DOID:998 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "achilles bursitis (DOID:12857 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "miliaria (DOID:1382 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "miliaria rubra (DOID:11153 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hyperlucent lung (DOID:10032 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ross river fever (DOID:0050518 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "clear cell basal cell carcinoma (DOID:4293 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pilar sheath acanthoma (DOID:4322 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "leiomyoma cutis (DOID:5132 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "eccrine acrospiroma (DOID:5442 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inflamed seborrheic keratosis (DOID:11685 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin pilomatrix carcinoma (DOID:5376 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pigmented basal cell carcinoma (DOID:4282 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tinea manuum (DOID:13369 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tinea barbae (DOID:0050096 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "exostosis (DOID:203 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hereditary multiple exostoses (DOID:206 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trichorhinophalangeal syndrome type ii (DOID:4998 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "trichorhinophalangeal syndrome type i (DOID:14743 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "esophageal adenosquamous carcinoma (DOID:5625 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pyriform sinus cancer (DOID:9235 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "small intestine neuroendocrine neoplasm (DOID:4434 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brooke-spiegler syndrome (DOID:0050693 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carbuncle (DOID:2176 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aarskog-scott syndrome (DOID:6683 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "hypertrichosis (DOID:420 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "borjeson-forssman-lehmann syndrome (DOID:0050681 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coffin-siris syndrome (DOID:1925 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "barrett's esophagus (DOID:9206 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sc phocomelia syndrome (DOID:0050536 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kbg syndrome (DOID:14780 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "roberts syndrome (DOID:5325 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cornelia de lange syndrome (DOID:11725 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast pericanalicular fibroadenoma (DOID:2639 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bjornstad syndrome (DOID:0050677 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anosognosia (DOID:0060133 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "mulibrey nanism (DOID:0050436 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "corneal staphyloma (DOID:12753 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "weaver syndrome (DOID:14731 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "shipyard eye (DOID:13014 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cutaneous solitary mastocytoma (DOID:3666 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dissociative amnesia (DOID:11037 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "punctate epithelial keratoconjunctivitis (DOID:12197 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "superficial keratitis (DOID:12196 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nut allergic reaction (DOID:4379 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "adie syndrome (DOID:11549 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "supravalvular aortic stenosis (DOID:1929 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "williams-beuren syndrome (DOID:1928 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dental pulp calcification (DOID:5608 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "weill-marchesani syndrome (DOID:0050475 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tactile agnosia (DOID:0060151 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "conidiobolomycosis (DOID:0050279 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "progressive multifocal leukoencephalopathy (DOID:643 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brachydactyly-syndactyly syndrome (DOID:0050689 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brachyolmia (DOID:0050690 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "seasonal affective disorder (DOID:0060167 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "neurocirculatory asthenia (DOID:11569 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "infantile onset spinocerebellar ataxia (DOID:0050556 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute stress disorder (DOID:6088 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "combat disorder (DOID:6950 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "aqueous misdirection (DOID:11149 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lens subluxation (DOID:11364 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "rubeosis iridis (DOID:14000 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "barbiturate dependence (DOID:2575 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "high pressure neurological syndrome (DOID:3230 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "acute inferolateral myocardial infarction (DOID:10649 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "basilar artery occlusion (DOID:13446 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "apical myocardial infarction (DOID:5848 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "posterolateral myocardial infarction (DOID:5851 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anterior cerebral artery infarction (DOID:3528 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "facial neuralgia (DOID:13865 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "amusia (DOID:0060132 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "corneal abscess (DOID:11543 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "basilar artery insufficiency (DOID:223 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "brain compression (DOID:11457 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "carotid artery dissection (DOID:9348 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anteroseptal myocardial infarction (DOID:5855 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lateral myocardial infarction (DOID:5853 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ophthalmomyiasis (DOID:0050268 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "inferior myocardial infarction (DOID:5850 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "posterior myocardial infarction (DOID:5847 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "middle cerebral artery infarction (DOID:3525 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "labyrinthine dysfunction (DOID:566 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "benign mesenchymoma (DOID:2667 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "diffuse lipomatosis (DOID:3923 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "pelvic lipomatosis (DOID:3927 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "kidney fibrosarcoma (DOID:5982 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "large intestine lipoma (DOID:6460 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "lipoma of colon (DOID:10655 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "nodular tenosynovitis (DOID:2701 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "sarcomatosis (DOID:7615 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "skin lipoma (DOID:10188 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "persian gulf syndrome (DOID:4491 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "facial hemiatrophy (DOID:1757 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tethered spinal cord syndrome (DOID:1089 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "meningocele (DOID:1088 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "spina bifida (DOID:0080016 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "colon mucinous adenocarcinoma (DOID:3029 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "malignant anus melanoma (DOID:14145 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fibroepithelial polyp of the anus (DOID:8170 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anal spasm (DOID:11374 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "keratomalacia (DOID:11267 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fourth cranial nerve palsy (DOID:10869 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "enterocele (DOID:1283 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prolapse of female genital organ (DOID:1284 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "peripheral retinal degeneration (DOID:12161 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "dissociative disorder (DOID:10935 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "multiple personality disorder (DOID:10934 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "external ear cancer (DOID:5665 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "external ear carcinoma (DOID:4288 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "prostate calculus (DOID:13689 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "tyrosinemia type iii (DOID:0050727 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alkaptonuria (DOID:9270 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ochronosis (DOID:14223 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "gum cancer (DOID:8602 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glottis squamous cell carcinoma (DOID:7031 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "patellofemoral pain syndrome (DOID:14284 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glottis cancer (DOID:2595 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "glottis carcinoma (DOID:2599 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "scalp dermatosis (DOID:3136 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "intermittent explosive disorder (DOID:12401 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "exposure keratitis (DOID:9461 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "paralytic lagophthalmos (DOID:12958 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "ovarian mucinous adenofibroma (DOID:6469 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "schneckenbecken dysplasia (DOID:0050775 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "soft palate cancer (DOID:8578 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "geotrichosis (DOID:2832 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "coenzyme q10 deficiency disease (DOID:0050730 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "bile duct sarcoma (DOID:4064 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "autosomal dominant microcephaly (DOID:14725 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "calcaneonavicular coalition (DOID:14762 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "alternating exotropia (DOID:1142 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "masters-allen syndrome (DOID:14133 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "charcot-marie-tooth disease type 4 (DOID:0050541 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "anal margin carcinoma (DOID:4284 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "poland syndrome (DOID:12961 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "cortical deafness (DOID:0060140 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "form agnosia (DOID:0060142 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "breast lipoma (DOID:10199 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "queensland tick typhus (DOID:10784 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "fatal infantile encephalocardiomyopathy (DOID:0050713 from DISEASES Text-mining Gene-Disease Assocation Evidence Scores)", "severe t lymphocytopenia (HP:0005379 from HPO Gene-Disease Associations)", "failure to thrive secondary to recurrent infections (HP:0008866 from HPO Gene-Disease Associations)", "recurrent opportunistic infections (HP:0005390 from HPO Gene-Disease Associations)", "abnormality of b cell number (HP:0010975 from HPO Gene-Disease Associations)", "b lymphocytopenia (HP:0010976 from HPO Gene-Disease Associations)", "severe b lymphocytopenia (HP:0005365 from HPO Gene-Disease Associations)", "abnormality of the mastoid (HP:0000264 from HPO Gene-Disease Associations)", "mastoiditis (HP:0000265 from HPO Gene-Disease Associations)", "abnormal lymphocyte count (HP:0040088 from HPO Gene-Disease Associations)", "abnormality of t cell number (HP:0011839 from HPO Gene-Disease Associations)", "t lymphocytopenia (HP:0005403 from HPO Gene-Disease Associations)", "leukocytosis (HP:0001974 from HPO Gene-Disease Associations)", "abnormality of eosinophils (HP:0001879 from HPO Gene-Disease Associations)", "eosinophilia (HP:0001880 from HPO Gene-Disease Associations)", "granulocytopenia (HP:0001913 from HPO Gene-Disease Associations)", "thyroiditis (HP:0100646 from HPO Gene-Disease Associations)", "combined immunodeficiency (HP:0005387 from HPO Gene-Disease Associations)", "severe combined immunodeficiency (HP:0004430 from HPO Gene-Disease Associations)", "sepsis (HP:0100806 from HPO Gene-Disease Associations)", "abnormality of the thymus (HP:0000777 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the thymus (HP:0010515 from HPO Gene-Disease Associations)", "hypoplasia of the thymus (HP:0000778 from HPO Gene-Disease Associations)", "autoimmunity (HP:0002960 from HPO Gene-Disease Associations)", "absent specific antibody response (HP:0005424 from HPO Gene-Disease Associations)", "b-cell lymphoma (HP:0012191 from HPO Gene-Disease Associations)", "aplasia of the thymus (HP:0005359 from HPO Gene-Disease Associations)", "genital ulcers (HP:0003249 from HPO Gene-Disease Associations)", "abnormality of cellular immune system (HP:0010987 from HPO Gene-Disease Associations)", "abnormality of leukocytes (HP:0001881 from HPO Gene-Disease Associations)", "abnormality of blood and blood-forming tissues (HP:0001871 from HPO Gene-Disease Associations)", "abnormality of bone marrow cell morphology (HP:0005561 from HPO Gene-Disease Associations)", "abnormality of cells of the erythroid lineage (HP:0012130 from HPO Gene-Disease Associations)", "abnormality of erythrocytes (HP:0001877 from HPO Gene-Disease Associations)", "anemia (HP:0001903 from HPO Gene-Disease Associations)", "abnormality of thrombocytes (HP:0001872 from HPO Gene-Disease Associations)", "abnormal platelet count (HP:0011873 from HPO Gene-Disease Associations)", "thrombocytopenia (HP:0001873 from HPO Gene-Disease Associations)", "abnormal neutrophil cell number (HP:0011991 from HPO Gene-Disease Associations)", "neutropenia (HP:0001875 from HPO Gene-Disease Associations)", "abnormality of granulocytes (HP:0001911 from HPO Gene-Disease Associations)", "abnormality of myeloid leukocytes (HP:0010974 from HPO Gene-Disease Associations)", "abnormality of neutrophils (HP:0001874 from HPO Gene-Disease Associations)", "abnormality of the lymph nodes (HP:0002733 from HPO Gene-Disease Associations)", "lymphadenopathy (HP:0002716 from HPO Gene-Disease Associations)", "abnormality of the lymphatic system (HP:0100763 from HPO Gene-Disease Associations)", "abnormality of the spleen (HP:0001743 from HPO Gene-Disease Associations)", "splenomegaly (HP:0001744 from HPO Gene-Disease Associations)", "hepatomegaly (HP:0002240 from HPO Gene-Disease Associations)", "visceromegaly (HP:0003271 from HPO Gene-Disease Associations)", "abnormality of lymphocytes (HP:0004332 from HPO Gene-Disease Associations)", "abnormal immunoglobulin level (HP:0010701 from HPO Gene-Disease Associations)", "abnormality of b cell physiology (HP:0005372 from HPO Gene-Disease Associations)", "abnormality of b cells (HP:0002846 from HPO Gene-Disease Associations)", "abnormality of humoral immunity (HP:0005368 from HPO Gene-Disease Associations)", "hypogammaglobulinemia (HP:0004313 from HPO Gene-Disease Associations)", "abnormality of cell physiology (HP:0011017 from HPO Gene-Disease Associations)", "iga deficiency (HP:0002720 from HPO Gene-Disease Associations)", "igg deficiency (HP:0004315 from HPO Gene-Disease Associations)", "abnormal leukocyte count (HP:0011893 from HPO Gene-Disease Associations)", "leukopenia (HP:0001882 from HPO Gene-Disease Associations)", "abnormality of cells of the lymphoid lineage (HP:0012140 from HPO Gene-Disease Associations)", "lymphopenia (HP:0001888 from HPO Gene-Disease Associations)", "lymphoma (HP:0002665 from HPO Gene-Disease Associations)", "restrictive lung disease (HP:0002091 from HPO Gene-Disease Associations)", "emphysema (HP:0002097 from HPO Gene-Disease Associations)", "gastrointestinal stroma tumor (HP:0100723 from HPO Gene-Disease Associations)", "arthralgia (HP:0002829 from HPO Gene-Disease Associations)", "vasculitis (HP:0002633 from HPO Gene-Disease Associations)", "abnormality of skin physiology (HP:0011122 from HPO Gene-Disease Associations)", "inflammatory abnormality of the skin (HP:0011123 from HPO Gene-Disease Associations)", "eczema (HP:0000964 from HPO Gene-Disease Associations)", "skin rash (HP:0000988 from HPO Gene-Disease Associations)", "skin ulcer (HP:0200042 from HPO Gene-Disease Associations)", "pruritus (HP:0000989 from HPO Gene-Disease Associations)", "dry skin (HP:0000958 from HPO Gene-Disease Associations)", "hypergammaglobulinemia (HP:0010702 from HPO Gene-Disease Associations)", "increased igm level (HP:0003496 from HPO Gene-Disease Associations)", "increased igg level (HP:0003237 from HPO Gene-Disease Associations)", "antineutrophil antibody positivity (HP:0003453 from HPO Gene-Disease Associations)", "coombs-positive hemolytic anemia (HP:0004844 from HPO Gene-Disease Associations)", "chronic noninfectious lymphadenopathy (HP:0002730 from HPO Gene-Disease Associations)", "rheumatoid factor positive (HP:0002923 from HPO Gene-Disease Associations)", "smooth muscle antibody positivity (HP:0003262 from HPO Gene-Disease Associations)", "increased number of peripheral cd3+ t cells (HP:0002845 from HPO Gene-Disease Associations)", "increased number of cd4-|cd8- t cells expressing alpha|beta t-cell receptors (HP:0002851 from HPO Gene-Disease Associations)", "defective lymphocyte apoptosis (HP:0002731 from HPO Gene-Disease Associations)", "increased proportion of hla dr+ and cd57+ t cells (HP:0002853 from HPO Gene-Disease Associations)", "increase in t cell number (HP:0100828 from HPO Gene-Disease Associations)", "follicular hyperplasia (HP:0002729 from HPO Gene-Disease Associations)", "reduced delayed hypersensitivity (HP:0002972 from HPO Gene-Disease Associations)", "platelet antibody positive (HP:0003454 from HPO Gene-Disease Associations)", "lymphocytosis (HP:0100827 from HPO Gene-Disease Associations)", "increased iga level (HP:0003261 from HPO Gene-Disease Associations)", "autoimmune neutropenia (HP:0001904 from HPO Gene-Disease Associations)", "antinuclear antibody positivity (HP:0003493 from HPO Gene-Disease Associations)", "autoimmune antibody positivity (HP:0030057 from HPO Gene-Disease Associations)", "antiphospholipid antibody positivity (HP:0003613 from HPO Gene-Disease Associations)", "autoimmune thrombocytopenia (HP:0001973 from HPO Gene-Disease Associations)", "increase in b cell number (HP:0005404 from HPO Gene-Disease Associations)", "autoimmune hemolytic anemia (HP:0001890 from HPO Gene-Disease Associations)", "hypochromic anemia (HP:0001931 from HPO Gene-Disease Associations)", "iron deficiency anemia (HP:0001891 from HPO Gene-Disease Associations)", "panhypogammaglobulinemia (HP:0003139 from HPO Gene-Disease Associations)", "cutaneous anergy (HP:0002965 from HPO Gene-Disease Associations)", "recurrent protozoan infections (HP:0005386 from HPO Gene-Disease Associations)", "chronic lymphocytic meningitis (HP:0007041 from HPO Gene-Disease Associations)", "protracted diarrhea (HP:0004385 from HPO Gene-Disease Associations)", "abnormality of small intestinal villus morphology (HP:0011472 from HPO Gene-Disease Associations)", "villous atrophy (HP:0011473 from HPO Gene-Disease Associations)", "agammaglobulinemia (HP:0004432 from HPO Gene-Disease Associations)", "recurrent skin infections (HP:0001581 from HPO Gene-Disease Associations)", "chronic mucocutaneous candidiasis (HP:0002728 from HPO Gene-Disease Associations)", "recurrent cutaneous fungal infections (HP:0011370 from HPO Gene-Disease Associations)", "recurrent fungal infections (HP:0002841 from HPO Gene-Disease Associations)", "abnormal delayed hypersensitivity skin test (HP:0002963 from HPO Gene-Disease Associations)", "abnormality of t cell physiology (HP:0011840 from HPO Gene-Disease Associations)", "abnormality of t cells (HP:0002843 from HPO Gene-Disease Associations)", "recurrent viral infections (HP:0004429 from HPO Gene-Disease Associations)", "recurrent bacterial infections (HP:0002718 from HPO Gene-Disease Associations)", "acute colitis (HP:0100282 from HPO Gene-Disease Associations)", "enterocolitis (HP:0004387 from HPO Gene-Disease Associations)", "colitis (HP:0002583 from HPO Gene-Disease Associations)", "inflammation of the large intestine (HP:0002037 from HPO Gene-Disease Associations)", "gastrointestinal inflammation (HP:0004386 from HPO Gene-Disease Associations)", "non-caseating epithelioid cell granulomatosis (HP:0012220 from HPO Gene-Disease Associations)", "iritis (HP:0001101 from HPO Gene-Disease Associations)", "nongranulomatous uveitis (HP:0007813 from HPO Gene-Disease Associations)", "intermittent generalized erythematous papular rash (HP:0007432 from HPO Gene-Disease Associations)", "papule (HP:0200034 from HPO Gene-Disease Associations)", "synovitis (HP:0100769 from HPO Gene-Disease Associations)", "cystoid macular edema (HP:0011505 from HPO Gene-Disease Associations)", "macular edema (HP:0040049 from HPO Gene-Disease Associations)", "acne (HP:0001061 from HPO Gene-Disease Associations)", "abnormal thrombosis (HP:0001977 from HPO Gene-Disease Associations)", "venous thrombosis (HP:0004936 from HPO Gene-Disease Associations)", "thrombophlebitis (HP:0004418 from HPO Gene-Disease Associations)", "arterial thrombosis (HP:0004420 from HPO Gene-Disease Associations)", "abnormality of the pleura (HP:0002103 from HPO Gene-Disease Associations)", "abnormality of the pericardium (HP:0001697 from HPO Gene-Disease Associations)", "pulmonary infiltrates (HP:0002113 from HPO Gene-Disease Associations)", "hemoptysis (HP:0002105 from HPO Gene-Disease Associations)", "gangrene (HP:0100758 from HPO Gene-Disease Associations)", "orchitis (HP:0100796 from HPO Gene-Disease Associations)", "optic neuritis (HP:0100653 from HPO Gene-Disease Associations)", "retrobulbar optic neuritis (HP:0100654 from HPO Gene-Disease Associations)", "myositis (HP:0100614 from HPO Gene-Disease Associations)", "keratoconjunctivitis (HP:0001096 from HPO Gene-Disease Associations)", "keratoconjunctivitis sicca (HP:0001097 from HPO Gene-Disease Associations)", "keratitis (HP:0000491 from HPO Gene-Disease Associations)", "polyneuropathy (HP:0001271 from HPO Gene-Disease Associations)", "meningitis (HP:0001287 from HPO Gene-Disease Associations)", "cns infection (HP:0011450 from HPO Gene-Disease Associations)", "encephalitis (HP:0002383 from HPO Gene-Disease Associations)", "vestibular dysfunction (HP:0001751 from HPO Gene-Disease Associations)", "vertigo (HP:0002321 from HPO Gene-Disease Associations)", "retinopathy (HP:0000488 from HPO Gene-Disease Associations)", "aseptic necrosis (HP:0010885 from HPO Gene-Disease Associations)", "abnormal blistering of the skin (HP:0008066 from HPO Gene-Disease Associations)", "abnormality of corneal epithelium (HP:0011495 from HPO Gene-Disease Associations)", "corneal erosion (HP:0200020 from HPO Gene-Disease Associations)", "recurrent corneal erosions (HP:0000495 from HPO Gene-Disease Associations)", "abnormality of the conjunctiva (HP:0000502 from HPO Gene-Disease Associations)", "conjunctivitis (HP:0000509 from HPO Gene-Disease Associations)", "inflammatory abnormality of the eye (HP:0100533 from HPO Gene-Disease Associations)", "anaphylactoid purpura (HP:0200144 from HPO Gene-Disease Associations)", "markedly reduced t cell function (HP:0005409 from HPO Gene-Disease Associations)", "cerebral vasculitis (HP:0005318 from HPO Gene-Disease Associations)", "lymph node hypoplasia (HP:0002732 from HPO Gene-Disease Associations)", "recurrent sinopulmonary infections (HP:0005425 from HPO Gene-Disease Associations)", "enteroviral dermatomyositis syndrome (HP:0003729 from HPO Gene-Disease Associations)", "enteroviral hepatitis (HP:0001412 from HPO Gene-Disease Associations)", "septic arthritis (HP:0003095 from HPO Gene-Disease Associations)", "epididymitis (HP:0000031 from HPO Gene-Disease Associations)", "abnormality of the tonsils (HP:0100765 from HPO Gene-Disease Associations)", "cor pulmonale (HP:0001648 from HPO Gene-Disease Associations)", "prostatitis (HP:0000024 from HPO Gene-Disease Associations)", "recurrent enteroviral infections (HP:0002743 from HPO Gene-Disease Associations)", "crohn's disease (HP:0100280 from HPO Gene-Disease Associations)", "recurrent abscess formation (HP:0002722 from HPO Gene-Disease Associations)", "recurrent bacterial skin infections (HP:0005406 from HPO Gene-Disease Associations)", "recurrent cutaneous abscess formation (HP:0100838 from HPO Gene-Disease Associations)", "pyoderma (HP:0000999 from HPO Gene-Disease Associations)", "chronic furunculosis (HP:0011132 from HPO Gene-Disease Associations)", "perifolliculitis (HP:0012322 from HPO Gene-Disease Associations)", "abnormality of neutrophil physiology (HP:0011990 from HPO Gene-Disease Associations)", "impaired neutrophil bactericidal activity (HP:0011993 from HPO Gene-Disease Associations)", "negative nitroblue tetrazolium (nbt) reduction test (HP:0003203 from HPO Gene-Disease Associations)", "recurrent serratia marcescens infections (HP:0002741 from HPO Gene-Disease Associations)", "recurrent klebsiella infections (HP:0002742 from HPO Gene-Disease Associations)", "recurrent e. coli infections (HP:0002740 from HPO Gene-Disease Associations)", "recurrent burkholderia cepacia infections (HP:0002842 from HPO Gene-Disease Associations)", "abnormality of phagocytes (HP:0010977 from HPO Gene-Disease Associations)", "decreased activity of nadph oxidase (HP:0003206 from HPO Gene-Disease Associations)", "osteomyelitis due to immunodeficiency (HP:0002755 from HPO Gene-Disease Associations)", "absence of bactericidal oxidative 'respiratory burst' in phagocytes (HP:0002723 from HPO Gene-Disease Associations)", "abnormality of superoxide metabolism (HP:0004358 from HPO Gene-Disease Associations)", "cellulitis due to immunodeficiency (HP:0003553 from HPO Gene-Disease Associations)", "hepatic abscesses due to immunodeficiency (HP:0001400 from HPO Gene-Disease Associations)", "recurrent aspergillus infections (HP:0002724 from HPO Gene-Disease Associations)", "lymphadenitis (HP:0002840 from HPO Gene-Disease Associations)", "discoid lupus erythematosus (HP:0007417 from HPO Gene-Disease Associations)", "granulomatosis (HP:0002955 from HPO Gene-Disease Associations)", "recurrent staphylococcal infections (HP:0007499 from HPO Gene-Disease Associations)", "recurrent staphylococcus aureus infections (HP:0002726 from HPO Gene-Disease Associations)", "liver abscess (HP:0100523 from HPO Gene-Disease Associations)", "rectal abscess (HP:0005224 from HPO Gene-Disease Associations)", "eczematoid dermatitis (HP:0000976 from HPO Gene-Disease Associations)", "recurrent gram-negative bacterial infections (HP:0005420 from HPO Gene-Disease Associations)", "severe recurrent varicella (HP:0005428 from HPO Gene-Disease Associations)", "deficiency or absence of cytochrome b(-245) (HP:0003514 from HPO Gene-Disease Associations)", "gingivitis (HP:0000230 from HPO Gene-Disease Associations)", "abnormality of the mediastinum (HP:0045026 from HPO Gene-Disease Associations)", "mediastinal lymphadenopathy (HP:0100721 from HPO Gene-Disease Associations)", "abnormality of the thoracic cavity (HP:0045027 from HPO Gene-Disease Associations)", "obstructive lung disease (HP:0006536 from HPO Gene-Disease Associations)", "chronic obstructive pulmonary disease (HP:0006510 from HPO Gene-Disease Associations)", "cellulitis (HP:0100658 from HPO Gene-Disease Associations)", "osteomyelitis (HP:0002754 from HPO Gene-Disease Associations)", "urticaria (HP:0001025 from HPO Gene-Disease Associations)", "recurrent lower respiratory tract infections (HP:0002783 from HPO Gene-Disease Associations)", "recurrent pneumonia (HP:0006532 from HPO Gene-Disease Associations)", "pneumonia (HP:0002090 from HPO Gene-Disease Associations)", "absence of cd8+ t cells (HP:0005422 from HPO Gene-Disease Associations)", "decreased number of cd8+ t cells (HP:0005415 from HPO Gene-Disease Associations)", "chronic oral candidiasis (HP:0009098 from HPO Gene-Disease Associations)", "recurrent bacterial meningitis (HP:0007274 from HPO Gene-Disease Associations)", "generalized seborrheic dermatitis (HP:0007569 from HPO Gene-Disease Associations)", "recurrent meningitis (HP:0006946 from HPO Gene-Disease Associations)", "chronic diarrhea (HP:0002028 from HPO Gene-Disease Associations)", "diarrhea (HP:0002014 from HPO Gene-Disease Associations)", "abnormal basal ganglia mri signal intensity (HP:0012751 from HPO Gene-Disease Associations)", "focal t2 hyperintense basal ganglia lesion (HP:0007183 from HPO Gene-Disease Associations)", "chronic hepatitis due to cryptospridium infection (HP:0200124 from HPO Gene-Disease Associations)", "dysgammaglobulinemia (HP:0002961 from HPO Gene-Disease Associations)", "progressive vitiligo (HP:0005602 from HPO Gene-Disease Associations)", "recurrent infection of the gastrointestinal tract (HP:0004798 from HPO Gene-Disease Associations)", "ige deficiency (HP:0005479 from HPO Gene-Disease Associations)", "absence of lymph node germinal center (HP:0002849 from HPO Gene-Disease Associations)", "impaired memory b-cell generation (HP:0002847 from HPO Gene-Disease Associations)", "impaired ig class switch recombination (HP:0002959 from HPO Gene-Disease Associations)", "recurrent upper and lower respiratory tract infections (HP:0200117 from HPO Gene-Disease Associations)", "monocytopenia (HP:0012312 from HPO Gene-Disease Associations)", "recurrent mycobacterial infections (HP:0011274 from HPO Gene-Disease Associations)", "recurrent mycobacterium avium complex infections (HP:0011275 from HPO Gene-Disease Associations)", "atrophic, patchy alopecia (HP:0004529 from HPO Gene-Disease Associations)", "retinal vascular proliferation (HP:0007850 from HPO Gene-Disease Associations)", "recurrent streptococcus pneumoniae infections (HP:0005366 from HPO Gene-Disease Associations)", "osteopetrosis (HP:0011002 from HPO Gene-Disease Associations)", "ridged nail (HP:0001807 from HPO Gene-Disease Associations)", "nail pits (HP:0001803 from HPO Gene-Disease Associations)", "immunoglobulin igg2 deficiency (HP:0008348 from HPO Gene-Disease Associations)", "penile hypospadias (HP:0003244 from HPO Gene-Disease Associations)", "white matter neuronal heterotopia (HP:0007314 from HPO Gene-Disease Associations)", "decreased number of cd4+ t cells (HP:0005407 from HPO Gene-Disease Associations)", "decreased t cell activation (HP:0005419 from HPO Gene-Disease Associations)", "defective b cell activation (HP:0005384 from HPO Gene-Disease Associations)", "defective b cell differentiation (HP:0005357 from HPO Gene-Disease Associations)", "hodgkin lymphoma (HP:0012189 from HPO Gene-Disease Associations)", "non-hodgkin lymphoma (HP:0012539 from HPO Gene-Disease Associations)", "t-cell lymphoma (HP:0012190 from HPO Gene-Disease Associations)", "t-cell lymphoma|leukemia (HP:0005517 from HPO Gene-Disease Associations)", "abnormal axonemal organization of respiratory motile cilia (HP:0012258 from HPO Gene-Disease Associations)", "male hypogonadism (HP:0000026 from HPO Gene-Disease Associations)", "decreased fertility (HP:0000144 from HPO Gene-Disease Associations)", "infertility (HP:0000789 from HPO Gene-Disease Associations)", "male infertility (HP:0003251 from HPO Gene-Disease Associations)", "abnormal central microtubular pair morphology of respiratory motile cilia (HP:0012260 from HPO Gene-Disease Associations)", "nonmotile sperm (HP:0012208 from HPO Gene-Disease Associations)", "chronic rhinitis (HP:0002257 from HPO Gene-Disease Associations)", "rhinitis (HP:0012384 from HPO Gene-Disease Associations)", "ciliary dyskinesia (HP:0012265 from HPO Gene-Disease Associations)", "abnormal respiratory epithelium morphology (HP:0012253 from HPO Gene-Disease Associations)", "abnormal respiratory motile cilium morphology (HP:0005938 from HPO Gene-Disease Associations)", "absent|shortened dynein arms (HP:0200106 from HPO Gene-Disease Associations)", "dynein arm defect of respiratory motile cilia (HP:0012255 from HPO Gene-Disease Associations)", "absent outer dynein arms (HP:0012256 from HPO Gene-Disease Associations)", "abnormal ciliary motility (HP:0012262 from HPO Gene-Disease Associations)", "abnormal respiratory motile cilium physiology (HP:0012261 from HPO Gene-Disease Associations)", "absent inner and outer dynein arms (HP:0012259 from HPO Gene-Disease Associations)", "immotile cilia (HP:0012263 from HPO Gene-Disease Associations)", "absent inner dynein arms (HP:0012257 from HPO Gene-Disease Associations)", "abnormality of the nasopharynx (HP:0001739 from HPO Gene-Disease Associations)", "recurrent upper respiratory tract infections (HP:0002788 from HPO Gene-Disease Associations)", "abnormality of the pharynx (HP:0000600 from HPO Gene-Disease Associations)", "bronchitis (HP:0012387 from HPO Gene-Disease Associations)", "recurrent bronchitis (HP:0002837 from HPO Gene-Disease Associations)", "sinusitis (HP:0000246 from HPO Gene-Disease Associations)", "abnormality of the sinuses (HP:0000245 from HPO Gene-Disease Associations)", "otitis media (HP:0000388 from HPO Gene-Disease Associations)", "abnormality of the bronchi (HP:0002109 from HPO Gene-Disease Associations)", "bronchiectasis (HP:0002110 from HPO Gene-Disease Associations)", "recurrent sinusitis (HP:0011108 from HPO Gene-Disease Associations)", "recurrent otitis media (HP:0000403 from HPO Gene-Disease Associations)", "chronic bronchitis (HP:0004469 from HPO Gene-Disease Associations)", "respiratory insufficiency due to defective ciliary clearance (HP:0200073 from HPO Gene-Disease Associations)", "abnormal sperm motility (HP:0012206 from HPO Gene-Disease Associations)", "reduced sperm motility (HP:0012207 from HPO Gene-Disease Associations)", "chronic sinusitis (HP:0011109 from HPO Gene-Disease Associations)", "chronic otitis media (HP:0000389 from HPO Gene-Disease Associations)", "acute respiratory tract infection (HP:0011948 from HPO Gene-Disease Associations)", "bronchiolitis (HP:0011950 from HPO Gene-Disease Associations)", "abnormality of the nasal mucosa (HP:0000433 from HPO Gene-Disease Associations)", "nasal polyposis (HP:0100582 from HPO Gene-Disease Associations)", "aglossia (HP:0012730 from HPO Gene-Disease Associations)", "absent nares (HP:0100596 from HPO Gene-Disease Associations)", "synotia (HP:0100663 from HPO Gene-Disease Associations)", "cyclopia (HP:0009914 from HPO Gene-Disease Associations)", "abnormal anatomic location of the heart (HP:0004307 from HPO Gene-Disease Associations)", "dextrocardia (HP:0001651 from HPO Gene-Disease Associations)", "situs inversus totalis (HP:0001696 from HPO Gene-Disease Associations)", "abnormal spatial orientation of the cardiac segments (HP:0011534 from HPO Gene-Disease Associations)", "abdominal situs inversus (HP:0003363 from HPO Gene-Disease Associations)", "abnormality of abdominal situs (HP:0011620 from HPO Gene-Disease Associations)", "cough (HP:0012735 from HPO Gene-Disease Associations)", "absent|shortened outer dynein arms (HP:0200109 from HPO Gene-Disease Associations)", "shortened outer dynein arms (HP:0200108 from HPO Gene-Disease Associations)", "increased ige level (HP:0003212 from HPO Gene-Disease Associations)", "nonepidermolytic palmoplantar keratoderma (HP:0007404 from HPO Gene-Disease Associations)", "localized epidermolytic hyperkeratosis (HP:0007559 from HPO Gene-Disease Associations)", "specific anti-polysaccharide antibody deficiency (HP:0002848 from HPO Gene-Disease Associations)", "small vessel vasculitis (HP:0011944 from HPO Gene-Disease Associations)", "large vessel vasculitis (HP:0005310 from HPO Gene-Disease Associations)", "specific antibody deficiency (HP:0012475 from HPO Gene-Disease Associations)", "decreased mean platelet volume (HP:0005537 from HPO Gene-Disease Associations)", "reduced lymphocyte surface expression of cd43 (sialophorin) (HP:0001983 from HPO Gene-Disease Associations)", "absent microvilli on the surface of peripheral blood lymphocytes (HP:0002971 from HPO Gene-Disease Associations)", "congenital neutropenia (HP:0005549 from HPO Gene-Disease Associations)", "intermittent thrombocytopenia (HP:0004854 from HPO Gene-Disease Associations)", "prolonged bleeding after dental extraction (HP:0006298 from HPO Gene-Disease Associations)", "igm deficiency (HP:0002850 from HPO Gene-Disease Associations)", "megaloblastic bone marrow (HP:0001980 from HPO Gene-Disease Associations)", "hyperapobetalipoproteinemia (HP:0008158 from HPO Gene-Disease Associations)", "episodic hemolytic anemia (HP:0004802 from HPO Gene-Disease Associations)", "coronary atherosclerosis (HP:0004929 from HPO Gene-Disease Associations)", "chronic hemolytic anemia (HP:0004870 from HPO Gene-Disease Associations)", "abnormal platelet volume (HP:0011876 from HPO Gene-Disease Associations)", "increased mean platelet volume (HP:0011877 from HPO Gene-Disease Associations)", "giant platelets (HP:0001902 from HPO Gene-Disease Associations)", "abnormal platelet function (HP:0011869 from HPO Gene-Disease Associations)", "impaired platelet aggregation (HP:0003540 from HPO Gene-Disease Associations)", "abnormal platelet membrane protein expression (HP:0011878 from HPO Gene-Disease Associations)", "decreased platelet glycoprotein iib-iiia (HP:0001975 from HPO Gene-Disease Associations)", "post-transfusion thrombocytopenia (HP:0004813 from HPO Gene-Disease Associations)", "neonatal alloimmune thrombocytopenia (HP:0004809 from HPO Gene-Disease Associations)", "purpura (HP:0000979 from HPO Gene-Disease Associations)", "petechiae (HP:0000967 from HPO Gene-Disease Associations)", "prolonged bleeding time (HP:0003010 from HPO Gene-Disease Associations)", "menorrhagia (HP:0000132 from HPO Gene-Disease Associations)", "gingival bleeding (HP:0000225 from HPO Gene-Disease Associations)", "epistaxis (HP:0000421 from HPO Gene-Disease Associations)", "vascular skin abnormality (HP:0011276 from HPO Gene-Disease Associations)", "subcutaneous hemorrhage (HP:0001933 from HPO Gene-Disease Associations)", "abnormal bleeding (HP:0001892 from HPO Gene-Disease Associations)", "bruising susceptibility (HP:0000978 from HPO Gene-Disease Associations)", "abnormality of von willebrand factor (HP:0012146 from HPO Gene-Disease Associations)", "reduced von willebrand factor activity (HP:0008330 from HPO Gene-Disease Associations)", "reduced quantity of von willebrand factor (HP:0012147 from HPO Gene-Disease Associations)", "impaired thrombin-induced platelet aggregation (HP:0011872 from HPO Gene-Disease Associations)", "impaired collagen-induced platelet aggregation (HP:0008320 from HPO Gene-Disease Associations)", "gastric ulcer (HP:0002592 from HPO Gene-Disease Associations)", "acute megakaryocytic leukemia (HP:0006733 from HPO Gene-Disease Associations)", "congenital thrombocytopenia (HP:0001905 from HPO Gene-Disease Associations)", "shallow acetabular fossae (HP:0003182 from HPO Gene-Disease Associations)", "abnormality of cells of the megakaryocyte lineage (HP:0012143 from HPO Gene-Disease Associations)", "megakaryocytopenia (HP:0005548 from HPO Gene-Disease Associations)", "limited pronation|supination of forearm (HP:0006394 from HPO Gene-Disease Associations)", "proximal radio-ulnar synostosis (HP:0005037 from HPO Gene-Disease Associations)", "acute promyelocytic leukemia (HP:0004836 from HPO Gene-Disease Associations)", "abnormality of cells of the granulocytic lineage (HP:0012135 from HPO Gene-Disease Associations)", "anterior radial head dislocation (HP:0005084 from HPO Gene-Disease Associations)", "abnormal platelet granules (HP:0011883 from HPO Gene-Disease Associations)", "abnormal platelet morphology (HP:0011875 from HPO Gene-Disease Associations)", "impaired adp-induced platelet aggregation (HP:0004866 from HPO Gene-Disease Associations)", "prolonged bleeding following procedure (HP:0011890 from HPO Gene-Disease Associations)", "prolonged bleeding after surgery (HP:0004846 from HPO Gene-Disease Associations)", "abnormal umbilical stump bleeding (HP:0011884 from HPO Gene-Disease Associations)", "impaired epinephrine-induced platelet aggregation (HP:0008148 from HPO Gene-Disease Associations)", "absent cellular immunity (HP:0005354 from HPO Gene-Disease Associations)", "agranulocytosis (HP:0012234 from HPO Gene-Disease Associations)", "congenital agranulocytosis (HP:0005541 from HPO Gene-Disease Associations)", "abnormal monocyte count (HP:0012310 from HPO Gene-Disease Associations)", "abnormality of cells of the monocyte|macrophage lineage (HP:0012144 from HPO Gene-Disease Associations)", "monocytosis (HP:0012311 from HPO Gene-Disease Associations)", "acute leukemia (HP:0002488 from HPO Gene-Disease Associations)", "leukemia (HP:0001909 from HPO Gene-Disease Associations)", "hematological neoplasm (HP:0004377 from HPO Gene-Disease Associations)", "acute myeloid leukemia (HP:0004808 from HPO Gene-Disease Associations)", "acute lymphatic leukemia (HP:0006721 from HPO Gene-Disease Associations)", "t-cell acute lymphoblastic leukemias (HP:0006727 from HPO Gene-Disease Associations)", "acute monocytic leukemia (HP:0004845 from HPO Gene-Disease Associations)", "biphenotypic acute leukaemia (HP:0005531 from HPO Gene-Disease Associations)", "acute myelomonocytic leukemia (HP:0004820 from HPO Gene-Disease Associations)", "pre-b-cell acute lymphoblastic leukemia (HP:0004812 from HPO Gene-Disease Associations)", "ph-positive acute lymphoblastic leukemia (HP:0004848 from HPO Gene-Disease Associations)", "chronic myelogenous leukemia (HP:0005506 from HPO Gene-Disease Associations)", "chronic leukemia (HP:0005558 from HPO Gene-Disease Associations)", "chronic lymphatic leukemia (HP:0005550 from HPO Gene-Disease Associations)", "vitiligo (HP:0001045 from HPO Gene-Disease Associations)", "corneal neovascularization (HP:0011496 from HPO Gene-Disease Associations)", "multifactorial inheritance (HP:0001426 from HPO Gene-Disease Associations)", "polygenic inheritance (HP:0010982 from HPO Gene-Disease Associations)", "polyclonal elevation of igm (HP:0003459 from HPO Gene-Disease Associations)", "impaired lymphocyte transformation with phytohemagglutinin (HP:0003347 from HPO Gene-Disease Associations)", "waldenstrom macroglobulinemia (HP:0005508 from HPO Gene-Disease Associations)", "cryoglobulinemia (HP:0100778 from HPO Gene-Disease Associations)", "lymphoproliferative disorder (HP:0005523 from HPO Gene-Disease Associations)", "hypercoagulability (HP:0100724 from HPO Gene-Disease Associations)", "abnormality of the fascia (HP:0100536 from HPO Gene-Disease Associations)", "fasciitis (HP:0100537 from HPO Gene-Disease Associations)", "hepatic amyloidosis (HP:0012280 from HPO Gene-Disease Associations)", "recurrent pharyngitis (HP:0100776 from HPO Gene-Disease Associations)", "abnormal natural killer cell physiology (HP:0012177 from HPO Gene-Disease Associations)", "abnormality of natural killer cells (HP:0012176 from HPO Gene-Disease Associations)", "reduced natural killer cell activity (HP:0012178 from HPO Gene-Disease Associations)", "fulminant hepatitis (HP:0004787 from HPO Gene-Disease Associations)", "hepatic encephalopathy (HP:0002480 from HPO Gene-Disease Associations)", "acute hepatic failure (HP:0006554 from HPO Gene-Disease Associations)", "fulminant hepatic failure (HP:0004448 from HPO Gene-Disease Associations)", "hypoglycemic encephalopathy (HP:0006929 from HPO Gene-Disease Associations)", "bronchiolitis obliterans organizing pneumonia (HP:0011945 from HPO Gene-Disease Associations)", "interstitial pneumonitis (HP:0006515 from HPO Gene-Disease Associations)", "interstitial pulmonary disease (HP:0006530 from HPO Gene-Disease Associations)", "chronic colitis (HP:0100281 from HPO Gene-Disease Associations)", "ulcerative colitis (HP:0100279 from HPO Gene-Disease Associations)", "allergy (HP:0012393 from HPO Gene-Disease Associations)", "allergic rhinitis (HP:0003193 from HPO Gene-Disease Associations)", "tapered finger (HP:0001182 from HPO Gene-Disease Associations)", "patchy palmoplantar keratoderma (HP:0005588 from HPO Gene-Disease Associations)", "generalized hyperkeratosis (HP:0005595 from HPO Gene-Disease Associations)", "erythema (HP:0010783 from HPO Gene-Disease Associations)", "broad jaw (HP:0012802 from HPO Gene-Disease Associations)", "abnormality of immune system physiology (HP:0010978 from HPO Gene-Disease Associations)", "recurrent infections (HP:0002719 from HPO Gene-Disease Associations)", "recurrent respiratory infections (HP:0002205 from HPO Gene-Disease Associations)", "respiratory tract infection (HP:0011947 from HPO Gene-Disease Associations)", "abnormality of the immune system (HP:0002715 from HPO Gene-Disease Associations)", "abnormal respiratory system morphology (HP:0012252 from HPO Gene-Disease Associations)", "abnormality of the respiratory system (HP:0002086 from HPO Gene-Disease Associations)", "abnormality of the lung (HP:0002088 from HPO Gene-Disease Associations)", "respiratory insufficiency (HP:0002093 from HPO Gene-Disease Associations)", "functional respiratory abnormality (HP:0002795 from HPO Gene-Disease Associations)", "abnormality of the abdomen (HP:0001438 from HPO Gene-Disease Associations)", "abnormality of the abdominal organs (HP:0002012 from HPO Gene-Disease Associations)", "abnormality of the liver (HP:0001392 from HPO Gene-Disease Associations)", "abnormality of the gastrointestinal tract (HP:0011024 from HPO Gene-Disease Associations)", "morphological abnormality of the gastrointestinal tract (HP:0012718 from HPO Gene-Disease Associations)", "abnormality of the intestine (HP:0002242 from HPO Gene-Disease Associations)", "malabsorption (HP:0002024 from HPO Gene-Disease Associations)", "abnormality of skin morphology (HP:0011121 from HPO Gene-Disease Associations)", "generalized abnormality of skin (HP:0011354 from HPO Gene-Disease Associations)", "abnormality of the skin (HP:0000951 from HPO Gene-Disease Associations)", "abnormality of the integument (HP:0001574 from HPO Gene-Disease Associations)", "localized skin lesion (HP:0011355 from HPO Gene-Disease Associations)", "abnormality of cardiac morphology (HP:0001627 from HPO Gene-Disease Associations)", "malformation of the heart and great vessels (HP:0002564 from HPO Gene-Disease Associations)", "abnormality of the cardiovascular system (HP:0001626 from HPO Gene-Disease Associations)", "abnormality of the myocardium (HP:0001637 from HPO Gene-Disease Associations)", "cardiomyopathy (HP:0001638 from HPO Gene-Disease Associations)", "hypertrophic cardiomyopathy (HP:0001639 from HPO Gene-Disease Associations)", "abdominal symptom (HP:0011458 from HPO Gene-Disease Associations)", "feeding difficulties (HP:0011968 from HPO Gene-Disease Associations)", "feeding difficulties in infancy (HP:0008872 from HPO Gene-Disease Associations)", "abnormality of body weight (HP:0004323 from HPO Gene-Disease Associations)", "decreased body weight (HP:0004325 from HPO Gene-Disease Associations)", "failure to thrive (HP:0001508 from HPO Gene-Disease Associations)", "abnormality of metabolism|homeostasis (HP:0001939 from HPO Gene-Disease Associations)", "all (HP:0000001 from HPO Gene-Disease Associations)", "phenotypic abnormality (HP:0000118 from HPO Gene-Disease Associations)", "mode of inheritance (HP:0000005 from HPO Gene-Disease Associations)", "autosomal recessive inheritance (HP:0000007 from HPO Gene-Disease Associations)", "abnormality of higher mental function (HP:0011446 from HPO Gene-Disease Associations)", "cognitive impairment (HP:0100543 from HPO Gene-Disease Associations)", "abnormality of brain morphology (HP:0012443 from HPO Gene-Disease Associations)", "morphological abnormality of the central nervous system (HP:0002011 from HPO Gene-Disease Associations)", "abnormality of nervous system morphology (HP:0012639 from HPO Gene-Disease Associations)", "abnormality of nervous system physiology (HP:0012638 from HPO Gene-Disease Associations)", "abnormality of the nervous system (HP:0000707 from HPO Gene-Disease Associations)", "abnormality of skeletal morphology (HP:0011842 from HPO Gene-Disease Associations)", "abnormality of the skeletal system (HP:0000924 from HPO Gene-Disease Associations)", "abnormal axial skeleton morphology (HP:0009121 from HPO Gene-Disease Associations)", "abnormality of the skull (HP:0000929 from HPO Gene-Disease Associations)", "abnormality of head or neck (HP:0000152 from HPO Gene-Disease Associations)", "abnormality of the head (HP:0000234 from HPO Gene-Disease Associations)", "abnormality of the face (HP:0000271 from HPO Gene-Disease Associations)", "abnormality of the mouth (HP:0000153 from HPO Gene-Disease Associations)", "abnormality of the oral cavity (HP:0000163 from HPO Gene-Disease Associations)", "abnormality of forebrain morphology (HP:0100547 from HPO Gene-Disease Associations)", "abnormality of the cerebrum (HP:0002060 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the central nervous system (HP:0002977 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the cerebrum (HP:0007364 from HPO Gene-Disease Associations)", "microcephaly (HP:0000252 from HPO Gene-Disease Associations)", "abnormality of skull size (HP:0000240 from HPO Gene-Disease Associations)", "seizures (HP:0001250 from HPO Gene-Disease Associations)", "abnormality of muscle physiology (HP:0011804 from HPO Gene-Disease Associations)", "abnormality of the musculature (HP:0003011 from HPO Gene-Disease Associations)", "muscular hypotonia (HP:0001252 from HPO Gene-Disease Associations)", "abnormal muscle tone (HP:0003808 from HPO Gene-Disease Associations)", "abnormality of body height (HP:0000002 from HPO Gene-Disease Associations)", "short stature (HP:0004322 from HPO Gene-Disease Associations)", "growth delay (HP:0001510 from HPO Gene-Disease Associations)", "growth abnormality (HP:0001507 from HPO Gene-Disease Associations)", "neurodevelopmental abnormality (HP:0012759 from HPO Gene-Disease Associations)", "intellectual disability (HP:0001249 from HPO Gene-Disease Associations)", "neurodevelopmental delay (HP:0012758 from HPO Gene-Disease Associations)", "global developmental delay (HP:0001263 from HPO Gene-Disease Associations)", "abnormal eye morphology (HP:0012372 from HPO Gene-Disease Associations)", "abnormality of the globe (HP:0012374 from HPO Gene-Disease Associations)", "abnormality of the eye (HP:0000478 from HPO Gene-Disease Associations)", "abnormality of the fundus (HP:0001098 from HPO Gene-Disease Associations)", "abnormality of the posterior segment of the eye (HP:0004329 from HPO Gene-Disease Associations)", "abnormality of the retina (HP:0000479 from HPO Gene-Disease Associations)", "abnormality of the optic disc (HP:0012795 from HPO Gene-Disease Associations)", "optic atrophy (HP:0000648 from HPO Gene-Disease Associations)", "abnormality of the optic nerve (HP:0000587 from HPO Gene-Disease Associations)", "abnormality of vision (HP:0000504 from HPO Gene-Disease Associations)", "visual impairment (HP:0000505 from HPO Gene-Disease Associations)", "abnormal conjugate eye movement (HP:0000549 from HPO Gene-Disease Associations)", "strabismus (HP:0000486 from HPO Gene-Disease Associations)", "abnormal eye physiology (HP:0012373 from HPO Gene-Disease Associations)", "abnormality of eye movement (HP:0000496 from HPO Gene-Disease Associations)", "abnormal involuntary eye movements (HP:0012547 from HPO Gene-Disease Associations)", "nystagmus (HP:0000639 from HPO Gene-Disease Associations)", "abnormality of the anterior segment of the eye (HP:0004328 from HPO Gene-Disease Associations)", "abnormality of the lens (HP:0000517 from HPO Gene-Disease Associations)", "cataract (HP:0000518 from HPO Gene-Disease Associations)", "abnormality of the cornea (HP:0000481 from HPO Gene-Disease Associations)", "glaucoma (HP:0000501 from HPO Gene-Disease Associations)", "abnormality of the ear (HP:0000598 from HPO Gene-Disease Associations)", "hearing abnormality (HP:0000364 from HPO Gene-Disease Associations)", "hearing impairment (HP:0000365 from HPO Gene-Disease Associations)", "abnormality of the middle ear (HP:0000370 from HPO Gene-Disease Associations)", "functional abnormality of the inner ear (HP:0011389 from HPO Gene-Disease Associations)", "abnormality of the inner ear (HP:0000359 from HPO Gene-Disease Associations)", "sensorineural hearing impairment (HP:0000407 from HPO Gene-Disease Associations)", "ptosis (HP:0000508 from HPO Gene-Disease Associations)", "abnormal external genitalia (HP:0000811 from HPO Gene-Disease Associations)", "abnormality of male external genitalia (HP:0000032 from HPO Gene-Disease Associations)", "abnormality of the male genitalia (HP:0010461 from HPO Gene-Disease Associations)", "abnormality of the testis (HP:0000035 from HPO Gene-Disease Associations)", "abnormal genital system morphology (HP:0012243 from HPO Gene-Disease Associations)", "abnormality of the genital system (HP:0000078 from HPO Gene-Disease Associations)", "cryptorchidism (HP:0000028 from HPO Gene-Disease Associations)", "abnormality of the penis (HP:0000036 from HPO Gene-Disease Associations)", "external genital hypoplasia (HP:0003241 from HPO Gene-Disease Associations)", "hypoplastic male external genitalia (HP:0000050 from HPO Gene-Disease Associations)", "hypoplasia of penis (HP:0008736 from HPO Gene-Disease Associations)", "increased body weight (HP:0004324 from HPO Gene-Disease Associations)", "obesity (HP:0001513 from HPO Gene-Disease Associations)", "micropenis (HP:0000054 from HPO Gene-Disease Associations)", "abnormal nasal morphology (HP:0005105 from HPO Gene-Disease Associations)", "abnormality of the external nose (HP:0010938 from HPO Gene-Disease Associations)", "abnormality of the nares (HP:0005288 from HPO Gene-Disease Associations)", "anteverted nares (HP:0000463 from HPO Gene-Disease Associations)", "abnormality of the nasal alae (HP:0000429 from HPO Gene-Disease Associations)", "abnormality of the nose (HP:0000366 from HPO Gene-Disease Associations)", "abnormality of the nasal bridge (HP:0000422 from HPO Gene-Disease Associations)", "wide nasal bridge (HP:0000431 from HPO Gene-Disease Associations)", "depressed nasal bridge (HP:0005280 from HPO Gene-Disease Associations)", "abnormality of the neck (HP:0000464 from HPO Gene-Disease Associations)", "abnormality of the cervical spine (HP:0003319 from HPO Gene-Disease Associations)", "short neck (HP:0000470 from HPO Gene-Disease Associations)", "abnormality of the philtrum (HP:0000288 from HPO Gene-Disease Associations)", "long philtrum (HP:0000343 from HPO Gene-Disease Associations)", "abnormality of lower limb bone (HP:0040069 from HPO Gene-Disease Associations)", "aplasia involving bones of the extremities (HP:0009825 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the extremities (HP:0009815 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving bones of the hand (HP:0005927 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving bones of the upper limbs (HP:0006496 from HPO Gene-Disease Associations)", "abnormal appendicular skeleton morphology (HP:0011844 from HPO Gene-Disease Associations)", "abnormality of limb bone morphology (HP:0002813 from HPO Gene-Disease Associations)", "abnormality of limb bone (HP:0040068 from HPO Gene-Disease Associations)", "abnormality of limbs (HP:0040064 from HPO Gene-Disease Associations)", "abnormality of the foot (HP:0001760 from HPO Gene-Disease Associations)", "abnormality of the lower limb (HP:0002814 from HPO Gene-Disease Associations)", "abnormality of digit (HP:0011297 from HPO Gene-Disease Associations)", "abnormality of finger (HP:0001167 from HPO Gene-Disease Associations)", "abnormality of the hand (HP:0001155 from HPO Gene-Disease Associations)", "abnormality of the upper limb (HP:0002817 from HPO Gene-Disease Associations)", "abnormality of phalanx of finger (HP:0005918 from HPO Gene-Disease Associations)", "abnormality of toe (HP:0001780 from HPO Gene-Disease Associations)", "abnormality of the 5th finger (HP:0004207 from HPO Gene-Disease Associations)", "clinodactyly (HP:0030084 from HPO Gene-Disease Associations)", "finger clinodactyly (HP:0040019 from HPO Gene-Disease Associations)", "clinodactyly of the 5th finger (HP:0004209 from HPO Gene-Disease Associations)", "deviation of the 5th finger (HP:0009179 from HPO Gene-Disease Associations)", "deviation of finger (HP:0004097 from HPO Gene-Disease Associations)", "deviation of the hand or of fingers of the hand (HP:0009484 from HPO Gene-Disease Associations)", "radial deviation of finger (HP:0009466 from HPO Gene-Disease Associations)", "radial deviation of the hand or of fingers of the hand (HP:0009485 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the skeleton (HP:0009115 from HPO Gene-Disease Associations)", "abnormality of the mandible (HP:0000277 from HPO Gene-Disease Associations)", "aplasia|hypoplasia affecting bones of the axial skeleton (HP:0009122 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving bones of the skull (HP:0009116 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the mandible (HP:0009118 from HPO Gene-Disease Associations)", "micrognathia (HP:0000347 from HPO Gene-Disease Associations)", "abnormality of facial skeleton (HP:0011821 from HPO Gene-Disease Associations)", "abnormal location of ears (HP:0000357 from HPO Gene-Disease Associations)", "low-set ears (HP:0000369 from HPO Gene-Disease Associations)", "low-set, posteriorly rotated ears (HP:0000368 from HPO Gene-Disease Associations)", "posteriorly rotated ears (HP:0000358 from HPO Gene-Disease Associations)", "abnormality of the outer ear (HP:0000356 from HPO Gene-Disease Associations)", "abnormality of the pinna (HP:0000377 from HPO Gene-Disease Associations)", "abnormality of the palpebral fissures (HP:0008050 from HPO Gene-Disease Associations)", "slanting of the palpebral fissure (HP:0200006 from HPO Gene-Disease Associations)", "downslanted palpebral fissures (HP:0000494 from HPO Gene-Disease Associations)", "abnormality of the eyelid (HP:0000492 from HPO Gene-Disease Associations)", "abnormality of the periorbital region (HP:0000606 from HPO Gene-Disease Associations)", "abnormality of the ocular region (HP:0000284 from HPO Gene-Disease Associations)", "abnormality of globe location (HP:0100886 from HPO Gene-Disease Associations)", "abnormality of the orbital region (HP:0000315 from HPO Gene-Disease Associations)", "hypertelorism (HP:0000316 from HPO Gene-Disease Associations)", "epicanthus (HP:0000286 from HPO Gene-Disease Associations)", "abnormal shape of the frontal region (HP:0011218 from HPO Gene-Disease Associations)", "frontal bossing (HP:0002007 from HPO Gene-Disease Associations)", "abnormality of calvarial morphology (HP:0002648 from HPO Gene-Disease Associations)", "abnormality of the calvaria (HP:0002683 from HPO Gene-Disease Associations)", "abnormality of the forehead (HP:0000290 from HPO Gene-Disease Associations)", "abnormality of the curvature of the vertebral column (HP:0010674 from HPO Gene-Disease Associations)", "scoliosis (HP:0002650 from HPO Gene-Disease Associations)", "abnormality of the vertebral column (HP:0000925 from HPO Gene-Disease Associations)", "kyphosis (HP:0002808 from HPO Gene-Disease Associations)", "abnormality of the lip (HP:0000159 from HPO Gene-Disease Associations)", "abnormality of upper lip (HP:0000177 from HPO Gene-Disease Associations)", "cleft upper lip (HP:0000204 from HPO Gene-Disease Associations)", "abnormality of the hard palate (HP:0100737 from HPO Gene-Disease Associations)", "cleft palate (HP:0000175 from HPO Gene-Disease Associations)", "oral cleft (HP:0000202 from HPO Gene-Disease Associations)", "abnormality of the palate (HP:0000174 from HPO Gene-Disease Associations)", "abnormality of the midface (HP:0000309 from HPO Gene-Disease Associations)", "abnormality of the zygomatic arch (HP:0005557 from HPO Gene-Disease Associations)", "hypoplastic facial bones (HP:0002692 from HPO Gene-Disease Associations)", "malar anomaly (HP:0012369 from HPO Gene-Disease Associations)", "malar flattening (HP:0000272 from HPO Gene-Disease Associations)", "abnormal facial shape (HP:0001999 from HPO Gene-Disease Associations)", "midface retrusion (HP:0011800 from HPO Gene-Disease Associations)", "macrocephaly (HP:0000256 from HPO Gene-Disease Associations)", "abdominal wall defect (HP:0010866 from HPO Gene-Disease Associations)", "hernia of the abdominal wall (HP:0004299 from HPO Gene-Disease Associations)", "hernia (HP:0100790 from HPO Gene-Disease Associations)", "abnormality of the abdominal wall (HP:0004298 from HPO Gene-Disease Associations)", "abnormality of the umbilicus (HP:0001551 from HPO Gene-Disease Associations)", "umbilical hernia (HP:0001537 from HPO Gene-Disease Associations)", "inguinal hernia (HP:0000023 from HPO Gene-Disease Associations)", "abnormality of the urethra (HP:0000795 from HPO Gene-Disease Associations)", "displacement of the external urethral meatus (HP:0100627 from HPO Gene-Disease Associations)", "abnormality of the lower urinary tract (HP:0010936 from HPO Gene-Disease Associations)", "hypospadias (HP:0000047 from HPO Gene-Disease Associations)", "intrauterine growth retardation (HP:0001511 from HPO Gene-Disease Associations)", "congenital malformation of the great arteries (HP:0011603 from HPO Gene-Disease Associations)", "patent ductus arteriosus (HP:0001643 from HPO Gene-Disease Associations)", "conotruncal defect (HP:0001710 from HPO Gene-Disease Associations)", "tetralogy of fallot (HP:0001636 from HPO Gene-Disease Associations)", "abnormality of cardiac atrium (HP:0005120 from HPO Gene-Disease Associations)", "abnormality of the atrial septum (HP:0011994 from HPO Gene-Disease Associations)", "defect in the atrial septum (HP:0001631 from HPO Gene-Disease Associations)", "abnormality of the cardiac septa (HP:0001671 from HPO Gene-Disease Associations)", "abnormality of cardiac ventricle (HP:0001713 from HPO Gene-Disease Associations)", "abnormality of the ventricular septum (HP:0010438 from HPO Gene-Disease Associations)", "ventricular septal defect (HP:0001629 from HPO Gene-Disease Associations)", "abnormality of upper limb joint (HP:0009810 from HPO Gene-Disease Associations)", "abnormality of the elbow (HP:0009811 from HPO Gene-Disease Associations)", "elbow flexion contracture (HP:0002987 from HPO Gene-Disease Associations)", "limited elbow movement (HP:0002996 from HPO Gene-Disease Associations)", "limitation of joint mobility (HP:0001376 from HPO Gene-Disease Associations)", "abnormal joint morphology (HP:0001367 from HPO Gene-Disease Associations)", "abnormality of joint mobility (HP:0011729 from HPO Gene-Disease Associations)", "abnormal tendon morphology (HP:0100261 from HPO Gene-Disease Associations)", "flexion contracture (HP:0001371 from HPO Gene-Disease Associations)", "abnormality of connective tissue (HP:0003549 from HPO Gene-Disease Associations)", "limb joint contracture (HP:0003121 from HPO Gene-Disease Associations)", "flexion contracture of digit (HP:0030044 from HPO Gene-Disease Associations)", "camptodactyly (HP:0012385 from HPO Gene-Disease Associations)", "contractures of the joints of the upper limbs (HP:0100360 from HPO Gene-Disease Associations)", "joint contracture of the hand (HP:0009473 from HPO Gene-Disease Associations)", "flexion contracture of finger (HP:0012785 from HPO Gene-Disease Associations)", "interphalangeal joint contracture of finger (HP:0001220 from HPO Gene-Disease Associations)", "camptodactyly of finger (HP:0100490 from HPO Gene-Disease Associations)", "abnormality of phalangeal joints of the hand (HP:0006261 from HPO Gene-Disease Associations)", "positional foot deformity (HP:0005656 from HPO Gene-Disease Associations)", "talipes (HP:0001883 from HPO Gene-Disease Associations)", "talipes equinovarus (HP:0001762 from HPO Gene-Disease Associations)", "abnormality of lower limb joint (HP:0100491 from HPO Gene-Disease Associations)", "abnormality of pelvic girdle bone morphology (HP:0002644 from HPO Gene-Disease Associations)", "abnormality of the hip bone (HP:0003272 from HPO Gene-Disease Associations)", "joint dislocation (HP:0001373 from HPO Gene-Disease Associations)", "abnormality of the hip joint (HP:0001384 from HPO Gene-Disease Associations)", "abnormality of the synovia (HP:0005262 from HPO Gene-Disease Associations)", "hip dislocation (HP:0002827 from HPO Gene-Disease Associations)", "lower extremity joint dislocation (HP:0030311 from HPO Gene-Disease Associations)", "congenital hip dislocation (HP:0001374 from HPO Gene-Disease Associations)", "high palate (HP:0000218 from HPO Gene-Disease Associations)", "abnormality of the urinary system physiology (HP:0011277 from HPO Gene-Disease Associations)", "abnormal renal physiology (HP:0012211 from HPO Gene-Disease Associations)", "renal insufficiency (HP:0000083 from HPO Gene-Disease Associations)", "abnormal renal morphology (HP:0012210 from HPO Gene-Disease Associations)", "abnormality of the kidney (HP:0000077 from HPO Gene-Disease Associations)", "abnormality of the upper urinary tract (HP:0010935 from HPO Gene-Disease Associations)", "abnormality of the genitourinary system (HP:0000119 from HPO Gene-Disease Associations)", "abnormality of the urinary system (HP:0000079 from HPO Gene-Disease Associations)", "abnormality of urine homeostasis (HP:0003110 from HPO Gene-Disease Associations)", "proteinuria (HP:0000093 from HPO Gene-Disease Associations)", "hypertension (HP:0000822 from HPO Gene-Disease Associations)", "nephrotic syndrome (HP:0000100 from HPO Gene-Disease Associations)", "abnormal urine cytology (HP:0012614 from HPO Gene-Disease Associations)", "hematuria (HP:0000790 from HPO Gene-Disease Associations)", "nephropathy (HP:0000112 from HPO Gene-Disease Associations)", "short toe (HP:0001831 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of toe (HP:0001991 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving bones of the feet (HP:0006494 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving bones of the lower limbs (HP:0006493 from HPO Gene-Disease Associations)", "short digit (HP:0011927 from HPO Gene-Disease Associations)", "brachydactyly syndrome (HP:0001156 from HPO Gene-Disease Associations)", "abnormal hand morphology (HP:0005922 from HPO Gene-Disease Associations)", "short finger (HP:0009381 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of fingers (HP:0006265 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the distal phalanges of the hand (HP:0009835 from HPO Gene-Disease Associations)", "short distal phalanx of finger (HP:0009882 from HPO Gene-Disease Associations)", "abnormality of the distal phalanx of finger (HP:0009832 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the phalanges of the hand (HP:0009767 from HPO Gene-Disease Associations)", "short phalanx of finger (HP:0009803 from HPO Gene-Disease Associations)", "abnormal metacarpal morphology (HP:0005916 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the metacarpal bones (HP:0005914 from HPO Gene-Disease Associations)", "short metacarpal (HP:0010049 from HPO Gene-Disease Associations)", "abnormality of the metacarpal bones (HP:0001163 from HPO Gene-Disease Associations)", "abnormal morphology of bones of the lower limbs (HP:0040066 from HPO Gene-Disease Associations)", "short long bone (HP:0003026 from HPO Gene-Disease Associations)", "abnormality of the metatarsal bones (HP:0001832 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of metatarsal bones (HP:0001964 from HPO Gene-Disease Associations)", "short metatarsal (HP:0010743 from HPO Gene-Disease Associations)", "abnormality of epiphysis morphology (HP:0005930 from HPO Gene-Disease Associations)", "abnormality of long bone morphology (HP:0011314 from HPO Gene-Disease Associations)", "abnormality of the knees (HP:0002815 from HPO Gene-Disease Associations)", "abnormality of the calf (HP:0002981 from HPO Gene-Disease Associations)", "bowing of the legs (HP:0002979 from HPO Gene-Disease Associations)", "abnormal diaphysis morphology (HP:0000940 from HPO Gene-Disease Associations)", "anomaly of the limb diaphyses (HP:0006504 from HPO Gene-Disease Associations)", "bowing of the long bones (HP:0006487 from HPO Gene-Disease Associations)", "genu valgum (HP:0002857 from HPO Gene-Disease Associations)", "abnormality of the rib cage (HP:0001547 from HPO Gene-Disease Associations)", "abnormality of the ribs (HP:0000772 from HPO Gene-Disease Associations)", "abnormality of the thorax (HP:0000765 from HPO Gene-Disease Associations)", "abnormal form of the vertebral bodies (HP:0003312 from HPO Gene-Disease Associations)", "abnormality of the vertebrae (HP:0003468 from HPO Gene-Disease Associations)", "platyspondyly (HP:0000926 from HPO Gene-Disease Associations)", "abnormality of the metaphyses (HP:0000944 from HPO Gene-Disease Associations)", "flared metaphysis (HP:0003015 from HPO Gene-Disease Associations)", "metaphyseal widening (HP:0003016 from HPO Gene-Disease Associations)", "skeletal dysplasia (HP:0002652 from HPO Gene-Disease Associations)", "limb undergrowth (HP:0009826 from HPO Gene-Disease Associations)", "micromelia (HP:0002983 from HPO Gene-Disease Associations)", "disproportionate short stature (HP:0003498 from HPO Gene-Disease Associations)", "disproportionate short-limb short stature (HP:0008873 from HPO Gene-Disease Associations)", "rhizomelia (HP:0008905 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the ribs (HP:0006712 from HPO Gene-Disease Associations)", "short ribs (HP:0000773 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving bones of the thorax (HP:0006711 from HPO Gene-Disease Associations)", "thoracic hypoplasia (HP:0005257 from HPO Gene-Disease Associations)", "narrow chest (HP:0000774 from HPO Gene-Disease Associations)", "short thorax (HP:0010306 from HPO Gene-Disease Associations)", "renal hypoplasia (HP:0000089 from HPO Gene-Disease Associations)", "renal hypoplasia|aplasia (HP:0008678 from HPO Gene-Disease Associations)", "abnormal localization of kidney (HP:0100542 from HPO Gene-Disease Associations)", "cutaneous syndactyly (HP:0012725 from HPO Gene-Disease Associations)", "cutaneous finger syndactyly (HP:0010554 from HPO Gene-Disease Associations)", "syndactyly (HP:0001159 from HPO Gene-Disease Associations)", "finger syndactyly (HP:0006101 from HPO Gene-Disease Associations)", "toe syndactyly (HP:0001770 from HPO Gene-Disease Associations)", "abnormal size of the palpebral fissures (HP:0200007 from HPO Gene-Disease Associations)", "blepharophimosis (HP:0000581 from HPO Gene-Disease Associations)", "short palpebral fissure (HP:0012745 from HPO Gene-Disease Associations)", "abnormal number of teeth (HP:0006483 from HPO Gene-Disease Associations)", "reduced number of teeth (HP:0009804 from HPO Gene-Disease Associations)", "hypodontia (HP:0000668 from HPO Gene-Disease Associations)", "abnormality of dental morphology (HP:0006482 from HPO Gene-Disease Associations)", "microdontia (HP:0000691 from HPO Gene-Disease Associations)", "misalignment of teeth (HP:0000692 from HPO Gene-Disease Associations)", "dental malocclusion (HP:0000689 from HPO Gene-Disease Associations)", "abnormality of dental eruption (HP:0006292 from HPO Gene-Disease Associations)", "delayed eruption of teeth (HP:0000684 from HPO Gene-Disease Associations)", "abnormality of the teeth (HP:0000164 from HPO Gene-Disease Associations)", "abnormality of dental enamel (HP:0000682 from HPO Gene-Disease Associations)", "abnormality of dental structure (HP:0011061 from HPO Gene-Disease Associations)", "carious teeth (HP:0000670 from HPO Gene-Disease Associations)", "hypoplasia of dental enamel (HP:0006297 from HPO Gene-Disease Associations)", "hypoplasia of teeth (HP:0000685 from HPO Gene-Disease Associations)", "abnormality of lower lip (HP:0000178 from HPO Gene-Disease Associations)", "thick lower lip vermilion (HP:0000179 from HPO Gene-Disease Associations)", "thick vermilion border (HP:0012471 from HPO Gene-Disease Associations)", "eclabion (HP:0012472 from HPO Gene-Disease Associations)", "everted lower lip vermilion (HP:0000232 from HPO Gene-Disease Associations)", "abnormality of mouth size (HP:0011337 from HPO Gene-Disease Associations)", "narrow mouth (HP:0000160 from HPO Gene-Disease Associations)", "wide mouth (HP:0000154 from HPO Gene-Disease Associations)", "abnormality of the chin (HP:0000306 from HPO Gene-Disease Associations)", "mandibular prognathia (HP:0000303 from HPO Gene-Disease Associations)", "pointed chin (HP:0000307 from HPO Gene-Disease Associations)", "abnormality of the eyelashes (HP:0000499 from HPO Gene-Disease Associations)", "long eyelashes (HP:0000527 from HPO Gene-Disease Associations)", "abnormal hair quantity (HP:0011362 from HPO Gene-Disease Associations)", "abnormality of skin adnexa (HP:0011138 from HPO Gene-Disease Associations)", "abnormality of the hair (HP:0001595 from HPO Gene-Disease Associations)", "abnormality of the eyebrow (HP:0000534 from HPO Gene-Disease Associations)", "hypertrichosis (HP:0000998 from HPO Gene-Disease Associations)", "alopecia (HP:0001596 from HPO Gene-Disease Associations)", "facial hypertrichosis (HP:0002219 from HPO Gene-Disease Associations)", "synophrys (HP:0000664 from HPO Gene-Disease Associations)", "thick eyebrow (HP:0000574 from HPO Gene-Disease Associations)", "abnormal hair pattern (HP:0010720 from HPO Gene-Disease Associations)", "congenital abnormal hair pattern (HP:0011361 from HPO Gene-Disease Associations)", "abnormality of the hairline (HP:0009553 from HPO Gene-Disease Associations)", "abnormality of the scalp (HP:0001965 from HPO Gene-Disease Associations)", "abnormality of the scalp hair (HP:0100037 from HPO Gene-Disease Associations)", "abnormality of the posterior hairline (HP:0030141 from HPO Gene-Disease Associations)", "low posterior hairline (HP:0002162 from HPO Gene-Disease Associations)", "abnormality of the frontal hairline (HP:0000599 from HPO Gene-Disease Associations)", "low anterior hairline (HP:0000294 from HPO Gene-Disease Associations)", "abnormality of the larynx (HP:0001600 from HPO Gene-Disease Associations)", "laryngomalacia (HP:0001601 from HPO Gene-Disease Associations)", "abnormality of the upper respiratory tract (HP:0002087 from HPO Gene-Disease Associations)", "abnormality of the tracheobronchial system (HP:0005607 from HPO Gene-Disease Associations)", "abnormality of the trachea (HP:0002778 from HPO Gene-Disease Associations)", "tracheoesophageal fistula (HP:0002575 from HPO Gene-Disease Associations)", "tracheal stenosis (HP:0002777 from HPO Gene-Disease Associations)", "abnormality of the nasal dorsum (HP:0011119 from HPO Gene-Disease Associations)", "depressed nasal ridge (HP:0000457 from HPO Gene-Disease Associations)", "convex nasal ridge (HP:0000444 from HPO Gene-Disease Associations)", "abnormal autonomic nervous system morphology (HP:0012331 from HPO Gene-Disease Associations)", "abnormality of the enteric ganglia (HP:0004362 from HPO Gene-Disease Associations)", "aganglionic megacolon (HP:0002251 from HPO Gene-Disease Associations)", "abnormality of the autonomic nervous system (HP:0002270 from HPO Gene-Disease Associations)", "prominent nasal bridge (HP:0000426 from HPO Gene-Disease Associations)", "abnormality of the 5th toe (HP:0010322 from HPO Gene-Disease Associations)", "postaxial foot polydactyly (HP:0001830 from HPO Gene-Disease Associations)", "duplication of bones involving the upper extremities (HP:0009142 from HPO Gene-Disease Associations)", "duplication of hand bones (HP:0004275 from HPO Gene-Disease Associations)", "duplication of phalanx of hand (HP:0009997 from HPO Gene-Disease Associations)", "hand polydactyly (HP:0001161 from HPO Gene-Disease Associations)", "polydactyly (HP:0010442 from HPO Gene-Disease Associations)", "postaxial hand polydactyly (HP:0001162 from HPO Gene-Disease Associations)", "postaxial polydactyly (HP:0100259 from HPO Gene-Disease Associations)", "duplication involving bones of the feet (HP:0009136 from HPO Gene-Disease Associations)", "foot polydactyly (HP:0001829 from HPO Gene-Disease Associations)", "preaxial polydactyly (HP:0100258 from HPO Gene-Disease Associations)", "preaxial hand polydactyly (HP:0001177 from HPO Gene-Disease Associations)", "multicystic kidney dysplasia (HP:0000003 from HPO Gene-Disease Associations)", "renal cyst (HP:0000107 from HPO Gene-Disease Associations)", "polycystic kidney dysplasia (HP:0000113 from HPO Gene-Disease Associations)", "apraxia (HP:0002186 from HPO Gene-Disease Associations)", "oculomotor apraxia (HP:0000657 from HPO Gene-Disease Associations)", "abnormality of midbrain morphology (HP:0002418 from HPO Gene-Disease Associations)", "molar tooth sign on mri (HP:0002419 from HPO Gene-Disease Associations)", "narrow forehead (HP:0000341 from HPO Gene-Disease Associations)", "highly arched eyebrow (HP:0002553 from HPO Gene-Disease Associations)", "large face (HP:0100729 from HPO Gene-Disease Associations)", "long face (HP:0000276 from HPO Gene-Disease Associations)", "abnormal biliary tract physiology (HP:0012439 from HPO Gene-Disease Associations)", "bile duct proliferation (HP:0001408 from HPO Gene-Disease Associations)", "congenital hepatic fibrosis (HP:0002612 from HPO Gene-Disease Associations)", "hepatic fibrosis (HP:0001395 from HPO Gene-Disease Associations)", "cystic liver disease (HP:0006706 from HPO Gene-Disease Associations)", "pancreatic cysts (HP:0001737 from HPO Gene-Disease Associations)", "pancreatic fibrosis (HP:0100732 from HPO Gene-Disease Associations)", "true hermaphroditism (HP:0010459 from HPO Gene-Disease Associations)", "abnormality of pancreas morphology (HP:0012090 from HPO Gene-Disease Associations)", "anencephaly (HP:0002323 from HPO Gene-Disease Associations)", "sclerocornea (HP:0000647 from HPO Gene-Disease Associations)", "furrowed tongue (HP:0000221 from HPO Gene-Disease Associations)", "occipital encephalocele (HP:0002085 from HPO Gene-Disease Associations)", "male pseudohermaphroditism (HP:0000037 from HPO Gene-Disease Associations)", "ambiguous genitalia (HP:0000062 from HPO Gene-Disease Associations)", "abnormality of the cheeks (HP:0004426 from HPO Gene-Disease Associations)", "full cheeks (HP:0000293 from HPO Gene-Disease Associations)", "abnormality of the cerebral subcortex (HP:0010993 from HPO Gene-Disease Associations)", "abnormality of the cerebral white matter (HP:0002500 from HPO Gene-Disease Associations)", "abnormality of the corpus callosum (HP:0001273 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the corpus callosum (HP:0007370 from HPO Gene-Disease Associations)", "hypoplasia of the corpus callosum (HP:0002079 from HPO Gene-Disease Associations)", "agenesis of corpus callosum (HP:0001274 from HPO Gene-Disease Associations)", "abnormality of the cerebellar vermis (HP:0002334 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the  cerebellar vermis (HP:0006817 from HPO Gene-Disease Associations)", "cerebellar vermis hypoplasia (HP:0001320 from HPO Gene-Disease Associations)", "cerebellar malformation (HP:0002438 from HPO Gene-Disease Associations)", "abnormality of the fourth ventricle (HP:0010950 from HPO Gene-Disease Associations)", "dilated fourth ventricle (HP:0002198 from HPO Gene-Disease Associations)", "dandy-walker malformation (HP:0001305 from HPO Gene-Disease Associations)", "widened posterior fossa (HP:0005445 from HPO Gene-Disease Associations)", "cerebellar cyst (HP:0002350 from HPO Gene-Disease Associations)", "abnormality of the posterior cranial fossa (HP:0000932 from HPO Gene-Disease Associations)", "abnormality of the skull base (HP:0002693 from HPO Gene-Disease Associations)", "intracranial cystic lesion (HP:0010576 from HPO Gene-Disease Associations)", "abnormality of the cerebral ventricles (HP:0002118 from HPO Gene-Disease Associations)", "ventriculomegaly (HP:0002119 from HPO Gene-Disease Associations)", "abnormality of the cerebrospinal fluid (HP:0002921 from HPO Gene-Disease Associations)", "hydrocephalus (HP:0000238 from HPO Gene-Disease Associations)", "cephalocele (HP:0011815 from HPO Gene-Disease Associations)", "encephalocele (HP:0002084 from HPO Gene-Disease Associations)", "holoprosencephaly (HP:0001360 from HPO Gene-Disease Associations)", "aplasia|hypoplasia affecting the eye (HP:0008056 from HPO Gene-Disease Associations)", "abnormality of globe size (HP:0100887 from HPO Gene-Disease Associations)", "microphthalmos (HP:0000568 from HPO Gene-Disease Associations)", "abnormality of corneal size (HP:0001120 from HPO Gene-Disease Associations)", "microcornea (HP:0000482 from HPO Gene-Disease Associations)", "chorioretinal coloboma (HP:0000567 from HPO Gene-Disease Associations)", "choroid coloboma (HP:0000611 from HPO Gene-Disease Associations)", "retinal coloboma (HP:0000480 from HPO Gene-Disease Associations)", "coloboma (HP:0000589 from HPO Gene-Disease Associations)", "iris coloboma (HP:0000612 from HPO Gene-Disease Associations)", "abnormality of the iris (HP:0000525 from HPO Gene-Disease Associations)", "abnormality of the uvea (HP:0000553 from HPO Gene-Disease Associations)", "abnormality of neural tube closure (HP:0045005 from HPO Gene-Disease Associations)", "spinal dysraphism (HP:0010301 from HPO Gene-Disease Associations)", "spina bifida (HP:0002414 from HPO Gene-Disease Associations)", "abnormality of the spinal cord (HP:0002143 from HPO Gene-Disease Associations)", "spina bifida occulta (HP:0003298 from HPO Gene-Disease Associations)", "meningocele (HP:0002435 from HPO Gene-Disease Associations)", "abnormality of the meninges (HP:0010651 from HPO Gene-Disease Associations)", "myelomeningocele (HP:0002475 from HPO Gene-Disease Associations)", "rib fusion (HP:0000902 from HPO Gene-Disease Associations)", "vertebral segmentation defect (HP:0003422 from HPO Gene-Disease Associations)", "hemivertebrae (HP:0002937 from HPO Gene-Disease Associations)", "abnormality of the clavicle (HP:0000889 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the clavicles (HP:0006710 from HPO Gene-Disease Associations)", "short clavicles (HP:0000894 from HPO Gene-Disease Associations)", "abnormality of cranial sutures (HP:0011329 from HPO Gene-Disease Associations)", "abnormality of the fontanelles or cranial sutures (HP:0000235 from HPO Gene-Disease Associations)", "craniosynostosis (HP:0001363 from HPO Gene-Disease Associations)", "abnormality of fontanelles (HP:0011328 from HPO Gene-Disease Associations)", "large fontanelles (HP:0000239 from HPO Gene-Disease Associations)", "abnormality of the anterior fontanelle (HP:0000236 from HPO Gene-Disease Associations)", "wide anterior fontanel (HP:0000260 from HPO Gene-Disease Associations)", "delayed closure of the anterior fontanelle (HP:0001476 from HPO Gene-Disease Associations)", "delayed cranial suture closure (HP:0000270 from HPO Gene-Disease Associations)", "kyphoscoliosis (HP:0002751 from HPO Gene-Disease Associations)", "postnatal growth retardation (HP:0008897 from HPO Gene-Disease Associations)", "very long chain fatty acid accumulation (HP:0008167 from HPO Gene-Disease Associations)", "generalized neonatal hypotonia (HP:0008935 from HPO Gene-Disease Associations)", "brushfield spots (HP:0001088 from HPO Gene-Disease Associations)", "abnormality of the line of schwalbe (HP:0008048 from HPO Gene-Disease Associations)", "posterior embryotoxon (HP:0000627 from HPO Gene-Disease Associations)", "abnormality of the supraorbital ridges (HP:0100538 from HPO Gene-Disease Associations)", "underdeveloped supraorbital ridges (HP:0009891 from HPO Gene-Disease Associations)", "abnormal bone ossification (HP:0011849 from HPO Gene-Disease Associations)", "abnormal enchondral ossification (HP:0003336 from HPO Gene-Disease Associations)", "abnormal epiphyseal ossification (HP:0010656 from HPO Gene-Disease Associations)", "epiphyseal stippling (HP:0010655 from HPO Gene-Disease Associations)", "abnormality of the stomach (HP:0002577 from HPO Gene-Disease Associations)", "abnormality of the pylorus (HP:0004400 from HPO Gene-Disease Associations)", "pyloric stenosis (HP:0002021 from HPO Gene-Disease Associations)", "abnormal dermatoglyphics (HP:0007477 from HPO Gene-Disease Associations)", "regional abnormality of skin (HP:0011356 from HPO Gene-Disease Associations)", "abnormal palmar dermatoglyphics (HP:0001018 from HPO Gene-Disease Associations)", "abnormality of the palmar creases (HP:0010490 from HPO Gene-Disease Associations)", "single transverse palmar crease (HP:0000954 from HPO Gene-Disease Associations)", "abnormality of the palm (HP:0100871 from HPO Gene-Disease Associations)", "abnormality of corneal stroma (HP:0011492 from HPO Gene-Disease Associations)", "opacification of the corneal stroma (HP:0007759 from HPO Gene-Disease Associations)", "corneal opacity (HP:0007957 from HPO Gene-Disease Associations)", "corneal dystrophy (HP:0001131 from HPO Gene-Disease Associations)", "abnormality of the esophagus (HP:0002031 from HPO Gene-Disease Associations)", "dysphagia (HP:0002015 from HPO Gene-Disease Associations)", "gastroesophageal reflux (HP:0002020 from HPO Gene-Disease Associations)", "abnormality of movement (HP:0100022 from HPO Gene-Disease Associations)", "gait disturbance (HP:0001288 from HPO Gene-Disease Associations)", "neurological speech impairment (HP:0002167 from HPO Gene-Disease Associations)", "dysarthria (HP:0001260 from HPO Gene-Disease Associations)", "abnormality of coordination (HP:0011443 from HPO Gene-Disease Associations)", "ataxia (HP:0001251 from HPO Gene-Disease Associations)", "abnormality of hindbrain morphology (HP:0011282 from HPO Gene-Disease Associations)", "abnormality of the metencephalon (HP:0011283 from HPO Gene-Disease Associations)", "abnormality of the cerebellum (HP:0001317 from HPO Gene-Disease Associations)", "incoordination (HP:0002311 from HPO Gene-Disease Associations)", "hypertonia (HP:0001276 from HPO Gene-Disease Associations)", "spasticity (HP:0001257 from HPO Gene-Disease Associations)", "abnormality of central motor function (HP:0011442 from HPO Gene-Disease Associations)", "upper motor neuron dysfunction (HP:0002493 from HPO Gene-Disease Associations)", "abnormal pyramidal signs (HP:0007256 from HPO Gene-Disease Associations)", "hyperreflexia (HP:0001347 from HPO Gene-Disease Associations)", "tremor (HP:0001337 from HPO Gene-Disease Associations)", "atrophy|degeneration affecting the central nervous system (HP:0007367 from HPO Gene-Disease Associations)", "atrophy|degeneration affecting the cerebrum (HP:0007369 from HPO Gene-Disease Associations)", "cerebral atrophy (HP:0002059 from HPO Gene-Disease Associations)", "brain atrophy (HP:0012444 from HPO Gene-Disease Associations)", "brain very small (HP:0001322 from HPO Gene-Disease Associations)", "cerebral cortical atrophy (HP:0002120 from HPO Gene-Disease Associations)", "weakness due to upper motor neuron dysfunction (HP:0010549 from HPO Gene-Disease Associations)", "hemiplegia|hemiparesis (HP:0004374 from HPO Gene-Disease Associations)", "developmental regression (HP:0002376 from HPO Gene-Disease Associations)", "involuntary movements (HP:0004305 from HPO Gene-Disease Associations)", "myoclonus (HP:0001336 from HPO Gene-Disease Associations)", "chorea (HP:0002072 from HPO Gene-Disease Associations)", "choreoathetosis (HP:0001266 from HPO Gene-Disease Associations)", "dystonia (HP:0001332 from HPO Gene-Disease Associations)", "onset (HP:0003674 from HPO Gene-Disease Associations)", "clinical modifier (HP:0012823 from HPO Gene-Disease Associations)", "infantile onset (HP:0003593 from HPO Gene-Disease Associations)", "phenotypic variability (HP:0003812 from HPO Gene-Disease Associations)", "variable expressivity (HP:0003828 from HPO Gene-Disease Associations)", "pace of progression (HP:0003679 from HPO Gene-Disease Associations)", "progressive disorder (HP:0003676 from HPO Gene-Disease Associations)", "slow progression (HP:0003677 from HPO Gene-Disease Associations)", "autosomal dominant inheritance (HP:0000006 from HPO Gene-Disease Associations)", "abnormal aggressive, impulsive or violent behavior (HP:0006919 from HPO Gene-Disease Associations)", "aggressive behavior (HP:0000718 from HPO Gene-Disease Associations)", "abnormal emotion|affect behavior (HP:0100851 from HPO Gene-Disease Associations)", "behavioral abnormality (HP:0000708 from HPO Gene-Disease Associations)", "self-injurious behavior (HP:0100716 from HPO Gene-Disease Associations)", "self-mutilation (HP:0000742 from HPO Gene-Disease Associations)", "stereotypic behavior (HP:0000733 from HPO Gene-Disease Associations)", "deeply set eye (HP:0000490 from HPO Gene-Disease Associations)", "sleep disturbance (HP:0002360 from HPO Gene-Disease Associations)", "coarse facial features (HP:0000280 from HPO Gene-Disease Associations)", "abnormality of the abdominal musculature (HP:0010991 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the abdominal wall musculature (HP:0010318 from HPO Gene-Disease Associations)", "abnormality of the tongue (HP:0000157 from HPO Gene-Disease Associations)", "macroglossia (HP:0000158 from HPO Gene-Disease Associations)", "skeletal muscle hypertrophy (HP:0003712 from HPO Gene-Disease Associations)", "abnormality of the voice (HP:0001608 from HPO Gene-Disease Associations)", "hoarse voice (HP:0001609 from HPO Gene-Disease Associations)", "osteoporosis (HP:0000939 from HPO Gene-Disease Associations)", "reduced bone mineral density (HP:0004349 from HPO Gene-Disease Associations)", "abnormality of bone mineral density (HP:0004348 from HPO Gene-Disease Associations)", "abnormal bone structure (HP:0003330 from HPO Gene-Disease Associations)", "increased susceptibility to fractures (HP:0002659 from HPO Gene-Disease Associations)", "recurrent fractures (HP:0002757 from HPO Gene-Disease Associations)", "osteopenia (HP:0000938 from HPO Gene-Disease Associations)", "pathologic fracture (HP:0002756 from HPO Gene-Disease Associations)", "bone pain (HP:0002653 from HPO Gene-Disease Associations)", "increased bone mineral density (HP:0011001 from HPO Gene-Disease Associations)", "cranial hyperostosis (HP:0004437 from HPO Gene-Disease Associations)", "hyperostosis (HP:0100774 from HPO Gene-Disease Associations)", "craniofacial hyperostosis (HP:0004493 from HPO Gene-Disease Associations)", "thickened calvaria (HP:0002684 from HPO Gene-Disease Associations)", "abnormality of reproductive system physiology (HP:0000080 from HPO Gene-Disease Associations)", "hypogonadism (HP:0000135 from HPO Gene-Disease Associations)", "puberty and gonadal disorders (HP:0008373 from HPO Gene-Disease Associations)", "abnormal internal genitalia (HP:0000812 from HPO Gene-Disease Associations)", "abnormality of female internal genitalia (HP:0000008 from HPO Gene-Disease Associations)", "abnormality of the female genitalia (HP:0010460 from HPO Gene-Disease Associations)", "abnormality of the menstrual cycle (HP:0000140 from HPO Gene-Disease Associations)", "menstrual irregularities (HP:0000858 from HPO Gene-Disease Associations)", "amenorrhea (HP:0000141 from HPO Gene-Disease Associations)", "primary amenorrhea (HP:0000786 from HPO Gene-Disease Associations)", "abnormality of the ovary (HP:0000137 from HPO Gene-Disease Associations)", "polycystic ovaries (HP:0000147 from HPO Gene-Disease Associations)", "ovarian cyst (HP:0000138 from HPO Gene-Disease Associations)", "hypogonadotrophic hypogonadism (HP:0000044 from HPO Gene-Disease Associations)", "erectile abnormalities (HP:0100639 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the breasts (HP:0010311 from HPO Gene-Disease Associations)", "breast aplasia (HP:0100783 from HPO Gene-Disease Associations)", "gynecomastia (HP:0000771 from HPO Gene-Disease Associations)", "abnormality of the sense of smell (HP:0004408 from HPO Gene-Disease Associations)", "anosmia (HP:0000458 from HPO Gene-Disease Associations)", "abnormality of the tarsal bones (HP:0001850 from HPO Gene-Disease Associations)", "abnormality of the talus (HP:0008365 from HPO Gene-Disease Associations)", "rocker bottom foot (HP:0001838 from HPO Gene-Disease Associations)", "abnormality of color vision (HP:0000551 from HPO Gene-Disease Associations)", "anterior hypopituitarism (HP:0000830 from HPO Gene-Disease Associations)", "hypopituitarism (HP:0040075 from HPO Gene-Disease Associations)", "abnormality of the anterior pituitary (HP:0011747 from HPO Gene-Disease Associations)", "abnormality of the pituitary gland (HP:0012503 from HPO Gene-Disease Associations)", "abnormality of the hypothalamus-pituitary axis (HP:0000864 from HPO Gene-Disease Associations)", "growth hormone deficiency (HP:0000824 from HPO Gene-Disease Associations)", "abnormality of skeletal maturation (HP:0000927 from HPO Gene-Disease Associations)", "delayed skeletal maturation (HP:0002750 from HPO Gene-Disease Associations)", "abnormality of skeletal physiology (HP:0011843 from HPO Gene-Disease Associations)", "sacral dimple (HP:0000960 from HPO Gene-Disease Associations)", "skin dimples (HP:0010781 from HPO Gene-Disease Associations)", "sacrococcygeal pilonidal abnormality (HP:0010767 from HPO Gene-Disease Associations)", "abnormality of the sacrum (HP:0005107 from HPO Gene-Disease Associations)", "insomnia (HP:0100785 from HPO Gene-Disease Associations)", "elfin facies (HP:0004428 from HPO Gene-Disease Associations)", "overriding aorta (HP:0002623 from HPO Gene-Disease Associations)", "hyperacusis (HP:0010780 from HPO Gene-Disease Associations)", "renovascular hypertension (HP:0100817 from HPO Gene-Disease Associations)", "flat cornea (HP:0007720 from HPO Gene-Disease Associations)", "renal duplication (HP:0000075 from HPO Gene-Disease Associations)", "abnormality of the diencephalon (HP:0010662 from HPO Gene-Disease Associations)", "bowel diverticulosis (HP:0005222 from HPO Gene-Disease Associations)", "bladder diverticulum (HP:0000015 from HPO Gene-Disease Associations)", "increased nuchal translucency (HP:0010880 from HPO Gene-Disease Associations)", "megalocornea (HP:0000485 from HPO Gene-Disease Associations)", "arnold-chiari malformation (HP:0002308 from HPO Gene-Disease Associations)", "abnormality of the gastric mucosa (HP:0004295 from HPO Gene-Disease Associations)", "abnormality of the hallux (HP:0001844 from HPO Gene-Disease Associations)", "deviation of toes (HP:0100498 from HPO Gene-Disease Associations)", "deviation of the hallux (HP:0010051 from HPO Gene-Disease Associations)", "hallux valgus (HP:0001822 from HPO Gene-Disease Associations)", "adducted thumb (HP:0001181 from HPO Gene-Disease Associations)", "abnormal heart morphology (HP:3000001 from HPO Gene-Disease Associations)", "cardiomegaly (HP:0001640 from HPO Gene-Disease Associations)", "abnormality of the zygomatic bone (HP:0010668 from HPO Gene-Disease Associations)", "cheekbone underdevelopment (HP:0010669 from HPO Gene-Disease Associations)", "narrow face (HP:0000275 from HPO Gene-Disease Associations)", "small face (HP:0000274 from HPO Gene-Disease Associations)", "macrotia (HP:0000400 from HPO Gene-Disease Associations)", "broad forehead (HP:0000337 from HPO Gene-Disease Associations)", "high forehead (HP:0000348 from HPO Gene-Disease Associations)", "abnormality of fluid regulation (HP:0011032 from HPO Gene-Disease Associations)", "edema (HP:0000969 from HPO Gene-Disease Associations)", "lymphedema (HP:0001004 from HPO Gene-Disease Associations)", "facial edema (HP:0000282 from HPO Gene-Disease Associations)", "periorbital edema (HP:0100539 from HPO Gene-Disease Associations)", "palpebral edema (HP:0100540 from HPO Gene-Disease Associations)", "prominent forehead (HP:0011220 from HPO Gene-Disease Associations)", "thin upper lip vermilion (HP:0000219 from HPO Gene-Disease Associations)", "abnormality of upper lip vermillion (HP:0011339 from HPO Gene-Disease Associations)", "thin vermilion border (HP:0000233 from HPO Gene-Disease Associations)", "smooth philtrum (HP:0000319 from HPO Gene-Disease Associations)", "tented upper lip vermilion (HP:0010804 from HPO Gene-Disease Associations)", "short nose (HP:0003196 from HPO Gene-Disease Associations)", "short philtrum (HP:0000322 from HPO Gene-Disease Associations)", "abnormality of mouth shape (HP:0011338 from HPO Gene-Disease Associations)", "downturned corners of mouth (HP:0002714 from HPO Gene-Disease Associations)", "open mouth (HP:0000194 from HPO Gene-Disease Associations)", "abnormality of the nasal tip (HP:0000436 from HPO Gene-Disease Associations)", "bulbous nose (HP:0000414 from HPO Gene-Disease Associations)", "broad nasal tip (HP:0000455 from HPO Gene-Disease Associations)", "thiamine-responsive megaloblastic anemia (HP:0004860 from HPO Gene-Disease Associations)", "retinal dystrophy (HP:0000556 from HPO Gene-Disease Associations)", "cone-rod dystrophy (HP:0000548 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the testes (HP:0010468 from HPO Gene-Disease Associations)", "decreased testicular size (HP:0008734 from HPO Gene-Disease Associations)", "genital tract atresia (HP:0001827 from HPO Gene-Disease Associations)", "vaginal atresia (HP:0000148 from HPO Gene-Disease Associations)", "gait imbalance (HP:0002141 from HPO Gene-Disease Associations)", "congenital primary aphakia (HP:0007707 from HPO Gene-Disease Associations)", "nephrogenic diabetes insipidus (HP:0009806 from HPO Gene-Disease Associations)", "medial flaring of the eyebrow (HP:0010747 from HPO Gene-Disease Associations)", "poor coordination (HP:0002370 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the lens (HP:0008063 from HPO Gene-Disease Associations)", "broad foot (HP:0001769 from HPO Gene-Disease Associations)", "diabetes insipidus (HP:0000873 from HPO Gene-Disease Associations)", "dental crowding (HP:0000678 from HPO Gene-Disease Associations)", "specific learning disability (HP:0001328 from HPO Gene-Disease Associations)", "abnormality of the left ventricle (HP:0001711 from HPO Gene-Disease Associations)", "left ventricular hypertrophy (HP:0001712 from HPO Gene-Disease Associations)", "ventricular hypertrophy (HP:0001714 from HPO Gene-Disease Associations)", "abnormality of the vagina (HP:0000142 from HPO Gene-Disease Associations)", "immunologic hypersensitivity (HP:0100326 from HPO Gene-Disease Associations)", "asthma (HP:0002099 from HPO Gene-Disease Associations)", "hirsutism (HP:0001007 from HPO Gene-Disease Associations)", "abnormality of the curvature of the cornea (HP:0100691 from HPO Gene-Disease Associations)", "astigmatism (HP:0000483 from HPO Gene-Disease Associations)", "abnormality of refraction (HP:0000539 from HPO Gene-Disease Associations)", "myopia (HP:0000545 from HPO Gene-Disease Associations)", "hypermetropia (HP:0000540 from HPO Gene-Disease Associations)", "small hand (HP:0200055 from HPO Gene-Disease Associations)", "short palm (HP:0004279 from HPO Gene-Disease Associations)", "short foot (HP:0001773 from HPO Gene-Disease Associations)", "myelodysplasia (HP:0002863 from HPO Gene-Disease Associations)", "abnormality of chromosome stability (HP:0003220 from HPO Gene-Disease Associations)", "abnormality of the ileum (HP:0001549 from HPO Gene-Disease Associations)", "meckel diverticulum (HP:0002245 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the uvula (HP:0010293 from HPO Gene-Disease Associations)", "abnormality of the preputium (HP:0100587 from HPO Gene-Disease Associations)", "abnormality of the carotid arteries (HP:0005344 from HPO Gene-Disease Associations)", "clubbing (HP:0001217 from HPO Gene-Disease Associations)", "clubbing of toes (HP:0100760 from HPO Gene-Disease Associations)", "arteriovenous malformation (HP:0100026 from HPO Gene-Disease Associations)", "abnormality of the small intestine (HP:0002244 from HPO Gene-Disease Associations)", "abnormality of the duodenum (HP:0002246 from HPO Gene-Disease Associations)", "duodenal stenosis (HP:0100867 from HPO Gene-Disease Associations)", "small intestinal stenosis (HP:0012848 from HPO Gene-Disease Associations)", "abnormality of the phalanges of the toes (HP:0010161 from HPO Gene-Disease Associations)", "cafe-au-lait spot (HP:0000957 from HPO Gene-Disease Associations)", "urogenital fistula (HP:0100589 from HPO Gene-Disease Associations)", "abnormality of the choanae (HP:0000415 from HPO Gene-Disease Associations)", "choanal atresia (HP:0000453 from HPO Gene-Disease Associations)", "facial asymmetry (HP:0000324 from HPO Gene-Disease Associations)", "external ear malformation (HP:0008572 from HPO Gene-Disease Associations)", "oligohydramnios (HP:0001562 from HPO Gene-Disease Associations)", "sloping forehead (HP:0000340 from HPO Gene-Disease Associations)", "aplasia|hypoplasia affecting the anterior segment of the eye (HP:0008062 from HPO Gene-Disease Associations)", "aplasia|hypoplasia affecting the uvea (HP:0008055 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the iris (HP:0008053 from HPO Gene-Disease Associations)", "recurrent urinary tract infections (HP:0000010 from HPO Gene-Disease Associations)", "pes planus (HP:0001763 from HPO Gene-Disease Associations)", "dolichocephaly (HP:0000268 from HPO Gene-Disease Associations)", "upslanted palpebral fissure (HP:0000582 from HPO Gene-Disease Associations)", "proptosis (HP:0000520 from HPO Gene-Disease Associations)", "chromsome breakage (HP:0040012 from HPO Gene-Disease Associations)", "chromosomal breakage induced by crosslinking agents (HP:0003221 from HPO Gene-Disease Associations)", "abnormality of the cell cycle (HP:0011018 from HPO Gene-Disease Associations)", "deficient excision of uv-induced pyrimidine dimers in dna (HP:0003213 from HPO Gene-Disease Associations)", "anemic pallor (HP:0001017 from HPO Gene-Disease Associations)", "prolonged g2 phase of cell cycle (HP:0003214 from HPO Gene-Disease Associations)", "complete duplication of thumb phalanx (HP:0009943 from HPO Gene-Disease Associations)", "complete duplication of phalanx of hand (HP:0009998 from HPO Gene-Disease Associations)", "reticulocytopenia (HP:0001896 from HPO Gene-Disease Associations)", "abnormality of the renal collecting system (HP:0004742 from HPO Gene-Disease Associations)", "duplicated collecting system (HP:0000081 from HPO Gene-Disease Associations)", "ureteral duplication (HP:0000073 from HPO Gene-Disease Associations)", "ectopic kidney (HP:0000086 from HPO Gene-Disease Associations)", "horseshoe kidney (HP:0000085 from HPO Gene-Disease Associations)", "hypergonadotropic hypogonadism (HP:0000815 from HPO Gene-Disease Associations)", "abnormality of the soft palate (HP:0100736 from HPO Gene-Disease Associations)", "abnormality of the uvula (HP:0000172 from HPO Gene-Disease Associations)", "bifid uvula (HP:0000193 from HPO Gene-Disease Associations)", "abnormal male reproductive system physiology (HP:0012874 from HPO Gene-Disease Associations)", "functional abnormality of male internal genitalia (HP:0000025 from HPO Gene-Disease Associations)", "abnormal spermatogenesis (HP:0008669 from HPO Gene-Disease Associations)", "azoospermia (HP:0000027 from HPO Gene-Disease Associations)", "abnormality of the pulmonary artery (HP:0004414 from HPO Gene-Disease Associations)", "abnormality of the pulmonary vasculature (HP:0004930 from HPO Gene-Disease Associations)", "elevated pulmonary artery pressure (HP:0004890 from HPO Gene-Disease Associations)", "pulmonary hypertension (HP:0002092 from HPO Gene-Disease Associations)", "abnormality of the aorta (HP:0001679 from HPO Gene-Disease Associations)", "abnormality of the systemic arterial tree (HP:0011004 from HPO Gene-Disease Associations)", "abnormality of the vasculature (HP:0002597 from HPO Gene-Disease Associations)", "abnormalities of the peripheral arteries (HP:0005114 from HPO Gene-Disease Associations)", "arterial stenosis (HP:0100545 from HPO Gene-Disease Associations)", "abnormality of cerebral artery (HP:0009145 from HPO Gene-Disease Associations)", "cerebral ischemia (HP:0002637 from HPO Gene-Disease Associations)", "abnormality of the cerebral vasculature (HP:0100659 from HPO Gene-Disease Associations)", "abnormality of the coronary arteries (HP:0006704 from HPO Gene-Disease Associations)", "coronary artery disease (HP:0001677 from HPO Gene-Disease Associations)", "arteriosclerosis (HP:0002634 from HPO Gene-Disease Associations)", "atherosclerosis (HP:0002621 from HPO Gene-Disease Associations)", "abnormality of cardiovascular system physiology (HP:0011025 from HPO Gene-Disease Associations)", "arrhythmia (HP:0011675 from HPO Gene-Disease Associations)", "cardiac arrest (HP:0001695 from HPO Gene-Disease Associations)", "sudden cardiac death (HP:0001645 from HPO Gene-Disease Associations)", "congestive heart failure (HP:0001635 from HPO Gene-Disease Associations)", "pulmonary embolism (HP:0002204 from HPO Gene-Disease Associations)", "spontaneous hematomas (HP:0007420 from HPO Gene-Disease Associations)", "anorexia (HP:0002039 from HPO Gene-Disease Associations)", "type i diabetes mellitus (HP:0100651 from HPO Gene-Disease Associations)", "hyperthyroidism (HP:0000836 from HPO Gene-Disease Associations)", "abnormality of the parathyroid gland (HP:0000828 from HPO Gene-Disease Associations)", "abnormality of the parathyroid physiology (HP:0011767 from HPO Gene-Disease Associations)", "hypoparathyroidism (HP:0000829 from HPO Gene-Disease Associations)", "lipomatous tumor (HP:0012031 from HPO Gene-Disease Associations)", "neoplasm of fatty tissue (HP:0200013 from HPO Gene-Disease Associations)", "multiple lipomas (HP:0001012 from HPO Gene-Disease Associations)", "abnormality of vision evoked potentials (HP:0000649 from HPO Gene-Disease Associations)", "abnormality of the pancreas (HP:0001732 from HPO Gene-Disease Associations)", "abnormality of pancreas physiology (HP:0012091 from HPO Gene-Disease Associations)", "pancreatitis (HP:0001733 from HPO Gene-Disease Associations)", "abnormality of the glomerulus (HP:0000095 from HPO Gene-Disease Associations)", "abnormality of the nephron (HP:0012575 from HPO Gene-Disease Associations)", "glomerulopathy (HP:0100820 from HPO Gene-Disease Associations)", "memory impairment (HP:0002354 from HPO Gene-Disease Associations)", "hallucinations (HP:0000738 from HPO Gene-Disease Associations)", "paresthesia (HP:0003401 from HPO Gene-Disease Associations)", "sensory neuropathy (HP:0000763 from HPO Gene-Disease Associations)", "amaurosis fugax (HP:0100576 from HPO Gene-Disease Associations)", "headache (HP:0002315 from HPO Gene-Disease Associations)", "migraine (HP:0002076 from HPO Gene-Disease Associations)", "myalgia (HP:0003326 from HPO Gene-Disease Associations)", "constipation (HP:0002019 from HPO Gene-Disease Associations)", "hypothyroidism (HP:0000821 from HPO Gene-Disease Associations)", "abnormality of thyroid physiology (HP:0002926 from HPO Gene-Disease Associations)", "abnormality of the thyroid gland (HP:0000820 from HPO Gene-Disease Associations)", "abnormality of thyroid morphology (HP:0011772 from HPO Gene-Disease Associations)", "goiter (HP:0000853 from HPO Gene-Disease Associations)", "attention deficit hyperactivity disorder (HP:0007018 from HPO Gene-Disease Associations)", "short attention span (HP:0000736 from HPO Gene-Disease Associations)", "hyperactivity (HP:0000752 from HPO Gene-Disease Associations)", "autistic behavior (HP:0000729 from HPO Gene-Disease Associations)", "autism (HP:0000717 from HPO Gene-Disease Associations)", "obsessive-compulsive behavior (HP:0000722 from HPO Gene-Disease Associations)", "abnormality of oral mucosa (HP:0011830 from HPO Gene-Disease Associations)", "abnormality of the gingiva (HP:0000168 from HPO Gene-Disease Associations)", "gingival overgrowth (HP:0000212 from HPO Gene-Disease Associations)", "abnormal urinary electrolyte concentration (HP:0012591 from HPO Gene-Disease Associations)", "abnormality of urine calcium concentration (HP:0011280 from HPO Gene-Disease Associations)", "hypercalciuria (HP:0002150 from HPO Gene-Disease Associations)", "nephrocalcinosis (HP:0000121 from HPO Gene-Disease Associations)", "abnormal concentration of calcium in blood (HP:0040077 from HPO Gene-Disease Associations)", "abnormality of calcium homeostasis (HP:0004363 from HPO Gene-Disease Associations)", "abnormality of divalent inorganic cation homeostasis (HP:0010927 from HPO Gene-Disease Associations)", "abnormality of cation homeostasis (HP:0010929 from HPO Gene-Disease Associations)", "abnormality of ion homeostasis (HP:0003111 from HPO Gene-Disease Associations)", "hypocalcemia (HP:0002901 from HPO Gene-Disease Associations)", "hypercalcemia (HP:0003072 from HPO Gene-Disease Associations)", "nephrolithiasis (HP:0000787 from HPO Gene-Disease Associations)", "bilateral basal ganglia lesions (HP:0007146 from HPO Gene-Disease Associations)", "papilledema (HP:0001085 from HPO Gene-Disease Associations)", "leber optic atrophy (HP:0001112 from HPO Gene-Disease Associations)", "large central visual field defect (HP:0001129 from HPO Gene-Disease Associations)", "sudden central visual loss (HP:0001117 from HPO Gene-Disease Associations)", "abnormality of adipose tissue (HP:0009124 from HPO Gene-Disease Associations)", "lipodystrophy (HP:0009125 from HPO Gene-Disease Associations)", "lipoatrophy (HP:0100578 from HPO Gene-Disease Associations)", "dilated cardiomyopathy (HP:0001644 from HPO Gene-Disease Associations)", "emg abnormality (HP:0003457 from HPO Gene-Disease Associations)", "myopathy (HP:0003198 from HPO Gene-Disease Associations)", "epidermal thickening (HP:0011368 from HPO Gene-Disease Associations)", "thickened skin (HP:0001072 from HPO Gene-Disease Associations)", "hyperkeratosis (HP:0000962 from HPO Gene-Disease Associations)", "palmoplantar keratoderma (HP:0000982 from HPO Gene-Disease Associations)", "ichthyosis (HP:0008064 from HPO Gene-Disease Associations)", "poor hand-eye coordination (HP:0007057 from HPO Gene-Disease Associations)", "underfolded helix (HP:0008577 from HPO Gene-Disease Associations)", "underfolded superior helices (HP:0008583 from HPO Gene-Disease Associations)", "abnormal facial expression (HP:0005346 from HPO Gene-Disease Associations)", "decreased facial expression (HP:0004673 from HPO Gene-Disease Associations)", "mask-like facies (HP:0000298 from HPO Gene-Disease Associations)", "myopathic facies (HP:0002058 from HPO Gene-Disease Associations)", "seborrheic dermatitis (HP:0001051 from HPO Gene-Disease Associations)", "hypertensive crisis (HP:0100735 from HPO Gene-Disease Associations)", "atelectasis (HP:0100750 from HPO Gene-Disease Associations)", "abnormality of the tricuspid valve (HP:0001702 from HPO Gene-Disease Associations)", "abnormal large intestine physiology (HP:0012700 from HPO Gene-Disease Associations)", "bowel incontinence (HP:0002607 from HPO Gene-Disease Associations)", "telecanthus (HP:0000506 from HPO Gene-Disease Associations)", "abnormality of earlobe (HP:0000363 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the earlobes (HP:0009906 from HPO Gene-Disease Associations)", "abnormality of the helix (HP:0011039 from HPO Gene-Disease Associations)", "abnormally folded helix (HP:0008544 from HPO Gene-Disease Associations)", "overfolded helix (HP:0000396 from HPO Gene-Disease Associations)", "intestinal malrotation (HP:0002566 from HPO Gene-Disease Associations)", "abnormality of the ureter (HP:0000069 from HPO Gene-Disease Associations)", "vesicoureteral reflux (HP:0000076 from HPO Gene-Disease Associations)", "abnormality of the bladder (HP:0000014 from HPO Gene-Disease Associations)", "functional abnormality of the bladder (HP:0000009 from HPO Gene-Disease Associations)", "hydroureter (HP:0000072 from HPO Gene-Disease Associations)", "abnormality of the renal pelvis (HP:0010944 from HPO Gene-Disease Associations)", "dilatation of the renal pelvis (HP:0010946 from HPO Gene-Disease Associations)", "hydronephrosis (HP:0000126 from HPO Gene-Disease Associations)", "gastrointestinal atresia (HP:0002589 from HPO Gene-Disease Associations)", "esophageal atresia (HP:0002032 from HPO Gene-Disease Associations)", "intestinal atresia (HP:0011100 from HPO Gene-Disease Associations)", "duodenal atresia (HP:0002247 from HPO Gene-Disease Associations)", "arrhinencephaly (HP:0002139 from HPO Gene-Disease Associations)", "parathyroid dysgenesis (HP:0011768 from HPO Gene-Disease Associations)", "parathyroid hypoplasia (HP:0000860 from HPO Gene-Disease Associations)", "monodactyly (hands) (HP:0004058 from HPO Gene-Disease Associations)", "bifid femur (HP:0010443 from HPO Gene-Disease Associations)", "posterior choanal atresia (HP:0004496 from HPO Gene-Disease Associations)", "square face (HP:0000321 from HPO Gene-Disease Associations)", "macular coloboma (HP:0001116 from HPO Gene-Disease Associations)", "gonadotropin deficiency (HP:0008213 from HPO Gene-Disease Associations)", "hypoplasia of the ear cartilage (HP:0100720 from HPO Gene-Disease Associations)", "chin dimple (HP:0010751 from HPO Gene-Disease Associations)", "aqueductal stenosis (HP:0002410 from HPO Gene-Disease Associations)", "delayed puberty (HP:0000823 from HPO Gene-Disease Associations)", "abnormality of the diaphragm (HP:0000775 from HPO Gene-Disease Associations)", "congenital diaphragmatic hernia (HP:0000776 from HPO Gene-Disease Associations)", "abnormality of the intervertebral disk (HP:0005108 from HPO Gene-Disease Associations)", "cutis marmorata (HP:0000965 from HPO Gene-Disease Associations)", "volvulus (HP:0002580 from HPO Gene-Disease Associations)", "deviation of the thumb (HP:0009603 from HPO Gene-Disease Associations)", "proximal placement of thumb (HP:0009623 from HPO Gene-Disease Associations)", "blepharitis (HP:0000498 from HPO Gene-Disease Associations)", "truncal obesity (HP:0001956 from HPO Gene-Disease Associations)", "short ear (HP:0400005 from HPO Gene-Disease Associations)", "cellular immunodeficiency (HP:0005374 from HPO Gene-Disease Associations)", "immunodeficiency (HP:0002721 from HPO Gene-Disease Associations)", "abnormal trabecular bone morphology (HP:0100671 from HPO Gene-Disease Associations)", "rough bone trabeculation (HP:0100670 from HPO Gene-Disease Associations)", "prematurely aged appearance (HP:0007495 from HPO Gene-Disease Associations)", "premature graying of hair (HP:0002216 from HPO Gene-Disease Associations)", "anal mucosal leukoplakia (HP:0005212 from HPO Gene-Disease Associations)", "esophageal stenosis (HP:0010450 from HPO Gene-Disease Associations)", "esophageal stricture (HP:0002043 from HPO Gene-Disease Associations)", "pterygium formation (nails) (HP:0002165 from HPO Gene-Disease Associations)", "increased lacrimation (HP:0009926 from HPO Gene-Disease Associations)", "oral leukoplakia (HP:0002745 from HPO Gene-Disease Associations)", "abnormality of multiple cell lineages in the bone marrow (HP:0012145 from HPO Gene-Disease Associations)", "bone marrow hypocellularity (HP:0005528 from HPO Gene-Disease Associations)", "pancytopenia (HP:0001876 from HPO Gene-Disease Associations)", "aplastic anemia (HP:0001915 from HPO Gene-Disease Associations)", "reticulated skin pigmentation (HP:0007427 from HPO Gene-Disease Associations)", "fine, reticulate skin pigmentation (HP:0007617 from HPO Gene-Disease Associations)", "ridged fingernail (HP:0008402 from HPO Gene-Disease Associations)", "leukocoria (HP:0000555 from HPO Gene-Disease Associations)", "perifollicular hyperkeratosis (HP:0007468 from HPO Gene-Disease Associations)", "brittle hair (HP:0002299 from HPO Gene-Disease Associations)", "hypotrichosis (HP:0001006 from HPO Gene-Disease Associations)", "abnormality of hair density (HP:0011357 from HPO Gene-Disease Associations)", "sparse hair (HP:0008070 from HPO Gene-Disease Associations)", "sparse eyelashes (HP:0000653 from HPO Gene-Disease Associations)", "sparse or absent eyelashes (HP:0200102 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the eyebrow (HP:0100840 from HPO Gene-Disease Associations)", "sparse eyebrow (HP:0000535 from HPO Gene-Disease Associations)", "sparse scalp hair (HP:0002209 from HPO Gene-Disease Associations)", "abnormality of hair growth rate (HP:0011363 from HPO Gene-Disease Associations)", "slow-growing hair (HP:0002217 from HPO Gene-Disease Associations)", "abnormality of hair texture (HP:0010719 from HPO Gene-Disease Associations)", "fine hair (HP:0002213 from HPO Gene-Disease Associations)", "congenital, generalized hypertrichosis (HP:0004540 from HPO Gene-Disease Associations)", "woolly hair (HP:0002224 from HPO Gene-Disease Associations)", "abnormality of the sweat gland (HP:0000971 from HPO Gene-Disease Associations)", "hypohidrosis or hyperhidrosis (HP:0007550 from HPO Gene-Disease Associations)", "hyperhidrosis (HP:0000975 from HPO Gene-Disease Associations)", "hypohidrosis (HP:0000966 from HPO Gene-Disease Associations)", "abnormality of the fingernails (HP:0001231 from HPO Gene-Disease Associations)", "abnormality of the nail (HP:0001597 from HPO Gene-Disease Associations)", "abnormality of the toenails (HP:0008388 from HPO Gene-Disease Associations)", "aplastic|hypoplastic toenail (HP:0010624 from HPO Gene-Disease Associations)", "anonychia (HP:0001798 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the nails (HP:0008386 from HPO Gene-Disease Associations)", "small nail (HP:0001792 from HPO Gene-Disease Associations)", "hypoplastic toenails (HP:0001800 from HPO Gene-Disease Associations)", "nail dysplasia (HP:0002164 from HPO Gene-Disease Associations)", "nail dystrophy (HP:0008404 from HPO Gene-Disease Associations)", "absent pubic hair (HP:0002555 from HPO Gene-Disease Associations)", "adult onset sensorineural hearing impairment (HP:0008615 from HPO Gene-Disease Associations)", "absent axillary hair (HP:0002221 from HPO Gene-Disease Associations)", "gastritis (HP:0005263 from HPO Gene-Disease Associations)", "chronic atrophic gastritis (HP:0002582 from HPO Gene-Disease Associations)", "chronic gastritis (HP:0005231 from HPO Gene-Disease Associations)", "hemimegalencephaly (HP:0007206 from HPO Gene-Disease Associations)", "epidermal nevus (HP:0010816 from HPO Gene-Disease Associations)", "nevus sebaceous (HP:0010815 from HPO Gene-Disease Associations)", "cranial asymmetry (HP:0000267 from HPO Gene-Disease Associations)", "enlarged cerebellum (HP:0012081 from HPO Gene-Disease Associations)", "somatic mosaicism (HP:0001442 from HPO Gene-Disease Associations)", "megalencephaly (HP:0001355 from HPO Gene-Disease Associations)", "coarctation of aorta (HP:0001680 from HPO Gene-Disease Associations)", "generalized hyperpigmentation (HP:0007440 from HPO Gene-Disease Associations)", "long palpebral fissure (HP:0000637 from HPO Gene-Disease Associations)", "thickened helices (HP:0000391 from HPO Gene-Disease Associations)", "fetal ultrasound soft marker (HP:0011425 from HPO Gene-Disease Associations)", "thickened nuchal skin fold (HP:0000474 from HPO Gene-Disease Associations)", "cystic hygroma (HP:0000476 from HPO Gene-Disease Associations)", "curly hair (HP:0002212 from HPO Gene-Disease Associations)", "coarse hair (HP:0002208 from HPO Gene-Disease Associations)", "webbed neck (HP:0000465 from HPO Gene-Disease Associations)", "abnormality of the pulmonary valve (HP:0001641 from HPO Gene-Disease Associations)", "pulmonic stenosis (HP:0001642 from HPO Gene-Disease Associations)", "triangular face (HP:0000325 from HPO Gene-Disease Associations)", "severe t-cell immunodeficiency (HP:0005352 from HPO Gene-Disease Associations)", "laryngeal atresia (HP:0008750 from HPO Gene-Disease Associations)", "cryptophthalmos (HP:0001126 from HPO Gene-Disease Associations)", "malformed lacrimal ducts (HP:0007993 from HPO Gene-Disease Associations)", "midline nasal groove (HP:0004112 from HPO Gene-Disease Associations)", "extension of hair growth on temples to lateral eyebrow (HP:0005325 from HPO Gene-Disease Associations)", "laryngeal web (HP:0005950 from HPO Gene-Disease Associations)", "lacrimal duct aplasia (HP:0007925 from HPO Gene-Disease Associations)", "cleft ala nasi (HP:0003191 from HPO Gene-Disease Associations)", "difficulty in tongue movements (HP:0000183 from HPO Gene-Disease Associations)", "movement abnormality of the tongue (HP:0000182 from HPO Gene-Disease Associations)", "upper eyelid coloboma (HP:0000636 from HPO Gene-Disease Associations)", "subglottic stenosis (HP:0001607 from HPO Gene-Disease Associations)", "wide pubic symphysis (HP:0003183 from HPO Gene-Disease Associations)", "hypoplastic helices (HP:0008589 from HPO Gene-Disease Associations)", "hypoplastic superior helix (HP:0008559 from HPO Gene-Disease Associations)", "laryngeal stenosis (HP:0001602 from HPO Gene-Disease Associations)", "bilateral microphthalmos (HP:0007633 from HPO Gene-Disease Associations)", "bifid tongue (HP:0010297 from HPO Gene-Disease Associations)", "absent eyelashes (HP:0000561 from HPO Gene-Disease Associations)", "absent facial hair (HP:0002550 from HPO Gene-Disease Associations)", "absent hair (HP:0002298 from HPO Gene-Disease Associations)", "absent eyebrow (HP:0002223 from HPO Gene-Disease Associations)", "midline defect of the nose (HP:0004122 from HPO Gene-Disease Associations)", "choanal stenosis (HP:0000452 from HPO Gene-Disease Associations)", "bicornuate uterus (HP:0000813 from HPO Gene-Disease Associations)", "anophthalmia (HP:0000528 from HPO Gene-Disease Associations)", "cleft eyelid (HP:0000625 from HPO Gene-Disease Associations)", "cupped ear (HP:0000378 from HPO Gene-Disease Associations)", "wide nose (HP:0000445 from HPO Gene-Disease Associations)", "underdeveloped nasal alae (HP:0000430 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the nose (HP:0009924 from HPO Gene-Disease Associations)", "omphalocele (HP:0001539 from HPO Gene-Disease Associations)", "median cleft lip (HP:0000161 from HPO Gene-Disease Associations)", "facial cleft (HP:0002006 from HPO Gene-Disease Associations)", "midline facial cleft (HP:0100629 from HPO Gene-Disease Associations)", "bladder exstrophy (HP:0002836 from HPO Gene-Disease Associations)", "exstrophy (HP:0100548 from HPO Gene-Disease Associations)", "ureterocele (HP:0000070 from HPO Gene-Disease Associations)", "progressive alopecia (HP:0002287 from HPO Gene-Disease Associations)", "early balding (HP:0002234 from HPO Gene-Disease Associations)", "scalp hair loss (HP:0200115 from HPO Gene-Disease Associations)", "decreased number of sweat glands (HP:0007500 from HPO Gene-Disease Associations)", "small, conical teeth (HP:0200141 from HPO Gene-Disease Associations)", "lacrimal duct atresia (HP:0000564 from HPO Gene-Disease Associations)", "premature loss of permanent teeth (HP:0006357 from HPO Gene-Disease Associations)", "pili canaliculi (HP:0002235 from HPO Gene-Disease Associations)", "central diabetes insipidus (HP:0000863 from HPO Gene-Disease Associations)", "oval face (HP:0000300 from HPO Gene-Disease Associations)", "adermatoglyphia (HP:0007455 from HPO Gene-Disease Associations)", "septate vagina (HP:0001153 from HPO Gene-Disease Associations)", "transverse vaginal septum (HP:0000145 from HPO Gene-Disease Associations)", "hydrometrocolpos (HP:0030010 from HPO Gene-Disease Associations)", "absent nipple (HP:0002561 from HPO Gene-Disease Associations)", "hypohidrotic ectodermal dysplasia (HP:0007607 from HPO Gene-Disease Associations)", "ectodermal dysplasia (HP:0000968 from HPO Gene-Disease Associations)", "head-banging (HP:0012168 from HPO Gene-Disease Associations)", "velopharyngeal insufficiency (HP:0000220 from HPO Gene-Disease Associations)", "scrotal hypoplasia (HP:0000046 from HPO Gene-Disease Associations)", "abnormality of the scrotum (HP:0000045 from HPO Gene-Disease Associations)", "bifid scrotum (HP:0000048 from HPO Gene-Disease Associations)", "abnormality of female external genitalia (HP:0000055 from HPO Gene-Disease Associations)", "female pseudohermaphroditism (HP:0010458 from HPO Gene-Disease Associations)", "abnormality of the clitoris (HP:0000056 from HPO Gene-Disease Associations)", "clitoromegaly (HP:0000057 from HPO Gene-Disease Associations)", "abnormality of the labia (HP:0000058 from HPO Gene-Disease Associations)", "hypoplastic female external genitalia (HP:0012815 from HPO Gene-Disease Associations)", "labial hypoplasia (HP:0000066 from HPO Gene-Disease Associations)", "abnormality of the labia majora (HP:0012881 from HPO Gene-Disease Associations)", "hypoplastic labia majora (HP:0000059 from HPO Gene-Disease Associations)", "ankyloblepharon (HP:0009755 from HPO Gene-Disease Associations)", "alopecia totalis (HP:0007418 from HPO Gene-Disease Associations)", "breast hypoplasia (HP:0003187 from HPO Gene-Disease Associations)", "birth length less than 3rd percentile (HP:0003561 from HPO Gene-Disease Associations)", "slender long bone (HP:0003100 from HPO Gene-Disease Associations)", "abnormality of the auditory canal (HP:0000372 from HPO Gene-Disease Associations)", "atresia of the external auditory canal (HP:0000413 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the ear (HP:0008771 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the external ear (HP:0008772 from HPO Gene-Disease Associations)", "microtia (HP:0008551 from HPO Gene-Disease Associations)", "abnormality of the maxilla (HP:0000326 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the maxilla (HP:0009117 from HPO Gene-Disease Associations)", "hypoplasia of the maxilla (HP:0000327 from HPO Gene-Disease Associations)", "brachycephaly (HP:0000248 from HPO Gene-Disease Associations)", "abnormality of the breast (HP:0000769 from HPO Gene-Disease Associations)", "abnormality of the nipple (HP:0004404 from HPO Gene-Disease Associations)", "wide intermamillary distance (HP:0006610 from HPO Gene-Disease Associations)", "supernumerary nipple (HP:0002558 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the nipples (HP:0006709 from HPO Gene-Disease Associations)", "hypoplastic nipples (HP:0002557 from HPO Gene-Disease Associations)", "pulmonary artery dilatation (HP:0004927 from HPO Gene-Disease Associations)", "incisional hernia (HP:0004872 from HPO Gene-Disease Associations)", "medial rotation of the medial malleolus (HP:0008132 from HPO Gene-Disease Associations)", "premature calcification of mitral annulus (HP:0005136 from HPO Gene-Disease Associations)", "increased axial globe length (HP:0007800 from HPO Gene-Disease Associations)", "fifth metacarpal with ulnar notch (HP:0005900 from HPO Gene-Disease Associations)", "broad skull (HP:0002682 from HPO Gene-Disease Associations)", "lens coloboma (HP:0100719 from HPO Gene-Disease Associations)", "shallow anterior chamber (HP:0000594 from HPO Gene-Disease Associations)", "broad metacarpals (HP:0001230 from HPO Gene-Disease Associations)", "broad metatarsal (HP:0001783 from HPO Gene-Disease Associations)", "shallow orbits (HP:0000586 from HPO Gene-Disease Associations)", "communicating hydrocephalus (HP:0001334 from HPO Gene-Disease Associations)", "abnormality of the spinal meninges (HP:0010303 from HPO Gene-Disease Associations)", "dural ectasia (HP:0100775 from HPO Gene-Disease Associations)", "joint hyperflexibility (HP:0005692 from HPO Gene-Disease Associations)", "spondylolisthesis (HP:0003302 from HPO Gene-Disease Associations)", "osteochondrosis dissecans (HP:0010886 from HPO Gene-Disease Associations)", "knee osteoarthritis (HP:0005086 from HPO Gene-Disease Associations)", "pulmonary artery aneurysm (HP:0004937 from HPO Gene-Disease Associations)", "generalized arterial tortuosity (HP:0004955 from HPO Gene-Disease Associations)", "dermal translucency (HP:0010648 from HPO Gene-Disease Associations)", "descending aortic aneurysm (HP:0004954 from HPO Gene-Disease Associations)", "dilatation of the descending thoracic aorta (HP:0004959 from HPO Gene-Disease Associations)", "bicuspid pulmonary valve (HP:0005182 from HPO Gene-Disease Associations)", "ascending aortic dissection (HP:0004933 from HPO Gene-Disease Associations)", "uterine rupture (HP:0100718 from HPO Gene-Disease Associations)", "arterial dissection (HP:0005294 from HPO Gene-Disease Associations)", "aortic aneurysm (HP:0004942 from HPO Gene-Disease Associations)", "dilatation of the abdominal aorta (HP:0005112 from HPO Gene-Disease Associations)", "thoracic aortic aneurysm (HP:0012727 from HPO Gene-Disease Associations)", "ascending aortic aneurysm (HP:0002631 from HPO Gene-Disease Associations)", "arterial tortuosity (HP:0005116 from HPO Gene-Disease Associations)", "vascular tortuosity (HP:0004948 from HPO Gene-Disease Associations)", "aneurysm (HP:0002617 from HPO Gene-Disease Associations)", "cerebral aneurysm (HP:0004944 from HPO Gene-Disease Associations)", "aortic dilatation (HP:0001724 from HPO Gene-Disease Associations)", "dilatation of the ascending aorta (HP:0005111 from HPO Gene-Disease Associations)", "aortic dissection (HP:0002647 from HPO Gene-Disease Associations)", "arachnodactyly (HP:0001166 from HPO Gene-Disease Associations)", "slender finger (HP:0001238 from HPO Gene-Disease Associations)", "long fingers (HP:0100807 from HPO Gene-Disease Associations)", "tall stature (HP:0000098 from HPO Gene-Disease Associations)", "disproportionate tall stature (HP:0001519 from HPO Gene-Disease Associations)", "joint hypermobility (HP:0001382 from HPO Gene-Disease Associations)", "joint laxity (HP:0001388 from HPO Gene-Disease Associations)", "abnormal elasticity of skin (HP:0010647 from HPO Gene-Disease Associations)", "abnormally lax or hyperextensible skin (HP:0008067 from HPO Gene-Disease Associations)", "cutis laxa (HP:0000973 from HPO Gene-Disease Associations)", "hyperextensible skin (HP:0000974 from HPO Gene-Disease Associations)", "soft skin (HP:0000977 from HPO Gene-Disease Associations)", "abnormality of the sternum (HP:0000766 from HPO Gene-Disease Associations)", "pectus excavatum (HP:0000767 from HPO Gene-Disease Associations)", "pectus carinatum (HP:0000768 from HPO Gene-Disease Associations)", "abnormality of the sclera (HP:0000591 from HPO Gene-Disease Associations)", "blue sclerae (HP:0000592 from HPO Gene-Disease Associations)", "abnormality of the atrioventricular valves (HP:0006705 from HPO Gene-Disease Associations)", "abnormality of the mitral valve (HP:0001633 from HPO Gene-Disease Associations)", "abnormality of the heart valves (HP:0001654 from HPO Gene-Disease Associations)", "abnormality of the aortic valve (HP:0001646 from HPO Gene-Disease Associations)", "mitral valve prolapse (HP:0001634 from HPO Gene-Disease Associations)", "mitral regurgitation (HP:0001653 from HPO Gene-Disease Associations)", "aortic regurgitation (HP:0001659 from HPO Gene-Disease Associations)", "aortic valve stenosis (HP:0001650 from HPO Gene-Disease Associations)", "bicuspid aortic valve (HP:0001647 from HPO Gene-Disease Associations)", "cystocele (HP:0100645 from HPO Gene-Disease Associations)", "vaginal hernia (HP:0100672 from HPO Gene-Disease Associations)", "premature delivery because of cervical insufficiency or membrane fragility (HP:0005267 from HPO Gene-Disease Associations)", "hypermobility of distal interphalangeal joints (HP:0006201 from HPO Gene-Disease Associations)", "hypermobility of interphalangeal joints (HP:0005620 from HPO Gene-Disease Associations)", "genital hernia (HP:0100823 from HPO Gene-Disease Associations)", "uterine prolapse (HP:0000139 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the skin (HP:0008065 from HPO Gene-Disease Associations)", "thin skin (HP:0000963 from HPO Gene-Disease Associations)", "dermal atrophy (HP:0004334 from HPO Gene-Disease Associations)", "atrophic scars (HP:0001075 from HPO Gene-Disease Associations)", "lack of skin elasticity (HP:0100679 from HPO Gene-Disease Associations)", "striae distensae (HP:0001065 from HPO Gene-Disease Associations)", "abnormality of the peritoneum (HP:0002585 from HPO Gene-Disease Associations)", "peritonitis (HP:0002586 from HPO Gene-Disease Associations)", "premature birth following premature rupture of fetal membranes (HP:0005100 from HPO Gene-Disease Associations)", "narrow maxilla (HP:0002010 from HPO Gene-Disease Associations)", "irregularly spaced teeth (HP:0006316 from HPO Gene-Disease Associations)", "poor wound healing (HP:0001058 from HPO Gene-Disease Associations)", "cigarette-paper scars (HP:0001073 from HPO Gene-Disease Associations)", "molluscoid pseudotumors (HP:0000993 from HPO Gene-Disease Associations)", "lop ear (HP:0000394 from HPO Gene-Disease Associations)", "aortic root dilatation (HP:0002616 from HPO Gene-Disease Associations)", "premature rupture of membranes (HP:0001788 from HPO Gene-Disease Associations)", "infantile muscular hypotonia (HP:0008947 from HPO Gene-Disease Associations)", "fragile skin (HP:0001030 from HPO Gene-Disease Associations)", "genu recurvatum (HP:0002816 from HPO Gene-Disease Associations)", "ectopia lentis (HP:0001083 from HPO Gene-Disease Associations)", "severe osteoporosis (HP:0005897 from HPO Gene-Disease Associations)", "otosclerosis (HP:0000362 from HPO Gene-Disease Associations)", "biconcave flattened vertebrae (HP:0003321 from HPO Gene-Disease Associations)", "platybasia (HP:0002691 from HPO Gene-Disease Associations)", "congenital bilateral hip dislocation (HP:0008780 from HPO Gene-Disease Associations)", "femoral bowing present at birth, straightening with time (HP:0005005 from HPO Gene-Disease Associations)", "crumpled long bones (HP:0006367 from HPO Gene-Disease Associations)", "beaded ribs (HP:0000923 from HPO Gene-Disease Associations)", "bowing of limbs due to multiple fractures (HP:0003023 from HPO Gene-Disease Associations)", "basilar impression (HP:0005758 from HPO Gene-Disease Associations)", "pulmonary insufficiency (HP:0010444 from HPO Gene-Disease Associations)", "multiple prenatal fractures (HP:0005855 from HPO Gene-Disease Associations)", "cortical irregularity (HP:0005731 from HPO Gene-Disease Associations)", "periosteal thickening of long tubular bones (HP:0006465 from HPO Gene-Disease Associations)", "abnormality of the middle ear ossicles (HP:0004452 from HPO Gene-Disease Associations)", "abnormality of the stapes (HP:0008628 from HPO Gene-Disease Associations)", "morphological abnormality of the middle ear (HP:0008609 from HPO Gene-Disease Associations)", "premature osteoarthritis (HP:0003088 from HPO Gene-Disease Associations)", "protrusio acetabuli (HP:0003179 from HPO Gene-Disease Associations)", "abnormality of dentin (HP:0010299 from HPO Gene-Disease Associations)", "dentinogenesis imperfecta (HP:0000703 from HPO Gene-Disease Associations)", "breech presentation (HP:0001623 from HPO Gene-Disease Associations)", "mild short stature (HP:0003502 from HPO Gene-Disease Associations)", "abnormality of skull ossification (HP:0002703 from HPO Gene-Disease Associations)", "decreased skull ossification (HP:0004331 from HPO Gene-Disease Associations)", "decreased calvarial ossification (HP:0005474 from HPO Gene-Disease Associations)", "motor delay (HP:0001270 from HPO Gene-Disease Associations)", "delayed gross motor development (HP:0002194 from HPO Gene-Disease Associations)", "anomalous tracheal cartilage (HP:0004468 from HPO Gene-Disease Associations)", "acrobrachycephaly (HP:0004487 from HPO Gene-Disease Associations)", "preauricular skin furrow (HP:0004450 from HPO Gene-Disease Associations)", "broad distal hallux (HP:0008111 from HPO Gene-Disease Associations)", "prominent scrotal raphe (HP:0003246 from HPO Gene-Disease Associations)", "limbic malformations (HP:0007343 from HPO Gene-Disease Associations)", "fused labia minora (HP:0000063 from HPO Gene-Disease Associations)", "cervical vertebrae fusion (c5|c6) (HP:0004635 from HPO Gene-Disease Associations)", "abnormality of the phalanges of the 3rd finger (HP:0009316 from HPO Gene-Disease Associations)", "abnormality of the distal phalanx of the 3rd finger (HP:0009357 from HPO Gene-Disease Associations)", "abnormality of the distal phalanx of the 2nd finger (HP:0009542 from HPO Gene-Disease Associations)", "duplication of the distal phalanx of the 3rd finger (HP:0009962 from HPO Gene-Disease Associations)", "partial duplication of the distal phalanx of the 3rd finger (HP:0009968 from HPO Gene-Disease Associations)", "duplication of phalanx of 3rd finger (HP:0009959 from HPO Gene-Disease Associations)", "polydactyly affecting the 3rd finger (HP:0009958 from HPO Gene-Disease Associations)", "partial duplication of the phalanges of the 3rd finger (HP:0009961 from HPO Gene-Disease Associations)", "duplication of the distal phalanx of the 2nd finger (HP:0009948 from HPO Gene-Disease Associations)", "partial duplication of the distal phalanx of the 2nd finger (HP:0009951 from HPO Gene-Disease Associations)", "duplication of phalanx of 2nd finger (HP:0009945 from HPO Gene-Disease Associations)", "polydactyly affecting the 2nd finger (HP:0009946 from HPO Gene-Disease Associations)", "partial duplication of the phalanges of the 2nd finger (HP:0009956 from HPO Gene-Disease Associations)", "absent first metatarsal (HP:0010104 from HPO Gene-Disease Associations)", "cleft of chin (HP:0011323 from HPO Gene-Disease Associations)", "abnormality of the crus of the helix (HP:0009895 from HPO Gene-Disease Associations)", "prominent crus of helix (HP:0009899 from HPO Gene-Disease Associations)", "oxycephaly (HP:0000263 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the 1st metatarsal (HP:0010067 from HPO Gene-Disease Associations)", "absent metatarsal bone (HP:0010744 from HPO Gene-Disease Associations)", "mesoaxial hand polydactyly (HP:0006159 from HPO Gene-Disease Associations)", "mesoaxial polydactyly (HP:0100260 from HPO Gene-Disease Associations)", "flat forehead (HP:0004425 from HPO Gene-Disease Associations)", "abnormality of the first metatarsal bone (HP:0010054 from HPO Gene-Disease Associations)", "narrow nose (HP:0000460 from HPO Gene-Disease Associations)", "abnormality of the parietal bone (HP:0002696 from HPO Gene-Disease Associations)", "parietal foramina (HP:0002697 from HPO Gene-Disease Associations)", "lambdoidal craniosynostosis (HP:0004443 from HPO Gene-Disease Associations)", "coronal craniosynostosis (HP:0004440 from HPO Gene-Disease Associations)", "sagittal craniosynostosis (HP:0004442 from HPO Gene-Disease Associations)", "long nose (HP:0003189 from HPO Gene-Disease Associations)", "buphthalmos (HP:0000557 from HPO Gene-Disease Associations)", "congenital glaucoma (HP:0001087 from HPO Gene-Disease Associations)", "cartilaginous trachea (HP:0005347 from HPO Gene-Disease Associations)", "calcaneonavicular fusion (HP:0008122 from HPO Gene-Disease Associations)", "hallux varus (HP:0008080 from HPO Gene-Disease Associations)", "lobar holoprosencephaly (HP:0006870 from HPO Gene-Disease Associations)", "frontal bone hypoplasia (HP:0005466 from HPO Gene-Disease Associations)", "lumbar hemivertebrae (HP:0008439 from HPO Gene-Disease Associations)", "short middle phalanx of toe (HP:0003795 from HPO Gene-Disease Associations)", "cloverleaf skull (HP:0002676 from HPO Gene-Disease Associations)", "elbow ankylosis (HP:0003070 from HPO Gene-Disease Associations)", "shortening of all middle phalanges of the fingers (HP:0006110 from HPO Gene-Disease Associations)", "brachyturricephaly (HP:0000244 from HPO Gene-Disease Associations)", "turricephaly (HP:0000262 from HPO Gene-Disease Associations)", "upper airway obstruction (HP:0002781 from HPO Gene-Disease Associations)", "coronal hypospadias (HP:0008743 from HPO Gene-Disease Associations)", "absent proximal phalanx of thumb (HP:0009637 from HPO Gene-Disease Associations)", "partial absence of thumb (HP:0009659 from HPO Gene-Disease Associations)", "bilateral triphalangeal thumbs (HP:0005707 from HPO Gene-Disease Associations)", "aplasia of the parotid gland (HP:0009740 from HPO Gene-Disease Associations)", "corneal perforation (HP:0100583 from HPO Gene-Disease Associations)", "hypoplastic lacrimal duct (HP:0007900 from HPO Gene-Disease Associations)", "abnormality of the lacrimal gland (HP:0011482 from HPO Gene-Disease Associations)", "aplastic|hypoplastic lacrimal glands (HP:0008038 from HPO Gene-Disease Associations)", "lacrimal gland aplasia (HP:0007656 from HPO Gene-Disease Associations)", "lacrimal gland hypoplasia (HP:0007732 from HPO Gene-Disease Associations)", "hypoplasia of the lacrimal puncta (HP:0007892 from HPO Gene-Disease Associations)", "absence of stensen duct (HP:0000198 from HPO Gene-Disease Associations)", "dacrocystitis (HP:0000620 from HPO Gene-Disease Associations)", "abnormality of the lacrimal punctum (HP:0011479 from HPO Gene-Disease Associations)", "absent lacrimal punctum (HP:0001092 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the proximal phalanx of the thumb (HP:0009629 from HPO Gene-Disease Associations)", "radial deviation of the 3rd finger (HP:0009462 from HPO Gene-Disease Associations)", "deviation of the 3rd finger (HP:0009317 from HPO Gene-Disease Associations)", "abnormality of the proximal phalanx of the thumb (HP:0009618 from HPO Gene-Disease Associations)", "nephrosclerosis (HP:0009741 from HPO Gene-Disease Associations)", "radial club hand (HP:0004059 from HPO Gene-Disease Associations)", "radial deviation of the hand (HP:0009486 from HPO Gene-Disease Associations)", "abnormality of the thenar eminence (HP:0001227 from HPO Gene-Disease Associations)", "small thenar eminence (HP:0001245 from HPO Gene-Disease Associations)", "abnormality of parotid gland (HP:0000197 from HPO Gene-Disease Associations)", "2-3 finger syndactyly (HP:0001233 from HPO Gene-Disease Associations)", "abnormality of the 3rd finger (HP:0004150 from HPO Gene-Disease Associations)", "tibial deviation of toes (HP:0100499 from HPO Gene-Disease Associations)", "delayed eruption of primary teeth (HP:0000680 from HPO Gene-Disease Associations)", "periorbital fullness (HP:0000629 from HPO Gene-Disease Associations)", "aplasia involving bones of the upper limbs (HP:0009823 from HPO Gene-Disease Associations)", "aplasia of the phalanges of the hand (HP:0009802 from HPO Gene-Disease Associations)", "aplasia of the middle phalanx of the hand (HP:0010239 from HPO Gene-Disease Associations)", "partial duplication of thumb phalanx (HP:0009944 from HPO Gene-Disease Associations)", "partial duplication of the phalanx of hand (HP:0009999 from HPO Gene-Disease Associations)", "duplication of thumb phalanx (HP:0009942 from HPO Gene-Disease Associations)", "limited hip extension (HP:0003093 from HPO Gene-Disease Associations)", "broad femoral metaphyses (HP:0006417 from HPO Gene-Disease Associations)", "thimble-shaped middle phalanges of hand (HP:0006193 from HPO Gene-Disease Associations)", "trident hand (HP:0004060 from HPO Gene-Disease Associations)", "wide-cupped costochondral junctions (HP:0000910 from HPO Gene-Disease Associations)", "small abnormally formed scapulae (HP:0006584 from HPO Gene-Disease Associations)", "small foramen magnum (HP:0002677 from HPO Gene-Disease Associations)", "lumbar kyphosis in infancy (HP:0008414 from HPO Gene-Disease Associations)", "spinal stenosis with reduced interpedicular distance (HP:0005733 from HPO Gene-Disease Associations)", "lethal short-limbed short stature (HP:0008909 from HPO Gene-Disease Associations)", "childhood onset short-limb short stature (HP:0011405 from HPO Gene-Disease Associations)", "generalized joint laxity (HP:0002761 from HPO Gene-Disease Associations)", "abnormality of the incisor (HP:0000676 from HPO Gene-Disease Associations)", "abnormality of incisor morphology (HP:0011063 from HPO Gene-Disease Associations)", "conical incisor (HP:0011065 from HPO Gene-Disease Associations)", "conical tooth (HP:0000698 from HPO Gene-Disease Associations)", "abnormality of the salivary glands (HP:0010286 from HPO Gene-Disease Associations)", "xerostomia (HP:0000217 from HPO Gene-Disease Associations)", "mixed hearing impairment (HP:0000410 from HPO Gene-Disease Associations)", "alacrima (HP:0000522 from HPO Gene-Disease Associations)", "decreased lacrimation (HP:0000633 from HPO Gene-Disease Associations)", "lacrimation abnormality (HP:0000632 from HPO Gene-Disease Associations)", "abnormality of the lacrimal duct (HP:0011481 from HPO Gene-Disease Associations)", "abnormality of the nasolacrimal system (HP:0000614 from HPO Gene-Disease Associations)", "nasolacrimal duct obstruction (HP:0000579 from HPO Gene-Disease Associations)", "lacrimal duct stenosis (HP:0007678 from HPO Gene-Disease Associations)", "hyperphosphatemia (HP:0002905 from HPO Gene-Disease Associations)", "decreased renal tubular phosphate excretion (HP:0005572 from HPO Gene-Disease Associations)", "increased renal tubular phosphate reabsorption (HP:0005571 from HPO Gene-Disease Associations)", "conjunctival whitish salt-like deposits (HP:0007799 from HPO Gene-Disease Associations)", "pulp stones (HP:0003771 from HPO Gene-Disease Associations)", "angioid streaks of the retina (HP:0001102 from HPO Gene-Disease Associations)", "abnormality of molar (HP:0011077 from HPO Gene-Disease Associations)", "abnormality of molar morphology (HP:0011070 from HPO Gene-Disease Associations)", "abnormality of permanent molar morphology (HP:0011071 from HPO Gene-Disease Associations)", "taurodontia (HP:0000679 from HPO Gene-Disease Associations)", "abnormality of the dental root (HP:0006486 from HPO Gene-Disease Associations)", "abnormality of the dental pulp (HP:0006479 from HPO Gene-Disease Associations)", "progressive congenital scoliosis (HP:0008458 from HPO Gene-Disease Associations)", "excessive wrinkled skin (HP:0007392 from HPO Gene-Disease Associations)", "excessive wrinkling of palmar skin (HP:0007605 from HPO Gene-Disease Associations)", "palmoplantar cutis laxa (HP:0007517 from HPO Gene-Disease Associations)", "premature skin wrinkling (HP:0100678 from HPO Gene-Disease Associations)", "neonatal wrinkled skin of hands and feet (HP:0007414 from HPO Gene-Disease Associations)", "atrial septal aneurysm (HP:0011995 from HPO Gene-Disease Associations)", "deep palmar crease (HP:0006191 from HPO Gene-Disease Associations)", "dysplastic corpus callosum (HP:0006989 from HPO Gene-Disease Associations)", "severe hearing impairment (HP:0012714 from HPO Gene-Disease Associations)", "severe sensorineural hearing impairment (HP:0008625 from HPO Gene-Disease Associations)", "choroid plexus papilloma (HP:0200022 from HPO Gene-Disease Associations)", "congenital giant melanocytic nevus (HP:0005600 from HPO Gene-Disease Associations)", "numerous congenital melanocytic nevi (HP:0005603 from HPO Gene-Disease Associations)", "follicular thyroid carcinoma (HP:0006731 from HPO Gene-Disease Associations)", "numerous nevi (HP:0001054 from HPO Gene-Disease Associations)", "abnormality of the arachnoid mater (HP:0100700 from HPO Gene-Disease Associations)", "arachnoid cyst (HP:0100702 from HPO Gene-Disease Associations)", "intestinal pseudo-obstruction (HP:0004389 from HPO Gene-Disease Associations)", "abnormality of the clivus (HP:0010558 from HPO Gene-Disease Associations)", "vertical clivus (HP:0010559 from HPO Gene-Disease Associations)", "irregular metacarpals (HP:0006160 from HPO Gene-Disease Associations)", "partial fusion of tarsals (HP:0008097 from HPO Gene-Disease Associations)", "partial fusion of carpals (HP:0006207 from HPO Gene-Disease Associations)", "abnormality of the fifth metatarsal bone (HP:0008089 from HPO Gene-Disease Associations)", "lateral femoral bowing (HP:0005090 from HPO Gene-Disease Associations)", "increased density of long bone diaphyses (HP:0006440 from HPO Gene-Disease Associations)", "mesomelic arm shortening (HP:0005011 from HPO Gene-Disease Associations)", "mesomelic leg shortening (HP:0004987 from HPO Gene-Disease Associations)", "abnormal metatarsal ossification (HP:0008371 from HPO Gene-Disease Associations)", "nonossified fifth metatarsal (HP:0008087 from HPO Gene-Disease Associations)", "bulbous tips of toes (HP:0001782 from HPO Gene-Disease Associations)", "undulate clavicles (HP:0010560 from HPO Gene-Disease Associations)", "coat hanger sign of ribs (HP:0006665 from HPO Gene-Disease Associations)", "obtuse angle of mandible (HP:0005446 from HPO Gene-Disease Associations)", "anteriorly placed odontoid process (HP:0004608 from HPO Gene-Disease Associations)", "frontal hirsutism (HP:0011335 from HPO Gene-Disease Associations)", "short chordae tendineae of the mitral valve (HP:0011580 from HPO Gene-Disease Associations)", "short chordae tendineae of the tricuspid valve (HP:0006692 from HPO Gene-Disease Associations)", "abnormality of superior crus of antihelix (HP:0011245 from HPO Gene-Disease Associations)", "underdeveloped superior crus of antihelix (HP:0011246 from HPO Gene-Disease Associations)", "tricuspid valve prolapse (HP:0001704 from HPO Gene-Disease Associations)", "anterior concavity of thoracic vertebrae (HP:0004611 from HPO Gene-Disease Associations)", "long phalanx of finger (HP:0006155 from HPO Gene-Disease Associations)", "rudimentary fibula (HP:0006381 from HPO Gene-Disease Associations)", "thick skull base (HP:0002737 from HPO Gene-Disease Associations)", "abnormality of the 3rd metacarpal (HP:0010011 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the 3rd metacarpal (HP:0010039 from HPO Gene-Disease Associations)", "short 3rd metacarpal (HP:0010041 from HPO Gene-Disease Associations)", "abnormality of the 5th metacarpal (HP:0010013 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the 5th metacarpal (HP:0010045 from HPO Gene-Disease Associations)", "short 5th metacarpal (HP:0010047 from HPO Gene-Disease Associations)", "long neck (HP:0000472 from HPO Gene-Disease Associations)", "overlapping fingers (HP:0010557 from HPO Gene-Disease Associations)", "shoulder dislocation (HP:0003834 from HPO Gene-Disease Associations)", "tricuspid regurgitation (HP:0005180 from HPO Gene-Disease Associations)", "sclerosis of skull base (HP:0002694 from HPO Gene-Disease Associations)", "short chin (HP:0000331 from HPO Gene-Disease Associations)", "abnormality of the tibia (HP:0002992 from HPO Gene-Disease Associations)", "tibial bowing (HP:0002982 from HPO Gene-Disease Associations)", "femoral bowing (HP:0002980 from HPO Gene-Disease Associations)", "abnormal shape of the radius (HP:0045008 from HPO Gene-Disease Associations)", "radial bowing (HP:0002986 from HPO Gene-Disease Associations)", "bowed forearm bones (HP:0003956 from HPO Gene-Disease Associations)", "bowing of the arm (HP:0006488 from HPO Gene-Disease Associations)", "ulnar bowing (HP:0003031 from HPO Gene-Disease Associations)", "limited knee extension (HP:0003066 from HPO Gene-Disease Associations)", "limited knee flexion (HP:0006389 from HPO Gene-Disease Associations)", "limited knee flexion|extension (HP:0005085 from HPO Gene-Disease Associations)", "anterolateral radial head dislocation (HP:0005050 from HPO Gene-Disease Associations)", "increased fibular diameter (HP:0012107 from HPO Gene-Disease Associations)", "hypoplastic distal humeri (HP:0005025 from HPO Gene-Disease Associations)", "limited elbow flexion|extension (HP:0005060 from HPO Gene-Disease Associations)", "limited elbow flexion (HP:0006376 from HPO Gene-Disease Associations)", "limited elbow extension (HP:0001377 from HPO Gene-Disease Associations)", "food intolerance (HP:0012537 from HPO Gene-Disease Associations)", "toe clinodactyly (HP:0001863 from HPO Gene-Disease Associations)", "clinodactyly of the 5th toe (HP:0001864 from HPO Gene-Disease Associations)", "deviation of the 5th toe (HP:0010344 from HPO Gene-Disease Associations)", "prominent frontal sinuses (HP:0005478 from HPO Gene-Disease Associations)", "bidirectional ventricular ectopy (HP:0005147 from HPO Gene-Disease Associations)", "antegonial notching of mandible (HP:0003779 from HPO Gene-Disease Associations)", "midline defect of mandible (HP:0010753 from HPO Gene-Disease Associations)", "persistence of primary teeth (HP:0006335 from HPO Gene-Disease Associations)", "rapid neurologic deterioration (HP:0007307 from HPO Gene-Disease Associations)", "large forehead (HP:0002003 from HPO Gene-Disease Associations)", "epispadias (HP:0000039 from HPO Gene-Disease Associations)", "cone-shaped epiphyses of phalanges 2 to 5 (HP:0006035 from HPO Gene-Disease Associations)", "abnormality of the capitate bone (HP:0004262 from HPO Gene-Disease Associations)", "capitate-hamate fusion (HP:0001241 from HPO Gene-Disease Associations)", "abnormality of the hamate bone (HP:0004259 from HPO Gene-Disease Associations)", "neonatal short-limb short stature (HP:0008921 from HPO Gene-Disease Associations)", "abnormality of the epiphyses of the hand (HP:0005924 from HPO Gene-Disease Associations)", "abnormality of upper limb epiphysis morphology (HP:0003839 from HPO Gene-Disease Associations)", "abnormality of the epiphyses of the phalanges of the hand (HP:0005920 from HPO Gene-Disease Associations)", "cone-shaped epiphyses of the phalanges of the hand (HP:0010230 from HPO Gene-Disease Associations)", "cone-shaped epiphysis (HP:0010579 from HPO Gene-Disease Associations)", "abnormality of the antihelix (HP:0009738 from HPO Gene-Disease Associations)", "prominent antihelix (HP:0000395 from HPO Gene-Disease Associations)", "2-3 toe syndactyly (HP:0004691 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the phalanges of the toes (HP:0010173 from HPO Gene-Disease Associations)", "abnormality of the middle phalanges of the toes (HP:0010183 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the middle phalanges of the toes (HP:0010194 from HPO Gene-Disease Associations)", "abnormality of the 2nd toe (HP:0010319 from HPO Gene-Disease Associations)", "abnormality of the epiphyses of the 5th finger (HP:0009152 from HPO Gene-Disease Associations)", "abnormality of the epiphysis of the middle phalanx of the 5th finger (HP:0004224 from HPO Gene-Disease Associations)", "abnormality of the epiphyses of the 2nd finger (HP:0006263 from HPO Gene-Disease Associations)", "abnormality of the epiphysis of the middle phalanx of the 2nd finger (HP:0009500 from HPO Gene-Disease Associations)", "bracket epiphyses of the 2nd finger (HP:0009489 from HPO Gene-Disease Associations)", "bracket epiphysis of the middle phalanx of the 2nd finger (HP:0009514 from HPO Gene-Disease Associations)", "bracket epiphyses (HP:0010578 from HPO Gene-Disease Associations)", "bracket epiphyses of the phalanges of the hand (HP:0010229 from HPO Gene-Disease Associations)", "bracket epiphyses of the 5th finger (HP:0009383 from HPO Gene-Disease Associations)", "bracket epiphyses of the middle phalanges of the hand (HP:0010258 from HPO Gene-Disease Associations)", "bracket epiphysis of the middle phalanx of the 5th finger (HP:0009204 from HPO Gene-Disease Associations)", "triangular shaped middle phalanx of the 5th finger (HP:0009182 from HPO Gene-Disease Associations)", "triangular shaped phalanges of the 5th finger (HP:0009378 from HPO Gene-Disease Associations)", "triangular shaped middle phalanges of the hand (HP:0009850 from HPO Gene-Disease Associations)", "triangular shaped middle phalanx of the 2nd finger (HP:0009575 from HPO Gene-Disease Associations)", "triangular shaped phalanges of the 2nd finger (HP:0009546 from HPO Gene-Disease Associations)", "deviation of the 2nd toe (HP:0010326 from HPO Gene-Disease Associations)", "medially deviated second toe (HP:0008096 from HPO Gene-Disease Associations)", "ulnar deviation of the 2nd finger (HP:0009464 from HPO Gene-Disease Associations)", "abnormality of the epiphyses of the middle phalanges of the hand (HP:0010244 from HPO Gene-Disease Associations)", "deviation of the 2nd finger (HP:0009468 from HPO Gene-Disease Associations)", "radial deviation of the 2nd finger (HP:0009467 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the middle phalanx of the 2nd finger (HP:0009568 from HPO Gene-Disease Associations)", "abnormality of the middle phalanx of the 2nd finger (HP:0009543 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the phalanges of the 2nd finger (HP:0009552 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the 2nd finger (HP:0006264 from HPO Gene-Disease Associations)", "short 2nd finger (HP:0009536 from HPO Gene-Disease Associations)", "abnormality of the 2nd finger (HP:0004100 from HPO Gene-Disease Associations)", "abnormality of the phalanges of the 2nd finger (HP:0009541 from HPO Gene-Disease Associations)", "aplasia of the proximal phalanges of the hand (HP:0010242 from HPO Gene-Disease Associations)", "widened proximal tibial metaphyses (HP:0005028 from HPO Gene-Disease Associations)", "shortening of all proximal phalanges of the fingers (HP:0006144 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the 3rd finger (HP:0009318 from HPO Gene-Disease Associations)", "short 3rd finger (HP:0009461 from HPO Gene-Disease Associations)", "cuboidal metacarpal (HP:0006011 from HPO Gene-Disease Associations)", "abnormality of the epiphysis of the middle phalanx of the 3rd finger (HP:0009334 from HPO Gene-Disease Associations)", "abnormality of the middle phalanx of the 3rd finger (HP:0004172 from HPO Gene-Disease Associations)", "abnormality of the epiphyses of the 3rd finger (HP:0009320 from HPO Gene-Disease Associations)", "abnormality of the epiphysis of the proximal phalanx of the 3rd finger (HP:0009333 from HPO Gene-Disease Associations)", "abnormality of the proximal phalanx of the 3rd finger (HP:0009358 from HPO Gene-Disease Associations)", "abnormality of the epiphysis of the proximal phalanx of the 2nd finger (HP:0009501 from HPO Gene-Disease Associations)", "abnormality of the proximal phalanx of the 2nd finger (HP:0009544 from HPO Gene-Disease Associations)", "triangular epiphyses of the 2nd finger (HP:0009498 from HPO Gene-Disease Associations)", "triangular epiphysis of the proximal phalanx of the 2nd finger (HP:0009534 from HPO Gene-Disease Associations)", "triangular epiphysis of the middle phalanx of the 2nd finger (HP:0009523 from HPO Gene-Disease Associations)", "triangular epiphyses (HP:0010587 from HPO Gene-Disease Associations)", "triangular epiphyses of the phalanges of the hand (HP:0010238 from HPO Gene-Disease Associations)", "triangular epiphyses of the middle phalanges of the hand (HP:0010267 from HPO Gene-Disease Associations)", "triangular epiphyses of the proximal phalanges of the hand (HP:0010278 from HPO Gene-Disease Associations)", "triangular epiphyses of the 3rd finger (HP:0009420 from HPO Gene-Disease Associations)", "triangular epiphysis of the proximal phalanx of the 3rd finger (HP:0009356 from HPO Gene-Disease Associations)", "triangular epiphysis of the middle phalanx of the 3rd finger (HP:0009331 from HPO Gene-Disease Associations)", "pseudoepiphyses of the 3rd finger (HP:0009417 from HPO Gene-Disease Associations)", "pseudoepiphyses of the 2nd finger (HP:0009495 from HPO Gene-Disease Associations)", "enlarged epiphyses of the phalanges of the hand (HP:0010231 from HPO Gene-Disease Associations)", "enlarged epiphyses of the middle phalanges of the hand (HP:0010260 from HPO Gene-Disease Associations)", "enlarged epiphyses of the 2nd finger (HP:0009491 from HPO Gene-Disease Associations)", "enlarged epiphysis of the proximal phalanx of the 2nd finger (HP:0009527 from HPO Gene-Disease Associations)", "enlarged epiphysis of the middle phalanx of the 2nd finger (HP:0009516 from HPO Gene-Disease Associations)", "enlarged epiphyses of the 3rd finger (HP:0009413 from HPO Gene-Disease Associations)", "enlarged epiphysis of the proximal phalanx of the 3rd finger (HP:0009349 from HPO Gene-Disease Associations)", "enlarged epiphysis of the middle phalanx of the 3rd finger (HP:0009324 from HPO Gene-Disease Associations)", "enlarged epiphyses of the proximal phalanges of the hand (HP:0010271 from HPO Gene-Disease Associations)", "triangular shaped proximal phalanges of the hand (HP:0009858 from HPO Gene-Disease Associations)", "triangular shaped middle phalanx of the 3rd finger (HP:0009436 from HPO Gene-Disease Associations)", "triangular shaped phalanges of the 3rd finger (HP:0009446 from HPO Gene-Disease Associations)", "triangular shaped proximal phalanx of the 3rd finger (HP:0009456 from HPO Gene-Disease Associations)", "triangular shaped proximal phalanx of the 2nd finger (HP:0009587 from HPO Gene-Disease Associations)", "malaligned carpal bone (HP:0006092 from HPO Gene-Disease Associations)", "hypersegmentation of proximal phalanx of second finger (HP:0006206 from HPO Gene-Disease Associations)", "hypersegmentation of proximal phalanx of third finger (HP:0011929 from HPO Gene-Disease Associations)", "ulnar deviation of the 3rd finger (HP:0009463 from HPO Gene-Disease Associations)", "distal femoral bowing (HP:0005096 from HPO Gene-Disease Associations)", "valgus hand deformity (HP:0006228 from HPO Gene-Disease Associations)", "severe short-limb dwarfism (HP:0008890 from HPO Gene-Disease Associations)", "valgus foot deformity (HP:0008081 from HPO Gene-Disease Associations)", "cone-shaped epiphyses of the middle phalanges of the hand (HP:0010259 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the tibia (HP:0005772 from HPO Gene-Disease Associations)", "short tibia (HP:0005736 from HPO Gene-Disease Associations)", "abnormality of the fibula (HP:0002991 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the fibula (HP:0006492 from HPO Gene-Disease Associations)", "fibular hypoplasia (HP:0003038 from HPO Gene-Disease Associations)", "fibular aplasia (HP:0002990 from HPO Gene-Disease Associations)", "absent toe (HP:0010760 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the hallux (HP:0008362 from HPO Gene-Disease Associations)", "short hallux (HP:0010109 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the 1st metacarpal (HP:0010026 from HPO Gene-Disease Associations)", "short 1st metacarpal (HP:0010034 from HPO Gene-Disease Associations)", "abnormality of the 1st metacarpal (HP:0010009 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the phalanges of the thumb (HP:0009658 from HPO Gene-Disease Associations)", "short phalanx of the thumb (HP:0009660 from HPO Gene-Disease Associations)", "fused cervical vertebrae (HP:0002949 from HPO Gene-Disease Associations)", "vertebral fusion (HP:0002948 from HPO Gene-Disease Associations)", "abnormality of the carpal bones (HP:0001191 from HPO Gene-Disease Associations)", "abnormality of the wrist (HP:0003019 from HPO Gene-Disease Associations)", "synostosis involving bones of the hand (HP:0004278 from HPO Gene-Disease Associations)", "carpal synostosis (HP:0009702 from HPO Gene-Disease Associations)", "synostosis of carpal bones (HP:0005048 from HPO Gene-Disease Associations)", "synostosis involving bones of the feet (HP:0009140 from HPO Gene-Disease Associations)", "synostosis involving bones of the lower limbs (HP:0009138 from HPO Gene-Disease Associations)", "tarsal synostosis (HP:0008368 from HPO Gene-Disease Associations)", "synostosis of carpals|tarsals (HP:0100266 from HPO Gene-Disease Associations)", "abnormality of the humerus (HP:0003063 from HPO Gene-Disease Associations)", "abnormality of the upper arm (HP:0001454 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the humerus (HP:0006507 from HPO Gene-Disease Associations)", "short humerus (HP:0005792 from HPO Gene-Disease Associations)", "symphalangism affecting the phalanges of the hand (HP:0009773 from HPO Gene-Disease Associations)", "humeroradial synostosis (HP:0003041 from HPO Gene-Disease Associations)", "synostosis involving the elbow (HP:0003938 from HPO Gene-Disease Associations)", "aplasia of the fingers (HP:0009380 from HPO Gene-Disease Associations)", "absent thumb (HP:0009777 from HPO Gene-Disease Associations)", "absent forearm bone (HP:0003953 from HPO Gene-Disease Associations)", "aplasia involving forearm bones (HP:0009822 from HPO Gene-Disease Associations)", "absent radius (HP:0003974 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the thumb (HP:0009601 from HPO Gene-Disease Associations)", "short thumb (HP:0009778 from HPO Gene-Disease Associations)", "triangular shaped phalanges of the hand (HP:0009774 from HPO Gene-Disease Associations)", "abnormality of thumb phalanx (HP:0009602 from HPO Gene-Disease Associations)", "triphalangeal thumb (HP:0001199 from HPO Gene-Disease Associations)", "abnormality of the thumb (HP:0001172 from HPO Gene-Disease Associations)", "synostosis of joints (HP:0100240 from HPO Gene-Disease Associations)", "synostosis involving bones of the upper limbs (HP:0100238 from HPO Gene-Disease Associations)", "radioulnar synostosis (HP:0002974 from HPO Gene-Disease Associations)", "abnormality of forearm bone (HP:0040072 from HPO Gene-Disease Associations)", "abnormality of the forearm (HP:0002973 from HPO Gene-Disease Associations)", "abnormality of upper limb bone (HP:0040070 from HPO Gene-Disease Associations)", "abnormality of the radius (HP:0002818 from HPO Gene-Disease Associations)", "abnormality of the ulna (HP:0002997 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving forearm bones (HP:0006503 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the radius (HP:0006501 from HPO Gene-Disease Associations)", "abnormal morphology of bones of the upper limbs (HP:0040065 from HPO Gene-Disease Associations)", "abnormal morphology of the radius (HP:0045009 from HPO Gene-Disease Associations)", "forearm undergrowth (HP:0009821 from HPO Gene-Disease Associations)", "upper limb undergrowth (HP:0009824 from HPO Gene-Disease Associations)", "hypoplasia of the radius (HP:0002984 from HPO Gene-Disease Associations)", "abnormal morphology of forearm bone (HP:0040073 from HPO Gene-Disease Associations)", "abnormal morphology of ulna (HP:0040071 from HPO Gene-Disease Associations)", "hypoplasia of the ulna (HP:0003022 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the ulna (HP:0006495 from HPO Gene-Disease Associations)", "broad long bones (HP:0005622 from HPO Gene-Disease Associations)", "broad phalanx (HP:0006009 from HPO Gene-Disease Associations)", "broad finger (HP:0001500 from HPO Gene-Disease Associations)", "broad phalanges of the hand (HP:0009768 from HPO Gene-Disease Associations)", "broad thumb (HP:0011304 from HPO Gene-Disease Associations)", "broad distal phalanx of finger (HP:0009836 from HPO Gene-Disease Associations)", "preaxial foot polydactyly (HP:0001841 from HPO Gene-Disease Associations)", "broad hallux (HP:0010055 from HPO Gene-Disease Associations)", "broad toe (HP:0001837 from HPO Gene-Disease Associations)", "flat face (HP:0012368 from HPO Gene-Disease Associations)", "abnormality of the patella (HP:0003045 from HPO Gene-Disease Associations)", "patellar dislocation (HP:0002999 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the patella (HP:0006498 from HPO Gene-Disease Associations)", "patellar aplasia (HP:0006443 from HPO Gene-Disease Associations)", "abnormality of the humeroradial joint (HP:0100744 from HPO Gene-Disease Associations)", "dislocated radial head (HP:0003083 from HPO Gene-Disease Associations)", "abnormality of the radial head (HP:0003995 from HPO Gene-Disease Associations)", "elbow dislocation (HP:0003042 from HPO Gene-Disease Associations)", "upper extremity joint dislocation (HP:0030310 from HPO Gene-Disease Associations)", "hypoplasia of the phalanges of the toes (HP:0010746 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the phalanges of the hallux (HP:0010058 from HPO Gene-Disease Associations)", "short phalanx of hallux (HP:0010111 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the proximal phalanx of the hallux (HP:0010085 from HPO Gene-Disease Associations)", "short proximal phalanx of hallux (HP:0010107 from HPO Gene-Disease Associations)", "short proximal phalanx of thumb (HP:0009638 from HPO Gene-Disease Associations)", "proportionate shortening of all digits (HP:0006165 from HPO Gene-Disease Associations)", "abnormality of the epiphysis of the 1st metacarpal (HP:0010014 from HPO Gene-Disease Associations)", "cone-shaped epiphysis of the 1st metacarpal (HP:0010017 from HPO Gene-Disease Associations)", "cone-shaped metacarpal epiphyses (HP:0006059 from HPO Gene-Disease Associations)", "broad metacarpal epiphyses (HP:0006146 from HPO Gene-Disease Associations)", "thin proximal phalanges with broad epiphyses of the hand (HP:0006213 from HPO Gene-Disease Associations)", "deviation of the 4th finger (HP:0009273 from HPO Gene-Disease Associations)", "radial deviation of the 4th finger (HP:0009279 from HPO Gene-Disease Associations)", "cone-shaped capital femoral epiphysis (HP:0008789 from HPO Gene-Disease Associations)", "enlargement of the distal femoral epiphysis (HP:0006438 from HPO Gene-Disease Associations)", "dysplasia of the femoral head (HP:0010575 from HPO Gene-Disease Associations)", "broad nail (HP:0001821 from HPO Gene-Disease Associations)", "abnormality of the distal femoral epiphysis (HP:0010590 from HPO Gene-Disease Associations)", "flattened metatarsal heads (HP:0005194 from HPO Gene-Disease Associations)", "abnormality of the epiphyses of the proximal phalanges of the hand (HP:0010245 from HPO Gene-Disease Associations)", "cone-shaped epiphyses of the proximal phalanges of the hand (HP:0010270 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the proximal phalanges of the hand (HP:0009851 from HPO Gene-Disease Associations)", "short proximal phalanx of finger (HP:0010241 from HPO Gene-Disease Associations)", "abnormality of the 4th finger (HP:0004188 from HPO Gene-Disease Associations)", "abnormality of the proximal phalanges of the hand (HP:0009834 from HPO Gene-Disease Associations)", "short femur (HP:0003097 from HPO Gene-Disease Associations)", "relative macrocephaly (HP:0004482 from HPO Gene-Disease Associations)", "absent nasal bridge (HP:0005285 from HPO Gene-Disease Associations)", "acromesomelia (HP:0003086 from HPO Gene-Disease Associations)", "lower thoracic kyphosis (HP:0004633 from HPO Gene-Disease Associations)", "thoracolumbar interpediculate narrowness (HP:0008484 from HPO Gene-Disease Associations)", "redundant skin on fingers (HP:0007516 from HPO Gene-Disease Associations)", "mesomelia (HP:0003027 from HPO Gene-Disease Associations)", "long hallux (HP:0001847 from HPO Gene-Disease Associations)", "long toe (HP:0010511 from HPO Gene-Disease Associations)", "abnormality of the proximal phalanx of the hallux (HP:0010052 from HPO Gene-Disease Associations)", "duplication of middle phalanx of toe (HP:0010202 from HPO Gene-Disease Associations)", "duplication of the proximal phalanx of the hallux (HP:0010093 from HPO Gene-Disease Associations)", "complete duplication of proximal phalanx of the thumb (HP:0009608 from HPO Gene-Disease Associations)", "duplication of the proximal phalanx of the thumb (HP:0009613 from HPO Gene-Disease Associations)", "pseudoepiphyses of the proximal phalanges of the hand (HP:0010275 from HPO Gene-Disease Associations)", "complete duplication of the middle phalanges of the hand (HP:0010002 from HPO Gene-Disease Associations)", "duplication of the middle phalanx of hand (HP:0010008 from HPO Gene-Disease Associations)", "lateral displacement of patellae (HP:0006397 from HPO Gene-Disease Associations)", "pseudoepiphyses of the phalanges of the hand (HP:0010235 from HPO Gene-Disease Associations)", "abnormality of the foramen magnum (HP:0002699 from HPO Gene-Disease Associations)", "large foramen magnum (HP:0002700 from HPO Gene-Disease Associations)", "abdominal distention (HP:0003270 from HPO Gene-Disease Associations)", "protuberant abdomen (HP:0001538 from HPO Gene-Disease Associations)", "abnormality of the ischium (HP:0003174 from HPO Gene-Disease Associations)", "hypoplastic ischia (HP:0003175 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the pubic bone (HP:0009104 from HPO Gene-Disease Associations)", "hypoplastic pubic bone (HP:0003173 from HPO Gene-Disease Associations)", "abnormality of the pubic bone (HP:0003172 from HPO Gene-Disease Associations)", "bell-shaped thorax (HP:0001591 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the 4th finger (HP:0009272 from HPO Gene-Disease Associations)", "short 4th finger (HP:0009280 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the phalanges of the 4th finger (HP:0009408 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the distal phalanx of the 4th finger (HP:0009289 from HPO Gene-Disease Associations)", "short distal phalanx of the 4th finger (HP:0009290 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the distal phalanx of the 2nd finger (HP:0009557 from HPO Gene-Disease Associations)", "short distal phalanx of the 2nd finger (HP:0009566 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the phalanges of the 3rd finger (HP:0009447 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the distal phalanx of the 3rd finger (HP:0009421 from HPO Gene-Disease Associations)", "short distal phalanx of the 3rd finger (HP:0004180 from HPO Gene-Disease Associations)", "abnormality of the phalanges of the 4th finger (HP:0009172 from HPO Gene-Disease Associations)", "abnormality of the distal phalanx of the 4th finger (HP:0009282 from HPO Gene-Disease Associations)", "limitation of knee mobility (HP:0010501 from HPO Gene-Disease Associations)", "abnormality of the styloid process of ulna (HP:0004035 from HPO Gene-Disease Associations)", "abnormality of the ulnar epiphyses (HP:0004037 from HPO Gene-Disease Associations)", "absent styloid process of ulna (HP:0005068 from HPO Gene-Disease Associations)", "flattened, squared-off epiphyses of tubular bones (HP:0006172 from HPO Gene-Disease Associations)", "severe limb shortening (HP:0200083 from HPO Gene-Disease Associations)", "metaphyseal dappling (HP:0011860 from HPO Gene-Disease Associations)", "delayed calcaneal ossification (HP:0008142 from HPO Gene-Disease Associations)", "heberden's node (HP:0012313 from HPO Gene-Disease Associations)", "abnormal cartilage collagen (HP:0008271 from HPO Gene-Disease Associations)", "decreased cranial base ossification (HP:0005451 from HPO Gene-Disease Associations)", "lumbar kyphoscoliosis (HP:0004619 from HPO Gene-Disease Associations)", "absent vertebral body mineralization (HP:0004605 from HPO Gene-Disease Associations)", "disc-like vertebral bodies (HP:0004591 from HPO Gene-Disease Associations)", "abnormality of vertebral epiphysis morphology (HP:0100734 from HPO Gene-Disease Associations)", "neonatal short-trunk short stature (HP:0008857 from HPO Gene-Disease Associations)", "splayed epiphyses (HP:0200003 from HPO Gene-Disease Associations)", "short tubular bones (hand) (HP:0001248 from HPO Gene-Disease Associations)", "pugilistic facies (HP:0000339 from HPO Gene-Disease Associations)", "rhegmatogenous retinal detachment (HP:0012230 from HPO Gene-Disease Associations)", "intervertebral space narrowing (HP:0002945 from HPO Gene-Disease Associations)", "cartilage destruction (HP:0100773 from HPO Gene-Disease Associations)", "club-shaped proximal femur (HP:0006406 from HPO Gene-Disease Associations)", "narrow femoral neck (HP:0008819 from HPO Gene-Disease Associations)", "large tarsal bones (HP:0004679 from HPO Gene-Disease Associations)", "prominent interphalangeal joints (HP:0006237 from HPO Gene-Disease Associations)", "platyspondyly (childhood) (HP:0003421 from HPO Gene-Disease Associations)", "acetabular spurs (HP:0010454 from HPO Gene-Disease Associations)", "enlarged interphalangeal joints (HP:0006247 from HPO Gene-Disease Associations)", "enlarged joints (HP:0003037 from HPO Gene-Disease Associations)", "juvenile aseptic necrosis (HP:0100323 from HPO Gene-Disease Associations)", "avascular necrosis of the capital femoral epiphysis (HP:0005743 from HPO Gene-Disease Associations)", "hip osteoarthritis (HP:0008843 from HPO Gene-Disease Associations)", "lumbar scoliosis (HP:0004626 from HPO Gene-Disease Associations)", "thoracolumbar scoliosis (HP:0002944 from HPO Gene-Disease Associations)", "dumbbell-shaped long bone (HP:0000947 from HPO Gene-Disease Associations)", "pierre-robin sequence (HP:0000201 from HPO Gene-Disease Associations)", "abnormal foot bone ossification (HP:0010675 from HPO Gene-Disease Associations)", "abnormal tarsal ossification (HP:0008369 from HPO Gene-Disease Associations)", "delayed tarsal ossification (HP:0008103 from HPO Gene-Disease Associations)", "narrow iliac wings (HP:0002868 from HPO Gene-Disease Associations)", "metaphyseal cupping (HP:0003021 from HPO Gene-Disease Associations)", "hypoplastic inferior ilia (HP:0008821 from HPO Gene-Disease Associations)", "severe platyspondyly (HP:0004565 from HPO Gene-Disease Associations)", "abnormality of the greater sacrosciatic notch (HP:0010456 from HPO Gene-Disease Associations)", "narrow greater sacrosciatic notches (HP:0003375 from HPO Gene-Disease Associations)", "waddling gait (HP:0002515 from HPO Gene-Disease Associations)", "hyperlordosis (HP:0003307 from HPO Gene-Disease Associations)", "lumbar hyperlordosis (HP:0002938 from HPO Gene-Disease Associations)", "abnormality of limb epiphysis morphology (HP:0006505 from HPO Gene-Disease Associations)", "abnormality of lower limb epiphysis morphology (HP:0006500 from HPO Gene-Disease Associations)", "abnormality of femoral epiphysis (HP:0006499 from HPO Gene-Disease Associations)", "abnormality of the epiphysis of the femoral head (HP:0010574 from HPO Gene-Disease Associations)", "abnormality of the femoral head (HP:0003368 from HPO Gene-Disease Associations)", "absent epiphyses (HP:0010577 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the capital femoral epiphysis (HP:0005003 from HPO Gene-Disease Associations)", "hypoplasia of the capital femoral epiphysis (HP:0003090 from HPO Gene-Disease Associations)", "irregular epiphyses (HP:0010582 from HPO Gene-Disease Associations)", "irregular femoral epiphysis (HP:0006361 from HPO Gene-Disease Associations)", "flat capital femoral epiphysis (HP:0003370 from HPO Gene-Disease Associations)", "flattened femoral epiphysis (HP:0030289 from HPO Gene-Disease Associations)", "flattened epiphysis (HP:0003071 from HPO Gene-Disease Associations)", "abnormality of the femoral neck or head region (HP:0003366 from HPO Gene-Disease Associations)", "abnormality of the femoral neck (HP:0003367 from HPO Gene-Disease Associations)", "abnormality of the femur (HP:0002823 from HPO Gene-Disease Associations)", "coxa valga (HP:0002673 from HPO Gene-Disease Associations)", "coxa vara (HP:0002812 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the pelvis (HP:0009103 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the femoral head and neck (HP:0009108 from HPO Gene-Disease Associations)", "short femoral neck (HP:0100864 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the femur (HP:0005613 from HPO Gene-Disease Associations)", "barrel-shaped chest (HP:0001552 from HPO Gene-Disease Associations)", "enlarged thorax (HP:0100625 from HPO Gene-Disease Associations)", "spondyloepiphyseal dysplasia (HP:0002655 from HPO Gene-Disease Associations)", "shield chest (HP:0000914 from HPO Gene-Disease Associations)", "hump-shaped mound of bone in central and posterior portions of vertebral endplate (HP:0004594 from HPO Gene-Disease Associations)", "abnormality of the ilium (HP:0002867 from HPO Gene-Disease Associations)", "abnormality of the wing of the ilium (HP:0011867 from HPO Gene-Disease Associations)", "hypoplastic ilia (HP:0000946 from HPO Gene-Disease Associations)", "hypoplastic iliac wing (HP:0002866 from HPO Gene-Disease Associations)", "flared iliac wings (HP:0002869 from HPO Gene-Disease Associations)", "abnormality of the acetabulum (HP:0003170 from HPO Gene-Disease Associations)", "flat acetabular roof (HP:0003180 from HPO Gene-Disease Associations)", "beaking of vertebral bodies (HP:0004568 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the vertebral column (HP:0008518 from HPO Gene-Disease Associations)", "abnormality of the odontoid process (HP:0003310 from HPO Gene-Disease Associations)", "hypoplasia of the odontoid process (HP:0003311 from HPO Gene-Disease Associations)", "disproportionate short-trunk short stature (HP:0003521 from HPO Gene-Disease Associations)", "genu varum (HP:0002970 from HPO Gene-Disease Associations)", "epiphyseal dysplasia (HP:0002656 from HPO Gene-Disease Associations)", "dysplastic iliac wings (HP:0008794 from HPO Gene-Disease Associations)", "arthralgia of the hip (HP:0003365 from HPO Gene-Disease Associations)", "multiple epiphyseal dysplasia (HP:0002654 from HPO Gene-Disease Associations)", "degenerative vitreoretinopathy (HP:0007964 from HPO Gene-Disease Associations)", "vitreoretinal abnormalities (HP:0007773 from HPO Gene-Disease Associations)", "severe myopia (HP:0011003 from HPO Gene-Disease Associations)", "small epiphyses (HP:0010585 from HPO Gene-Disease Associations)", "abnormality of the vertebral endplates (HP:0005106 from HPO Gene-Disease Associations)", "irregular vertebral endplates (HP:0003301 from HPO Gene-Disease Associations)", "flared, irregular rib ends (HP:0006603 from HPO Gene-Disease Associations)", "irregular sclerotic endplates (HP:0008476 from HPO Gene-Disease Associations)", "pear-shaped vertebrae (HP:0004566 from HPO Gene-Disease Associations)", "spondyloepimetaphyseal dysplasia (HP:0002651 from HPO Gene-Disease Associations)", "delayed patellar ossification (HP:0006454 from HPO Gene-Disease Associations)", "delayed phalangeal epiphyseal ossification (HP:0006016 from HPO Gene-Disease Associations)", "large joint dislocations (HP:0005008 from HPO Gene-Disease Associations)", "long proximal phalanx of finger (HP:0006127 from HPO Gene-Disease Associations)", "long distal phalanx of finger (HP:0012299 from HPO Gene-Disease Associations)", "slender distal phalanx of finger (HP:0012296 from HPO Gene-Disease Associations)", "slender proximal phalanx of finger (HP:0012297 from HPO Gene-Disease Associations)", "caudal interpedicular narrowing (HP:0008457 from HPO Gene-Disease Associations)", "posterior scalloping of vertebral bodies (HP:0005121 from HPO Gene-Disease Associations)", "streaky metaphyseal sclerosis (HP:0005092 from HPO Gene-Disease Associations)", "metaphyseal sclerosis (HP:0004979 from HPO Gene-Disease Associations)", "narrow vertebral interpedicular distance (HP:0008450 from HPO Gene-Disease Associations)", "vertebral arch anomaly (HP:0008438 from HPO Gene-Disease Associations)", "joint swelling (HP:0001386 from HPO Gene-Disease Associations)", "arthritis (HP:0001369 from HPO Gene-Disease Associations)", "osteoarthritis (HP:0002758 from HPO Gene-Disease Associations)", "enlargement of the proximal femoral epiphysis (HP:0003371 from HPO Gene-Disease Associations)", "enlarged metacarpophalangeal joints (HP:0006163 from HPO Gene-Disease Associations)", "decreased cervical spine mobility (HP:0004637 from HPO Gene-Disease Associations)", "osteoporosis of vertebrae (HP:0005625 from HPO Gene-Disease Associations)", "multiple small vertebral fractures (HP:0005877 from HPO Gene-Disease Associations)", "absent paranasal sinuses (HP:0002689 from HPO Gene-Disease Associations)", "abnormal facility in opposing the shoulders (HP:0005259 from HPO Gene-Disease Associations)", "long second metacarpal (HP:0006040 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the 2nd metacarpal (HP:0010036 from HPO Gene-Disease Associations)", "abnormality of the 2nd metacarpal (HP:0010010 from HPO Gene-Disease Associations)", "short middle phalanx of the 2nd finger (HP:0009577 from HPO Gene-Disease Associations)", "aplastic clavicles (HP:0006660 from HPO Gene-Disease Associations)", "abnormal ossification of the pubic bone (HP:0009105 from HPO Gene-Disease Associations)", "abnormal pelvis bone ossification (HP:0009106 from HPO Gene-Disease Associations)", "delayed pubic bone ossification (HP:0008788 from HPO Gene-Disease Associations)", "absent|hypoplastic paranasal sinuses (HP:0005453 from HPO Gene-Disease Associations)", "delayed eruption of permanent teeth (HP:0000696 from HPO Gene-Disease Associations)", "abnormality of the frontal sinuses (HP:0002687 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the frontal sinuses (HP:0009119 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the sinuses (HP:0009120 from HPO Gene-Disease Associations)", "absent frontal sinuses (HP:0002688 from HPO Gene-Disease Associations)", "hypoplastic frontal sinuses (HP:0002738 from HPO Gene-Disease Associations)", "spondylolysis (HP:0003304 from HPO Gene-Disease Associations)", "metaphyseal spurs (HP:0005054 from HPO Gene-Disease Associations)", "persistent open anterior fontanelle (HP:0004474 from HPO Gene-Disease Associations)", "carotid artery tortuosity (HP:0005302 from HPO Gene-Disease Associations)", "clitoral hypoplasia (HP:0000060 from HPO Gene-Disease Associations)", "bifid distal phalanx of toe (HP:0001853 from HPO Gene-Disease Associations)", "right ventricular outlet obstruction (HP:0001705 from HPO Gene-Disease Associations)", "type b brachydactyly (HP:0005831 from HPO Gene-Disease Associations)", "thoracic hemivertebrae (HP:0008467 from HPO Gene-Disease Associations)", "absent uvula (HP:0010292 from HPO Gene-Disease Associations)", "exaggerated cupid's bow (HP:0002263 from HPO Gene-Disease Associations)", "nevus flammeus (HP:0001052 from HPO Gene-Disease Associations)", "triangular mouth (HP:0000207 from HPO Gene-Disease Associations)", "short hard palate (HP:0010290 from HPO Gene-Disease Associations)", "increased number of teeth (HP:0011069 from HPO Gene-Disease Associations)", "testicular seminoma (HP:0100617 from HPO Gene-Disease Associations)", "craniofacial disproportion (HP:0005461 from HPO Gene-Disease Associations)", "craniopharyngioma (HP:0030062 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the distal phalanx of the 5th finger (HP:0009239 from HPO Gene-Disease Associations)", "short distal phalanx of the 5th finger (HP:0004227 from HPO Gene-Disease Associations)", "abnormality of the distal phalanx of the 5th finger (HP:0004225 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the middle phalanges of the hand (HP:0009843 from HPO Gene-Disease Associations)", "abnormality of the middle phalanges of the hand (HP:0009833 from HPO Gene-Disease Associations)", "short middle phalanx of finger (HP:0005819 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the 5th finger (HP:0006262 from HPO Gene-Disease Associations)", "short 5th finger (HP:0009237 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the phalanges of the 5th finger (HP:0009376 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the middle phalanx of the 5th finger (HP:0009161 from HPO Gene-Disease Associations)", "abnormality of the phalanges of the 5th finger (HP:0004213 from HPO Gene-Disease Associations)", "abnormality of the middle phalanx of the 5th finger (HP:0004219 from HPO Gene-Disease Associations)", "short middle phalanx of the 5th finger (HP:0004220 from HPO Gene-Disease Associations)", "meningeal calcification (HP:0100250 from HPO Gene-Disease Associations)", "wide tufts of distal phalanges (HP:0006095 from HPO Gene-Disease Associations)", "abnormality of the proximal tibial epiphysis (HP:0010591 from HPO Gene-Disease Associations)", "abnormality of tibial epiphyses (HP:0006508 from HPO Gene-Disease Associations)", "small proximal tibial epiphyses (HP:0012284 from HPO Gene-Disease Associations)", "irregular proximal tibial epiphyses (HP:0006456 from HPO Gene-Disease Associations)", "small distal femoral epiphysis (HP:0012283 from HPO Gene-Disease Associations)", "irregular distal femoral epiphysis (HP:0006407 from HPO Gene-Disease Associations)", "widely patent sagittal suture (HP:0005476 from HPO Gene-Disease Associations)", "widely patent coronal suture (HP:0005442 from HPO Gene-Disease Associations)", "posterior vertebral hypoplasia (HP:0008451 from HPO Gene-Disease Associations)", "lens luxation (HP:0012019 from HPO Gene-Disease Associations)", "incisor macrodontia (HP:0011081 from HPO Gene-Disease Associations)", "macrodontia of permanent maxillary central incisor (HP:0000675 from HPO Gene-Disease Associations)", "broad ischia (HP:0100865 from HPO Gene-Disease Associations)", "widened distal phalanges (HP:0006200 from HPO Gene-Disease Associations)", "hypoplastic fingernail (HP:0001804 from HPO Gene-Disease Associations)", "macrodontia (HP:0001572 from HPO Gene-Disease Associations)", "thick upper lip vermilion (HP:0000215 from HPO Gene-Disease Associations)", "anterior rib cupping (HP:0000907 from HPO Gene-Disease Associations)", "cupped ribs (HP:0000887 from HPO Gene-Disease Associations)", "posterior rib cupping (HP:0000922 from HPO Gene-Disease Associations)", "loss of retinal pigment epithelium (HP:0007722 from HPO Gene-Disease Associations)", "peripheral traction retinal detachment (HP:0007643 from HPO Gene-Disease Associations)", "tractional retinal detachment (HP:0007917 from HPO Gene-Disease Associations)", "retinal degeneration (HP:0000546 from HPO Gene-Disease Associations)", "vitreoretinal degeneration (HP:0000655 from HPO Gene-Disease Associations)", "peripheral vitreoretinal degeneration (HP:0200071 from HPO Gene-Disease Associations)", "drumstick terminal phalanges (HP:0006129 from HPO Gene-Disease Associations)", "bifid sternum (HP:0010309 from HPO Gene-Disease Associations)", "hyperconvex fingernails (HP:0001812 from HPO Gene-Disease Associations)", "thick nasal septum (HP:0009746 from HPO Gene-Disease Associations)", "lumbar kyphosis (HP:0008454 from HPO Gene-Disease Associations)", "broad palm (HP:0001169 from HPO Gene-Disease Associations)", "hyperextensibility of the finger joints (HP:0001187 from HPO Gene-Disease Associations)", "long palm (HP:0011302 from HPO Gene-Disease Associations)", "pilonidal sinus (HP:0010769 from HPO Gene-Disease Associations)", "anteriorly displaced genitalia (HP:0003252 from HPO Gene-Disease Associations)", "aplastic pubic bones (HP:0008817 from HPO Gene-Disease Associations)", "long ear (HP:0400004 from HPO Gene-Disease Associations)", "occipital meningocele (HP:0002436 from HPO Gene-Disease Associations)", "carpal bone aplasia (HP:0004231 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the tarsal bones (HP:0008363 from HPO Gene-Disease Associations)", "absent ulna (HP:0003982 from HPO Gene-Disease Associations)", "oligodactyly (feet) (HP:0001849 from HPO Gene-Disease Associations)", "oligodactyly (HP:0012165 from HPO Gene-Disease Associations)", "oligodactyly (hands) (HP:0001180 from HPO Gene-Disease Associations)", "phocomelia (HP:0009829 from HPO Gene-Disease Associations)", "esophageal varix (HP:0002040 from HPO Gene-Disease Associations)", "abnormality of the hepatic vasculature (HP:0006707 from HPO Gene-Disease Associations)", "portal hypertension (HP:0001409 from HPO Gene-Disease Associations)", "adactyly (HP:0009776 from HPO Gene-Disease Associations)", "skull defect (HP:0001362 from HPO Gene-Disease Associations)", "absent hand (HP:0004050 from HPO Gene-Disease Associations)", "ectrodactyly (HP:0100257 from HPO Gene-Disease Associations)", "split hand (HP:0001171 from HPO Gene-Disease Associations)", "split foot (HP:0001839 from HPO Gene-Disease Associations)", "hiatus hernia (HP:0002036 from HPO Gene-Disease Associations)", "bifid ureter (HP:0030037 from HPO Gene-Disease Associations)", "osteopathia striata (HP:0010740 from HPO Gene-Disease Associations)", "linear hyperpigmentation (HP:0007546 from HPO Gene-Disease Associations)", "midclavicular aplasia (HP:0006638 from HPO Gene-Disease Associations)", "midclavicular hypoplasia (HP:0006608 from HPO Gene-Disease Associations)", "absent fingernail (HP:0001817 from HPO Gene-Disease Associations)", "reticular hyperpigmentation (HP:0007588 from HPO Gene-Disease Associations)", "stenosis of the external auditory canal (HP:0000402 from HPO Gene-Disease Associations)", "absent toenail (HP:0001802 from HPO Gene-Disease Associations)", "absent fifth toenail (HP:0200105 from HPO Gene-Disease Associations)", "absent fifth fingernail (HP:0200104 from HPO Gene-Disease Associations)", "abnormal cortical gyration (HP:0002536 from HPO Gene-Disease Associations)", "abnormality of the cerebral cortex (HP:0002538 from HPO Gene-Disease Associations)", "polymicrogyria (HP:0002126 from HPO Gene-Disease Associations)", "abnormality of neuronal migration (HP:0002269 from HPO Gene-Disease Associations)", "pachygyria (HP:0001302 from HPO Gene-Disease Associations)", "lissencephaly (HP:0001339 from HPO Gene-Disease Associations)", "type ii lissencephaly (HP:0007260 from HPO Gene-Disease Associations)", "retinal dysplasia (HP:0007973 from HPO Gene-Disease Associations)", "cerebellar dysplasia (HP:0007033 from HPO Gene-Disease Associations)", "non-midline cleft lip (HP:0100335 from HPO Gene-Disease Associations)", "abnormality of the vitreous humor (HP:0004327 from HPO Gene-Disease Associations)", "retinal detachment (HP:0000541 from HPO Gene-Disease Associations)", "severe muscular hypotonia (HP:0006829 from HPO Gene-Disease Associations)", "abnormality of brainstem morphology (HP:0002363 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the brainstem (HP:0007362 from HPO Gene-Disease Associations)", "hypoplasia of the brainstem (HP:0002365 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the cerebellum (HP:0007360 from HPO Gene-Disease Associations)", "cerebellar hypoplasia (HP:0001321 from HPO Gene-Disease Associations)", "abnormality of the pons (HP:0007361 from HPO Gene-Disease Associations)", "hypoplasia of the pons (HP:0012110 from HPO Gene-Disease Associations)", "intellectual disability, profound (HP:0002187 from HPO Gene-Disease Associations)", "type i lissencephaly (HP:0006818 from HPO Gene-Disease Associations)", "thick cerebral cortex (HP:0006891 from HPO Gene-Disease Associations)", "congenital muscular dystrophy (HP:0003741 from HPO Gene-Disease Associations)", "meningoencephalocele (HP:0006888 from HPO Gene-Disease Associations)", "retinal malformation (HP:0007901 from HPO Gene-Disease Associations)", "abnormality of the anterior chamber (HP:0000593 from HPO Gene-Disease Associations)", "anterior segment dysgenesis (HP:0007700 from HPO Gene-Disease Associations)", "peters anomaly (HP:0000659 from HPO Gene-Disease Associations)", "large iliac wings (HP:0008818 from HPO Gene-Disease Associations)", "congenital myopia (HP:0008012 from HPO Gene-Disease Associations)", "long upper lip (HP:0011341 from HPO Gene-Disease Associations)", "short nasal bridge (HP:0003194 from HPO Gene-Disease Associations)", "retinal hypoplasia (HP:0007770 from HPO Gene-Disease Associations)", "uncontrolled eye movements (HP:0007738 from HPO Gene-Disease Associations)", "enlarged flash visual evoked potentials (HP:0008045 from HPO Gene-Disease Associations)", "abnormal flash visual evoked potentials (HP:0007928 from HPO Gene-Disease Associations)", "reduced amplitude of b-wave (erg) (HP:0007984 from HPO Gene-Disease Associations)", "cystic retinal degeneration (HP:0007667 from HPO Gene-Disease Associations)", "peripheral retinal atrophy (HP:0200070 from HPO Gene-Disease Associations)", "retinal atrophy (HP:0001105 from HPO Gene-Disease Associations)", "polymicrogyria, anterior to posterior gradient (HP:0006821 from HPO Gene-Disease Associations)", "frontoparietal polymicrogyria (HP:0007095 from HPO Gene-Disease Associations)", "hyperlipoproteinemia (HP:0010980 from HPO Gene-Disease Associations)", "increased circulating very-low-density lipoprotein cholesterol (HP:0003362 from HPO Gene-Disease Associations)", "urethral fistula (HP:0010480 from HPO Gene-Disease Associations)", "midline skin dimples over anterior|posterior fontanelles (HP:0005498 from HPO Gene-Disease Associations)", "hypoplasia of the primary teeth (HP:0006334 from HPO Gene-Disease Associations)", "urethrovaginal fistula (HP:0008716 from HPO Gene-Disease Associations)", "anasarca (HP:0012050 from HPO Gene-Disease Associations)", "generalized edema (HP:0007430 from HPO Gene-Disease Associations)", "symmetrical, oval parietal bone defects (HP:0002695 from HPO Gene-Disease Associations)", "aplasia cutis congenita (HP:0001057 from HPO Gene-Disease Associations)", "aplasia cutis congenita of scalp (HP:0007385 from HPO Gene-Disease Associations)", "aplasia cutis congenita over the scalp vertex (HP:0004471 from HPO Gene-Disease Associations)", "abnormality of the anus (HP:0004378 from HPO Gene-Disease Associations)", "anorectal anomaly (HP:0012732 from HPO Gene-Disease Associations)", "anal atresia (HP:0002023 from HPO Gene-Disease Associations)", "anal stenosis (HP:0002025 from HPO Gene-Disease Associations)", "ectopic anus (HP:0004397 from HPO Gene-Disease Associations)", "anteriorly placed anus (HP:0001545 from HPO Gene-Disease Associations)", "intestinal fistula (HP:0100819 from HPO Gene-Disease Associations)", "rectal fistula (HP:0100590 from HPO Gene-Disease Associations)", "rectovaginal fistula (HP:0000143 from HPO Gene-Disease Associations)", "vaginal fistula (HP:0004320 from HPO Gene-Disease Associations)", "perineal fistula (HP:0004871 from HPO Gene-Disease Associations)", "aphalangy of the hands (HP:0005886 from HPO Gene-Disease Associations)", "stiff interphalangeal joints (HP:0005198 from HPO Gene-Disease Associations)", "limited shoulder movement (HP:0006467 from HPO Gene-Disease Associations)", "anomalous splenoportal venous system (HP:0005201 from HPO Gene-Disease Associations)", "juvenile zonular cataracts (HP:0007713 from HPO Gene-Disease Associations)", "juvenile cataract (HP:0001118 from HPO Gene-Disease Associations)", "forearm reduction defects (HP:0006368 from HPO Gene-Disease Associations)", "abnormal number of permanent teeth (HP:0011044 from HPO Gene-Disease Associations)", "agenesis of permanent teeth (HP:0006349 from HPO Gene-Disease Associations)", "rectoperineal fistula (HP:0004792 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the 3rd toe (HP:0010331 from HPO Gene-Disease Associations)", "pseudoepiphyses of second metacarpal (HP:0006179 from HPO Gene-Disease Associations)", "abnormality of the 3rd toe (HP:0010320 from HPO Gene-Disease Associations)", "2-4 finger syndactyly (HP:0010709 from HPO Gene-Disease Associations)", "pseudoepiphyses of the metacarpals (HP:0009193 from HPO Gene-Disease Associations)", "abnormality of metacarpal epiphyses (HP:0005913 from HPO Gene-Disease Associations)", "synostosis involving metatarsal bones (HP:0001440 from HPO Gene-Disease Associations)", "pseudoepiphyses (HP:0010584 from HPO Gene-Disease Associations)", "pseudoepiphyses of hand bones (HP:0004288 from HPO Gene-Disease Associations)", "involuntary writhing movements (HP:0007316 from HPO Gene-Disease Associations)", "additional crus of antihelix (HP:0011235 from HPO Gene-Disease Associations)", "stahl ear (HP:0100015 from HPO Gene-Disease Associations)", "patellar hypoplasia (HP:0003065 from HPO Gene-Disease Associations)", "wide capital femoral epiphyses (HP:0008784 from HPO Gene-Disease Associations)", "hypoplasia of the lesser trochanter (HP:0008801 from HPO Gene-Disease Associations)", "increased sensitivity to ionizing radiation (HP:0011133 from HPO Gene-Disease Associations)", "mild global developmental delay (HP:0011342 from HPO Gene-Disease Associations)", "4-5 toe syndactyly (HP:0004692 from HPO Gene-Disease Associations)", "absent fourth finger distal interphalangeal crease (HP:0005780 from HPO Gene-Disease Associations)", "few cafe-au-lait spots (HP:0007429 from HPO Gene-Disease Associations)", "single interphalangeal crease of fifth finger (HP:0006216 from HPO Gene-Disease Associations)", "abnormal finger flexion creases (HP:0006143 from HPO Gene-Disease Associations)", "absent phalangeal crease (HP:0006109 from HPO Gene-Disease Associations)", "absent distal interphalangeal creases (HP:0001032 from HPO Gene-Disease Associations)", "abnormality of the urachus (HP:0010478 from HPO Gene-Disease Associations)", "patent urachus (HP:0010479 from HPO Gene-Disease Associations)", "broad distal phalanx of the toes (HP:0010186 from HPO Gene-Disease Associations)", "broad distal phalanx of the hallux (HP:0010077 from HPO Gene-Disease Associations)", "enlarged proximal interphalangeal joints (HP:0006185 from HPO Gene-Disease Associations)", "type e brachydactyly (HP:0005863 from HPO Gene-Disease Associations)", "type d brachydactyly (HP:0005627 from HPO Gene-Disease Associations)", "2nd-5th toe middle phalangeal hypoplasia (HP:0008083 from HPO Gene-Disease Associations)", "contracture of the proximal interphalangeal joint of the 5th finger (HP:0009185 from HPO Gene-Disease Associations)", "abnormality of the distal phalanx of the hallux (HP:0010053 from HPO Gene-Disease Associations)", "broad distal phalanx of the thumb (HP:0009642 from HPO Gene-Disease Associations)", "impacted tooth (HP:0011079 from HPO Gene-Disease Associations)", "multiple impacted teeth (HP:0001571 from HPO Gene-Disease Associations)", "moderately short stature (HP:0008848 from HPO Gene-Disease Associations)", "straight clavicles (HP:0006587 from HPO Gene-Disease Associations)", "unerupted tooth (HP:0000706 from HPO Gene-Disease Associations)", "metacarpal synostosis (HP:0009701 from HPO Gene-Disease Associations)", "synostosis of metacarpals|metatarsals (HP:0100265 from HPO Gene-Disease Associations)", "synostosis involving the 4th metacarpal (HP:0009707 from HPO Gene-Disease Associations)", "fused fourth and fifth metacarpals (HP:0005867 from HPO Gene-Disease Associations)", "camptodactyly of 2nd-5th fingers (HP:0001215 from HPO Gene-Disease Associations)", "glandular hypospadias (HP:0000807 from HPO Gene-Disease Associations)", "longitudinal vaginal septum (HP:0008740 from HPO Gene-Disease Associations)", "short first metatarsal (HP:0010105 from HPO Gene-Disease Associations)", "short 2nd toe (HP:0001885 from HPO Gene-Disease Associations)", "uterus didelphys (HP:0003762 from HPO Gene-Disease Associations)", "chordee (HP:0000041 from HPO Gene-Disease Associations)", "ureteral obstruction (HP:0006000 from HPO Gene-Disease Associations)", "ureteral stenosis (HP:0000071 from HPO Gene-Disease Associations)", "ureteropelvic junction obstruction (HP:0000074 from HPO Gene-Disease Associations)", "violent behavior (HP:0008760 from HPO Gene-Disease Associations)", "low-set nipples (HP:0002562 from HPO Gene-Disease Associations)", "large for gestational age (HP:0001520 from HPO Gene-Disease Associations)", "1-5 finger complete cutaneous syndactyly (HP:0006088 from HPO Gene-Disease Associations)", "1-5 finger syndactyly (HP:0010708 from HPO Gene-Disease Associations)", "complete duplication of distal phalanx of the thumb (HP:0009606 from HPO Gene-Disease Associations)", "complete duplication of the distal phalanges of the hand (HP:0010001 from HPO Gene-Disease Associations)", "opposable triphalangeal thumb (HP:0005866 from HPO Gene-Disease Associations)", "lower limb peromelia (HP:0009820 from HPO Gene-Disease Associations)", "peromelia (HP:0009828 from HPO Gene-Disease Associations)", "aplasia of the tarsal bones (HP:0010509 from HPO Gene-Disease Associations)", "absent forearm (HP:0005632 from HPO Gene-Disease Associations)", "6 metacarpals (HP:0001501 from HPO Gene-Disease Associations)", "supernumerary metacarpal bones (HP:0005917 from HPO Gene-Disease Associations)", "aplasia of metacarpal bones (HP:0010048 from HPO Gene-Disease Associations)", "aplasia involving bones of the lower limbs (HP:0009817 from HPO Gene-Disease Associations)", "absent tibia (HP:0009556 from HPO Gene-Disease Associations)", "fibular duplication (HP:0010503 from HPO Gene-Disease Associations)", "limb duplication (HP:0100524 from HPO Gene-Disease Associations)", "duplication of phalanx of toe (HP:0010181 from HPO Gene-Disease Associations)", "duplication of phalanx of hallux (HP:0010066 from HPO Gene-Disease Associations)", "abnormality of the phalanges of the hallux (HP:0010057 from HPO Gene-Disease Associations)", "bifid distal phalanx of the thumb (HP:0009611 from HPO Gene-Disease Associations)", "duplication of the distal phalanx of the thumb (HP:0009612 from HPO Gene-Disease Associations)", "pulmonary valve defects (HP:0005148 from HPO Gene-Disease Associations)", "duplication of the distal phalanx of hand (HP:0009883 from HPO Gene-Disease Associations)", "partial duplication of the distal phalanges of the hand (HP:0010004 from HPO Gene-Disease Associations)", "abnormality of the distal phalanx of the thumb (HP:0009617 from HPO Gene-Disease Associations)", "duplication of distal phalanx of toe (HP:0010193 from HPO Gene-Disease Associations)", "duplication of the distal phalanx of the hallux (HP:0010084 from HPO Gene-Disease Associations)", "partial duplication of the distal phalanx of the hallux (HP:0010097 from HPO Gene-Disease Associations)", "partial duplication of the phalanges of the hallux (HP:0010101 from HPO Gene-Disease Associations)", "phalangeal dislocation (HP:0006243 from HPO Gene-Disease Associations)", "proximal fibular overgrowth (HP:0005067 from HPO Gene-Disease Associations)", "abnormality of the radioulnar joints (HP:0003059 from HPO Gene-Disease Associations)", "radioulnar dislocation (HP:0006439 from HPO Gene-Disease Associations)", "medial deviation of the foot (HP:0008082 from HPO Gene-Disease Associations)", "fibular overgrowth (HP:0003099 from HPO Gene-Disease Associations)", "broad first metatarsal (HP:0010068 from HPO Gene-Disease Associations)", "advanced ossification of carpal bones (HP:0004233 from HPO Gene-Disease Associations)", "advanced tarsal ossification (HP:0008108 from HPO Gene-Disease Associations)", "abnormality of phytanic acid metabolism (HP:0010965 from HPO Gene-Disease Associations)", "elevated levels of phytanic acid (HP:0010571 from HPO Gene-Disease Associations)", "calcific stippling of infantile cartilaginous skeleton (HP:0005841 from HPO Gene-Disease Associations)", "camptodactyly of toe (HP:0001836 from HPO Gene-Disease Associations)", "flexion contracture of toe (HP:0005830 from HPO Gene-Disease Associations)", "joint contractures involving the joints of the feet (HP:0100492 from HPO Gene-Disease Associations)", "contractures involving the joints of the feet (HP:0008366 from HPO Gene-Disease Associations)", "contractures of the joints of the lower limbs (HP:0005750 from HPO Gene-Disease Associations)", "pulmonary fibrosis (HP:0002206 from HPO Gene-Disease Associations)", "acrocyanosis (HP:0001063 from HPO Gene-Disease Associations)", "cyanosis (HP:0000961 from HPO Gene-Disease Associations)", "hypoplasia of the prostate (HP:0008687 from HPO Gene-Disease Associations)", "shortening of all distal phalanges of the fingers (HP:0006118 from HPO Gene-Disease Associations)", "morbus scheuermann (HP:0010891 from HPO Gene-Disease Associations)", "cervical spinal canal stenosis (HP:0008445 from HPO Gene-Disease Associations)", "scheuermann-like vertebral changes (HP:0008478 from HPO Gene-Disease Associations)", "widely spaced toes (HP:0008094 from HPO Gene-Disease Associations)", "large earlobe (HP:0009748 from HPO Gene-Disease Associations)", "widened metacarpal shaft (HP:0006012 from HPO Gene-Disease Associations)", "interphalangeal joint erosions (HP:0006252 from HPO Gene-Disease Associations)", "sclerotic cranial sutures (HP:0005441 from HPO Gene-Disease Associations)", "thin metatarsal cortices (HP:0008078 from HPO Gene-Disease Associations)", "ankylosis of feet small joints (HP:0008090 from HPO Gene-Disease Associations)", "distal tapering of metatarsals (HP:0008133 from HPO Gene-Disease Associations)", "thin metacarpal cortices (HP:0006086 from HPO Gene-Disease Associations)", "metacarpal osteolysis (HP:0001504 from HPO Gene-Disease Associations)", "osteolysis involving tarsal bones (HP:0006234 from HPO Gene-Disease Associations)", "carpal osteolysis (HP:0001495 from HPO Gene-Disease Associations)", "metatarsal osteolysis (HP:0001473 from HPO Gene-Disease Associations)", "c1-c2 subluxation (HP:0003320 from HPO Gene-Disease Associations)", "c1-c2 vertebral abnormality (HP:0008440 from HPO Gene-Disease Associations)", "cervical subluxation (HP:0003308 from HPO Gene-Disease Associations)", "testicular torsion (HP:0100813 from HPO Gene-Disease Associations)", "anterior bowing of long bones (HP:0006473 from HPO Gene-Disease Associations)", "abnormally straight spine (HP:0100795 from HPO Gene-Disease Associations)", "long eyelashes in irregular rows (HP:0007740 from HPO Gene-Disease Associations)", "generalized hirsutism (HP:0002230 from HPO Gene-Disease Associations)", "distichiasis (HP:0009743 from HPO Gene-Disease Associations)", "multiple rows of eyelashes (HP:0008496 from HPO Gene-Disease Associations)", "slender toe (HP:0011308 from HPO Gene-Disease Associations)", "palmoplantar cutis gyrata (HP:0007469 from HPO Gene-Disease Associations)", "ulnar deviation of the wrist (HP:0003049 from HPO Gene-Disease Associations)", "abnormality of the nasolabial region (HP:0005289 from HPO Gene-Disease Associations)", "prominent nasolabial fold (HP:0005272 from HPO Gene-Disease Associations)", "round ear (HP:0100830 from HPO Gene-Disease Associations)", "distal arthrogryposis (HP:0005684 from HPO Gene-Disease Associations)", "abnormality of the calcaneus (HP:0008364 from HPO Gene-Disease Associations)", "calcaneovalgus deformity (HP:0001848 from HPO Gene-Disease Associations)", "deformed tarsal bones (HP:0008119 from HPO Gene-Disease Associations)", "metatarsus adductus (HP:0001840 from HPO Gene-Disease Associations)", "ulnar deviation of finger (HP:0009465 from HPO Gene-Disease Associations)", "ulnar deviation of the hand or of fingers of the hand (HP:0001193 from HPO Gene-Disease Associations)", "stiff shoulders (HP:0009742 from HPO Gene-Disease Associations)", "hand clenching (HP:0001188 from HPO Gene-Disease Associations)", "knee flexion contracture (HP:0006380 from HPO Gene-Disease Associations)", "limited hip movement (HP:0008800 from HPO Gene-Disease Associations)", "hip contracture (HP:0003273 from HPO Gene-Disease Associations)", "shoulder flexion contracture (HP:0003044 from HPO Gene-Disease Associations)", "pursed lips (HP:0000205 from HPO Gene-Disease Associations)", "whistling appearance (HP:0000346 from HPO Gene-Disease Associations)", "chin with h-shaped crease (HP:0011824 from HPO Gene-Disease Associations)", "decreased hip abduction (HP:0003184 from HPO Gene-Disease Associations)", "limited wrist extension (HP:0006251 from HPO Gene-Disease Associations)", "fixed facial expression (HP:0005329 from HPO Gene-Disease Associations)", "decreased palmar creases (HP:0006184 from HPO Gene-Disease Associations)", "firm muscles (HP:0003725 from HPO Gene-Disease Associations)", "keratoglobus (HP:0001119 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the palmar creases (HP:0010488 from HPO Gene-Disease Associations)", "absent palmar crease (HP:0010489 from HPO Gene-Disease Associations)", "patellar subluxation (HP:0010499 from HPO Gene-Disease Associations)", "calf muscle hypoplasia (HP:0008962 from HPO Gene-Disease Associations)", "congenital kyphoscoliosis (HP:0008453 from HPO Gene-Disease Associations)", "crumpled ear (HP:0009901 from HPO Gene-Disease Associations)", "equinus calcaneus (HP:0008138 from HPO Gene-Disease Associations)", "hamartomatous polyps (HP:0004390 from HPO Gene-Disease Associations)", "hamartomatous stomach polyps (HP:0004795 from HPO Gene-Disease Associations)", "cardiac fibroma (HP:0010617 from HPO Gene-Disease Associations)", "irregular ossification of hand bones (HP:0004280 from HPO Gene-Disease Associations)", "bridged sella turcica (HP:0005449 from HPO Gene-Disease Associations)", "keratocystic odontogenic tumor (HP:0010603 from HPO Gene-Disease Associations)", "short distal phalanx of the thumb (HP:0009650 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the distal phalanx of the thumb (HP:0009641 from HPO Gene-Disease Associations)", "ovarian fibroma (HP:0010618 from HPO Gene-Disease Associations)", "plantar pits (HP:0010612 from HPO Gene-Disease Associations)", "palmar pits (HP:0010610 from HPO Gene-Disease Associations)", "bifid ribs (HP:0000892 from HPO Gene-Disease Associations)", "orbital cyst (HP:0001144 from HPO Gene-Disease Associations)", "parietal bossing (HP:0000242 from HPO Gene-Disease Associations)", "cardiac rhabdomyoma (HP:0009729 from HPO Gene-Disease Associations)", "rhabdomyoma (HP:0009730 from HPO Gene-Disease Associations)", "neoplasm of the heart (HP:0100544 from HPO Gene-Disease Associations)", "abnormality of the dura mater (HP:0010652 from HPO Gene-Disease Associations)", "abnormality of the falx cerebri (HP:0010653 from HPO Gene-Disease Associations)", "calcification of falx cerebri (HP:0005462 from HPO Gene-Disease Associations)", "vertebral wedging (HP:0008422 from HPO Gene-Disease Associations)", "neoplasm of the oral cavity (HP:0100649 from HPO Gene-Disease Associations)", "odontogenic neoplasm (HP:0100612 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the 4th metacarpal (HP:0010042 from HPO Gene-Disease Associations)", "short 4th metacarpal (HP:0010044 from HPO Gene-Disease Associations)", "abnormality of the 4th metacarpal (HP:0010012 from HPO Gene-Disease Associations)", "abnormality of the shoulder (HP:0003043 from HPO Gene-Disease Associations)", "down-sloping shoulders (HP:0200021 from HPO Gene-Disease Associations)", "semilobar holoprosencephaly (HP:0002507 from HPO Gene-Disease Associations)", "median cleft lip and palate (HP:0008501 from HPO Gene-Disease Associations)", "absent nasal septal cartilage (HP:0005273 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the nasal septum (HP:0009935 from HPO Gene-Disease Associations)", "median cleft palate (HP:0009099 from HPO Gene-Disease Associations)", "abnormality of the nasal septum (HP:0000419 from HPO Gene-Disease Associations)", "abnormality of thalamus morphology (HP:0010663 from HPO Gene-Disease Associations)", "hypoplastic philtrum (HP:0005326 from HPO Gene-Disease Associations)", "flat nasal alae (HP:0010649 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the premaxilla (HP:0010756 from HPO Gene-Disease Associations)", "premaxillary underdevelopment (HP:0010650 from HPO Gene-Disease Associations)", "bilateral cleft lip (HP:0100336 from HPO Gene-Disease Associations)", "bilateral cleft lip and palate (HP:0002744 from HPO Gene-Disease Associations)", "bilateral cleft palate (HP:0100337 from HPO Gene-Disease Associations)", "non-midline cleft palate (HP:0100338 from HPO Gene-Disease Associations)", "panhypopituitarism (HP:0000871 from HPO Gene-Disease Associations)", "anterior pituitary agenesis (HP:0010626 from HPO Gene-Disease Associations)", "aplasia of the nose (HP:0009927 from HPO Gene-Disease Associations)", "abnormal number of incisors (HP:0011064 from HPO Gene-Disease Associations)", "single median maxillary incisor (HP:0006315 from HPO Gene-Disease Associations)", "3-4 finger cutaneous syndactyly (HP:0011939 from HPO Gene-Disease Associations)", "underdeveloped antitragus (HP:0011251 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the tragus (HP:0009913 from HPO Gene-Disease Associations)", "underdeveloped tragus (HP:0011272 from HPO Gene-Disease Associations)", "abnormality of the tragus (HP:0009912 from HPO Gene-Disease Associations)", "small earlobe (HP:0000385 from HPO Gene-Disease Associations)", "hypotelorism (HP:0000601 from HPO Gene-Disease Associations)", "imperforate hymen (HP:0030011 from HPO Gene-Disease Associations)", "axillary apocrine gland hypoplasia (HP:0007397 from HPO Gene-Disease Associations)", "short 4th toe (HP:0008093 from HPO Gene-Disease Associations)", "deformed forearm bones (HP:0003959 from HPO Gene-Disease Associations)", "deformed radius (HP:0003977 from HPO Gene-Disease Associations)", "short 5th toe (HP:0011917 from HPO Gene-Disease Associations)", "abnormality of the posterior pituitary (HP:0011751 from HPO Gene-Disease Associations)", "posterior pituitary dysgenesis (HP:0011753 from HPO Gene-Disease Associations)", "ectopic posterior pituitary (HP:0011755 from HPO Gene-Disease Associations)", "anterior pituitary dysgenesis (HP:0010625 from HPO Gene-Disease Associations)", "anterior pituitary hypoplasia (HP:0010627 from HPO Gene-Disease Associations)", "skin vesicle (HP:0200037 from HPO Gene-Disease Associations)", "abnormality of secondary sexual hair (HP:0009888 from HPO Gene-Disease Associations)", "abnormality of the axillary hair (HP:0100134 from HPO Gene-Disease Associations)", "sparse axillary hair (HP:0002215 from HPO Gene-Disease Associations)", "aplasia of the pectoralis major muscle (HP:0009751 from HPO Gene-Disease Associations)", "pectoral muscle hypoplasia|aplasia (HP:0005258 from HPO Gene-Disease Associations)", "mild intrauterine growth retardation (HP:0008883 from HPO Gene-Disease Associations)", "single ventricle (HP:0001750 from HPO Gene-Disease Associations)", "abnormality of the scapula (HP:0000782 from HPO Gene-Disease Associations)", "sprengel anomaly (HP:0000912 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the scapulae (HP:0006713 from HPO Gene-Disease Associations)", "hypoplastic scapulae (HP:0000882 from HPO Gene-Disease Associations)", "abnormality of chromosome segregation (HP:0002916 from HPO Gene-Disease Associations)", "premature chromatid separation (HP:0200024 from HPO Gene-Disease Associations)", "hypodysplasia of the corpus callosum (HP:0006849 from HPO Gene-Disease Associations)", "abnormal lung lobation (HP:0002101 from HPO Gene-Disease Associations)", "vaginal neoplasm (HP:0100650 from HPO Gene-Disease Associations)", "premature separation of centromeric heterochromatin (HP:0003616 from HPO Gene-Disease Associations)", "enlarged labia minora (HP:0008683 from HPO Gene-Disease Associations)", "frontal encephalocele (HP:0007330 from HPO Gene-Disease Associations)", "narrow naris (HP:0009933 from HPO Gene-Disease Associations)", "absent earlobe (HP:0000387 from HPO Gene-Disease Associations)", "midface capillary hemangioma (HP:0007452 from HPO Gene-Disease Associations)", "upper limb phocomelia (HP:0009813 from HPO Gene-Disease Associations)", "capillary hemangiomas (HP:0005306 from HPO Gene-Disease Associations)", "facial capillary hemangioma (HP:0000996 from HPO Gene-Disease Associations)", "facial hemangioma (HP:0000329 from HPO Gene-Disease Associations)", "abnormality of the epiglottis (HP:0005483 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the epiglottis (HP:0010565 from HPO Gene-Disease Associations)", "hypoplasia of the epiglottis (HP:0005349 from HPO Gene-Disease Associations)", "disproportionate shortening of the tibia (HP:0005766 from HPO Gene-Disease Associations)", "postaxial polysyndactyly of foot (HP:0005817 from HPO Gene-Disease Associations)", "polysyndactyly of hallux (HP:0005873 from HPO Gene-Disease Associations)", "horizontal ribs (HP:0000888 from HPO Gene-Disease Associations)", "lethal skeletal dysplasia (HP:0005716 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the tongue (HP:0010295 from HPO Gene-Disease Associations)", "microglossia (HP:0000171 from HPO Gene-Disease Associations)", "bifid epiglottis (HP:0010564 from HPO Gene-Disease Associations)", "distal urethral duplication (HP:0008706 from HPO Gene-Disease Associations)", "midline facial capillary hemangioma (HP:0007601 from HPO Gene-Disease Associations)", "preductal coarctation of the aorta (HP:0005151 from HPO Gene-Disease Associations)", "coarctation of the descending aortic arch (HP:0012305 from HPO Gene-Disease Associations)", "metopic synostosis (HP:0011330 from HPO Gene-Disease Associations)", "mesoaxial foot polydactyly (HP:0010112 from HPO Gene-Disease Associations)", "dysplastic distal thumb phalanges with a central hole (HP:0005688 from HPO Gene-Disease Associations)", "1-5 toe syndactyly (HP:0010713 from HPO Gene-Disease Associations)", "1-3 toe syndactyly (HP:0001459 from HPO Gene-Disease Associations)", "radial head subluxation (HP:0003048 from HPO Gene-Disease Associations)", "laryngeal cleft (HP:0008751 from HPO Gene-Disease Associations)", "3-4 finger syndactyly (HP:0006097 from HPO Gene-Disease Associations)", "y-shaped metacarpals (HP:0006042 from HPO Gene-Disease Associations)", "broad hallux phalanx (HP:0010059 from HPO Gene-Disease Associations)", "broad phalanx of the toes (HP:0010174 from HPO Gene-Disease Associations)", "abnormal hypothalamus morphology (HP:0012286 from HPO Gene-Disease Associations)", "hypothalamic hamartoma (HP:0002444 from HPO Gene-Disease Associations)", "cerebral hamartomata (HP:0009731 from HPO Gene-Disease Associations)", "distal shortening of limbs (HP:0006402 from HPO Gene-Disease Associations)", "hypoplasia of the calcaneus (HP:0012789 from HPO Gene-Disease Associations)", "renal dysplasia (HP:0000110 from HPO Gene-Disease Associations)", "hemifacial hypoplasia (HP:0011332 from HPO Gene-Disease Associations)", "myeloproliferative disorder (HP:0005547 from HPO Gene-Disease Associations)", "myelofibrosis (HP:0011974 from HPO Gene-Disease Associations)", "thrombocytosis (HP:0001894 from HPO Gene-Disease Associations)", "increased megakaryocyte count (HP:0005513 from HPO Gene-Disease Associations)", "budd-chiari syndrome (HP:0002639 from HPO Gene-Disease Associations)", "thromboembolism (HP:0001907 from HPO Gene-Disease Associations)", "gastrointestinal infarctions (HP:0005244 from HPO Gene-Disease Associations)", "chest pain (HP:0100749 from HPO Gene-Disease Associations)", "increased hematocrit (HP:0001899 from HPO Gene-Disease Associations)", "increased hemoglobin (HP:0001900 from HPO Gene-Disease Associations)", "increased red blood cell mass (HP:0001898 from HPO Gene-Disease Associations)", "peripheral thrombosis (HP:0002641 from HPO Gene-Disease Associations)", "plethora (HP:0001050 from HPO Gene-Disease Associations)", "polycythemia (HP:0001901 from HPO Gene-Disease Associations)", "fatigue (HP:0012378 from HPO Gene-Disease Associations)", "abnormality of the epididymis (HP:0009714 from HPO Gene-Disease Associations)", "papillary cystadenoma of the epididymis (HP:0009715 from HPO Gene-Disease Associations)", "multiple renal cysts (HP:0005562 from HPO Gene-Disease Associations)", "cerebellar hemangioblastoma (HP:0006880 from HPO Gene-Disease Associations)", "retinal hemangioblastoma (HP:0009711 from HPO Gene-Disease Associations)", "spinal hemangioblastoma (HP:0009713 from HPO Gene-Disease Associations)", "hemangioblastoma (HP:0010797 from HPO Gene-Disease Associations)", "pulmonary capillary hemangiomatosis (HP:0005954 from HPO Gene-Disease Associations)", "neoplasm of the middle ear (HP:0100799 from HPO Gene-Disease Associations)", "spinal cord tumor (HP:0010302 from HPO Gene-Disease Associations)", "occasional neurofibromas (HP:0009595 from HPO Gene-Disease Associations)", "epiretinal membrane (HP:0100014 from HPO Gene-Disease Associations)", "juvenile posterior subcapsular lenticular opacities (HP:0007935 from HPO Gene-Disease Associations)", "juvenile cortical cataract (HP:0007876 from HPO Gene-Disease Associations)", "peripheral schwannoma (HP:0009593 from HPO Gene-Disease Associations)", "bilateral vestibular schwannoma (HP:0009589 from HPO Gene-Disease Associations)", "unilateral vestibular schwannoma (HP:0009590 from HPO Gene-Disease Associations)", "abnormality of the vestibulocochlear nerve (HP:0009591 from HPO Gene-Disease Associations)", "neoplasm of the inner ear (HP:0040096 from HPO Gene-Disease Associations)", "vestibular schwannoma (HP:0009588 from HPO Gene-Disease Associations)", "schwannoma (HP:0100008 from HPO Gene-Disease Associations)", "neoplasm of the ear (HP:0012780 from HPO Gene-Disease Associations)", "polar cataract (HP:0010696 from HPO Gene-Disease Associations)", "posterior subcapsular cataract (HP:0007787 from HPO Gene-Disease Associations)", "subcapsular cataract (HP:0000523 from HPO Gene-Disease Associations)", "hashimoto thyroiditis (HP:0000872 from HPO Gene-Disease Associations)", "intraocular melanoma (HP:0007716 from HPO Gene-Disease Associations)", "subcutaneous lipoma (HP:0001031 from HPO Gene-Disease Associations)", "biparietal narrowing (HP:0004422 from HPO Gene-Disease Associations)", "atypical nevi (>5mm with irregular edge and pigmentation) (HP:0001062 from HPO Gene-Disease Associations)", "atypical nevi in non-sun exposed areas (HP:0001074 from HPO Gene-Disease Associations)", "pseudopapilledema (HP:0000538 from HPO Gene-Disease Associations)", "abnormally prominent line of schwalbe (HP:0007873 from HPO Gene-Disease Associations)", "postnatal macrocephaly (HP:0005490 from HPO Gene-Disease Associations)", "birth length greater than 97th percentile (HP:0003517 from HPO Gene-Disease Associations)", "thick corpus callosum (HP:0007074 from HPO Gene-Disease Associations)", "abnormality of the endometrium (HP:0030126 from HPO Gene-Disease Associations)", "endometrial carcinoma (HP:0012114 from HPO Gene-Disease Associations)", "bronchogenic cyst (HP:0100730 from HPO Gene-Disease Associations)", "neoplasm of the thymus (HP:0100521 from HPO Gene-Disease Associations)", "thymus hyperplasia (HP:0010516 from HPO Gene-Disease Associations)", "epibulbar dermoid (HP:0001140 from HPO Gene-Disease Associations)", "mandibular hyperostosis (HP:0004472 from HPO Gene-Disease Associations)", "depigmentation|hyperpigmentation of skin (HP:0007483 from HPO Gene-Disease Associations)", "hypertrophy of skin of soles (HP:0007403 from HPO Gene-Disease Associations)", "venous malformation (HP:0012721 from HPO Gene-Disease Associations)", "lipoma (HP:0012032 from HPO Gene-Disease Associations)", "sirenomelia (HP:0010497 from HPO Gene-Disease Associations)", "asymmetry of the thorax (HP:0001555 from HPO Gene-Disease Associations)", "macroorchidism (HP:0000053 from HPO Gene-Disease Associations)", "germ cell neoplasia (HP:0100728 from HPO Gene-Disease Associations)", "dysgerminoma (HP:0100621 from HPO Gene-Disease Associations)", "germinoma (HP:0100620 from HPO Gene-Disease Associations)", "ovarian papillary adenocarcinoma (HP:0006774 from HPO Gene-Disease Associations)", "breast carcinoma (HP:0003002 from HPO Gene-Disease Associations)", "neoplasm of the breast (HP:0100013 from HPO Gene-Disease Associations)", "spinal canal stenosis (HP:0003416 from HPO Gene-Disease Associations)", "asymmetric growth (HP:0100555 from HPO Gene-Disease Associations)", "lower limb asymmetry (HP:0100559 from HPO Gene-Disease Associations)", "abnormality of the vocal cords (HP:0008777 from HPO Gene-Disease Associations)", "vocal cord paralysis (HP:0001605 from HPO Gene-Disease Associations)", "vocal cord paralysis (caused by tumor impingement) (HP:0001606 from HPO Gene-Disease Associations)", "hoarse voice (caused by tumor impingement) (HP:0001613 from HPO Gene-Disease Associations)", "loss of voice (HP:0001686 from HPO Gene-Disease Associations)", "abnormality of circulating catecholamine level (HP:0012099 from HPO Gene-Disease Associations)", "elevated circulating catecholamine level (HP:0003334 from HPO Gene-Disease Associations)", "diaphoresis (with pheochromocytoma) (HP:0001011 from HPO Gene-Disease Associations)", "adrenal pheochromocytoma (HP:0006748 from HPO Gene-Disease Associations)", "rhythm disturbances associated with pheochromocytoma (HP:0001675 from HPO Gene-Disease Associations)", "tachycardia (with pheochromocytoma) (HP:0001673 from HPO Gene-Disease Associations)", "palpitations (with pheochromocytoma) (HP:0001676 from HPO Gene-Disease Associations)", "headache (with pheochromocytoma) (HP:0002331 from HPO Gene-Disease Associations)", "neoplasm of the adrenal medulla (HP:0100642 from HPO Gene-Disease Associations)", "anxiety (with pheochromocytoma) (HP:0000740 from HPO Gene-Disease Associations)", "extraadrenal pheochromocytoma (HP:0006737 from HPO Gene-Disease Associations)", "paraganglioma (HP:0002668 from HPO Gene-Disease Associations)", "paraganglioma of head and neck (HP:0002864 from HPO Gene-Disease Associations)", "paraganglioma-related cranial nerve palsy (HP:0002377 from HPO Gene-Disease Associations)", "pulsatile tinnitus (HP:0008629 from HPO Gene-Disease Associations)", "glomus jugular tumor (HP:0003001 from HPO Gene-Disease Associations)", "pulsatile tinnitus (tympanic paraganglioma) (HP:0000361 from HPO Gene-Disease Associations)", "intestinal carcinoid (HP:0006723 from HPO Gene-Disease Associations)", "vagal paraganglioma (HP:0002886 from HPO Gene-Disease Associations)", "glomus tympanicum paraganglioma (HP:0006715 from HPO Gene-Disease Associations)", "abnormality of urine catecholamine concentration (HP:0011281 from HPO Gene-Disease Associations)", "elevated urinary catecholamines (HP:0011976 from HPO Gene-Disease Associations)", "elevated urinary norepinephrine (HP:0003345 from HPO Gene-Disease Associations)", "positive regitine blocking test (HP:0003574 from HPO Gene-Disease Associations)", "episodic hypertension (HP:0000875 from HPO Gene-Disease Associations)", "hypertensive retinopathy (HP:0001095 from HPO Gene-Disease Associations)", "hypertension associated with pheochromocytoma (HP:0002640 from HPO Gene-Disease Associations)", "abnormality of the renal artery (HP:0008776 from HPO Gene-Disease Associations)", "renal artery stenosis (HP:0001920 from HPO Gene-Disease Associations)", "pheochromocytoma (HP:0002666 from HPO Gene-Disease Associations)", "neuroendocrine neoplasm (HP:0100634 from HPO Gene-Disease Associations)", "cerebral hemorrhage (HP:0001342 from HPO Gene-Disease Associations)", "tinnitus (HP:0000360 from HPO Gene-Disease Associations)", "neurofibromas (HP:0001067 from HPO Gene-Disease Associations)", "neoplasm of the peripheral nervous system (HP:0100007 from HPO Gene-Disease Associations)", "palpitations (HP:0001962 from HPO Gene-Disease Associations)", "laryngeal carcinoma (HP:0012118 from HPO Gene-Disease Associations)", "malignant genitourinary tract tumor (HP:0006758 from HPO Gene-Disease Associations)", "benign gastrointestinal tract tumors (HP:0006719 from HPO Gene-Disease Associations)", "benign genitourinary tract neoplasm (HP:0006778 from HPO Gene-Disease Associations)", "neoplasm of the larynx (HP:0100605 from HPO Gene-Disease Associations)", "salivary gland neoplasm (HP:0100684 from HPO Gene-Disease Associations)", "colonic diverticulosis (HP:0002253 from HPO Gene-Disease Associations)", "agnosia (HP:0010524 from HPO Gene-Disease Associations)", "abnormality of the astrocytes (HP:0100707 from HPO Gene-Disease Associations)", "astrocytoma (HP:0009592 from HPO Gene-Disease Associations)", "glioma (HP:0009733 from HPO Gene-Disease Associations)", "ependymoma (HP:0002888 from HPO Gene-Disease Associations)", "glioblastoma (HP:0100843 from HPO Gene-Disease Associations)", "axillary freckling (HP:0000997 from HPO Gene-Disease Associations)", "neoplasm of striated muscle (HP:0009728 from HPO Gene-Disease Associations)", "rhabdomyosarcoma (HP:0002859 from HPO Gene-Disease Associations)", "medulloblastoma (HP:0002885 from HPO Gene-Disease Associations)", "hypoventilation (HP:0002791 from HPO Gene-Disease Associations)", "ganglioneuroblastoma (HP:0006747 from HPO Gene-Disease Associations)", "ganglioneuroma (HP:0003005 from HPO Gene-Disease Associations)", "malignant neoplasm of the central nervous system (HP:0100836 from HPO Gene-Disease Associations)", "nervous tissue neoplasm (HP:0030060 from HPO Gene-Disease Associations)", "neuroectodermal neoplasm (HP:0030061 from HPO Gene-Disease Associations)", "neuroepithelial neoplasm (HP:0030063 from HPO Gene-Disease Associations)", "neuroblastic tumors (HP:0004376 from HPO Gene-Disease Associations)", "primitive neuroectodermal tumor (HP:0030065 from HPO Gene-Disease Associations)", "peripheral primitive neuroectodermal neoplasm (HP:0030067 from HPO Gene-Disease Associations)", "neuroblastoma (HP:0003006 from HPO Gene-Disease Associations)", "neoplasm of the central nervous system (HP:0100006 from HPO Gene-Disease Associations)", "neoplasm of the nervous system (HP:0004375 from HPO Gene-Disease Associations)", "abdominal pain (HP:0002027 from HPO Gene-Disease Associations)", "gastrointestinal obstruction (HP:0004796 from HPO Gene-Disease Associations)", "intestinal obstruction (HP:0005214 from HPO Gene-Disease Associations)", "functional abnormality of the gastrointestinal tract (HP:0012719 from HPO Gene-Disease Associations)", "abnormality of blood circulation (HP:0011028 from HPO Gene-Disease Associations)", "internal hemorrhage (HP:0011029 from HPO Gene-Disease Associations)", "gastrointestinal hemorrhage (HP:0002239 from HPO Gene-Disease Associations)", "weight loss (HP:0001824 from HPO Gene-Disease Associations)", "ascites (HP:0001541 from HPO Gene-Disease Associations)", "abnormality of the large intestine (HP:0002250 from HPO Gene-Disease Associations)", "abnormality of the rectum (HP:0002034 from HPO Gene-Disease Associations)", "neoplasm of the large intestine (HP:0100834 from HPO Gene-Disease Associations)", "neoplasm of the colon (HP:0100273 from HPO Gene-Disease Associations)", "neoplasm of the rectum (HP:0100743 from HPO Gene-Disease Associations)", "neoplasm of the small intestine (HP:0100833 from HPO Gene-Disease Associations)", "biliary tract neoplasm (HP:0100574 from HPO Gene-Disease Associations)", "abnormal biliary tract morphology (HP:0012440 from HPO Gene-Disease Associations)", "neoplasm of the pancreas (HP:0002894 from HPO Gene-Disease Associations)", "intestinal polyp (HP:0005266 from HPO Gene-Disease Associations)", "intestinal polyposis (HP:0200008 from HPO Gene-Disease Associations)", "neoplasm of the gastrointestinal tract (HP:0007378 from HPO Gene-Disease Associations)", "neoplasm of the stomach (HP:0006753 from HPO Gene-Disease Associations)", "genital neoplasm (HP:0010787 from HPO Gene-Disease Associations)", "gonadal neoplasm (HP:0010785 from HPO Gene-Disease Associations)", "ovarian neoplasm (HP:0100615 from HPO Gene-Disease Associations)", "neoplasm of the genitourinary tract (HP:0007379 from HPO Gene-Disease Associations)", "renal neoplasm (HP:0009726 from HPO Gene-Disease Associations)", "urinary tract neoplasm (HP:0010786 from HPO Gene-Disease Associations)", "sarcoma (HP:0100242 from HPO Gene-Disease Associations)", "neoplasm by histology (HP:0011792 from HPO Gene-Disease Associations)", "gastrointestinal carcinoma (HP:0002672 from HPO Gene-Disease Associations)", "malignant gastrointestinal tract tumors (HP:0006749 from HPO Gene-Disease Associations)", "hereditary nonpolyposis colorectal carcinoma (HP:0006716 from HPO Gene-Disease Associations)", "uterine neoplasm (HP:0010784 from HPO Gene-Disease Associations)", "bladder carcinoma (HP:0002862 from HPO Gene-Disease Associations)", "bladder neoplasm (HP:0009725 from HPO Gene-Disease Associations)", "transitional cell carcinoma of the bladder (HP:0006740 from HPO Gene-Disease Associations)", "leiomyosarcoma (HP:0100243 from HPO Gene-Disease Associations)", "uterine leiomyosarcoma (HP:0002891 from HPO Gene-Disease Associations)", "renal cell carcinoma (HP:0005584 from HPO Gene-Disease Associations)", "abnormality of the uterus (HP:0000130 from HPO Gene-Disease Associations)", "hamartoma (HP:0010566 from HPO Gene-Disease Associations)", "lymphangioma (HP:0100764 from HPO Gene-Disease Associations)", "hemangioma (HP:0001028 from HPO Gene-Disease Associations)", "vascular neoplasm (HP:0100742 from HPO Gene-Disease Associations)", "cavernous hemangioma (HP:0001048 from HPO Gene-Disease Associations)", "hemangiomatosis (HP:0007461 from HPO Gene-Disease Associations)", "visceral angiomatosis (HP:0100761 from HPO Gene-Disease Associations)", "conjunctival hamartoma (HP:0100780 from HPO Gene-Disease Associations)", "hamartoma of the eye (HP:0010568 from HPO Gene-Disease Associations)", "adenoma sebaceum (HP:0009720 from HPO Gene-Disease Associations)", "angiofibromas (HP:0010615 from HPO Gene-Disease Associations)", "fibroma (HP:0010614 from HPO Gene-Disease Associations)", "fibrous tissue neoplasm (HP:0012316 from HPO Gene-Disease Associations)", "benign neoplasm of the central nervous system (HP:0100835 from HPO Gene-Disease Associations)", "meningioma (HP:0002858 from HPO Gene-Disease Associations)", "bone cyst (HP:0012062 from HPO Gene-Disease Associations)", "abnormality of intracranial pressure (HP:0012640 from HPO Gene-Disease Associations)", "increased intracranial pressure (HP:0002516 from HPO Gene-Disease Associations)", "melanocytic nevus (HP:0000995 from HPO Gene-Disease Associations)", "nevus (HP:0003764 from HPO Gene-Disease Associations)", "papilloma (HP:0012740 from HPO Gene-Disease Associations)", "verrucae (HP:0200043 from HPO Gene-Disease Associations)", "neoplasm (HP:0002664 from HPO Gene-Disease Associations)", "neoplasm by anatomical site (HP:0011793 from HPO Gene-Disease Associations)", "neoplasm of the skin (HP:0008069 from HPO Gene-Disease Associations)", "abnormality of skin pigmentation (HP:0001000 from HPO Gene-Disease Associations)", "hypopigmentation of the skin (HP:0001010 from HPO Gene-Disease Associations)", "hypopigmented skin patches (HP:0001053 from HPO Gene-Disease Associations)", "hypermelanotic macule (HP:0001034 from HPO Gene-Disease Associations)", "macule (HP:0012733 from HPO Gene-Disease Associations)", "hyperpigmentation of the skin (HP:0000953 from HPO Gene-Disease Associations)", "irregular hyperpigmentation (HP:0007400 from HPO Gene-Disease Associations)", "sporadic (HP:0003745 from HPO Gene-Disease Associations)", "neoplasia of the pleura (HP:0100527 from HPO Gene-Disease Associations)", "pleuropulmonary blastoma (HP:0100528 from HPO Gene-Disease Associations)", "euthyroid multinodular goiter (HP:0000866 from HPO Gene-Disease Associations)", "familial predisposition (HP:0001472 from HPO Gene-Disease Associations)", "euthyroid goiter (HP:0009798 from HPO Gene-Disease Associations)", "neoplasm of the endocrine system (HP:0100568 from HPO Gene-Disease Associations)", "neoplasm of the thyroid gland (HP:0100031 from HPO Gene-Disease Associations)", "thyroid carcinoma (HP:0002890 from HPO Gene-Disease Associations)", "papillary thyroid carcinoma (HP:0002895 from HPO Gene-Disease Associations)", "renal angiomyolipoma (HP:0006772 from HPO Gene-Disease Associations)", "renal hamartoma (HP:0008696 from HPO Gene-Disease Associations)", "subependymal nodules (HP:0009716 from HPO Gene-Disease Associations)", "cortical tubers (HP:0009717 from HPO Gene-Disease Associations)", "neoplasm of the nail (HP:0100826 from HPO Gene-Disease Associations)", "ungual fibroma (HP:0100804 from HPO Gene-Disease Associations)", "chordoma (HP:0010762 from HPO Gene-Disease Associations)", "subungual fibromas (HP:0009724 from HPO Gene-Disease Associations)", "achromatic retinal patches (HP:0009727 from HPO Gene-Disease Associations)", "connective tissue nevi (HP:0100898 from HPO Gene-Disease Associations)", "shagreen patch (HP:0009721 from HPO Gene-Disease Associations)", "optic glioma (HP:0009734 from HPO Gene-Disease Associations)", "infantile spasms (HP:0012469 from HPO Gene-Disease Associations)", "retinal hamartoma (HP:0009594 from HPO Gene-Disease Associations)", "macrodactyly (HP:0004099 from HPO Gene-Disease Associations)", "macrodactyly of finger (HP:0100746 from HPO Gene-Disease Associations)", "gingival fibromatosis (HP:0000169 from HPO Gene-Disease Associations)", "epileptic spasms (HP:0011097 from HPO Gene-Disease Associations)", "ventricular preexcitation (HP:0004309 from HPO Gene-Disease Associations)", "wolff-parkinson-white syndrome (HP:0001716 from HPO Gene-Disease Associations)", "focal white matter lesions (HP:0007042 from HPO Gene-Disease Associations)", "projection of scalp hair onto lateral cheek (HP:0009554 from HPO Gene-Disease Associations)", "dental enamel pits (HP:0009722 from HPO Gene-Disease Associations)", "skin nodule (HP:0200036 from HPO Gene-Disease Associations)", "subcutaneous nodule (HP:0001482 from HPO Gene-Disease Associations)", "alveolar cell carcinoma (HP:0006519 from HPO Gene-Disease Associations)", "neoplasm of the tracheobronchial system (HP:0100552 from HPO Gene-Disease Associations)", "neoplasm of the lung (HP:0100526 from HPO Gene-Disease Associations)", "neoplasm of the respiratory system (HP:0100606 from HPO Gene-Disease Associations)", "stomach cancer (HP:0012126 from HPO Gene-Disease Associations)", "glioblastoma multiforme (HP:0012174 from HPO Gene-Disease Associations)", "embryonal rhabdomyosarcoma (HP:0006743 from HPO Gene-Disease Associations)", "lung adenocarcinoma (HP:0030078 from HPO Gene-Disease Associations)", "neoplasm of the eye (HP:0100012 from HPO Gene-Disease Associations)", "retinal neoplasm (HP:0012777 from HPO Gene-Disease Associations)", "retinoblastoma (HP:0009919 from HPO Gene-Disease Associations)", "osteosarcoma (HP:0002669 from HPO Gene-Disease Associations)", "ewing's sarcoma (HP:0012254 from HPO Gene-Disease Associations)", "diastasis recti (HP:0001540 from HPO Gene-Disease Associations)", "hepatoblastoma (HP:0002884 from HPO Gene-Disease Associations)", "pancreatic hyperplasia (HP:0006277 from HPO Gene-Disease Associations)", "adrenocortical cytomegaly (HP:0008186 from HPO Gene-Disease Associations)", "overgrowth of external genitalia (HP:0003247 from HPO Gene-Disease Associations)", "adrenocortical carcinoma (HP:0006744 from HPO Gene-Disease Associations)", "gonadoblastoma (HP:0000150 from HPO Gene-Disease Associations)", "hemihypertrophy (HP:0001528 from HPO Gene-Disease Associations)", "neonatal hypoglycemia (HP:0001998 from HPO Gene-Disease Associations)", "neoplasm of the adrenal cortex (HP:0100641 from HPO Gene-Disease Associations)", "neoplasm of the adrenal gland (HP:0100631 from HPO Gene-Disease Associations)", "overgrowth (HP:0001548 from HPO Gene-Disease Associations)", "enlarged kidneys (HP:0000105 from HPO Gene-Disease Associations)", "embryonal neoplasm (HP:0002898 from HPO Gene-Disease Associations)", "embryonal renal neoplasm (HP:0011794 from HPO Gene-Disease Associations)", "nephroblastoma (wilms tumor) (HP:0002667 from HPO Gene-Disease Associations)", "abnormal shape of the occiput (HP:0011217 from HPO Gene-Disease Associations)", "prominent occiput (HP:0000269 from HPO Gene-Disease Associations)", "abnormality of adrenal morphology (HP:0011732 from HPO Gene-Disease Associations)", "adrenal hypoplasia (HP:0000835 from HPO Gene-Disease Associations)", "adrenal medullary hypoplasia (HP:0008239 from HPO Gene-Disease Associations)", "large intestinal polyposis (HP:0030255 from HPO Gene-Disease Associations)", "adenomatous colonic polyposis (HP:0005227 from HPO Gene-Disease Associations)", "juvenile colonic polyposis (HP:0012198 from HPO Gene-Disease Associations)", "hyperplastic colonic polyposis (HP:0012183 from HPO Gene-Disease Associations)", "colon cancer (HP:0003003 from HPO Gene-Disease Associations)", "duodenal carcinoma (HP:0006771 from HPO Gene-Disease Associations)", "multiple gastric polyps (HP:0004394 from HPO Gene-Disease Associations)", "duodenal polyposis (HP:0004783 from HPO Gene-Disease Associations)", "desmoid tumors (HP:0100245 from HPO Gene-Disease Associations)", "fibroma of the breast (HP:0010619 from HPO Gene-Disease Associations)", "odontoma (HP:0011068 from HPO Gene-Disease Associations)", "congenital hypertrophy of retinal pigment epithelium (HP:0007649 from HPO Gene-Disease Associations)", "small intestinal polyposis (HP:0030256 from HPO Gene-Disease Associations)", "small intestine carcinoid (HP:0006722 from HPO Gene-Disease Associations)", "keloids (HP:0010562 from HPO Gene-Disease Associations)", "fibrosarcoma (HP:0100244 from HPO Gene-Disease Associations)", "carcinoid (HP:0100570 from HPO Gene-Disease Associations)", "adrenocortical adenoma (HP:0008256 from HPO Gene-Disease Associations)", "hepatocellular carcinoma (HP:0001402 from HPO Gene-Disease Associations)", "neoplasm of the liver (HP:0002896 from HPO Gene-Disease Associations)", "hepatitis (HP:0012115 from HPO Gene-Disease Associations)", "subacute progressive viral hepatitis (HP:0006572 from HPO Gene-Disease Associations)", "viral hepatitis (HP:0006562 from HPO Gene-Disease Associations)", "micronodular cirrhosis (HP:0001413 from HPO Gene-Disease Associations)", "somatic mutation (HP:0001428 from HPO Gene-Disease Associations)", "tenesmus (HP:0012702 from HPO Gene-Disease Associations)", "left ventricular septal hypertrophy (HP:0005144 from HPO Gene-Disease Associations)", "juvenile gastrointestinal polyposis (HP:0004784 from HPO Gene-Disease Associations)", "enlarged vertebral pedicles (HP:0004621 from HPO Gene-Disease Associations)", "stiff skin (HP:0030053 from HPO Gene-Disease Associations)", "abnormal vertebral pedicle morphology (HP:0030277 from HPO Gene-Disease Associations)", "generalized muscle hypertrophy (HP:0003720 from HPO Gene-Disease Associations)", "intussusception (HP:0002576 from HPO Gene-Disease Associations)", "hematochezia (HP:0002573 from HPO Gene-Disease Associations)", "rectal prolapse (HP:0002035 from HPO Gene-Disease Associations)", "brain abscess (HP:0030049 from HPO Gene-Disease Associations)", "spinal arteriovenous malformation (HP:0002390 from HPO Gene-Disease Associations)", "gastrointestinal telangiectasia (HP:0002604 from HPO Gene-Disease Associations)", "gastrointestinal arteriovenous malformation (HP:0002629 from HPO Gene-Disease Associations)", "nasal mucosa telangiectasia (HP:0000434 from HPO Gene-Disease Associations)", "fingerpad telangiectases (HP:0006107 from HPO Gene-Disease Associations)", "tongue telangiectasia (HP:0000227 from HPO Gene-Disease Associations)", "palate telangiectasia (HP:0002707 from HPO Gene-Disease Associations)", "nail bed telangiectasia (HP:0001232 from HPO Gene-Disease Associations)", "spontaneous, recurrent epistaxis (HP:0004406 from HPO Gene-Disease Associations)", "abnormality of the subarachnoid space (HP:0012703 from HPO Gene-Disease Associations)", "subarachnoid hemorrhage (HP:0002138 from HPO Gene-Disease Associations)", "hematemesis (HP:0002248 from HPO Gene-Disease Associations)", "melena (HP:0002249 from HPO Gene-Disease Associations)", "pulmonary arteriovenous malformation (HP:0006548 from HPO Gene-Disease Associations)", "cerebral arteriovenous malformation (HP:0002408 from HPO Gene-Disease Associations)", "hepatic arteriovenous malformation (HP:0006574 from HPO Gene-Disease Associations)", "cardiac shunt (HP:0001693 from HPO Gene-Disease Associations)", "right-to-left shunt (HP:0001694 from HPO Gene-Disease Associations)", "abnormality of gastrointestinal vasculature (HP:0004296 from HPO Gene-Disease Associations)", "gastrointestinal angiodysplasia (HP:0000471 from HPO Gene-Disease Associations)", "arteriovenous fistulas of celiac and mesenteric vessels (HP:0002642 from HPO Gene-Disease Associations)", "venous varicosities of celiac and mesenteric vessels (HP:0002626 from HPO Gene-Disease Associations)", "aneurysm of an abdominal artery (HP:0002636 from HPO Gene-Disease Associations)", "mesenteric artery aneurysm (HP:0011934 from HPO Gene-Disease Associations)", "celiac artery aneurysm (HP:0100858 from HPO Gene-Disease Associations)", "high-output congestive heart failure (HP:0001722 from HPO Gene-Disease Associations)", "transient ischemic attack (HP:0002326 from HPO Gene-Disease Associations)", "lip telangiectasia (HP:0000214 from HPO Gene-Disease Associations)", "oral cavity teleangiectasia (HP:0000228 from HPO Gene-Disease Associations)", "ischemic stroke (HP:0002140 from HPO Gene-Disease Associations)", "arteriovenous fistula (HP:0004947 from HPO Gene-Disease Associations)", "peripheral arteriovenous fistula (HP:0100784 from HPO Gene-Disease Associations)", "telangiectasia (HP:0001009 from HPO Gene-Disease Associations)", "teleangiectasia of the skin (HP:0100585 from HPO Gene-Disease Associations)", "mucosal telangiectasiae (HP:0100579 from HPO Gene-Disease Associations)", "abnormality of the vasculature of the conjunctiva (HP:0008054 from HPO Gene-Disease Associations)", "conjunctival telangiectasia (HP:0000524 from HPO Gene-Disease Associations)", "stroke (HP:0001297 from HPO Gene-Disease Associations)", "intracranial hemorrhage (HP:0002170 from HPO Gene-Disease Associations)", "subcortical dementia (HP:0007123 from HPO Gene-Disease Associations)", "nonarteritic anterior ischemic optic neuropathy (HP:0007634 from HPO Gene-Disease Associations)", "recurrent subcortical infarcts (HP:0007236 from HPO Gene-Disease Associations)", "optic neuropathy (HP:0001138 from HPO Gene-Disease Associations)", "venous abnormality (HP:0002624 from HPO Gene-Disease Associations)", "venous insufficiency (HP:0005293 from HPO Gene-Disease Associations)", "varicose veins (HP:0002619 from HPO Gene-Disease Associations)", "vocal cord paresis (HP:0001604 from HPO Gene-Disease Associations)", "diffuse palmoplantar hyperkeratosis (HP:0007447 from HPO Gene-Disease Associations)", "barrett esophagus (HP:0100580 from HPO Gene-Disease Associations)", "esophageal carcinoma (HP:0011459 from HPO Gene-Disease Associations)", "esophageal neoplasm (HP:0100751 from HPO Gene-Disease Associations)", "neoplasm of head and neck (HP:0012288 from HPO Gene-Disease Associations)", "uterine leiomyoma (HP:0000131 from HPO Gene-Disease Associations)", "decreased fumarate hydratase activity (HP:0003536 from HPO Gene-Disease Associations)", "open operculum (HP:0100954 from HPO Gene-Disease Associations)", "cutaneous leiomyosarcoma (HP:0006755 from HPO Gene-Disease Associations)", "cutaneous leiomyoma (HP:0007620 from HPO Gene-Disease Associations)", "multiple cutaneous leiomyomas (HP:0007437 from HPO Gene-Disease Associations)", "abnormality of the choroid plexus (HP:0007376 from HPO Gene-Disease Associations)", "choroid plexus cyst (HP:0002190 from HPO Gene-Disease Associations)", "extramedullary hematopoiesis (HP:0001978 from HPO Gene-Disease Associations)", "laryngeal calcification (HP:0008754 from HPO Gene-Disease Associations)", "hepatic calcification (HP:0006559 from HPO Gene-Disease Associations)", "patchy variation in bone mineral density (HP:0010659 from HPO Gene-Disease Associations)", "severe hydrops fetalis (HP:0005099 from HPO Gene-Disease Associations)", "short diaphyses (HP:0000941 from HPO Gene-Disease Associations)", "anterior rib punctate calcifications (HP:0006619 from HPO Gene-Disease Associations)", "calcification of ribs (HP:0040059 from HPO Gene-Disease Associations)", "sternal punctate calcifications (HP:0006637 from HPO Gene-Disease Associations)", "abnormality of the vertebral spinous processes (HP:0008516 from HPO Gene-Disease Associations)", "sclerodactyly (HP:0011838 from HPO Gene-Disease Associations)", "palmar telangiectasia (HP:0100869 from HPO Gene-Disease Associations)", "supernumerary vertebral ossification centers (HP:0004598 from HPO Gene-Disease Associations)", "tracheal calcification (HP:0002787 from HPO Gene-Disease Associations)", "punctate vertebral calcifications (HP:0008420 from HPO Gene-Disease Associations)", "diaphyseal thickening (HP:0005019 from HPO Gene-Disease Associations)", "biliary cirrhosis (HP:0002613 from HPO Gene-Disease Associations)", "ureteral atresia (HP:0005999 from HPO Gene-Disease Associations)", "congenital symmetrical palmoplantar keratosis (HP:0007553 from HPO Gene-Disease Associations)", "lichenification (HP:0100725 from HPO Gene-Disease Associations)", "ectopic ossification (HP:0011986 from HPO Gene-Disease Associations)", "ectopic ossification in tendon tissue (HP:0011988 from HPO Gene-Disease Associations)", "ectopic ossification in ligament tissue (HP:0011989 from HPO Gene-Disease Associations)", "small cervical vertebral bodies (HP:0004629 from HPO Gene-Disease Associations)", "progressive cervical vertebral spine fusion (HP:0008449 from HPO Gene-Disease Associations)", "ectopic ossification in muscle tissue (HP:0011987 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the vertebrae (HP:0008515 from HPO Gene-Disease Associations)", "vertebral hypoplasia (HP:0008417 from HPO Gene-Disease Associations)", "hypoplastic vertebral bodies (HP:0008479 from HPO Gene-Disease Associations)", "fragmented epiphyses (HP:0100168 from HPO Gene-Disease Associations)", "fragmented, irregular epiphyses (HP:0005063 from HPO Gene-Disease Associations)", "spatulate ribs (HP:0012307 from HPO Gene-Disease Associations)", "ulnar deviation of the hand (HP:0009487 from HPO Gene-Disease Associations)", "degenerative joint disease (HP:0001379 from HPO Gene-Disease Associations)", "flattened femoral head (HP:0008812 from HPO Gene-Disease Associations)", "broad femoral neck (HP:0006429 from HPO Gene-Disease Associations)", "large basal ganglia (HP:0007048 from HPO Gene-Disease Associations)", "hypoplasia of proximal fibula (HP:0006442 from HPO Gene-Disease Associations)", "hypoplasia of proximal radius (HP:0006434 from HPO Gene-Disease Associations)", "small anterior fontanelle (HP:0000237 from HPO Gene-Disease Associations)", "missing ribs (HP:0000921 from HPO Gene-Disease Associations)", "11 pairs of ribs (HP:0000878 from HPO Gene-Disease Associations)", "large eyes (HP:0001090 from HPO Gene-Disease Associations)", "absent knee epiphyses (HP:0006400 from HPO Gene-Disease Associations)", "bowed humerus (HP:0003865 from HPO Gene-Disease Associations)", "cleft vertebral arch (HP:0004616 from HPO Gene-Disease Associations)", "enlarged metaphyses (HP:0003051 from HPO Gene-Disease Associations)", "long clavicles (HP:0000890 from HPO Gene-Disease Associations)", "abnormality of the lymphatic vessels (HP:0100766 from HPO Gene-Disease Associations)", "hypoplasia of lymphatic vessels (HP:0003759 from HPO Gene-Disease Associations)", "hyperkeratosis over edematous areas (HP:0007448 from HPO Gene-Disease Associations)", "hydrocele testis (HP:0000034 from HPO Gene-Disease Associations)", "predominantly lower limb lymphedema (HP:0003550 from HPO Gene-Disease Associations)", "hydrops fetalis (HP:0001789 from HPO Gene-Disease Associations)", "nonimmune hydrops fetalis (HP:0001790 from HPO Gene-Disease Associations)", "cartilaginous ossification of larynx (HP:0008747 from HPO Gene-Disease Associations)", "premature fusion of phalangeal epiphyses (HP:0006140 from HPO Gene-Disease Associations)", "cartilaginous ossification of nose (HP:0005275 from HPO Gene-Disease Associations)", "costal cartilage calcification (HP:0006646 from HPO Gene-Disease Associations)", "calcification of cartilage (HP:0100593 from HPO Gene-Disease Associations)", "calcification of the auricular cartilage (HP:0005103 from HPO Gene-Disease Associations)", "abnormal rib ossification (HP:0012306 from HPO Gene-Disease Associations)", "abnormal delivery (HP:0001787 from HPO Gene-Disease Associations)", "spontaneous abortion (HP:0005268 from HPO Gene-Disease Associations)", "recurrent spontaneous abortion (HP:0200067 from HPO Gene-Disease Associations)", "laryngotracheal stenosis (HP:0004894 from HPO Gene-Disease Associations)", "glabellar hemangioma (HP:0001076 from HPO Gene-Disease Associations)", "dumbbell-shaped femur (HP:0006375 from HPO Gene-Disease Associations)", "cystic lesions of the pinnae (HP:0010723 from HPO Gene-Disease Associations)", "hypertrophic auricular cartilage (HP:0008608 from HPO Gene-Disease Associations)", "hypoplasia of the femoral head (HP:0008802 from HPO Gene-Disease Associations)", "hitchhiker thumb (HP:0001234 from HPO Gene-Disease Associations)", "horizontal sacrum (HP:0003440 from HPO Gene-Disease Associations)", "cervical kyphosis (HP:0002947 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the cervical spine (HP:0011041 from HPO Gene-Disease Associations)", "hypoplastic cervical vertebrae (HP:0008434 from HPO Gene-Disease Associations)", "coronal cleft vertebrae (HP:0003417 from HPO Gene-Disease Associations)", "vertebral clefting (HP:0008428 from HPO Gene-Disease Associations)", "spatulate thumbs (HP:0001222 from HPO Gene-Disease Associations)", "talipes equinovalgus (HP:0001772 from HPO Gene-Disease Associations)", "dislocated wrist (HP:0003994 from HPO Gene-Disease Associations)", "distal tapering femur (HP:0006408 from HPO Gene-Disease Associations)", "tombstone-shaped proximal phalanges (HP:0006060 from HPO Gene-Disease Associations)", "thoracic platyspondyly (HP:0004592 from HPO Gene-Disease Associations)", "cervical segmentation defect (HP:0004632 from HPO Gene-Disease Associations)", "c2-c3 subluxation (HP:0008456 from HPO Gene-Disease Associations)", "rarefaction of retinal pigmentation (HP:0007961 from HPO Gene-Disease Associations)", "hypoplastic nasal septum (HP:0005104 from HPO Gene-Disease Associations)", "bipartite calcaneus (HP:0008127 from HPO Gene-Disease Associations)", "accessory carpal bones (HP:0004232 from HPO Gene-Disease Associations)", "hypoplastic iliac body (HP:0008824 from HPO Gene-Disease Associations)", "block vertebrae (HP:0003305 from HPO Gene-Disease Associations)", "broad face (HP:0000283 from HPO Gene-Disease Associations)", "sandal gap (HP:0001852 from HPO Gene-Disease Associations)", "generalized bone demineralization (HP:0006462 from HPO Gene-Disease Associations)", "fixed elbow flexion (HP:0006471 from HPO Gene-Disease Associations)", "tricuspid stenosis (HP:0010446 from HPO Gene-Disease Associations)", "multiple carpal ossification centers (HP:0006067 from HPO Gene-Disease Associations)", "knee dislocation (HP:0004976 from HPO Gene-Disease Associations)", "bronchomalacia (HP:0002780 from HPO Gene-Disease Associations)", "tracheomalacia (HP:0002779 from HPO Gene-Disease Associations)", "tracheobronchomalacia (HP:0002786 from HPO Gene-Disease Associations)", "shortening of all phalanges of the toes (HP:0005035 from HPO Gene-Disease Associations)", "shortening of all phalanges of fingers (HP:0011910 from HPO Gene-Disease Associations)", "anterior tibial bowing (HP:0006390 from HPO Gene-Disease Associations)", "poorly ossified cervical vertebrae (HP:0008477 from HPO Gene-Disease Associations)", "poorly ossified vertebrae (HP:0100856 from HPO Gene-Disease Associations)", "abnormal sternal ossification (HP:0011863 from HPO Gene-Disease Associations)", "absent sternal ossification (HP:0006628 from HPO Gene-Disease Associations)", "urogenital sinus anomaly (HP:0100779 from HPO Gene-Disease Associations)", "absence of secondary sex characteristics (HP:0008187 from HPO Gene-Disease Associations)", "y-linked inheritance (HP:0001450 from HPO Gene-Disease Associations)", "abnormal sex determination (HP:0012244 from HPO Gene-Disease Associations)", "sex reversal (HP:0012245 from HPO Gene-Disease Associations)", "adrenocorticotropic hormone excess (HP:0011749 from HPO Gene-Disease Associations)", "lung segmentation defects (HP:0006525 from HPO Gene-Disease Associations)", "duplication of renal pelvis (HP:0005580 from HPO Gene-Disease Associations)", "two carpal ossification centers present at birth (HP:0006176 from HPO Gene-Disease Associations)", "six lumbar vertebrae (HP:0008416 from HPO Gene-Disease Associations)", "submucous cleft lip (HP:0009101 from HPO Gene-Disease Associations)", "broad secondary alveolar ridge (HP:0000216 from HPO Gene-Disease Associations)", "abnormality of the sacroiliac joint (HP:0100781 from HPO Gene-Disease Associations)", "abnormality of the sacroiliac notch (HP:0030266 from HPO Gene-Disease Associations)", "short sacroiliac notch (HP:0003185 from HPO Gene-Disease Associations)", "narrow sacroiliac notch (HP:0008803 from HPO Gene-Disease Associations)", "midgut malrotation (HP:0005211 from HPO Gene-Disease Associations)", "abnormal number of vertebrae (HP:0030304 from HPO Gene-Disease Associations)", "supernumerary vertebrae (HP:0002946 from HPO Gene-Disease Associations)", "squared iliac bones (HP:0003177 from HPO Gene-Disease Associations)", "failure of eruption of permanent teeth (HP:0006352 from HPO Gene-Disease Associations)", "prominent supraorbital arches in adult (HP:0004676 from HPO Gene-Disease Associations)", "generalized osteosclerosis (HP:0005789 from HPO Gene-Disease Associations)", "irregular ossification at anterior rib ends (HP:0006598 from HPO Gene-Disease Associations)", "myocardial necrosis (HP:0001700 from HPO Gene-Disease Associations)", "metaphyseal chondrodysplasia (HP:0005871 from HPO Gene-Disease Associations)", "metaphyseal dysplasia (HP:0100255 from HPO Gene-Disease Associations)", "hyperechogenic pancreas (HP:0006276 from HPO Gene-Disease Associations)", "delayed peripheral myelination (HP:0011401 from HPO Gene-Disease Associations)", "mesomelic|rhizomelic limb shortening (HP:0005026 from HPO Gene-Disease Associations)", "thick hair (HP:0100874 from HPO Gene-Disease Associations)", "deep plantar creases (HP:0001869 from HPO Gene-Disease Associations)", "congenital foot contractures (HP:0005745 from HPO Gene-Disease Associations)", "u-shaped upper lip vermilion (HP:0010806 from HPO Gene-Disease Associations)", "abnormality of the alveolar ridges (HP:0006477 from HPO Gene-Disease Associations)", "broad alveolar ridges (HP:0000187 from HPO Gene-Disease Associations)", "tongue nodules (HP:0000199 from HPO Gene-Disease Associations)", "lobulated tongue (HP:0000180 from HPO Gene-Disease Associations)", "fused sternal ossification centers (HP:0006643 from HPO Gene-Disease Associations)", "thick anterior alveolar ridges (HP:0009100 from HPO Gene-Disease Associations)", "accessory oral frenulum (HP:0000191 from HPO Gene-Disease Associations)", "trigonocephaly (HP:0000243 from HPO Gene-Disease Associations)", "fingernail dysplasia (HP:0100798 from HPO Gene-Disease Associations)", "granular osmiophilic deposits (grod) in cells (HP:0003657 from HPO Gene-Disease Associations)", "auditory hallucinations (HP:0008765 from HPO Gene-Disease Associations)", "fingerprint intracellular accumulation of autofluorescent lipopigment storage material (HP:0003208 from HPO Gene-Disease Associations)", "rectilinear intracellular accumulation of autofluorescent lipopigment storage material (HP:0003226 from HPO Gene-Disease Associations)", "curvilinear intracellular accumulation of autofluorescent lipopigment storage material (HP:0003205 from HPO Gene-Disease Associations)", "intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204 from HPO Gene-Disease Associations)", "increased cerebral lipofuscin (HP:0011813 from HPO Gene-Disease Associations)", "increased neuronal autofluorescent lipopigment (HP:0002074 from HPO Gene-Disease Associations)", "motor deterioration (HP:0002333 from HPO Gene-Disease Associations)", "progressive visual loss (HP:0000529 from HPO Gene-Disease Associations)", "visual loss (HP:0000572 from HPO Gene-Disease Associations)", "increased extraneuronal autofluorescent lipopigment (HP:0003463 from HPO Gene-Disease Associations)", "hypermetric saccades (HP:0007338 from HPO Gene-Disease Associations)", "abolished electroretinogram (erg) (HP:0000550 from HPO Gene-Disease Associations)", "abnormality of threonine metabolism (HP:0010900 from HPO Gene-Disease Associations)", "hyperthreoninemia (HP:0003354 from HPO Gene-Disease Associations)", "hyperthreoninuria (HP:0003296 from HPO Gene-Disease Associations)", "eye poking (HP:0001483 from HPO Gene-Disease Associations)", "fundus atrophy (HP:0001099 from HPO Gene-Disease Associations)", "decreased electroretinogram (erg) amplitude (HP:0000654 from HPO Gene-Disease Associations)", "abnormal glucose homeostasis (HP:0011014 from HPO Gene-Disease Associations)", "abnormality of carbohydrate metabolism|homeostasis (HP:0011013 from HPO Gene-Disease Associations)", "diabetes mellitus (HP:0000819 from HPO Gene-Disease Associations)", "abnormality of the endocrine system (HP:0000818 from HPO Gene-Disease Associations)", "type ii diabetes mellitus (HP:0005978 from HPO Gene-Disease Associations)", "abnormality of circulating hormone level (HP:0003117 from HPO Gene-Disease Associations)", "hyperinsulinemia (HP:0000842 from HPO Gene-Disease Associations)", "atypical scarring of skin (HP:0000987 from HPO Gene-Disease Associations)", "scarring (HP:0100699 from HPO Gene-Disease Associations)", "abnormality of corneal thickness (HP:0011486 from HPO Gene-Disease Associations)", "decreased corneal thickness (HP:0100689 from HPO Gene-Disease Associations)", "photophobia (HP:0000613 from HPO Gene-Disease Associations)", "abnormality of the choroid (HP:0000610 from HPO Gene-Disease Associations)", "chorioretinal abnormality (HP:0000532 from HPO Gene-Disease Associations)", "abnormality of the retinal vasculature (HP:0008046 from HPO Gene-Disease Associations)", "abnormality of the vasculature of the eye (HP:0008047 from HPO Gene-Disease Associations)", "conductive hearing impairment (HP:0000405 from HPO Gene-Disease Associations)", "functional abnormality of the middle ear (HP:0011452 from HPO Gene-Disease Associations)", "abnormal electroretinogram (HP:0000512 from HPO Gene-Disease Associations)", "abnormal retinal pigmentation (HP:0007703 from HPO Gene-Disease Associations)", "abnormality of the retinal pigment epithelium (HP:0008051 from HPO Gene-Disease Associations)", "night blindness (HP:0000662 from HPO Gene-Disease Associations)", "retinitis pigmentosa (HP:0000510 from HPO Gene-Disease Associations)", "visual field defect (HP:0001123 from HPO Gene-Disease Associations)", "constricted visual fields (HP:0001133 from HPO Gene-Disease Associations)", "abnormal rod and cone electroretinograms (HP:0008323 from HPO Gene-Disease Associations)", "absent rod-and cone-mediated responses on erg (HP:0007688 from HPO Gene-Disease Associations)", "attenuation of retinal blood vessels (HP:0007843 from HPO Gene-Disease Associations)", "bony spicule pigmentary retinopathy (HP:0007737 from HPO Gene-Disease Associations)", "pigmentary retinopathy (HP:0000580 from HPO Gene-Disease Associations)", "pigmented paravenous chorioretinal atrophy (HP:0007903 from HPO Gene-Disease Associations)", "high-grade hypermetropia (HP:0008499 from HPO Gene-Disease Associations)", "pendular nystagmus (HP:0012043 from HPO Gene-Disease Associations)", "increased corneal curvature (HP:0100692 from HPO Gene-Disease Associations)", "keratoconus (HP:0000563 from HPO Gene-Disease Associations)", "noninflammatory macular atrophy (HP:0007401 from HPO Gene-Disease Associations)", "macular retinal pigment epithelial mottling (HP:0007793 from HPO Gene-Disease Associations)", "progressive central visual loss (HP:0008008 from HPO Gene-Disease Associations)", "decreased central vision (HP:0007663 from HPO Gene-Disease Associations)", "abnormality of the macula (HP:0001103 from HPO Gene-Disease Associations)", "macular degeneration (HP:0000608 from HPO Gene-Disease Associations)", "macular dystrophy (HP:0007754 from HPO Gene-Disease Associations)", "macular flecks (HP:0011507 from HPO Gene-Disease Associations)", "arachnoid hemangiomatosis (HP:0012222 from HPO Gene-Disease Associations)", "choroidal hemangiomata (HP:0007872 from HPO Gene-Disease Associations)", "choroideremia (HP:0001139 from HPO Gene-Disease Associations)", "abnormality of retinal arteries (HP:0000630 from HPO Gene-Disease Associations)", "retinal arteriolar constriction (HP:0008043 from HPO Gene-Disease Associations)", "progressive visual field defects (HP:0007987 from HPO Gene-Disease Associations)", "retinal arteriolar occlusion (HP:0007985 from HPO Gene-Disease Associations)", "chorioretinal hypopigmentation or hyperpigmentation (HP:0007661 from HPO Gene-Disease Associations)", "cystoid macular degeneration (HP:0008028 from HPO Gene-Disease Associations)", "vitelliform maculopathy (HP:0007677 from HPO Gene-Disease Associations)", "reticular retinal dystrophy (HP:0007913 from HPO Gene-Disease Associations)", "macroreticular retinal dystrophy (HP:0007963 from HPO Gene-Disease Associations)", "adult-onset night blindness (HP:0007830 from HPO Gene-Disease Associations)", "peripheral visual field loss (HP:0007994 from HPO Gene-Disease Associations)", "retinal flecks (HP:0012045 from HPO Gene-Disease Associations)", "depigmented lesions of the retinal pigment epithelium (HP:0008017 from HPO Gene-Disease Associations)", "choroidoretinal degeneration (HP:0200065 from HPO Gene-Disease Associations)", "choroidal degeneration (HP:0007945 from HPO Gene-Disease Associations)", "poliosis (HP:0002290 from HPO Gene-Disease Associations)", "microdontia of primary teeth (HP:0006347 from HPO Gene-Disease Associations)", "abnormality of macular pigmentation (HP:0008002 from HPO Gene-Disease Associations)", "bull's eye maculopathy (HP:0011504 from HPO Gene-Disease Associations)", "retinitis pigmentosa inversa (HP:0008035 from HPO Gene-Disease Associations)", "absent retinal pigment epithelium (HP:0007980 from HPO Gene-Disease Associations)", "foveal hyperpigmentation (HP:0008001 from HPO Gene-Disease Associations)", "central scotoma (HP:0000603 from HPO Gene-Disease Associations)", "scotoma (HP:0000575 from HPO Gene-Disease Associations)", "abnormal cone-mediated electroretinogram (HP:0008275 from HPO Gene-Disease Associations)", "reduced amplitude of pattern visual evoked potentials (HP:0000650 from HPO Gene-Disease Associations)", "centrocecal scotoma (HP:0000576 from HPO Gene-Disease Associations)", "dyschromatopsia (HP:0007641 from HPO Gene-Disease Associations)", "red-green dyschromatopsia (HP:0000642 from HPO Gene-Disease Associations)", "anomalous trichromacy (HP:0011519 from HPO Gene-Disease Associations)", "tritanomaly (HP:0000552 from HPO Gene-Disease Associations)", "protanomaly (HP:0200018 from HPO Gene-Disease Associations)", "deuteranomoly (HP:0011520 from HPO Gene-Disease Associations)", "blue cone monochromacy (HP:0007939 from HPO Gene-Disease Associations)", "cone monochromacy (HP:0011517 from HPO Gene-Disease Associations)", "monochromacy (HP:0007803 from HPO Gene-Disease Associations)", "rod monochromacy (HP:0011516 from HPO Gene-Disease Associations)", "peripheral arterial stenosis (HP:0004928 from HPO Gene-Disease Associations)", "supravalvular aortic stenosis (HP:0004381 from HPO Gene-Disease Associations)", "drusen (HP:0011510 from HPO Gene-Disease Associations)", "choroidal neovascularization of the macula (HP:0011506 from HPO Gene-Disease Associations)", "foveoschisis (HP:0012152 from HPO Gene-Disease Associations)", "optic disc drusen (HP:0012426 from HPO Gene-Disease Associations)", "retinal pigment epithelial atrophy (HP:0007698 from HPO Gene-Disease Associations)", "hypopigmentation of the fundus (HP:0007894 from HPO Gene-Disease Associations)", "skin dimple over apex of long bone angulation (HP:0001024 from HPO Gene-Disease Associations)", "elevated plasma pyrophosphate (HP:0011864 from HPO Gene-Disease Associations)", "phosphoethanolaminuria (HP:0003239 from HPO Gene-Disease Associations)", "elevated urine pyrophosphate (HP:0003491 from HPO Gene-Disease Associations)", "low alkaline phosphatase (HP:0003282 from HPO Gene-Disease Associations)", "lower limb undergrowth (HP:0009816 from HPO Gene-Disease Associations)", "short lower limbs (HP:0006385 from HPO Gene-Disease Associations)", "abnormal vertebral ossification (HP:0100569 from HPO Gene-Disease Associations)", "absent or minimally ossified vertebral bodies (HP:0004599 from HPO Gene-Disease Associations)", "unossified vertebral bodies (HP:0004606 from HPO Gene-Disease Associations)", "abnormal female reproductive system physiology (HP:0030012 from HPO Gene-Disease Associations)", "endometriosis (HP:0030127 from HPO Gene-Disease Associations)", "abnormality of the columella (HP:0009929 from HPO Gene-Disease Associations)", "low hanging columella (HP:0009765 from HPO Gene-Disease Associations)", "limitation of neck motion (HP:0005986 from HPO Gene-Disease Associations)", "limited neck range of motion (HP:0000466 from HPO Gene-Disease Associations)", "abnormality of the proximal phalanx of the 5th finger (HP:0009150 from HPO Gene-Disease Associations)", "metacarpophalangeal synostosis (HP:0005880 from HPO Gene-Disease Associations)", "symphalangism affecting the proximal phalanges of the hand (HP:0009857 from HPO Gene-Disease Associations)", "proximal|middle symphalangism of 5th finger (HP:0009177 from HPO Gene-Disease Associations)", "symphalangism affecting the proximal phalanx of the 5th finger (HP:0009232 from HPO Gene-Disease Associations)", "progressive fusion 2nd-5th pip joints (HP:0006147 from HPO Gene-Disease Associations)", "fusion of midphalangeal joints (HP:0006187 from HPO Gene-Disease Associations)", "hypoplastic spinal processes (HP:0008460 from HPO Gene-Disease Associations)", "progressive conductive hearing impairment (HP:0008607 from HPO Gene-Disease Associations)", "congenital stapes ankylosis (HP:0007943 from HPO Gene-Disease Associations)", "stapes ankylosis (HP:0000381 from HPO Gene-Disease Associations)", "proximal symphalangism (HP:0100264 from HPO Gene-Disease Associations)", "proximal symphalangism (hands) (HP:0006152 from HPO Gene-Disease Associations)", "absent distal phalanges (HP:0005807 from HPO Gene-Disease Associations)", "synostosis involving digits (HP:0100262 from HPO Gene-Disease Associations)", "synostosis involving bones of the fingers (HP:0009700 from HPO Gene-Disease Associations)", "distal symphalangism (HP:0100263 from HPO Gene-Disease Associations)", "distal symphalangism (hands) (HP:0001204 from HPO Gene-Disease Associations)", "symphalangism of middle phalanx of finger (HP:0009849 from HPO Gene-Disease Associations)", "symphalangism of middle phalanx of 5th finger (HP:0009178 from HPO Gene-Disease Associations)", "symphalangism of the 5th finger (HP:0004218 from HPO Gene-Disease Associations)", "distal|middle symphalangism of 5th finger (HP:0009244 from HPO Gene-Disease Associations)", "malformation of the hepatic ductal plate (HP:0006563 from HPO Gene-Disease Associations)", "broad distal phalanges of all fingers (HP:0009880 from HPO Gene-Disease Associations)", "abnormality of metacarpophalangeal joint (HP:0011911 from HPO Gene-Disease Associations)", "metacarpophalangeal joint hyperextensibility (HP:0006099 from HPO Gene-Disease Associations)", "bilateral elbow dislocations (HP:0005021 from HPO Gene-Disease Associations)", "ligamentous laxity (HP:0001380 from HPO Gene-Disease Associations)", "prominent nipples (HP:0004405 from HPO Gene-Disease Associations)", "slender forearm bones (HP:0003969 from HPO Gene-Disease Associations)", "slender ulna (HP:0003992 from HPO Gene-Disease Associations)", "absence of visual evoked potentials (HP:0007965 from HPO Gene-Disease Associations)", "asymmetry of the ears (HP:0010722 from HPO Gene-Disease Associations)", "abnormality of the antitragus (HP:0009896 from HPO Gene-Disease Associations)", "prominent antitragus (HP:0008593 from HPO Gene-Disease Associations)", "overlapping toe (HP:0001845 from HPO Gene-Disease Associations)", "increased cellular sensitivity to uv light (HP:0003224 from HPO Gene-Disease Associations)", "progeroid facial appearance (HP:0005328 from HPO Gene-Disease Associations)", "thymic hormone decreased (HP:0003357 from HPO Gene-Disease Associations)", "salt and pepper retinopathy (HP:0007814 from HPO Gene-Disease Associations)", "normal pressure hydrocephalus (HP:0002343 from HPO Gene-Disease Associations)", "patchy demyelination of subcortical white matter (HP:0002545 from HPO Gene-Disease Associations)", "peripheral dysmyelination (HP:0003469 from HPO Gene-Disease Associations)", "square pelvis (HP:0003278 from HPO Gene-Disease Associations)", "abnormality of facial adipose tissue (HP:0000291 from HPO Gene-Disease Associations)", "loss of facial adipose tissue (HP:0000292 from HPO Gene-Disease Associations)", "sclerosis of finger phalanx (HP:0100899 from HPO Gene-Disease Associations)", "sclerosis of hand bone (HP:0004054 from HPO Gene-Disease Associations)", "ivory epiphyses of the phalanges of the hand (HP:0010234 from HPO Gene-Disease Associations)", "slender nose (HP:0000417 from HPO Gene-Disease Associations)", "ivory epiphyses (HP:0010583 from HPO Gene-Disease Associations)", "gonadal hypoplasia (HP:0008639 from HPO Gene-Disease Associations)", "subcortical white matter calcifications (HP:0007346 from HPO Gene-Disease Associations)", "pigmentation anomalies of sun-exposed skin (HP:0007623 from HPO Gene-Disease Associations)", "deep longitudinal plantar crease (HP:0004681 from HPO Gene-Disease Associations)", "second metatarsal posteriorly placed (HP:0008125 from HPO Gene-Disease Associations)", "hypoplastic pelvis (HP:0008839 from HPO Gene-Disease Associations)", "dry hair (HP:0011359 from HPO Gene-Disease Associations)", "abnormality of the basal ganglia (HP:0002134 from HPO Gene-Disease Associations)", "basal ganglia calcification (HP:0002135 from HPO Gene-Disease Associations)", "cerebral calcification (HP:0002514 from HPO Gene-Disease Associations)", "ectopic calcification (HP:0010766 from HPO Gene-Disease Associations)", "abnormality of dna repair (HP:0003254 from HPO Gene-Disease Associations)", "defective dna repair after ultraviolet radiation damage (HP:0003079 from HPO Gene-Disease Associations)", "poikiloderma (HP:0001029 from HPO Gene-Disease Associations)", "entropion (HP:0000621 from HPO Gene-Disease Associations)", "ectropion (HP:0000656 from HPO Gene-Disease Associations)", "cutaneous photosensitivity (HP:0000992 from HPO Gene-Disease Associations)", "basal cell carcinoma (HP:0002671 from HPO Gene-Disease Associations)", "squamous cell carcinoma (HP:0002860 from HPO Gene-Disease Associations)", "squamous cell carcinoma of the skin (HP:0006739 from HPO Gene-Disease Associations)", "cutaneous melanoma (HP:0012056 from HPO Gene-Disease Associations)", "melanoma (HP:0002861 from HPO Gene-Disease Associations)", "freckling (HP:0001480 from HPO Gene-Disease Associations)", "athetosis (HP:0002305 from HPO Gene-Disease Associations)", "calcification of the small brain vessels (HP:0002504 from HPO Gene-Disease Associations)", "dense calcifications in the cerebellar dentate nucleus (HP:0002461 from HPO Gene-Disease Associations)", "cerebellar calcifications (HP:0007352 from HPO Gene-Disease Associations)", "limb dysmetria (HP:0002406 from HPO Gene-Disease Associations)", "fetal cystic hygroma (HP:0010878 from HPO Gene-Disease Associations)", "abnormality of the dentate nucleus (HP:0100321 from HPO Gene-Disease Associations)", "atrophy of the dentate nucleus (HP:0007047 from HPO Gene-Disease Associations)", "aplasia of the inferior half of the cerebellar vermis (HP:0007063 from HPO Gene-Disease Associations)", "thoracic scoliosis (HP:0002943 from HPO Gene-Disease Associations)", "abnormal auditory evoked potentials (HP:0006958 from HPO Gene-Disease Associations)", "abnormal middle ear reflexes (HP:0004454 from HPO Gene-Disease Associations)", "abnormality of the acoustic reflex (HP:0040121 from HPO Gene-Disease Associations)", "absence of acoustic reflex (HP:0008529 from HPO Gene-Disease Associations)", "abnormal speech discrimination (HP:0001963 from HPO Gene-Disease Associations)", "irregular myelin loops (HP:0007208 from HPO Gene-Disease Associations)", "abnormally low-pitched voice (HP:0010300 from HPO Gene-Disease Associations)", "abnormality of the epiphyses of the distal phalanx of finger (HP:0010243 from HPO Gene-Disease Associations)", "sclerosis of distal finger phalanx (HP:0100915 from HPO Gene-Disease Associations)", "ivory epiphyses of the distal phalanges of the hand (HP:0010252 from HPO Gene-Disease Associations)", "accelerated bone age after puberty (HP:0002805 from HPO Gene-Disease Associations)", "coxa magna (HP:0003279 from HPO Gene-Disease Associations)", "swelling of proximal interphalangeal joints (HP:0006253 from HPO Gene-Disease Associations)", "chin with horizontal crease (HP:0011823 from HPO Gene-Disease Associations)", "pear-shaped nose (HP:0000447 from HPO Gene-Disease Associations)", "abnormality of nail color (HP:0100643 from HPO Gene-Disease Associations)", "leukonychia (HP:0001820 from HPO Gene-Disease Associations)", "deep philtrum (HP:0002002 from HPO Gene-Disease Associations)", "dysharmonic bone age (HP:0200000 from HPO Gene-Disease Associations)", "deep-set nails (HP:0001814 from HPO Gene-Disease Associations)", "thin nail (HP:0001816 from HPO Gene-Disease Associations)", "moderate global developmental delay (HP:0011343 from HPO Gene-Disease Associations)", "sparse lateral eyebrow (HP:0005338 from HPO Gene-Disease Associations)", "aged leonine appearance (HP:0008509 from HPO Gene-Disease Associations)", "susceptibility to chickenpox (HP:0005360 from HPO Gene-Disease Associations)", "flaring of lower rib cage (HP:0006589 from HPO Gene-Disease Associations)", "sparse facial hair (HP:0007464 from HPO Gene-Disease Associations)", "congenital hemolytic anemia (HP:0004804 from HPO Gene-Disease Associations)", "cervical cord compression (HP:0002341 from HPO Gene-Disease Associations)", "spinal cord compression (HP:0002176 from HPO Gene-Disease Associations)", "abnormal hand bone ossification (HP:0010660 from HPO Gene-Disease Associations)", "abnormal ossification of hand bones (HP:0005921 from HPO Gene-Disease Associations)", "abnormality of carpal bone ossification (HP:0006257 from HPO Gene-Disease Associations)", "delayed ossification of carpal bones (HP:0001216 from HPO Gene-Disease Associations)", "proportionate short stature (HP:0003508 from HPO Gene-Disease Associations)", "severe short stature (HP:0003510 from HPO Gene-Disease Associations)", "intercostal muscle weakness (HP:0004878 from HPO Gene-Disease Associations)", "decreased distal sensory nerve action potential (HP:0007230 from HPO Gene-Disease Associations)", "short distal phalanx of toe (HP:0001857 from HPO Gene-Disease Associations)", "severe carpal ossification delay (HP:0006069 from HPO Gene-Disease Associations)", "proximal femoral metaphyseal irregularity (HP:0003411 from HPO Gene-Disease Associations)", "lower-limb metaphyseal irregularity (HP:0030291 from HPO Gene-Disease Associations)", "abnormality of the humeral metaphyses (HP:0003907 from HPO Gene-Disease Associations)", "abnormality of upper limb metaphysis (HP:0009809 from HPO Gene-Disease Associations)", "flared femoral metaphysis (HP:0002834 from HPO Gene-Disease Associations)", "flared lower limb metaphysis (HP:0030307 from HPO Gene-Disease Associations)", "flared humeral metaphysis (HP:0003911 from HPO Gene-Disease Associations)", "flared upper limb metaphysis (HP:0003849 from HPO Gene-Disease Associations)", "upper limb metaphyseal widening (HP:0003856 from HPO Gene-Disease Associations)", "irregular, rachitic-like metaphyses (HP:0005042 from HPO Gene-Disease Associations)", "absent primary metaphyseal spongiosa (HP:0003332 from HPO Gene-Disease Associations)", "hyperplasia of the femoral trochanters (HP:0002822 from HPO Gene-Disease Associations)", "long coccyx (HP:0002831 from HPO Gene-Disease Associations)", "caudal appendage (HP:0002825 from HPO Gene-Disease Associations)", "halberd-shaped pelvis (HP:0002826 from HPO Gene-Disease Associations)", "brachytelomesophalangy (HP:0005872 from HPO Gene-Disease Associations)", "dumbbell-shaped metaphyses (HP:0002810 from HPO Gene-Disease Associations)", "abnormal metaphyseal vascular invasion (HP:0003562 from HPO Gene-Disease Associations)", "abducens palsy (HP:0011349 from HPO Gene-Disease Associations)", "abnormality of the sixth cranial nerve (HP:0011348 from HPO Gene-Disease Associations)", "scapular muscle atrophy (HP:0009060 from HPO Gene-Disease Associations)", "nonprogressive muscular atrophy (HP:0008964 from HPO Gene-Disease Associations)", "relatively short spine (HP:0002766 from HPO Gene-Disease Associations)", "childhood-onset short-trunk short stature (HP:0008922 from HPO Gene-Disease Associations)", "oculomotor nerve palsy (HP:0012246 from HPO Gene-Disease Associations)", "anisospondyly (HP:0002879 from HPO Gene-Disease Associations)", "abnormality of the coccyx (HP:0008519 from HPO Gene-Disease Associations)", "abnormal metaphyseal trabeculation (HP:0005089 from HPO Gene-Disease Associations)", "amyotrophy involving the shoulder musculature (HP:0001465 from HPO Gene-Disease Associations)", "scapuloperoneal amyotrophy (HP:0003697 from HPO Gene-Disease Associations)", "peroneal muscle weakness (HP:0011727 from HPO Gene-Disease Associations)", "peroneal muscle atrophy (HP:0009049 from HPO Gene-Disease Associations)", "long thorax (HP:0100818 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the distal phalanges of the toes (HP:0010185 from HPO Gene-Disease Associations)", "abnormality of the distal phalanges of the toes (HP:0010182 from HPO Gene-Disease Associations)", "broad middle phalanx of finger (HP:0009844 from HPO Gene-Disease Associations)", "distal tibial bowing (HP:0006414 from HPO Gene-Disease Associations)", "osteosclerosis of ribs (HP:0006634 from HPO Gene-Disease Associations)", "proximal femoral metaphyseal abnormality (HP:0006431 from HPO Gene-Disease Associations)", "irregular acetabular roof (HP:0008833 from HPO Gene-Disease Associations)", "metaphyseal cupping of proximal phalanges (HP:0006208 from HPO Gene-Disease Associations)", "metaphyseal cupping of metacarpals (HP:0006028 from HPO Gene-Disease Associations)", "abnormality of lower-limb metaphyses (HP:0006490 from HPO Gene-Disease Associations)", "abnormality of the femoral metaphysis (HP:0006489 from HPO Gene-Disease Associations)", "hoarse cry (HP:0001615 from HPO Gene-Disease Associations)", "progressive distal muscular atrophy (HP:0008955 from HPO Gene-Disease Associations)", "periarticular subcutaneous nodules (HP:0007470 from HPO Gene-Disease Associations)", "abnormal pattern of respiration (HP:0002793 from HPO Gene-Disease Associations)", "apnea (HP:0002104 from HPO Gene-Disease Associations)", "obstructive sleep apnea (HP:0002870 from HPO Gene-Disease Associations)", "sleep apnea (HP:0010535 from HPO Gene-Disease Associations)", "mitochondrial malic enzyme reduced (HP:0003232 from HPO Gene-Disease Associations)", "abnormal echocardiogram (HP:0003116 from HPO Gene-Disease Associations)", "decreased pyruvate carboxylase activity (HP:0003209 from HPO Gene-Disease Associations)", "abnormal peripheral action potential amplitude (HP:0030179 from HPO Gene-Disease Associations)", "decreased amplitude of sensory action potentials (HP:0007078 from HPO Gene-Disease Associations)", "abnormal sensory nerve conduction velocity (HP:0040132 from HPO Gene-Disease Associations)", "decreased sensory nerve conduction velocity (HP:0003448 from HPO Gene-Disease Associations)", "elevated tissue non-specific alkaline phosphatase (HP:0010679 from HPO Gene-Disease Associations)", "elevated alkaline phosphatase of bone origin (HP:0010639 from HPO Gene-Disease Associations)", "temporal cortical atrophy (HP:0007112 from HPO Gene-Disease Associations)", "frontal cortical atrophy (HP:0006913 from HPO Gene-Disease Associations)", "pelvic girdle amyotrophy (HP:0008946 from HPO Gene-Disease Associations)", "abnormality of the hip-girdle musculature (HP:0001445 from HPO Gene-Disease Associations)", "abnormality of the musculature of the pelvis (HP:0001469 from HPO Gene-Disease Associations)", "pelvic girdle muscle weakness (HP:0003749 from HPO Gene-Disease Associations)", "shoulder girdle muscle weakness (HP:0003547 from HPO Gene-Disease Associations)", "limb-girdle muscle weakness (HP:0003325 from HPO Gene-Disease Associations)", "difficulty climbing stairs (HP:0003551 from HPO Gene-Disease Associations)", "rimmed vacuoles (HP:0003805 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the musculature of the pelvis (HP:0001471 from HPO Gene-Disease Associations)", "pelvic girdle muscle atrophy (HP:0008988 from HPO Gene-Disease Associations)", "limb-girdle muscle atrophy (HP:0003797 from HPO Gene-Disease Associations)", "shoulder girdle muscle atrophy (HP:0003724 from HPO Gene-Disease Associations)", "quadriceps muscle weakness (HP:0003731 from HPO Gene-Disease Associations)", "abnormality of the musculature of the upper limbs (HP:0001446 from HPO Gene-Disease Associations)", "abnormality of the shoulder girdle musculature (HP:0001435 from HPO Gene-Disease Associations)", "scapular winging (HP:0003691 from HPO Gene-Disease Associations)", "abnormal levels of creatine kinase in blood (HP:0040081 from HPO Gene-Disease Associations)", "elevated serum creatine phosphokinase (HP:0003236 from HPO Gene-Disease Associations)", "abnormality of circulating enzyme level (HP:0011021 from HPO Gene-Disease Associations)", "abnormality of circulating protein level (HP:0010876 from HPO Gene-Disease Associations)", "muscular dystrophy (HP:0003560 from HPO Gene-Disease Associations)", "emg: myopathic abnormalities (HP:0003458 from HPO Gene-Disease Associations)", "abnormality of the calf musculature (HP:0001430 from HPO Gene-Disease Associations)", "calf muscle hypertrophy (HP:0008981 from HPO Gene-Disease Associations)", "muscle hypertrophy of the lower extremities (HP:0008968 from HPO Gene-Disease Associations)", "exercise-induced myoglobinuria (HP:0008305 from HPO Gene-Disease Associations)", "thigh hypertrophy (HP:0003733 from HPO Gene-Disease Associations)", "impaired left ventricular function (HP:0005162 from HPO Gene-Disease Associations)", "frequent falls (HP:0002359 from HPO Gene-Disease Associations)", "decreased finger mobility (HP:0006135 from HPO Gene-Disease Associations)", "decreased movement range in interphalangeal joints (HP:0006203 from HPO Gene-Disease Associations)", "flexion limitation of toes (HP:0008116 from HPO Gene-Disease Associations)", "limb-girdle muscular dystrophy (HP:0006785 from HPO Gene-Disease Associations)", "abnormality of the musculature of the upper arm (HP:0001457 from HPO Gene-Disease Associations)", "proximal upper limb amyotrophy (HP:0008948 from HPO Gene-Disease Associations)", "proximal muscle weakness in upper limbs (HP:0008997 from HPO Gene-Disease Associations)", "type 2 muscle fiber predominance (HP:0010602 from HPO Gene-Disease Associations)", "decreased patellar reflex (HP:0011808 from HPO Gene-Disease Associations)", "abnormality of the musculature of the thigh (HP:0001441 from HPO Gene-Disease Associations)", "proximal lower limb amyotrophy (HP:0008956 from HPO Gene-Disease Associations)", "proximal amyotrophy (HP:0007126 from HPO Gene-Disease Associations)", "nasal, dysarthic speech (HP:0008376 from HPO Gene-Disease Associations)", "progressive distal muscle weakness (HP:0009063 from HPO Gene-Disease Associations)", "muscle fiber splitting (HP:0003555 from HPO Gene-Disease Associations)", "myofibrillar myopathy (HP:0003715 from HPO Gene-Disease Associations)", "autophagic vacuoles (HP:0003736 from HPO Gene-Disease Associations)", "progressive proximal muscle weakness (HP:0009073 from HPO Gene-Disease Associations)", "distal lower limb muscle weakness (HP:0009053 from HPO Gene-Disease Associations)", "paresis of extensor muscles of the big toe (HP:0002601 from HPO Gene-Disease Associations)", "areflexia of lower limbs (HP:0002522 from HPO Gene-Disease Associations)", "hyporeflexia of lower limbs (HP:0002600 from HPO Gene-Disease Associations)", "distal upper limb muscle weakness (HP:0008959 from HPO Gene-Disease Associations)", "increased connective tissue (HP:0009025 from HPO Gene-Disease Associations)", "difficulty running (HP:0009046 from HPO Gene-Disease Associations)", "deposits immunoreactive to beta-amyloid protein (HP:0003791 from HPO Gene-Disease Associations)", "decreased achilles reflex (HP:0009072 from HPO Gene-Disease Associations)", "late-onset proximal muscle weakness (HP:0003694 from HPO Gene-Disease Associations)", "restrictive heart failure (HP:0005130 from HPO Gene-Disease Associations)", "mildly elevated creatine phosphokinase (HP:0008180 from HPO Gene-Disease Associations)", "type 1 muscle fiber predominance (HP:0003803 from HPO Gene-Disease Associations)", "slender build (HP:0001533 from HPO Gene-Disease Associations)", "nocturnal hypoventilation (HP:0002877 from HPO Gene-Disease Associations)", "congenital muscular torticollis (HP:0005988 from HPO Gene-Disease Associations)", "abnormality of hand joint mobility (HP:0006256 from HPO Gene-Disease Associations)", "finger joint hypermobility (HP:0006094 from HPO Gene-Disease Associations)", "increased laxity of fingers (HP:0006149 from HPO Gene-Disease Associations)", "hyperextensibility at wrists (HP:0005072 from HPO Gene-Disease Associations)", "increased laxity of ankles (HP:0006460 from HPO Gene-Disease Associations)", "muscle fiber necrosis (HP:0003713 from HPO Gene-Disease Associations)", "follicular hyperkeratosis (HP:0007502 from HPO Gene-Disease Associations)", "ankle contracture (HP:0006466 from HPO Gene-Disease Associations)", "abnormality of skeletal muscle fiber size (HP:0012084 from HPO Gene-Disease Associations)", "increased variability in muscle fiber diameter (HP:0003557 from HPO Gene-Disease Associations)", "generalized amyotrophy (HP:0003700 from HPO Gene-Disease Associations)", "spinal rigidity (HP:0003306 from HPO Gene-Disease Associations)", "protruding ear (HP:0000411 from HPO Gene-Disease Associations)", "round face (HP:0000311 from HPO Gene-Disease Associations)", "reduced vital capacity (HP:0002792 from HPO Gene-Disease Associations)", "limited neck flexion (HP:0005991 from HPO Gene-Disease Associations)", "type 1 fibers relatively smaller than type 2 fibers (HP:0003755 from HPO Gene-Disease Associations)", "centrally nucleated skeletal muscle fibers (HP:0003687 from HPO Gene-Disease Associations)", "mixed respiratory and metabolic acidosis (HP:0005967 from HPO Gene-Disease Associations)", "minicore (multicore) myopathy (HP:0003789 from HPO Gene-Disease Associations)", "type 1 and type 2 muscle fiber minicore regions (HP:0003787 from HPO Gene-Disease Associations)", "axial muscle weakness (HP:0003327 from HPO Gene-Disease Associations)", "nonprogressive disorder (HP:0003680 from HPO Gene-Disease Associations)", "abnormality of the musculature of the neck (HP:0011006 from HPO Gene-Disease Associations)", "neck muscle weakness (HP:0000467 from HPO Gene-Disease Associations)", "neck flexor weakness (HP:0003722 from HPO Gene-Disease Associations)", "late-onset distal muscle weakness (HP:0003810 from HPO Gene-Disease Associations)", "muscle fiber cytoplasmatic inclusion bodies (HP:0100303 from HPO Gene-Disease Associations)", "muscle fiber inclusion bodies (HP:0100299 from HPO Gene-Disease Associations)", "nemaline bodies (HP:0003798 from HPO Gene-Disease Associations)", "sudden episodic apnea (HP:0002882 from HPO Gene-Disease Associations)", "generalized hypotonia due to defect at the neuromuscular junction (HP:0003397 from HPO Gene-Disease Associations)", "apneic episodes precipitated by illness, fatigue, stress (HP:0002872 from HPO Gene-Disease Associations)", "weak cry (HP:0001612 from HPO Gene-Disease Associations)", "decreased size of nerve terminals (HP:0003443 from HPO Gene-Disease Associations)", "muscle fiber atrophy (HP:0100295 from HPO Gene-Disease Associations)", "type 2 muscle fiber atrophy (HP:0003554 from HPO Gene-Disease Associations)", "abnormal peripheral nervous system synaptic transmission (HP:0030191 from HPO Gene-Disease Associations)", "abnormal synaptic transmission (HP:0012535 from HPO Gene-Disease Associations)", "abnormal synaptic transmission at the neuromuscular junction (HP:0003398 from HPO Gene-Disease Associations)", "fatigable weakness (HP:0003473 from HPO Gene-Disease Associations)", "emg: impaired neuromuscular transmission (HP:0100285 from HPO Gene-Disease Associations)", "emg: decremental response of compound muscle action potential to repetitive nerve stimulation (HP:0003403 from HPO Gene-Disease Associations)", "prolonged miniature endplate currents (HP:0003436 from HPO Gene-Disease Associations)", "intermittent episodes of respiratory insufficiency due to muscle weakness (HP:0004889 from HPO Gene-Disease Associations)", "decreased miniature endplate potentials (HP:0003402 from HPO Gene-Disease Associations)", "easy fatigability (HP:0003388 from HPO Gene-Disease Associations)", "gowers sign (HP:0003391 from HPO Gene-Disease Associations)", "decreased muscle mass (HP:0003199 from HPO Gene-Disease Associations)", "respiratory insufficiency due to muscle weakness (HP:0002747 from HPO Gene-Disease Associations)", "weakness of muscles of respiration (HP:0004347 from HPO Gene-Disease Associations)", "abnormality of muscle fibers (HP:0004303 from HPO Gene-Disease Associations)", "bulbar palsy (HP:0001283 from HPO Gene-Disease Associations)", "generalized muscle weakness (HP:0003324 from HPO Gene-Disease Associations)", "premature birth (HP:0001622 from HPO Gene-Disease Associations)", "abnormality of prenatal development or birth (HP:0001197 from HPO Gene-Disease Associations)", "abnormality of the amniotic fluid (HP:0001560 from HPO Gene-Disease Associations)", "polyhydramnios (HP:0001561 from HPO Gene-Disease Associations)", "decreased fetal movement (HP:0001558 from HPO Gene-Disease Associations)", "prenatal movement abnormality (HP:0001557 from HPO Gene-Disease Associations)", "arthrogryposis multiplex congenita (HP:0002804 from HPO Gene-Disease Associations)", "congenital contracture (HP:0002803 from HPO Gene-Disease Associations)", "abnormality of facial musculature (HP:0000301 from HPO Gene-Disease Associations)", "abnormality of the seventh cranial nerve (HP:0010827 from HPO Gene-Disease Associations)", "facial palsy (HP:0010628 from HPO Gene-Disease Associations)", "abnormality of the cranial nerves (HP:0001291 from HPO Gene-Disease Associations)", "cranial nerve paralysis (HP:0006824 from HPO Gene-Disease Associations)", "abnormality of facial soft tissue (HP:0011799 from HPO Gene-Disease Associations)", "neonatal hypotonia (HP:0001319 from HPO Gene-Disease Associations)", "external ophthalmoplegia (HP:0000544 from HPO Gene-Disease Associations)", "ophthalmoplegia (HP:0000602 from HPO Gene-Disease Associations)", "ophthalmoparesis (HP:0000597 from HPO Gene-Disease Associations)", "absence of labia majora (HP:0008729 from HPO Gene-Disease Associations)", "exostosis of the external auditory canal (HP:0004459 from HPO Gene-Disease Associations)", "neck pterygia (HP:0009759 from HPO Gene-Disease Associations)", "neoplasm of the outer ear (HP:0040095 from HPO Gene-Disease Associations)", "anterior clefting of vertebral bodies (HP:0009761 from HPO Gene-Disease Associations)", "bilateral camptodactyly (HP:0005617 from HPO Gene-Disease Associations)", "dysplastic patella (HP:0006446 from HPO Gene-Disease Associations)", "intercrural pterygium (HP:0009757 from HPO Gene-Disease Associations)", "abnormality of placental membranes (HP:0011409 from HPO Gene-Disease Associations)", "amniotic constriction ring (HP:0009775 from HPO Gene-Disease Associations)", "fetal akinesia sequence (HP:0001989 from HPO Gene-Disease Associations)", "amyoplasia (HP:0003634 from HPO Gene-Disease Associations)", "multiple pterygia (HP:0001040 from HPO Gene-Disease Associations)", "abnormal cervical curvature (HP:0005905 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the skeletal musculature (HP:0001460 from HPO Gene-Disease Associations)", "aplasia of the musculature (HP:0100854 from HPO Gene-Disease Associations)", "pterygium (HP:0001059 from HPO Gene-Disease Associations)", "popliteal pterygium (HP:0009756 from HPO Gene-Disease Associations)", "malignant hyperthermia (HP:0002047 from HPO Gene-Disease Associations)", "thin ribs (HP:0000883 from HPO Gene-Disease Associations)", "long chain 3 hydroxyacyl coa dehydrogenase deficiency (HP:0100950 from HPO Gene-Disease Associations)", "sudden death (HP:0001699 from HPO Gene-Disease Associations)", "episodes of ventricular tachycardia (HP:0005141 from HPO Gene-Disease Associations)", "pulmonary artery hypoplasia (HP:0004971 from HPO Gene-Disease Associations)", "scapuloperoneal myopathy (HP:0009054 from HPO Gene-Disease Associations)", "weakness of long finger extensor muscles (HP:0009077 from HPO Gene-Disease Associations)", "toe extensor amyotrophy (HP:0011916 from HPO Gene-Disease Associations)", "amyotrophy of ankle musculature (HP:0009031 from HPO Gene-Disease Associations)", "generalized limb muscle atrophy (HP:0009055 from HPO Gene-Disease Associations)", "scapuloperoneal weakness (HP:0003704 from HPO Gene-Disease Associations)", "abnormality of the left ventricular outflow tract (HP:0011103 from HPO Gene-Disease Associations)", "subaortic stenosis (HP:0001682 from HPO Gene-Disease Associations)", "calf muscle pseudohypertrophy (HP:0003707 from HPO Gene-Disease Associations)", "right ventricular dilatation (HP:0005133 from HPO Gene-Disease Associations)", "respiratory failure requiring assisted ventilation (HP:0004887 from HPO Gene-Disease Associations)", "ventilator dependence with inability to wean (HP:0005946 from HPO Gene-Disease Associations)", "denervation of the diaphragm (HP:0009109 from HPO Gene-Disease Associations)", "diaphragmatic eventration (HP:0009110 from HPO Gene-Disease Associations)", "inspiratory stridor (HP:0005348 from HPO Gene-Disease Associations)", "stridor (HP:0010307 from HPO Gene-Disease Associations)", "progressive inspiratory stridor (HP:0005951 from HPO Gene-Disease Associations)", "cranial nerve motor loss (HP:0007097 from HPO Gene-Disease Associations)", "generalized hyperreflexia (HP:0007034 from HPO Gene-Disease Associations)", "tongue atrophy (HP:0012473 from HPO Gene-Disease Associations)", "hand tremor (HP:0002378 from HPO Gene-Disease Associations)", "limb fasciculations (HP:0007289 from HPO Gene-Disease Associations)", "abnormal anterior horn cell morphology (HP:0006802 from HPO Gene-Disease Associations)", "degeneration of anterior horn cells (HP:0002398 from HPO Gene-Disease Associations)", "spinal muscular atrophy (HP:0007269 from HPO Gene-Disease Associations)", "fasciculations (HP:0002380 from HPO Gene-Disease Associations)", "muscle fibrillation (HP:0010546 from HPO Gene-Disease Associations)", "tongue fasciculations (HP:0001308 from HPO Gene-Disease Associations)", "spastic dysarthria (HP:0002464 from HPO Gene-Disease Associations)", "pseudobulbar behavioral symptoms (HP:0002193 from HPO Gene-Disease Associations)", "spasticity of facial muscles (HP:0002491 from HPO Gene-Disease Associations)", "spasticity of pharyngeal muscles (HP:0002501 from HPO Gene-Disease Associations)", "anarthria (HP:0002425 from HPO Gene-Disease Associations)", "saccadic smooth pursuit (HP:0001152 from HPO Gene-Disease Associations)", "abnormal motor neuron morphology (HP:0002450 from HPO Gene-Disease Associations)", "abnormal neuron morphology (HP:0012757 from HPO Gene-Disease Associations)", "motor neuron atrophy (HP:0007373 from HPO Gene-Disease Associations)", "amyotrophic lateral sclerosis (HP:0007354 from HPO Gene-Disease Associations)", "abnormal lower motor neuron morphology (HP:0002366 from HPO Gene-Disease Associations)", "abnormal upper motor neuron morphology (HP:0002127 from HPO Gene-Disease Associations)", "frontotemporal cerebral atrophy (HP:0006892 from HPO Gene-Disease Associations)", "emg: chronic denervation signs (HP:0003444 from HPO Gene-Disease Associations)", "emg: neuropathic changes (HP:0003445 from HPO Gene-Disease Associations)", "pontocerebellar atrophy (HP:0006879 from HPO Gene-Disease Associations)", "abnormality of the dorsal column of the spinal cord (HP:0011397 from HPO Gene-Disease Associations)", "pallor of dorsal columns of the spinal cord (HP:0006825 from HPO Gene-Disease Associations)", "diffuse axonal swelling (HP:0003405 from HPO Gene-Disease Associations)", "impaired distal tactile sensation (HP:0006937 from HPO Gene-Disease Associations)", "impaired tactile sensation (HP:0010830 from HPO Gene-Disease Associations)", "impaired distal vibration sensation (HP:0006886 from HPO Gene-Disease Associations)", "congenital laryngeal stridor (HP:0004886 from HPO Gene-Disease Associations)", "abnormality of the oligodendroglia (HP:0100706 from HPO Gene-Disease Associations)", "reduction of oligodendroglia (HP:0100709 from HPO Gene-Disease Associations)", "psychomotor deterioration (HP:0002361 from HPO Gene-Disease Associations)", "cerebral dysmyelination (HP:0007266 from HPO Gene-Disease Associations)", "diaminoaciduria (HP:0008339 from HPO Gene-Disease Associations)", "progressive spastic quadriplegia (HP:0002478 from HPO Gene-Disease Associations)", "progressive spasticity (HP:0002191 from HPO Gene-Disease Associations)", "abnormal head movements (HP:0002457 from HPO Gene-Disease Associations)", "titubation (HP:0030187 from HPO Gene-Disease Associations)", "head titubation (HP:0002599 from HPO Gene-Disease Associations)", "head tremor (HP:0002346 from HPO Gene-Disease Associations)", "tremor by anatomical site (HP:0030188 from HPO Gene-Disease Associations)", "demyelinating motor neuropathy (HP:0007220 from HPO Gene-Disease Associations)", "rotary nystagmus (HP:0001583 from HPO Gene-Disease Associations)", "urinary incontinence (HP:0000020 from HPO Gene-Disease Associations)", "urinary urgency (HP:0000012 from HPO Gene-Disease Associations)", "urinary bladder sphincter dysfunction (HP:0002839 from HPO Gene-Disease Associations)", "impaired vibratory sensation (HP:0002495 from HPO Gene-Disease Associations)", "impaired vibration sensation in the lower limbs (HP:0002166 from HPO Gene-Disease Associations)", "lower limb spasticity (HP:0002061 from HPO Gene-Disease Associations)", "paraplegia|paraparesis (HP:0010551 from HPO Gene-Disease Associations)", "paraplegia (HP:0010550 from HPO Gene-Disease Associations)", "spastic paraplegia (HP:0001258 from HPO Gene-Disease Associations)", "spastic gait (HP:0002064 from HPO Gene-Disease Associations)", "lower limb muscle weakness (HP:0007340 from HPO Gene-Disease Associations)", "babinski sign (HP:0003487 from HPO Gene-Disease Associations)", "abnormality of the corticospinal tract (HP:0002492 from HPO Gene-Disease Associations)", "atrophy|degeneration involving the corticospinal tracts (HP:0007372 from HPO Gene-Disease Associations)", "degeneration of the lateral corticospinal tracts (HP:0002314 from HPO Gene-Disease Associations)", "morphological abnormality of the pyramidal tract (HP:0002062 from HPO Gene-Disease Associations)", "insidious onset (HP:0003587 from HPO Gene-Disease Associations)", "termporal pattern (HP:0011008 from HPO Gene-Disease Associations)", "tip-toe gait (HP:0030051 from HPO Gene-Disease Associations)", "distal peripheral sensory neuropathy (HP:0007067 from HPO Gene-Disease Associations)", "motor polyneuropathy (HP:0007178 from HPO Gene-Disease Associations)", "hyperextensible hand joints (HP:0005639 from HPO Gene-Disease Associations)", "midface prominence (HP:0012371 from HPO Gene-Disease Associations)", "upper limb spasticity (HP:0006986 from HPO Gene-Disease Associations)", "ankle clonus (HP:0011448 from HPO Gene-Disease Associations)", "clonus (HP:0002169 from HPO Gene-Disease Associations)", "knee clonus (HP:0011449 from HPO Gene-Disease Associations)", "abnormality of the ankles (HP:0003028 from HPO Gene-Disease Associations)", "decreased serum estradiol (HP:0008214 from HPO Gene-Disease Associations)", "acute rhabdomyolysis (HP:0008942 from HPO Gene-Disease Associations)", "malar prominence (HP:0010620 from HPO Gene-Disease Associations)", "peripheral hypomyelination (HP:0007182 from HPO Gene-Disease Associations)", "gait instability, worse in the dark (HP:0006962 from HPO Gene-Disease Associations)", "positive romberg sign (HP:0002403 from HPO Gene-Disease Associations)", "axonal degeneration|regeneration (HP:0003378 from HPO Gene-Disease Associations)", "peripheral axonal atrophy (HP:0003384 from HPO Gene-Disease Associations)", "slow decrease in visual acuity (HP:0007924 from HPO Gene-Disease Associations)", "mild hearing impairment (HP:0012712 from HPO Gene-Disease Associations)", "mild neurosensory hearing impairment (HP:0008587 from HPO Gene-Disease Associations)", "distal sensory impairment of all modalities (HP:0003409 from HPO Gene-Disease Associations)", "distal sensory loss of all modalities (HP:0006984 from HPO Gene-Disease Associations)", "osteomyelitis or necrosis, distal, due to sensory neuropathy (feet) (HP:0001886 from HPO Gene-Disease Associations)", "autoamputation (feet) (HP:0001868 from HPO Gene-Disease Associations)", "steppage gait (HP:0003376 from HPO Gene-Disease Associations)", "hammertoe (HP:0001765 from HPO Gene-Disease Associations)", "abnormality of the musculature of the limbs (HP:0009127 from HPO Gene-Disease Associations)", "limb muscle weakness (HP:0003690 from HPO Gene-Disease Associations)", "abnormality of the musculature of the lower limbs (HP:0001437 from HPO Gene-Disease Associations)", "abnormality of the foot musculature (HP:0001436 from HPO Gene-Disease Associations)", "foot dorsiflexor weakness (HP:0009027 from HPO Gene-Disease Associations)", "proximal muscle weakness in lower limbs (HP:0008994 from HPO Gene-Disease Associations)", "proximal muscle weakness (HP:0003701 from HPO Gene-Disease Associations)", "abnormal motor nerve conduction velocity (HP:0040131 from HPO Gene-Disease Associations)", "decreased motor nerve conduction velocity (HP:0003431 from HPO Gene-Disease Associations)", "abnormal nerve conduction velocity (HP:0040129 from HPO Gene-Disease Associations)", "decreased nerve conduction velocity (HP:0000762 from HPO Gene-Disease Associations)", "abnormality of peripheral nerve conduction (HP:0003134 from HPO Gene-Disease Associations)", "abnormality of peripheral nerves (HP:0045010 from HPO Gene-Disease Associations)", "abnormality of peripheral nervous system electrophysiology (HP:0030177 from HPO Gene-Disease Associations)", "abnormal peripheral myelination (HP:0003130 from HPO Gene-Disease Associations)", "decreased number of peripheral myelinated nerve fibers (HP:0003380 from HPO Gene-Disease Associations)", "onion bulb formation (HP:0003383 from HPO Gene-Disease Associations)", "peripheral demyelination (HP:0011096 from HPO Gene-Disease Associations)", "sensory impairment (HP:0003474 from HPO Gene-Disease Associations)", "distal sensory impairment (HP:0002936 from HPO Gene-Disease Associations)", "distal muscle weakness (HP:0002460 from HPO Gene-Disease Associations)", "distal amyotrophy (HP:0003693 from HPO Gene-Disease Associations)", "pes cavus (HP:0001761 from HPO Gene-Disease Associations)", "abnormal peripheral nervous system morphology (HP:0000759 from HPO Gene-Disease Associations)", "peripheral neuropathy (HP:0009830 from HPO Gene-Disease Associations)", "muscle weakness (HP:0001324 from HPO Gene-Disease Associations)", "abnormality of muscle morphology (HP:0011805 from HPO Gene-Disease Associations)", "abnormality of muscle size (HP:0030236 from HPO Gene-Disease Associations)", "skeletal muscle atrophy (HP:0003202 from HPO Gene-Disease Associations)", "areflexia (HP:0001284 from HPO Gene-Disease Associations)", "reduced tendon reflexes (HP:0001315 from HPO Gene-Disease Associations)", "hyporeflexia (HP:0001265 from HPO Gene-Disease Associations)", "upper limb postural tremor (HP:0007351 from HPO Gene-Disease Associations)", "tonic pupil (HP:0012074 from HPO Gene-Disease Associations)", "myelin outfoldings (HP:0004336 from HPO Gene-Disease Associations)", "peripheral hypermyelination (HP:0030173 from HPO Gene-Disease Associations)", "acute demyelinating polyneuropathy (HP:0007131 from HPO Gene-Disease Associations)", "segmental peripheral demyelination|remyelination (HP:0003481 from HPO Gene-Disease Associations)", "hypertrophic nerve changes (HP:0003382 from HPO Gene-Disease Associations)", "ulnar claw (HP:0001178 from HPO Gene-Disease Associations)", "impaired proprioception (HP:0010831 from HPO Gene-Disease Associations)", "sensory ataxia (HP:0010871 from HPO Gene-Disease Associations)", "increased csf protein (HP:0002922 from HPO Gene-Disease Associations)", "peripheral axonal degeneration (HP:0000764 from HPO Gene-Disease Associations)", "peripheral axonal neuropathy (HP:0003477 from HPO Gene-Disease Associations)", "sensory axonal neuropathy (HP:0003390 from HPO Gene-Disease Associations)", "prolonged brainstem auditory evoked potentials (HP:0004466 from HPO Gene-Disease Associations)", "mononeuropathy (HP:0009831 from HPO Gene-Disease Associations)", "abnormal pupillary light reflex (HP:0007695 from HPO Gene-Disease Associations)", "segmental peripheral demyelination (HP:0007107 from HPO Gene-Disease Associations)", "decreased number of large peripheral myelinated nerve fibers (HP:0003387 from HPO Gene-Disease Associations)", "basal lamina 'onion bulb' formation (HP:0003400 from HPO Gene-Disease Associations)", "gait ataxia (HP:0002066 from HPO Gene-Disease Associations)", "limb ataxia (HP:0002070 from HPO Gene-Disease Associations)", "gaze-evoked nystagmus (HP:0000640 from HPO Gene-Disease Associations)", "cerebellar atrophy (HP:0001272 from HPO Gene-Disease Associations)", "truncal ataxia (HP:0002078 from HPO Gene-Disease Associations)", "abnormality of ocular smooth pursuit (HP:0000617 from HPO Gene-Disease Associations)", "impaired smooth pursuit (HP:0007772 from HPO Gene-Disease Associations)", "impaired horizontal smooth pursuit (HP:0001151 from HPO Gene-Disease Associations)", "dysmetric saccades (HP:0000641 from HPO Gene-Disease Associations)", "abnormality of saccadic eye movements (HP:0000570 from HPO Gene-Disease Associations)", "slow saccadic eye movements (HP:0000514 from HPO Gene-Disease Associations)", "action tremor (HP:0002345 from HPO Gene-Disease Associations)", "intention tremor (HP:0002080 from HPO Gene-Disease Associations)", "kinetic tremor (HP:0030186 from HPO Gene-Disease Associations)", "dysmetria (HP:0001310 from HPO Gene-Disease Associations)", "dysdiadochokinesis (HP:0002075 from HPO Gene-Disease Associations)", "postural tremor (HP:0002174 from HPO Gene-Disease Associations)", "progressive cerebellar ataxia (HP:0002073 from HPO Gene-Disease Associations)", "genetic anticipation (HP:0003743 from HPO Gene-Disease Associations)", "olivopontocerebellar atrophy (HP:0002542 from HPO Gene-Disease Associations)", "dorsal column degeneration (HP:0007006 from HPO Gene-Disease Associations)", "supranuclear ophthalmoplegia (HP:0000623 from HPO Gene-Disease Associations)", "genetic anticipation with paternal anticipation bias (HP:0003744 from HPO Gene-Disease Associations)", "abnormality of the spinocerebellar tracts (HP:0003133 from HPO Gene-Disease Associations)", "spinocerebellar tract degeneration (HP:0002503 from HPO Gene-Disease Associations)", "late-onset spinocerebellar degeneration (HP:0006904 from HPO Gene-Disease Associations)", "cogwheel rigidity (HP:0002396 from HPO Gene-Disease Associations)", "gaze-evoked horizontal nystagmus (HP:0007979 from HPO Gene-Disease Associations)", "intermittent microsaccadic pursuits (HP:0007944 from HPO Gene-Disease Associations)", "horizontal nystagmus (HP:0000666 from HPO Gene-Disease Associations)", "falls (HP:0002527 from HPO Gene-Disease Associations)", "progressive truncal ataxia (HP:0007221 from HPO Gene-Disease Associations)", "hypermyelinated retinal fibers (HP:0007922 from HPO Gene-Disease Associations)", "swan neck-like deformities of the fingers (HP:0006150 from HPO Gene-Disease Associations)", "retinal striation (HP:0007654 from HPO Gene-Disease Associations)", "loss of purkinje cells in the cerebellar vermis (HP:0007001 from HPO Gene-Disease Associations)", "cerebellar vermis atrophy (HP:0006855 from HPO Gene-Disease Associations)", "spastic ataxia (HP:0002497 from HPO Gene-Disease Associations)", "leg muscle stiffness (HP:0008969 from HPO Gene-Disease Associations)", "facial-lingual fasciculations (HP:0007089 from HPO Gene-Disease Associations)", "chronic pain (HP:0012532 from HPO Gene-Disease Associations)", "absent achilles reflex (HP:0003438 from HPO Gene-Disease Associations)", "decreased|absent ankle reflexes (HP:0200101 from HPO Gene-Disease Associations)", "impaired vibration sensation at ankles (HP:0006938 from HPO Gene-Disease Associations)", "facial myokymia (HP:0000317 from HPO Gene-Disease Associations)", "myokymia (HP:0002411 from HPO Gene-Disease Associations)", "jerky ocular pursuit movements (HP:0008003 from HPO Gene-Disease Associations)", "recurrent myoglobinuria (HP:0003652 from HPO Gene-Disease Associations)", "scanning speech (HP:0002168 from HPO Gene-Disease Associations)", "spinocerebellar atrophy (HP:0007263 from HPO Gene-Disease Associations)", "choroidal dystrophy (HP:0007712 from HPO Gene-Disease Associations)", "progressive spastic paraplegia (HP:0007020 from HPO Gene-Disease Associations)", "atrophy of the spinal cord (HP:0006827 from HPO Gene-Disease Associations)", "atrophy|degeneration involving the spinal cord (HP:0007344 from HPO Gene-Disease Associations)", "chorioretinal dystrophy (HP:0001135 from HPO Gene-Disease Associations)", "low frustration tolerance (HP:0000744 from HPO Gene-Disease Associations)", "talipes calcaneovarus (HP:0008124 from HPO Gene-Disease Associations)", "alopecia areata (HP:0002229 from HPO Gene-Disease Associations)", "small forehead (HP:0000350 from HPO Gene-Disease Associations)", "facial hypotonia (HP:0000297 from HPO Gene-Disease Associations)", "distal lower limb amyotrophy (HP:0008944 from HPO Gene-Disease Associations)", "lower limb amyotrophy (HP:0007210 from HPO Gene-Disease Associations)", "hypobetalipoproteinemia (HP:0003563 from HPO Gene-Disease Associations)", "hypolipoproteinemia (HP:0010981 from HPO Gene-Disease Associations)", "abnormality of the level of lipoprotein cholesterol (HP:0010979 from HPO Gene-Disease Associations)", "hypoalphalipoproteinemia (HP:0003233 from HPO Gene-Disease Associations)", "abnormality of cholesterol metabolism (HP:0003107 from HPO Gene-Disease Associations)", "hypercholesterolemia (HP:0003124 from HPO Gene-Disease Associations)", "abnormality of lipid metabolism (HP:0003119 from HPO Gene-Disease Associations)", "hyperlipidemia (HP:0003077 from HPO Gene-Disease Associations)", "hypertriglyceridemia (HP:0002155 from HPO Gene-Disease Associations)", "elevated plasma citrulline (HP:0011966 from HPO Gene-Disease Associations)", "hyperbetalipoproteinemia (HP:0003141 from HPO Gene-Disease Associations)", "abnormality of vitamin e metabolism (HP:0100514 from HPO Gene-Disease Associations)", "vitamin e deficiency (HP:0100513 from HPO Gene-Disease Associations)", "abnormality of central somatosensory evoked potentials (HP:0100291 from HPO Gene-Disease Associations)", "eeg with abnormally slow frequencies (HP:0011203 from HPO Gene-Disease Associations)", "eeg with generalized slow activity (HP:0010845 from HPO Gene-Disease Associations)", "emg: axonal abnormality (HP:0003482 from HPO Gene-Disease Associations)", "abnormality of somatosensory evoked potentials (HP:0007377 from HPO Gene-Disease Associations)", "tendon xanthomatosis (HP:0010874 from HPO Gene-Disease Associations)", "angina pectoris (HP:0001681 from HPO Gene-Disease Associations)", "myocardial infarction (HP:0001658 from HPO Gene-Disease Associations)", "xanthelasma (HP:0001114 from HPO Gene-Disease Associations)", "cyst of the eyelid (HP:0010604 from HPO Gene-Disease Associations)", "nodular changes affecting the eyelids (HP:0010732 from HPO Gene-Disease Associations)", "epidermoid cyst (HP:0200040 from HPO Gene-Disease Associations)", "xanthomatosis (HP:0000991 from HPO Gene-Disease Associations)", "corneal arcus (HP:0001084 from HPO Gene-Disease Associations)", "peripheral opacification of the cornea (HP:0008011 from HPO Gene-Disease Associations)", "hyperchylomicronemia (HP:0012238 from HPO Gene-Disease Associations)", "combined hyperlipidemia (HP:0008356 from HPO Gene-Disease Associations)", "episodic abdominal pain (HP:0002574 from HPO Gene-Disease Associations)", "eruptive xanthomas (HP:0001013 from HPO Gene-Disease Associations)", "lipemia retinalis (HP:0000660 from HPO Gene-Disease Associations)", "abnormal glucose tolerance (HP:0001952 from HPO Gene-Disease Associations)", "glucose intolerance (HP:0000833 from HPO Gene-Disease Associations)", "absence of subcutaneous fat over entire body except buttocks, hips, and thighs (HP:0007409 from HPO Gene-Disease Associations)", "absence of subcutaneous fat (HP:0007485 from HPO Gene-Disease Associations)", "generalized osteoporosis with pathologic fractures (HP:0005744 from HPO Gene-Disease Associations)", "precocious atherosclerosis (HP:0004416 from HPO Gene-Disease Associations)", "labial pseudohypertrophy (HP:0008739 from HPO Gene-Disease Associations)", "increased intraabdominal fat (HP:0008993 from HPO Gene-Disease Associations)", "increased intramuscular fat (HP:0008985 from HPO Gene-Disease Associations)", "increased adipose tissue around the neck (HP:0000468 from HPO Gene-Disease Associations)", "increased adipose tissue (HP:0009126 from HPO Gene-Disease Associations)", "increased facial adipose tissue (HP:0000287 from HPO Gene-Disease Associations)", "enlarged peripheral nerve (HP:0012645 from HPO Gene-Disease Associations)", "premature coronary artery disease (HP:0005181 from HPO Gene-Disease Associations)", "restricted neck movement due to contractures (HP:0005997 from HPO Gene-Disease Associations)", "calcinosis (HP:0003761 from HPO Gene-Disease Associations)", "hydropic placenta (HP:0011414 from HPO Gene-Disease Associations)", "increased anterioposterior diameter of thorax (HP:0005253 from HPO Gene-Disease Associations)", "overtubulated long bones (HP:0006391 from HPO Gene-Disease Associations)", "epidermal hyperkeratosis (HP:0007543 from HPO Gene-Disease Associations)", "osteolytic defects of the distal phalanges of the toes (HP:0010189 from HPO Gene-Disease Associations)", "acroosteolysis of distal phalanges (feet) (HP:0001870 from HPO Gene-Disease Associations)", "loss of truncal subcutaneous adipose tissue (HP:0009002 from HPO Gene-Disease Associations)", "bird-like facies (HP:0000320 from HPO Gene-Disease Associations)", "skin erosion (HP:0200041 from HPO Gene-Disease Associations)", "osteolytic defects of the distal phalanges of the hand (HP:0009839 from HPO Gene-Disease Associations)", "progressive clavicular acroosteolysis (HP:0000905 from HPO Gene-Disease Associations)", "mottled pigmentation (HP:0001070 from HPO Gene-Disease Associations)", "large placenta (HP:0006267 from HPO Gene-Disease Associations)", "decreased adipose tissue around neck (HP:0005995 from HPO Gene-Disease Associations)", "generalized lipodystrophy (HP:0009064 from HPO Gene-Disease Associations)", "congenital pseudoarthrosis of the clavicle (HP:0006585 from HPO Gene-Disease Associations)", "pseudoarthrosis (HP:0005864 from HPO Gene-Disease Associations)", "narrow nasal ridge (HP:0000418 from HPO Gene-Disease Associations)", "thin clavicles (HP:0006645 from HPO Gene-Disease Associations)", "acroosteolysis (feet) (HP:0001842 from HPO Gene-Disease Associations)", "osteolytic defects of the phalanges of the toes (HP:0010177 from HPO Gene-Disease Associations)", "osteolysis involving bones of the feet (HP:0009134 from HPO Gene-Disease Associations)", "osteolysis involving bones of the lower limbs (HP:0009139 from HPO Gene-Disease Associations)", "osteolytic defects of the hand bones (HP:0009699 from HPO Gene-Disease Associations)", "osteolytic defects of the phalanges of the hand (HP:0009771 from HPO Gene-Disease Associations)", "short nail (HP:0001799 from HPO Gene-Disease Associations)", "cleft secondary palate (HP:0410004 from HPO Gene-Disease Associations)", "cleft hard palate (HP:0410005 from HPO Gene-Disease Associations)", "submucous cleft hard palate (HP:0000176 from HPO Gene-Disease Associations)", "advanced eruption of teeth (HP:0006288 from HPO Gene-Disease Associations)", "natal tooth (HP:0000695 from HPO Gene-Disease Associations)", "toxemia of pregnancy (HP:0100603 from HPO Gene-Disease Associations)", "preeclampsia (HP:0100602 from HPO Gene-Disease Associations)", "loss of gluteal subcutaneous adipose tissue (HP:0009017 from HPO Gene-Disease Associations)", "increased carotid artery intimal medial thickness (HP:0012273 from HPO Gene-Disease Associations)", "loss of subcutaneous adipose tissue in limbs (HP:0003635 from HPO Gene-Disease Associations)", "prominent superficial blood vessels (HP:0007394 from HPO Gene-Disease Associations)", "prominent superficial veins (HP:0001015 from HPO Gene-Disease Associations)", "abnormality of subcutaneous fat tissue (HP:0001001 from HPO Gene-Disease Associations)", "decreased subcutaneous fat (HP:0001002 from HPO Gene-Disease Associations)", "reduced subcutaneous adipose tissue (HP:0003758 from HPO Gene-Disease Associations)", "adipose tissue loss (HP:0008887 from HPO Gene-Disease Associations)", "decreased adipose tissue (HP:0040063 from HPO Gene-Disease Associations)", "abnormality of the achilles tendon (HP:0005109 from HPO Gene-Disease Associations)", "achilles tendon contracture (HP:0001771 from HPO Gene-Disease Associations)", "decreased cervical spine flexion due to contractures of posterior cervical muscles (HP:0004631 from HPO Gene-Disease Associations)", "type 1 muscle fiber atrophy (HP:0011807 from HPO Gene-Disease Associations)", "bifid uterus (HP:0000136 from HPO Gene-Disease Associations)", "congenital microcephaly (HP:0011451 from HPO Gene-Disease Associations)", "yellow subcutaneous tissue covered by thin, scaly skin (HP:0007525 from HPO Gene-Disease Associations)", "ablepharon (HP:0011224 from HPO Gene-Disease Associations)", "aplasia|hypoplasia affecting the eyelid (HP:0011226 from HPO Gene-Disease Associations)", "short umbilical cord (HP:0001196 from HPO Gene-Disease Associations)", "abnormal placental size (HP:0012767 from HPO Gene-Disease Associations)", "abnormality of the placenta (HP:0100767 from HPO Gene-Disease Associations)", "small placenta (HP:0006266 from HPO Gene-Disease Associations)", "stillbirth (HP:0003826 from HPO Gene-Disease Associations)", "prominent umbilicus (HP:0001544 from HPO Gene-Disease Associations)", "acute pancreatitis (HP:0001735 from HPO Gene-Disease Associations)", "labial hypertrophy (HP:0000065 from HPO Gene-Disease Associations)", "insulin-resistant diabetes mellitus at puberty (HP:0000877 from HPO Gene-Disease Associations)", "generalized muscular appearance from birth (HP:0003716 from HPO Gene-Disease Associations)", "cystic angiomatosis of bone (HP:0002833 from HPO Gene-Disease Associations)", "nearly complete absence of metabolically active adipose tissue (subcutaneous, intraabdominal, intrathoracic) (HP:0003809 from HPO Gene-Disease Associations)", "abnormality of circulating leptin level (HP:0004361 from HPO Gene-Disease Associations)", "decreased serum leptin (HP:0003292 from HPO Gene-Disease Associations)", "large hands (HP:0001176 from HPO Gene-Disease Associations)", "long foot (HP:0001833 from HPO Gene-Disease Associations)", "abnormal eating behavior (HP:0100738 from HPO Gene-Disease Associations)", "polyphagia (HP:0002591 from HPO Gene-Disease Associations)", "first dorsal interossei muscle weakness (HP:0003392 from HPO Gene-Disease Associations)", "cold-induced hand cramps (HP:0003435 from HPO Gene-Disease Associations)", "first dorsal interossei muscle atrophy (HP:0003426 from HPO Gene-Disease Associations)", "interosseus muscle atrophy (HP:0007181 from HPO Gene-Disease Associations)", "thenar muscle weakness (HP:0003427 from HPO Gene-Disease Associations)", "hand muscle weakness (HP:0030237 from HPO Gene-Disease Associations)", "cold-induced muscle cramps (HP:0003449 from HPO Gene-Disease Associations)", "upper limb muscle weakness (HP:0003484 from HPO Gene-Disease Associations)", "distal upper limb amyotrophy (HP:0007149 from HPO Gene-Disease Associations)", "upper limb amyotrophy (HP:0009129 from HPO Gene-Disease Associations)", "hand muscle atrophy (HP:0009130 from HPO Gene-Disease Associations)", "thenar muscle atrophy (HP:0003393 from HPO Gene-Disease Associations)", "abnormality of the musculature of the hand (HP:0001421 from HPO Gene-Disease Associations)", "decreased fertility in females (HP:0000868 from HPO Gene-Disease Associations)", "female infertility (HP:0008222 from HPO Gene-Disease Associations)", "early onset of sexual maturation (HP:0100000 from HPO Gene-Disease Associations)", "precocious puberty (HP:0000826 from HPO Gene-Disease Associations)", "accelerated skeletal maturation (HP:0005616 from HPO Gene-Disease Associations)", "acanthosis nigricans (HP:0000956 from HPO Gene-Disease Associations)", "premature pubarche (HP:0012411 from HPO Gene-Disease Associations)", "abnormality of endocrine pancreas physiology (HP:0012093 from HPO Gene-Disease Associations)", "abnormality of the pancreatic islet cells (HP:0006476 from HPO Gene-Disease Associations)", "pancreatic islet-cell hyperplasia (HP:0004510 from HPO Gene-Disease Associations)", "beta-cell dysfunction (HP:0006279 from HPO Gene-Disease Associations)", "symptomatic seizures (HP:0011145 from HPO Gene-Disease Associations)", "hypoglycemic seizures (HP:0002173 from HPO Gene-Disease Associations)", "hypoglycemic coma (HP:0001325 from HPO Gene-Disease Associations)", "hyperinsulinemic hypoglycemia (HP:0000825 from HPO Gene-Disease Associations)", "hyperglycemia (HP:0003074 from HPO Gene-Disease Associations)", "insulin resistance (HP:0000855 from HPO Gene-Disease Associations)", "insulin-resistant diabetes mellitus (HP:0000831 from HPO Gene-Disease Associations)", "neonatal insulin-dependent diabetes mellitus (HP:0000857 from HPO Gene-Disease Associations)", "transient neonatal diabetes mellitus (HP:0008255 from HPO Gene-Disease Associations)", "abnormality of the metopic suture (HP:0005556 from HPO Gene-Disease Associations)", "prominent metopic ridge (HP:0005487 from HPO Gene-Disease Associations)", "small for gestational age (HP:0001518 from HPO Gene-Disease Associations)", "diabetic ketoacidosis (HP:0001953 from HPO Gene-Disease Associations)", "fasting hyperinsulinemia (HP:0008283 from HPO Gene-Disease Associations)", "onychauxis (HP:0012542 from HPO Gene-Disease Associations)", "postprandial hyperglycemia (HP:0011998 from HPO Gene-Disease Associations)", "fasting hypoglycemia (HP:0003162 from HPO Gene-Disease Associations)", "severe failure to thrive (HP:0001525 from HPO Gene-Disease Associations)", "ketoacidosis (HP:0001993 from HPO Gene-Disease Associations)", "ketosis (HP:0001946 from HPO Gene-Disease Associations)", "episodic ketoacidosis (HP:0005974 from HPO Gene-Disease Associations)", "metabolic ketoacidosis (HP:0005979 from HPO Gene-Disease Associations)", "diffuse cerebellar atrophy (HP:0100275 from HPO Gene-Disease Associations)", "asymptomatic hyperammonemia (HP:0008162 from HPO Gene-Disease Associations)", "anoperineal fistula (HP:0005218 from HPO Gene-Disease Associations)", "eversion of lateral third of lower eyelids (HP:0007655 from HPO Gene-Disease Associations)", "abnormality of the fingertips (HP:0001211 from HPO Gene-Disease Associations)", "prominent digit pad (HP:0011298 from HPO Gene-Disease Associations)", "prominent fingertip pads (HP:0001212 from HPO Gene-Disease Associations)", "depressed nasal tip (HP:0000437 from HPO Gene-Disease Associations)", "premature thelarche (HP:0010314 from HPO Gene-Disease Associations)", "radial deviation of thumb terminal phalanx (HP:0005895 from HPO Gene-Disease Associations)", "high axial triradius (HP:0001042 from HPO Gene-Disease Associations)", "plantar crease between first and second toes (HP:0008107 from HPO Gene-Disease Associations)", "vascular ring (HP:0010775 from HPO Gene-Disease Associations)", "talon cusp (HP:0011087 from HPO Gene-Disease Associations)", "agoraphobia (HP:0000756 from HPO Gene-Disease Associations)", "bimanual synkinesia (HP:0001335 from HPO Gene-Disease Associations)", "motor tics (HP:0100034 from HPO Gene-Disease Associations)", "tics (HP:0100033 from HPO Gene-Disease Associations)", "abnormality of the globus pallidus (HP:0002453 from HPO Gene-Disease Associations)", "eye of the tiger anomaly of globus pallidus (HP:0002454 from HPO Gene-Disease Associations)", "pallidal degeneration (HP:0007132 from HPO Gene-Disease Associations)", "subcortical cerebral atrophy (HP:0012157 from HPO Gene-Disease Associations)", "disturbance of facial expression (HP:0005324 from HPO Gene-Disease Associations)", "facial grimacing (HP:0000273 from HPO Gene-Disease Associations)", "dyskinesia (HP:0100660 from HPO Gene-Disease Associations)", "orofacial dyskinesia (HP:0002310 from HPO Gene-Disease Associations)", "abnormality of the labia minora (HP:0012880 from HPO Gene-Disease Associations)", "hypoplastic labia minora (HP:0000064 from HPO Gene-Disease Associations)", "temperature instability (HP:0005968 from HPO Gene-Disease Associations)", "abnormal shape of the palpebral fissure (HP:0200005 from HPO Gene-Disease Associations)", "almond-shaped palpebral fissure (HP:0007874 from HPO Gene-Disease Associations)", "poor fine motor coordination (HP:0007010 from HPO Gene-Disease Associations)", "poor gross motor coordination (HP:0007015 from HPO Gene-Disease Associations)", "poor motor coordination (HP:0002275 from HPO Gene-Disease Associations)", "abnormal hair whorl (HP:0010721 from HPO Gene-Disease Associations)", "frontal upsweep of hair (HP:0002236 from HPO Gene-Disease Associations)", "oligomenorrhea (HP:0000876 from HPO Gene-Disease Associations)", "failure to thrive in infancy (HP:0001531 from HPO Gene-Disease Associations)", "narrow nasal bridge (HP:0000446 from HPO Gene-Disease Associations)", "generalized hypotonia (HP:0001290 from HPO Gene-Disease Associations)", "hip dysplasia (HP:0001385 from HPO Gene-Disease Associations)", "aberrant melanosome maturation (HP:0007384 from HPO Gene-Disease Associations)", "nasal speech (HP:0001611 from HPO Gene-Disease Associations)", "conspicuously happy disposition (HP:0100024 from HPO Gene-Disease Associations)", "broad chin (HP:0011822 from HPO Gene-Disease Associations)", "narrow palm (HP:0004283 from HPO Gene-Disease Associations)", "high, narrow palate (HP:0002705 from HPO Gene-Disease Associations)", "narrow palate (HP:0000189 from HPO Gene-Disease Associations)", "axonal regeneration (HP:0003450 from HPO Gene-Disease Associations)", "clusters of axonal regeneration (HP:0007233 from HPO Gene-Disease Associations)", "hypotrophy of the small hand muscles (HP:0006006 from HPO Gene-Disease Associations)", "jerky head movements (HP:0006961 from HPO Gene-Disease Associations)", "poor speech (HP:0002465 from HPO Gene-Disease Associations)", "paroxysmal choreoathetosis (HP:0007098 from HPO Gene-Disease Associations)", "paroxysmal dystonia (HP:0002268 from HPO Gene-Disease Associations)", "normal interictal eeg (HP:0002372 from HPO Gene-Disease Associations)", "phonic tics (HP:0100035 from HPO Gene-Disease Associations)", "abnormality of lysosomal metabolism (HP:0004356 from HPO Gene-Disease Associations)", "elevated serum acid phosphatase (HP:0003148 from HPO Gene-Disease Associations)", "hydroxyprolinemia (HP:0003260 from HPO Gene-Disease Associations)", "abnormality of urine bicarbonate concentration (HP:0011279 from HPO Gene-Disease Associations)", "bicarbonaturia (HP:0003646 from HPO Gene-Disease Associations)", "abnormality of vitamin d metabolism (HP:0100511 from HPO Gene-Disease Associations)", "dense posterior cortical cataract (HP:0007948 from HPO Gene-Disease Associations)", "posterior cortical cataract (HP:0010924 from HPO Gene-Disease Associations)", "vitamin d deficiency (HP:0100512 from HPO Gene-Disease Associations)", "hypoammonemia (HP:0100493 from HPO Gene-Disease Associations)", "cortical cataract (HP:0100019 from HPO Gene-Disease Associations)", "periventricular cysts (HP:0007109 from HPO Gene-Disease Associations)", "wrist swelling (HP:0001225 from HPO Gene-Disease Associations)", "ankle swelling (HP:0001785 from HPO Gene-Disease Associations)", "renal tubular acidosis (HP:0001947 from HPO Gene-Disease Associations)", "renal tubular dysfunction (HP:0000124 from HPO Gene-Disease Associations)", "proximal renal tubular acidosis (HP:0002049 from HPO Gene-Disease Associations)", "low-molecular-weight proteinuria (HP:0003126 from HPO Gene-Disease Associations)", "non-acidotic proximal tubulopathy (HP:0005574 from HPO Gene-Disease Associations)", "infra-orbital crease (HP:0100876 from HPO Gene-Disease Associations)", "partial agenesis of the corpus callosum (HP:0001338 from HPO Gene-Disease Associations)", "neuronal loss in the cerebral cortex (HP:0007190 from HPO Gene-Disease Associations)", "periventricular leukomalacia (HP:0006970 from HPO Gene-Disease Associations)", "aplasia cutis congenita over parietal area (HP:0004476 from HPO Gene-Disease Associations)", "aplasia cutis congenita over posterior parietal area (HP:0007590 from HPO Gene-Disease Associations)", "aplasia cutis congenita on trunk or limbs (HP:0007589 from HPO Gene-Disease Associations)", "abnormality of the periventricular white matter (HP:0002518 from HPO Gene-Disease Associations)", "leukoencephalopathy (HP:0002352 from HPO Gene-Disease Associations)", "elevated alpha-fetoprotein (HP:0006254 from HPO Gene-Disease Associations)", "elevated maternal serum alpha-fetoprotein (HP:0005984 from HPO Gene-Disease Associations)", "congenital pyloric atresia (HP:0004399 from HPO Gene-Disease Associations)", "intractable diarrhea (HP:0002041 from HPO Gene-Disease Associations)", "axillary pterygia (HP:0001060 from HPO Gene-Disease Associations)", "congenital localized absence of skin (HP:0007383 from HPO Gene-Disease Associations)", "palmar hyperhidrosis (HP:0006089 from HPO Gene-Disease Associations)", "oral mucosal blisters (HP:0200097 from HPO Gene-Disease Associations)", "junctional split (HP:0003341 from HPO Gene-Disease Associations)", "milia (HP:0001056 from HPO Gene-Disease Associations)", "fragile nails (HP:0001808 from HPO Gene-Disease Associations)", "onycholysis (HP:0001806 from HPO Gene-Disease Associations)", "recurrent loss of toenails and fingernails (HP:0008390 from HPO Gene-Disease Associations)", "abnormal pigmentation of the oral mucosa (HP:0100669 from HPO Gene-Disease Associations)", "progressive microcephaly (HP:0000253 from HPO Gene-Disease Associations)", "severe global developmental delay (HP:0011344 from HPO Gene-Disease Associations)", "congenital onset (HP:0003577 from HPO Gene-Disease Associations)", "death in childhood (HP:0003819 from HPO Gene-Disease Associations)", "mortality|aging (HP:0040006 from HPO Gene-Disease Associations)", "time of death (HP:0011420 from HPO Gene-Disease Associations)", "death in infancy (HP:0001522 from HPO Gene-Disease Associations)", "abnormal enzyme|coenzyme activity (HP:0012379 from HPO Gene-Disease Associations)", "abnormality of alkaline phosphatase activity (HP:0004379 from HPO Gene-Disease Associations)", "elevated alkaline phosphatase (HP:0003155 from HPO Gene-Disease Associations)", "abdominal wall muscle weakness (HP:0009023 from HPO Gene-Disease Associations)", "hypocalcemic seizures (HP:0002199 from HPO Gene-Disease Associations)", "secondary hyperparathyroidism (HP:0000867 from HPO Gene-Disease Associations)", "subperiosteal erosions due to secondary hyperparathyroidism (HP:0003106 from HPO Gene-Disease Associations)", "increased serum 1,25-dihydroxyvitamin d3 (HP:0003152 from HPO Gene-Disease Associations)", "enlargement of the wrists (HP:0003020 from HPO Gene-Disease Associations)", "bulging epiphyses (HP:0003013 from HPO Gene-Disease Associations)", "enlargement of the ankles (HP:0003029 from HPO Gene-Disease Associations)", "sparse bone trabeculae (HP:0002752 from HPO Gene-Disease Associations)", "fibular bowing (HP:0010502 from HPO Gene-Disease Associations)", "difficulty standing (HP:0003698 from HPO Gene-Disease Associations)", "bulging of the costochondral junction (HP:0000893 from HPO Gene-Disease Associations)", "deformed rib cage (HP:0000886 from HPO Gene-Disease Associations)", "thin bony cortex (HP:0002753 from HPO Gene-Disease Associations)", "delayed epiphyseal ossification (HP:0002663 from HPO Gene-Disease Associations)", "enlarged epiphyses (HP:0010580 from HPO Gene-Disease Associations)", "abnormality of the costochondral junction (HP:0000919 from HPO Gene-Disease Associations)", "enlargement of the costochondral junction (HP:0000920 from HPO Gene-Disease Associations)", "metaphyseal irregularity (HP:0003025 from HPO Gene-Disease Associations)", "flat occiput (HP:0005469 from HPO Gene-Disease Associations)", "renal phosphate wasting (HP:0000117 from HPO Gene-Disease Associations)", "abnormality of phosphate homeostasis (HP:0100529 from HPO Gene-Disease Associations)", "hypophosphatemia (HP:0002148 from HPO Gene-Disease Associations)", "hypophosphatemic rickets (HP:0004912 from HPO Gene-Disease Associations)", "rickets (HP:0002748 from HPO Gene-Disease Associations)", "osteomalacia (HP:0002749 from HPO Gene-Disease Associations)", "difficulty walking (HP:0002355 from HPO Gene-Disease Associations)", "abnormality of calcium-phosphate metabolism (HP:0100530 from HPO Gene-Disease Associations)", "elevated circulating parathyroid hormone (pth) level (HP:0003165 from HPO Gene-Disease Associations)", "shortening of the talar neck (HP:0008117 from HPO Gene-Disease Associations)", "trapezoidal distal femoral condyles (HP:0006432 from HPO Gene-Disease Associations)", "enthesitis (HP:0100686 from HPO Gene-Disease Associations)", "flattening of the talar dome (HP:0008144 from HPO Gene-Disease Associations)", "hypomineralization of enamel (HP:0006285 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the lungs (HP:0006703 from HPO Gene-Disease Associations)", "pulmonary hypoplasia (HP:0002089 from HPO Gene-Disease Associations)", "renotubular dysgenesis (HP:0008660 from HPO Gene-Disease Associations)", "decreased urine output (HP:0011037 from HPO Gene-Disease Associations)", "anuria (HP:0100519 from HPO Gene-Disease Associations)", "facial shape deformation (HP:0011334 from HPO Gene-Disease Associations)", "potter facies (HP:0002009 from HPO Gene-Disease Associations)", "wide cranial sutures (HP:0010537 from HPO Gene-Disease Associations)", "widely patent fontanelles and sutures (HP:0004492 from HPO Gene-Disease Associations)", "elevated diastolic blood pressure (HP:0005117 from HPO Gene-Disease Associations)", "elevated mean arterial pressure (HP:0004972 from HPO Gene-Disease Associations)", "elevated systolic blood pressure (HP:0004421 from HPO Gene-Disease Associations)", "hair-nail ectodermal dysplasia (HP:0007436 from HPO Gene-Disease Associations)", "temporal hypotrichosis (HP:0004524 from HPO Gene-Disease Associations)", "congenital onychodystrophy (HP:0008394 from HPO Gene-Disease Associations)", "sparse body hair (HP:0002231 from HPO Gene-Disease Associations)", "abnormal hair laboratory examination (HP:0003328 from HPO Gene-Disease Associations)", "pili torti (HP:0003777 from HPO Gene-Disease Associations)", "generalized papillary lesions (HP:0007482 from HPO Gene-Disease Associations)", "alopecia universalis (HP:0002289 from HPO Gene-Disease Associations)", "subcutaneous calcification (HP:0007618 from HPO Gene-Disease Associations)", "premature arteriosclerosis (HP:0005177 from HPO Gene-Disease Associations)", "atopic dermatitis (HP:0001047 from HPO Gene-Disease Associations)", "multiple palmar creases (HP:0006114 from HPO Gene-Disease Associations)", "multiple plantar creases (HP:0008113 from HPO Gene-Disease Associations)", "multiple cafe-au-lait spots (HP:0007565 from HPO Gene-Disease Associations)", "multiple lentigines (HP:0001003 from HPO Gene-Disease Associations)", "optic nerve dysplasia (HP:0001093 from HPO Gene-Disease Associations)", "white hair (HP:0011364 from HPO Gene-Disease Associations)", "elevated 7-dehydrocholesterol (HP:0010569 from HPO Gene-Disease Associations)", "severe photosensitivity (HP:0007537 from HPO Gene-Disease Associations)", "cerebral hypoplasia (HP:0006872 from HPO Gene-Disease Associations)", "hypoplasia of the frontal lobes (HP:0007333 from HPO Gene-Disease Associations)", "hypocholesterolemia (HP:0003146 from HPO Gene-Disease Associations)", "cholestatic liver disease (HP:0002611 from HPO Gene-Disease Associations)", "talipes calcaneovalgus (HP:0001884 from HPO Gene-Disease Associations)", "giant cell hepatitis (HP:0200084 from HPO Gene-Disease Associations)", "poor suck (HP:0002033 from HPO Gene-Disease Associations)", "abnormality of the intrahepatic bile duct (HP:0011040 from HPO Gene-Disease Associations)", "intrahepatic biliary dysgenesis (HP:0001401 from HPO Gene-Disease Associations)", "stippled chondral calcification (HP:0002764 from HPO Gene-Disease Associations)", "calcific stippling (HP:0002832 from HPO Gene-Disease Associations)", "cubitus valgus (HP:0002967 from HPO Gene-Disease Associations)", "albuminuria (HP:0012592 from HPO Gene-Disease Associations)", "hypoplastic olfactory lobes (HP:0006894 from HPO Gene-Disease Associations)", "olfactory lobe agenesis (HP:0001341 from HPO Gene-Disease Associations)", "redundant skin (HP:0001582 from HPO Gene-Disease Associations)", "redundant neck skin (HP:0005989 from HPO Gene-Disease Associations)", "folate-dependent fragile site at xq28 (HP:0003564 from HPO Gene-Disease Associations)", "macroorchidism, postpubertal (HP:0002050 from HPO Gene-Disease Associations)", "congenital macroorchidism (HP:0008640 from HPO Gene-Disease Associations)", "obsessive-compulsive trait (HP:0008770 from HPO Gene-Disease Associations)", "diffuse cerebral atrophy (HP:0002506 from HPO Gene-Disease Associations)", "hypertrophic labia minora (HP:0008694 from HPO Gene-Disease Associations)", "hypoplastic inferior pubic rami (HP:0008823 from HPO Gene-Disease Associations)", "gray matter heterotopias (HP:0002281 from HPO Gene-Disease Associations)", "periventricular gray matter heterotopia (HP:0007165 from HPO Gene-Disease Associations)", "heterotopia (HP:0002282 from HPO Gene-Disease Associations)", "clitoral hypertrophy (HP:0008665 from HPO Gene-Disease Associations)", "colpocephaly (HP:0030048 from HPO Gene-Disease Associations)", "ovotestis (HP:0012861 from HPO Gene-Disease Associations)", "oncocytic cardiomyopathy (HP:0005152 from HPO Gene-Disease Associations)", "asymmetric, linear skin defects (HP:0007398 from HPO Gene-Disease Associations)", "anterior creases of earlobe (HP:0009908 from HPO Gene-Disease Associations)", "d-2-hydroxyglutaric aciduria (HP:0012321 from HPO Gene-Disease Associations)", "multifocal cerebral white matter abnormalities (HP:0007052 from HPO Gene-Disease Associations)", "subependymal cysts (HP:0002416 from HPO Gene-Disease Associations)", "abnormality of lateral ventricle (HP:0030047 from HPO Gene-Disease Associations)", "dilation of lateral ventricles (HP:0006956 from HPO Gene-Disease Associations)", "symmetrical progressive peripheral demyelination (HP:0006873 from HPO Gene-Disease Associations)", "infantile encephalopathy (HP:0007105 from HPO Gene-Disease Associations)", "progressive language deterioration (HP:0007064 from HPO Gene-Disease Associations)", "repetitive compulsive behavior (HP:0008762 from HPO Gene-Disease Associations)", "progressive neurologic deterioration (HP:0002344 from HPO Gene-Disease Associations)", "juvenile myelomonocytic leukemia (HP:0012209 from HPO Gene-Disease Associations)", "myeloid leukemia (HP:0012324 from HPO Gene-Disease Associations)", "lisch nodules (HP:0009737 from HPO Gene-Disease Associations)", "spinal neurofibromas (HP:0009735 from HPO Gene-Disease Associations)", "symmetric spinal nerve root neurofibromas (HP:0006851 from HPO Gene-Disease Associations)", "plexiform neurofibroma (HP:0009732 from HPO Gene-Disease Associations)", "tibial pseudoarthrosis (HP:0009736 from HPO Gene-Disease Associations)", "inguinal freckling (HP:0030052 from HPO Gene-Disease Associations)", "deviated nasal septum (HP:0004411 from HPO Gene-Disease Associations)", "neurofibrosarcoma (HP:0100697 from HPO Gene-Disease Associations)", "superior pectus carinatum (HP:0000917 from HPO Gene-Disease Associations)", "pectus excavatum of inferior sternum (HP:0000915 from HPO Gene-Disease Associations)", "reduced factor xiii activity (HP:0008357 from HPO Gene-Disease Associations)", "amegakaryocytic thrombocytopenia (HP:0004859 from HPO Gene-Disease Associations)", "aplasia of the ovary (HP:0010463 from HPO Gene-Disease Associations)", "multiple digital exostoses (HP:0005655 from HPO Gene-Disease Associations)", "third degree atrioventricular block (HP:0001709 from HPO Gene-Disease Associations)", "delayed menarche (HP:0012569 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the ovary (HP:0010462 from HPO Gene-Disease Associations)", "hypoplasia of the ovary (HP:0008724 from HPO Gene-Disease Associations)", "streak ovary (HP:0010464 from HPO Gene-Disease Associations)", "gonadal dysgenesis, male (HP:0008668 from HPO Gene-Disease Associations)", "increased carrying angle (HP:0003102 from HPO Gene-Disease Associations)", "shortening of the tibia (HP:0006436 from HPO Gene-Disease Associations)", "broad forearm bones (HP:0003971 from HPO Gene-Disease Associations)", "broad ulna (HP:0003993 from HPO Gene-Disease Associations)", "dorsal subluxation of ulna (HP:0006459 from HPO Gene-Disease Associations)", "mesomelic short stature (HP:0008845 from HPO Gene-Disease Associations)", "multiple exostoses (HP:0002762 from HPO Gene-Disease Associations)", "limited wrist movement (HP:0006248 from HPO Gene-Disease Associations)", "malignant eosinophil proliferation (HP:0006782 from HPO Gene-Disease Associations)", "peripheral nerve compression (HP:0003406 from HPO Gene-Disease Associations)", "scapular exostoses (HP:0000918 from HPO Gene-Disease Associations)", "rib exostoses (HP:0000896 from HPO Gene-Disease Associations)", "protuberances at ends of long bones (HP:0003105 from HPO Gene-Disease Associations)", "madelung-like forearm deformities (HP:0003068 from HPO Gene-Disease Associations)", "pelvic exostoses (HP:0003276 from HPO Gene-Disease Associations)", "chondrosarcoma (HP:0006765 from HPO Gene-Disease Associations)", "madelung deformity (HP:0003067 from HPO Gene-Disease Associations)", "osteolysis (HP:0002797 from HPO Gene-Disease Associations)", "abnormality of sharpey fibers (HP:0100685 from HPO Gene-Disease Associations)", "chondrocalcinosis (HP:0000934 from HPO Gene-Disease Associations)", "hypoplasia of the pharynx (HP:0009555 from HPO Gene-Disease Associations)", "abnormality of lower eyelashes (HP:0040052 from HPO Gene-Disease Associations)", "sparse lower eyelashes (HP:0007776 from HPO Gene-Disease Associations)", "lower eyelid coloboma (HP:0000652 from HPO Gene-Disease Associations)", "cleft soft palate (HP:0000185 from HPO Gene-Disease Associations)", "submucous cleft soft palate (HP:0011819 from HPO Gene-Disease Associations)", "trismus (HP:0000211 from HPO Gene-Disease Associations)", "craniofacial dysostosis (HP:0004439 from HPO Gene-Disease Associations)", "mandibulofacial dysostosis (HP:0005321 from HPO Gene-Disease Associations)", "rheumatoid arthritis (HP:0001370 from HPO Gene-Disease Associations)", "spondylometaphyseal dysplasia (HP:0002657 from HPO Gene-Disease Associations)", "hypopigmented skin patches on arms (HP:0007526 from HPO Gene-Disease Associations)", "abnormal cartilage morphology (HP:0002763 from HPO Gene-Disease Associations)", "enchondroma (HP:0030038 from HPO Gene-Disease Associations)", "multiple enchondromatosis (HP:0005701 from HPO Gene-Disease Associations)", "exostoses (HP:0100777 from HPO Gene-Disease Associations)", "neoplasm of the skeletal system (HP:0010622 from HPO Gene-Disease Associations)", "aplasia of the uterus (HP:0000151 from HPO Gene-Disease Associations)", "axial malrotation of the kidney (HP:0004717 from HPO Gene-Disease Associations)", "cow milk allergy (HP:0100327 from HPO Gene-Disease Associations)", "nevus flammeus of the forehead (HP:0007413 from HPO Gene-Disease Associations)", "edema of the dorsum of feet (HP:0012098 from HPO Gene-Disease Associations)", "edema of the dorsum of hands (HP:0007514 from HPO Gene-Disease Associations)", "bilateral radial aplasia (HP:0004977 from HPO Gene-Disease Associations)", "tibial torsion (HP:0100694 from HPO Gene-Disease Associations)", "cavum septum pellucidum (HP:0002389 from HPO Gene-Disease Associations)", "lateral clavicle hook (HP:0000895 from HPO Gene-Disease Associations)", "cervical ribs (HP:0000891 from HPO Gene-Disease Associations)", "supernumerary ribs (HP:0005815 from HPO Gene-Disease Associations)", "supernumerary bones of the axial skeleton (HP:0009144 from HPO Gene-Disease Associations)", "crossed fused renal ectopia (HP:0004736 from HPO Gene-Disease Associations)", "limited interphalangeal movement (HP:0006064 from HPO Gene-Disease Associations)", "upper limb muscle hypoplasia (HP:0009016 from HPO Gene-Disease Associations)", "hypoplasia of deltoid muscle (HP:0030241 from HPO Gene-Disease Associations)", "pectoralis hypoplasia (HP:0008998 from HPO Gene-Disease Associations)", "pectoralis major hypoplasia (HP:0008953 from HPO Gene-Disease Associations)", "palpebral fissure narrowing on adduction (HP:0000661 from HPO Gene-Disease Associations)", "congenital strabismus (HP:0000487 from HPO Gene-Disease Associations)", "impaired convergence (HP:0000619 from HPO Gene-Disease Associations)", "abnormality of ocular abduction (HP:0011347 from HPO Gene-Disease Associations)", "impaired ocular abduction (HP:0000634 from HPO Gene-Disease Associations)", "impaired ocular adduction (HP:0000542 from HPO Gene-Disease Associations)", "slit-like opening of the exterior auditory meatus (HP:0008588 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the shoulder musculature (HP:0001464 from HPO Gene-Disease Associations)", "shoulder muscle hypoplasia (HP:0008952 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the musculature of the extremities (HP:0009128 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the musculature of the upper limbs (HP:0001467 from HPO Gene-Disease Associations)", "abnormality of the musculature of the thorax (HP:0009131 from HPO Gene-Disease Associations)", "abnormality of the pectoral muscle (HP:0011957 from HPO Gene-Disease Associations)", "renal malrotation (HP:0004712 from HPO Gene-Disease Associations)", "hypoplasia of the musculature (HP:0009004 from HPO Gene-Disease Associations)", "duane anomaly (HP:0009921 from HPO Gene-Disease Associations)", "hypoplastic radial head (HP:0003997 from HPO Gene-Disease Associations)", "elongated radius (HP:0006424 from HPO Gene-Disease Associations)", "disproportionate prominence of the femoral medial condyle (HP:0006437 from HPO Gene-Disease Associations)", "iliac horns (HP:0009780 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the musculature of the upper arm (HP:0001468 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the triceps (HP:0009784 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the biceps (HP:0009782 from HPO Gene-Disease Associations)", "triceps aplasia (HP:0009785 from HPO Gene-Disease Associations)", "biceps aplasia (HP:0009783 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the musculature of the thigh (HP:0009786 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the quadriceps (HP:0009787 from HPO Gene-Disease Associations)", "quadriceps aplasia (HP:0009788 from HPO Gene-Disease Associations)", "absence of pectoralis minor muscle (HP:0005255 from HPO Gene-Disease Associations)", "thickening of the lateral border of the scapula (HP:0006650 from HPO Gene-Disease Associations)", "lester's sign (HP:0009781 from HPO Gene-Disease Associations)", "microphakia (HP:0012376 from HPO Gene-Disease Associations)", "antecubital pterygium (HP:0009760 from HPO Gene-Disease Associations)", "abnormality of the glenoid fossa (HP:0011912 from HPO Gene-Disease Associations)", "glenoid fossa hypoplasia (HP:0006633 from HPO Gene-Disease Associations)", "concave nail (HP:0001598 from HPO Gene-Disease Associations)", "crusting erythematous dermatitis (HP:0007473 from HPO Gene-Disease Associations)", "urinary bladder inflammation (HP:0100577 from HPO Gene-Disease Associations)", "diffuse telangiectasia (HP:0007489 from HPO Gene-Disease Associations)", "chronic lung disease (HP:0006528 from HPO Gene-Disease Associations)", "abnormality of the aryepiglottic fold (HP:0008744 from HPO Gene-Disease Associations)", "aplasia of the epiglottis (HP:0008753 from HPO Gene-Disease Associations)", "alveolar ridge cleft (HP:0010289 from HPO Gene-Disease Associations)", "cleft lower alveolar ridge (HP:0009094 from HPO Gene-Disease Associations)", "agenesis of mandibular central incisor (HP:0006355 from HPO Gene-Disease Associations)", "agenesis of mandibular incisor (HP:0200161 from HPO Gene-Disease Associations)", "agenesis of central incisor (HP:0006289 from HPO Gene-Disease Associations)", "cleft mandible (HP:0010752 from HPO Gene-Disease Associations)", "acetabular dysplasia (HP:0008807 from HPO Gene-Disease Associations)", "microretrognathia (HP:0000308 from HPO Gene-Disease Associations)", "retrognathia (HP:0000278 from HPO Gene-Disease Associations)", "bilobate gallbladder (HP:0005608 from HPO Gene-Disease Associations)", "short lingual frenulum (HP:0000200 from HPO Gene-Disease Associations)", "microtia, second degree (HP:0008569 from HPO Gene-Disease Associations)", "facial telangiectasia in butterfly midface distribution (HP:0005598 from HPO Gene-Disease Associations)", "agenesis of incisor (HP:0006485 from HPO Gene-Disease Associations)", "agenesis of lateral incisor (HP:0200153 from HPO Gene-Disease Associations)", "agenesis of maxillary incisor (HP:0200160 from HPO Gene-Disease Associations)", "agenesis of maxillary lateral incisor (HP:0000690 from HPO Gene-Disease Associations)", "selective tooth agenesis (HP:0001592 from HPO Gene-Disease Associations)", "minimal subcutaneous fat (HP:0003717 from HPO Gene-Disease Associations)", "spotty hypopigmentation (HP:0005590 from HPO Gene-Disease Associations)", "spotty hyperpigmentation (HP:0005585 from HPO Gene-Disease Associations)", "diffuse skin atrophy (HP:0007488 from HPO Gene-Disease Associations)", "telangiectases in sun-exposed and nonexposed skin (HP:0007561 from HPO Gene-Disease Associations)", "sinus tachycardia (HP:0011703 from HPO Gene-Disease Associations)", "facial telangiectasia (HP:0007380 from HPO Gene-Disease Associations)", "telangiectases of the cheeks (HP:0007421 from HPO Gene-Disease Associations)", "aortic tortuosity (HP:0006687 from HPO Gene-Disease Associations)", "joint swelling onset late infancy (HP:0005833 from HPO Gene-Disease Associations)", "facial wrinkling (HP:0009762 from HPO Gene-Disease Associations)", "multiple joint contractures (HP:0002828 from HPO Gene-Disease Associations)", "high pitched voice (HP:0001620 from HPO Gene-Disease Associations)", "prominent nose (HP:0000448 from HPO Gene-Disease Associations)", "choroidal sclerosis (HP:0001150 from HPO Gene-Disease Associations)", "marginal corneal dystrophy (HP:0007880 from HPO Gene-Disease Associations)", "progressive night blindness (HP:0007675 from HPO Gene-Disease Associations)", "malrotation of colon (HP:0004785 from HPO Gene-Disease Associations)", "duplication of internal organs (HP:0005217 from HPO Gene-Disease Associations)", "supraauricular pit (HP:0008606 from HPO Gene-Disease Associations)", "postauricular pit (HP:0004464 from HPO Gene-Disease Associations)", "fusion of middle ear ossicles (HP:0005473 from HPO Gene-Disease Associations)", "short nasal septum (HP:0000420 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the vagina (HP:0011026 from HPO Gene-Disease Associations)", "hypoplasia of the vagina (HP:0008726 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the uterus (HP:0008684 from HPO Gene-Disease Associations)", "hypoplasia of the uterus (HP:0000013 from HPO Gene-Disease Associations)", "pyramidal skinfold extending from the base to the top of the nails (HP:0009758 from HPO Gene-Disease Associations)", "fibrous syngnathia (HP:0009754 from HPO Gene-Disease Associations)", "paramedian lip pit (HP:0100269 from HPO Gene-Disease Associations)", "lower lip pit (HP:0000196 from HPO Gene-Disease Associations)", "renal sodium wasting (HP:0012606 from HPO Gene-Disease Associations)", "salt craving (HP:0030083 from HPO Gene-Disease Associations)", "chronic axonal neuropathy (HP:0007267 from HPO Gene-Disease Associations)", "abnormality of cochlea (HP:0000375 from HPO Gene-Disease Associations)", "morphological abnormality of the inner ear (HP:0011390 from HPO Gene-Disease Associations)", "cochlear malformation (HP:0008554 from HPO Gene-Disease Associations)", "incomplete partition of the cochlea (HP:0011373 from HPO Gene-Disease Associations)", "incomplete partition of the cochlea type ii (HP:0000376 from HPO Gene-Disease Associations)", "morphological abnormality of the vestibule of the inner ear (HP:0011376 from HPO Gene-Disease Associations)", "enlarged vestibular aqueduct (HP:0011387 from HPO Gene-Disease Associations)", "impaired gluconeogenesis (HP:0005959 from HPO Gene-Disease Associations)", "renal steatosis (HP:0000799 from HPO Gene-Disease Associations)", "branchial anomaly (HP:0009794 from HPO Gene-Disease Associations)", "branchial fistula (HP:0009795 from HPO Gene-Disease Associations)", "commissural lip pit (HP:0002710 from HPO Gene-Disease Associations)", "lip pit (HP:0100267 from HPO Gene-Disease Associations)", "branchial cyst (HP:0009796 from HPO Gene-Disease Associations)", "gustatory lacrimation (HP:0100274 from HPO Gene-Disease Associations)", "cholesteatoma (HP:0009797 from HPO Gene-Disease Associations)", "abnormality of the internal auditory canal (HP:0011384 from HPO Gene-Disease Associations)", "dilatated internal auditory canal (HP:0004458 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the cochlea (HP:0011395 from HPO Gene-Disease Associations)", "hypoplasia of the cochlea (HP:0008586 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the inner ear (HP:0008774 from HPO Gene-Disease Associations)", "overbite (HP:0011094 from HPO Gene-Disease Associations)", "abnormality of periauricular region (HP:0000383 from HPO Gene-Disease Associations)", "preauricular skin tag (HP:0000384 from HPO Gene-Disease Associations)", "skin tags (HP:0010609 from HPO Gene-Disease Associations)", "periauricular skin pits (HP:0100277 from HPO Gene-Disease Associations)", "preauricular pit (HP:0004467 from HPO Gene-Disease Associations)", "skin pit (HP:0100276 from HPO Gene-Disease Associations)", "delayed ossification of pubic rami (HP:0008785 from HPO Gene-Disease Associations)", "scapulohumeral synostosis (HP:0006595 from HPO Gene-Disease Associations)", "elevated amniotic fluid alpha-fetoprotein (HP:0004639 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the bladder (HP:0010476 from HPO Gene-Disease Associations)", "hypoplasia of the bladder (HP:0005343 from HPO Gene-Disease Associations)", "accessory spleen (HP:0001747 from HPO Gene-Disease Associations)", "supernumerary spleens (HP:0009799 from HPO Gene-Disease Associations)", "polysplenia (HP:0001748 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the spleen (HP:0010451 from HPO Gene-Disease Associations)", "asplenia (HP:0001746 from HPO Gene-Disease Associations)", "laryngeal hypoplasia (HP:0008749 from HPO Gene-Disease Associations)", "agenesis of the diaphragm (HP:0008986 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the diaphragm (HP:0010315 from HPO Gene-Disease Associations)", "cleft in skull base (HP:0009752 from HPO Gene-Disease Associations)", "severe hydrocephalus (HP:0006882 from HPO Gene-Disease Associations)", "proximal tibial hypopolasia (HP:0006379 from HPO Gene-Disease Associations)", "bifid nose (HP:0011803 from HPO Gene-Disease Associations)", "broad neck (HP:0000475 from HPO Gene-Disease Associations)", "peripheral pulmonary vessel aplasia (HP:0005316 from HPO Gene-Disease Associations)", "amelia (HP:0009827 from HPO Gene-Disease Associations)", "tetraamelia (HP:0003057 from HPO Gene-Disease Associations)", "urethral atresia (HP:0000068 from HPO Gene-Disease Associations)", "gastroschisis (HP:0001543 from HPO Gene-Disease Associations)", "adrenal gland agenesis (HP:0011743 from HPO Gene-Disease Associations)", "adrenal gland dysgenesis (HP:0008216 from HPO Gene-Disease Associations)", "abnormality of the fallopian tube (HP:0011027 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the fallopian tube (HP:0008655 from HPO Gene-Disease Associations)", "hypoplasia of the fallopian tube (HP:0008697 from HPO Gene-Disease Associations)", "single naris (HP:0009932 from HPO Gene-Disease Associations)", "abnormal umbilical cord blood vessels (HP:0011403 from HPO Gene-Disease Associations)", "abnormality of the fetal cardiovascular system (HP:0010948 from HPO Gene-Disease Associations)", "single umbilical artery (HP:0001195 from HPO Gene-Disease Associations)", "abnormality of the umbilical cord (HP:0010881 from HPO Gene-Disease Associations)", "abnormalities of placenta or umbilical cord (HP:0001194 from HPO Gene-Disease Associations)", "slender metacarpals (HP:0006236 from HPO Gene-Disease Associations)", "long metacarpals (HP:0010493 from HPO Gene-Disease Associations)", "distal ulnar hypoplasia (HP:0005033 from HPO Gene-Disease Associations)", "narrow foot (HP:0001786 from HPO Gene-Disease Associations)", "maternal diabetes (HP:0009800 from HPO Gene-Disease Associations)", "prenatal maternal abnormality (HP:0002686 from HPO Gene-Disease Associations)", "aplasia|hypoplasia affecting the fundus (HP:0008057 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the optic nerve (HP:0008058 from HPO Gene-Disease Associations)", "optic nerve hypoplasia (HP:0000609 from HPO Gene-Disease Associations)", "abnormality of the septum pellucidum (HP:0007375 from HPO Gene-Disease Associations)", "absent septum pellucidum (HP:0001331 from HPO Gene-Disease Associations)", "septo-optic dysplasia (HP:0100842 from HPO Gene-Disease Associations)", "pituitary dwarfism (HP:0000839 from HPO Gene-Disease Associations)", "marked delay in bone age (HP:0003799 from HPO Gene-Disease Associations)", "small sella turcica (HP:0010538 from HPO Gene-Disease Associations)", "abnormal prolactin level (HP:0040086 from HPO Gene-Disease Associations)", "prolactin deficiency (HP:0008202 from HPO Gene-Disease Associations)", "pulmonary artery atresia (HP:0004935 from HPO Gene-Disease Associations)", "abnormal branching pattern of the aortic arch (HP:0011587 from HPO Gene-Disease Associations)", "abnormality of the aortic arch (HP:0012303 from HPO Gene-Disease Associations)", "right aortic arch (HP:0012020 from HPO Gene-Disease Associations)", "right aortic arch with mirror image branching (HP:0002627 from HPO Gene-Disease Associations)", "atrioventricular canal defect with right ventricle aorta and pulmonary atresia (HP:0005298 from HPO Gene-Disease Associations)", "agenesis of pulmonary vessels (HP:0005311 from HPO Gene-Disease Associations)", "hypoplastic left atrium (HP:0005156 from HPO Gene-Disease Associations)", "bilateral lung agenesis (HP:0005944 from HPO Gene-Disease Associations)", "pelvic kidney (HP:0000125 from HPO Gene-Disease Associations)", "annular pancreas (HP:0001734 from HPO Gene-Disease Associations)", "ectopia of the spleen (HP:0010452 from HPO Gene-Disease Associations)", "unilateral primary pulmonary dysgenesis (HP:0006549 from HPO Gene-Disease Associations)", "femoral hernia (HP:0100541 from HPO Gene-Disease Associations)", "parathyroid agenesis (HP:0008211 from HPO Gene-Disease Associations)", "bipolar affective disorder (HP:0007302 from HPO Gene-Disease Associations)", "mania (HP:0100754 from HPO Gene-Disease Associations)", "schizophrenia (HP:0100753 from HPO Gene-Disease Associations)", "subungual hyperkeratotic fragments (HP:0008410 from HPO Gene-Disease Associations)", "acrokeratosis (HP:0200016 from HPO Gene-Disease Associations)", "enlargement of parotid gland (HP:0011801 from HPO Gene-Disease Associations)", "mood swings (HP:0000720 from HPO Gene-Disease Associations)", "horizontal eyebrow (HP:0011228 from HPO Gene-Disease Associations)", "abnormality of the pulmonary veins (HP:0011718 from HPO Gene-Disease Associations)", "anomalous pulmonary venous return (HP:0010772 from HPO Gene-Disease Associations)", "abnormal atrial arrangement (HP:0011535 from HPO Gene-Disease Associations)", "right atrial isomerism (HP:0011536 from HPO Gene-Disease Associations)", "common atrium (HP:0011565 from HPO Gene-Disease Associations)", "abnormal connection of the cardiac segments (HP:0011545 from HPO Gene-Disease Associations)", "abnormal ventriculo-arterial connection (HP:0011563 from HPO Gene-Disease Associations)", "transposition of the great arteries (HP:0001669 from HPO Gene-Disease Associations)", "truncus arteriosus (HP:0001660 from HPO Gene-Disease Associations)", "congenital malformation of the right heart (HP:0011723 from HPO Gene-Disease Associations)", "double outlet right ventricle (HP:0001719 from HPO Gene-Disease Associations)", "hypoplastic heart (HP:0001961 from HPO Gene-Disease Associations)", "congenital malformation of the left heart (HP:0045017 from HPO Gene-Disease Associations)", "hypoplastic left heart (HP:0004383 from HPO Gene-Disease Associations)", "atrioventricular canal defect (HP:0006695 from HPO Gene-Disease Associations)", "complete atrioventricular canal defect (HP:0001674 from HPO Gene-Disease Associations)", "ectopic thyroid (HP:0100028 from HPO Gene-Disease Associations)", "abnormal atrioventricular connection (HP:0011546 from HPO Gene-Disease Associations)", "mitral atresia (HP:0011560 from HPO Gene-Disease Associations)", "aortic valve atresia (HP:0010883 from HPO Gene-Disease Associations)", "prolonged pr interval (HP:0012248 from HPO Gene-Disease Associations)", "secundum atrial septal defect (HP:0001684 from HPO Gene-Disease Associations)", "thyroid dysgenesis (HP:0008188 from HPO Gene-Disease Associations)", "thyroid hypoplasia (HP:0005990 from HPO Gene-Disease Associations)", "thyroid agenesis (HP:0008191 from HPO Gene-Disease Associations)", "large posterior fontanelle (HP:0004491 from HPO Gene-Disease Associations)", "recurrent bronchopulmonary infections (HP:0006538 from HPO Gene-Disease Associations)", "gastrointestinal dysmotility (HP:0002579 from HPO Gene-Disease Associations)", "ileus (HP:0002595 from HPO Gene-Disease Associations)", "mechanical ileus (HP:0010676 from HPO Gene-Disease Associations)", "meconium ileus (HP:0004401 from HPO Gene-Disease Associations)", "vitamin b12 deficiency (HP:0100502 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the colon (HP:0100811 from HPO Gene-Disease Associations)", "intestinal hypoplasia (HP:0005245 from HPO Gene-Disease Associations)", "microcolon (HP:0004388 from HPO Gene-Disease Associations)", "fetal megacystis (HP:0010956 from HPO Gene-Disease Associations)", "muscular ventricular septal defect (HP:0011623 from HPO Gene-Disease Associations)", "perimembranous ventricular septal defect (HP:0011682 from HPO Gene-Disease Associations)", "pleural effusion (HP:0002202 from HPO Gene-Disease Associations)", "pancreatic pseudocyst (HP:0005206 from HPO Gene-Disease Associations)", "pancreatic calcification (HP:0005213 from HPO Gene-Disease Associations)", "insulin-dependent but ketosis-resistant diabetes (HP:0008205 from HPO Gene-Disease Associations)", "abnormality of exocrine pancreas physiology (HP:0012092 from HPO Gene-Disease Associations)", "exocrine pancreatic insufficiency (HP:0001738 from HPO Gene-Disease Associations)", "abnormal pancreas size (HP:0012094 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the pancreas (HP:0100800 from HPO Gene-Disease Associations)", "pancreatic hypoplasia (HP:0002594 from HPO Gene-Disease Associations)", "multiple glomerular cysts (HP:0100611 from HPO Gene-Disease Associations)", "decreased numbers of nephrons (HP:0005563 from HPO Gene-Disease Associations)", "maturity-onset diabetes of the young (HP:0004904 from HPO Gene-Disease Associations)", "late onset (HP:0003584 from HPO Gene-Disease Associations)", "adult onset (HP:0003581 from HPO Gene-Disease Associations)", "hepatocellular adenoma (HP:0012028 from HPO Gene-Disease Associations)", "ambiguous genitalia, female (HP:0000061 from HPO Gene-Disease Associations)", "ambiguous genitalia, male (HP:0000033 from HPO Gene-Disease Associations)", "hydranencephaly (HP:0002324 from HPO Gene-Disease Associations)", "prominent coccyx (HP:0040016 from HPO Gene-Disease Associations)", "prominent protruding coccyx (HP:0008472 from HPO Gene-Disease Associations)", "protruding coccyx (HP:0040017 from HPO Gene-Disease Associations)", "absent proximal finger flexion creases (HP:0006077 from HPO Gene-Disease Associations)", "anterior rounding of vertebral bodies (HP:0008488 from HPO Gene-Disease Associations)", "facial hirsutism (HP:0009937 from HPO Gene-Disease Associations)", "localized hirsutism (HP:0009889 from HPO Gene-Disease Associations)", "alveolar ridge overgrowth (HP:0009085 from HPO Gene-Disease Associations)", "profound hearing impairment (HP:0012715 from HPO Gene-Disease Associations)", "profound sensorineural hearing impairment (HP:0011476 from HPO Gene-Disease Associations)", "aplasia of the inner ear (HP:0011372 from HPO Gene-Disease Associations)", "microtia, first degree (HP:0011266 from HPO Gene-Disease Associations)", "short metacarpals with rounded proximal ends (HP:0006161 from HPO Gene-Disease Associations)", "irregular capital femoral epiphysis (HP:0005041 from HPO Gene-Disease Associations)", "wrist flexion contracture (HP:0001239 from HPO Gene-Disease Associations)", "flattened metacarpal heads (HP:0011909 from HPO Gene-Disease Associations)", "generalized morning stiffness (HP:0005197 from HPO Gene-Disease Associations)", "synovial hypertrophy (HP:0005186 from HPO Gene-Disease Associations)", "constrictive pericarditis (HP:0002563 from HPO Gene-Disease Associations)", "congenital finger flexion contractures (HP:0005879 from HPO Gene-Disease Associations)", "arthropathy (HP:0003040 from HPO Gene-Disease Associations)", "deficiency of n-acetylglucosamine-1-phosphotransferase (HP:0003264 from HPO Gene-Disease Associations)", "beaking of vertebral bodies t12-l3 (HP:0004562 from HPO Gene-Disease Associations)", "progressive alveolar ridge hypertropy (HP:0009092 from HPO Gene-Disease Associations)", "lower thoracic interpediculate narrowness (HP:0008470 from HPO Gene-Disease Associations)", "soft tissue swelling of interphalangeal joints (HP:0006162 from HPO Gene-Disease Associations)", "varus deformity of humeral neck (HP:0006362 from HPO Gene-Disease Associations)", "abnormality of the humeral heads (HP:0003887 from HPO Gene-Disease Associations)", "increased serum iduronate sulfatase activity (HP:0003538 from HPO Gene-Disease Associations)", "abnormality of proteoglycan metabolism (HP:0004355 from HPO Gene-Disease Associations)", "hyperopic astigmatism (HP:0000484 from HPO Gene-Disease Associations)", "increased serum beta-hexosaminidase (HP:0003333 from HPO Gene-Disease Associations)", "bullet-shaped phalanges of the hand (HP:0009769 from HPO Gene-Disease Associations)", "atlantoaxial dislocation (HP:0003414 from HPO Gene-Disease Associations)", "large sella turcica (HP:0002690 from HPO Gene-Disease Associations)", "severe postnatal growth retardation (HP:0008850 from HPO Gene-Disease Associations)", "reduced pancreatic beta cells (HP:0006274 from HPO Gene-Disease Associations)", "irregular tarsal ossification (HP:0008134 from HPO Gene-Disease Associations)", "abnormally shaped carpal bones (HP:0006014 from HPO Gene-Disease Associations)", "irregular carpal bones (HP:0004236 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the carpal bones (HP:0006502 from HPO Gene-Disease Associations)", "carpal bone hypoplasia (HP:0001498 from HPO Gene-Disease Associations)", "reduced factor xii activity (HP:0004841 from HPO Gene-Disease Associations)", "midfrontal capillary hemangioma (HP:0007466 from HPO Gene-Disease Associations)", "thoracolumbar kyphoscoliosis (HP:0003423 from HPO Gene-Disease Associations)", "abnormality of the thoracic spine (HP:0100711 from HPO Gene-Disease Associations)", "thoracic kyphosis (HP:0002942 from HPO Gene-Disease Associations)", "thoracolumbar kyphosis (HP:0005619 from HPO Gene-Disease Associations)", "abnormality of the lumbar spine (HP:0100712 from HPO Gene-Disease Associations)", "abnormality of ganglioside metabolism (HP:0004345 from HPO Gene-Disease Associations)", "abnormality of glycolipid metabolism (HP:0010969 from HPO Gene-Disease Associations)", "abnormality of glycosphingolipid metabolism (HP:0004343 from HPO Gene-Disease Associations)", "abnormality of liposaccharide metabolism (HP:0010968 from HPO Gene-Disease Associations)", "gm2-ganglioside accumulation (HP:0003495 from HPO Gene-Disease Associations)", "aspiration (HP:0002835 from HPO Gene-Disease Associations)", "exaggerated startle response (HP:0002267 from HPO Gene-Disease Associations)", "poor head control (HP:0002421 from HPO Gene-Disease Associations)", "endopolyploidy on chromosome studies of bone marrow (HP:0003352 from HPO Gene-Disease Associations)", "reduced activity of n-acetylglucosaminyltransferase ii (HP:0003655 from HPO Gene-Disease Associations)", "abnormality of glycoprotein metabolism (HP:0004367 from HPO Gene-Disease Associations)", "macrocytic dyserythropoietic anemia (HP:0005532 from HPO Gene-Disease Associations)", "weak voice (HP:0001621 from HPO Gene-Disease Associations)", "pericardial constriction (HP:0005132 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the choroid (HP:0001122 from HPO Gene-Disease Associations)", "hypoplasia of choroid (HP:0007757 from HPO Gene-Disease Associations)", "decreased retinal pigmentation with dispersion (HP:0007659 from HPO Gene-Disease Associations)", "abnormality of the sella turcica (HP:0002679 from HPO Gene-Disease Associations)", "deformed sella turcica (HP:0002681 from HPO Gene-Disease Associations)", "j-shaped sella turcica (HP:0002680 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the pyramidal tract (HP:0007363 from HPO Gene-Disease Associations)", "hypoplasia of the pyramidal tract (HP:0007348 from HPO Gene-Disease Associations)", "myocardial fibrosis (HP:0001685 from HPO Gene-Disease Associations)", "spinocerebellar tract disease in lower limbs (HP:0007232 from HPO Gene-Disease Associations)", "progressive retinal degeneration (HP:0007893 from HPO Gene-Disease Associations)", "spinal cord lesions (HP:0100561 from HPO Gene-Disease Associations)", "syringomyelia (HP:0003396 from HPO Gene-Disease Associations)", "osteopoikilosis (HP:0010739 from HPO Gene-Disease Associations)", "triangular shaped distal phalanges of the hand (HP:0009875 from HPO Gene-Disease Associations)", "progressive calcification of costochondral cartilage (HP:0006600 from HPO Gene-Disease Associations)", "long fibula (HP:0003085 from HPO Gene-Disease Associations)", "abnormal calcification of the carpal bones (HP:0009164 from HPO Gene-Disease Associations)", "atlantoaxial abnormality (HP:0003413 from HPO Gene-Disease Associations)", "atlantoaxial instability (HP:0003467 from HPO Gene-Disease Associations)", "abnormal humeral ossification (HP:0012791 from HPO Gene-Disease Associations)", "irregular ossification of the humeral epiphyses (HP:0003897 from HPO Gene-Disease Associations)", "multicentric ossification of proximal humeral epiphyses (HP:0004997 from HPO Gene-Disease Associations)", "multicentric ossification of proximal femoral epiphyses (HP:0006450 from HPO Gene-Disease Associations)", "delayed femoral head ossification (HP:0008829 from HPO Gene-Disease Associations)", "multicentric femoral head ossification (HP:0008835 from HPO Gene-Disease Associations)", "iliac crest serration (HP:0008786 from HPO Gene-Disease Associations)", "irregular iliac crest (HP:0003796 from HPO Gene-Disease Associations)", "abnormal ossification involving the femoral head and neck (HP:0009107 from HPO Gene-Disease Associations)", "hypoplastic acetabulae (HP:0003274 from HPO Gene-Disease Associations)", "prominent sternum (HP:0000884 from HPO Gene-Disease Associations)", "absent glenoid fossa (HP:0006591 from HPO Gene-Disease Associations)", "flat glenoid fossa (HP:0000911 from HPO Gene-Disease Associations)", "abnormality of the humeral epiphysis (HP:0003891 from HPO Gene-Disease Associations)", "stippled calcification of the humeral epiphyses (HP:0003901 from HPO Gene-Disease Associations)", "stippled calcification proximal humeral epiphyses (HP:0008838 from HPO Gene-Disease Associations)", "vacuolated lymphocytes (HP:0001922 from HPO Gene-Disease Associations)", "aspartylglucosaminuria (HP:0012068 from HPO Gene-Disease Associations)", "angiokeratoma (HP:0001014 from HPO Gene-Disease Associations)", "angiokeratoma corporis diffusum (HP:0001071 from HPO Gene-Disease Associations)", "glycopeptiduria (HP:0012067 from HPO Gene-Disease Associations)", "increased urinary o-linked sialopeptides (HP:0003461 from HPO Gene-Disease Associations)", "white mater abnormalities in the posterior periventricular region (HP:0006812 from HPO Gene-Disease Associations)", "telangiectasia of the oral mucosa (HP:0007428 from HPO Gene-Disease Associations)", "urinary excretion of sialylated oligosaccharides (HP:0012061 from HPO Gene-Disease Associations)", "slurred speech (HP:0001350 from HPO Gene-Disease Associations)", "oligosacchariduria (HP:0010471 from HPO Gene-Disease Associations)", "cervical platyspondyly (HP:0004558 from HPO Gene-Disease Associations)", "anterior beaking of thoracic vertebrae (HP:0004630 from HPO Gene-Disease Associations)", "absent|hypoplastic coccyx (HP:0008436 from HPO Gene-Disease Associations)", "tortuosity of conjunctival vessels (HP:0000503 from HPO Gene-Disease Associations)", "abnormal sweat homeostasis (HP:0040127 from HPO Gene-Disease Associations)", "elevated sweat chloride (HP:0012236 from HPO Gene-Disease Associations)", "pseudohypoaldosteronism (HP:0008242 from HPO Gene-Disease Associations)", "abnormality of glycosaminoglycan metabolism (HP:0004371 from HPO Gene-Disease Associations)", "abnormality of mucopolysaccharide metabolism (HP:0011020 from HPO Gene-Disease Associations)", "abnormality of polysaccharide metabolism (HP:0011012 from HPO Gene-Disease Associations)", "mucopolysacchariduria (HP:0008155 from HPO Gene-Disease Associations)", "urinary glycosaminoglycan excretion (HP:0003541 from HPO Gene-Disease Associations)", "dysostosis multiplex (HP:0000943 from HPO Gene-Disease Associations)", "heparan sulfate excretion in urine (HP:0002159 from HPO Gene-Disease Associations)", "thickened ribs (HP:0000900 from HPO Gene-Disease Associations)", "dense calvaria (HP:0000250 from HPO Gene-Disease Associations)", "increased skull ossification (HP:0004330 from HPO Gene-Disease Associations)", "ovoid thoracolumbar vertebrae (HP:0003309 from HPO Gene-Disease Associations)", "asymmetric septal hypertrophy (HP:0001670 from HPO Gene-Disease Associations)", "cellular metachromasia (HP:0003653 from HPO Gene-Disease Associations)", "joint stiffness (HP:0001387 from HPO Gene-Disease Associations)", "ovoid vertebral bodies (HP:0003300 from HPO Gene-Disease Associations)", "dermatan sulfate excretion in urine (HP:0008301 from HPO Gene-Disease Associations)", "anterior wedging of l1 (HP:0008432 from HPO Gene-Disease Associations)", "anterior wedging of l2 (HP:0011941 from HPO Gene-Disease Associations)", "chondroitin sulfate excretion in urine (HP:0012070 from HPO Gene-Disease Associations)", "keratan sulfate excretion in urine (HP:0012069 from HPO Gene-Disease Associations)", "pointed proximal second through fifth metacarpals (HP:0001223 from HPO Gene-Disease Associations)", "constricted iliac wings (HP:0003277 from HPO Gene-Disease Associations)", "grayish enamel (HP:0000683 from HPO Gene-Disease Associations)", "epiphyseal deformities of tubular bones (HP:0003053 from HPO Gene-Disease Associations)", "proximal tapering of metacarpals (HP:0006119 from HPO Gene-Disease Associations)", "flaring of rib cage (HP:0000904 from HPO Gene-Disease Associations)", "cervical myelopathy (HP:0002318 from HPO Gene-Disease Associations)", "myelopathy (HP:0002196 from HPO Gene-Disease Associations)", "abnormality of galactoside metabolism (HP:0004342 from HPO Gene-Disease Associations)", "abnormality of glycoside metabolism (HP:0003649 from HPO Gene-Disease Associations)", "decreased beta-galactosidase activity (HP:0008166 from HPO Gene-Disease Associations)", "cerebral degeneration (HP:0007313 from HPO Gene-Disease Associations)", "intimal thickening in the coronary arteries (HP:0005292 from HPO Gene-Disease Associations)", "impaired thermal sensitivity (HP:0006901 from HPO Gene-Disease Associations)", "progressive psychomotor deterioration (HP:0007272 from HPO Gene-Disease Associations)", "cherry red spot of the macula (HP:0010729 from HPO Gene-Disease Associations)", "neurodegeneration (HP:0002180 from HPO Gene-Disease Associations)", "anterior beaking of lower thoracic vertebrae (HP:0004607 from HPO Gene-Disease Associations)", "anterior beaking of lumbar vertebrae (HP:0008430 from HPO Gene-Disease Associations)", "reye syndrome-like episodes (HP:0006582 from HPO Gene-Disease Associations)", "osteomyelitis leading to amputation due to slow healing fractures (HP:0005010 from HPO Gene-Disease Associations)", "stenosis of the medullary cavity of the long bones (HP:0100254 from HPO Gene-Disease Associations)", "presenile cataracts (HP:0007819 from HPO Gene-Disease Associations)", "diaphyseal cortical sclerosis (HP:0005045 from HPO Gene-Disease Associations)", "quadriceps muscle atrophy (HP:0009050 from HPO Gene-Disease Associations)", "hypoplastic spleen (HP:0006270 from HPO Gene-Disease Associations)", "transient hypophosphatemia (HP:0008285 from HPO Gene-Disease Associations)", "abnormality of the medullary cavity of the long bones (HP:0100253 from HPO Gene-Disease Associations)", "retinal calcification (HP:0007862 from HPO Gene-Disease Associations)", "aniridia (HP:0000526 from HPO Gene-Disease Associations)", "anterior segment of eye aplasia (HP:0007779 from HPO Gene-Disease Associations)", "dysesthesia (HP:0012534 from HPO Gene-Disease Associations)", "sensorimotor neuropathy (HP:0007141 from HPO Gene-Disease Associations)", "hepatosplenomegaly (HP:0001433 from HPO Gene-Disease Associations)", "mandibular osteomyelitis (HP:0007626 from HPO Gene-Disease Associations)", "facial paralysis (HP:0007209 from HPO Gene-Disease Associations)", "chronic rhinitis due to narrow nasal airway (HP:0004499 from HPO Gene-Disease Associations)", "periodontitis (HP:0000704 from HPO Gene-Disease Associations)", "abnormality of primary teeth (HP:0006481 from HPO Gene-Disease Associations)", "premature loss of primary teeth (HP:0006323 from HPO Gene-Disease Associations)", "premature loss of teeth (HP:0006480 from HPO Gene-Disease Associations)", "sandwich appearance of vertebral bodies (HP:0004618 from HPO Gene-Disease Associations)", "progressive sclerosis of skull base (HP:0005477 from HPO Gene-Disease Associations)", "prominent scalp veins (HP:0001043 from HPO Gene-Disease Associations)", "broad clavicles (HP:0000916 from HPO Gene-Disease Associations)", "broad ribs (HP:0000885 from HPO Gene-Disease Associations)", "abnormal cortical bone morphology (HP:0003103 from HPO Gene-Disease Associations)", "thickened cortex of bones (HP:0100039 from HPO Gene-Disease Associations)", "thickened cortex of long bones (HP:0000935 from HPO Gene-Disease Associations)", "cortically dense long tubular bones (HP:0006415 from HPO Gene-Disease Associations)", "sclerotic scapulae (HP:0001474 from HPO Gene-Disease Associations)", "facial palsy secondary to cranial hyperostosis (HP:0007285 from HPO Gene-Disease Associations)", "optic atrophy from cranial nerve compression (HP:0007958 from HPO Gene-Disease Associations)", "sclerotic vertebral endplates (HP:0004576 from HPO Gene-Disease Associations)", "facial hyperostosis (HP:0005465 from HPO Gene-Disease Associations)", "concave nasal ridge (HP:0011120 from HPO Gene-Disease Associations)", "cortical thickening of long bone diaphyses (HP:0005791 from HPO Gene-Disease Associations)", "limb pain (HP:0009763 from HPO Gene-Disease Associations)", "diaphyseal sclerosis (HP:0003034 from HPO Gene-Disease Associations)", "increased density of long bones (HP:0006392 from HPO Gene-Disease Associations)", "cranial nerve compression (HP:0001293 from HPO Gene-Disease Associations)", "optic nerve compression (HP:0007807 from HPO Gene-Disease Associations)", "cardiac myxoma (HP:0011672 from HPO Gene-Disease Associations)", "cutaneous syndactyly of toes (HP:0010621 from HPO Gene-Disease Associations)", "2-3 toe cutaneous syndactyly (HP:0005709 from HPO Gene-Disease Associations)", "progressive hypotrichosis (HP:0002296 from HPO Gene-Disease Associations)", "anodontia (HP:0000674 from HPO Gene-Disease Associations)", "congenital hypoparathyroidism (HP:0008198 from HPO Gene-Disease Associations)", "calvarial osteosclerosis (HP:0005450 from HPO Gene-Disease Associations)", "severe intrauterine growth retardation (HP:0008846 from HPO Gene-Disease Associations)", "patchy changes of bone mineral density (HP:0010658 from HPO Gene-Disease Associations)", "patchy osteosclerosis (HP:0005686 from HPO Gene-Disease Associations)", "paranasal sinus hypoplasia (HP:0006784 from HPO Gene-Disease Associations)", "craniofacial osteosclerosis (HP:0005464 from HPO Gene-Disease Associations)", "2-4 toe cutaneous syndactyly (HP:0005768 from HPO Gene-Disease Associations)", "4-5 finger syndactyly (HP:0010705 from HPO Gene-Disease Associations)", "absent middle phalanx of 5th finger (HP:0009162 from HPO Gene-Disease Associations)", "aplasia of the 5th finger (HP:0009238 from HPO Gene-Disease Associations)", "irregular sclerosis of hand bones (HP:0004281 from HPO Gene-Disease Associations)", "patchy sclerosis of finger phalanx (HP:0009772 from HPO Gene-Disease Associations)", "patchy sclerosis of hand bones (HP:0004286 from HPO Gene-Disease Associations)", "fifth finger distal phalanx clinodactyly (HP:0005769 from HPO Gene-Disease Associations)", "vertebral hyperostosis (HP:0008442 from HPO Gene-Disease Associations)", "thin anteverted nares (HP:0004495 from HPO Gene-Disease Associations)", "inlet ventricular septal defect (HP:0011622 from HPO Gene-Disease Associations)", "primum atrial septal defect (HP:0010445 from HPO Gene-Disease Associations)", "broad columella (HP:0010761 from HPO Gene-Disease Associations)", "3-4 toe syndactyly (HP:0009779 from HPO Gene-Disease Associations)", "club-shaped distal femur (HP:0006384 from HPO Gene-Disease Associations)", "bony paranasal bossing (HP:0004407 from HPO Gene-Disease Associations)", "fullness of paranasal tissue (HP:0012812 from HPO Gene-Disease Associations)", "nasal obstruction (HP:0001742 from HPO Gene-Disease Associations)", "polyarticular chondrocalcinosis (HP:0005017 from HPO Gene-Disease Associations)", "hyperactive deep tendon reflexes (HP:0006801 from HPO Gene-Disease Associations)", "externally rotated hips (HP:0008796 from HPO Gene-Disease Associations)", "prominent epicanthal folds (HP:0007930 from HPO Gene-Disease Associations)", "radially deviated wrists (HP:0006190 from HPO Gene-Disease Associations)", "joint contracture of the 5th finger (HP:0009183 from HPO Gene-Disease Associations)", "atrial cardiomyopathy (HP:0200127 from HPO Gene-Disease Associations)", "ectopic supraventricular rhythms (HP:0006699 from HPO Gene-Disease Associations)", "first degree atrioventricular block (HP:0011705 from HPO Gene-Disease Associations)", "brain stem compression (HP:0002512 from HPO Gene-Disease Associations)", "bilateral conductive hearing impairment (HP:0008513 from HPO Gene-Disease Associations)", "fractures of the long bones (HP:0003084 from HPO Gene-Disease Associations)", "tetraparesis (HP:0002273 from HPO Gene-Disease Associations)", "long-tract signs (HP:0002423 from HPO Gene-Disease Associations)", "alzheimer disease (HP:0002511 from HPO Gene-Disease Associations)", "premature peripheral vascular disease (HP:0005299 from HPO Gene-Disease Associations)", "tortuous cerebral arteries (HP:0004938 from HPO Gene-Disease Associations)", "recurrent cerebral hemorrhage (HP:0004968 from HPO Gene-Disease Associations)", "cerebral amyloid angiopathy (HP:0011970 from HPO Gene-Disease Associations)", "amyloidosis (HP:0011034 from HPO Gene-Disease Associations)", "generalized amyloid deposition (HP:0003216 from HPO Gene-Disease Associations)", "age-related macular degeneration (HP:0007868 from HPO Gene-Disease Associations)", "cutaneous amyloidosis (HP:0012309 from HPO Gene-Disease Associations)", "increased red cell osmotic resistance (HP:0005546 from HPO Gene-Disease Associations)", "bicarbonate-wasting renal tubular acidosis (HP:0004910 from HPO Gene-Disease Associations)", "central opacification of the cornea (HP:0011493 from HPO Gene-Disease Associations)", "band keratopathy (HP:0000585 from HPO Gene-Disease Associations)", "reduced number of intrahepatic bile ducts (HP:0006571 from HPO Gene-Disease Associations)", "butterfly vertebral arch (HP:0004617 from HPO Gene-Disease Associations)", "pigmentary retinal deposits (HP:0007702 from HPO Gene-Disease Associations)", "axenfeld anomaly (HP:0001492 from HPO Gene-Disease Associations)", "hyperpigmentation of the fundus (HP:0011512 from HPO Gene-Disease Associations)", "peripheral pulmonary artery stenosis (HP:0004969 from HPO Gene-Disease Associations)", "pulmonary artery stenosis (HP:0004415 from HPO Gene-Disease Associations)", "crowded carpal bones (HP:0006180 from HPO Gene-Disease Associations)", "elongated sella turcica (HP:0005463 from HPO Gene-Disease Associations)", "cervical instability (HP:0008462 from HPO Gene-Disease Associations)", "tall lumbar vertebral bodies (HP:0008421 from HPO Gene-Disease Associations)", "spinal instability (HP:0005881 from HPO Gene-Disease Associations)", "increased vertebral height (HP:0004570 from HPO Gene-Disease Associations)", "wormian bones (HP:0002645 from HPO Gene-Disease Associations)", "biconcave vertebral bodies (HP:0004586 from HPO Gene-Disease Associations)", "vertebral compression fractures (HP:0002953 from HPO Gene-Disease Associations)", "absent pulmonary artery (HP:0004960 from HPO Gene-Disease Associations)", "multiple rib fractures (HP:0006640 from HPO Gene-Disease Associations)", "hypoplastic pulmonary veins (HP:0005304 from HPO Gene-Disease Associations)", "abnormal bone collagen fibril morphology (HP:0011862 from HPO Gene-Disease Associations)", "type 1 collagen overmodification (HP:0003784 from HPO Gene-Disease Associations)", "externally rotated|abducted legs (HP:0003783 from HPO Gene-Disease Associations)", "personality disorder (HP:0012075 from HPO Gene-Disease Associations)", "episodic vomiting (HP:0002572 from HPO Gene-Disease Associations)", "adrenocortical hypoplasia (HP:0008182 from HPO Gene-Disease Associations)", "acute hepatitis (HP:0200119 from HPO Gene-Disease Associations)", "abnormality of ornithine metabolism (HP:0012025 from HPO Gene-Disease Associations)", "hyperornithinemia (HP:0012026 from HPO Gene-Disease Associations)", "arnold-chiari type i malformation (HP:0007099 from HPO Gene-Disease Associations)", "macular hyperpigmentation (HP:0011509 from HPO Gene-Disease Associations)", "chorioretinal atrophy (HP:0000533 from HPO Gene-Disease Associations)", "peripapillary chorioretinal atrophy (HP:0007950 from HPO Gene-Disease Associations)", "pustule (HP:0200039 from HPO Gene-Disease Associations)", "tapered distal phalanges of finger (HP:0009884 from HPO Gene-Disease Associations)", "tapering pointed ends of distal finger phalanges (HP:0006224 from HPO Gene-Disease Associations)", "severe periodontitis (HP:0000166 from HPO Gene-Disease Associations)", "atrophy of alveolar ridges (HP:0006308 from HPO Gene-Disease Associations)", "congenital palmoplantar keratosis (HP:0007545 from HPO Gene-Disease Associations)", "abnormality of the plantar skin of foot (HP:0100872 from HPO Gene-Disease Associations)", "palmar hyperkeratosis (HP:0010765 from HPO Gene-Disease Associations)", "palmoplantar hyperkeratosis (HP:0000972 from HPO Gene-Disease Associations)", "plantar hyperkeratosis (HP:0007556 from HPO Gene-Disease Associations)", "thick nail (HP:0001805 from HPO Gene-Disease Associations)", "discrete 2 to 5-mm hyper- and hypopigmented macules (HP:0007494 from HPO Gene-Disease Associations)", "progressive reticulate hyperpigmentation (HP:0007456 from HPO Gene-Disease Associations)", "mottled pigmentation of the trunk and proximal extremities (HP:0007438 from HPO Gene-Disease Associations)", "punctate palmoplantar hyperkeratosis (HP:0007530 from HPO Gene-Disease Associations)", "hyperpigmented|hypopigmented macules (HP:0007441 from HPO Gene-Disease Associations)", "mixed hypo- and hyperpigmentation of the skin (HP:0009123 from HPO Gene-Disease Associations)", "palmoplantar blistering (HP:0007446 from HPO Gene-Disease Associations)", "neonatal respiratory distress (HP:0002643 from HPO Gene-Disease Associations)", "congenital nephrotic syndrome (HP:0008677 from HPO Gene-Disease Associations)", "urethral stenosis (HP:0008661 from HPO Gene-Disease Associations)", "urethral stricture (HP:0012227 from HPO Gene-Disease Associations)", "skin fragility with non-scarring blistering (HP:0007585 from HPO Gene-Disease Associations)", "onychogryposis of toenails (HP:0008401 from HPO Gene-Disease Associations)", "punctate keratitis (HP:0011859 from HPO Gene-Disease Associations)", "steatocystoma multiplex (HP:0012035 from HPO Gene-Disease Associations)", "palmoplantar hyperhidrosis (HP:0007410 from HPO Gene-Disease Associations)", "abnormality of the subungual region (HP:0009723 from HPO Gene-Disease Associations)", "subungual hyperkeratosis (HP:0008392 from HPO Gene-Disease Associations)", "unilateral chest hypoplasia (HP:0005254 from HPO Gene-Disease Associations)", "facial erythema (HP:0001041 from HPO Gene-Disease Associations)", "perifollicular fibrosis (HP:0030054 from HPO Gene-Disease Associations)", "dystrophic fingernails (HP:0008391 from HPO Gene-Disease Associations)", "alopecia of scalp (HP:0002293 from HPO Gene-Disease Associations)", "scarring alopecia of scalp (HP:0004552 from HPO Gene-Disease Associations)", "abnormality of dental color (HP:0011073 from HPO Gene-Disease Associations)", "erythroderma (HP:0001019 from HPO Gene-Disease Associations)", "congenital ichthyosiform erythroderma (HP:0007431 from HPO Gene-Disease Associations)", "congenital nonbullous ichthyosiform erythroderma (HP:0007479 from HPO Gene-Disease Associations)", "parakeratosis (HP:0001036 from HPO Gene-Disease Associations)", "lack of subcutaneous fatty tissue (HP:0007519 from HPO Gene-Disease Associations)", "numerous pigmented freckles (HP:0007587 from HPO Gene-Disease Associations)", "large beaked nose (HP:0003683 from HPO Gene-Disease Associations)", "honeycomb palmoplantar keratoderma (HP:0007465 from HPO Gene-Disease Associations)", "trichiasis (HP:0001128 from HPO Gene-Disease Associations)", "linear arrays of macular hyperkeratoses in flexural areas (HP:0007490 from HPO Gene-Disease Associations)", "hyperconvex nail (HP:0001795 from HPO Gene-Disease Associations)", "elevated 8(9)-cholestenol (HP:0003465 from HPO Gene-Disease Associations)", "elevated 8-dehydrocholesterol (HP:0003462 from HPO Gene-Disease Associations)", "stippled calcification in carpal bones (HP:0004241 from HPO Gene-Disease Associations)", "tarsal stippling (HP:0008131 from HPO Gene-Disease Associations)", "hemiatrophy (HP:0100556 from HPO Gene-Disease Associations)", "total anomalous pulmonary venous return (HP:0005160 from HPO Gene-Disease Associations)", "hypoplastic nasal bridge (HP:0005281 from HPO Gene-Disease Associations)", "bilateral talipes equinovarus (HP:0001776 from HPO Gene-Disease Associations)", "psoriasis (HP:0003765 from HPO Gene-Disease Associations)", "multiple myeloma (HP:0006775 from HPO Gene-Disease Associations)", "abnormality of cerebrosidase metabolism (HP:0004344 from HPO Gene-Disease Associations)", "decreased beta-glucocerebrosidase protein and activity (HP:0003656 from HPO Gene-Disease Associations)", "calcific mitral stenosis (HP:0200129 from HPO Gene-Disease Associations)", "calcific aortic valve stenosis (HP:0005173 from HPO Gene-Disease Associations)", "hypometric horizontal saccades (HP:0007975 from HPO Gene-Disease Associations)", "slowed horizontal saccades (HP:0007885 from HPO Gene-Disease Associations)", "horizontal supranuclear gaze palsy (HP:0007817 from HPO Gene-Disease Associations)", "calcification of the aorta (HP:0004963 from HPO Gene-Disease Associations)", "desquamation of skin soon after birth (HP:0007549 from HPO Gene-Disease Associations)", "hypersplenism (HP:0001971 from HPO Gene-Disease Associations)", "hypometric saccades (HP:0000571 from HPO Gene-Disease Associations)", "edema of the lower limbs (HP:0010741 from HPO Gene-Disease Associations)", "akinesia (HP:0002304 from HPO Gene-Disease Associations)", "diminished movement (HP:0002374 from HPO Gene-Disease Associations)", "hypokinesia (HP:0002375 from HPO Gene-Disease Associations)", "thickened achilles tendon (HP:0004690 from HPO Gene-Disease Associations)", "intervertebral disk calcification (HP:0005645 from HPO Gene-Disease Associations)", "aortic valve calcification (HP:0004380 from HPO Gene-Disease Associations)", "pigmentation of the sclera (HP:0007832 from HPO Gene-Disease Associations)", "intervertebral disc degeneration (HP:0008419 from HPO Gene-Disease Associations)", "mitral stenosis (HP:0001718 from HPO Gene-Disease Associations)", "cardiac valve calcification (HP:0005146 from HPO Gene-Disease Associations)", "mitral valve calcification (HP:0004382 from HPO Gene-Disease Associations)", "arterial calcification (HP:0003207 from HPO Gene-Disease Associations)", "vascular calcification (HP:0004934 from HPO Gene-Disease Associations)", "cardiovascular calcification (HP:0011915 from HPO Gene-Disease Associations)", "coronary artery calcification (HP:0001717 from HPO Gene-Disease Associations)", "generalized arterial calcification (HP:0004940 from HPO Gene-Disease Associations)", "bowing of the vocal cords (HP:0008756 from HPO Gene-Disease Associations)", "bulbar signs (HP:0002483 from HPO Gene-Disease Associations)", "brisk reflexes (HP:0001348 from HPO Gene-Disease Associations)", "sleepy facial expression (HP:0005335 from HPO Gene-Disease Associations)", "retinal hemorrhage (HP:0000573 from HPO Gene-Disease Associations)", "medial arterial calcification (HP:0012456 from HPO Gene-Disease Associations)", "large artery calcification (HP:0012455 from HPO Gene-Disease Associations)", "medial calcification of large arteries (HP:0004966 from HPO Gene-Disease Associations)", "premature occlusive vascular disease (HP:0005297 from HPO Gene-Disease Associations)", "accelerated atherosclerosis (HP:0004943 from HPO Gene-Disease Associations)", "abnormal vascular physiology (HP:0030163 from HPO Gene-Disease Associations)", "intermittent claudication (HP:0004417 from HPO Gene-Disease Associations)", "peripheral arterial disease (HP:0004950 from HPO Gene-Disease Associations)", "restrictive cardiomyopathy (HP:0001723 from HPO Gene-Disease Associations)", "endocardial fibrosis (HP:0006685 from HPO Gene-Disease Associations)", "progressive ophthalmoplegia (HP:0007650 from HPO Gene-Disease Associations)", "absent external genitalia (HP:0000042 from HPO Gene-Disease Associations)", "mandibular aplasia (HP:0009939 from HPO Gene-Disease Associations)", "anotia (HP:0009892 from HPO Gene-Disease Associations)", "aplasia of the sweat glands (HP:0011136 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the sweat glands (HP:0011135 from HPO Gene-Disease Associations)", "heat intolerance (HP:0002046 from HPO Gene-Disease Associations)", "periorbital wrinkles (HP:0000607 from HPO Gene-Disease Associations)", "periorbital hyperpigmentation (HP:0001106 from HPO Gene-Disease Associations)", "everted upper lip vermilion (HP:0010803 from HPO Gene-Disease Associations)", "hypoplastic-absent sebaceous glands (HP:0007411 from HPO Gene-Disease Associations)", "aplasia|hypoplastia of the eccrine sweat glands (HP:0007592 from HPO Gene-Disease Associations)", "anhidrosis (HP:0000970 from HPO Gene-Disease Associations)", "perianal abscess (HP:0009789 from HPO Gene-Disease Associations)", "bifid sacrum (HP:0009791 from HPO Gene-Disease Associations)", "hemisacrum (s2-s5) (HP:0009790 from HPO Gene-Disease Associations)", "sacral segmentation defect (HP:0008490 from HPO Gene-Disease Associations)", "anal fistula (HP:0010447 from HPO Gene-Disease Associations)", "chronic constipation (HP:0012450 from HPO Gene-Disease Associations)", "tethered cord (HP:0002144 from HPO Gene-Disease Associations)", "neurogenic bladder (HP:0000011 from HPO Gene-Disease Associations)", "sacral lipoma (HP:0012033 from HPO Gene-Disease Associations)", "anterior sacral meningocele (HP:0007293 from HPO Gene-Disease Associations)", "sacral meningocele (HP:0005765 from HPO Gene-Disease Associations)", "asymmetry of spinal facet joints (HP:0008482 from HPO Gene-Disease Associations)", "aspiration pneumonia (HP:0011951 from HPO Gene-Disease Associations)", "recurrent aspiration pneumonia (HP:0002100 from HPO Gene-Disease Associations)", "macrogyria (HP:0007227 from HPO Gene-Disease Associations)", "distal widening of metacarpals (HP:0006048 from HPO Gene-Disease Associations)", "bullet-shaped middle phalanges of the hand (HP:0009845 from HPO Gene-Disease Associations)", "large sternal ossification centers (HP:0006642 from HPO Gene-Disease Associations)", "abnormality of the premaxilla (HP:0010758 from HPO Gene-Disease Associations)", "premaxillary prominence (HP:0010759 from HPO Gene-Disease Associations)", "teratoma (HP:0009792 from HPO Gene-Disease Associations)", "presacral teratoma (HP:0009793 from HPO Gene-Disease Associations)", "abnormality of renal calyx morphology (HP:0011130 from HPO Gene-Disease Associations)", "metopic suture patent to nasal root (HP:0005495 from HPO Gene-Disease Associations)", "distal femoral metaphyseal abnormality (HP:0030299 from HPO Gene-Disease Associations)", "wide distal femoral metaphysis (HP:0006387 from HPO Gene-Disease Associations)", "megacalicosis (HP:0100581 from HPO Gene-Disease Associations)", "hypoplasia of first ribs (HP:0006657 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the sternum (HP:0006714 from HPO Gene-Disease Associations)", "short sternum (HP:0000879 from HPO Gene-Disease Associations)", "chewing difficulties (HP:0005216 from HPO Gene-Disease Associations)", "postauricular skin tag (HP:0004451 from HPO Gene-Disease Associations)", "speech articulation difficulties (HP:0009088 from HPO Gene-Disease Associations)", "short mandibular condyles (HP:0005790 from HPO Gene-Disease Associations)", "mandibular condyle hypoplasia (HP:0007628 from HPO Gene-Disease Associations)", "mandibular condyle aplasia (HP:0007627 from HPO Gene-Disease Associations)", "cleft at the superior portion of the pinna (HP:0008537 from HPO Gene-Disease Associations)", "cleft helix (HP:0009902 from HPO Gene-Disease Associations)", "overfolding of the superior helices (HP:0004453 from HPO Gene-Disease Associations)", "short mandibular rami (HP:0003778 from HPO Gene-Disease Associations)", "glossoptosis (HP:0000162 from HPO Gene-Disease Associations)", "yellow-brown discoloration of the teeth (HP:0006286 from HPO Gene-Disease Associations)", "anterior open-bite malocclusion (HP:0009102 from HPO Gene-Disease Associations)", "immune dysregulation (HP:0002958 from HPO Gene-Disease Associations)", "central hypothyroidism (HP:0011787 from HPO Gene-Disease Associations)", "pituitary hypothyroidism (HP:0008245 from HPO Gene-Disease Associations)", "hypothalamic hypothyroidism (HP:0008237 from HPO Gene-Disease Associations)", "insulin insensitivity (HP:0008189 from HPO Gene-Disease Associations)", "iridescent posterior subcapsular cataract (HP:0007889 from HPO Gene-Disease Associations)", "frontal balding (HP:0002292 from HPO Gene-Disease Associations)", "acquired abnormal hair pattern (HP:0011360 from HPO Gene-Disease Associations)", "oligospermia (HP:0000798 from HPO Gene-Disease Associations)", "perineal hypospadias (HP:0000051 from HPO Gene-Disease Associations)", "female external genitalia in individual with 46,xy karyotype (HP:0008730 from HPO Gene-Disease Associations)", "absent vas deferens (HP:0012873 from HPO Gene-Disease Associations)", "abnormal vas deferens morphology (HP:0012872 from HPO Gene-Disease Associations)", "elevated follicle stimulating hormone (HP:0008232 from HPO Gene-Disease Associations)", "gonadotropin excess (HP:0000837 from HPO Gene-Disease Associations)", "abnormality of male internal genitalia (HP:0000022 from HPO Gene-Disease Associations)", "abnormality of the prostate (HP:0008775 from HPO Gene-Disease Associations)", "prostate cancer (HP:0012125 from HPO Gene-Disease Associations)", "prostate neoplasm (HP:0100787 from HPO Gene-Disease Associations)", "testicular atrophy (HP:0000029 from HPO Gene-Disease Associations)", "gout (feet) (HP:0001854 from HPO Gene-Disease Associations)", "leydig cell insensitivity to gonadotropin (HP:0002929 from HPO Gene-Disease Associations)", "impaired fsh and lh secretion (HP:0003295 from HPO Gene-Disease Associations)", "hypothalamic gonadotropin-releasing hormone (gnrh) deficiency (HP:0003164 from HPO Gene-Disease Associations)", "abnormal hypothalamus physiology (HP:0012285 from HPO Gene-Disease Associations)", "eunuchoid habitus (HP:0003782 from HPO Gene-Disease Associations)", "abnormality of the pubic hair (HP:0100133 from HPO Gene-Disease Associations)", "sparse pubic hair (HP:0002225 from HPO Gene-Disease Associations)", "renal agenesis (HP:0000104 from HPO Gene-Disease Associations)", "unilateral renal agenesis (HP:0000122 from HPO Gene-Disease Associations)", "morbilliform rash (HP:0012282 from HPO Gene-Disease Associations)", "fluctuating hepatomegaly (HP:0006564 from HPO Gene-Disease Associations)", "fluctuating splenomegaly (HP:0006268 from HPO Gene-Disease Associations)", "normocytic hypoplastic anemia (HP:0004819 from HPO Gene-Disease Associations)", "porokeratosis (HP:0200044 from HPO Gene-Disease Associations)", "abnormal hemoglobin (HP:0011902 from HPO Gene-Disease Associations)", "persistence of hemoglobin f (HP:0011904 from HPO Gene-Disease Associations)", "methemoglobinemia (HP:0012119 from HPO Gene-Disease Associations)", "imbalanced hemoglobin synthesis (HP:0005560 from HPO Gene-Disease Associations)", "hypochromic microcytic anemia (HP:0004840 from HPO Gene-Disease Associations)", "reduced alpha|beta synthesis ratio (HP:0011907 from HPO Gene-Disease Associations)", "microcytic anemia (HP:0001935 from HPO Gene-Disease Associations)", "abnormality of the heme biosynthetic pathway (HP:0010472 from HPO Gene-Disease Associations)", "reduced beta|alpha synthesis ratio (HP:0011906 from HPO Gene-Disease Associations)", "heinz body anemia (HP:0005511 from HPO Gene-Disease Associations)", "macrocytic hemolytic disease (HP:0005524 from HPO Gene-Disease Associations)", "priapism (HP:0200023 from HPO Gene-Disease Associations)", "increased red cell sickling tendency (HP:0008346 from HPO Gene-Disease Associations)", "congenital hypoplastic anemia (HP:0004810 from HPO Gene-Disease Associations)", "hypoplastic anemia (HP:0001908 from HPO Gene-Disease Associations)", "bifid thoracic vertebrae (HP:0008437 from HPO Gene-Disease Associations)", "hypoplastic sacral vertebrae (HP:0008475 from HPO Gene-Disease Associations)", "hypoplastic coccygeal vertebrae (HP:0008447 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the sacrum (HP:0008517 from HPO Gene-Disease Associations)", "hypoplastic sacrum (HP:0004590 from HPO Gene-Disease Associations)", "impaired renal concentrating ability (HP:0004727 from HPO Gene-Disease Associations)", "dagger-shaped pulp calcifications (HP:0006302 from HPO Gene-Disease Associations)", "enuresis (HP:0000805 from HPO Gene-Disease Associations)", "enuresis nocturna (HP:0010677 from HPO Gene-Disease Associations)", "abetalipoproteinemia (HP:0008181 from HPO Gene-Disease Associations)", "acanthocytosis (HP:0001927 from HPO Gene-Disease Associations)", "poikilocytosis (HP:0004447 from HPO Gene-Disease Associations)", "elliptocytosis (HP:0004445 from HPO Gene-Disease Associations)", "spherocytosis (HP:0004444 from HPO Gene-Disease Associations)", "microspherocytosis (HP:0004835 from HPO Gene-Disease Associations)", "pyropoikilocytosis (HP:0004839 from HPO Gene-Disease Associations)", "stomatocytosis (HP:0004446 from HPO Gene-Disease Associations)", "increased red cell osmotic fragility (HP:0005502 from HPO Gene-Disease Associations)", "increased intracellular sodium (HP:0003575 from HPO Gene-Disease Associations)", "distal renal tubular acidosis (HP:0008341 from HPO Gene-Disease Associations)", "generalized distal tubular acidosis (HP:0004916 from HPO Gene-Disease Associations)", "anemia due to reduced life span of red cells (HP:0011895 from HPO Gene-Disease Associations)", "hemolytic anemia (HP:0001878 from HPO Gene-Disease Associations)", "abnormality of reticulocytes (HP:0004312 from HPO Gene-Disease Associations)", "reticulocytosis (HP:0001923 from HPO Gene-Disease Associations)", "nonspherocytic hemolytic anemia (HP:0001930 from HPO Gene-Disease Associations)", "normochromic anemia (HP:0001895 from HPO Gene-Disease Associations)", "normocytic anemia (HP:0001897 from HPO Gene-Disease Associations)", "abnormal gallbladder physiology (HP:0012438 from HPO Gene-Disease Associations)", "cholecystitis (HP:0001082 from HPO Gene-Disease Associations)", "abnormal gallbladder morphology (HP:0012437 from HPO Gene-Disease Associations)", "cholelithiasis (HP:0001081 from HPO Gene-Disease Associations)", "abnormality of the gallbladder (HP:0005264 from HPO Gene-Disease Associations)", "spontaneous hemolytic crises (HP:0005525 from HPO Gene-Disease Associations)", "decreased glucosephosphate isomerase activity (HP:0003568 from HPO Gene-Disease Associations)", "pigment gallstones (HP:0011981 from HPO Gene-Disease Associations)", "biliary tract abnormality (HP:0001080 from HPO Gene-Disease Associations)", "abnormality of the biliary system (HP:0004297 from HPO Gene-Disease Associations)", "cholestasis (HP:0001396 from HPO Gene-Disease Associations)", "jaundice (HP:0000952 from HPO Gene-Disease Associations)", "dermatological manifestations of systemic disorders (HP:0001005 from HPO Gene-Disease Associations)", "prolonged neonatal jaundice (HP:0006579 from HPO Gene-Disease Associations)", "decreased liver function (HP:0001410 from HPO Gene-Disease Associations)", "hepatic failure (HP:0001399 from HPO Gene-Disease Associations)", "cirrhosis (HP:0001394 from HPO Gene-Disease Associations)", "elevated hepatic transaminases (HP:0002910 from HPO Gene-Disease Associations)", "fat malabsorption (HP:0002630 from HPO Gene-Disease Associations)", "steatorrhea (HP:0002570 from HPO Gene-Disease Associations)", "intrahepatic cholestasis (HP:0001406 from HPO Gene-Disease Associations)", "abnormality of vitamin k metabolism (HP:0100831 from HPO Gene-Disease Associations)", "vitamin k deficiency (HP:0011892 from HPO Gene-Disease Associations)", "increased serum bile acid concentration (HP:0012202 from HPO Gene-Disease Associations)", "cholesterol gallstones (HP:0011980 from HPO Gene-Disease Associations)", "abnormal liver function tests during pregnancy (HP:0200148 from HPO Gene-Disease Associations)", "increased serum bile acid concentration during pregnancy (HP:0200150 from HPO Gene-Disease Associations)", "portal fibrosis (HP:0006580 from HPO Gene-Disease Associations)", "intermittent jaundice (HP:0001046 from HPO Gene-Disease Associations)", "intrahepatic cholestasis with episodic jaundice (HP:0006575 from HPO Gene-Disease Associations)", "conjugated hyperbilirubinemia (HP:0002908 from HPO Gene-Disease Associations)", "hyperbilirubinemia (HP:0002904 from HPO Gene-Disease Associations)", "fava bean-induced hemolytic anemia (HP:0004814 from HPO Gene-Disease Associations)", "unconjugated hyperbilirubinemia (HP:0008282 from HPO Gene-Disease Associations)", "neonatal unconjugated hyperbilirubinemia (HP:0008176 from HPO Gene-Disease Associations)", "kernicterus (HP:0001343 from HPO Gene-Disease Associations)", "abdominal colic (HP:0011848 from HPO Gene-Disease Associations)", "cerebral palsy (HP:0100021 from HPO Gene-Disease Associations)", "abnormality of the jejunum (HP:0005265 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the gallbladder (HP:0011466 from HPO Gene-Disease Associations)", "jejunal atresia (HP:0005235 from HPO Gene-Disease Associations)", "absent gallbladder (HP:0011467 from HPO Gene-Disease Associations)", "biliary atresia (HP:0005912 from HPO Gene-Disease Associations)", "acholic stools (HP:0011985 from HPO Gene-Disease Associations)", "exercise-induced hemolysis (HP:0005535 from HPO Gene-Disease Associations)", "increased red cell hemolysis by shear stress (HP:0008269 from HPO Gene-Disease Associations)", "hemoglobinuria (HP:0003641 from HPO Gene-Disease Associations)", "paroxysmal nocturnal hemoglobinuria (HP:0004818 from HPO Gene-Disease Associations)", "central hypotonia (HP:0011398 from HPO Gene-Disease Associations)", "adrenal calcification (HP:0010512 from HPO Gene-Disease Associations)", "absence of lutheran antigen on erythrocytes (HP:0010971 from HPO Gene-Disease Associations)", "blood group antigen abnormality (HP:0010970 from HPO Gene-Disease Associations)", "anisopoikilocytosis (HP:0004823 from HPO Gene-Disease Associations)", "schistocytosis (HP:0001981 from HPO Gene-Disease Associations)", "butterfly vertebrae (HP:0003316 from HPO Gene-Disease Associations)", "diffuse reticular or finely nodular infiltrations (HP:0002207 from HPO Gene-Disease Associations)", "foam cells with lamellar inclusion bodies (HP:0003609 from HPO Gene-Disease Associations)", "hypoplasia of the abdominal wall musculature (HP:0005247 from HPO Gene-Disease Associations)", "ileal atresia (HP:0011102 from HPO Gene-Disease Associations)", "distal ileal atresia (HP:0200116 from HPO Gene-Disease Associations)", "nephroblastomatosis (HP:0008643 from HPO Gene-Disease Associations)", "nephrogenic rest (HP:0100880 from HPO Gene-Disease Associations)", "interrupted aortic arch (HP:0011611 from HPO Gene-Disease Associations)", "cystic renal dysplasia (HP:0000800 from HPO Gene-Disease Associations)", "narrow pelvis (HP:0003275 from HPO Gene-Disease Associations)", "absent in utero rib ossification (HP:0006615 from HPO Gene-Disease Associations)", "absent in utero ossification of vertebral bodies (HP:0008435 from HPO Gene-Disease Associations)", "lumbosacral meningocele (HP:0200133 from HPO Gene-Disease Associations)", "abnormality of prostaglandin metabolism (HP:0011023 from HPO Gene-Disease Associations)", "abnormality of unsaturated fatty acid metabolism (HP:0011022 from HPO Gene-Disease Associations)", "low-to-normal blood pressure (HP:0002632 from HPO Gene-Disease Associations)", "increased serum prostaglandin e2 (HP:0003566 from HPO Gene-Disease Associations)", "renal juxtaglomerular cell hypertrophy|hyperplasia (HP:0000111 from HPO Gene-Disease Associations)", "hyperprostaglandinuria (HP:0003527 from HPO Gene-Disease Associations)", "hyposthenuria (HP:0003158 from HPO Gene-Disease Associations)", "renal potassium wasting (HP:0000128 from HPO Gene-Disease Associations)", "increased circulating renin level (HP:0000848 from HPO Gene-Disease Associations)", "abnormality of magnesium homeostasis (HP:0004921 from HPO Gene-Disease Associations)", "hypomagnesemia (HP:0002917 from HPO Gene-Disease Associations)", "tetany (HP:0001281 from HPO Gene-Disease Associations)", "abnormal urine output (HP:0012590 from HPO Gene-Disease Associations)", "abnormality of renal excretion (HP:0011036 from HPO Gene-Disease Associations)", "polyuria (HP:0000103 from HPO Gene-Disease Associations)", "abnormal drinking behavior (HP:0030082 from HPO Gene-Disease Associations)", "polydipsia (HP:0001959 from HPO Gene-Disease Associations)", "abnormal urine sodium concentration (HP:0012603 from HPO Gene-Disease Associations)", "hypernatriuria (HP:0012605 from HPO Gene-Disease Associations)", "hypochloremic metabolic alkalosis (HP:0005977 from HPO Gene-Disease Associations)", "hypokalemic hypochloremic metabolic alkalosis (HP:0004909 from HPO Gene-Disease Associations)", "abnormal urine potassium concentration (HP:0012598 from HPO Gene-Disease Associations)", "hypokalemic metabolic alkalosis (HP:0001960 from HPO Gene-Disease Associations)", "increased urinary potassium (HP:0003081 from HPO Gene-Disease Associations)", "fetal polyuria (HP:0001563 from HPO Gene-Disease Associations)", "hyperchloridura (HP:0002914 from HPO Gene-Disease Associations)", "abnormal urine chloride concentration (HP:0012600 from HPO Gene-Disease Associations)", "hypochloremia (HP:0003113 from HPO Gene-Disease Associations)", "metabolic alkalosis (HP:0200114 from HPO Gene-Disease Associations)", "alkalosis (HP:0001948 from HPO Gene-Disease Associations)", "hypokalemic alkalosis (HP:0001949 from HPO Gene-Disease Associations)", "renal salt wasting (HP:0000127 from HPO Gene-Disease Associations)", "abnormality of chloride homeostasis (HP:0011422 from HPO Gene-Disease Associations)", "abnormal glomerular filtration rate (HP:0012212 from HPO Gene-Disease Associations)", "decreased glomerular filtration rate (HP:0012213 from HPO Gene-Disease Associations)", "impaired reabsorption of chloride (HP:0005579 from HPO Gene-Disease Associations)", "abnormality of monovalent inorganic cation homeostasis (HP:0010930 from HPO Gene-Disease Associations)", "abnormality of potassium homeostasis (HP:0011042 from HPO Gene-Disease Associations)", "hypokalemia (HP:0002900 from HPO Gene-Disease Associations)", "abnormality of renin-angiotensin system (HP:0000847 from HPO Gene-Disease Associations)", "hyperactive renin-angiotensin system (HP:0000841 from HPO Gene-Disease Associations)", "hyperaldosteronism (HP:0000859 from HPO Gene-Disease Associations)", "abnormality of sodium homeostasis (HP:0010931 from HPO Gene-Disease Associations)", "hyponatremia (HP:0002902 from HPO Gene-Disease Associations)", "dehydration (HP:0001944 from HPO Gene-Disease Associations)", "reduced renal corticomedullary differentiation (HP:0005565 from HPO Gene-Disease Associations)", "global glomerulosclerosis (HP:0004737 from HPO Gene-Disease Associations)", "long penis (HP:0000040 from HPO Gene-Disease Associations)", "precocious puberty in males (HP:0008185 from HPO Gene-Disease Associations)", "sex-limited autosomal dominant (HP:0001470 from HPO Gene-Disease Associations)", "adrenogenital syndrome (HP:0000840 from HPO Gene-Disease Associations)", "maternal hypertension (HP:0008071 from HPO Gene-Disease Associations)", "abnormal circulating aldosterone (HP:0040085 from HPO Gene-Disease Associations)", "decreased circulating aldosterone level (HP:0002924 from HPO Gene-Disease Associations)", "abnormal circulating renin (HP:0040084 from HPO Gene-Disease Associations)", "decreased circulating renin level (HP:0003351 from HPO Gene-Disease Associations)", "abnormal oral glucose tolerance (HP:0004924 from HPO Gene-Disease Associations)", "hypernatremia (HP:0003228 from HPO Gene-Disease Associations)", "dilatation of the bladder (HP:0010955 from HPO Gene-Disease Associations)", "megacystis (HP:0000021 from HPO Gene-Disease Associations)", "unexplained fevers (HP:0001955 from HPO Gene-Disease Associations)", "hypertonic dehydration (HP:0001986 from HPO Gene-Disease Associations)", "neonatal onset (HP:0003623 from HPO Gene-Disease Associations)", "diffuse hepatic steatosis (HP:0006555 from HPO Gene-Disease Associations)", "no social interaction (HP:0008763 from HPO Gene-Disease Associations)", "tapetoretinal degeneration (HP:0000547 from HPO Gene-Disease Associations)", "inverted nipples (HP:0003186 from HPO Gene-Disease Associations)", "abnormal urine magnesium concentration (HP:0012607 from HPO Gene-Disease Associations)", "renal magnesium wasting (HP:0005567 from HPO Gene-Disease Associations)", "hypermagnesiuria (HP:0012608 from HPO Gene-Disease Associations)", "renal calcium wasting (HP:0012637 from HPO Gene-Disease Associations)", "abnormal urine citrate concentration (HP:0012404 from HPO Gene-Disease Associations)", "hypocitraturia (HP:0012405 from HPO Gene-Disease Associations)", "hyperchloremic acidosis (HP:0001995 from HPO Gene-Disease Associations)", "hyperchloremic metabolic acidosis (HP:0004918 from HPO Gene-Disease Associations)", "hyperkalemia (HP:0002153 from HPO Gene-Disease Associations)", "hyperchloremia (HP:0011423 from HPO Gene-Disease Associations)", "impairment of galactose metabolism (HP:0004915 from HPO Gene-Disease Associations)", "galactosuria (HP:0012023 from HPO Gene-Disease Associations)", "hypergalactosemia (HP:0012024 from HPO Gene-Disease Associations)", "central apnea (HP:0002871 from HPO Gene-Disease Associations)", "episodic tachypnea (HP:0002876 from HPO Gene-Disease Associations)", "neonatal breathing dysregulation (HP:0002790 from HPO Gene-Disease Associations)", "breathing dysregulation (HP:0005957 from HPO Gene-Disease Associations)", "enlarged fossa interpeduncularis (HP:0100951 from HPO Gene-Disease Associations)", "abnormality of the brainstem white matter (HP:0012501 from HPO Gene-Disease Associations)", "abnormality of the cerebellar peduncle (HP:0011931 from HPO Gene-Disease Associations)", "abnormality of the superior cerebellar peduncle (HP:0011932 from HPO Gene-Disease Associations)", "elongated superior cerebellar peduncle (HP:0011933 from HPO Gene-Disease Associations)", "thickened superior cerebellar peduncle (HP:0002404 from HPO Gene-Disease Associations)", "agenesis of cerebellar vermis (HP:0002335 from HPO Gene-Disease Associations)", "hemifacial spasm (HP:0010828 from HPO Gene-Disease Associations)", "triangular-shaped open mouth (HP:0200096 from HPO Gene-Disease Associations)", "nonprogressive congenital retinal dystrophy (HP:0007910 from HPO Gene-Disease Associations)", "occipital myelomeningocele (HP:0007271 from HPO Gene-Disease Associations)", "dysgenesis of the cerebellar vermis (HP:0002195 from HPO Gene-Disease Associations)", "brainstem dysplasia (HP:0002508 from HPO Gene-Disease Associations)", "childhood-onset truncal obesity (HP:0008915 from HPO Gene-Disease Associations)", "chronic hepatic failure (HP:0100626 from HPO Gene-Disease Associations)", "multiple small medullary renal cysts (HP:0008659 from HPO Gene-Disease Associations)", "optic nerve coloboma (HP:0000588 from HPO Gene-Disease Associations)", "intellectual disability, moderate (HP:0002342 from HPO Gene-Disease Associations)", "congenital blindness (HP:0007875 from HPO Gene-Disease Associations)", "mild proteinuria (HP:0012595 from HPO Gene-Disease Associations)", "short iliac bones (HP:0100866 from HPO Gene-Disease Associations)", "tubulointerstitial nephritis (HP:0001970 from HPO Gene-Disease Associations)", "abnormal circulating creatinine level (HP:0012100 from HPO Gene-Disease Associations)", "elevated serum creatinine (HP:0003259 from HPO Gene-Disease Associations)", "hyperkalemic metabolic acidosis (HP:0005976 from HPO Gene-Disease Associations)", "chronic tubulointerstitial nephritis (HP:0004743 from HPO Gene-Disease Associations)", "abnormal renal corticomedullary differentiation (HP:0005932 from HPO Gene-Disease Associations)", "absence of renal corticomedullary differentiation (HP:0005564 from HPO Gene-Disease Associations)", "hyperechogenic kidneys (HP:0004719 from HPO Gene-Disease Associations)", "abnormality of the renal cortex (HP:0011035 from HPO Gene-Disease Associations)", "renal cortical cysts (HP:0000803 from HPO Gene-Disease Associations)", "renal cortical microcysts (HP:0004734 from HPO Gene-Disease Associations)", "abnormality of the renal medulla (HP:0100957 from HPO Gene-Disease Associations)", "nephronophthisis (HP:0000090 from HPO Gene-Disease Associations)", "chronic kidney disease (HP:0012622 from HPO Gene-Disease Associations)", "stage 5 chronic kidney disease (HP:0003774 from HPO Gene-Disease Associations)", "renal corticomedullary cysts (HP:0000108 from HPO Gene-Disease Associations)", "tubular basement membrane disintegration (HP:0005583 from HPO Gene-Disease Associations)", "tubular atrophy (HP:0000092 from HPO Gene-Disease Associations)", "renal atrophy (HP:0012585 from HPO Gene-Disease Associations)", "renal cortical atrophy (HP:0002048 from HPO Gene-Disease Associations)", "impaired renal uric acid clearance (HP:0004732 from HPO Gene-Disease Associations)", "abnormality of the renal tubule (HP:0000091 from HPO Gene-Disease Associations)", "tubulointerstitial abnormality (HP:0001969 from HPO Gene-Disease Associations)", "tubulointerstitial fibrosis (HP:0005576 from HPO Gene-Disease Associations)", "neoplasia of the nasopharynx (HP:0100630 from HPO Gene-Disease Associations)", "neoplasm of the nose (HP:0012720 from HPO Gene-Disease Associations)", "malignant mesothelioma (HP:0100001 from HPO Gene-Disease Associations)", "ovarian gonadoblastoma (HP:0000149 from HPO Gene-Disease Associations)", "gonadal tissue inappropriate for external genitalia or chromosomal sex (HP:0003248 from HPO Gene-Disease Associations)", "precocious puberty with sertoli cell tumor (HP:0008204 from HPO Gene-Disease Associations)", "sertoli cell neoplasm (HP:0100619 from HPO Gene-Disease Associations)", "lip hyperpigmentation (HP:0100816 from HPO Gene-Disease Associations)", "clubbing of fingers (HP:0100759 from HPO Gene-Disease Associations)", "intestinal bleeding (HP:0002584 from HPO Gene-Disease Associations)", "retinal telangiectasia (HP:0007763 from HPO Gene-Disease Associations)", "achalasia (HP:0002571 from HPO Gene-Disease Associations)", "adrenocorticotropin (acth) receptor (acthr) defect (HP:0008259 from HPO Gene-Disease Associations)", "anisocoria (HP:0009916 from HPO Gene-Disease Associations)", "central adrenal insufficiency (HP:0011734 from HPO Gene-Disease Associations)", "motor axonal neuropathy (HP:0007002 from HPO Gene-Disease Associations)", "reactive hypoglycemia (HP:0012051 from HPO Gene-Disease Associations)", "hypocortisolemia (HP:0008220 from HPO Gene-Disease Associations)", "absence of pubertal development (HP:0008197 from HPO Gene-Disease Associations)", "low gonadotropins (secondary hypogonadism) (HP:0003335 from HPO Gene-Disease Associations)", "hypoaldosteronism (HP:0004319 from HPO Gene-Disease Associations)", "testicular neoplasm (HP:0010788 from HPO Gene-Disease Associations)", "gonadal dysgenesis (HP:0000133 from HPO Gene-Disease Associations)", "abnormality of the adrenal glands (HP:0000834 from HPO Gene-Disease Associations)", "abnormality of adrenal physiology (HP:0011733 from HPO Gene-Disease Associations)", "adrenal insufficiency (HP:0000846 from HPO Gene-Disease Associations)", "primary adrenal insufficiency (HP:0008207 from HPO Gene-Disease Associations)", "bladder fistula (HP:0004321 from HPO Gene-Disease Associations)", "vesicovaginal fistula (HP:0001586 from HPO Gene-Disease Associations)", "abnormal maternal serum screening (HP:0011436 from HPO Gene-Disease Associations)", "low maternal serum estriol (HP:0008073 from HPO Gene-Disease Associations)", "maternal virilization in pregnancy (HP:0008072 from HPO Gene-Disease Associations)", "congenital adrenal hyperplasia (HP:0008258 from HPO Gene-Disease Associations)", "symmetric lesions of the basal ganglia (HP:0007039 from HPO Gene-Disease Associations)", "adrenal hyperplasia (HP:0008221 from HPO Gene-Disease Associations)", "recurrent hypoglycemia (HP:0001988 from HPO Gene-Disease Associations)", "decreased circulating cortisol level (HP:0008163 from HPO Gene-Disease Associations)", "increased circulating acth level (HP:0003154 from HPO Gene-Disease Associations)", "high maternal serum alpha-fetoprotein (HP:0011432 from HPO Gene-Disease Associations)", "low urinary cyclic amp response to pth administration (HP:0003456 from HPO Gene-Disease Associations)", "pseudohypoparathyroidism (HP:0000852 from HPO Gene-Disease Associations)", "hypocalcemic tetany (HP:0003472 from HPO Gene-Disease Associations)", "macronodular adrenal hyperplasia (HP:0008231 from HPO Gene-Disease Associations)", "prolactin excess (HP:0000870 from HPO Gene-Disease Associations)", "large cafe-au-lait macules with irregular margins (HP:0005605 from HPO Gene-Disease Associations)", "polyostotic fibrous dysplasia (HP:0010735 from HPO Gene-Disease Associations)", "fibrous dysplasia of the bones (HP:0010734 from HPO Gene-Disease Associations)", "choroid plexus calcification (HP:0006960 from HPO Gene-Disease Associations)", "osteoma (HP:0100246 from HPO Gene-Disease Associations)", "neoplasm of the anterior pituitary (HP:0011750 from HPO Gene-Disease Associations)", "pituitary adenoma (HP:0002893 from HPO Gene-Disease Associations)", "pituitary prolactin cell adenoma (HP:0006767 from HPO Gene-Disease Associations)", "galactorrhea (HP:0100829 from HPO Gene-Disease Associations)", "hyperpituitarism (HP:0010514 from HPO Gene-Disease Associations)", "growth hormone excess (HP:0000845 from HPO Gene-Disease Associations)", "adrenal overactivity (HP:0002717 from HPO Gene-Disease Associations)", "hypercortisolism (HP:0001578 from HPO Gene-Disease Associations)", "hyperparathyroidism (HP:0000843 from HPO Gene-Disease Associations)", "anxiety (HP:0000739 from HPO Gene-Disease Associations)", "psychosis (HP:0000709 from HPO Gene-Disease Associations)", "mood changes (HP:0001575 from HPO Gene-Disease Associations)", "primary hypercorticolism (HP:0001579 from HPO Gene-Disease Associations)", "decreased circulating acth level (HP:0002920 from HPO Gene-Disease Associations)", "increased circulating cortisol level (HP:0003118 from HPO Gene-Disease Associations)", "adrenocortical abnormality (HP:0000849 from HPO Gene-Disease Associations)", "pigmented micronodular adrenocortical disease (HP:0001580 from HPO Gene-Disease Associations)", "paradoxical increased cortisol secretion on dexamethasone suppression test (HP:0003466 from HPO Gene-Disease Associations)", "abnormality of circulating adrenocorticotropin level (HP:0011043 from HPO Gene-Disease Associations)", "abnormality of circulating cortisol level (HP:0011731 from HPO Gene-Disease Associations)", "abnormality of circulating glucocorticoid level (HP:0012111 from HPO Gene-Disease Associations)", "thyroid follicular hyperplasia (HP:0008225 from HPO Gene-Disease Associations)", "myxoid subcutaneous tumors (HP:0006769 from HPO Gene-Disease Associations)", "neonatal epiphyseal stippling (HP:0005756 from HPO Gene-Disease Associations)", "profuse pigmented skin lesions (HP:0005587 from HPO Gene-Disease Associations)", "pulmonic valve myxoma (HP:0006691 from HPO Gene-Disease Associations)", "endocarditis (HP:0100584 from HPO Gene-Disease Associations)", "bacterial endocarditis (HP:0006689 from HPO Gene-Disease Associations)", "thyroid hyperplasia (HP:0008249 from HPO Gene-Disease Associations)", "mild postnatal growth retardation (HP:0001530 from HPO Gene-Disease Associations)", "calvarial hyperostosis (HP:0004490 from HPO Gene-Disease Associations)", "agitation (HP:0000713 from HPO Gene-Disease Associations)", "restlessness (HP:0000711 from HPO Gene-Disease Associations)", "esophagitis (HP:0100633 from HPO Gene-Disease Associations)", "confetti-like hypopigmented macules (HP:0007449 from HPO Gene-Disease Associations)", "hypomelanotic macules (HP:0009719 from HPO Gene-Disease Associations)", "zollinger-ellison syndrome (HP:0002044 from HPO Gene-Disease Associations)", "pancreatic islet cell adenoma (HP:0008261 from HPO Gene-Disease Associations)", "insulinoma (HP:0012197 from HPO Gene-Disease Associations)", "pancreatic squamous cell carcinoma (HP:0012142 from HPO Gene-Disease Associations)", "oropharyngeal squamous cell carcinoma (HP:0012182 from HPO Gene-Disease Associations)", "pancreatic adenocarcinoma (HP:0006725 from HPO Gene-Disease Associations)", "recurrent pancreatitis (HP:0100027 from HPO Gene-Disease Associations)", "renal cortical adenoma (HP:0006735 from HPO Gene-Disease Associations)", "hurthle cell thyroid adenoma (HP:0006781 from HPO Gene-Disease Associations)", "parathyroid carcinoma (HP:0006780 from HPO Gene-Disease Associations)", "thyroid adenoma (HP:0000854 from HPO Gene-Disease Associations)", "papillary renal cell carcinoma (HP:0006766 from HPO Gene-Disease Associations)", "abnormality of the parathyroid morphology (HP:0011766 from HPO Gene-Disease Associations)", "neoplasm of the parathyroid gland (HP:0100733 from HPO Gene-Disease Associations)", "parathyroid adenoma (HP:0002897 from HPO Gene-Disease Associations)", "peptic ulcer (HP:0004398 from HPO Gene-Disease Associations)", "parathormone-independent increased renal tubular calcium reabsorption (HP:0003529 from HPO Gene-Disease Associations)", "hypermagnesemia (HP:0002918 from HPO Gene-Disease Associations)", "primary hyperparathyroidism (HP:0008200 from HPO Gene-Disease Associations)", "hypocalciuria (HP:0003127 from HPO Gene-Disease Associations)", "chronic active hepatitis (HP:0200120 from HPO Gene-Disease Associations)", "chronic hepatitis (HP:0200123 from HPO Gene-Disease Associations)", "nodular goiter (HP:0005994 from HPO Gene-Disease Associations)", "multinodular goiter (HP:0005987 from HPO Gene-Disease Associations)", "hyperostosis frontalis interna (HP:0004438 from HPO Gene-Disease Associations)", "elevated urinary epinephrine (HP:0003639 from HPO Gene-Disease Associations)", "parathyroid hyperplasia (HP:0008208 from HPO Gene-Disease Associations)", "elevated calcitonin (HP:0003528 from HPO Gene-Disease Associations)", "medullary thyroid carcinoma (HP:0002865 from HPO Gene-Disease Associations)", "proximal femoral epiphysiolysis (HP:0006461 from HPO Gene-Disease Associations)", "aplasia of the abdominal wall musculature (HP:0005199 from HPO Gene-Disease Associations)", "prune belly (HP:0004392 from HPO Gene-Disease Associations)", "congenital posterior urethral valve (HP:0010957 from HPO Gene-Disease Associations)", "urethral valve (HP:0010481 from HPO Gene-Disease Associations)", "urethral obstruction (HP:0000796 from HPO Gene-Disease Associations)", "varicocele (HP:0012871 from HPO Gene-Disease Associations)", "expressive language delay (HP:0002474 from HPO Gene-Disease Associations)", "abnormality of the vena cava (HP:0005345 from HPO Gene-Disease Associations)", "persistent left superior vena cava (HP:0005301 from HPO Gene-Disease Associations)", "celiac disease (HP:0002608 from HPO Gene-Disease Associations)", "mesocardia (HP:0011599 from HPO Gene-Disease Associations)", "left atrial isomerism (HP:0011537 from HPO Gene-Disease Associations)", "sea-blue histiocytosis (HP:0001982 from HPO Gene-Disease Associations)", "foam cells (HP:0003651 from HPO Gene-Disease Associations)", "bone-marrow foam cells (HP:0004333 from HPO Gene-Disease Associations)", "low cholesterol esterification rates (HP:0003349 from HPO Gene-Disease Associations)", "abnormal cholesterol homeostasis (HP:0003464 from HPO Gene-Disease Associations)", "foam cells in visceral organs and cns (HP:0003640 from HPO Gene-Disease Associations)", "vertical supranuclear gaze palsy (HP:0000511 from HPO Gene-Disease Associations)", "fetal ascites (HP:0001791 from HPO Gene-Disease Associations)", "fatal liver failure in infancy (HP:0006583 from HPO Gene-Disease Associations)", "cerebral inclusion bodies (HP:0100314 from HPO Gene-Disease Associations)", "neurofibrillary tangles (HP:0002185 from HPO Gene-Disease Associations)", "supranuclear gaze palsy (HP:0000605 from HPO Gene-Disease Associations)", "loss of speech (HP:0002371 from HPO Gene-Disease Associations)", "excessive daytime sleepiness (HP:0002189 from HPO Gene-Disease Associations)", "cataplexy (HP:0002524 from HPO Gene-Disease Associations)", "abnormal rapid eye movement (rem) sleep (HP:0002494 from HPO Gene-Disease Associations)", "hypnopompic hallucinations (HP:0006896 from HPO Gene-Disease Associations)", "paroxysmal drowsiness (HP:0002330 from HPO Gene-Disease Associations)", "hypnagogic hallucinations (HP:0002519 from HPO Gene-Disease Associations)", "drowsiness (HP:0002329 from HPO Gene-Disease Associations)", "scissor gait (HP:0012407 from HPO Gene-Disease Associations)", "parkinsonism with favorable response to dopaminergic medication (HP:0002548 from HPO Gene-Disease Associations)", "resting tremor (HP:0002322 from HPO Gene-Disease Associations)", "postural instability (HP:0002172 from HPO Gene-Disease Associations)", "abnormality of extrapyramidal motor function (HP:0002071 from HPO Gene-Disease Associations)", "parkinsonism (HP:0001300 from HPO Gene-Disease Associations)", "bradykinesia (HP:0002067 from HPO Gene-Disease Associations)", "rigidity (HP:0002063 from HPO Gene-Disease Associations)", "abnormality of the substantia nigra (HP:0045007 from HPO Gene-Disease Associations)", "substantia nigra gliosis (HP:0011960 from HPO Gene-Disease Associations)", "progressive choreoathetosis (HP:0007326 from HPO Gene-Disease Associations)", "self-mutilation of tongue and lips due to involuntary movements (HP:0008767 from HPO Gene-Disease Associations)", "abnormality of the caudate nucleus (HP:0002339 from HPO Gene-Disease Associations)", "abnormality of the striatum (HP:0010994 from HPO Gene-Disease Associations)", "caudate atrophy (HP:0002340 from HPO Gene-Disease Associations)", "atrophy|degeneration involving the caudate nucleus (HP:0007374 from HPO Gene-Disease Associations)", "disinhibition (HP:0000734 from HPO Gene-Disease Associations)", "inappropriate behavior (HP:0000719 from HPO Gene-Disease Associations)", "personality changes (HP:0000751 from HPO Gene-Disease Associations)", "primitive reflexes (palmomental, snout, glabellar) (HP:0002476 from HPO Gene-Disease Associations)", "akinetic mutism (HP:0012672 from HPO Gene-Disease Associations)", "frontal release signs (HP:0000743 from HPO Gene-Disease Associations)", "impaired pursuit initiation and maintenance (HP:0007668 from HPO Gene-Disease Associations)", "frontal lobe dementia (HP:0000727 from HPO Gene-Disease Associations)", "lack of insight (HP:0000757 from HPO Gene-Disease Associations)", "mutism (HP:0002300 from HPO Gene-Disease Associations)", "neuronal loss in central nervous system (HP:0002529 from HPO Gene-Disease Associations)", "axial dystonia (HP:0002530 from HPO Gene-Disease Associations)", "frontolimbic dementia (HP:0002439 from HPO Gene-Disease Associations)", "granulovacuolar degeneration (HP:0002528 from HPO Gene-Disease Associations)", "eyelid apraxia (HP:0000658 from HPO Gene-Disease Associations)", "language impairment (HP:0002463 from HPO Gene-Disease Associations)", "inappropriate sexual behavior (HP:0008768 from HPO Gene-Disease Associations)", "echolalia (HP:0010529 from HPO Gene-Disease Associations)", "frontotemporal dementia (HP:0002145 from HPO Gene-Disease Associations)", "hyperorality (HP:0000710 from HPO Gene-Disease Associations)", "mental deterioration (HP:0001268 from HPO Gene-Disease Associations)", "dementia (HP:0000726 from HPO Gene-Disease Associations)", "depression (HP:0000716 from HPO Gene-Disease Associations)", "diminished motivation (HP:0000745 from HPO Gene-Disease Associations)", "apathy (HP:0000741 from HPO Gene-Disease Associations)", "rapidly progressive (HP:0003678 from HPO Gene-Disease Associations)", "blepharospasm (HP:0000643 from HPO Gene-Disease Associations)", "craniofacial dystonia (HP:0012179 from HPO Gene-Disease Associations)", "focal dystonia (HP:0004373 from HPO Gene-Disease Associations)", "torticollis (HP:0000473 from HPO Gene-Disease Associations)", "writer's cramp (HP:0002356 from HPO Gene-Disease Associations)", "oromandibular dystonia (HP:0012048 from HPO Gene-Disease Associations)", "retrocollis (HP:0002544 from HPO Gene-Disease Associations)", "lower limb pain (HP:0012514 from HPO Gene-Disease Associations)", "limb dystonia (HP:0002451 from HPO Gene-Disease Associations)", "dysphonia (HP:0001618 from HPO Gene-Disease Associations)", "laryngeal dystonia (HP:0012049 from HPO Gene-Disease Associations)", "torsion dystonia (HP:0001304 from HPO Gene-Disease Associations)", "generalized dystonia (HP:0007325 from HPO Gene-Disease Associations)", "sunken cheeks (HP:0009938 from HPO Gene-Disease Associations)", "secondary amenorrhea (HP:0000869 from HPO Gene-Disease Associations)", "premature ovarian failure (HP:0008209 from HPO Gene-Disease Associations)", "primary gonadal insufficiency (HP:0008193 from HPO Gene-Disease Associations)", "cessation of head growth (HP:0004485 from HPO Gene-Disease Associations)", "decreased serum progesterone (HP:0008233 from HPO Gene-Disease Associations)", "cerebral hypomyelination (HP:0006808 from HPO Gene-Disease Associations)", "cns hypomyelination (HP:0003429 from HPO Gene-Disease Associations)", "unsteady gait (HP:0002317 from HPO Gene-Disease Associations)", "postnatal microcephaly (HP:0005484 from HPO Gene-Disease Associations)", "juvenile onset (HP:0003621 from HPO Gene-Disease Associations)", "fluctuations in consciousness (HP:0007159 from HPO Gene-Disease Associations)", "middle age onset (HP:0003596 from HPO Gene-Disease Associations)", "lewy bodies (HP:0100315 from HPO Gene-Disease Associations)", "bilateral intracranial calcifications (HP:0005671 from HPO Gene-Disease Associations)", "patchy alopecia (HP:0002232 from HPO Gene-Disease Associations)", "delusions (HP:0000746 from HPO Gene-Disease Associations)", "paranoia (HP:0011999 from HPO Gene-Disease Associations)", "aphasia (HP:0002381 from HPO Gene-Disease Associations)", "dysphasia (HP:0002357 from HPO Gene-Disease Associations)", "speech apraxia (HP:0011098 from HPO Gene-Disease Associations)", "eeg with focal epileptiform discharges (HP:0011185 from HPO Gene-Disease Associations)", "eeg with focal spike waves (HP:0011197 from HPO Gene-Disease Associations)", "eeg with centrotemporal focal spike waves (HP:0012557 from HPO Gene-Disease Associations)", "incomplete penetrance (HP:0003829 from HPO Gene-Disease Associations)", "paroxysmal lethargy (HP:0011973 from HPO Gene-Disease Associations)", "hypoglycorrhachia (HP:0011972 from HPO Gene-Disease Associations)", "paroxysmal involuntary eye movements (HP:0007704 from HPO Gene-Disease Associations)", "episodic ataxia (HP:0002131 from HPO Gene-Disease Associations)", "confusion (HP:0001289 from HPO Gene-Disease Associations)", "abnormality of binocular vision (HP:0011514 from HPO Gene-Disease Associations)", "diplopia (HP:0000651 from HPO Gene-Disease Associations)", "dyscalculia (HP:0002442 from HPO Gene-Disease Associations)", "downbeat nystagmus (HP:0010545 from HPO Gene-Disease Associations)", "vertical nystagmus (HP:0010544 from HPO Gene-Disease Associations)", "hemianopic blurring of vision (HP:0001125 from HPO Gene-Disease Associations)", "hemiplegia (HP:0002301 from HPO Gene-Disease Associations)", "hemiparesis (HP:0001269 from HPO Gene-Disease Associations)", "abnormal vestibulo-ocular reflex (HP:0007670 from HPO Gene-Disease Associations)", "vestibular areflexia (HP:0008568 from HPO Gene-Disease Associations)", "episodic quadriplegia (HP:0200072 from HPO Gene-Disease Associations)", "episodic hemiplegia (HP:0012194 from HPO Gene-Disease Associations)", "tetraplegia (HP:0002445 from HPO Gene-Disease Associations)", "tetraplegia|tetraparesis (HP:0030182 from HPO Gene-Disease Associations)", "schizencephaly (HP:0010636 from HPO Gene-Disease Associations)", "posterior leukoencephalopathy (HP:0006859 from HPO Gene-Disease Associations)", "retinal vascular tortuosity (HP:0012841 from HPO Gene-Disease Associations)", "retinal arteriolar tortuosity (HP:0001136 from HPO Gene-Disease Associations)", "blurred vision (HP:0000622 from HPO Gene-Disease Associations)", "amblyopia (HP:0000646 from HPO Gene-Disease Associations)", "phonophobia (HP:0002183 from HPO Gene-Disease Associations)", "migraine without aura (HP:0002083 from HPO Gene-Disease Associations)", "migraine with aura (HP:0002077 from HPO Gene-Disease Associations)", "reduced dihydropyrimidine dehydrogenase activity (HP:0003654 from HPO Gene-Disease Associations)", "extrapyramidal dyskinesia (HP:0007308 from HPO Gene-Disease Associations)", "somnolence (HP:0001262 from HPO Gene-Disease Associations)", "hyperventilation (HP:0002883 from HPO Gene-Disease Associations)", "intermittent hyperventilation (HP:0004879 from HPO Gene-Disease Associations)", "intermittent hyperpnea at rest (HP:0005941 from HPO Gene-Disease Associations)", "renal aminoaciduria (HP:0008335 from HPO Gene-Disease Associations)", "central hypoventilation (HP:0007110 from HPO Gene-Disease Associations)", "gait apraxia (HP:0010521 from HPO Gene-Disease Associations)", "prolonged qtc interval (HP:0005184 from HPO Gene-Disease Associations)", "short stepped shuffling gait (HP:0007311 from HPO Gene-Disease Associations)", "shuffling gait (HP:0002362 from HPO Gene-Disease Associations)", "ekg: t-wave abnormalities (HP:0005135 from HPO Gene-Disease Associations)", "t-wave alternans (HP:0012266 from HPO Gene-Disease Associations)", "sleep-wake cycle disturbance (HP:0006979 from HPO Gene-Disease Associations)", "progressive gait ataxia (HP:0007240 from HPO Gene-Disease Associations)", "inappropriate laughter (HP:0000748 from HPO Gene-Disease Associations)", "paroxysmal bursts of laughter (HP:0000749 from HPO Gene-Disease Associations)", "limb tremor (HP:0200085 from HPO Gene-Disease Associations)", "protruding tongue (HP:0010808 from HPO Gene-Disease Associations)", "clumsiness (HP:0002312 from HPO Gene-Disease Associations)", "broad-based gait (HP:0002136 from HPO Gene-Disease Associations)", "abnormality of salivation (HP:0100755 from HPO Gene-Disease Associations)", "drooling (HP:0002307 from HPO Gene-Disease Associations)", "excessive salivation (HP:0003781 from HPO Gene-Disease Associations)", "intellectual disability, progressive (HP:0006887 from HPO Gene-Disease Associations)", "intellectual disability, severe (HP:0010864 from HPO Gene-Disease Associations)", "widely spaced teeth (HP:0000687 from HPO Gene-Disease Associations)", "absent speech (HP:0001344 from HPO Gene-Disease Associations)", "delayed speech and language development (HP:0000750 from HPO Gene-Disease Associations)", "bruxism (HP:0003763 from HPO Gene-Disease Associations)", "tongue thrusting (HP:0100703 from HPO Gene-Disease Associations)", "toenail dysplasia (HP:0100797 from HPO Gene-Disease Associations)", "abnormal social behavior (HP:0012433 from HPO Gene-Disease Associations)", "impaired social interactions (HP:0000735 from HPO Gene-Disease Associations)", "poor eye contact (HP:0000817 from HPO Gene-Disease Associations)", "paroxysmal dyskinesia (HP:0007166 from HPO Gene-Disease Associations)", "eeg with spike-wave complexes (HP:0010850 from HPO Gene-Disease Associations)", "eeg with spike-wave complexes (>3.5 hz) (HP:0010849 from HPO Gene-Disease Associations)", "visual hallucinations (HP:0002367 from HPO Gene-Disease Associations)", "auras (HP:0011157 from HPO Gene-Disease Associations)", "bilateral convulsive seizures (HP:0007334 from HPO Gene-Disease Associations)", "visual auras (HP:0011165 from HPO Gene-Disease Associations)", "focal motor seizures (HP:0011153 from HPO Gene-Disease Associations)", "focal seizures with impairment of consciousness or awareness (HP:0002384 from HPO Gene-Disease Associations)", "focal seizures (HP:0007359 from HPO Gene-Disease Associations)", "auditory auras (HP:0011158 from HPO Gene-Disease Associations)", "focal seizures without impairment of consciousness or awareness (HP:0002349 from HPO Gene-Disease Associations)", "absence seizures (HP:0002121 from HPO Gene-Disease Associations)", "dialeptic seizures (HP:0011146 from HPO Gene-Disease Associations)", "atonic seizures (HP:0010819 from HPO Gene-Disease Associations)", "febrile seizures (HP:0002373 from HPO Gene-Disease Associations)", "generalized seizures (HP:0002197 from HPO Gene-Disease Associations)", "generalized tonic-clonic seizures (HP:0002069 from HPO Gene-Disease Associations)", "generalized myoclonic seizures (HP:0002123 from HPO Gene-Disease Associations)", "status epilepticus (HP:0002133 from HPO Gene-Disease Associations)", "focal clonic seizures (HP:0002266 from HPO Gene-Disease Associations)", "hemiclonic seizures (HP:0006813 from HPO Gene-Disease Associations)", "abnormal nervous system electrophysiology (HP:0001311 from HPO Gene-Disease Associations)", "abnormality of central nervous system electrophysiology (HP:0030178 from HPO Gene-Disease Associations)", "eeg abnormality (HP:0002353 from HPO Gene-Disease Associations)", "epileptiform eeg discharges (HP:0011182 from HPO Gene-Disease Associations)", "eeg with generalized epileptiform discharges (HP:0011198 from HPO Gene-Disease Associations)", "hypsarrhythmia (HP:0002521 from HPO Gene-Disease Associations)", "muscular hypotonia of the trunk (HP:0008936 from HPO Gene-Disease Associations)", "eeg with burst suppression (HP:0010851 from HPO Gene-Disease Associations)", "generalized tonic seizures (HP:0010818 from HPO Gene-Disease Associations)", "encephalopathy (HP:0001298 from HPO Gene-Disease Associations)", "epileptic encephalopathy (HP:0200134 from HPO Gene-Disease Associations)", "inability to walk (HP:0002540 from HPO Gene-Disease Associations)", "progressive inability to walk (HP:0002505 from HPO Gene-Disease Associations)", "loss of ability to walk (HP:0006957 from HPO Gene-Disease Associations)", "inability to walk by childhood|adolescence (HP:0006915 from HPO Gene-Disease Associations)", "loss of ability to walk in early childhood (HP:0008945 from HPO Gene-Disease Associations)", "facial diplegia (HP:0001349 from HPO Gene-Disease Associations)", "spinal deformities (HP:0008443 from HPO Gene-Disease Associations)", "loss of ability to walk in first decade (HP:0006794 from HPO Gene-Disease Associations)", "photosensitive tonic-clonic seizures (HP:0007207 from HPO Gene-Disease Associations)", "hyperkinesis (HP:0002487 from HPO Gene-Disease Associations)", "generalized clonic seizures (HP:0011169 from HPO Gene-Disease Associations)", "atypical or prolonged hepatitis (HP:0200122 from HPO Gene-Disease Associations)", "high nonceruloplasmin-bound serum copper (HP:0010838 from HPO Gene-Disease Associations)", "kayser-fleischer ring (HP:0200032 from HPO Gene-Disease Associations)", "mixed demyelinating and axonal polyneuropathy (HP:0007327 from HPO Gene-Disease Associations)", "abnormality of copper homeostasis (HP:0010836 from HPO Gene-Disease Associations)", "decreased serum ceruloplasmin (HP:0010837 from HPO Gene-Disease Associations)", "lower limb hyperreflexia (HP:0002395 from HPO Gene-Disease Associations)", "motor aphasia (HP:0002427 from HPO Gene-Disease Associations)", "developmental stagnation (HP:0007281 from HPO Gene-Disease Associations)", "developmental stagnation at onset of seizures (HP:0006834 from HPO Gene-Disease Associations)", "hyporeflexia of upper limbs (HP:0012391 from HPO Gene-Disease Associations)", "cortical visual impairment (HP:0100704 from HPO Gene-Disease Associations)", "inflexible adherence to routines or rituals (HP:0000732 from HPO Gene-Disease Associations)", "lack of peer relationships (HP:0002332 from HPO Gene-Disease Associations)", "impaired use of nonverbal behaviors (HP:0000758 from HPO Gene-Disease Associations)", "restrictive behavior (HP:0000723 from HPO Gene-Disease Associations)", "increased serum serotonin (HP:0003144 from HPO Gene-Disease Associations)", "lack of spontaneous play (HP:0000721 from HPO Gene-Disease Associations)", "low-frequency hearing loss (HP:0008542 from HPO Gene-Disease Associations)", "childhood onset (HP:0011463 from HPO Gene-Disease Associations)", "impaired t cell function (HP:0005435 from HPO Gene-Disease Associations)", "folate-unresponsive megaloblastic anemia (HP:0004826 from HPO Gene-Disease Associations)", "reduced orotidine 5-prime phosphate decarboxylase activity (HP:0003267 from HPO Gene-Disease Associations)", "pyrimidine-responsive megaloblastic anemia (HP:0003339 from HPO Gene-Disease Associations)", "orotic acid crystalluria (HP:0003526 from HPO Gene-Disease Associations)", "anisocytosis (HP:0011273 from HPO Gene-Disease Associations)", "abnormality of monocarboxylic acid metabolism (HP:0010996 from HPO Gene-Disease Associations)", "abnormality of orotic acid metabolism (HP:0010928 from HPO Gene-Disease Associations)", "oroticaciduria (HP:0003218 from HPO Gene-Disease Associations)", "abnormality of pyrimidine metabolism (HP:0004353 from HPO Gene-Disease Associations)", "protein avoidance (HP:0002038 from HPO Gene-Disease Associations)", "respiratory alkalosis (HP:0001950 from HPO Gene-Disease Associations)", "episodic ammonia intoxication (HP:0001951 from HPO Gene-Disease Associations)", "hypoargininemia (HP:0005961 from HPO Gene-Disease Associations)", "abnormality of glutamine metabolism (HP:0010903 from HPO Gene-Disease Associations)", "hyperglutaminemia (HP:0003217 from HPO Gene-Disease Associations)", "abnormality of arginine metabolism (HP:0010909 from HPO Gene-Disease Associations)", "abnormality of citrulline metabolism (HP:0011965 from HPO Gene-Disease Associations)", "low plasma citrulline (HP:0003572 from HPO Gene-Disease Associations)", "irritability (HP:0000737 from HPO Gene-Disease Associations)", "trichorrhexis nodosa (HP:0009886 from HPO Gene-Disease Associations)", "malnutrition (HP:0004395 from HPO Gene-Disease Associations)", "transient aminoaciduria (HP:0008273 from HPO Gene-Disease Associations)", "fructose intolerance (HP:0005973 from HPO Gene-Disease Associations)", "impairment of fructose metabolism (HP:0011033 from HPO Gene-Disease Associations)", "hyperuricosuria (HP:0003149 from HPO Gene-Disease Associations)", "abnormality of nucleobase metabolism (HP:0010932 from HPO Gene-Disease Associations)", "abnormality of purine metabolism (HP:0004352 from HPO Gene-Disease Associations)", "increased purine levels (HP:0004368 from HPO Gene-Disease Associations)", "hyperuricemia (HP:0002149 from HPO Gene-Disease Associations)", "gout (HP:0001997 from HPO Gene-Disease Associations)", "abnormality of nitrogen compound homeostasis (HP:0004364 from HPO Gene-Disease Associations)", "azotemia (HP:0002157 from HPO Gene-Disease Associations)", "hyperammonemia (HP:0001987 from HPO Gene-Disease Associations)", "chronic pancreatitis (HP:0006280 from HPO Gene-Disease Associations)", "spider hemangioma (HP:0012522 from HPO Gene-Disease Associations)", "doll-like facies (HP:0000295 from HPO Gene-Disease Associations)", "focal segmental glomerulosclerosis (HP:0000097 from HPO Gene-Disease Associations)", "glomerulosclerosis (HP:0000096 from HPO Gene-Disease Associations)", "increased urinary urate (HP:0012611 from HPO Gene-Disease Associations)", "acute kidney injury (HP:0001919 from HPO Gene-Disease Associations)", "uric acid nephrolithiasis (HP:0000791 from HPO Gene-Disease Associations)", "spinal cord posterior columns myelin loss (HP:0008311 from HPO Gene-Disease Associations)", "reduced catalase activity (HP:0012517 from HPO Gene-Disease Associations)", "folate-responsive megaloblastic anemia (HP:0004851 from HPO Gene-Disease Associations)", "oral ulcer (HP:0000155 from HPO Gene-Disease Associations)", "abnormal activity of mitochondrial respiratory chain (HP:0011922 from HPO Gene-Disease Associations)", "decreased activity of mitochondrial respiratory chain (HP:0008972 from HPO Gene-Disease Associations)", "decreased activity of mitochondrial complex ii (HP:0008314 from HPO Gene-Disease Associations)", "stress|infection-induced lactic acidosis (HP:0004897 from HPO Gene-Disease Associations)", "progressive leukoencephalopathy (HP:0006980 from HPO Gene-Disease Associations)", "decreased activity of mitochondrial complex iv (HP:0008347 from HPO Gene-Disease Associations)", "decreased activity of mitochondrial complex iii (HP:0011924 from HPO Gene-Disease Associations)", "decreased activity of mitochondrial complex i (HP:0011923 from HPO Gene-Disease Associations)", "concentric hypertrophic cardiomyopathy (HP:0005157 from HPO Gene-Disease Associations)", "abnormal iron deposition in mitochondria (HP:0008306 from HPO Gene-Disease Associations)", "abnormality of mitochondrial metabolism (HP:0003287 from HPO Gene-Disease Associations)", "abnormality of the mitochondrion (HP:0012103 from HPO Gene-Disease Associations)", "abnormal mitochondria in muscle tissue (HP:0008316 from HPO Gene-Disease Associations)", "acute necrotizing encephalopathy (HP:0006965 from HPO Gene-Disease Associations)", "progressive macrocephaly (HP:0004481 from HPO Gene-Disease Associations)", "acute encephalopathy (HP:0006846 from HPO Gene-Disease Associations)", "cerebral edema (HP:0002181 from HPO Gene-Disease Associations)", "leukodystrophy (HP:0002415 from HPO Gene-Disease Associations)", "respiratory failure (HP:0002878 from HPO Gene-Disease Associations)", "abnormal csf lactate level (HP:0030085 from HPO Gene-Disease Associations)", "increased csf lactate (HP:0002490 from HPO Gene-Disease Associations)", "mitochondrial inheritance (HP:0001427 from HPO Gene-Disease Associations)", "optic disc pallor (HP:0000543 from HPO Gene-Disease Associations)", "functional motor problems (HP:0004302 from HPO Gene-Disease Associations)", "exercise intolerance (HP:0003546 from HPO Gene-Disease Associations)", "blindness (HP:0000618 from HPO Gene-Disease Associations)", "abnormal cns myelination (HP:0011400 from HPO Gene-Disease Associations)", "abnormal myelination (HP:0012447 from HPO Gene-Disease Associations)", "nausea and vomiting (HP:0002017 from HPO Gene-Disease Associations)", "vomiting (HP:0002013 from HPO Gene-Disease Associations)", "coma (HP:0001259 from HPO Gene-Disease Associations)", "lethargy (HP:0001254 from HPO Gene-Disease Associations)", "reduced consciousness|confusion (HP:0004372 from HPO Gene-Disease Associations)", "abnormality of blood glucose concentration (HP:0011015 from HPO Gene-Disease Associations)", "hypoglycemia (HP:0001943 from HPO Gene-Disease Associations)", "abnormality of acid-base homeostasis (HP:0004360 from HPO Gene-Disease Associations)", "acidosis (HP:0001941 from HPO Gene-Disease Associations)", "lactic acidosis (HP:0003128 from HPO Gene-Disease Associations)", "increased serum lactate (HP:0002151 from HPO Gene-Disease Associations)", "metabolic acidosis (HP:0001942 from HPO Gene-Disease Associations)", "hepatic necrosis (HP:0002605 from HPO Gene-Disease Associations)", "hepatocellular necrosis (HP:0001404 from HPO Gene-Disease Associations)", "cns demyelination (HP:0007305 from HPO Gene-Disease Associations)", "gliosis (HP:0002171 from HPO Gene-Disease Associations)", "abnormality of the glial cells (HP:0100705 from HPO Gene-Disease Associations)", "abnormal fear|anxiety-related behavior (HP:0100852 from HPO Gene-Disease Associations)", "emotional lability (HP:0000712 from HPO Gene-Disease Associations)", "heterogeneous (HP:0001425 from HPO Gene-Disease Associations)", "gonosomal inheritance (HP:0010985 from HPO Gene-Disease Associations)", "x-linked inheritance (HP:0001417 from HPO Gene-Disease Associations)", "x-linked recessive inheritance (HP:0001419 from HPO Gene-Disease Associations)", "x-linked dominant inheritance (HP:0001423 from HPO Gene-Disease Associations)", "exertional dyspnea (HP:0002875 from HPO Gene-Disease Associations)", "increased hepatocellular lipid droplets (HP:0006565 from HPO Gene-Disease Associations)", "lipid accumulation in hepatocytes (HP:0006561 from HPO Gene-Disease Associations)", "renal fanconi syndrome (HP:0001994 from HPO Gene-Disease Associations)", "increased intramyocellular lipid droplets (HP:0012240 from HPO Gene-Disease Associations)", "increased muscle lipid content (HP:0009058 from HPO Gene-Disease Associations)", "respiratory difficulties (HP:0002880 from HPO Gene-Disease Associations)", "abnormality of renal resorption (HP:0011038 from HPO Gene-Disease Associations)", "decreased activity of cytochrome c oxidase in muscle tissue (HP:0003688 from HPO Gene-Disease Associations)", "muscle abnormality related to mitochondrial dysfunction (HP:0003800 from HPO Gene-Disease Associations)", "abnormal urine phosphate concentration (HP:0012599 from HPO Gene-Disease Associations)", "hyperphosphaturia (HP:0003109 from HPO Gene-Disease Associations)", "abnormality of urine glucose concentration (HP:0011016 from HPO Gene-Disease Associations)", "glycosuria (HP:0003076 from HPO Gene-Disease Associations)", "electron transfer flavoprotein-ubiquinone oxidoreductase defect (HP:0003647 from HPO Gene-Disease Associations)", "hepatic periportal necrosis (HP:0002614 from HPO Gene-Disease Associations)", "defective dehydrogenation of isovaleryl coa and butyryl coa (HP:0003490 from HPO Gene-Disease Associations)", "glutaric acidemia (HP:0003530 from HPO Gene-Disease Associations)", "abnormality of leucine metabolism (HP:0004357 from HPO Gene-Disease Associations)", "ethylmalonic aciduria (HP:0003219 from HPO Gene-Disease Associations)", "glutaric aciduria (HP:0003150 from HPO Gene-Disease Associations)", "generalized aminoaciduria (HP:0002909 from HPO Gene-Disease Associations)", "proximal tubulopathy (HP:0000114 from HPO Gene-Disease Associations)", "nausea (HP:0002018 from HPO Gene-Disease Associations)", "neonatal death (HP:0003811 from HPO Gene-Disease Associations)", "abnormality of branched chain family amino acid metabolism (HP:0010892 from HPO Gene-Disease Associations)", "elevated plasma branched chain amino acids (HP:0008344 from HPO Gene-Disease Associations)", "dyspnea (HP:0002094 from HPO Gene-Disease Associations)", "respiratory distress (HP:0002098 from HPO Gene-Disease Associations)", "desquamative interstitial pneumonitis (HP:0005942 from HPO Gene-Disease Associations)", "alveolar proteinosis (HP:0006517 from HPO Gene-Disease Associations)", "tachypnea (HP:0002789 from HPO Gene-Disease Associations)", "mitochondrial respiratory chain defects (HP:0200125 from HPO Gene-Disease Associations)", "decreased activity of the pyruvate dehydrogenase (pdh) complex (HP:0002928 from HPO Gene-Disease Associations)", "severe lactic acidosis (HP:0004900 from HPO Gene-Disease Associations)", "flared nostrils (HP:0000454 from HPO Gene-Disease Associations)", "abnormality of alanine metabolism (HP:0010916 from HPO Gene-Disease Associations)", "abnormality of pyruvate family amino acid metabolism (HP:0010915 from HPO Gene-Disease Associations)", "hyperalaninemia (HP:0003348 from HPO Gene-Disease Associations)", "abnormality of serum amino acid levels (HP:0003112 from HPO Gene-Disease Associations)", "decreased mitochondrial complex iii activity in liver tissue (HP:0006558 from HPO Gene-Disease Associations)", "mitochondrial encephalopathy (HP:0006789 from HPO Gene-Disease Associations)", "hair shafts flattened at irregular intervals and twisted through 180 degrees about their axes (HP:0003329 from HPO Gene-Disease Associations)", "chronic lactic acidosis (HP:0004925 from HPO Gene-Disease Associations)", "chronic acidosis (HP:0012468 from HPO Gene-Disease Associations)", "abnormal serum iron (HP:0040130 from HPO Gene-Disease Associations)", "increased serum iron (HP:0003452 from HPO Gene-Disease Associations)", "abnormality of glycolysis (HP:0004366 from HPO Gene-Disease Associations)", "increased serum pyruvate (HP:0003542 from HPO Gene-Disease Associations)", "decreased activity of mitochondrial atp synthase complex (HP:0011925 from HPO Gene-Disease Associations)", "3-methylglutaconic aciduria (HP:0003535 from HPO Gene-Disease Associations)", "exercise-induced lactic acidemia (HP:0004901 from HPO Gene-Disease Associations)", "normochromic microcytic anemia (HP:0004856 from HPO Gene-Disease Associations)", "noncompaction cardiomyopathy (HP:0012817 from HPO Gene-Disease Associations)", "3-methylglutaric aciduria (HP:0003344 from HPO Gene-Disease Associations)", "nonprogressive cerebellar ataxia (HP:0002470 from HPO Gene-Disease Associations)", "hepatic steatosis (HP:0001397 from HPO Gene-Disease Associations)", "microvesicular hepatic steatosis (HP:0001414 from HPO Gene-Disease Associations)", "intermittent diarrhea (HP:0002254 from HPO Gene-Disease Associations)", "gastroparesis (HP:0002578 from HPO Gene-Disease Associations)", "death in early adulthood (HP:0100613 from HPO Gene-Disease Associations)", "cachexia (HP:0004326 from HPO Gene-Disease Associations)", "ragged-red muscle fibers (HP:0003200 from HPO Gene-Disease Associations)", "depletion of mitochondrial dna in muscle tissue (HP:0009141 from HPO Gene-Disease Associations)", "multiple mitochondrial dna deletions (HP:0003689 from HPO Gene-Disease Associations)", "progressive external ophthalmoplegia (HP:0000590 from HPO Gene-Disease Associations)", "mitochondrial myopathy (HP:0003737 from HPO Gene-Disease Associations)", "subsarcolemmal accumulations of abnormally shaped mitochondria (HP:0003548 from HPO Gene-Disease Associations)", "cerebral cortical neurodegeneration (HP:0006964 from HPO Gene-Disease Associations)", "sensory ataxic neuropathy (HP:0003434 from HPO Gene-Disease Associations)", "impaired distal proprioception (HP:0006858 from HPO Gene-Disease Associations)", "epilepsia partialis continua (HP:0012847 from HPO Gene-Disease Associations)", "astrocytosis (HP:0002446 from HPO Gene-Disease Associations)", "cerebellar cortical atrophy (HP:0008278 from HPO Gene-Disease Associations)", "progressive muscle weakness (HP:0003323 from HPO Gene-Disease Associations)", "abnormal number of erythroid precursors (HP:0012131 from HPO Gene-Disease Associations)", "erythroid hyperplasia (HP:0012132 from HPO Gene-Disease Associations)", "megaloblastic erythroid hyperplasia (HP:0200143 from HPO Gene-Disease Associations)", "absence of intrinsic factor (HP:0005219 from HPO Gene-Disease Associations)", "malabsorption of vitamin b12 (HP:0200118 from HPO Gene-Disease Associations)", "anemia of inadequate production (HP:0010972 from HPO Gene-Disease Associations)", "macrocytic anemia (HP:0001972 from HPO Gene-Disease Associations)", "megaloblastic anemia (HP:0001889 from HPO Gene-Disease Associations)", "pallor (HP:0000980 from HPO Gene-Disease Associations)", "erythrocyte macrocytosis (HP:0005518 from HPO Gene-Disease Associations)", "abnormality of the hypothenar eminence (HP:0010486 from HPO Gene-Disease Associations)", "small hypothenar eminence (HP:0010487 from HPO Gene-Disease Associations)", "abnormality of dicarboxylic acid metabolism (HP:0010995 from HPO Gene-Disease Associations)", "dicarboxylic aciduria (HP:0003215 from HPO Gene-Disease Associations)", "organic aciduria (HP:0001992 from HPO Gene-Disease Associations)", "abnormality of amino acid metabolism (HP:0004337 from HPO Gene-Disease Associations)", "abnormality of carboxylic acid metabolism (HP:0004354 from HPO Gene-Disease Associations)", "aciduria (HP:0012072 from HPO Gene-Disease Associations)", "aminoaciduria (HP:0003355 from HPO Gene-Disease Associations)", "methylmalonic aciduria (HP:0012120 from HPO Gene-Disease Associations)", "methylmalonic acidemia (HP:0002912 from HPO Gene-Disease Associations)", "abnormality of the vitamin b12 metabolism (HP:0004341 from HPO Gene-Disease Associations)", "abnormality of vitamin b metabolism (HP:0004340 from HPO Gene-Disease Associations)", "decreased adenosylcobalamin (HP:0003145 from HPO Gene-Disease Associations)", "abnormality of krebs cycle metabolism (HP:0000816 from HPO Gene-Disease Associations)", "decreased methylmalonyl-coa mutase activity (HP:0003210 from HPO Gene-Disease Associations)", "hypomethioninemia (HP:0003658 from HPO Gene-Disease Associations)", "decreased methionine synthase activity (HP:0003524 from HPO Gene-Disease Associations)", "hyperhomocystinemia (HP:0002160 from HPO Gene-Disease Associations)", "decreased methylcobalamin (HP:0003223 from HPO Gene-Disease Associations)", "abnormality of homocysteine metabolism (HP:0010919 from HPO Gene-Disease Associations)", "homocystinuria (HP:0002156 from HPO Gene-Disease Associations)", "cystathioninuria (HP:0003153 from HPO Gene-Disease Associations)", "cystathioninemia (HP:0003286 from HPO Gene-Disease Associations)", "abnormality of aspartate family amino acid metabolism (HP:0010899 from HPO Gene-Disease Associations)", "abnormality of methionine metabolism (HP:0010901 from HPO Gene-Disease Associations)", "abnormality of sulfur amino acid metabolism (HP:0004339 from HPO Gene-Disease Associations)", "hypermethioninemia (HP:0003235 from HPO Gene-Disease Associations)", "poor appetite (HP:0004396 from HPO Gene-Disease Associations)", "propionyl-coa carboxylase deficiency (HP:0003353 from HPO Gene-Disease Associations)", "cerebellar hemorrhage (HP:0011695 from HPO Gene-Disease Associations)", "abnormality of vitamin metabolism (HP:0100508 from HPO Gene-Disease Associations)", "abnormality of glycine metabolism (HP:0010895 from HPO Gene-Disease Associations)", "abnormality of serine family amino acid metabolism (HP:0010894 from HPO Gene-Disease Associations)", "hyperglycinuria (HP:0003108 from HPO Gene-Disease Associations)", "hyperglycinemia (HP:0002154 from HPO Gene-Disease Associations)", "recurrent singultus (HP:0100247 from HPO Gene-Disease Associations)", "impulsivity (HP:0100710 from HPO Gene-Disease Associations)", "neutral hyperaminoaciduria (HP:0008353 from HPO Gene-Disease Associations)", "glossitis (HP:0000206 from HPO Gene-Disease Associations)", "abnormality of glutamine family amino acid metabolism (HP:0010902 from HPO Gene-Disease Associations)", "abnormality of proline metabolism (HP:0010907 from HPO Gene-Disease Associations)", "hydroxyprolinuria (HP:0003080 from HPO Gene-Disease Associations)", "prolinuria (HP:0003137 from HPO Gene-Disease Associations)", "hyperprolinemia (HP:0008358 from HPO Gene-Disease Associations)", "hyperoxaluria (HP:0003159 from HPO Gene-Disease Associations)", "calcium nephrolithiasis (HP:0004724 from HPO Gene-Disease Associations)", "calcium oxalate nephrolithiasis (HP:0008672 from HPO Gene-Disease Associations)", "peripheral vascular insufficiency (HP:0005309 from HPO Gene-Disease Associations)", "acute hepatic steatosis (HP:0006573 from HPO Gene-Disease Associations)", "acute hyperammonemia (HP:0008281 from HPO Gene-Disease Associations)", "episodic metabolic acidosis (HP:0004911 from HPO Gene-Disease Associations)", "elevated intracellular cystine (HP:0003358 from HPO Gene-Disease Associations)", "primary hypothyroidism (HP:0000832 from HPO Gene-Disease Associations)", "peripheral retinopathy (HP:0007869 from HPO Gene-Disease Associations)", "corneal crystals (HP:0000531 from HPO Gene-Disease Associations)", "rachitic rosary (HP:0000897 from HPO Gene-Disease Associations)", "microscopic hematuria (HP:0002907 from HPO Gene-Disease Associations)", "abnormality of urine hormone level (HP:0012029 from HPO Gene-Disease Associations)", "increased urinary cortisol level (HP:0012030 from HPO Gene-Disease Associations)", "ketonuria (HP:0002919 from HPO Gene-Disease Associations)", "ornithinuria (HP:0003532 from HPO Gene-Disease Associations)", "cystinuria (HP:0003131 from HPO Gene-Disease Associations)", "argininuria (HP:0003268 from HPO Gene-Disease Associations)", "abnormality of cysteine metabolism (HP:0010918 from HPO Gene-Disease Associations)", "abnormality of lysine metabolism (HP:0010908 from HPO Gene-Disease Associations)", "hyperlysinuria (HP:0003297 from HPO Gene-Disease Associations)", "hyperlysinemia (HP:0002161 from HPO Gene-Disease Associations)", "abnormality of histidine metabolism (HP:0010904 from HPO Gene-Disease Associations)", "histidinuria (HP:0002927 from HPO Gene-Disease Associations)", "spastic diplegia (HP:0001264 from HPO Gene-Disease Associations)", "respiratory acidosis (HP:0005972 from HPO Gene-Disease Associations)", "abnormality of carnitine metabolism (HP:0010967 from HPO Gene-Disease Associations)", "decreased plasma carnitine (HP:0003234 from HPO Gene-Disease Associations)", "abnormality of fatty-acid anion metabolism (HP:0010966 from HPO Gene-Disease Associations)", "medium chain dicarboxylic aciduria (HP:0008309 from HPO Gene-Disease Associations)", "exercise-induced rhabdomyolysis (HP:0009045 from HPO Gene-Disease Associations)", "decreased plasma total carnitine (HP:0011936 from HPO Gene-Disease Associations)", "antenatal intracerebral hemorrhage (HP:0007023 from HPO Gene-Disease Associations)", "long-chain dicarboxylic aciduria (HP:0008293 from HPO Gene-Disease Associations)", "decreased plasma free carnitine (HP:0008315 from HPO Gene-Disease Associations)", "intracerebral periventricular calcifications (HP:0007229 from HPO Gene-Disease Associations)", "nonketotic hypoglycemia (HP:0001958 from HPO Gene-Disease Associations)", "tapered toe (HP:0011309 from HPO Gene-Disease Associations)", "basal ganglia cysts (HP:0006799 from HPO Gene-Disease Associations)", "macrovesicular hepatic steatosis (HP:0001403 from HPO Gene-Disease Associations)", "abnormality of fatty-acid metabolism (HP:0004359 from HPO Gene-Disease Associations)", "abnormality of long-chain fatty-acid metabolism (HP:0010964 from HPO Gene-Disease Associations)", "elevated long chain fatty acids (HP:0003455 from HPO Gene-Disease Associations)", "polycystic liver disease (HP:0006557 from HPO Gene-Disease Associations)", "increased total bilirubin (HP:0003573 from HPO Gene-Disease Associations)", "transient hyperlipidemia (HP:0008279 from HPO Gene-Disease Associations)", "recurrent encephalopathy (HP:0007335 from HPO Gene-Disease Associations)", "hypoketotic hypoglycemia (HP:0001985 from HPO Gene-Disease Associations)", "cardiorespiratory arrest (HP:0006543 from HPO Gene-Disease Associations)", "respiratory arrest (HP:0005943 from HPO Gene-Disease Associations)", "partial development of the penile shaft (HP:0008708 from HPO Gene-Disease Associations)", "dysplastic testes (HP:0008733 from HPO Gene-Disease Associations)", "testicular dysgenesis (HP:0008715 from HPO Gene-Disease Associations)", "myoglobinuria (HP:0002913 from HPO Gene-Disease Associations)", "rhabdomyolysis (HP:0003201 from HPO Gene-Disease Associations)", "exercise-induced myalgia (HP:0003738 from HPO Gene-Disease Associations)", "exercise-induced muscle cramps (HP:0003710 from HPO Gene-Disease Associations)", "muscle cramps (HP:0003394 from HPO Gene-Disease Associations)", "dyslexia (HP:0010522 from HPO Gene-Disease Associations)", "weakness of the intrinsic hand muscles (HP:0009005 from HPO Gene-Disease Associations)", "exercise-induced muscle fatigue (HP:0009020 from HPO Gene-Disease Associations)", "increased muscle fatiguability (HP:0003750 from HPO Gene-Disease Associations)", "apneic episodes in infancy (HP:0005949 from HPO Gene-Disease Associations)", "muscular edema (HP:0100748 from HPO Gene-Disease Associations)", "paradoxical myotonia (HP:0011809 from HPO Gene-Disease Associations)", "episodic flaccid weakness (HP:0003752 from HPO Gene-Disease Associations)", "muscle flaccidity (HP:0010547 from HPO Gene-Disease Associations)", "periodic hyperkalemic paralysis (HP:0007215 from HPO Gene-Disease Associations)", "paralysis (HP:0003470 from HPO Gene-Disease Associations)", "periodic paralysis (HP:0003768 from HPO Gene-Disease Associations)", "periodic hypokalemic paresis (HP:0008153 from HPO Gene-Disease Associations)", "emg: myotonic runs (HP:0003730 from HPO Gene-Disease Associations)", "myotonia with warm-up phenomenon (HP:0003740 from HPO Gene-Disease Associations)", "handgrip myotonia (HP:0012899 from HPO Gene-Disease Associations)", "muscle mounding (HP:0003719 from HPO Gene-Disease Associations)", "percussion-induced rapid rolling muscle contractions (pirc) (HP:0003760 from HPO Gene-Disease Associations)", "muscle hyperirritability (HP:0003559 from HPO Gene-Disease Associations)", "percussion myotonia (HP:0010548 from HPO Gene-Disease Associations)", "exercise-induced muscle stiffness (HP:0008967 from HPO Gene-Disease Associations)", "muscle stiffness (HP:0003552 from HPO Gene-Disease Associations)", "myotonia (HP:0002486 from HPO Gene-Disease Associations)", "abnormal muscle glycogen content (HP:0012269 from HPO Gene-Disease Associations)", "increased muscle glycogen content (HP:0009051 from HPO Gene-Disease Associations)", "decreased muscle glycogen content (HP:0012270 from HPO Gene-Disease Associations)", "intraaxonal accumulation of curvilinear autofluorescent lipopigment storage material (HP:0006916 from HPO Gene-Disease Associations)", "talipes cavus equinovarus (HP:0004696 from HPO Gene-Disease Associations)", "axonal loss (HP:0003447 from HPO Gene-Disease Associations)", "increased urinary taurine (HP:0003166 from HPO Gene-Disease Associations)", "increased urinary hypoxanthine (HP:0011814 from HPO Gene-Disease Associations)", "molybdenum cofactor deficiency (HP:0003570 from HPO Gene-Disease Associations)", "abnormality of xanthine metabolism (HP:0010933 from HPO Gene-Disease Associations)", "xanthinuria (HP:0010934 from HPO Gene-Disease Associations)", "xanthine nephrolithiasis (HP:0000804 from HPO Gene-Disease Associations)", "myoclonic spasms (HP:0003739 from HPO Gene-Disease Associations)", "sulfite oxidase deficiency (HP:0003643 from HPO Gene-Disease Associations)", "abnormal urinary sulfate concentration (HP:0012612 from HPO Gene-Disease Associations)", "decreased urinary sulfate (HP:0003359 from HPO Gene-Disease Associations)", "increased urinary sulfite (HP:0011942 from HPO Gene-Disease Associations)", "decreased urinary urate (HP:0011935 from HPO Gene-Disease Associations)", "reduced xanthine dehydrogenase activity (HP:0003534 from HPO Gene-Disease Associations)", "aldehyde oxidase deficiency (HP:0002932 from HPO Gene-Disease Associations)", "absent urinary urothione (HP:0003606 from HPO Gene-Disease Associations)", "increased urinary thiosulfate (HP:0011943 from HPO Gene-Disease Associations)", "abnormality of urinary uric acid concentration (HP:0012610 from HPO Gene-Disease Associations)", "hypouricemia (HP:0003537 from HPO Gene-Disease Associations)", "decreased purine levels (HP:0004369 from HPO Gene-Disease Associations)", "nonketotic hyperglycinemia (HP:0008288 from HPO Gene-Disease Associations)", "opisthotonus (HP:0002179 from HPO Gene-Disease Associations)", "spastic tetraplegia (HP:0002510 from HPO Gene-Disease Associations)", "autosomal dominant inheritance with maternal imprinting (HP:0012275 from HPO Gene-Disease Associations)", "chronic metabolic acidosis (HP:0001996 from HPO Gene-Disease Associations)", "peripheral retinal pigmentation abnormalities (HP:0200099 from HPO Gene-Disease Associations)", "glyoxalase deficiency (HP:0003258 from HPO Gene-Disease Associations)", "glutathione synthetase deficiency (HP:0003343 from HPO Gene-Disease Associations)", "psychotic mentation (HP:0001345 from HPO Gene-Disease Associations)", "spastic tetraparesis (HP:0001285 from HPO Gene-Disease Associations)", "pulmonary artery sling (HP:0004961 from HPO Gene-Disease Associations)", "prominent nasal tip (HP:0005274 from HPO Gene-Disease Associations)", "broad eyebrow (HP:0011229 from HPO Gene-Disease Associations)", "long eyebrows (HP:0004523 from HPO Gene-Disease Associations)", "female hypogonadism (HP:0000134 from HPO Gene-Disease Associations)", "aplasia of the optic tract (HP:0010999 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the optic tract (HP:0011000 from HPO Gene-Disease Associations)", "uplifted earlobe (HP:0009909 from HPO Gene-Disease Associations)", "delayed cns myelination (HP:0002188 from HPO Gene-Disease Associations)", "delayed myelination (HP:0012448 from HPO Gene-Disease Associations)", "aplasia|hypoplasia involving the corticospinal tracts (HP:0007365 from HPO Gene-Disease Associations)", "corticospinal tract hypoplasia (HP:0007016 from HPO Gene-Disease Associations)", "inferior vermis hypoplasia (HP:0007068 from HPO Gene-Disease Associations)", "contractures of the interphalangeal joint of the thumb (HP:0009626 from HPO Gene-Disease Associations)", "flexion contracture of thumb (HP:0009600 from HPO Gene-Disease Associations)", "hemoglobin h (HP:0011903 from HPO Gene-Disease Associations)", "triangular nasal tip (HP:0000451 from HPO Gene-Disease Associations)", "short upper lip (HP:0000188 from HPO Gene-Disease Associations)", "limb hypertonia (HP:0002509 from HPO Gene-Disease Associations)", "lower limb hypertonia (HP:0006895 from HPO Gene-Disease Associations)", "lipoma of corpus callosum (HP:0006931 from HPO Gene-Disease Associations)", "cranium bifidum occultum (HP:0004423 from HPO Gene-Disease Associations)", "anterior basal encephalocele (HP:0006992 from HPO Gene-Disease Associations)", "midline central nervous system lipomas (HP:0006866 from HPO Gene-Disease Associations)", "lipomas of the central neryous system (HP:0100251 from HPO Gene-Disease Associations)", "frontal cutaneous lipoma (HP:0007541 from HPO Gene-Disease Associations)", "diastema (HP:0000699 from HPO Gene-Disease Associations)", "misalignment of incisors (HP:0011062 from HPO Gene-Disease Associations)", "widely-spaced incisors (HP:0006304 from HPO Gene-Disease Associations)", "widely-spaced maxillary central incisors (HP:0001566 from HPO Gene-Disease Associations)", "short columella (HP:0002000 from HPO Gene-Disease Associations)", "laterally curved eyebrow (HP:0007733 from HPO Gene-Disease Associations)", "double tooth (HP:0011089 from HPO Gene-Disease Associations)", "fused teeth (HP:0011090 from HPO Gene-Disease Associations)", "persistent hyperplastic primary vitreous (HP:0007968 from HPO Gene-Disease Associations)", "bifid nasal tip (HP:0000456 from HPO Gene-Disease Associations)", "oligodontia (HP:0000677 from HPO Gene-Disease Associations)", "posterior pharyngeal cleft (HP:0006783 from HPO Gene-Disease Associations)", "partial abdominal muscle agenesis (HP:0005243 from HPO Gene-Disease Associations)", "broad philtrum (HP:0000289 from HPO Gene-Disease Associations)", "epicanthus inversus (HP:0000537 from HPO Gene-Disease Associations)", "shawl scrotum (HP:0000049 from HPO Gene-Disease Associations)", "finger joint hyperextensibility (HP:0006158 from HPO Gene-Disease Associations)", "curved linear dimple below the lower lip (HP:0002055 from HPO Gene-Disease Associations)", "increased upper to lower segment ratio (HP:0012774 from HPO Gene-Disease Associations)", "abnormal upper to lower segment ratio (HP:0012772 from HPO Gene-Disease Associations)", "cervical spine hypermobility (HP:0003318 from HPO Gene-Disease Associations)", "high anterior hairline (HP:0009890 from HPO Gene-Disease Associations)", "widow's peak (HP:0000349 from HPO Gene-Disease Associations)", "unilateral breast hypoplasia (HP:0012813 from HPO Gene-Disease Associations)", "hemihypotrophy of lower limb (HP:0200053 from HPO Gene-Disease Associations)", "hypoplastic nasal tip (HP:0005278 from HPO Gene-Disease Associations)", "split nail (HP:0001809 from HPO Gene-Disease Associations)", "skull asymmetry (HP:0002678 from HPO Gene-Disease Associations)", "unilateral polymicrogyria (HP:0006927 from HPO Gene-Disease Associations)", "frontoparietal cortical dysplasia (HP:0006930 from HPO Gene-Disease Associations)", "limited extraocular movements (HP:0007941 from HPO Gene-Disease Associations)", "cortical dysplasia (HP:0002539 from HPO Gene-Disease Associations)", "bilateral ptosis (HP:0001488 from HPO Gene-Disease Associations)", "restrictive external ophthalmoplegia (HP:0007936 from HPO Gene-Disease Associations)", "abnormality of the extraocular muscles (HP:0008049 from HPO Gene-Disease Associations)", "congenital fibrosis of extraocular muscles (HP:0001491 from HPO Gene-Disease Associations)", "superior rectus atrophy (HP:0012242 from HPO Gene-Disease Associations)", "levator palpebrae superioris atrophy (HP:0012241 from HPO Gene-Disease Associations)", "compensatory chin elevation (HP:0001477 from HPO Gene-Disease Associations)", "nonprogressive restrictive external ophthalmoplegia (HP:0007831 from HPO Gene-Disease Associations)", "exotropia (HP:0000577 from HPO Gene-Disease Associations)", "abnormality of neutrophil morphology (HP:0011992 from HPO Gene-Disease Associations)", "hypersegmentation of neutrophil nuclei (HP:0004821 from HPO Gene-Disease Associations)", "positive ferric chloride test (HP:0003612 from HPO Gene-Disease Associations)", "absent neutrophil specific granules (HP:0012551 from HPO Gene-Disease Associations)", "hyposegmentation of neutrophil nuclei (HP:0011447 from HPO Gene-Disease Associations)", "neutrophil inclusion bodies (HP:0008264 from HPO Gene-Disease Associations)", "high-frequency sensorineural hearing impairment (HP:0001757 from HPO Gene-Disease Associations)", "high-frequency hearing impairment (HP:0005101 from HPO Gene-Disease Associations)", "bilateral sensorineural hearing impairment (HP:0008619 from HPO Gene-Disease Associations)", "absent vestibular function (HP:0008555 from HPO Gene-Disease Associations)", "vestibular hypofunction (HP:0001756 from HPO Gene-Disease Associations)", "obliteration of the pulp chamber (HP:0006350 from HPO Gene-Disease Associations)", "shell teeth (HP:0000694 from HPO Gene-Disease Associations)", "periapical radiolucency (HP:0000700 from HPO Gene-Disease Associations)", "abnormality of mast cells (HP:0100494 from HPO Gene-Disease Associations)", "telangiectasia macularis eruptiva perstans (HP:0007583 from HPO Gene-Disease Associations)", "mastocytosis (HP:0100495 from HPO Gene-Disease Associations)", "cutaneous mastocytosis (HP:0200151 from HPO Gene-Disease Associations)", "absent pigmentation of chest (HP:0040007 from HPO Gene-Disease Associations)", "absent pigmentation of the ventral chest (HP:0007542 from HPO Gene-Disease Associations)", "piebaldism (HP:0007544 from HPO Gene-Disease Associations)", "absent skin pigmentation (HP:0200098 from HPO Gene-Disease Associations)", "partial albinism (HP:0007443 from HPO Gene-Disease Associations)", "impaired temperature sensation (HP:0010829 from HPO Gene-Disease Associations)", "long-segment aganglionic megacolon (HP:0011285 from HPO Gene-Disease Associations)", "morphological abnormality of the semicircular canal (HP:0011380 from HPO Gene-Disease Associations)", "aplasia of the semicircular canal (HP:0011381 from HPO Gene-Disease Associations)", "hypoplasia of the semicircular canal (HP:0011382 from HPO Gene-Disease Associations)", "dilated vestibule of the inner ear (HP:0011379 from HPO Gene-Disease Associations)", "autonomic dysregulation (HP:0002271 from HPO Gene-Disease Associations)", "absent brainstem auditory responses (HP:0004463 from HPO Gene-Disease Associations)", "dysmyelinating leukodystrophy (HP:0006978 from HPO Gene-Disease Associations)", "white eyebrow (HP:0002226 from HPO Gene-Disease Associations)", "white eyelashes (HP:0002227 from HPO Gene-Disease Associations)", "patchy hypopigmentation of hair (HP:0011365 from HPO Gene-Disease Associations)", "white forelock (HP:0002211 from HPO Gene-Disease Associations)", "heterochromia iridis (HP:0001100 from HPO Gene-Disease Associations)", "paraparesis (HP:0002385 from HPO Gene-Disease Associations)", "spastic paraparesis (HP:0002313 from HPO Gene-Disease Associations)", "increased urinary disaccharide excretion (HP:0012066 from HPO Gene-Disease Associations)", "demyelinating peripheral neuropathy (HP:0007108 from HPO Gene-Disease Associations)", "abnormality of dermal melanosomes (HP:0011125 from HPO Gene-Disease Associations)", "giant melanosomes in melanocytes (HP:0005592 from HPO Gene-Disease Associations)", "depigmented fundus (HP:0007680 from HPO Gene-Disease Associations)", "nystagmus-induced head nodding (HP:0001361 from HPO Gene-Disease Associations)", "hypopigmented fundi (HP:0001487 from HPO Gene-Disease Associations)", "accumulation of melanosomes in melanocytes (HP:0001008 from HPO Gene-Disease Associations)", "silver-gray hair (HP:0002218 from HPO Gene-Disease Associations)", "melanin pigment aggregation in hair shafts (HP:0002220 from HPO Gene-Disease Associations)", "large clumps of pigment irregularly distributed along hair shaft (HP:0004527 from HPO Gene-Disease Associations)", "abnormality of hair pigmentation (HP:0009887 from HPO Gene-Disease Associations)", "hypopigmentation of hair (HP:0005599 from HPO Gene-Disease Associations)", "generalized hypopigmentation of hair (HP:0011358 from HPO Gene-Disease Associations)", "fair hair (HP:0002286 from HPO Gene-Disease Associations)", "blue irides (HP:0000635 from HPO Gene-Disease Associations)", "albinism (HP:0001022 from HPO Gene-Disease Associations)", "generalized hypopigmentation (HP:0007513 from HPO Gene-Disease Associations)", "abnormal iris pigmentation (HP:0008034 from HPO Gene-Disease Associations)", "iris hypopigmentation (HP:0007730 from HPO Gene-Disease Associations)", "ocular albinism (HP:0001107 from HPO Gene-Disease Associations)", "recurrent systemic pyogenic infections (HP:0005429 from HPO Gene-Disease Associations)", "macular hypoplasia (HP:0001104 from HPO Gene-Disease Associations)", "gallbladder dysfunction (HP:0005609 from HPO Gene-Disease Associations)", "progressive peripheral neuropathy (HP:0007133 from HPO Gene-Disease Associations)", "aplasia of the testes (HP:0010469 from HPO Gene-Disease Associations)", "abnormal vertebral segmentation and fusion (HP:0005640 from HPO Gene-Disease Associations)", "cervical vertebral fusion (c2|c3) (HP:0004602 from HPO Gene-Disease Associations)", "abnormality of the temporal bone (HP:0009911 from HPO Gene-Disease Associations)", "optic disc hypoplasia (HP:0007766 from HPO Gene-Disease Associations)", "digenic inheritance (HP:0010984 from HPO Gene-Disease Associations)", "abnormality of the fovea (HP:0000493 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the fovea (HP:0008060 from HPO Gene-Disease Associations)", "hypoplasia of the fovea (HP:0007750 from HPO Gene-Disease Associations)", "aplasia|hypoplasia affecting the retina (HP:0008061 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the macula (HP:0008059 from HPO Gene-Disease Associations)", "adrenocorticotropic hormone deficiency (HP:0011748 from HPO Gene-Disease Associations)", "red hair (HP:0002297 from HPO Gene-Disease Associations)", "freckles in sun-exposed areas (HP:0007603 from HPO Gene-Disease Associations)", "hyperpigmentation in sun-exposed areas (HP:0005586 from HPO Gene-Disease Associations)", "erythroid hypoplasia (HP:0012133 from HPO Gene-Disease Associations)", "refractory macrocytic anemia (HP:0004861 from HPO Gene-Disease Associations)", "autosomal dominant contiguous gene syndrome (HP:0001452 from HPO Gene-Disease Associations)", "contiguous gene syndrome (HP:0001466 from HPO Gene-Disease Associations)", "aplasia of the vagina (HP:0003250 from HPO Gene-Disease Associations)", "alveolar rhabdomyosarcoma (HP:0006779 from HPO Gene-Disease Associations)", "retrocerebellar cyst (HP:0006951 from HPO Gene-Disease Associations)", "disorganization of the anterior cerebellar vermis (HP:0007065 from HPO Gene-Disease Associations)", "enlarged cisterna magna (HP:0002280 from HPO Gene-Disease Associations)", "polycoria (HP:0011500 from HPO Gene-Disease Associations)", "rieger anomaly (HP:0000558 from HPO Gene-Disease Associations)", "hypoplasia of the iris (HP:0007676 from HPO Gene-Disease Associations)", "hypoplastic iris stroma (HP:0007990 from HPO Gene-Disease Associations)", "ectopia pupillae (HP:0009918 from HPO Gene-Disease Associations)", "abnormal iris vasculature (HP:0007905 from HPO Gene-Disease Associations)", "urocanic aciduria (HP:0012237 from HPO Gene-Disease Associations)", "pleuritis (HP:0002102 from HPO Gene-Disease Associations)", "pericarditis (HP:0001701 from HPO Gene-Disease Associations)", "polyarticular arthritis (HP:0005764 from HPO Gene-Disease Associations)", "polyarticular arthropathy (HP:0005195 from HPO Gene-Disease Associations)", "renal amyloidosis (HP:0001917 from HPO Gene-Disease Associations)", "elevated erythrocyte sedimentation rate (HP:0003565 from HPO Gene-Disease Associations)", "progressive forgetfulness (HP:0007017 from HPO Gene-Disease Associations)", "punctate vasculitis skin lesions (HP:0200030 from HPO Gene-Disease Associations)", "vasculitis in the skin (HP:0200029 from HPO Gene-Disease Associations)", "increased csf interferon alpha (HP:0009709 from HPO Gene-Disease Associations)", "deep white matter hypodensities (HP:0007321 from HPO Gene-Disease Associations)", "central nervous system degeneration (HP:0007009 from HPO Gene-Disease Associations)", "chilblain lesions (HP:0009710 from HPO Gene-Disease Associations)", "chronic csf lymphocytosis (HP:0009704 from HPO Gene-Disease Associations)", "csf lymphocytic pleiocytosis (HP:0200149 from HPO Gene-Disease Associations)", "csf pleocytosis (HP:0012229 from HPO Gene-Disease Associations)", "hypointensity of cerebral white matter on mri (HP:0007103 from HPO Gene-Disease Associations)", "porencephaly (HP:0002132 from HPO Gene-Disease Associations)", "plagiocephaly (HP:0001357 from HPO Gene-Disease Associations)", "diffuse white matter abnormalities (HP:0007204 from HPO Gene-Disease Associations)", "arteriosclerosis of small cerebral arteries (HP:0004931 from HPO Gene-Disease Associations)", "diffuse demyelination of the cerebral white matter (HP:0007162 from HPO Gene-Disease Associations)", "progressive encephalopathy (HP:0002448 from HPO Gene-Disease Associations)", "posterior rib fusion (HP:0000913 from HPO Gene-Disease Associations)", "low back pain (HP:0003419 from HPO Gene-Disease Associations)", "back pain (HP:0003418 from HPO Gene-Disease Associations)", "intellectual disability, mild (HP:0001256 from HPO Gene-Disease Associations)", "torus palatinus (HP:0100789 from HPO Gene-Disease Associations)", "prominent median palatal raphe (HP:0002708 from HPO Gene-Disease Associations)", "proboscis (HP:0012806 from HPO Gene-Disease Associations)", "abnormality of the midnasal cavity (HP:0010641 from HPO Gene-Disease Associations)", "abnormality of the nasal cavity (HP:0010640 from HPO Gene-Disease Associations)", "midnasal stenosis (HP:0010644 from HPO Gene-Disease Associations)", "irido-fundal coloboma (HP:0007748 from HPO Gene-Disease Associations)", "metacarpal diaphyseal endosteal sclerosis (HP:0006174 from HPO Gene-Disease Associations)", "metatarsal diaphyseal endosteal sclerosis (HP:0008114 from HPO Gene-Disease Associations)", "clavicular sclerosis (HP:0100923 from HPO Gene-Disease Associations)", "vertebral body sclerosis (HP:0100861 from HPO Gene-Disease Associations)", "absent anterior eye chamber (HP:0008037 from HPO Gene-Disease Associations)", "iris atrophy (HP:0001089 from HPO Gene-Disease Associations)", "sclerosis of foot bone (HP:0100925 from HPO Gene-Disease Associations)", "vitreous detachment (HP:0001489 from HPO Gene-Disease Associations)", "peripheral retinal avascularization (HP:0007685 from HPO Gene-Disease Associations)", "abnormal retinal folds (HP:0008052 from HPO Gene-Disease Associations)", "falciform retinal fold (HP:0001493 from HPO Gene-Disease Associations)", "congenital nystagmus (HP:0006934 from HPO Gene-Disease Associations)", "horizontal pendular nystagmus (HP:0007811 from HPO Gene-Disease Associations)", "hemorrhage of the eye (HP:0011885 from HPO Gene-Disease Associations)", "vitreous hemorrhage (HP:0007902 from HPO Gene-Disease Associations)", "peripheral vitreous opacities (HP:0007710 from HPO Gene-Disease Associations)", "intraretinal exudate (HP:0007989 from HPO Gene-Disease Associations)", "subretinal exudate (HP:0011532 from HPO Gene-Disease Associations)", "anterior chamber synechiae (HP:0007833 from HPO Gene-Disease Associations)", "exudative retinopathy (HP:0007898 from HPO Gene-Disease Associations)", "retinal exudate (HP:0001147 from HPO Gene-Disease Associations)", "pigmentary retinal degeneration (HP:0001146 from HPO Gene-Disease Associations)", "hemeralopia (HP:0012047 from HPO Gene-Disease Associations)", "congenital stationary night blindness (HP:0007642 from HPO Gene-Disease Associations)", "hyphema (HP:0011886 from HPO Gene-Disease Associations)", "retinal nonattachment (HP:0007899 from HPO Gene-Disease Associations)", "phthisis bulbi (HP:0000667 from HPO Gene-Disease Associations)", "persistent pupillary membrane (HP:0009917 from HPO Gene-Disease Associations)", "neovascularization of peripheral and posterior retina (HP:0007778 from HPO Gene-Disease Associations)", "large hyperpigmented retinal spots (HP:0007658 from HPO Gene-Disease Associations)", "uveitis (HP:0000554 from HPO Gene-Disease Associations)", "mildly reduced visual acuity (HP:0007739 from HPO Gene-Disease Associations)", "herpes simplex encephalitis (HP:0012302 from HPO Gene-Disease Associations)", "susceptibility to herpesvirus (HP:0005353 from HPO Gene-Disease Associations)", "recurrent infections in infancy and early childhood (HP:0005437 from HPO Gene-Disease Associations)", "intermittent lactic acidemia (HP:0004913 from HPO Gene-Disease Associations)", "skeletal myopathy (HP:0003756 from HPO Gene-Disease Associations)", "abnormal mitochondrial morphology (HP:0008322 from HPO Gene-Disease Associations)", "abnormality of the endocardium (HP:0004306 from HPO Gene-Disease Associations)", "endocardial fibroelastosis (HP:0001706 from HPO Gene-Disease Associations)", "abnormal mitochondrial shape (HP:0012087 from HPO Gene-Disease Associations)", "recurrent vulvovaginal candidiasis (HP:0012204 from HPO Gene-Disease Associations)", "onychomycosis (HP:0012203 from HPO Gene-Disease Associations)", "cheilitis (HP:0100825 from HPO Gene-Disease Associations)", "spontaneous esophageal perforation (HP:0005203 from HPO Gene-Disease Associations)", "mitten deformity (HP:0004057 from HPO Gene-Disease Associations)", "pretibial blistering (HP:0012221 from HPO Gene-Disease Associations)", "abnormality of oral frenula (HP:0000190 from HPO Gene-Disease Associations)", "ankyloglossia (HP:0010296 from HPO Gene-Disease Associations)", "phimosis (HP:0001741 from HPO Gene-Disease Associations)", "palmoplantar keratosis with erythema and scale (HP:0007548 from HPO Gene-Disease Associations)", "right ventricular cardiomyopathy (HP:0011663 from HPO Gene-Disease Associations)", "ventricular tachycardia (HP:0004756 from HPO Gene-Disease Associations)", "ventricular extrasystoles (HP:0006682 from HPO Gene-Disease Associations)", "ventricular aneurysm (HP:0006698 from HPO Gene-Disease Associations)", "effort-induced polymorphic ventricular tachycardias (HP:0004758 from HPO Gene-Disease Associations)", "streaks of hyperkeratosis along each finger onto the palm (HP:0007501 from HPO Gene-Disease Associations)", "congenital bullous ichthyosiform erythroderma (HP:0007475 from HPO Gene-Disease Associations)", "abnormality of epidermal morphology (HP:0011124 from HPO Gene-Disease Associations)", "acantholysis (HP:0100792 from HPO Gene-Disease Associations)", "bilateral coxa valga (HP:0010665 from HPO Gene-Disease Associations)", "thromboembolic stroke (HP:0001727 from HPO Gene-Disease Associations)", "congenital sensorineural hearing impairment (HP:0008527 from HPO Gene-Disease Associations)", "j wave (HP:0012272 from HPO Gene-Disease Associations)", "shortened qt interval (HP:0012232 from HPO Gene-Disease Associations)", "erlenmeyer flask deformity of the femurs (HP:0004975 from HPO Gene-Disease Associations)", "dense metaphyseal bands (HP:0100959 from HPO Gene-Disease Associations)", "hypoplastic ischiopubic rami (HP:0008822 from HPO Gene-Disease Associations)", "cuboid-shaped vertebral bodies (HP:0004634 from HPO Gene-Disease Associations)", "congenital hypertrophy of left ventricle (HP:0005129 from HPO Gene-Disease Associations)", "impaired myocardial contractility (HP:0006670 from HPO Gene-Disease Associations)", "curly eyelashes (HP:0007665 from HPO Gene-Disease Associations)", "paroxysmal atrial fibrillation (HP:0004757 from HPO Gene-Disease Associations)", "reduced systolic function (HP:0006673 from HPO Gene-Disease Associations)", "contractures of the large joints (HP:0005781 from HPO Gene-Disease Associations)", "atrial flutter (HP:0004749 from HPO Gene-Disease Associations)", "abnormal atrioventricular conduction (HP:0005150 from HPO Gene-Disease Associations)", "heart block (HP:0012722 from HPO Gene-Disease Associations)", "atrioventricular block (HP:0001678 from HPO Gene-Disease Associations)", "bundle branch block (HP:0011710 from HPO Gene-Disease Associations)", "right bundle branch block (HP:0011712 from HPO Gene-Disease Associations)", "complete heart block with broad rs complexes (HP:0005170 from HPO Gene-Disease Associations)", "left postterior fascicular block (HP:0005172 from HPO Gene-Disease Associations)", "paroxysmal atrial tachycardia (HP:0006671 from HPO Gene-Disease Associations)", "sick sinus syndrome (HP:0011704 from HPO Gene-Disease Associations)", "ventricular escape rhythms (HP:0005155 from HPO Gene-Disease Associations)", "paroxysmal supraventricular tachycardia (HP:0004763 from HPO Gene-Disease Associations)", "left bundle branch block (HP:0011713 from HPO Gene-Disease Associations)", "left anterior fascicular block (HP:0011711 from HPO Gene-Disease Associations)", "abnormal electrophysiology of sinoatrial node origin (HP:0011702 from HPO Gene-Disease Associations)", "sinus bradycardia (HP:0001688 from HPO Gene-Disease Associations)", "primary atrial arrhythmia (HP:0001692 from HPO Gene-Disease Associations)", "supraventricular arrhythmia (HP:0005115 from HPO Gene-Disease Associations)", "supraventricular tachycardia (HP:0004755 from HPO Gene-Disease Associations)", "atrial fibrillation (HP:0005110 from HPO Gene-Disease Associations)", "tachycardia (HP:0001649 from HPO Gene-Disease Associations)", "bradycardia (HP:0001662 from HPO Gene-Disease Associations)", "ventricular arrhythmia (HP:0004308 from HPO Gene-Disease Associations)", "ventricular fibrillation (HP:0001663 from HPO Gene-Disease Associations)", "torsade de pointes (HP:0001664 from HPO Gene-Disease Associations)", "abnormal ekg (HP:0003115 from HPO Gene-Disease Associations)", "prolonged qt interval (HP:0001657 from HPO Gene-Disease Associations)", "syncope (HP:0001279 from HPO Gene-Disease Associations)", "ventricular preexcitation with multiple accessory pathways (HP:0006684 from HPO Gene-Disease Associations)", "prolonged qrs complex (HP:0006677 from HPO Gene-Disease Associations)", "shortened pr interval (HP:0005165 from HPO Gene-Disease Associations)", "abnormal st segment (HP:0012249 from HPO Gene-Disease Associations)", "st segment elevation (HP:0012251 from HPO Gene-Disease Associations)", "paroxysmal ventricular tachycardia (HP:0004751 from HPO Gene-Disease Associations)", "abnormality of macrophages (HP:0004311 from HPO Gene-Disease Associations)", "hemophagocytosis (HP:0012156 from HPO Gene-Disease Associations)", "abnormal serum ferritin (HP:0040133 from HPO Gene-Disease Associations)", "increased serum ferritin (HP:0003281 from HPO Gene-Disease Associations)", "abnormality of iron homeostasis (HP:0011031 from HPO Gene-Disease Associations)", "abnormality of transition element cation homeostasis (HP:0011030 from HPO Gene-Disease Associations)", "abnormality of coagulation (HP:0001928 from HPO Gene-Disease Associations)", "abnormality of the coagulation cascade (HP:0003256 from HPO Gene-Disease Associations)", "abnormality of the common coagulation pathway (HP:0010990 from HPO Gene-Disease Associations)", "abnormality of circulating fibrinogen (HP:0011898 from HPO Gene-Disease Associations)", "hypofibrinogenemia (HP:0011900 from HPO Gene-Disease Associations)", "splenic rupture (HP:0012223 from HPO Gene-Disease Associations)", "recurrent thrombophlebitis (HP:0004419 from HPO Gene-Disease Associations)", "abnormality of prothrombin (HP:0012200 from HPO Gene-Disease Associations)", "prolonged prothrombin time (HP:0008151 from HPO Gene-Disease Associations)", "prolonged partial thromboplastin time (HP:0003645 from HPO Gene-Disease Associations)", "joint hemorrhage (HP:0005261 from HPO Gene-Disease Associations)", "reduced factor x activity (HP:0008321 from HPO Gene-Disease Associations)", "reduced prothrombin activity (HP:0012201 from HPO Gene-Disease Associations)", "abnormality of the extrinsic pathway (HP:0010988 from HPO Gene-Disease Associations)", "reduced factor vii activity (HP:0008169 from HPO Gene-Disease Associations)", "reduced factor ix activity (HP:0011858 from HPO Gene-Disease Associations)", "intramuscular hematoma (HP:0012233 from HPO Gene-Disease Associations)", "factor x activation deficiency (HP:0008354 from HPO Gene-Disease Associations)", "abnormality of the intrinsic pathway (HP:0010989 from HPO Gene-Disease Associations)", "reduced factor xi activity (HP:0001929 from HPO Gene-Disease Associations)", "reduced antithrombin iii activity (HP:0001976 from HPO Gene-Disease Associations)", "abnormal glycosylation (HP:0012345 from HPO Gene-Disease Associations)", "abnormal protein glycosylation (HP:0012346 from HPO Gene-Disease Associations)", "abnormal protein n-linked glycosylation (HP:0012347 from HPO Gene-Disease Associations)", "abnormal isoelectric focusing of serum transferrin (HP:0003160 from HPO Gene-Disease Associations)", "type i transferrin isoform profile (HP:0003642 from HPO Gene-Disease Associations)", "primary ovarian failure (HP:0001587 from HPO Gene-Disease Associations)", "olivopontocerebellar hypoplasia (HP:0006955 from HPO Gene-Disease Associations)", "abnormal subcutaneous fat tissue distribution (HP:0007552 from HPO Gene-Disease Associations)", "pericardial effusion (HP:0001698 from HPO Gene-Disease Associations)", "type ii transferrin isoform profile (HP:0012301 from HPO Gene-Disease Associations)", "loss of consciousness (HP:0007185 from HPO Gene-Disease Associations)", "atrophy|degeneration affecting the brainstem (HP:0007366 from HPO Gene-Disease Associations)", "elevated serum transaminases during infections (HP:0008150 from HPO Gene-Disease Associations)", "alternating esotropia (HP:0001137 from HPO Gene-Disease Associations)", "esotropia (HP:0000565 from HPO Gene-Disease Associations)", "superficial thrombophlebitis (HP:0002638 from HPO Gene-Disease Associations)", "warfarin-induced skin necrosis (HP:0001038 from HPO Gene-Disease Associations)", "cerebral venous thrombosis (HP:0005305 from HPO Gene-Disease Associations)", "reduced protein c activity (HP:0005543 from HPO Gene-Disease Associations)", "reduced protein s activity (HP:0004855 from HPO Gene-Disease Associations)", "deep venous thrombosis (HP:0002625 from HPO Gene-Disease Associations)", "recurrent deep vein thrombosis (HP:0004850 from HPO Gene-Disease Associations)", "disseminated intravascular coagulation (HP:0005521 from HPO Gene-Disease Associations)", "post-angioplasty coronary artery restenosis (HP:0004761 from HPO Gene-Disease Associations)", "reduced factor v activity (HP:0003225 from HPO Gene-Disease Associations)", "resistance to activated protein c (HP:0012175 from HPO Gene-Disease Associations)", "reduced factor viii activity (HP:0003125 from HPO Gene-Disease Associations)", "persistent bleeding after trauma (HP:0001934 from HPO Gene-Disease Associations)", "hemothorax (HP:0012151 from HPO Gene-Disease Associations)", "prolonged whole-blood clotting time (HP:0005542 from HPO Gene-Disease Associations)", "episodic upper airway obstruction (HP:0012271 from HPO Gene-Disease Associations)", "intestinal edema (HP:0005225 from HPO Gene-Disease Associations)", "angioedema (HP:0100665 from HPO Gene-Disease Associations)", "hypernatremic dehydration (HP:0004906 from HPO Gene-Disease Associations)", "laryngeal edema (HP:0012027 from HPO Gene-Disease Associations)", "pharyngeal edema (HP:0011855 from HPO Gene-Disease Associations)", "reduced prothrombin consumption (HP:0003337 from HPO Gene-Disease Associations)", "erysipelas (HP:0001055 from HPO Gene-Disease Associations)", "intestinal lymphangiectasia (HP:0002593 from HPO Gene-Disease Associations)", "pericardial lymphangiectasia (HP:0005183 from HPO Gene-Disease Associations)", "abnormal pulmonary lymphatics (HP:0006529 from HPO Gene-Disease Associations)", "pulmonary lymphangiectasia (HP:0006521 from HPO Gene-Disease Associations)", "abnormality of the fourth metatarsal bone (HP:0040035 from HPO Gene-Disease Associations)", "short fourth metatarsal (HP:0004689 from HPO Gene-Disease Associations)", "abnormal albumin level (HP:0012116 from HPO Gene-Disease Associations)", "hypoalbuminemia (HP:0003073 from HPO Gene-Disease Associations)", "pleural lymphangiectasia (HP:0006531 from HPO Gene-Disease Associations)", "thyroid lymphangiectasia (HP:0008229 from HPO Gene-Disease Associations)", "bilateral single transverse palmar creases (HP:0007598 from HPO Gene-Disease Associations)", "protein-losing enteropathy (HP:0002243 from HPO Gene-Disease Associations)", "chorioretinal dysplasia (HP:0007731 from HPO Gene-Disease Associations)", "lacunar retinal depigmentation (HP:0007786 from HPO Gene-Disease Associations)", "chorioretinopathy (HP:0001145 from HPO Gene-Disease Associations)", "sideroblastic anemia (HP:0001924 from HPO Gene-Disease Associations)", "increased erythrocyte protoporphyrin concentration (HP:0012187 from HPO Gene-Disease Associations)", "limited mobility of proximal interphalangeal joint (HP:0006217 from HPO Gene-Disease Associations)", "low-frequency sensorineural hearing impairment (HP:0008573 from HPO Gene-Disease Associations)", "stroke-like episodes (HP:0002401 from HPO Gene-Disease Associations)", "progressive hearing impairment (HP:0001730 from HPO Gene-Disease Associations)", "progressive sensorineural hearing impairment (HP:0000408 from HPO Gene-Disease Associations)", "abnormal posturing (HP:0002533 from HPO Gene-Disease Associations)", "infantile sensorineural hearing impairment (HP:0008610 from HPO Gene-Disease Associations)", "postlingual sensorineural hearing impairment (HP:0008596 from HPO Gene-Disease Associations)", "cochlear degeneration (HP:0005102 from HPO Gene-Disease Associations)", "childhood onset sensorineural hearing impairment (HP:0011474 from HPO Gene-Disease Associations)", "prelingual sensorineural hearing impairment (HP:0000399 from HPO Gene-Disease Associations)", "decreased serum ferritin (HP:0012343 from HPO Gene-Disease Associations)", "cavitation of the basal ganglia (HP:0007007 from HPO Gene-Disease Associations)", "congenital nuclear cataract (HP:0008024 from HPO Gene-Disease Associations)", "zonular cataract (HP:0010920 from HPO Gene-Disease Associations)", "nuclear cataract (HP:0100018 from HPO Gene-Disease Associations)", "pulverulent cataract (HP:0010693 from HPO Gene-Disease Associations)", "punctate cataract (HP:0007648 from HPO Gene-Disease Associations)", "congenital cataract (HP:0000519 from HPO Gene-Disease Associations)", "supernumerary maxillary incisor (HP:0006332 from HPO Gene-Disease Associations)", "screwdriver-shaped incisors (HP:0006346 from HPO Gene-Disease Associations)", "posterior y-sutural cataract (HP:0008031 from HPO Gene-Disease Associations)", "sutural cataract (HP:0010695 from HPO Gene-Disease Associations)", "severe visual impairment (HP:0001141 from HPO Gene-Disease Associations)", "cortical pulverulent cataract (HP:0007780 from HPO Gene-Disease Associations)", "cerulean cataract (HP:0007976 from HPO Gene-Disease Associations)", "high iliac wings (HP:0008808 from HPO Gene-Disease Associations)", "forehead hyperpigmentation (HP:0005336 from HPO Gene-Disease Associations)", "posterior wedging of vertebral bodies (HP:0008444 from HPO Gene-Disease Associations)", "prominent supraorbital ridges (HP:0000336 from HPO Gene-Disease Associations)", "diffuse nuclear cataract (HP:0007657 from HPO Gene-Disease Associations)", "perioral eczema (HP:0011127 from HPO Gene-Disease Associations)", "elevated c-reactive protein level (HP:0011227 from HPO Gene-Disease Associations)", "recurrent aphthous stomatitis (HP:0011107 from HPO Gene-Disease Associations)", "stomatitis (HP:0010280 from HPO Gene-Disease Associations)", "abnormality of temperature regulation (HP:0004370 from HPO Gene-Disease Associations)", "fever (HP:0001945 from HPO Gene-Disease Associations)", "episodic fever (HP:0001954 from HPO Gene-Disease Associations)", "postural hypotension with compensatory tachycardia (HP:0005307 from HPO Gene-Disease Associations)", "decreased number of small peripheral myelinated nerve fibers (HP:0007249 from HPO Gene-Disease Associations)", "hypotrichosis of the scalp (HP:0004782 from HPO Gene-Disease Associations)", "abnormality of pain sensation (HP:0010832 from HPO Gene-Disease Associations)", "impaired pain sensation (HP:0007328 from HPO Gene-Disease Associations)", "pain insensitivity (HP:0007021 from HPO Gene-Disease Associations)", "painless fractures due to injury (HP:0002661 from HPO Gene-Disease Associations)", "acral ulceration and osteomyelitis leading to autoamputation of digits (HP:0001226 from HPO Gene-Disease Associations)", "autoamputation (HP:0001218 from HPO Gene-Disease Associations)", "autoamputation of digits (HP:0007460 from HPO Gene-Disease Associations)", "acral ulceration and osteomyelitis leading to autoamputation of the digits (feet) (HP:0001862 from HPO Gene-Disease Associations)", "pain (HP:0012531 from HPO Gene-Disease Associations)", "mandibular pain (HP:0200025 from HPO Gene-Disease Associations)", "ocular pain (HP:0200026 from HPO Gene-Disease Associations)", "hyposmia (HP:0004409 from HPO Gene-Disease Associations)", "recurrent candida infections (HP:0005401 from HPO Gene-Disease Associations)", "abnormal testosterone level (HP:0030087 from HPO Gene-Disease Associations)", "decreased testosterone in males (HP:0008230 from HPO Gene-Disease Associations)", "abnormality of the periungual region (HP:0100803 from HPO Gene-Disease Associations)", "paronychia (HP:0001818 from HPO Gene-Disease Associations)", "hyperalphalipoproteinemia (HP:0012184 from HPO Gene-Disease Associations)", "hypolipidemia (HP:0045014 from HPO Gene-Disease Associations)", "hypotriglyceridemia (HP:0012153 from HPO Gene-Disease Associations)", "microangiopathic hemolytic anemia (HP:0001937 from HPO Gene-Disease Associations)", "increased blood urea nitrogen (bun) (HP:0003138 from HPO Gene-Disease Associations)", "hemolytic-uremic syndrome (HP:0005575 from HPO Gene-Disease Associations)", "recurrent infections due to aspiration (HP:0004891 from HPO Gene-Disease Associations)", "decreased sensitivity to hypoxemia (HP:0005947 from HPO Gene-Disease Associations)", "decreased corneal reflex (HP:0008000 from HPO Gene-Disease Associations)", "neuropathic arthropathy (HP:0002821 from HPO Gene-Disease Associations)", "acral ulceration leading to autoamputation of digits (HP:0006121 from HPO Gene-Disease Associations)", "episodic hyperhidrosis (HP:0001069 from HPO Gene-Disease Associations)", "abnormality of taste sensation (HP:0000223 from HPO Gene-Disease Associations)", "decreased taste sensation (HP:0000224 from HPO Gene-Disease Associations)", "projectile vomiting (HP:0002587 from HPO Gene-Disease Associations)", "diffuse cerebral sclerosis (HP:0006918 from HPO Gene-Disease Associations)", "sudanophilic leukodystrophy (HP:0003269 from HPO Gene-Disease Associations)", "progressive flexion contractures (HP:0005876 from HPO Gene-Disease Associations)", "cerebral white matter atrophy (HP:0012762 from HPO Gene-Disease Associations)", "corpus callosum atrophy (HP:0007371 from HPO Gene-Disease Associations)", "generalized cerebral atrophy|hypoplasia (HP:0007058 from HPO Gene-Disease Associations)", "global brain atrophy (HP:0002283 from HPO Gene-Disease Associations)", "severe demyelination of the white matter (HP:0007258 from HPO Gene-Disease Associations)", "abnormal autonomic nervous system physiology (HP:0012332 from HPO Gene-Disease Associations)", "dysautonomia (HP:0002459 from HPO Gene-Disease Associations)", "hypotension (HP:0002615 from HPO Gene-Disease Associations)", "orthostatic hypotension (HP:0001278 from HPO Gene-Disease Associations)", "orthostatic hypotension due to autonomic dysfunction (HP:0004926 from HPO Gene-Disease Associations)", "vitamin b6 deficiency (HP:0008326 from HPO Gene-Disease Associations)", "constrictive median neuropathy (HP:0012185 from HPO Gene-Disease Associations)", "digital flexor tenosynovitis (HP:0012276 from HPO Gene-Disease Associations)", "amyloid deposition in the vitreous humor (HP:0007841 from HPO Gene-Disease Associations)", "entrapment neuropathy (HP:0012181 from HPO Gene-Disease Associations)", "impotence (HP:0000802 from HPO Gene-Disease Associations)", "autonomic erectile dysfunction (HP:0008652 from HPO Gene-Disease Associations)", "diffuse leukoencephalopathy (HP:0006994 from HPO Gene-Disease Associations)", "decreased sweating due to autonomic dysfunction (HP:0007480 from HPO Gene-Disease Associations)", "autonomic bladder dysfunction (HP:0005341 from HPO Gene-Disease Associations)", "symmetric peripheral demyelination (HP:0007262 from HPO Gene-Disease Associations)", "pseudobulbar paralysis (HP:0007024 from HPO Gene-Disease Associations)", "pseudobulbar signs (HP:0002200 from HPO Gene-Disease Associations)", "periportal fibrosis (HP:0001405 from HPO Gene-Disease Associations)", "depletion of mitochondrial dna in liver (HP:0006581 from HPO Gene-Disease Associations)", "hepatic cysts (HP:0001407 from HPO Gene-Disease Associations)", "increased prevalence of valvular disease (HP:0001726 from HPO Gene-Disease Associations)", "abnormal ejaculation (HP:0012875 from HPO Gene-Disease Associations)", "retrograde ejaculation (HP:0012877 from HPO Gene-Disease Associations)", "nocturia (HP:0000017 from HPO Gene-Disease Associations)", "intermittent hypothermia (HP:0005964 from HPO Gene-Disease Associations)", "hypothermia (HP:0002045 from HPO Gene-Disease Associations)", "involuntary jerking movements (HP:0007087 from HPO Gene-Disease Associations)", "decreased csf homovanillic acid (hva) (HP:0003785 from HPO Gene-Disease Associations)", "hyperperistalsis (HP:0100770 from HPO Gene-Disease Associations)", "focal retinal infarction (HP:0007866 from HPO Gene-Disease Associations)", "mydriasis (HP:0011499 from HPO Gene-Disease Associations)", "abnormality of circle of willis (HP:0012518 from HPO Gene-Disease Associations)", "moyamoya phenomenon (HP:0011834 from HPO Gene-Disease Associations)", "elevated urinary dopamine (HP:0011979 from HPO Gene-Disease Associations)", "elevated urinary homovanillic acid (HP:0011977 from HPO Gene-Disease Associations)", "horner syndrome (HP:0002277 from HPO Gene-Disease Associations)", "opsoclonus (HP:0010543 from HPO Gene-Disease Associations)", "elevated urinary vanillylmandelic acid (HP:0011978 from HPO Gene-Disease Associations)", "abnormal pupillary function (HP:0007686 from HPO Gene-Disease Associations)", "miosis (HP:0000616 from HPO Gene-Disease Associations)", "abnormality of the pupil (HP:0000615 from HPO Gene-Disease Associations)", "pulmonary aterial intimal fibrosis (HP:0005312 from HPO Gene-Disease Associations)", "pulmonary venoocclusive disease (HP:0006518 from HPO Gene-Disease Associations)", "elevated right atrial pressure (HP:0005168 from HPO Gene-Disease Associations)", "right ventricular failure (HP:0001708 from HPO Gene-Disease Associations)", "arterial intimal fibrosis (HP:0011353 from HPO Gene-Disease Associations)", "pulmonary artery vasoconstriction (HP:0005308 from HPO Gene-Disease Associations)", "pulmonary arterial medial hypertrophy (HP:0004964 from HPO Gene-Disease Associations)", "increased pulmonary vascular resistance (HP:0005317 from HPO Gene-Disease Associations)", "patent foramen ovale (HP:0001655 from HPO Gene-Disease Associations)", "biventricular hypertrophy (HP:0200128 from HPO Gene-Disease Associations)", "right ventricular hypertrophy (HP:0001667 from HPO Gene-Disease Associations)", "abnormality of the right ventricle (HP:0001707 from HPO Gene-Disease Associations)", "metaphyseal rarefaction (HP:0004980 from HPO Gene-Disease Associations)", "absent patellar reflexes (HP:0006844 from HPO Gene-Disease Associations)", "blotching pigmentation of the skin (HP:0007610 from HPO Gene-Disease Associations)", "talipes valgus (HP:0004684 from HPO Gene-Disease Associations)", "unilateral narrow palpebral fissure (HP:0007946 from HPO Gene-Disease Associations)", "abnormal nasal base (HP:0012808 from HPO Gene-Disease Associations)", "wide nasal base (HP:0012810 from HPO Gene-Disease Associations)", "narrow nail (HP:0011313 from HPO Gene-Disease Associations)", "peg-shaped maxillary lateral incisors (HP:0006342 from HPO Gene-Disease Associations)", "smooth tongue (HP:0010298 from HPO Gene-Disease Associations)", "dystrophic toenail (HP:0001810 from HPO Gene-Disease Associations)", "loss of eyelashes (HP:0011457 from HPO Gene-Disease Associations)", "corneal scarring (HP:0000559 from HPO Gene-Disease Associations)", "generalized opacification of the cornea (HP:0011494 from HPO Gene-Disease Associations)", "nodular corneal dystrophy (HP:0007827 from HPO Gene-Disease Associations)", "punctate corneal dystrophy (HP:0007809 from HPO Gene-Disease Associations)", "granular corneal dystrophy (HP:0007802 from HPO Gene-Disease Associations)", "map-dot-fingerprint corneal dystrophy (HP:0007690 from HPO Gene-Disease Associations)", "juvenile epithelial corneal dystrophy (HP:0007755 from HPO Gene-Disease Associations)", "lattice corneal dystrophy (HP:0001149 from HPO Gene-Disease Associations)", "refractory anemia (HP:0005505 from HPO Gene-Disease Associations)", "hyperostosis cranialis interna (HP:0005890 from HPO Gene-Disease Associations)", "diaphyseal dysplasia (HP:0100252 from HPO Gene-Disease Associations)", "pneumothorax (HP:0002107 from HPO Gene-Disease Associations)", "spontaneous pneumothorax (HP:0002108 from HPO Gene-Disease Associations)", "spontaneous neonatal pneumothorax (HP:0004876 from HPO Gene-Disease Associations)", "abnormality of primary molar morphology (HP:0006344 from HPO Gene-Disease Associations)", "frontal open bite (HP:0200094 from HPO Gene-Disease Associations)", "gingival hyperkeratosis (HP:0000222 from HPO Gene-Disease Associations)", "recurrent mandibular subluxations (HP:0005332 from HPO Gene-Disease Associations)", "blepharochalasis (HP:0010749 from HPO Gene-Disease Associations)", "soft, doughy skin (HP:0001027 from HPO Gene-Disease Associations)", "amelogenesis imperfecta (HP:0000705 from HPO Gene-Disease Associations)", "anterior open bite (HP:0200095 from HPO Gene-Disease Associations)", "open bite (HP:0010807 from HPO Gene-Disease Associations)", "hypomature dental enamel (HP:0011085 from HPO Gene-Disease Associations)", "erythema nodosum (HP:0012219 from HPO Gene-Disease Associations)", "panniculitis (HP:0012490 from HPO Gene-Disease Associations)", "retroperitoneal fibrosis (HP:0005200 from HPO Gene-Disease Associations)", "episcleritis (HP:0100534 from HPO Gene-Disease Associations)", "bilateral cryptorchidism (HP:0008689 from HPO Gene-Disease Associations)", "superiorly displaced ears (HP:0008541 from HPO Gene-Disease Associations)", "posterior polar cataract (HP:0001115 from HPO Gene-Disease Associations)", "total cataract (HP:0010700 from HPO Gene-Disease Associations)", "diaphragmatic paralysis (HP:0006597 from HPO Gene-Disease Associations)", "diaphragmatic weakness (HP:0009113 from HPO Gene-Disease Associations)", "dysuria (HP:0100518 from HPO Gene-Disease Associations)", "acute episodes of neuropathic symptoms (HP:0003489 from HPO Gene-Disease Associations)", "respiratory paralysis (HP:0002203 from HPO Gene-Disease Associations)", "psychotic episodes (HP:0000725 from HPO Gene-Disease Associations)", "paralytic ileus (HP:0002590 from HPO Gene-Disease Associations)", "elevated urinary delta-aminolevulinic acid (HP:0003163 from HPO Gene-Disease Associations)", "episodic peripheral neuropathy (HP:0006949 from HPO Gene-Disease Associations)", "urinary retention (HP:0000016 from HPO Gene-Disease Associations)", "extrapyramidal muscular rigidity (HP:0007076 from HPO Gene-Disease Associations)", "loss of facial expression (HP:0005327 from HPO Gene-Disease Associations)", "basal ganglia gliosis (HP:0006999 from HPO Gene-Disease Associations)", "neuronal loss in basal ganglia (HP:0200147 from HPO Gene-Disease Associations)", "hypoplasia of the ventral pons (HP:0006850 from HPO Gene-Disease Associations)", "abnormality of aromatic amino acid family metabolism (HP:0004338 from HPO Gene-Disease Associations)", "abnormality of phenylalanine metabolism (HP:0010893 from HPO Gene-Disease Associations)", "hyperphenylalaninemia (HP:0004923 from HPO Gene-Disease Associations)", "transient hyperphenylalaninemia (HP:0008297 from HPO Gene-Disease Associations)", "reduced phenylalanine hydroxylase activity (HP:0005982 from HPO Gene-Disease Associations)", "maternal hyperphenylalaninemia (HP:0100610 from HPO Gene-Disease Associations)", "phenylpyruvic acidemia (HP:0004920 from HPO Gene-Disease Associations)", "scleroderma (HP:0100324 from HPO Gene-Disease Associations)", "abnormality of tyrosine metabolism (HP:0010917 from HPO Gene-Disease Associations)", "hypertyrosinemia (HP:0003231 from HPO Gene-Disease Associations)", "4-hydroxyphenylpyruvic aciduria (HP:0003161 from HPO Gene-Disease Associations)", "4-hydroxyphenylacetic aciduria (HP:0003607 from HPO Gene-Disease Associations)", "corneal ulceration (HP:0012804 from HPO Gene-Disease Associations)", "herpetiform corneal ulceration (HP:0007812 from HPO Gene-Disease Associations)", "hypoglycinemia (HP:0012277 from HPO Gene-Disease Associations)", "hyposerinemia (HP:0012279 from HPO Gene-Disease Associations)", "abnormality of serine metabolism (HP:0012278 from HPO Gene-Disease Associations)", "hyperemesis gravidarum (HP:0012188 from HPO Gene-Disease Associations)", "thyroid-stimulating hormone excess (HP:0002925 from HPO Gene-Disease Associations)", "lateral displacement of the femoral head (HP:0006453 from HPO Gene-Disease Associations)", "compensated hypothyroidism (HP:0008223 from HPO Gene-Disease Associations)", "congenital goiter (HP:0008251 from HPO Gene-Disease Associations)", "congenital septal defect (HP:0004760 from HPO Gene-Disease Associations)", "congenital hypothyroidism (HP:0000851 from HPO Gene-Disease Associations)", "abnormal t3|t4 ratio (HP:0012558 from HPO Gene-Disease Associations)", "increased t3|t4 ratio (HP:0012559 from HPO Gene-Disease Associations)", "thyroid hormone receptor defect (HP:0002930 from HPO Gene-Disease Associations)", "increased serum free triiodothyronine (ft3) (HP:0011788 from HPO Gene-Disease Associations)", "multiple suture craniosynostosis (HP:0011324 from HPO Gene-Disease Associations)", "posterior plagiocephaly (HP:0011327 from HPO Gene-Disease Associations)", "pansynostosis (HP:0011325 from HPO Gene-Disease Associations)", "restrictive respiratory insufficiency (HP:0002111 from HPO Gene-Disease Associations)", "multiple skeletal anomalies (HP:0005775 from HPO Gene-Disease Associations)", "intraalveolar nodular calcifications (HP:0006514 from HPO Gene-Disease Associations)", "testicular microlithiasis (HP:0012215 from HPO Gene-Disease Associations)", "progressive pulmonary function impairment (HP:0006520 from HPO Gene-Disease Associations)", "decreased pulmonary function (HP:0005952 from HPO Gene-Disease Associations)", "abnormality of complement system (HP:0005339 from HPO Gene-Disease Associations)", "complement deficiency (HP:0004431 from HPO Gene-Disease Associations)", "decreased serum complement factor i (HP:0005356 from HPO Gene-Disease Associations)", "membranoproliferative glomerulonephritis (HP:0000793 from HPO Gene-Disease Associations)", "glomerulonephritis (HP:0000099 from HPO Gene-Disease Associations)", "nephritis (HP:0000123 from HPO Gene-Disease Associations)", "systemic lupus erythematosus (HP:0002725 from HPO Gene-Disease Associations)", "decreased serum complement factor b (HP:0005416 from HPO Gene-Disease Associations)", "decreased serum complement c3 (HP:0005421 from HPO Gene-Disease Associations)", "pyelonephritis (HP:0012330 from HPO Gene-Disease Associations)", "recurrent meningococcal disease (HP:0005381 from HPO Gene-Disease Associations)", "recurrent neisserial infections (HP:0005430 from HPO Gene-Disease Associations)", "decreased serum complement factor h (HP:0005369 from HPO Gene-Disease Associations)", "depletion of components of the alternative complement pathway (HP:0005389 from HPO Gene-Disease Associations)", "dense deposit disease (HP:0004746 from HPO Gene-Disease Associations)", "thickening of the glomerular basement membrane (HP:0004722 from HPO Gene-Disease Associations)", "abnormality of the alternate complement pathway (HP:0005482 from HPO Gene-Disease Associations)", "dysfunctional alternative complement pathway (HP:0005423 from HPO Gene-Disease Associations)", "c8 deficiency (HP:0004434 from HPO Gene-Disease Associations)", "recurrent haemophilus influenzae infections (HP:0005376 from HPO Gene-Disease Associations)", "progressive macular scarring (HP:0007949 from HPO Gene-Disease Associations)", "macular scarring (HP:0200056 from HPO Gene-Disease Associations)", "marcus gunn pupil (HP:0200057 from HPO Gene-Disease Associations)", "membranous nephropathy (HP:0012578 from HPO Gene-Disease Associations)", "decreased serum complement c9 (HP:0012308 from HPO Gene-Disease Associations)", "hypoproteinemia (HP:0003075 from HPO Gene-Disease Associations)", "hypoproteinemic edema (HP:0007609 from HPO Gene-Disease Associations)", "diffuse mesangial sclerosis (HP:0001967 from HPO Gene-Disease Associations)", "mesangial abnormality (HP:0001966 from HPO Gene-Disease Associations)", "abnormality of the ciliary body (HP:0012776 from HPO Gene-Disease Associations)", "hypoplasia of the ciliary body (HP:0007774 from HPO Gene-Disease Associations)", "posterior lenticonus (HP:0011502 from HPO Gene-Disease Associations)", "thin glomerular basement membrane (HP:0012577 from HPO Gene-Disease Associations)", "diffuse glomerular basement membrane lamellation (HP:0030034 from HPO Gene-Disease Associations)", "anterior lenticonus (HP:0011501 from HPO Gene-Disease Associations)", "abnormality of lens shape (HP:0011526 from HPO Gene-Disease Associations)", "lenticonus (HP:0001142 from HPO Gene-Disease Associations)", "diffuse leiomyomatosis (HP:0006756 from HPO Gene-Disease Associations)", "lamellar cataract (HP:0007971 from HPO Gene-Disease Associations)", "anterior polar cataract (HP:0001134 from HPO Gene-Disease Associations)", "duodenal ulcer (HP:0002588 from HPO Gene-Disease Associations)", "bulimia (HP:0100739 from HPO Gene-Disease Associations)", "incomprehensible speech (HP:0002546 from HPO Gene-Disease Associations)", "oromotor apraxia (HP:0007301 from HPO Gene-Disease Associations)", "hypomimic face (HP:0000338 from HPO Gene-Disease Associations)", "posterior fossa cyst (HP:0007291 from HPO Gene-Disease Associations)", "anterior encephalocele (HP:0007035 from HPO Gene-Disease Associations)", "abnormal migration of corneal endothelium (HP:0011489 from HPO Gene-Disease Associations)", "polymorphous posterior corneal dystrophy (HP:0007915 from HPO Gene-Disease Associations)", "reduced number of corneal endothelial cells (HP:0011491 from HPO Gene-Disease Associations)", "young adult onset (HP:0011462 from HPO Gene-Disease Associations)", "abnormality of corneal endothelium (HP:0011488 from HPO Gene-Disease Associations)", "abnormality of descemet's membrane (HP:0011490 from HPO Gene-Disease Associations)", "corneal guttata (HP:0012038 from HPO Gene-Disease Associations)", "descemet membrane folds (HP:0012039 from HPO Gene-Disease Associations)", "corneal stromal edema (HP:0012040 from HPO Gene-Disease Associations)", "corneal degeneration (HP:0007705 from HPO Gene-Disease Associations)", "isosexual precocious puberty (HP:0008236 from HPO Gene-Disease Associations)", "abnormality of chromosome condensation (HP:0011019 from HPO Gene-Disease Associations)", "increased rate of premature chromosome condensation (HP:0003451 from HPO Gene-Disease Associations)", "small cerebral cortex (HP:0002472 from HPO Gene-Disease Associations)", "steep acetabular roof (HP:0010455 from HPO Gene-Disease Associations)", "cortical gyral simplification (HP:0009879 from HPO Gene-Disease Associations)", "premature closure of fontanelles (HP:0005458 from HPO Gene-Disease Associations)", "abnormal size of pituitary gland (HP:0012504 from HPO Gene-Disease Associations)", "small pituitary gland (HP:0012506 from HPO Gene-Disease Associations)", "paucity of anterior horn motor neurons (HP:0007277 from HPO Gene-Disease Associations)", "widening of cervical spinal canal (HP:0004571 from HPO Gene-Disease Associations)", "large fleshy ears (HP:0002265 from HPO Gene-Disease Associations)", "abnormality of the glabella (HP:0002056 from HPO Gene-Disease Associations)", "prominent glabella (HP:0002057 from HPO Gene-Disease Associations)", "nonprogressive visual loss (HP:0200068 from HPO Gene-Disease Associations)", "infantile axial hypotonia (HP:0009062 from HPO Gene-Disease Associations)", "opacification of the corneal epithelium (HP:0007727 from HPO Gene-Disease Associations)", "infantile hypercalcemia (HP:0008250 from HPO Gene-Disease Associations)", "iridodonesis (HP:0100693 from HPO Gene-Disease Associations)", "deep anterior chamber (HP:0007765 from HPO Gene-Disease Associations)", "primary congenital glaucoma (HP:0008007 from HPO Gene-Disease Associations)", "abnormal intraocular pressure (HP:0012632 from HPO Gene-Disease Associations)", "increased intraocular pressure (HP:0007906 from HPO Gene-Disease Associations)", "late onset congenital glaucoma (HP:0008041 from HPO Gene-Disease Associations)", "mosaic corneal dystrophy (HP:0007836 from HPO Gene-Disease Associations)", "lens subluxation (HP:0001132 from HPO Gene-Disease Associations)", "increased corneal thickness (HP:0011487 from HPO Gene-Disease Associations)", "congenital corneal dystrophy (HP:0008005 from HPO Gene-Disease Associations)", "progressive ptosis (HP:0007838 from HPO Gene-Disease Associations)", "reduction of neutrophil motility (HP:0005400 from HPO Gene-Disease Associations)", "penoscrotal hypospadias (HP:0000808 from HPO Gene-Disease Associations)", "dissecting aortic aneurysm (HP:0002622 from HPO Gene-Disease Associations)", "cystic medial necrosis (HP:0012180 from HPO Gene-Disease Associations)", "abnormality of the nasal bone (HP:0010939 from HPO Gene-Disease Associations)", "aplasia|hypoplasia of the nasal bone (HP:0010940 from HPO Gene-Disease Associations)", "hypoplasia of the nasal bone (HP:0004646 from HPO Gene-Disease Associations)", "abnormality of the nasal skeleton (HP:0010937 from HPO Gene-Disease Associations)", "fatty replacement of skeletal muscle (HP:0012548 from HPO Gene-Disease Associations)", "diffuse swelling of cerebral white matter (HP:0007341 from HPO Gene-Disease Associations)", "diffuse spongiform leukoencephalopathy (HP:0006943 from HPO Gene-Disease Associations)", "trimethylaminuria (HP:0003614 from HPO Gene-Disease Associations)", "thyroid defect in oxidation and organification of iodide (HP:0008263 from HPO Gene-Disease Associations)", "hepatic vascular malformations (HP:0006576 from HPO Gene-Disease Associations)", "retinal vascular malformation (HP:0007797 from HPO Gene-Disease Associations)", "congenital lactic acidosis (HP:0004902 from HPO Gene-Disease Associations)", "secondary growth hormone deficiency (HP:0008240 from HPO Gene-Disease Associations)", "chromosomal breakage induced by ionizing radiation (HP:0010997 from HPO Gene-Disease Associations)", "progressive cataract (HP:0007834 from HPO Gene-Disease Associations)", "elevated leukocyte alkaline phosphatase (HP:0008318 from HPO Gene-Disease Associations)", "androgen insufficiency (HP:0008226 from HPO Gene-Disease Associations)", "abnormality of creatine metabolism (HP:0012113 from HPO Gene-Disease Associations)", "progressive cone degeneration (HP:0008020 from HPO Gene-Disease Associations)", "cerebellar hemisphere hypoplasia (HP:0100307 from HPO Gene-Disease Associations)", "atransferrinemia (HP:0012239 from HPO Gene-Disease Associations)", "secretory diarrhea (HP:0005208 from HPO Gene-Disease Associations)", "abdominal aortic aneurysm (HP:0004953 from HPO Gene-Disease Associations)", "progressive extrapyramidal movement disorder (HP:0007153 from HPO Gene-Disease Associations)", "social and occupational deterioration (HP:0007086 from HPO Gene-Disease Associations)", "abnormality of pineal morphology (HP:0012681 from HPO Gene-Disease Associations)", "abnormality of the pineal gland (HP:0012680 from HPO Gene-Disease Associations)", "agenesis of pineal gland (HP:0012687 from HPO Gene-Disease Associations)", "primary open angle glaucoma (HP:0012108 from HPO Gene-Disease Associations)", "unilateral cleft lip (HP:0100333 from HPO Gene-Disease Associations)", "unilateral cleft palate (HP:0100334 from HPO Gene-Disease Associations)", "crystalline corneal dystrophy (HP:0007760 from HPO Gene-Disease Associations)", "punctate opacification of the cornea (HP:0007856 from HPO Gene-Disease Associations)", "liposarcoma (HP:0012034 from HPO Gene-Disease Associations)", "myxoid liposarcoma (HP:0012268 from HPO Gene-Disease Associations)", "aspirin-induced asthma (HP:0012042 from HPO Gene-Disease Associations)", "progressive hyperpigmentation (HP:0007505 from HPO Gene-Disease Associations)", "lactose intolerance (HP:0004789 from HPO Gene-Disease Associations)", "abnormality of zinc homeostasis (HP:0008277 from HPO Gene-Disease Associations)", "diffuse palmoplantar keratoderma (HP:0007435 from HPO Gene-Disease Associations)", "ring fibers (HP:0100305 from HPO Gene-Disease Associations)", "exudative retinal detachment (HP:0012231 from HPO Gene-Disease Associations)", "increased hepatic glycogen content (HP:0006568 from HPO Gene-Disease Associations)", "compensated hemolytic anemia (HP:0004863 from HPO Gene-Disease Associations)", "neonatal hyperbilirubinemia (HP:0003265 from HPO Gene-Disease Associations)", "speckled corneal dystrophy (HP:0007962 from HPO Gene-Disease Associations)", "eclampsia (HP:0100601 from HPO Gene-Disease Associations)", "euthyroid hyperthyroxinemia (HP:0008247 from HPO Gene-Disease Associations)", "synovial sarcoma (HP:0012570 from HPO Gene-Disease Associations)", "reduced thyroxin-binding globulin (HP:0012509 from HPO Gene-Disease Associations)", "lymphoid leukemia (HP:0005526 from HPO Gene-Disease Associations)", "autosomal dominant somatic cell mutation (HP:0001444 from HPO Gene-Disease Associations)", "abnormal germ cell morphology (HP:0012862 from HPO Gene-Disease Associations)", "abnormal sperm morphology (HP:0012864 from HPO Gene-Disease Associations)", "abnormal male germ cell morphology (HP:0012863 from HPO Gene-Disease Associations)", "sperm head anomaly (HP:0012865 from HPO Gene-Disease Associations)", "globozoospermia (HP:0012205 from HPO Gene-Disease Associations)", "chronic calcifying pancreatitis (HP:0005236 from HPO Gene-Disease Associations)", "histiocytoma (HP:0012315 from HPO Gene-Disease Associations)", "honeycomb retinal degeneration (HP:0007937 from HPO Gene-Disease Associations)", "orthostatic tachycardia (HP:0012173 from HPO Gene-Disease Associations)", "alveolar soft part sarcoma (HP:0012218 from HPO Gene-Disease Associations)", "salmonella osteomyelitis (HP:0005661 from HPO Gene-Disease Associations)", "facial flushing after alcohol intake (HP:0001033 from HPO Gene-Disease Associations)", "delayed oxidation of acetaldehyde (HP:0003533 from HPO Gene-Disease Associations)", "membranous cataract (HP:0010922 from HPO Gene-Disease Associations)", "congenital ptosis (HP:0007970 from HPO Gene-Disease Associations)", "abnormal vagal neural crest cell morphology (MP:0013010 from MPO Gene-Phenotype Associations)", "absent vagal neural crest cells (MP:0013011 from MPO Gene-Phenotype Associations)", "absent first pharyngeal arch (MP:0006342 from MPO Gene-Phenotype Associations)", "abnormal neural crest cell delamination (MP:0012746 from MPO Gene-Phenotype Associations)", "abnormal neural crest cell morphology (MP:0009845 from MPO Gene-Phenotype Associations)", "abnormal neural crest morphology (MP:0009846 from MPO Gene-Phenotype Associations)", "decreased neural crest cell number (MP:0009843 from MPO Gene-Phenotype Associations)", "abnormal embryonic tissue physiology (MP:0008932 from MPO Gene-Phenotype Associations)", "abnormal neural crest cell physiology (MP:0012745 from MPO Gene-Phenotype Associations)", "abnormal neural crest cell migration (MP:0002950 from MPO Gene-Phenotype Associations)", "increased vagal neural crest cell apoptosis (MP:0013009 from MPO Gene-Phenotype Associations)", "abnormal melanocyte number (MP:0012021 from MPO Gene-Phenotype Associations)", "decreased melanocyte number (MP:0012023 from MPO Gene-Phenotype Associations)", "abnormal frontonasal mesenchyme morphology (MP:0011266 from MPO Gene-Phenotype Associations)", "dorsal root ganglion degeneration (MP:0008492 from MPO Gene-Phenotype Associations)", "dorsal root ganglion hypoplasia (MP:0006408 from MPO Gene-Phenotype Associations)", "decreased foot pigmentation (MP:0011568 from MPO Gene-Phenotype Associations)", "abnormal enteric neural crest cell morphology (MP:0013001 from MPO Gene-Phenotype Associations)", "decreased enteric neural crest cell number (MP:0013002 from MPO Gene-Phenotype Associations)", "abnormal enteric neural crest cell migration (MP:0013006 from MPO Gene-Phenotype Associations)", "absent enteric neural crest cell (MP:0013003 from MPO Gene-Phenotype Associations)", "absent kidney medulla (MP:0011438 from MPO Gene-Phenotype Associations)", "increased ganglioneuroma incidence (MP:0010362 from MPO Gene-Phenotype Associations)", "absent kidney cortex (MP:0009857 from MPO Gene-Phenotype Associations)", "absent nephrogenic zone (MP:0011407 from MPO Gene-Phenotype Associations)", "oligohydramnios (MP:0012171 from MPO Gene-Phenotype Associations)", "abnormal cardiac ganglion morphology (MP:0003685 from MPO Gene-Phenotype Associations)", "adrenergic chromaffin cell hyperplasia (MP:0008298 from MPO Gene-Phenotype Associations)", "abnormal kidney medulla development (MP:0003613 from MPO Gene-Phenotype Associations)", "abnormal stellate ganglion morphology (MP:0001017 from MPO Gene-Phenotype Associations)", "ureter stenosis (MP:0003588 from MPO Gene-Phenotype Associations)", "abnormal sympathetic postganglionic fiber morphology (MP:0008312 from MPO Gene-Phenotype Associations)", "blind ureter (MP:0011797 from MPO Gene-Phenotype Associations)", "ectopic testis (MP:0011410 from MPO Gene-Phenotype Associations)", "ureter obstruction (MP:0003587 from MPO Gene-Phenotype Associations)", "large ureter (MP:0003585 from MPO Gene-Phenotype Associations)", "ectopic ovary (MP:0011727 from MPO Gene-Phenotype Associations)", "abnormal ileum morphology (MP:0002581 from MPO Gene-Phenotype Associations)", "distended ileum (MP:0009485 from MPO Gene-Phenotype Associations)", "abnormal enteric nervous system morphology (MP:0001044 from MPO Gene-Phenotype Associations)", "abnormal enteric neuron morphology (MP:0001046 from MPO Gene-Phenotype Associations)", "absent enteric neurons (MP:0001048 from MPO Gene-Phenotype Associations)", "abnormal enteric ganglia morphology (MP:0001045 from MPO Gene-Phenotype Associations)", "megacolon (MP:0002731 from MPO Gene-Phenotype Associations)", "aganglionic megacolon (MP:0002926 from MPO Gene-Phenotype Associations)", "abnormal autonomic nervous system morphology (MP:0002751 from MPO Gene-Phenotype Associations)", "abnormal paravertebral ganglion morphology (MP:0008317 from MPO Gene-Phenotype Associations)", "abnormal sympathetic ganglion morphology (MP:0001008 from MPO Gene-Phenotype Associations)", "abnormal superior cervical ganglion morphology (MP:0001011 from MPO Gene-Phenotype Associations)", "abnormal sympathetic system morphology (MP:0001007 from MPO Gene-Phenotype Associations)", "small superior cervical ganglion (MP:0001015 from MPO Gene-Phenotype Associations)", "abnormal sympathetic neuron morphology (MP:0001025 from MPO Gene-Phenotype Associations)", "superior cervical ganglion degeneration (MP:0009561 from MPO Gene-Phenotype Associations)", "abnormal sympathetic neuron innervation pattern (MP:0009284 from MPO Gene-Phenotype Associations)", "absent superior cervical ganglion (MP:0001014 from MPO Gene-Phenotype Associations)", "blepharoptosis (MP:0001344 from MPO Gene-Phenotype Associations)", "abnormal parasympathetic ganglion morphology (MP:0001034 from MPO Gene-Phenotype Associations)", "abnormal parasympathetic system morphology (MP:0001033 from MPO Gene-Phenotype Associations)", "abnormal ciliary ganglion morphology (MP:0004990 from MPO Gene-Phenotype Associations)", "abnormal parasympathetic postganglionic fiber morphology (MP:0008313 from MPO Gene-Phenotype Associations)", "abnormal parasympathetic neuron morphology (MP:0001037 from MPO Gene-Phenotype Associations)", "dry eyes (MP:0001337 from MPO Gene-Phenotype Associations)", "abnormal intestinal peristalsis (MP:0003289 from MPO Gene-Phenotype Associations)", "intestinal hypoperistalsis (MP:0003290 from MPO Gene-Phenotype Associations)", "abnormal submandibular ganglion morphology (MP:0001035 from MPO Gene-Phenotype Associations)", "small submandibular ganglion (MP:0001036 from MPO Gene-Phenotype Associations)", "abnormal sublingual ganglion morphology (MP:0010105 from MPO Gene-Phenotype Associations)", "abnormal pterygopalatine ganglion morphology (MP:0008314 from MPO Gene-Phenotype Associations)", "abnormal otic ganglion morphology (MP:0008315 from MPO Gene-Phenotype Associations)", "abnormal enteric neural crest cell proliferation (MP:0013004 from MPO Gene-Phenotype Associations)", "decreased enteric neural crest cell proliferation (MP:0013005 from MPO Gene-Phenotype Associations)", "abnormal retrotrapezoid nucleus morphology (MP:0011406 from MPO Gene-Phenotype Associations)", "abnormal area postrema morphology (MP:0004186 from MPO Gene-Phenotype Associations)", "absent trigeminal nerve (MP:0001066 from MPO Gene-Phenotype Associations)", "abnormal locus ceruleus morphology (MP:0003661 from MPO Gene-Phenotype Associations)", "abnormal pulmonary ventilation (MP:0002338 from MPO Gene-Phenotype Associations)", "decreased pulmonary ventilation (MP:0005576 from MPO Gene-Phenotype Associations)", "hypoventilation (MP:0002321 from MPO Gene-Phenotype Associations)", "abnormal spinal cord interneuron morphology (MP:0004100 from MPO Gene-Phenotype Associations)", "decreased solitary pulmonary neuroendocrine cell number (MP:0010916 from MPO Gene-Phenotype Associations)", "absent solitary pulmonary neuroendocrine cells (MP:0010917 from MPO Gene-Phenotype Associations)", "absent pulmonary neuroendocrine bodies (MP:0010921 from MPO Gene-Phenotype Associations)", "decreased number of pulmonary neuroendocrine bodies (MP:0010920 from MPO Gene-Phenotype Associations)", "impaired neuron differentiation (MP:0011827 from MPO Gene-Phenotype Associations)", "abnormal cochlear nerve morphology (MP:0004716 from MPO Gene-Phenotype Associations)", "abnormal vestibulocochlear nerve morphology (MP:0001072 from MPO Gene-Phenotype Associations)", "abnormal vestibular ganglion morphology (MP:0002856 from MPO Gene-Phenotype Associations)", "small vestibular ganglion (MP:0003987 from MPO Gene-Phenotype Associations)", "abnormal vestibular nerve morphology (MP:0004718 from MPO Gene-Phenotype Associations)", "abnormal cochlear ohc afferent innervation pattern (MP:0004747 from MPO Gene-Phenotype Associations)", "abnormal type i vestibular cell (MP:0004428 from MPO Gene-Phenotype Associations)", "abnormal hair-down neuron morphology (MP:0000979 from MPO Gene-Phenotype Associations)", "absent hair-down neurons (MP:0000980 from MPO Gene-Phenotype Associations)", "abnormal vibrissae reflex (MP:0001490 from MPO Gene-Phenotype Associations)", "abnormal nodose ganglion morphology (MP:0001087 from MPO Gene-Phenotype Associations)", "small nodose ganglion (MP:0001088 from MPO Gene-Phenotype Associations)", "small petrosal ganglion (MP:0001085 from MPO Gene-Phenotype Associations)", "abnormal petrosal ganglion morphology (MP:0001084 from MPO Gene-Phenotype Associations)", "abnormal vagus ganglion morphology (MP:0001100 from MPO Gene-Phenotype Associations)", "abnormal glossopharyngeal ganglion morphology (MP:0001096 from MPO Gene-Phenotype Associations)", "abnormal geniculate ganglion morphology (MP:0001082 from MPO Gene-Phenotype Associations)", "small geniculate ganglion (MP:0001083 from MPO Gene-Phenotype Associations)", "abnormal trigeminal ganglion morphology (MP:0001092 from MPO Gene-Phenotype Associations)", "small trigeminal ganglion (MP:0001093 from MPO Gene-Phenotype Associations)", "abnormal l5 dorsal root ganglion morphology (MP:0001022 from MPO Gene-Phenotype Associations)", "abnormal lumbar dorsal root ganglion morphology (MP:0006404 from MPO Gene-Phenotype Associations)", "abnormal l4 dorsal root ganglion morphology (MP:0001019 from MPO Gene-Phenotype Associations)", "small l4 dorsal root ganglion (MP:0001021 from MPO Gene-Phenotype Associations)", "abnormal dorsal root ganglion morphology (MP:0000961 from MPO Gene-Phenotype Associations)", "small dorsal root ganglion (MP:0000964 from MPO Gene-Phenotype Associations)", "small mesencephalic trigeminal nucleus (MP:0000907 from MPO Gene-Phenotype Associations)", "abnormal adrenergic neuron morphology (MP:0001026 from MPO Gene-Phenotype Associations)", "abnormal fungiform papillae morphology (MP:0006257 from MPO Gene-Phenotype Associations)", "abnormal circumvallate papillae morphology (MP:0006258 from MPO Gene-Phenotype Associations)", "abnormal gustatory papillae morphology (MP:0006256 from MPO Gene-Phenotype Associations)", "abnormal gustatory papillae taste bud morphology (MP:0006260 from MPO Gene-Phenotype Associations)", "abnormal gustatory system morphology (MP:0005500 from MPO Gene-Phenotype Associations)", "abnormal taste bud morphology (MP:0001002 from MPO Gene-Phenotype Associations)", "abnormal axon pruning (MP:0008960 from MPO Gene-Phenotype Associations)", "abnormal tongue epithelium morphology (MP:0000764 from MPO Gene-Phenotype Associations)", "abnormal tongue morphology (MP:0000762 from MPO Gene-Phenotype Associations)", "abnormal filiform papillae morphology (MP:0000763 from MPO Gene-Phenotype Associations)", "abnormal cutaneous|subcutaneous mechanoreceptor morphology (MP:0000973 from MPO Gene-Phenotype Associations)", "abnormal pacinian corpuscle morphology (MP:0000988 from MPO Gene-Phenotype Associations)", "impaired limb coordination (MP:0001524 from MPO Gene-Phenotype Associations)", "abnormal merkel's receptor morphology (MP:0000985 from MPO Gene-Phenotype Associations)", "abnormal atrium myocardial trabeculae morphology (MP:0010581 from MPO Gene-Phenotype Associations)", "atrium myocardium hypoplasia (MP:0010501 from MPO Gene-Phenotype Associations)", "sinus venosus hypoplasia (MP:0010558 from MPO Gene-Phenotype Associations)", "absent proprioceptive neurons (MP:0008467 from MPO Gene-Phenotype Associations)", "vascular smooth muscle hypotrophy (MP:0002976 from MPO Gene-Phenotype Associations)", "abnormal golgi tendon organ morphology (MP:0000999 from MPO Gene-Phenotype Associations)", "absent golgi tendon organ (MP:0001000 from MPO Gene-Phenotype Associations)", "premature closure of the ductus arteriosus (MP:0010576 from MPO Gene-Phenotype Associations)", "abnormal atrium myocardium morphology (MP:0010493 from MPO Gene-Phenotype Associations)", "small l5 dorsal root ganglion (MP:0001024 from MPO Gene-Phenotype Associations)", "athetotic walking movements (MP:0001527 from MPO Gene-Phenotype Associations)", "abnormal trigeminal v mesencephalic nucleus morphology (MP:0000906 from MPO Gene-Phenotype Associations)", "decreased spinal cord size (MP:0000956 from MPO Gene-Phenotype Associations)", "ostium secundum atrial septal defect (MP:0010405 from MPO Gene-Phenotype Associations)", "abnormal proprioceptive neuron morphology (MP:0004297 from MPO Gene-Phenotype Associations)", "abnormal muscle spindle morphology (MP:0004069 from MPO Gene-Phenotype Associations)", "abnormal skeletal muscle mechanoreceptor morphology (MP:0000990 from MPO Gene-Phenotype Associations)", "decreased muscle spindle number (MP:0008486 from MPO Gene-Phenotype Associations)", "absent muscle spindles (MP:0008468 from MPO Gene-Phenotype Associations)", "abnormal cholinergic neuron morphology (MP:0001038 from MPO Gene-Phenotype Associations)", "abnormal pulmonary collagen fibril morphology (MP:0011641 from MPO Gene-Phenotype Associations)", "abnormal limb posture (MP:0004263 from MPO Gene-Phenotype Associations)", "absent mandibular nerve (MP:0001067 from MPO Gene-Phenotype Associations)", "absent schwann cells (MP:0001108 from MPO Gene-Phenotype Associations)", "decreased schwann cell number (MP:0001107 from MPO Gene-Phenotype Associations)", "absent trigeminal nerve connections to hindbrain (MP:0001069 from MPO Gene-Phenotype Associations)", "abnormal schwann cell precursor morphology (MP:0004074 from MPO Gene-Phenotype Associations)", "decreased schwann cell precursor number (MP:0004075 from MPO Gene-Phenotype Associations)", "defasiculated phrenic nerve (MP:0001080 from MPO Gene-Phenotype Associations)", "small superior vagus ganglion (MP:0001102 from MPO Gene-Phenotype Associations)", "abnormal secondary muscle spindle morphology (MP:0000994 from MPO Gene-Phenotype Associations)", "partial loss of secondary muscle spindle (MP:0000996 from MPO Gene-Phenotype Associations)", "abnormal primary muscle spindle morphology (MP:0000991 from MPO Gene-Phenotype Associations)", "absent primary muscle spindle (MP:0000992 from MPO Gene-Phenotype Associations)", "abnormal hypoglossal nerve morphology (MP:0001076 from MPO Gene-Phenotype Associations)", "poor circulation (MP:0001633 from MPO Gene-Phenotype Associations)", "absent myocardial trabeculae (MP:0000293 from MPO Gene-Phenotype Associations)", "absent trabeculae carneae (MP:0000296 from MPO Gene-Phenotype Associations)", "abnormal innervation pattern to muscle (MP:0001052 from MPO Gene-Phenotype Associations)", "abnormal motor neuron innervation pattern (MP:0000940 from MPO Gene-Phenotype Associations)", "abnormal phrenic nerve innervation pattern (MP:0012054 from MPO Gene-Phenotype Associations)", "abnormal phrenic nerve innervation pattern to diaphragm (MP:0012055 from MPO Gene-Phenotype Associations)", "abnormal phrenic nerve morphology (MP:0001078 from MPO Gene-Phenotype Associations)", "abnormal motor neuron morphology (MP:0000937 from MPO Gene-Phenotype Associations)", "abnormal spinal cord grey matter morphology (MP:0008503 from MPO Gene-Phenotype Associations)", "abnormal spinal cord morphology (MP:0000955 from MPO Gene-Phenotype Associations)", "decreased motor neuron number (MP:0000939 from MPO Gene-Phenotype Associations)", "motor neuron degeneration (MP:0000938 from MPO Gene-Phenotype Associations)", "increased motor neuron number (MP:0005192 from MPO Gene-Phenotype Associations)", "carpoptosis (MP:0005162 from MPO Gene-Phenotype Associations)", "abnormal neuromuscular synapse morphology (MP:0001053 from MPO Gene-Phenotype Associations)", "abnormal somatic motor system morphology (MP:0001051 from MPO Gene-Phenotype Associations)", "abnormal synapse morphology (MP:0009538 from MPO Gene-Phenotype Associations)", "abnormal endplate potential (MP:0002914 from MPO Gene-Phenotype Associations)", "abnormal miniature endplate potential (MP:0004835 from MPO Gene-Phenotype Associations)", "abnormal pns synaptic transmission (MP:0002913 from MPO Gene-Phenotype Associations)", "abnormal hensen cell morphology (MP:0004303 from MPO Gene-Phenotype Associations)", "cochlear ganglion hypoplasia (MP:0003637 from MPO Gene-Phenotype Associations)", "small cochlear ganglion (MP:0003986 from MPO Gene-Phenotype Associations)", "absent pancreatic islets (MP:0009173 from MPO Gene-Phenotype Associations)", "ectopic pancreatic acinar cells (MP:0009157 from MPO Gene-Phenotype Associations)", "abnormal red nucleus morphology (MP:0012267 from MPO Gene-Phenotype Associations)", "absent red nucleus (MP:0012268 from MPO Gene-Phenotype Associations)", "abnormal inferior olivary complex morphology (MP:0003684 from MPO Gene-Phenotype Associations)", "abnormal tegmentum morphology (MP:0006100 from MPO Gene-Phenotype Associations)", "aspiration (MP:0002296 from MPO Gene-Phenotype Associations)", "no swallowing reflex (MP:0001437 from MPO Gene-Phenotype Associations)", "abnormal suckling behavior (MP:0001436 from MPO Gene-Phenotype Associations)", "no suckling reflex (MP:0001435 from MPO Gene-Phenotype Associations)", "increased salivation (MP:0000622 from MPO Gene-Phenotype Associations)", "abnormal biopterin level (MP:0005320 from MPO Gene-Phenotype Associations)", "abnormal neopterin level (MP:0005321 from MPO Gene-Phenotype Associations)", "abnormal brain development (MP:0000913 from MPO Gene-Phenotype Associations)", "abnormal nervous system development (MP:0003861 from MPO Gene-Phenotype Associations)", "abnormal brain morphology (MP:0002152 from MPO Gene-Phenotype Associations)", "abnormal nervous system morphology (MP:0003632 from MPO Gene-Phenotype Associations)", "nervous system phenotype (MP:0003631 from MPO Gene-Phenotype Associations)", "abnormal forebrain morphology (MP:0000783 from MPO Gene-Phenotype Associations)", "abnormal telencephalon morphology (MP:0000787 from MPO Gene-Phenotype Associations)", "abnormal cerebrum morphology (MP:0008540 from MPO Gene-Phenotype Associations)", "abnormal hippocampus morphology (MP:0000807 from MPO Gene-Phenotype Associations)", "abnormal temporal lobe morphology (MP:0000801 from MPO Gene-Phenotype Associations)", "abnormal limbic system morphology (MP:0004166 from MPO Gene-Phenotype Associations)", "abnormal cerebral cortex morphology (MP:0000788 from MPO Gene-Phenotype Associations)", "abnormal dentate gyrus morphology (MP:0000812 from MPO Gene-Phenotype Associations)", "abnormal hippocampus layer morphology (MP:0000813 from MPO Gene-Phenotype Associations)", "abnormal hippocampus pyramidal cell layer (MP:0008284 from MPO Gene-Phenotype Associations)", "abnormal hippocampus pyramidal cell morphology (MP:0009940 from MPO Gene-Phenotype Associations)", "abnormal hippocampus neuron morphology (MP:0009939 from MPO Gene-Phenotype Associations)", "decreased hippocampus pyramidal cell number (MP:0009971 from MPO Gene-Phenotype Associations)", "abnormal ammon gyrus morphology (MP:0000815 from MPO Gene-Phenotype Associations)", "abnormal hippocampus region morphology (MP:0008262 from MPO Gene-Phenotype Associations)", "abnormal hippocampus ca1 region morphology (MP:0008263 from MPO Gene-Phenotype Associations)", "abnormal hippocampus ca3 region morphology (MP:0008267 from MPO Gene-Phenotype Associations)", "abnormal hippocampus development (MP:0000808 from MPO Gene-Phenotype Associations)", "mammalian phenotype (MP:0000001 from MPO Gene-Phenotype Associations)", "abnormal survival (MP:0010769 from MPO Gene-Phenotype Associations)", "mortality|aging (MP:0010768 from MPO Gene-Phenotype Associations)", "preweaning lethality (MP:0010770 from MPO Gene-Phenotype Associations)", "lethality during fetal growth through weaning (MP:0010832 from MPO Gene-Phenotype Associations)", "partial postnatal lethality (MP:0011086 from MPO Gene-Phenotype Associations)", "postnatal lethality (MP:0002082 from MPO Gene-Phenotype Associations)", "growth|size|body phenotype (MP:0005378 from MPO Gene-Phenotype Associations)", "abnormal body composition (MP:0005451 from MPO Gene-Phenotype Associations)", "abnormal total tissue mass (MP:0012321 from MPO Gene-Phenotype Associations)", "abnormal body weight (MP:0001259 from MPO Gene-Phenotype Associations)", "decreased body weight (MP:0001262 from MPO Gene-Phenotype Associations)", "decreased total tissue mass (MP:0012322 from MPO Gene-Phenotype Associations)", "decreased body size (MP:0001265 from MPO Gene-Phenotype Associations)", "abnormal body size (MP:0003956 from MPO Gene-Phenotype Associations)", "abnormal postnatal growth|weight|body size (MP:0002089 from MPO Gene-Phenotype Associations)", "abnormal postnatal growth (MP:0001731 from MPO Gene-Phenotype Associations)", "postnatal growth retardation (MP:0001732 from MPO Gene-Phenotype Associations)", "abnormal blood homeostasis (MP:0009642 from MPO Gene-Phenotype Associations)", "abnormal homeostasis (MP:0001764 from MPO Gene-Phenotype Associations)", "homeostasis|metabolism phenotype (MP:0005376 from MPO Gene-Phenotype Associations)", "premature death (MP:0002083 from MPO Gene-Phenotype Associations)", "complete postnatal lethality (MP:0011085 from MPO Gene-Phenotype Associations)", "abnormal apoptosis (MP:0001648 from MPO Gene-Phenotype Associations)", "abnormal cell death (MP:0000313 from MPO Gene-Phenotype Associations)", "increased apoptosis (MP:0006042 from MPO Gene-Phenotype Associations)", "increased cell death (MP:0012556 from MPO Gene-Phenotype Associations)", "abnormal cell physiology (MP:0005621 from MPO Gene-Phenotype Associations)", "cellular phenotype (MP:0005384 from MPO Gene-Phenotype Associations)", "abnormal behavior (MP:0004924 from MPO Gene-Phenotype Associations)", "behavior|neurological phenotype (MP:0005386 from MPO Gene-Phenotype Associations)", "abnormal motor capabilities|coordination|movement (MP:0002066 from MPO Gene-Phenotype Associations)", "abnormal locomotor activation (MP:0003313 from MPO Gene-Phenotype Associations)", "abnormal locomotor behavior (MP:0001392 from MPO Gene-Phenotype Associations)", "abnormal voluntary movement (MP:0003491 from MPO Gene-Phenotype Associations)", "abnormal involuntary movement (MP:0003492 from MPO Gene-Phenotype Associations)", "abnormal reflex (MP:0001961 from MPO Gene-Phenotype Associations)", "abnormal sensory capabilities|reflexes|nociception (MP:0002067 from MPO Gene-Phenotype Associations)", "hyperactivity (MP:0001399 from MPO Gene-Phenotype Associations)", "hypoactivity (MP:0001402 from MPO Gene-Phenotype Associations)", "abnormal gait (MP:0001406 from MPO Gene-Phenotype Associations)", "abnormal locomotor coordination (MP:0003312 from MPO Gene-Phenotype Associations)", "ataxia (MP:0001393 from MPO Gene-Phenotype Associations)", "abnormal motor coordination| balance (MP:0001516 from MPO Gene-Phenotype Associations)", "impaired coordination (MP:0001405 from MPO Gene-Phenotype Associations)", "tremors (MP:0000745 from MPO Gene-Phenotype Associations)", "limb grasping (MP:0001513 from MPO Gene-Phenotype Associations)", "abnormal postural reflex (MP:0002980 from MPO Gene-Phenotype Associations)", "altered righting response (MP:0002862 from MPO Gene-Phenotype Associations)", "impaired righting response (MP:0001523 from MPO Gene-Phenotype Associations)", "impaired balance (MP:0001525 from MPO Gene-Phenotype Associations)", "abnormal posture (MP:0001504 from MPO Gene-Phenotype Associations)", "hunched posture (MP:0001505 from MPO Gene-Phenotype Associations)", "no abnormal phenotype detected (MP:0002169 from MPO Gene-Phenotype Associations)", "normal phenotype (MP:0002873 from MPO Gene-Phenotype Associations)", "cachexia (MP:0005150 from MPO Gene-Phenotype Associations)", "weight loss (MP:0001263 from MPO Gene-Phenotype Associations)", "slow postnatal weight gain (MP:0008489 from MPO Gene-Phenotype Associations)", "partial perinatal lethality (MP:0011090 from MPO Gene-Phenotype Associations)", "partial prenatal lethality (MP:0011101 from MPO Gene-Phenotype Associations)", "decreased survivor rate (MP:0008770 from MPO Gene-Phenotype Associations)", "partial lethality (MP:0010831 from MPO Gene-Phenotype Associations)", "abnormal grip strength (MP:0001515 from MPO Gene-Phenotype Associations)", "decreased grip strength (MP:0010053 from MPO Gene-Phenotype Associations)", "abnormal physical strength (MP:0004262 from MPO Gene-Phenotype Associations)", "increased grip strength (MP:0010052 from MPO Gene-Phenotype Associations)", "paraparesis (MP:0009434 from MPO Gene-Phenotype Associations)", "weakness (MP:0000746 from MPO Gene-Phenotype Associations)", "abnormal hindbrain development (MP:0006108 from MPO Gene-Phenotype Associations)", "abnormal cerebellum development (MP:0000854 from MPO Gene-Phenotype Associations)", "abnormal cerebellum lobule morphology (MP:0009964 from MPO Gene-Phenotype Associations)", "abnormal cerebellar foliation (MP:0000857 from MPO Gene-Phenotype Associations)", "abnormal cerebellum external granule cell layer morphology (MP:0000872 from MPO Gene-Phenotype Associations)", "small cerebellum (MP:0000852 from MPO Gene-Phenotype Associations)", "reduced cerebellar foliation (MP:0009719 from MPO Gene-Phenotype Associations)", "purkinje cell degeneration (MP:0000876 from MPO Gene-Phenotype Associations)", "abnormal cerebellar cortex morphology (MP:0004097 from MPO Gene-Phenotype Associations)", "abnormal cerebellar layer morphology (MP:0009956 from MPO Gene-Phenotype Associations)", "abnormal cerebellar purkinje cell layer (MP:0000875 from MPO Gene-Phenotype Associations)", "abnormal purkinje cell morphology (MP:0000877 from MPO Gene-Phenotype Associations)", "abnormal cerebellum morphology (MP:0000849 from MPO Gene-Phenotype Associations)", "abnormal metencephalon morphology (MP:0000847 from MPO Gene-Phenotype Associations)", "abnormal hindbrain morphology (MP:0000841 from MPO Gene-Phenotype Associations)", "abnormal purkinje cell number (MP:0000878 from MPO Gene-Phenotype Associations)", "decreased purkinje cell number (MP:0000880 from MPO Gene-Phenotype Associations)", "ectopic neuron (MP:0011723 from MPO Gene-Phenotype Associations)", "ectopic purkinje cell (MP:0000885 from MPO Gene-Phenotype Associations)", "abnormal cerebellar granule cell morphology (MP:0004098 from MPO Gene-Phenotype Associations)", "abnormal cerebellar granule layer morphology (MP:0000886 from MPO Gene-Phenotype Associations)", "ectopic cerebellar granule cells (MP:0002762 from MPO Gene-Phenotype Associations)", "abnormal cerebellar molecular layer (MP:0000889 from MPO Gene-Phenotype Associations)", "thin cerebellar molecular layer (MP:0000890 from MPO Gene-Phenotype Associations)", "abnormal dendrite morphology (MP:0008143 from MPO Gene-Phenotype Associations)", "abnormal purkinje cell dendrite morphology (MP:0008572 from MPO Gene-Phenotype Associations)", "abnormal motor learning (MP:0002804 from MPO Gene-Phenotype Associations)", "ectopic hippocampus pyramidal cells (MP:0010011 from MPO Gene-Phenotype Associations)", "increased purkinje cell number (MP:0000879 from MPO Gene-Phenotype Associations)", "absent cerebellar lobules (MP:0006098 from MPO Gene-Phenotype Associations)", "absent cerebellum fissure (MP:0009268 from MPO Gene-Phenotype Associations)", "abnormal cerebellar lobule formation (MP:0006097 from MPO Gene-Phenotype Associations)", "abnormal cerebellar golgi cell morphology (MP:0009512 from MPO Gene-Phenotype Associations)", "complete lethality at weaning (MP:0011083 from MPO Gene-Phenotype Associations)", "lethality at weaning (MP:0008569 from MPO Gene-Phenotype Associations)", "partial lethality at weaning (MP:0011084 from MPO Gene-Phenotype Associations)", "complete preweaning lethality (MP:0011100 from MPO Gene-Phenotype Associations)", "partial preweaning lethality (MP:0011110 from MPO Gene-Phenotype Associations)", "axon degeneration (MP:0005405 from MPO Gene-Phenotype Associations)", "axonal dystrophy (MP:0003225 from MPO Gene-Phenotype Associations)", "axonal spheroids (MP:0010047 from MPO Gene-Phenotype Associations)", "l5 dorsal root ganglion hypertrophy (MP:0001023 from MPO Gene-Phenotype Associations)", "abnormal axonal transport (MP:0004768 from MPO Gene-Phenotype Associations)", "abnormal dorsal spinal root morphology (MP:0003994 from MPO Gene-Phenotype Associations)", "abnormal ventral spinal root morphology (MP:0003993 from MPO Gene-Phenotype Associations)", "abnormal spinal nerve morphology (MP:0001077 from MPO Gene-Phenotype Associations)", "abnormal sciatic nerve morphology (MP:0002651 from MPO Gene-Phenotype Associations)", "abnormal pns glial cell morphology (MP:0001105 from MPO Gene-Phenotype Associations)", "abnormal schwann cell morphology (MP:0001106 from MPO Gene-Phenotype Associations)", "abnormal axon morphology (MP:0005404 from MPO Gene-Phenotype Associations)", "abnormal neurite morphology (MP:0008415 from MPO Gene-Phenotype Associations)", "abnormal myelin sheath morphology (MP:0003871 from MPO Gene-Phenotype Associations)", "abnormal myelination (MP:0000920 from MPO Gene-Phenotype Associations)", "demyelination (MP:0000921 from MPO Gene-Phenotype Associations)", "abnormal nerve conduction (MP:0005403 from MPO Gene-Phenotype Associations)", "decreased nerve conduction velocity (MP:0008814 from MPO Gene-Phenotype Associations)", "muscle weakness (MP:0000747 from MPO Gene-Phenotype Associations)", "progressive muscle weakness (MP:0000748 from MPO Gene-Phenotype Associations)", "paralysis (MP:0000753 from MPO Gene-Phenotype Associations)", "hindlimb paralysis (MP:0000755 from MPO Gene-Phenotype Associations)", "forelimb paralysis (MP:0000756 from MPO Gene-Phenotype Associations)", "spongiform encephalopathy (MP:0002654 from MPO Gene-Phenotype Associations)", "brain vacuoles (MP:0008025 from MPO Gene-Phenotype Associations)", "abnormal astrocyte morphology (MP:0002182 from MPO Gene-Phenotype Associations)", "abnormal astrocyte number (MP:0012064 from MPO Gene-Phenotype Associations)", "increased astrocyte number (MP:0012065 from MPO Gene-Phenotype Associations)", "astrocytosis (MP:0003354 from MPO Gene-Phenotype Associations)", "gliosis (MP:0002183 from MPO Gene-Phenotype Associations)", "abnormal cns glial cell morphology (MP:0000952 from MPO Gene-Phenotype Associations)", "abnormal glial cell morphology (MP:0003634 from MPO Gene-Phenotype Associations)", "microgliosis (MP:0008918 from MPO Gene-Phenotype Associations)", "abnormal microglial cell morphology (MP:0000136 from MPO Gene-Phenotype Associations)", "abnormal oligodendrocyte morphology (MP:0000953 from MPO Gene-Phenotype Associations)", "decreased oligodendrocyte number (MP:0009808 from MPO Gene-Phenotype Associations)", "increased oligodendrocyte number (MP:0010160 from MPO Gene-Phenotype Associations)", "abnormal glial cell apoptosis (MP:0010170 from MPO Gene-Phenotype Associations)", "abnormal oligodendrocyte apoptosis (MP:0010205 from MPO Gene-Phenotype Associations)", "abnormal oligodendrocyte physiology (MP:0008917 from MPO Gene-Phenotype Associations)", "abnormal hippocampus ca4 region morphology (MP:0008269 from MPO Gene-Phenotype Associations)", "abnormal central medial nucleus morphology (MP:0008929 from MPO Gene-Phenotype Associations)", "increased pancreatic delta cell number (MP:0009180 from MPO Gene-Phenotype Associations)", "enlarged seminiferous tubules (MP:0006308 from MPO Gene-Phenotype Associations)", "abnormal glutaminergic neuron morphology (MP:0003247 from MPO Gene-Phenotype Associations)", "abnormal gabaergic neuron morphology (MP:0003245 from MPO Gene-Phenotype Associations)", "loss of gabaergic neurons (MP:0003246 from MPO Gene-Phenotype Associations)", "abnormal behavioral response to xenobiotic (MP:0009745 from MPO Gene-Phenotype Associations)", "abnormal seizure response to inducing agent (MP:0009357 from MPO Gene-Phenotype Associations)", "abnormal seizure response to pharmacological agent (MP:0000950 from MPO Gene-Phenotype Associations)", "increased susceptibility to induction of seizure by inducing agent (MP:0012349 from MPO Gene-Phenotype Associations)", "increased susceptibility to pharmacologically induced seizures (MP:0002906 from MPO Gene-Phenotype Associations)", "seizures (MP:0002064 from MPO Gene-Phenotype Associations)", "convulsive seizures (MP:0000947 from MPO Gene-Phenotype Associations)", "tonic-clonic seizures (MP:0003997 from MPO Gene-Phenotype Associations)", "clonic seizures (MP:0003996 from MPO Gene-Phenotype Associations)", "abnormal brain wave pattern (MP:0004994 from MPO Gene-Phenotype Associations)", "abnormal spike wave discharge (MP:0008840 from MPO Gene-Phenotype Associations)", "absence seizures (MP:0003216 from MPO Gene-Phenotype Associations)", "nonconvulsive seizures (MP:0000948 from MPO Gene-Phenotype Associations)", "tonic seizures (MP:0002826 from MPO Gene-Phenotype Associations)", "muscle spasm (MP:0000743 from MPO Gene-Phenotype Associations)", "muscle twitch (MP:0009046 from MPO Gene-Phenotype Associations)", "myoclonus (MP:0000243 from MPO Gene-Phenotype Associations)", "audiogenic seizures (MP:0001496 from MPO Gene-Phenotype Associations)", "environmentally induced seizures (MP:0009358 from MPO Gene-Phenotype Associations)", "abnormal substantia nigra morphology (MP:0000836 from MPO Gene-Phenotype Associations)", "abnormal substantia nigra pars compacta morphology (MP:0013219 from MPO Gene-Phenotype Associations)", "abnormal dopaminergic neuron morphology (MP:0003243 from MPO Gene-Phenotype Associations)", "decreased dopaminergic neuron number (MP:0011448 from MPO Gene-Phenotype Associations)", "loss of dopaminergic neurons (MP:0003244 from MPO Gene-Phenotype Associations)", "abnormal catecholamine level (MP:0011479 from MPO Gene-Phenotype Associations)", "abnormal dopamine level (MP:0001905 from MPO Gene-Phenotype Associations)", "increased dopamine level (MP:0001906 from MPO Gene-Phenotype Associations)", "decreased dopamine level (MP:0005643 from MPO Gene-Phenotype Associations)", "decreased apoptosis (MP:0006043 from MPO Gene-Phenotype Associations)", "decreased cell death (MP:0012555 from MPO Gene-Phenotype Associations)", "decreased neuron apoptosis (MP:0003204 from MPO Gene-Phenotype Associations)", "decreased susceptibility to neuronal excitotoxicity (MP:0008236 from MPO Gene-Phenotype Associations)", "decreased susceptibility to dopaminergic neuron neurotoxicity (MP:0011452 from MPO Gene-Phenotype Associations)", "abnormal neuron physiology (MP:0004811 from MPO Gene-Phenotype Associations)", "abnormal neuron apoptosis (MP:0003202 from MPO Gene-Phenotype Associations)", "increased neuron apoptosis (MP:0003203 from MPO Gene-Phenotype Associations)", "increased susceptibility to neuronal excitotoxicity (MP:0008235 from MPO Gene-Phenotype Associations)", "increased susceptibility to dopaminergic neuron neurotoxicity (MP:0011451 from MPO Gene-Phenotype Associations)", "abnormal dendritic spine morphology (MP:0009936 from MPO Gene-Phenotype Associations)", "decreased stereotypic behavior (MP:0003908 from MPO Gene-Phenotype Associations)", "abnormal thalamus neuron morphology (MP:0010369 from MPO Gene-Phenotype Associations)", "abnormal avoidance learning behavior (MP:0001462 from MPO Gene-Phenotype Associations)", "abnormal passive avoidance behavior (MP:0002799 from MPO Gene-Phenotype Associations)", "abnormal fear-related response (MP:0003106 from MPO Gene-Phenotype Associations)", "decreased fear-related response (MP:0003460 from MPO Gene-Phenotype Associations)", "impaired passive avoidance behavior (MP:0004000 from MPO Gene-Phenotype Associations)", "impaired avoidance learning behavior (MP:0012312 from MPO Gene-Phenotype Associations)", "impaired learning (MP:0012315 from MPO Gene-Phenotype Associations)", "abnormal associative learning (MP:0002062 from MPO Gene-Phenotype Associations)", "abnormal contextual conditioning behavior (MP:0001469 from MPO Gene-Phenotype Associations)", "abnormal temporal memory (MP:0001468 from MPO Gene-Phenotype Associations)", "impaired conditioning behavior (MP:0012317 from MPO Gene-Phenotype Associations)", "impaired contextual conditioning behavior (MP:0009454 from MPO Gene-Phenotype Associations)", "abnormal cued conditioning behavior (MP:0001454 from MPO Gene-Phenotype Associations)", "impaired cued conditioning behavior (MP:0009456 from MPO Gene-Phenotype Associations)", "abnormal learning|memory|conditioning (MP:0002063 from MPO Gene-Phenotype Associations)", "abnormal spatial learning (MP:0001463 from MPO Gene-Phenotype Associations)", "abnormal cns synaptic transmission (MP:0002206 from MPO Gene-Phenotype Associations)", "abnormal synaptic transmission (MP:0003635 from MPO Gene-Phenotype Associations)", "abnormal nervous system physiology (MP:0003633 from MPO Gene-Phenotype Associations)", "abnormal long term potentiation (MP:0002207 from MPO Gene-Phenotype Associations)", "reduced long term potentiation (MP:0001473 from MPO Gene-Phenotype Associations)", "abnormal excitatory postsynaptic potential (MP:0002912 from MPO Gene-Phenotype Associations)", "abnormal synaptic plasticity (MP:0004859 from MPO Gene-Phenotype Associations)", "impaired synaptic plasticity (MP:0001900 from MPO Gene-Phenotype Associations)", "abnormal long term depression (MP:0001898 from MPO Gene-Phenotype Associations)", "abnormal synaptic depression (MP:0002915 from MPO Gene-Phenotype Associations)", "reduced long term depression (MP:0001475 from MPO Gene-Phenotype Associations)", "absent long term depression (MP:0001899 from MPO Gene-Phenotype Associations)", "enhanced long term potentiation (MP:0003008 from MPO Gene-Phenotype Associations)", "abnormal long term object recognition memory (MP:0002801 from MPO Gene-Phenotype Associations)", "abnormal object recognition memory (MP:0001458 from MPO Gene-Phenotype Associations)", "abnormal emotion|affect behavior (MP:0002572 from MPO Gene-Phenotype Associations)", "abnormal fear|anxiety-related behavior (MP:0002065 from MPO Gene-Phenotype Associations)", "abnormal anxiety-related response (MP:0001362 from MPO Gene-Phenotype Associations)", "increased anxiety-related response (MP:0001363 from MPO Gene-Phenotype Associations)", "decreased anxiety-related response (MP:0001364 from MPO Gene-Phenotype Associations)", "increased thigmotaxis (MP:0002797 from MPO Gene-Phenotype Associations)", "abnormal exploration in a new environment (MP:0013189 from MPO Gene-Phenotype Associations)", "decreased exploration in new environment (MP:0001417 from MPO Gene-Phenotype Associations)", "abnormal response to new environment (MP:0001413 from MPO Gene-Phenotype Associations)", "abnormal response to novelty (MP:0003107 from MPO Gene-Phenotype Associations)", "increased exploration in new environment (MP:0001415 from MPO Gene-Phenotype Associations)", "abnormal response to novel object (MP:0003461 from MPO Gene-Phenotype Associations)", "abnormal vertical activity (MP:0020167 from MPO Gene-Phenotype Associations)", "decreased vertical activity (MP:0002757 from MPO Gene-Phenotype Associations)", "increased vertical activity (MP:0002574 from MPO Gene-Phenotype Associations)", "abnormal long term spatial reference memory (MP:0008432 from MPO Gene-Phenotype Associations)", "abnormal spatial reference memory (MP:0008414 from MPO Gene-Phenotype Associations)", "abnormal spatial working memory (MP:0008428 from MPO Gene-Phenotype Associations)", "abnormal startle reflex (MP:0001486 from MPO Gene-Phenotype Associations)", "decreased startle reflex (MP:0001489 from MPO Gene-Phenotype Associations)", "increased startle reflex (MP:0001488 from MPO Gene-Phenotype Associations)", "abnormal prepulse inhibition (MP:0003088 from MPO Gene-Phenotype Associations)", "decreased prepulse inhibition (MP:0009142 from MPO Gene-Phenotype Associations)", "increased prepulse inhibition (MP:0009141 from MPO Gene-Phenotype Associations)", "abnormal maternal grooming (MP:0009327 from MPO Gene-Phenotype Associations)", "absence of nmda-mediated synaptic currents (MP:0001901 from MPO Gene-Phenotype Associations)", "abnormal huddling behavior (MP:0001448 from MPO Gene-Phenotype Associations)", "abnormal social investigation (MP:0001360 from MPO Gene-Phenotype Associations)", "social withdrawal (MP:0001361 from MPO Gene-Phenotype Associations)", "abnormal nest building behavior (MP:0001447 from MPO Gene-Phenotype Associations)", "abnormal ampa-mediated synaptic currents (MP:0002885 from MPO Gene-Phenotype Associations)", "abnormal glutamate-mediated receptor currents (MP:0002886 from MPO Gene-Phenotype Associations)", "reduced ampa-mediated synaptic currents (MP:0011003 from MPO Gene-Phenotype Associations)", "abnormal excitatory postsynaptic currents (MP:0002910 from MPO Gene-Phenotype Associations)", "abnormal miniature excitatory postsynaptic currents (MP:0004753 from MPO Gene-Phenotype Associations)", "abnormal nmda-mediated synaptic currents (MP:0002888 from MPO Gene-Phenotype Associations)", "reduced nmda-mediated synaptic currents (MP:0001902 from MPO Gene-Phenotype Associations)", "enhanced nmda-mediated synaptic currents (MP:0003234 from MPO Gene-Phenotype Associations)", "enhanced contextual conditioning behavior (MP:0009453 from MPO Gene-Phenotype Associations)", "enhanced conditioning behavior (MP:0012316 from MPO Gene-Phenotype Associations)", "enhanced cued conditioning behavior (MP:0009455 from MPO Gene-Phenotype Associations)", "abnormal gaba-mediated receptor currents (MP:0004008 from MPO Gene-Phenotype Associations)", "abnormal miniature inhibitory postsynaptic currents (MP:0009435 from MPO Gene-Phenotype Associations)", "abnormal inhibitory postsynaptic currents (MP:0002945 from MPO Gene-Phenotype Associations)", "alpha-synuclein inclusion body (MP:0008493 from MPO Gene-Phenotype Associations)", "impaired gastric peristalsis (MP:0009854 from MPO Gene-Phenotype Associations)", "early parturition (MP:0012009 from MPO Gene-Phenotype Associations)", "increased behavioral withdrawal response (MP:0009775 from MPO Gene-Phenotype Associations)", "anhedonia (MP:0009710 from MPO Gene-Phenotype Associations)", "abnormal conditioned place preference behavior (MP:0009711 from MPO Gene-Phenotype Associations)", "impaired conditioned place preference behavior (MP:0009712 from MPO Gene-Phenotype Associations)", "abnormal behavioral response to morphine (MP:0020159 from MPO Gene-Phenotype Associations)", "impaired behavioral response to morphine (MP:0009757 from MPO Gene-Phenotype Associations)", "abnormal chemically-elicited antinociception (MP:0001980 from MPO Gene-Phenotype Associations)", "decreased chemically-elicited antinociception (MP:0001982 from MPO Gene-Phenotype Associations)", "enhanced behavioral response to morphine (MP:0009753 from MPO Gene-Phenotype Associations)", "increased chemically-elicited antinociception (MP:0001981 from MPO Gene-Phenotype Associations)", "abnormal behavioral withdrawal response (MP:0009774 from MPO Gene-Phenotype Associations)", "decreased behavioral withdrawal response (MP:0009776 from MPO Gene-Phenotype Associations)", "abnormal behavioral response to addictive substance (MP:0009748 from MPO Gene-Phenotype Associations)", "impaired behavioral response to addictive substance (MP:0009750 from MPO Gene-Phenotype Associations)", "impaired behavioral response to xenobiotic (MP:0009747 from MPO Gene-Phenotype Associations)", "impaired behavioral response to cocaine (MP:0009758 from MPO Gene-Phenotype Associations)", "enhanced behavioral response to addictive substance (MP:0009749 from MPO Gene-Phenotype Associations)", "enhanced behavioral response to xenobiotic (MP:0009746 from MPO Gene-Phenotype Associations)", "abnormal behavioral response to cocaine (MP:0020158 from MPO Gene-Phenotype Associations)", "enhanced behavioral response to cocaine (MP:0009754 from MPO Gene-Phenotype Associations)", "abnormal coping response (MP:0003062 from MPO Gene-Phenotype Associations)", "increased coping response (MP:0003063 from MPO Gene-Phenotype Associations)", "abnormal depression-related behavior (MP:0003360 from MPO Gene-Phenotype Associations)", "behavioral despair (MP:0002573 from MPO Gene-Phenotype Associations)", "decreased abdominal fat pad weight (MP:0009287 from MPO Gene-Phenotype Associations)", "increased coronary flow rate (MP:0003022 from MPO Gene-Phenotype Associations)", "decreased left ventricle diastolic pressure (MP:0003821 from MPO Gene-Phenotype Associations)", "abnormal hair cycle telogen phase (MP:0008860 from MPO Gene-Phenotype Associations)", "increased left ventricle developed pressure (MP:0003823 from MPO Gene-Phenotype Associations)", "impaired febrile response (MP:0003829 from MPO Gene-Phenotype Associations)", "decreased circulating antidiuretic hormone level (MP:0005611 from MPO Gene-Phenotype Associations)", "decreased blood osmolality (MP:0008998 from MPO Gene-Phenotype Associations)", "urinary incontinence (MP:0003280 from MPO Gene-Phenotype Associations)", "abnormal blood osmolality (MP:0008996 from MPO Gene-Phenotype Associations)", "increased blood osmolality (MP:0008997 from MPO Gene-Phenotype Associations)", "no spontaneous movement (MP:0001404 from MPO Gene-Phenotype Associations)", "hyporesponsive to tactile stimuli (MP:0005498 from MPO Gene-Phenotype Associations)", "abnormal response to tactile stimuli (MP:0005316 from MPO Gene-Phenotype Associations)", "abnormal spinal reflex (MP:0012079 from MPO Gene-Phenotype Associations)", "analgesia (MP:0004270 from MPO Gene-Phenotype Associations)", "unresponsive to tactile stimuli (MP:0001491 from MPO Gene-Phenotype Associations)", "abnormal chemical nociception (MP:0002735 from MPO Gene-Phenotype Associations)", "increased chemical nociceptive threshold (MP:0008531 from MPO Gene-Phenotype Associations)", "abnormal pain threshold (MP:0001970 from MPO Gene-Phenotype Associations)", "abnormal touch| nociception (MP:0001968 from MPO Gene-Phenotype Associations)", "abnormal thermal nociception (MP:0002733 from MPO Gene-Phenotype Associations)", "hypoalgesia (MP:0003043 from MPO Gene-Phenotype Associations)", "increased thermal nociceptive threshold (MP:0001973 from MPO Gene-Phenotype Associations)", "abnormal nociception after inflammation (MP:0002736 from MPO Gene-Phenotype Associations)", "abnormal mechanical nociception (MP:0002734 from MPO Gene-Phenotype Associations)", "decreased thermal nociceptive threshold (MP:0003998 from MPO Gene-Phenotype Associations)", "hyperalgesia (MP:0005407 from MPO Gene-Phenotype Associations)", "hyperresponsive to tactile stimuli (MP:0002738 from MPO Gene-Phenotype Associations)", "increased placenta apoptosis (MP:0009658 from MPO Gene-Phenotype Associations)", "abnormal orbitofrontal cortex morphology (MP:0004170 from MPO Gene-Phenotype Associations)", "abnormal dosage compensation (MP:0010381 from MPO Gene-Phenotype Associations)", "abnormal dosage compensation, by inactivation of x chromosome (MP:0010382 from MPO Gene-Phenotype Associations)", "sporadic seizures (MP:0000951 from MPO Gene-Phenotype Associations)", "abnormal pulmonary respiratory rate (MP:0005572 from MPO Gene-Phenotype Associations)", "increased pulmonary respiratory rate (MP:0005573 from MPO Gene-Phenotype Associations)", "tachypnea (MP:0005426 from MPO Gene-Phenotype Associations)", "decreased pulmonary respiratory rate (MP:0005574 from MPO Gene-Phenotype Associations)", "apnea (MP:0001957 from MPO Gene-Phenotype Associations)", "abnormal cerebellum hemisphere lobule morphology (MP:0009963 from MPO Gene-Phenotype Associations)", "decreased colliculi size (MP:0000900 from MPO Gene-Phenotype Associations)", "thin external granule cell layer (MP:0000873 from MPO Gene-Phenotype Associations)", "abnormal defecation amount (MP:0020147 from MPO Gene-Phenotype Associations)", "increased defecation amount (MP:0003867 from MPO Gene-Phenotype Associations)", "decreased defecation amount (MP:0012311 from MPO Gene-Phenotype Associations)", "abnormal allogrooming behavior (MP:0011000 from MPO Gene-Phenotype Associations)", "abnormal whisker trimming behavior (MP:0001446 from MPO Gene-Phenotype Associations)", "abnormal grooming behavior (MP:0001440 from MPO Gene-Phenotype Associations)", "increased grooming behavior (MP:0001441 from MPO Gene-Phenotype Associations)", "decreased grooming behavior (MP:0001442 from MPO Gene-Phenotype Associations)", "loss of basal ganglia neurons (MP:0003242 from MPO Gene-Phenotype Associations)", "bradykinesia (MP:0005156 from MPO Gene-Phenotype Associations)", "increased horizontal stereotypic behavior (MP:0009848 from MPO Gene-Phenotype Associations)", "increased vertical stereotypic behavior (MP:0009849 from MPO Gene-Phenotype Associations)", "increased stereotypic behavior (MP:0001409 from MPO Gene-Phenotype Associations)", "enhanced ampa-mediated synaptic currents (MP:0011002 from MPO Gene-Phenotype Associations)", "abnormal neural tube mantle layer morphology (MP:0009690 from MPO Gene-Phenotype Associations)", "decreased forebrain volume (MP:0012559 from MPO Gene-Phenotype Associations)", "abnormal cerebral cortex pyramidal cell morphology (MP:0009969 from MPO Gene-Phenotype Associations)", "decreased cerebral cortex pyramidal cell number (MP:0009974 from MPO Gene-Phenotype Associations)", "abnormal hippocampus size (MP:0008281 from MPO Gene-Phenotype Associations)", "small hippocampus (MP:0008283 from MPO Gene-Phenotype Associations)", "thin cerebral cortex (MP:0006254 from MPO Gene-Phenotype Associations)", "abnormal embryonic|fetal subventricular zone morphology (MP:0004274 from MPO Gene-Phenotype Associations)", "abnormal lateral ganglionic eminence morphology (MP:0004277 from MPO Gene-Phenotype Associations)", "abnormal forebrain development (MP:0003232 from MPO Gene-Phenotype Associations)", "abnormal telencephalon development (MP:0000934 from MPO Gene-Phenotype Associations)", "small embryonic telencephalon (MP:0000936 from MPO Gene-Phenotype Associations)", "abnormal cortical plate morphology (MP:0008439 from MPO Gene-Phenotype Associations)", "thin cortical plate (MP:0008441 from MPO Gene-Phenotype Associations)", "abnormal cortical ventricular zone morphology (MP:0008458 from MPO Gene-Phenotype Associations)", "abnormal neuron proliferation (MP:0009967 from MPO Gene-Phenotype Associations)", "abnormal neuronal precursor proliferation (MP:0004948 from MPO Gene-Phenotype Associations)", "abnormal neuronal precursor cell number (MP:0004979 from MPO Gene-Phenotype Associations)", "decreased neuronal precursor cell number (MP:0004981 from MPO Gene-Phenotype Associations)", "increased neuronal precursor cell number (MP:0004980 from MPO Gene-Phenotype Associations)", "abnormal hippocampus ca2 region morphology (MP:0008265 from MPO Gene-Phenotype Associations)", "thin body (MP:0013138 from MPO Gene-Phenotype Associations)", "abnormal stratification in cerebral cortex (MP:0000790 from MPO Gene-Phenotype Associations)", "absent purkinje cell layer (MP:0009718 from MPO Gene-Phenotype Associations)", "absent cerebellar foliation (MP:0000853 from MPO Gene-Phenotype Associations)", "abnormal hippocampus granule cell layer (MP:0008285 from MPO Gene-Phenotype Associations)", "abnormal hippocampus granule cell morphology (MP:0009938 from MPO Gene-Phenotype Associations)", "slow extinction of fear memory (MP:0012318 from MPO Gene-Phenotype Associations)", "delaminated purkinje cell layer (MP:0000884 from MPO Gene-Phenotype Associations)", "disorganized cortical plate (MP:0008442 from MPO Gene-Phenotype Associations)", "abnormal subplate morphology (MP:0008440 from MPO Gene-Phenotype Associations)", "absent subplate (MP:0008443 from MPO Gene-Phenotype Associations)", "ectopic cerebral cortex pyramidal cells (MP:0010012 from MPO Gene-Phenotype Associations)", "abnormal cerebellar granule cell migration (MP:0009977 from MPO Gene-Phenotype Associations)", "abnormal neuronal migration (MP:0006009 from MPO Gene-Phenotype Associations)", "long stride length (MP:0010540 from MPO Gene-Phenotype Associations)", "abnormal innervation (MP:0002184 from MPO Gene-Phenotype Associations)", "abnormal sensory neuron innervation pattern (MP:0000968 from MPO Gene-Phenotype Associations)", "abnormal olfactory neuron innervation pattern (MP:0012014 from MPO Gene-Phenotype Associations)", "abnormal axon extension (MP:0003651 from MPO Gene-Phenotype Associations)", "abnormal cell differentiation (MP:0005076 from MPO Gene-Phenotype Associations)", "abnormal neuron differentiation (MP:0009937 from MPO Gene-Phenotype Associations)", "abnormal axon guidance (MP:0002961 from MPO Gene-Phenotype Associations)", "abnormal spinal cord dorsal column morphology (MP:0009677 from MPO Gene-Phenotype Associations)", "abnormal spinal cord white matter morphology (MP:0008027 from MPO Gene-Phenotype Associations)", "abnormal medulla oblongata anterior median fissure morphology (MP:0009680 from MPO Gene-Phenotype Associations)", "abnormal pyramidal decussation morphology (MP:0009681 from MPO Gene-Phenotype Associations)", "abnormal corticospinal tract morphology (MP:0002878 from MPO Gene-Phenotype Associations)", "abnormal medulla oblongata morphology (MP:0000846 from MPO Gene-Phenotype Associations)", "abnormal anterior commissure morphology (MP:0008225 from MPO Gene-Phenotype Associations)", "abnormal ventral commissure morphology (MP:0008220 from MPO Gene-Phenotype Associations)", "absent anterior commissure (MP:0008227 from MPO Gene-Phenotype Associations)", "abnormal brain commissure morphology (MP:0002199 from MPO Gene-Phenotype Associations)", "abnormal nervous system tract morphology (MP:0000778 from MPO Gene-Phenotype Associations)", "abnormal brain white matter morphology (MP:0008026 from MPO Gene-Phenotype Associations)", "abnormal corpus callosum morphology (MP:0000780 from MPO Gene-Phenotype Associations)", "abnormal dorsal telencephalic commissure morphology (MP:0008219 from MPO Gene-Phenotype Associations)", "absent corpus callosum (MP:0002196 from MPO Gene-Phenotype Associations)", "decreased corpus callosum size (MP:0000781 from MPO Gene-Phenotype Associations)", "abnormal hippocampal commissure morphology (MP:0008221 from MPO Gene-Phenotype Associations)", "absent hippocampal commissure (MP:0008223 from MPO Gene-Phenotype Associations)", "decreased anterior commissure size (MP:0008226 from MPO Gene-Phenotype Associations)", "decreased hippocampal commissure size (MP:0008222 from MPO Gene-Phenotype Associations)", "abnormal anterior commissure pars posterior morphology (MP:0010860 from MPO Gene-Phenotype Associations)", "abnormal anterior commissure pars anterior morphology (MP:0010859 from MPO Gene-Phenotype Associations)", "abnormal cingulum morphology (MP:0008232 from MPO Gene-Phenotype Associations)", "abnormal wallerian degeneration (MP:0010653 from MPO Gene-Phenotype Associations)", "slow wallerian degeneration (MP:0010654 from MPO Gene-Phenotype Associations)", "abnormal barrel cortex morphology (MP:0003989 from MPO Gene-Phenotype Associations)", "abnormal primary somatosensory cortex morphology (MP:0000860 from MPO Gene-Phenotype Associations)", "abnormal parietal lobe morphology (MP:0000794 from MPO Gene-Phenotype Associations)", "abnormal somatosensory cortex morphology (MP:0000859 from MPO Gene-Phenotype Associations)", "disorganized barrel cortex (MP:0000861 from MPO Gene-Phenotype Associations)", "small sperm head (MP:0009235 from MPO Gene-Phenotype Associations)", "abnormal spinal cord lateral column morphology (MP:0009678 from MPO Gene-Phenotype Associations)", "abnormal olfactory cortex morphology (MP:0005267 from MPO Gene-Phenotype Associations)", "abnormal olfactory tract morphology (MP:0005237 from MPO Gene-Phenotype Associations)", "abnormal cerebellar peduncle morphology (MP:0009976 from MPO Gene-Phenotype Associations)", "abnormal cerebellum white matter morphology (MP:0009978 from MPO Gene-Phenotype Associations)", "increased mammary gland epithelium proliferation (MP:0010173 from MPO Gene-Phenotype Associations)", "erythrocyturia (MP:0011419 from MPO Gene-Phenotype Associations)", "abnormal globus pallidus morphology (MP:0004081 from MPO Gene-Phenotype Associations)", "decreased corticospinal tract size (MP:0012484 from MPO Gene-Phenotype Associations)", "distended duodenum (MP:0011881 from MPO Gene-Phenotype Associations)", "abnormal brain internal capsule morphology (MP:0008128 from MPO Gene-Phenotype Associations)", "absent brain internal capsule (MP:0008129 from MPO Gene-Phenotype Associations)", "optic nerve swelling (MP:0006223 from MPO Gene-Phenotype Associations)", "distended abdomen (MP:0001270 from MPO Gene-Phenotype Associations)", "meteorism (MP:0009247 from MPO Gene-Phenotype Associations)", "abnormal cardiac neural crest cell migration (MP:0012752 from MPO Gene-Phenotype Associations)", "decreased susceptibility to induction of seizure by inducing agent (MP:0012348 from MPO Gene-Phenotype Associations)", "decreased susceptibility to pharmacologically induced seizures (MP:0002887 from MPO Gene-Phenotype Associations)", "peripheral nervous system degeneration (MP:0000958 from MPO Gene-Phenotype Associations)", "cervical vertebrae degeneration (MP:0004709 from MPO Gene-Phenotype Associations)", "abnormal atrium endocardium morphology (MP:0010492 from MPO Gene-Phenotype Associations)", "abnormal behavioral response to anesthetic (MP:0009777 from MPO Gene-Phenotype Associations)", "enhanced behavioral response to anesthetic (MP:0009779 from MPO Gene-Phenotype Associations)", "impaired behavioral response to anesthetic (MP:0009778 from MPO Gene-Phenotype Associations)", "abnormal optic eminence morphology (MP:0006305 from MPO Gene-Phenotype Associations)", "rathke's pouch hypoplasia (MP:0013350 from MPO Gene-Phenotype Associations)", "increased periosteum thickness (MP:0010973 from MPO Gene-Phenotype Associations)", "thin atrioventricular cushion (MP:0000300 from MPO Gene-Phenotype Associations)", "long snout (MP:0000446 from MPO Gene-Phenotype Associations)", "abnormal periosteum morphology (MP:0010971 from MPO Gene-Phenotype Associations)", "abnormal stapes footplate morphology (MP:0004290 from MPO Gene-Phenotype Associations)", "abnormal inner ear canal fusion (MP:0002859 from MPO Gene-Phenotype Associations)", "decreased circulating bilirubin level (MP:0005635 from MPO Gene-Phenotype Associations)", "abnormal neocortex morphology (MP:0008547 from MPO Gene-Phenotype Associations)", "enlarged cranium (MP:0000439 from MPO Gene-Phenotype Associations)", "increased caudal vertebrae number (MP:0010102 from MPO Gene-Phenotype Associations)", "decreased circulating gastrin level (MP:0004732 from MPO Gene-Phenotype Associations)", "abnormal placing response (MP:0001526 from MPO Gene-Phenotype Associations)", "abnormal cochlea morphology (MP:0000031 from MPO Gene-Phenotype Associations)", "abnormal cochlear labyrinth morphology (MP:0004426 from MPO Gene-Phenotype Associations)", "abnormal scala media morphology (MP:0003169 from MPO Gene-Phenotype Associations)", "abnormal membranous labyrinth morphology (MP:0000035 from MPO Gene-Phenotype Associations)", "abnormal inner ear morphology (MP:0000026 from MPO Gene-Phenotype Associations)", "abnormal cochlear hair cell morphology (MP:0002622 from MPO Gene-Phenotype Associations)", "abnormal cochlear sensory epithelium morphology (MP:0003308 from MPO Gene-Phenotype Associations)", "abnormal organ of corti morphology (MP:0000042 from MPO Gene-Phenotype Associations)", "abnormal hair cell morphology (MP:0000045 from MPO Gene-Phenotype Associations)", "abnormal mechanoreceptor morphology (MP:0000972 from MPO Gene-Phenotype Associations)", "abnormal cochlear outer hair cell morphology (MP:0004399 from MPO Gene-Phenotype Associations)", "abnormal cochlear inner hair cell morphology (MP:0004393 from MPO Gene-Phenotype Associations)", "abnormal ear morphology (MP:0002102 from MPO Gene-Phenotype Associations)", "hearing|vestibular|ear phenotype (MP:0005377 from MPO Gene-Phenotype Associations)", "abnormal auditory brainstem response (MP:0004738 from MPO Gene-Phenotype Associations)", "abnormal hearing electrophysiology (MP:0006335 from MPO Gene-Phenotype Associations)", "increased or absent threshold for auditory brainstem response (MP:0011967 from MPO Gene-Phenotype Associations)", "abnormal ear physiology (MP:0003878 from MPO Gene-Phenotype Associations)", "abnormal hearing physiology (MP:0001963 from MPO Gene-Phenotype Associations)", "impaired hearing (MP:0006325 from MPO Gene-Phenotype Associations)", "deafness (MP:0001967 from MPO Gene-Phenotype Associations)", "cochlear hair cell degeneration (MP:0004362 from MPO Gene-Phenotype Associations)", "cochlear outer hair cell degeneration (MP:0004404 from MPO Gene-Phenotype Associations)", "cochlear inner hair cell degeneration (MP:0004398 from MPO Gene-Phenotype Associations)", "cochlear degeneration (MP:0000032 from MPO Gene-Phenotype Associations)", "organ of corti degeneration (MP:0000043 from MPO Gene-Phenotype Associations)", "abnormal cochlear ganglion morphology (MP:0002855 from MPO Gene-Phenotype Associations)", "cochlear ganglion degeneration (MP:0002857 from MPO Gene-Phenotype Associations)", "abnormal cranial ganglia morphology (MP:0001081 from MPO Gene-Phenotype Associations)", "abnormal sensory ganglion morphology (MP:0000960 from MPO Gene-Phenotype Associations)", "abnormal pinna reflex (MP:0001485 from MPO Gene-Phenotype Associations)", "absent pinna reflex (MP:0006358 from MPO Gene-Phenotype Associations)", "abnormal neuron morphology (MP:0002882 from MPO Gene-Phenotype Associations)", "abnormal sensory neuron morphology (MP:0000965 from MPO Gene-Phenotype Associations)", "abnormal somatic sensory system morphology (MP:0000959 from MPO Gene-Phenotype Associations)", "abnormal somatic nervous system morphology (MP:0002752 from MPO Gene-Phenotype Associations)", "abnormal neuron number (MP:0008946 from MPO Gene-Phenotype Associations)", "decreased neuron number (MP:0008948 from MPO Gene-Phenotype Associations)", "decreased sensory neuron number (MP:0000966 from MPO Gene-Phenotype Associations)", "neurodegeneration (MP:0002229 from MPO Gene-Phenotype Associations)", "neuron degeneration (MP:0003224 from MPO Gene-Phenotype Associations)", "abnormal cochlear hair cell number (MP:0004406 from MPO Gene-Phenotype Associations)", "decreased cochlear hair cell number (MP:0004408 from MPO Gene-Phenotype Associations)", "abnormal cochlear outer hair cell number (MP:0004400 from MPO Gene-Phenotype Associations)", "decreased cochlear outer hair cell number (MP:0004402 from MPO Gene-Phenotype Associations)", "abnormal cochlear inner hair cell number (MP:0004394 from MPO Gene-Phenotype Associations)", "decreased cochlear inner hair cell number (MP:0004396 from MPO Gene-Phenotype Associations)", "absent cochlear hair cells (MP:0004405 from MPO Gene-Phenotype Associations)", "absent cochlear outer hair cells (MP:0004403 from MPO Gene-Phenotype Associations)", "absent cochlear inner hair cells (MP:0004397 from MPO Gene-Phenotype Associations)", "abnormal inner ear vestibule morphology (MP:0000034 from MPO Gene-Phenotype Associations)", "abnormal otolith organ morphology (MP:0004425 from MPO Gene-Phenotype Associations)", "abnormal vestibular saccule morphology (MP:0006089 from MPO Gene-Phenotype Associations)", "abnormal vestibular labyrinth morphology (MP:0004427 from MPO Gene-Phenotype Associations)", "abnormal utricle morphology (MP:0006090 from MPO Gene-Phenotype Associations)", "abnormal crista ampullaris morphology (MP:0004249 from MPO Gene-Phenotype Associations)", "abnormal semicircular canal ampulla morphology (MP:0008488 from MPO Gene-Phenotype Associations)", "abnormal inner ear canal morphology (MP:0002729 from MPO Gene-Phenotype Associations)", "abnormal semicircular canal morphology (MP:0002428 from MPO Gene-Phenotype Associations)", "vestibular hair cell degeneration (MP:0004324 from MPO Gene-Phenotype Associations)", "abnormal utricular macula morphology (MP:0004333 from MPO Gene-Phenotype Associations)", "utricular macular degeneration (MP:0004334 from MPO Gene-Phenotype Associations)", "abnormal vestibular saccular macula morphology (MP:0004330 from MPO Gene-Phenotype Associations)", "vestibular saccular macula degeneration (MP:0004331 from MPO Gene-Phenotype Associations)", "abnormal crista ampullaris neuroepithelium morphology (MP:0004409 from MPO Gene-Phenotype Associations)", "vestibular ganglion degeneration (MP:0004298 from MPO Gene-Phenotype Associations)", "impaired swimming (MP:0001522 from MPO Gene-Phenotype Associations)", "abnormal stationary movement (MP:0001388 from MPO Gene-Phenotype Associations)", "abnormal head movements (MP:0000436 from MPO Gene-Phenotype Associations)", "head bobbing (MP:0001410 from MPO Gene-Phenotype Associations)", "circling (MP:0001394 from MPO Gene-Phenotype Associations)", "stereotypic behavior (MP:0001408 from MPO Gene-Phenotype Associations)", "head tossing (MP:0005307 from MPO Gene-Phenotype Associations)", "bidirectional circling (MP:0001395 from MPO Gene-Phenotype Associations)", "head shaking (MP:0002730 from MPO Gene-Phenotype Associations)", "abnormal vestibular hair cell morphology (MP:0002623 from MPO Gene-Phenotype Associations)", "abnormal vestibular hair cell stereociliary bundle morphology (MP:0004515 from MPO Gene-Phenotype Associations)", "decreased vestibular hair cell stereocilia number (MP:0004517 from MPO Gene-Phenotype Associations)", "absent startle reflex (MP:0006359 from MPO Gene-Phenotype Associations)", "abnormal otolith morphology (MP:0002894 from MPO Gene-Phenotype Associations)", "abnormal otolithic membrane morphology (MP:0002895 from MPO Gene-Phenotype Associations)", "absent otoliths (MP:0002978 from MPO Gene-Phenotype Associations)", "head tilt (MP:0005191 from MPO Gene-Phenotype Associations)", "enlarged otoliths (MP:0003143 from MPO Gene-Phenotype Associations)", "decreased otolith number (MP:0003144 from MPO Gene-Phenotype Associations)", "abnormal vestibular system physiology (MP:0004742 from MPO Gene-Phenotype Associations)", "abnormal linear vestibular evoked potential (MP:0004812 from MPO Gene-Phenotype Associations)", "absent linear vestibular evoked potential (MP:0004813 from MPO Gene-Phenotype Associations)", "reduced linear vestibular evoked potential (MP:0004814 from MPO Gene-Phenotype Associations)", "abnormal cochlear hair cell stereociliary bundle morphology (MP:0004521 from MPO Gene-Phenotype Associations)", "abnormal outer hair cell stereociliary bundle morphology (MP:0004527 from MPO Gene-Phenotype Associations)", "abnormal inner hair cell stereociliary bundle morphology (MP:0004532 from MPO Gene-Phenotype Associations)", "abnormal orientation of cochlear hair cell stereociliary bundles (MP:0004522 from MPO Gene-Phenotype Associations)", "abnormal orientation of outer hair cell stereociliary bundles (MP:0004491 from MPO Gene-Phenotype Associations)", "abnormal orientation of inner hair cell stereociliary bundles (MP:0004492 from MPO Gene-Phenotype Associations)", "abnormal kinocilium morphology (MP:0011060 from MPO Gene-Phenotype Associations)", "abnormal outer hair cell kinocilium morphology (MP:0011062 from MPO Gene-Phenotype Associations)", "decreased cochlear hair cell stereocilia number (MP:0004523 from MPO Gene-Phenotype Associations)", "decreased outer hair cell stereocilia number (MP:0004529 from MPO Gene-Phenotype Associations)", "decreased inner hair cell stereocilia number (MP:0004534 from MPO Gene-Phenotype Associations)", "abnormal cochlear hair cell inter-stereocilial links morphology (MP:0004577 from MPO Gene-Phenotype Associations)", "abnormal cochlear hair bundle tip links morphology (MP:0004578 from MPO Gene-Phenotype Associations)", "abnormal inner hair cell kinocilium morphology (MP:0011061 from MPO Gene-Phenotype Associations)", "abnormal a wave implicit time (MP:0012038 from MPO Gene-Phenotype Associations)", "abnormal erg implicit time (MP:0012033 from MPO Gene-Phenotype Associations)", "decreased a wave implicit time (MP:0012148 from MPO Gene-Phenotype Associations)", "abnormal b wave implicit time (MP:0012039 from MPO Gene-Phenotype Associations)", "decreased b wave implicit time (MP:0012149 from MPO Gene-Phenotype Associations)", "novel environmental response-related retropulsion (MP:0005357 from MPO Gene-Phenotype Associations)", "retropulsion (MP:0010323 from MPO Gene-Phenotype Associations)", "tail dragging (MP:0005507 from MPO Gene-Phenotype Associations)", "abnormal cochlear hair bundle ankle links morphology (MP:0004581 from MPO Gene-Phenotype Associations)", "absent cochlear hair bundle ankle links (MP:0004582 from MPO Gene-Phenotype Associations)", "abnormal cochlear basement membrane morphology (MP:0004598 from MPO Gene-Phenotype Associations)", "abnormal auditory summating potential (MP:0006388 from MPO Gene-Phenotype Associations)", "short cochlear outer hair cells (MP:0004466 from MPO Gene-Phenotype Associations)", "increased cochlear nerve compound action potential (MP:0004767 from MPO Gene-Phenotype Associations)", "abnormal cochlear outer hair cell electromotility (MP:0004435 from MPO Gene-Phenotype Associations)", "decreased cochlear outer hair cell electromotility (MP:0004437 from MPO Gene-Phenotype Associations)", "absent cochlear outer hair cell electromotility (MP:0004436 from MPO Gene-Phenotype Associations)", "degeneration of organ of corti supporting cells (MP:0004465 from MPO Gene-Phenotype Associations)", "abnormal claudius cell morphology (MP:0004430 from MPO Gene-Phenotype Associations)", "abnormal cochlear hair cell physiology (MP:0004432 from MPO Gene-Phenotype Associations)", "abnormal hair cell physiology (MP:0003879 from MPO Gene-Phenotype Associations)", "abnormal cochlear outer hair cell physiology (MP:0004434 from MPO Gene-Phenotype Associations)", "abnormal sensory neuron physiology (MP:0010055 from MPO Gene-Phenotype Associations)", "abnormal somatic nervous system physiology (MP:0005423 from MPO Gene-Phenotype Associations)", "abnormal cochlear microphonics (MP:0004412 from MPO Gene-Phenotype Associations)", "abnormal cochlear potential (MP:0006332 from MPO Gene-Phenotype Associations)", "absent cochlear microphonics (MP:0004413 from MPO Gene-Phenotype Associations)", "decreased cochlear microphonics (MP:0004414 from MPO Gene-Phenotype Associations)", "abnormal distortion product otoacoustic emission (MP:0004736 from MPO Gene-Phenotype Associations)", "abnormal otoacoustic response (MP:0006336 from MPO Gene-Phenotype Associations)", "absent distortion product otoacoustic emissions (MP:0004737 from MPO Gene-Phenotype Associations)", "abnormal hair cell mechanoelectric transduction (MP:0004431 from MPO Gene-Phenotype Associations)", "fused vestibular hair cell stereocilia (MP:0004516 from MPO Gene-Phenotype Associations)", "absent cochlear nerve compound action potential (MP:0004416 from MPO Gene-Phenotype Associations)", "abnormal nervous system electrophysiology (MP:0002272 from MPO Gene-Phenotype Associations)", "abnormal action potential (MP:0005402 from MPO Gene-Phenotype Associations)", "abnormal cochlear nerve compound action potential (MP:0004415 from MPO Gene-Phenotype Associations)", "decreased cochlear nerve compound action potential (MP:0004417 from MPO Gene-Phenotype Associations)", "abnormal tectorial membrane morphology (MP:0003149 from MPO Gene-Phenotype Associations)", "detached tectorial membrane (MP:0003150 from MPO Gene-Phenotype Associations)", "enlarged tectorial membrane (MP:0004591 from MPO Gene-Phenotype Associations)", "abnormal cochlear frequency tuning (MP:0006383 from MPO Gene-Phenotype Associations)", "enhanced cochlear frequency tuning (MP:0006384 from MPO Gene-Phenotype Associations)", "absent outer hair cell stereocilia (MP:0004530 from MPO Gene-Phenotype Associations)", "increased vestibular hair cell number (MP:0004327 from MPO Gene-Phenotype Associations)", "absent neutrophils (MP:0011689 from MPO Gene-Phenotype Associations)", "absent inner hair cell stereocilia (MP:0004535 from MPO Gene-Phenotype Associations)", "abnormal cuticular plate morphology (MP:0010015 from MPO Gene-Phenotype Associations)", "small rosenthal canal (MP:0004306 from MPO Gene-Phenotype Associations)", "abnormal vestibular hair cell development (MP:0004588 from MPO Gene-Phenotype Associations)", "absent deiters cells (MP:0004590 from MPO Gene-Phenotype Associations)", "absent cochlear hair cell stereocilia (MP:0004526 from MPO Gene-Phenotype Associations)", "abnormal organ of corti supporting cell differentiation (MP:0008304 from MPO Gene-Phenotype Associations)", "abnormal pillar cell differentiation (MP:0003152 from MPO Gene-Phenotype Associations)", "absent vestibular hair cell stereocilia (MP:0004518 from MPO Gene-Phenotype Associations)", "abnormal basilar membrane morphology (MP:0004308 from MPO Gene-Phenotype Associations)", "absent pillar cells (MP:0004312 from MPO Gene-Phenotype Associations)", "absent tunnel of corti (MP:0003151 from MPO Gene-Phenotype Associations)", "abnormal organ of corti supporting cell number (MP:0004496 from MPO Gene-Phenotype Associations)", "decreased organ of corti supporting cell number (MP:0004497 from MPO Gene-Phenotype Associations)", "absent organ of corti supporting cells (MP:0004301 from MPO Gene-Phenotype Associations)", "abnormal vestibular hair cell number (MP:0004326 from MPO Gene-Phenotype Associations)", "decreased vestibular hair cell number (MP:0004328 from MPO Gene-Phenotype Associations)", "absent vestibular hair cells (MP:0004325 from MPO Gene-Phenotype Associations)", "abnormal cochlear hair cell development (MP:0004589 from MPO Gene-Phenotype Associations)", "abnormal organ of corti supporting cell morphology (MP:0004300 from MPO Gene-Phenotype Associations)", "abnormal pillar cell morphology (MP:0003825 from MPO Gene-Phenotype Associations)", "pillar cell degeneration (MP:0004586 from MPO Gene-Phenotype Associations)", "fused outer hair cell stereocilia (MP:0004528 from MPO Gene-Phenotype Associations)", "fused inner hair cell stereocilia (MP:0004533 from MPO Gene-Phenotype Associations)", "short cochlear hair cell stereocilia (MP:0004524 from MPO Gene-Phenotype Associations)", "short outer hair cell stereocilia (MP:0004531 from MPO Gene-Phenotype Associations)", "short inner hair cell stereocilia (MP:0004536 from MPO Gene-Phenotype Associations)", "abnormal vestibular hair bundle inter-stereocilial links (MP:0004583 from MPO Gene-Phenotype Associations)", "abnormal vestibular hair bundle shaft connectors (MP:0004584 from MPO Gene-Phenotype Associations)", "absent vestibular hair bundle shaft connectors (MP:0004585 from MPO Gene-Phenotype Associations)", "thin cochlear hair cell stereocilia (MP:0004525 from MPO Gene-Phenotype Associations)", "thin vestibular hair cell stereocilia (MP:0004519 from MPO Gene-Phenotype Associations)", "absent inner hair cell kinocilia (MP:0011063 from MPO Gene-Phenotype Associations)", "abnormal patterning of the organ of corti (MP:0006331 from MPO Gene-Phenotype Associations)", "abnormal interdental cell morphology (MP:0004482 from MPO Gene-Phenotype Associations)", "abnormal boettcher cell morphology (MP:0011739 from MPO Gene-Phenotype Associations)", "remittent intestinal hemorrhage (MP:0000510 from MPO Gene-Phenotype Associations)", "small intestinal prolapse (MP:0000500 from MPO Gene-Phenotype Associations)", "abnormal sulcus ampullaris morphology (MP:0000046 from MPO Gene-Phenotype Associations)", "utricular degeneration (MP:0004332 from MPO Gene-Phenotype Associations)", "vestibular saccular degeneration (MP:0004329 from MPO Gene-Phenotype Associations)", "spinning (MP:0001411 from MPO Gene-Phenotype Associations)", "abnormal vestibular dark cell morphology (MP:0004775 from MPO Gene-Phenotype Associations)", "vestibular dark cell degeneration (MP:0004776 from MPO Gene-Phenotype Associations)", "absent vestibuloocular reflex (MP:0004845 from MPO Gene-Phenotype Associations)", "abnormal vestibuloocular reflex (MP:0004844 from MPO Gene-Phenotype Associations)", "abnormal reissner membrane morphology (MP:0006021 from MPO Gene-Phenotype Associations)", "collapsed reissner membrane (MP:0006024 from MPO Gene-Phenotype Associations)", "abnormal otic pigmentation (MP:0009390 from MPO Gene-Phenotype Associations)", "abnormal strial intermediate cell morphology (MP:0004367 from MPO Gene-Phenotype Associations)", "thin stria vascularis (MP:0004364 from MPO Gene-Phenotype Associations)", "abnormal strial basal cell morphology (MP:0004365 from MPO Gene-Phenotype Associations)", "abnormal strial marginal cell morphology (MP:0004366 from MPO Gene-Phenotype Associations)", "abnormal stria vascularis vasculature morphology (MP:0004368 from MPO Gene-Phenotype Associations)", "abnormal stria vascularis morphology (MP:0000048 from MPO Gene-Phenotype Associations)", "stria vascularis degeneration (MP:0004363 from MPO Gene-Phenotype Associations)", "abnormal cochlear endolymph (MP:0006390 from MPO Gene-Phenotype Associations)", "abnormal endocochlear potential (MP:0002630 from MPO Gene-Phenotype Associations)", "abnormal endolymph (MP:0004885 from MPO Gene-Phenotype Associations)", "decreased endocochlear potential (MP:0004411 from MPO Gene-Phenotype Associations)", "absent endocochlear potential (MP:0004410 from MPO Gene-Phenotype Associations)", "abnormal cochlear endolymph ionic homeostasis (MP:0006403 from MPO Gene-Phenotype Associations)", "abnormal type ii spiral ligament fibrocytes (MP:0004294 from MPO Gene-Phenotype Associations)", "abnormal spiral limbus morphology (MP:0004287 from MPO Gene-Phenotype Associations)", "distended reissner membrane (MP:0006025 from MPO Gene-Phenotype Associations)", "abnormal scala tympani morphology (MP:0003167 from MPO Gene-Phenotype Associations)", "small scala tympani (MP:0004862 from MPO Gene-Phenotype Associations)", "detached reissner membrane (MP:0006023 from MPO Gene-Phenotype Associations)", "abnormal internal auditory canal morphology (MP:0004286 from MPO Gene-Phenotype Associations)", "abnormal oval window morphology (MP:0004479 from MPO Gene-Phenotype Associations)", "type ii spiral ligament fibrocyte degeneration (MP:0004488 from MPO Gene-Phenotype Associations)", "thin spiral ligament (MP:0004863 from MPO Gene-Phenotype Associations)", "abnormal vestibular aqueduct morphology (MP:0009821 from MPO Gene-Phenotype Associations)", "enlarged vestibular saccule (MP:0004316 from MPO Gene-Phenotype Associations)", "abnormal urine ammonia level (MP:0011734 from MPO Gene-Phenotype Associations)", "increased urine ammonia level (MP:0011735 from MPO Gene-Phenotype Associations)", "dilated scala media (MP:0008309 from MPO Gene-Phenotype Associations)", "dilated cochlea (MP:0004493 from MPO Gene-Phenotype Associations)", "nonsyndromic hearing impairment (MP:0006328 from MPO Gene-Phenotype Associations)", "nonsyndromic hearing loss (MP:0004749 from MPO Gene-Phenotype Associations)", "increased circulating bicarbonate level (MP:0003016 from MPO Gene-Phenotype Associations)", "abnormal ligament morphology (MP:0005504 from MPO Gene-Phenotype Associations)", "abnormal spiral ligament fibrocyte morphology (MP:0004292 from MPO Gene-Phenotype Associations)", "abnormal spiral ligament morphology (MP:0004288 from MPO Gene-Phenotype Associations)", "abnormal type iv spiral ligament fibrocytes (MP:0004296 from MPO Gene-Phenotype Associations)", "type iv spiral ligament fibrocyte degeneration (MP:0004490 from MPO Gene-Phenotype Associations)", "sensorineural hearing impairment (MP:0006329 from MPO Gene-Phenotype Associations)", "sensorineural hearing loss (MP:0004740 from MPO Gene-Phenotype Associations)", "abnormal auditory brainstem response waveform shape (MP:0011966 from MPO Gene-Phenotype Associations)", "abnormal type iii spiral ligament fibrocytes (MP:0004295 from MPO Gene-Phenotype Associations)", "spinal cord degeneration (MP:0012712 from MPO Gene-Phenotype Associations)", "type iii spiral ligament fibrocyte degeneration (MP:0004489 from MPO Gene-Phenotype Associations)", "abnormal type i spiral ligament fibrocytes (MP:0004293 from MPO Gene-Phenotype Associations)", "type i spiral ligament fibrocyte degeneration (MP:0004487 from MPO Gene-Phenotype Associations)", "limp posture (MP:0001506 from MPO Gene-Phenotype Associations)", "akinesia (MP:0002690 from MPO Gene-Phenotype Associations)", "small inguinal lymph nodes (MP:0009624 from MPO Gene-Phenotype Associations)", "impaired humoral immune response (MP:0020154 from MPO Gene-Phenotype Associations)", "abnormal susceptibility to hearing loss (MP:0006334 from MPO Gene-Phenotype Associations)", "increased susceptibility to age-related hearing loss (MP:0004748 from MPO Gene-Phenotype Associations)", "increased susceptibility to noise-induced hearing loss (MP:0004597 from MPO Gene-Phenotype Associations)", "abnormal purkinje cell innervation (MP:0003894 from MPO Gene-Phenotype Associations)", "abnormal trigeminal motor nucleus morphology (MP:0000911 from MPO Gene-Phenotype Associations)", "titubation (MP:0009514 from MPO Gene-Phenotype Associations)", "weaving (MP:0008913 from MPO Gene-Phenotype Associations)", "small trigeminal motor nucleus (MP:0000912 from MPO Gene-Phenotype Associations)", "decreased spinal cord ventral horn cell number (MP:0005113 from MPO Gene-Phenotype Associations)", "abnormal resting posture (MP:0009393 from MPO Gene-Phenotype Associations)", "jerky movement (MP:0005424 from MPO Gene-Phenotype Associations)", "increased spinal cord size (MP:0002809 from MPO Gene-Phenotype Associations)", "increased embryonic neuroepithelial cell proliferation (MP:0012705 from MPO Gene-Phenotype Associations)", "abnormal autophagy (MP:0008260 from MPO Gene-Phenotype Associations)", "abnormal stylohyoid ligament morphology (MP:0009918 from MPO Gene-Phenotype Associations)", "absent meckel's cartilage (MP:0004439 from MPO Gene-Phenotype Associations)", "otic capsule hypoplasia (MP:0006289 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb granule cell morphology (MP:0009942 from MPO Gene-Phenotype Associations)", "cleft primary palate (MP:0009893 from MPO Gene-Phenotype Associations)", "abnormal lacrimal bone morphology (MP:0005271 from MPO Gene-Phenotype Associations)", "ectopic cartilage (MP:0003869 from MPO Gene-Phenotype Associations)", "abnormal mitral cell morphology (MP:0009954 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb mitral cell layer morphology (MP:0009951 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb external plexiform layer morphology (MP:0009947 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb tufted cell morphology (MP:0009955 from MPO Gene-Phenotype Associations)", "olfactory bulb hypoplasia (MP:0010059 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb glomerular layer morphology (MP:0009948 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb layer morphology (MP:0009946 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb periglomerular cell morphology (MP:0009943 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb interneuron morphology (MP:0009941 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb morphology (MP:0000819 from MPO Gene-Phenotype Associations)", "abnormal olfactory lobe morphology (MP:0009944 from MPO Gene-Phenotype Associations)", "small olfactory bulb (MP:0002741 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb development (MP:0002739 from MPO Gene-Phenotype Associations)", "abnormal rostral migratory stream morphology (MP:0004279 from MPO Gene-Phenotype Associations)", "abnormal postnatal subventricular zone morphology (MP:0004275 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb granule cell layer morphology (MP:0009949 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb subventricular zone morphology (MP:0009952 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb internal plexiform layer morphology (MP:0009950 from MPO Gene-Phenotype Associations)", "absent cerebellar granule cells (MP:0009958 from MPO Gene-Phenotype Associations)", "increased interleukin-1 secretion (MP:0008651 from MPO Gene-Phenotype Associations)", "abnormal duvet hair morphology (MP:0000407 from MPO Gene-Phenotype Associations)", "absent duvet hair (MP:0000408 from MPO Gene-Phenotype Associations)", "abnormal olfactory bulb outer nerve layer morphology (MP:0010057 from MPO Gene-Phenotype Associations)", "delayed estrous cycle (MP:0009008 from MPO Gene-Phenotype Associations)", "decreased cerebellar granule cell number (MP:0008924 from MPO Gene-Phenotype Associations)", "absent cerebellar granule layer (MP:0000888 from MPO Gene-Phenotype Associations)", "abnormal purkinje cell differentiation (MP:0008579 from MPO Gene-Phenotype Associations)", "abnormal cerebellar granule cell proliferation (MP:0009968 from MPO Gene-Phenotype Associations)", "thymus atrophy (MP:0003644 from MPO Gene-Phenotype Associations)", "spleen atrophy (MP:0003643 from MPO Gene-Phenotype Associations)", "absent malleus manubrium (MP:0008377 from MPO Gene-Phenotype Associations)", "aerophagia (MP:0010994 from MPO Gene-Phenotype Associations)", "small floor plate (MP:0000927 from MPO Gene-Phenotype Associations)", "abnormal spinal cord ependymal layer morphology (MP:0010151 from MPO Gene-Phenotype Associations)", "abnormal spinal cord motile cilium morphology (MP:0011058 from MPO Gene-Phenotype Associations)", "absent subcommissural organ (MP:0009717 from MPO Gene-Phenotype Associations)", "abnormal axon initial segment morphology (MP:0010733 from MPO Gene-Phenotype Associations)", "cerebral aqueductal stenosis (MP:0002958 from MPO Gene-Phenotype Associations)", "obstructive hydrocephaly (MP:0000917 from MPO Gene-Phenotype Associations)", "abnormal cerebral aqueduct morphology (MP:0005537 from MPO Gene-Phenotype Associations)", "decreased striatum area (MP:0012468 from MPO Gene-Phenotype Associations)", "abnormal brain ependyma motile cilium physiology (MP:0011069 from MPO Gene-Phenotype Associations)", "abnormal ependyma motile cilium physiology (MP:0011068 from MPO Gene-Phenotype Associations)", "abnormal brain ependyma morphology (MP:0010152 from MPO Gene-Phenotype Associations)", "abnormal ependyma morphology (MP:0002653 from MPO Gene-Phenotype Associations)", "abnormal brain ependyma motile cilium morphology (MP:0011056 from MPO Gene-Phenotype Associations)", "abnormal ependyma motile cilium morphology (MP:0011059 from MPO Gene-Phenotype Associations)", "abnormal brain ventricle morphology (MP:0000822 from MPO Gene-Phenotype Associations)", "abnormal brain ventricular system morphology (MP:0002200 from MPO Gene-Phenotype Associations)", "abnormal lateral ventricle morphology (MP:0000823 from MPO Gene-Phenotype Associations)", "abnormal brain ventricle size (MP:0013229 from MPO Gene-Phenotype Associations)", "enlarged brain ventricles (MP:0011380 from MPO Gene-Phenotype Associations)", "enlarged lateral ventricles (MP:0008535 from MPO Gene-Phenotype Associations)", "enlarged third ventricle (MP:0008536 from MPO Gene-Phenotype Associations)", "dilated lateral ventricles (MP:0000825 from MPO Gene-Phenotype Associations)", "dilated brain ventricles (MP:0012676 from MPO Gene-Phenotype Associations)", "dilated third ventricle (MP:0000827 from MPO Gene-Phenotype Associations)", "abnormal third ventricle morphology (MP:0000826 from MPO Gene-Phenotype Associations)", "hydroencephaly (MP:0001891 from MPO Gene-Phenotype Associations)", "domed cranium (MP:0000440 from MPO Gene-Phenotype Associations)", "abnormal choroid plexus morphology (MP:0000820 from MPO Gene-Phenotype Associations)", "abnormal tela choroidea morphology (MP:0013306 from MPO Gene-Phenotype Associations)", "abnormal fourth ventricle morphology (MP:0000828 from MPO Gene-Phenotype Associations)", "dilated fourth ventricle (MP:0000829 from MPO Gene-Phenotype Associations)", "enlarged fourth ventricle (MP:0008534 from MPO Gene-Phenotype Associations)", "cerebellum vermis hypoplasia (MP:0000866 from MPO Gene-Phenotype Associations)", "abnormal interventricular foramen morphology (MP:0009804 from MPO Gene-Phenotype Associations)", "abnormal cerebellum lateral hemisphere morphology (MP:0009965 from MPO Gene-Phenotype Associations)", "abnormal cerebellar hemisphere morphology (MP:0009959 from MPO Gene-Phenotype Associations)", "absent cerebellum vermis (MP:0000865 from MPO Gene-Phenotype Associations)", "abnormal cerebellar plate morphology (MP:0000856 from MPO Gene-Phenotype Associations)", "cerebellum hypoplasia (MP:0000851 from MPO Gene-Phenotype Associations)", "abnormal cingulate gyrus morphology (MP:0004167 from MPO Gene-Phenotype Associations)", "abnormal retrosplenial region morphology (MP:0012489 from MPO Gene-Phenotype Associations)", "bronchiectasis (MP:0011012 from MPO Gene-Phenotype Associations)", "abnormal embryonic cilium location or orientation (MP:0012027 from MPO Gene-Phenotype Associations)", "abnormal primary cilium physiology (MP:0013210 from MPO Gene-Phenotype Associations)", "abnormal motile primary cilium physiology (MP:0008933 from MPO Gene-Phenotype Associations)", "absent nodal flow (MP:0012093 from MPO Gene-Phenotype Associations)", "absent brain ependyma motile cilia (MP:0011057 from MPO Gene-Phenotype Associations)", "absent respiratory motile cilia (MP:0011054 from MPO Gene-Phenotype Associations)", "absent oviduct epithelium motile cilium (MP:0011645 from MPO Gene-Phenotype Associations)", "abnormal oviduct epithelium motile cilium morphology (MP:0011644 from MPO Gene-Phenotype Associations)", "increased alveolar lamellar body number (MP:0010891 from MPO Gene-Phenotype Associations)", "abnormal lung tissue damping (MP:0011046 from MPO Gene-Phenotype Associations)", "increased lung tissue damping (MP:0011047 from MPO Gene-Phenotype Associations)", "abnormal respiratory motile cilium number (MP:0011051 from MPO Gene-Phenotype Associations)", "decreased respiratory motile cilia number (MP:0011053 from MPO Gene-Phenotype Associations)", "abnormal respiratory motile cilium morphology (MP:0011050 from MPO Gene-Phenotype Associations)", "sinus inflammation (MP:0001872 from MPO Gene-Phenotype Associations)", "abnormal rhombomere 1 morphology (MP:0012784 from MPO Gene-Phenotype Associations)", "decreased rhombomere 1 size (MP:0012785 from MPO Gene-Phenotype Associations)", "absent midbrain-hindbrain boundary (MP:0012133 from MPO Gene-Phenotype Associations)", "absent cerebellum (MP:0000850 from MPO Gene-Phenotype Associations)", "cornea ulcer (MP:0009825 from MPO Gene-Phenotype Associations)", "abnormal limb position (MP:0012000 from MPO Gene-Phenotype Associations)", "absence of all nails (MP:0008494 from MPO Gene-Phenotype Associations)", "abnormal pretectal region morphology (MP:0009637 from MPO Gene-Phenotype Associations)", "decreased superior colliculus size (MP:0002892 from MPO Gene-Phenotype Associations)", "small tectum (MP:0006105 from MPO Gene-Phenotype Associations)", "abnormal patella morphology (MP:0005353 from MPO Gene-Phenotype Associations)", "absent patella (MP:0004694 from MPO Gene-Phenotype Associations)", "absent ilium (MP:0004688 from MPO Gene-Phenotype Associations)", "diastematomyelia (MP:0012710 from MPO Gene-Phenotype Associations)", "enlarged tectum (MP:0009048 from MPO Gene-Phenotype Associations)", "increased superior colliculus size (MP:0000905 from MPO Gene-Phenotype Associations)", "increased inferior colliculus size (MP:0000777 from MPO Gene-Phenotype Associations)", "abnormal midbrain-hindbrain boundary development (MP:0004096 from MPO Gene-Phenotype Associations)", "abnormal midbrain-hindbrain boundary morphology (MP:0012132 from MPO Gene-Phenotype Associations)", "abnormal brainstem morphology (MP:0005277 from MPO Gene-Phenotype Associations)", "abnormal midbrain morphology (MP:0000897 from MPO Gene-Phenotype Associations)", "abnormal corpora quadrigemina morphology (MP:0000899 from MPO Gene-Phenotype Associations)", "abnormal midbrain roof plate morphology (MP:0006103 from MPO Gene-Phenotype Associations)", "abnormal tectum morphology (MP:0006104 from MPO Gene-Phenotype Associations)", "abnormal inferior colliculus morphology (MP:0000776 from MPO Gene-Phenotype Associations)", "decreased inferior colliculus size (MP:0009038 from MPO Gene-Phenotype Associations)", "abnormal superior colliculus morphology (MP:0000904 from MPO Gene-Phenotype Associations)", "abnormal oculomotor nerve morphology (MP:0001061 from MPO Gene-Phenotype Associations)", "abnormal trochlear nerve morphology (MP:0001063 from MPO Gene-Phenotype Associations)", "absent trochlear nerve (MP:0001064 from MPO Gene-Phenotype Associations)", "abnormal epithalamus morphology (MP:0000840 from MPO Gene-Phenotype Associations)", "abnormal habenula morphology (MP:0004082 from MPO Gene-Phenotype Associations)", "absent oculomotor nerve (MP:0001062 from MPO Gene-Phenotype Associations)", "ectopic dopaminergic neuron (MP:0011450 from MPO Gene-Phenotype Associations)", "truncation of digits (MP:0000567 from MPO Gene-Phenotype Associations)", "decreased anterior vermis size (MP:0000868 from MPO Gene-Phenotype Associations)", "abnormal digit pigmentation (MP:0000569 from MPO Gene-Phenotype Associations)", "absent inferior colliculus (MP:0009039 from MPO Gene-Phenotype Associations)", "ectopic digits (MP:0000568 from MPO Gene-Phenotype Associations)", "retina coloboma (MP:0010715 from MPO Gene-Phenotype Associations)", "absent fourth ventricle (MP:0012678 from MPO Gene-Phenotype Associations)", "absent cerebral aqueduct (MP:0013000 from MPO Gene-Phenotype Associations)", "increased hindbrain size (MP:0012265 from MPO Gene-Phenotype Associations)", "increased embryonic neuroepithelium apoptosis (MP:0012701 from MPO Gene-Phenotype Associations)", "increased neural tube apoptosis (MP:0012505 from MPO Gene-Phenotype Associations)", "abnormal brain size (MP:0000771 from MPO Gene-Phenotype Associations)", "decreased brain size (MP:0000774 from MPO Gene-Phenotype Associations)", "abnormal brain weight (MP:0012775 from MPO Gene-Phenotype Associations)", "decreased brain weight (MP:0002175 from MPO Gene-Phenotype Associations)", "increased brain size (MP:0005238 from MPO Gene-Phenotype Associations)", "increased brain weight (MP:0002176 from MPO Gene-Phenotype Associations)", "abnormal forebrain size (MP:0012137 from MPO Gene-Phenotype Associations)", "decreased forebrain size (MP:0012138 from MPO Gene-Phenotype Associations)", "forebrain hypoplasia (MP:0000784 from MPO Gene-Phenotype Associations)", "abnormal midbrain size (MP:0012088 from MPO Gene-Phenotype Associations)", "decreased midbrain size (MP:0012089 from MPO Gene-Phenotype Associations)", "midbrain hypoplasia (MP:0012090 from MPO Gene-Phenotype Associations)", "hindbrain hypoplasia (MP:0012264 from MPO Gene-Phenotype Associations)", "abnormal hindbrain size (MP:0012262 from MPO Gene-Phenotype Associations)", "decreased hindbrain size (MP:0012263 from MPO Gene-Phenotype Associations)", "abnormal cochlear ihc afferent innervation pattern (MP:0004746 from MPO Gene-Phenotype Associations)", "abnormal vertical vestibuloocular reflex (MP:0011041 from MPO Gene-Phenotype Associations)", "abnormal cochlear ohc efferent innervation pattern (MP:0004632 from MPO Gene-Phenotype Associations)", "vestibular ganglion hypoplasia (MP:0006409 from MPO Gene-Phenotype Associations)", "abnormal cerebellum vermis lobule iv morphology (MP:0009991 from MPO Gene-Phenotype Associations)", "abnormal cerebellum vermis lobule v morphology (MP:0009993 from MPO Gene-Phenotype Associations)", "abnormal cerebellum vermis lobule vii morphology (MP:0009995 from MPO Gene-Phenotype Associations)", "abnormal cerebellum vermis lobule vi morphology (MP:0009994 from MPO Gene-Phenotype Associations)", "abnormal cerebellum vermis lobule ii morphology (MP:0009989 from MPO Gene-Phenotype Associations)", "abnormal cerebellum vermis lobule iii morphology (MP:0009990 from MPO Gene-Phenotype Associations)", "abnormal cerebellum vermis lobule i morphology (MP:0009988 from MPO Gene-Phenotype Associations)", "abnormal cerebellum anterior lobe morphology (MP:0009960 from MPO Gene-Phenotype Associations)", "abnormal cerebellum anterior vermis morphology (MP:0000867 from MPO Gene-Phenotype Associations)", "abnormal cerebellum vermis morphology (MP:0000864 from MPO Gene-Phenotype Associations)", "abnormal cerebellum vermis lobule morphology (MP:0009957 from MPO Gene-Phenotype Associations)", "abnormal cerebellum posterior lobe morphology (MP:0009962 from MPO Gene-Phenotype Associations)", "abnormal cerebellum posterior vermis morphology (MP:0000869 from MPO Gene-Phenotype Associations)", "abnormal cerebellum vermis lobule x morphology (MP:0009997 from MPO Gene-Phenotype Associations)", "abnormal flocculonodular lobe morphology (MP:0009961 from MPO Gene-Phenotype Associations)", "abnormal hair shaft melanin granule distribution (MP:0008733 from MPO Gene-Phenotype Associations)", "neurofibrillary tangles (MP:0003214 from MPO Gene-Phenotype Associations)", "delaminated cerebellar granule layer (MP:0000887 from MPO Gene-Phenotype Associations)", "abnormal cerebellum vermis lobule viii morphology (MP:0009996 from MPO Gene-Phenotype Associations)", "absent cerebellum vermis lobule viii (MP:0000870 from MPO Gene-Phenotype Associations)", "absent cerebellum vermis lobule ix (MP:0000871 from MPO Gene-Phenotype Associations)", "abnormal nail matrix morphology (MP:0012405 from MPO Gene-Phenotype Associations)", "abnormal cerebellum vermis lobule ix morphology (MP:0009992 from MPO Gene-Phenotype Associations)", "ameloblast degeneration (MP:0000129 from MPO Gene-Phenotype Associations)", "degenerate molars (MP:0000127 from MPO Gene-Phenotype Associations)", "delayed hair regrowth (MP:0000423 from MPO Gene-Phenotype Associations)", "frontal bone foramen (MP:0004378 from MPO Gene-Phenotype Associations)", "abnormal hair shedding (MP:0008861 from MPO Gene-Phenotype Associations)", "abnormal nail morphology (MP:0000579 from MPO Gene-Phenotype Associations)", "deformed nails (MP:0000580 from MPO Gene-Phenotype Associations)", "long nails (MP:0012401 from MPO Gene-Phenotype Associations)", "long toenails (MP:0000583 from MPO Gene-Phenotype Associations)", "abnormal posterior primitive streak morphology (MP:0012740 from MPO Gene-Phenotype Associations)", "abnormal lateral plate mesoderm morphology (MP:0010117 from MPO Gene-Phenotype Associations)", "abnormal extraembryonic mesoderm development (MP:0006323 from MPO Gene-Phenotype Associations)", "absent trabecular meshwork (MP:0004224 from MPO Gene-Phenotype Associations)", "cortical cataracts (MP:0010255 from MPO Gene-Phenotype Associations)", "anterior cortical cataracts (MP:0010256 from MPO Gene-Phenotype Associations)", "partial atrioventricular septal defect (MP:0010414 from MPO Gene-Phenotype Associations)", "abnormal vestibulocollic reflex (MP:0006377 from MPO Gene-Phenotype Associations)", "abnormal ureteral orifice morphology (MP:0011783 from MPO Gene-Phenotype Associations)", "absent schlemm's canal (MP:0004226 from MPO Gene-Phenotype Associations)", "abnormal cardiac mesenchyme morphology (MP:0011264 from MPO Gene-Phenotype Associations)", "abnormal line of schwalbe morphology (MP:0006250 from MPO Gene-Phenotype Associations)", "ectopic ureter (MP:0011486 from MPO Gene-Phenotype Associations)", "ectopic ureteric bud (MP:0010980 from MPO Gene-Phenotype Associations)", "bifid ureter (MP:0003584 from MPO Gene-Phenotype Associations)", "opacity of vitreous body (MP:0002700 from MPO Gene-Phenotype Associations)", "abnormal ventral body wall morphology (MP:0003384 from MPO Gene-Phenotype Associations)", "failure of ventral body wall closure (MP:0013283 from MPO Gene-Phenotype Associations)", "abnormal anterior uvea morphology (MP:0005194 from MPO Gene-Phenotype Associations)", "abnormal iris morphology (MP:0001322 from MPO Gene-Phenotype Associations)", "abnormal uvea morphology (MP:0005197 from MPO Gene-Phenotype Associations)", "abnormal pupil morphology (MP:0001317 from MPO Gene-Phenotype Associations)", "mydriasis (MP:0002546 from MPO Gene-Phenotype Associations)", "abnormal placement of pupils (MP:0006241 from MPO Gene-Phenotype Associations)", "abnormal iris stroma morphology (MP:0005208 from MPO Gene-Phenotype Associations)", "iris stroma hypoplasia (MP:0006230 from MPO Gene-Phenotype Associations)", "iris hypoplasia (MP:0006226 from MPO Gene-Phenotype Associations)", "anterior iris synechia (MP:0011481 from MPO Gene-Phenotype Associations)", "iris synechia (MP:0004222 from MPO Gene-Phenotype Associations)", "abnormal aqueous drainage system morphology (MP:0005198 from MPO Gene-Phenotype Associations)", "abnormal iridocorneal angle (MP:0004221 from MPO Gene-Phenotype Associations)", "abnormal trabecular meshwork morphology (MP:0005203 from MPO Gene-Phenotype Associations)", "abnormal canal of schlemm morphology (MP:0005204 from MPO Gene-Phenotype Associations)", "hypoplastic trabecular meshwork (MP:0004223 from MPO Gene-Phenotype Associations)", "abnormal ciliary body morphology (MP:0005099 from MPO Gene-Phenotype Associations)", "pathological neovascularization (MP:0003711 from MPO Gene-Phenotype Associations)", "corneal vascularization (MP:0005542 from MPO Gene-Phenotype Associations)", "abnormal cornea morphology (MP:0001312 from MPO Gene-Phenotype Associations)", "corneal opacity (MP:0001314 from MPO Gene-Phenotype Associations)", "abnormal corneal stroma morphology (MP:0005300 from MPO Gene-Phenotype Associations)", "abnormal corneal epithelium morphology (MP:0006000 from MPO Gene-Phenotype Associations)", "increased incidence of corneal inflammation (MP:0001313 from MPO Gene-Phenotype Associations)", "abnormal urogenital fold morphology (MP:0011835 from MPO Gene-Phenotype Associations)", "abnormal right renal artery morphology (MP:0011318 from MPO Gene-Phenotype Associations)", "abnormal renal artery morphology (MP:0011317 from MPO Gene-Phenotype Associations)", "abnormal lacrimal gland development (MP:0013331 from MPO Gene-Phenotype Associations)", "abnormal sternum body morphology (MP:0012512 from MPO Gene-Phenotype Associations)", "absent sternum body (MP:0012513 from MPO Gene-Phenotype Associations)", "absent epiglottis (MP:0013261 from MPO Gene-Phenotype Associations)", "failure of endochondral bone ossification (MP:0008275 from MPO Gene-Phenotype Associations)", "short oviduct (MP:0009071 from MPO Gene-Phenotype Associations)", "abnormal arytenoid cartilage morphology (MP:0002257 from MPO Gene-Phenotype Associations)", "absent sternum (MP:0000158 from MPO Gene-Phenotype Associations)", "increased cornea thickness (MP:0011962 from MPO Gene-Phenotype Associations)", "failure of sternum ossification (MP:0008278 from MPO Gene-Phenotype Associations)", "failure of bone ossification (MP:0008274 from MPO Gene-Phenotype Associations)", "failure of intramembranous bone ossification (MP:0008276 from MPO Gene-Phenotype Associations)", "non-obstructive hydrocephaly (MP:0001893 from MPO Gene-Phenotype Associations)", "oocyte degeneration (MP:0009093 from MPO Gene-Phenotype Associations)", "polyovular ovarian follicle (MP:0009433 from MPO Gene-Phenotype Associations)", "abnormal reichert's cartilage morphology (MP:0004915 from MPO Gene-Phenotype Associations)", "absent reichert cartilage (MP:0004916 from MPO Gene-Phenotype Associations)", "absent reichert's membrane (MP:0011116 from MPO Gene-Phenotype Associations)", "abnormal retina inner limiting membrane morphology (MP:0010235 from MPO Gene-Phenotype Associations)", "retinal spots (MP:0012671 from MPO Gene-Phenotype Associations)", "irregularly shaped pupil (MP:0001319 from MPO Gene-Phenotype Associations)", "buphthalmos (MP:0009274 from MPO Gene-Phenotype Associations)", "macrophthalmia (MP:0001296 from MPO Gene-Phenotype Associations)", "vitreal fibroplasia (MP:0003381 from MPO Gene-Phenotype Associations)", "sutural cataracts (MP:0010261 from MPO Gene-Phenotype Associations)", "delaminated cerebral cortex (MP:0000791 from MPO Gene-Phenotype Associations)", "abnormal brain pia mater morphology (MP:0009026 from MPO Gene-Phenotype Associations)", "subcapsular cataracts (MP:0010251 from MPO Gene-Phenotype Associations)", "anterior subcapsular cataracts (MP:0010252 from MPO Gene-Phenotype Associations)", "abnormal meninges morphology (MP:0005623 from MPO Gene-Phenotype Associations)", "abnormal brain meninges morphology (MP:0009022 from MPO Gene-Phenotype Associations)", "abnormal brain dura mater morphology (MP:0009025 from MPO Gene-Phenotype Associations)", "abnormal anterior eye segment morphology (MP:0005193 from MPO Gene-Phenotype Associations)", "abnormal lens morphology (MP:0001303 from MPO Gene-Phenotype Associations)", "cataracts (MP:0001304 from MPO Gene-Phenotype Associations)", "small lens (MP:0001306 from MPO Gene-Phenotype Associations)", "abnormal eye development (MP:0001286 from MPO Gene-Phenotype Associations)", "abnormal lens development (MP:0005545 from MPO Gene-Phenotype Associations)", "abnormal lens induction (MP:0001288 from MPO Gene-Phenotype Associations)", "abnormal lens vesicle development (MP:0001292 from MPO Gene-Phenotype Associations)", "aphakia (MP:0003078 from MPO Gene-Phenotype Associations)", "abnormal eye size (MP:0002697 from MPO Gene-Phenotype Associations)", "microphthalmia (MP:0001297 from MPO Gene-Phenotype Associations)", "anophthalmia (MP:0001293 from MPO Gene-Phenotype Associations)", "vacuolated lens (MP:0011697 from MPO Gene-Phenotype Associations)", "total cataracts (MP:0010263 from MPO Gene-Phenotype Associations)", "abnormal lens capsule morphology (MP:0003236 from MPO Gene-Phenotype Associations)", "ruptured lens capsule (MP:0008841 from MPO Gene-Phenotype Associations)", "abnormal lens fiber morphology (MP:0002840 from MPO Gene-Phenotype Associations)", "nuclear cataracts (MP:0010254 from MPO Gene-Phenotype Associations)", "aniridia (MP:0005261 from MPO Gene-Phenotype Associations)", "absent snout (MP:0000450 from MPO Gene-Phenotype Associations)", "abnormal anterior stroma morphology (MP:0003093 from MPO Gene-Phenotype Associations)", "abnormal bowman membrane (MP:0008521 from MPO Gene-Phenotype Associations)", "absent lens vesicle (MP:0009725 from MPO Gene-Phenotype Associations)", "delayed eyelid fusion (MP:0009265 from MPO Gene-Phenotype Associations)", "abnormal medial nasal prominence morphology (MP:0009903 from MPO Gene-Phenotype Associations)", "abnormal lateral nasal prominence morphology (MP:0009902 from MPO Gene-Phenotype Associations)", "corneal-lenticular stalk (MP:0010713 from MPO Gene-Phenotype Associations)", "anterior polar cataracts (MP:0010259 from MPO Gene-Phenotype Associations)", "polar cataracts (MP:0010258 from MPO Gene-Phenotype Associations)", "abnormal lens epithelium morphology (MP:0003237 from MPO Gene-Phenotype Associations)", "fused cornea and lens (MP:0001307 from MPO Gene-Phenotype Associations)", "telencephalon hypoplasia (MP:0000785 from MPO Gene-Phenotype Associations)", "increased susceptibility to induced pancreatitis (MP:0004761 from MPO Gene-Phenotype Associations)", "partial embryonic lethality before implantation (MP:0011104 from MPO Gene-Phenotype Associations)", "abnormal optic placode morphology (MP:0012168 from MPO Gene-Phenotype Associations)", "absent optic placodes (MP:0012170 from MPO Gene-Phenotype Associations)", "absent retina (MP:0009773 from MPO Gene-Phenotype Associations)", "absent hippocampus (MP:0000809 from MPO Gene-Phenotype Associations)", "abnormal corneal stroma development (MP:0003095 from MPO Gene-Phenotype Associations)", "decreased guard hair length (MP:0009272 from MPO Gene-Phenotype Associations)", "eyelid hyperplasia (MP:0013396 from MPO Gene-Phenotype Associations)", "meibomian gland hypoplasia (MP:0013389 from MPO Gene-Phenotype Associations)", "small meibomian gland (MP:0013388 from MPO Gene-Phenotype Associations)", "increased corneal stroma thickness (MP:0009742 from MPO Gene-Phenotype Associations)", "absent anterior chamber (MP:0010709 from MPO Gene-Phenotype Associations)", "abnormal eyelid development (MP:0009651 from MPO Gene-Phenotype Associations)", "abnormal eyelid fusion (MP:0009263 from MPO Gene-Phenotype Associations)", "failure of eyelid fusion (MP:0009264 from MPO Gene-Phenotype Associations)", "abnormal eyelid morphology (MP:0001340 from MPO Gene-Phenotype Associations)", "eyelids open at birth (MP:0001302 from MPO Gene-Phenotype Associations)", "long hair (MP:0002881 from MPO Gene-Phenotype Associations)", "abnormal guard hair length (MP:0009270 from MPO Gene-Phenotype Associations)", "increased guard hair length (MP:0009271 from MPO Gene-Phenotype Associations)", "increased vibrissae length (MP:0001281 from MPO Gene-Phenotype Associations)", "optic neuropathy (MP:0006222 from MPO Gene-Phenotype Associations)", "uveitis (MP:0005515 from MPO Gene-Phenotype Associations)", "abnormal eye anterior chamber morphology (MP:0005205 from MPO Gene-Phenotype Associations)", "enlarged eye anterior chamber (MP:0009829 from MPO Gene-Phenotype Associations)", "abnormal intraocular pressure (MP:0005257 from MPO Gene-Phenotype Associations)", "ocular hypertension (MP:0005258 from MPO Gene-Phenotype Associations)", "posterior microphthalmia (MP:0010081 from MPO Gene-Phenotype Associations)", "phthisis bulbi (MP:0006249 from MPO Gene-Phenotype Associations)", "decreased abdominal adipose tissue amount (MP:0008853 from MPO Gene-Phenotype Associations)", "abnormal aqueous humor (MP:0005206 from MPO Gene-Phenotype Associations)", "ocular hypotension (MP:0005260 from MPO Gene-Phenotype Associations)", "eye opacity (MP:0009859 from MPO Gene-Phenotype Associations)", "abnormal bulbar conjunctiva morphology (MP:0013402 from MPO Gene-Phenotype Associations)", "symblepharon (MP:0013393 from MPO Gene-Phenotype Associations)", "abnormal palpebral conjunctiva morphology (MP:0013394 from MPO Gene-Phenotype Associations)", "excessive tearing (MP:0001349 from MPO Gene-Phenotype Associations)", "abnormal cranial nerve morphology (MP:0001056 from MPO Gene-Phenotype Associations)", "abnormal optic nerve morphology (MP:0001330 from MPO Gene-Phenotype Associations)", "optic nerve hypoplasia (MP:0006221 from MPO Gene-Phenotype Associations)", "absent optic nerve (MP:0001333 from MPO Gene-Phenotype Associations)", "abnormal optic chiasm morphology (MP:0009770 from MPO Gene-Phenotype Associations)", "abnormal optic nerve innervation (MP:0001332 from MPO Gene-Phenotype Associations)", "abnormal optic tract morphology (MP:0004267 from MPO Gene-Phenotype Associations)", "absent optic tract (MP:0001334 from MPO Gene-Phenotype Associations)", "ureteral reflux (MP:0003590 from MPO Gene-Phenotype Associations)", "increased retinal photoreceptor cell number (MP:0006070 from MPO Gene-Phenotype Associations)", "increased retinal cone cell number (MP:0008445 from MPO Gene-Phenotype Associations)", "absent retinal rod cells (MP:0008454 from MPO Gene-Phenotype Associations)", "decreased retinal rod cell number (MP:0008453 from MPO Gene-Phenotype Associations)", "abnormal total retina thickness (MP:0011963 from MPO Gene-Phenotype Associations)", "decreased total retina thickness (MP:0011965 from MPO Gene-Phenotype Associations)", "abnormal muller cell morphology (MP:0005547 from MPO Gene-Phenotype Associations)", "increased cellular hemoglobin content (MP:0008955 from MPO Gene-Phenotype Associations)", "absent retinal ganglion cell (MP:0008068 from MPO Gene-Phenotype Associations)", "absent retinal ganglion layer (MP:0008510 from MPO Gene-Phenotype Associations)", "abnormal retinal cone bipolar cell morphology (MP:0006075 from MPO Gene-Phenotype Associations)", "abnormal retinal bipolar cell morphology (MP:0006073 from MPO Gene-Phenotype Associations)", "abnormal retinal rod bipolar cell morphology (MP:0006074 from MPO Gene-Phenotype Associations)", "abnormal eye morphology (MP:0002092 from MPO Gene-Phenotype Associations)", "vision|eye phenotype (MP:0005391 from MPO Gene-Phenotype Associations)", "abnormal ocular fundus morphology (MP:0002864 from MPO Gene-Phenotype Associations)", "abnormal retina morphology (MP:0001325 from MPO Gene-Phenotype Associations)", "abnormal posterior eye segment morphology (MP:0005195 from MPO Gene-Phenotype Associations)", "abnormal retinal layer morphology (MP:0003727 from MPO Gene-Phenotype Associations)", "abnormal retinal neuronal layer morphology (MP:0006069 from MPO Gene-Phenotype Associations)", "abnormal extracutaneous pigmentation (MP:0009389 from MPO Gene-Phenotype Associations)", "abnormal eye pigmentation (MP:0001324 from MPO Gene-Phenotype Associations)", "abnormal eye pigment epithelium morphology (MP:0005200 from MPO Gene-Phenotype Associations)", "abnormal retinal pigment epithelium morphology (MP:0005201 from MPO Gene-Phenotype Associations)", "abnormal retinal pigmentation (MP:0005103 from MPO Gene-Phenotype Associations)", "abnormal retinal photoreceptor layer morphology (MP:0003728 from MPO Gene-Phenotype Associations)", "abnormal retinal photoreceptor morphology (MP:0001004 from MPO Gene-Phenotype Associations)", "abnormal photoreceptor outer segment morphology (MP:0003729 from MPO Gene-Phenotype Associations)", "retinal photoreceptor degeneration (MP:0008450 from MPO Gene-Phenotype Associations)", "abnormal retinal outer nuclear layer morphology (MP:0003731 from MPO Gene-Phenotype Associations)", "abnormal retinal outer nuclear layer thickness (MP:0011997 from MPO Gene-Phenotype Associations)", "thin retinal outer nuclear layer (MP:0008515 from MPO Gene-Phenotype Associations)", "short photoreceptor outer segment (MP:0008587 from MPO Gene-Phenotype Associations)", "retinal degeneration (MP:0001326 from MPO Gene-Phenotype Associations)", "abnormal eye physiology (MP:0005253 from MPO Gene-Phenotype Associations)", "abnormal eye electrophysiology (MP:0005551 from MPO Gene-Phenotype Associations)", "abnormal cone electrophysiology (MP:0004022 from MPO Gene-Phenotype Associations)", "abnormal rod electrophysiology (MP:0004021 from MPO Gene-Phenotype Associations)", "abnormal photoreceptor inner segment morphology (MP:0003730 from MPO Gene-Phenotype Associations)", "short photoreceptor inner segment (MP:0008582 from MPO Gene-Phenotype Associations)", "abnormal retinal rod cell morphology (MP:0001005 from MPO Gene-Phenotype Associations)", "abnormal retinal rod cell outer segment morphology (MP:0008456 from MPO Gene-Phenotype Associations)", "abnormal retinal cone cell morphology (MP:0001006 from MPO Gene-Phenotype Associations)", "retinal cone cell degeneration (MP:0008444 from MPO Gene-Phenotype Associations)", "retinal rod cell degeneration (MP:0008451 from MPO Gene-Phenotype Associations)", "decreased retinal photoreceptor cell number (MP:0001327 from MPO Gene-Phenotype Associations)", "decreased retinal cone cell number (MP:0008446 from MPO Gene-Phenotype Associations)", "retinal outer nuclear layer degeneration (MP:0008518 from MPO Gene-Phenotype Associations)", "abnormal retinal apoptosis (MP:0006072 from MPO Gene-Phenotype Associations)", "abnormal vision (MP:0002090 from MPO Gene-Phenotype Associations)", "blindness (MP:0002001 from MPO Gene-Phenotype Associations)", "photoreceptor outer segment degeneration (MP:0008584 from MPO Gene-Phenotype Associations)", "photoreceptor inner segment degeneration (MP:0008580 from MPO Gene-Phenotype Associations)", "abnormal retinal cone cell outer segment morphology (MP:0008449 from MPO Gene-Phenotype Associations)", "abnormal retinal cone cell inner segment morphology (MP:0008448 from MPO Gene-Phenotype Associations)", "abnormal retinal rod cell inner segment morphology (MP:0008455 from MPO Gene-Phenotype Associations)", "amacrine cell degeneration (MP:0008103 from MPO Gene-Phenotype Associations)", "increased catalase activity (MP:0011593 from MPO Gene-Phenotype Associations)", "increased peroxidase activity (MP:0012582 from MPO Gene-Phenotype Associations)", "retinal ganglion cell degeneration (MP:0008067 from MPO Gene-Phenotype Associations)", "abnormal retinal ganglion cell morphology (MP:0008056 from MPO Gene-Phenotype Associations)", "abnormal retinal ganglion layer morphology (MP:0005241 from MPO Gene-Phenotype Associations)", "decreased retinal ganglion cell number (MP:0006309 from MPO Gene-Phenotype Associations)", "abnormal retinal nerve fiber layer morphology (MP:0006303 from MPO Gene-Phenotype Associations)", "abnormal retinal inner plexiform layer morphology (MP:0003734 from MPO Gene-Phenotype Associations)", "thin retinal inner plexiform layer (MP:0008513 from MPO Gene-Phenotype Associations)", "disorganized retinal outer nuclear layer (MP:0008516 from MPO Gene-Phenotype Associations)", "disorganized retinal inner nuclear layer (MP:0008512 from MPO Gene-Phenotype Associations)", "abnormal retinal inner nuclear layer morphology (MP:0003733 from MPO Gene-Phenotype Associations)", "abnormal retinal inner nuclear layer thickness (MP:0011996 from MPO Gene-Phenotype Associations)", "thin retinal inner nuclear layer (MP:0008511 from MPO Gene-Phenotype Associations)", "abnormal retinal outer plexiform layer morphology (MP:0003732 from MPO Gene-Phenotype Associations)", "thin retinal outer plexiform layer (MP:0008519 from MPO Gene-Phenotype Associations)", "disorganized retinal outer plexiform layer (MP:0008520 from MPO Gene-Phenotype Associations)", "abnormal amacrine cell morphology (MP:0005240 from MPO Gene-Phenotype Associations)", "abnormal amacrine cell number (MP:0008104 from MPO Gene-Phenotype Associations)", "decreased amacrine cell number (MP:0008106 from MPO Gene-Phenotype Associations)", "increased amacrine cell number (MP:0008105 from MPO Gene-Phenotype Associations)", "absent amacrine cells (MP:0006095 from MPO Gene-Phenotype Associations)", "absent retinal inner plexiform layer (MP:0008514 from MPO Gene-Phenotype Associations)", "increased retinal ganglion cell number (MP:0002983 from MPO Gene-Phenotype Associations)", "thick retinal ganglion layer (MP:0008508 from MPO Gene-Phenotype Associations)", "abnormal horizontal cell morphology (MP:0006068 from MPO Gene-Phenotype Associations)", "absent horizontal cells (MP:0008107 from MPO Gene-Phenotype Associations)", "abnormal spinal cord dorsal horn morphology (MP:0006282 from MPO Gene-Phenotype Associations)", "abnormal vitreous body morphology (MP:0002699 from MPO Gene-Phenotype Associations)", "persistence of hyaloid vascular system (MP:0001289 from MPO Gene-Phenotype Associations)", "abnormal pupillary reflex (MP:0002638 from MPO Gene-Phenotype Associations)", "impaired pupillary reflex (MP:0006243 from MPO Gene-Phenotype Associations)", "abnormal timing of postnatal eyelid opening (MP:0004874 from MPO Gene-Phenotype Associations)", "delayed eyelid opening (MP:0001290 from MPO Gene-Phenotype Associations)", "eyelids fail to open (MP:0005176 from MPO Gene-Phenotype Associations)", "exocrine pancreas atrophy (MP:0009164 from MPO Gene-Phenotype Associations)", "hypoactivity in response to feed restriction (MP:0012298 from MPO Gene-Phenotype Associations)", "abnormal urine antidiuretic hormone level (MP:0011542 from MPO Gene-Phenotype Associations)", "increased urine antidiuretic hormone level (MP:0011543 from MPO Gene-Phenotype Associations)", "increased mitotic index (MP:0004760 from MPO Gene-Phenotype Associations)", "abnormal dna replication (MP:0008057 from MPO Gene-Phenotype Associations)", "disorganized retinal ganglion layer (MP:0008509 from MPO Gene-Phenotype Associations)", "absent strial marginal cells (MP:0004758 from MPO Gene-Phenotype Associations)", "disorganized retinal layers (MP:0001328 from MPO Gene-Phenotype Associations)", "abnormal subiculum morphology (MP:0008287 from MPO Gene-Phenotype Associations)", "increased aggression toward humans (MP:0001357 from MPO Gene-Phenotype Associations)", "abnormal cortical intermediate zone morphology (MP:0008457 from MPO Gene-Phenotype Associations)", "abnormal fornicate gyrus morphology (MP:0004169 from MPO Gene-Phenotype Associations)", "abnormal entorhinal cortex morphology (MP:0006300 from MPO Gene-Phenotype Associations)", "abnormal parahippocampal gyrus morphology (MP:0004168 from MPO Gene-Phenotype Associations)", "abnormal amygdala morphology (MP:0000818 from MPO Gene-Phenotype Associations)", "abnormal spinal cord commissure morphology (MP:0009694 from MPO Gene-Phenotype Associations)", "abnormal spinal cord ventral commissure morphology (MP:0009695 from MPO Gene-Phenotype Associations)", "abnormal axon fasciculation (MP:0009450 from MPO Gene-Phenotype Associations)", "abnormal radial glial cell morphology (MP:0003648 from MPO Gene-Phenotype Associations)", "miotic pupils (MP:0002003 from MPO Gene-Phenotype Associations)", "increased muscle spindle number (MP:0008485 from MPO Gene-Phenotype Associations)", "abnormal thermosensation (MP:0003663 from MPO Gene-Phenotype Associations)", "ulcerated paws (MP:0000578 from MPO Gene-Phenotype Associations)", "extremity edema (MP:0003201 from MPO Gene-Phenotype Associations)", "thin retinal ganglion layer (MP:0008507 from MPO Gene-Phenotype Associations)", "retina hypoplasia (MP:0002984 from MPO Gene-Phenotype Associations)", "abnormal eye movement (MP:0001389 from MPO Gene-Phenotype Associations)", "abnormal visual pursuit (MP:0006156 from MPO Gene-Phenotype Associations)", "abnormal embryogenesis| development (MP:0001672 from MPO Gene-Phenotype Associations)", "embryogenesis phenotype (MP:0005380 from MPO Gene-Phenotype Associations)", "embryonic lethality (MP:0008762 from MPO Gene-Phenotype Associations)", "prenatal lethality (MP:0002080 from MPO Gene-Phenotype Associations)", "complete embryonic lethality during organogenesis (MP:0011098 from MPO Gene-Phenotype Associations)", "embryonic lethality during organogenesis (MP:0006207 from MPO Gene-Phenotype Associations)", "abnormal embryo size (MP:0001697 from MPO Gene-Phenotype Associations)", "decreased embryo size (MP:0001698 from MPO Gene-Phenotype Associations)", "abnormal prenatal body size (MP:0010866 from MPO Gene-Phenotype Associations)", "abnormal embryonic growth|weight|body size (MP:0002088 from MPO Gene-Phenotype Associations)", "abnormal prenatal growth|weight|body size (MP:0004196 from MPO Gene-Phenotype Associations)", "embryonic growth retardation (MP:0003984 from MPO Gene-Phenotype Associations)", "prenatal growth retardation (MP:0010865 from MPO Gene-Phenotype Associations)", "abnormal embryonic tissue morphology (MP:0002085 from MPO Gene-Phenotype Associations)", "abnormal neural tube morphology|development (MP:0002151 from MPO Gene-Phenotype Associations)", "abnormal neural tube closure (MP:0003720 from MPO Gene-Phenotype Associations)", "open neural tube (MP:0000929 from MPO Gene-Phenotype Associations)", "exencephaly (MP:0000914 from MPO Gene-Phenotype Associations)", "abnormal blood vessel morphology (MP:0001614 from MPO Gene-Phenotype Associations)", "abnormal cardiovascular system morphology (MP:0002127 from MPO Gene-Phenotype Associations)", "cardiovascular system phenotype (MP:0005385 from MPO Gene-Phenotype Associations)", "abnormal heart morphology (MP:0000266 from MPO Gene-Phenotype Associations)", "abnormal cardiovascular system physiology (MP:0001544 from MPO Gene-Phenotype Associations)", "abnormal angiogenesis (MP:0000260 from MPO Gene-Phenotype Associations)", "abnormal vascular development (MP:0000259 from MPO Gene-Phenotype Associations)", "abnormal cardiovascular development (MP:0002925 from MPO Gene-Phenotype Associations)", "abnormal blood circulation (MP:0002128 from MPO Gene-Phenotype Associations)", "hemorrhage (MP:0001914 from MPO Gene-Phenotype Associations)", "internal hemorrhage (MP:0001634 from MPO Gene-Phenotype Associations)", "abnormal placenta development (MP:0001712 from MPO Gene-Phenotype Associations)", "abnormal chorioallantoic fusion (MP:0002824 from MPO Gene-Phenotype Associations)", "failure of chorioallantoic fusion (MP:0009657 from MPO Gene-Phenotype Associations)", "abnormal extraembryonic tissue morphology (MP:0002086 from MPO Gene-Phenotype Associations)", "abnormal placenta morphology (MP:0001711 from MPO Gene-Phenotype Associations)", "abnormal placenta labyrinth morphology (MP:0001716 from MPO Gene-Phenotype Associations)", "abnormal placenta vasculature (MP:0003231 from MPO Gene-Phenotype Associations)", "abnormal placental labyrinth vasculature morphology (MP:0008803 from MPO Gene-Phenotype Associations)", "abnormal artery development (MP:0003410 from MPO Gene-Phenotype Associations)", "abnormal dorsal aorta morphology (MP:0004787 from MPO Gene-Phenotype Associations)", "dilated dorsal aorta (MP:0004068 from MPO Gene-Phenotype Associations)", "abnormal visceral yolk sac morphology (MP:0001718 from MPO Gene-Phenotype Associations)", "abnormal vitelline vasculature morphology (MP:0003229 from MPO Gene-Phenotype Associations)", "abnormal vitelline vascular remodeling (MP:0004076 from MPO Gene-Phenotype Associations)", "pale yolk sac (MP:0001722 from MPO Gene-Phenotype Associations)", "absent vitelline blood vessels (MP:0001719 from MPO Gene-Phenotype Associations)", "disorganized yolk sac vascular plexus (MP:0001723 from MPO Gene-Phenotype Associations)", "partial embryonic lethality during organogenesis (MP:0011108 from MPO Gene-Phenotype Associations)", "complete lethality throughout fetal growth and development (MP:0011099 from MPO Gene-Phenotype Associations)", "lethality throughout fetal growth and development (MP:0006208 from MPO Gene-Phenotype Associations)", "partial lethality throughout fetal growth and development (MP:0011109 from MPO Gene-Phenotype Associations)", "complete prenatal lethality (MP:0011091 from MPO Gene-Phenotype Associations)", "abnormal fluid regulation (MP:0001784 from MPO Gene-Phenotype Associations)", "edema (MP:0001785 from MPO Gene-Phenotype Associations)", "hydrops fetalis (MP:0002192 from MPO Gene-Phenotype Associations)", "pericardial edema (MP:0001787 from MPO Gene-Phenotype Associations)", "abnormal pericardium morphology (MP:0000288 from MPO Gene-Phenotype Associations)", "pericardial effusion (MP:0005312 from MPO Gene-Phenotype Associations)", "abnormal pericardial cavity morphology (MP:0012501 from MPO Gene-Phenotype Associations)", "hemopericardium (MP:0005244 from MPO Gene-Phenotype Associations)", "heart hemorrhage (MP:0009698 from MPO Gene-Phenotype Associations)", "abnormal craniofacial development (MP:0003935 from MPO Gene-Phenotype Associations)", "abnormal pharyngeal arch morphology (MP:0002884 from MPO Gene-Phenotype Associations)", "abnormal first pharyngeal arch morphology (MP:0006337 from MPO Gene-Phenotype Associations)", "small pharyngeal arch (MP:0006346 from MPO Gene-Phenotype Associations)", "small first pharyngeal arch (MP:0006341 from MPO Gene-Phenotype Associations)", "abnormal heart development (MP:0000267 from MPO Gene-Phenotype Associations)", "abnormal heart looping (MP:0000269 from MPO Gene-Phenotype Associations)", "failure of heart looping (MP:0004251 from MPO Gene-Phenotype Associations)", "distended pericardium (MP:0000292 from MPO Gene-Phenotype Associations)", "kinked neural tube (MP:0003400 from MPO Gene-Phenotype Associations)", "abnormal somite size (MP:0005222 from MPO Gene-Phenotype Associations)", "decreased somite size (MP:0011732 from MPO Gene-Phenotype Associations)", "abnormal somite shape (MP:0001691 from MPO Gene-Phenotype Associations)", "abnormal neural plate morphology (MP:0005657 from MPO Gene-Phenotype Associations)", "abnormal embryo turning (MP:0001700 from MPO Gene-Phenotype Associations)", "incomplete embryo turning (MP:0001701 from MPO Gene-Phenotype Associations)", "failure of initiation of embryo turning (MP:0004180 from MPO Gene-Phenotype Associations)", "abnormal somite development (MP:0001688 from MPO Gene-Phenotype Associations)", "impaired somite development (MP:0009768 from MPO Gene-Phenotype Associations)", "incomplete somite formation (MP:0001689 from MPO Gene-Phenotype Associations)", "absent somites (MP:0006386 from MPO Gene-Phenotype Associations)", "failure of somite differentiation (MP:0001690 from MPO Gene-Phenotype Associations)", "abnormal rostral-caudal axis patterning (MP:0005221 from MPO Gene-Phenotype Associations)", "caudal body truncation (MP:0004073 from MPO Gene-Phenotype Associations)", "abnormal paraxial mesoderm morphology (MP:0008029 from MPO Gene-Phenotype Associations)", "decreased paraxial mesoderm size (MP:0012183 from MPO Gene-Phenotype Associations)", "absent paraxial mesoderm (MP:0012184 from MPO Gene-Phenotype Associations)", "abnormal primitive streak morphology (MP:0002231 from MPO Gene-Phenotype Associations)", "abnormal primitive streak formation (MP:0002230 from MPO Gene-Phenotype Associations)", "failure of primitive streak formation (MP:0001693 from MPO Gene-Phenotype Associations)", "absent mesoderm (MP:0001683 from MPO Gene-Phenotype Associations)", "abnormal developmental patterning (MP:0002084 from MPO Gene-Phenotype Associations)", "abnormal gastrulation (MP:0001695 from MPO Gene-Phenotype Associations)", "abnormal mesoderm development (MP:0001680 from MPO Gene-Phenotype Associations)", "abnormal triploblastic development (MP:0001674 from MPO Gene-Phenotype Associations)", "failure to gastrulate (MP:0001696 from MPO Gene-Phenotype Associations)", "embryonic growth arrest (MP:0001730 from MPO Gene-Phenotype Associations)", "embryonic lethality prior to organogenesis (MP:0013292 from MPO Gene-Phenotype Associations)", "embryonic lethality prior to tooth bud stage (MP:0013293 from MPO Gene-Phenotype Associations)", "embryonic lethality between implantation and placentation (MP:0009850 from MPO Gene-Phenotype Associations)", "complete embryonic lethality between implantation and somite formation (MP:0011096 from MPO Gene-Phenotype Associations)", "embryonic lethality between implantation and somite formation (MP:0006205 from MPO Gene-Phenotype Associations)", "complete embryonic lethality between somite formation and embryo turning (MP:0011097 from MPO Gene-Phenotype Associations)", "embryonic lethality between somite formation and embryo turning (MP:0006206 from MPO Gene-Phenotype Associations)", "complete embryonic lethality (MP:0011092 from MPO Gene-Phenotype Associations)", "disorganized embryonic tissue (MP:0003988 from MPO Gene-Phenotype Associations)", "disorganized extraembryonic tissue (MP:0002582 from MPO Gene-Phenotype Associations)", "abnormal extraembryonic ectoderm morphology (MP:0010736 from MPO Gene-Phenotype Associations)", "absent extraembryonic ectoderm (MP:0002583 from MPO Gene-Phenotype Associations)", "abnormal bilaminar embryonic disc (MP:0012103 from MPO Gene-Phenotype Associations)", "abnormal embryonic epiblast morphology (MP:0003886 from MPO Gene-Phenotype Associations)", "absent embryonic epiblast (MP:0011184 from MPO Gene-Phenotype Associations)", "abnormal primitive endoderm morphology (MP:0011183 from MPO Gene-Phenotype Associations)", "absent primitive endoderm (MP:0011185 from MPO Gene-Phenotype Associations)", "abnormal allantois morphology (MP:0001726 from MPO Gene-Phenotype Associations)", "absent allantois (MP:0003087 from MPO Gene-Phenotype Associations)", "abnormal amnion morphology (MP:0005029 from MPO Gene-Phenotype Associations)", "absent amnion (MP:0005030 from MPO Gene-Phenotype Associations)", "abnormal chorion morphology (MP:0002836 from MPO Gene-Phenotype Associations)", "absent chorion (MP:0009593 from MPO Gene-Phenotype Associations)", "absent amniotic folds (MP:0001710 from MPO Gene-Phenotype Associations)", "absent visceral yolk sac (MP:0011206 from MPO Gene-Phenotype Associations)", "abnormal blastocyst morphology (MP:0004957 from MPO Gene-Phenotype Associations)", "abnormal preimplantation embryo development (MP:0009781 from MPO Gene-Phenotype Associations)", "abnormal parietal yolk sac morphology (MP:0011203 from MPO Gene-Phenotype Associations)", "abnormal trophectoderm morphology (MP:0005028 from MPO Gene-Phenotype Associations)", "abnormal mural trophectoderm morphology (MP:0012057 from MPO Gene-Phenotype Associations)", "abnormal trophoblast giant cells (MP:0005033 from MPO Gene-Phenotype Associations)", "abnormal trophoblast layer morphology (MP:0005031 from MPO Gene-Phenotype Associations)", "decreased trophoblast giant cell number (MP:0001713 from MPO Gene-Phenotype Associations)", "increased trophoblast giant cell number (MP:0009397 from MPO Gene-Phenotype Associations)", "abnormal ectoplacental cone morphology (MP:0005032 from MPO Gene-Phenotype Associations)", "abnormal polar trophectoderm morphology (MP:0012056 from MPO Gene-Phenotype Associations)", "small ectoplacental cone (MP:0002584 from MPO Gene-Phenotype Associations)", "absent ectoplacental cone (MP:0001717 from MPO Gene-Phenotype Associations)", "abnormal chorionic plate morphology (MP:0004560 from MPO Gene-Phenotype Associations)", "absent placental labyrinth (MP:0003403 from MPO Gene-Phenotype Associations)", "thick embryonic epiblast (MP:0011190 from MPO Gene-Phenotype Associations)", "abnormal distal visceral endoderm morphology (MP:0010126 from MPO Gene-Phenotype Associations)", "absent distal visceral endoderm (MP:0012161 from MPO Gene-Phenotype Associations)", "abnormal anterior visceral endoderm morphology (MP:0008533 from MPO Gene-Phenotype Associations)", "absent anterior visceral endoderm (MP:0012159 from MPO Gene-Phenotype Associations)", "abnormal visceral endoderm morphology (MP:0011186 from MPO Gene-Phenotype Associations)", "abnormal head development (MP:0012176 from MPO Gene-Phenotype Associations)", "abnormal head mesenchyme morphology (MP:0011260 from MPO Gene-Phenotype Associations)", "abnormal cardiac jelly morphology (MP:0009382 from MPO Gene-Phenotype Associations)", "absent cardiac jelly (MP:0010655 from MPO Gene-Phenotype Associations)", "head mesenchyme hypoplasia (MP:0013200 from MPO Gene-Phenotype Associations)", "increased tail bud apoptosis (MP:0012277 from MPO Gene-Phenotype Associations)", "thick myocardium (MP:0010656 from MPO Gene-Phenotype Associations)", "short rostral-caudal axis (MP:0012173 from MPO Gene-Phenotype Associations)", "abnormal visceral yolk sac blood island morphology (MP:0011204 from MPO Gene-Phenotype Associations)", "absent visceral yolk sac blood islands (MP:0001721 from MPO Gene-Phenotype Associations)", "abnormal head fold morphology (MP:0011257 from MPO Gene-Phenotype Associations)", "absent heart tube (MP:0012081 from MPO Gene-Phenotype Associations)", "abnormal amniotic cavity morphology (MP:0011199 from MPO Gene-Phenotype Associations)", "small amniotic cavity (MP:0012104 from MPO Gene-Phenotype Associations)", "small allantois (MP:0004559 from MPO Gene-Phenotype Associations)", "abnormal visceral yolk sac cavity morphology (MP:0011201 from MPO Gene-Phenotype Associations)", "abnormal vitelline artery morphology (MP:0010664 from MPO Gene-Phenotype Associations)", "abnormal mesocardium morphology (MP:0010547 from MPO Gene-Phenotype Associations)", "small visceral yolk sac (MP:0012131 from MPO Gene-Phenotype Associations)", "delayed heart development (MP:0012082 from MPO Gene-Phenotype Associations)", "enlarged allantois (MP:0004556 from MPO Gene-Phenotype Associations)", "abnormal hindgut morphology (MP:0008786 from MPO Gene-Phenotype Associations)", "absent hindgut (MP:0012086 from MPO Gene-Phenotype Associations)", "holoprosencephaly (MP:0005157 from MPO Gene-Phenotype Associations)", "cyclopia (MP:0005163 from MPO Gene-Phenotype Associations)", "fused first pharyngeal arch (MP:0010335 from MPO Gene-Phenotype Associations)", "truncated foregut (MP:0012084 from MPO Gene-Phenotype Associations)", "abnormal nasopharynx morphology (MP:0002251 from MPO Gene-Phenotype Associations)", "abnormal oropharynx morphology (MP:0002252 from MPO Gene-Phenotype Associations)", "abnormal pharynx morphology (MP:0002234 from MPO Gene-Phenotype Associations)", "absent mandible (MP:0000087 from MPO Gene-Phenotype Associations)", "microstomia (MP:0009880 from MPO Gene-Phenotype Associations)", "abnormal axial mesoderm (MP:0001684 from MPO Gene-Phenotype Associations)", "increased axial mesoderm size (MP:0012274 from MPO Gene-Phenotype Associations)", "increased somite number (MP:0012181 from MPO Gene-Phenotype Associations)", "rostral-caudal axis duplication (MP:0012156 from MPO Gene-Phenotype Associations)", "split notochord (MP:0004713 from MPO Gene-Phenotype Associations)", "abnormal prechordal mesoderm morphology (MP:0012275 from MPO Gene-Phenotype Associations)", "absent prechordal mesoderm (MP:0012276 from MPO Gene-Phenotype Associations)", "acephaly (MP:0009579 from MPO Gene-Phenotype Associations)", "absent metencephalon (MP:0012516 from MPO Gene-Phenotype Associations)", "absent midbrain (MP:0012087 from MPO Gene-Phenotype Associations)", "absent nasal capsule (MP:0008384 from MPO Gene-Phenotype Associations)", "otocephaly (MP:0009578 from MPO Gene-Phenotype Associations)", "absent forebrain (MP:0012136 from MPO Gene-Phenotype Associations)", "retinal pigment epithelium hyperplasia (MP:0005549 from MPO Gene-Phenotype Associations)", "abnormal endoderm development (MP:0001685 from MPO Gene-Phenotype Associations)", "abnormal mesendoderm development (MP:0009266 from MPO Gene-Phenotype Associations)", "fused somites (MP:0011733 from MPO Gene-Phenotype Associations)", "rostral body truncation (MP:0012157 from MPO Gene-Phenotype Associations)", "abnormal embryonic-extraembryonic boundary morphology (MP:0003890 from MPO Gene-Phenotype Associations)", "embryonic-extraembryonic boundary constriction (MP:0012135 from MPO Gene-Phenotype Associations)", "abnormal notochord morphology (MP:0002825 from MPO Gene-Phenotype Associations)", "absent notochord (MP:0000932 from MPO Gene-Phenotype Associations)", "abnormal digestive system development (MP:0003119 from MPO Gene-Phenotype Associations)", "abnormal foregut morphology (MP:0000474 from MPO Gene-Phenotype Associations)", "absent endoderm (MP:0013207 from MPO Gene-Phenotype Associations)", "absent ectoderm (MP:0013216 from MPO Gene-Phenotype Associations)", "failure of head fold formation (MP:0012724 from MPO Gene-Phenotype Associations)", "absent foregut (MP:0012083 from MPO Gene-Phenotype Associations)", "abnormal cephalic neural fold morphology (MP:0011259 from MPO Gene-Phenotype Associations)", "absent diencephalon (MP:0012517 from MPO Gene-Phenotype Associations)", "abnormal prechordal plate morphology (MP:0004387 from MPO Gene-Phenotype Associations)", "absent prechordal plate (MP:0004388 from MPO Gene-Phenotype Associations)", "abnormal anterior definitive endoderm morphology (MP:0008926 from MPO Gene-Phenotype Associations)", "absent anterior definitive endoderm (MP:0013185 from MPO Gene-Phenotype Associations)", "absent telencephalon (MP:0012683 from MPO Gene-Phenotype Associations)", "abnormal embryonic neuroepithelial cell proliferation (MP:0012704 from MPO Gene-Phenotype Associations)", "decreased embryonic neuroepithelial cell proliferation (MP:0012706 from MPO Gene-Phenotype Associations)", "abnormal forelimb bud morphology (MP:0013164 from MPO Gene-Phenotype Associations)", "small forelimb buds (MP:0013166 from MPO Gene-Phenotype Associations)", "small limb buds (MP:0004575 from MPO Gene-Phenotype Associations)", "absent forelimb buds (MP:0013165 from MPO Gene-Phenotype Associations)", "absent hindlimb buds (MP:0013168 from MPO Gene-Phenotype Associations)", "abnormal hindlimb bud morphology (MP:0013167 from MPO Gene-Phenotype Associations)", "absent limb buds (MP:0004573 from MPO Gene-Phenotype Associations)", "pharyngeal arch hypoplasia (MP:0003873 from MPO Gene-Phenotype Associations)", "abnormal trachea morphology (MP:0002282 from MPO Gene-Phenotype Associations)", "abnormal tracheal cartilage morphology (MP:0003120 from MPO Gene-Phenotype Associations)", "decreased tracheal cartilage ring number (MP:0004551 from MPO Gene-Phenotype Associations)", "short trachea (MP:0004550 from MPO Gene-Phenotype Associations)", "small trachea (MP:0004549 from MPO Gene-Phenotype Associations)", "abnormal atrioventricular cushion morphology (MP:0000297 from MPO Gene-Phenotype Associations)", "abnormal fetal atrioventricular canal morphology (MP:0006107 from MPO Gene-Phenotype Associations)", "absent atrioventricular cushions (MP:0000298 from MPO Gene-Phenotype Associations)", "increased atrioventricular cushion size (MP:0003808 from MPO Gene-Phenotype Associations)", "abnormal cardiac epithelial to mesenchymal transition (MP:0008825 from MPO Gene-Phenotype Associations)", "abnormal conotruncal ridge morphology (MP:0010585 from MPO Gene-Phenotype Associations)", "abnormal conotruncus morphology (MP:0010583 from MPO Gene-Phenotype Associations)", "conotruncal ridge hypoplasia (MP:0010587 from MPO Gene-Phenotype Associations)", "failure of conotruncal ridge closure (MP:0010645 from MPO Gene-Phenotype Associations)", "abnormal heart tube morphology (MP:0000270 from MPO Gene-Phenotype Associations)", "cardia bifida (MP:0004187 from MPO Gene-Phenotype Associations)", "abnormal medial ganglionic eminence morphology (MP:0004276 from MPO Gene-Phenotype Associations)", "conotruncal ridge hyperplasia (MP:0010588 from MPO Gene-Phenotype Associations)", "absent liver (MP:0011877 from MPO Gene-Phenotype Associations)", "abnormal hepatoblast migration (MP:0012245 from MPO Gene-Phenotype Associations)", "abnormal monocyte differentiation (MP:0008112 from MPO Gene-Phenotype Associations)", "abnormal mononuclear cell differentiation (MP:0002445 from MPO Gene-Phenotype Associations)", "abnormal hepatic diverticulum morphology (MP:0012234 from MPO Gene-Phenotype Associations)", "abnormal liver bud morphology (MP:0012235 from MPO Gene-Phenotype Associations)", "abnormal hepatobiliary system development (MP:0003943 from MPO Gene-Phenotype Associations)", "abnormal liver development (MP:0000596 from MPO Gene-Phenotype Associations)", "delayed hepatic development (MP:0000597 from MPO Gene-Phenotype Associations)", "increased forebrain apoptosis (MP:0012504 from MPO Gene-Phenotype Associations)", "abnormal caudal neuropore morphology (MP:0012544 from MPO Gene-Phenotype Associations)", "incomplete caudal neuropore closure (MP:0012707 from MPO Gene-Phenotype Associations)", "abnormal neuropore morphology (MP:0012542 from MPO Gene-Phenotype Associations)", "abnormal rostral neuropore morphology (MP:0012543 from MPO Gene-Phenotype Associations)", "incomplete rostral neuropore closure (MP:0000928 from MPO Gene-Phenotype Associations)", "abnormal neural fold elevation formation (MP:0004838 from MPO Gene-Phenotype Associations)", "abnormal neural fold formation (MP:0004837 from MPO Gene-Phenotype Associations)", "abnormal neural fold morphology (MP:0011256 from MPO Gene-Phenotype Associations)", "delayed neural tube closure (MP:0002621 from MPO Gene-Phenotype Associations)", "everted embryonic neuroepithelium (MP:0012686 from MPO Gene-Phenotype Associations)", "thoracoschisis (MP:0008923 from MPO Gene-Phenotype Associations)", "absent lateral ventricles (MP:0012680 from MPO Gene-Phenotype Associations)", "anencephaly (MP:0001890 from MPO Gene-Phenotype Associations)", "acrania (MP:0003104 from MPO Gene-Phenotype Associations)", "absent craniofacial bones (MP:0000073 from MPO Gene-Phenotype Associations)", "splayed ribs (MP:0004673 from MPO Gene-Phenotype Associations)", "abnormal aortic arch development (MP:0010241 from MPO Gene-Phenotype Associations)", "absent pericardium (MP:0003388 from MPO Gene-Phenotype Associations)", "delayed rostral neuropore closure (MP:0012708 from MPO Gene-Phenotype Associations)", "absent trigeminal ganglion (MP:0013183 from MPO Gene-Phenotype Associations)", "abnormal folic acid level (MP:0011230 from MPO Gene-Phenotype Associations)", "abnormal embryonic neuroepithelial layer differentiation (MP:0000786 from MPO Gene-Phenotype Associations)", "abnormal embryonic neuroepithelium morphology (MP:0004261 from MPO Gene-Phenotype Associations)", "decreased embryonic neuroepithelium thickness (MP:0012703 from MPO Gene-Phenotype Associations)", "abnormal vitamin b12 level (MP:0011227 from MPO Gene-Phenotype Associations)", "abnormal circulating homocysteine level (MP:0006076 from MPO Gene-Phenotype Associations)", "wavy neural tube (MP:0000930 from MPO Gene-Phenotype Associations)", "absent brain ventricles (MP:0012677 from MPO Gene-Phenotype Associations)", "absent erythrocytes (MP:0000215 from MPO Gene-Phenotype Associations)", "absent parietal endoderm (MP:0012162 from MPO Gene-Phenotype Associations)", "absent visceral endoderm (MP:0012158 from MPO Gene-Phenotype Associations)", "abnormal extraembryonic endoderm formation (MP:0001724 from MPO Gene-Phenotype Associations)", "abnormal proamniotic cavity morphology (MP:0011197 from MPO Gene-Phenotype Associations)", "absent proamniotic cavity (MP:0011198 from MPO Gene-Phenotype Associations)", "abnormal extraembryonic coelom morphology (MP:0011200 from MPO Gene-Phenotype Associations)", "abnormal ectoplacental cavity morphology (MP:0011202 from MPO Gene-Phenotype Associations)", "absent ectoplacental cavity (MP:0011207 from MPO Gene-Phenotype Associations)", "absent extraembryonic coelom (MP:0011209 from MPO Gene-Phenotype Associations)", "abnormal floor plate morphology (MP:0000925 from MPO Gene-Phenotype Associations)", "absent floor plate (MP:0000926 from MPO Gene-Phenotype Associations)", "broad limb buds (MP:0004574 from MPO Gene-Phenotype Associations)", "abnormal cranial flexure morphology (MP:0004203 from MPO Gene-Phenotype Associations)", "abnormal midbrain development (MP:0003864 from MPO Gene-Phenotype Associations)", "abnormal motile primary cilium morphology (MP:0004131 from MPO Gene-Phenotype Associations)", "abnormal primitive node morphology (MP:0004066 from MPO Gene-Phenotype Associations)", "absent embryonic cilia (MP:0004132 from MPO Gene-Phenotype Associations)", "abnormal direction of heart looping (MP:0004252 from MPO Gene-Phenotype Associations)", "abnormal left-right axis patterning (MP:0001706 from MPO Gene-Phenotype Associations)", "abnormal direction of embryo turning (MP:0004190 from MPO Gene-Phenotype Associations)", "pancreas atrophy (MP:0013295 from MPO Gene-Phenotype Associations)", "pancreatic acinar cell atrophy (MP:0009150 from MPO Gene-Phenotype Associations)", "abnormal liver zinc level (MP:0011924 from MPO Gene-Phenotype Associations)", "abnormal oval cell morphology (MP:0010040 from MPO Gene-Phenotype Associations)", "absent oval cells (MP:0010041 from MPO Gene-Phenotype Associations)", "abnormal oval cell physiology (MP:0010042 from MPO Gene-Phenotype Associations)", "abnormal pharyngeal arch development (MP:0010395 from MPO Gene-Phenotype Associations)", "abnormal pharyngeal arch mesenchyme morphology (MP:0011262 from MPO Gene-Phenotype Associations)", "absent plasma cells (MP:0008100 from MPO Gene-Phenotype Associations)", "delayed embryo turning (MP:0004188 from MPO Gene-Phenotype Associations)", "delayed limb development (MP:0012531 from MPO Gene-Phenotype Associations)", "elongated neck (MP:0012720 from MPO Gene-Phenotype Associations)", "abnormal neck morphology (MP:0012719 from MPO Gene-Phenotype Associations)", "ectrodactyly (MP:0005230 from MPO Gene-Phenotype Associations)", "polysyndactyly (MP:0004083 from MPO Gene-Phenotype Associations)", "abnormal cranial neural crest cell proliferation (MP:0012758 from MPO Gene-Phenotype Associations)", "decreased neural crest cell proliferation (MP:0012741 from MPO Gene-Phenotype Associations)", "decreased cranial neural crest cell proliferation (MP:0012760 from MPO Gene-Phenotype Associations)", "abnormal neural crest cell proliferation (MP:0009842 from MPO Gene-Phenotype Associations)", "absent glossopharyngeal nerve (MP:0004570 from MPO Gene-Phenotype Associations)", "cup-shaped ears (MP:0003735 from MPO Gene-Phenotype Associations)", "temporal bone hypoplasia (MP:0004424 from MPO Gene-Phenotype Associations)", "frontal bone hypoplasia (MP:0004869 from MPO Gene-Phenotype Associations)", "abnormal turbinate morphology (MP:0002244 from MPO Gene-Phenotype Associations)", "absent turbinates (MP:0004873 from MPO Gene-Phenotype Associations)", "abnormal nasal cavity morphology (MP:0002237 from MPO Gene-Phenotype Associations)", "increased osteochondroma incidence (MP:0010079 from MPO Gene-Phenotype Associations)", "absent cornea (MP:0012247 from MPO Gene-Phenotype Associations)", "diencephalon hypoplasia (MP:0012092 from MPO Gene-Phenotype Associations)", "absent tooth primordium (MP:0000117 from MPO Gene-Phenotype Associations)", "tongue hypoplasia (MP:0009904 from MPO Gene-Phenotype Associations)", "absent nasal septum (MP:0004872 from MPO Gene-Phenotype Associations)", "abnormal frontonasal prominence morphology (MP:0009901 from MPO Gene-Phenotype Associations)", "abnormal maxillary prominence morphology (MP:0010940 from MPO Gene-Phenotype Associations)", "abnormal mandibular prominence morphology (MP:0010939 from MPO Gene-Phenotype Associations)", "abnormal nasal capsule morphology (MP:0004726 from MPO Gene-Phenotype Associations)", "abnormal optic vesicle formation (MP:0003425 from MPO Gene-Phenotype Associations)", "absent optic vesicle (MP:0006294 from MPO Gene-Phenotype Associations)", "abnormal nasal placode morphology (MP:0006292 from MPO Gene-Phenotype Associations)", "absent nasal placodes (MP:0006293 from MPO Gene-Phenotype Associations)", "absent maxilla (MP:0004539 from MPO Gene-Phenotype Associations)", "absent nasal bone (MP:0004473 from MPO Gene-Phenotype Associations)", "absent frontonasal prominence (MP:0012178 from MPO Gene-Phenotype Associations)", "abnormal head size (MP:0011496 from MPO Gene-Phenotype Associations)", "microcephaly (MP:0000433 from MPO Gene-Phenotype Associations)", "abnormal optic cup morphology (MP:0004269 from MPO Gene-Phenotype Associations)", "absent otic vesicle (MP:0004309 from MPO Gene-Phenotype Associations)", "ectopic adenohypophysis (MP:0013357 from MPO Gene-Phenotype Associations)", "ectopic pituitary gland (MP:0013356 from MPO Gene-Phenotype Associations)", "abnormal septum of telencephalon morphology (MP:0012003 from MPO Gene-Phenotype Associations)", "abnormal septum pellucidum morphology (MP:0012004 from MPO Gene-Phenotype Associations)", "bifurcated rathke's pouch (MP:0013342 from MPO Gene-Phenotype Associations)", "abnormal nasal pit morphology (MP:0006306 from MPO Gene-Phenotype Associations)", "abnormal nasal septum morphology (MP:0002239 from MPO Gene-Phenotype Associations)", "abnormal vomeronasal organ morphology (MP:0002243 from MPO Gene-Phenotype Associations)", "abnormal anterior primitive streak morphology (MP:0012739 from MPO Gene-Phenotype Associations)", "absent primitive node (MP:0009331 from MPO Gene-Phenotype Associations)", "abnormal primitive streak elongation (MP:0012685 from MPO Gene-Phenotype Associations)", "abnormal left-right axis symmetry of the somites (MP:0005224 from MPO Gene-Phenotype Associations)", "premaxilla hypoplasia (MP:0004871 from MPO Gene-Phenotype Associations)", "absent hyoid bone greater horns (MP:0009916 from MPO Gene-Phenotype Associations)", "ectopia cordis (MP:0011660 from MPO Gene-Phenotype Associations)", "maxilla hypoplasia (MP:0000457 from MPO Gene-Phenotype Associations)", "abnormal otic capsule development (MP:0010397 from MPO Gene-Phenotype Associations)", "ectopic pharyngeal arch (MP:0010396 from MPO Gene-Phenotype Associations)", "abnormal hyoid bone greater horn morphology (MP:0009913 from MPO Gene-Phenotype Associations)", "anuria (MP:0003624 from MPO Gene-Phenotype Associations)", "absent cardiac neural crest cells (MP:0012750 from MPO Gene-Phenotype Associations)", "decreased cardiac neural crest cell number (MP:0012749 from MPO Gene-Phenotype Associations)", "abnormal spinal cord central canal morphology (MP:0009688 from MPO Gene-Phenotype Associations)", "pulmonary artery stenosis (MP:0010457 from MPO Gene-Phenotype Associations)", "coloboma (MP:0005262 from MPO Gene-Phenotype Associations)", "uveal coloboma (MP:0012533 from MPO Gene-Phenotype Associations)", "iris coloboma (MP:0010714 from MPO Gene-Phenotype Associations)", "absent aortic valve cusps (MP:0010597 from MPO Gene-Phenotype Associations)", "absent pulmonary valve cusps (MP:0010604 from MPO Gene-Phenotype Associations)", "decreased atrioventricular cushion size (MP:0000301 from MPO Gene-Phenotype Associations)", "abnormal posterior stroma morphology (MP:0003094 from MPO Gene-Phenotype Associations)", "abnormal cornea thickness (MP:0011961 from MPO Gene-Phenotype Associations)", "decreased cornea thickness (MP:0005543 from MPO Gene-Phenotype Associations)", "decreased corneal stroma thickness (MP:0003092 from MPO Gene-Phenotype Associations)", "primary vitreous hyperplasia (MP:0009621 from MPO Gene-Phenotype Associations)", "absent interdental cells (MP:0004483 from MPO Gene-Phenotype Associations)", "absent spiral limbus (MP:0004304 from MPO Gene-Phenotype Associations)", "absent rosenthal canal (MP:0004307 from MPO Gene-Phenotype Associations)", "absent pterygoid process (MP:0004454 from MPO Gene-Phenotype Associations)", "patent aortic valve (MP:0010610 from MPO Gene-Phenotype Associations)", "patent pulmonary valve (MP:0010611 from MPO Gene-Phenotype Associations)", "cystic bulbourethral gland (MP:0005304 from MPO Gene-Phenotype Associations)", "bulbourethral gland hyperplasia (MP:0001170 from MPO Gene-Phenotype Associations)", "prostate gland anterior lobe hyperplasia (MP:0005305 from MPO Gene-Phenotype Associations)", "double inlet heart left ventricle (MP:0010433 from MPO Gene-Phenotype Associations)", "inlet ventricular septal defect (MP:0010419 from MPO Gene-Phenotype Associations)", "abnormal rosenthal canal morphology (MP:0004305 from MPO Gene-Phenotype Associations)", "heart valve hyperplasia (MP:0003958 from MPO Gene-Phenotype Associations)", "small temporal bone (MP:0004422 from MPO Gene-Phenotype Associations)", "retrognathia (MP:0004282 from MPO Gene-Phenotype Associations)", "abnormal trochanter morphology (MP:0004627 from MPO Gene-Phenotype Associations)", "retina hyperplasia (MP:0001329 from MPO Gene-Phenotype Associations)", "abnormal corneal endothelium morphology (MP:0005301 from MPO Gene-Phenotype Associations)", "absent corneal endothelium (MP:0004283 from MPO Gene-Phenotype Associations)", "abnormal descemet membrane (MP:0004284 from MPO Gene-Phenotype Associations)", "absent descemet membrane (MP:0004285 from MPO Gene-Phenotype Associations)", "corneal scarring (MP:0001316 from MPO Gene-Phenotype Associations)", "vitreous body deposition (MP:0006200 from MPO Gene-Phenotype Associations)", "abnormal eye anterior chamber depth (MP:0011960 from MPO Gene-Phenotype Associations)", "abnormal eye posterior chamber morphology (MP:0005299 from MPO Gene-Phenotype Associations)", "aortic arch hypoplasia (MP:0010485 from MPO Gene-Phenotype Associations)", "aortic valve atresia (MP:0006115 from MPO Gene-Phenotype Associations)", "failure of myelopoiesis (MP:0001603 from MPO Gene-Phenotype Associations)", "abnormal mitral valve cusp morphology (MP:0010614 from MPO Gene-Phenotype Associations)", "thick mitral valve cusps (MP:0010617 from MPO Gene-Phenotype Associations)", "thick mitral valve (MP:0010620 from MPO Gene-Phenotype Associations)", "heart right ventricle aneurysm (MP:0010423 from MPO Gene-Phenotype Associations)", "ventricular aneurysm (MP:0010421 from MPO Gene-Phenotype Associations)", "thick tricuspid valve (MP:0010629 from MPO Gene-Phenotype Associations)", "abnormal aortic valve cusp morphology (MP:0010595 from MPO Gene-Phenotype Associations)", "thick aortic valve cusps (MP:0010593 from MPO Gene-Phenotype Associations)", "thick heart valve cusps (MP:0011648 from MPO Gene-Phenotype Associations)", "abnormal pulmonary valve cusp morphology (MP:0010602 from MPO Gene-Phenotype Associations)", "thick pulmonary valve cusps (MP:0010605 from MPO Gene-Phenotype Associations)", "thick aortic valve (MP:0010594 from MPO Gene-Phenotype Associations)", "thick pulmonary valve (MP:0010601 from MPO Gene-Phenotype Associations)", "abnormal aortic valve morphology (MP:0002747 from MPO Gene-Phenotype Associations)", "abnormal heart left ventricle outflow tract morphology (MP:0010429 from MPO Gene-Phenotype Associations)", "abnormal heart ventricle outflow tract morphology (MP:0010224 from MPO Gene-Phenotype Associations)", "abnormal semilunar valve morphology (MP:0002746 from MPO Gene-Phenotype Associations)", "abnormal heart valve morphology (MP:0000285 from MPO Gene-Phenotype Associations)", "abnormal heart right ventricle outflow tract morphology (MP:0010428 from MPO Gene-Phenotype Associations)", "abnormal pulmonary valve morphology (MP:0002748 from MPO Gene-Phenotype Associations)", "heart right ventricle outflow tract stenosis (MP:0010449 from MPO Gene-Phenotype Associations)", "pulmonary valve stenosis (MP:0006128 from MPO Gene-Phenotype Associations)", "aortic valve stenosis (MP:0006117 from MPO Gene-Phenotype Associations)", "heart left ventricle outflow tract stenosis (MP:0010448 from MPO Gene-Phenotype Associations)", "abnormal atrioventricular valve morphology (MP:0002745 from MPO Gene-Phenotype Associations)", "abnormal heart atrium and ventricle connection (MP:0010435 from MPO Gene-Phenotype Associations)", "abnormal mitral valve morphology (MP:0000286 from MPO Gene-Phenotype Associations)", "abnormal tricuspid valve morphology (MP:0002624 from MPO Gene-Phenotype Associations)", "tricuspid valve atresia (MP:0006123 from MPO Gene-Phenotype Associations)", "absent interventricular septum membranous part (MP:0008824 from MPO Gene-Phenotype Associations)", "tricuspid valve regurgitation (MP:0006044 from MPO Gene-Phenotype Associations)", "tricuspid valve stenosis (MP:0006124 from MPO Gene-Phenotype Associations)", "atrioventricular valve regurgitation (MP:0006046 from MPO Gene-Phenotype Associations)", "mitral valve regurgitation (MP:0006045 from MPO Gene-Phenotype Associations)", "bicuspid aortic valve (MP:0010484 from MPO Gene-Phenotype Associations)", "pulmonary valve regurgitation (MP:0006048 from MPO Gene-Phenotype Associations)", "abnormal cardiac valve physiology (MP:0011926 from MPO Gene-Phenotype Associations)", "cardiac valve regurgitation (MP:0009384 from MPO Gene-Phenotype Associations)", "semilunar valve regurgitation (MP:0006049 from MPO Gene-Phenotype Associations)", "aortic valve regurgitation (MP:0006047 from MPO Gene-Phenotype Associations)", "abnormal pulmonary artery morphology (MP:0000484 from MPO Gene-Phenotype Associations)", "pulmonary artery hypoplasia (MP:0010460 from MPO Gene-Phenotype Associations)", "thick diaphragm muscle (MP:0012059 from MPO Gene-Phenotype Associations)", "diaphragm muscle hyperplasia (MP:0012060 from MPO Gene-Phenotype Associations)", "abnormal central tendon morphology (MP:0012061 from MPO Gene-Phenotype Associations)", "micrognathia (MP:0002639 from MPO Gene-Phenotype Associations)", "double outlet right ventricle, taussig bing type (MP:0011668 from MPO Gene-Phenotype Associations)", "double outlet right ventricle with atrioventricular septal defect (MP:0011667 from MPO Gene-Phenotype Associations)", "abdominal situs ambiguus (MP:0011250 from MPO Gene-Phenotype Associations)", "dual inferior vena cava (MP:0011683 from MPO Gene-Phenotype Associations)", "abnormal inferior vena cava morphology (MP:0006063 from MPO Gene-Phenotype Associations)", "abnormal vena cava morphology (MP:0006062 from MPO Gene-Phenotype Associations)", "abnormal heart position or orientation (MP:0006065 from MPO Gene-Phenotype Associations)", "dextrocardia (MP:0000644 from MPO Gene-Phenotype Associations)", "heterotaxia (MP:0004133 from MPO Gene-Phenotype Associations)", "situs inversus (MP:0002766 from MPO Gene-Phenotype Associations)", "abnormal lung position or orientation (MP:0010853 from MPO Gene-Phenotype Associations)", "left pulmonary isomerism (MP:0003178 from MPO Gene-Phenotype Associations)", "left-sided isomerism (MP:0000542 from MPO Gene-Phenotype Associations)", "abnormal right lung morphology (MP:0009570 from MPO Gene-Phenotype Associations)", "mesocardia (MP:0000650 from MPO Gene-Phenotype Associations)", "right atrial isomerism (MP:0006061 from MPO Gene-Phenotype Associations)", "abnormal left lung morphology (MP:0009569 from MPO Gene-Phenotype Associations)", "right pulmonary isomerism (MP:0000531 from MPO Gene-Phenotype Associations)", "right-sided isomerism (MP:0000508 from MPO Gene-Phenotype Associations)", "abnormal digestive organ placement (MP:0003283 from MPO Gene-Phenotype Associations)", "abnormal stomach position or orientation (MP:0010807 from MPO Gene-Phenotype Associations)", "right-sided stomach (MP:0010808 from MPO Gene-Phenotype Associations)", "situs inversus totalis (MP:0011252 from MPO Gene-Phenotype Associations)", "immotile respiratory cilia (MP:0011649 from MPO Gene-Phenotype Associations)", "abdominal situs inversus (MP:0011249 from MPO Gene-Phenotype Associations)", "abnormal cilium physiology (MP:0013208 from MPO Gene-Phenotype Associations)", "abnormal motile cilium physiology (MP:0013209 from MPO Gene-Phenotype Associations)", "abnormal respiratory motile cilium physiology (MP:0011055 from MPO Gene-Phenotype Associations)", "lung situs inversus (MP:0010854 from MPO Gene-Phenotype Associations)", "situs ambiguus (MP:0002767 from MPO Gene-Phenotype Associations)", "superior-inferior ventricles (MP:0011254 from MPO Gene-Phenotype Associations)", "biventricular, discordant atrioventricular connection (MP:0011510 from MPO Gene-Phenotype Associations)", "biventricular, ambiguous atrioventricular connection (MP:0011511 from MPO Gene-Phenotype Associations)", "situs inversus with levocardia (MP:0011253 from MPO Gene-Phenotype Associations)", "isolation of the left subclavian artery (MP:0011745 from MPO Gene-Phenotype Associations)", "abnormal heart atrium auricular region morphology (MP:0010489 from MPO Gene-Phenotype Associations)", "duplex kidney (MP:0004017 from MPO Gene-Phenotype Associations)", "double outlet right ventricle, ventricular defect committed to aorta (MP:0011666 from MPO Gene-Phenotype Associations)", "d-loop transposition of the great arteries (MP:0011665 from MPO Gene-Phenotype Associations)", "accessory spleen (MP:0003342 from MPO Gene-Phenotype Associations)", "transposition of great arteries (MP:0004110 from MPO Gene-Phenotype Associations)", "interrupted aortic arch, type b (MP:0011659 from MPO Gene-Phenotype Associations)", "absent spleen (MP:0000690 from MPO Gene-Phenotype Associations)", "abnormal aorta morphology (MP:0000272 from MPO Gene-Phenotype Associations)", "abnormal systemic artery morphology (MP:0011655 from MPO Gene-Phenotype Associations)", "abnormal artery morphology (MP:0002191 from MPO Gene-Phenotype Associations)", "abnormal aortic arch morphology (MP:0004113 from MPO Gene-Phenotype Associations)", "abnormal thoracic aorta morphology (MP:0010468 from MPO Gene-Phenotype Associations)", "right aortic arch (MP:0004158 from MPO Gene-Phenotype Associations)", "interrupted aorta (MP:0010544 from MPO Gene-Phenotype Associations)", "interrupted aortic arch (MP:0004157 from MPO Gene-Phenotype Associations)", "aberrant origin of the right subclavian artery (MP:0010465 from MPO Gene-Phenotype Associations)", "abnormal right subclavian artery morphology (MP:0010487 from MPO Gene-Phenotype Associations)", "abnormal aortic arch and aortic arch branch attachment (MP:0010464 from MPO Gene-Phenotype Associations)", "abnormal subclavian artery morphology (MP:0003395 from MPO Gene-Phenotype Associations)", "retroesophageal right subclavian artery (MP:0004160 from MPO Gene-Phenotype Associations)", "persistent right dorsal aorta (MP:0010572 from MPO Gene-Phenotype Associations)", "double aortic arch (MP:0004159 from MPO Gene-Phenotype Associations)", "vascular ring (MP:0010466 from MPO Gene-Phenotype Associations)", "abnormal pharyngeal arch artery morphology (MP:0002672 from MPO Gene-Phenotype Associations)", "abnormal fourth pharyngeal arch artery morphology (MP:0006354 from MPO Gene-Phenotype Associations)", "abnormal fourth pharyngeal arch morphology (MP:0006340 from MPO Gene-Phenotype Associations)", "abnormal sixth pharyngeal arch artery morphology (MP:0006355 from MPO Gene-Phenotype Associations)", "abnormal sixth pharyngeal arch morphology (MP:0006347 from MPO Gene-Phenotype Associations)", "abnormal third pharyngeal arch artery morphology (MP:0006356 from MPO Gene-Phenotype Associations)", "abnormal third pharyngeal arch morphology (MP:0006339 from MPO Gene-Phenotype Associations)", "abnormal aorticopulmonary septum morphology (MP:0010650 from MPO Gene-Phenotype Associations)", "aorticopulmonary septal defect (MP:0010651 from MPO Gene-Phenotype Associations)", "persistent truncus arteriosis (MP:0002633 from MPO Gene-Phenotype Associations)", "abnormal truncus arteriosus septation (MP:0010454 from MPO Gene-Phenotype Associations)", "abnormal outflow tract development (MP:0006126 from MPO Gene-Phenotype Associations)", "abnormal heart and great artery attachment (MP:0010426 from MPO Gene-Phenotype Associations)", "abnormal heart and great vessel attachment (MP:0010425 from MPO Gene-Phenotype Associations)", "double outlet right ventricle (MP:0000284 from MPO Gene-Phenotype Associations)", "abnormal heart septum morphology (MP:0006113 from MPO Gene-Phenotype Associations)", "abnormal interventricular septum morphology (MP:0000281 from MPO Gene-Phenotype Associations)", "ventricular septal defect (MP:0010402 from MPO Gene-Phenotype Associations)", "abnormal heart ventricle morphology (MP:0005294 from MPO Gene-Phenotype Associations)", "abnormal interatrial septum morphology (MP:0000282 from MPO Gene-Phenotype Associations)", "atrial septal defect (MP:0010403 from MPO Gene-Phenotype Associations)", "abnormal heart atrium morphology (MP:0003105 from MPO Gene-Phenotype Associations)", "abnormal atrioventricular septum morphology (MP:0010592 from MPO Gene-Phenotype Associations)", "atrioventricular septal defect (MP:0010412 from MPO Gene-Phenotype Associations)", "complete atrioventricular septal defect (MP:0010413 from MPO Gene-Phenotype Associations)", "overriding aortic valve (MP:0000273 from MPO Gene-Phenotype Associations)", "abnormal interventricular septum membranous part morphology (MP:0008823 from MPO Gene-Phenotype Associations)", "perimembraneous ventricular septal defect (MP:0010418 from MPO Gene-Phenotype Associations)", "abnormal interventricular septum muscular part morphology (MP:0010498 from MPO Gene-Phenotype Associations)", "muscular ventricular septal defect (MP:0010420 from MPO Gene-Phenotype Associations)", "left atrial isomerism (MP:0008461 from MPO Gene-Phenotype Associations)", "abnormal hepatic portal vein morphology (MP:0010668 from MPO Gene-Phenotype Associations)", "abnormal large intestine placement (MP:0003284 from MPO Gene-Phenotype Associations)", "abnormal kidney venous blood vessel morphology (MP:0011311 from MPO Gene-Phenotype Associations)", "abnormal renal vein morphology (MP:0011323 from MPO Gene-Phenotype Associations)", "abnormal left renal vein morphology (MP:0011327 from MPO Gene-Phenotype Associations)", "abnormal left subclavian artery morphology (MP:0010488 from MPO Gene-Phenotype Associations)", "abnormal ascending aorta and coronary artery attachment (MP:0010472 from MPO Gene-Phenotype Associations)", "persistent truncus arteriosus type ii (MP:0011662 from MPO Gene-Phenotype Associations)", "atrium cysts (MP:0011681 from MPO Gene-Phenotype Associations)", "absent fetal ductus arteriosus (MP:0010565 from MPO Gene-Phenotype Associations)", "persistent truncus arteriosus type i (MP:0011661 from MPO Gene-Phenotype Associations)", "abnormal vascular endothelial cell development (MP:0003542 from MPO Gene-Phenotype Associations)", "abnormal vascular endothelial cell migration (MP:0003544 from MPO Gene-Phenotype Associations)", "descending aorta dilation (MP:0010473 from MPO Gene-Phenotype Associations)", "brain aneurysm (MP:0010479 from MPO Gene-Phenotype Associations)", "abnormal coronary artery morphology (MP:0004111 from MPO Gene-Phenotype Associations)", "abnormal coronary vessel morphology (MP:0010551 from MPO Gene-Phenotype Associations)", "coronary fistula (MP:0010476 from MPO Gene-Phenotype Associations)", "coronary-cameral fistula (MP:0011657 from MPO Gene-Phenotype Associations)", "coronary-cameral fistula to right ventricle (MP:0011684 from MPO Gene-Phenotype Associations)", "abnormal developmental vascular remodeling (MP:0009577 from MPO Gene-Phenotype Associations)", "abnormal vascular regression (MP:0000364 from MPO Gene-Phenotype Associations)", "patent ductus arteriosus (MP:0003139 from MPO Gene-Phenotype Associations)", "abnormal fetal ductus arteriosus morphology (MP:0010564 from MPO Gene-Phenotype Associations)", "neural tube degeneration (MP:0012509 from MPO Gene-Phenotype Associations)", "abnormal septum transversum morphology (MP:0012252 from MPO Gene-Phenotype Associations)", "abnormal blood vessel endothelium morphology (MP:0009489 from MPO Gene-Phenotype Associations)", "abnormal vascular endothelial cell morphology (MP:0006055 from MPO Gene-Phenotype Associations)", "decreased vascular endothelial cell number (MP:0006057 from MPO Gene-Phenotype Associations)", "abnormal vascular branching morphogenesis (MP:0003227 from MPO Gene-Phenotype Associations)", "failure of vascular branching (MP:0000264 from MPO Gene-Phenotype Associations)", "retinal fibrosis (MP:0006186 from MPO Gene-Phenotype Associations)", "mesangial cell hypoplasia (MP:0011428 from MPO Gene-Phenotype Associations)", "increased vascular endothelial cell number (MP:0006056 from MPO Gene-Phenotype Associations)", "abnormal pericyte morphology (MP:0003719 from MPO Gene-Phenotype Associations)", "abnormal induced retinal neovascularization (MP:0009660 from MPO Gene-Phenotype Associations)", "retinal neovascularization (MP:0008852 from MPO Gene-Phenotype Associations)", "abnormal retinal vasculature morphology (MP:0002792 from MPO Gene-Phenotype Associations)", "decreased angiogenesis (MP:0005602 from MPO Gene-Phenotype Associations)", "abnormal vascular endothelial cell physiology (MP:0004003 from MPO Gene-Phenotype Associations)", "abnormal vascular permeability (MP:0001619 from MPO Gene-Phenotype Associations)", "increased vascular permeability (MP:0003070 from MPO Gene-Phenotype Associations)", "decreased vascular permeability (MP:0003071 from MPO Gene-Phenotype Associations)", "kidney microaneurysm (MP:0010451 from MPO Gene-Phenotype Associations)", "absent mesangial cell (MP:0011429 from MPO Gene-Phenotype Associations)", "decreased kidney cell proliferation (MP:0011441 from MPO Gene-Phenotype Associations)", "glomerular capillary thrombosis (MP:0011508 from MPO Gene-Phenotype Associations)", "kidney thrombosis (MP:0011507 from MPO Gene-Phenotype Associations)", "renal glomerulus lipidosis (MP:0011561 from MPO Gene-Phenotype Associations)", "abnormal fetal cardiomyocyte apoptosis (MP:0011391 from MPO Gene-Phenotype Associations)", "increased fetal cardiomyocyte apoptosis (MP:0011392 from MPO Gene-Phenotype Associations)", "abnormal polar body morphology (MP:0012736 from MPO Gene-Phenotype Associations)", "abnormal primary polar body morphology (MP:0012737 from MPO Gene-Phenotype Associations)", "parthenogenesis (MP:0009443 from MPO Gene-Phenotype Associations)", "abnormal blood-cerebrospinal fluid barrier function (MP:0006088 from MPO Gene-Phenotype Associations)", "abnormal blood-brain barrier function (MP:0005167 from MPO Gene-Phenotype Associations)", "persistent truncus arteriosus type iv (MP:0011664 from MPO Gene-Phenotype Associations)", "increased pulmonary vascular resistance (MP:0003034 from MPO Gene-Phenotype Associations)", "absent heart valves (MP:0012250 from MPO Gene-Phenotype Associations)", "abnormal pulmonary vascular resistance (MP:0003033 from MPO Gene-Phenotype Associations)", "partial embryonic lethality between implantation and placentation (MP:0011105 from MPO Gene-Phenotype Associations)", "abnormal pulmonary pressure (MP:0003547 from MPO Gene-Phenotype Associations)", "increased pulmonary artery pressure (MP:0004012 from MPO Gene-Phenotype Associations)", "pulmonary hypertension (MP:0003548 from MPO Gene-Phenotype Associations)", "abnormal heart right ventricle pressure (MP:0010755 from MPO Gene-Phenotype Associations)", "increased right ventricle systolic pressure (MP:0010758 from MPO Gene-Phenotype Associations)", "myopia (MP:0003100 from MPO Gene-Phenotype Associations)", "increased platelet aggregation (MP:0009586 from MPO Gene-Phenotype Associations)", "loss of cortex neurons (MP:0003241 from MPO Gene-Phenotype Associations)", "loss of glutamate neurons (MP:0003248 from MPO Gene-Phenotype Associations)", "decreased left ventricle developed pressure (MP:0003824 from MPO Gene-Phenotype Associations)", "abnormal cardiac muscle relaxation (MP:0004084 from MPO Gene-Phenotype Associations)", "abnormal muscle relaxation (MP:0004036 from MPO Gene-Phenotype Associations)", "abnormal heart left ventricle pressure (MP:0010754 from MPO Gene-Phenotype Associations)", "abnormal heart ventricle pressure (MP:0008775 from MPO Gene-Phenotype Associations)", "decreased left ventricle systolic pressure (MP:0003822 from MPO Gene-Phenotype Associations)", "increased left ventricle diastolic pressure (MP:0003819 from MPO Gene-Phenotype Associations)", "abnormal interventricular septum thickness (MP:0020136 from MPO Gene-Phenotype Associations)", "thick interventricular septum (MP:0010724 from MPO Gene-Phenotype Associations)", "thick ventricular wall (MP:0002953 from MPO Gene-Phenotype Associations)", "thin interventricular septum (MP:0010725 from MPO Gene-Phenotype Associations)", "abnormal heart left ventricle morphology (MP:0003921 from MPO Gene-Phenotype Associations)", "abnormal heart left ventricle size (MP:0010578 from MPO Gene-Phenotype Associations)", "increased heart left ventricle size (MP:0010579 from MPO Gene-Phenotype Associations)", "heart left ventricle hypertrophy (MP:0002625 from MPO Gene-Phenotype Associations)", "increased heart ventricle size (MP:0008772 from MPO Gene-Phenotype Associations)", "abnormal heart size (MP:0005406 from MPO Gene-Phenotype Associations)", "enlarged heart (MP:0000274 from MPO Gene-Phenotype Associations)", "cardiac hypertrophy (MP:0001625 from MPO Gene-Phenotype Associations)", "abnormal heart weight (MP:0004857 from MPO Gene-Phenotype Associations)", "increased heart weight (MP:0002833 from MPO Gene-Phenotype Associations)", "abnormal heart right ventricle morphology (MP:0003920 from MPO Gene-Phenotype Associations)", "increased heart right ventricle size (MP:0010563 from MPO Gene-Phenotype Associations)", "abnormal heart right ventricle size (MP:0010577 from MPO Gene-Phenotype Associations)", "dilated heart right ventricle (MP:0002754 from MPO Gene-Phenotype Associations)", "dilated heart (MP:0004937 from MPO Gene-Phenotype Associations)", "dilated heart ventricle (MP:0008022 from MPO Gene-Phenotype Associations)", "dilated heart left ventricle (MP:0002753 from MPO Gene-Phenotype Associations)", "heart right ventricle hypertrophy (MP:0000276 from MPO Gene-Phenotype Associations)", "cardiomyopathy (MP:0005330 from MPO Gene-Phenotype Associations)", "dilated cardiomyopathy (MP:0002795 from MPO Gene-Phenotype Associations)", "cardiac fibrosis (MP:0003141 from MPO Gene-Phenotype Associations)", "cardiac interstitial fibrosis (MP:0005608 from MPO Gene-Phenotype Associations)", "abnormal cardiac muscle tissue morphology (MP:0010630 from MPO Gene-Phenotype Associations)", "abnormal heart layer morphology (MP:0010545 from MPO Gene-Phenotype Associations)", "abnormal myocardium layer morphology (MP:0005329 from MPO Gene-Phenotype Associations)", "abnormal myocardial fiber morphology (MP:0000278 from MPO Gene-Phenotype Associations)", "abnormal muscle fiber morphology (MP:0004087 from MPO Gene-Phenotype Associations)", "abnormal muscle morphology (MP:0002108 from MPO Gene-Phenotype Associations)", "muscle phenotype (MP:0005369 from MPO Gene-Phenotype Associations)", "abnormal muscle physiology (MP:0002106 from MPO Gene-Phenotype Associations)", "abnormal cardiac muscle contractility (MP:0002972 from MPO Gene-Phenotype Associations)", "decreased cardiac muscle contractility (MP:0005140 from MPO Gene-Phenotype Associations)", "abnormal muscle contractility (MP:0005620 from MPO Gene-Phenotype Associations)", "impaired muscle contractility (MP:0000738 from MPO Gene-Phenotype Associations)", "decreased ventricle muscle contractility (MP:0005598 from MPO Gene-Phenotype Associations)", "enlarged myocardial fiber (MP:0004564 from MPO Gene-Phenotype Associations)", "abnormal heart left ventricle weight (MP:0020204 from MPO Gene-Phenotype Associations)", "increased left ventricle weight (MP:0003915 from MPO Gene-Phenotype Associations)", "decreased heart weight (MP:0002834 from MPO Gene-Phenotype Associations)", "small heart (MP:0002188 from MPO Gene-Phenotype Associations)", "ventricular hypoplasia (MP:0000279 from MPO Gene-Phenotype Associations)", "abnormal heart ventricle wall thickness (MP:0020135 from MPO Gene-Phenotype Associations)", "thin ventricular wall (MP:0000280 from MPO Gene-Phenotype Associations)", "abnormal myocardial trabeculae morphology (MP:0002189 from MPO Gene-Phenotype Associations)", "abnormal trabecula carnea morphology (MP:0004067 from MPO Gene-Phenotype Associations)", "abnormal ventricle myocardium morphology (MP:0010499 from MPO Gene-Phenotype Associations)", "myocardial trabeculae hypoplasia (MP:0010503 from MPO Gene-Phenotype Associations)", "trabecula carnea hypoplasia (MP:0000295 from MPO Gene-Phenotype Associations)", "myocardium hypoplasia (MP:0010500 from MPO Gene-Phenotype Associations)", "ventricle myocardium hypoplasia (MP:0010502 from MPO Gene-Phenotype Associations)", "thin myocardium (MP:0002652 from MPO Gene-Phenotype Associations)", "abnormal myocardium compact layer morphology (MP:0004056 from MPO Gene-Phenotype Associations)", "thin myocardium compact layer (MP:0004057 from MPO Gene-Phenotype Associations)", "thin ventricle myocardium compact layer (MP:0010556 from MPO Gene-Phenotype Associations)", "abnormal fetal cardiomyocyte physiology (MP:0011390 from MPO Gene-Phenotype Associations)", "abnormal fetal cardiomyocyte proliferation (MP:0003567 from MPO Gene-Phenotype Associations)", "decreased fetal cardiomyocyte proliferation (MP:0011395 from MPO Gene-Phenotype Associations)", "abnormal cardiomyocyte apoptosis (MP:0003221 from MPO Gene-Phenotype Associations)", "increased cardiomyocyte apoptosis (MP:0003222 from MPO Gene-Phenotype Associations)", "abnormal myocardial fiber physiology (MP:0004215 from MPO Gene-Phenotype Associations)", "decreased cardiomyocyte apoptosis (MP:0003223 from MPO Gene-Phenotype Associations)", "altered response to myocardial infarction (MP:0000343 from MPO Gene-Phenotype Associations)", "increased myocardial infarction size (MP:0003037 from MPO Gene-Phenotype Associations)", "decreased myocardial infarction size (MP:0003038 from MPO Gene-Phenotype Associations)", "abnormal response to injury (MP:0005164 from MPO Gene-Phenotype Associations)", "decreased susceptibility to injury (MP:0005166 from MPO Gene-Phenotype Associations)", "altered response to cns ischemic injury (MP:0003075 from MPO Gene-Phenotype Associations)", "decreased cerebral infarction size (MP:0006058 from MPO Gene-Phenotype Associations)", "decreased susceptibility to ischemic brain injury (MP:0006059 from MPO Gene-Phenotype Associations)", "increased cerebral infarction size (MP:0006060 from MPO Gene-Phenotype Associations)", "increased susceptibility to ischemic brain injury (MP:0003076 from MPO Gene-Phenotype Associations)", "increased susceptibility to injury (MP:0005165 from MPO Gene-Phenotype Associations)", "altered response of heart to induced stress (MP:0004484 from MPO Gene-Phenotype Associations)", "increased response of heart to induced stress (MP:0004485 from MPO Gene-Phenotype Associations)", "decreased response of heart to induced stress (MP:0004486 from MPO Gene-Phenotype Associations)", "abnormal blood vessel physiology (MP:0000249 from MPO Gene-Phenotype Associations)", "abnormal vascular smooth muscle physiology (MP:0005595 from MPO Gene-Phenotype Associations)", "abnormal vasodilation (MP:0001613 from MPO Gene-Phenotype Associations)", "decreased vasodilation (MP:0005591 from MPO Gene-Phenotype Associations)", "abnormal vasoconstriction (MP:0000250 from MPO Gene-Phenotype Associations)", "increased vasoconstriction (MP:0003025 from MPO Gene-Phenotype Associations)", "impaired smooth muscle contractility (MP:0000740 from MPO Gene-Phenotype Associations)", "decreased vasoconstriction (MP:0003026 from MPO Gene-Phenotype Associations)", "increased vasodilation (MP:0005590 from MPO Gene-Phenotype Associations)", "abnormal systemic arterial blood pressure (MP:0000230 from MPO Gene-Phenotype Associations)", "increased systemic arterial blood pressure (MP:0002842 from MPO Gene-Phenotype Associations)", "increased systemic arterial diastolic blood pressure (MP:0006143 from MPO Gene-Phenotype Associations)", "increased systemic arterial systolic blood pressure (MP:0006144 from MPO Gene-Phenotype Associations)", "hypertension (MP:0000231 from MPO Gene-Phenotype Associations)", "increased mean systemic arterial blood pressure (MP:0004875 from MPO Gene-Phenotype Associations)", "abnormal vascular wound healing (MP:0004883 from MPO Gene-Phenotype Associations)", "abnormal wound healing (MP:0005023 from MPO Gene-Phenotype Associations)", "delayed wound healing (MP:0002908 from MPO Gene-Phenotype Associations)", "impaired wound healing (MP:0001792 from MPO Gene-Phenotype Associations)", "abnormal response|metabolism to endogenous compounds (MP:0003638 from MPO Gene-Phenotype Associations)", "abnormal enzyme|coenzyme activity (MP:0005584 from MPO Gene-Phenotype Associations)", "abnormal metabolism (MP:0005266 from MPO Gene-Phenotype Associations)", "enlarged hind paws (MP:0000573 from MPO Gene-Phenotype Associations)", "thick ears (MP:0000019 from MPO Gene-Phenotype Associations)", "cellular necrosis (MP:0000316 from MPO Gene-Phenotype Associations)", "abnormal heart left atrium weight (MP:0020206 from MPO Gene-Phenotype Associations)", "increased heart left atrium weight (MP:0011915 from MPO Gene-Phenotype Associations)", "abnormal m lines (MP:0004094 from MPO Gene-Phenotype Associations)", "abnormal diastolic filling velocity (MP:0004009 from MPO Gene-Phenotype Associations)", "decreased diastolic filling velocity (MP:0004011 from MPO Gene-Phenotype Associations)", "increased left ventricle systolic pressure (MP:0003820 from MPO Gene-Phenotype Associations)", "abnormal vasculogenesis (MP:0001622 from MPO Gene-Phenotype Associations)", "absent organized vascular network (MP:0000263 from MPO Gene-Phenotype Associations)", "absent heartbeat (MP:0004086 from MPO Gene-Phenotype Associations)", "short frontal bone (MP:0004380 from MPO Gene-Phenotype Associations)", "otic hypertelorism (MP:0000025 from MPO Gene-Phenotype Associations)", "increased cranium width (MP:0000441 from MPO Gene-Phenotype Associations)", "abnormal heart right atrium morphology (MP:0003922 from MPO Gene-Phenotype Associations)", "dilated heart right atrium (MP:0004062 from MPO Gene-Phenotype Associations)", "dilated heart atrium (MP:0003140 from MPO Gene-Phenotype Associations)", "abnormal heart left atrium morphology (MP:0003923 from MPO Gene-Phenotype Associations)", "dilated heart left atrium (MP:0004063 from MPO Gene-Phenotype Associations)", "absent choroid plexus (MP:0008934 from MPO Gene-Phenotype Associations)", "aorta pulmonary collateral arteries (MP:0010635 from MPO Gene-Phenotype Associations)", "multiple major aortopulmonary collateral arteries (MP:0011674 from MPO Gene-Phenotype Associations)", "pulmonary valve atresia (MP:0006130 from MPO Gene-Phenotype Associations)", "abnormal podocyte motility (MP:0011865 from MPO Gene-Phenotype Associations)", "tracheoesophageal fistula (MP:0003321 from MPO Gene-Phenotype Associations)", "abnormal esophagus morphology (MP:0000467 from MPO Gene-Phenotype Associations)", "dilated esophagus (MP:0004548 from MPO Gene-Phenotype Associations)", "persistent ductus caroticus (MP:0012310 from MPO Gene-Phenotype Associations)", "abnormal kidney efferent arteriole morphology (MP:0011313 from MPO Gene-Phenotype Associations)", "renal ischemia (MP:0011758 from MPO Gene-Phenotype Associations)", "cardiac ischemia (MP:0004120 from MPO Gene-Phenotype Associations)", "ectopic thymus (MP:0003007 from MPO Gene-Phenotype Associations)", "abnormal vascular endothelial cell differentiation (MP:0003543 from MPO Gene-Phenotype Associations)", "abnormal pulmonary trunk morphology (MP:0000486 from MPO Gene-Phenotype Associations)", "pulmonary trunk hypoplasia (MP:0010458 from MPO Gene-Phenotype Associations)", "abnormal venule morphology (MP:0004125 from MPO Gene-Phenotype Associations)", "eye hemorrhage (MP:0006203 from MPO Gene-Phenotype Associations)", "retinal hemorrhage (MP:0006185 from MPO Gene-Phenotype Associations)", "purpura (MP:0011515 from MPO Gene-Phenotype Associations)", "absent podocytes (MP:0008137 from MPO Gene-Phenotype Associations)", "abnormal arteriole morphology (MP:0004112 from MPO Gene-Phenotype Associations)", "abnormal vascular smooth muscle development (MP:0011401 from MPO Gene-Phenotype Associations)", "abnormal circulating pancreatic peptide level (MP:0008459 from MPO Gene-Phenotype Associations)", "abnormal st segment (MP:0003897 from MPO Gene-Phenotype Associations)", "prolonged st segment (MP:0010570 from MPO Gene-Phenotype Associations)", "absent kidney papilla (MP:0011303 from MPO Gene-Phenotype Associations)", "increased mitochondria number (MP:0011628 from MPO Gene-Phenotype Associations)", "increased rhombomere 3 size (MP:0012794 from MPO Gene-Phenotype Associations)", "absent superior olivary complex (MP:0000842 from MPO Gene-Phenotype Associations)", "abnormal external carotid artery morphology (MP:0012731 from MPO Gene-Phenotype Associations)", "absent vestibular nerve (MP:0004719 from MPO Gene-Phenotype Associations)", "absent vestibulocochlear nerve (MP:0004715 from MPO Gene-Phenotype Associations)", "rhombomere fusion (MP:0012817 from MPO Gene-Phenotype Associations)", "small superior glossopharyngeal ganglion (MP:0001098 from MPO Gene-Phenotype Associations)", "absent endolymphatic sac (MP:0006013 from MPO Gene-Phenotype Associations)", "abnormal superior vagus ganglion morphology (MP:0001101 from MPO Gene-Phenotype Associations)", "abnormal superior glossopharyngeal ganglion morphology (MP:0001097 from MPO Gene-Phenotype Associations)", "abnormal internal carotid artery morphology (MP:0012730 from MPO Gene-Phenotype Associations)", "anoxia (MP:0002316 from MPO Gene-Phenotype Associations)", "abnormal cranial neural crest cell migration (MP:0012757 from MPO Gene-Phenotype Associations)", "parathyroid hypoplasia (MP:0003494 from MPO Gene-Phenotype Associations)", "small parathyroid gland (MP:0003113 from MPO Gene-Phenotype Associations)", "decreased activity of parathyroid (MP:0003433 from MPO Gene-Phenotype Associations)", "absent facial nerve (MP:0004561 from MPO Gene-Phenotype Associations)", "absent facial nuclei (MP:0000843 from MPO Gene-Phenotype Associations)", "abnormal lower lip morphology (MP:0012524 from MPO Gene-Phenotype Associations)", "small facial motor nucleus (MP:0000910 from MPO Gene-Phenotype Associations)", "abnormal facial motor nucleus morphology (MP:0000909 from MPO Gene-Phenotype Associations)", "abnormal pons morphology (MP:0000848 from MPO Gene-Phenotype Associations)", "abnormal cochlear viii nucleus morphology (MP:0012490 from MPO Gene-Phenotype Associations)", "abnormal endolymphatic duct morphology (MP:0006011 from MPO Gene-Phenotype Associations)", "decreased cochlear coiling (MP:0003148 from MPO Gene-Phenotype Associations)", "short endolymphatic duct (MP:0008065 from MPO Gene-Phenotype Associations)", "small endolymphatic duct (MP:0008066 from MPO Gene-Phenotype Associations)", "abnormal ear development (MP:0003938 from MPO Gene-Phenotype Associations)", "abnormal otic vesicle morphology (MP:0009806 from MPO Gene-Phenotype Associations)", "abnormal otic vesicle development (MP:0006030 from MPO Gene-Phenotype Associations)", "small otic vesicle (MP:0004310 from MPO Gene-Phenotype Associations)", "abnormal vestibulocochlear ganglion morphology (MP:0003703 from MPO Gene-Phenotype Associations)", "absent utricle (MP:0004369 from MPO Gene-Phenotype Associations)", "absent vestibular saccule (MP:0004315 from MPO Gene-Phenotype Associations)", "abnormal common crus morphology (MP:0004922 from MPO Gene-Phenotype Associations)", "absent common crus (MP:0004923 from MPO Gene-Phenotype Associations)", "absent cochlear ganglion (MP:0003146 from MPO Gene-Phenotype Associations)", "absent endolymphatic duct (MP:0000041 from MPO Gene-Phenotype Associations)", "absent superior semicircular canal (MP:0003165 from MPO Gene-Phenotype Associations)", "absent posterior semicircular canal (MP:0003163 from MPO Gene-Phenotype Associations)", "abnormal superior semicircular canal morphology (MP:0003069 from MPO Gene-Phenotype Associations)", "abnormal posterior semicircular canal morphology (MP:0002858 from MPO Gene-Phenotype Associations)", "abnormal lateral semicircular canal morphology (MP:0000037 from MPO Gene-Phenotype Associations)", "absent lateral semicircular canal (MP:0003161 from MPO Gene-Phenotype Associations)", "decreased lateral semicircular canal size (MP:0003162 from MPO Gene-Phenotype Associations)", "absent semicircular canals (MP:0000036 from MPO Gene-Phenotype Associations)", "abnormal roof plate morphology (MP:0000923 from MPO Gene-Phenotype Associations)", "abnormal rhombic lip morphology (MP:0012525 from MPO Gene-Phenotype Associations)", "increased hindbrain apoptosis (MP:0012261 from MPO Gene-Phenotype Associations)", "meroanencephaly (MP:0002778 from MPO Gene-Phenotype Associations)", "increased embryonic neuroepithelium thickness (MP:0012702 from MPO Gene-Phenotype Associations)", "abnormal zygomatic bone morphology (MP:0005270 from MPO Gene-Phenotype Associations)", "short zygomatic bone (MP:0003108 from MPO Gene-Phenotype Associations)", "small zygomatic bone (MP:0004468 from MPO Gene-Phenotype Associations)", "absent scala media (MP:0000033 from MPO Gene-Phenotype Associations)", "absent vestibulocochlear ganglion (MP:0004313 from MPO Gene-Phenotype Associations)", "short squamosal bone (MP:0008430 from MPO Gene-Phenotype Associations)", "abnormal epaxial muscle morphology (MP:0004248 from MPO Gene-Phenotype Associations)", "absent parotid gland (MP:0008429 from MPO Gene-Phenotype Associations)", "unilateral deafness (MP:0004699 from MPO Gene-Phenotype Associations)", "small utricle (MP:0004336 from MPO Gene-Phenotype Associations)", "small vestibular saccule (MP:0004317 from MPO Gene-Phenotype Associations)", "abnormal rhombomere 2 morphology (MP:0012788 from MPO Gene-Phenotype Associations)", "abnormal rhombomere boundary morphology (MP:0012816 from MPO Gene-Phenotype Associations)", "absent styloid process (MP:0008386 from MPO Gene-Phenotype Associations)", "increased rhombomere 1 size (MP:0012786 from MPO Gene-Phenotype Associations)", "enlarged gonial bone (MP:0008383 from MPO Gene-Phenotype Associations)", "increased oligodendrocyte progenitor number (MP:0010892 from MPO Gene-Phenotype Associations)", "abnormal scala vestibuli morphology (MP:0003168 from MPO Gene-Phenotype Associations)", "abnormal malleus processus brevis morphology (MP:0010324 from MPO Gene-Phenotype Associations)", "absent malleus processus brevis (MP:0003110 from MPO Gene-Phenotype Associations)", "small malleus processus brevis (MP:0008378 from MPO Gene-Phenotype Associations)", "abnormal tympanic membrane morphology (MP:0006018 from MPO Gene-Phenotype Associations)", "abnormal external auditory canal morphology (MP:0006033 from MPO Gene-Phenotype Associations)", "mandible hypoplasia (MP:0000460 from MPO Gene-Phenotype Associations)", "abnormal meckel's cartilage morphology (MP:0005587 from MPO Gene-Phenotype Associations)", "abnormal squamosal bone morphology (MP:0004423 from MPO Gene-Phenotype Associations)", "abnormal temporal bone morphology (MP:0005272 from MPO Gene-Phenotype Associations)", "abnormal styloid process morphology (MP:0008023 from MPO Gene-Phenotype Associations)", "absent stapes (MP:0004204 from MPO Gene-Phenotype Associations)", "abnormal malleus morphology (MP:0000029 from MPO Gene-Phenotype Associations)", "abnormal stapes morphology (MP:0005107 from MPO Gene-Phenotype Associations)", "abnormal incus morphology (MP:0005106 from MPO Gene-Phenotype Associations)", "abnormal middle ear morphology (MP:0000049 from MPO Gene-Phenotype Associations)", "abnormal middle ear ossicle morphology (MP:0005105 from MPO Gene-Phenotype Associations)", "abnormal tympanic ring morphology (MP:0000030 from MPO Gene-Phenotype Associations)", "decreased tympanic ring size (MP:0006020 from MPO Gene-Phenotype Associations)", "abnormal gonial bone morphology (MP:0008380 from MPO Gene-Phenotype Associations)", "absent gonial bone (MP:0008381 from MPO Gene-Phenotype Associations)", "gonial bone hypoplasia (MP:0008382 from MPO Gene-Phenotype Associations)", "palatine bone hypoplasia (MP:0004475 from MPO Gene-Phenotype Associations)", "absent external auditory canal (MP:0009707 from MPO Gene-Phenotype Associations)", "absent tympanic membrane (MP:0006019 from MPO Gene-Phenotype Associations)", "absent malleus (MP:0004319 from MPO Gene-Phenotype Associations)", "absent incus (MP:0004318 from MPO Gene-Phenotype Associations)", "absent salivary gland (MP:0000614 from MPO Gene-Phenotype Associations)", "absent middle ear ossicles (MP:0000040 from MPO Gene-Phenotype Associations)", "absent tympanic ring (MP:0003138 from MPO Gene-Phenotype Associations)", "abnormal alisphenoid bone morphology (MP:0003235 from MPO Gene-Phenotype Associations)", "abnormal pterygoid bone morphology (MP:0004453 from MPO Gene-Phenotype Associations)", "abnormal pterygoid process morphology (MP:0004452 from MPO Gene-Phenotype Associations)", "small pterygoid bone (MP:0004456 from MPO Gene-Phenotype Associations)", "alisphenoid bone hypoplasia (MP:0004460 from MPO Gene-Phenotype Associations)", "small alisphenoid bone (MP:0004459 from MPO Gene-Phenotype Associations)", "absent alisphenoid bone (MP:0004458 from MPO Gene-Phenotype Associations)", "pterygoid bone hypoplasia (MP:0004455 from MPO Gene-Phenotype Associations)", "absent squamosal bone (MP:0004899 from MPO Gene-Phenotype Associations)", "decreased maxillary shelf size (MP:0009897 from MPO Gene-Phenotype Associations)", "maxillary shelf hypoplasia (MP:0009898 from MPO Gene-Phenotype Associations)", "abnormal malleus manubrium morphology (MP:0008374 from MPO Gene-Phenotype Associations)", "short malleus manubrium (MP:0008375 from MPO Gene-Phenotype Associations)", "small malleus manubrium (MP:0008376 from MPO Gene-Phenotype Associations)", "palatine bone horizontal plate hypoplasia (MP:0009896 from MPO Gene-Phenotype Associations)", "absent vomer bone (MP:0000099 from MPO Gene-Phenotype Associations)", "vomer bone hypoplasia (MP:0009900 from MPO Gene-Phenotype Associations)", "basisphenoid bone hypoplasia (MP:0004461 from MPO Gene-Phenotype Associations)", "abnormal vomer bone morphology (MP:0000098 from MPO Gene-Phenotype Associations)", "abnormal hard palate morphology (MP:0003756 from MPO Gene-Phenotype Associations)", "abnormal palate bone morphology (MP:0009891 from MPO Gene-Phenotype Associations)", "abnormal palatine bone horizontal plate morphology (MP:0004537 from MPO Gene-Phenotype Associations)", "abnormal palatine bone morphology (MP:0005249 from MPO Gene-Phenotype Associations)", "decreased palatine bone horizontal plate size (MP:0009895 from MPO Gene-Phenotype Associations)", "absent palatine bone horizontal plate (MP:0000431 from MPO Gene-Phenotype Associations)", "abnormal maxillary shelf morphology (MP:0004538 from MPO Gene-Phenotype Associations)", "absent maxillary shelf (MP:0000430 from MPO Gene-Phenotype Associations)", "abnormal multipotent stem cell morphology (MP:0002400 from MPO Gene-Phenotype Associations)", "ocular distichiasis (MP:0004095 from MPO Gene-Phenotype Associations)", "increased lymph node number (MP:0002218 from MPO Gene-Phenotype Associations)", "abnormal thoracic duct morphology (MP:0004107 from MPO Gene-Phenotype Associations)", "corneal abrasion (MP:0004105 from MPO Gene-Phenotype Associations)", "absent palatine bone (MP:0004476 from MPO Gene-Phenotype Associations)", "absent cartilage (MP:0002898 from MPO Gene-Phenotype Associations)", "abnormal iris pigment epithelium (MP:0005199 from MPO Gene-Phenotype Associations)", "aorta coarctation (MP:0003387 from MPO Gene-Phenotype Associations)", "aortic arch coarctation (MP:0010526 from MPO Gene-Phenotype Associations)", "abnormal pluripotent precursor cell morphology|development (MP:0002399 from MPO Gene-Phenotype Associations)", "periorbital edema (MP:0001788 from MPO Gene-Phenotype Associations)", "lymphatic vessel hyperplasia (MP:0004106 from MPO Gene-Phenotype Associations)", "abnormal glomerular endothelium fenestra morphology (MP:0011454 from MPO Gene-Phenotype Associations)", "absent glomerular endothelium fenestra (MP:0011455 from MPO Gene-Phenotype Associations)", "absent podocyte foot process (MP:0008138 from MPO Gene-Phenotype Associations)", "abnormal podocyte slit diaphragm morphology (MP:0008060 from MPO Gene-Phenotype Associations)", "absent podocyte slit diaphragm (MP:0008061 from MPO Gene-Phenotype Associations)", "abnormal podocyte slit junction morphology (MP:0008062 from MPO Gene-Phenotype Associations)", "abnormal sphenoid bone morphology (MP:0000104 from MPO Gene-Phenotype Associations)", "abnormal presphenoid bone morphology (MP:0004448 from MPO Gene-Phenotype Associations)", "abnormal basicranium morphology (MP:0010029 from MPO Gene-Phenotype Associations)", "abnormal basisphenoid bone morphology (MP:0000106 from MPO Gene-Phenotype Associations)", "small basisphenoid bone (MP:0004462 from MPO Gene-Phenotype Associations)", "absent presphenoid bone (MP:0004449 from MPO Gene-Phenotype Associations)", "abnormal basioccipital bone morphology (MP:0000079 from MPO Gene-Phenotype Associations)", "small basioccipital bone (MP:0004447 from MPO Gene-Phenotype Associations)", "abnormal occipital bone morphology (MP:0005269 from MPO Gene-Phenotype Associations)", "abnormal supraoccipital bone morphology (MP:0000078 from MPO Gene-Phenotype Associations)", "absent supraoccipital bone (MP:0004443 from MPO Gene-Phenotype Associations)", "abnormal exoccipital bone morphology (MP:0000080 from MPO Gene-Phenotype Associations)", "small exoccipital bone (MP:0004445 from MPO Gene-Phenotype Associations)", "abnormal first pharyngeal pouch morphology (MP:0013222 from MPO Gene-Phenotype Associations)", "absent vestibular ganglion (MP:0004299 from MPO Gene-Phenotype Associations)", "increased otic epithelium apoptosis (MP:0008063 from MPO Gene-Phenotype Associations)", "absent premaxilla (MP:0000090 from MPO Gene-Phenotype Associations)", "decreased otic epithelium proliferation (MP:0008064 from MPO Gene-Phenotype Associations)", "absent inner ear vestibule (MP:0004314 from MPO Gene-Phenotype Associations)", "absent cochlea (MP:0003147 from MPO Gene-Phenotype Associations)", "absent inner ear (MP:0006285 from MPO Gene-Phenotype Associations)", "absent outer ear (MP:0005579 from MPO Gene-Phenotype Associations)", "anotia (MP:0003142 from MPO Gene-Phenotype Associations)", "abnormal pharyngeal pouch morphology (MP:0006031 from MPO Gene-Phenotype Associations)", "abnormal ultimobranchial body morphology (MP:0003955 from MPO Gene-Phenotype Associations)", "absent ultimobranchial body (MP:0004914 from MPO Gene-Phenotype Associations)", "abnormal thyroid gland development (MP:0003421 from MPO Gene-Phenotype Associations)", "abnormal parathyroid gland morphology (MP:0000678 from MPO Gene-Phenotype Associations)", "absent parathyroid glands (MP:0000680 from MPO Gene-Phenotype Associations)", "athymia (MP:0000705 from MPO Gene-Phenotype Associations)", "small thyroid gland (MP:0002951 from MPO Gene-Phenotype Associations)", "abnormal accessory nerve morphology (MP:0001075 from MPO Gene-Phenotype Associations)", "otic vesicle hypoplasia (MP:0004311 from MPO Gene-Phenotype Associations)", "abnormal pterygoid muscle morphology (MP:0004237 from MPO Gene-Phenotype Associations)", "malleus hypoplasia (MP:0010326 from MPO Gene-Phenotype Associations)", "abnormal malleus neck morphology (MP:0010327 from MPO Gene-Phenotype Associations)", "thin malleus neck (MP:0010328 from MPO Gene-Phenotype Associations)", "abnormal ear lobe morphology (MP:0003677 from MPO Gene-Phenotype Associations)", "ear lobe hypoplasia (MP:0003679 from MPO Gene-Phenotype Associations)", "pharynx stenosis (MP:0013174 from MPO Gene-Phenotype Associations)", "abnormal pharyngeal muscle morphology (MP:0002253 from MPO Gene-Phenotype Associations)", "absent masseter muscle (MP:0004236 from MPO Gene-Phenotype Associations)", "absent pterygoid muscle (MP:0004238 from MPO Gene-Phenotype Associations)", "short neck (MP:0012721 from MPO Gene-Phenotype Associations)", "pharynx hypoplasia (MP:0004555 from MPO Gene-Phenotype Associations)", "small pharynx (MP:0004554 from MPO Gene-Phenotype Associations)", "fusion of basioccipital and basisphenoid bone (MP:0004572 from MPO Gene-Phenotype Associations)", "cervical aortic arch (MP:0004161 from MPO Gene-Phenotype Associations)", "glossopharyngeal nerve hypoplasia (MP:0004569 from MPO Gene-Phenotype Associations)", "abnormal mandibular nerve branching (MP:0001068 from MPO Gene-Phenotype Associations)", "abnormal mandibular nerve morphology (MP:0009800 from MPO Gene-Phenotype Associations)", "small malleus (MP:0008372 from MPO Gene-Phenotype Associations)", "absent pharyngeal arch arteries (MP:0012493 from MPO Gene-Phenotype Associations)", "absent second pharyngeal arch (MP:0006345 from MPO Gene-Phenotype Associations)", "absent third pharyngeal arch (MP:0010642 from MPO Gene-Phenotype Associations)", "abnormal second pharyngeal arch morphology (MP:0006338 from MPO Gene-Phenotype Associations)", "small second pharyngeal arch (MP:0006344 from MPO Gene-Phenotype Associations)", "absent pharyngeal arches (MP:0003874 from MPO Gene-Phenotype Associations)", "abnormal trigeminal nerve morphology (MP:0001065 from MPO Gene-Phenotype Associations)", "abnormal facial nerve morphology (MP:0001071 from MPO Gene-Phenotype Associations)", "abnormal glossopharyngeal nerve morphology (MP:0001073 from MPO Gene-Phenotype Associations)", "abnormal vagus nerve morphology (MP:0001074 from MPO Gene-Phenotype Associations)", "fusion of glossopharyngeal and vagus nerve (MP:0004568 from MPO Gene-Phenotype Associations)", "abnormal ear distance| position (MP:0000023 from MPO Gene-Phenotype Associations)", "lowered ear position (MP:0000024 from MPO Gene-Phenotype Associations)", "abnormal ear shape (MP:0000022 from MPO Gene-Phenotype Associations)", "abnormal outer ear morphology (MP:0002177 from MPO Gene-Phenotype Associations)", "small ears (MP:0000018 from MPO Gene-Phenotype Associations)", "abnormal soft palate morphology (MP:0003154 from MPO Gene-Phenotype Associations)", "abnormal epiglottis morphology (MP:0010371 from MPO Gene-Phenotype Associations)", "abnormal throat morphology (MP:0010370 from MPO Gene-Phenotype Associations)", "absent hyoid bone lesser horns (MP:0009915 from MPO Gene-Phenotype Associations)", "larynx stenosis (MP:0012491 from MPO Gene-Phenotype Associations)", "bicuspid pulmonary valve (MP:0010527 from MPO Gene-Phenotype Associations)", "abnormal thyroid gland isthmus morphology (MP:0013162 from MPO Gene-Phenotype Associations)", "absent thyroid gland isthmus (MP:0013163 from MPO Gene-Phenotype Associations)", "abnormal hyoid bone morphology (MP:0003056 from MPO Gene-Phenotype Associations)", "abnormal hyoid bone lesser horn morphology (MP:0009914 from MPO Gene-Phenotype Associations)", "abnormal cricoid cartilage morphology (MP:0002258 from MPO Gene-Phenotype Associations)", "abnormal laryngeal cartilage morphology (MP:0002256 from MPO Gene-Phenotype Associations)", "abnormal larynx morphology (MP:0002249 from MPO Gene-Phenotype Associations)", "abnormal thyroid cartilage morphology (MP:0002260 from MPO Gene-Phenotype Associations)", "absent nodose ganglion (MP:0001089 from MPO Gene-Phenotype Associations)", "absent mandibular condyloid process (MP:0004911 from MPO Gene-Phenotype Associations)", "absent pulmonary trunk (MP:0010657 from MPO Gene-Phenotype Associations)", "abnormal brachiocephalic trunk morphology (MP:0010663 from MPO Gene-Phenotype Associations)", "absent esophagus (MP:0004544 from MPO Gene-Phenotype Associations)", "increased neurotransmitter release (MP:0008921 from MPO Gene-Phenotype Associations)", "absent petrosal ganglion (MP:0001086 from MPO Gene-Phenotype Associations)", "absent auditory tube (MP:0004541 from MPO Gene-Phenotype Associations)", "thyroid hypoplasia (MP:0003499 from MPO Gene-Phenotype Associations)", "decreased hyoid bone size (MP:0009912 from MPO Gene-Phenotype Associations)", "hyoid bone hypoplasia (MP:0009899 from MPO Gene-Phenotype Associations)", "presphenoid bone hypoplasia (MP:0004450 from MPO Gene-Phenotype Associations)", "abnormal auditory tube (MP:0003330 from MPO Gene-Phenotype Associations)", "abnormal mandibule ramus morphology (MP:0010150 from MPO Gene-Phenotype Associations)", "abnormal mandibular coronoid process morphology (MP:0004594 from MPO Gene-Phenotype Associations)", "abnormal mandibular condyloid process morphology (MP:0004595 from MPO Gene-Phenotype Associations)", "absent mandibular coronoid process (MP:0004912 from MPO Gene-Phenotype Associations)", "abnormal mandibular angle morphology (MP:0004596 from MPO Gene-Phenotype Associations)", "absent mandibular angle (MP:0004913 from MPO Gene-Phenotype Associations)", "abnormal arcus anterior morphology (MP:0009879 from MPO Gene-Phenotype Associations)", "absent arcus anterior (MP:0010729 from MPO Gene-Phenotype Associations)", "absent odontoid process (MP:0010730 from MPO Gene-Phenotype Associations)", "abnormal vertebral artery morphology (MP:0011513 from MPO Gene-Phenotype Associations)", "fusion of atlas and occipital bones (MP:0010728 from MPO Gene-Phenotype Associations)", "spina bifida (MP:0003054 from MPO Gene-Phenotype Associations)", "abnormal vertebrae development (MP:0005225 from MPO Gene-Phenotype Associations)", "abnormal vertebral arch development (MP:0005226 from MPO Gene-Phenotype Associations)", "spina bifida occulta (MP:0005297 from MPO Gene-Phenotype Associations)", "abnormal vertebral body morphology (MP:0000141 from MPO Gene-Phenotype Associations)", "small vertebral body (MP:0004670 from MPO Gene-Phenotype Associations)", "short vertebral body (MP:0004706 from MPO Gene-Phenotype Associations)", "abnormal vertebral articular process morphology (MP:0004602 from MPO Gene-Phenotype Associations)", "enlarged tail bud (MP:0003401 from MPO Gene-Phenotype Associations)", "enlarged vertebral body (MP:0004669 from MPO Gene-Phenotype Associations)", "abnormal vertebral body development (MP:0005227 from MPO Gene-Phenotype Associations)", "abnormal intervertebral disk morphology (MP:0004173 from MPO Gene-Phenotype Associations)", "abnormal intervertebral disk development (MP:0005229 from MPO Gene-Phenotype Associations)", "persistence of notochord tissue (MP:0004711 from MPO Gene-Phenotype Associations)", "absent intervertebral disk (MP:0004683 from MPO Gene-Phenotype Associations)", "abnormal ventral tubercle of atlas morphology (MP:0004658 from MPO Gene-Phenotype Associations)", "absent vertebral body (MP:0004668 from MPO Gene-Phenotype Associations)", "vertebral compression (MP:0004626 from MPO Gene-Phenotype Associations)", "small caudal vertebrae (MP:0004652 from MPO Gene-Phenotype Associations)", "vertebral body hypoplasia (MP:0004667 from MPO Gene-Phenotype Associations)", "absent basisphenoid bone (MP:0008385 from MPO Gene-Phenotype Associations)", "abnormal hyoid bone body morphology (MP:0009917 from MPO Gene-Phenotype Associations)", "absent ventral tubercle of atlas (MP:0010731 from MPO Gene-Phenotype Associations)", "barrel chest (MP:0001268 from MPO Gene-Phenotype Associations)", "enlarged chest (MP:0001267 from MPO Gene-Phenotype Associations)", "small vertebrae (MP:0004610 from MPO Gene-Phenotype Associations)", "short vertebral column (MP:0004704 from MPO Gene-Phenotype Associations)", "abnormal vertebral transverse process morphology (MP:0004600 from MPO Gene-Phenotype Associations)", "abnormal vertebral pedicle morphology (MP:0004604 from MPO Gene-Phenotype Associations)", "abnormal vertebral lamina morphology (MP:0004605 from MPO Gene-Phenotype Associations)", "absent vertebral transverse processes (MP:0000139 from MPO Gene-Phenotype Associations)", "asymmetric rib-vertebral column attachment (MP:0008147 from MPO Gene-Phenotype Associations)", "abnormal rib-vertebral column attachment (MP:0008149 from MPO Gene-Phenotype Associations)", "absent vertebral pedicles (MP:0000140 from MPO Gene-Phenotype Associations)", "absent proximal rib (MP:0000152 from MPO Gene-Phenotype Associations)", "absent ribs (MP:0000151 from MPO Gene-Phenotype Associations)", "abnormal chest morphology (MP:0004134 from MPO Gene-Phenotype Associations)", "abnormal thoracic cavity morphology (MP:0004733 from MPO Gene-Phenotype Associations)", "small thoracic cavity (MP:0004734 from MPO Gene-Phenotype Associations)", "abnormal dorsal-ventral polarity of the somites (MP:0005223 from MPO Gene-Phenotype Associations)", "fused dorsal root ganglion (MP:0000963 from MPO Gene-Phenotype Associations)", "abnormal rostral-caudal patterning of the somites (MP:0008530 from MPO Gene-Phenotype Associations)", "abnormal somite segmentation clock (MP:0012669 from MPO Gene-Phenotype Associations)", "prolonged somite segmentation clock period (MP:0012670 from MPO Gene-Phenotype Associations)", "fusion of vertebral bodies (MP:0004612 from MPO Gene-Phenotype Associations)", "decreased cervical vertebrae number (MP:0004646 from MPO Gene-Phenotype Associations)", "absent caudal vertebrae (MP:0004653 from MPO Gene-Phenotype Associations)", "abnormal vertebral arch morphology (MP:0004599 from MPO Gene-Phenotype Associations)", "fusion of vertebral arches (MP:0004613 from MPO Gene-Phenotype Associations)", "abnormal joint morphology (MP:0002932 from MPO Gene-Phenotype Associations)", "fused joints (MP:0003189 from MPO Gene-Phenotype Associations)", "vertebral fusion (MP:0004609 from MPO Gene-Phenotype Associations)", "cervical vertebral fusion (MP:0004620 from MPO Gene-Phenotype Associations)", "abnormal cervical atlas morphology (MP:0004607 from MPO Gene-Phenotype Associations)", "abnormal cervical axis morphology (MP:0004608 from MPO Gene-Phenotype Associations)", "abnormal odontoid process morphology (MP:0004659 from MPO Gene-Phenotype Associations)", "fusion of atlas and odontoid process (MP:0010701 from MPO Gene-Phenotype Associations)", "abnormal pectoral girdle bone morphology (MP:0004508 from MPO Gene-Phenotype Associations)", "abnormal sternum morphology (MP:0000157 from MPO Gene-Phenotype Associations)", "abnormal thoracic cage morphology (MP:0004624 from MPO Gene-Phenotype Associations)", "abnormal rib morphology (MP:0000150 from MPO Gene-Phenotype Associations)", "abnormal axial skeleton morphology (MP:0002114 from MPO Gene-Phenotype Associations)", "abnormal skeleton morphology (MP:0005508 from MPO Gene-Phenotype Associations)", "skeleton phenotype (MP:0005390 from MPO Gene-Phenotype Associations)", "abnormal vertebrae morphology (MP:0000137 from MPO Gene-Phenotype Associations)", "abnormal vertebral column morphology (MP:0004703 from MPO Gene-Phenotype Associations)", "abnormal cervical vertebrae morphology (MP:0003048 from MPO Gene-Phenotype Associations)", "abnormal presacral vertebrae morphology (MP:0000459 from MPO Gene-Phenotype Associations)", "abnormal thoracic vertebrae morphology (MP:0003047 from MPO Gene-Phenotype Associations)", "lumbar vertebral transformation (MP:0004616 from MPO Gene-Phenotype Associations)", "thoracic vertebral transformation (MP:0004618 from MPO Gene-Phenotype Associations)", "vertebral transformation (MP:0003036 from MPO Gene-Phenotype Associations)", "cervical vertebral transformation (MP:0004615 from MPO Gene-Phenotype Associations)", "abnormal rib attachment (MP:0004625 from MPO Gene-Phenotype Associations)", "abnormal rib-sternum attachment (MP:0008148 from MPO Gene-Phenotype Associations)", "asymmetric rib attachment (MP:0000155 from MPO Gene-Phenotype Associations)", "asymmetric rib-sternum attachment (MP:0008146 from MPO Gene-Phenotype Associations)", "decreased rib number (MP:0003345 from MPO Gene-Phenotype Associations)", "rib bifurcation (MP:0000153 from MPO Gene-Phenotype Associations)", "rib fusion (MP:0000154 from MPO Gene-Phenotype Associations)", "abnormal sternebra morphology (MP:0004322 from MPO Gene-Phenotype Associations)", "sternebra fusion (MP:0010082 from MPO Gene-Phenotype Associations)", "abnormal sternebra number (MP:0012282 from MPO Gene-Phenotype Associations)", "increased sternebra number (MP:0012284 from MPO Gene-Phenotype Associations)", "sacral vertebral transformation (MP:0004617 from MPO Gene-Phenotype Associations)", "abnormal tail morphology (MP:0002111 from MPO Gene-Phenotype Associations)", "kinked tail (MP:0000585 from MPO Gene-Phenotype Associations)", "abnormal tail length (MP:0011999 from MPO Gene-Phenotype Associations)", "short tail (MP:0000592 from MPO Gene-Phenotype Associations)", "decreased caudal vertebrae number (MP:0001539 from MPO Gene-Phenotype Associations)", "abnormal caudal vertebrae morphology (MP:0002759 from MPO Gene-Phenotype Associations)", "curly tail (MP:0003051 from MPO Gene-Phenotype Associations)", "increased rib number (MP:0000480 from MPO Gene-Phenotype Associations)", "increased presacral vertebrae number (MP:0000464 from MPO Gene-Phenotype Associations)", "increased thoracic vertebrae number (MP:0004651 from MPO Gene-Phenotype Associations)", "abnormal lumbar vertebrae morphology (MP:0003049 from MPO Gene-Phenotype Associations)", "abnormal sacral vertebrae morphology (MP:0003050 from MPO Gene-Phenotype Associations)", "abnormal vertebrae number (MP:0004643 from MPO Gene-Phenotype Associations)", "decreased vertebrae number (MP:0004645 from MPO Gene-Phenotype Associations)", "decreased lumbar vertebrae number (MP:0004647 from MPO Gene-Phenotype Associations)", "decreased presacral vertebrae number (MP:0000461 from MPO Gene-Phenotype Associations)", "increased vertebrae number (MP:0004644 from MPO Gene-Phenotype Associations)", "increased sacral vertebrae number (MP:0010101 from MPO Gene-Phenotype Associations)", "abnormal xiphoid process morphology (MP:0000159 from MPO Gene-Phenotype Associations)", "split xiphoid process (MP:0004678 from MPO Gene-Phenotype Associations)", "short sternum (MP:0004321 from MPO Gene-Phenotype Associations)", "abnormal sternum ossification (MP:0008277 from MPO Gene-Phenotype Associations)", "short ribs (MP:0004672 from MPO Gene-Phenotype Associations)", "abnormal appendicular skeleton morphology (MP:0009250 from MPO Gene-Phenotype Associations)", "abnormal long bone morphology (MP:0003723 from MPO Gene-Phenotype Associations)", "abnormal limb bone morphology (MP:0002115 from MPO Gene-Phenotype Associations)", "abnormal limb long bone morphology (MP:0011504 from MPO Gene-Phenotype Associations)", "abnormal hindlimb morphology (MP:0000556 from MPO Gene-Phenotype Associations)", "decreased length of long bones (MP:0004686 from MPO Gene-Phenotype Associations)", "abnormal limb morphology (MP:0002109 from MPO Gene-Phenotype Associations)", "limbs|digits|tail phenotype (MP:0005371 from MPO Gene-Phenotype Associations)", "abnormal hindlimb zeugopod morphology (MP:0003857 from MPO Gene-Phenotype Associations)", "abnormal tibia morphology (MP:0000558 from MPO Gene-Phenotype Associations)", "short tibia (MP:0002764 from MPO Gene-Phenotype Associations)", "abnormal femur morphology (MP:0000559 from MPO Gene-Phenotype Associations)", "abnormal hindlimb stylopod morphology (MP:0003856 from MPO Gene-Phenotype Associations)", "short femur (MP:0003109 from MPO Gene-Phenotype Associations)", "abnormal forelimb morphology (MP:0000550 from MPO Gene-Phenotype Associations)", "abnormal forelimb zeugopod morphology (MP:0003855 from MPO Gene-Phenotype Associations)", "abnormal ulna morphology (MP:0005108 from MPO Gene-Phenotype Associations)", "abnormal radius morphology (MP:0000552 from MPO Gene-Phenotype Associations)", "short ulna (MP:0004359 from MPO Gene-Phenotype Associations)", "short radius (MP:0004355 from MPO Gene-Phenotype Associations)", "abnormal forelimb stylopod morphology (MP:0003854 from MPO Gene-Phenotype Associations)", "abnormal humerus morphology (MP:0005296 from MPO Gene-Phenotype Associations)", "short humerus (MP:0004351 from MPO Gene-Phenotype Associations)", "abnormal fibula morphology (MP:0002187 from MPO Gene-Phenotype Associations)", "short fibula (MP:0002765 from MPO Gene-Phenotype Associations)", "short limbs (MP:0000547 from MPO Gene-Phenotype Associations)", "abnormal cartilage development (MP:0000164 from MPO Gene-Phenotype Associations)", "abnormal long bone hypertrophic chondrocyte zone (MP:0000165 from MPO Gene-Phenotype Associations)", "abnormal epiphyseal plate morphology (MP:0006395 from MPO Gene-Phenotype Associations)", "abnormal long bone epiphyseal plate morphology (MP:0003055 from MPO Gene-Phenotype Associations)", "abnormal cartilage morphology (MP:0000163 from MPO Gene-Phenotype Associations)", "abnormal skeleton development (MP:0002113 from MPO Gene-Phenotype Associations)", "abnormal long bone epiphyseal plate proliferative zone (MP:0003662 from MPO Gene-Phenotype Associations)", "decreased width of hypertrophic chondrocyte zone (MP:0003409 from MPO Gene-Phenotype Associations)", "increased width of hypertrophic chondrocyte zone (MP:0003408 from MPO Gene-Phenotype Associations)", "increased long bone epiphyseal plate size (MP:0006398 from MPO Gene-Phenotype Associations)", "disorganized long bone epiphyseal plate (MP:0006397 from MPO Gene-Phenotype Associations)", "abnormal chondrocyte morphology (MP:0000166 from MPO Gene-Phenotype Associations)", "decreased chondrocyte number (MP:0000167 from MPO Gene-Phenotype Associations)", "chondrodystrophy (MP:0002657 from MPO Gene-Phenotype Associations)", "disproportionate dwarf (MP:0002427 from MPO Gene-Phenotype Associations)", "decreased long bone epiphyseal plate size (MP:0006396 from MPO Gene-Phenotype Associations)", "abnormal bone mineralization (MP:0002896 from MPO Gene-Phenotype Associations)", "abnormal bone ossification (MP:0008271 from MPO Gene-Phenotype Associations)", "abnormal skeleton physiology (MP:0001533 from MPO Gene-Phenotype Associations)", "delayed bone ossification (MP:0000060 from MPO Gene-Phenotype Associations)", "delayed endochondral bone ossification (MP:0003419 from MPO Gene-Phenotype Associations)", "abnormal endochondral bone ossification (MP:0008272 from MPO Gene-Phenotype Associations)", "abnormal craniofacial bone morphology (MP:0002116 from MPO Gene-Phenotype Associations)", "abnormal cranium morphology (MP:0000438 from MPO Gene-Phenotype Associations)", "abnormal viscerocranium morphology (MP:0005274 from MPO Gene-Phenotype Associations)", "abnormal jaw morphology (MP:0000454 from MPO Gene-Phenotype Associations)", "abnormal neurocranium morphology (MP:0000074 from MPO Gene-Phenotype Associations)", "abnormal craniofacial morphology (MP:0000428 from MPO Gene-Phenotype Associations)", "craniofacial phenotype (MP:0005382 from MPO Gene-Phenotype Associations)", "abnormal facial morphology (MP:0003743 from MPO Gene-Phenotype Associations)", "abnormal head morphology (MP:0000432 from MPO Gene-Phenotype Associations)", "abnormal mouth morphology (MP:0000452 from MPO Gene-Phenotype Associations)", "abnormal mandible morphology (MP:0000458 from MPO Gene-Phenotype Associations)", "small mandible (MP:0004592 from MPO Gene-Phenotype Associations)", "short mandible (MP:0000088 from MPO Gene-Phenotype Associations)", "abnormal snout morphology (MP:0000443 from MPO Gene-Phenotype Associations)", "short snout (MP:0000445 from MPO Gene-Phenotype Associations)", "abnormal palate morphology (MP:0003755 from MPO Gene-Phenotype Associations)", "cleft palate (MP:0000111 from MPO Gene-Phenotype Associations)", "abnormal palate development (MP:0009653 from MPO Gene-Phenotype Associations)", "abnormal secondary palate development (MP:0009655 from MPO Gene-Phenotype Associations)", "cleft secondary palate (MP:0009890 from MPO Gene-Phenotype Associations)", "abnormal palatal shelf fusion at midline (MP:0009887 from MPO Gene-Phenotype Associations)", "palatal shelves fail to meet at midline (MP:0009888 from MPO Gene-Phenotype Associations)", "abnormal palatal shelf elevation (MP:0009885 from MPO Gene-Phenotype Associations)", "failure of palatal shelf elevation (MP:0009886 from MPO Gene-Phenotype Associations)", "abnormal maxilla morphology (MP:0000455 from MPO Gene-Phenotype Associations)", "short maxilla (MP:0000097 from MPO Gene-Phenotype Associations)", "small maxilla (MP:0004540 from MPO Gene-Phenotype Associations)", "abnormal premaxilla morphology (MP:0002820 from MPO Gene-Phenotype Associations)", "small premaxilla (MP:0004870 from MPO Gene-Phenotype Associations)", "short premaxilla (MP:0000091 from MPO Gene-Phenotype Associations)", "abnormal nasal bone morphology (MP:0000102 from MPO Gene-Phenotype Associations)", "small nasal bone (MP:0004470 from MPO Gene-Phenotype Associations)", "short nasal bone (MP:0004471 from MPO Gene-Phenotype Associations)", "abnormal frontal bone morphology (MP:0000107 from MPO Gene-Phenotype Associations)", "abnormal parietal bone morphology (MP:0000109 from MPO Gene-Phenotype Associations)", "abnormal interparietal bone morphology (MP:0000077 from MPO Gene-Phenotype Associations)", "small interparietal bone (MP:0004384 from MPO Gene-Phenotype Associations)", "small frontal bone (MP:0004377 from MPO Gene-Phenotype Associations)", "small parietal bone (MP:0004418 from MPO Gene-Phenotype Associations)", "abnormal spine curvature (MP:0004174 from MPO Gene-Phenotype Associations)", "kyphosis (MP:0000160 from MPO Gene-Phenotype Associations)", "lordosis (MP:0000162 from MPO Gene-Phenotype Associations)", "scoliosis (MP:0000161 from MPO Gene-Phenotype Associations)", "kyphoscoliosis (MP:0000069 from MPO Gene-Phenotype Associations)", "abnormal apical ectodermal ridge morphology (MP:0001676 from MPO Gene-Phenotype Associations)", "abnormal ectoderm development (MP:0001675 from MPO Gene-Phenotype Associations)", "abnormal limb bud morphology (MP:0005650 from MPO Gene-Phenotype Associations)", "abnormal limb development (MP:0006279 from MPO Gene-Phenotype Associations)", "absent radius (MP:0000553 from MPO Gene-Phenotype Associations)", "absent tibia (MP:0002728 from MPO Gene-Phenotype Associations)", "thick apical ectodermal ridge (MP:0001678 from MPO Gene-Phenotype Associations)", "abnormal foot plate morphology (MP:0004576 from MPO Gene-Phenotype Associations)", "acoria (MP:0012101 from MPO Gene-Phenotype Associations)", "abnormal pineal gland morphology (MP:0000632 from MPO Gene-Phenotype Associations)", "absent pineal gland (MP:0013362 from MPO Gene-Phenotype Associations)", "abnormal right lung caudal lobe morphology (MP:0009574 from MPO Gene-Phenotype Associations)", "ectopic adrenal gland (MP:0011362 from MPO Gene-Phenotype Associations)", "abnormal interfrontal bone morphology (MP:0008818 from MPO Gene-Phenotype Associations)", "abnormal sternum manubrium morphology (MP:0008785 from MPO Gene-Phenotype Associations)", "split sternal manubrium (MP:0012667 from MPO Gene-Phenotype Associations)", "increased diameter of humerus (MP:0008160 from MPO Gene-Phenotype Associations)", "increased diameter of ulna (MP:0008163 from MPO Gene-Phenotype Associations)", "increased diameter of radius (MP:0008161 from MPO Gene-Phenotype Associations)", "basisphenoid bone foramen (MP:0004463 from MPO Gene-Phenotype Associations)", "camptomelia (MP:0011505 from MPO Gene-Phenotype Associations)", "abnormal lip morphology (MP:0003769 from MPO Gene-Phenotype Associations)", "abnormal upper lip morphology (MP:0012523 from MPO Gene-Phenotype Associations)", "abnormal lip shape (MP:0003771 from MPO Gene-Phenotype Associations)", "cleft lip (MP:0005170 from MPO Gene-Phenotype Associations)", "xiphoid process foramen (MP:0004679 from MPO Gene-Phenotype Associations)", "long fibula (MP:0000482 from MPO Gene-Phenotype Associations)", "bowed fibula (MP:0004372 from MPO Gene-Phenotype Associations)", "hemimelia (MP:0008985 from MPO Gene-Phenotype Associations)", "polyphalangy (MP:0000413 from MPO Gene-Phenotype Associations)", "absent fibula (MP:0005430 from MPO Gene-Phenotype Associations)", "fused metatarsal bones (MP:0004642 from MPO Gene-Phenotype Associations)", "oligodactyly (MP:0000565 from MPO Gene-Phenotype Associations)", "abnormal metatarsal bone morphology (MP:0003072 from MPO Gene-Phenotype Associations)", "abnormal metacarpal bone morphology (MP:0003073 from MPO Gene-Phenotype Associations)", "abnormal phalanx morphology (MP:0005306 from MPO Gene-Phenotype Associations)", "short metatarsal bones (MP:0004635 from MPO Gene-Phenotype Associations)", "short metacarpal bones (MP:0004634 from MPO Gene-Phenotype Associations)", "brachyphalangia (MP:0002543 from MPO Gene-Phenotype Associations)", "brachydactyly (MP:0002544 from MPO Gene-Phenotype Associations)", "abnormal carpal bone morphology (MP:0000554 from MPO Gene-Phenotype Associations)", "fused carpal bones (MP:0008915 from MPO Gene-Phenotype Associations)", "abnormal tarsal bone morphology (MP:0005104 from MPO Gene-Phenotype Associations)", "fused tarsal bones (MP:0008919 from MPO Gene-Phenotype Associations)", "abnormal autopod morphology (MP:0000572 from MPO Gene-Phenotype Associations)", "abnormal digit morphology (MP:0002110 from MPO Gene-Phenotype Associations)", "polydactyly (MP:0000562 from MPO Gene-Phenotype Associations)", "syndactyly (MP:0000564 from MPO Gene-Phenotype Associations)", "preaxial polydactyly (MP:0009743 from MPO Gene-Phenotype Associations)", "brachypodia (MP:0002772 from MPO Gene-Phenotype Associations)", "abnormal digit development (MP:0006280 from MPO Gene-Phenotype Associations)", "abnormal interdigital cell death (MP:0009874 from MPO Gene-Phenotype Associations)", "interdigital webbing (MP:0000571 from MPO Gene-Phenotype Associations)", "abnormal pollex morphology (MP:0010772 from MPO Gene-Phenotype Associations)", "high palate (MP:0003757 from MPO Gene-Phenotype Associations)", "clubfoot (MP:0000576 from MPO Gene-Phenotype Associations)", "radius hypoplasia (MP:0004356 from MPO Gene-Phenotype Associations)", "platyspondylia (MP:0011175 from MPO Gene-Phenotype Associations)", "absent palatal shelf (MP:0009882 from MPO Gene-Phenotype Associations)", "proboscis (MP:0006290 from MPO Gene-Phenotype Associations)", "micromelia (MP:0008736 from MPO Gene-Phenotype Associations)", "abnormal articular cartilage morphology (MP:0006433 from MPO Gene-Phenotype Associations)", "abnormal hyaline cartilage morphology (MP:0006429 from MPO Gene-Phenotype Associations)", "abnormal head shape (MP:0011495 from MPO Gene-Phenotype Associations)", "shortened head (MP:0000435 from MPO Gene-Phenotype Associations)", "abnormal gastrulation movements (MP:0002174 from MPO Gene-Phenotype Associations)", "small proamniotic cavity (MP:0011208 from MPO Gene-Phenotype Associations)", "long incisors (MP:0004831 from MPO Gene-Phenotype Associations)", "midface hypoplasia (MP:0012085 from MPO Gene-Phenotype Associations)", "abnormal round window morphology (MP:0004480 from MPO Gene-Phenotype Associations)", "craniofacial asymmetry (MP:0008863 from MPO Gene-Phenotype Associations)", "abnormal rostral-caudal body axis extension (MP:0003885 from MPO Gene-Phenotype Associations)", "excessive folding of visceral yolk sac (MP:0011205 from MPO Gene-Phenotype Associations)", "abnormal intramembranous bone ossification (MP:0008273 from MPO Gene-Phenotype Associations)", "delayed intramembranous bone ossification (MP:0003420 from MPO Gene-Phenotype Associations)", "delayed suture closure (MP:0010743 from MPO Gene-Phenotype Associations)", "premature bone ossification (MP:0003416 from MPO Gene-Phenotype Associations)", "premature intramembranous bone ossification (MP:0003418 from MPO Gene-Phenotype Associations)", "premature suture closure (MP:0000081 from MPO Gene-Phenotype Associations)", "premature endochondral bone ossification (MP:0003417 from MPO Gene-Phenotype Associations)", "abnormal limb mesenchyme morphology (MP:0011261 from MPO Gene-Phenotype Associations)", "abnormal limb paddle morphology (MP:0011685 from MPO Gene-Phenotype Associations)", "parietal bone hypoplasia (MP:0004420 from MPO Gene-Phenotype Associations)", "interparietal bone hypoplasia (MP:0004385 from MPO Gene-Phenotype Associations)", "abnormal clavicle morphology (MP:0005298 from MPO Gene-Phenotype Associations)", "small clavicle (MP:0004338 from MPO Gene-Phenotype Associations)", "clavicle hypoplasia (MP:0004337 from MPO Gene-Phenotype Associations)", "absent clavicle (MP:0004339 from MPO Gene-Phenotype Associations)", "small ischium (MP:0004689 from MPO Gene-Phenotype Associations)", "ischium hypoplasia (MP:0004690 from MPO Gene-Phenotype Associations)", "pubis hypoplasia (MP:0004693 from MPO Gene-Phenotype Associations)", "absent zygomatic arch (MP:0004900 from MPO Gene-Phenotype Associations)", "absent occipital bone (MP:0004440 from MPO Gene-Phenotype Associations)", "nasal bone hypoplasia (MP:0000103 from MPO Gene-Phenotype Associations)", "growth retardation of molars (MP:0000128 from MPO Gene-Phenotype Associations)", "growth retardation of incisors (MP:0005359 from MPO Gene-Phenotype Associations)", "wide frontal bone (MP:0004379 from MPO Gene-Phenotype Associations)", "abnormal fontanelle morphology (MP:0000084 from MPO Gene-Phenotype Associations)", "large anterior fontanelle (MP:0000085 from MPO Gene-Phenotype Associations)", "abnormal long bone epiphyseal ossification zone morphology (MP:0006399 from MPO Gene-Phenotype Associations)", "abnormal ossification involved in bone maturation (MP:0011722 from MPO Gene-Phenotype Associations)", "abnormal scapula morphology (MP:0000149 from MPO Gene-Phenotype Associations)", "small scapula (MP:0004343 from MPO Gene-Phenotype Associations)", "short scapula (MP:0004340 from MPO Gene-Phenotype Associations)", "abnormal scapular spine morphology (MP:0004347 from MPO Gene-Phenotype Associations)", "abnormal deltoid tuberosity morphology (MP:0004353 from MPO Gene-Phenotype Associations)", "absent deltoid tuberosity (MP:0004354 from MPO Gene-Phenotype Associations)", "scapular bone hypoplasia (MP:0004344 from MPO Gene-Phenotype Associations)", "bifid tongue (MP:0009909 from MPO Gene-Phenotype Associations)", "bifurcated tongue (MP:0009910 from MPO Gene-Phenotype Associations)", "abnormal ischium morphology (MP:0004507 from MPO Gene-Phenotype Associations)", "abnormal pubis morphology (MP:0004506 from MPO Gene-Phenotype Associations)", "small pubis (MP:0004692 from MPO Gene-Phenotype Associations)", "abnormal ilium morphology (MP:0005354 from MPO Gene-Phenotype Associations)", "abnormal pelvic girdle bone morphology (MP:0004509 from MPO Gene-Phenotype Associations)", "abnormal deiters cell morphology (MP:0004302 from MPO Gene-Phenotype Associations)", "increased deiters cell number (MP:0004840 from MPO Gene-Phenotype Associations)", "long tail (MP:0002758 from MPO Gene-Phenotype Associations)", "long ulna (MP:0004370 from MPO Gene-Phenotype Associations)", "elongated vertebral body (MP:0004705 from MPO Gene-Phenotype Associations)", "long limbs (MP:0000548 from MPO Gene-Phenotype Associations)", "increased hyoid bone size (MP:0009911 from MPO Gene-Phenotype Associations)", "wavy tail (MP:0013179 from MPO Gene-Phenotype Associations)", "long radius (MP:0008951 from MPO Gene-Phenotype Associations)", "long humerus (MP:0004350 from MPO Gene-Phenotype Associations)", "long femur (MP:0004348 from MPO Gene-Phenotype Associations)", "abnormal foramen magnum morphology (MP:0010941 from MPO Gene-Phenotype Associations)", "abnormal synchondrosis (MP:0004053 from MPO Gene-Phenotype Associations)", "increased length of long bones (MP:0004695 from MPO Gene-Phenotype Associations)", "long tibia (MP:0004357 from MPO Gene-Phenotype Associations)", "bowed ulna (MP:0004361 from MPO Gene-Phenotype Associations)", "bowed radius (MP:0004374 from MPO Gene-Phenotype Associations)", "bowed tibia (MP:0004358 from MPO Gene-Phenotype Associations)", "bowed humerus (MP:0004373 from MPO Gene-Phenotype Associations)", "bowed femur (MP:0004371 from MPO Gene-Phenotype Associations)", "small occipital bone (MP:0004441 from MPO Gene-Phenotype Associations)", "abnormal bulbus cordis morphology (MP:0010568 from MPO Gene-Phenotype Associations)", "abnormal basicranium angle (MP:0009782 from MPO Gene-Phenotype Associations)", "prognathia (MP:0010208 from MPO Gene-Phenotype Associations)", "abnormal optic pit morphology (MP:0012155 from MPO Gene-Phenotype Associations)", "complete embryonic lethality between implantation and placentation (MP:0011095 from MPO Gene-Phenotype Associations)", "small thoracic cage (MP:0010103 from MPO Gene-Phenotype Associations)", "unbalanced complete common atrioventricular canal (MP:0011673 from MPO Gene-Phenotype Associations)", "elongated metatarsal bones (MP:0004641 from MPO Gene-Phenotype Associations)", "arachnodactyly (MP:0006296 from MPO Gene-Phenotype Associations)", "elongated vertebral column (MP:0008771 from MPO Gene-Phenotype Associations)", "absent nucleus pulposus (MP:0006393 from MPO Gene-Phenotype Associations)", "abnormal nucleus pulposus morphology (MP:0006392 from MPO Gene-Phenotype Associations)", "abnormal vertebral epiphyseal plate morphology (MP:0006394 from MPO Gene-Phenotype Associations)", "enlarged frontal bone (MP:0004375 from MPO Gene-Phenotype Associations)", "enlarged nasal bone (MP:0004474 from MPO Gene-Phenotype Associations)", "enlarged interparietal bone (MP:0004386 from MPO Gene-Phenotype Associations)", "enlarged parietal bone (MP:0004421 from MPO Gene-Phenotype Associations)", "megacephaly (MP:0000434 from MPO Gene-Phenotype Associations)", "absent spongiotrophoblast (MP:0012100 from MPO Gene-Phenotype Associations)", "abnormal spongiotrophoblast cell morphology (MP:0008959 from MPO Gene-Phenotype Associations)", "impaired placental function (MP:0006372 from MPO Gene-Phenotype Associations)", "abnormal sebaceous gland number (MP:0013190 from MPO Gene-Phenotype Associations)", "increased sebaceous gland number (MP:0013191 from MPO Gene-Phenotype Associations)", "absent olfactory bulb (MP:0003451 from MPO Gene-Phenotype Associations)", "disorganized myocardium (MP:0002190 from MPO Gene-Phenotype Associations)", "abnormal epicardium morphology (MP:0003057 from MPO Gene-Phenotype Associations)", "abnormal eye distance| position (MP:0001299 from MPO Gene-Phenotype Associations)", "ocular hypertelorism (MP:0001300 from MPO Gene-Phenotype Associations)", "exophthalmos (MP:0002750 from MPO Gene-Phenotype Associations)", "abnormal coronal suture morphology (MP:0003840 from MPO Gene-Phenotype Associations)", "abnormal cranial suture morphology (MP:0002835 from MPO Gene-Phenotype Associations)", "abnormal sagittal suture morphology (MP:0003843 from MPO Gene-Phenotype Associations)", "abnormal lambdoidal suture morphology (MP:0003841 from MPO Gene-Phenotype Associations)", "synostosis (MP:0000566 from MPO Gene-Phenotype Associations)", "ocular hypotelorism (MP:0006197 from MPO Gene-Phenotype Associations)", "small xiphoid process (MP:0004680 from MPO Gene-Phenotype Associations)", "abnormal orbit size (MP:0006210 from MPO Gene-Phenotype Associations)", "shallow orbits (MP:0006213 from MPO Gene-Phenotype Associations)", "prominent ears (MP:0000021 from MPO Gene-Phenotype Associations)", "abnormal epidermal melanocyte morphology (MP:0009388 from MPO Gene-Phenotype Associations)", "decreased sebaceous gland number (MP:0013192 from MPO Gene-Phenotype Associations)", "calcified thoracic aorta (MP:0010523 from MPO Gene-Phenotype Associations)", "calcified aortic arch (MP:0010524 from MPO Gene-Phenotype Associations)", "cardiac muscle degeneration (MP:0009416 from MPO Gene-Phenotype Associations)", "abnormal nuclear lamina morphology (MP:0008890 from MPO Gene-Phenotype Associations)", "abnormal frontonasal suture morphology (MP:0010043 from MPO Gene-Phenotype Associations)", "small myocardial fiber (MP:0004565 from MPO Gene-Phenotype Associations)", "abnormal epidermal pigmentation (MP:0009387 from MPO Gene-Phenotype Associations)", "abnormal cranium size (MP:0010031 from MPO Gene-Phenotype Associations)", "decreased cranium height (MP:0008525 from MPO Gene-Phenotype Associations)", "small cranium (MP:0005352 from MPO Gene-Phenotype Associations)", "decreased cranium width (MP:0008526 from MPO Gene-Phenotype Associations)", "malocclusion (MP:0000120 from MPO Gene-Phenotype Associations)", "rib fractures (MP:0004675 from MPO Gene-Phenotype Associations)", "epidermal atrophy (MP:0001221 from MPO Gene-Phenotype Associations)", "abnormal circulating glutamate dehydrogenase level (MP:0011008 from MPO Gene-Phenotype Associations)", "increased circulating glutamate dehydrogenase level (MP:0011009 from MPO Gene-Phenotype Associations)", "abnormal zygomatic arch morphology (MP:0004469 from MPO Gene-Phenotype Associations)", "abnormal corticotroph morphology (MP:0008327 from MPO Gene-Phenotype Associations)", "decreased corticotroph cell number (MP:0008341 from MPO Gene-Phenotype Associations)", "abnormal perichondrium morphology (MP:0006322 from MPO Gene-Phenotype Associations)", "abnormal body height (MP:0001253 from MPO Gene-Phenotype Associations)", "decreased body height (MP:0001255 from MPO Gene-Phenotype Associations)", "hyperpituitarism (MP:0003347 from MPO Gene-Phenotype Associations)", "hypersecretion of adrenocorticotropin (MP:0001747 from MPO Gene-Phenotype Associations)", "enlarged floor plate (MP:0012675 from MPO Gene-Phenotype Associations)", "abnormal cervical flexure morphology (MP:0010744 from MPO Gene-Phenotype Associations)", "short umbilical cord (MP:0012304 from MPO Gene-Phenotype Associations)", "abnormal hymen development (MP:0003538 from MPO Gene-Phenotype Associations)", "imperforate hymen (MP:0003540 from MPO Gene-Phenotype Associations)", "common truncal valve (MP:0010589 from MPO Gene-Phenotype Associations)", "abnormal otic pit morphology (MP:0011172 from MPO Gene-Phenotype Associations)", "abnormal branching involved in terminal bronchiole morphogenesis (MP:0011031 from MPO Gene-Phenotype Associations)", "impaired branching involved in terminal bronchiole morphogenesis (MP:0011032 from MPO Gene-Phenotype Associations)", "abnormal terminal bronchiole morphology (MP:0002268 from MPO Gene-Phenotype Associations)", "dilated terminal bronchiole tubes (MP:0006026 from MPO Gene-Phenotype Associations)", "craniorachischisis (MP:0008784 from MPO Gene-Phenotype Associations)", "abnormal lung lobe morphology (MP:0010975 from MPO Gene-Phenotype Associations)", "small lung lobe (MP:0010976 from MPO Gene-Phenotype Associations)", "short scala media (MP:0008307 from MPO Gene-Phenotype Associations)", "small scala media (MP:0008308 from MPO Gene-Phenotype Associations)", "dilated endolymphatic sac (MP:0006014 from MPO Gene-Phenotype Associations)", "dilated endolymphatic duct (MP:0006012 from MPO Gene-Phenotype Associations)", "inner ear hypoplasia (MP:0006286 from MPO Gene-Phenotype Associations)", "complete lethality (MP:0011400 from MPO Gene-Phenotype Associations)", "whorled hair (MP:0009457 from MPO Gene-Phenotype Associations)", "increased susceptibility to induced muscular atrophy (MP:0004065 from MPO Gene-Phenotype Associations)", "decreased lactate dehydrogenase level (MP:0005571 from MPO Gene-Phenotype Associations)", "absent hippocampus ca3 region (MP:0008268 from MPO Gene-Phenotype Associations)", "absent lung saccules (MP:0010826 from MPO Gene-Phenotype Associations)", "abnormal wet-to-dry lung weight ratio (MP:0011162 from MPO Gene-Phenotype Associations)", "increased wet-to-dry lung weight ratio (MP:0011163 from MPO Gene-Phenotype Associations)", "abnormal lung saccule morphology (MP:0010825 from MPO Gene-Phenotype Associations)", "thick lung-associated mesenchyme (MP:0011143 from MPO Gene-Phenotype Associations)", "small lung saccule (MP:0010827 from MPO Gene-Phenotype Associations)", "abnormal alveolar lamellar body morphology (MP:0010813 from MPO Gene-Phenotype Associations)", "abnormal pulmonary alveolar parenchyma morphology (MP:0010901 from MPO Gene-Phenotype Associations)", "abnormal pulmonary alveolus epithelial cell morphology (MP:0002273 from MPO Gene-Phenotype Associations)", "abnormal pulmonary alveolus epithelium morphology (MP:0010898 from MPO Gene-Phenotype Associations)", "abnormal type ii pneumocyte morphology (MP:0002275 from MPO Gene-Phenotype Associations)", "abnormal lung epithelium morphology (MP:0006382 from MPO Gene-Phenotype Associations)", "abnormal surfactant physiology (MP:0004782 from MPO Gene-Phenotype Associations)", "abnormal surfactant secretion (MP:0004780 from MPO Gene-Phenotype Associations)", "abnormal respiratory epithelium morphology (MP:0010942 from MPO Gene-Phenotype Associations)", "abnormal pulmonary alveolus morphology (MP:0002270 from MPO Gene-Phenotype Associations)", "abnormal pulmonary acinus morphology (MP:0010911 from MPO Gene-Phenotype Associations)", "abnormal pulmonary alveolar system morphology (MP:0010899 from MPO Gene-Phenotype Associations)", "abnormal lung morphology (MP:0001175 from MPO Gene-Phenotype Associations)", "abnormal respiratory system morphology (MP:0002132 from MPO Gene-Phenotype Associations)", "abnormal pulmonary interalveolar septum morphology (MP:0010900 from MPO Gene-Phenotype Associations)", "thick pulmonary interalveolar septum (MP:0001179 from MPO Gene-Phenotype Associations)", "abnormal lung development (MP:0001176 from MPO Gene-Phenotype Associations)", "abnormal respiratory system development (MP:0003115 from MPO Gene-Phenotype Associations)", "abnormal lung alveolus development (MP:0010995 from MPO Gene-Phenotype Associations)", "impaired lung alveolus development (MP:0006027 from MPO Gene-Phenotype Associations)", "decreased alveolar lamellar body number (MP:0010890 from MPO Gene-Phenotype Associations)", "abnormal type i pneumocyte morphology (MP:0002274 from MPO Gene-Phenotype Associations)", "decreased type i pneumocyte number (MP:0010816 from MPO Gene-Phenotype Associations)", "absent type i pneumocytes (MP:0010817 from MPO Gene-Phenotype Associations)", "atelectasis (MP:0001177 from MPO Gene-Phenotype Associations)", "primary atelectasis (MP:0010819 from MPO Gene-Phenotype Associations)", "respiratory system phenotype (MP:0005388 from MPO Gene-Phenotype Associations)", "abnormal respiratory system physiology (MP:0002133 from MPO Gene-Phenotype Associations)", "abnormal respiration (MP:0001943 from MPO Gene-Phenotype Associations)", "abnormal breathing pattern (MP:0001951 from MPO Gene-Phenotype Associations)", "abnormal respiratory function (MP:0002327 from MPO Gene-Phenotype Associations)", "respiratory distress (MP:0001954 from MPO Gene-Phenotype Associations)", "respiratory failure (MP:0001953 from MPO Gene-Phenotype Associations)", "abnormal gas homeostasis (MP:0003948 from MPO Gene-Phenotype Associations)", "abnormal oxygen level (MP:0001574 from MPO Gene-Phenotype Associations)", "cyanosis (MP:0001575 from MPO Gene-Phenotype Associations)", "complete neonatal lethality (MP:0011087 from MPO Gene-Phenotype Associations)", "neonatal lethality (MP:0002058 from MPO Gene-Phenotype Associations)", "perinatal lethality (MP:0002081 from MPO Gene-Phenotype Associations)", "partial neonatal lethality (MP:0011088 from MPO Gene-Phenotype Associations)", "complete perinatal lethality (MP:0011089 from MPO Gene-Phenotype Associations)", "abnormal lung size (MP:0004881 from MPO Gene-Phenotype Associations)", "small lung (MP:0003641 from MPO Gene-Phenotype Associations)", "pulmonary hypoplasia (MP:0001178 from MPO Gene-Phenotype Associations)", "abnormal lung weight (MP:0005629 from MPO Gene-Phenotype Associations)", "decreased lung weight (MP:0005631 from MPO Gene-Phenotype Associations)", "enlarged lung (MP:0004882 from MPO Gene-Phenotype Associations)", "increased lung weight (MP:0005630 from MPO Gene-Phenotype Associations)", "small alveolar lamellar bodies (MP:0010889 from MPO Gene-Phenotype Associations)", "abnormal surfactant composition (MP:0004781 from MPO Gene-Phenotype Associations)", "absent alveolar lamellar bodies (MP:0010814 from MPO Gene-Phenotype Associations)", "decreased total lung capacity (MP:0010938 from MPO Gene-Phenotype Associations)", "abnormal lung vasculature morphology (MP:0004007 from MPO Gene-Phenotype Associations)", "vasculature congestion (MP:0000255 from MPO Gene-Phenotype Associations)", "visceral vascular congestion (MP:0010017 from MPO Gene-Phenotype Associations)", "pulmonary vascular congestion (MP:0010018 from MPO Gene-Phenotype Associations)", "liver vascular congestion (MP:0010019 from MPO Gene-Phenotype Associations)", "pulmonary edema (MP:0003828 from MPO Gene-Phenotype Associations)", "congestive heart failure (MP:0006138 from MPO Gene-Phenotype Associations)", "dilated pulmonary artery (MP:0010557 from MPO Gene-Phenotype Associations)", "decreased pulmonary vascular resistance (MP:0003035 from MPO Gene-Phenotype Associations)", "preneoplasia (MP:0002009 from MPO Gene-Phenotype Associations)", "abnormal pulmonary circulation (MP:0002295 from MPO Gene-Phenotype Associations)", "lung hemorrhage (MP:0001182 from MPO Gene-Phenotype Associations)", "pulmonary alveolar hemorrhage (MP:0010909 from MPO Gene-Phenotype Associations)", "delayed ear emergence (MP:0000054 from MPO Gene-Phenotype Associations)", "cricoid and tracheal cartilage fusion (MP:0009438 from MPO Gene-Phenotype Associations)", "abnormal branching involved in respiratory bronchiole morphogenesis (MP:0011033 from MPO Gene-Phenotype Associations)", "impaired branching involved in respiratory bronchiole morphogenesis (MP:0011034 from MPO Gene-Phenotype Associations)", "abnormal respiratory bronchiole morphology (MP:0004389 from MPO Gene-Phenotype Associations)", "abnormal branching involved in lung morphogenesis (MP:0011024 from MPO Gene-Phenotype Associations)", "abnormal branching involved in bronchus morphogenesis (MP:0011027 from MPO Gene-Phenotype Associations)", "impaired branching involved in bronchus morphogenesis (MP:0011028 from MPO Gene-Phenotype Associations)", "abnormal mesenchymal cell differentiation involved in lung development (MP:0011145 from MPO Gene-Phenotype Associations)", "decreased surfactant secretion (MP:0010993 from MPO Gene-Phenotype Associations)", "abnormal pleural cavity morphology (MP:0012684 from MPO Gene-Phenotype Associations)", "absent type ii pneumocytes (MP:0010812 from MPO Gene-Phenotype Associations)", "decreased type ii pneumocyte number (MP:0010811 from MPO Gene-Phenotype Associations)", "abnormal branching involved in alveolar sac morphogenesis (MP:0011037 from MPO Gene-Phenotype Associations)", "impaired branching involved in alveolar sac morphogenesis (MP:0011038 from MPO Gene-Phenotype Associations)", "absent proximal convoluted tubule brush border (MP:0011351 from MPO Gene-Phenotype Associations)", "abnormal heart apex morphology (MP:0012515 from MPO Gene-Phenotype Associations)", "absent pulmonary alveoli (MP:0001184 from MPO Gene-Phenotype Associations)", "abnormal pulmonary alveolar sac morphology (MP:0010902 from MPO Gene-Phenotype Associations)", "abnormal bronchus morphology (MP:0002264 from MPO Gene-Phenotype Associations)", "abnormal respiratory conducting tube morphology (MP:0004391 from MPO Gene-Phenotype Associations)", "abnormal bronchus epithelium morphology (MP:0010943 from MPO Gene-Phenotype Associations)", "bronchial epithelial hyperplasia (MP:0005488 from MPO Gene-Phenotype Associations)", "abnormal bronchiole epithelium morphology (MP:0010897 from MPO Gene-Phenotype Associations)", "abnormal bronchiole morphology (MP:0002267 from MPO Gene-Phenotype Associations)", "abnormal clara cell morphology (MP:0010809 from MPO Gene-Phenotype Associations)", "increased clara cell number (MP:0005490 from MPO Gene-Phenotype Associations)", "decreased pulse pressure (MP:0006266 from MPO Gene-Phenotype Associations)", "abnormal cystic duct morphology (MP:0009493 from MPO Gene-Phenotype Associations)", "abnormal extrahepatic bile duct morphology (MP:0009498 from MPO Gene-Phenotype Associations)", "exocrine pancreas hypoplasia (MP:0005492 from MPO Gene-Phenotype Associations)", "pancreas hypoplasia (MP:0009111 from MPO Gene-Phenotype Associations)", "decreased clara cell number (MP:0010949 from MPO Gene-Phenotype Associations)", "absent gallbladder (MP:0003250 from MPO Gene-Phenotype Associations)", "abnormal hepatoblast differentiation (MP:0012242 from MPO Gene-Phenotype Associations)", "sternum hypoplasia (MP:0004323 from MPO Gene-Phenotype Associations)", "abnormal esophageal smooth muscle morphology (MP:0003159 from MPO Gene-Phenotype Associations)", "abnormal temporomandibular joint morphology (MP:0011210 from MPO Gene-Phenotype Associations)", "trachea hypoplasia (MP:0010882 from MPO Gene-Phenotype Associations)", "esophagus hypoplasia (MP:0010881 from MPO Gene-Phenotype Associations)", "small esophagus (MP:0010880 from MPO Gene-Phenotype Associations)", "esophagus stenosis (MP:0010884 from MPO Gene-Phenotype Associations)", "abnormal mesenchymal cell proliferation involved in lung development (MP:0011146 from MPO Gene-Phenotype Associations)", "decreased mesenchymal cell proliferation involved in lung development (MP:0011148 from MPO Gene-Phenotype Associations)", "trachea stenosis (MP:0010883 from MPO Gene-Phenotype Associations)", "increased type ii pneumocyte number (MP:0010810 from MPO Gene-Phenotype Associations)", "abnormal right lung accessory lobe morphology (MP:0009571 from MPO Gene-Phenotype Associations)", "abnormal right lung middle lobe morphology (MP:0009573 from MPO Gene-Phenotype Associations)", "absent right lung accessory lobe (MP:0010824 from MPO Gene-Phenotype Associations)", "supravalvar pulmonary trunk stenosis (MP:0010459 from MPO Gene-Phenotype Associations)", "absent coronary vessels (MP:0010561 from MPO Gene-Phenotype Associations)", "caudal rachischisis (MP:0009245 from MPO Gene-Phenotype Associations)", "dilated pulmonary trunk (MP:0010649 from MPO Gene-Phenotype Associations)", "patent tricuspid valve (MP:0010628 from MPO Gene-Phenotype Associations)", "absent hypaxial muscle (MP:0006284 from MPO Gene-Phenotype Associations)", "absent dorsal root ganglion (MP:0008460 from MPO Gene-Phenotype Associations)", "abnormal somite border morphology (MP:0012728 from MPO Gene-Phenotype Associations)", "disorganized dorsal root ganglion (MP:0000962 from MPO Gene-Phenotype Associations)", "abnormal tongue muscle morphology (MP:0004136 from MPO Gene-Phenotype Associations)", "absent skeletal muscle (MP:0004846 from MPO Gene-Phenotype Associations)", "decreased tongue size (MP:0009907 from MPO Gene-Phenotype Associations)", "absent diaphragm (MP:0011883 from MPO Gene-Phenotype Associations)", "hypaxial muscle hypoplasia (MP:0003359 from MPO Gene-Phenotype Associations)", "increased myoepithelioma incidence (MP:0012043 from MPO Gene-Phenotype Associations)", "decreased lung tumor incidence (MP:0010267 from MPO Gene-Phenotype Associations)", "abnormal muscle precursor cell migration (MP:0003090 from MPO Gene-Phenotype Associations)", "abnormal muscle precursor cell physiology (MP:0012186 from MPO Gene-Phenotype Associations)", "muscle hypoplasia (MP:0000734 from MPO Gene-Phenotype Associations)", "abnormal diaphragm development (MP:0012251 from MPO Gene-Phenotype Associations)", "herniated diaphragm (MP:0003924 from MPO Gene-Phenotype Associations)", "abnormal diaphragm morphology (MP:0002279 from MPO Gene-Phenotype Associations)", "abnormal hypaxial muscle morphology (MP:0003358 from MPO Gene-Phenotype Associations)", "thin diaphragm muscle (MP:0000761 from MPO Gene-Phenotype Associations)", "delayed somite formation (MP:0003794 from MPO Gene-Phenotype Associations)", "abnormal sclerotome morphology (MP:0006029 from MPO Gene-Phenotype Associations)", "abnormal dermomyotome development (MP:0004206 from MPO Gene-Phenotype Associations)", "abnormal myotome development (MP:0000737 from MPO Gene-Phenotype Associations)", "abnormal muscle development (MP:0000733 from MPO Gene-Phenotype Associations)", "abnormal myogenesis (MP:0000729 from MPO Gene-Phenotype Associations)", "absent sclerotome (MP:0006295 from MPO Gene-Phenotype Associations)", "absent myotome (MP:0012249 from MPO Gene-Phenotype Associations)", "abnormal dermatome morphology (MP:0003940 from MPO Gene-Phenotype Associations)", "absent dermatome (MP:0012248 from MPO Gene-Phenotype Associations)", "abnormal myotome morphology (MP:0003939 from MPO Gene-Phenotype Associations)", "abnormal intercostal muscle morphology (MP:0002280 from MPO Gene-Phenotype Associations)", "truncated ribs (MP:0004677 from MPO Gene-Phenotype Associations)", "disorganized placental labyrinth (MP:0011527 from MPO Gene-Phenotype Associations)", "axial skeleton hypoplasia (MP:0000071 from MPO Gene-Phenotype Associations)", "absent nephron (MP:0011292 from MPO Gene-Phenotype Associations)", "pale placenta (MP:0004266 from MPO Gene-Phenotype Associations)", "increased liver free fatty acids level (MP:0010359 from MPO Gene-Phenotype Associations)", "partial lethality during fetal growth through weaning (MP:0011112 from MPO Gene-Phenotype Associations)", "partial embryonic lethality (MP:0011102 from MPO Gene-Phenotype Associations)", "abnormal rhombomere 4 morphology (MP:0012796 from MPO Gene-Phenotype Associations)", "rhombomere transformation (MP:0012818 from MPO Gene-Phenotype Associations)", "increased rhombomere 4 size (MP:0012798 from MPO Gene-Phenotype Associations)", "abnormal maxillary nerve morphology (MP:0009799 from MPO Gene-Phenotype Associations)", "abnormal ophthalmic nerve morphology (MP:0009798 from MPO Gene-Phenotype Associations)", "ectopic kidney (MP:0003600 from MPO Gene-Phenotype Associations)", "pelvic kidney (MP:0011361 from MPO Gene-Phenotype Associations)", "abnormal ureteric bud trunk morphology (MP:0011761 from MPO Gene-Phenotype Associations)", "fused kidneys (MP:0003605 from MPO Gene-Phenotype Associations)", "abnormal ureteric bud tip morphology (MP:0011760 from MPO Gene-Phenotype Associations)", "small supraoccipital bone (MP:0004444 from MPO Gene-Phenotype Associations)", "broad nasal bone (MP:0004472 from MPO Gene-Phenotype Associations)", "absent epididymal fat pad (MP:0008901 from MPO Gene-Phenotype Associations)", "short lumbar vertebrae (MP:0004708 from MPO Gene-Phenotype Associations)", "small sacral vertebrae (MP:0004657 from MPO Gene-Phenotype Associations)", "entropion (MP:0006165 from MPO Gene-Phenotype Associations)", "abnormal genital tubercle morphology (MP:0011771 from MPO Gene-Phenotype Associations)", "genital tubercle hypoplasia (MP:0011772 from MPO Gene-Phenotype Associations)", "abnormal primordial germ cell apoptosis (MP:0011610 from MPO Gene-Phenotype Associations)", "abnormal presomitic mesoderm morphology (MP:0012182 from MPO Gene-Phenotype Associations)", "adactyly (MP:0000561 from MPO Gene-Phenotype Associations)", "absent external male genitalia (MP:0009204 from MPO Gene-Phenotype Associations)", "absent external female genitalia (MP:0009211 from MPO Gene-Phenotype Associations)", "abnormal anal canal morphology (MP:0009053 from MPO Gene-Phenotype Associations)", "abnormal anus morphology (MP:0005034 from MPO Gene-Phenotype Associations)", "anal atresia (MP:0003130 from MPO Gene-Phenotype Associations)", "absent anus (MP:0008999 from MPO Gene-Phenotype Associations)", "sirenomelia (MP:0003445 from MPO Gene-Phenotype Associations)", "truncated notochord (MP:0004714 from MPO Gene-Phenotype Associations)", "abnormal tailgut morphology (MP:0008787 from MPO Gene-Phenotype Associations)", "small notochord (MP:0004710 from MPO Gene-Phenotype Associations)", "abnormal posterior definitive endoderm morphology (MP:0013217 from MPO Gene-Phenotype Associations)", "abnormal coccygeal vertebrae morphology (MP:0010112 from MPO Gene-Phenotype Associations)", "hydrometra (MP:0009709 from MPO Gene-Phenotype Associations)", "abnormal coccyx morphology (MP:0010114 from MPO Gene-Phenotype Associations)", "ureter hypoplasia (MP:0011298 from MPO Gene-Phenotype Associations)", "blind uterus (MP:0009084 from MPO Gene-Phenotype Associations)", "absent vagina (MP:0003535 from MPO Gene-Phenotype Associations)", "short ureter (MP:0002990 from MPO Gene-Phenotype Associations)", "abnormal ventral ectodermal ridge morphology (MP:0012713 from MPO Gene-Phenotype Associations)", "absent tail bud (MP:0012063 from MPO Gene-Phenotype Associations)", "decreased ventral ectodermal ridge size (MP:0012714 from MPO Gene-Phenotype Associations)", "vestigial tail (MP:0002632 from MPO Gene-Phenotype Associations)", "absent tail (MP:0003456 from MPO Gene-Phenotype Associations)", "absent sacral vertebrae (MP:0004656 from MPO Gene-Phenotype Associations)", "abnormal cervical rib (MP:0008922 from MPO Gene-Phenotype Associations)", "decreased thoracic vertebrae number (MP:0004648 from MPO Gene-Phenotype Associations)", "abnormal zone of polarizing activity morphology (MP:0012528 from MPO Gene-Phenotype Associations)", "occipital bone foramen (MP:0004442 from MPO Gene-Phenotype Associations)", "annular pancreas (MP:0006261 from MPO Gene-Phenotype Associations)", "abnormal tracheal smooth muscle morphology (MP:0002284 from MPO Gene-Phenotype Associations)", "notochord degeneration (MP:0004712 from MPO Gene-Phenotype Associations)", "absent vertebrae (MP:0000138 from MPO Gene-Phenotype Associations)", "abnorrmal surface ectoderm morphology (MP:0012532 from MPO Gene-Phenotype Associations)", "truncated tail bud (MP:0013180 from MPO Gene-Phenotype Associations)", "abnormal optic stalk morphology (MP:0004268 from MPO Gene-Phenotype Associations)", "absent mouth (MP:0000453 from MPO Gene-Phenotype Associations)", "fused right lung lobes (MP:0010977 from MPO Gene-Phenotype Associations)", "impaired lung lobe morphogenesis (MP:0011011 from MPO Gene-Phenotype Associations)", "adhesive atelectasis (MP:0010818 from MPO Gene-Phenotype Associations)", "split sternum (MP:0004320 from MPO Gene-Phenotype Associations)", "arched palate (MP:0003761 from MPO Gene-Phenotype Associations)", "absent tracheal cartilage rings (MP:0004553 from MPO Gene-Phenotype Associations)", "abnormal talus morphology (MP:0005109 from MPO Gene-Phenotype Associations)", "paternal effect (MP:0010723 from MPO Gene-Phenotype Associations)", "bifurcated tail (MP:0013175 from MPO Gene-Phenotype Associations)", "rectal atresia (MP:0011775 from MPO Gene-Phenotype Associations)", "twin decidual capsule (MP:0009353 from MPO Gene-Phenotype Associations)", "reversion by viral sequence excision (MP:0003176 from MPO Gene-Phenotype Associations)", "urethra atresia (MP:0003591 from MPO Gene-Phenotype Associations)", "flat head (MP:0012174 from MPO Gene-Phenotype Associations)", "phenotypic reversion (MP:0003171 from MPO Gene-Phenotype Associations)", "delayed embryo implantation (MP:0009649 from MPO Gene-Phenotype Associations)", "impaired spacing of implantation sites (MP:0009352 from MPO Gene-Phenotype Associations)", "lumbar vertebral fusion (MP:0004621 from MPO Gene-Phenotype Associations)", "thoracic vertebral fusion (MP:0004623 from MPO Gene-Phenotype Associations)", "sacral vertebral fusion (MP:0004622 from MPO Gene-Phenotype Associations)", "caudal vertebral fusion (MP:0004619 from MPO Gene-Phenotype Associations)", "abnormal vertebral spinous process morphology (MP:0004601 from MPO Gene-Phenotype Associations)", "absent vertebral spinous process (MP:0004606 from MPO Gene-Phenotype Associations)", "hemivertebra (MP:0008832 from MPO Gene-Phenotype Associations)", "abnormal optic canal morphology (MP:0010704 from MPO Gene-Phenotype Associations)", "absent metoptic pilar (MP:0010705 from MPO Gene-Phenotype Associations)", "split cervical axis (MP:0010703 from MPO Gene-Phenotype Associations)", "split cervical atlas (MP:0010702 from MPO Gene-Phenotype Associations)", "decreased pulmonary endothelial cell surface (MP:0003182 from MPO Gene-Phenotype Associations)", "abnormal orbitosphenoid bone morphology (MP:0004457 from MPO Gene-Phenotype Associations)", "abnormal orbit morphology (MP:0010030 from MPO Gene-Phenotype Associations)", "fused tracheal cartilage rings (MP:0004552 from MPO Gene-Phenotype Associations)", "squamous metaplasia of seminal vesicles (MP:0013321 from MPO Gene-Phenotype Associations)", "squamous metaplasia of prostate gland (MP:0013322 from MPO Gene-Phenotype Associations)", "seminal vesicle atrophy (MP:0013319 from MPO Gene-Phenotype Associations)", "abnormal response to vitamins (MP:0003639 from MPO Gene-Phenotype Associations)", "abnormal eyelid aperture (MP:0003671 from MPO Gene-Phenotype Associations)", "narrow eye opening (MP:0005287 from MPO Gene-Phenotype Associations)", "absent vertebral arch (MP:0004603 from MPO Gene-Phenotype Associations)", "fused synovial joints (MP:0003190 from MPO Gene-Phenotype Associations)", "esophageal atresia (MP:0003276 from MPO Gene-Phenotype Associations)", "absent pituitary gland (MP:0005315 from MPO Gene-Phenotype Associations)", "abnormal neurohypophysis morphology (MP:0004164 from MPO Gene-Phenotype Associations)", "abnormal pituitary infundibular stalk morphology (MP:0009463 from MPO Gene-Phenotype Associations)", "abnormal bulbourethral gland morphology (MP:0001169 from MPO Gene-Phenotype Associations)", "absent bulbourethral gland (MP:0002770 from MPO Gene-Phenotype Associations)", "increased cochlear hair cell number (MP:0004407 from MPO Gene-Phenotype Associations)", "increased cochlear outer hair cell number (MP:0004401 from MPO Gene-Phenotype Associations)", "increased cochlear inner hair cell number (MP:0004395 from MPO Gene-Phenotype Associations)", "increased neuron number (MP:0008947 from MPO Gene-Phenotype Associations)", "increased sensory neuron number (MP:0006006 from MPO Gene-Phenotype Associations)", "conductive hearing impairment (MP:0006326 from MPO Gene-Phenotype Associations)", "conductive hearing loss (MP:0004739 from MPO Gene-Phenotype Associations)", "abnormal vestibular hair cell kinocilium morphology (MP:0011064 from MPO Gene-Phenotype Associations)", "absent humerus (MP:0004352 from MPO Gene-Phenotype Associations)", "abnormal stomach submucosa morphology (MP:0010794 from MPO Gene-Phenotype Associations)", "epididymal cyst (MP:0003595 from MPO Gene-Phenotype Associations)", "abnormal neurohypophysis development (MP:0013338 from MPO Gene-Phenotype Associations)", "abnormal metanephric ureteric bud development (MP:0011457 from MPO Gene-Phenotype Associations)", "abnormal rathke's pouch apoptosis (MP:0013352 from MPO Gene-Phenotype Associations)", "absent adenohypophysis (MP:0008320 from MPO Gene-Phenotype Associations)", "absent forelimb (MP:0000551 from MPO Gene-Phenotype Associations)", "absent pulmonary vein (MP:0010646 from MPO Gene-Phenotype Associations)", "abnormal cecum development (MP:0009479 from MPO Gene-Phenotype Associations)", "cecal atresia (MP:0009510 from MPO Gene-Phenotype Associations)", "absent rectum (MP:0009509 from MPO Gene-Phenotype Associations)", "absent pulmonary artery (MP:0010521 from MPO Gene-Phenotype Associations)", "short palate (MP:0003760 from MPO Gene-Phenotype Associations)", "tongue ankylosis (MP:0013264 from MPO Gene-Phenotype Associations)", "decreased submandibular gland size (MP:0009520 from MPO Gene-Phenotype Associations)", "submandibular gland hypoplasia (MP:0009522 from MPO Gene-Phenotype Associations)", "abnormal submandibular duct morphology (MP:0009525 from MPO Gene-Phenotype Associations)", "absent thyroid gland (MP:0005314 from MPO Gene-Phenotype Associations)", "athyroidism (MP:0004663 from MPO Gene-Phenotype Associations)", "absent hindlimb (MP:0000557 from MPO Gene-Phenotype Associations)", "absent limbs (MP:0000549 from MPO Gene-Phenotype Associations)", "abnormal palatal rugae morphology (MP:0009652 from MPO Gene-Phenotype Associations)", "abnormal salivary gland duct morphology (MP:0009517 from MPO Gene-Phenotype Associations)", "abnormal external urethral orifice morphology (MP:0011796 from MPO Gene-Phenotype Associations)", "hypospadia (MP:0003124 from MPO Gene-Phenotype Associations)", "abnormal urethra morphology (MP:0000537 from MPO Gene-Phenotype Associations)", "abnormal pulmonary vein morphology (MP:0002726 from MPO Gene-Phenotype Associations)", "abnormal otic capsule morphology (MP:0000039 from MPO Gene-Phenotype Associations)", "small otic capsule (MP:0006288 from MPO Gene-Phenotype Associations)", "translucent skin (MP:0001201 from MPO Gene-Phenotype Associations)", "abnormal branching involved in trachea morphogenesis (MP:0011025 from MPO Gene-Phenotype Associations)", "impaired branching involved in trachea morphogenesis (MP:0011026 from MPO Gene-Phenotype Associations)", "absent lung buds (MP:0010907 from MPO Gene-Phenotype Associations)", "absent lungs (MP:0001181 from MPO Gene-Phenotype Associations)", "absent sixth pharyngeal arch (MP:0010644 from MPO Gene-Phenotype Associations)", "absent fourth pharyngeal arch (MP:0010643 from MPO Gene-Phenotype Associations)", "abnormal lung bud morphology (MP:0010906 from MPO Gene-Phenotype Associations)", "small stomach (MP:0002691 from MPO Gene-Phenotype Associations)", "abnormal acromion morphology (MP:0004345 from MPO Gene-Phenotype Associations)", "absent acromion (MP:0004346 from MPO Gene-Phenotype Associations)", "absent pubis (MP:0004691 from MPO Gene-Phenotype Associations)", "abnormal hypodermis muscle layer morphology (MP:0011157 from MPO Gene-Phenotype Associations)", "absent hypodermis muscle layer (MP:0011158 from MPO Gene-Phenotype Associations)", "abnormal atrioventricular bundle morphology (MP:0004117 from MPO Gene-Phenotype Associations)", "abnormal left posterior bundle morphology (MP:0010566 from MPO Gene-Phenotype Associations)", "abnormal right bundle morphology (MP:0010567 from MPO Gene-Phenotype Associations)", "atrium hypoplasia (MP:0004055 from MPO Gene-Phenotype Associations)", "abnormal forced expiratory flow rates (MP:0002297 from MPO Gene-Phenotype Associations)", "abnormal inspiratory capacity (MP:0002311 from MPO Gene-Phenotype Associations)", "absent barrels in primary somatosensory cortex (MP:0000862 from MPO Gene-Phenotype Associations)", "absent mesencephalic trigeminal nucleus (MP:0000908 from MPO Gene-Phenotype Associations)", "abnormal mammary gland pattern (MP:0009720 from MPO Gene-Phenotype Associations)", "absent mammary gland (MP:0000629 from MPO Gene-Phenotype Associations)", "abnormal mammary gland embryonic development (MP:0004135 from MPO Gene-Phenotype Associations)", "arrest of tooth development (MP:0000118 from MPO Gene-Phenotype Associations)", "absent teeth (MP:0000124 from MPO Gene-Phenotype Associations)", "thin skin (MP:0001199 from MPO Gene-Phenotype Associations)", "absent seminal vesicle (MP:0003642 from MPO Gene-Phenotype Associations)", "absent prostate gland (MP:0001159 from MPO Gene-Phenotype Associations)", "decreased urine major urinary protein level (MP:0011532 from MPO Gene-Phenotype Associations)", "decreased urine protein level (MP:0002963 from MPO Gene-Phenotype Associations)", "abnormal kidney outer medulla inner stripe morphology (MP:0011378 from MPO Gene-Phenotype Associations)", "abnormal kidney outer medulla morphology (MP:0011332 from MPO Gene-Phenotype Associations)", "abnormal kidney outer medulla outer stripe morphology (MP:0011379 from MPO Gene-Phenotype Associations)", "absent apical ectodermal ridge (MP:0001677 from MPO Gene-Phenotype Associations)", "abnormal pubic symphysis morphology (MP:0009575 from MPO Gene-Phenotype Associations)", "absent tongue squamous epithelium (MP:0000766 from MPO Gene-Phenotype Associations)", "abnormal olfactory gland morphology (MP:0012067 from MPO Gene-Phenotype Associations)", "absent sebaceous gland (MP:0000648 from MPO Gene-Phenotype Associations)", "absent epidermis stratum spinosum (MP:0009614 from MPO Gene-Phenotype Associations)", "absent epidermis (MP:0001217 from MPO Gene-Phenotype Associations)", "urinary bladder exstrophy (MP:0013282 from MPO Gene-Phenotype Associations)", "thin urinary bladder urothelium (MP:0000544 from MPO Gene-Phenotype Associations)", "absent urinary bladder urothelium (MP:0000543 from MPO Gene-Phenotype Associations)", "rectovaginal fistula (MP:0003320 from MPO Gene-Phenotype Associations)", "uterine cervix inflammation (MP:0009228 from MPO Gene-Phenotype Associations)", "clitoris hypoplasia (MP:0009101 from MPO Gene-Phenotype Associations)", "small clitoris (MP:0003530 from MPO Gene-Phenotype Associations)", "esophagogastric junction metaplasia (MP:0005494 from MPO Gene-Phenotype Associations)", "gastric cysts (MP:0010787 from MPO Gene-Phenotype Associations)", "intervertebral disk degeneration (MP:0004684 from MPO Gene-Phenotype Associations)", "gastric metaplasia (MP:0005213 from MPO Gene-Phenotype Associations)", "absent hair follicles (MP:0000378 from MPO Gene-Phenotype Associations)", "abnormal embryonic cloaca morphology (MP:0010115 from MPO Gene-Phenotype Associations)", "abnormal primitive urogenital sinus morphology (MP:0010116 from MPO Gene-Phenotype Associations)", "abnormal septation of the cloaca (MP:0003125 from MPO Gene-Phenotype Associations)", "abnormal esophagus development (MP:0003160 from MPO Gene-Phenotype Associations)", "absent ulna (MP:0004360 from MPO Gene-Phenotype Associations)", "abnormal tracheal ciliated epithelium morphology (MP:0002285 from MPO Gene-Phenotype Associations)", "abnormal esophageal squamous epithelium morphology (MP:0000469 from MPO Gene-Phenotype Associations)", "impaired luteal cell differentiation (MP:0001133 from MPO Gene-Phenotype Associations)", "abnormal tail bud morphology (MP:0002861 from MPO Gene-Phenotype Associations)", "abnormal tail development (MP:0006281 from MPO Gene-Phenotype Associations)", "small tail bud (MP:0012062 from MPO Gene-Phenotype Associations)", "absent epidermis stratum basale (MP:0001232 from MPO Gene-Phenotype Associations)", "abnormal skin exfoliation (MP:0009473 from MPO Gene-Phenotype Associations)", "blistering (MP:0001208 from MPO Gene-Phenotype Associations)", "abnormal epidermal-dermal junction morphology (MP:0011159 from MPO Gene-Phenotype Associations)", "dermal-epidermal separation (MP:0011160 from MPO Gene-Phenotype Associations)", "abnormal external nares morphology (MP:0002235 from MPO Gene-Phenotype Associations)", "thin lip (MP:0003775 from MPO Gene-Phenotype Associations)", "fused lips (MP:0009553 from MPO Gene-Phenotype Associations)", "flattened snout (MP:0000447 from MPO Gene-Phenotype Associations)", "palatal shelf fusion with tongue or mandible (MP:0009884 from MPO Gene-Phenotype Associations)", "oral atresia (MP:0009576 from MPO Gene-Phenotype Associations)", "absent epidermis stratum corneum (MP:0001241 from MPO Gene-Phenotype Associations)", "absent epidermis stratum granulosum (MP:0009560 from MPO Gene-Phenotype Associations)", "abnormal keratinocyte differentiation (MP:0002656 from MPO Gene-Phenotype Associations)", "abnormal keratinocyte morphology (MP:0002655 from MPO Gene-Phenotype Associations)", "abnormal epidermis stratum basale morphology (MP:0001231 from MPO Gene-Phenotype Associations)", "abnormal epidermis suprabasal layer morphology (MP:0001233 from MPO Gene-Phenotype Associations)", "abnormal retinal development (MP:0009772 from MPO Gene-Phenotype Associations)", "abnormal retinal progenitor cell morphology (MP:0006071 from MPO Gene-Phenotype Associations)", "abnormal optic fissure morphology (MP:0012534 from MPO Gene-Phenotype Associations)", "abnormal lacrimal apparatus morphology (MP:0008968 from MPO Gene-Phenotype Associations)", "abnormal lacrimal gland morphology (MP:0001346 from MPO Gene-Phenotype Associations)", "absent lacrimal glands (MP:0001347 from MPO Gene-Phenotype Associations)", "enlarged meibomian gland (MP:0013386 from MPO Gene-Phenotype Associations)", "meibomian gland hypertrophy (MP:0013387 from MPO Gene-Phenotype Associations)", "abnormal harderian gland morphology (MP:0005248 from MPO Gene-Phenotype Associations)", "increased striatum area (MP:0012467 from MPO Gene-Phenotype Associations)", "small axillary lymph nodes (MP:0009632 from MPO Gene-Phenotype Associations)", "small brachial lymph nodes (MP:0009629 from MPO Gene-Phenotype Associations)", "keratoconjunctivitis (MP:0006194 from MPO Gene-Phenotype Associations)", "abnormal small intestinal crypt cell proliferation (MP:0010157 from MPO Gene-Phenotype Associations)", "abnormal hair follicle physiology (MP:0011194 from MPO Gene-Phenotype Associations)", "increased hair follicle apoptosis (MP:0011195 from MPO Gene-Phenotype Associations)", "abnormal synaptic vesicle clustering (MP:0004793 from MPO Gene-Phenotype Associations)", "sparse vibrissae (MP:0001283 from MPO Gene-Phenotype Associations)", "abnormal bergmann glial cell differentiation (MP:0010388 from MPO Gene-Phenotype Associations)", "early eyelid opening (MP:0003153 from MPO Gene-Phenotype Associations)", "abnormal gubernaculum morphology (MP:0005149 from MPO Gene-Phenotype Associations)", "abnormal inguinal canal morphology (MP:0003673 from MPO Gene-Phenotype Associations)", "abnormal peritoneal vaginal process morphology (MP:0009217 from MPO Gene-Phenotype Associations)", "absent peritoneal vaginal process (MP:0009218 from MPO Gene-Phenotype Associations)", "abnormal male inguinal canal morphology (MP:0008016 from MPO Gene-Phenotype Associations)", "absent male inguinal canal (MP:0009213 from MPO Gene-Phenotype Associations)", "decreased ductal branching in the coagulating gland (MP:0000665 from MPO Gene-Phenotype Associations)", "abnormal peritoneum morphology (MP:0009216 from MPO Gene-Phenotype Associations)", "decreased sternebra number (MP:0012283 from MPO Gene-Phenotype Associations)", "short perineum (MP:0003550 from MPO Gene-Phenotype Associations)", "abnormal scrotum morphology (MP:0002669 from MPO Gene-Phenotype Associations)", "absent scrotum (MP:0002670 from MPO Gene-Phenotype Associations)", "abnormal prostate gland anterior lobe morphology (MP:0001163 from MPO Gene-Phenotype Associations)", "small prostate gland anterior lobe (MP:0000664 from MPO Gene-Phenotype Associations)", "absent prostate gland anterior lobe (MP:0002771 from MPO Gene-Phenotype Associations)", "abnormal foreskin morphology (MP:0003553 from MPO Gene-Phenotype Associations)", "decreased ductal branching in the palatine gland (MP:0000616 from MPO Gene-Phenotype Associations)", "narrow salivary ducts (MP:0000620 from MPO Gene-Phenotype Associations)", "increased salivary gland mucosal cell number (MP:0000617 from MPO Gene-Phenotype Associations)", "bulbourethral gland hypoplasia (MP:0000671 from MPO Gene-Phenotype Associations)", "lateral prostate gland hypoplasia (MP:0000660 from MPO Gene-Phenotype Associations)", "small salivary gland (MP:0000618 from MPO Gene-Phenotype Associations)", "abnormal prostate gland duct morphology (MP:0009734 from MPO Gene-Phenotype Associations)", "decreased prostate gland duct number (MP:0000666 from MPO Gene-Phenotype Associations)", "abnormal prostate gland ventral lobe morphology (MP:0009380 from MPO Gene-Phenotype Associations)", "small prostate gland ventral lobe (MP:0000661 from MPO Gene-Phenotype Associations)", "abnormal prostate gland branching morphogenesis (MP:0009736 from MPO Gene-Phenotype Associations)", "abnormal prostate gland development (MP:0009735 from MPO Gene-Phenotype Associations)", "decreased adrenal gland weight (MP:0013308 from MPO Gene-Phenotype Associations)", "abnormal uterine cervix size (MP:0009225 from MPO Gene-Phenotype Associations)", "small uterine cervix (MP:0009226 from MPO Gene-Phenotype Associations)", "abnormal hallux morphology (MP:0009049 from MPO Gene-Phenotype Associations)", "absent hallux (MP:0009001 from MPO Gene-Phenotype Associations)", "monodactyly (MP:0003800 from MPO Gene-Phenotype Associations)", "vesicovaginal fistula (MP:0011829 from MPO Gene-Phenotype Associations)", "urinary bladder hypoplasia (MP:0003617 from MPO Gene-Phenotype Associations)", "urinary bladder cysts (MP:0011828 from MPO Gene-Phenotype Associations)", "abnormal ampullary gland morphology (MP:0013323 from MPO Gene-Phenotype Associations)", "uterine cervix hypoplasia (MP:0009227 from MPO Gene-Phenotype Associations)", "abnormal penile bone morphology (MP:0009103 from MPO Gene-Phenotype Associations)", "small penile bone (MP:0009104 from MPO Gene-Phenotype Associations)", "abnormal female urethra morphology (MP:0011780 from MPO Gene-Phenotype Associations)", "umbilical artery stenosis (MP:0012302 from MPO Gene-Phenotype Associations)", "dilated uterine horn (MP:0009087 from MPO Gene-Phenotype Associations)", "absent urinary bladder (MP:0009252 from MPO Gene-Phenotype Associations)", "clinodactyly (MP:0006253 from MPO Gene-Phenotype Associations)", "abnormal umbilical artery morphology (MP:0003230 from MPO Gene-Phenotype Associations)", "abnormal umbilical cord blood vessel morphology (MP:0012300 from MPO Gene-Phenotype Associations)", "abnormal umbilical vein morphology (MP:0010667 from MPO Gene-Phenotype Associations)", "umbilical vein stenosis (MP:0012303 from MPO Gene-Phenotype Associations)", "abnormal umbilical cord morphology (MP:0001725 from MPO Gene-Phenotype Associations)", "umbilical hernia (MP:0010146 from MPO Gene-Phenotype Associations)", "abnormal branching involved in seminal vesicle morphogenesis (MP:0013318 from MPO Gene-Phenotype Associations)", "abnormal seminal vesicle development (MP:0013317 from MPO Gene-Phenotype Associations)", "oviduct atrophy (MP:0009064 from MPO Gene-Phenotype Associations)", "abnormal oviduct transport (MP:0003700 from MPO Gene-Phenotype Associations)", "abnormal oviduct physiology (MP:0012018 from MPO Gene-Phenotype Associations)", "abnormal placenta junctional zone morphology (MP:0008957 from MPO Gene-Phenotype Associations)", "abnormal spongiotrophoblast layer morphology (MP:0004255 from MPO Gene-Phenotype Associations)", "abnormal spongiotrophoblast size (MP:0012097 from MPO Gene-Phenotype Associations)", "decreased spongiotrophoblast size (MP:0012099 from MPO Gene-Phenotype Associations)", "increased spongiotrophoblast size (MP:0012098 from MPO Gene-Phenotype Associations)", "abnormal trophoblast glycogen cell morphology (MP:0008958 from MPO Gene-Phenotype Associations)", "decreased trophoblast glycogen cell number (MP:0012109 from MPO Gene-Phenotype Associations)", "abnormal placenta labyrinth size (MP:0011519 from MPO Gene-Phenotype Associations)", "decreased placental labyrinth size (MP:0011521 from MPO Gene-Phenotype Associations)", "placental labyrinth hypoplasia (MP:0001715 from MPO Gene-Phenotype Associations)", "thin placenta labyrinth (MP:0011523 from MPO Gene-Phenotype Associations)", "increased trophoblast glycogen cell number (MP:0012108 from MPO Gene-Phenotype Associations)", "enlarged placenta (MP:0004260 from MPO Gene-Phenotype Associations)", "increased placenta weight (MP:0004920 from MPO Gene-Phenotype Associations)", "abnormal placenta size (MP:0004258 from MPO Gene-Phenotype Associations)", "small placenta (MP:0004259 from MPO Gene-Phenotype Associations)", "abnormal placenta weight (MP:0004257 from MPO Gene-Phenotype Associations)", "decreased placenta weight (MP:0004921 from MPO Gene-Phenotype Associations)", "abnormal fetal growth|weight|body size (MP:0004197 from MPO Gene-Phenotype Associations)", "abnormal fetal size (MP:0004198 from MPO Gene-Phenotype Associations)", "decreased fetal size (MP:0004200 from MPO Gene-Phenotype Associations)", "decreased fetal weight (MP:0009431 from MPO Gene-Phenotype Associations)", "fetal growth retardation (MP:0004201 from MPO Gene-Phenotype Associations)", "abnormal birth body size (MP:0009701 from MPO Gene-Phenotype Associations)", "decreased birth body size (MP:0009703 from MPO Gene-Phenotype Associations)", "abnormal birth weight (MP:0009672 from MPO Gene-Phenotype Associations)", "decreased birth weight (MP:0009674 from MPO Gene-Phenotype Associations)", "increased fetal size (MP:0004199 from MPO Gene-Phenotype Associations)", "increased fetal weight (MP:0009432 from MPO Gene-Phenotype Associations)", "abnormal branching involved in preterminal bronchiole morphogenesis (MP:0011029 from MPO Gene-Phenotype Associations)", "impaired branching involved in preterminal bronchiole morphogenesis (MP:0011030 from MPO Gene-Phenotype Associations)", "enlarged uterine horn (MP:0011873 from MPO Gene-Phenotype Associations)", "pulmonary hyperplasia (MP:0004202 from MPO Gene-Phenotype Associations)", "increased birth body size (MP:0009702 from MPO Gene-Phenotype Associations)", "increased birth weight (MP:0009673 from MPO Gene-Phenotype Associations)", "insensitivity to parathyroid hormone (MP:0003497 from MPO Gene-Phenotype Associations)", "increased brown fat cell lipid droplet size (MP:0009124 from MPO Gene-Phenotype Associations)", "abnormal urine catecholamine level (MP:0011478 from MPO Gene-Phenotype Associations)", "abnormal dna methylation (MP:0008877 from MPO Gene-Phenotype Associations)", "abnormal epigenetic regulation of gene expression (MP:0012167 from MPO Gene-Phenotype Associations)", "genetic imprinting (MP:0003121 from MPO Gene-Phenotype Associations)", "maternal imprinting (MP:0003122 from MPO Gene-Phenotype Associations)", "abnormal imprinting (MP:0003787 from MPO Gene-Phenotype Associations)", "paternal imprinting (MP:0003123 from MPO Gene-Phenotype Associations)", "abnormal placenta fetal blood space morphology (MP:0011526 from MPO Gene-Phenotype Associations)", "abnormal placenta intervillous maternal lacunae morphology (MP:0011525 from MPO Gene-Phenotype Associations)", "increased placenta intervillous maternal lacunae size (MP:0011529 from MPO Gene-Phenotype Associations)", "abnormal placental labyrinth villi branching morphogenesis (MP:0011528 from MPO Gene-Phenotype Associations)", "abnormal placental labyrinth villi morphology (MP:0011522 from MPO Gene-Phenotype Associations)", "abnormal syncytiotrophoblast morphology (MP:0011531 from MPO Gene-Phenotype Associations)", "increased placental labyrinth size (MP:0011520 from MPO Gene-Phenotype Associations)", "thick placenta labyrinth (MP:0011524 from MPO Gene-Phenotype Associations)", "maternal effect (MP:0003718 from MPO Gene-Phenotype Associations)", "other phenotype (MP:0005395 from MPO Gene-Phenotype Associations)", "other aberrant phenotype (MP:0002168 from MPO Gene-Phenotype Associations)", "ectopia lentis (MP:0005263 from MPO Gene-Phenotype Associations)", "hydropic eye lens fibers (MP:0001309 from MPO Gene-Phenotype Associations)", "premature neuronal precursor differentiation (MP:0003424 from MPO Gene-Phenotype Associations)", "abnormal kidney inner medulla morphology (MP:0011333 from MPO Gene-Phenotype Associations)", "small inner medullary pyramid (MP:0000526 from MPO Gene-Phenotype Associations)", "ureteropelvic junction stenosis (MP:0011490 from MPO Gene-Phenotype Associations)", "distended jejunum (MP:0011503 from MPO Gene-Phenotype Associations)", "abnormal oropharyngeal lymphoid tissue morphology (MP:0002379 from MPO Gene-Phenotype Associations)", "abnormal mucosa-associated lymphoid tissue morphology (MP:0002377 from MPO Gene-Phenotype Associations)", "ischuria (MP:0003622 from MPO Gene-Phenotype Associations)", "abnormal stomach cardiac region morphology (MP:0010798 from MPO Gene-Phenotype Associations)", "increased plasmacytoid dendritic cell number (MP:0008524 from MPO Gene-Phenotype Associations)", "abnormal lymph node number (MP:0000700 from MPO Gene-Phenotype Associations)", "decreased lymph node number (MP:0002219 from MPO Gene-Phenotype Associations)", "abnormal abdominal wall morphology (MP:0003257 from MPO Gene-Phenotype Associations)", "abnormal body wall morphology (MP:0003385 from MPO Gene-Phenotype Associations)", "omphalocele (MP:0003052 from MPO Gene-Phenotype Associations)", "herniated abdominal wall (MP:0000757 from MPO Gene-Phenotype Associations)", "absent jejunum (MP:0000498 from MPO Gene-Phenotype Associations)", "uterus atresia (MP:0003568 from MPO Gene-Phenotype Associations)", "short gestation period (MP:0002294 from MPO Gene-Phenotype Associations)", "increased midbrain apoptosis (MP:0012503 from MPO Gene-Phenotype Associations)", "abnormal lens epithelium apoptosis (MP:0008793 from MPO Gene-Phenotype Associations)", "increased lens epithelium apoptosis (MP:0008794 from MPO Gene-Phenotype Associations)", "dysphagia (MP:0003158 from MPO Gene-Phenotype Associations)", "abnormal periocular mesenchyme morphology (MP:0004054 from MPO Gene-Phenotype Associations)", "absent nasolacrimal duct (MP:0010712 from MPO Gene-Phenotype Associations)", "ethmoturbinate hypoplasia (MP:0008972 from MPO Gene-Phenotype Associations)", "choanal atresia (MP:0008970 from MPO Gene-Phenotype Associations)", "abnormal ethmoturbinate morphology (MP:0008971 from MPO Gene-Phenotype Associations)", "absent harderian gland (MP:0008881 from MPO Gene-Phenotype Associations)", "abnormal nasolacrimal duct morphology (MP:0008969 from MPO Gene-Phenotype Associations)", "abnormal ethmoidal bone morphology (MP:0000100 from MPO Gene-Phenotype Associations)", "increased total retina thickness (MP:0011964 from MPO Gene-Phenotype Associations)", "abnormal primary vitreous morphology (MP:0009620 from MPO Gene-Phenotype Associations)", "persistent hyperplastic primary vitreous (MP:0010711 from MPO Gene-Phenotype Associations)", "abnormal internal nares morphology (MP:0002236 from MPO Gene-Phenotype Associations)", "abnormal paranasal sinus morphology (MP:0002240 from MPO Gene-Phenotype Associations)", "abnormal maxillary sinus morphology (MP:0002247 from MPO Gene-Phenotype Associations)", "abnormal mucociliary clearance (MP:0001947 from MPO Gene-Phenotype Associations)", "impaired mucociliary clearance (MP:0010752 from MPO Gene-Phenotype Associations)", "ear inflammation (MP:0001849 from MPO Gene-Phenotype Associations)", "increased susceptibility to otitis media (MP:0001850 from MPO Gene-Phenotype Associations)", "intracerebral hemorrhage (MP:0001916 from MPO Gene-Phenotype Associations)", "intraventricular hemorrhage (MP:0001917 from MPO Gene-Phenotype Associations)", "intracranial hemorrhage (MP:0001915 from MPO Gene-Phenotype Associations)", "spinal hemorrhage (MP:0006054 from MPO Gene-Phenotype Associations)", "abnormal cardiogenic mesoderm morphology (MP:0012278 from MPO Gene-Phenotype Associations)", "absent heart (MP:0011388 from MPO Gene-Phenotype Associations)", "abnormal optic disc morphology (MP:0008259 from MPO Gene-Phenotype Associations)", "absent optic disc (MP:0011389 from MPO Gene-Phenotype Associations)", "abnormal lens polarity (MP:0001308 from MPO Gene-Phenotype Associations)", "ventral rotation of lens (MP:0010706 from MPO Gene-Phenotype Associations)", "absent sclera (MP:0010710 from MPO Gene-Phenotype Associations)", "mitral valve atresia (MP:0006119 from MPO Gene-Phenotype Associations)", "absent sublingual duct (MP:0010720 from MPO Gene-Phenotype Associations)", "abnormal sublingual duct morphology (MP:0009527 from MPO Gene-Phenotype Associations)", "aortopulmonary window (MP:0010455 from MPO Gene-Phenotype Associations)", "decreased ventral retina size (MP:0010707 from MPO Gene-Phenotype Associations)", "ventricular myocardium compact layer hypoplasia (MP:0010640 from MPO Gene-Phenotype Associations)", "abnormal ventricle papillary muscle morphology (MP:0004058 from MPO Gene-Phenotype Associations)", "papillary muscle hypoplasia (MP:0004061 from MPO Gene-Phenotype Associations)", "submucous cleft palate (MP:0011615 from MPO Gene-Phenotype Associations)", "abnormal sublingual gland morphology (MP:0004035 from MPO Gene-Phenotype Associations)", "abnormal major salivary gland morphology (MP:0003792 from MPO Gene-Phenotype Associations)", "abnormal submandibular gland morphology (MP:0003793 from MPO Gene-Phenotype Associations)", "abnormal salivary gland morphology (MP:0000613 from MPO Gene-Phenotype Associations)", "thick tail (MP:0000588 from MPO Gene-Phenotype Associations)", "broad head (MP:0000346 from MPO Gene-Phenotype Associations)", "abnormal glycosaminoglycan level (MP:0011475 from MPO Gene-Phenotype Associations)", "abnormal urine glycosaminoglycan level (MP:0011472 from MPO Gene-Phenotype Associations)", "increased urine glycosaminoglycan level (MP:0011473 from MPO Gene-Phenotype Associations)", "abnormal uterine artery morphology (MP:0003995 from MPO Gene-Phenotype Associations)", "decreased cardiac stroke volume (MP:0011952 from MPO Gene-Phenotype Associations)", "abnormal cardiac output (MP:0001627 from MPO Gene-Phenotype Associations)", "decreased cardiac output (MP:0003393 from MPO Gene-Phenotype Associations)", "abnormal long bone diaphysis morphology (MP:0004214 from MPO Gene-Phenotype Associations)", "abnormal bone collagen fibril morphology (MP:0011642 from MPO Gene-Phenotype Associations)", "increased collagen deposition in the muscles (MP:0000731 from MPO Gene-Phenotype Associations)", "abnormal tendon collagen fibril morphology (MP:0011643 from MPO Gene-Phenotype Associations)", "abnormal neuromere morphology (MP:0003208 from MPO Gene-Phenotype Associations)", "abnormal rhombomere morphology (MP:0000933 from MPO Gene-Phenotype Associations)", "abnormal rhombomere 5 morphology (MP:0012800 from MPO Gene-Phenotype Associations)", "abnormal rhombomere 3 morphology (MP:0012792 from MPO Gene-Phenotype Associations)", "decreased rhombomere 5 size (MP:0012801 from MPO Gene-Phenotype Associations)", "decreased rhombomere 3 size (MP:0012793 from MPO Gene-Phenotype Associations)", "delayed caudal neuropore closure (MP:0012709 from MPO Gene-Phenotype Associations)", "abnormal rhombomere 6 morphology (MP:0012804 from MPO Gene-Phenotype Associations)", "absent rhombomere 3 (MP:0012795 from MPO Gene-Phenotype Associations)", "abnormal abducens nerve morphology (MP:0001070 from MPO Gene-Phenotype Associations)", "absent rhombomere 5 (MP:0012803 from MPO Gene-Phenotype Associations)", "decreased rhombomere 6 size (MP:0012805 from MPO Gene-Phenotype Associations)", "decreased diameter of radius (MP:0008155 from MPO Gene-Phenotype Associations)", "abnormal schwann cell physiology (MP:0011904 from MPO Gene-Phenotype Associations)", "abnormal schwann cell proliferation (MP:0011905 from MPO Gene-Phenotype Associations)", "increased schwann cell proliferation (MP:0011906 from MPO Gene-Phenotype Associations)", "decreased diameter of long bones (MP:0008150 from MPO Gene-Phenotype Associations)", "decreased diameter of femur (MP:0008152 from MPO Gene-Phenotype Associations)", "decreased diameter of tibia (MP:0008156 from MPO Gene-Phenotype Associations)", "decreased diameter of ulna (MP:0008157 from MPO Gene-Phenotype Associations)", "abnormal mesonephros morphology (MP:0008487 from MPO Gene-Phenotype Associations)", "abnormal wolffian duct morphology (MP:0003827 from MPO Gene-Phenotype Associations)", "absent wolffian ducts (MP:0009073 from MPO Gene-Phenotype Associations)", "abnormal mullerian duct morphology (MP:0003826 from MPO Gene-Phenotype Associations)", "absent vas deferens (MP:0003557 from MPO Gene-Phenotype Associations)", "absent uterus (MP:0003558 from MPO Gene-Phenotype Associations)", "absent epididymis (MP:0004727 from MPO Gene-Phenotype Associations)", "oviduct hypoplasia (MP:0003576 from MPO Gene-Phenotype Associations)", "abnormal cranial vagina morphology (MP:0009077 from MPO Gene-Phenotype Associations)", "absent cranial vagina (MP:0009072 from MPO Gene-Phenotype Associations)", "abnormal vas deferens morphology (MP:0002769 from MPO Gene-Phenotype Associations)", "abnormal oviduct morphology (MP:0003574 from MPO Gene-Phenotype Associations)", "abnormal oviduct size (MP:0009063 from MPO Gene-Phenotype Associations)", "small oviduct (MP:0009070 from MPO Gene-Phenotype Associations)", "rudimentary mullerian ducts (MP:0009076 from MPO Gene-Phenotype Associations)", "abnormal intermediate mesoderm (MP:0010118 from MPO Gene-Phenotype Associations)", "absent tectum (MP:0006106 from MPO Gene-Phenotype Associations)", "abnormal kidney lobule morphology (MP:0011382 from MPO Gene-Phenotype Associations)", "optic disc coloboma (MP:0010716 from MPO Gene-Phenotype Associations)", "mullerian duct degeneration (MP:0006426 from MPO Gene-Phenotype Associations)", "absent semicircular canal ampulla (MP:0009262 from MPO Gene-Phenotype Associations)", "absent cochlear nerve (MP:0004717 from MPO Gene-Phenotype Associations)", "absent optic chiasm (MP:0009771 from MPO Gene-Phenotype Associations)", "rudimentary wolffian ducts (MP:0009075 from MPO Gene-Phenotype Associations)", "abnormal mesonephric mesenchyme morphology (MP:0010986 from MPO Gene-Phenotype Associations)", "wolffian duct degeneration (MP:0009074 from MPO Gene-Phenotype Associations)", "absent oviduct (MP:0003575 from MPO Gene-Phenotype Associations)", "absent efferent ductules of testis (MP:0004729 from MPO Gene-Phenotype Associations)", "absent uterine horn (MP:0009215 from MPO Gene-Phenotype Associations)", "kidney medulla hypoplasia (MP:0003626 from MPO Gene-Phenotype Associations)", "absent organ of corti (MP:0000044 from MPO Gene-Phenotype Associations)", "abnormal retinal blood vessel pattern (MP:0010098 from MPO Gene-Phenotype Associations)", "abnormal retinal blood vessel morphology (MP:0010097 from MPO Gene-Phenotype Associations)", "abnormal optic fissure closure (MP:0012535 from MPO Gene-Phenotype Associations)", "delayed optic fissure closure (MP:0012536 from MPO Gene-Phenotype Associations)", "increased lumbar vertebrae number (MP:0004650 from MPO Gene-Phenotype Associations)", "abnormal spinal cord lateral motor column morphology (MP:0009684 from MPO Gene-Phenotype Associations)", "abnormal spinal cord motor column morphology (MP:0009685 from MPO Gene-Phenotype Associations)", "abnormal enteric cholinergic neuron morphology (MP:0001047 from MPO Gene-Phenotype Associations)", "abnormal submucous nerve plexus morphology (MP:0010800 from MPO Gene-Phenotype Associations)", "chronic constipation (MP:0003268 from MPO Gene-Phenotype Associations)", "constipation (MP:0003267 from MPO Gene-Phenotype Associations)", "absent ureteric bud (MP:0010978 from MPO Gene-Phenotype Associations)", "fused podocyte foot processes (MP:0008139 from MPO Gene-Phenotype Associations)", "abnormal branching involved in ureteric bud morphogenesis (MP:0010981 from MPO Gene-Phenotype Associations)", "impaired branching involved in ureteric bud morphogenesis (MP:0004936 from MPO Gene-Phenotype Associations)", "abnormal ureteric bud morphology (MP:0006032 from MPO Gene-Phenotype Associations)", "abnormal kidney development (MP:0000527 from MPO Gene-Phenotype Associations)", "abnormal urinary system development (MP:0003942 from MPO Gene-Phenotype Associations)", "abnormal kidney mesenchyme morphology (MP:0010985 from MPO Gene-Phenotype Associations)", "abnormal metanephric mesenchyme morphology (MP:0010984 from MPO Gene-Phenotype Associations)", "increased metanephric mesenchyme apoptosis (MP:0011386 from MPO Gene-Phenotype Associations)", "abnormal ureteric bud elongation (MP:0010982 from MPO Gene-Phenotype Associations)", "abnormal ureteric bud invasion (MP:0010983 from MPO Gene-Phenotype Associations)", "absent ureter (MP:0003722 from MPO Gene-Phenotype Associations)", "single kidney (MP:0003604 from MPO Gene-Phenotype Associations)", "absent kidney (MP:0000520 from MPO Gene-Phenotype Associations)", "renal hypoplasia (MP:0003446 from MPO Gene-Phenotype Associations)", "abnormal metanephros morphology (MP:0011364 from MPO Gene-Phenotype Associations)", "absent metanephros (MP:0011366 from MPO Gene-Phenotype Associations)", "abnormal nephrogenic zone morphology (MP:0011334 from MPO Gene-Phenotype Associations)", "decreased renal glomerulus number (MP:0004505 from MPO Gene-Phenotype Associations)", "abnormal nephron number (MP:0011289 from MPO Gene-Phenotype Associations)", "decreased nephron number (MP:0011290 from MPO Gene-Phenotype Associations)", "delayed kidney development (MP:0000528 from MPO Gene-Phenotype Associations)", "absent mullerian ducts (MP:0006425 from MPO Gene-Phenotype Associations)", "absent internal male genitalia (MP:0009206 from MPO Gene-Phenotype Associations)", "absent internal female genitalia (MP:0009210 from MPO Gene-Phenotype Associations)", "absent dentate gyrus (MP:0000814 from MPO Gene-Phenotype Associations)", "abnormal pallium development (MP:0004171 from MPO Gene-Phenotype Associations)", "abnormal hippocampal fimbria morphology (MP:0003005 from MPO Gene-Phenotype Associations)", "abnormal hippocampal fornix morphology (MP:0003006 from MPO Gene-Phenotype Associations)", "abnormal gonadal ridge morphology (MP:0011411 from MPO Gene-Phenotype Associations)", "gonadal ridge hypoplasia (MP:0011412 from MPO Gene-Phenotype Associations)", "absent ovary (MP:0003578 from MPO Gene-Phenotype Associations)", "absent sex gland (MP:0000654 from MPO Gene-Phenotype Associations)", "agonadal (MP:0005644 from MPO Gene-Phenotype Associations)", "absent testes (MP:0006415 from MPO Gene-Phenotype Associations)", "absent adrenal gland (MP:0005313 from MPO Gene-Phenotype Associations)", "insensitivity to growth hormone (MP:0003429 from MPO Gene-Phenotype Associations)", "syndromic hearing impairment (MP:0006330 from MPO Gene-Phenotype Associations)", "syndromic hearing loss (MP:0004750 from MPO Gene-Phenotype Associations)", "abnormal nephrogenic mesenchyme morphogenesis (MP:0010987 from MPO Gene-Phenotype Associations)", "small metanephros (MP:0011365 from MPO Gene-Phenotype Associations)", "abnormal ovary capsule morphology (MP:0013311 from MPO Gene-Phenotype Associations)", "absent ovary capsule (MP:0013312 from MPO Gene-Phenotype Associations)", "abnormal ovary development (MP:0003582 from MPO Gene-Phenotype Associations)", "stomach hypoplasia (MP:0010788 from MPO Gene-Phenotype Associations)", "abnormal gonad rudiment morphology (MP:0005651 from MPO Gene-Phenotype Associations)", "abnormal lymph node primary follicle morphology (MP:0002345 from MPO Gene-Phenotype Associations)", "syringomyelia (MP:0012545 from MPO Gene-Phenotype Associations)", "abnormal piriform cortex morphology (MP:0010009 from MPO Gene-Phenotype Associations)", "ureteropelvic junction atresia (MP:0011489 from MPO Gene-Phenotype Associations)", "ureterovesical junction obstruction (MP:0011492 from MPO Gene-Phenotype Associations)", "abnormal ureterovesical junction morphology (MP:0011488 from MPO Gene-Phenotype Associations)", "double ureter (MP:0011493 from MPO Gene-Phenotype Associations)", "vesicoureteral reflux (MP:0001948 from MPO Gene-Phenotype Associations)", "abnormal ureter development (MP:0003672 from MPO Gene-Phenotype Associations)", "dilated ureter (MP:0003586 from MPO Gene-Phenotype Associations)", "abnormal ureter smooth muscle morphology (MP:0011426 from MPO Gene-Phenotype Associations)", "hydroureter (MP:0000536 from MPO Gene-Phenotype Associations)", "abnormal kidney pelvis morphology (MP:0004194 from MPO Gene-Phenotype Associations)", "hydronephrosis (MP:0000519 from MPO Gene-Phenotype Associations)", "abnormal ureter morphology (MP:0000534 from MPO Gene-Phenotype Associations)", "abnormal kidney calyx morphology (MP:0004195 from MPO Gene-Phenotype Associations)", "dilated kidney calyx (MP:0011305 from MPO Gene-Phenotype Associations)", "abnormal ureteropelvic junction morphology (MP:0011487 from MPO Gene-Phenotype Associations)", "ureteropelvic junction obstruction (MP:0011491 from MPO Gene-Phenotype Associations)", "decreased urine glucose level (MP:0003870 from MPO Gene-Phenotype Associations)", "leukocyturia (MP:0011418 from MPO Gene-Phenotype Associations)", "abnormal vestibular hair cell physiology (MP:0004438 from MPO Gene-Phenotype Associations)", "abnormal blood flow velocity (MP:0000233 from MPO Gene-Phenotype Associations)", "abnormal renal plasma flow rate (MP:0005524 from MPO Gene-Phenotype Associations)", "decreased renal plasma flow rate (MP:0005526 from MPO Gene-Phenotype Associations)", "abnormal renal vascular resistance (MP:0005529 from MPO Gene-Phenotype Associations)", "increased renal vascular resistance (MP:0005531 from MPO Gene-Phenotype Associations)", "abnormal vascular resistance (MP:0005532 from MPO Gene-Phenotype Associations)", "increased renal glomerular filtration rate (MP:0005527 from MPO Gene-Phenotype Associations)", "increased renal plasma flow rate (MP:0005525 from MPO Gene-Phenotype Associations)", "decreased renal vascular resistance (MP:0005530 from MPO Gene-Phenotype Associations)", "decreased right ventricle systolic pressure (MP:0010759 from MPO Gene-Phenotype Associations)", "abnormal urine nitrite level (MP:0011740 from MPO Gene-Phenotype Associations)", "increased urine nitrite level (MP:0011741 from MPO Gene-Phenotype Associations)", "decreased embryonic cilium number (MP:0013197 from MPO Gene-Phenotype Associations)", "dilated nephron (MP:0011293 from MPO Gene-Phenotype Associations)", "decreased embryonic cilium length (MP:0011998 from MPO Gene-Phenotype Associations)", "abnormal nonmotile primary cilium morphology (MP:0013205 from MPO Gene-Phenotype Associations)", "abnormal primary cilium morphology (MP:0013203 from MPO Gene-Phenotype Associations)", "abnormal kidney epithelial cell primary cilium morphology (MP:0011065 from MPO Gene-Phenotype Associations)", "abnormal renal tubule epithelial cell primary cilium morphology (MP:0011066 from MPO Gene-Phenotype Associations)", "abnormal kidney epithelium morphology (MP:0004967 from MPO Gene-Phenotype Associations)", "abnormal renal tubule epithelium morphology (MP:0009640 from MPO Gene-Phenotype Associations)", "kidney cysts (MP:0003675 from MPO Gene-Phenotype Associations)", "polycystic kidney (MP:0008528 from MPO Gene-Phenotype Associations)", "accelerated tooth eruption (MP:0000122 from MPO Gene-Phenotype Associations)", "intracranial aneurysm (MP:0010478 from MPO Gene-Phenotype Associations)", "abnormal distal convoluted tubule morphology (MP:0004757 from MPO Gene-Phenotype Associations)", "dilated distal convoluted tubules (MP:0009051 from MPO Gene-Phenotype Associations)", "dilated renal glomerular capsule (MP:0003670 from MPO Gene-Phenotype Associations)", "atrial situs inversus (MP:0010431 from MPO Gene-Phenotype Associations)", "abnormal loop of henle descending limb morphology (MP:0011341 from MPO Gene-Phenotype Associations)", "abnormal loop of henle ascending limb morphology (MP:0011342 from MPO Gene-Phenotype Associations)", "abnormal loop of henle ascending limb thick segment morphology (MP:0011344 from MPO Gene-Phenotype Associations)", "abnormal loop of henle morphology (MP:0004755 from MPO Gene-Phenotype Associations)", "decreased pancreatic acinar cell number (MP:0009149 from MPO Gene-Phenotype Associations)", "renal glomerulus cysts (MP:0011682 from MPO Gene-Phenotype Associations)", "abnormal kidney collecting duct morphology (MP:0004754 from MPO Gene-Phenotype Associations)", "dilated kidney collecting duct (MP:0004860 from MPO Gene-Phenotype Associations)", "abnormal pleuropericardial membrane morphology (MP:0012496 from MPO Gene-Phenotype Associations)", "juxtaglomerular cell hyperplasia (MP:0011301 from MPO Gene-Phenotype Associations)", "streak gonad (MP:0002214 from MPO Gene-Phenotype Associations)", "abnormal adrenal gland development (MP:0013310 from MPO Gene-Phenotype Associations)", "podocyte hypertrophy (MP:0011871 from MPO Gene-Phenotype Associations)", "decreased glomerular capsule space (MP:0011500 from MPO Gene-Phenotype Associations)", "abnormal glomerular capsule parietal layer morphology (MP:0011498 from MPO Gene-Phenotype Associations)", "podocyte microvillus transformation (MP:0011868 from MPO Gene-Phenotype Associations)", "glomerular crescent (MP:0011506 from MPO Gene-Phenotype Associations)", "abnormal spleen development (MP:0009323 from MPO Gene-Phenotype Associations)", "abnormal spleen mesenchyme morphology (MP:0011263 from MPO Gene-Phenotype Associations)", "abnormal splenocyte apoptosis (MP:0009340 from MPO Gene-Phenotype Associations)", "increased splenocyte apoptosis (MP:0009322 from MPO Gene-Phenotype Associations)", "abnormal l3 dorsal root ganglion morphology (MP:0006405 from MPO Gene-Phenotype Associations)", "increased compensatory renal growth (MP:0002955 from MPO Gene-Phenotype Associations)", "parietal capsular epithelium metaplasia (MP:0011502 from MPO Gene-Phenotype Associations)", "small ureteric bud (MP:0010979 from MPO Gene-Phenotype Associations)", "increased follicular lymphoma incidence (MP:0009317 from MPO Gene-Phenotype Associations)", "renal glomerular synechia (MP:0011483 from MPO Gene-Phenotype Associations)", "renal tubule hypertrophy (MP:0011408 from MPO Gene-Phenotype Associations)", "abnormal capillary morphology (MP:0003658 from MPO Gene-Phenotype Associations)", "abnormal kidney capillary morphology (MP:0011310 from MPO Gene-Phenotype Associations)", "abnormal glomerular capillary morphology (MP:0011320 from MPO Gene-Phenotype Associations)", "abnormal kidney blood vessel morphology (MP:0000530 from MPO Gene-Phenotype Associations)", "abnormal glomerular capillary endothelium morphology (MP:0011453 from MPO Gene-Phenotype Associations)", "decreased glomerular capillary number (MP:0011359 from MPO Gene-Phenotype Associations)", "dilated glomerular capillary (MP:0011509 from MPO Gene-Phenotype Associations)", "abnormal glomerular mesangium morphology (MP:0011339 from MPO Gene-Phenotype Associations)", "abnormal mesangial matrix morphology (MP:0011338 from MPO Gene-Phenotype Associations)", "expanded mesangial matrix (MP:0011353 from MPO Gene-Phenotype Associations)", "abnormal mesangial cell morphology (MP:0005327 from MPO Gene-Phenotype Associations)", "mesangial cell hyperplasia (MP:0011427 from MPO Gene-Phenotype Associations)", "abnormal glomerular capsule visceral layer morphology (MP:0011497 from MPO Gene-Phenotype Associations)", "abnormal podocyte morphology (MP:0005326 from MPO Gene-Phenotype Associations)", "abnormal podocyte foot process morphology (MP:0008059 from MPO Gene-Phenotype Associations)", "abnormal renal glomerular capsule morphology (MP:0002828 from MPO Gene-Phenotype Associations)", "podocyte foot process effacement (MP:0008140 from MPO Gene-Phenotype Associations)", "glomerulosclerosis (MP:0005264 from MPO Gene-Phenotype Associations)", "abnormal renal glomerulus basement membrane morphology (MP:0011348 from MPO Gene-Phenotype Associations)", "abnormal renal glomerulus basement membrane thickness (MP:0011349 from MPO Gene-Phenotype Associations)", "increased renal glomerulus basement membrane thickness (MP:0011409 from MPO Gene-Phenotype Associations)", "mesangiolysis (MP:0011430 from MPO Gene-Phenotype Associations)", "renal glomerulus hypertrophy (MP:0011294 from MPO Gene-Phenotype Associations)", "abnormal kidney cortex morphology (MP:0000521 from MPO Gene-Phenotype Associations)", "abnormal renal corpuscle morphology (MP:0002827 from MPO Gene-Phenotype Associations)", "abnormal renal glomerulus morphology (MP:0005325 from MPO Gene-Phenotype Associations)", "abnormal nephron morphology (MP:0003881 from MPO Gene-Phenotype Associations)", "abnormal kidney morphology (MP:0002135 from MPO Gene-Phenotype Associations)", "abnormal renal|urinary system morphology (MP:0000516 from MPO Gene-Phenotype Associations)", "renal|urinary system phenotype (MP:0005367 from MPO Gene-Phenotype Associations)", "cortical renal glomerulopathies (MP:0000523 from MPO Gene-Phenotype Associations)", "glomerulonephritis (MP:0002743 from MPO Gene-Phenotype Associations)", "kidney inflammation (MP:0001859 from MPO Gene-Phenotype Associations)", "renal|urinary system inflammation (MP:0011762 from MPO Gene-Phenotype Associations)", "abnormal kidney physiology (MP:0002136 from MPO Gene-Phenotype Associations)", "abnormal renal|urinary system physiology (MP:0005502 from MPO Gene-Phenotype Associations)", "abnormal urine homeostasis (MP:0009643 from MPO Gene-Phenotype Associations)", "abnormal urine protein level (MP:0006315 from MPO Gene-Phenotype Associations)", "increased urine protein level (MP:0002962 from MPO Gene-Phenotype Associations)", "albuminuria (MP:0002871 from MPO Gene-Phenotype Associations)", "abnormal glomerular capsule space morphology (MP:0011499 from MPO Gene-Phenotype Associations)", "increased glomerular capsule space (MP:0011501 from MPO Gene-Phenotype Associations)", "kidney cortex cysts (MP:0000522 from MPO Gene-Phenotype Associations)", "kidney medulla cysts (MP:0011307 from MPO Gene-Phenotype Associations)", "dilated proximal convoluted tubules (MP:0009050 from MPO Gene-Phenotype Associations)", "abnormal proximal convoluted tubule morphology (MP:0004756 from MPO Gene-Phenotype Associations)", "dilated renal tubules (MP:0002705 from MPO Gene-Phenotype Associations)", "abnormal renal tubule morphology (MP:0002703 from MPO Gene-Phenotype Associations)", "kidney atrophy (MP:0004970 from MPO Gene-Phenotype Associations)", "renal tubule atrophy (MP:0011346 from MPO Gene-Phenotype Associations)", "abnormal kidney interstitium morphology (MP:0011425 from MPO Gene-Phenotype Associations)", "renal interstitial fibrosis (MP:0003215 from MPO Gene-Phenotype Associations)", "renal fibrosis (MP:0003985 from MPO Gene-Phenotype Associations)", "granular kidney (MP:0011534 from MPO Gene-Phenotype Associations)", "tubulointerstitial nephritis (MP:0011405 from MPO Gene-Phenotype Associations)", "renal cast (MP:0011402 from MPO Gene-Phenotype Associations)", "kidney failure (MP:0003606 from MPO Gene-Phenotype Associations)", "pale kidney (MP:0004969 from MPO Gene-Phenotype Associations)", "abnormal amino acid level (MP:0005332 from MPO Gene-Phenotype Associations)", "abnormal circulating amino acid level (MP:0005311 from MPO Gene-Phenotype Associations)", "abnormal circulating creatinine level (MP:0005328 from MPO Gene-Phenotype Associations)", "increased circulating creatinine level (MP:0005553 from MPO Gene-Phenotype Associations)", "abnormal blood urea nitrogen level (MP:0005265 from MPO Gene-Phenotype Associations)", "increased blood urea nitrogen level (MP:0005565 from MPO Gene-Phenotype Associations)", "uremia (MP:0009644 from MPO Gene-Phenotype Associations)", "abnormal kidney size (MP:0002706 from MPO Gene-Phenotype Associations)", "small kidney (MP:0002989 from MPO Gene-Phenotype Associations)", "abnormal kidney weight (MP:0002707 from MPO Gene-Phenotype Associations)", "decreased kidney weight (MP:0003918 from MPO Gene-Phenotype Associations)", "enlarged kidney (MP:0003068 from MPO Gene-Phenotype Associations)", "increased kidney weight (MP:0003917 from MPO Gene-Phenotype Associations)", "abnormal kidney apoptosis (MP:0011367 from MPO Gene-Phenotype Associations)", "increased kidney apoptosis (MP:0011368 from MPO Gene-Phenotype Associations)", "increased renal tubule apoptosis (MP:0004153 from MPO Gene-Phenotype Associations)", "increased renal glomerulus apoptosis (MP:0011369 from MPO Gene-Phenotype Associations)", "abnormal kidney cell proliferation (MP:0011439 from MPO Gene-Phenotype Associations)", "increased kidney cell proliferation (MP:0011440 from MPO Gene-Phenotype Associations)", "abnormal proximal convoluted tubule brush border morphology (MP:0011350 from MPO Gene-Phenotype Associations)", "proximal convoluted tubule brush border loss (MP:0011352 from MPO Gene-Phenotype Associations)", "renal glomerulus fibrosis (MP:0011377 from MPO Gene-Phenotype Associations)", "kidney degeneration (MP:0009641 from MPO Gene-Phenotype Associations)", "renal necrosis (MP:0003946 from MPO Gene-Phenotype Associations)", "renal tubular necrosis (MP:0004154 from MPO Gene-Phenotype Associations)", "absent phrenic nerve (MP:0001079 from MPO Gene-Phenotype Associations)", "abnormal amniotic fluid composition (MP:0012172 from MPO Gene-Phenotype Associations)", "short presphenoid bone (MP:0004451 from MPO Gene-Phenotype Associations)", "pancreas lipomatosis (MP:0003338 from MPO Gene-Phenotype Associations)", "abnormal kidney epithelial cell primary cilium physiology (MP:0011744 from MPO Gene-Phenotype Associations)", "abnormal nonmotile primary cilium physiology (MP:0013211 from MPO Gene-Phenotype Associations)", "increased renal hamartoma incidence (MP:0003602 from MPO Gene-Phenotype Associations)", "abnormal common bile duct morphology (MP:0009495 from MPO Gene-Phenotype Associations)", "polyhydramnios (MP:0004020 from MPO Gene-Phenotype Associations)", "dissociated hepatocytes (MP:0000608 from MPO Gene-Phenotype Associations)", "abnormal parathyroid gland physiology (MP:0003431 from MPO Gene-Phenotype Associations)", "increased activity of parathyroid (MP:0003432 from MPO Gene-Phenotype Associations)", "decreased liver function (MP:0003325 from MPO Gene-Phenotype Associations)", "ostium primum atrial septal defect (MP:0010404 from MPO Gene-Phenotype Associations)", "common atrioventricular valve (MP:0010607 from MPO Gene-Phenotype Associations)", "abnormal fetal atrioventricular canal septation (MP:0010599 from MPO Gene-Phenotype Associations)", "failure of atrioventricular cushion closure (MP:0000299 from MPO Gene-Phenotype Associations)", "decreased mammary fat pad weight (MP:0009297 from MPO Gene-Phenotype Associations)", "dilated bile duct (MP:0003253 from MPO Gene-Phenotype Associations)", "bile duct proliferation (MP:0003255 from MPO Gene-Phenotype Associations)", "bile duct inflammation (MP:0003254 from MPO Gene-Phenotype Associations)", "bile duct hyperplasia (MP:0004839 from MPO Gene-Phenotype Associations)", "abnormal papillary duct morphology (MP:0011331 from MPO Gene-Phenotype Associations)", "abnormal cholangiocyte morphology (MP:0012236 from MPO Gene-Phenotype Associations)", "abnormal cholangiocyte primary cilium morphology (MP:0012238 from MPO Gene-Phenotype Associations)", "increased cholangiocyte apoptosis (MP:0012237 from MPO Gene-Phenotype Associations)", "abnormal intrahepatic bile duct morphology (MP:0009497 from MPO Gene-Phenotype Associations)", "abnormal hepatic duct morphology (MP:0009501 from MPO Gene-Phenotype Associations)", "abnormal pancreatic duct morphology (MP:0009143 from MPO Gene-Phenotype Associations)", "dilated pancreatic duct (MP:0009144 from MPO Gene-Phenotype Associations)", "pancreas cysts (MP:0003336 from MPO Gene-Phenotype Associations)", "biliary cyst (MP:0003266 from MPO Gene-Phenotype Associations)", "liver cysts (MP:0003327 from MPO Gene-Phenotype Associations)", "pancreas fibrosis (MP:0003334 from MPO Gene-Phenotype Associations)", "abnormal bile duct morphology (MP:0002928 from MPO Gene-Phenotype Associations)", "abnormal biliary tract morphology (MP:0005083 from MPO Gene-Phenotype Associations)", "abnormal bile duct development (MP:0002929 from MPO Gene-Phenotype Associations)", "abnormal gallbladder morphology (MP:0005084 from MPO Gene-Phenotype Associations)", "dilated gallbladder (MP:0009343 from MPO Gene-Phenotype Associations)", "liver fibrosis (MP:0003333 from MPO Gene-Phenotype Associations)", "abnormal skin turgor (MP:0003652 from MPO Gene-Phenotype Associations)", "decreased skin turgor (MP:0003653 from MPO Gene-Phenotype Associations)", "abnormal tubuloglomerular feedback response (MP:0011295 from MPO Gene-Phenotype Associations)", "decreased tubuloglomerular feedback response (MP:0011296 from MPO Gene-Phenotype Associations)", "pyelonephritis (MP:0011403 from MPO Gene-Phenotype Associations)", "pyelitis (MP:0011404 from MPO Gene-Phenotype Associations)", "increased urine prostaglandin level (MP:0011563 from MPO Gene-Phenotype Associations)", "decreased circulating renin level (MP:0003353 from MPO Gene-Phenotype Associations)", "abnormal circulating atrial natriuretic factor level (MP:0005521 from MPO Gene-Phenotype Associations)", "increased circulating atrial natriuretic factor (MP:0005522 from MPO Gene-Phenotype Associations)", "alkalosis (MP:0003028 from MPO Gene-Phenotype Associations)", "hypocapnia (MP:0003032 from MPO Gene-Phenotype Associations)", "abnormal bladder urine volume (MP:0011923 from MPO Gene-Phenotype Associations)", "increased urine urea nitrogen level (MP:0011466 from MPO Gene-Phenotype Associations)", "abnormal renal glucose reabsorption (MP:0011447 from MPO Gene-Phenotype Associations)", "increased urine creatinine level (MP:0011470 from MPO Gene-Phenotype Associations)", "abnormal urine magnesium level (MP:0011434 from MPO Gene-Phenotype Associations)", "increased urine magnesium level (MP:0011435 from MPO Gene-Phenotype Associations)", "increased urine potassium level (MP:0005619 from MPO Gene-Phenotype Associations)", "increased urine sodium level (MP:0006316 from MPO Gene-Phenotype Associations)", "increased urine chloride ion level (MP:0011459 from MPO Gene-Phenotype Associations)", "abnormal renal reabsorbtion (MP:0010107 from MPO Gene-Phenotype Associations)", "abnormal renal transport (MP:0011417 from MPO Gene-Phenotype Associations)", "abnormal renal water homeostasis (MP:0011444 from MPO Gene-Phenotype Associations)", "abnormal renal water transport (MP:0011443 from MPO Gene-Phenotype Associations)", "abnormal renal water reabsorbtion (MP:0010108 from MPO Gene-Phenotype Associations)", "abnormal urine creatinine level (MP:0011469 from MPO Gene-Phenotype Associations)", "decreased urine creatinine level (MP:0011471 from MPO Gene-Phenotype Associations)", "abnormal urine urea nitrogen level (MP:0011465 from MPO Gene-Phenotype Associations)", "decreased urine urea nitrogen level (MP:0011467 from MPO Gene-Phenotype Associations)", "abnormal urine potassium level (MP:0004820 from MPO Gene-Phenotype Associations)", "decreased urine potassium level (MP:0005618 from MPO Gene-Phenotype Associations)", "abnormal urine sodium level (MP:0006274 from MPO Gene-Phenotype Associations)", "decreased urine sodium level (MP:0006317 from MPO Gene-Phenotype Associations)", "abnormal urine chloride ion level (MP:0011458 from MPO Gene-Phenotype Associations)", "decreased urine chloride ion level (MP:0011460 from MPO Gene-Phenotype Associations)", "abnormal urine osmolality (MP:0002987 from MPO Gene-Phenotype Associations)", "decreased urine osmolality (MP:0002988 from MPO Gene-Phenotype Associations)", "abnormal urination (MP:0001756 from MPO Gene-Phenotype Associations)", "polyuria (MP:0001762 from MPO Gene-Phenotype Associations)", "abnormal drinking behavior (MP:0001422 from MPO Gene-Phenotype Associations)", "abnormal fluid intake (MP:0011947 from MPO Gene-Phenotype Associations)", "increased fluid intake (MP:0011941 from MPO Gene-Phenotype Associations)", "polydipsia (MP:0001426 from MPO Gene-Phenotype Associations)", "abnormal aldosterone level (MP:0011415 from MPO Gene-Phenotype Associations)", "abnormal circulating aldosterone level (MP:0005346 from MPO Gene-Phenotype Associations)", "abnormal circulating mineralocorticoid level (MP:0003372 from MPO Gene-Phenotype Associations)", "increased circulating aldosterone level (MP:0002666 from MPO Gene-Phenotype Associations)", "increased circulating mineralocorticoid level (MP:0003373 from MPO Gene-Phenotype Associations)", "decreased circulating aldosterone level (MP:0002667 from MPO Gene-Phenotype Associations)", "decreased circulating mineralocorticoid level (MP:0003374 from MPO Gene-Phenotype Associations)", "abnormal circulating potassium level (MP:0002668 from MPO Gene-Phenotype Associations)", "abnormal potassium ion homeostasis (MP:0011978 from MPO Gene-Phenotype Associations)", "increased circulating potassium level (MP:0005627 from MPO Gene-Phenotype Associations)", "decreased circulating potassium level (MP:0005628 from MPO Gene-Phenotype Associations)", "hypokalemia (MP:0004119 from MPO Gene-Phenotype Associations)", "abnormal circulating sodium level (MP:0001776 from MPO Gene-Phenotype Associations)", "abnormal sodium ion homeostasis (MP:0011977 from MPO Gene-Phenotype Associations)", "decreased circulating sodium level (MP:0005634 from MPO Gene-Phenotype Associations)", "increased circulating sodium level (MP:0005633 from MPO Gene-Phenotype Associations)", "abnormal chloride level (MP:0012007 from MPO Gene-Phenotype Associations)", "abnormal circulating chloride level (MP:0003018 from MPO Gene-Phenotype Associations)", "increased circulating chloride level (MP:0003019 from MPO Gene-Phenotype Associations)", "decreased circulating chloride level (MP:0003020 from MPO Gene-Phenotype Associations)", "decreased mean systemic arterial blood pressure (MP:0004876 from MPO Gene-Phenotype Associations)", "decreased systemic arterial blood pressure (MP:0002843 from MPO Gene-Phenotype Associations)", "decreased systemic arterial systolic blood pressure (MP:0006264 from MPO Gene-Phenotype Associations)", "hypotension (MP:0001596 from MPO Gene-Phenotype Associations)", "abnormal kidney medullary ray morphology (MP:0011347 from MPO Gene-Phenotype Associations)", "decreased angiotensin i-converting enzyme activity (MP:0003185 from MPO Gene-Phenotype Associations)", "abnormal angiotensin i-converting enzyme activity (MP:0013254 from MPO Gene-Phenotype Associations)", "increased angiotensin i-converting enzyme activity (MP:0003184 from MPO Gene-Phenotype Associations)", "abnormal circulating renin level (MP:0003349 from MPO Gene-Phenotype Associations)", "increased circulating renin level (MP:0003352 from MPO Gene-Phenotype Associations)", "abnormal renin activity (MP:0005581 from MPO Gene-Phenotype Associations)", "increased renin activity (MP:0005582 from MPO Gene-Phenotype Associations)", "abnormal circulating angiotensinogen level (MP:0006373 from MPO Gene-Phenotype Associations)", "increased circulating angiotensinogen level (MP:0006375 from MPO Gene-Phenotype Associations)", "decreased circulating angiotensinogen level (MP:0006376 from MPO Gene-Phenotype Associations)", "decreased systemic arterial diastolic blood pressure (MP:0006263 from MPO Gene-Phenotype Associations)", "abnormal juxtaglomerular apparatus morphology (MP:0002829 from MPO Gene-Phenotype Associations)", "abnormal juxtaglomerular cell morphology (MP:0011300 from MPO Gene-Phenotype Associations)", "abnormal kidney afferent arteriole morphology (MP:0011312 from MPO Gene-Phenotype Associations)", "abnormal kidney cortex artery morphology (MP:0011314 from MPO Gene-Phenotype Associations)", "abnormal kidney interlobular artery morphology (MP:0011316 from MPO Gene-Phenotype Associations)", "abnormal kidney arterial blood vessel morphology (MP:0011309 from MPO Gene-Phenotype Associations)", "kidney medulla atrophy (MP:0011422 from MPO Gene-Phenotype Associations)", "kidney cortex atrophy (MP:0011423 from MPO Gene-Phenotype Associations)", "abnormal kidney medulla morphology (MP:0003014 from MPO Gene-Phenotype Associations)", "abnormal kidney papilla morphology (MP:0004193 from MPO Gene-Phenotype Associations)", "abnormal kidney pyramid morphology (MP:0004192 from MPO Gene-Phenotype Associations)", "kidney papillary atrophy (MP:0011304 from MPO Gene-Phenotype Associations)", "kidney papillary hypoplasia (MP:0011565 from MPO Gene-Phenotype Associations)", "abnormal kidney corticomedullary boundary morphology (MP:0011376 from MPO Gene-Phenotype Associations)", "abnormal renal filtration (MP:0013285 from MPO Gene-Phenotype Associations)", "abnormal renal filtration rate (MP:0005556 from MPO Gene-Phenotype Associations)", "decreased creatinine clearance (MP:0005558 from MPO Gene-Phenotype Associations)", "abnormal renal glomerular filtration (MP:0013284 from MPO Gene-Phenotype Associations)", "abnormal renal glomerular filtration rate (MP:0002847 from MPO Gene-Phenotype Associations)", "decreased renal glomerular filtration rate (MP:0005528 from MPO Gene-Phenotype Associations)", "increased urine osmolality (MP:0008055 from MPO Gene-Phenotype Associations)", "hypodipsia (MP:0011737 from MPO Gene-Phenotype Associations)", "oliguria (MP:0003620 from MPO Gene-Phenotype Associations)", "salt-sensitive hypertension (MP:0004217 from MPO Gene-Phenotype Associations)", "increased right ventricle peak pressure (MP:0008776 from MPO Gene-Phenotype Associations)", "abnormal renal sodium ion transport (MP:0011442 from MPO Gene-Phenotype Associations)", "abnormal renal sodium reabsorbtion (MP:0010109 from MPO Gene-Phenotype Associations)", "abnormal extraglomerular mesangial cell morphology (MP:0011302 from MPO Gene-Phenotype Associations)", "abnormal extraglomerular mesangium morphology (MP:0011340 from MPO Gene-Phenotype Associations)", "abnormal macula densa morphology (MP:0011299 from MPO Gene-Phenotype Associations)", "abnormal q wave (MP:0010515 from MPO Gene-Phenotype Associations)", "decreased blood uric acid level (MP:0008822 from MPO Gene-Phenotype Associations)", "abnormal blood uric acid level (MP:0008820 from MPO Gene-Phenotype Associations)", "increased blood uric acid level (MP:0008821 from MPO Gene-Phenotype Associations)", "decreased circulating ferritin level (MP:0011891 from MPO Gene-Phenotype Associations)", "increased urine flow rate (MP:0011431 from MPO Gene-Phenotype Associations)", "decreased urine flow rate (MP:0011432 from MPO Gene-Phenotype Associations)", "abnormal urine uric acid level (MP:0009809 from MPO Gene-Phenotype Associations)", "decreased urine uric acid level (MP:0011424 from MPO Gene-Phenotype Associations)", "abnormal urine organic anion level (MP:0006272 from MPO Gene-Phenotype Associations)", "increased urine uric acid level (MP:0009810 from MPO Gene-Phenotype Associations)", "uraturia (MP:0011537 from MPO Gene-Phenotype Associations)", "abnormal urinary bladder mucosa morphology (MP:0011766 from MPO Gene-Phenotype Associations)", "distended stomach (MP:0009511 from MPO Gene-Phenotype Associations)", "cystolithiasis (MP:0011625 from MPO Gene-Phenotype Associations)", "urolithiasis (MP:0005360 from MPO Gene-Phenotype Associations)", "crystalluria (MP:0009645 from MPO Gene-Phenotype Associations)", "nephrocalcinosis (MP:0003197 from MPO Gene-Phenotype Associations)", "hyperoxaluria (MP:0011517 from MPO Gene-Phenotype Associations)", "eye bleb (MP:0008855 from MPO Gene-Phenotype Associations)", "cryptophthalmos (MP:0005242 from MPO Gene-Phenotype Associations)", "bleb (MP:0008854 from MPO Gene-Phenotype Associations)", "abnormal skin development (MP:0003941 from MPO Gene-Phenotype Associations)", "fetal bleb (MP:0008856 from MPO Gene-Phenotype Associations)", "absent eyelids (MP:0001341 from MPO Gene-Phenotype Associations)", "fused phalanges (MP:0008730 from MPO Gene-Phenotype Associations)", "delayed skin barrier formation (MP:0009441 from MPO Gene-Phenotype Associations)", "hippocampus pyramidal cell degeneration (MP:0010014 from MPO Gene-Phenotype Associations)", "cerebral edema (MP:0011854 from MPO Gene-Phenotype Associations)", "increased susceptibility to parasitic infection induced morbidity|mortality (MP:0010750 from MPO Gene-Phenotype Associations)", "glomerulus hemorrhage (MP:0011437 from MPO Gene-Phenotype Associations)", "kidney hemorrhage (MP:0000533 from MPO Gene-Phenotype Associations)", "abnormal peritubular capillary endothelium morphology (MP:0011860 from MPO Gene-Phenotype Associations)", "decreased renal glomerulus basement membrane thickness (MP:0011859 from MPO Gene-Phenotype Associations)", "short kidney papilla (MP:0011857 from MPO Gene-Phenotype Associations)", "abnormal glomerular filtration barrier function (MP:0011856 from MPO Gene-Phenotype Associations)", "abnormal peritubular capillary morphology (MP:0011321 from MPO Gene-Phenotype Associations)", "abnormal ureter physiology (MP:0003589 from MPO Gene-Phenotype Associations)", "impaired ureteric peristalsis (MP:0011480 from MPO Gene-Phenotype Associations)", "decreased urine nitrite level (MP:0011742 from MPO Gene-Phenotype Associations)", "decreased podocyte number (MP:0011753 from MPO Gene-Phenotype Associations)", "increased podocyte apoptosis (MP:0011282 from MPO Gene-Phenotype Associations)", "abnormal podocyte adhesion (MP:0011864 from MPO Gene-Phenotype Associations)", "detached podocyte (MP:0011869 from MPO Gene-Phenotype Associations)", "increased cell chemotaxis (MP:0011824 from MPO Gene-Phenotype Associations)", "increased lymphocyte chemotaxis (MP:0011826 from MPO Gene-Phenotype Associations)", "abnormal podocyte physiology (MP:0011863 from MPO Gene-Phenotype Associations)", "increased urine microalbumin level (MP:0002959 from MPO Gene-Phenotype Associations)", "abnormal cell adhesion (MP:0003566 from MPO Gene-Phenotype Associations)", "abnormal fibroblast migration (MP:0011706 from MPO Gene-Phenotype Associations)", "decreased fibroblast cell migration (MP:0011708 from MPO Gene-Phenotype Associations)", "decreased cell migration (MP:0011805 from MPO Gene-Phenotype Associations)", "impaired fibroblast cell migration (MP:0011707 from MPO Gene-Phenotype Associations)", "increased cell migration (MP:0011804 from MPO Gene-Phenotype Associations)", "increased keratinocyte migration (MP:0012193 from MPO Gene-Phenotype Associations)", "increased fibroblast cell migration (MP:0011709 from MPO Gene-Phenotype Associations)", "enhanced wound healing (MP:0002724 from MPO Gene-Phenotype Associations)", "abnormal kidney collecting duct number (MP:0011845 from MPO Gene-Phenotype Associations)", "decreased kidney collecting duct number (MP:0011846 from MPO Gene-Phenotype Associations)", "abnormal keratinocyte migration (MP:0012192 from MPO Gene-Phenotype Associations)", "decreased keratinocyte migration (MP:0012194 from MPO Gene-Phenotype Associations)", "partial embryonic lethality between somite formation and embryo turning (MP:0011107 from MPO Gene-Phenotype Associations)", "abnormal hyaloid artery morphology (MP:0012537 from MPO Gene-Phenotype Associations)", "bergmeister's papilla (MP:0012539 from MPO Gene-Phenotype Associations)", "persistent hyaloid artery (MP:0012538 from MPO Gene-Phenotype Associations)", "abnormal urinary bladder blood vessel morphology (MP:0011773 from MPO Gene-Phenotype Associations)", "urinary bladder fibrosis (MP:0011769 from MPO Gene-Phenotype Associations)", "small prostate gland dorsolateral lobe (MP:0009740 from MPO Gene-Phenotype Associations)", "abnormal horizontal vestibuloocular reflex (MP:0011042 from MPO Gene-Phenotype Associations)", "patent ductus venosus (MP:0004004 from MPO Gene-Phenotype Associations)", "abnormal optokinetic reflex (MP:0009619 from MPO Gene-Phenotype Associations)", "chronic diarrhea (MP:0001665 from MPO Gene-Phenotype Associations)", "pulmonary alveolar edema (MP:0010894 from MPO Gene-Phenotype Associations)", "abnormal cauda epididymis morphology (MP:0002662 from MPO Gene-Phenotype Associations)", "vascular smooth muscle hypertrophy (MP:0002975 from MPO Gene-Phenotype Associations)", "atrial thrombosis (MP:0001855 from MPO Gene-Phenotype Associations)", "thrombosis (MP:0005048 from MPO Gene-Phenotype Associations)", "decreased clearance of atrial thrombosis (MP:0006066 from MPO Gene-Phenotype Associations)", "abnormal urinary bladder urothelium morphology (MP:0000540 from MPO Gene-Phenotype Associations)", "abnormal urothelium morphology (MP:0003630 from MPO Gene-Phenotype Associations)", "neurogenic bladder (MP:0005302 from MPO Gene-Phenotype Associations)", "aspartylglucosaminuria (MP:0011516 from MPO Gene-Phenotype Associations)", "abnormal urinary bladder morphology (MP:0000538 from MPO Gene-Phenotype Associations)", "distended urinary bladder (MP:0000539 from MPO Gene-Phenotype Associations)", "abnormal urinary bladder physiology (MP:0010386 from MPO Gene-Phenotype Associations)", "urinary bladder inflammation (MP:0009646 from MPO Gene-Phenotype Associations)", "abnormal urinary bladder weight (MP:0011798 from MPO Gene-Phenotype Associations)", "increased urinary bladder weight (MP:0011799 from MPO Gene-Phenotype Associations)", "abnormal urinary bladder detrusor smooth muscle morphology (MP:0011774 from MPO Gene-Phenotype Associations)", "abnormal urinary bladder neck morphology (MP:0011784 from MPO Gene-Phenotype Associations)", "abnormal male prostatic urethra morphology (MP:0011777 from MPO Gene-Phenotype Associations)", "urethra obstruction (MP:0011801 from MPO Gene-Phenotype Associations)", "seminal vesiculitis (MP:0011802 from MPO Gene-Phenotype Associations)", "abnormal male urethra morphology (MP:0011776 from MPO Gene-Phenotype Associations)", "urinary bladder obstruction (MP:0009552 from MPO Gene-Phenotype Associations)", "abnormal prostate gland physiology (MP:0003607 from MPO Gene-Phenotype Associations)", "prostate gland inflammation (MP:0003608 from MPO Gene-Phenotype Associations)", "bilirubinuria (MP:0011464 from MPO Gene-Phenotype Associations)", "abnormal urine organic cation level (MP:0006273 from MPO Gene-Phenotype Associations)", "abnormal xenobiotic pharmacokinetics (MP:0008875 from MPO Gene-Phenotype Associations)", "abnormal lamina terminalis morphology (MP:0012540 from MPO Gene-Phenotype Associations)", "absent lamina terminalis (MP:0012541 from MPO Gene-Phenotype Associations)", "abnormal primary palate development (MP:0009654 from MPO Gene-Phenotype Associations)", "absent incisors (MP:0000125 from MPO Gene-Phenotype Associations)", "absent upper incisors (MP:0004790 from MPO Gene-Phenotype Associations)", "abnormal philtrum morphology (MP:0012256 from MPO Gene-Phenotype Associations)", "philtrum hypoplasia (MP:0012258 from MPO Gene-Phenotype Associations)", "abnormal subcommissural organ morphology (MP:0009716 from MPO Gene-Phenotype Associations)", "overlapping parietal bones (MP:0000082 from MPO Gene-Phenotype Associations)", "short malleus (MP:0008373 from MPO Gene-Phenotype Associations)", "absent alveolar process (MP:0000094 from MPO Gene-Phenotype Associations)", "absent molars (MP:0003931 from MPO Gene-Phenotype Associations)", "abnormal metopic suture morphology (MP:0003842 from MPO Gene-Phenotype Associations)", "abnormal alveolar process morphology (MP:0004189 from MPO Gene-Phenotype Associations)", "palatal shelf hypoplasia (MP:0009883 from MPO Gene-Phenotype Associations)", "hairless tail (MP:0010233 from MPO Gene-Phenotype Associations)", "abnormal enamel knot morphology (MP:0010864 from MPO Gene-Phenotype Associations)", "abnormal enamel organ morphology (MP:0010747 from MPO Gene-Phenotype Associations)", "absent auchene hairs (MP:0006363 from MPO Gene-Phenotype Associations)", "abnormal anterior lingual gland morphology (MP:0009518 from MPO Gene-Phenotype Associations)", "absent anterior lingual gland (MP:0009534 from MPO Gene-Phenotype Associations)", "absent palatine gland (MP:0009533 from MPO Gene-Phenotype Associations)", "abnormal minor salivary gland morphology (MP:0003791 from MPO Gene-Phenotype Associations)", "abnormal palatine gland morphology (MP:0000615 from MPO Gene-Phenotype Associations)", "abnormal ebner's gland morphology (MP:3000003 from MPO Gene-Phenotype Associations)", "abnormal auchene hair morphology (MP:0000405 from MPO Gene-Phenotype Associations)", "abnormal awl hair morphology (MP:0000400 from MPO Gene-Phenotype Associations)", "abnormal zigzag hair morphology (MP:0000402 from MPO Gene-Phenotype Associations)", "shiny fur (MP:0000411 from MPO Gene-Phenotype Associations)", "abnormal eccrine gland morphology (MP:0000675 from MPO Gene-Phenotype Associations)", "abnormal sweat gland morphology (MP:0000674 from MPO Gene-Phenotype Associations)", "absent eccrine glands (MP:0000577 from MPO Gene-Phenotype Associations)", "absent zigzag hairs (MP:0006366 from MPO Gene-Phenotype Associations)", "absent guard hair (MP:0006365 from MPO Gene-Phenotype Associations)", "abnormal guard hair morphology (MP:0000397 from MPO Gene-Phenotype Associations)", "abnormal meibomian gland morphology (MP:0005252 from MPO Gene-Phenotype Associations)", "abnormal skin sebaceous gland morphology (MP:0009535 from MPO Gene-Phenotype Associations)", "absent meibomian glands (MP:0006236 from MPO Gene-Phenotype Associations)", "abnormal hair follicle pheomelanosome pheomelanin content (MP:0006370 from MPO Gene-Phenotype Associations)", "abnormal pheomelanosome morphology (MP:0013315 from MPO Gene-Phenotype Associations)", "abnormal pheomelanosome pheomelanin content (MP:0013316 from MPO Gene-Phenotype Associations)", "absent hair follicle pheomelanosome pheomelanin (MP:0006371 from MPO Gene-Phenotype Associations)", "abnormal sweat gland physiology (MP:0013368 from MPO Gene-Phenotype Associations)", "abnormal sweat gland secretion (MP:0013369 from MPO Gene-Phenotype Associations)", "anhidrosis (MP:0013370 from MPO Gene-Phenotype Associations)", "striated fur (MP:0009659 from MPO Gene-Phenotype Associations)", "transverse fur striping (MP:0010231 from MPO Gene-Phenotype Associations)", "decreased zigzag hair amount (MP:0008538 from MPO Gene-Phenotype Associations)", "decreased molar number (MP:0006400 from MPO Gene-Phenotype Associations)", "abnormal vibrissa number (MP:0009003 from MPO Gene-Phenotype Associations)", "supernumerary incisors (MP:0006369 from MPO Gene-Phenotype Associations)", "supernumerary teeth (MP:0004033 from MPO Gene-Phenotype Associations)", "hairless (MP:0003815 from MPO Gene-Phenotype Associations)", "disorganized inner root sheath cells (MP:0000387 from MPO Gene-Phenotype Associations)", "abnormal ameloblast morphology (MP:0002650 from MPO Gene-Phenotype Associations)", "abnormal enamel morphology (MP:0002576 from MPO Gene-Phenotype Associations)", "abnormal tooth hard tissue morphology (MP:0003930 from MPO Gene-Phenotype Associations)", "absent enamel (MP:0003404 from MPO Gene-Phenotype Associations)", "abnormal dentin morphology (MP:0002818 from MPO Gene-Phenotype Associations)", "abnormal tooth development (MP:0000116 from MPO Gene-Phenotype Associations)", "abnormal tooth morphology (MP:0002100 from MPO Gene-Phenotype Associations)", "abnormal incisor morphology (MP:0005358 from MPO Gene-Phenotype Associations)", "abnormal molar crown morphology (MP:0003932 from MPO Gene-Phenotype Associations)", "abnormal molar morphology (MP:0002689 from MPO Gene-Phenotype Associations)", "short incisors (MP:0004830 from MPO Gene-Phenotype Associations)", "small molars (MP:0006402 from MPO Gene-Phenotype Associations)", "abnormal tooth mineralization (MP:0002817 from MPO Gene-Phenotype Associations)", "abnormal incisor color (MP:0010096 from MPO Gene-Phenotype Associations)", "abnormal tooth color (MP:0013129 from MPO Gene-Phenotype Associations)", "delaminated enamel (MP:0002648 from MPO Gene-Phenotype Associations)", "abnormal enamel rod pattern (MP:0002649 from MPO Gene-Phenotype Associations)", "abnormal pulp cavity morphology (MP:0002819 from MPO Gene-Phenotype Associations)", "hair follicle outer rooth sheath hyperplasia (MP:0010688 from MPO Gene-Phenotype Associations)", "hair follicle degeneration (MP:0003413 from MPO Gene-Phenotype Associations)", "abnormal hair cycle catagen phase (MP:0008859 from MPO Gene-Phenotype Associations)", "folliculitis (MP:0000376 from MPO Gene-Phenotype Associations)", "abnormal lymph node medullary sinus morphology (MP:0011222 from MPO Gene-Phenotype Associations)", "dilated lymph node medullary sinus (MP:0011223 from MPO Gene-Phenotype Associations)", "hypergranulosis (MP:0009600 from MPO Gene-Phenotype Associations)", "thick epidermis stratum granulosum (MP:0009599 from MPO Gene-Phenotype Associations)", "lymph node inflammation (MP:0003865 from MPO Gene-Phenotype Associations)", "thick dermal layer (MP:0001245 from MPO Gene-Phenotype Associations)", "thick skin (MP:0001200 from MPO Gene-Phenotype Associations)", "focal hair loss (MP:0000418 from MPO Gene-Phenotype Associations)", "focal dorsal hair loss (MP:0010202 from MPO Gene-Phenotype Associations)", "delayed hair appearance (MP:0000422 from MPO Gene-Phenotype Associations)", "everted lip (MP:0003773 from MPO Gene-Phenotype Associations)", "thin epidermis stratum spinosum (MP:0001238 from MPO Gene-Phenotype Associations)", "abnormal corneocyte envelope morphology (MP:0009594 from MPO Gene-Phenotype Associations)", "epidermal desquamation (MP:0001230 from MPO Gene-Phenotype Associations)", "abnormal epidermal lamellar body morphology (MP:0009608 from MPO Gene-Phenotype Associations)", "abnormal epidermis stratum granulosum morphology (MP:0001239 from MPO Gene-Phenotype Associations)", "impaired skin barrier function (MP:0002796 from MPO Gene-Phenotype Associations)", "shiny skin (MP:0001196 from MPO Gene-Phenotype Associations)", "tight skin (MP:0001198 from MPO Gene-Phenotype Associations)", "thin epidermis (MP:0001218 from MPO Gene-Phenotype Associations)", "abnormal coat appearance (MP:0001510 from MPO Gene-Phenotype Associations)", "abnormal coat| hair morphology (MP:0000367 from MPO Gene-Phenotype Associations)", "abnormal skin adnexa morphology (MP:0010678 from MPO Gene-Phenotype Associations)", "abnormal hair growth (MP:0002073 from MPO Gene-Phenotype Associations)", "alopecia (MP:0000414 from MPO Gene-Phenotype Associations)", "sparse hair (MP:0000416 from MPO Gene-Phenotype Associations)", "abnormal hair follicle morphology (MP:0000377 from MPO Gene-Phenotype Associations)", "decreased hair follicle number (MP:0000379 from MPO Gene-Phenotype Associations)", "abnormal hair follicle development (MP:0003704 from MPO Gene-Phenotype Associations)", "underdeveloped hair follicles (MP:0000382 from MPO Gene-Phenotype Associations)", "integument phenotype (MP:0010771 from MPO Gene-Phenotype Associations)", "abnormal skin morphology (MP:0002060 from MPO Gene-Phenotype Associations)", "abnormal skin appearance (MP:0009931 from MPO Gene-Phenotype Associations)", "pallor (MP:0003717 from MPO Gene-Phenotype Associations)", "skin edema (MP:0001786 from MPO Gene-Phenotype Associations)", "abnormal skin condition (MP:0001191 from MPO Gene-Phenotype Associations)", "mixed cellular infiltration to dermis (MP:0001246 from MPO Gene-Phenotype Associations)", "abnormal epidermis stratum corneum morphology (MP:0001240 from MPO Gene-Phenotype Associations)", "hyperkeratosis (MP:0001242 from MPO Gene-Phenotype Associations)", "abnormal epidermal layer morphology (MP:0001216 from MPO Gene-Phenotype Associations)", "abnormal epidermis stratum spinosum morphology (MP:0001236 from MPO Gene-Phenotype Associations)", "acanthosis (MP:0001874 from MPO Gene-Phenotype Associations)", "epidermis stratum spinosum hyperplasia (MP:0009611 from MPO Gene-Phenotype Associations)", "scaly skin (MP:0001192 from MPO Gene-Phenotype Associations)", "reddish skin (MP:0001190 from MPO Gene-Phenotype Associations)", "parakeratosis (MP:0003427 from MPO Gene-Phenotype Associations)", "epidermal hyperplasia (MP:0001222 from MPO Gene-Phenotype Associations)", "thick epidermis (MP:0001219 from MPO Gene-Phenotype Associations)", "orthokeratosis (MP:0009675 from MPO Gene-Phenotype Associations)", "flaky skin (MP:0001195 from MPO Gene-Phenotype Associations)", "abnormal skin physiology (MP:0005501 from MPO Gene-Phenotype Associations)", "dermatitis (MP:0001194 from MPO Gene-Phenotype Associations)", "skin inflammation (MP:0004947 from MPO Gene-Phenotype Associations)", "skin lesions (MP:0001212 from MPO Gene-Phenotype Associations)", "spontaneous skin ulceration (MP:0001209 from MPO Gene-Phenotype Associations)", "abnormal tongue squamous epithelium morphology (MP:0000765 from MPO Gene-Phenotype Associations)", "thick eyelids (MP:0006162 from MPO Gene-Phenotype Associations)", "esophageal inflammation (MP:0003278 from MPO Gene-Phenotype Associations)", "abnormal joint capsule morphology (MP:0000997 from MPO Gene-Phenotype Associations)", "premature hair loss (MP:0005114 from MPO Gene-Phenotype Associations)", "abnormal keratinocyte apoptosis (MP:0001224 from MPO Gene-Phenotype Associations)", "increased keratinocyte apoptosis (MP:0009580 from MPO Gene-Phenotype Associations)", "abnormal keratinocyte physiology (MP:0003453 from MPO Gene-Phenotype Associations)", "abnormal keratinocyte proliferation (MP:0009582 from MPO Gene-Phenotype Associations)", "increased keratinocyte proliferation (MP:0009583 from MPO Gene-Phenotype Associations)", "decreased keratinocyte proliferation (MP:0009584 from MPO Gene-Phenotype Associations)", "enlarged corneocyte envelope (MP:0009595 from MPO Gene-Phenotype Associations)", "abnormal stratum corneum lipid matrix formation (MP:0009596 from MPO Gene-Phenotype Associations)", "impaired stratum corneum desquamation (MP:0009597 from MPO Gene-Phenotype Associations)", "dry skin (MP:0003853 from MPO Gene-Phenotype Associations)", "dehydration (MP:0001429 from MPO Gene-Phenotype Associations)", "progressive hair loss (MP:0009004 from MPO Gene-Phenotype Associations)", "absent hair follicle dermal papilla (MP:0010687 from MPO Gene-Phenotype Associations)", "distended hair follicles (MP:0000385 from MPO Gene-Phenotype Associations)", "decreased sebocyte cell number (MP:0013379 from MPO Gene-Phenotype Associations)", "enlarged popliteal lymph nodes (MP:0009635 from MPO Gene-Phenotype Associations)", "lymph node medullary cord hyperplasia (MP:0011225 from MPO Gene-Phenotype Associations)", "epidermis stratum granulosum hyperplasia (MP:0009601 from MPO Gene-Phenotype Associations)", "meibomian gland atrophy (MP:0001345 from MPO Gene-Phenotype Associations)", "sebaceous gland atrophy (MP:0000649 from MPO Gene-Phenotype Associations)", "thin hypodermis (MP:0004126 from MPO Gene-Phenotype Associations)", "abnormal skin cell number (MP:0001213 from MPO Gene-Phenotype Associations)", "skin hyperplasia (MP:0001214 from MPO Gene-Phenotype Associations)", "abnormal hair follicle bulb morphology (MP:0010681 from MPO Gene-Phenotype Associations)", "abnormal hair follicle dermal papilla morphology (MP:0003813 from MPO Gene-Phenotype Associations)", "wrinkled skin (MP:0001211 from MPO Gene-Phenotype Associations)", "loss of vibrissae (MP:0001280 from MPO Gene-Phenotype Associations)", "pyuria (MP:0011420 from MPO Gene-Phenotype Associations)", "abnormal sebocyte morphology (MP:0013375 from MPO Gene-Phenotype Associations)", "abnormal sebocyte number (MP:0013377 from MPO Gene-Phenotype Associations)", "increased sebocyte number (MP:0013378 from MPO Gene-Phenotype Associations)", "abnormal blood-inner ear barrier function (MP:0004999 from MPO Gene-Phenotype Associations)", "decreased threshold for auditory brainstem response (MP:0011968 from MPO Gene-Phenotype Associations)", "greasy coat (MP:0003849 from MPO Gene-Phenotype Associations)", "abnormal sebaceous gland morphology (MP:0000647 from MPO Gene-Phenotype Associations)", "enlarged sebaceous gland (MP:0000652 from MPO Gene-Phenotype Associations)", "abnormal hair medullary septa cells (MP:0008767 from MPO Gene-Phenotype Associations)", "increased sebum secretion (MP:0013373 from MPO Gene-Phenotype Associations)", "dilated hair follicle infundibulum (MP:0010683 from MPO Gene-Phenotype Associations)", "abnormal hair follicle infundibulum morphology (MP:0010682 from MPO Gene-Phenotype Associations)", "dilated hair follicles (MP:0010699 from MPO Gene-Phenotype Associations)", "sebaceous gland hyperplasia (MP:0009794 from MPO Gene-Phenotype Associations)", "thick epidermis stratum basale (MP:0009715 from MPO Gene-Phenotype Associations)", "thick epidermis suprabasal layer (MP:0009612 from MPO Gene-Phenotype Associations)", "abnormal meibomian gland development (MP:0013385 from MPO Gene-Phenotype Associations)", "abnormal perianal sebaceous gland morphology (MP:0013381 from MPO Gene-Phenotype Associations)", "small perianal sebaceous gland (MP:0013382 from MPO Gene-Phenotype Associations)", "small sebaceous gland (MP:0012725 from MPO Gene-Phenotype Associations)", "absent spleen white pulp (MP:0005046 from MPO Gene-Phenotype Associations)", "abnormal sebaceous gland physiology (MP:0002991 from MPO Gene-Phenotype Associations)", "abnormal sebaceous lipid secretion (MP:0002992 from MPO Gene-Phenotype Associations)", "increased saturated fatty acid level (MP:0005284 from MPO Gene-Phenotype Associations)", "reduced hair shaft melanin granule number (MP:0008732 from MPO Gene-Phenotype Associations)", "short nails (MP:0012399 from MPO Gene-Phenotype Associations)", "abnormal nail plate morphology (MP:0012403 from MPO Gene-Phenotype Associations)", "decreased classified tumor incidence (MP:0010283 from MPO Gene-Phenotype Associations)", "decreased lymphoma incidence (MP:0010268 from MPO Gene-Phenotype Associations)", "absent thymus cortex (MP:0010250 from MPO Gene-Phenotype Associations)", "nail dystrophy (MP:0012400 from MPO Gene-Phenotype Associations)", "increased plasmacytoma incidence (MP:0010286 from MPO Gene-Phenotype Associations)", "increased dn1 thymic pro-t cell number (MP:0010129 from MPO Gene-Phenotype Associations)", "decreased circulating interleukin-2 level (MP:0008600 from MPO Gene-Phenotype Associations)", "brittle hair (MP:0003848 from MPO Gene-Phenotype Associations)", "abnormal hair cortex keratinization (MP:0009801 from MPO Gene-Phenotype Associations)", "abnormal hair cortex morphology (MP:0003811 from MPO Gene-Phenotype Associations)", "abnormal response to transplant (MP:0005671 from MPO Gene-Phenotype Associations)", "increased length of allograft survival (MP:0004751 from MPO Gene-Phenotype Associations)", "short hair (MP:0000417 from MPO Gene-Phenotype Associations)", "abnormal vibrissa morphology (MP:0002098 from MPO Gene-Phenotype Associations)", "absent vibrissae (MP:0001284 from MPO Gene-Phenotype Associations)", "short vibrissae (MP:0001282 from MPO Gene-Phenotype Associations)", "abnormal hair shaft morphology (MP:0003809 from MPO Gene-Phenotype Associations)", "abnormal hair cuticle (MP:0003810 from MPO Gene-Phenotype Associations)", "abnormal hair medulla (MP:0003812 from MPO Gene-Phenotype Associations)", "waved hair (MP:0000410 from MPO Gene-Phenotype Associations)", "curly vibrissae (MP:0001274 from MPO Gene-Phenotype Associations)", "abnormal hair follicle inner root sheath morphology (MP:0010685 from MPO Gene-Phenotype Associations)", "wavy vibrissae (MP:0001279 from MPO Gene-Phenotype Associations)", "kinked vibrissae (MP:0001278 from MPO Gene-Phenotype Associations)", "abnormal hair follicle orientation (MP:0000383 from MPO Gene-Phenotype Associations)", "abnormal hair texture (MP:0002074 from MPO Gene-Phenotype Associations)", "rough coat (MP:0010179 from MPO Gene-Phenotype Associations)", "thin hair shaft (MP:0009351 from MPO Gene-Phenotype Associations)", "thick hair follicle outer rooth sheath (MP:0010690 from MPO Gene-Phenotype Associations)", "disorganized outer root sheath cells (MP:0000389 from MPO Gene-Phenotype Associations)", "thin hair follicle inner rooth sheath (MP:0010693 from MPO Gene-Phenotype Associations)", "abnormal hair follicle regression (MP:0003875 from MPO Gene-Phenotype Associations)", "accelerated hair follicle regression (MP:0000392 from MPO Gene-Phenotype Associations)", "distorted hair follicle pattern (MP:0000384 from MPO Gene-Phenotype Associations)", "abnormal hair cycle (MP:0000427 from MPO Gene-Phenotype Associations)", "abnormal hair cycle anagen phase (MP:0008858 from MPO Gene-Phenotype Associations)", "increased curvature of auchene hairs (MP:0000406 from MPO Gene-Phenotype Associations)", "increased curvature of awl hairs (MP:0000401 from MPO Gene-Phenotype Associations)", "increased curvature of zigzag hairs (MP:0000403 from MPO Gene-Phenotype Associations)", "increased curvature of hairs (MP:0000396 from MPO Gene-Phenotype Associations)", "increased curvature of guard hairs (MP:0000399 from MPO Gene-Phenotype Associations)", "plush coat (MP:0008899 from MPO Gene-Phenotype Associations)", "abnormal hair follicle bulge morphology (MP:0009759 from MPO Gene-Phenotype Associations)", "abnormal hair follicle outer root sheath morphology (MP:0010684 from MPO Gene-Phenotype Associations)", "retarded hair growth (MP:0000424 from MPO Gene-Phenotype Associations)", "matted coat (MP:0003846 from MPO Gene-Phenotype Associations)", "abnormal hair medulla air spaces (MP:0008768 from MPO Gene-Phenotype Associations)", "ruffled hair (MP:0000420 from MPO Gene-Phenotype Associations)", "disheveled coat (MP:0001511 from MPO Gene-Phenotype Associations)", "intestinal edema (MP:0003288 from MPO Gene-Phenotype Associations)", "hyperchylomicronemia (MP:0009699 from MPO Gene-Phenotype Associations)", "abnormal lipoprotein lipase activity (MP:0011577 from MPO Gene-Phenotype Associations)", "abnormal triglyceride lipase activity (MP:0011580 from MPO Gene-Phenotype Associations)", "decreased lipoprotein lipase activity (MP:0011579 from MPO Gene-Phenotype Associations)", "decreased triglyceride lipase activity (MP:0011582 from MPO Gene-Phenotype Associations)", "abnormal hormone-sensitive lipase activity (MP:0011589 from MPO Gene-Phenotype Associations)", "decreased hormone-sensitive lipase activity (MP:0011591 from MPO Gene-Phenotype Associations)", "increased lipoprotein lipase activity (MP:0011578 from MPO Gene-Phenotype Associations)", "increased triglyceride lipase activity (MP:0011581 from MPO Gene-Phenotype Associations)", "abnormal proximal-distal axis patterning (MP:0001705 from MPO Gene-Phenotype Associations)", "absent keratohyalin granules (MP:0009603 from MPO Gene-Phenotype Associations)", "decreased keratohyalin granule number (MP:0009605 from MPO Gene-Phenotype Associations)", "thin epidermis stratum granulosum (MP:0009598 from MPO Gene-Phenotype Associations)", "epidermal spongiosis (MP:0009795 from MPO Gene-Phenotype Associations)", "tail necrosis (MP:0013178 from MPO Gene-Phenotype Associations)", "abnormal keratohyalin granule morphology (MP:0009602 from MPO Gene-Phenotype Associations)", "increased keratohyalin granule size (MP:0009606 from MPO Gene-Phenotype Associations)", "abnormal mitochondrial proliferation (MP:0006037 from MPO Gene-Phenotype Associations)", "increased mitochondrial proliferation (MP:0006038 from MPO Gene-Phenotype Associations)", "scaly muzzle (MP:0000451 from MPO Gene-Phenotype Associations)", "acantholysis (MP:0004241 from MPO Gene-Phenotype Associations)", "mouth mucosal ulcer (MP:0003747 from MPO Gene-Phenotype Associations)", "absent cardiac desmosomes (MP:0006268 from MPO Gene-Phenotype Associations)", "myelencephalic blebs (MP:0008857 from MPO Gene-Phenotype Associations)", "abnormal hind foot hair pigmentation (MP:0009934 from MPO Gene-Phenotype Associations)", "abnormal stomach squamous epithelium morphology (MP:0000472 from MPO Gene-Phenotype Associations)", "abnormal forestomach morphology (MP:0010784 from MPO Gene-Phenotype Associations)", "abnormal ventral coat pigmentation (MP:0008237 from MPO Gene-Phenotype Associations)", "abnormal tail hair pigmentation (MP:0009933 from MPO Gene-Phenotype Associations)", "abnormal primordial germ cell morphology (MP:0008391 from MPO Gene-Phenotype Associations)", "decreased primordial germ cell number (MP:0008392 from MPO Gene-Phenotype Associations)", "absent primordial germ cells (MP:0008393 from MPO Gene-Phenotype Associations)", "abnormal primordial germ cell migration (MP:0002982 from MPO Gene-Phenotype Associations)", "abnormal primordial germ cell proliferation (MP:0008390 from MPO Gene-Phenotype Associations)", "abnormal melanoblast migration (MP:0009784 from MPO Gene-Phenotype Associations)", "abnormal melanoblast morphology (MP:0009783 from MPO Gene-Phenotype Associations)", "abnormal hair follicle melanin granule distribution (MP:0009555 from MPO Gene-Phenotype Associations)", "belted (MP:0002671 from MPO Gene-Phenotype Associations)", "abnormal myenteric nerve plexus morphology (MP:0010801 from MPO Gene-Phenotype Associations)", "belly blaze (MP:0004034 from MPO Gene-Phenotype Associations)", "abnormal interstitial cell of cajal morphology (MP:0009536 from MPO Gene-Phenotype Associations)", "interstitial cells of cajal hyperplasia (MP:0009537 from MPO Gene-Phenotype Associations)", "reversion by mitotic recombination (MP:0003175 from MPO Gene-Phenotype Associations)", "high mean erythrocyte cell number (MP:0002593 from MPO Gene-Phenotype Associations)", "abnormal histamine physiology (MP:0002503 from MPO Gene-Phenotype Associations)", "abnormal cecum morphology (MP:0000494 from MPO Gene-Phenotype Associations)", "distended cecum (MP:0009480 from MPO Gene-Phenotype Associations)", "enlarged cecum (MP:0009476 from MPO Gene-Phenotype Associations)", "absent strial intermediate cells (MP:0006010 from MPO Gene-Phenotype Associations)", "variable depigmentation (MP:0010016 from MPO Gene-Phenotype Associations)", "head spot (MP:0002939 from MPO Gene-Phenotype Associations)", "absent coat pigmentation (MP:0005171 from MPO Gene-Phenotype Associations)", "absent skin pigmentation (MP:0001189 from MPO Gene-Phenotype Associations)", "variable body spotting (MP:0002940 from MPO Gene-Phenotype Associations)", "head blaze (MP:0000370 from MPO Gene-Phenotype Associations)", "abnormal tail tip morphology (MP:0013177 from MPO Gene-Phenotype Associations)", "non-pigmented tail tip (MP:0005175 from MPO Gene-Phenotype Associations)", "belly spot (MP:0000373 from MPO Gene-Phenotype Associations)", "white spotting (MP:0002938 from MPO Gene-Phenotype Associations)", "abnormal coat|hair pigmentation (MP:0002075 from MPO Gene-Phenotype Associations)", "pigmentation phenotype (MP:0001186 from MPO Gene-Phenotype Associations)", "diluted coat color (MP:0000371 from MPO Gene-Phenotype Associations)", "decreased eye pigmentation (MP:0005172 from MPO Gene-Phenotype Associations)", "hypopigmentation (MP:0005408 from MPO Gene-Phenotype Associations)", "abnormal ear pigmentation (MP:0000015 from MPO Gene-Phenotype Associations)", "decreased ear pigmentation (MP:0011279 from MPO Gene-Phenotype Associations)", "decreased tail pigmentation (MP:0011277 from MPO Gene-Phenotype Associations)", "abnormal skin coloration (MP:0011239 from MPO Gene-Phenotype Associations)", "abnormal skin pigmentation (MP:0002095 from MPO Gene-Phenotype Associations)", "abnormal tail pigmentation (MP:0005174 from MPO Gene-Phenotype Associations)", "abnormal foot pigmentation (MP:0009379 from MPO Gene-Phenotype Associations)", "abnormal iris stromal pigmentation (MP:0005541 from MPO Gene-Phenotype Associations)", "absent retinal cone cells (MP:0008447 from MPO Gene-Phenotype Associations)", "exostosis (MP:0009877 from MPO Gene-Phenotype Associations)", "increased trabecular bone connectivity density (MP:0010932 from MPO Gene-Phenotype Associations)", "absent eye pigmentation (MP:0008480 from MPO Gene-Phenotype Associations)", "ocular albinism (MP:0006159 from MPO Gene-Phenotype Associations)", "irregular coat pigmentation (MP:0000372 from MPO Gene-Phenotype Associations)", "variegated coat color (MP:0005366 from MPO Gene-Phenotype Associations)", "mottled coat (MP:0000421 from MPO Gene-Phenotype Associations)", "abnormal agouti pigmentation (MP:0012076 from MPO Gene-Phenotype Associations)", "darkened coat color (MP:0005409 from MPO Gene-Phenotype Associations)", "yellow coat color (MP:0003136 from MPO Gene-Phenotype Associations)", "abnormal dorsoventral coat patterning (MP:0008238 from MPO Gene-Phenotype Associations)", "abnormal pinna hair pigmentation (MP:0009928 from MPO Gene-Phenotype Associations)", "decreased skin pigmentation (MP:0011627 from MPO Gene-Phenotype Associations)", "abnormal hair follicle melanogenesis (MP:0004382 from MPO Gene-Phenotype Associations)", "abnormal melanogenesis (MP:0005077 from MPO Gene-Phenotype Associations)", "abnormal iris pigmentation (MP:0005102 from MPO Gene-Phenotype Associations)", "iris atrophy (MP:0006228 from MPO Gene-Phenotype Associations)", "abnormal ciliary body pigmentation (MP:0005101 from MPO Gene-Phenotype Associations)", "abnormal hair shaft melanin granule shape (MP:0009273 from MPO Gene-Phenotype Associations)", "enlarged hair follicle melanin granules (MP:0005071 from MPO Gene-Phenotype Associations)", "abnormal urine enzyme level (MP:0001760 from MPO Gene-Phenotype Associations)", "abnormal bergmann glial cell morphology (MP:0010387 from MPO Gene-Phenotype Associations)", "ectopic bergmann glia cells (MP:0002763 from MPO Gene-Phenotype Associations)", "abnormal dermal mast cell morphology (MP:0008020 from MPO Gene-Phenotype Associations)", "absent nk t cells (MP:0008041 from MPO Gene-Phenotype Associations)", "enlarged alveolar lamellar bodies (MP:0010815 from MPO Gene-Phenotype Associations)", "alveolitis (MP:0010922 from MPO Gene-Phenotype Associations)", "abnormal hair follicle melanin granule morphology (MP:0005072 from MPO Gene-Phenotype Associations)", "abnormal hair follicle melanocyte morphology (MP:0004381 from MPO Gene-Phenotype Associations)", "absent hair follicle melanin granules (MP:0000394 from MPO Gene-Phenotype Associations)", "abnormal melanocyte morphology (MP:0002877 from MPO Gene-Phenotype Associations)", "abnormal melanosome morphology (MP:0005075 from MPO Gene-Phenotype Associations)", "abnormal hair shaft melanin granule morphology (MP:0008731 from MPO Gene-Phenotype Associations)", "abnormal blood coagulation (MP:0002551 from MPO Gene-Phenotype Associations)", "abnormal hemostasis (MP:0009676 from MPO Gene-Phenotype Associations)", "increased bleeding time (MP:0005606 from MPO Gene-Phenotype Associations)", "abnormal platelet activation (MP:0006298 from MPO Gene-Phenotype Associations)", "abnormal platelet aggregation (MP:0009548 from MPO Gene-Phenotype Associations)", "abnormal platelet physiology (MP:0005464 from MPO Gene-Phenotype Associations)", "decreased platelet aggregation (MP:0009549 from MPO Gene-Phenotype Associations)", "abnormal platelet dense granule physiology (MP:0009446 from MPO Gene-Phenotype Associations)", "abnormal platelet dense granule morphology (MP:0004721 from MPO Gene-Phenotype Associations)", "abnormal platelet dense granule number (MP:0004722 from MPO Gene-Phenotype Associations)", "abnormal platelet serotonin level (MP:0004723 from MPO Gene-Phenotype Associations)", "decreased platelet serotonin level (MP:0004725 from MPO Gene-Phenotype Associations)", "decreased serotonin level (MP:0010070 from MPO Gene-Phenotype Associations)", "abnormal platelet atp level (MP:0009447 from MPO Gene-Phenotype Associations)", "decreased platelet atp level (MP:0009448 from MPO Gene-Phenotype Associations)", "abnormal platelet adp level (MP:0009556 from MPO Gene-Phenotype Associations)", "decreased platelet adp level (MP:0009557 from MPO Gene-Phenotype Associations)", "decreased lysosomal enzyme secretion (MP:0003173 from MPO Gene-Phenotype Associations)", "abnormal serotonin level (MP:0005322 from MPO Gene-Phenotype Associations)", "abnormal lysosome morphology (MP:0005058 from MPO Gene-Phenotype Associations)", "accumulation of giant lysosomes in kidney|renal tubule cells (MP:0005060 from MPO Gene-Phenotype Associations)", "abnormal lysosome physiology (MP:0003172 from MPO Gene-Phenotype Associations)", "lysosomal protein accumulation (MP:0005059 from MPO Gene-Phenotype Associations)", "increased lysosomal enzyme secretion (MP:0003174 from MPO Gene-Phenotype Associations)", "abnormal choroid melanin granule morphology (MP:0010193 from MPO Gene-Phenotype Associations)", "abnormal choroid melanocyte morphology (MP:0010191 from MPO Gene-Phenotype Associations)", "abnormal retinal melanin granule morphology (MP:0010192 from MPO Gene-Phenotype Associations)", "abnormal retinal melanocyte morphology (MP:0010190 from MPO Gene-Phenotype Associations)", "abnormal choroid pigmentation (MP:0005100 from MPO Gene-Phenotype Associations)", "abnormal airway responsiveness (MP:0002334 from MPO Gene-Phenotype Associations)", "abnormal bronchial provocation (MP:0002330 from MPO Gene-Phenotype Associations)", "decreased airway responsiveness (MP:0002335 from MPO Gene-Phenotype Associations)", "increased airway responsiveness (MP:0001952 from MPO Gene-Phenotype Associations)", "abnormal mast cell degranulation (MP:0008763 from MPO Gene-Phenotype Associations)", "decreased mast cell degranulation (MP:0008765 from MPO Gene-Phenotype Associations)", "abnormal mast cell physiology (MP:0002423 from MPO Gene-Phenotype Associations)", "increased mast cell degranulation (MP:0008764 from MPO Gene-Phenotype Associations)", "abnormal type i hypersensitivity reaction (MP:0002531 from MPO Gene-Phenotype Associations)", "decreased susceptibility to type i hypersensitivity reaction (MP:0005597 from MPO Gene-Phenotype Associations)", "increased susceptibility to type i hypersensitivity reaction (MP:0005596 from MPO Gene-Phenotype Associations)", "abnormal type ii hypersensitivity reaction (MP:0002532 from MPO Gene-Phenotype Associations)", "decreased susceptibility to type ii hypersensitivity reaction (MP:0005612 from MPO Gene-Phenotype Associations)", "decreased susceptibility to autoimmune hemolytic anemia (MP:0004828 from MPO Gene-Phenotype Associations)", "prostate gland cysts (MP:0009737 from MPO Gene-Phenotype Associations)", "abnormal mast cell differentiation (MP:0005462 from MPO Gene-Phenotype Associations)", "increased mast cell number (MP:0000324 from MPO Gene-Phenotype Associations)", "abnormal mast cell morphology (MP:0000359 from MPO Gene-Phenotype Associations)", "abnormal mast cell number (MP:0020203 from MPO Gene-Phenotype Associations)", "decreased mast cell number (MP:0000336 from MPO Gene-Phenotype Associations)", "decreased mast cell protease storage (MP:0000361 from MPO Gene-Phenotype Associations)", "decreased mast cell histamine storage (MP:0000362 from MPO Gene-Phenotype Associations)", "abnormal activation-induced cell death of t cells (MP:0010670 from MPO Gene-Phenotype Associations)", "decreased activation-induced cell death of t cells (MP:0010677 from MPO Gene-Phenotype Associations)", "peritoneal inflammation (MP:0003303 from MPO Gene-Phenotype Associations)", "abnormal harderian gland pigmentation (MP:0003798 from MPO Gene-Phenotype Associations)", "abnormal melanosome transport (MP:0008834 from MPO Gene-Phenotype Associations)", "abnormal nk cell degranulation (MP:0008790 from MPO Gene-Phenotype Associations)", "decreased nk cell degranulation (MP:0008791 from MPO Gene-Phenotype Associations)", "abnormal circulating lactate dehydrogenase level (MP:0011970 from MPO Gene-Phenotype Associations)", "increased circulating lactate dehydrogenase level (MP:0011971 from MPO Gene-Phenotype Associations)", "pancytopenia (MP:0005152 from MPO Gene-Phenotype Associations)", "abnormal lactate dehydrogenase level (MP:0002943 from MPO Gene-Phenotype Associations)", "increased lactate dehydrogenase level (MP:0002944 from MPO Gene-Phenotype Associations)", "lethargy (MP:0005202 from MPO Gene-Phenotype Associations)", "abnormal macrophage activation involved in immune response (MP:0011075 from MPO Gene-Phenotype Associations)", "abnormal choroid vasculature morphology (MP:0006237 from MPO Gene-Phenotype Associations)", "choroidal neovascularization (MP:0005546 from MPO Gene-Phenotype Associations)", "decreased susceptibility to induced choroidal neovascularization (MP:0003434 from MPO Gene-Phenotype Associations)", "abnormal optic choroid morphology (MP:0005098 from MPO Gene-Phenotype Associations)", "abnormal mammary gland connective tissue morphology (MP:0009507 from MPO Gene-Phenotype Associations)", "ectropion (MP:0006164 from MPO Gene-Phenotype Associations)", "increased circulating fibrinogen level (MP:0012331 from MPO Gene-Phenotype Associations)", "esophageal ulcer (MP:0004547 from MPO Gene-Phenotype Associations)", "perianal ulcer (MP:0005035 from MPO Gene-Phenotype Associations)", "duodenal ulcer (MP:0003273 from MPO Gene-Phenotype Associations)", "venoocclusion (MP:0006137 from MPO Gene-Phenotype Associations)", "gastric ulcer (MP:0003282 from MPO Gene-Phenotype Associations)", "peptic ulcer (MP:0003301 from MPO Gene-Phenotype Associations)", "increased hepatocyte proliferation (MP:0003893 from MPO Gene-Phenotype Associations)", "decreased susceptibility to induced retinal damage (MP:0003455 from MPO Gene-Phenotype Associations)", "chronic joint inflammation (MP:0002935 from MPO Gene-Phenotype Associations)", "joint swelling (MP:0002936 from MPO Gene-Phenotype Associations)", "abnormal active avoidance behavior (MP:0002798 from MPO Gene-Phenotype Associations)", "abnormal lung interstitium morphology (MP:0002276 from MPO Gene-Phenotype Associations)", "pulmonary interstitial fibrosis (MP:0003426 from MPO Gene-Phenotype Associations)", "pulmonary fibrosis (MP:0006050 from MPO Gene-Phenotype Associations)", "abnormal thrombolysis (MP:0003422 from MPO Gene-Phenotype Associations)", "reduced thrombolysis (MP:0003423 from MPO Gene-Phenotype Associations)", "herniated seminal vesicle (MP:0003435 from MPO Gene-Phenotype Associations)", "vascular restenosis (MP:0005413 from MPO Gene-Phenotype Associations)", "kidney corticomedullary cysts (MP:0011308 from MPO Gene-Phenotype Associations)", "abnormal kidney capsule morphology (MP:0011383 from MPO Gene-Phenotype Associations)", "abnormal memory b cell differentiation (MP:0008095 from MPO Gene-Phenotype Associations)", "decreased susceptibility to induced pancreatitis (MP:0004155 from MPO Gene-Phenotype Associations)", "abnormal platelet calcium level (MP:0004865 from MPO Gene-Phenotype Associations)", "decreased platelet calcium level (MP:0004867 from MPO Gene-Phenotype Associations)", "abnormal urine prostaglandin level (MP:0011562 from MPO Gene-Phenotype Associations)", "decreased urine prostaglandin level (MP:0011564 from MPO Gene-Phenotype Associations)", "allodynia (MP:0003177 from MPO Gene-Phenotype Associations)", "abnormal bone healing (MP:0002999 from MPO Gene-Phenotype Associations)", "abnormal leukotriene level (MP:0009813 from MPO Gene-Phenotype Associations)", "decreased leukotriene level (MP:0009817 from MPO Gene-Phenotype Associations)", "abnormal prostaglandin level (MP:0009811 from MPO Gene-Phenotype Associations)", "decreased prostaglandin level (MP:0009815 from MPO Gene-Phenotype Associations)", "increased prostaglandin level (MP:0009814 from MPO Gene-Phenotype Associations)", "abnormal thromboxane level (MP:0009818 from MPO Gene-Phenotype Associations)", "absent neural folds (MP:0012165 from MPO Gene-Phenotype Associations)", "abnormal nipple development (MP:0009722 from MPO Gene-Phenotype Associations)", "absent nipple (MP:0009733 from MPO Gene-Phenotype Associations)", "abnormal endocardial heart tube morphology (MP:0012700 from MPO Gene-Phenotype Associations)", "increased desmoid tumor incidence (MP:0010338 from MPO Gene-Phenotype Associations)", "abnormal nipple morphology (MP:0006078 from MPO Gene-Phenotype Associations)", "dermal cysts (MP:0001247 from MPO Gene-Phenotype Associations)", "epidermal cyst (MP:0003414 from MPO Gene-Phenotype Associations)", "gastrointestinal tract polyps (MP:0010352 from MPO Gene-Phenotype Associations)", "intestine polyps (MP:0008011 from MPO Gene-Phenotype Associations)", "colon polyps (MP:0003269 from MPO Gene-Phenotype Associations)", "gastric polyps (MP:0003299 from MPO Gene-Phenotype Associations)", "increased hamartoma incidence (MP:0010306 from MPO Gene-Phenotype Associations)", "liver hyperplasia (MP:0005141 from MPO Gene-Phenotype Associations)", "increased alimentary system tumor incidence (MP:0010292 from MPO Gene-Phenotype Associations)", "increased gastrointestinal tumor incidence (MP:0010279 from MPO Gene-Phenotype Associations)", "increased intestinal adenocarcinoma incidence (MP:0002957 from MPO Gene-Phenotype Associations)", "increased intestinal adenoma incidence (MP:0002404 from MPO Gene-Phenotype Associations)", "increased stomach tumor incidence (MP:0010301 from MPO Gene-Phenotype Associations)", "increased colon hamartoma incidence (MP:0002043 from MPO Gene-Phenotype Associations)", "increased colon tumor incidence (MP:0012436 from MPO Gene-Phenotype Associations)", "increased colonic adenoma incidence (MP:0002044 from MPO Gene-Phenotype Associations)", "increased ear pigmentation (MP:0011278 from MPO Gene-Phenotype Associations)", "increased tail pigmentation (MP:0011276 from MPO Gene-Phenotype Associations)", "hyperpigmentation (MP:0001188 from MPO Gene-Phenotype Associations)", "abnormal foot pad morphology (MP:0000574 from MPO Gene-Phenotype Associations)", "dark foot pads (MP:0000575 from MPO Gene-Phenotype Associations)", "enhanced cellular glucose import (MP:0003927 from MPO Gene-Phenotype Associations)", "abnormal mucosal lining of the mouth (MP:0003745 from MPO Gene-Phenotype Associations)", "oral leukoplakia (MP:0003751 from MPO Gene-Phenotype Associations)", "increased splenic marginal zone lymphoma incidence (MP:0009318 from MPO Gene-Phenotype Associations)", "increased hibernoma incidence (MP:0010344 from MPO Gene-Phenotype Associations)", "increased lipoma incidence (MP:0010343 from MPO Gene-Phenotype Associations)", "abnormal hematopoietic stem cell proliferation (MP:0011901 from MPO Gene-Phenotype Associations)", "decreased hematopoietic stem cell proliferation (MP:0011903 from MPO Gene-Phenotype Associations)", "liver cirrhosis (MP:0003046 from MPO Gene-Phenotype Associations)", "increased blastoma incidence (MP:0008021 from MPO Gene-Phenotype Associations)", "increased medulloblastoma incidence (MP:0006283 from MPO Gene-Phenotype Associations)", "increased brain tumor incidence (MP:0009277 from MPO Gene-Phenotype Associations)", "increased muscle tumor incidence (MP:0010290 from MPO Gene-Phenotype Associations)", "increased rhabdomyosarcoma incidence (MP:0002036 from MPO Gene-Phenotype Associations)", "increased leiomyosarcoma incidence (MP:0002035 from MPO Gene-Phenotype Associations)", "decreased splenocyte apoptosis (MP:0009341 from MPO Gene-Phenotype Associations)", "decreased sensitivity to skin irradiation (MP:0001204 from MPO Gene-Phenotype Associations)", "increased incidence of tumors by ionizing radiation induction (MP:0004500 from MPO Gene-Phenotype Associations)", "delayed cellular replicative senescence (MP:0008009 from MPO Gene-Phenotype Associations)", "absent ovarian follicles (MP:0002777 from MPO Gene-Phenotype Associations)", "ovary degeneration (MP:0013236 from MPO Gene-Phenotype Associations)", "abnormal tumor latency (MP:0010307 from MPO Gene-Phenotype Associations)", "decreased tumor latency (MP:0010308 from MPO Gene-Phenotype Associations)", "increased tumor latency (MP:0009828 from MPO Gene-Phenotype Associations)", "abnormal physiological response to xenobiotic (MP:0008872 from MPO Gene-Phenotype Associations)", "decreased physiological sensitivity to xenobiotic (MP:0008874 from MPO Gene-Phenotype Associations)", "decreased incidence of induced tumors (MP:0002053 from MPO Gene-Phenotype Associations)", "decreased incidence of tumors by chemical induction (MP:0004502 from MPO Gene-Phenotype Associations)", "decreased tumor incidence (MP:0002052 from MPO Gene-Phenotype Associations)", "increased physiological sensitivity to xenobiotic (MP:0008873 from MPO Gene-Phenotype Associations)", "abnormal incidence of induced tumors (MP:0013151 from MPO Gene-Phenotype Associations)", "increased incidence of induced tumors (MP:0002021 from MPO Gene-Phenotype Associations)", "increased incidence of tumors by chemical induction (MP:0004499 from MPO Gene-Phenotype Associations)", "abnormal induced morbidity|mortality (MP:0001657 from MPO Gene-Phenotype Associations)", "abnormal sensitivity to induced morbidity|mortality (MP:0020148 from MPO Gene-Phenotype Associations)", "increased sensitivity to induced morbidity|mortality (MP:0009763 from MPO Gene-Phenotype Associations)", "abnormal xenobiotic induced morbidity|mortality (MP:0009765 from MPO Gene-Phenotype Associations)", "increased sensitivity to xenobiotic induced morbidity|mortality (MP:0009766 from MPO Gene-Phenotype Associations)", "decreased sensitivity to induced morbidity|mortality (MP:0009764 from MPO Gene-Phenotype Associations)", "decreased sensitivity to xenobiotic induced morbidity|mortality (MP:0009767 from MPO Gene-Phenotype Associations)", "abnormal adenoma incidence (MP:0020189 from MPO Gene-Phenotype Associations)", "increased adenoma incidence (MP:0010383 from MPO Gene-Phenotype Associations)", "abnormal lung adenoma incidence (MP:0020190 from MPO Gene-Phenotype Associations)", "increased lung adenoma incidence (MP:0002048 from MPO Gene-Phenotype Associations)", "abnormal classified tumor incidence (MP:0020188 from MPO Gene-Phenotype Associations)", "increased classified tumor incidence (MP:0010273 from MPO Gene-Phenotype Associations)", "abnormal organ|body region tumor incidence (MP:0013152 from MPO Gene-Phenotype Associations)", "increased organ|body region tumor incidence (MP:0010274 from MPO Gene-Phenotype Associations)", "abnormal tumor incidence (MP:0002019 from MPO Gene-Phenotype Associations)", "altered tumor susceptibility (MP:0002166 from MPO Gene-Phenotype Associations)", "tumorigenesis (MP:0002006 from MPO Gene-Phenotype Associations)", "increased tumor incidence (MP:0002020 from MPO Gene-Phenotype Associations)", "increased lymphoma incidence (MP:0012431 from MPO Gene-Phenotype Associations)", "increased hemolymphoid system tumor incidence (MP:0010296 from MPO Gene-Phenotype Associations)", "increased adenocarcinoma incidence (MP:0009308 from MPO Gene-Phenotype Associations)", "increased carcinoma incidence (MP:0002038 from MPO Gene-Phenotype Associations)", "increased malignant tumor incidence (MP:0002018 from MPO Gene-Phenotype Associations)", "increased lung adenocarcinoma incidence (MP:0002027 from MPO Gene-Phenotype Associations)", "increased lung non-small cell carcinoma incidence (MP:0008716 from MPO Gene-Phenotype Associations)", "increased lung carcinoma incidence (MP:0008714 from MPO Gene-Phenotype Associations)", "increased lung tumor incidence (MP:0008014 from MPO Gene-Phenotype Associations)", "increased respiratory system tumor incidence (MP:0010298 from MPO Gene-Phenotype Associations)", "increased hepatobiliary system tumor incidence (MP:0010297 from MPO Gene-Phenotype Associations)", "increased liver tumor incidence (MP:0008019 from MPO Gene-Phenotype Associations)", "increased hepatocellular carcinoma incidence (MP:0003331 from MPO Gene-Phenotype Associations)", "increased gland tumor incidence (MP:0010288 from MPO Gene-Phenotype Associations)", "increased t cell derived lymphoma incidence (MP:0002024 from MPO Gene-Phenotype Associations)", "increased thymus tumor incidence (MP:0010365 from MPO Gene-Phenotype Associations)", "increased cardiovascular system tumor incidence (MP:0010291 from MPO Gene-Phenotype Associations)", "increased hemangiosarcoma incidence (MP:0003667 from MPO Gene-Phenotype Associations)", "increased sarcoma incidence (MP:0002032 from MPO Gene-Phenotype Associations)", "increased histiocytic sarcoma incidence (MP:0009321 from MPO Gene-Phenotype Associations)", "increased b cell derived lymphoma incidence (MP:0002023 from MPO Gene-Phenotype Associations)", "increased mammary adenocarcinoma incidence (MP:0001883 from MPO Gene-Phenotype Associations)", "increased mammary gland tumor incidence (MP:0010299 from MPO Gene-Phenotype Associations)", "increased skin squamous cell carcinoma incidence (MP:0009704 from MPO Gene-Phenotype Associations)", "increased squamous cell carcinoma incidence (MP:0004207 from MPO Gene-Phenotype Associations)", "increased integument system tumor incidence (MP:0010293 from MPO Gene-Phenotype Associations)", "increased skin tumor incidence (MP:0010300 from MPO Gene-Phenotype Associations)", "increased skin papilloma incidence (MP:0002051 from MPO Gene-Phenotype Associations)", "increased papilloma incidence (MP:0002014 from MPO Gene-Phenotype Associations)", "increased gonad tumor incidence (MP:0009590 from MPO Gene-Phenotype Associations)", "increased ovary tumor incidence (MP:0008000 from MPO Gene-Phenotype Associations)", "increased reproductive system tumor incidence (MP:0010287 from MPO Gene-Phenotype Associations)", "increased testis tumor incidence (MP:0006262 from MPO Gene-Phenotype Associations)", "increased testicular teratoma incidence (MP:0004478 from MPO Gene-Phenotype Associations)", "increased teratoma incidence (MP:0002627 from MPO Gene-Phenotype Associations)", "abnormal cell morphology (MP:0000358 from MPO Gene-Phenotype Associations)", "abnormal cell nucleus morphology (MP:0003111 from MPO Gene-Phenotype Associations)", "abnormal chromosome morphology (MP:0003702 from MPO Gene-Phenotype Associations)", "abnormal chromosome number (MP:0004023 from MPO Gene-Phenotype Associations)", "aneuploidy (MP:0004024 from MPO Gene-Phenotype Associations)", "polyploidy (MP:0004025 from MPO Gene-Phenotype Associations)", "abnormal cell cycle (MP:0003077 from MPO Gene-Phenotype Associations)", "abnormal mitosis (MP:0004046 from MPO Gene-Phenotype Associations)", "abnormal mitotic spindle morphology (MP:0009760 from MPO Gene-Phenotype Associations)", "abnormal cell cycle checkpoint function (MP:0004045 from MPO Gene-Phenotype Associations)", "abnormal mitotic spindle assembly checkpoint (MP:0009762 from MPO Gene-Phenotype Associations)", "abnormal telomere morphology (MP:0010207 from MPO Gene-Phenotype Associations)", "abnormal telomere length (MP:0003155 from MPO Gene-Phenotype Associations)", "abnormal cell proliferation (MP:0000350 from MPO Gene-Phenotype Associations)", "decreased cell proliferation (MP:0000352 from MPO Gene-Phenotype Associations)", "abnormal fibroblast proliferation (MP:0011702 from MPO Gene-Phenotype Associations)", "decreased fibroblast proliferation (MP:0011704 from MPO Gene-Phenotype Associations)", "abnormal cellular replicative senescence (MP:0008007 from MPO Gene-Phenotype Associations)", "early cellular replicative senescence (MP:0008008 from MPO Gene-Phenotype Associations)", "absent fibroblast proliferation (MP:0011705 from MPO Gene-Phenotype Associations)", "increased cell proliferation (MP:0000351 from MPO Gene-Phenotype Associations)", "increased fibroblast proliferation (MP:0011703 from MPO Gene-Phenotype Associations)", "abnormal induced cell death (MP:0008942 from MPO Gene-Phenotype Associations)", "increased sensitivity to induced cell death (MP:0008943 from MPO Gene-Phenotype Associations)", "increased cellular sensitivity to gamma-irradiation (MP:0002007 from MPO Gene-Phenotype Associations)", "increased cellular sensitivity to ionizing radiation (MP:0004227 from MPO Gene-Phenotype Associations)", "increased cellular sensitivity to ultraviolet irradiation (MP:0008410 from MPO Gene-Phenotype Associations)", "abnormal mortality induced by ionizing radiation (MP:0020149 from MPO Gene-Phenotype Associations)", "abnormal response to radiation (MP:0012734 from MPO Gene-Phenotype Associations)", "increased mortality induced by ionizing radiation (MP:0003992 from MPO Gene-Phenotype Associations)", "increased mortality induced by gamma-irradiation (MP:0001658 from MPO Gene-Phenotype Associations)", "abnormal chromosome stability (MP:0010094 from MPO Gene-Phenotype Associations)", "chromosomal instability (MP:0008866 from MPO Gene-Phenotype Associations)", "chromosome breakage (MP:0004028 from MPO Gene-Phenotype Associations)", "spontaneous chromosome breakage (MP:0004029 from MPO Gene-Phenotype Associations)", "induced chromosome breakage (MP:0004030 from MPO Gene-Phenotype Associations)", "increased cellular sensitivity to hydroxyurea (MP:0008409 from MPO Gene-Phenotype Associations)", "increased granulosa cell tumor incidence (MP:0012411 from MPO Gene-Phenotype Associations)", "increased harderian gland tumor incidence (MP:0012437 from MPO Gene-Phenotype Associations)", "increased liver adenocarcinoma incidence (MP:0009591 from MPO Gene-Phenotype Associations)", "increased spindle cell carcinoma incidence (MP:0010367 from MPO Gene-Phenotype Associations)", "abnormal uterine nk cell physiology (MP:0009099 from MPO Gene-Phenotype Associations)", "increased susceptibility to graft versus host disease (MP:0005672 from MPO Gene-Phenotype Associations)", "liver abscess (MP:0003332 from MPO Gene-Phenotype Associations)", "decreased susceptibility to experimental autoimmune myasthenia gravis (MP:0004824 from MPO Gene-Phenotype Associations)", "abnormal tumor vascularization (MP:0010144 from MPO Gene-Phenotype Associations)", "altered tumor morphology (MP:0003448 from MPO Gene-Phenotype Associations)", "altered tumor pathology (MP:0010639 from MPO Gene-Phenotype Associations)", "decreased tumor growth|size (MP:0003447 from MPO Gene-Phenotype Associations)", "increased tumor growth|size (MP:0003721 from MPO Gene-Phenotype Associations)", "altered metastatic potential (MP:0000858 from MPO Gene-Phenotype Associations)", "increased metastatic potential (MP:0001272 from MPO Gene-Phenotype Associations)", "decreased metastatic potential (MP:0001273 from MPO Gene-Phenotype Associations)", "increased duodenum adenocarcinoma incidence (MP:0009311 from MPO Gene-Phenotype Associations)", "increased neuroblastoma incidence (MP:0002039 from MPO Gene-Phenotype Associations)", "increased urinary bladder transitional cell carcinoma incidence (MP:0009551 from MPO Gene-Phenotype Associations)", "increased urinary bladder carcinoma incidence (MP:0009550 from MPO Gene-Phenotype Associations)", "increased leiomyoma incidence (MP:0003569 from MPO Gene-Phenotype Associations)", "increased uterus leiomyoma incidence (MP:0003570 from MPO Gene-Phenotype Associations)", "increased uterus tumor incidence (MP:0009222 from MPO Gene-Phenotype Associations)", "increased jejunum adenocarcinoma incidence (MP:0009312 from MPO Gene-Phenotype Associations)", "increased small intestine adenocarcinoma incidence (MP:0009309 from MPO Gene-Phenotype Associations)", "increased hemangioma incidence (MP:0002947 from MPO Gene-Phenotype Associations)", "increased hepatic hemangioma incidence (MP:0002047 from MPO Gene-Phenotype Associations)", "increased renal cystadenoma incidence (MP:0002045 from MPO Gene-Phenotype Associations)", "increased extremity angiosarcoma incidence (MP:0002049 from MPO Gene-Phenotype Associations)", "increased myeloid sarcoma incidence (MP:0009439 from MPO Gene-Phenotype Associations)", "abnormal extraembryonic tissue physiology (MP:0004264 from MPO Gene-Phenotype Associations)", "abnormal placenta physiology (MP:0010038 from MPO Gene-Phenotype Associations)", "abnormal placental transport (MP:0004265 from MPO Gene-Phenotype Associations)", "abnormal trophoblast giant cell proliferation (MP:0010039 from MPO Gene-Phenotype Associations)", "abnormal frontal lobe morphology (MP:0000798 from MPO Gene-Phenotype Associations)", "thin cerebellar granule layer (MP:0006099 from MPO Gene-Phenotype Associations)", "abnormal macrophage differentiation (MP:0008113 from MPO Gene-Phenotype Associations)", "abnormal lens fiber apoptosis (MP:0008795 from MPO Gene-Phenotype Associations)", "increased lens fiber apoptosis (MP:0008796 from MPO Gene-Phenotype Associations)", "increased thyroid c-cell carcinoma incidence (MP:0010345 from MPO Gene-Phenotype Associations)", "increased pituitary melanotroph tumor incidence (MP:0010351 from MPO Gene-Phenotype Associations)", "adrenal gland cyst (MP:0013309 from MPO Gene-Phenotype Associations)", "increased adrenal cortical tumor incidence (MP:0010366 from MPO Gene-Phenotype Associations)", "increased glioma incidence (MP:0010278 from MPO Gene-Phenotype Associations)", "increased tongue size (MP:0009906 from MPO Gene-Phenotype Associations)", "visceromegaly (MP:0013328 from MPO Gene-Phenotype Associations)", "abnormal bronchioalveolar stem cell morphology (MP:0010828 from MPO Gene-Phenotype Associations)", "increased bronchioalveolar stem cell number (MP:0010829 from MPO Gene-Phenotype Associations)", "increased adrenal gland tumor incidence (MP:0002031 from MPO Gene-Phenotype Associations)", "increased pheochromocytoma incidence (MP:0002050 from MPO Gene-Phenotype Associations)", "dyskeratosis (MP:0009563 from MPO Gene-Phenotype Associations)", "increased kidney tumor incidence (MP:0010294 from MPO Gene-Phenotype Associations)", "increased renal carcinoma incidence (MP:0010384 from MPO Gene-Phenotype Associations)", "increased urinary system tumor incidence (MP:0010289 from MPO Gene-Phenotype Associations)", "pancreas necrosis (MP:0009148 from MPO Gene-Phenotype Associations)", "parathyroid gland hyperplasia (MP:0003493 from MPO Gene-Phenotype Associations)", "increased glucagonoma incidence (MP:0003365 from MPO Gene-Phenotype Associations)", "increased adrenocortical adenoma incidence (MP:0010390 from MPO Gene-Phenotype Associations)", "increased adrenal gland adenoma incidence (MP:0009044 from MPO Gene-Phenotype Associations)", "increased parathyroid adenoma incidence (MP:0003495 from MPO Gene-Phenotype Associations)", "increased parathyroid gland tumor incidence (MP:0010321 from MPO Gene-Phenotype Associations)", "increased pancreatic islet cell carcinoma incidence (MP:0010348 from MPO Gene-Phenotype Associations)", "increased insulinoma incidence (MP:0003364 from MPO Gene-Phenotype Associations)", "increased pancreas adenoma incidence (MP:0009043 from MPO Gene-Phenotype Associations)", "increased pancreatic islet cell adenoma incidence (MP:0003430 from MPO Gene-Phenotype Associations)", "increased pancreas tumor incidence (MP:0009153 from MPO Gene-Phenotype Associations)", "increased thyroid adenoma incidence (MP:0003496 from MPO Gene-Phenotype Associations)", "increased leydig cell tumor incidence (MP:0009592 from MPO Gene-Phenotype Associations)", "increased thyroid carcinoma incidence (MP:0010346 from MPO Gene-Phenotype Associations)", "increased thyroid tumor incidence (MP:0010316 from MPO Gene-Phenotype Associations)", "increased nervous system tumor incidence (MP:0010281 from MPO Gene-Phenotype Associations)", "increased pituitary adenoma incidence (MP:0002041 from MPO Gene-Phenotype Associations)", "increased pituitary gland tumor incidence (MP:0010320 from MPO Gene-Phenotype Associations)", "increased pituitary adenohypophysis tumor incidence (MP:0010350 from MPO Gene-Phenotype Associations)", "increased prolactinoma incidence (MP:0003505 from MPO Gene-Phenotype Associations)", "paravertebral ganglia hyperplasia (MP:0001009 from MPO Gene-Phenotype Associations)", "prevertebral ganglia hyperplasia (MP:0001010 from MPO Gene-Phenotype Associations)", "skeletal muscle hypoplasia (MP:0009460 from MPO Gene-Phenotype Associations)", "abnormal prevertebral ganglion morphology (MP:0008316 from MPO Gene-Phenotype Associations)", "delayed muscle development (MP:0000736 from MPO Gene-Phenotype Associations)", "increased fibroma incidence (MP:0003580 from MPO Gene-Phenotype Associations)", "increased neurofibroma incidence (MP:0010314 from MPO Gene-Phenotype Associations)", "increased neurofibrosarcoma incidence (MP:0002030 from MPO Gene-Phenotype Associations)", "increased meningioma incidence (MP:0010311 from MPO Gene-Phenotype Associations)", "increased osteoma incidence (MP:0010313 from MPO Gene-Phenotype Associations)", "osseous metaplasia (MP:0010347 from MPO Gene-Phenotype Associations)", "increased mesothelioma incidence (MP:0010309 from MPO Gene-Phenotype Associations)", "increased fibrosarcoma incidence (MP:0010363 from MPO Gene-Phenotype Associations)", "increased osteosarcoma incidence (MP:0003789 from MPO Gene-Phenotype Associations)", "increased skeletal tumor incidence (MP:0010280 from MPO Gene-Phenotype Associations)", "increased thymus weight (MP:0004955 from MPO Gene-Phenotype Associations)", "enlarged thymus (MP:0000709 from MPO Gene-Phenotype Associations)", "thymus hyperplasia (MP:0000708 from MPO Gene-Phenotype Associations)", "abnormal melanocyte proliferation (MP:0010741 from MPO Gene-Phenotype Associations)", "increased cutaneous melanoma incidence (MP:0010322 from MPO Gene-Phenotype Associations)", "increased melanoma incidence (MP:0010275 from MPO Gene-Phenotype Associations)", "increased fibrohistocytoma incidence (MP:0002037 from MPO Gene-Phenotype Associations)", "increased small lymphocytic lymphoma incidence (MP:0009319 from MPO Gene-Phenotype Associations)", "increased gastrointestinal stromal tumor incidence (MP:0009515 from MPO Gene-Phenotype Associations)", "increased organ of corti supporting cell number (MP:0004498 from MPO Gene-Phenotype Associations)", "adrenal medulla hyperplasia (MP:0008301 from MPO Gene-Phenotype Associations)", "enlarged adrenal medulla (MP:0008300 from MPO Gene-Phenotype Associations)", "abnormal retina outer limiting membrane morphology (MP:0010236 from MPO Gene-Phenotype Associations)", "abnormal parametrial fat pad morphology (MP:0008906 from MPO Gene-Phenotype Associations)", "increased parametrial fat pad weight (MP:0009300 from MPO Gene-Phenotype Associations)", "increased white fat cell number (MP:0009130 from MPO Gene-Phenotype Associations)", "decreased incidence of tumors by ionizing radiation induction (MP:0004503 from MPO Gene-Phenotype Associations)", "increased sebaceous gland adenoma incidence (MP:0013383 from MPO Gene-Phenotype Associations)", "increased sebaceous gland tumor incidence (MP:0013374 from MPO Gene-Phenotype Associations)", "decreased mortality induced by ionizing radiation (MP:0003010 from MPO Gene-Phenotype Associations)", "increased prostate gland weight (MP:0004961 from MPO Gene-Phenotype Associations)", "enlarged prostate gland (MP:0004958 from MPO Gene-Phenotype Associations)", "prostate gland hyperplasia (MP:0000659 from MPO Gene-Phenotype Associations)", "enlarged prostate gland anterior lobe (MP:0009738 from MPO Gene-Phenotype Associations)", "abnormal prostate gland dorsolateral lobe morphology (MP:0009381 from MPO Gene-Phenotype Associations)", "abnormal prostate gland epithelium morphology (MP:0001168 from MPO Gene-Phenotype Associations)", "prostate gland epithelial hyperplasia (MP:0001167 from MPO Gene-Phenotype Associations)", "increased prostate gland adenocarcinoma incidence (MP:0009220 from MPO Gene-Phenotype Associations)", "increased prostate gland tumor incidence (MP:0010357 from MPO Gene-Phenotype Associations)", "increased prostate intraepithelial neoplasia incidence (MP:0009219 from MPO Gene-Phenotype Associations)", "increased fibroadenoma incidence (MP:0010364 from MPO Gene-Phenotype Associations)", "increased mammary adenoacanthoma incidence (MP:0006422 from MPO Gene-Phenotype Associations)", "increased uterus carcinoma incidence (MP:0009223 from MPO Gene-Phenotype Associations)", "increased endometrial carcinoma incidence (MP:0004868 from MPO Gene-Phenotype Associations)", "increased liver adenoma incidence (MP:0003324 from MPO Gene-Phenotype Associations)", "enlarged trigeminal ganglion (MP:0001095 from MPO Gene-Phenotype Associations)", "decreased tegmentum size (MP:0006102 from MPO Gene-Phenotype Associations)", "decreased cellular sensitivity to ultraviolet irradiation (MP:0008411 from MPO Gene-Phenotype Associations)", "decreased cellular sensitivity to alkylating agents (MP:0008403 from MPO Gene-Phenotype Associations)", "decreased cellular sensitivity to methylmethanesulfonate (MP:0008405 from MPO Gene-Phenotype Associations)", "decreased sensitivity to induced cell death (MP:0008944 from MPO Gene-Phenotype Associations)", "decreased cellular sensitivity to gamma-irradiation (MP:0003207 from MPO Gene-Phenotype Associations)", "decreased cellular sensitivity to ionizing radiation (MP:0004228 from MPO Gene-Phenotype Associations)", "decreased cellular sensitivity to x-ray irradiation (MP:0004587 from MPO Gene-Phenotype Associations)", "heart vascular congestion (MP:0010021 from MPO Gene-Phenotype Associations)", "decreased cellular sensitivity to hydrogen peroxide (MP:0008407 from MPO Gene-Phenotype Associations)", "decreased cellular sensitivity to oxidative stress (MP:0008413 from MPO Gene-Phenotype Associations)", "increased ovarian teratoma incidence (MP:0009442 from MPO Gene-Phenotype Associations)", "abnormal placenta hemotrichorial membrane morphology (MP:0012126 from MPO Gene-Phenotype Associations)", "increased brown fat cell size (MP:0009119 from MPO Gene-Phenotype Associations)", "leukostasis (MP:0008541 from MPO Gene-Phenotype Associations)", "lipodystrophy (MP:0011174 from MPO Gene-Phenotype Associations)", "abnormal bone marrow development (MP:0000168 from MPO Gene-Phenotype Associations)", "abnormal brown fat lipid droplet number (MP:0009134 from MPO Gene-Phenotype Associations)", "decreased brown fat lipid droplet number (MP:0009137 from MPO Gene-Phenotype Associations)", "small endometrial glands (MP:0009396 from MPO Gene-Phenotype Associations)", "abnormal adipocyte glucose uptake (MP:0004185 from MPO Gene-Phenotype Associations)", "abnormal adipose tissue physiology (MP:0005666 from MPO Gene-Phenotype Associations)", "abnormal white adipose tissue physiology (MP:0005670 from MPO Gene-Phenotype Associations)", "abnormal femoral fat pad morphology (MP:0008905 from MPO Gene-Phenotype Associations)", "decreased femoral fat pad weight (MP:0009291 from MPO Gene-Phenotype Associations)", "abnormal total fat pad weight (MP:0020130 from MPO Gene-Phenotype Associations)", "decreased total fat pad weight (MP:0008907 from MPO Gene-Phenotype Associations)", "increased total fat pad weight (MP:0008908 from MPO Gene-Phenotype Associations)", "abnormal body mass index (MP:0020182 from MPO Gene-Phenotype Associations)", "decreased body mass index (MP:0006086 from MPO Gene-Phenotype Associations)", "increased body mass index (MP:0006087 from MPO Gene-Phenotype Associations)", "abnormal abdominal fat pad morphology (MP:0000010 from MPO Gene-Phenotype Associations)", "abnormal fat pad morphology (MP:0005334 from MPO Gene-Phenotype Associations)", "abnormal epididymal fat pad morphology (MP:0006319 from MPO Gene-Phenotype Associations)", "decreased epididymal fat pad weight (MP:0009289 from MPO Gene-Phenotype Associations)", "abnormal fat cell morphology (MP:0009115 from MPO Gene-Phenotype Associations)", "abnormal white fat cell morphology (MP:0009117 from MPO Gene-Phenotype Associations)", "abnormal white fat cell size (MP:0009132 from MPO Gene-Phenotype Associations)", "decreased fat cell size (MP:0009269 from MPO Gene-Phenotype Associations)", "decreased white fat cell size (MP:0009133 from MPO Gene-Phenotype Associations)", "abnormal adipose tissue morphology (MP:0000003 from MPO Gene-Phenotype Associations)", "adipose tissue phenotype (MP:0005375 from MPO Gene-Phenotype Associations)", "abnormal adipose tissue amount (MP:0005452 from MPO Gene-Phenotype Associations)", "abnormal body fat mass (MP:0012320 from MPO Gene-Phenotype Associations)", "decreased total body fat amount (MP:0010025 from MPO Gene-Phenotype Associations)", "abnormal percent body fat (MP:0005457 from MPO Gene-Phenotype Associations)", "decreased percent body fat (MP:0005459 from MPO Gene-Phenotype Associations)", "abnormal susceptibility to weight gain (MP:0011117 from MPO Gene-Phenotype Associations)", "decreased susceptibility to weight gain (MP:0010182 from MPO Gene-Phenotype Associations)", "decreased susceptibility to diet-induced obesity (MP:0005659 from MPO Gene-Phenotype Associations)", "increased energy expenditure (MP:0004889 from MPO Gene-Phenotype Associations)", "abnormal energy expenditure (MP:0005450 from MPO Gene-Phenotype Associations)", "abnormal energy homeostasis (MP:0005448 from MPO Gene-Phenotype Associations)", "decreased susceptibility to hepatic steatosis (MP:0002310 from MPO Gene-Phenotype Associations)", "decreased circulating leptin level (MP:0005668 from MPO Gene-Phenotype Associations)", "abnormal oxygen consumption (MP:0005288 from MPO Gene-Phenotype Associations)", "increased oxygen consumption (MP:0005289 from MPO Gene-Phenotype Associations)", "abnormal carbon dioxide production (MP:0008962 from MPO Gene-Phenotype Associations)", "increased carbon dioxide production (MP:0008963 from MPO Gene-Phenotype Associations)", "abnormal white adipose tissue morphology (MP:0002970 from MPO Gene-Phenotype Associations)", "abnormal white adipose tissue amount (MP:0001781 from MPO Gene-Phenotype Associations)", "decreased white adipose tissue amount (MP:0001783 from MPO Gene-Phenotype Associations)", "abnormal hypodermis fat layer morphology (MP:0011156 from MPO Gene-Phenotype Associations)", "abnormal hypodermis morphology (MP:0003705 from MPO Gene-Phenotype Associations)", "decreased subcutaneous adipose tissue amount (MP:0008844 from MPO Gene-Phenotype Associations)", "absent subcutaneous adipose tissue (MP:0008843 from MPO Gene-Phenotype Associations)", "abnormal brown adipose tissue morphology (MP:0002971 from MPO Gene-Phenotype Associations)", "abnormal brown adipose tissue amount (MP:0001778 from MPO Gene-Phenotype Associations)", "decreased brown adipose tissue amount (MP:0001780 from MPO Gene-Phenotype Associations)", "increased brown adipose tissue amount (MP:0000005 from MPO Gene-Phenotype Associations)", "abnormal brown fat cell morphology (MP:0009116 from MPO Gene-Phenotype Associations)", "abnormal brown fat cell lipid droplet size (MP:0009123 from MPO Gene-Phenotype Associations)", "decreased brown fat cell lipid droplet size (MP:0009125 from MPO Gene-Phenotype Associations)", "abnormal adiponectin level (MP:0004891 from MPO Gene-Phenotype Associations)", "increased adiponectin level (MP:0004892 from MPO Gene-Phenotype Associations)", "decreased adiponectin level (MP:0004893 from MPO Gene-Phenotype Associations)", "abnormal respiratory quotient (MP:0004129 from MPO Gene-Phenotype Associations)", "increased respiratory quotient (MP:0010378 from MPO Gene-Phenotype Associations)", "decreased respiratory quotient (MP:0010379 from MPO Gene-Phenotype Associations)", "abnormal cholesterol homeostasis (MP:0005278 from MPO Gene-Phenotype Associations)", "abnormal cholesterol level (MP:0003947 from MPO Gene-Phenotype Associations)", "abnormal sterol level (MP:0012224 from MPO Gene-Phenotype Associations)", "abnormal circulating cholesterol level (MP:0000180 from MPO Gene-Phenotype Associations)", "increased cholesterol level (MP:0003982 from MPO Gene-Phenotype Associations)", "increased sterol level (MP:0012226 from MPO Gene-Phenotype Associations)", "increased circulating cholesterol level (MP:0005178 from MPO Gene-Phenotype Associations)", "abnormal circulating lipid level (MP:0003949 from MPO Gene-Phenotype Associations)", "abnormal lipid homeostasis (MP:0002118 from MPO Gene-Phenotype Associations)", "abnormal lipid level (MP:0001547 from MPO Gene-Phenotype Associations)", "abnormal circulating lipoprotein level (MP:0010330 from MPO Gene-Phenotype Associations)", "abnormal lipoprotein level (MP:0010329 from MPO Gene-Phenotype Associations)", "abnormal circulating hdl cholesterol level (MP:0000184 from MPO Gene-Phenotype Associations)", "decreased circulating hdl cholesterol level (MP:0000186 from MPO Gene-Phenotype Associations)", "decreased cholesterol level (MP:0003983 from MPO Gene-Phenotype Associations)", "decreased sterol level (MP:0012225 from MPO Gene-Phenotype Associations)", "decreased circulating cholesterol level (MP:0005179 from MPO Gene-Phenotype Associations)", "abnormal circulating non-hdl cholesterol level (MP:0020151 from MPO Gene-Phenotype Associations)", "abnormal circulating ldl cholesterol level (MP:0000181 from MPO Gene-Phenotype Associations)", "decreased circulating ldl cholesterol level (MP:0000183 from MPO Gene-Phenotype Associations)", "increased circulating hdl cholesterol level (MP:0001556 from MPO Gene-Phenotype Associations)", "abnormal circulating vldl cholesterol level (MP:0005144 from MPO Gene-Phenotype Associations)", "decreased circulating vldl cholesterol level (MP:0005146 from MPO Gene-Phenotype Associations)", "abnormal circulating triglyceride level (MP:0011969 from MPO Gene-Phenotype Associations)", "abnormal triglyceride level (MP:0000187 from MPO Gene-Phenotype Associations)", "decreased circulating triglyceride level (MP:0002644 from MPO Gene-Phenotype Associations)", "decreased triglyceride level (MP:0005318 from MPO Gene-Phenotype Associations)", "increased circulating triglyceride level (MP:0001552 from MPO Gene-Phenotype Associations)", "increased triglyceride level (MP:0005317 from MPO Gene-Phenotype Associations)", "abnormal liver triglyceride level (MP:0012778 from MPO Gene-Phenotype Associations)", "increased liver triglyceride level (MP:0009355 from MPO Gene-Phenotype Associations)", "decreased liver triglyceride level (MP:0009356 from MPO Gene-Phenotype Associations)", "increased circulating vldl cholesterol level (MP:0005145 from MPO Gene-Phenotype Associations)", "increased circulating ldl cholesterol level (MP:0000182 from MPO Gene-Phenotype Associations)", "abnormal circulating free fatty acids level (MP:0001553 from MPO Gene-Phenotype Associations)", "abnormal free fatty acids level (MP:0010358 from MPO Gene-Phenotype Associations)", "abnormal fatty acid level (MP:0005280 from MPO Gene-Phenotype Associations)", "decreased circulating free fatty acid level (MP:0002702 from MPO Gene-Phenotype Associations)", "decreased fatty acid level (MP:0005282 from MPO Gene-Phenotype Associations)", "increased circulating free fatty acid level (MP:0001554 from MPO Gene-Phenotype Associations)", "increased fatty acid level (MP:0005281 from MPO Gene-Phenotype Associations)", "abnormal hepatobiliary system morphology (MP:0002138 from MPO Gene-Phenotype Associations)", "abnormal liver morphology (MP:0000598 from MPO Gene-Phenotype Associations)", "liver|biliary system phenotype (MP:0005370 from MPO Gene-Phenotype Associations)", "hepatic steatosis (MP:0002628 from MPO Gene-Phenotype Associations)", "abnormal liver weight (MP:0004847 from MPO Gene-Phenotype Associations)", "increased liver weight (MP:0002981 from MPO Gene-Phenotype Associations)", "enlarged liver (MP:0000599 from MPO Gene-Phenotype Associations)", "abnormal liver size (MP:0004848 from MPO Gene-Phenotype Associations)", "small liver (MP:0000601 from MPO Gene-Phenotype Associations)", "decreased liver weight (MP:0003402 from MPO Gene-Phenotype Associations)", "increased epididymal fat pad weight (MP:0009288 from MPO Gene-Phenotype Associations)", "increased interscapular fat pad weight (MP:0009294 from MPO Gene-Phenotype Associations)", "increased white adipose tissue amount (MP:0000008 from MPO Gene-Phenotype Associations)", "increased fat cell size (MP:0006094 from MPO Gene-Phenotype Associations)", "increased white fat cell size (MP:0009118 from MPO Gene-Phenotype Associations)", "increased percent body fat (MP:0005458 from MPO Gene-Phenotype Associations)", "increased total body fat amount (MP:0010024 from MPO Gene-Phenotype Associations)", "increased body size (MP:0001264 from MPO Gene-Phenotype Associations)", "increased body weight (MP:0001260 from MPO Gene-Phenotype Associations)", "increased total tissue mass (MP:0012323 from MPO Gene-Phenotype Associations)", "obese (MP:0001261 from MPO Gene-Phenotype Associations)", "increased susceptibility to weight gain (MP:0005455 from MPO Gene-Phenotype Associations)", "decreased energy expenditure (MP:0004890 from MPO Gene-Phenotype Associations)", "increased susceptibility to diet-induced obesity (MP:0005658 from MPO Gene-Phenotype Associations)", "increased circulating insulin level (MP:0002079 from MPO Gene-Phenotype Associations)", "insulin resistance (MP:0005331 from MPO Gene-Phenotype Associations)", "abnormal circulating leptin level (MP:0005667 from MPO Gene-Phenotype Associations)", "increased circulating leptin level (MP:0005669 from MPO Gene-Phenotype Associations)", "increased body length (MP:0001257 from MPO Gene-Phenotype Associations)", "abnormal consumption behavior (MP:0002069 from MPO Gene-Phenotype Associations)", "abnormal eating behavior (MP:0001431 from MPO Gene-Phenotype Associations)", "abnormal food intake (MP:0005449 from MPO Gene-Phenotype Associations)", "increased food intake (MP:0011939 from MPO Gene-Phenotype Associations)", "polyphagia (MP:0001433 from MPO Gene-Phenotype Associations)", "absent gastric milk in neonates (MP:0009546 from MPO Gene-Phenotype Associations)", "aphagia (MP:0001438 from MPO Gene-Phenotype Associations)", "abnormal endocrine pancreas morphology (MP:0009165 from MPO Gene-Phenotype Associations)", "abnormal pancreatic islet morphology (MP:0005215 from MPO Gene-Phenotype Associations)", "abnormal pancreas morphology (MP:0001944 from MPO Gene-Phenotype Associations)", "abnormal pancreatic beta cell morphology (MP:0005217 from MPO Gene-Phenotype Associations)", "abnormal pancreatic islet size (MP:0009170 from MPO Gene-Phenotype Associations)", "small pancreatic islets (MP:0009172 from MPO Gene-Phenotype Associations)", "enlarged pancreatic islets (MP:0009171 from MPO Gene-Phenotype Associations)", "pancreatic islet hyperplasia (MP:0005491 from MPO Gene-Phenotype Associations)", "abnormal endocrine pancreas physiology (MP:0010147 from MPO Gene-Phenotype Associations)", "abnormal pancreatic beta cell physiology (MP:0003562 from MPO Gene-Phenotype Associations)", "abnormal pancreas secretion (MP:0002694 from MPO Gene-Phenotype Associations)", "abnormal insulin secretion (MP:0003564 from MPO Gene-Phenotype Associations)", "decreased insulin secretion (MP:0003059 from MPO Gene-Phenotype Associations)", "abnormal pancreas physiology (MP:0002693 from MPO Gene-Phenotype Associations)", "abnormal gland physiology (MP:0002164 from MPO Gene-Phenotype Associations)", "increased insulin secretion (MP:0003058 from MPO Gene-Phenotype Associations)", "abnormal circulating glucose level (MP:0000188 from MPO Gene-Phenotype Associations)", "abnormal glucose homeostasis (MP:0002078 from MPO Gene-Phenotype Associations)", "decreased circulating glucose level (MP:0005560 from MPO Gene-Phenotype Associations)", "abnormal circulating insulin level (MP:0001560 from MPO Gene-Phenotype Associations)", "decreased circulating insulin level (MP:0002727 from MPO Gene-Phenotype Associations)", "abnormal circulating hormone level (MP:0005418 from MPO Gene-Phenotype Associations)", "abnormal hormone level (MP:0003953 from MPO Gene-Phenotype Associations)", "abnormal glucose tolerance (MP:0005291 from MPO Gene-Phenotype Associations)", "impaired glucose tolerance (MP:0005293 from MPO Gene-Phenotype Associations)", "improved glucose tolerance (MP:0005292 from MPO Gene-Phenotype Associations)", "increased insulin sensitivity (MP:0002891 from MPO Gene-Phenotype Associations)", "increased circulating glucose level (MP:0005559 from MPO Gene-Phenotype Associations)", "hyperglycemia (MP:0001559 from MPO Gene-Phenotype Associations)", "abnormal pancreatic beta cell mass (MP:0009112 from MPO Gene-Phenotype Associations)", "decreased pancreatic beta cell mass (MP:0009114 from MPO Gene-Phenotype Associations)", "increased pancreatic beta cell mass (MP:0009113 from MPO Gene-Phenotype Associations)", "abnormal pancreatic islet cell apoptosis (MP:0009488 from MPO Gene-Phenotype Associations)", "increased pancreatic beta cell number (MP:0003645 from MPO Gene-Phenotype Associations)", "hypoglycemia (MP:0000189 from MPO Gene-Phenotype Associations)", "abnormal gluconeogenesis (MP:0003383 from MPO Gene-Phenotype Associations)", "abnormal body temperature (MP:0005535 from MPO Gene-Phenotype Associations)", "decreased body temperature (MP:0005534 from MPO Gene-Phenotype Associations)", "decreased core body temperature (MP:0011014 from MPO Gene-Phenotype Associations)", "abnormal adaptive thermogenesis (MP:0011019 from MPO Gene-Phenotype Associations)", "impaired adaptive thermogenesis (MP:0011049 from MPO Gene-Phenotype Associations)", "abnormal retroperitoneal fat pad morphology (MP:0005337 from MPO Gene-Phenotype Associations)", "decreased retroperitoneal fat pad weight (MP:0009305 from MPO Gene-Phenotype Associations)", "abnormal inguinal fat pad morphology (MP:0005336 from MPO Gene-Phenotype Associations)", "decreased inguinal fat pad weight (MP:0009293 from MPO Gene-Phenotype Associations)", "abnormal interscapular fat pad morphology (MP:0006320 from MPO Gene-Phenotype Associations)", "decreased interscapular fat pad weight (MP:0009295 from MPO Gene-Phenotype Associations)", "abnormal gonadal fat pad morphology (MP:0005335 from MPO Gene-Phenotype Associations)", "decreased gonadal fat pad weight (MP:0009283 from MPO Gene-Phenotype Associations)", "abnormal mesenteric fat pad morphology (MP:0008903 from MPO Gene-Phenotype Associations)", "decreased mesenteric fat pad weight (MP:0009299 from MPO Gene-Phenotype Associations)", "abnormal white fat cell number (MP:0009129 from MPO Gene-Phenotype Associations)", "decreased white fat cell number (MP:0009131 from MPO Gene-Phenotype Associations)", "abnormal adipose tissue development (MP:0011167 from MPO Gene-Phenotype Associations)", "decreased oxygen consumption (MP:0005290 from MPO Gene-Phenotype Associations)", "decreased carbon dioxide production (MP:0008964 from MPO Gene-Phenotype Associations)", "abnormal fat cell differentiation (MP:0011168 from MPO Gene-Phenotype Associations)", "abnormal white fat cell differentation (MP:0011169 from MPO Gene-Phenotype Associations)", "increased subcutaneous adipose tissue amount (MP:0010934 from MPO Gene-Phenotype Associations)", "abnormal circulating glycerol level (MP:0011973 from MPO Gene-Phenotype Associations)", "abnormal glycerol level (MP:0003439 from MPO Gene-Phenotype Associations)", "decreased circulating glycerol level (MP:0003442 from MPO Gene-Phenotype Associations)", "decreased glycerol level (MP:0003440 from MPO Gene-Phenotype Associations)", "increased circulating glycerol level (MP:0003443 from MPO Gene-Phenotype Associations)", "increased glycerol level (MP:0003441 from MPO Gene-Phenotype Associations)", "abnormal lipolysis (MP:0008032 from MPO Gene-Phenotype Associations)", "enhanced lipolysis (MP:0008034 from MPO Gene-Phenotype Associations)", "impaired lipolysis (MP:0008033 from MPO Gene-Phenotype Associations)", "increased white fat cell lipid droplet size (MP:0009121 from MPO Gene-Phenotype Associations)", "hyperlipidemia (MP:0001548 from MPO Gene-Phenotype Associations)", "abnormal compensatory feeding amount (MP:0011956 from MPO Gene-Phenotype Associations)", "decreased compensatory feeding amount (MP:0011957 from MPO Gene-Phenotype Associations)", "decreased food intake (MP:0011940 from MPO Gene-Phenotype Associations)", "increased compensatory feeding amount (MP:0011958 from MPO Gene-Phenotype Associations)", "abnormal brown fat cell size (MP:0009135 from MPO Gene-Phenotype Associations)", "decreased brown fat cell size (MP:0009136 from MPO Gene-Phenotype Associations)", "abnormal brown fat cell number (MP:0009126 from MPO Gene-Phenotype Associations)", "decreased brown fat cell number (MP:0009128 from MPO Gene-Phenotype Associations)", "increased brown fat cell number (MP:0009127 from MPO Gene-Phenotype Associations)", "decreased susceptibility to hyperlipidemia (MP:0002323 from MPO Gene-Phenotype Associations)", "abnormal functional residual capacity (MP:0002306 from MPO Gene-Phenotype Associations)", "increased omental fat pad weight (MP:0010045 from MPO Gene-Phenotype Associations)", "decreased urine albumin level (MP:0005540 from MPO Gene-Phenotype Associations)", "increased creatinine clearance (MP:0005557 from MPO Gene-Phenotype Associations)", "periinsulitis (MP:0005580 from MPO Gene-Phenotype Associations)", "degranulated pancreatic beta cells (MP:0009255 from MPO Gene-Phenotype Associations)", "skeletal muscle hypotrophy (MP:0009462 from MPO Gene-Phenotype Associations)", "abnormal glycosylated hemoglobin level (MP:0006351 from MPO Gene-Phenotype Associations)", "increased glycosylated hemoglobin level (MP:0006353 from MPO Gene-Phenotype Associations)", "abnormal urine glucose level (MP:0001758 from MPO Gene-Phenotype Associations)", "increased urine glucose level (MP:0001759 from MPO Gene-Phenotype Associations)", "abnormal omental fat pad morphology (MP:0010044 from MPO Gene-Phenotype Associations)", "decreased omental fat pad weight (MP:0010046 from MPO Gene-Phenotype Associations)", "decreased renal fat pad weight (MP:0009303 from MPO Gene-Phenotype Associations)", "abnormal glucokinase activity (MP:0011604 from MPO Gene-Phenotype Associations)", "decreased glucokinase activity (MP:0011606 from MPO Gene-Phenotype Associations)", "abnormal glycogen homeostasis (MP:0005438 from MPO Gene-Phenotype Associations)", "abnormal glycogen level (MP:0005437 from MPO Gene-Phenotype Associations)", "decreased glycogen level (MP:0005439 from MPO Gene-Phenotype Associations)", "abnormal liver glycogen level (MP:0012777 from MPO Gene-Phenotype Associations)", "decreased liver glycogen level (MP:0010398 from MPO Gene-Phenotype Associations)", "increased glycogen level (MP:0005440 from MPO Gene-Phenotype Associations)", "increased liver glycogen level (MP:0010400 from MPO Gene-Phenotype Associations)", "increased skeletal muscle glycogen level (MP:0010401 from MPO Gene-Phenotype Associations)", "decreased skeletal muscle glycogen level (MP:0010399 from MPO Gene-Phenotype Associations)", "abnormal glycogen catabolism (MP:0002713 from MPO Gene-Phenotype Associations)", "decreased glycogen catabolism rate (MP:0002715 from MPO Gene-Phenotype Associations)", "increased glycogen catabolism rate (MP:0002714 from MPO Gene-Phenotype Associations)", "pancreas hyperplasia (MP:0009110 from MPO Gene-Phenotype Associations)", "abnormal alpha-fetoprotein level (MP:0012600 from MPO Gene-Phenotype Associations)", "increased alpha-fetoprotein level (MP:0012602 from MPO Gene-Phenotype Associations)", "decreased hepatocyte apoptosis (MP:0008891 from MPO Gene-Phenotype Associations)", "liver failure (MP:0003326 from MPO Gene-Phenotype Associations)", "abnormal liver lobule morphology (MP:0008987 from MPO Gene-Phenotype Associations)", "abnormal liver parenchyma morphology (MP:0008986 from MPO Gene-Phenotype Associations)", "abnormal hepatocyte morphology (MP:0000607 from MPO Gene-Phenotype Associations)", "abnormal kupffer cell morphology (MP:0008114 from MPO Gene-Phenotype Associations)", "abnormal liver sinusoid morphology (MP:0008989 from MPO Gene-Phenotype Associations)", "abnormal liver vasculature morphology (MP:0009820 from MPO Gene-Phenotype Associations)", "enlarged liver sinusoidal spaces (MP:0000602 from MPO Gene-Phenotype Associations)", "decreased hepatocyte number (MP:0000606 from MPO Gene-Phenotype Associations)", "focal hepatic necrosis (MP:0001656 from MPO Gene-Phenotype Associations)", "hepatic necrosis (MP:0001654 from MPO Gene-Phenotype Associations)", "liver degeneration (MP:0003103 from MPO Gene-Phenotype Associations)", "abnormal hepatobiliary system physiology (MP:0002139 from MPO Gene-Phenotype Associations)", "abnormal liver physiology (MP:0000609 from MPO Gene-Phenotype Associations)", "liver inflammation (MP:0001860 from MPO Gene-Phenotype Associations)", "abnormal hepatocyte physiology (MP:0010080 from MPO Gene-Phenotype Associations)", "increased hepatocyte apoptosis (MP:0003887 from MPO Gene-Phenotype Associations)", "decreased hepatocyte proliferation (MP:0004001 from MPO Gene-Phenotype Associations)", "abnormal liver regeneration (MP:0002658 from MPO Gene-Phenotype Associations)", "decreased liver regeneration (MP:0005517 from MPO Gene-Phenotype Associations)", "abnormal circulating protein level (MP:0005416 from MPO Gene-Phenotype Associations)", "abnormal protein level (MP:0008469 from MPO Gene-Phenotype Associations)", "abnormal circulating enzyme level (MP:0001570 from MPO Gene-Phenotype Associations)", "abnormal enzyme| coenzyme level (MP:0005319 from MPO Gene-Phenotype Associations)", "abnormal circulating alkaline phosphatase level (MP:0000202 from MPO Gene-Phenotype Associations)", "increased circulating alkaline phosphatase level (MP:0002968 from MPO Gene-Phenotype Associations)", "abnormal circulating alanine transaminase level (MP:0001573 from MPO Gene-Phenotype Associations)", "increased circulating alanine transaminase level (MP:0002941 from MPO Gene-Phenotype Associations)", "abnormal circulating aspartate transaminase level (MP:0000203 from MPO Gene-Phenotype Associations)", "increased circulating aspartate transaminase level (MP:0005343 from MPO Gene-Phenotype Associations)", "decreased circulating alkaline phosphatase level (MP:0002966 from MPO Gene-Phenotype Associations)", "decreased circulating alanine transaminase level (MP:0002942 from MPO Gene-Phenotype Associations)", "decreased circulating aspartate transaminase level (MP:0005632 from MPO Gene-Phenotype Associations)", "abnormal circulating amylase level (MP:0008804 from MPO Gene-Phenotype Associations)", "decreased circulating amylase level (MP:0008805 from MPO Gene-Phenotype Associations)", "increased circulating amylase level (MP:0008806 from MPO Gene-Phenotype Associations)", "abnormal circulating total protein level (MP:0011888 from MPO Gene-Phenotype Associations)", "decreased circulating total protein level (MP:0005567 from MPO Gene-Phenotype Associations)", "abnormal circulating serum albumin level (MP:0000199 from MPO Gene-Phenotype Associations)", "decreased circulating serum albumin level (MP:0005419 from MPO Gene-Phenotype Associations)", "increased circulating total protein level (MP:0005568 from MPO Gene-Phenotype Associations)", "increased circulating serum albumin level (MP:0002965 from MPO Gene-Phenotype Associations)", "abnormal circulating fructosamine level (MP:0010086 from MPO Gene-Phenotype Associations)", "decreased circulating fructosamine level (MP:0010088 from MPO Gene-Phenotype Associations)", "increased circulating fructosamine level (MP:0010087 from MPO Gene-Phenotype Associations)", "decreased circulating creatine kinase level (MP:0010091 from MPO Gene-Phenotype Associations)", "decreased creatine kinase level (MP:0020281 from MPO Gene-Phenotype Associations)", "absent photoreceptor outer segment (MP:0008585 from MPO Gene-Phenotype Associations)", "absent photoreceptor inner segment (MP:0008583 from MPO Gene-Phenotype Associations)", "cerebral cortex pyramidal cell degeneration (MP:0010013 from MPO Gene-Phenotype Associations)", "abnormal bone marrow morphology (MP:0002397 from MPO Gene-Phenotype Associations)", "myelofibrosis (MP:0011747 from MPO Gene-Phenotype Associations)", "abnormal tooth eruption (MP:0000119 from MPO Gene-Phenotype Associations)", "failure of tooth eruption (MP:0000121 from MPO Gene-Phenotype Associations)", "increased bone mass (MP:0005605 from MPO Gene-Phenotype Associations)", "osteopetrosis (MP:0000067 from MPO Gene-Phenotype Associations)", "increased bone trabecula number (MP:0010868 from MPO Gene-Phenotype Associations)", "increased bone volume (MP:0010875 from MPO Gene-Phenotype Associations)", "increased trabecular bone volume (MP:0010878 from MPO Gene-Phenotype Associations)", "abnormal bone resorption (MP:0004945 from MPO Gene-Phenotype Associations)", "decreased bone resorption (MP:0004993 from MPO Gene-Phenotype Associations)", "abnormal trabecular bone morphology (MP:0000130 from MPO Gene-Phenotype Associations)", "abnormal compact bone morphology (MP:0003797 from MPO Gene-Phenotype Associations)", "abnormal compact bone thickness (MP:0000134 from MPO Gene-Phenotype Associations)", "decreased compact bone thickness (MP:0000135 from MPO Gene-Phenotype Associations)", "abnormal bone trabecula morphology (MP:0010867 from MPO Gene-Phenotype Associations)", "decreased bone trabecula number (MP:0010869 from MPO Gene-Phenotype Associations)", "abnormal bone volume (MP:0010874 from MPO Gene-Phenotype Associations)", "abnormal trabecular bone volume (MP:0010877 from MPO Gene-Phenotype Associations)", "decreased bone volume (MP:0010876 from MPO Gene-Phenotype Associations)", "decreased trabecular bone volume (MP:0010879 from MPO Gene-Phenotype Associations)", "abnormal bone remodeling (MP:0002998 from MPO Gene-Phenotype Associations)", "abnormal osteoclast physiology (MP:0001541 from MPO Gene-Phenotype Associations)", "abnormal osteoblast physiology (MP:0005006 from MPO Gene-Phenotype Associations)", "abnormal trabecular bone thickness (MP:0009345 from MPO Gene-Phenotype Associations)", "increased trabecular bone thickness (MP:0009347 from MPO Gene-Phenotype Associations)", "decreased trabecular bone thickness (MP:0009346 from MPO Gene-Phenotype Associations)", "abnormal professional antigen presenting cell morphology (MP:0008195 from MPO Gene-Phenotype Associations)", "abnormal macrophage morphology (MP:0002446 from MPO Gene-Phenotype Associations)", "abnormal mononuclear phagocyte morphology (MP:0008248 from MPO Gene-Phenotype Associations)", "abnormal phagocyte morphology (MP:0008251 from MPO Gene-Phenotype Associations)", "abnormal myeloid leukocyte morphology (MP:0008250 from MPO Gene-Phenotype Associations)", "abnormal macrophage cell number (MP:0020202 from MPO Gene-Phenotype Associations)", "increased macrophage cell number (MP:0005425 from MPO Gene-Phenotype Associations)", "abnormal osteoclast cell number (MP:0004983 from MPO Gene-Phenotype Associations)", "abnormal osteoclast morphology (MP:0004982 from MPO Gene-Phenotype Associations)", "increased osteoclast cell number (MP:0004984 from MPO Gene-Phenotype Associations)", "abnormal osteoclast differentiation (MP:0008396 from MPO Gene-Phenotype Associations)", "decreased macrophage cell number (MP:0003884 from MPO Gene-Phenotype Associations)", "decreased osteoclast cell number (MP:0004985 from MPO Gene-Phenotype Associations)", "abnormal osteoblast cell number (MP:0004987 from MPO Gene-Phenotype Associations)", "decreased osteoblast cell number (MP:0004989 from MPO Gene-Phenotype Associations)", "abnormal osteoblast morphology (MP:0004986 from MPO Gene-Phenotype Associations)", "increased osteoblast cell number (MP:0004988 from MPO Gene-Phenotype Associations)", "abnormal osteoblast differentiation (MP:0008395 from MPO Gene-Phenotype Associations)", "decreased bone mass (MP:0004016 from MPO Gene-Phenotype Associations)", "osteoporosis (MP:0000066 from MPO Gene-Phenotype Associations)", "increased bone resorption (MP:0004992 from MPO Gene-Phenotype Associations)", "abnormal bone marrow cavity morphology (MP:0000065 from MPO Gene-Phenotype Associations)", "altered susceptibility to osteoporosis (MP:0012070 from MPO Gene-Phenotype Associations)", "decreased susceptibility to osteoporosis (MP:0012072 from MPO Gene-Phenotype Associations)", "osteosclerosis (MP:0005422 from MPO Gene-Phenotype Associations)", "increased compact bone thickness (MP:0004148 from MPO Gene-Phenotype Associations)", "abnormal bone mineral content (MP:0010122 from MPO Gene-Phenotype Associations)", "decreased bone mineral content (MP:0010124 from MPO Gene-Phenotype Associations)", "abnormal bone mineral density (MP:0010119 from MPO Gene-Phenotype Associations)", "decreased bone mineral density (MP:0000063 from MPO Gene-Phenotype Associations)", "abnormal bone structure (MP:0003795 from MPO Gene-Phenotype Associations)", "abnormal lean body mass (MP:0003959 from MPO Gene-Phenotype Associations)", "decreased lean body mass (MP:0003961 from MPO Gene-Phenotype Associations)", "increased lean body mass (MP:0003960 from MPO Gene-Phenotype Associations)", "increased bone mineral content (MP:0010123 from MPO Gene-Phenotype Associations)", "increased bone mineral density (MP:0000062 from MPO Gene-Phenotype Associations)", "abnormal body length (MP:0001256 from MPO Gene-Phenotype Associations)", "decreased body length (MP:0001258 from MPO Gene-Phenotype Associations)", "abnormal osteocyte morphology (MP:0008753 from MPO Gene-Phenotype Associations)", "abnormal compact bone lamellar structure (MP:0010970 from MPO Gene-Phenotype Associations)", "failure of secondary bone resorption (MP:0000064 from MPO Gene-Phenotype Associations)", "abnormal bone strength (MP:0001542 from MPO Gene-Phenotype Associations)", "fragile skeleton (MP:0000061 from MPO Gene-Phenotype Associations)", "decreased bone strength (MP:0004991 from MPO Gene-Phenotype Associations)", "abnormal compact bone mass (MP:0010960 from MPO Gene-Phenotype Associations)", "decreased compact bone mass (MP:0010962 from MPO Gene-Phenotype Associations)", "decreased trabecular bone mass (MP:0010873 from MPO Gene-Phenotype Associations)", "abnormal trabecular bone mass (MP:0010871 from MPO Gene-Phenotype Associations)", "increased trabecular bone mass (MP:0010872 from MPO Gene-Phenotype Associations)", "abnormal bronchial cartilage morphology (MP:0010988 from MPO Gene-Phenotype Associations)", "pulmonary arteriovenous malformation (MP:0010480 from MPO Gene-Phenotype Associations)", "calcified aortic valve (MP:0006116 from MPO Gene-Phenotype Associations)", "abnormal circulating osteocalcin level (MP:0011922 from MPO Gene-Phenotype Associations)", "enhanced osteoblast differentiation (MP:0011710 from MPO Gene-Phenotype Associations)", "abnormal long bone metaphysis morphology (MP:0000133 from MPO Gene-Phenotype Associations)", "abnormal long bone epiphysis morphology (MP:0000131 from MPO Gene-Phenotype Associations)", "thickened long bone epiphysis (MP:0000132 from MPO Gene-Phenotype Associations)", "abnormal osteoid morphology (MP:0010924 from MPO Gene-Phenotype Associations)", "abnormal osteoid thickness (MP:0010928 from MPO Gene-Phenotype Associations)", "increased osteoid thickness (MP:0010929 from MPO Gene-Phenotype Associations)", "abnormal osteoid volume (MP:0010925 from MPO Gene-Phenotype Associations)", "increased osteoid volume (MP:0010926 from MPO Gene-Phenotype Associations)", "decreased osteoid volume (MP:0010927 from MPO Gene-Phenotype Associations)", "decreased osteoid thickness (MP:0010930 from MPO Gene-Phenotype Associations)", "abnormal fibrocartilage morphology (MP:0006431 from MPO Gene-Phenotype Associations)", "abnormal intestinal calcium absorption (MP:0011219 from MPO Gene-Phenotype Associations)", "decreased intestinal calcium absorption (MP:0011221 from MPO Gene-Phenotype Associations)", "rickets (MP:0003116 from MPO Gene-Phenotype Associations)", "abnormal intestinal mineral absorption (MP:0001670 from MPO Gene-Phenotype Associations)", "osteomalacia (MP:0009445 from MPO Gene-Phenotype Associations)", "abnormal renal phosphate reabsorbtion (MP:0010110 from MPO Gene-Phenotype Associations)", "enlarged parathyroid gland (MP:0003112 from MPO Gene-Phenotype Associations)", "pigmented parathyroid gland (MP:0003114 from MPO Gene-Phenotype Associations)", "decreased urine phosphate level (MP:0002902 from MPO Gene-Phenotype Associations)", "decreased urine calcium level (MP:0002986 from MPO Gene-Phenotype Associations)", "abnormal calcium ion homeostasis (MP:0004231 from MPO Gene-Phenotype Associations)", "abnormal circulating calcium level (MP:0001562 from MPO Gene-Phenotype Associations)", "increased circulating calcium level (MP:0000194 from MPO Gene-Phenotype Associations)", "abnormal circulating mineral level (MP:0006357 from MPO Gene-Phenotype Associations)", "abnormal mineral homeostasis (MP:0005636 from MPO Gene-Phenotype Associations)", "abnormal mineral level (MP:0000192 from MPO Gene-Phenotype Associations)", "abnormal ion homeostasis (MP:0001765 from MPO Gene-Phenotype Associations)", "decreased circulating calcium level (MP:0000195 from MPO Gene-Phenotype Associations)", "abnormal circulating phosphate level (MP:0001565 from MPO Gene-Phenotype Associations)", "increased circulating phosphate level (MP:0001566 from MPO Gene-Phenotype Associations)", "abnormal circulating parathyroid hormone level (MP:0002903 from MPO Gene-Phenotype Associations)", "increased circulating parathyroid hormone level (MP:0002904 from MPO Gene-Phenotype Associations)", "decreased circulating parathyroid hormone level (MP:0002905 from MPO Gene-Phenotype Associations)", "abnormal urine phosphate level (MP:0002900 from MPO Gene-Phenotype Associations)", "increased urine phosphate level (MP:0002901 from MPO Gene-Phenotype Associations)", "decreased circulating phosphate level (MP:0000198 from MPO Gene-Phenotype Associations)", "abnormal urine calcium level (MP:0002985 from MPO Gene-Phenotype Associations)", "increased urine calcium level (MP:0005441 from MPO Gene-Phenotype Associations)", "abnormal fat-soluble vitamin level (MP:0005401 from MPO Gene-Phenotype Associations)", "abnormal vitamin homeostasis (MP:0004019 from MPO Gene-Phenotype Associations)", "abnormal vitamin level (MP:0005400 from MPO Gene-Phenotype Associations)", "abnormal vitamin d level (MP:0011228 from MPO Gene-Phenotype Associations)", "abnormal retinol level (MP:0011234 from MPO Gene-Phenotype Associations)", "abnormal vitamin a level (MP:0011232 from MPO Gene-Phenotype Associations)", "abnormal retinol metabolism (MP:0005444 from MPO Gene-Phenotype Associations)", "abnormal vitamin a metabolism (MP:0011233 from MPO Gene-Phenotype Associations)", "abnormal vitamin metabolism (MP:0013244 from MPO Gene-Phenotype Associations)", "abnormal vitamin or vitamin cofactor metabolism (MP:0013274 from MPO Gene-Phenotype Associations)", "abnormal ethanol metabolism (MP:0005443 from MPO Gene-Phenotype Associations)", "delayed dark adaptation (MP:0003011 from MPO Gene-Phenotype Associations)", "abnormal trabecular bone connectivity density (MP:0010931 from MPO Gene-Phenotype Associations)", "decreased trabecular bone connectivity density (MP:0010933 from MPO Gene-Phenotype Associations)", "decreased vitamin d level (MP:0012336 from MPO Gene-Phenotype Associations)", "biliary cirrhosis (MP:0003256 from MPO Gene-Phenotype Associations)", "abnormal portal lobule morphology (MP:0008992 from MPO Gene-Phenotype Associations)", "abnormal portal triad morphology (MP:0008993 from MPO Gene-Phenotype Associations)", "abnormal bile canaliculus morphology (MP:0008991 from MPO Gene-Phenotype Associations)", "cholestasis (MP:0000610 from MPO Gene-Phenotype Associations)", "intrahepatic cholestasis (MP:0005415 from MPO Gene-Phenotype Associations)", "abnormal compact bone volume (MP:0010963 from MPO Gene-Phenotype Associations)", "increased compact bone volume (MP:0010964 from MPO Gene-Phenotype Associations)", "decreased compact bone volume (MP:0010965 from MPO Gene-Phenotype Associations)", "increased liver regeneration (MP:0005516 from MPO Gene-Phenotype Associations)", "abnormal alkaline phosphatase activity (MP:0011583 from MPO Gene-Phenotype Associations)", "increased alkaline phosphatase activity (MP:0011584 from MPO Gene-Phenotype Associations)", "abnormal liver cholesterol level (MP:0012776 from MPO Gene-Phenotype Associations)", "increased liver cholesterol level (MP:0010027 from MPO Gene-Phenotype Associations)", "decreased liver cholesterol level (MP:0010026 from MPO Gene-Phenotype Associations)", "abnormal bile salt homeostasis (MP:0005365 from MPO Gene-Phenotype Associations)", "abnormal bile salt level (MP:0004774 from MPO Gene-Phenotype Associations)", "increased bile salt level (MP:0004789 from MPO Gene-Phenotype Associations)", "abnormal bile composition (MP:0004773 from MPO Gene-Phenotype Associations)", "abnormal gallbladder physiology (MP:0005085 from MPO Gene-Phenotype Associations)", "abnormal bile secretion (MP:0004772 from MPO Gene-Phenotype Associations)", "abnormal bile duct physiology (MP:0003252 from MPO Gene-Phenotype Associations)", "abnormal ito cell morphology (MP:0008990 from MPO Gene-Phenotype Associations)", "abnormal liver perisinusoidal space morphology (MP:0008988 from MPO Gene-Phenotype Associations)", "decreased circulating vldl triglyceride level (MP:0003976 from MPO Gene-Phenotype Associations)", "abnormal gallbladder epithelium morphology (MP:0009492 from MPO Gene-Phenotype Associations)", "enlarged gallbladder (MP:0009342 from MPO Gene-Phenotype Associations)", "increased body temperature (MP:0005533 from MPO Gene-Phenotype Associations)", "increased core body temperature (MP:0011016 from MPO Gene-Phenotype Associations)", "hyperdipsia (MP:0005111 from MPO Gene-Phenotype Associations)", "oily skin (MP:0001197 from MPO Gene-Phenotype Associations)", "abnormal digestion (MP:0001664 from MPO Gene-Phenotype Associations)", "abnormal intestinal absorption (MP:0001666 from MPO Gene-Phenotype Associations)", "abnormal intestinal cholesterol absorption (MP:0002645 from MPO Gene-Phenotype Associations)", "decreased intestinal cholesterol absorption (MP:0002647 from MPO Gene-Phenotype Associations)", "abnormal intestinal lipid absorption (MP:0005342 from MPO Gene-Phenotype Associations)", "abnormal feces composition (MP:0003868 from MPO Gene-Phenotype Associations)", "steatorrhea (MP:0002791 from MPO Gene-Phenotype Associations)", "ocular pterygium (MP:0003664 from MPO Gene-Phenotype Associations)", "endophthalmitis (MP:0003665 from MPO Gene-Phenotype Associations)", "decreased liver free fatty acids level (MP:0010360 from MPO Gene-Phenotype Associations)", "abnormal carbohydrate absorption (MP:0001667 from MPO Gene-Phenotype Associations)", "abnormal glucose absorption (MP:0001669 from MPO Gene-Phenotype Associations)", "increased intestinal cholesterol absorption (MP:0002646 from MPO Gene-Phenotype Associations)", "abnormal small intestinal transit time (MP:0006002 from MPO Gene-Phenotype Associations)", "gallstones (MP:0002830 from MPO Gene-Phenotype Associations)", "abnormal fructose absorption (MP:0001668 from MPO Gene-Phenotype Associations)", "abnormal cardiac cell glucose uptake (MP:0004039 from MPO Gene-Phenotype Associations)", "abnormal muscle cell glucose uptake (MP:0004130 from MPO Gene-Phenotype Associations)", "abnormal cellular glucose import (MP:0003925 from MPO Gene-Phenotype Associations)", "impaired cellular glucose import (MP:0003926 from MPO Gene-Phenotype Associations)", "abnormal prothrombin time (MP:0012354 from MPO Gene-Phenotype Associations)", "increased prothrombin time (MP:0012356 from MPO Gene-Phenotype Associations)", "abnormal circulating antithrombin level (MP:0012324 from MPO Gene-Phenotype Associations)", "decreased circulating antithrombin level (MP:0012325 from MPO Gene-Phenotype Associations)", "hematuria (MP:0005161 from MPO Gene-Phenotype Associations)", "decreased mitochondrial proliferation (MP:0006039 from MPO Gene-Phenotype Associations)", "abnormal circulating lactate level (MP:0013403 from MPO Gene-Phenotype Associations)", "decreased circulating lactate level (MP:0013404 from MPO Gene-Phenotype Associations)", "increased circulating lactate level (MP:0013405 from MPO Gene-Phenotype Associations)", "abnormal circulating ketone body level (MP:0003457 from MPO Gene-Phenotype Associations)", "increased circulating ketone body level (MP:0002575 from MPO Gene-Phenotype Associations)", "decreased circulating ketone body level (MP:0003458 from MPO Gene-Phenotype Associations)", "abnormal partial thromboplastin time (MP:0012357 from MPO Gene-Phenotype Associations)", "increased partial thromboplastin time (MP:0012359 from MPO Gene-Phenotype Associations)", "abnormal circulating factor ix level (MP:0012614 from MPO Gene-Phenotype Associations)", "decreased circulating factor ix level (MP:0012615 from MPO Gene-Phenotype Associations)", "abnormal circulating prothrombin level (MP:0012221 from MPO Gene-Phenotype Associations)", "decreased circulating prothrombin level (MP:0012222 from MPO Gene-Phenotype Associations)", "abnormal circulating factor viii level (MP:0012327 from MPO Gene-Phenotype Associations)", "decreased circulating factor viii level (MP:0012328 from MPO Gene-Phenotype Associations)", "decreased red blood cell distribution width (MP:0010068 from MPO Gene-Phenotype Associations)", "abnormal dental pulp morphology (MP:0013250 from MPO Gene-Phenotype Associations)", "dental pulp necrosis (MP:0013251 from MPO Gene-Phenotype Associations)", "decreased transforming growth factor level (MP:0008838 from MPO Gene-Phenotype Associations)", "decreased susceptibility to experimental autoimmune uveoretinitis (MP:0004822 from MPO Gene-Phenotype Associations)", "osteomyelitis (MP:0005190 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-18 level (MP:0008635 from MPO Gene-Phenotype Associations)", "increased growth rate (MP:0002865 from MPO Gene-Phenotype Associations)", "increased retroperitoneal fat pad weight (MP:0009304 from MPO Gene-Phenotype Associations)", "increased inguinal fat pad weight (MP:0009292 from MPO Gene-Phenotype Associations)", "increased gonadal fat pad weight (MP:0009285 from MPO Gene-Phenotype Associations)", "increased mesenteric fat pad weight (MP:0009298 from MPO Gene-Phenotype Associations)", "decreased kidney apoptosis (MP:0011371 from MPO Gene-Phenotype Associations)", "decreased renal tubule apoptosis (MP:0011372 from MPO Gene-Phenotype Associations)", "altered susceptibility to kidney reperfusion injury (MP:0004040 from MPO Gene-Phenotype Associations)", "decreased susceptibility to kidney reperfusion injury (MP:0004042 from MPO Gene-Phenotype Associations)", "decreased blood urea nitrogen level (MP:0005566 from MPO Gene-Phenotype Associations)", "decreased circulating creatinine level (MP:0005554 from MPO Gene-Phenotype Associations)", "elevated level of mitotic sister chromatid exchange (MP:0003701 from MPO Gene-Phenotype Associations)", "psoriasis (MP:0001193 from MPO Gene-Phenotype Associations)", "decreased circulating interleukin-1 level (MP:0008592 from MPO Gene-Phenotype Associations)", "rheumatoid arthritis (MP:0003561 from MPO Gene-Phenotype Associations)", "abnormal acute phase protein level (MP:0010211 from MPO Gene-Phenotype Associations)", "abnormal circulating serum amyloid protein level (MP:0010214 from MPO Gene-Phenotype Associations)", "abnormal uterine receptivity (MP:0009662 from MPO Gene-Phenotype Associations)", "abnormal embryo apposition (MP:0009665 from MPO Gene-Phenotype Associations)", "abnormal embryo attachment (MP:0009666 from MPO Gene-Phenotype Associations)", "increased circulating insulin-like growth factor i level (MP:0004702 from MPO Gene-Phenotype Associations)", "abnormal pilomotor reflex (MP:0001492 from MPO Gene-Phenotype Associations)", "abnormal thalamus morphology (MP:0000832 from MPO Gene-Phenotype Associations)", "abnormal lateral geniculate nucleus morphology (MP:0004165 from MPO Gene-Phenotype Associations)", "increased gamma-delta intraepithelial t cell number (MP:0008350 from MPO Gene-Phenotype Associations)", "increased interleukin-3 secretion (MP:0008696 from MPO Gene-Phenotype Associations)", "increased mature gamma-delta t cell number (MP:0008353 from MPO Gene-Phenotype Associations)", "increased gamma-delta t cell number (MP:0008346 from MPO Gene-Phenotype Associations)", "abnormal cd8-positive, alpha-beta cytotoxic t cell morphology (MP:0002436 from MPO Gene-Phenotype Associations)", "turbinate hypoplasia (MP:0004477 from MPO Gene-Phenotype Associations)", "abnormal navicular morphology (MP:0009727 from MPO Gene-Phenotype Associations)", "intervertebral disk hypoplasia (MP:0004681 from MPO Gene-Phenotype Associations)", "abnormal memory b cell physiology (MP:0008194 from MPO Gene-Phenotype Associations)", "abnormal serous gland morphology (MP:0008052 from MPO Gene-Phenotype Associations)", "small intervertebral disk (MP:0004682 from MPO Gene-Phenotype Associations)", "palate bone hypoplasia (MP:0009892 from MPO Gene-Phenotype Associations)", "absent marginal zone b cells (MP:0008183 from MPO Gene-Phenotype Associations)", "abnormal thymus development (MP:0000704 from MPO Gene-Phenotype Associations)", "absent b-1b cells (MP:0008204 from MPO Gene-Phenotype Associations)", "decreased b-1b cell number (MP:0008170 from MPO Gene-Phenotype Associations)", "abnormal plasma cell differentiation (MP:0008099 from MPO Gene-Phenotype Associations)", "abnormal splenocyte morphology (MP:0009332 from MPO Gene-Phenotype Associations)", "abnormal splenocyte number (MP:0009337 from MPO Gene-Phenotype Associations)", "decreased splenocyte number (MP:0009339 from MPO Gene-Phenotype Associations)", "increased splenocyte number (MP:0009338 from MPO Gene-Phenotype Associations)", "abnormal b-1b b cell morphology (MP:0008165 from MPO Gene-Phenotype Associations)", "increased b-1b cell number (MP:0008169 from MPO Gene-Phenotype Associations)", "increased hematopoietic stem cell proliferation (MP:0011902 from MPO Gene-Phenotype Associations)", "increased b-1 b cell number (MP:0004977 from MPO Gene-Phenotype Associations)", "increased b-1a cell number (MP:0008167 from MPO Gene-Phenotype Associations)", "decreased circulating atrial natriuretic factor (MP:0005523 from MPO Gene-Phenotype Associations)", "scaly ears (MP:0000020 from MPO Gene-Phenotype Associations)", "absent regulatory t cells (MP:0004975 from MPO Gene-Phenotype Associations)", "melena (MP:0003292 from MPO Gene-Phenotype Associations)", "crypts of lieberkuhn abscesses (MP:0000491 from MPO Gene-Phenotype Associations)", "abnormal cd4-positive, cd25-positive, alpha-beta regulatory t cell morphology (MP:0008397 from MPO Gene-Phenotype Associations)", "abnormal cd4-positive, cd25-positive, alpha-beta regulatory t cell number (MP:0012773 from MPO Gene-Phenotype Associations)", "decreased cd4-positive, cd25-positive, alpha-beta regulatory t cell number (MP:0010169 from MPO Gene-Phenotype Associations)", "abnormal hepatic cord morphology (MP:0012246 from MPO Gene-Phenotype Associations)", "abnormal lymph node t cell domain morphology (MP:0002347 from MPO Gene-Phenotype Associations)", "abnormal lymph node medulla morphology (MP:0002348 from MPO Gene-Phenotype Associations)", "abnormal lymph node medullary cord morphology (MP:0011224 from MPO Gene-Phenotype Associations)", "hemosiderosis (MP:0005639 from MPO Gene-Phenotype Associations)", "abnormal regulatory t cell morphology (MP:0004941 from MPO Gene-Phenotype Associations)", "abnormal regulatory t cell number (MP:0004972 from MPO Gene-Phenotype Associations)", "decreased regulatory t cell number (MP:0004974 from MPO Gene-Phenotype Associations)", "increased regulatory t cell number (MP:0004973 from MPO Gene-Phenotype Associations)", "abnormal regulatory t cell physiology (MP:0004946 from MPO Gene-Phenotype Associations)", "increased cd4-positive, cd25-positive, alpha-beta regulatory t cell number (MP:0010168 from MPO Gene-Phenotype Associations)", "increased dendritic cell number (MP:0008126 from MPO Gene-Phenotype Associations)", "abnormal abdominal lymph node morphology (MP:0009625 from MPO Gene-Phenotype Associations)", "abnormal mesenteric lymph node morphology (MP:0005232 from MPO Gene-Phenotype Associations)", "enlarged mesenteric lymph nodes (MP:0008466 from MPO Gene-Phenotype Associations)", "absent mesenteric lymph nodes (MP:0008465 from MPO Gene-Phenotype Associations)", "absent axillary lymph nodes (MP:0009630 from MPO Gene-Phenotype Associations)", "absent inguinal lymph nodes (MP:0009622 from MPO Gene-Phenotype Associations)", "absent cervical lymph nodes (MP:0009633 from MPO Gene-Phenotype Associations)", "abnormal brachial lymph node morphology (MP:0005231 from MPO Gene-Phenotype Associations)", "absent brachial lymph nodes (MP:0009628 from MPO Gene-Phenotype Associations)", "abnormal axillary lymph node morphology (MP:0002340 from MPO Gene-Phenotype Associations)", "abnormal inguinal lymph node morphology (MP:0002353 from MPO Gene-Phenotype Associations)", "abnormal peripheral lymph node morphology (MP:0008463 from MPO Gene-Phenotype Associations)", "abnormal popliteal lymph node morphology (MP:0002352 from MPO Gene-Phenotype Associations)", "absent popliteal lymph nodes (MP:0009634 from MPO Gene-Phenotype Associations)", "absent peripheral lymph nodes (MP:0008464 from MPO Gene-Phenotype Associations)", "absent lymph nodes (MP:0008024 from MPO Gene-Phenotype Associations)", "absent peyer's patches (MP:0002831 from MPO Gene-Phenotype Associations)", "abnormal follicular dendritic cell morphology (MP:0008196 from MPO Gene-Phenotype Associations)", "decreased follicular dendritic cell number (MP:0008200 from MPO Gene-Phenotype Associations)", "absent follicular dendritic cells (MP:0008201 from MPO Gene-Phenotype Associations)", "abnormal spleen follicular dendritic cell network (MP:0008473 from MPO Gene-Phenotype Associations)", "absent spleen marginal zone (MP:0008234 from MPO Gene-Phenotype Associations)", "intermingled spleen red and white pulp (MP:0008475 from MPO Gene-Phenotype Associations)", "abnormal cervical lymph node morphology (MP:0002351 from MPO Gene-Phenotype Associations)", "enlarged cervical lymph nodes (MP:0008542 from MPO Gene-Phenotype Associations)", "abnormal metallophilic macrophage morphology (MP:0008241 from MPO Gene-Phenotype Associations)", "abnormal spleen marginal zone macrophage morphology (MP:0008240 from MPO Gene-Phenotype Associations)", "abnormal spleen marginal sinus morphology (MP:0002363 from MPO Gene-Phenotype Associations)", "abnormal spleen primary b follicle morphology (MP:0008471 from MPO Gene-Phenotype Associations)", "abnormal spleen periarteriolar lymphoid sheath morphology (MP:0002358 from MPO Gene-Phenotype Associations)", "abnormal gut-associated lymphoid tissue morphology (MP:0002378 from MPO Gene-Phenotype Associations)", "abnormal peyer's patch morphology (MP:0000696 from MPO Gene-Phenotype Associations)", "abnormal peyer's patch number (MP:0008131 from MPO Gene-Phenotype Associations)", "decreased peyer's patch number (MP:0008133 from MPO Gene-Phenotype Associations)", "abnormal peyer's patch size (MP:0008134 from MPO Gene-Phenotype Associations)", "small peyer's patches (MP:0008135 from MPO Gene-Phenotype Associations)", "abnormal peyer's patch follicle morphology (MP:0002389 from MPO Gene-Phenotype Associations)", "abnormal peyer's patch germinal center morphology (MP:0002391 from MPO Gene-Phenotype Associations)", "abnormal peyer's patch t cell area morphology (MP:0002392 from MPO Gene-Phenotype Associations)", "abnormal lymph node b cell domain morphology (MP:0002344 from MPO Gene-Phenotype Associations)", "abnormal lymph node cortex morphology (MP:0002343 from MPO Gene-Phenotype Associations)", "abnormal lymph node secondary follicle morphology (MP:0002346 from MPO Gene-Phenotype Associations)", "abnormal lymph node germinal center morphology (MP:0008522 from MPO Gene-Phenotype Associations)", "absent lymph node germinal center (MP:0008523 from MPO Gene-Phenotype Associations)", "absent spleen germinal center (MP:0008474 from MPO Gene-Phenotype Associations)", "abnormal spleen white pulp morphology (MP:0002357 from MPO Gene-Phenotype Associations)", "abnormal spleen b cell follicle morphology (MP:0008470 from MPO Gene-Phenotype Associations)", "abnormal spleen germinal center morphology (MP:0002359 from MPO Gene-Phenotype Associations)", "abnormal spleen secondary b follicle morphology (MP:0008472 from MPO Gene-Phenotype Associations)", "decreased spleen germinal center size (MP:0008484 from MPO Gene-Phenotype Associations)", "decreased spleen germinal center number (MP:0008482 from MPO Gene-Phenotype Associations)", "abnormal lymph node morphology (MP:0002339 from MPO Gene-Phenotype Associations)", "abnormal lymph node size (MP:0000701 from MPO Gene-Phenotype Associations)", "enlarged lymph nodes (MP:0000702 from MPO Gene-Phenotype Associations)", "lymph node hyperplasia (MP:0008102 from MPO Gene-Phenotype Associations)", "spleen hyperplasia (MP:0000693 from MPO Gene-Phenotype Associations)", "abnormal lymph organ size (MP:0002221 from MPO Gene-Phenotype Associations)", "abnormal spleen size (MP:0002224 from MPO Gene-Phenotype Associations)", "abnormal immune system organ morphology (MP:0002722 from MPO Gene-Phenotype Associations)", "abnormal spleen morphology (MP:0000689 from MPO Gene-Phenotype Associations)", "enlarged spleen (MP:0000691 from MPO Gene-Phenotype Associations)", "abnormal spleen weight (MP:0004951 from MPO Gene-Phenotype Associations)", "increased spleen weight (MP:0004952 from MPO Gene-Phenotype Associations)", "extramedullary hematopoiesis (MP:0000240 from MPO Gene-Phenotype Associations)", "abnormal alpha-beta t cell morphology (MP:0012762 from MPO Gene-Phenotype Associations)", "abnormal alpha-beta t cell number (MP:0012763 from MPO Gene-Phenotype Associations)", "abnormal effector t cell morphology (MP:0002435 from MPO Gene-Phenotype Associations)", "abnormal cd4-positive, alpha beta t cell morphology (MP:0002432 from MPO Gene-Phenotype Associations)", "abnormal cd4-positive, alpha beta t cell number (MP:0008073 from MPO Gene-Phenotype Associations)", "decreased alpha-beta t cell number (MP:0012765 from MPO Gene-Phenotype Associations)", "decreased cd4-positive, alpha beta t cell number (MP:0008075 from MPO Gene-Phenotype Associations)", "abnormal cd8-positive, alpha beta t cell morphology (MP:0005010 from MPO Gene-Phenotype Associations)", "abnormal cd8-positive, alpha-beta t cell number (MP:0008077 from MPO Gene-Phenotype Associations)", "decreased cd8-positive, alpha-beta t cell number (MP:0008079 from MPO Gene-Phenotype Associations)", "increased alpha-beta t cell number (MP:0012764 from MPO Gene-Phenotype Associations)", "increased cd4-positive, alpha beta t cell number (MP:0008074 from MPO Gene-Phenotype Associations)", "increased cd8-positive, alpha-beta t cell number (MP:0008078 from MPO Gene-Phenotype Associations)", "abnormal blood cell morphology|development (MP:0002429 from MPO Gene-Phenotype Associations)", "abnormal hematopoiesis (MP:0002123 from MPO Gene-Phenotype Associations)", "abnormal hematopoietic system morphology|development (MP:0002396 from MPO Gene-Phenotype Associations)", "hematopoietic system phenotype (MP:0005397 from MPO Gene-Phenotype Associations)", "abnormal immune system cell morphology (MP:0000716 from MPO Gene-Phenotype Associations)", "abnormal leukocyte morphology (MP:0008246 from MPO Gene-Phenotype Associations)", "abnormal mononuclear cell morphology (MP:0008247 from MPO Gene-Phenotype Associations)", "abnormal immune system morphology (MP:0000685 from MPO Gene-Phenotype Associations)", "abnormal hematopoietic cell number (MP:0011180 from MPO Gene-Phenotype Associations)", "abnormal leukocyte cell number (MP:0000217 from MPO Gene-Phenotype Associations)", "abnormal lymphocyte morphology (MP:0002619 from MPO Gene-Phenotype Associations)", "abnormal lymphocyte cell number (MP:0000717 from MPO Gene-Phenotype Associations)", "abnormal t cell morphology (MP:0008037 from MPO Gene-Phenotype Associations)", "abnormal t cell number (MP:0006387 from MPO Gene-Phenotype Associations)", "decreased t cell number (MP:0005018 from MPO Gene-Phenotype Associations)", "decreased hematopoietic cell number (MP:0011182 from MPO Gene-Phenotype Associations)", "decreased leukocyte cell number (MP:0000221 from MPO Gene-Phenotype Associations)", "decreased lymphocyte cell number (MP:0005016 from MPO Gene-Phenotype Associations)", "abnormal adaptive immunity (MP:0002420 from MPO Gene-Phenotype Associations)", "abnormal cell-mediated immunity (MP:0002421 from MPO Gene-Phenotype Associations)", "abnormal immune cell physiology (MP:0001819 from MPO Gene-Phenotype Associations)", "abnormal leukocyte physiology (MP:0002442 from MPO Gene-Phenotype Associations)", "abnormal blood cell physiology (MP:0012382 from MPO Gene-Phenotype Associations)", "abnormal hematopoietic system physiology (MP:0001545 from MPO Gene-Phenotype Associations)", "abnormal lymphocyte physiology (MP:0003945 from MPO Gene-Phenotype Associations)", "abnormal professional antigen presenting cell physiology (MP:0002452 from MPO Gene-Phenotype Associations)", "abnormal immune system physiology (MP:0001790 from MPO Gene-Phenotype Associations)", "immune system phenotype (MP:0005387 from MPO Gene-Phenotype Associations)", "increased hematopoietic cell number (MP:0011181 from MPO Gene-Phenotype Associations)", "increased leukocyte cell number (MP:0000218 from MPO Gene-Phenotype Associations)", "increased lymphocyte cell number (MP:0005013 from MPO Gene-Phenotype Associations)", "increased t cell number (MP:0005015 from MPO Gene-Phenotype Associations)", "abnormal leukopoiesis (MP:0005460 from MPO Gene-Phenotype Associations)", "abnormal lymphopoiesis (MP:0002401 from MPO Gene-Phenotype Associations)", "abnormal t cell differentiation (MP:0002145 from MPO Gene-Phenotype Associations)", "abnormal t cell physiology (MP:0002444 from MPO Gene-Phenotype Associations)", "abnormal t cell activation (MP:0001828 from MPO Gene-Phenotype Associations)", "abnormal t cell proliferation (MP:0005094 from MPO Gene-Phenotype Associations)", "decreased t cell proliferation (MP:0005095 from MPO Gene-Phenotype Associations)", "abnormal cytokine secretion (MP:0003009 from MPO Gene-Phenotype Associations)", "abnormal interleukin secretion (MP:0008568 from MPO Gene-Phenotype Associations)", "abnormal immune serum protein physiology (MP:0002723 from MPO Gene-Phenotype Associations)", "abnormal interferon secretion (MP:0008555 from MPO Gene-Phenotype Associations)", "abnormal interferon-gamma secretion (MP:0008559 from MPO Gene-Phenotype Associations)", "decreased interferon-gamma secretion (MP:0008567 from MPO Gene-Phenotype Associations)", "increased interferon-gamma secretion (MP:0008566 from MPO Gene-Phenotype Associations)", "abnormal interleukin-2 secretion (MP:0008686 from MPO Gene-Phenotype Associations)", "decreased interleukin-2 secretion (MP:0008688 from MPO Gene-Phenotype Associations)", "abnormal double-positive t cell morphology (MP:0002408 from MPO Gene-Phenotype Associations)", "decreased double-positive t cell number (MP:0005092 from MPO Gene-Phenotype Associations)", "abnormal double-negative t cell morphology (MP:0002407 from MPO Gene-Phenotype Associations)", "increased double-negative t cell number (MP:0005090 from MPO Gene-Phenotype Associations)", "decreased double-negative t cell number (MP:0005089 from MPO Gene-Phenotype Associations)", "decreased thymocyte number (MP:0000715 from MPO Gene-Phenotype Associations)", "abnormal thymus morphology (MP:0000703 from MPO Gene-Phenotype Associations)", "abnormal thyroid gland morphology (MP:0000681 from MPO Gene-Phenotype Associations)", "abnormal thymus size (MP:0002364 from MPO Gene-Phenotype Associations)", "small thymus (MP:0000706 from MPO Gene-Phenotype Associations)", "thymus hypoplasia (MP:0001823 from MPO Gene-Phenotype Associations)", "abnormal inflammatory response (MP:0001845 from MPO Gene-Phenotype Associations)", "increased inflammatory response (MP:0001846 from MPO Gene-Phenotype Associations)", "lung inflammation (MP:0001861 from MPO Gene-Phenotype Associations)", "respiratory system inflammation (MP:0002405 from MPO Gene-Phenotype Associations)", "abnormal b cell differentiation (MP:0002144 from MPO Gene-Phenotype Associations)", "abnormal b cell morphology (MP:0004939 from MPO Gene-Phenotype Associations)", "abnormal b cell number (MP:0002458 from MPO Gene-Phenotype Associations)", "decreased b cell number (MP:0005017 from MPO Gene-Phenotype Associations)", "decreased mature b cell number (MP:0008211 from MPO Gene-Phenotype Associations)", "abnormal mature b cell morphology (MP:0008171 from MPO Gene-Phenotype Associations)", "increased b cell number (MP:0005014 from MPO Gene-Phenotype Associations)", "increased mature b cell number (MP:0008210 from MPO Gene-Phenotype Associations)", "abnormal follicular b cell morphology (MP:0008172 from MPO Gene-Phenotype Associations)", "decreased follicular b cell number (MP:0008174 from MPO Gene-Phenotype Associations)", "abnormal marginal zone b cell morphology (MP:0008180 from MPO Gene-Phenotype Associations)", "abnormal spleen marginal zone morphology (MP:0002362 from MPO Gene-Phenotype Associations)", "decreased marginal zone b cell number (MP:0008182 from MPO Gene-Phenotype Associations)", "increased marginal zone b cell number (MP:0008181 from MPO Gene-Phenotype Associations)", "abnormal b cell activation (MP:0008217 from MPO Gene-Phenotype Associations)", "abnormal b cell proliferation (MP:0005153 from MPO Gene-Phenotype Associations)", "decreased b cell proliferation (MP:0005093 from MPO Gene-Phenotype Associations)", "increased b cell proliferation (MP:0005154 from MPO Gene-Phenotype Associations)", "abnormal b-1 b cell morphology (MP:0004940 from MPO Gene-Phenotype Associations)", "abnormal b-1 b cell number (MP:0004976 from MPO Gene-Phenotype Associations)", "decreased b-1 b cell number (MP:0004978 from MPO Gene-Phenotype Associations)", "abnormal b-1a b cell morphology (MP:0008164 from MPO Gene-Phenotype Associations)", "decreased b-1a cell number (MP:0008168 from MPO Gene-Phenotype Associations)", "absent b-1 b cells (MP:0008202 from MPO Gene-Phenotype Associations)", "absent b-1a cells (MP:0008203 from MPO Gene-Phenotype Associations)", "abnormal b cell physiology (MP:0002459 from MPO Gene-Phenotype Associations)", "abnormal humoral immune response (MP:0001800 from MPO Gene-Phenotype Associations)", "abnormal immunoglobulin level (MP:0002490 from MPO Gene-Phenotype Associations)", "abnormal igg level (MP:0020174 from MPO Gene-Phenotype Associations)", "decreased igg level (MP:0001805 from MPO Gene-Phenotype Associations)", "decreased immunoglobulin level (MP:0002460 from MPO Gene-Phenotype Associations)", "abnormal igg1 level (MP:0020175 from MPO Gene-Phenotype Associations)", "decreased igg1 level (MP:0008495 from MPO Gene-Phenotype Associations)", "abnormal igg2a level (MP:0020176 from MPO Gene-Phenotype Associations)", "decreased igg2a level (MP:0008496 from MPO Gene-Phenotype Associations)", "decreased igg3 level (MP:0008498 from MPO Gene-Phenotype Associations)", "abnormal igg3 level (MP:0020179 from MPO Gene-Phenotype Associations)", "abnormal igg2b level (MP:0020177 from MPO Gene-Phenotype Associations)", "decreased igg2b level (MP:0008497 from MPO Gene-Phenotype Associations)", "abnormal igm level (MP:0020180 from MPO Gene-Phenotype Associations)", "increased igm level (MP:0002494 from MPO Gene-Phenotype Associations)", "decreased igm level (MP:0001806 from MPO Gene-Phenotype Associations)", "decreased iga level (MP:0001807 from MPO Gene-Phenotype Associations)", "abnormal class switch recombination (MP:0004816 from MPO Gene-Phenotype Associations)", "increased igg level (MP:0002493 from MPO Gene-Phenotype Associations)", "increased immunoglobulin level (MP:0002461 from MPO Gene-Phenotype Associations)", "increased igg1 level (MP:0008499 from MPO Gene-Phenotype Associations)", "increased igg2a level (MP:0008500 from MPO Gene-Phenotype Associations)", "increased igg2b level (MP:0008501 from MPO Gene-Phenotype Associations)", "abnormal iga level (MP:0020171 from MPO Gene-Phenotype Associations)", "increased iga level (MP:0002495 from MPO Gene-Phenotype Associations)", "abnormal ige level (MP:0020173 from MPO Gene-Phenotype Associations)", "increased ige level (MP:0002497 from MPO Gene-Phenotype Associations)", "decreased ige level (MP:0002492 from MPO Gene-Phenotype Associations)", "abnormal immune tolerance (MP:0005000 from MPO Gene-Phenotype Associations)", "abnormal self tolerance (MP:0005005 from MPO Gene-Phenotype Associations)", "autoimmune response (MP:0001844 from MPO Gene-Phenotype Associations)", "altered susceptibility to autoimmune disorder (MP:0002425 from MPO Gene-Phenotype Associations)", "decreased susceptibility to autoimmune disorder (MP:0005351 from MPO Gene-Phenotype Associations)", "decreased susceptibility to experimental autoimmune encephalomyelitis (MP:0004800 from MPO Gene-Phenotype Associations)", "arthritis (MP:0002993 from MPO Gene-Phenotype Associations)", "joint inflammation (MP:0002933 from MPO Gene-Phenotype Associations)", "decreased susceptibility to induced arthritis (MP:0003436 from MPO Gene-Phenotype Associations)", "decreased susceptibility to induced joint inflammation (MP:0003079 from MPO Gene-Phenotype Associations)", "increased susceptibility to autoimmune disorder (MP:0005350 from MPO Gene-Phenotype Associations)", "increased susceptibility to experimental autoimmune encephalomyelitis (MP:0004799 from MPO Gene-Phenotype Associations)", "increased susceptibility to induced arthritis (MP:0003724 from MPO Gene-Phenotype Associations)", "abnormal plasma cell morphology (MP:0002439 from MPO Gene-Phenotype Associations)", "abnormal plasma cell number (MP:0008096 from MPO Gene-Phenotype Associations)", "increased plasma cell number (MP:0008097 from MPO Gene-Phenotype Associations)", "decreased plasma cell number (MP:0008098 from MPO Gene-Phenotype Associations)", "increased double-positive t cell number (MP:0005091 from MPO Gene-Phenotype Associations)", "abnormal t cell subpopulation ratio (MP:0003944 from MPO Gene-Phenotype Associations)", "lymph node hypoplasia (MP:0008101 from MPO Gene-Phenotype Associations)", "small lymph nodes (MP:0002217 from MPO Gene-Phenotype Associations)", "abnormal immature b cell morphology (MP:0005022 from MPO Gene-Phenotype Associations)", "decreased immature b cell number (MP:0008215 from MPO Gene-Phenotype Associations)", "abnormal transitional stage b cell morphology (MP:0008188 from MPO Gene-Phenotype Associations)", "decreased transitional stage b cell number (MP:0008190 from MPO Gene-Phenotype Associations)", "abnormal transitional stage t2 b cell morphology (MP:0009920 from MPO Gene-Phenotype Associations)", "decreased transitional stage t2 b cell number (MP:0009926 from MPO Gene-Phenotype Associations)", "abnormal transitional stage t1 b cell morphology (MP:0009919 from MPO Gene-Phenotype Associations)", "decreased transitional stage t1 b cell number (MP:0009923 from MPO Gene-Phenotype Associations)", "abnormal b-2 b cell morphology (MP:0008166 from MPO Gene-Phenotype Associations)", "decreased b-2 b cell number (MP:0008207 from MPO Gene-Phenotype Associations)", "abnormal transitional stage t3 b cell morphology (MP:0009921 from MPO Gene-Phenotype Associations)", "decreased transitional stage t3 b cell number (MP:0010228 from MPO Gene-Phenotype Associations)", "absent follicular b cells (MP:0008175 from MPO Gene-Phenotype Associations)", "absent immature b cells (MP:0008213 from MPO Gene-Phenotype Associations)", "absent pre-b cells (MP:0000238 from MPO Gene-Phenotype Associations)", "absent b cells (MP:0008071 from MPO Gene-Phenotype Associations)", "absent mature b cells (MP:0008212 from MPO Gene-Phenotype Associations)", "absent lymphocyte (MP:0000726 from MPO Gene-Phenotype Associations)", "arrested b cell differentiation (MP:0001802 from MPO Gene-Phenotype Associations)", "abnormal pre-b cell morphology (MP:0002403 from MPO Gene-Phenotype Associations)", "decreased pre-b cell number (MP:0008209 from MPO Gene-Phenotype Associations)", "abnormal pro-b cell morphology (MP:0005432 from MPO Gene-Phenotype Associations)", "decreased pro-b cell number (MP:0008208 from MPO Gene-Phenotype Associations)", "increased pro-b cell number (MP:0008186 from MPO Gene-Phenotype Associations)", "abnormal b cell apoptosis (MP:0008781 from MPO Gene-Phenotype Associations)", "increased b cell apoptosis (MP:0008782 from MPO Gene-Phenotype Associations)", "increased immature b cell number (MP:0008214 from MPO Gene-Phenotype Associations)", "increased transitional stage b cell number (MP:0008189 from MPO Gene-Phenotype Associations)", "increased follicular b cell number (MP:0008173 from MPO Gene-Phenotype Associations)", "decreased b cell apoptosis (MP:0008783 from MPO Gene-Phenotype Associations)", "increased anti-chromatin antibody level (MP:0004829 from MPO Gene-Phenotype Associations)", "increased anti-double stranded dna antibody level (MP:0004762 from MPO Gene-Phenotype Associations)", "increased anti-nuclear antigen antibody level (MP:0004794 from MPO Gene-Phenotype Associations)", "increased autoantibody level (MP:0003725 from MPO Gene-Phenotype Associations)", "increased anti-histone antibody level (MP:0004796 from MPO Gene-Phenotype Associations)", "increased anti-single stranded dna antibody level (MP:0004771 from MPO Gene-Phenotype Associations)", "increased germinal center b cell number (MP:0008177 from MPO Gene-Phenotype Associations)", "increased spleen germinal center size (MP:0008483 from MPO Gene-Phenotype Associations)", "increased spleen germinal center number (MP:0008481 from MPO Gene-Phenotype Associations)", "increased igg3 level (MP:0008502 from MPO Gene-Phenotype Associations)", "abnormal monocyte cell number (MP:0012441 from MPO Gene-Phenotype Associations)", "abnormal monocyte morphology (MP:0002620 from MPO Gene-Phenotype Associations)", "increased monocyte cell number (MP:0000220 from MPO Gene-Phenotype Associations)", "decreased monocyte cell number (MP:0000223 from MPO Gene-Phenotype Associations)", "abnormal eosinophil cell number (MP:0002602 from MPO Gene-Phenotype Associations)", "abnormal eosinophil morphology (MP:0005061 from MPO Gene-Phenotype Associations)", "abnormal myeloblast morphology|development (MP:0002414 from MPO Gene-Phenotype Associations)", "increased eosinophil cell number (MP:0005011 from MPO Gene-Phenotype Associations)", "decreased eosinophil cell number (MP:0005012 from MPO Gene-Phenotype Associations)", "abnormal granulocyte morphology (MP:0002441 from MPO Gene-Phenotype Associations)", "abnormal granulocyte number (MP:0020201 from MPO Gene-Phenotype Associations)", "increased granulocyte number (MP:0000322 from MPO Gene-Phenotype Associations)", "abnormal neutrophil cell number (MP:0012440 from MPO Gene-Phenotype Associations)", "abnormal neutrophil morphology (MP:0005065 from MPO Gene-Phenotype Associations)", "increased neutrophil cell number (MP:0000219 from MPO Gene-Phenotype Associations)", "decreased granulocyte number (MP:0000334 from MPO Gene-Phenotype Associations)", "decreased neutrophil cell number (MP:0000222 from MPO Gene-Phenotype Associations)", "abnormal innate immunity (MP:0002419 from MPO Gene-Phenotype Associations)", "abnormal macrophage physiology (MP:0002451 from MPO Gene-Phenotype Associations)", "abnormal cell chemotaxis (MP:0011518 from MPO Gene-Phenotype Associations)", "abnormal macrophage chemotaxis (MP:0010760 from MPO Gene-Phenotype Associations)", "impaired macrophage chemotaxis (MP:0003799 from MPO Gene-Phenotype Associations)", "abnormal cell migration (MP:0003091 from MPO Gene-Phenotype Associations)", "abnormal leukocyte migration (MP:0003156 from MPO Gene-Phenotype Associations)", "abnormal granulocyte physiology (MP:0002462 from MPO Gene-Phenotype Associations)", "abnormal neutrophil physiology (MP:0002463 from MPO Gene-Phenotype Associations)", "impaired neutrophil recruitment (MP:0008719 from MPO Gene-Phenotype Associations)", "impaired neutrophil chemotaxis (MP:0008720 from MPO Gene-Phenotype Associations)", "abnormal cellular extravasation (MP:0009858 from MPO Gene-Phenotype Associations)", "abnormal leukocyte tethering or rolling (MP:0003627 from MPO Gene-Phenotype Associations)", "abnormal leukocyte adhesion (MP:0003628 from MPO Gene-Phenotype Associations)", "abnormal thymus weight (MP:0004954 from MPO Gene-Phenotype Associations)", "decreased thymus weight (MP:0004956 from MPO Gene-Phenotype Associations)", "small spleen (MP:0000692 from MPO Gene-Phenotype Associations)", "spleen hypoplasia (MP:0000694 from MPO Gene-Phenotype Associations)", "decreased spleen weight (MP:0004953 from MPO Gene-Phenotype Associations)", "abnormal chemokine secretion (MP:0008722 from MPO Gene-Phenotype Associations)", "abnormal interleukin-6 secretion (MP:0008704 from MPO Gene-Phenotype Associations)", "decreased interleukin-6 secretion (MP:0008706 from MPO Gene-Phenotype Associations)", "abnormal tumor necrosis factor secretion (MP:0008556 from MPO Gene-Phenotype Associations)", "decreased tumor necrosis factor secretion (MP:0008561 from MPO Gene-Phenotype Associations)", "increased interleukin-6 secretion (MP:0008705 from MPO Gene-Phenotype Associations)", "increased tumor necrosis factor secretion (MP:0008560 from MPO Gene-Phenotype Associations)", "abnormal interleukin-12b secretion (MP:0008668 from MPO Gene-Phenotype Associations)", "decreased interleukin-12b secretion (MP:0008670 from MPO Gene-Phenotype Associations)", "increased interleukin-12b secretion (MP:0008669 from MPO Gene-Phenotype Associations)", "abnormal interleukin-12 secretion (MP:0008662 from MPO Gene-Phenotype Associations)", "decreased interleukin-12 secretion (MP:0008664 from MPO Gene-Phenotype Associations)", "increased interleukin-12 secretion (MP:0008663 from MPO Gene-Phenotype Associations)", "abnormal acute inflammation (MP:0002498 from MPO Gene-Phenotype Associations)", "abnormal hypersensitivity reaction (MP:0002148 from MPO Gene-Phenotype Associations)", "decreased acute inflammation (MP:0005087 from MPO Gene-Phenotype Associations)", "decreased inflammatory response (MP:0001876 from MPO Gene-Phenotype Associations)", "abnormal type iv hypersensitivity reaction (MP:0002534 from MPO Gene-Phenotype Associations)", "decreased susceptibility to type iv hypersensitivity reaction (MP:0005616 from MPO Gene-Phenotype Associations)", "decreased susceptibility to endotoxin shock (MP:0008734 from MPO Gene-Phenotype Associations)", "increased acute inflammation (MP:0005088 from MPO Gene-Phenotype Associations)", "increased susceptibility to endotoxin shock (MP:0008735 from MPO Gene-Phenotype Associations)", "increased susceptibility to type iv hypersensitivity reaction (MP:0005617 from MPO Gene-Phenotype Associations)", "abnormal circulating cytokine level (MP:0010210 from MPO Gene-Phenotype Associations)", "abnormal cytokine level (MP:0008713 from MPO Gene-Phenotype Associations)", "abnormal intercellular signaling peptide or protein level (MP:0008835 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin level (MP:0008588 from MPO Gene-Phenotype Associations)", "abnormal interleukin level (MP:0008751 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-6 level (MP:0008595 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-6 level (MP:0008596 from MPO Gene-Phenotype Associations)", "abnormal circulating tumor necrosis factor level (MP:0008552 from MPO Gene-Phenotype Associations)", "abnormal tumor necrosis factor level (MP:0008752 from MPO Gene-Phenotype Associations)", "increased circulating tumor necrosis factor level (MP:0008553 from MPO Gene-Phenotype Associations)", "abnormal circulating interferon level (MP:0008548 from MPO Gene-Phenotype Associations)", "abnormal circulating interferon-gamma level (MP:0008551 from MPO Gene-Phenotype Associations)", "abnormal interferon level (MP:0008750 from MPO Gene-Phenotype Associations)", "increased circulating interferon-gamma level (MP:0008577 from MPO Gene-Phenotype Associations)", "decreased circulating interferon-gamma level (MP:0008578 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-1 beta level (MP:0008640 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-1 level (MP:0008589 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-1 beta level (MP:0008641 from MPO Gene-Phenotype Associations)", "decreased circulating interleukin-1 beta level (MP:0008642 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-10 level (MP:0008590 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-10 level (MP:0008593 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-12 level (MP:0008616 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-12 level (MP:0008617 from MPO Gene-Phenotype Associations)", "decreased circulating interleukin-6 level (MP:0008597 from MPO Gene-Phenotype Associations)", "decreased circulating tumor necrosis factor level (MP:0008554 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-12b level (MP:0008646 from MPO Gene-Phenotype Associations)", "decreased circulating interleukin-12b level (MP:0008648 from MPO Gene-Phenotype Associations)", "abnormal chemokine level (MP:0008721 from MPO Gene-Phenotype Associations)", "abnormal circulating chemokine level (MP:0010209 from MPO Gene-Phenotype Associations)", "abnormal response to infection (MP:0005025 from MPO Gene-Phenotype Associations)", "altered susceptibility to infection (MP:0001793 from MPO Gene-Phenotype Associations)", "increased susceptibility to infection (MP:0002406 from MPO Gene-Phenotype Associations)", "altered susceptibility to bacterial infection (MP:0020186 from MPO Gene-Phenotype Associations)", "increased susceptibility to bacterial infection (MP:0002412 from MPO Gene-Phenotype Associations)", "altered susceptibility to infection induced morbidity|mortality (MP:0009785 from MPO Gene-Phenotype Associations)", "increased susceptibility to infection induced morbidity|mortality (MP:0009787 from MPO Gene-Phenotype Associations)", "increased susceptibility to bacterial infection induced morbidity|mortality (MP:0009788 from MPO Gene-Phenotype Associations)", "altered susceptibility to viral infection (MP:0020185 from MPO Gene-Phenotype Associations)", "increased susceptibility to viral infection (MP:0002418 from MPO Gene-Phenotype Associations)", "increased susceptibility to viral infection induced morbidity|mortality (MP:0009791 from MPO Gene-Phenotype Associations)", "decreased susceptibility to infection (MP:0002409 from MPO Gene-Phenotype Associations)", "decreased susceptibility to bacterial infection (MP:0002411 from MPO Gene-Phenotype Associations)", "decreased susceptibility to infection induced morbidity|mortality (MP:0009786 from MPO Gene-Phenotype Associations)", "decreased susceptibility to bacterial infection induced morbidity|mortality (MP:0009789 from MPO Gene-Phenotype Associations)", "decreased susceptibility to viral infection induced morbidity|mortality (MP:0009790 from MPO Gene-Phenotype Associations)", "decreased susceptibility to viral infection (MP:0002410 from MPO Gene-Phenotype Associations)", "altered susceptibility to parasitic infection (MP:0020184 from MPO Gene-Phenotype Associations)", "increased susceptibility to parasitic infection (MP:0005027 from MPO Gene-Phenotype Associations)", "decreased susceptibility to parasitic infection (MP:0005026 from MPO Gene-Phenotype Associations)", "decreased susceptibility to parasitic infection induced morbidity|mortality (MP:0010751 from MPO Gene-Phenotype Associations)", "abnormal t cell apoptosis (MP:0006412 from MPO Gene-Phenotype Associations)", "increased t cell apoptosis (MP:0006413 from MPO Gene-Phenotype Associations)", "abnormal thymocyte apoptosis (MP:0009258 from MPO Gene-Phenotype Associations)", "increased thymocyte apoptosis (MP:0009541 from MPO Gene-Phenotype Associations)", "abnormal thymus physiology (MP:0003763 from MPO Gene-Phenotype Associations)", "abnormal immune organ physiology (MP:0003762 from MPO Gene-Phenotype Associations)", "decreased t cell apoptosis (MP:0006414 from MPO Gene-Phenotype Associations)", "decreased thymocyte apoptosis (MP:0009542 from MPO Gene-Phenotype Associations)", "abnormal spleen physiology (MP:0008737 from MPO Gene-Phenotype Associations)", "abnormal splenocyte physiology (MP:0009333 from MPO Gene-Phenotype Associations)", "abnormal splenocyte proliferation (MP:0009334 from MPO Gene-Phenotype Associations)", "decreased splenocyte proliferation (MP:0009335 from MPO Gene-Phenotype Associations)", "increased splenocyte proliferation (MP:0009336 from MPO Gene-Phenotype Associations)", "abnormal lymph node cell ratio (MP:0008828 from MPO Gene-Phenotype Associations)", "abnormal splenic cell ratio (MP:0008826 from MPO Gene-Phenotype Associations)", "abnormal thymus cell ratio (MP:0008827 from MPO Gene-Phenotype Associations)", "absent cd8-positive, alpha-beta t cells (MP:0000727 from MPO Gene-Phenotype Associations)", "absent cd4-positive, alpha beta t cells (MP:0003790 from MPO Gene-Phenotype Associations)", "absent t cells (MP:0008070 from MPO Gene-Phenotype Associations)", "arrested t cell differentiation (MP:0001825 from MPO Gene-Phenotype Associations)", "abnormal thymocyte activation (MP:0003850 from MPO Gene-Phenotype Associations)", "increased activated t cell number (MP:0001829 from MPO Gene-Phenotype Associations)", "abnormal t cell receptor gamma chain v-j recombination (MP:0008757 from MPO Gene-Phenotype Associations)", "increased anti-erythrocyte antigen antibody level (MP:0004797 from MPO Gene-Phenotype Associations)", "abnormal t cell receptor delta chain v(d)j recombination (MP:0008759 from MPO Gene-Phenotype Associations)", "increased susceptibility to autoimmune hemolytic anemia (MP:0004827 from MPO Gene-Phenotype Associations)", "abnormal clonal deletion (MP:0005001 from MPO Gene-Phenotype Associations)", "abnormal t cell clonal deletion (MP:0005002 from MPO Gene-Phenotype Associations)", "abnormal negative t cell selection (MP:0004918 from MPO Gene-Phenotype Associations)", "abnormal t cell selection (MP:0004917 from MPO Gene-Phenotype Associations)", "abnormal positive t cell selection (MP:0004919 from MPO Gene-Phenotype Associations)", "abnormal cd8-positive, gamma-delta intraepithelial t cell morphology (MP:0008361 from MPO Gene-Phenotype Associations)", "decreased cd8-positive, gamma-delta intraepithelial t cell number (MP:0008363 from MPO Gene-Phenotype Associations)", "abnormal gamma-delta intraepithelial t cell morphology (MP:0008349 from MPO Gene-Phenotype Associations)", "abnormal mature gamma-delta t cell morphology (MP:0008344 from MPO Gene-Phenotype Associations)", "decreased gamma-delta intraepithelial t cell number (MP:0008351 from MPO Gene-Phenotype Associations)", "decreased mature gamma-delta t cell number (MP:0008354 from MPO Gene-Phenotype Associations)", "abnormal intraepithelial t cell morphology (MP:0008894 from MPO Gene-Phenotype Associations)", "abnormal intraepithelial t cell number (MP:0008895 from MPO Gene-Phenotype Associations)", "decreased gamma-delta t cell number (MP:0008347 from MPO Gene-Phenotype Associations)", "abnormal gamma-delta t cell morphology (MP:0008343 from MPO Gene-Phenotype Associations)", "abnormal gamma-delta t cell number (MP:0008345 from MPO Gene-Phenotype Associations)", "absent gamma-delta intraepithelial t cell (MP:0008352 from MPO Gene-Phenotype Associations)", "absent gamma-delta t cells (MP:0008348 from MPO Gene-Phenotype Associations)", "absent mature gamma-delta t cells (MP:0008355 from MPO Gene-Phenotype Associations)", "abnormal gamma-delta t cell differentiation (MP:0008356 from MPO Gene-Phenotype Associations)", "absent nk cells (MP:0008046 from MPO Gene-Phenotype Associations)", "absent uterine nk cells (MP:0008047 from MPO Gene-Phenotype Associations)", "abnormal basophil physiology (MP:0002464 from MPO Gene-Phenotype Associations)", "abnormal nk t cell morphology (MP:0008036 from MPO Gene-Phenotype Associations)", "abnormal nk t cell number (MP:0008038 from MPO Gene-Phenotype Associations)", "decreased nk t cell number (MP:0008040 from MPO Gene-Phenotype Associations)", "increased nk t cell number (MP:0008039 from MPO Gene-Phenotype Associations)", "increased nk cell number (MP:0008044 from MPO Gene-Phenotype Associations)", "abnormal nk cell morphology (MP:0005068 from MPO Gene-Phenotype Associations)", "abnormal nk cell number (MP:0008043 from MPO Gene-Phenotype Associations)", "decreased nk cell number (MP:0008045 from MPO Gene-Phenotype Associations)", "abnormal natural killer cell mediated cytotoxicity (MP:0011719 from MPO Gene-Phenotype Associations)", "impaired natural killer cell mediated cytotoxicity (MP:0005070 from MPO Gene-Phenotype Associations)", "abnormal nk cell physiology (MP:0010766 from MPO Gene-Phenotype Associations)", "increased natural killer cell mediated cytotoxicity (MP:0003080 from MPO Gene-Phenotype Associations)", "abnormal nk t cell physiology (MP:0008042 from MPO Gene-Phenotype Associations)", "abnormal single-positive t cell number (MP:0008081 from MPO Gene-Phenotype Associations)", "decreased single-positive t cell number (MP:0008083 from MPO Gene-Phenotype Associations)", "increased single-positive t cell number (MP:0008082 from MPO Gene-Phenotype Associations)", "abnormal thymus medulla morphology (MP:0002375 from MPO Gene-Phenotype Associations)", "abnormal thymus cortex morphology (MP:0002371 from MPO Gene-Phenotype Associations)", "abnormal thymus lobule morphology (MP:0002367 from MPO Gene-Phenotype Associations)", "thymus cortex hypoplasia (MP:0000711 from MPO Gene-Phenotype Associations)", "abnormal thymus corticomedullary boundary morphology (MP:0009543 from MPO Gene-Phenotype Associations)", "abnormal cd4-positive helper t cell morphology (MP:0010183 from MPO Gene-Phenotype Associations)", "abnormal t-helper 2 cell morphology (MP:0002434 from MPO Gene-Phenotype Associations)", "abnormal t-helper 2 cell differentiation (MP:0008092 from MPO Gene-Phenotype Associations)", "abnormal t-helper 2 cell number (MP:0008089 from MPO Gene-Phenotype Associations)", "increased t-helper 2 cell number (MP:0008090 from MPO Gene-Phenotype Associations)", "abnormal cd4-positive t cell differentiation (MP:0008076 from MPO Gene-Phenotype Associations)", "abnormal t-helper 1 cell differentiation (MP:0008088 from MPO Gene-Phenotype Associations)", "abnormal t-helper 1 cell morphology (MP:0002433 from MPO Gene-Phenotype Associations)", "abnormal t-helper 1 cell number (MP:0008085 from MPO Gene-Phenotype Associations)", "increased t-helper 1 cell number (MP:0008086 from MPO Gene-Phenotype Associations)", "abnormal t-helper 17 cell differentiation (MP:0010221 from MPO Gene-Phenotype Associations)", "abnormal t-helper 17 cell morphology (MP:0010217 from MPO Gene-Phenotype Associations)", "abnormal t-helper 17 cell number (MP:0010218 from MPO Gene-Phenotype Associations)", "increased t-helper 17 cell number (MP:0010219 from MPO Gene-Phenotype Associations)", "abnormal interleukin-9 secretion (MP:0008710 from MPO Gene-Phenotype Associations)", "decreased interleukin-9 secretion (MP:0008712 from MPO Gene-Phenotype Associations)", "abnormal interleukin-17 secretion (MP:0008680 from MPO Gene-Phenotype Associations)", "increased interleukin-17 secretion (MP:0008681 from MPO Gene-Phenotype Associations)", "decreased interleukin-17 secretion (MP:0008682 from MPO Gene-Phenotype Associations)", "decreased t-helper 17 cell number (MP:0010220 from MPO Gene-Phenotype Associations)", "decreased t helper 1 cell number (MP:0008087 from MPO Gene-Phenotype Associations)", "abnormal t follicular helper cell physiology (MP:0010189 from MPO Gene-Phenotype Associations)", "increased late pro-b cell number (MP:0003134 from MPO Gene-Phenotype Associations)", "abnormal cd4-positive, alpha-beta t cell physiology (MP:0005463 from MPO Gene-Phenotype Associations)", "abnormal t-helper 2 physiology (MP:0005466 from MPO Gene-Phenotype Associations)", "abnormal t-helper 1 physiology (MP:0005465 from MPO Gene-Phenotype Associations)", "abnormal interleukin-10 secretion (MP:0008659 from MPO Gene-Phenotype Associations)", "decreased interleukin-10 secretion (MP:0008661 from MPO Gene-Phenotype Associations)", "increased interleukin-10 secretion (MP:0008660 from MPO Gene-Phenotype Associations)", "abnormal interleukin-13 secretion (MP:0008671 from MPO Gene-Phenotype Associations)", "decreased interleukin-13 secretion (MP:0008673 from MPO Gene-Phenotype Associations)", "abnormal interleukin-5 secretion (MP:0008701 from MPO Gene-Phenotype Associations)", "decreased interleukin-5 secretion (MP:0008703 from MPO Gene-Phenotype Associations)", "abnormal interleukin-4 secretion (MP:0008698 from MPO Gene-Phenotype Associations)", "decreased interleukin-4 secretion (MP:0008700 from MPO Gene-Phenotype Associations)", "increased interleukin-13 secretion (MP:0008672 from MPO Gene-Phenotype Associations)", "increased interleukin-5 secretion (MP:0008702 from MPO Gene-Phenotype Associations)", "increased interleukin-4 secretion (MP:0008699 from MPO Gene-Phenotype Associations)", "abnormal interleukin-3 secretion (MP:0008695 from MPO Gene-Phenotype Associations)", "decreased interleukin-3 secretion (MP:0008697 from MPO Gene-Phenotype Associations)", "pale spleen (MP:0009246 from MPO Gene-Phenotype Associations)", "decreased anti-double stranded dna antibody level (MP:0004798 from MPO Gene-Phenotype Associations)", "decreased anti-nuclear antigen antibody level (MP:0004795 from MPO Gene-Phenotype Associations)", "abnormal dendritic cell chemotaxis (MP:0010740 from MPO Gene-Phenotype Associations)", "abnormal langerhans cell physiology (MP:0005362 from MPO Gene-Phenotype Associations)", "abnormal antigen presentation (MP:0001835 from MPO Gene-Phenotype Associations)", "abnormal dendritic cell antigen presentation (MP:0002455 from MPO Gene-Phenotype Associations)", "abnormal dendritic cell physiology (MP:0002376 from MPO Gene-Phenotype Associations)", "abnormal antigen presentation via mhc class ii (MP:0005041 from MPO Gene-Phenotype Associations)", "abnormal b lymphocyte antigen presentation (MP:0002453 from MPO Gene-Phenotype Associations)", "abnormal level of surface class ii molecules (MP:0005042 from MPO Gene-Phenotype Associations)", "abnormal macrophage antigen presentation (MP:0002454 from MPO Gene-Phenotype Associations)", "abnormal mhc ii cell surface expression on macrophages (MP:0005040 from MPO Gene-Phenotype Associations)", "defective assembly of class ii molecules (MP:0005043 from MPO Gene-Phenotype Associations)", "abnormal cd8-positive, alpha-beta t cell physiology (MP:0004392 from MPO Gene-Phenotype Associations)", "abnormal cytotoxic t cell physiology (MP:0005078 from MPO Gene-Phenotype Associations)", "abnormal cytotoxic t cell cytolysis (MP:0013280 from MPO Gene-Phenotype Associations)", "decreased cytotoxic t cell cytolysis (MP:0005079 from MPO Gene-Phenotype Associations)", "abnormal antigen presentation via mhc class i (MP:0001836 from MPO Gene-Phenotype Associations)", "abnormal level of surface class i molecules (MP:0001839 from MPO Gene-Phenotype Associations)", "decreased level of surface class i molecules (MP:0001841 from MPO Gene-Phenotype Associations)", "defective assembly of class i molecules (MP:0001837 from MPO Gene-Phenotype Associations)", "defective intracellular transport of class i molecules (MP:0001838 from MPO Gene-Phenotype Associations)", "increased level of surface class i molecules (MP:0001840 from MPO Gene-Phenotype Associations)", "increased t cell proliferation (MP:0005348 from MPO Gene-Phenotype Associations)", "increased interleukin-2 secretion (MP:0008687 from MPO Gene-Phenotype Associations)", "increased interleukin-21 secretion (MP:0009057 from MPO Gene-Phenotype Associations)", "abnormal peripheral t cell anergy (MP:0008749 from MPO Gene-Phenotype Associations)", "abnormal lymphocyte anergy (MP:0005004 from MPO Gene-Phenotype Associations)", "abnormal t cell anergy (MP:0008747 from MPO Gene-Phenotype Associations)", "disorganized suprabasal layer (MP:0001235 from MPO Gene-Phenotype Associations)", "increased enterocyte cell number (MP:0000328 from MPO Gene-Phenotype Associations)", "abnormal enteroendocrine cell morphology (MP:0004141 from MPO Gene-Phenotype Associations)", "abnormal intestinal enteroendocrine cell morphology (MP:0010802 from MPO Gene-Phenotype Associations)", "abnormal small intestinal microvillus morphology (MP:0008109 from MPO Gene-Phenotype Associations)", "decreased small intestinal microvillus size (MP:0008141 from MPO Gene-Phenotype Associations)", "abnormal paneth cell morphology (MP:0004843 from MPO Gene-Phenotype Associations)", "abnormal small intestine crypts of lieberkuhn morphology (MP:0004841 from MPO Gene-Phenotype Associations)", "abnormal enterocyte morphology (MP:0000479 from MPO Gene-Phenotype Associations)", "abnormal small intestinal villus morphology (MP:0008108 from MPO Gene-Phenotype Associations)", "abnormal small intestine morphology (MP:0000496 from MPO Gene-Phenotype Associations)", "decreased small intestinal villus size (MP:0008142 from MPO Gene-Phenotype Associations)", "abnormal duodenum morphology (MP:0003271 from MPO Gene-Phenotype Associations)", "abnormal jejunum morphology (MP:0004002 from MPO Gene-Phenotype Associations)", "abnormal pyloric gastric gland morphology (MP:0010797 from MPO Gene-Phenotype Associations)", "abnormal intestine development (MP:0010158 from MPO Gene-Phenotype Associations)", "delayed intestine development (MP:0000478 from MPO Gene-Phenotype Associations)", "gastrointestinal hemorrhage (MP:0000465 from MPO Gene-Phenotype Associations)", "rectal hemorrhage (MP:0003293 from MPO Gene-Phenotype Associations)", "gastrointestinal ulcer (MP:0003300 from MPO Gene-Phenotype Associations)", "intestinal ulcer (MP:0000512 from MPO Gene-Phenotype Associations)", "abnormal gut flora balance (MP:0010377 from MPO Gene-Phenotype Associations)", "abnormal large intestine crypts of lieberkuhn morphology (MP:0004842 from MPO Gene-Phenotype Associations)", "abnormal crypts of lieberkuhn morphology (MP:0000490 from MPO Gene-Phenotype Associations)", "abnormal intestinal epithelium morphology (MP:0000488 from MPO Gene-Phenotype Associations)", "abnormal intestinal mucosa morphology (MP:0000511 from MPO Gene-Phenotype Associations)", "abnormal intestine morphology (MP:0000477 from MPO Gene-Phenotype Associations)", "abnormal intestinal goblet cell morphology (MP:0003449 from MPO Gene-Phenotype Associations)", "abnormal digestive system morphology (MP:0000462 from MPO Gene-Phenotype Associations)", "digestive|alimentary phenotype (MP:0005381 from MPO Gene-Phenotype Associations)", "abnormal digestive system physiology (MP:0001663 from MPO Gene-Phenotype Associations)", "abnormal intestine physiology (MP:0010155 from MPO Gene-Phenotype Associations)", "colitis (MP:0002816 from MPO Gene-Phenotype Associations)", "large intestinal inflammation (MP:0003304 from MPO Gene-Phenotype Associations)", "intestinal inflammation (MP:0001858 from MPO Gene-Phenotype Associations)", "abnormal susceptibility to induced colitis (MP:0013296 from MPO Gene-Phenotype Associations)", "increased susceptibility to induced colitis (MP:0008537 from MPO Gene-Phenotype Associations)", "decreased susceptibility to induced colitis (MP:0008539 from MPO Gene-Phenotype Associations)", "abnormal colon morphology (MP:0000495 from MPO Gene-Phenotype Associations)", "abnormal large intestine morphology (MP:0000489 from MPO Gene-Phenotype Associations)", "abnormal rectum morphology (MP:0000492 from MPO Gene-Phenotype Associations)", "rectal prolapse (MP:0000493 from MPO Gene-Phenotype Associations)", "abnormal defecation (MP:0003866 from MPO Gene-Phenotype Associations)", "diarrhea (MP:0005036 from MPO Gene-Phenotype Associations)", "abnormal enterocyte apoptosis (MP:0008884 from MPO Gene-Phenotype Associations)", "increased enterocyte apoptosis (MP:0008885 from MPO Gene-Phenotype Associations)", "abnormal enterocyte physiology (MP:0008882 from MPO Gene-Phenotype Associations)", "abnormal enterocyte proliferation (MP:0008883 from MPO Gene-Phenotype Associations)", "abnormal dendritic cell differentiation (MP:0008115 from MPO Gene-Phenotype Associations)", "ileum inflammation (MP:0009482 from MPO Gene-Phenotype Associations)", "small intestinal inflammation (MP:0003306 from MPO Gene-Phenotype Associations)", "abnormal susceptibility to weight loss (MP:0011118 from MPO Gene-Phenotype Associations)", "increased susceptibility to weight loss (MP:0010180 from MPO Gene-Phenotype Associations)", "decreased susceptibility to weight loss (MP:0010181 from MPO Gene-Phenotype Associations)", "small gallbladder (MP:0005675 from MPO Gene-Phenotype Associations)", "abnormal enterocyte differentiation (MP:0010159 from MPO Gene-Phenotype Associations)", "decreased susceptibility to bone fracture (MP:0009878 from MPO Gene-Phenotype Associations)", "increased bone strength (MP:0004149 from MPO Gene-Phenotype Associations)", "abnormal interleukin-1 beta secretion (MP:0008656 from MPO Gene-Phenotype Associations)", "abnormal interleukin-1 secretion (MP:0008650 from MPO Gene-Phenotype Associations)", "increased interleukin-1 beta secretion (MP:0008657 from MPO Gene-Phenotype Associations)", "decreased interleukin-1 beta secretion (MP:0008658 from MPO Gene-Phenotype Associations)", "abnormal interleukin-1 alpha secretion (MP:0008653 from MPO Gene-Phenotype Associations)", "decreased interleukin-1 alpha secretion (MP:0008655 from MPO Gene-Phenotype Associations)", "increased interleukin-1 alpha secretion (MP:0008654 from MPO Gene-Phenotype Associations)", "abnormal interleukin-18 secretion (MP:0008683 from MPO Gene-Phenotype Associations)", "decreased interleukin-18 secretion (MP:0008685 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-18 level (MP:0008634 from MPO Gene-Phenotype Associations)", "decreased circulating interleukin-18 level (MP:0008636 from MPO Gene-Phenotype Associations)", "increased interferon-beta secretion (MP:0008564 from MPO Gene-Phenotype Associations)", "increased interleukin-18 secretion (MP:0008684 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-9 level (MP:0008628 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-9 level (MP:0008629 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-13 level (MP:0008608 from MPO Gene-Phenotype Associations)", "decreased circulating interleukin-5 level (MP:0008627 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-3 level (MP:0008622 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-3 level (MP:0008623 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-5 level (MP:0008625 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-5 level (MP:0008626 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-4 level (MP:0008602 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-4 level (MP:0008601 from MPO Gene-Phenotype Associations)", "decreased circulating interleukin-4 level (MP:0008603 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-13 level (MP:0008607 from MPO Gene-Phenotype Associations)", "decreased circulating interleukin-13 level (MP:0008609 from MPO Gene-Phenotype Associations)", "increased myeloid dendritic cell number (MP:0008121 from MPO Gene-Phenotype Associations)", "increased leukotriene level (MP:0009816 from MPO Gene-Phenotype Associations)", "decreased incidence of tumors by uv induction (MP:0004504 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-1 alpha level (MP:0008638 from MPO Gene-Phenotype Associations)", "decreased length of allograft survival (MP:0004752 from MPO Gene-Phenotype Associations)", "absent erythroid progenitor cell (MP:0000216 from MPO Gene-Phenotype Associations)", "decreased circulating interleukin-10 level (MP:0008594 from MPO Gene-Phenotype Associations)", "decreased spleen red pulp amount (MP:0008477 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-1 alpha level (MP:0008637 from MPO Gene-Phenotype Associations)", "decreased circulating interleukin-1 alpha level (MP:0008639 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-17 level (MP:0008613 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-17 level (MP:0008614 from MPO Gene-Phenotype Associations)", "increased peyer's patch number (MP:0008132 from MPO Gene-Phenotype Associations)", "enlarged peyer's patches (MP:0008136 from MPO Gene-Phenotype Associations)", "panniculitis (MP:0011164 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-2 level (MP:0008598 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-2 level (MP:0008599 from MPO Gene-Phenotype Associations)", "eyelid edema (MP:0006167 from MPO Gene-Phenotype Associations)", "excessive scratching (MP:0001412 from MPO Gene-Phenotype Associations)", "abnormal conjunctiva goblet cell morphology (MP:0012164 from MPO Gene-Phenotype Associations)", "abnormal conjunctival epithelium morphology (MP:0004481 from MPO Gene-Phenotype Associations)", "abnormal tear production (MP:0020218 from MPO Gene-Phenotype Associations)", "decreased tear production (MP:0020220 from MPO Gene-Phenotype Associations)", "abnormal conjunctiva morphology (MP:0001310 from MPO Gene-Phenotype Associations)", "conjunctivitis (MP:0001852 from MPO Gene-Phenotype Associations)", "eye inflammation (MP:0001851 from MPO Gene-Phenotype Associations)", "blepharitis (MP:0005251 from MPO Gene-Phenotype Associations)", "ovary inflammation (MP:0001868 from MPO Gene-Phenotype Associations)", "abnormal t-helper 17 cell physiology (MP:0010222 from MPO Gene-Phenotype Associations)", "increased interleukin-23 secretion (MP:0008690 from MPO Gene-Phenotype Associations)", "vitreous body inflammation (MP:0006201 from MPO Gene-Phenotype Associations)", "chronic pancreas inflammation (MP:0003341 from MPO Gene-Phenotype Associations)", "abnormal hassall's corpuscle morphology (MP:0009539 from MPO Gene-Phenotype Associations)", "absent hassall's corpuscle (MP:0009540 from MPO Gene-Phenotype Associations)", "abnormal thymus epithelium morphology (MP:0009544 from MPO Gene-Phenotype Associations)", "abnormal b cell receptor editing (MP:0008766 from MPO Gene-Phenotype Associations)", "thyroid inflammation (MP:0003504 from MPO Gene-Phenotype Associations)", "abnormal salivary gland physiology (MP:0005310 from MPO Gene-Phenotype Associations)", "salivary gland inflammation (MP:0001870 from MPO Gene-Phenotype Associations)", "submandibular gland inflammation (MP:0008879 from MPO Gene-Phenotype Associations)", "parotid gland inflammation (MP:0013367 from MPO Gene-Phenotype Associations)", "abnormal lacrimal gland physiology (MP:0001348 from MPO Gene-Phenotype Associations)", "lacrimal gland inflammation (MP:0008880 from MPO Gene-Phenotype Associations)", "insulitis (MP:0004031 from MPO Gene-Phenotype Associations)", "pancreas inflammation (MP:0001869 from MPO Gene-Phenotype Associations)", "increased susceptibility to autoimmune diabetes (MP:0004803 from MPO Gene-Phenotype Associations)", "decreased susceptibility to autoimmune diabetes (MP:0004804 from MPO Gene-Phenotype Associations)", "decreased circulating interleukin-17 level (MP:0008615 from MPO Gene-Phenotype Associations)", "altered susceptibility to fungal infection (MP:0020183 from MPO Gene-Phenotype Associations)", "increased susceptibility to fungal infection (MP:0005399 from MPO Gene-Phenotype Associations)", "decreased susceptibility to fungal infection (MP:0005398 from MPO Gene-Phenotype Associations)", "abnormal blood volume (MP:0001599 from MPO Gene-Phenotype Associations)", "hypervolemia (MP:0010127 from MPO Gene-Phenotype Associations)", "hypovolemia (MP:0010128 from MPO Gene-Phenotype Associations)", "colonic necrosis (MP:0001652 from MPO Gene-Phenotype Associations)", "gastric necrosis (MP:0001653 from MPO Gene-Phenotype Associations)", "proctitis (MP:0003305 from MPO Gene-Phenotype Associations)", "phlebitis (MP:0010140 from MPO Gene-Phenotype Associations)", "atrial endocarditis (MP:0001854 from MPO Gene-Phenotype Associations)", "increased anal adenocarcinoma incidence (MP:0009316 from MPO Gene-Phenotype Associations)", "increased rectum adenocarcinoma incidence (MP:0009315 from MPO Gene-Phenotype Associations)", "pericarditis (MP:0001857 from MPO Gene-Phenotype Associations)", "increased gastric adenocarcinoma incidence (MP:0008010 from MPO Gene-Phenotype Associations)", "increased large intestine adenocarcinoma incidence (MP:0009310 from MPO Gene-Phenotype Associations)", "increased colon adenocarcinoma incidence (MP:0009314 from MPO Gene-Phenotype Associations)", "multifocal hepatic necrosis (MP:0001655 from MPO Gene-Phenotype Associations)", "absent tubuloglomerular feedback response (MP:0011297 from MPO Gene-Phenotype Associations)", "increased susceptibility to kidney reperfusion injury (MP:0004041 from MPO Gene-Phenotype Associations)", "abnormal dendritic cell morphology (MP:0005461 from MPO Gene-Phenotype Associations)", "abnormal dendritic cell number (MP:0008125 from MPO Gene-Phenotype Associations)", "decreased dendritic cell number (MP:0008127 from MPO Gene-Phenotype Associations)", "abnormal myeloid dendritic cell morphology (MP:0006173 from MPO Gene-Phenotype Associations)", "abnormal myeloid dendritic cell number (MP:0008120 from MPO Gene-Phenotype Associations)", "decreased myeloid dendritic cell number (MP:0008122 from MPO Gene-Phenotype Associations)", "abnormal langerhans cell morphology (MP:0008117 from MPO Gene-Phenotype Associations)", "abnormal langerhans cell number (MP:0013411 from MPO Gene-Phenotype Associations)", "decreased langerhans cell number (MP:0008119 from MPO Gene-Phenotype Associations)", "absent langerhans cell (MP:0008118 from MPO Gene-Phenotype Associations)", "brain inflammation (MP:0001847 from MPO Gene-Phenotype Associations)", "cns inflammation (MP:0006082 from MPO Gene-Phenotype Associations)", "abnormal cd4-positive, alpha-beta memory t cell morphology (MP:0010834 from MPO Gene-Phenotype Associations)", "abnormal effector memory cd4-positive, alpha-beta t cell morphology (MP:0010843 from MPO Gene-Phenotype Associations)", "abnormal effector memory cd4-positive, alpha-beta t cell number (MP:0012770 from MPO Gene-Phenotype Associations)", "increased effector memory cd4-positive, alpha-beta t cell number (MP:0010844 from MPO Gene-Phenotype Associations)", "abnormal effector memory cd8-positive, alpha-beta t cell number (MP:0010849 from MPO Gene-Phenotype Associations)", "increased effector memory cd8-positive, alpha-beta t cell number (MP:0010850 from MPO Gene-Phenotype Associations)", "abnormal cd4-positive, alpha-beta memory t cell number (MP:0012769 from MPO Gene-Phenotype Associations)", "increased cd4-positive, alpha-beta memory t cell number (MP:0010835 from MPO Gene-Phenotype Associations)", "abnormal cd8-positive, alpha-beta memory t cell morphology (MP:0010837 from MPO Gene-Phenotype Associations)", "abnormal cd8-positive, alpha-beta memory t cell number (MP:0012774 from MPO Gene-Phenotype Associations)", "increased cd8-positive, alpha-beta memory t cell number (MP:0010838 from MPO Gene-Phenotype Associations)", "abnormal memory t cell morphology (MP:0010833 from MPO Gene-Phenotype Associations)", "abnormal memory t cell number (MP:0008048 from MPO Gene-Phenotype Associations)", "increased memory t cell number (MP:0008049 from MPO Gene-Phenotype Associations)", "increased anti-insulin autoantibody level (MP:0002869 from MPO Gene-Phenotype Associations)", "decreased cd4-positive, alpha-beta memory t cell number (MP:0010836 from MPO Gene-Phenotype Associations)", "decreased memory t cell number (MP:0008050 from MPO Gene-Phenotype Associations)", "decreased cd8-positive, alpha-beta memory t cell number (MP:0010839 from MPO Gene-Phenotype Associations)", "abnormal klrg1+ cd8 alpha beta t cell number (MP:0013153 from MPO Gene-Phenotype Associations)", "increased klrg1+ cd8 alpha beta t cell number (MP:0013154 from MPO Gene-Phenotype Associations)", "increased klrg1+ cd4 alpha beta t cell number (MP:0013157 from MPO Gene-Phenotype Associations)", "increased ly6c high monocyte number (MP:0013022 from MPO Gene-Phenotype Associations)", "abnormal ly6c low monocyte number (MP:0013024 from MPO Gene-Phenotype Associations)", "increased klrg1-positive nk cell number (MP:0012767 from MPO Gene-Phenotype Associations)", "abnormal klrg1-positive nk cell number (MP:0012766 from MPO Gene-Phenotype Associations)", "increased ly6c low monocyte number (MP:0013025 from MPO Gene-Phenotype Associations)", "abnormal ly6c high monocyte number (MP:0013021 from MPO Gene-Phenotype Associations)", "abnormal klrg1+ cd4 alpha beta t cell number (MP:0013156 from MPO Gene-Phenotype Associations)", "abnormal germinal center b cell morphology (MP:0008176 from MPO Gene-Phenotype Associations)", "decreased germinal center b cell number (MP:0008178 from MPO Gene-Phenotype Associations)", "absent germinal center b cells (MP:0008179 from MPO Gene-Phenotype Associations)", "abnormal cd8-positive, alpha-beta t cell differentiation (MP:0008080 from MPO Gene-Phenotype Associations)", "abnormal thymus subcapsular epithelium morphology (MP:0002369 from MPO Gene-Phenotype Associations)", "abnormal plasmacytoid dendritic cell physiology (MP:0008769 from MPO Gene-Phenotype Associations)", "abnormal circulating interferon-beta level (MP:0008550 from MPO Gene-Phenotype Associations)", "decreased circulating interferon-beta level (MP:0008576 from MPO Gene-Phenotype Associations)", "abnormal circulating interferon-alpha level (MP:0008549 from MPO Gene-Phenotype Associations)", "decreased circulating interferon-alpha level (MP:0008574 from MPO Gene-Phenotype Associations)", "abnormal interferon-beta secretion (MP:0008558 from MPO Gene-Phenotype Associations)", "decreased interferon-beta secretion (MP:0008565 from MPO Gene-Phenotype Associations)", "abnormal interferon-alpha secretion (MP:0008557 from MPO Gene-Phenotype Associations)", "decreased interferon-alpha secretion (MP:0008563 from MPO Gene-Phenotype Associations)", "increased interferon-alpha secretion (MP:0008562 from MPO Gene-Phenotype Associations)", "increased submandibular gland size (MP:0009521 from MPO Gene-Phenotype Associations)", "xerostomia (MP:0000624 from MPO Gene-Phenotype Associations)", "abnormal pruritus (MP:0010071 from MPO Gene-Phenotype Associations)", "increased pruritus (MP:0010072 from MPO Gene-Phenotype Associations)", "abnormal spleen b cell corona morphology (MP:0002360 from MPO Gene-Phenotype Associations)", "abnormal submandibular lymph node morphology (MP:0009627 from MPO Gene-Phenotype Associations)", "enlarged submandibular lymph nodes (MP:0002742 from MPO Gene-Phenotype Associations)", "large lymphoid organs (MP:0002220 from MPO Gene-Phenotype Associations)", "lymphoid hyperplasia (MP:0000688 from MPO Gene-Phenotype Associations)", "increased transitional stage t3 b cell number (MP:0010229 from MPO Gene-Phenotype Associations)", "increased transitional stage t2 b cell number (MP:0009925 from MPO Gene-Phenotype Associations)", "increased transitional stage t1 b cell number (MP:0009922 from MPO Gene-Phenotype Associations)", "abnormal igg2c level (MP:0020178 from MPO Gene-Phenotype Associations)", "increased igg2c level (MP:0008896 from MPO Gene-Phenotype Associations)", "decreased igg2c level (MP:0008897 from MPO Gene-Phenotype Associations)", "decreased heart left ventricle size (MP:0010580 from MPO Gene-Phenotype Associations)", "decreased heart left ventricle weight (MP:0003916 from MPO Gene-Phenotype Associations)", "decreased mitochondria number (MP:0011629 from MPO Gene-Phenotype Associations)", "decreased interleukin-1 secretion (MP:0008652 from MPO Gene-Phenotype Associations)", "decreased organ|body region tumor incidence (MP:0010282 from MPO Gene-Phenotype Associations)", "decreased hepatobiliary system tumor incidence (MP:0012421 from MPO Gene-Phenotype Associations)", "decreased liver tumor incidence (MP:0010266 from MPO Gene-Phenotype Associations)", "decreased hepatoma incidence (MP:0010265 from MPO Gene-Phenotype Associations)", "abnormal golgi apparatus morphology (MP:0011743 from MPO Gene-Phenotype Associations)", "abnormal endoplasmic reticulum morphology (MP:0009378 from MPO Gene-Phenotype Associations)", "abnormal alpha-beta intraepithelial t cell morphology (MP:0008399 from MPO Gene-Phenotype Associations)", "abnormal cd8 positive, alpha-beta intraepithelial t cell morphology (MP:0008401 from MPO Gene-Phenotype Associations)", "abnormal cd4-positive, alpha-beta intraepithelial t cell morphology (MP:0008400 from MPO Gene-Phenotype Associations)", "abnormal follicular dendritic cell antigen presentation (MP:0008198 from MPO Gene-Phenotype Associations)", "abnormal follicular dendritic cell physiology (MP:0008197 from MPO Gene-Phenotype Associations)", "abnormal peritoneal macrophage morphology (MP:0008244 from MPO Gene-Phenotype Associations)", "abnormal macrophage nitric oxide production (MP:0011074 from MPO Gene-Phenotype Associations)", "decreased macrophage nitric oxide production (MP:0011077 from MPO Gene-Phenotype Associations)", "abnormal nitric oxide homeostasis (MP:0003957 from MPO Gene-Phenotype Associations)", "abnormal macrophage cytokine production (MP:0011072 from MPO Gene-Phenotype Associations)", "decreased macrophage cytokine production (MP:0011079 from MPO Gene-Phenotype Associations)", "abnormal immunoglobulin transcytosis (MP:0010223 from MPO Gene-Phenotype Associations)", "increased b-2 b cell number (MP:0008206 from MPO Gene-Phenotype Associations)", "abnormal b cell selection (MP:0004942 from MPO Gene-Phenotype Associations)", "decreased autoantibody level (MP:0003726 from MPO Gene-Phenotype Associations)", "decreased anti-insulin autoantibody level (MP:0002870 from MPO Gene-Phenotype Associations)", "abnormal long lived plasma cell morphology (MP:0010084 from MPO Gene-Phenotype Associations)", "abnormal interleukin-21 secretion (MP:0009056 from MPO Gene-Phenotype Associations)", "decreased interleukin-21 secretion (MP:0009058 from MPO Gene-Phenotype Associations)", "abnormal memory t cell physiology (MP:0008051 from MPO Gene-Phenotype Associations)", "abnormal memory b cell morphology (MP:0002440 from MPO Gene-Phenotype Associations)", "abnormal memory b cell number (MP:0008093 from MPO Gene-Phenotype Associations)", "absent memory b cells (MP:0008094 from MPO Gene-Phenotype Associations)", "decreased memory b cell number (MP:0008729 from MPO Gene-Phenotype Associations)", "increased activation-induced b cell apoptosis (MP:0010674 from MPO Gene-Phenotype Associations)", "abnormal b cell anergy (MP:0008744 from MPO Gene-Phenotype Associations)", "abnormal peripheral b cell anergy (MP:0008746 from MPO Gene-Phenotype Associations)", "abnormal activation-induced b cell apoptosis (MP:0010669 from MPO Gene-Phenotype Associations)", "decreased activation-induced b cell apoptosis (MP:0010675 from MPO Gene-Phenotype Associations)", "abnormal germinal center b cell physiology (MP:0008192 from MPO Gene-Phenotype Associations)", "increased macrophage cytokine production (MP:0011078 from MPO Gene-Phenotype Associations)", "abnormal macrophage apoptosis (MP:0011073 from MPO Gene-Phenotype Associations)", "decreased macrophage apoptosis (MP:0011081 from MPO Gene-Phenotype Associations)", "increased macrophage apoptosis (MP:0011080 from MPO Gene-Phenotype Associations)", "hypoxemia (MP:0012549 from MPO Gene-Phenotype Associations)", "abnormal interleukin-23 secretion (MP:0008689 from MPO Gene-Phenotype Associations)", "decreased interleukin-23 secretion (MP:0008691 from MPO Gene-Phenotype Associations)", "impaired macrophage phagocytosis (MP:0001798 from MPO Gene-Phenotype Associations)", "protruding tongue (MP:0009908 from MPO Gene-Phenotype Associations)", "decreased keratohyalin granule size (MP:0009607 from MPO Gene-Phenotype Associations)", "epidermal necrosis (MP:0001220 from MPO Gene-Phenotype Associations)", "kidney collecting duct atrophy (MP:0011844 from MPO Gene-Phenotype Associations)", "abnormal urine color (MP:0003619 from MPO Gene-Phenotype Associations)", "colorless urine (MP:0011413 from MPO Gene-Phenotype Associations)", "increased fetal derived definitive erythrocyte cell number (MP:0011242 from MPO Gene-Phenotype Associations)", "dacryocytosis (MP:0010176 from MPO Gene-Phenotype Associations)", "acanthocytosis (MP:0010177 from MPO Gene-Phenotype Associations)", "thin hair follicle outer rooth sheath (MP:0010689 from MPO Gene-Phenotype Associations)", "abnormal heart iron level (MP:0008741 from MPO Gene-Phenotype Associations)", "leptocytosis (MP:0010175 from MPO Gene-Phenotype Associations)", "abnormal circulating lipase level (MP:0011885 from MPO Gene-Phenotype Associations)", "increased circulating lipase level (MP:0011886 from MPO Gene-Phenotype Associations)", "abnormal circulating transferrin level (MP:0011892 from MPO Gene-Phenotype Associations)", "abnormal circulating unsaturated transferrin level (MP:0011895 from MPO Gene-Phenotype Associations)", "increased circulating transferrin level (MP:0011893 from MPO Gene-Phenotype Associations)", "increased circulating unsaturated transferrin level (MP:0011896 from MPO Gene-Phenotype Associations)", "decreased circulating transferrin level (MP:0011894 from MPO Gene-Phenotype Associations)", "decreased circulating unsaturated transferrin level (MP:0011897 from MPO Gene-Phenotype Associations)", "abnormal pancreas iron level (MP:0013301 from MPO Gene-Phenotype Associations)", "increased pancreas iron level (MP:0013302 from MPO Gene-Phenotype Associations)", "abnormal circulating ferritin level (MP:0011889 from MPO Gene-Phenotype Associations)", "increased circulating ferritin level (MP:0011890 from MPO Gene-Phenotype Associations)", "abnormal brain iron level (MP:0008811 from MPO Gene-Phenotype Associations)", "hemochromatosis (MP:0005638 from MPO Gene-Phenotype Associations)", "decreased liver iron level (MP:0008743 from MPO Gene-Phenotype Associations)", "abnormal intestinal iron level (MP:0008740 from MPO Gene-Phenotype Associations)", "abnormal circulating iron level (MP:0004152 from MPO Gene-Phenotype Associations)", "decreased circulating iron level (MP:0004151 from MPO Gene-Phenotype Associations)", "abnormal iron homeostasis (MP:0005637 from MPO Gene-Phenotype Associations)", "abnormal iron level (MP:0001770 from MPO Gene-Phenotype Associations)", "increased circulating iron level (MP:0008810 from MPO Gene-Phenotype Associations)", "abnormal spleen iron level (MP:0008739 from MPO Gene-Phenotype Associations)", "decreased spleen iron level (MP:0008808 from MPO Gene-Phenotype Associations)", "abnormal liver iron level (MP:0008738 from MPO Gene-Phenotype Associations)", "increased liver iron level (MP:0008807 from MPO Gene-Phenotype Associations)", "increased spleen iron level (MP:0008809 from MPO Gene-Phenotype Associations)", "abnormal kidney iron level (MP:0008742 from MPO Gene-Phenotype Associations)", "increased kidney iron level (MP:0010375 from MPO Gene-Phenotype Associations)", "increased hemoglobin content (MP:0005564 from MPO Gene-Phenotype Associations)", "increased erythrocyte cell number (MP:0003131 from MPO Gene-Phenotype Associations)", "increased hematocrit (MP:0002608 from MPO Gene-Phenotype Associations)", "polycythemia (MP:0002872 from MPO Gene-Phenotype Associations)", "abnormal erythroblast morphology (MP:0011176 from MPO Gene-Phenotype Associations)", "abnormal erythroblast number (MP:0011177 from MPO Gene-Phenotype Associations)", "abnormal proerythroblast morphology (MP:0002416 from MPO Gene-Phenotype Associations)", "erythroblastosis (MP:0005096 from MPO Gene-Phenotype Associations)", "increased erythroblast number (MP:0011178 from MPO Gene-Phenotype Associations)", "abnormal nucleated erythrocyte cell number (MP:0012397 from MPO Gene-Phenotype Associations)", "increased nucleated erythrocyte cell number (MP:0009395 from MPO Gene-Phenotype Associations)", "abnormal cellular hemoglobin content (MP:0008954 from MPO Gene-Phenotype Associations)", "decreased cellular hemoglobin content (MP:0008956 from MPO Gene-Phenotype Associations)", "abnormal erythrocyte clearance (MP:0010034 from MPO Gene-Phenotype Associations)", "increased erythrocyte clearance (MP:0010035 from MPO Gene-Phenotype Associations)", "low mean erythrocyte cell number (MP:0002594 from MPO Gene-Phenotype Associations)", "abnormal porphyrin level (MP:0011989 from MPO Gene-Phenotype Associations)", "increased porphyrin level (MP:0004147 from MPO Gene-Phenotype Associations)", "increased erythrocyte protoporphyrin level (MP:0011188 from MPO Gene-Phenotype Associations)", "anisopoikilocytosis (MP:0002641 from MPO Gene-Phenotype Associations)", "microcytosis (MP:0002813 from MPO Gene-Phenotype Associations)", "hypochromic anemia (MP:0008387 from MPO Gene-Phenotype Associations)", "hypochromic microcytic anemia (MP:0008388 from MPO Gene-Phenotype Associations)", "microcytic anemia (MP:0002810 from MPO Gene-Phenotype Associations)", "macrocytosis (MP:0000248 from MPO Gene-Phenotype Associations)", "elliptocytosis (MP:0009547 from MPO Gene-Phenotype Associations)", "abnormal red blood cell deformability (MP:0009568 from MPO Gene-Phenotype Associations)", "abnormal erythrocyte morphology (MP:0002447 from MPO Gene-Phenotype Associations)", "abnormal erythropoiesis (MP:0000245 from MPO Gene-Phenotype Associations)", "abnormal hemoglobin (MP:0001588 from MPO Gene-Phenotype Associations)", "abnormal hemoglobin content (MP:0005563 from MPO Gene-Phenotype Associations)", "decreased hemoglobin content (MP:0002874 from MPO Gene-Phenotype Associations)", "abnormal hematocrit (MP:0002596 from MPO Gene-Phenotype Associations)", "decreased hematocrit (MP:0000208 from MPO Gene-Phenotype Associations)", "abnormal erythrocyte cell number (MP:0001586 from MPO Gene-Phenotype Associations)", "decreased erythrocyte cell number (MP:0002875 from MPO Gene-Phenotype Associations)", "abnormal mean corpuscular hemoglobin (MP:0001589 from MPO Gene-Phenotype Associations)", "decreased mean corpuscular hemoglobin (MP:0005562 from MPO Gene-Phenotype Associations)", "decreased mean corpuscular volume (MP:0002591 from MPO Gene-Phenotype Associations)", "abnormal mean corpuscular volume (MP:0000226 from MPO Gene-Phenotype Associations)", "increased mean corpuscular volume (MP:0002590 from MPO Gene-Phenotype Associations)", "abnormal red blood cell distribution width (MP:0010066 from MPO Gene-Phenotype Associations)", "increased red blood cell distribution width (MP:0010067 from MPO Gene-Phenotype Associations)", "anisocytosis (MP:0002642 from MPO Gene-Phenotype Associations)", "polychromatophilia (MP:0005097 from MPO Gene-Phenotype Associations)", "abnormal reticulocyte cell number (MP:0011913 from MPO Gene-Phenotype Associations)", "abnormal reticulocyte morphology (MP:0002424 from MPO Gene-Phenotype Associations)", "reticulocytosis (MP:0002640 from MPO Gene-Phenotype Associations)", "anemia (MP:0001577 from MPO Gene-Phenotype Associations)", "hemolytic anemia (MP:0001585 from MPO Gene-Phenotype Associations)", "abnormal erythrocyte physiology (MP:0003656 from MPO Gene-Phenotype Associations)", "abnormal erythrocyte osmotic lysis (MP:0003657 from MPO Gene-Phenotype Associations)", "hemolysis (MP:0010163 from MPO Gene-Phenotype Associations)", "poikilocytosis (MP:0002643 from MPO Gene-Phenotype Associations)", "schistocytosis (MP:0000314 from MPO Gene-Phenotype Associations)", "spherocytosis (MP:0002812 from MPO Gene-Phenotype Associations)", "abnormal circulating bilirubin level (MP:0001569 from MPO Gene-Phenotype Associations)", "increased circulating bilirubin level (MP:0005344 from MPO Gene-Phenotype Associations)", "jaundice (MP:0000611 from MPO Gene-Phenotype Associations)", "abnormal mean corpuscular hemoglobin concentration (MP:0005640 from MPO Gene-Phenotype Associations)", "decreased mean corpuscular hemoglobin concentration (MP:0005642 from MPO Gene-Phenotype Associations)", "increased mean corpuscular hemoglobin concentration (MP:0005641 from MPO Gene-Phenotype Associations)", "increased mean corpuscular hemoglobin (MP:0005561 from MPO Gene-Phenotype Associations)", "stomatocytosis (MP:0010074 from MPO Gene-Phenotype Associations)", "hyperchromasia (MP:0002814 from MPO Gene-Phenotype Associations)", "abnormal circulating erythropoietin level (MP:0011284 from MPO Gene-Phenotype Associations)", "abnormal erythropoietin level (MP:0011283 from MPO Gene-Phenotype Associations)", "increased circulating erythropoietin level (MP:0011285 from MPO Gene-Phenotype Associations)", "increased erythropoietin level (MP:0011287 from MPO Gene-Phenotype Associations)", "abnormal granulocyte differentiation (MP:0008111 from MPO Gene-Phenotype Associations)", "abnormal myelopoiesis (MP:0001601 from MPO Gene-Phenotype Associations)", "abnormal neutrophil differentiation (MP:0002415 from MPO Gene-Phenotype Associations)", "impaired myelopoiesis (MP:0001602 from MPO Gene-Phenotype Associations)", "myeloid hyperplasia (MP:0010373 from MPO Gene-Phenotype Associations)", "increased bone marrow cell number (MP:0000321 from MPO Gene-Phenotype Associations)", "increased leukemia incidence (MP:0002026 from MPO Gene-Phenotype Associations)", "increased chronic myelocytic leukemia incidence (MP:0005481 from MPO Gene-Phenotype Associations)", "decreased spleen white pulp amount (MP:0008479 from MPO Gene-Phenotype Associations)", "abnormal spleen red pulp morphology (MP:0002356 from MPO Gene-Phenotype Associations)", "increased spleen red pulp amount (MP:0008476 from MPO Gene-Phenotype Associations)", "abnormal bone marrow cell morphology|development (MP:0002398 from MPO Gene-Phenotype Associations)", "abnormal megakaryocyte morphology (MP:0002417 from MPO Gene-Phenotype Associations)", "abnormal megakaryocyte progenitor cell morphology (MP:0002413 from MPO Gene-Phenotype Associations)", "abnormal platelet morphology (MP:0004720 from MPO Gene-Phenotype Associations)", "abnormal thrombopoiesis (MP:0000228 from MPO Gene-Phenotype Associations)", "abnormal platelet cell number (MP:0011898 from MPO Gene-Phenotype Associations)", "decreased platelet cell number (MP:0003179 from MPO Gene-Phenotype Associations)", "increased platelet cell number (MP:0005505 from MPO Gene-Phenotype Associations)", "abnormal platelet volume (MP:0002586 from MPO Gene-Phenotype Associations)", "increased mean platelet volume (MP:0002599 from MPO Gene-Phenotype Associations)", "abnormal megakaryocyte differentiation (MP:0000229 from MPO Gene-Phenotype Associations)", "increased megakaryocyte cell number (MP:0008254 from MPO Gene-Phenotype Associations)", "abnormal bone marrow cell number (MP:0000172 from MPO Gene-Phenotype Associations)", "decreased bone marrow cell number (MP:0000333 from MPO Gene-Phenotype Associations)", "abnormal common myeloid progenitor cell morphology (MP:0006410 from MPO Gene-Phenotype Associations)", "decreased common myeloid progenitor cell number (MP:0008813 from MPO Gene-Phenotype Associations)", "absent common myeloid progenitor cells (MP:0000239 from MPO Gene-Phenotype Associations)", "absent bone marrow cell (MP:0000175 from MPO Gene-Phenotype Associations)", "abnormal hematopoietic stem cell morphology (MP:0004808 from MPO Gene-Phenotype Associations)", "decreased hematopoietic stem cell number (MP:0004810 from MPO Gene-Phenotype Associations)", "abnormal hematopoietic stem cell physiology (MP:0010763 from MPO Gene-Phenotype Associations)", "increased hematopoietic stem cell number (MP:0004809 from MPO Gene-Phenotype Associations)", "abnormal common lymphocyte progenitor cell morphology (MP:0008249 from MPO Gene-Phenotype Associations)", "abnormal erythroid progenitor cell morphology (MP:0008801 from MPO Gene-Phenotype Associations)", "decreased erythroid progenitor cell number (MP:0008973 from MPO Gene-Phenotype Associations)", "increased erythroid progenitor cell number (MP:0003135 from MPO Gene-Phenotype Associations)", "impaired hematopoiesis (MP:0001606 from MPO Gene-Phenotype Associations)", "pale liver (MP:0000603 from MPO Gene-Phenotype Associations)", "liver hypoplasia (MP:0000600 from MPO Gene-Phenotype Associations)", "abnormal platelet shape (MP:0003405 from MPO Gene-Phenotype Associations)", "increased number of howell-jolly bodies (MP:0010178 from MPO Gene-Phenotype Associations)", "increased tumor incidence following infection (MP:0012563 from MPO Gene-Phenotype Associations)", "hyperventilation (MP:0002320 from MPO Gene-Phenotype Associations)", "hyperoxia (MP:0002319 from MPO Gene-Phenotype Associations)", "abnormal fetal derived definitive erythrocyte cell number (MP:0011241 from MPO Gene-Phenotype Associations)", "abnormal fetal derived definitive erythrocyte morphology (MP:0011240 from MPO Gene-Phenotype Associations)", "decreased fetal derived definitive erythrocyte cell number (MP:0011243 from MPO Gene-Phenotype Associations)", "abnormal interventricular groove morphology (MP:0004032 from MPO Gene-Phenotype Associations)", "abnormal heart right ventricle weight (MP:0020205 from MPO Gene-Phenotype Associations)", "increased heart right ventricle weight (MP:0003913 from MPO Gene-Phenotype Associations)", "increased time of peak ischemic contracture (MP:0003039 from MPO Gene-Phenotype Associations)", "dermal hyperplasia (MP:0004971 from MPO Gene-Phenotype Associations)", "abnormal basophil cell number (MP:0012442 from MPO Gene-Phenotype Associations)", "abnormal basophil morphology (MP:0002422 from MPO Gene-Phenotype Associations)", "decreased basophil cell number (MP:0002607 from MPO Gene-Phenotype Associations)", "increased basophil cell number (MP:0002606 from MPO Gene-Phenotype Associations)", "absent mast cells (MP:0011696 from MPO Gene-Phenotype Associations)", "increased pre-pro b cell number (MP:0011815 from MPO Gene-Phenotype Associations)", "decreased circulating interleukin-12 level (MP:0008618 from MPO Gene-Phenotype Associations)", "abnormal pre-pro b cell morphology (MP:0011814 from MPO Gene-Phenotype Associations)", "decreased pre-pro b cell number (MP:0011816 from MPO Gene-Phenotype Associations)", "decreased dn3 thymocyte number (MP:0010134 from MPO Gene-Phenotype Associations)", "decreased dn2 thymocyte number (MP:0010132 from MPO Gene-Phenotype Associations)", "abnormal plasmacytoid dendritic cell morphology (MP:0004242 from MPO Gene-Phenotype Associations)", "abnormal plasmacytoid dendritic cell number (MP:0008123 from MPO Gene-Phenotype Associations)", "decreased plasmacytoid dendritic cell number (MP:0008124 from MPO Gene-Phenotype Associations)", "increased spleen white pulp amount (MP:0008478 from MPO Gene-Phenotype Associations)", "reticulocytopenia (MP:0008941 from MPO Gene-Phenotype Associations)", "hyperchromic macrocytic anemia (MP:0008945 from MPO Gene-Phenotype Associations)", "macrocytic anemia (MP:0002811 from MPO Gene-Phenotype Associations)", "small popliteal lymph nodes (MP:0009636 from MPO Gene-Phenotype Associations)", "decreased activated t cell number (MP:0001830 from MPO Gene-Phenotype Associations)", "abnormal t follicular helper cell morphology (MP:0010184 from MPO Gene-Phenotype Associations)", "abnormal t follicular helper cell number (MP:0010185 from MPO Gene-Phenotype Associations)", "increased t follicular helper cell number (MP:0010186 from MPO Gene-Phenotype Associations)", "decreased t follicular helper cell number (MP:0010187 from MPO Gene-Phenotype Associations)", "abnormal urine nucleoside level (MP:0011477 from MPO Gene-Phenotype Associations)", "abnormal urine nucleotide level (MP:0011476 from MPO Gene-Phenotype Associations)", "abnormal purine-nucleoside phosphorylase activity (MP:0011595 from MPO Gene-Phenotype Associations)", "decreased purine-nucleoside phosphorylase activity (MP:0011597 from MPO Gene-Phenotype Associations)", "increased pre-b cell number (MP:0003132 from MPO Gene-Phenotype Associations)", "abnormal naive b cell morphology (MP:0008184 from MPO Gene-Phenotype Associations)", "decreased naive b cell number (MP:0008185 from MPO Gene-Phenotype Associations)", "absent zona pellucida (MP:0003697 from MPO Gene-Phenotype Associations)", "abnormal theca folliculi (MP:0009365 from MPO Gene-Phenotype Associations)", "absent theca folliculi (MP:0009368 from MPO Gene-Phenotype Associations)", "decreased unsaturated fatty acid level (MP:0005285 from MPO Gene-Phenotype Associations)", "lymphoid hypoplasia (MP:0002223 from MPO Gene-Phenotype Associations)", "small lymphoid organs (MP:0000687 from MPO Gene-Phenotype Associations)", "decreased saturated fatty acid level (MP:0005286 from MPO Gene-Phenotype Associations)", "ovary hypoplasia (MP:0005158 from MPO Gene-Phenotype Associations)", "increased cellular sensitivity to alkylating agents (MP:0008402 from MPO Gene-Phenotype Associations)", "increased cellular sensitivity to methylmethanesulfonate (MP:0008404 from MPO Gene-Phenotype Associations)", "abnormal t cell receptor alpha chain v-j recombination (MP:0008756 from MPO Gene-Phenotype Associations)", "increased cellular sensitivity to x-ray irradiation (MP:0002879 from MPO Gene-Phenotype Associations)", "abnormal small intestinal crypt cell physiology (MP:0010156 from MPO Gene-Phenotype Associations)", "increased small intestinal crypt cell apoptosis (MP:0008800 from MPO Gene-Phenotype Associations)", "interstitial pneumonia (MP:0001862 from MPO Gene-Phenotype Associations)", "absent b-2 b cells (MP:0008205 from MPO Gene-Phenotype Associations)", "abnormal late pro-b cell (MP:0005020 from MPO Gene-Phenotype Associations)", "absent late pro-b cells (MP:0005434 from MPO Gene-Phenotype Associations)", "absent pro-b cells (MP:0008187 from MPO Gene-Phenotype Associations)", "abnormal immunoglobulin heavy chain v(d)j recombination (MP:0008760 from MPO Gene-Phenotype Associations)", "abnormal immunoglobulin v(d)j recombination (MP:0008755 from MPO Gene-Phenotype Associations)", "abnormal immunoglobulin light chain v-j recombination (MP:0008761 from MPO Gene-Phenotype Associations)", "abnormal t cell receptor v(d)j recombination (MP:0008754 from MPO Gene-Phenotype Associations)", "abnormal t cell receptor beta chain v(d)j recombination (MP:0008758 from MPO Gene-Phenotype Associations)", "abnormal complement pathway (MP:0002471 from MPO Gene-Phenotype Associations)", "impaired complement alternative pathway (MP:0002472 from MPO Gene-Phenotype Associations)", "impaired complement classical pathway (MP:0002473 from MPO Gene-Phenotype Associations)", "increased susceptibility to experimental autoimmune myasthenia gravis (MP:0004823 from MPO Gene-Phenotype Associations)", "impaired lectin complement pathway (MP:0009062 from MPO Gene-Phenotype Associations)", "abnormal intestinal secretion (MP:0008864 from MPO Gene-Phenotype Associations)", "abnormal pontine flexure morphology (MP:0000844 from MPO Gene-Phenotype Associations)", "absent schwann cell precursors (MP:0001109 from MPO Gene-Phenotype Associations)", "abnormal adrenergic chromaffin cell morphology (MP:0003834 from MPO Gene-Phenotype Associations)", "absent adrenergic chromaffin cells (MP:0000645 from MPO Gene-Phenotype Associations)", "abnormal adrenal chromaffin cell morphology (MP:0008504 from MPO Gene-Phenotype Associations)", "abnormal neuroendocrine cell morphology (MP:0010913 from MPO Gene-Phenotype Associations)", "abnormal adrenal medulla morphology (MP:0008289 from MPO Gene-Phenotype Associations)", "absent adrenal chromaffin cells (MP:0008505 from MPO Gene-Phenotype Associations)", "abnormal adrenocortical cell morphology (MP:0008291 from MPO Gene-Phenotype Associations)", "enlarged adrenocortical cells (MP:0000646 from MPO Gene-Phenotype Associations)", "abnormal zona glomerulosa morphology (MP:0008293 from MPO Gene-Phenotype Associations)", "absent adrenal medulla (MP:0000643 from MPO Gene-Phenotype Associations)", "enlarged adrenocortical cell nuclei (MP:0008292 from MPO Gene-Phenotype Associations)", "abnormal zona reticularis morphology (MP:0008295 from MPO Gene-Phenotype Associations)", "abnormal adrenal cortex morphology (MP:0008288 from MPO Gene-Phenotype Associations)", "abnormal adrenal gland morphology (MP:0000639 from MPO Gene-Phenotype Associations)", "abnormal zona fasciculata morphology (MP:0008294 from MPO Gene-Phenotype Associations)", "abnormal circulating corticosterone level (MP:0005345 from MPO Gene-Phenotype Associations)", "abnormal circulating glucocorticoid level (MP:0003366 from MPO Gene-Phenotype Associations)", "abnormal corticosterone level (MP:0003963 from MPO Gene-Phenotype Associations)", "increased circulating corticosterone level (MP:0001745 from MPO Gene-Phenotype Associations)", "increased circulating glucocorticoid level (MP:0003367 from MPO Gene-Phenotype Associations)", "decreased circulating corticosterone level (MP:0002665 from MPO Gene-Phenotype Associations)", "decreased circulating glucocorticoid level (MP:0003368 from MPO Gene-Phenotype Associations)", "abnormal adrenocorticotropin level (MP:0003966 from MPO Gene-Phenotype Associations)", "increased adrenocorticotropin level (MP:0005129 from MPO Gene-Phenotype Associations)", "increased circulating adrenocorticotropin level (MP:0001748 from MPO Gene-Phenotype Associations)", "adrenal gland hypoplasia (MP:0000640 from MPO Gene-Phenotype Associations)", "small adrenal glands (MP:0002768 from MPO Gene-Phenotype Associations)", "decreased adrenocorticotropin level (MP:0005128 from MPO Gene-Phenotype Associations)", "decreased circulating adrenocorticotropin level (MP:0002664 from MPO Gene-Phenotype Associations)", "absent circulating adrenaline (MP:0001742 from MPO Gene-Phenotype Associations)", "absent circulating noradrenaline (MP:0001743 from MPO Gene-Phenotype Associations)", "enlarged superior cervical ganglion (MP:0001013 from MPO Gene-Phenotype Associations)", "abnormal carotid body morphology (MP:0003437 from MPO Gene-Phenotype Associations)", "abnormal adrenaline level (MP:0003962 from MPO Gene-Phenotype Associations)", "abnormal circulating adrenaline level (MP:0005660 from MPO Gene-Phenotype Associations)", "decreased circulating adrenaline level (MP:0005661 from MPO Gene-Phenotype Associations)", "abnormal circulating noradrenaline level (MP:0005663 from MPO Gene-Phenotype Associations)", "abnormal noradrenaline level (MP:0003964 from MPO Gene-Phenotype Associations)", "decreased circulating noradrenaline level (MP:0005664 from MPO Gene-Phenotype Associations)", "decreased noradrenaline level (MP:0012574 from MPO Gene-Phenotype Associations)", "abnormal bradykinin level (MP:0009812 from MPO Gene-Phenotype Associations)", "abnormal circulating antidiuretic hormone level (MP:0005609 from MPO Gene-Phenotype Associations)", "increased circulating antidiuretic hormone level (MP:0005610 from MPO Gene-Phenotype Associations)", "increased circulating adrenaline level (MP:0005662 from MPO Gene-Phenotype Associations)", "increased circulating noradrenaline level (MP:0005665 from MPO Gene-Phenotype Associations)", "increased noradrenaline level (MP:0012575 from MPO Gene-Phenotype Associations)", "abnormal adrenal gland physiology (MP:0002909 from MPO Gene-Phenotype Associations)", "abnormal adrenal gland secretion (MP:0001739 from MPO Gene-Phenotype Associations)", "failure of adrenal epinephrine secretion (MP:0001740 from MPO Gene-Phenotype Associations)", "adrenal cortical hyperplasia (MP:0008299 from MPO Gene-Phenotype Associations)", "ecchymosis (MP:0009276 from MPO Gene-Phenotype Associations)", "bruising (MP:0009275 from MPO Gene-Phenotype Associations)", "hematoma (MP:0008817 from MPO Gene-Phenotype Associations)", "abnormal adrenal gland weight (MP:0012689 from MPO Gene-Phenotype Associations)", "increased adrenal gland weight (MP:0013307 from MPO Gene-Phenotype Associations)", "abnormal urine corticosterone level (MP:0011548 from MPO Gene-Phenotype Associations)", "increased urine corticosterone level (MP:0011549 from MPO Gene-Phenotype Associations)", "thin tail (MP:0000589 from MPO Gene-Phenotype Associations)", "adrenal gland hyperplasia (MP:0009078 from MPO Gene-Phenotype Associations)", "enlarged adrenal glands (MP:0000642 from MPO Gene-Phenotype Associations)", "uterus cysts (MP:0009082 from MPO Gene-Phenotype Associations)", "uterus adenomyosis (MP:0009221 from MPO Gene-Phenotype Associations)", "abnormal urine aldosterone level (MP:0011539 from MPO Gene-Phenotype Associations)", "decreased urine aldosterone level (MP:0011541 from MPO Gene-Phenotype Associations)", "abnormal urine hormone level (MP:0011538 from MPO Gene-Phenotype Associations)", "decreased urine corticosterone level (MP:0011550 from MPO Gene-Phenotype Associations)", "abnormal urine progesterone level (MP:0011545 from MPO Gene-Phenotype Associations)", "increased urine progesterone level (MP:0011546 from MPO Gene-Phenotype Associations)", "abnormal urine deoxycorticosterone level (MP:0011552 from MPO Gene-Phenotype Associations)", "increased urine deoxycorticosterone level (MP:0011553 from MPO Gene-Phenotype Associations)", "bronchiolar epithelial hyperplasia (MP:0010910 from MPO Gene-Phenotype Associations)", "lung epithelium hyperplasia (MP:0010945 from MPO Gene-Phenotype Associations)", "pale lung (MP:0010887 from MPO Gene-Phenotype Associations)", "endometrium hyperplasia (MP:0009092 from MPO Gene-Phenotype Associations)", "increased uterus weight (MP:0004904 from MPO Gene-Phenotype Associations)", "enlarged uterus (MP:0004906 from MPO Gene-Phenotype Associations)", "increased thyrotroph cell number (MP:0008337 from MPO Gene-Phenotype Associations)", "iodide oxidation defect (MP:0003501 from MPO Gene-Phenotype Associations)", "unidirectional circling (MP:0001396 from MPO Gene-Phenotype Associations)", "increased lactotroph cell number (MP:0008331 from MPO Gene-Phenotype Associations)", "pituitary gland peliosis (MP:0013333 from MPO Gene-Phenotype Associations)", "short uterine horn (MP:0009089 from MPO Gene-Phenotype Associations)", "decreased lactotroph cell size (MP:0008423 from MPO Gene-Phenotype Associations)", "abnormal melanotroph morphology (MP:0008324 from MPO Gene-Phenotype Associations)", "adenohypophysis peliosis (MP:0013334 from MPO Gene-Phenotype Associations)", "peliosis (MP:0013332 from MPO Gene-Phenotype Associations)", "abnormal large intestinal transit time (MP:0006003 from MPO Gene-Phenotype Associations)", "uterus hyperplasia (MP:0002676 from MPO Gene-Phenotype Associations)", "abnormal pituitary intermediate lobe morphology (MP:0008130 from MPO Gene-Phenotype Associations)", "enlarged pituitary intermediate lobe (MP:0008370 from MPO Gene-Phenotype Associations)", "pituitary intermediate lobe hyperplasia (MP:0008371 from MPO Gene-Phenotype Associations)", "enlarged adenohypophysis (MP:0008366 from MPO Gene-Phenotype Associations)", "abnormal latent inhibition of conditioning behavior (MP:0006299 from MPO Gene-Phenotype Associations)", "abnormal response to novel odor (MP:0003462 from MPO Gene-Phenotype Associations)", "catalepsy (MP:0002822 from MPO Gene-Phenotype Associations)", "enlarged pituitary gland (MP:0000636 from MPO Gene-Phenotype Associations)", "pituitary gland hyperplasia (MP:0000635 from MPO Gene-Phenotype Associations)", "abnormal pituitary gland weight (MP:0008937 from MPO Gene-Phenotype Associations)", "increased pituitary gland weight (MP:0008939 from MPO Gene-Phenotype Associations)", "pituitary gland hypertrophy (MP:0013336 from MPO Gene-Phenotype Associations)", "abnormal operant conditioning behavior (MP:0002803 from MPO Gene-Phenotype Associations)", "abnormal response to stress-induced hyperthermia (MP:0010165 from MPO Gene-Phenotype Associations)", "decreased response to stress-induced hyperthermia (MP:0010167 from MPO Gene-Phenotype Associations)", "decreased pituitary gland weight (MP:0008938 from MPO Gene-Phenotype Associations)", "delayed balanopreputial separation (MP:0008940 from MPO Gene-Phenotype Associations)", "increased abdominal fat pad weight (MP:0009286 from MPO Gene-Phenotype Associations)", "impaired luteinization (MP:0003356 from MPO Gene-Phenotype Associations)", "increased circulating prolactin level (MP:0005124 from MPO Gene-Phenotype Associations)", "increased prolactin level (MP:0005139 from MPO Gene-Phenotype Associations)", "lipofuscinosis (MP:0008842 from MPO Gene-Phenotype Associations)", "abnormal conditioned taste aversion behavior (MP:0002805 from MPO Gene-Phenotype Associations)", "decreased alcohol consumption (MP:0003546 from MPO Gene-Phenotype Associations)", "decreased fluid intake (MP:0011942 from MPO Gene-Phenotype Associations)", "alcohol aversion (MP:0002570 from MPO Gene-Phenotype Associations)", "aversion to addictive substance (MP:0002554 from MPO Gene-Phenotype Associations)", "abnormal microglial cell activation (MP:0010762 from MPO Gene-Phenotype Associations)", "abnormal microglial cell physiology (MP:0003691 from MPO Gene-Phenotype Associations)", "abnormal glial cell physiology (MP:0003690 from MPO Gene-Phenotype Associations)", "abnormal astrocyte physiology (MP:0008916 from MPO Gene-Phenotype Associations)", "abnormal alcohol consumption (MP:0001425 from MPO Gene-Phenotype Associations)", "increased alcohol consumption (MP:0003545 from MPO Gene-Phenotype Associations)", "abnormal liquid preference (MP:0001423 from MPO Gene-Phenotype Associations)", "alcohol preference (MP:0001987 from MPO Gene-Phenotype Associations)", "preference for addictive substance (MP:0002553 from MPO Gene-Phenotype Associations)", "abnormal behavioral response to alcohol (MP:0020157 from MPO Gene-Phenotype Associations)", "enhanced behavioral response to alcohol (MP:0009751 from MPO Gene-Phenotype Associations)", "hyperactivity elicited by ethanol administration (MP:0002629 from MPO Gene-Phenotype Associations)", "impaired behavioral response to alcohol (MP:0009755 from MPO Gene-Phenotype Associations)", "abnormal saccharin consumption (MP:0002849 from MPO Gene-Phenotype Associations)", "sweet preference (MP:0011976 from MPO Gene-Phenotype Associations)", "saccharin preference (MP:0002850 from MPO Gene-Phenotype Associations)", "abnormal food preference (MP:0001432 from MPO Gene-Phenotype Associations)", "axial mesoderm hypoplasia (MP:0012273 from MPO Gene-Phenotype Associations)", "absent gonadotrophs (MP:0008336 from MPO Gene-Phenotype Associations)", "anisocoria (MP:0006240 from MPO Gene-Phenotype Associations)", "abnormal eye muscle development (MP:0003818 from MPO Gene-Phenotype Associations)", "abnormal superior vena cava morphology (MP:0006064 from MPO Gene-Phenotype Associations)", "enlarged heart left atrium (MP:0008726 from MPO Gene-Phenotype Associations)", "decreased axial mesoderm size (MP:0012272 from MPO Gene-Phenotype Associations)", "abnormal coronary sinus morphology (MP:0010436 from MPO Gene-Phenotype Associations)", "absent coronary sinus (MP:0010437 from MPO Gene-Phenotype Associations)", "anomalous pulmonary venous connection (MP:0010440 from MPO Gene-Phenotype Associations)", "abnormal extraocular muscle morphology (MP:0005247 from MPO Gene-Phenotype Associations)", "abnormal eye muscle morphology (MP:0003686 from MPO Gene-Phenotype Associations)", "enophthalmos (MP:0006198 from MPO Gene-Phenotype Associations)", "abnormal rib development (MP:0002823 from MPO Gene-Phenotype Associations)", "total anomalous pulmonary venous connection (MP:0010441 from MPO Gene-Phenotype Associations)", "total anomalous pulmonary venous connection, intracardiac (MP:0010443 from MPO Gene-Phenotype Associations)", "abnormal azygos vein morphology (MP:0011569 from MPO Gene-Phenotype Associations)", "decreased heart right ventricle size (MP:0003649 from MPO Gene-Phenotype Associations)", "heart right ventricle hypoplasia (MP:0010422 from MPO Gene-Phenotype Associations)", "common atrium (MP:0010406 from MPO Gene-Phenotype Associations)", "abnormal adenohypophysis development (MP:0013337 from MPO Gene-Phenotype Associations)", "abnormal pituitary diverticulum morphology (MP:0003817 from MPO Gene-Phenotype Associations)", "abnormal pituitary gland development (MP:0003816 from MPO Gene-Phenotype Associations)", "abnormal rathke's pouch development (MP:0013351 from MPO Gene-Phenotype Associations)", "absent rathke's pouch (MP:0011759 from MPO Gene-Phenotype Associations)", "small rathke's pouch (MP:0013349 from MPO Gene-Phenotype Associations)", "abnormal adenohypophysis morphology (MP:0004163 from MPO Gene-Phenotype Associations)", "abnormal neuroendocrine gland morphology (MP:0000631 from MPO Gene-Phenotype Associations)", "abnormal pituitary gland morphology (MP:0000633 from MPO Gene-Phenotype Associations)", "abnormal diencephalon morphology (MP:0000830 from MPO Gene-Phenotype Associations)", "abnormal somatotroph morphology (MP:0008322 from MPO Gene-Phenotype Associations)", "decreased somatotroph cell number (MP:0008329 from MPO Gene-Phenotype Associations)", "abnormal thyrotroph morphology (MP:0008326 from MPO Gene-Phenotype Associations)", "decreased thyrotroph cell number (MP:0008338 from MPO Gene-Phenotype Associations)", "abnormal gonadotroph morphology (MP:0008325 from MPO Gene-Phenotype Associations)", "decreased gonadotroph cell number (MP:0008335 from MPO Gene-Phenotype Associations)", "absent somatotrophs (MP:0008330 from MPO Gene-Phenotype Associations)", "absent lactotrophs (MP:0008333 from MPO Gene-Phenotype Associations)", "abnormal lactotroph morphology (MP:0008323 from MPO Gene-Phenotype Associations)", "decreased lactotroph cell number (MP:0008332 from MPO Gene-Phenotype Associations)", "adenohypophysis hypoplasia (MP:0008365 from MPO Gene-Phenotype Associations)", "small adenohypophysis (MP:0008321 from MPO Gene-Phenotype Associations)", "absent thyrotrophs (MP:0008339 from MPO Gene-Phenotype Associations)", "absent pituitary intermediate lobe (MP:0008367 from MPO Gene-Phenotype Associations)", "small pituitary intermediate lobe (MP:0008368 from MPO Gene-Phenotype Associations)", "abnormal pituitary gland size (MP:0008936 from MPO Gene-Phenotype Associations)", "small pituitary gland (MP:0005361 from MPO Gene-Phenotype Associations)", "pituitary gland hypoplasia (MP:0002659 from MPO Gene-Phenotype Associations)", "abnormal pituitary gland apoptosis (MP:0013343 from MPO Gene-Phenotype Associations)", "increased pituitary gland apoptosis (MP:0013344 from MPO Gene-Phenotype Associations)", "extended life span (MP:0001661 from MPO Gene-Phenotype Associations)", "absent somatotroph secretory granules (MP:0008437 from MPO Gene-Phenotype Associations)", "decreased somatotroph cell size (MP:0008417 from MPO Gene-Phenotype Associations)", "decreased bone mineral density of femur (MP:0020010 from MPO Gene-Phenotype Associations)", "decreased somatotroph secretory granule number (MP:0008436 from MPO Gene-Phenotype Associations)", "proportional dwarf (MP:0008974 from MPO Gene-Phenotype Associations)", "abnormal growth hormone level (MP:0003968 from MPO Gene-Phenotype Associations)", "decreased growth hormone level (MP:0005136 from MPO Gene-Phenotype Associations)", "decreased circulating growth hormone level (MP:0005120 from MPO Gene-Phenotype Associations)", "increased circulating growth hormone level (MP:0005123 from MPO Gene-Phenotype Associations)", "increased growth hormone level (MP:0005137 from MPO Gene-Phenotype Associations)", "abnormal circulating insulin-like growth factor i level (MP:0004700 from MPO Gene-Phenotype Associations)", "abnormal insulin-like growth factor i level (MP:0008831 from MPO Gene-Phenotype Associations)", "decreased circulating insulin-like growth factor i level (MP:0004701 from MPO Gene-Phenotype Associations)", "increased susceptibility to age related obesity (MP:0003212 from MPO Gene-Phenotype Associations)", "hyperchlorhydria (MP:0008002 from MPO Gene-Phenotype Associations)", "abnormal inhibitory postsynaptic potential (MP:0002911 from MPO Gene-Phenotype Associations)", "abnormal circulating ghrelin level (MP:0011611 from MPO Gene-Phenotype Associations)", "increased circulating ghrelin level (MP:0011612 from MPO Gene-Phenotype Associations)", "abnormal somatostatin level (MP:0011067 from MPO Gene-Phenotype Associations)", "decreased circulating ghrelin level (MP:0011613 from MPO Gene-Phenotype Associations)", "abnormal thyroid diverticulum morphology (MP:0004662 from MPO Gene-Phenotype Associations)", "absent endometrium (MP:0009224 from MPO Gene-Phenotype Associations)", "absent thyroid follicular cells (MP:0004660 from MPO Gene-Phenotype Associations)", "dilated oviduct (MP:0009069 from MPO Gene-Phenotype Associations)", "abnormal stapedial artery morphology (MP:0004665 from MPO Gene-Phenotype Associations)", "absent stapedial artery (MP:0004666 from MPO Gene-Phenotype Associations)", "abnormal inner hair cell synaptic ribbon morphology (MP:0004562 from MPO Gene-Phenotype Associations)", "abnormal cochlear inner hair cell physiology (MP:0004433 from MPO Gene-Phenotype Associations)", "abnormal cochlear ihc efferent innervation pattern (MP:0004633 from MPO Gene-Phenotype Associations)", "absent active-zone-anchored inner hair cell synaptic ribbon (MP:0004563 from MPO Gene-Phenotype Associations)", "splitting of guard hairs (MP:0000398 from MPO Gene-Phenotype Associations)", "constricted vagina orifice (MP:0001143 from MPO Gene-Phenotype Associations)", "abnormal uterine cervix morphology (MP:0001135 from MPO Gene-Phenotype Associations)", "dilated uterine cervix (MP:0001136 from MPO Gene-Phenotype Associations)", "abnormal vagina orifice morphology (MP:0001142 from MPO Gene-Phenotype Associations)", "abnormal vagina morphology (MP:0001139 from MPO Gene-Phenotype Associations)", "vagina atresia (MP:0001144 from MPO Gene-Phenotype Associations)", "spiral ligament degeneration (MP:0004864 from MPO Gene-Phenotype Associations)", "increased thyroid gland weight (MP:0020169 from MPO Gene-Phenotype Associations)", "increased activity of thyroid (MP:0003502 from MPO Gene-Phenotype Associations)", "increased circulating thyroxine level (MP:0005477 from MPO Gene-Phenotype Associations)", "increased thyroxine level (MP:0005470 from MPO Gene-Phenotype Associations)", "increased circulating levels of thyroid hormone (MP:0003350 from MPO Gene-Phenotype Associations)", "increased circulating triiodothyronine level (MP:0005480 from MPO Gene-Phenotype Associations)", "increased triiodothyronine level (MP:0005474 from MPO Gene-Phenotype Associations)", "abnormal inner ear development (MP:0011238 from MPO Gene-Phenotype Associations)", "delayed inner ear development (MP:0004664 from MPO Gene-Phenotype Associations)", "enlarged thyroid gland (MP:0005355 from MPO Gene-Phenotype Associations)", "thyroid gland hyperplasia (MP:0003498 from MPO Gene-Phenotype Associations)", "abnormal thyroid follicle morphology (MP:0004696 from MPO Gene-Phenotype Associations)", "abnormal thyroid follicular cell morphology (MP:0004697 from MPO Gene-Phenotype Associations)", "abnormal thyroid-stimulating hormone level (MP:0003971 from MPO Gene-Phenotype Associations)", "increased circulating thyroid-stimulating hormone level (MP:0005122 from MPO Gene-Phenotype Associations)", "increased thyroid-stimulating hormone level (MP:0005135 from MPO Gene-Phenotype Associations)", "abnormal thyroid physiology (MP:0002876 from MPO Gene-Phenotype Associations)", "decreased activity of thyroid (MP:0003503 from MPO Gene-Phenotype Associations)", "abnormal circulating thyroxine level (MP:0005475 from MPO Gene-Phenotype Associations)", "decreased circulating levels of thyroid hormone (MP:0003351 from MPO Gene-Phenotype Associations)", "decreased circulating thyroxine level (MP:0005478 from MPO Gene-Phenotype Associations)", "abnormal thyroxine level (MP:0005469 from MPO Gene-Phenotype Associations)", "decreased thyroxine level (MP:0005471 from MPO Gene-Phenotype Associations)", "abnormal thyroid hormone level (MP:0005468 from MPO Gene-Phenotype Associations)", "abnormal circulating triiodothyronine level (MP:0005476 from MPO Gene-Phenotype Associations)", "abnormal triiodothyronine level (MP:0005472 from MPO Gene-Phenotype Associations)", "decreased circulating triiodothyronine level (MP:0005479 from MPO Gene-Phenotype Associations)", "decreased triiodothyronine level (MP:0005473 from MPO Gene-Phenotype Associations)", "abnormal oviduct weight (MP:0009065 from MPO Gene-Phenotype Associations)", "decreased oviduct weight (MP:0009066 from MPO Gene-Phenotype Associations)", "decreased circulating thyroid-stimulating hormone level (MP:0005119 from MPO Gene-Phenotype Associations)", "decreased thyroid-stimulating hormone level (MP:0005134 from MPO Gene-Phenotype Associations)", "abnormal basal metabolism (MP:0008961 from MPO Gene-Phenotype Associations)", "increased basal metabolism (MP:0008965 from MPO Gene-Phenotype Associations)", "retina microaneurysm (MP:0010452 from MPO Gene-Phenotype Associations)", "retinal gliosis (MP:0009392 from MPO Gene-Phenotype Associations)", "enlarged spinous cells (MP:0001237 from MPO Gene-Phenotype Associations)", "short diestrus (MP:0009012 from MPO Gene-Phenotype Associations)", "short estrous cycle (MP:0009007 from MPO Gene-Phenotype Associations)", "increased circulating progesterone level (MP:0005186 from MPO Gene-Phenotype Associations)", "pointed snout (MP:0000448 from MPO Gene-Phenotype Associations)", "short estrus (MP:0009018 from MPO Gene-Phenotype Associations)", "prolonged proestrus (MP:0009014 from MPO Gene-Phenotype Associations)", "absent leydig cells (MP:0002785 from MPO Gene-Phenotype Associations)", "short metestrus (MP:0009047 from MPO Gene-Phenotype Associations)", "abnormal proestrus (MP:0009013 from MPO Gene-Phenotype Associations)", "short proestrus (MP:0009015 from MPO Gene-Phenotype Associations)", "abnormal accessory olfactory bulb morphology (MP:0009945 from MPO Gene-Phenotype Associations)", "abnormal vomeronasal sensory neuron morphology (MP:0011679 from MPO Gene-Phenotype Associations)", "decreased aggression (MP:0005656 from MPO Gene-Phenotype Associations)", "decreased aggression towards mice (MP:0003863 from MPO Gene-Phenotype Associations)", "decreased aggression towards males (MP:0003862 from MPO Gene-Phenotype Associations)", "abnormal aggression-related behavior (MP:0002061 from MPO Gene-Phenotype Associations)", "increased aggression (MP:0005655 from MPO Gene-Phenotype Associations)", "increased aggression towards mice (MP:0001353 from MPO Gene-Phenotype Associations)", "increased aggression towards males (MP:0001354 from MPO Gene-Phenotype Associations)", "abnormal maternal behavior (MP:0008779 from MPO Gene-Phenotype Associations)", "abnormal maternal nurturing (MP:0001386 from MPO Gene-Phenotype Associations)", "abnormal parental behavior (MP:0002068 from MPO Gene-Phenotype Associations)", "abnormal social|conspecific interaction (MP:0002557 from MPO Gene-Phenotype Associations)", "abnormal nursing (MP:0001382 from MPO Gene-Phenotype Associations)", "absent maternal crouching (MP:0009326 from MPO Gene-Phenotype Associations)", "abnormal offspring retrieval (MP:0009731 from MPO Gene-Phenotype Associations)", "abnormal pup retrieval (MP:0001384 from MPO Gene-Phenotype Associations)", "pup cannibalization (MP:0001385 from MPO Gene-Phenotype Associations)", "brain ventricle stenosis (MP:0013228 from MPO Gene-Phenotype Associations)", "collapsed brain ventricles (MP:0012681 from MPO Gene-Phenotype Associations)", "ovarian follicular cyst (MP:0009444 from MPO Gene-Phenotype Associations)", "ovary cysts (MP:0002016 from MPO Gene-Phenotype Associations)", "abnormal compact bone area (MP:0010966 from MPO Gene-Phenotype Associations)", "increased compact bone area (MP:0010967 from MPO Gene-Phenotype Associations)", "decreased compact bone area (MP:0010968 from MPO Gene-Phenotype Associations)", "abnormal chondrocyte physiology (MP:0009780 from MPO Gene-Phenotype Associations)", "abnormal mammary fat pad morphology (MP:0008904 from MPO Gene-Phenotype Associations)", "increased mammary fat pad weight (MP:0009296 from MPO Gene-Phenotype Associations)", "increased aggression towards females (MP:0001356 from MPO Gene-Phenotype Associations)", "abnormal labium morphology (MP:0003511 from MPO Gene-Phenotype Associations)", "abnormal ejaculation (MP:0001378 from MPO Gene-Phenotype Associations)", "failure of ejaculation (MP:0009856 from MPO Gene-Phenotype Associations)", "abnormal renal fat pad morphology (MP:0008902 from MPO Gene-Phenotype Associations)", "increased renal fat pad weight (MP:0009302 from MPO Gene-Phenotype Associations)", "abnormal short term spatial reference memory (MP:0008431 from MPO Gene-Phenotype Associations)", "abnormal uterus development (MP:0003572 from MPO Gene-Phenotype Associations)", "abnormal cremaster muscle morphology (MP:0011833 from MPO Gene-Phenotype Associations)", "vagina hypoplasia (MP:0008984 from MPO Gene-Phenotype Associations)", "increased thecal cell number (MP:0009371 from MPO Gene-Phenotype Associations)", "spermatic granuloma (MP:0009824 from MPO Gene-Phenotype Associations)", "enlarged endometrial glands (MP:0009251 from MPO Gene-Phenotype Associations)", "abnormal mating receptivity (MP:0001376 from MPO Gene-Phenotype Associations)", "abnormal efferent ductules of testis morphology (MP:0004728 from MPO Gene-Phenotype Associations)", "dilated efferent ductules of testis (MP:0009140 from MPO Gene-Phenotype Associations)", "abnormal rete testis morphology (MP:0006416 from MPO Gene-Phenotype Associations)", "dilated rete testis (MP:0006423 from MPO Gene-Phenotype Associations)", "dilated seminiferous tubules (MP:0009257 from MPO Gene-Phenotype Associations)", "abnormal mating frequency (MP:0001377 from MPO Gene-Phenotype Associations)", "reduced male mating frequency (MP:0001380 from MPO Gene-Phenotype Associations)", "abnormal sexual interaction (MP:0002566 from MPO Gene-Phenotype Associations)", "abnormal primordial ovarian follicle morphology (MP:0009361 from MPO Gene-Phenotype Associations)", "abnormal primordial ovarian follicle number (MP:0011119 from MPO Gene-Phenotype Associations)", "decreased primordial ovarian follicle number (MP:0011121 from MPO Gene-Phenotype Associations)", "absent primordial ovarian follicles (MP:0011122 from MPO Gene-Phenotype Associations)", "abnormal zona pellucida morphology (MP:0003696 from MPO Gene-Phenotype Associations)", "thin zona pellucida (MP:0009375 from MPO Gene-Phenotype Associations)", "abnormal cumulus oophorus (MP:0009372 from MPO Gene-Phenotype Associations)", "abnormal granulosa cell morphology (MP:0008868 from MPO Gene-Phenotype Associations)", "impaired granulosa cell differentiation (MP:0003357 from MPO Gene-Phenotype Associations)", "abnormal ovulation (MP:0001928 from MPO Gene-Phenotype Associations)", "decreased ovulation rate (MP:0003355 from MPO Gene-Phenotype Associations)", "abnormal superovulation (MP:0009648 from MPO Gene-Phenotype Associations)", "decreased corpora lutea number (MP:0002680 from MPO Gene-Phenotype Associations)", "increased gonadotroph cell number (MP:0008334 from MPO Gene-Phenotype Associations)", "early vaginal opening (MP:0008994 from MPO Gene-Phenotype Associations)", "decreased vagina weight (MP:0008980 from MPO Gene-Phenotype Associations)", "increased ovarian carcinoma incidence (MP:0003579 from MPO Gene-Phenotype Associations)", "myometrium hypoplasia (MP:0009090 from MPO Gene-Phenotype Associations)", "increased follicle recruitment (MP:0002678 from MPO Gene-Phenotype Associations)", "abnormal vagina weight (MP:0008978 from MPO Gene-Phenotype Associations)", "small caput epididymis (MP:0009248 from MPO Gene-Phenotype Associations)", "abnormal vagina size (MP:0008977 from MPO Gene-Phenotype Associations)", "small vagina (MP:0008983 from MPO Gene-Phenotype Associations)", "vagina atrophy (MP:0004895 from MPO Gene-Phenotype Associations)", "enlarged sperm head (MP:0009233 from MPO Gene-Phenotype Associations)", "ovary atrophy (MP:0004833 from MPO Gene-Phenotype Associations)", "uterus atrophy (MP:0004894 from MPO Gene-Phenotype Associations)", "abnormal gestational length (MP:0002292 from MPO Gene-Phenotype Associations)", "long gestation period (MP:0002293 from MPO Gene-Phenotype Associations)", "abnormal male reproductive gland physiology (MP:0013327 from MPO Gene-Phenotype Associations)", "abnormal testis physiology (MP:0004884 from MPO Gene-Phenotype Associations)", "abnormal sex gland physiology (MP:0005647 from MPO Gene-Phenotype Associations)", "abnormal sex gland secretion (MP:0002779 from MPO Gene-Phenotype Associations)", "abnormal testes secretion (MP:0002782 from MPO Gene-Phenotype Associations)", "abnormal female reproductive gland physiology (MP:0013326 from MPO Gene-Phenotype Associations)", "abnormal ovary physiology (MP:0003507 from MPO Gene-Phenotype Associations)", "abnormal ovarian secretion (MP:0002783 from MPO Gene-Phenotype Associations)", "ovary hemorrhage (MP:0004834 from MPO Gene-Phenotype Associations)", "genital hemorrhage (MP:0004245 from MPO Gene-Phenotype Associations)", "abnormal caput epididymis morphology (MP:0002660 from MPO Gene-Phenotype Associations)", "abnormal corpus epididymis morphology (MP:0002661 from MPO Gene-Phenotype Associations)", "enlarged caput epididymis (MP:0009249 from MPO Gene-Phenotype Associations)", "enlarged corpus epididymis (MP:0009256 from MPO Gene-Phenotype Associations)", "abnormal posterior cardinal vein morphology (MP:0004785 from MPO Gene-Phenotype Associations)", "absent estrus (MP:0009021 from MPO Gene-Phenotype Associations)", "abnormal diestrus (MP:0009010 from MPO Gene-Phenotype Associations)", "prolonged diestrus (MP:0009011 from MPO Gene-Phenotype Associations)", "abnormal estrous cycle (MP:0001927 from MPO Gene-Phenotype Associations)", "abnormal ovulation cycle (MP:0009344 from MPO Gene-Phenotype Associations)", "prolonged estrous cycle (MP:0009006 from MPO Gene-Phenotype Associations)", "abnormal metestrus (MP:0009019 from MPO Gene-Phenotype Associations)", "prolonged metestrus (MP:0009020 from MPO Gene-Phenotype Associations)", "abnormal estrus (MP:0009016 from MPO Gene-Phenotype Associations)", "prolonged estrus (MP:0009017 from MPO Gene-Phenotype Associations)", "abnormal secondary sex determination (MP:0002212 from MPO Gene-Phenotype Associations)", "abnormal sexual maturation (MP:0001937 from MPO Gene-Phenotype Associations)", "delayed sexual maturation (MP:0001938 from MPO Gene-Phenotype Associations)", "abnormal timing of vaginal opening (MP:0020150 from MPO Gene-Phenotype Associations)", "delayed vaginal opening (MP:0002636 from MPO Gene-Phenotype Associations)", "delayed female fertility (MP:0008976 from MPO Gene-Phenotype Associations)", "delayed fertility (MP:0002683 from MPO Gene-Phenotype Associations)", "delayed male fertility (MP:0008975 from MPO Gene-Phenotype Associations)", "abnormal anogenital distance (MP:0005189 from MPO Gene-Phenotype Associations)", "abnormal perineum morphology (MP:0003315 from MPO Gene-Phenotype Associations)", "small penis (MP:0005188 from MPO Gene-Phenotype Associations)", "cryptorchism (MP:0002286 from MPO Gene-Phenotype Associations)", "abnormal external male genitalia morphology (MP:0009199 from MPO Gene-Phenotype Associations)", "abnormal penis morphology (MP:0005187 from MPO Gene-Phenotype Associations)", "abnormal glans penis morphology (MP:0009102 from MPO Gene-Phenotype Associations)", "abnormal male preputial gland morphology (MP:0002717 from MPO Gene-Phenotype Associations)", "abnormal preputial gland morphology (MP:0013329 from MPO Gene-Phenotype Associations)", "small male preputial glands (MP:0002716 from MPO Gene-Phenotype Associations)", "absent male preputial gland (MP:0006401 from MPO Gene-Phenotype Associations)", "abnormal male accessory sex gland morphology (MP:0013330 from MPO Gene-Phenotype Associations)", "abnormal seminal vesicle morphology (MP:0002059 from MPO Gene-Phenotype Associations)", "abnormal seminal vesicle size (MP:0004907 from MPO Gene-Phenotype Associations)", "small seminal vesicle (MP:0001157 from MPO Gene-Phenotype Associations)", "abnormal seminal vesicle weight (MP:0004908 from MPO Gene-Phenotype Associations)", "decreased seminal vesicle weight (MP:0004910 from MPO Gene-Phenotype Associations)", "abnormal prostate gland morphology (MP:0001158 from MPO Gene-Phenotype Associations)", "abnormal prostate gland size (MP:0004959 from MPO Gene-Phenotype Associations)", "small prostate gland (MP:0002774 from MPO Gene-Phenotype Associations)", "abnormal prostate gland weight (MP:0004960 from MPO Gene-Phenotype Associations)", "decreased prostate gland weight (MP:0004962 from MPO Gene-Phenotype Associations)", "abnormal epididymis morphology (MP:0002631 from MPO Gene-Phenotype Associations)", "abnormal epididymis size (MP:0004926 from MPO Gene-Phenotype Associations)", "small epididymis (MP:0004930 from MPO Gene-Phenotype Associations)", "abnormal epididymis weight (MP:0004927 from MPO Gene-Phenotype Associations)", "decreased epididymis weight (MP:0004929 from MPO Gene-Phenotype Associations)", "leydig cell hypoplasia (MP:0005536 from MPO Gene-Phenotype Associations)", "abnormal circulating androgen level (MP:0009819 from MPO Gene-Phenotype Associations)", "abnormal circulating testosterone level (MP:0005180 from MPO Gene-Phenotype Associations)", "abnormal testosterone level (MP:0011385 from MPO Gene-Phenotype Associations)", "decreased circulating testosterone level (MP:0002780 from MPO Gene-Phenotype Associations)", "increased circulating testosterone level (MP:0002781 from MPO Gene-Phenotype Associations)", "abnormal circulating progesterone level (MP:0005184 from MPO Gene-Phenotype Associations)", "abnormal progesterone level (MP:0011384 from MPO Gene-Phenotype Associations)", "decreased circulating progesterone level (MP:0005185 from MPO Gene-Phenotype Associations)", "abnormal circulating estradiol level (MP:0005183 from MPO Gene-Phenotype Associations)", "abnormal circulating estrogen level (MP:0003369 from MPO Gene-Phenotype Associations)", "decreased circulating estradiol level (MP:0005181 from MPO Gene-Phenotype Associations)", "decreased circulating estrogen level (MP:0003371 from MPO Gene-Phenotype Associations)", "increased circulating estradiol level (MP:0005182 from MPO Gene-Phenotype Associations)", "increased circulating estrogen level (MP:0003370 from MPO Gene-Phenotype Associations)", "abnormal ovary weight (MP:0004854 from MPO Gene-Phenotype Associations)", "decreased ovary weight (MP:0004856 from MPO Gene-Phenotype Associations)", "abnormal corpus luteum morphology (MP:0002679 from MPO Gene-Phenotype Associations)", "absent corpus luteum (MP:0001134 from MPO Gene-Phenotype Associations)", "anovulation (MP:0008869 from MPO Gene-Phenotype Associations)", "absent estrous cycle (MP:0009009 from MPO Gene-Phenotype Associations)", "abnormal uterus morphology (MP:0001120 from MPO Gene-Phenotype Associations)", "abnormal uterus size (MP:0004902 from MPO Gene-Phenotype Associations)", "small uterus (MP:0002637 from MPO Gene-Phenotype Associations)", "abnormal uterus weight (MP:0004903 from MPO Gene-Phenotype Associations)", "decreased uterus weight (MP:0004905 from MPO Gene-Phenotype Associations)", "uterus hypoplasia (MP:0001121 from MPO Gene-Phenotype Associations)", "abnormal circulating gonadotropin level (MP:0003361 from MPO Gene-Phenotype Associations)", "abnormal follicle stimulating hormone level (MP:0003967 from MPO Gene-Phenotype Associations)", "increased circulating follicle stimulating hormone level (MP:0001750 from MPO Gene-Phenotype Associations)", "increased follicle stimulating hormone level (MP:0005131 from MPO Gene-Phenotype Associations)", "increased circulating gonadotropin level (MP:0003362 from MPO Gene-Phenotype Associations)", "abnormal circulating pituitary hormone level (MP:0005116 from MPO Gene-Phenotype Associations)", "abnormal pituitary hormone level (MP:0003965 from MPO Gene-Phenotype Associations)", "increased circulating pituitary hormone level (MP:0005117 from MPO Gene-Phenotype Associations)", "increased pituitary hormone level (MP:0003973 from MPO Gene-Phenotype Associations)", "abnormal luteinizing hormone level (MP:0003969 from MPO Gene-Phenotype Associations)", "increased circulating luteinizing hormone level (MP:0001751 from MPO Gene-Phenotype Associations)", "increased luteinizing hormone level (MP:0005133 from MPO Gene-Phenotype Associations)", "decreased circulating gonadotropin level (MP:0003363 from MPO Gene-Phenotype Associations)", "decreased circulating pituitary hormone level (MP:0005118 from MPO Gene-Phenotype Associations)", "decreased pituitary hormone level (MP:0003972 from MPO Gene-Phenotype Associations)", "decreased circulating follicle stimulating hormone level (MP:0002790 from MPO Gene-Phenotype Associations)", "decreased follicle stimulating hormone level (MP:0005130 from MPO Gene-Phenotype Associations)", "decreased circulating luteinizing hormone level (MP:0002773 from MPO Gene-Phenotype Associations)", "decreased luteinizing hormone level (MP:0005132 from MPO Gene-Phenotype Associations)", "decreased circulating prolactin level (MP:0005121 from MPO Gene-Phenotype Associations)", "decreased prolactin level (MP:0005138 from MPO Gene-Phenotype Associations)", "abnormal prolactin level (MP:0003970 from MPO Gene-Phenotype Associations)", "abnormal gametes (MP:0001124 from MPO Gene-Phenotype Associations)", "abnormal male germ cell morphology (MP:0006362 from MPO Gene-Phenotype Associations)", "abnormal germ cell morphology (MP:0002208 from MPO Gene-Phenotype Associations)", "abnormal spermatogenesis (MP:0001156 from MPO Gene-Phenotype Associations)", "abnormal gametogenesis (MP:0001929 from MPO Gene-Phenotype Associations)", "abnormal sperm number (MP:0002673 from MPO Gene-Phenotype Associations)", "decreased male germ cell number (MP:0004901 from MPO Gene-Phenotype Associations)", "decreased germ cell number (MP:0002209 from MPO Gene-Phenotype Associations)", "oligozoospermia (MP:0002687 from MPO Gene-Phenotype Associations)", "abnormal internal male genitalia morphology (MP:0009205 from MPO Gene-Phenotype Associations)", "abnormal male genitalia morphology (MP:0009198 from MPO Gene-Phenotype Associations)", "abnormal male reproductive system morphology (MP:0001145 from MPO Gene-Phenotype Associations)", "abnormal male reproductive gland morphology (MP:0013325 from MPO Gene-Phenotype Associations)", "abnormal testis morphology (MP:0001146 from MPO Gene-Phenotype Associations)", "abnormal sex gland morphology (MP:0000653 from MPO Gene-Phenotype Associations)", "abnormal primary sex determination (MP:0002211 from MPO Gene-Phenotype Associations)", "small gonad (MP:0001116 from MPO Gene-Phenotype Associations)", "abnormal sex determination (MP:0002210 from MPO Gene-Phenotype Associations)", "abnormal testis size (MP:0004849 from MPO Gene-Phenotype Associations)", "small testis (MP:0001147 from MPO Gene-Phenotype Associations)", "abnormal reproductive system morphology (MP:0002160 from MPO Gene-Phenotype Associations)", "abnormal seminiferous tubule morphology (MP:0002216 from MPO Gene-Phenotype Associations)", "abnormal testis weight (MP:0004850 from MPO Gene-Phenotype Associations)", "decreased testis weight (MP:0004852 from MPO Gene-Phenotype Associations)", "reproductive system phenotype (MP:0005389 from MPO Gene-Phenotype Associations)", "abnormal reproductive system physiology (MP:0001919 from MPO Gene-Phenotype Associations)", "abnormal fertility|fecundity (MP:0002161 from MPO Gene-Phenotype Associations)", "abnormal male reproductive system physiology (MP:0003698 from MPO Gene-Phenotype Associations)", "infertility (MP:0001924 from MPO Gene-Phenotype Associations)", "male infertility (MP:0001925 from MPO Gene-Phenotype Associations)", "abnormal gland morphology (MP:0002163 from MPO Gene-Phenotype Associations)", "endocrine|exocrine gland phenotype (MP:0005379 from MPO Gene-Phenotype Associations)", "absent gametes (MP:0001117 from MPO Gene-Phenotype Associations)", "azoospermia (MP:0005159 from MPO Gene-Phenotype Associations)", "absent germ cells (MP:0004806 from MPO Gene-Phenotype Associations)", "abnormal male meiosis (MP:0005169 from MPO Gene-Phenotype Associations)", "abnormal meiosis (MP:0001930 from MPO Gene-Phenotype Associations)", "arrest of male meiosis (MP:0008261 from MPO Gene-Phenotype Associations)", "arrest of spermatogenesis (MP:0001155 from MPO Gene-Phenotype Associations)", "abnormal male germ cell apoptosis (MP:0008280 from MPO Gene-Phenotype Associations)", "abnormal seminiferous tubule size (MP:0006307 from MPO Gene-Phenotype Associations)", "small seminiferous tubules (MP:0001153 from MPO Gene-Phenotype Associations)", "abnormal female germ cell morphology (MP:0006361 from MPO Gene-Phenotype Associations)", "abnormal oocyte morphology (MP:0001125 from MPO Gene-Phenotype Associations)", "abnormal oogenesis (MP:0001931 from MPO Gene-Phenotype Associations)", "abnormal oocyte number (MP:0020152 from MPO Gene-Phenotype Associations)", "decreased oocyte number (MP:0005431 from MPO Gene-Phenotype Associations)", "absent oocytes (MP:0004805 from MPO Gene-Phenotype Associations)", "abnormal female meiosis (MP:0005168 from MPO Gene-Phenotype Associations)", "abnormal ovary size (MP:0004853 from MPO Gene-Phenotype Associations)", "small ovary (MP:0001127 from MPO Gene-Phenotype Associations)", "abnormal female genitalia morphology (MP:0009208 from MPO Gene-Phenotype Associations)", "abnormal female reproductive system morphology (MP:0001119 from MPO Gene-Phenotype Associations)", "abnormal internal female genitalia morphology (MP:0009209 from MPO Gene-Phenotype Associations)", "abnormal female reproductive gland morphology (MP:0013324 from MPO Gene-Phenotype Associations)", "abnormal ovary morphology (MP:0001126 from MPO Gene-Phenotype Associations)", "abnormal ovarian follicle morphology (MP:0001131 from MPO Gene-Phenotype Associations)", "abnormal ovarian follicle number (MP:0008871 from MPO Gene-Phenotype Associations)", "abnormal female reproductive system physiology (MP:0003699 from MPO Gene-Phenotype Associations)", "female infertility (MP:0001926 from MPO Gene-Phenotype Associations)", "abnormal ovarian folliculogenesis (MP:0001130 from MPO Gene-Phenotype Associations)", "impaired ovarian folliculogenesis (MP:0001129 from MPO Gene-Phenotype Associations)", "abnormal mature ovarian follicle morphology (MP:0009364 from MPO Gene-Phenotype Associations)", "decreased mature ovarian follicle number (MP:0002682 from MPO Gene-Phenotype Associations)", "absent mature ovarian follicles (MP:0001132 from MPO Gene-Phenotype Associations)", "reduced fertility (MP:0001921 from MPO Gene-Phenotype Associations)", "reduced female fertility (MP:0001923 from MPO Gene-Phenotype Associations)", "reduced male fertility (MP:0001922 from MPO Gene-Phenotype Associations)", "abnormal litter size (MP:0001933 from MPO Gene-Phenotype Associations)", "decreased litter size (MP:0001935 from MPO Gene-Phenotype Associations)", "testicular atrophy (MP:0003205 from MPO Gene-Phenotype Associations)", "abnormal leydig cell morphology (MP:0002786 from MPO Gene-Phenotype Associations)", "enlarged testis (MP:0001148 from MPO Gene-Phenotype Associations)", "testicular hyperplasia (MP:0001149 from MPO Gene-Phenotype Associations)", "leydig cell hyperplasia (MP:0001152 from MPO Gene-Phenotype Associations)", "seminiferous tubule degeneration (MP:0001154 from MPO Gene-Phenotype Associations)", "abnormal seminiferous tubule epithelium morphology (MP:0011750 from MPO Gene-Phenotype Associations)", "abnormal sertoli cell morphology (MP:0002784 from MPO Gene-Phenotype Associations)", "sertoli cell hypoplasia (MP:0005250 from MPO Gene-Phenotype Associations)", "abnormal spermatid morphology (MP:0006380 from MPO Gene-Phenotype Associations)", "arrest of spermiogenesis (MP:0008279 from MPO Gene-Phenotype Associations)", "abnormal spermiogenesis (MP:0001932 from MPO Gene-Phenotype Associations)", "abnormal spermiation (MP:0004182 from MPO Gene-Phenotype Associations)", "abnormal spermatocyte morphology (MP:0006379 from MPO Gene-Phenotype Associations)", "abnormal dna methylation during gametogenesis (MP:0008878 from MPO Gene-Phenotype Associations)", "vas deferens hypoplasia (MP:0009214 from MPO Gene-Phenotype Associations)", "absent endometrial glands (MP:0009097 from MPO Gene-Phenotype Associations)", "thin endometrium (MP:0008258 from MPO Gene-Phenotype Associations)", "abnormal endometrial gland morphology (MP:0009094 from MPO Gene-Phenotype Associations)", "abnormal endometrium morphology (MP:0004896 from MPO Gene-Phenotype Associations)", "abnormal endometrial gland number (MP:0009095 from MPO Gene-Phenotype Associations)", "decreased endometrial gland number (MP:0009096 from MPO Gene-Phenotype Associations)", "thin uterus (MP:0009081 from MPO Gene-Phenotype Associations)", "abnormal myometrium morphology (MP:0008256 from MPO Gene-Phenotype Associations)", "thin myometrium (MP:0008257 from MPO Gene-Phenotype Associations)", "abnormal vagina development (MP:0003531 from MPO Gene-Phenotype Associations)", "scrotum hypoplasia (MP:0003611 from MPO Gene-Phenotype Associations)", "increased urine major urinary protein level (MP:0011533 from MPO Gene-Phenotype Associations)", "small scrotum (MP:0003609 from MPO Gene-Phenotype Associations)", "reproductive system inflammation (MP:0002254 from MPO Gene-Phenotype Associations)", "epididymal inflammation (MP:0003596 from MPO Gene-Phenotype Associations)", "abnormal uterine horn morphology (MP:0009085 from MPO Gene-Phenotype Associations)", "thin uterine horn (MP:0009088 from MPO Gene-Phenotype Associations)", "enlarged seminal vesicle (MP:0002997 from MPO Gene-Phenotype Associations)", "increased seminal vesicle weight (MP:0004909 from MPO Gene-Phenotype Associations)", "abnormal barbering behavior (MP:0002808 from MPO Gene-Phenotype Associations)", "early sexual maturation (MP:0003378 from MPO Gene-Phenotype Associations)", "enlarged epididymis (MP:0004931 from MPO Gene-Phenotype Associations)", "increased epididymis weight (MP:0004928 from MPO Gene-Phenotype Associations)", "enlarged ovary (MP:0004832 from MPO Gene-Phenotype Associations)", "ovary hyperplasia (MP:0001128 from MPO Gene-Phenotype Associations)", "increased corpora lutea number (MP:0002681 from MPO Gene-Phenotype Associations)", "prostate gland hypoplasia (MP:0005147 from MPO Gene-Phenotype Associations)", "increased circulating corticotropin-releasing hormone level (MP:0001754 from MPO Gene-Phenotype Associations)", "seminal vesicle hypoplasia (MP:0005148 from MPO Gene-Phenotype Associations)", "male pseudohermaphroditism (MP:0002789 from MPO Gene-Phenotype Associations)", "pseudohermaphroditism (MP:0002787 from MPO Gene-Phenotype Associations)", "abnormal spermatogonia morphology (MP:0006378 from MPO Gene-Phenotype Associations)", "abnormal spermatogonia proliferation (MP:0002685 from MPO Gene-Phenotype Associations)", "meiotic nondisjunction (MP:0009566 from MPO Gene-Phenotype Associations)", "meiotic nondisjunction during m1 phase (MP:0004218 from MPO Gene-Phenotype Associations)", "early reproductive senescence (MP:0008995 from MPO Gene-Phenotype Associations)", "premature aging (MP:0003786 from MPO Gene-Phenotype Associations)", "coarse hair (MP:0002832 from MPO Gene-Phenotype Associations)", "abnormal primary ovarian follicle number (MP:0011123 from MPO Gene-Phenotype Associations)", "decreased primary ovarian follicle number (MP:0011125 from MPO Gene-Phenotype Associations)", "abnormal harderian gland physiology (MP:0003859 from MPO Gene-Phenotype Associations)", "abnormal oviduct environment (MP:0004015 from MPO Gene-Phenotype Associations)", "abnormal epididymis epithelium morphology (MP:0004933 from MPO Gene-Phenotype Associations)", "epididymis degeneration (MP:0004935 from MPO Gene-Phenotype Associations)", "epididymis epithelium degeneration (MP:0004934 from MPO Gene-Phenotype Associations)", "chronic inflammation (MP:0002499 from MPO Gene-Phenotype Associations)", "granulomatous inflammation (MP:0002500 from MPO Gene-Phenotype Associations)", "abnormal acrosome morphology (MP:0008898 from MPO Gene-Phenotype Associations)", "globozoospermia (MP:0002686 from MPO Gene-Phenotype Associations)", "abnormal sperm head morphology (MP:0009230 from MPO Gene-Phenotype Associations)", "teratozoospermia (MP:0005578 from MPO Gene-Phenotype Associations)", "abnormal cilium morphology (MP:0013202 from MPO Gene-Phenotype Associations)", "abnormal motile cilium morphology (MP:0013206 from MPO Gene-Phenotype Associations)", "abnormal sperm flagellum morphology (MP:0008892 from MPO Gene-Phenotype Associations)", "abnormal sperm physiology (MP:0004543 from MPO Gene-Phenotype Associations)", "abnormal sperm motility (MP:0002674 from MPO Gene-Phenotype Associations)", "asthenozoospermia (MP:0002675 from MPO Gene-Phenotype Associations)", "coiled sperm flagellum (MP:0009238 from MPO Gene-Phenotype Associations)", "abnormal sperm midpiece morphology (MP:0009831 from MPO Gene-Phenotype Associations)", "abnormal sperm mitochondrial sheath morphology (MP:0009832 from MPO Gene-Phenotype Associations)", "abnormal sperm principal piece morphology (MP:0009836 from MPO Gene-Phenotype Associations)", "kinked sperm flagellum (MP:0009237 from MPO Gene-Phenotype Associations)", "abnormal sperm axoneme morphology (MP:0009838 from MPO Gene-Phenotype Associations)", "detached acrosome (MP:0009231 from MPO Gene-Phenotype Associations)", "abnormal sperm nucleus morphology (MP:0009232 from MPO Gene-Phenotype Associations)", "absent acrosome (MP:0008839 from MPO Gene-Phenotype Associations)", "short sperm flagellum (MP:0009239 from MPO Gene-Phenotype Associations)", "absent sperm flagellum (MP:0008545 from MPO Gene-Phenotype Associations)", "detached sperm flagellum (MP:0008893 from MPO Gene-Phenotype Associations)", "abnormal acrosome reaction (MP:0013287 from MPO Gene-Phenotype Associations)", "impaired acrosome reaction (MP:0004542 from MPO Gene-Phenotype Associations)", "abnormal vesicle-mediated transport (MP:0008546 from MPO Gene-Phenotype Associations)", "abnormal fertilization (MP:0005410 from MPO Gene-Phenotype Associations)", "impaired fertilization (MP:0000242 from MPO Gene-Phenotype Associations)", "pinhead sperm (MP:0009236 from MPO Gene-Phenotype Associations)", "absent sperm mitochondrial sheath (MP:0009833 from MPO Gene-Phenotype Associations)", "multiflagellated sperm (MP:0009839 from MPO Gene-Phenotype Associations)", "abnormal sperm annulus morphology (MP:0009834 from MPO Gene-Phenotype Associations)", "absent sperm annulus (MP:0009835 from MPO Gene-Phenotype Associations)", "thin sperm flagellum (MP:0009242 from MPO Gene-Phenotype Associations)", "hairpin sperm flagellum (MP:0009243 from MPO Gene-Phenotype Associations)", "abnormal sperm end piece morphology (MP:0009837 from MPO Gene-Phenotype Associations)", "abnormal hyperactivated sperm motility (MP:0009281 from MPO Gene-Phenotype Associations)", "reduced hyperactivated sperm motility (MP:0009282 from MPO Gene-Phenotype Associations)", "abnormal activated sperm motility (MP:0009279 from MPO Gene-Phenotype Associations)", "reduced activated sperm motility (MP:0009280 from MPO Gene-Phenotype Associations)", "thick sperm flagellum (MP:0009241 from MPO Gene-Phenotype Associations)", "abnormal manchette morphology (MP:0009376 from MPO Gene-Phenotype Associations)", "ectopic manchette (MP:0009377 from MPO Gene-Phenotype Associations)", "transmission ratio distortion (MP:0004179 from MPO Gene-Phenotype Associations)", "abnormal x-zone morphology (MP:0008296 from MPO Gene-Phenotype Associations)", "retention of the x-zone (MP:0008297 from MPO Gene-Phenotype Associations)", "abnormal reproductive system development (MP:0003936 from MPO Gene-Phenotype Associations)", "abnormal testis development (MP:0003830 from MPO Gene-Phenotype Associations)", "abnormal sertoli cell development (MP:0004109 from MPO Gene-Phenotype Associations)", "abnormal testis cord formation (MP:0006418 from MPO Gene-Phenotype Associations)", "disorganized testis cords (MP:0006419 from MPO Gene-Phenotype Associations)", "abnormal peritubular myoid cell morphology (MP:0006420 from MPO Gene-Phenotype Associations)", "decreased number of peritubular myoid cells (MP:0006421 from MPO Gene-Phenotype Associations)", "ovotestis (MP:0002996 from MPO Gene-Phenotype Associations)", "primary sex reversal (MP:0002995 from MPO Gene-Phenotype Associations)", "ectopic leydig cells (MP:0006427 from MPO Gene-Phenotype Associations)", "ectopic sertoli cells (MP:0006428 from MPO Gene-Phenotype Associations)", "rete testis obstruction (MP:0006417 from MPO Gene-Phenotype Associations)", "sertoli cell hyperplasia (MP:0002776 from MPO Gene-Phenotype Associations)", "absent testis cords (MP:0006424 from MPO Gene-Phenotype Associations)", "true hermaphroditism (MP:0002213 from MPO Gene-Phenotype Associations)", "secondary sex reversal (MP:0001939 from MPO Gene-Phenotype Associations)", "sex reversal (MP:0005652 from MPO Gene-Phenotype Associations)", "wide ribs (MP:0004676 from MPO Gene-Phenotype Associations)", "increased diameter of fibula (MP:0008159 from MPO Gene-Phenotype Associations)", "epididymis hypoplasia (MP:0004932 from MPO Gene-Phenotype Associations)", "hypopnea (MP:0001956 from MPO Gene-Phenotype Associations)", "increased diameter of tibia (MP:0008162 from MPO Gene-Phenotype Associations)", "increased diameter of femur (MP:0008158 from MPO Gene-Phenotype Associations)", "increased diameter of long bones (MP:0008151 from MPO Gene-Phenotype Associations)", "testis hypoplasia (MP:0001940 from MPO Gene-Phenotype Associations)", "absent strial basal cell tight junctions (MP:0004464 from MPO Gene-Phenotype Associations)", "abnormal visual evoked potential (MP:0010748 from MPO Gene-Phenotype Associations)", "absent visual evoked potential (MP:0010749 from MPO Gene-Phenotype Associations)", "abnormal tooth root development (MP:0011165 from MPO Gene-Phenotype Associations)", "absent molar root (MP:0011166 from MPO Gene-Phenotype Associations)", "decreased cranium length (MP:0011862 from MPO Gene-Phenotype Associations)", "short excitatory postsynaptic current decay time (MP:0011274 from MPO Gene-Phenotype Associations)", "abnormal masseter muscle morphology (MP:0004235 from MPO Gene-Phenotype Associations)", "abnormal masticatory muscle morphology (MP:0004234 from MPO Gene-Phenotype Associations)", "abnormal temporalis muscle morphology (MP:0004239 from MPO Gene-Phenotype Associations)", "necrospermia (MP:0009325 from MPO Gene-Phenotype Associations)", "endometrium hypoplasia (MP:0009091 from MPO Gene-Phenotype Associations)", "abnormal perivascular macrophage morphology (MP:0008242 from MPO Gene-Phenotype Associations)", "abnormal thyroid parafollicular c-cell morphology (MP:0004698 from MPO Gene-Phenotype Associations)", "increased testis weight (MP:0004851 from MPO Gene-Phenotype Associations)", "decreased fertilization frequency (MP:0009647 from MPO Gene-Phenotype Associations)", "delayed fertilization (MP:0005411 from MPO Gene-Phenotype Associations)", "absent sperm head (MP:0009234 from MPO Gene-Phenotype Associations)", "increased secondary ovarian follicle number (MP:0011128 from MPO Gene-Phenotype Associations)", "decreased circulating dihydrotestosterone level (MP:0003510 from MPO Gene-Phenotype Associations)", "decreased cumulus expansion (MP:0011701 from MPO Gene-Phenotype Associations)", "abnormal secondary ovarian follicle number (MP:0011127 from MPO Gene-Phenotype Associations)", "decreased secondary ovarian follicle number (MP:0011129 from MPO Gene-Phenotype Associations)", "abnormal secondary ovarian follicle morphology (MP:0009363 from MPO Gene-Phenotype Associations)", "abnormal thecal cell number (MP:0009369 from MPO Gene-Phenotype Associations)", "decreased thecal cell number (MP:0009370 from MPO Gene-Phenotype Associations)", "thin lung-associated mesenchyme (MP:0011144 from MPO Gene-Phenotype Associations)", "small hair follicles (MP:0000380 from MPO Gene-Phenotype Associations)", "abnormal hepatoblast physiology (MP:0012241 from MPO Gene-Phenotype Associations)", "increased hepatoblast apoptosis (MP:0012244 from MPO Gene-Phenotype Associations)", "enlarged heart atrium (MP:0008725 from MPO Gene-Phenotype Associations)", "enlarged heart right atrium (MP:0008727 from MPO Gene-Phenotype Associations)", "increased cardiac muscle contractility (MP:0005599 from MPO Gene-Phenotype Associations)", "increased ventricle muscle contractility (MP:0005600 from MPO Gene-Phenotype Associations)", "abnormal urethra urothelium morphology (MP:0011485 from MPO Gene-Phenotype Associations)", "perineal fistula (MP:0003316 from MPO Gene-Phenotype Associations)", "abnormal female preputial gland morphology (MP:0011834 from MPO Gene-Phenotype Associations)", "female preputial gland hypoplasia (MP:0013313 from MPO Gene-Phenotype Associations)", "abnormal clitoral bone morphology (MP:0011849 from MPO Gene-Phenotype Associations)", "absent clitoral bone (MP:0011850 from MPO Gene-Phenotype Associations)", "urethritis (MP:0011763 from MPO Gene-Phenotype Associations)", "sebaceous gland hypoplasia (MP:0013193 from MPO Gene-Phenotype Associations)", "abnormal clitoris morphology (MP:0003127 from MPO Gene-Phenotype Associations)", "abnormal clitoris size (MP:0009100 from MPO Gene-Phenotype Associations)", "enlarged clitoris (MP:0003529 from MPO Gene-Phenotype Associations)", "abnormal external female genitalia morphology (MP:0003126 from MPO Gene-Phenotype Associations)", "abnormal vagina epithelium morphology (MP:0001140 from MPO Gene-Phenotype Associations)", "hydrometrocolpos (MP:0003537 from MPO Gene-Phenotype Associations)", "endometrium inflammation (MP:0009360 from MPO Gene-Phenotype Associations)", "vaginal inflammation (MP:0003541 from MPO Gene-Phenotype Associations)", "uterus inflammation (MP:0009080 from MPO Gene-Phenotype Associations)", "abnormal egg cylinder morphology (MP:0003085 from MPO Gene-Phenotype Associations)", "failure to form egg cylinders (MP:0001694 from MPO Gene-Phenotype Associations)", "mammary gland duct hyperplasia (MP:0001885 from MPO Gene-Phenotype Associations)", "mammary gland hyperplasia (MP:0000630 from MPO Gene-Phenotype Associations)", "abnormal uterine cervix epithelium morphology (MP:0001137 from MPO Gene-Phenotype Associations)", "abnormal uterine cervix squamous epithelium morphology (MP:0001138 from MPO Gene-Phenotype Associations)", "increased mammary gland ductal carcinoma incidence (MP:0009508 from MPO Gene-Phenotype Associations)", "empty decidua capsularis (MP:0009687 from MPO Gene-Phenotype Associations)", "abnormal mammillary body morphology (MP:0004162 from MPO Gene-Phenotype Associations)", "abnormal milk ejection (MP:0003838 from MPO Gene-Phenotype Associations)", "abnormal branching of the mammary ductal tree (MP:0000662 from MPO Gene-Phenotype Associations)", "abnormal mammary gland duct morphology (MP:0009503 from MPO Gene-Phenotype Associations)", "abnormal mammary gland development (MP:0000628 from MPO Gene-Phenotype Associations)", "abnormal mammary gland morphology (MP:0000627 from MPO Gene-Phenotype Associations)", "abnormal mammary gland growth during pregnancy (MP:0006269 from MPO Gene-Phenotype Associations)", "abnormal skin adnexa physiology (MP:0010680 from MPO Gene-Phenotype Associations)", "abnormal lactation (MP:0001882 from MPO Gene-Phenotype Associations)", "abnormal mammary gland physiology (MP:0001881 from MPO Gene-Phenotype Associations)", "abnormal milk composition (MP:0004047 from MPO Gene-Phenotype Associations)", "lactation failure (MP:0010249 from MPO Gene-Phenotype Associations)", "abnormal involution of the mammary gland (MP:0006271 from MPO Gene-Phenotype Associations)", "abnormal mammary gland growth during lactation (MP:0006270 from MPO Gene-Phenotype Associations)", "abnormal mammary gland alveolus morphology (MP:0009506 from MPO Gene-Phenotype Associations)", "abnormal mammary gland lobule morphology (MP:0009505 from MPO Gene-Phenotype Associations)", "abnormal mammary gland epithelium morphology (MP:0009504 from MPO Gene-Phenotype Associations)", "mammary gland alveolar hyperplasia (MP:0001884 from MPO Gene-Phenotype Associations)", "impaired mammary gland growth during pregnancy (MP:0012075 from MPO Gene-Phenotype Associations)", "decreased t-helper 2 cell number (MP:0008091 from MPO Gene-Phenotype Associations)", "impaired eosinophil chemotaxis (MP:0008724 from MPO Gene-Phenotype Associations)", "increased circulating creatine level (MP:0010064 from MPO Gene-Phenotype Associations)", "increased creatine level (MP:0010061 from MPO Gene-Phenotype Associations)", "abnormal mammary gland epithelium physiology (MP:0010172 from MPO Gene-Phenotype Associations)", "decreased mammary gland epithelium proliferation (MP:0010174 from MPO Gene-Phenotype Associations)", "abnormal eosinophil physiology (MP:0002465 from MPO Gene-Phenotype Associations)", "impaired eosinophil recruitment (MP:0008723 from MPO Gene-Phenotype Associations)", "increased serotonin level (MP:0010069 from MPO Gene-Phenotype Associations)", "abnormal circulating creatine level (MP:0010063 from MPO Gene-Phenotype Associations)", "decreased circulating creatine level (MP:0010065 from MPO Gene-Phenotype Associations)", "abnormal creatine level (MP:0010060 from MPO Gene-Phenotype Associations)", "decreased creatine level (MP:0010062 from MPO Gene-Phenotype Associations)", "abnormal short term object recognition memory (MP:0002800 from MPO Gene-Phenotype Associations)", "abnormal parturition (MP:0002907 from MPO Gene-Phenotype Associations)", "parturition failure (MP:0012010 from MPO Gene-Phenotype Associations)", "pregnancy-related premature death (MP:0008028 from MPO Gene-Phenotype Associations)", "acromegaly (MP:0003506 from MPO Gene-Phenotype Associations)", "dystocia (MP:0004514 from MPO Gene-Phenotype Associations)", "hemarthrosis (MP:0005245 from MPO Gene-Phenotype Associations)", "abnormal circulating fibrinogen level (MP:0010213 from MPO Gene-Phenotype Associations)", "uterine hemorrhage (MP:0004898 from MPO Gene-Phenotype Associations)", "abnormal uterus physiology (MP:0009671 from MPO Gene-Phenotype Associations)", "hemoperitoneum (MP:0005435 from MPO Gene-Phenotype Associations)", "petechiae (MP:0008816 from MPO Gene-Phenotype Associations)", "skin hemorrhage (MP:0011514 from MPO Gene-Phenotype Associations)", "abnormal decidualization (MP:0003845 from MPO Gene-Phenotype Associations)", "abnormal uterine environment (MP:0004014 from MPO Gene-Phenotype Associations)", "abnormal embryo implantation (MP:0001727 from MPO Gene-Phenotype Associations)", "failure of embryo implantation (MP:0001728 from MPO Gene-Phenotype Associations)", "abnormal pregnancy (MP:0009661 from MPO Gene-Phenotype Associations)", "impaired embryo implantation (MP:0001729 from MPO Gene-Phenotype Associations)", "abnormal postimplantation uterine environment (MP:0009669 from MPO Gene-Phenotype Associations)", "abnormal uterine angiogenesis (MP:0009670 from MPO Gene-Phenotype Associations)", "abnormal uterine spiral artery remodeling (MP:0012727 from MPO Gene-Phenotype Associations)", "decreased uterine nk cell number (MP:0008876 from MPO Gene-Phenotype Associations)", "abnormal uterine spiral artery morphology (MP:0012726 from MPO Gene-Phenotype Associations)", "abnormal maternal decidual layer morphology (MP:0004256 from MPO Gene-Phenotype Associations)", "abnormal placenta metrial gland morphology (MP:0010776 from MPO Gene-Phenotype Associations)", "abnormal uterine nk cell morphology (MP:0008054 from MPO Gene-Phenotype Associations)", "increased uterine nk cell number (MP:0009394 from MPO Gene-Phenotype Associations)", "abnormal decidua basalis morphology (MP:0012529 from MPO Gene-Phenotype Associations)", "abnormal decidua capsularis morphology (MP:0012530 from MPO Gene-Phenotype Associations)", "abnormal purkinje cell migration (MP:0010008 from MPO Gene-Phenotype Associations)", "abnormal sensorimotor gating (MP:0002634 from MPO Gene-Phenotype Associations)", "reduced sensorimotor gating (MP:0002635 from MPO Gene-Phenotype Associations)", "enhanced sensorimotor gating (MP:0003889 from MPO Gene-Phenotype Associations)", "abnormal cardiac neural crest cell morphology (MP:0012747 from MPO Gene-Phenotype Associations)", "impaired cardiac neural crest cell differentiation (MP:0012751 from MPO Gene-Phenotype Associations)", "impaired neural crest cell differentiation (MP:0012195 from MPO Gene-Phenotype Associations)", "abnormal basilar artery morphology (MP:0013186 from MPO Gene-Phenotype Associations)", "dilated basilar artery (MP:0013187 from MPO Gene-Phenotype Associations)", "absent aorticopulmonary septum (MP:0010652 from MPO Gene-Phenotype Associations)", "aorta dilation (MP:0010574 from MPO Gene-Phenotype Associations)", "abnormal carotid artery morphology (MP:0004181 from MPO Gene-Phenotype Associations)", "abnormal common carotid artery morphology (MP:0012729 from MPO Gene-Phenotype Associations)", "liver hemorrhage (MP:0003888 from MPO Gene-Phenotype Associations)", "descending aorta stenosis (MP:0010641 from MPO Gene-Phenotype Associations)", "vascular smooth muscle cell hyperplasia (MP:0005489 from MPO Gene-Phenotype Associations)", "abnormal smooth muscle morphology (MP:0000767 from MPO Gene-Phenotype Associations)", "abnormal vascular smooth muscle morphology (MP:0005592 from MPO Gene-Phenotype Associations)", "vascular smooth muscle cell hypoplasia (MP:0003814 from MPO Gene-Phenotype Associations)", "abdominal aorta aneurysm (MP:0010659 from MPO Gene-Phenotype Associations)", "abnormal abdominal aorta morphology (MP:0009870 from MPO Gene-Phenotype Associations)", "abnormal descending aorta morphology (MP:0009869 from MPO Gene-Phenotype Associations)", "aortic hypertrophy (MP:0002844 from MPO Gene-Phenotype Associations)", "enlarged optic nerve (MP:0008529 from MPO Gene-Phenotype Associations)", "absent alveolar pores (MP:0010905 from MPO Gene-Phenotype Associations)", "absent sexual maturation (MP:0003379 from MPO Gene-Phenotype Associations)", "abnormal alveolar pore morphology (MP:0010904 from MPO Gene-Phenotype Associations)", "impaired osteoblast differentiation (MP:0011711 from MPO Gene-Phenotype Associations)", "skin fibrosis (MP:0009932 from MPO Gene-Phenotype Associations)", "delayed tooth eruption (MP:0003053 from MPO Gene-Phenotype Associations)", "abnormal solitary pulmonary neuroendocrine cell morphology (MP:0010914 from MPO Gene-Phenotype Associations)", "abnormal pulmonary neuroendocrine body morphology (MP:0010918 from MPO Gene-Phenotype Associations)", "increased number of pulmonary neuroendocrine bodies (MP:0010919 from MPO Gene-Phenotype Associations)", "increased solitary pulmonary neuroendocrine cell number (MP:0010915 from MPO Gene-Phenotype Associations)", "long ribs (MP:0004671 from MPO Gene-Phenotype Associations)", "long mandible (MP:0004593 from MPO Gene-Phenotype Associations)", "enlarged lumbar vertebrae (MP:0004707 from MPO Gene-Phenotype Associations)", "abnormal dermis reticular layer collagen network (MP:0009826 from MPO Gene-Phenotype Associations)", "abnormal cutaneous microfibril morphology (MP:0008419 from MPO Gene-Phenotype Associations)", "abnormal aortic sinus morphology (MP:0010482 from MPO Gene-Phenotype Associations)", "aortic sinus aneurysm (MP:0010483 from MPO Gene-Phenotype Associations)", "mitral valve prolapse (MP:0006120 from MPO Gene-Phenotype Associations)", "aortic elastic tissue lesions (MP:0002964 from MPO Gene-Phenotype Associations)", "thick hypodermis (MP:0004127 from MPO Gene-Phenotype Associations)", "increased interleukin-9 secretion (MP:0008711 from MPO Gene-Phenotype Associations)", "abnormal dermis reticular layer morphology (MP:0005081 from MPO Gene-Phenotype Associations)", "abnormal dermis papillary layer morphology (MP:0009545 from MPO Gene-Phenotype Associations)", "abnormal costal cartilage morphology (MP:0006432 from MPO Gene-Phenotype Associations)", "pneumothorax (MP:0010822 from MPO Gene-Phenotype Associations)", "enlarged thoracic cavity (MP:0004735 from MPO Gene-Phenotype Associations)", "abnormal aorta endothelium morphology (MP:0009864 from MPO Gene-Phenotype Associations)", "abnormal aorta tunica intima morphology (MP:0009872 from MPO Gene-Phenotype Associations)", "aortitis (MP:0010139 from MPO Gene-Phenotype Associations)", "arteritis (MP:0010138 from MPO Gene-Phenotype Associations)", "vascular inflammation (MP:0001863 from MPO Gene-Phenotype Associations)", "vasculitis (MP:0001864 from MPO Gene-Phenotype Associations)", "abnormal pulmonary alveolar duct morphology (MP:0002271 from MPO Gene-Phenotype Associations)", "dilated pulmonary alveolar ducts (MP:0010908 from MPO Gene-Phenotype Associations)", "abnormal total lung capacity (MP:0002304 from MPO Gene-Phenotype Associations)", "increased total lung capacity (MP:0010937 from MPO Gene-Phenotype Associations)", "abnormal lung compliance (MP:0002333 from MPO Gene-Phenotype Associations)", "increased lung compliance (MP:0010895 from MPO Gene-Phenotype Associations)", "abnormal respiratory mechanics (MP:0002314 from MPO Gene-Phenotype Associations)", "abnormal pulmonary alveolus wall morphology (MP:0010903 from MPO Gene-Phenotype Associations)", "overexpanded pulmonary alveoli (MP:0001183 from MPO Gene-Phenotype Associations)", "emphysema (MP:0001958 from MPO Gene-Phenotype Associations)", "abnormal pulmonary elastic fiber morphology (MP:0003209 from MPO Gene-Phenotype Associations)", "abnormal aorta bulb morphology (MP:0011572 from MPO Gene-Phenotype Associations)", "dilated aorta bulb (MP:0011575 from MPO Gene-Phenotype Associations)", "thoracic aorta aneurysm (MP:0010658 from MPO Gene-Phenotype Associations)", "ascending aorta aneurysm (MP:0010661 from MPO Gene-Phenotype Associations)", "increased aorta wall thickness (MP:0010996 from MPO Gene-Phenotype Associations)", "abnormal ascending aorta morphology (MP:0009867 from MPO Gene-Phenotype Associations)", "hemothorax (MP:0005243 from MPO Gene-Phenotype Associations)", "aneurysm (MP:0003279 from MPO Gene-Phenotype Associations)", "aortic aneurysm (MP:0006278 from MPO Gene-Phenotype Associations)", "aortic dissection (MP:0004044 from MPO Gene-Phenotype Associations)", "abnormal aorta elastic fiber morphology (MP:0003211 from MPO Gene-Phenotype Associations)", "abnormal aorta elastic tissue morphology (MP:0009862 from MPO Gene-Phenotype Associations)", "abnormal blood vessel elastic tissue morphology (MP:0006083 from MPO Gene-Phenotype Associations)", "abnormal aorta tunica media morphology (MP:0009873 from MPO Gene-Phenotype Associations)", "abnormal aorta wall morphology (MP:0009866 from MPO Gene-Phenotype Associations)", "abnormal aorta smooth muscle morphology (MP:0009865 from MPO Gene-Phenotype Associations)", "abnormal descending thoracic aorta morphology (MP:0009868 from MPO Gene-Phenotype Associations)", "supravalvar aortic stenosis (MP:0010471 from MPO Gene-Phenotype Associations)", "abnormal aorta elastin content (MP:0003905 from MPO Gene-Phenotype Associations)", "decreased aorta elastin content (MP:0003907 from MPO Gene-Phenotype Associations)", "decreased aorta wall thickness (MP:0010997 from MPO Gene-Phenotype Associations)", "abnormal aortic valve anulus morphology (MP:0010598 from MPO Gene-Phenotype Associations)", "aorta stenosis (MP:0010463 from MPO Gene-Phenotype Associations)", "artery stenosis (MP:0006135 from MPO Gene-Phenotype Associations)", "vascular stenosis (MP:0005412 from MPO Gene-Phenotype Associations)", "dilated respiratory conducting tubes (MP:0010856 from MPO Gene-Phenotype Associations)", "abnormal cutaneous elastic fiber morphology (MP:0008418 from MPO Gene-Phenotype Associations)", "uterus prolapse (MP:0005577 from MPO Gene-Phenotype Associations)", "abnormal aorta collagen fibril morphology (MP:0011640 from MPO Gene-Phenotype Associations)", "myocardial hypertrophy (MP:0010633 from MPO Gene-Phenotype Associations)", "abnormal testis interstitial tissue morphology (MP:0011416 from MPO Gene-Phenotype Associations)", "abnormal collagen level (MP:0020252 from MPO Gene-Phenotype Associations)", "decreased collagen level (MP:0020254 from MPO Gene-Phenotype Associations)", "abnormal aorta tunica adventitia morphology (MP:0009871 from MPO Gene-Phenotype Associations)", "small pupils (MP:0001320 from MPO Gene-Phenotype Associations)", "tubular nephritis (MP:0002704 from MPO Gene-Phenotype Associations)", "abnormal periodontal ligament morphology (MP:0003668 from MPO Gene-Phenotype Associations)", "periodontal ligament hypercellularity (MP:0003669 from MPO Gene-Phenotype Associations)", "salivary gland epithelial hyperplasia (MP:0000619 from MPO Gene-Phenotype Associations)", "loose skin (MP:0005421 from MPO Gene-Phenotype Associations)", "abnormal dermal layer morphology (MP:0001243 from MPO Gene-Phenotype Associations)", "thin dermal layer (MP:0001244 from MPO Gene-Phenotype Associations)", "abnormal cutaneous collagen fibril morphology (MP:0008438 from MPO Gene-Phenotype Associations)", "abnormal skin tensile strength (MP:0005275 from MPO Gene-Phenotype Associations)", "decreased skin tensile strength (MP:0003089 from MPO Gene-Phenotype Associations)", "abnormal sclera morphology (MP:0002698 from MPO Gene-Phenotype Associations)", "sclera thinning (MP:0003102 from MPO Gene-Phenotype Associations)", "increased corneal light-scattering (MP:0003096 from MPO Gene-Phenotype Associations)", "abnormal tendon morphology (MP:0005503 from MPO Gene-Phenotype Associations)", "abnormal tendon stiffness (MP:0003097 from MPO Gene-Phenotype Associations)", "decreased tendon stiffness (MP:0003098 from MPO Gene-Phenotype Associations)", "osteoarthritis (MP:0003560 from MPO Gene-Phenotype Associations)", "mosaic coat color (MP:0010389 from MPO Gene-Phenotype Associations)", "abnormal aortic weight (MP:0002845 from MPO Gene-Phenotype Associations)", "abnormal intestine copper level (MP:0010246 from MPO Gene-Phenotype Associations)", "increased intestine copper level (MP:0010247 from MPO Gene-Phenotype Associations)", "decreased circulating ceruloplasmin level (MP:0012661 from MPO Gene-Phenotype Associations)", "ascending aorta dilation (MP:0010470 from MPO Gene-Phenotype Associations)", "altered susceptibility to prion infection (MP:0020187 from MPO Gene-Phenotype Associations)", "decreased susceptibility to prion infection (MP:0005363 from MPO Gene-Phenotype Associations)", "increased susceptibility to prion infection (MP:0005364 from MPO Gene-Phenotype Associations)", "abnormal brain copper level (MP:0011213 from MPO Gene-Phenotype Associations)", "decreased brain copper level (MP:0011215 from MPO Gene-Phenotype Associations)", "abnormal copper homeostasis (MP:0003951 from MPO Gene-Phenotype Associations)", "abnormal copper level (MP:0003952 from MPO Gene-Phenotype Associations)", "abnormal liver copper level (MP:0003065 from MPO Gene-Phenotype Associations)", "increased brain copper level (MP:0011214 from MPO Gene-Phenotype Associations)", "increased circulating copper level (MP:0006350 from MPO Gene-Phenotype Associations)", "decreased liver copper level (MP:0003067 from MPO Gene-Phenotype Associations)", "abnormal circulating copper level (MP:0006348 from MPO Gene-Phenotype Associations)", "decreased circulating copper level (MP:0006349 from MPO Gene-Phenotype Associations)", "abnormal kidney copper level (MP:0010242 from MPO Gene-Phenotype Associations)", "increased kidney copper level (MP:0010243 from MPO Gene-Phenotype Associations)", "increased liver copper level (MP:0003066 from MPO Gene-Phenotype Associations)", "orotic acid urinary bladder stones (MP:0011626 from MPO Gene-Phenotype Associations)", "abnormal ornithine carbamoyltransferase activity (MP:0011586 from MPO Gene-Phenotype Associations)", "decreased ornithine carbamoyltransferase activity (MP:0011588 from MPO Gene-Phenotype Associations)", "oroticaciduria (MP:0011765 from MPO Gene-Phenotype Associations)", "abnormal circulating ammonia level (MP:0005308 from MPO Gene-Phenotype Associations)", "increased circulating ammonia level (MP:0005309 from MPO Gene-Phenotype Associations)", "abnormal nucleotide metabolism (MP:0003806 from MPO Gene-Phenotype Associations)", "abnormal copulation (MP:0009697 from MPO Gene-Phenotype Associations)", "abnormal penile erection (MP:0001379 from MPO Gene-Phenotype Associations)", "priapism (MP:0003415 from MPO Gene-Phenotype Associations)", "portal hypertension (MP:0003328 from MPO Gene-Phenotype Associations)", "abnormal subendocardium layer morphology (MP:0010546 from MPO Gene-Phenotype Associations)", "disorganized photoreceptor outer segment (MP:0008586 from MPO Gene-Phenotype Associations)", "disorganized photoreceptor inner segment (MP:0008581 from MPO Gene-Phenotype Associations)", "abnormal a wave amplitude (MP:0012030 from MPO Gene-Phenotype Associations)", "abnormal a wave shape (MP:0012034 from MPO Gene-Phenotype Associations)", "decreased a wave amplitude (MP:0012143 from MPO Gene-Phenotype Associations)", "abnormal b wave amplitude (MP:0012031 from MPO Gene-Phenotype Associations)", "abnormal b-wave shape (MP:0012035 from MPO Gene-Phenotype Associations)", "decreased b wave amplitude (MP:0012144 from MPO Gene-Phenotype Associations)", "abnormal electroretinogram waveform feature (MP:0012029 from MPO Gene-Phenotype Associations)", "absent bone trabeculae (MP:0010870 from MPO Gene-Phenotype Associations)", "calcified pulmonary alveolus (MP:0010923 from MPO Gene-Phenotype Associations)", "calcified mitral valve (MP:0006121 from MPO Gene-Phenotype Associations)", "vulva atrophy (MP:0009212 from MPO Gene-Phenotype Associations)", "abnormal a wave latency (MP:0012036 from MPO Gene-Phenotype Associations)", "increased a wave latency (MP:0012151 from MPO Gene-Phenotype Associations)", "abnormal b wave latency (MP:0012037 from MPO Gene-Phenotype Associations)", "abnormal erg latency (MP:0012032 from MPO Gene-Phenotype Associations)", "increased b wave latency (MP:0012153 from MPO Gene-Phenotype Associations)", "external male genitalia atrophy (MP:0009201 from MPO Gene-Phenotype Associations)", "small external male genitalia (MP:0009202 from MPO Gene-Phenotype Associations)", "small vulva (MP:0003527 from MPO Gene-Phenotype Associations)", "kidney cortex hypoplasia (MP:0011360 from MPO Gene-Phenotype Associations)", "abnormal rr interval (MP:0010504 from MPO Gene-Phenotype Associations)", "prolonged rr interval (MP:0010506 from MPO Gene-Phenotype Associations)", "calcified intraocular region (MP:0006209 from MPO Gene-Phenotype Associations)", "calcified retina (MP:0006188 from MPO Gene-Phenotype Associations)", "retinal deposits (MP:0006187 from MPO Gene-Phenotype Associations)", "decreased susceptibility to dystrophic cardiac calcinosis (MP:0002838 from MPO Gene-Phenotype Associations)", "increased susceptibility to dystrophic cardiac calcinosis (MP:0002839 from MPO Gene-Phenotype Associations)", "calcified skin (MP:0003196 from MPO Gene-Phenotype Associations)", "calcinosis (MP:0003195 from MPO Gene-Phenotype Associations)", "calcified aorta (MP:0010522 from MPO Gene-Phenotype Associations)", "calcified artery (MP:0006133 from MPO Gene-Phenotype Associations)", "abnormal vibrissa follicle morphology (MP:0010234 from MPO Gene-Phenotype Associations)", "abnormal sesamoid bone of gastrocnemius morphology (MP:0009005 from MPO Gene-Phenotype Associations)", "abnormal cementum morphology (MP:0003933 from MPO Gene-Phenotype Associations)", "fusion of middle ear ossicles (MP:0003740 from MPO Gene-Phenotype Associations)", "abnormal joint mobility (MP:0008069 from MPO Gene-Phenotype Associations)", "mesangial cell interposition (MP:0011512 from MPO Gene-Phenotype Associations)", "abnormal circulating complement protein level (MP:0010215 from MPO Gene-Phenotype Associations)", "abnormal complement protein level (MP:0011566 from MPO Gene-Phenotype Associations)", "decreased circulating complement protein level (MP:0020216 from MPO Gene-Phenotype Associations)", "increased susceptibility to type iii hypersensitivity reaction (MP:0005615 from MPO Gene-Phenotype Associations)", "abnormal visual acuity (MP:0011832 from MPO Gene-Phenotype Associations)", "decreased visual acuity (MP:0006149 from MPO Gene-Phenotype Associations)", "increased macrophage nitric oxide production (MP:0011076 from MPO Gene-Phenotype Associations)", "abnormal type iii hypersensitivity reaction (MP:0002533 from MPO Gene-Phenotype Associations)", "decreased susceptibility to type iii hypersensitivity reaction (MP:0005614 from MPO Gene-Phenotype Associations)", "cecum inflammation (MP:0009481 from MPO Gene-Phenotype Associations)", "abnormal cns synapse formation (MP:0004996 from MPO Gene-Phenotype Associations)", "decreased cns synapse formation (MP:0004998 from MPO Gene-Phenotype Associations)", "abnormal hippocampus stratum lacunosum morphology (MP:0011149 from MPO Gene-Phenotype Associations)", "abnormal brain interneuron morphology (MP:0004101 from MPO Gene-Phenotype Associations)", "abnormal airway basal cell differentiation (MP:0011114 from MPO Gene-Phenotype Associations)", "abnormal airway basal cell morphology (MP:0011113 from MPO Gene-Phenotype Associations)", "airway basal cell hyperplasia (MP:0011115 from MPO Gene-Phenotype Associations)", "abnormal nicotine-mediated receptor currents (MP:0009475 from MPO Gene-Phenotype Associations)", "decreased erythroblast number (MP:0011179 from MPO Gene-Phenotype Associations)", "abnormal cocaine consumption (MP:0002556 from MPO Gene-Phenotype Associations)", "cocaine preference (MP:0001988 from MPO Gene-Phenotype Associations)", "abnormal gabaergic neuron physiology (MP:0011987 from MPO Gene-Phenotype Associations)", "failure of neuromuscular synapse presynaptic differentiation (MP:0001054 from MPO Gene-Phenotype Associations)", "failure of neuromuscular synapse postsynaptic differentiation (MP:0001055 from MPO Gene-Phenotype Associations)", "absent metanephric mesenchyme (MP:0011387 from MPO Gene-Phenotype Associations)", "metacarpal bone hypoplasia (MP:0004637 from MPO Gene-Phenotype Associations)", "fused metacarpal bones (MP:0004639 from MPO Gene-Phenotype Associations)", "renal glomerulus atrophy (MP:0011363 from MPO Gene-Phenotype Associations)", "abnormal cerebellum dentate nucleus morphology (MP:0009980 from MPO Gene-Phenotype Associations)", "behavioral arrest (MP:0008035 from MPO Gene-Phenotype Associations)", "poor grooming (MP:0001443 from MPO Gene-Phenotype Associations)", "abnormal synaptic bouton morphology (MP:0008571 from MPO Gene-Phenotype Associations)", "abnormal systemic vascular resistance (MP:0004877 from MPO Gene-Phenotype Associations)", "increased systemic vascular resistance (MP:0004878 from MPO Gene-Phenotype Associations)", "abnormal behavioral response to nicotine (MP:0020160 from MPO Gene-Phenotype Associations)", "enhanced behavioral response to nicotine (MP:0009752 from MPO Gene-Phenotype Associations)", "impaired behavioral response to nicotine (MP:0009756 from MPO Gene-Phenotype Associations)", "abnormal synaptic dopamine release (MP:0010149 from MPO Gene-Phenotype Associations)", "abnormal olfactory nerve morphology (MP:0005236 from MPO Gene-Phenotype Associations)", "abnormal nose morphology (MP:0002233 from MPO Gene-Phenotype Associations)", "abnormal chemoreceptor morphology (MP:0001001 from MPO Gene-Phenotype Associations)", "abnormal olfactory sensory neuron morphology (MP:0006092 from MPO Gene-Phenotype Associations)", "abnormal olfactory epithelium morphology (MP:0008789 from MPO Gene-Phenotype Associations)", "abnormal olfactory system morphology (MP:0005499 from MPO Gene-Phenotype Associations)", "taste|olfaction phenotype (MP:0005394 from MPO Gene-Phenotype Associations)", "abnormal olfaction (MP:0001984 from MPO Gene-Phenotype Associations)", "abnormal olfactory system physiology (MP:0001983 from MPO Gene-Phenotype Associations)", "impaired olfaction (MP:0008544 from MPO Gene-Phenotype Associations)", "anosmia (MP:0004512 from MPO Gene-Phenotype Associations)", "abnormal olfactory receptor morphology (MP:0001003 from MPO Gene-Phenotype Associations)", "abnormal olfactory epithelium cilium morphology (MP:0011281 from MPO Gene-Phenotype Associations)", "abnormal olfactory epithelium physiology (MP:0012020 from MPO Gene-Phenotype Associations)", "corneal deposits (MP:0005544 from MPO Gene-Phenotype Associations)", "endometrium atrophy (MP:0009359 from MPO Gene-Phenotype Associations)", "abnormal plasma membrane sphingolipid content (MP:0009587 from MPO Gene-Phenotype Associations)", "increased plasma membrane sphingolipid content (MP:0009588 from MPO Gene-Phenotype Associations)", "sphingomyelinosis (MP:0009589 from MPO Gene-Phenotype Associations)", "increased brain cholesterol level (MP:0010162 from MPO Gene-Phenotype Associations)", "increased brain sterol level (MP:0012228 from MPO Gene-Phenotype Associations)", "abnormal sphingomyelin level (MP:0009823 from MPO Gene-Phenotype Associations)", "abnormal brain cholesterol level (MP:0012779 from MPO Gene-Phenotype Associations)", "decreased brain cholesterol level (MP:0010161 from MPO Gene-Phenotype Associations)", "decreased brain sterol level (MP:0012227 from MPO Gene-Phenotype Associations)", "proteinosis (MP:0010999 from MPO Gene-Phenotype Associations)", "pulmonary alveolar proteinosis (MP:0010998 from MPO Gene-Phenotype Associations)", "abnormal alveolar macrophage morphology (MP:0008245 from MPO Gene-Phenotype Associations)", "lipidosis (MP:0008570 from MPO Gene-Phenotype Associations)", "brain atrophy (MP:0012506 from MPO Gene-Phenotype Associations)", "midbrain atrophy (MP:0012507 from MPO Gene-Phenotype Associations)", "abnormal foam cell morphology (MP:0009840 from MPO Gene-Phenotype Associations)", "abnormal macrophage derived foam cell morphology (MP:0008243 from MPO Gene-Phenotype Associations)", "foam cell reticulosis (MP:0009841 from MPO Gene-Phenotype Associations)", "increased macrophage derived foam cell number (MP:0004778 from MPO Gene-Phenotype Associations)", "abnormal circulating plant sterol level (MP:0010075 from MPO Gene-Phenotype Associations)", "abnormal plant sterol level (MP:0010076 from MPO Gene-Phenotype Associations)", "increased circulating plant sterol level (MP:0010078 from MPO Gene-Phenotype Associations)", "increased plant sterol level (MP:0010077 from MPO Gene-Phenotype Associations)", "abnormal circulating phospholipid level (MP:0006084 from MPO Gene-Phenotype Associations)", "increased circulating phospholipid level (MP:0003980 from MPO Gene-Phenotype Associations)", "abnormal phospholipid level (MP:0004777 from MPO Gene-Phenotype Associations)", "increased cholesterol efflux (MP:0003192 from MPO Gene-Phenotype Associations)", "decreased circulating phospholipid level (MP:0003981 from MPO Gene-Phenotype Associations)", "abnormal cellular cholesterol metabolism (MP:0003191 from MPO Gene-Phenotype Associations)", "abnormal lipid metabolism (MP:0013245 from MPO Gene-Phenotype Associations)", "decreased cholesterol efflux (MP:0003193 from MPO Gene-Phenotype Associations)", "retinal pigment epithelium atrophy (MP:0005548 from MPO Gene-Phenotype Associations)", "inguinal hernia (MP:0006077 from MPO Gene-Phenotype Associations)", "abnormal bruch membrane morphology (MP:0005239 from MPO Gene-Phenotype Associations)", "abnormal choriocapillaris morphology (MP:0006238 from MPO Gene-Phenotype Associations)", "posterior subcapsular cataracts (MP:0010253 from MPO Gene-Phenotype Associations)", "retinal detachment (MP:0003099 from MPO Gene-Phenotype Associations)", "pituitary intermediate lobe hypoplasia (MP:0008369 from MPO Gene-Phenotype Associations)", "hypopituitarism (MP:0003348 from MPO Gene-Phenotype Associations)", "abnormal pituitary gland physiology (MP:0005646 from MPO Gene-Phenotype Associations)", "abnormal pituitary secretion (MP:0001746 from MPO Gene-Phenotype Associations)", "abnormal lung hysteresivity (MP:0010950 from MPO Gene-Phenotype Associations)", "abnormal spiral modiolar artery morphology (MP:0004629 from MPO Gene-Phenotype Associations)", "spiral modiolar artery stenosis (MP:0004630 from MPO Gene-Phenotype Associations)", "decreased systemic vascular resistance (MP:0004879 from MPO Gene-Phenotype Associations)", "xanthoma (MP:0003692 from MPO Gene-Phenotype Associations)", "hypersecretion of corticosterone (MP:0001744 from MPO Gene-Phenotype Associations)", "abnormal cardiac stroke volume (MP:0000304 from MPO Gene-Phenotype Associations)", "increased cardiac stroke volume (MP:0011951 from MPO Gene-Phenotype Associations)", "increased cardiac output (MP:0003394 from MPO Gene-Phenotype Associations)", "altered susceptibility to atherosclerosis (MP:0005340 from MPO Gene-Phenotype Associations)", "arteriosclerosis (MP:0003991 from MPO Gene-Phenotype Associations)", "atherosclerotic lesions (MP:0005338 from MPO Gene-Phenotype Associations)", "decreased susceptibility to atherosclerosis (MP:0005341 from MPO Gene-Phenotype Associations)", "increased susceptibility to atherosclerosis (MP:0005339 from MPO Gene-Phenotype Associations)", "decreased chemical nociceptive threshold (MP:0008532 from MPO Gene-Phenotype Associations)", "jumpy (MP:0001401 from MPO Gene-Phenotype Associations)", "reduced kindling response (MP:0001500 from MPO Gene-Phenotype Associations)", "abnormal kindling response (MP:0001499 from MPO Gene-Phenotype Associations)", "abnormal seizure response to electrical stimulation (MP:0001650 from MPO Gene-Phenotype Associations)", "minimal clonic seizures (MP:0002193 from MPO Gene-Phenotype Associations)", "maximal tonic hindlimb extension seizures (MP:0002194 from MPO Gene-Phenotype Associations)", "hippocampal neuron degeneration (MP:0000811 from MPO Gene-Phenotype Associations)", "tau protein deposits (MP:0004250 from MPO Gene-Phenotype Associations)", "decreased mitochondria size (MP:0011631 from MPO Gene-Phenotype Associations)", "neuronal cytoplasmic inclusions (MP:0011975 from MPO Gene-Phenotype Associations)", "abnormal white fat cell lipid droplet size (MP:0009120 from MPO Gene-Phenotype Associations)", "decreased white fat cell lipid droplet size (MP:0009122 from MPO Gene-Phenotype Associations)", "amyloid beta deposits (MP:0003329 from MPO Gene-Phenotype Associations)", "amyloidosis (MP:0000604 from MPO Gene-Phenotype Associations)", "increased circulating vldl triglyceride level (MP:0003975 from MPO Gene-Phenotype Associations)", "decreased lung compliance (MP:0010896 from MPO Gene-Phenotype Associations)", "increased lung elastance (MP:0011044 from MPO Gene-Phenotype Associations)", "pulmonary hyperemia (MP:0010855 from MPO Gene-Phenotype Associations)", "increased endometrial gland number (MP:0013401 from MPO Gene-Phenotype Associations)", "increased lung endothelial cell proliferation (MP:0011139 from MPO Gene-Phenotype Associations)", "abnormal pulmonary endothelial cell surface (MP:0003180 from MPO Gene-Phenotype Associations)", "cns ischemia (MP:0006080 from MPO Gene-Phenotype Associations)", "abnormal plasma membrane morphology (MP:0003950 from MPO Gene-Phenotype Associations)", "absent caveolae (MP:0004150 from MPO Gene-Phenotype Associations)", "abnormal airway resistance (MP:0002328 from MPO Gene-Phenotype Associations)", "decreased airway resistance (MP:0010936 from MPO Gene-Phenotype Associations)", "increased airway resistance (MP:0010935 from MPO Gene-Phenotype Associations)", "abnormal basal lamina morphology (MP:0004273 from MPO Gene-Phenotype Associations)", "skin detachment (MP:0009827 from MPO Gene-Phenotype Associations)", "respiratory epithelium hypertrophy (MP:0010944 from MPO Gene-Phenotype Associations)", "abnormal lung elastance (MP:0011043 from MPO Gene-Phenotype Associations)", "decreased lung elastance (MP:0011045 from MPO Gene-Phenotype Associations)", "abnormal kidney pelvis urothelium morphology (MP:0011336 from MPO Gene-Phenotype Associations)", "ureter urothelium hyperplasia (MP:0000535 from MPO Gene-Phenotype Associations)", "abnormal ureter urothelium morphology (MP:0011484 from MPO Gene-Phenotype Associations)", "abnormal renal calcium reabsorbtion (MP:0010111 from MPO Gene-Phenotype Associations)", "glomerular capillary congestion (MP:0011433 from MPO Gene-Phenotype Associations)", "abnormal lung endothelial cell migration (MP:0011132 from MPO Gene-Phenotype Associations)", "decreased lung endothelial cell migration (MP:0011134 from MPO Gene-Phenotype Associations)", "spleen vascular congestion (MP:0010020 from MPO Gene-Phenotype Associations)", "kidney vascular congestion (MP:0000532 from MPO Gene-Phenotype Associations)", "abnormal lung endothelial cell physiology (MP:0011131 from MPO Gene-Phenotype Associations)", "abnormal lung endothelial cell proliferation (MP:0011138 from MPO Gene-Phenotype Associations)", "decreased lung endothelial cell proliferation (MP:0011140 from MPO Gene-Phenotype Associations)", "increased lung endothelial cell apoptosis (MP:0011141 from MPO Gene-Phenotype Associations)", "tumor regression (MP:0010537 from MPO Gene-Phenotype Associations)", "abnormal odor adaptation (MP:0009562 from MPO Gene-Phenotype Associations)", "abnormal nociceptor morphology (MP:0000969 from MPO Gene-Phenotype Associations)", "abnormal splanchnic mesoderm morphology (MP:0012179 from MPO Gene-Phenotype Associations)", "abnormal pancreas mesenchyme morphology (MP:0011265 from MPO Gene-Phenotype Associations)", "absent heart right ventricle (MP:0003872 from MPO Gene-Phenotype Associations)", "abnormal heart shape (MP:0000277 from MPO Gene-Phenotype Associations)", "abnormal first pharyngeal arch artery morphology (MP:0010355 from MPO Gene-Phenotype Associations)", "abnormal second pharyngeal arch artery morphology (MP:0010356 from MPO Gene-Phenotype Associations)", "abnormal aortic sac morphology (MP:0012510 from MPO Gene-Phenotype Associations)", "dilated aortic sac (MP:0012511 from MPO Gene-Phenotype Associations)", "split vertebrae (MP:0004687 from MPO Gene-Phenotype Associations)", "thick epidermis stratum spinosum (MP:0009474 from MPO Gene-Phenotype Associations)", "complete lethality during fetal growth through weaning (MP:0011111 from MPO Gene-Phenotype Associations)", "cardiac edema (MP:0012270 from MPO Gene-Phenotype Associations)", "abnormal midgut morphology (MP:0009705 from MPO Gene-Phenotype Associations)", "absent midgut (MP:0009706 from MPO Gene-Phenotype Associations)", "detached otolithic membrane (MP:0003145 from MPO Gene-Phenotype Associations)", "increased qrs amplitude (MP:0010634 from MPO Gene-Phenotype Associations)", "opisthotonus (MP:0002880 from MPO Gene-Phenotype Associations)", "abnormal chief cell morphology (MP:0004140 from MPO Gene-Phenotype Associations)", "abnormal gastric gland morphology (MP:0003892 from MPO Gene-Phenotype Associations)", "abnormal gastric parietal cell morphology (MP:0004139 from MPO Gene-Phenotype Associations)", "abnormal stomach ph (MP:0008004 from MPO Gene-Phenotype Associations)", "increased stomach ph (MP:0008006 from MPO Gene-Phenotype Associations)", "abnormal circulating gastrin level (MP:0004730 from MPO Gene-Phenotype Associations)", "increased circulating gastrin level (MP:0004731 from MPO Gene-Phenotype Associations)", "enlarged stomach (MP:0003883 from MPO Gene-Phenotype Associations)", "abnormal mucous neck cell morphology (MP:0004138 from MPO Gene-Phenotype Associations)", "hypochlorhydria (MP:0008001 from MPO Gene-Phenotype Associations)", "abnormal stomach morphology (MP:0000470 from MPO Gene-Phenotype Associations)", "abnormal stomach mucosa morphology (MP:0010792 from MPO Gene-Phenotype Associations)", "abnormal stomach wall morphology (MP:0010783 from MPO Gene-Phenotype Associations)", "abnormal stomach epithelium morphology (MP:0000471 from MPO Gene-Phenotype Associations)", "abnormal stomach glandular epithelium morphology (MP:0000473 from MPO Gene-Phenotype Associations)", "increased stomach mucosa thickness (MP:0005211 from MPO Gene-Phenotype Associations)", "stomach mucosa hyperplasia (MP:0010799 from MPO Gene-Phenotype Associations)", "achlorhydria (MP:0008003 from MPO Gene-Phenotype Associations)", "abnormal gastric surface mucous cell morphology (MP:0004137 from MPO Gene-Phenotype Associations)", "absent digestive secretion (MP:0000507 from MPO Gene-Phenotype Associations)", "abnormal digestive secretion (MP:0000501 from MPO Gene-Phenotype Associations)", "decreased digestive secretion (MP:0000505 from MPO Gene-Phenotype Associations)", "abnormal laryngeal mucosa goblet cell morphology (MP:0002241 from MPO Gene-Phenotype Associations)", "abnormal laryngeal mucosa morphology (MP:0002261 from MPO Gene-Phenotype Associations)", "abnormal stomach pyloric antrum morphology (MP:0010790 from MPO Gene-Phenotype Associations)", "absent respiratory mucosa goblet cells (MP:0010863 from MPO Gene-Phenotype Associations)", "decreased respiratory mucosa goblet cell number (MP:0010862 from MPO Gene-Phenotype Associations)", "stomach inflammation (MP:0001873 from MPO Gene-Phenotype Associations)", "ectopic pancreas (MP:0013291 from MPO Gene-Phenotype Associations)", "toenail hyperkeratosis (MP:0000582 from MPO Gene-Phenotype Associations)", "penis prolapse (MP:0009105 from MPO Gene-Phenotype Associations)", "increased oral papilloma incidence (MP:0003752 from MPO Gene-Phenotype Associations)", "increased esophageal papilloma incidence (MP:0003277 from MPO Gene-Phenotype Associations)", "ascending aorta hypoplasia (MP:0010469 from MPO Gene-Phenotype Associations)", "abnormal esophageal epithelium morphology (MP:0000468 from MPO Gene-Phenotype Associations)", "esophageal epithelium hyperplasia (MP:0000466 from MPO Gene-Phenotype Associations)", "duodenal lesions (MP:0002580 from MPO Gene-Phenotype Associations)", "stomach epithelial hyperplasia (MP:0005493 from MPO Gene-Phenotype Associations)", "increased mouth tumor incidence (MP:0003750 from MPO Gene-Phenotype Associations)", "increased salivary gland tumor incidence (MP:0010318 from MPO Gene-Phenotype Associations)", "increased salivary adenocarcinoma incidence (MP:0000621 from MPO Gene-Phenotype Associations)", "absent oligodendrocytes (MP:0003647 from MPO Gene-Phenotype Associations)", "increased pancreatic epsilon cell number (MP:0009190 from MPO Gene-Phenotype Associations)", "abnormal serotonergic neuron morphology (MP:0003877 from MPO Gene-Phenotype Associations)", "abnormal neuron specification (MP:0002948 from MPO Gene-Phenotype Associations)", "increased pancreatic alpha cell number (MP:0009176 from MPO Gene-Phenotype Associations)", "increased circulating glucagon level (MP:0002712 from MPO Gene-Phenotype Associations)", "abnormal circulating glucagon level (MP:0002695 from MPO Gene-Phenotype Associations)", "decreased circulating glucagon level (MP:0002696 from MPO Gene-Phenotype Associations)", "abnormal glucagon secretion (MP:0003565 from MPO Gene-Phenotype Associations)", "abnormal pancreatic alpha cell physiology (MP:0003563 from MPO Gene-Phenotype Associations)", "decreased glucagon secretion (MP:0002711 from MPO Gene-Phenotype Associations)", "increased glucagon secretion (MP:0002710 from MPO Gene-Phenotype Associations)", "abnormal pancreatic delta cell physiology (MP:0008952 from MPO Gene-Phenotype Associations)", "abnormal pancreatic somatostatin secretion (MP:0008953 from MPO Gene-Phenotype Associations)", "abnormal small intestine placement (MP:0000497 from MPO Gene-Phenotype Associations)", "absent brunner's glands (MP:0012520 from MPO Gene-Phenotype Associations)", "abnormal brunner's gland morphology (MP:0012518 from MPO Gene-Phenotype Associations)", "increased pp cell number (MP:0009185 from MPO Gene-Phenotype Associations)", "abnormal pancreatic endocrine progenitor cell physiology (MP:0011911 from MPO Gene-Phenotype Associations)", "pancreatic islet hypoplasia (MP:0009169 from MPO Gene-Phenotype Associations)", "absent pancreas (MP:0003655 from MPO Gene-Phenotype Associations)", "abnormal stomach enteroendocrine cell morphology (MP:0010803 from MPO Gene-Phenotype Associations)", "abnormal pancreatic epsilon cell morphology (MP:0009189 from MPO Gene-Phenotype Associations)", "abnormal pp cell morphology (MP:0009184 from MPO Gene-Phenotype Associations)", "decreased pp cell number (MP:0009186 from MPO Gene-Phenotype Associations)", "decreased pancreatic epsilon cell number (MP:0009191 from MPO Gene-Phenotype Associations)", "absent pp cells (MP:0009187 from MPO Gene-Phenotype Associations)", "abnormal pancreatic endocrine progenitor cell proliferation (MP:0011908 from MPO Gene-Phenotype Associations)", "decreased pancreatic endocrine progenitor cell proliferation (MP:0011910 from MPO Gene-Phenotype Associations)", "increased pancreas apoptosis (MP:0013220 from MPO Gene-Phenotype Associations)", "abnormal pancreatic delta cell morphology (MP:0005218 from MPO Gene-Phenotype Associations)", "decreased pancreatic delta cell number (MP:0009181 from MPO Gene-Phenotype Associations)", "abnormal endocrine pancreas development (MP:0011932 from MPO Gene-Phenotype Associations)", "abnormal pancreatic beta cell differentiation (MP:0009175 from MPO Gene-Phenotype Associations)", "abnormal pancreas development (MP:0003934 from MPO Gene-Phenotype Associations)", "abnormal pp cell differentiation (MP:0009188 from MPO Gene-Phenotype Associations)", "abnormal pancreatic delta cell differentiation (MP:0009183 from MPO Gene-Phenotype Associations)", "abnormal pancreatic epsilon cell differentiation (MP:0009193 from MPO Gene-Phenotype Associations)", "abnormal pancreatic alpha cell differentiation (MP:0009179 from MPO Gene-Phenotype Associations)", "disorganized stomach mucosa (MP:0005210 from MPO Gene-Phenotype Associations)", "regional gastric metaplasia (MP:0005214 from MPO Gene-Phenotype Associations)", "abnormal pancreatic alpha cell morphology (MP:0005216 from MPO Gene-Phenotype Associations)", "decreased pancreatic alpha cell number (MP:0009177 from MPO Gene-Phenotype Associations)", "decreased pancreatic beta cell number (MP:0003339 from MPO Gene-Phenotype Associations)", "absent pancreatic alpha cells (MP:0009178 from MPO Gene-Phenotype Associations)", "absent pancreatic beta cells (MP:0009174 from MPO Gene-Phenotype Associations)", "disorganized pancreatic islets (MP:0009254 from MPO Gene-Phenotype Associations)", "abnormal pancreatic islet number (MP:0009166 from MPO Gene-Phenotype Associations)", "decreased pancreatic islet number (MP:0009168 from MPO Gene-Phenotype Associations)", "increased pancreatic islet number (MP:0009167 from MPO Gene-Phenotype Associations)", "abnormal pancreas size (MP:0009106 from MPO Gene-Phenotype Associations)", "small pancreas (MP:0004247 from MPO Gene-Phenotype Associations)", "abnormal pancreas weight (MP:0009107 from MPO Gene-Phenotype Associations)", "decreased pancreas weight (MP:0009109 from MPO Gene-Phenotype Associations)", "enlarged pancreas (MP:0003450 from MPO Gene-Phenotype Associations)", "increased pancreas weight (MP:0009108 from MPO Gene-Phenotype Associations)", "hemorrhagic ascites (MP:0013184 from MPO Gene-Phenotype Associations)", "increased pancreatic acinar cell carcinoma incidence (MP:0008780 from MPO Gene-Phenotype Associations)", "pancreatic acinar hyperplasia (MP:0009155 from MPO Gene-Phenotype Associations)", "abnormal parotid gland morphology (MP:0003452 from MPO Gene-Phenotype Associations)", "abnormal exocrine pancreas physiology (MP:0010148 from MPO Gene-Phenotype Associations)", "exocrine pancreatic insufficiency (MP:0003335 from MPO Gene-Phenotype Associations)", "abnormal exocrine pancreas morphology (MP:0005220 from MPO Gene-Phenotype Associations)", "abnormal pancreatic acinar cell morphology (MP:0009146 from MPO Gene-Phenotype Associations)", "abnormal pancreatic acinus morphology (MP:0009145 from MPO Gene-Phenotype Associations)", "abnormal pancreatic acinar cell zymogen granule morphology (MP:0009160 from MPO Gene-Phenotype Associations)", "pancreatic acinar cell zymogen granule accumulation (MP:0009161 from MPO Gene-Phenotype Associations)", "absent pancreatic acinar cell zymogen granule (MP:0009162 from MPO Gene-Phenotype Associations)", "pancreatic acinar hypoplasia (MP:0009154 from MPO Gene-Phenotype Associations)", "abnormal eating frequency (MP:0011944 from MPO Gene-Phenotype Associations)", "increased eating frequency (MP:0011945 from MPO Gene-Phenotype Associations)", "absent pancreatic delta cells (MP:0009182 from MPO Gene-Phenotype Associations)", "abnormal nasal mucosa morphology (MP:0002238 from MPO Gene-Phenotype Associations)", "abnormal vital capacity (MP:0002309 from MPO Gene-Phenotype Associations)", "dilated brunner's glands (MP:0012519 from MPO Gene-Phenotype Associations)", "ileum hypertrophy (MP:0009484 from MPO Gene-Phenotype Associations)", "acute pancreas inflammation (MP:0003340 from MPO Gene-Phenotype Associations)", "enlarged ileum (MP:0009483 from MPO Gene-Phenotype Associations)", "small cecum (MP:0009477 from MPO Gene-Phenotype Associations)", "coiled cecum (MP:0009478 from MPO Gene-Phenotype Associations)", "abnormal respiratory mucosa goblet cell morphology (MP:0002281 from MPO Gene-Phenotype Associations)", "abnormal respiratory mucosa morphology (MP:0002277 from MPO Gene-Phenotype Associations)", "increased respiratory mucosa goblet cell number (MP:0010861 from MPO Gene-Phenotype Associations)", "abnormal sperm capacitation (MP:0013286 from MPO Gene-Phenotype Associations)", "impaired sperm capacitation (MP:0003666 from MPO Gene-Phenotype Associations)", "abnormal gastrointestinal motility (MP:0011082 from MPO Gene-Phenotype Associations)", "intestinal obstruction (MP:0003270 from MPO Gene-Phenotype Associations)", "abnormal intestinal transit time (MP:0006001 from MPO Gene-Phenotype Associations)", "abnormal thymus involution (MP:0001824 from MPO Gene-Phenotype Associations)", "hypochromic macrocytic anemia (MP:0008389 from MPO Gene-Phenotype Associations)", "abnormal bone marrow cell physiology (MP:0009278 from MPO Gene-Phenotype Associations)", "embryo tissue necrosis (MP:0013241 from MPO Gene-Phenotype Associations)", "enlarged pericardium (MP:0000291 from MPO Gene-Phenotype Associations)", "absent placenta hemotrichorial membrane (MP:0012127 from MPO Gene-Phenotype Associations)", "abnormal mitochondrial matrix morphology (MP:0011637 from MPO Gene-Phenotype Associations)", "enlarged first pharyngeal arch (MP:0006343 from MPO Gene-Phenotype Associations)", "absent z lines (MP:0004092 from MPO Gene-Phenotype Associations)", "abnormal mitochondrial shape (MP:0011633 from MPO Gene-Phenotype Associations)", "abnormal fetal cardiomyocyte morphology (MP:0008788 from MPO Gene-Phenotype Associations)", "decreased myocardial fiber number (MP:0004567 from MPO Gene-Phenotype Associations)", "abnormal mitochondrial chromosome morphology (MP:0011638 from MPO Gene-Phenotype Associations)", "decreased mitochondrial dna content (MP:0011639 from MPO Gene-Phenotype Associations)", "abnormal mitochondrial crista morphology (MP:0011635 from MPO Gene-Phenotype Associations)", "abnormal mitochondrial inner membrane morphology (MP:0011634 from MPO Gene-Phenotype Associations)", "abnormal mitochondrion morphology (MP:0006035 from MPO Gene-Phenotype Associations)", "disorganized mitochondrial cristae (MP:0011636 from MPO Gene-Phenotype Associations)", "dilated mitochondria (MP:0011632 from MPO Gene-Phenotype Associations)", "increased mitochondria size (MP:0011630 from MPO Gene-Phenotype Associations)", "abnormal cellular respiration (MP:0010954 from MPO Gene-Phenotype Associations)", "abnormal respiratory electron transport chain (MP:0010955 from MPO Gene-Phenotype Associations)", "abnormal mitochondrial physiology (MP:0006036 from MPO Gene-Phenotype Associations)", "abnormal mitochondrial atp synthesis coupled electron transport (MP:0010956 from MPO Gene-Phenotype Associations)", "abnormal oxidative phosphorylation (MP:0010959 from MPO Gene-Phenotype Associations)", "spasticity (MP:0012051 from MPO Gene-Phenotype Associations)", "abnormal cerebellum deep nucleus morphology (MP:0009979 from MPO Gene-Phenotype Associations)", "abnormal cerebellum fastigial nucleus morphology (MP:0009983 from MPO Gene-Phenotype Associations)", "straub tail (MP:0003382 from MPO Gene-Phenotype Associations)", "brainstem hemorrhage (MP:0006051 from MPO Gene-Phenotype Associations)", "trunk curl (MP:0001512 from MPO Gene-Phenotype Associations)", "abnormal tail movements (MP:0001391 from MPO Gene-Phenotype Associations)", "abnormal pre-botzinger complex morphology (MP:0010745 from MPO Gene-Phenotype Associations)", "abnormal central pattern generator function (MP:0003880 from MPO Gene-Phenotype Associations)", "abnormal pre-botzinger complex physiology (MP:0010746 from MPO Gene-Phenotype Associations)", "abnormal parasympathetic nervous system physiology (MP:0006277 from MPO Gene-Phenotype Associations)", "absence of ampa-mediated synaptic currents (MP:0011001 from MPO Gene-Phenotype Associations)", "abnormal muscle tone (MP:0004142 from MPO Gene-Phenotype Associations)", "hypotonia (MP:0004144 from MPO Gene-Phenotype Associations)", "dystonia (MP:0005323 from MPO Gene-Phenotype Associations)", "muscle hypertonia (MP:0004143 from MPO Gene-Phenotype Associations)", "increased b wave amplitude (MP:0012146 from MPO Gene-Phenotype Associations)", "hyperekplexia (MP:0005604 from MPO Gene-Phenotype Associations)", "short stride length (MP:0001407 from MPO Gene-Phenotype Associations)", "abnormal aerobic respiration (MP:0010957 from MPO Gene-Phenotype Associations)", "abnormal tricarboxylic acid cycle (MP:0010958 from MPO Gene-Phenotype Associations)", "abnormal circulating carnitine level (MP:0003977 from MPO Gene-Phenotype Associations)", "increased circulating carnitine level (MP:0003979 from MPO Gene-Phenotype Associations)", "decreased circulating carnitine level (MP:0003978 from MPO Gene-Phenotype Associations)", "increased unsaturated fatty acid level (MP:0005283 from MPO Gene-Phenotype Associations)", "pulmonary epithelial necrosis (MP:0010858 from MPO Gene-Phenotype Associations)", "pulmonary necrosis (MP:0010857 from MPO Gene-Phenotype Associations)", "abnormal redox activity (MP:0003186 from MPO Gene-Phenotype Associations)", "oxidative stress (MP:0003674 from MPO Gene-Phenotype Associations)", "abnormal glutathione level (MP:0012603 from MPO Gene-Phenotype Associations)", "decreased glutathione level (MP:0012604 from MPO Gene-Phenotype Associations)", "abnormal spinal cord ventral horn morphology (MP:0005112 from MPO Gene-Phenotype Associations)", "abnormal vitamin e level (MP:0011231 from MPO Gene-Phenotype Associations)", "paresis (MP:0000754 from MPO Gene-Phenotype Associations)", "chromatolysis (MP:0002883 from MPO Gene-Phenotype Associations)", "fecal incontinence (MP:0003281 from MPO Gene-Phenotype Associations)", "positive geotaxis (MP:0005356 from MPO Gene-Phenotype Associations)", "nephrosclerosis (MP:0009860 from MPO Gene-Phenotype Associations)", "abnormal thiamin level (MP:0011226 from MPO Gene-Phenotype Associations)", "abnormal vitamin absorption (MP:0001671 from MPO Gene-Phenotype Associations)", "thin apical ectodermal ridge (MP:0001679 from MPO Gene-Phenotype Associations)", "small hindlimb buds (MP:0013169 from MPO Gene-Phenotype Associations)", "absent metacarpal bones (MP:0003074 from MPO Gene-Phenotype Associations)", "absent pr interval (MP:0010512 from MPO Gene-Phenotype Associations)", "absent tarsus bones (MP:0009729 from MPO Gene-Phenotype Associations)", "mammary gland hypoplasia (MP:0003344 from MPO Gene-Phenotype Associations)", "absent p wave (MP:0010510 from MPO Gene-Phenotype Associations)", "abnormal impulse conducting system morphology (MP:0004123 from MPO Gene-Phenotype Associations)", "abnormal sinoatrial node morphology (MP:0004115 from MPO Gene-Phenotype Associations)", "sinus bradycardia (MP:0010637 from MPO Gene-Phenotype Associations)", "delayed heart looping (MP:0009328 from MPO Gene-Phenotype Associations)", "decreased metatarsal bone number (MP:0004640 from MPO Gene-Phenotype Associations)", "decreased metacarpal bone number (MP:0004636 from MPO Gene-Phenotype Associations)", "abnormal internal anal sphincter morphology (MP:0009055 from MPO Gene-Phenotype Associations)", "absent carpal bone (MP:0000555 from MPO Gene-Phenotype Associations)", "postaxial polydactyly (MP:0009744 from MPO Gene-Phenotype Associations)", "reduced enamel thickness (MP:0002577 from MPO Gene-Phenotype Associations)", "brittle teeth (MP:0000126 from MPO Gene-Phenotype Associations)", "abnormal pulmonary gas exchange (MP:0002336 from MPO Gene-Phenotype Associations)", "abnormal respiratory transport (MP:0002322 from MPO Gene-Phenotype Associations)", "coronary artery aneurysm (MP:0010477 from MPO Gene-Phenotype Associations)", "abnormal coronary vein morphology (MP:0010453 from MPO Gene-Phenotype Associations)", "shortened qt interval (MP:0003900 from MPO Gene-Phenotype Associations)", "patent foramen ovale (MP:0004225 from MPO Gene-Phenotype Associations)", "abnormal atrioventricular bundle conduction (MP:0004116 from MPO Gene-Phenotype Associations)", "abnormal r wave (MP:0011919 from MPO Gene-Phenotype Associations)", "mitral valve stenosis (MP:0006122 from MPO Gene-Phenotype Associations)", "bifid atrial appendage (MP:0004253 from MPO Gene-Phenotype Associations)", "fragmented qrs complex (MP:0010514 from MPO Gene-Phenotype Associations)", "abnormal pq interval (MP:0011918 from MPO Gene-Phenotype Associations)", "prolonged pq interval (MP:0011953 from MPO Gene-Phenotype Associations)", "abnormal atrioventricular node conduction (MP:0006141 from MPO Gene-Phenotype Associations)", "atrioventricular block (MP:0010519 from MPO Gene-Phenotype Associations)", "abnormal pr interval (MP:0003901 from MPO Gene-Phenotype Associations)", "prolonged pr interval (MP:0003896 from MPO Gene-Phenotype Associations)", "heart block (MP:0010559 from MPO Gene-Phenotype Associations)", "abnormal heart electrocardiography waveform feature (MP:0010508 from MPO Gene-Phenotype Associations)", "abnormal impulse conducting system conduction (MP:0003137 from MPO Gene-Phenotype Associations)", "abnormal qrs complex (MP:0003898 from MPO Gene-Phenotype Associations)", "bundle branch block (MP:0010636 from MPO Gene-Phenotype Associations)", "intraventricular block (MP:0010560 from MPO Gene-Phenotype Associations)", "prolonged qrs complex duration (MP:0010392 from MPO Gene-Phenotype Associations)", "abnormal p wave (MP:0004070 from MPO Gene-Phenotype Associations)", "prolonged p wave (MP:0004071 from MPO Gene-Phenotype Associations)", "sinoatrial block (MP:0010520 from MPO Gene-Phenotype Associations)", "abnormal sinoatrial node conduction (MP:0006142 from MPO Gene-Phenotype Associations)", "abnormal qt interval (MP:0003899 from MPO Gene-Phenotype Associations)", "prolonged qt interval (MP:0003233 from MPO Gene-Phenotype Associations)", "abnormal t wave (MP:0010505 from MPO Gene-Phenotype Associations)", "abnormal heart rate (MP:0001629 from MPO Gene-Phenotype Associations)", "abnormal heartbeat (MP:0004085 from MPO Gene-Phenotype Associations)", "decreased heart rate (MP:0005333 from MPO Gene-Phenotype Associations)", "increased heart rate (MP:0002626 from MPO Gene-Phenotype Associations)", "ventricular tachycardia (MP:0008950 from MPO Gene-Phenotype Associations)", "ventricular premature beat (MP:0009732 from MPO Gene-Phenotype Associations)", "atrial fibrillation (MP:0008543 from MPO Gene-Phenotype Associations)", "fibrillation (MP:0006109 from MPO Gene-Phenotype Associations)", "irregular heartbeat (MP:0001636 from MPO Gene-Phenotype Associations)", "ventricular fibrillation (MP:0006110 from MPO Gene-Phenotype Associations)", "abnormal lung-associated mesenchyme development (MP:0011142 from MPO Gene-Phenotype Associations)", "increased surfactant secretion (MP:0010992 from MPO Gene-Phenotype Associations)", "prolonged hv interval (MP:0010553 from MPO Gene-Phenotype Associations)", "abnormal frontal plane axis (MP:0004072 from MPO Gene-Phenotype Associations)", "heart hyperplasia (MP:0000275 from MPO Gene-Phenotype Associations)", "increased myocardial fiber number (MP:0006321 from MPO Gene-Phenotype Associations)", "increased fetal cardiomyocyte proliferation (MP:0011394 from MPO Gene-Phenotype Associations)", "abnormal intercalated disc morphology (MP:0006267 from MPO Gene-Phenotype Associations)", "shortened qrs complex duration (MP:0010393 from MPO Gene-Phenotype Associations)", "abnormal hv interval (MP:0010552 from MPO Gene-Phenotype Associations)", "shortened hv interval (MP:0010554 from MPO Gene-Phenotype Associations)", "common ventricle (MP:0010432 from MPO Gene-Phenotype Associations)", "atrial septal aneurysm (MP:0010450 from MPO Gene-Phenotype Associations)", "abnormal atrioventricular node morphology (MP:0004114 from MPO Gene-Phenotype Associations)", "abnormal purkinje fiber morphology (MP:0004124 from MPO Gene-Phenotype Associations)", "pharyngeal arch artery hypoplasia (MP:0012492 from MPO Gene-Phenotype Associations)", "abnormal sinus venosus morphology (MP:0003228 from MPO Gene-Phenotype Associations)", "pharyngeal arch artery stenosis (MP:0012495 from MPO Gene-Phenotype Associations)", "abnormal intersomitic artery morphology (MP:0010662 from MPO Gene-Phenotype Associations)", "optic nerve degeneration (MP:0006219 from MPO Gene-Phenotype Associations)", "optic nerve cupping (MP:0005497 from MPO Gene-Phenotype Associations)", "increased susceptibility to ototoxicity-induced hearing loss (MP:0004611 from MPO Gene-Phenotype Associations)", "disorganized secondary lens fibers (MP:0002579 from MPO Gene-Phenotype Associations)", "decreased brain internal capsule size (MP:0012462 from MPO Gene-Phenotype Associations)", "abnormal lateral corticospinal tract morphology (MP:0009683 from MPO Gene-Phenotype Associations)", "abnormal anterior corticospinal tract morphology (MP:0009682 from MPO Gene-Phenotype Associations)", "increased heart rate variability (MP:0003928 from MPO Gene-Phenotype Associations)", "abnormal cardiogenic plate morphology (MP:0012498 from MPO Gene-Phenotype Associations)", "increased schwannoma incidence (MP:0010310 from MPO Gene-Phenotype Associations)", "absent cardiogenic plate (MP:0012499 from MPO Gene-Phenotype Associations)", "abnormal qt variability (MP:0004156 from MPO Gene-Phenotype Associations)", "abnormal sinus arrhythmia (MP:0004122 from MPO Gene-Phenotype Associations)", "decreased heart rate variability (MP:0003929 from MPO Gene-Phenotype Associations)", "increased myelin sheath thickness (MP:0011730 from MPO Gene-Phenotype Associations)", "abnormal erythrocyte ion content (MP:0012372 from MPO Gene-Phenotype Associations)", "increased erythrocyte magnesium level (MP:0012368 from MPO Gene-Phenotype Associations)", "decreased myelin sheath thickness (MP:0011731 from MPO Gene-Phenotype Associations)", "abnormal internode morphology (MP:0010738 from MPO Gene-Phenotype Associations)", "shortened pr interval (MP:0010511 from MPO Gene-Phenotype Associations)", "shortened pq interval (MP:0011954 from MPO Gene-Phenotype Associations)", "abnormal erythrocyte potassium level (MP:0012369 from MPO Gene-Phenotype Associations)", "decreased erythrocyte potassium level (MP:0012370 from MPO Gene-Phenotype Associations)", "decreased urine magnesium level (MP:0011436 from MPO Gene-Phenotype Associations)", "abnormal erythrocyte magnesium level (MP:0012366 from MPO Gene-Phenotype Associations)", "decreased erythrocyte magnesium level (MP:0012367 from MPO Gene-Phenotype Associations)", "abnormal circulating magnesium level (MP:0001771 from MPO Gene-Phenotype Associations)", "abnormal magnesium ion homeostasis (MP:0011979 from MPO Gene-Phenotype Associations)", "increased circulating magnesium level (MP:0010092 from MPO Gene-Phenotype Associations)", "decreased circulating magnesium level (MP:0010093 from MPO Gene-Phenotype Associations)", "increased parotid gland size (MP:0009531 from MPO Gene-Phenotype Associations)", "abnormal hemoglobin concentration distribution width (MP:0008849 from MPO Gene-Phenotype Associations)", "increased hemoglobin concentration distribution width (MP:0008850 from MPO Gene-Phenotype Associations)", "enlarged utricle (MP:0004335 from MPO Gene-Phenotype Associations)", "abnormal modiolus morphology (MP:0003309 from MPO Gene-Phenotype Associations)", "absent modiolus (MP:0003226 from MPO Gene-Phenotype Associations)", "dilated lateral semicircular canal (MP:0006015 from MPO Gene-Phenotype Associations)", "dilated posterior semicircular canal (MP:0006016 from MPO Gene-Phenotype Associations)", "inner ear cysts (MP:0006287 from MPO Gene-Phenotype Associations)", "abnormal kidney collecting duct epithelium morphology (MP:0011843 from MPO Gene-Phenotype Associations)", "abnormal kidney collecting duct intercalated cell morphology (MP:0011754 from MPO Gene-Phenotype Associations)", "abnormal kidney collecting duct principal cell morphology (MP:0011757 from MPO Gene-Phenotype Associations)", "abnormal circulating bicarbonate level (MP:0003015 from MPO Gene-Phenotype Associations)", "decreased circulating bicarbonate level (MP:0003017 from MPO Gene-Phenotype Associations)", "abnormal ph regulation (MP:0004043 from MPO Gene-Phenotype Associations)", "acidosis (MP:0003031 from MPO Gene-Phenotype Associations)", "renal tubular acidosis (MP:0000525 from MPO Gene-Phenotype Associations)", "abnormal blood ph regulation (MP:0003027 from MPO Gene-Phenotype Associations)", "acidemia (MP:0003030 from MPO Gene-Phenotype Associations)", "abnormal urine ph (MP:0009348 from MPO Gene-Phenotype Associations)", "decreased urine ph (MP:0009350 from MPO Gene-Phenotype Associations)", "increased urine ph (MP:0009349 from MPO Gene-Phenotype Associations)", "decreased urine ammonia level (MP:0011736 from MPO Gene-Phenotype Associations)", "thin ribs (MP:0004674 from MPO Gene-Phenotype Associations)", "abnormal thoracic cage shape (MP:0010099 from MPO Gene-Phenotype Associations)", "pectus excavatum (MP:0012514 from MPO Gene-Phenotype Associations)", "muscle tetany (MP:0009045 from MPO Gene-Phenotype Associations)", "susceptible to malignant hyperthermia (MP:0020214 from MPO Gene-Phenotype Associations)", "decreased skeletal muscle fiber number (MP:0009406 from MPO Gene-Phenotype Associations)", "ventricular cardiomyopathy (MP:0002952 from MPO Gene-Phenotype Associations)", "diffuse z lines (MP:0004093 from MPO Gene-Phenotype Associations)", "abnormal z lines (MP:0004091 from MPO Gene-Phenotype Associations)", "abnormal sarcomere morphology (MP:0004090 from MPO Gene-Phenotype Associations)", "cleft chin (MP:0000114 from MPO Gene-Phenotype Associations)", "absent right subclavian artery (MP:0010486 from MPO Gene-Phenotype Associations)", "aorta tubular hypoplasia (MP:0010543 from MPO Gene-Phenotype Associations)", "absent hyoid bone (MP:0004205 from MPO Gene-Phenotype Associations)", "absent submandibular gland (MP:0009524 from MPO Gene-Phenotype Associations)", "aorta hypoplasia (MP:0010541 from MPO Gene-Phenotype Associations)", "abnormal blood gas level (MP:0002329 from MPO Gene-Phenotype Associations)", "abnormal carbon dioxide level (MP:0003860 from MPO Gene-Phenotype Associations)", "hypercapnia (MP:0002318 from MPO Gene-Phenotype Associations)", "hypoxia (MP:0005039 from MPO Gene-Phenotype Associations)", "increased pulmonary ventilation (MP:0005575 from MPO Gene-Phenotype Associations)", "increased tidal volume (MP:0005585 from MPO Gene-Phenotype Associations)", "abnormal tidal volume (MP:0002313 from MPO Gene-Phenotype Associations)", "abnormal lung volume (MP:0001942 from MPO Gene-Phenotype Associations)", "decreased tidal volume (MP:0005586 from MPO Gene-Phenotype Associations)", "abnormal coronary circulation (MP:0006111 from MPO Gene-Phenotype Associations)", "abnormal coronary flow rate (MP:0003021 from MPO Gene-Phenotype Associations)", "decreased coronary flow rate (MP:0003023 from MPO Gene-Phenotype Associations)", "abnormal stomach muscularis externa morphology (MP:0010779 from MPO Gene-Phenotype Associations)", "abnormal stomach smooth muscle circular layer morphology (MP:0010780 from MPO Gene-Phenotype Associations)", "stomach smooth muscle circular layer hypertrophy (MP:0010782 from MPO Gene-Phenotype Associations)", "abnormal gastroesophageal sphincter physiology (MP:0010154 from MPO Gene-Phenotype Associations)", "gastric hypertrophy (MP:0003285 from MPO Gene-Phenotype Associations)", "abnormal urine bicarbonate level (MP:0011461 from MPO Gene-Phenotype Associations)", "increased urine bicarbonate level (MP:0011462 from MPO Gene-Phenotype Associations)", "abnormal pyloric sphincter morphology (MP:0009861 from MPO Gene-Phenotype Associations)", "abnormal stomach pyloric region morphology (MP:0010785 from MPO Gene-Phenotype Associations)", "pyloric sphincter hypertrophy (MP:0010781 from MPO Gene-Phenotype Associations)", "pyloric stenosis (MP:0003307 from MPO Gene-Phenotype Associations)", "late onset of menarche (MP:0003377 from MPO Gene-Phenotype Associations)", "abnormal hypothalamus physiology (MP:0005645 from MPO Gene-Phenotype Associations)", "abnormal hypothalamus secretion (MP:0001752 from MPO Gene-Phenotype Associations)", "blotchy skin (MP:0002897 from MPO Gene-Phenotype Associations)", "abnormal impulsive behavior control (MP:0010698 from MPO Gene-Phenotype Associations)", "abnormal neurotransmitter level (MP:0002204 from MPO Gene-Phenotype Associations)", "abnormal neurotransmitter secretion (MP:0005445 from MPO Gene-Phenotype Associations)", "decreased neurotransmitter release (MP:0003990 from MPO Gene-Phenotype Associations)", "abnormal synaptic glutamate release (MP:0004494 from MPO Gene-Phenotype Associations)", "decreased synaptic glutamate release (MP:0004495 from MPO Gene-Phenotype Associations)", "abnormal neurotransmitter uptake (MP:0003444 from MPO Gene-Phenotype Associations)", "abnormal brown adipose tissue physiology (MP:0011698 from MPO Gene-Phenotype Associations)", "hyperactivity elicited by feed restriction (MP:0012297 from MPO Gene-Phenotype Associations)", "slow aging (MP:0011614 from MPO Gene-Phenotype Associations)", "abnormal brown adipose tissue thermogenesis (MP:0011699 from MPO Gene-Phenotype Associations)", "stomach fundus hypertrophy (MP:0010786 from MPO Gene-Phenotype Associations)", "abnormal stomach fundus morphology (MP:0010778 from MPO Gene-Phenotype Associations)", "salt-resistant hypertension (MP:0004216 from MPO Gene-Phenotype Associations)", "decreased body surface temperature (MP:0011015 from MPO Gene-Phenotype Associations)", "double kidney pelvis (MP:0011803 from MPO Gene-Phenotype Associations)", "dilated seminal vesicles (MP:0013320 from MPO Gene-Phenotype Associations)", "abnormal somatosensory cortex physiology (MP:0001908 from MPO Gene-Phenotype Associations)", "reduced nmda receptor mediated synaptic activity in barrel cortex (MP:0001909 from MPO Gene-Phenotype Associations)", "abnormal central nervous system regeneration (MP:0003407 from MPO Gene-Phenotype Associations)", "abnormal nervous system regeneration (MP:0004858 from MPO Gene-Phenotype Associations)", "abnormal peripheral nervous system regeneration (MP:0004220 from MPO Gene-Phenotype Associations)", "absent hard palate (MP:0009894 from MPO Gene-Phenotype Associations)", "abnormal pectoral muscle morphology (MP:0003346 from MPO Gene-Phenotype Associations)", "large penis (MP:0003599 from MPO Gene-Phenotype Associations)", "enlarged external male genitalia (MP:0009200 from MPO Gene-Phenotype Associations)", "absent lower incisors (MP:0004791 from MPO Gene-Phenotype Associations)", "increased muscle weight (MP:0003397 from MPO Gene-Phenotype Associations)", "increased skeletal muscle weight (MP:0010238 from MPO Gene-Phenotype Associations)", "decreased parametrial fat pad weight (MP:0009301 from MPO Gene-Phenotype Associations)", "increased gastrocnemius weight (MP:0009421 from MPO Gene-Phenotype Associations)", "increased skeletal muscle fiber number (MP:0009405 from MPO Gene-Phenotype Associations)", "increased skeletal muscle fiber diameter (MP:0009401 from MPO Gene-Phenotype Associations)", "increased skeletal muscle fiber size (MP:0009399 from MPO Gene-Phenotype Associations)", "increased skeletal muscle mass (MP:0004818 from MPO Gene-Phenotype Associations)", "increased skeletal muscle size (MP:0003398 from MPO Gene-Phenotype Associations)", "skeletal muscle hypertrophy (MP:0009461 from MPO Gene-Phenotype Associations)", "abnormal skeletal muscle morphology (MP:0000759 from MPO Gene-Phenotype Associations)", "abnormal skeletal muscle fiber morphology (MP:0003084 from MPO Gene-Phenotype Associations)", "abnormal skeletal muscle fiber size (MP:0009398 from MPO Gene-Phenotype Associations)", "decreased skeletal muscle fiber size (MP:0009400 from MPO Gene-Phenotype Associations)", "decreased skeletal muscle fiber diameter (MP:0009402 from MPO Gene-Phenotype Associations)", "abnormal skeletal muscle mass (MP:0004817 from MPO Gene-Phenotype Associations)", "decreased skeletal muscle mass (MP:0004819 from MPO Gene-Phenotype Associations)", "abnormal skeletal muscle size (MP:0009458 from MPO Gene-Phenotype Associations)", "decreased skeletal muscle size (MP:0010240 from MPO Gene-Phenotype Associations)", "skeletal muscle atrophy (MP:0009417 from MPO Gene-Phenotype Associations)", "skeletal muscle fiber atrophy (MP:0009413 from MPO Gene-Phenotype Associations)", "muscular atrophy (MP:0002269 from MPO Gene-Phenotype Associations)", "increased variability of skeletal muscle fiber size (MP:0009403 from MPO Gene-Phenotype Associations)", "centrally nucleated skeletal muscle fibers (MP:0009404 from MPO Gene-Phenotype Associations)", "myopathy (MP:0000751 from MPO Gene-Phenotype Associations)", "abnormal muscle weight (MP:0004233 from MPO Gene-Phenotype Associations)", "decreased muscle weight (MP:0004232 from MPO Gene-Phenotype Associations)", "abnormal skeletal muscle weight (MP:0010237 from MPO Gene-Phenotype Associations)", "decreased skeletal muscle weight (MP:0010239 from MPO Gene-Phenotype Associations)", "abnormal extensor digitorum longus morphology (MP:0004246 from MPO Gene-Phenotype Associations)", "abnormal extensor digitorum longus weight (MP:0012783 from MPO Gene-Phenotype Associations)", "decreased extensor digitorum longus weight (MP:0009424 from MPO Gene-Phenotype Associations)", "abnormal soleus weight (MP:0020165 from MPO Gene-Phenotype Associations)", "decreased soleus weight (MP:0009426 from MPO Gene-Phenotype Associations)", "abnormal soleus morphology (MP:0003081 from MPO Gene-Phenotype Associations)", "decreased satellite cell number (MP:0003833 from MPO Gene-Phenotype Associations)", "abnormal gastrocnemius morphology (MP:0003082 from MPO Gene-Phenotype Associations)", "abnormal gastrocnemius weight (MP:0013188 from MPO Gene-Phenotype Associations)", "decreased gastrocnemius weight (MP:0009422 from MPO Gene-Phenotype Associations)", "abnormal quadriceps morphology (MP:0010225 from MPO Gene-Phenotype Associations)", "abnormal quadriceps weight (MP:0020164 from MPO Gene-Phenotype Associations)", "decreased quadriceps weight (MP:0010227 from MPO Gene-Phenotype Associations)", "increased quadriceps weight (MP:0010226 from MPO Gene-Phenotype Associations)", "abnormal tibialis anterior morphology (MP:0003083 from MPO Gene-Phenotype Associations)", "abnormal tibialis anterior weight (MP:0020166 from MPO Gene-Phenotype Associations)", "decreased tibialis anterior weight (MP:0009428 from MPO Gene-Phenotype Associations)", "skeletal muscle fiber necrosis (MP:0009414 from MPO Gene-Phenotype Associations)", "skeletal muscle necrosis (MP:0003852 from MPO Gene-Phenotype Associations)", "dystrophic muscle (MP:0000752 from MPO Gene-Phenotype Associations)", "skeletal muscle endomysial fibrosis (MP:0009420 from MPO Gene-Phenotype Associations)", "abnormal sarcolemma morphology (MP:0004121 from MPO Gene-Phenotype Associations)", "muscle degeneration (MP:0000749 from MPO Gene-Phenotype Associations)", "skeletal muscle degeneration (MP:0009415 from MPO Gene-Phenotype Associations)", "skeletal muscle fiber degeneration (MP:0009412 from MPO Gene-Phenotype Associations)", "abnormal circulating creatine kinase level (MP:0010089 from MPO Gene-Phenotype Associations)", "abnormal creatine kinase level (MP:0020279 from MPO Gene-Phenotype Associations)", "increased circulating creatine kinase level (MP:0010090 from MPO Gene-Phenotype Associations)", "increased creatine kinase level (MP:0020280 from MPO Gene-Phenotype Associations)", "skeletal muscle fibrosis (MP:0009419 from MPO Gene-Phenotype Associations)", "skeletal muscle interstitial fibrosis (MP:0003851 from MPO Gene-Phenotype Associations)", "myositis (MP:0004510 from MPO Gene-Phenotype Associations)", "abnormal sarcoplasmic reticulum morphology (MP:0004088 from MPO Gene-Phenotype Associations)", "dilated sarcoplasmic reticulum (MP:0004089 from MPO Gene-Phenotype Associations)", "impaired skeletal muscle contractility (MP:0002841 from MPO Gene-Phenotype Associations)", "muscle fatigue (MP:0003646 from MPO Gene-Phenotype Associations)", "increased satellite cell number (MP:0000730 from MPO Gene-Phenotype Associations)", "decreased p wave amplitude (MP:0010509 from MPO Gene-Phenotype Associations)", "abnormal circulating pyruvate kinase level (MP:0010106 from MPO Gene-Phenotype Associations)", "retinal ischemia (MP:0006190 from MPO Gene-Phenotype Associations)", "abnormal skeletal muscle satellite cell proliferation (MP:0009410 from MPO Gene-Phenotype Associations)", "abnormal transforming growth factor beta level (MP:0008836 from MPO Gene-Phenotype Associations)", "increased transforming growth factor level (MP:0008837 from MPO Gene-Phenotype Associations)", "impaired muscle relaxation (MP:0003157 from MPO Gene-Phenotype Associations)", "abnormal muscle electrophysiology (MP:0004145 from MPO Gene-Phenotype Associations)", "cardiac muscle necrosis (MP:0010632 from MPO Gene-Phenotype Associations)", "abnormal response to exercise (MP:0012735 from MPO Gene-Phenotype Associations)", "increased extensor digitorum longus weight (MP:0009423 from MPO Gene-Phenotype Associations)", "increased soleus weight (MP:0009425 from MPO Gene-Phenotype Associations)", "calcified muscle (MP:0003199 from MPO Gene-Phenotype Associations)", "abnormal uterine fat pad morphology (MP:0008900 from MPO Gene-Phenotype Associations)", "decreased uterine fat pad weight (MP:0009307 from MPO Gene-Phenotype Associations)", "enlarged axillary lymph nodes (MP:0009631 from MPO Gene-Phenotype Associations)", "enlarged inguinal lymph nodes (MP:0009623 from MPO Gene-Phenotype Associations)", "abnormal skeletal muscle fiber type ratio (MP:0009409 from MPO Gene-Phenotype Associations)", "abnormal muscle regeneration (MP:0000750 from MPO Gene-Phenotype Associations)", "impaired muscle regeneration (MP:0013160 from MPO Gene-Phenotype Associations)", "impaired skeletal muscle regeneration (MP:0013239 from MPO Gene-Phenotype Associations)", "abnormal skeletal muscle regeneration (MP:0013237 from MPO Gene-Phenotype Associations)", "abnormal aerobic fitness (MP:0000348 from MPO Gene-Phenotype Associations)", "decreased aerobic running capacity (MP:0003061 from MPO Gene-Phenotype Associations)", "enhanced exercise endurance (MP:0012107 from MPO Gene-Phenotype Associations)", "increased aerobic running capacity (MP:0003060 from MPO Gene-Phenotype Associations)", "abnormal exercise endurance (MP:0002332 from MPO Gene-Phenotype Associations)", "fatigue (MP:0002899 from MPO Gene-Phenotype Associations)", "impaired exercise endurance (MP:0012106 from MPO Gene-Phenotype Associations)", "coronary artery stenosis (MP:0003024 from MPO Gene-Phenotype Associations)", "perivascular fibrosis (MP:0011749 from MPO Gene-Phenotype Associations)", "decreased qrs amplitude (MP:0010394 from MPO Gene-Phenotype Associations)", "dystrophic cardiac calcinosis (MP:0002837 from MPO Gene-Phenotype Associations)", "myocardial necrosis (MP:0006085 from MPO Gene-Phenotype Associations)", "myocardial fiber degeneration (MP:0004566 from MPO Gene-Phenotype Associations)", "heart inflammation (MP:0001853 from MPO Gene-Phenotype Associations)", "myocarditis (MP:0001856 from MPO Gene-Phenotype Associations)", "increased tibialis anterior weight (MP:0009427 from MPO Gene-Phenotype Associations)", "increased circulating interferon-beta level (MP:0008575 from MPO Gene-Phenotype Associations)", "abnormal skeletal muscle fiber triad morphology (MP:0009411 from MPO Gene-Phenotype Associations)", "decreased susceptibility to induced muscular atrophy (MP:0004064 from MPO Gene-Phenotype Associations)", "absent roof plate (MP:0000924 from MPO Gene-Phenotype Associations)", "impaired ossification of basisphenoid bone (MP:0000105 from MPO Gene-Phenotype Associations)", "increased mesenchymal cell proliferation involved in lung development (MP:0011147 from MPO Gene-Phenotype Associations)", "wide sternum (MP:0012279 from MPO Gene-Phenotype Associations)", "enlarged esophagus (MP:0004545 from MPO Gene-Phenotype Associations)", "esophagus hyperplasia (MP:0004546 from MPO Gene-Phenotype Associations)", "decreased oligodendrocyte progenitor number (MP:0000954 from MPO Gene-Phenotype Associations)", "absent zygomatic bone (MP:0004467 from MPO Gene-Phenotype Associations)", "truncated loop of henle (MP:0011345 from MPO Gene-Phenotype Associations)", "increased embryo size (MP:0001699 from MPO Gene-Phenotype Associations)", "increased embryo weight (MP:0009430 from MPO Gene-Phenotype Associations)", "decreased corticotroph cell size (MP:0008427 from MPO Gene-Phenotype Associations)", "abnormal folliculo-stellate cell morphology (MP:0013341 from MPO Gene-Phenotype Associations)", "thin adrenal cortex (MP:0008302 from MPO Gene-Phenotype Associations)", "ectopic bone formation (MP:0009585 from MPO Gene-Phenotype Associations)", "ectopic cranial bone growth (MP:0000083 from MPO Gene-Phenotype Associations)", "spina bifida cystica (MP:0012547 from MPO Gene-Phenotype Associations)", "meningomyelocele (MP:0009929 from MPO Gene-Phenotype Associations)", "increased forebrain size (MP:0012139 from MPO Gene-Phenotype Associations)", "encephalomeningocele (MP:0012260 from MPO Gene-Phenotype Associations)", "abnormal dorsal-ventral axis patterning (MP:0001704 from MPO Gene-Phenotype Associations)", "abnormal neural tube marginal layer morphology (MP:0009691 from MPO Gene-Phenotype Associations)", "abnormal neural tube ventricular layer morphology (MP:0009689 from MPO Gene-Phenotype Associations)", "thickened cerebral cortex (MP:0000789 from MPO Gene-Phenotype Associations)", "abnormal folding of telencephalic vesicles (MP:0000935 from MPO Gene-Phenotype Associations)", "diencephalon hyperplasia (MP:0000831 from MPO Gene-Phenotype Associations)", "choroid plexus hyperplasia (MP:0000821 from MPO Gene-Phenotype Associations)", "hypothalamus hyperplasia (MP:0000839 from MPO Gene-Phenotype Associations)", "thalamus hyperplasia (MP:0000833 from MPO Gene-Phenotype Associations)", "absent ethmoidal bone (MP:0000101 from MPO Gene-Phenotype Associations)", "persistence of medial edge epithelium during palatal shelf fusion (MP:0009889 from MPO Gene-Phenotype Associations)", "increased midbrain size (MP:0012091 from MPO Gene-Phenotype Associations)", "midbrain hyperplasia (MP:0000898 from MPO Gene-Phenotype Associations)", "cranioschisis (MP:0000919 from MPO Gene-Phenotype Associations)", "abnormal ectomesenchyme morphology (MP:0006302 from MPO Gene-Phenotype Associations)", "absent frontal bone (MP:0004376 from MPO Gene-Phenotype Associations)", "absent parietal bone (MP:0004419 from MPO Gene-Phenotype Associations)", "absent interparietal bone (MP:0004383 from MPO Gene-Phenotype Associations)", "facial cleft (MP:0008797 from MPO Gene-Phenotype Associations)", "midline facial cleft (MP:0000108 from MPO Gene-Phenotype Associations)", "dilated allantois (MP:0004557 from MPO Gene-Phenotype Associations)", "large orbits (MP:0006212 from MPO Gene-Phenotype Associations)", "abnormal mastication (MP:0008819 from MPO Gene-Phenotype Associations)", "abnormal laryngeal muscle morphology (MP:0002263 from MPO Gene-Phenotype Associations)", "narrow head (MP:0003742 from MPO Gene-Phenotype Associations)", "increased response to stress-induced hyperthermia (MP:0010166 from MPO Gene-Phenotype Associations)", "asymmetric snout (MP:0008862 from MPO Gene-Phenotype Associations)", "lenticonus (MP:0002794 from MPO Gene-Phenotype Associations)", "abnormal paranodal axoglial junction morphology (MP:0010735 from MPO Gene-Phenotype Associations)", "abnormal paranode morphology (MP:0010734 from MPO Gene-Phenotype Associations)", "hypermyelination (MP:0010050 from MPO Gene-Phenotype Associations)", "abnormal node of ranvier morphology (MP:0010732 from MPO Gene-Phenotype Associations)", "increased schwann cell number (MP:0010742 from MPO Gene-Phenotype Associations)", "flat face (MP:0012175 from MPO Gene-Phenotype Associations)", "absent conotruncal ridges (MP:0010586 from MPO Gene-Phenotype Associations)", "abnormal conotruncus septation (MP:0010584 from MPO Gene-Phenotype Associations)", "skeletal muscle hyperplasia (MP:0009459 from MPO Gene-Phenotype Associations)", "abnormal basement membrane morphology (MP:0004272 from MPO Gene-Phenotype Associations)", "abnormal extracellular matrix morphology (MP:0013258 from MPO Gene-Phenotype Associations)", "impaired basement membrane formation (MP:0003044 from MPO Gene-Phenotype Associations)", "absent neurocranium (MP:0000075 from MPO Gene-Phenotype Associations)", "abnormal pleura morphology (MP:0010820 from MPO Gene-Phenotype Associations)", "abnormal visceral pleura morphology (MP:0010821 from MPO Gene-Phenotype Associations)", "decreased keratinocyte apoptosis (MP:0009581 from MPO Gene-Phenotype Associations)", "abnormal cranial neural crest cell morphology (MP:0012754 from MPO Gene-Phenotype Associations)", "decreased cranial neural crest cell number (MP:0012755 from MPO Gene-Phenotype Associations)", "abnormal afferent lymphatic vessel morphology (MP:0002349 from MPO Gene-Phenotype Associations)", "decreased endolymph production (MP:0004887 from MPO Gene-Phenotype Associations)", "splayed clitoris (MP:0003128 from MPO Gene-Phenotype Associations)", "abnormal trunk neural crest cell migration (MP:0013012 from MPO Gene-Phenotype Associations)", "abnormal vestibular endolymph (MP:0006389 from MPO Gene-Phenotype Associations)", "abnormal vestibular endolymph ionic homeostasis (MP:0006391 from MPO Gene-Phenotype Associations)", "abnormal neural crest cell apoptosis (MP:0009844 from MPO Gene-Phenotype Associations)", "increased neural crest cell apoptosis (MP:0012744 from MPO Gene-Phenotype Associations)", "increased cranial neural crest cell apoptosis (MP:0012761 from MPO Gene-Phenotype Associations)", "decreased superior semicircular canal size (MP:0003166 from MPO Gene-Phenotype Associations)", "decreased posterior semicircular canal size (MP:0003164 from MPO Gene-Phenotype Associations)", "enlarged aortic valve (MP:0010591 from MPO Gene-Phenotype Associations)", "enlarged pulmonary valve (MP:0010600 from MPO Gene-Phenotype Associations)", "chylothorax (MP:0003660 from MPO Gene-Phenotype Associations)", "pleural effusion (MP:0010334 from MPO Gene-Phenotype Associations)", "abnormal anterior cardinal vein morphology (MP:0004784 from MPO Gene-Phenotype Associations)", "abnormal cardinal vein morphology (MP:0004783 from MPO Gene-Phenotype Associations)", "abnormal vein development (MP:0003411 from MPO Gene-Phenotype Associations)", "abnormal vein morphology (MP:0002725 from MPO Gene-Phenotype Associations)", "abnormal common cardinal vein morphology (MP:0004786 from MPO Gene-Phenotype Associations)", "small embryonic epiblast (MP:0011189 from MPO Gene-Phenotype Associations)", "delayed blastocyst hatching from the zona pellucida (MP:0003695 from MPO Gene-Phenotype Associations)", "elongated metacarpal bones (MP:0004638 from MPO Gene-Phenotype Associations)", "persistent cloaca (MP:0003129 from MPO Gene-Phenotype Associations)", "anovaginal fistula (MP:0009098 from MPO Gene-Phenotype Associations)", "brain vascular congestion (MP:0010022 from MPO Gene-Phenotype Associations)", "increased pancreatic acinar cell number (MP:0009159 from MPO Gene-Phenotype Associations)", "abnormal lymphatic vessel endothelial cell morphology (MP:0010197 from MPO Gene-Phenotype Associations)", "abnormal lymphatic vessel endothelium morphology (MP:0010195 from MPO Gene-Phenotype Associations)", "decreased lymphatic vessel endothelial cell number (MP:0010198 from MPO Gene-Phenotype Associations)", "lymphedema (MP:0003390 from MPO Gene-Phenotype Associations)", "absent lymphatic vessels (MP:0010194 from MPO Gene-Phenotype Associations)", "abnormal lymphangiogenesis (MP:0008778 from MPO Gene-Phenotype Associations)", "abnormal lymph circulation (MP:0003659 from MPO Gene-Phenotype Associations)", "abnormal lymphatic system physiology (MP:0010368 from MPO Gene-Phenotype Associations)", "abnormal lymphatic vessel morphology (MP:0001879 from MPO Gene-Phenotype Associations)", "enlarged lymphatic vessel (MP:0010200 from MPO Gene-Phenotype Associations)", "lymphangiectasis (MP:0004038 from MPO Gene-Phenotype Associations)", "ascites (MP:0005324 from MPO Gene-Phenotype Associations)", "chylous ascites (MP:0012080 from MPO Gene-Phenotype Associations)", "abnormal brain vasculature morphology (MP:0004950 from MPO Gene-Phenotype Associations)", "arteriovenous malformation (MP:0006093 from MPO Gene-Phenotype Associations)", "cerebral arteriovenous malformation (MP:0010530 from MPO Gene-Phenotype Associations)", "telangiectases (MP:0004175 from MPO Gene-Phenotype Associations)", "tail telangiectases (MP:0004177 from MPO Gene-Phenotype Associations)", "neck telangiectases (MP:0004178 from MPO Gene-Phenotype Associations)", "ear telangiectases (MP:0004176 from MPO Gene-Phenotype Associations)", "atretic vasculature (MP:0000265 from MPO Gene-Phenotype Associations)", "abnormal perineural vascular plexus morphology (MP:0012732 from MPO Gene-Phenotype Associations)", "heart hypoplasia (MP:0002740 from MPO Gene-Phenotype Associations)", "dilated pharyngeal arch arteries (MP:0012494 from MPO Gene-Phenotype Associations)", "abnormal intersomitic vessel morphology (MP:0012253 from MPO Gene-Phenotype Associations)", "absent intersomitic vessels (MP:0012254 from MPO Gene-Phenotype Associations)", "abnormal endocardium morphology (MP:0003974 from MPO Gene-Phenotype Associations)", "poor arterial differentiation (MP:0000262 from MPO Gene-Phenotype Associations)", "phimosis (MP:0003554 from MPO Gene-Phenotype Associations)", "abnormal mitral valve anulus morphology (MP:0010613 from MPO Gene-Phenotype Associations)", "abnormal tricuspid valve anulus morphology (MP:0010621 from MPO Gene-Phenotype Associations)", "decreased bleeding time (MP:0005607 from MPO Gene-Phenotype Associations)", "dilated vasculature (MP:0004938 from MPO Gene-Phenotype Associations)", "increased mature ovarian follicle number (MP:0008870 from MPO Gene-Phenotype Associations)", "uterus hypertrophy (MP:0009083 from MPO Gene-Phenotype Associations)", "decreased dn4 thymocyte number (MP:0010136 from MPO Gene-Phenotype Associations)", "decreased dn1 thymic pro-t cell number (MP:0010130 from MPO Gene-Phenotype Associations)", "increased acute lymphoblastic leukemia incidence (MP:0010336 from MPO Gene-Phenotype Associations)", "increased dn2 thymocyte number (MP:0010131 from MPO Gene-Phenotype Associations)", "increased dn3 thymocyte number (MP:0010133 from MPO Gene-Phenotype Associations)", "increased thymocyte number (MP:0000714 from MPO Gene-Phenotype Associations)", "impaired neutrophil phagocytosis (MP:0002467 from MPO Gene-Phenotype Associations)", "impaired granulocyte bactericidal activity (MP:0005074 from MPO Gene-Phenotype Associations)", "abnormal circulating interleukin-16 level (MP:0008631 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-16 level (MP:0008632 from MPO Gene-Phenotype Associations)", "increased circulating interleukin-12b level (MP:0008647 from MPO Gene-Phenotype Associations)", "increased hippocampus pyramidal cell number (MP:0009970 from MPO Gene-Phenotype Associations)", "enhanced avoidance learning behavior (MP:0012313 from MPO Gene-Phenotype Associations)", "enhanced passive avoidance behavior (MP:0003999 from MPO Gene-Phenotype Associations)", "increased susceptibility to experimental autoimmune uveoretinitis (MP:0004821 from MPO Gene-Phenotype Associations)", "increased fear-related response (MP:0003459 from MPO Gene-Phenotype Associations)", "enhanced learning (MP:0012314 from MPO Gene-Phenotype Associations)", "enhanced spatial learning (MP:0012306 from MPO Gene-Phenotype Associations)", "abnormal auditory cortex tonotopy (MP:0004788 from MPO Gene-Phenotype Associations)", "abnormal bronchoconstrictive response (MP:0012123 from MPO Gene-Phenotype Associations)", "increased bronchoconstrictive response (MP:0012124 from MPO Gene-Phenotype Associations)", "delayed parturition (MP:0012008 from MPO Gene-Phenotype Associations)", "impaired contractility of ileal smooth muscle (MP:0000742 from MPO Gene-Phenotype Associations)", "abnormal submandibular gland physiology (MP:0013300 from MPO Gene-Phenotype Associations)", "impaired contractility of urinary bladder detrusor smooth muscle (MP:0000741 from MPO Gene-Phenotype Associations)", "decreased bronchoconstrictive response (MP:0012125 from MPO Gene-Phenotype Associations)", "decreased salivation (MP:0000623 from MPO Gene-Phenotype Associations)", "abnormal adipose tissue distribution (MP:0000013 from MPO Gene-Phenotype Associations)", "impaired contractility of intestinal smooth muscle (MP:0004005 from MPO Gene-Phenotype Associations)", "impaired contractility of jejunal smooth muscle (MP:0004006 from MPO Gene-Phenotype Associations)", "intestinal|bowel diverticulum (MP:0003262 from MPO Gene-Phenotype Associations)", "sepsis (MP:0005044 from MPO Gene-Phenotype Associations)", "abnormal pituicyte morphology (MP:0013340 from MPO Gene-Phenotype Associations)", "abnormal magnocellular neurosecretory cell morphology (MP:0009467 from MPO Gene-Phenotype Associations)", "absent magnocellular neurosecretory cells (MP:0009468 from MPO Gene-Phenotype Associations)", "abnormal paraventricular hypothalamic nucleus morphology (MP:0008845 from MPO Gene-Phenotype Associations)", "abnormal supraoptic nucleus morphology (MP:0008846 from MPO Gene-Phenotype Associations)", "abnormal median eminence morphology (MP:0009229 from MPO Gene-Phenotype Associations)", "abnormal hypothalamus morphology (MP:0000837 from MPO Gene-Phenotype Associations)", "abnormal suprachiasmatic nucleus morphology (MP:0008847 from MPO Gene-Phenotype Associations)", "decreased coping response (MP:0003064 from MPO Gene-Phenotype Associations)", "abnormal mating preference (MP:0001375 from MPO Gene-Phenotype Associations)", "calcified joint (MP:0003200 from MPO Gene-Phenotype Associations)", "calcified intervertebral disk (MP:0004685 from MPO Gene-Phenotype Associations)", "calcified tendon (MP:0003198 from MPO Gene-Phenotype Associations)", "abnormal plasma anion gap (MP:0005624 from MPO Gene-Phenotype Associations)", "decreased plasma anion gap (MP:0005626 from MPO Gene-Phenotype Associations)", "abnormal hair follicle matrix region morphology (MP:0010686 from MPO Gene-Phenotype Associations)", "abnormal blood pressure regulation (MP:0010695 from MPO Gene-Phenotype Associations)", "abnormal systemic arterial blood pressure regulation (MP:0010697 from MPO Gene-Phenotype Associations)", "abnormal circadian regulation of systemic arterial blood pressure (MP:0011022 from MPO Gene-Phenotype Associations)", "abnormal circadian regulation of heart rate (MP:0011021 from MPO Gene-Phenotype Associations)", "delayed circadian phase (MP:0002565 from MPO Gene-Phenotype Associations)", "abnormal circadian period (MP:0002558 from MPO Gene-Phenotype Associations)", "shortened circadian period (MP:0002563 from MPO Gene-Phenotype Associations)", "abnormal circadian rhythm (MP:0001502 from MPO Gene-Phenotype Associations)", "abnormal circadian phase (MP:0002561 from MPO Gene-Phenotype Associations)", "advanced circadian phase (MP:0002564 from MPO Gene-Phenotype Associations)", "abnormal circadian persistence (MP:0002559 from MPO Gene-Phenotype Associations)", "arrhythmic circadian persistence (MP:0002560 from MPO Gene-Phenotype Associations)", "prolonged circadian period (MP:0002562 from MPO Gene-Phenotype Associations)", "abnormal body temperature homeostasis (MP:0001777 from MPO Gene-Phenotype Associations)", "abnormal circadian temperature homeostasis (MP:0011020 from MPO Gene-Phenotype Associations)", "enhanced conditioned place preference behavior (MP:0009713 from MPO Gene-Phenotype Associations)", "abnormal sensitization (MP:0011618 from MPO Gene-Phenotype Associations)", "abnormal sensitization to xenobiotic (MP:0011624 from MPO Gene-Phenotype Associations)", "decreased frequency of paradoxical sleep (MP:0012286 from MPO Gene-Phenotype Associations)", "enhanced coordination (MP:0003858 from MPO Gene-Phenotype Associations)", "abnormal frequency of paradoxical sleep (MP:0003194 from MPO Gene-Phenotype Associations)", "abnormal paradoxical sleep pattern (MP:0012288 from MPO Gene-Phenotype Associations)", "abnormal sleep behavior (MP:0011396 from MPO Gene-Phenotype Associations)", "abnormal sleep pattern (MP:0001501 from MPO Gene-Phenotype Associations)", "increased frequency of paradoxical sleep (MP:0012287 from MPO Gene-Phenotype Associations)", "abnormal non-rapid eye movement sleep pattern (MP:0012289 from MPO Gene-Phenotype Associations)", "narcolepsy (MP:0005279 from MPO Gene-Phenotype Associations)", "fragmentation of sleep|wake states (MP:0009436 from MPO Gene-Phenotype Associations)", "abnormal sphingolipid level (MP:0012230 from MPO Gene-Phenotype Associations)", "abnormal ceramide level (MP:0012232 from MPO Gene-Phenotype Associations)", "abnormal habituation (MP:0011617 from MPO Gene-Phenotype Associations)", "abnormal nonassociative learning (MP:0011616 from MPO Gene-Phenotype Associations)", "abnormal habituation to a new environment (MP:0011620 from MPO Gene-Phenotype Associations)", "induced hyperactivity (MP:0008911 from MPO Gene-Phenotype Associations)", "nervous (MP:0008912 from MPO Gene-Phenotype Associations)", "abnormal habituation to a novel object (MP:0011621 from MPO Gene-Phenotype Associations)", "abnormal fatty acid beta-oxidation (MP:0010952 from MPO Gene-Phenotype Associations)", "abnormal fatty acid oxidation (MP:0010953 from MPO Gene-Phenotype Associations)", "abnormal lipid oxidation (MP:0010951 from MPO Gene-Phenotype Associations)", "abnormal sperm connecting piece morphology (MP:0009830 from MPO Gene-Phenotype Associations)", "abnormal olfactory -discrimination memory (MP:0001460 from MPO Gene-Phenotype Associations)", "abnormal discrimination learning (MP:0002802 from MPO Gene-Phenotype Associations)", "impaired discrimination learning (MP:0012296 from MPO Gene-Phenotype Associations)", "impaired social transmission of food preference (MP:0002969 from MPO Gene-Phenotype Associations)", "abnormal summary potential (MP:0003470 from MPO Gene-Phenotype Associations)", "abnormal behavioral response to methamphetamine (MP:0012733 from MPO Gene-Phenotype Associations)", "abnormal autonomic nervous system physiology (MP:0006276 from MPO Gene-Phenotype Associations)", "abnormal sympathetic nervous system physiology (MP:0004183 from MPO Gene-Phenotype Associations)", "abnormal baroreceptor physiology (MP:0004184 from MPO Gene-Phenotype Associations)", "abnormal sympathetic neuron physiology (MP:0009253 from MPO Gene-Phenotype Associations)", "abnormal channel response (MP:0003484 from MPO Gene-Phenotype Associations)", "abnormal channel response intensity (MP:0003486 from MPO Gene-Phenotype Associations)", "decreased channel response intensity (MP:0003488 from MPO Gene-Phenotype Associations)", "abnormal channel response threshold (MP:0003485 from MPO Gene-Phenotype Associations)", "increased channel response threshold (MP:0003489 from MPO Gene-Phenotype Associations)", "abnormal afterhyperpolarization (MP:0003412 from MPO Gene-Phenotype Associations)", "abnormal single cell response (MP:0003463 from MPO Gene-Phenotype Associations)", "abnormal single cell response threshold (MP:0003464 from MPO Gene-Phenotype Associations)", "decreased single cell response threshold (MP:0003466 from MPO Gene-Phenotype Associations)", "increased single cell response threshold (MP:0003465 from MPO Gene-Phenotype Associations)", "abnormal embryonic erythrocyte morphology (MP:0004230 from MPO Gene-Phenotype Associations)", "abnormal embryonic erythropoiesis (MP:0004229 from MPO Gene-Phenotype Associations)", "abnormal embryonic hematopoiesis (MP:0003396 from MPO Gene-Phenotype Associations)", "abnormal physiological neovascularization (MP:0003710 from MPO Gene-Phenotype Associations)", "abnormal hemangioblast morphology (MP:0012715 from MPO Gene-Phenotype Associations)", "abnormal yolk sac hematopoietic stem cell morphology (MP:0011247 from MPO Gene-Phenotype Associations)", "abnormal hemangioblast number (MP:0012716 from MPO Gene-Phenotype Associations)", "increased hemangioblast number (MP:0012717 from MPO Gene-Phenotype Associations)", "increased angiogenesis (MP:0005601 from MPO Gene-Phenotype Associations)", "exocrine pancreas hyperplasia (MP:0003337 from MPO Gene-Phenotype Associations)", "abnormal hepatic vein morphology (MP:0010439 from MPO Gene-Phenotype Associations)", "abnormal nuchal region morphology (MP:0012723 from MPO Gene-Phenotype Associations)", "nuchal edema (MP:0012269 from MPO Gene-Phenotype Associations)", "abnormal lymph organ development (MP:0002450 from MPO Gene-Phenotype Associations)", "herniated intestine (MP:0005155 from MPO Gene-Phenotype Associations)", "herniated liver (MP:0010912 from MPO Gene-Phenotype Associations)", "abnormal fetal liver hematopoietic progenitor cell morphology (MP:0011246 from MPO Gene-Phenotype Associations)", "abnormal hepatoblast morphology (MP:0012240 from MPO Gene-Phenotype Associations)", "decreased hepatoblast number (MP:0012243 from MPO Gene-Phenotype Associations)", "loss of hippocampal neurons (MP:0003240 from MPO Gene-Phenotype Associations)", "abnormal hippocampal mossy fiber morphology (MP:0002761 from MPO Gene-Phenotype Associations)", "abnormal brain zinc level (MP:0009616 from MPO Gene-Phenotype Associations)", "decreased brain zinc level (MP:0009617 from MPO Gene-Phenotype Associations)", "abnormal zinc homeostasis (MP:0009615 from MPO Gene-Phenotype Associations)", "abnormal cajal-retzius cell morphology (MP:0008030 from MPO Gene-Phenotype Associations)", "decreased cajal-retzius cell number (MP:0008031 from MPO Gene-Phenotype Associations)", "abnormal cortical marginal zone morphology (MP:0000792 from MPO Gene-Phenotype Associations)", "absent cajal-retzius cell (MP:0000344 from MPO Gene-Phenotype Associations)", "absent enterocytes (MP:0000487 from MPO Gene-Phenotype Associations)", "abnormal cerebrospinal fluid production (MP:0001911 from MPO Gene-Phenotype Associations)", "submission towards male mice (MP:0001355 from MPO Gene-Phenotype Associations)", "excessive digestive secretion (MP:0000503 from MPO Gene-Phenotype Associations)", "abnormal enterocyte cell number (MP:0000481 from MPO Gene-Phenotype Associations)", "decreased enterocyte cell number (MP:0000339 from MPO Gene-Phenotype Associations)", "abnormal alveolocapillary membrane morphology (MP:0002324 from MPO Gene-Phenotype Associations)", "absent awl hair (MP:0006364 from MPO Gene-Phenotype Associations)", "absent hair follicle inner root sheath (MP:0000388 from MPO Gene-Phenotype Associations)", "enlarged hair follicles (MP:0000381 from MPO Gene-Phenotype Associations)", "abnormal eosinophil differentiation (MP:0002443 from MPO Gene-Phenotype Associations)", "nasal inflammation (MP:0001866 from MPO Gene-Phenotype Associations)", "rhinitis (MP:0001867 from MPO Gene-Phenotype Associations)", "abnormal meiotic spindle morphology (MP:0009761 from MPO Gene-Phenotype Associations)", "increased sertoli cell phagocytosis (MP:0009852 from MPO Gene-Phenotype Associations)", "abnormal sertoli cell phagocytosis (MP:0009851 from MPO Gene-Phenotype Associations)", "decreased sertoli cell phagocytosis (MP:0009853 from MPO Gene-Phenotype Associations)", "decreased susceptibility to graft versus host disease (MP:0005673 from MPO Gene-Phenotype Associations)", "increased basal cell carcinoma incidence (MP:0004208 from MPO Gene-Phenotype Associations)", "abnormal fasted circulating glucose level (MP:0013277 from MPO Gene-Phenotype Associations)", "increased fasted circulating glucose level (MP:0013279 from MPO Gene-Phenotype Associations)", "decreased fasted circulating glucose level (MP:0013278 from MPO Gene-Phenotype Associations)", "failure of mullerian duct regression (MP:0009139 from MPO Gene-Phenotype Associations)", "scapular bone foramen (MP:0004342 from MPO Gene-Phenotype Associations)", "decreased diameter of humerus (MP:0008154 from MPO Gene-Phenotype Associations)", "broad nasal bridge (MP:0000449 from MPO Gene-Phenotype Associations)", "misaligned sternebrae (MP:0012285 from MPO Gene-Phenotype Associations)", "lung cysts (MP:0004880 from MPO Gene-Phenotype Associations)", "camptodactyly (MP:0003807 from MPO Gene-Phenotype Associations)", "absent tongue (MP:0009905 from MPO Gene-Phenotype Associations)", "abnormal lymphatic vessel smooth muscle morphology (MP:0010196 from MPO Gene-Phenotype Associations)", "enlarged salivary gland (MP:0009516 from MPO Gene-Phenotype Associations)", "abnormal base-excision repair (MP:0009796 from MPO Gene-Phenotype Associations)", "increased susceptibility to systemic lupus erythematosus (MP:0004801 from MPO Gene-Phenotype Associations)", "decreased susceptibility to systemic lupus erythematosus (MP:0004802 from MPO Gene-Phenotype Associations)", "abnormal primary ovarian follicle morphology (MP:0009362 from MPO Gene-Phenotype Associations)", "decreased mitotic index (MP:0004759 from MPO Gene-Phenotype Associations)", "skin photosensitivity (MP:0001202 from MPO Gene-Phenotype Associations)", "increased sensitivity to skin irradiation (MP:0001203 from MPO Gene-Phenotype Associations)", "increased incidence of tumors by uv-induction (MP:0004501 from MPO Gene-Phenotype Associations)", "photosensitivity (MP:0001999 from MPO Gene-Phenotype Associations)", "abnormal chiasmata formation (MP:0008966 from MPO Gene-Phenotype Associations)", "abnormal meiotic configurations (MP:0009564 from MPO Gene-Phenotype Associations)", "absent chiasmata formation (MP:0008967 from MPO Gene-Phenotype Associations)", "abnormal synaptonemal complex (MP:0009452 from MPO Gene-Phenotype Associations)", "abnormal chromosome pairing during meiosis (MP:0009451 from MPO Gene-Phenotype Associations)", "abnormal dna repair (MP:0008058 from MPO Gene-Phenotype Associations)", "abnormal double-strand dna break repair (MP:0010948 from MPO Gene-Phenotype Associations)", "abnormal female meiosis i arrest (MP:0010767 from MPO Gene-Phenotype Associations)", "abnormal x-y chromosome synapsis during male meiosis (MP:0011751 from MPO Gene-Phenotype Associations)", "abnormal somatic hypermutation frequency (MP:0004815 from MPO Gene-Phenotype Associations)", "abnormal mismatch repair (MP:0009797 from MPO Gene-Phenotype Associations)", "increased lymphoblastic lymphoma incidence (MP:0009320 from MPO Gene-Phenotype Associations)", "abnormal single-strand dna break repair (MP:0010947 from MPO Gene-Phenotype Associations)", "abnormal bony labyrinth (MP:0004289 from MPO Gene-Phenotype Associations)", "otosclerosis (MP:0004897 from MPO Gene-Phenotype Associations)", "abnormal pro-b cell differentiation (MP:0008233 from MPO Gene-Phenotype Associations)", "increased igd level (MP:0002496 from MPO Gene-Phenotype Associations)", "absent transitional stage b cells (MP:0008216 from MPO Gene-Phenotype Associations)", "abnormal igd level (MP:0020172 from MPO Gene-Phenotype Associations)", "decreased igd level (MP:0002491 from MPO Gene-Phenotype Associations)", "abnormal marginal zone b cell physiology (MP:0008193 from MPO Gene-Phenotype Associations)", "abnormal follicular b cell physiology (MP:0008191 from MPO Gene-Phenotype Associations)", "increased circulating interferon-alpha level (MP:0008573 from MPO Gene-Phenotype Associations)", "decreased embryo weight (MP:0009429 from MPO Gene-Phenotype Associations)", "increased renal glomerulus lobularity (MP:0011567 from MPO Gene-Phenotype Associations)", "abnormal auditory cortex morphology (MP:0004631 from MPO Gene-Phenotype Associations)", "dysmetria (MP:0003314 from MPO Gene-Phenotype Associations)", "abnormal occipital lobe morphology (MP:0000804 from MPO Gene-Phenotype Associations)", "abnormal visual cortex morphology (MP:0000805 from MPO Gene-Phenotype Associations)", "abnormal dermal melanocyte morphology (MP:0009386 from MPO Gene-Phenotype Associations)", "abnormal dermal pigmentation (MP:0009385 from MPO Gene-Phenotype Associations)", "increased compact bone mass (MP:0010961 from MPO Gene-Phenotype Associations)", "absent platelets (MP:0003714 from MPO Gene-Phenotype Associations)", "absent megakaryocytes (MP:0008253 from MPO Gene-Phenotype Associations)", "decreased megakaryocyte cell number (MP:0008255 from MPO Gene-Phenotype Associations)", "erythroderma (MP:0003454 from MPO Gene-Phenotype Associations)", "echinocytosis (MP:0000256 from MPO Gene-Phenotype Associations)", "hemoglobinemia (MP:0000332 from MPO Gene-Phenotype Associations)", "hemosiderinuria (MP:0000327 from MPO Gene-Phenotype Associations)", "abnormal haptoglobin level (MP:0013215 from MPO Gene-Phenotype Associations)", "increased circulating haptoglobin level (MP:0012666 from MPO Gene-Phenotype Associations)", "increased haptoglobin level (MP:0012665 from MPO Gene-Phenotype Associations)", "hemoglobinuria (MP:0000315 from MPO Gene-Phenotype Associations)", "abnormal inner cell mass apoptosis (MP:0010380 from MPO Gene-Phenotype Associations)", "abnormal inner cell mass proliferation (MP:0004966 from MPO Gene-Phenotype Associations)", "absent inner cell mass proliferation (MP:0012114 from MPO Gene-Phenotype Associations)", "decreased inner cell mass proliferation (MP:0012113 from MPO Gene-Phenotype Associations)", "abnormal blastocyst hatching (MP:0003693 from MPO Gene-Phenotype Associations)", "failure of blastocyst to hatch from the zona pellucida (MP:0003694 from MPO Gene-Phenotype Associations)", "complete embryonic lethality at implantation (MP:0011093 from MPO Gene-Phenotype Associations)", "embryonic lethality at implantation (MP:0008527 from MPO Gene-Phenotype Associations)", "abnormal trophectoderm cell proliferation (MP:0012115 from MPO Gene-Phenotype Associations)", "absent trophectoderm cell proliferation (MP:0012118 from MPO Gene-Phenotype Associations)", "increased trophectoderm apoptosis (MP:0012119 from MPO Gene-Phenotype Associations)", "increased facial tumor incidence (MP:0008018 from MPO Gene-Phenotype Associations)", "trophectoderm cell degeneration (MP:0012120 from MPO Gene-Phenotype Associations)", "decreased trophectoderm cell proliferation (MP:0012117 from MPO Gene-Phenotype Associations)", "enlarged mitral valve (MP:0010618 from MPO Gene-Phenotype Associations)", "partial embryonic lethality at implantation (MP:0011103 from MPO Gene-Phenotype Associations)", "failure of morula compaction (MP:0012111 from MPO Gene-Phenotype Associations)", "abnormal blastocoele morphology (MP:0004963 from MPO Gene-Phenotype Associations)", "failure to form blastocele (MP:0002663 from MPO Gene-Phenotype Associations)", "abnormal blastocyst formation (MP:0012128 from MPO Gene-Phenotype Associations)", "failure of blastocyst formation (MP:0012129 from MPO Gene-Phenotype Associations)", "abnormal nucleolus morphology (MP:0008830 from MPO Gene-Phenotype Associations)", "complete embryonic lethality before implantation (MP:0011094 from MPO Gene-Phenotype Associations)", "embryonic lethality before implantation (MP:0006204 from MPO Gene-Phenotype Associations)", "abnormal inner cell mass morphology (MP:0002718 from MPO Gene-Phenotype Associations)", "inner cell mass degeneration (MP:0004965 from MPO Gene-Phenotype Associations)", "absent inner cell mass (MP:0004964 from MPO Gene-Phenotype Associations)", "embryonic epiblast cell degeneration (MP:0011193 from MPO Gene-Phenotype Associations)", "optic nerve atrophy (MP:0001059 from MPO Gene-Phenotype Associations)", "optic nerve coloboma (MP:0010717 from MPO Gene-Phenotype Associations)", "absent trophoblast giant cells (MP:0001714 from MPO Gene-Phenotype Associations)", "absent trophectoderm (MP:0012102 from MPO Gene-Phenotype Associations)", "abnormal morula morphology (MP:0012058 from MPO Gene-Phenotype Associations)", "increased inner cell mass apoptosis (MP:0012743 from MPO Gene-Phenotype Associations)", "abnormal cajal body morphology (MP:0008888 from MPO Gene-Phenotype Associations)", "increased allantois apoptosis (MP:0003891 from MPO Gene-Phenotype Associations)", "absent placenta (MP:0013181 from MPO Gene-Phenotype Associations)", "abnormal cell nucleus count (MP:0003706 from MPO Gene-Phenotype Associations)", "increased cell nucleus count (MP:0003707 from MPO Gene-Phenotype Associations)", "binucleate (MP:0003708 from MPO Gene-Phenotype Associations)", "increased spinal cord apoptosis (MP:0013182 from MPO Gene-Phenotype Associations)", "delayed allantois development (MP:0004558 from MPO Gene-Phenotype Associations)", "absent umbilical cord (MP:0012134 from MPO Gene-Phenotype Associations)", "delayed chorioallantoic fusion (MP:0009656 from MPO Gene-Phenotype Associations)", "heart right ventricle degeneration (MP:0005648 from MPO Gene-Phenotype Associations)", "abnormal cerebellum fissure morphology (MP:0009267 from MPO Gene-Phenotype Associations)", "vaginal septum (MP:0009708 from MPO Gene-Phenotype Associations)", "increased urine selenium level (MP:0011770 from MPO Gene-Phenotype Associations)", "abnormal circulating dihydrotestosterone level (MP:0003508 from MPO Gene-Phenotype Associations)", "increased circulating dihydrotestosterone level (MP:0003509 from MPO Gene-Phenotype Associations)", "abnormal selenium level (MP:0001775 from MPO Gene-Phenotype Associations)", "abnormal glutathione peroxidase activity (MP:0011601 from MPO Gene-Phenotype Associations)", "decreased glutathione peroxidase activity (MP:0011603 from MPO Gene-Phenotype Associations)", "dilated uterus (MP:0001123 from MPO Gene-Phenotype Associations)", "increased number of heinz bodies (MP:0011171 from MPO Gene-Phenotype Associations)", "decreased catalase activity (MP:0011594 from MPO Gene-Phenotype Associations)", "abnormal catalase activity (MP:0011592 from MPO Gene-Phenotype Associations)", "abnormal peroxidase activity (MP:0012579 from MPO Gene-Phenotype Associations)", "decreased peroxidase activity (MP:0012580 from MPO Gene-Phenotype Associations)", "increased cellular sensitivity to hydrogen peroxide (MP:0008406 from MPO Gene-Phenotype Associations)", "increased cellular sensitivity to oxidative stress (MP:0008412 from MPO Gene-Phenotype Associations)", "increased trichoepithelioma incidence (MP:0002732 from MPO Gene-Phenotype Associations)", "increased hepatoma incidence (MP:0010264 from MPO Gene-Phenotype Associations)", "decreased gland tumor incidence (MP:0012416 from MPO Gene-Phenotype Associations)", "decreased integument system tumor incidence (MP:0012422 from MPO Gene-Phenotype Associations)", "decreased mammary gland tumor incidence (MP:0010269 from MPO Gene-Phenotype Associations)", "abnormal vitamin c level (MP:0011229 from MPO Gene-Phenotype Associations)", "abnormal urine amino acid level (MP:0011468 from MPO Gene-Phenotype Associations)", "aciduria (MP:0010028 from MPO Gene-Phenotype Associations)", "aminoaciduria (MP:0003311 from MPO Gene-Phenotype Associations)", "ketoaciduria (MP:0002893 from MPO Gene-Phenotype Associations)", "glutaricadicuria (MP:0002931 from MPO Gene-Phenotype Associations)", "increased urine histidine level (MP:0011654 from MPO Gene-Phenotype Associations)", "abnormal renal protein reabsorption (MP:0011445 from MPO Gene-Phenotype Associations)", "abnormal urine insulin level (MP:0011558 from MPO Gene-Phenotype Associations)", "increased urine insulin level (MP:0011559 from MPO Gene-Phenotype Associations)", "increased urine beta2-microglobulin level (MP:0011556 from MPO Gene-Phenotype Associations)", "increased urine microglobulin level (MP:0011555 from MPO Gene-Phenotype Associations)", "abnormal mesenchyme morphology (MP:0006301 from MPO Gene-Phenotype Associations)", "thin endoderm (MP:0001687 from MPO Gene-Phenotype Associations)", "decreased reichert's membrane thickness (MP:0012096 from MPO Gene-Phenotype Associations)", "abnormal anterior visceral endoderm cell migration (MP:0011255 from MPO Gene-Phenotype Associations)", "abnormal visceral endoderm physiology (MP:0012028 from MPO Gene-Phenotype Associations)", "abnormal glyceraldehyde-3-phosphate dehydrogenase (nad+) (phosphorylating) activity (MP:0011607 from MPO Gene-Phenotype Associations)", "decreased glyceraldehyde-3-phosphate dehydrogenase (nad+) (phosphorylating) activity (MP:0011609 from MPO Gene-Phenotype Associations)", "partial embryonic lethality between implantation and somite formation (MP:0011106 from MPO Gene-Phenotype Associations)", "delayed gastrulation (MP:0012105 from MPO Gene-Phenotype Associations)", "increased ectoderm apoptosis (MP:0003895 from MPO Gene-Phenotype Associations)", "absent amniotic cavity (MP:0012142 from MPO Gene-Phenotype Associations)", "hydropic allantois (MP:0012299 from MPO Gene-Phenotype Associations)", "abnormal parietal endoderm morphology (MP:0011187 from MPO Gene-Phenotype Associations)", "abnormal reichert's membrane morphology (MP:0003954 from MPO Gene-Phenotype Associations)", "abnormal reichert's membrane thickness (MP:0012094 from MPO Gene-Phenotype Associations)", "increased reichert's membrane thickness (MP:0012095 from MPO Gene-Phenotype Associations)", "duodenum polyps (MP:0008012 from MPO Gene-Phenotype Associations)", "decreased embryonic epiblast cell proliferation (MP:0011192 from MPO Gene-Phenotype Associations)", "increased embryonic epiblast cell apoptosis (MP:0011191 from MPO Gene-Phenotype Associations)", "abnormal subthalamic nucleus morphology (MP:0000835 from MPO Gene-Phenotype Associations)", "abnormal subthalamus morphology (MP:0000834 from MPO Gene-Phenotype Associations)", "absent hippocampal fimbria (MP:0009324 from MPO Gene-Phenotype Associations)", "hyperresponsive (MP:0001400 from MPO Gene-Phenotype Associations)", "neuronal intranuclear inclusions (MP:0004191 from MPO Gene-Phenotype Associations)", "abnormal basal ganglion morphology (MP:0006007 from MPO Gene-Phenotype Associations)", "abnormal striatum morphology (MP:0004077 from MPO Gene-Phenotype Associations)", "abnormal nucleus accumbens morphology (MP:0004080 from MPO Gene-Phenotype Associations)", "abnormal ventral striatum morphology (MP:0004103 from MPO Gene-Phenotype Associations)", "abnormal dorsal striatum morphology (MP:0004102 from MPO Gene-Phenotype Associations)", "abnormal putamen morphology (MP:0004079 from MPO Gene-Phenotype Associations)", "abnormal meiotic spindle assembly checkpoint (MP:0009769 from MPO Gene-Phenotype Associations)", "enlarged cerebellum (MP:0008914 from MPO Gene-Phenotype Associations)", "abnormal vocalization (MP:0001529 from MPO Gene-Phenotype Associations)", "delayed cns synapse formation (MP:0002924 from MPO Gene-Phenotype Associations)", "abnormal hippocampus physiology (MP:0012006 from MPO Gene-Phenotype Associations)", "increased synaptic depression (MP:0002916 from MPO Gene-Phenotype Associations)", "delayed axon extension (MP:0002946 from MPO Gene-Phenotype Associations)", "abnormal synaptic vesicle morphology (MP:0004769 from MPO Gene-Phenotype Associations)", "abnormal synaptic vesicle number (MP:0004792 from MPO Gene-Phenotype Associations)", "abnormal synaptic vesicle recycling (MP:0004770 from MPO Gene-Phenotype Associations)", "abnormal pulse pressure (MP:0003882 from MPO Gene-Phenotype Associations)", "increased pulse pressure (MP:0006265 from MPO Gene-Phenotype Associations)", "increased post-tetanic potentiation (MP:0002923 from MPO Gene-Phenotype Associations)", "abnormal post-tetanic potentiation (MP:0002921 from MPO Gene-Phenotype Associations)", "decreased post-tetanic potentiation (MP:0002922 from MPO Gene-Phenotype Associations)", "decreased paired-pulse facilitation (MP:0002920 from MPO Gene-Phenotype Associations)", "abnormal paired-pulse facilitation (MP:0002918 from MPO Gene-Phenotype Associations)", "enhanced paired-pulse facilitation (MP:0002919 from MPO Gene-Phenotype Associations)", "abnormal medium spiny neuron morphology (MP:0008462 from MPO Gene-Phenotype Associations)", "abnormal conditioned emotional response (MP:0002806 from MPO Gene-Phenotype Associations)", "abnormal innate avoidance response (MP:0012013 from MPO Gene-Phenotype Associations)", "abnormal behavioral response to light (MP:0011275 from MPO Gene-Phenotype Associations)", "decreased synaptic depression (MP:0002917 from MPO Gene-Phenotype Associations)", "decreased dentate gyrus size (MP:0012460 from MPO Gene-Phenotype Associations)", "impaired active avoidance behavior (MP:0012293 from MPO Gene-Phenotype Associations)", "impaired spatial learning (MP:0012307 from MPO Gene-Phenotype Associations)", "improved righting response (MP:0002863 from MPO Gene-Phenotype Associations)", "delayed brain development (MP:0001889 from MPO Gene-Phenotype Associations)", "abnormal hippocampus stratum oriens morphology (MP:0011150 from MPO Gene-Phenotype Associations)", "absent hippocampus stratum oriens (MP:0011155 from MPO Gene-Phenotype Associations)", "thick hippocampus stratum oriens (MP:0011153 from MPO Gene-Phenotype Associations)", "enlarged hippocampus (MP:0008282 from MPO Gene-Phenotype Associations)", "increased cns synapse formation (MP:0004997 from MPO Gene-Phenotype Associations)", "abnormal excitatory postsynaptic current amplitude (MP:0011267 from MPO Gene-Phenotype Associations)", "increased excitatory postsynaptic current amplitude (MP:0011269 from MPO Gene-Phenotype Associations)", "decreased excitatory postsynaptic current amplitude (MP:0011270 from MPO Gene-Phenotype Associations)", "abnormal nerve fiber response intensity (MP:0003479 from MPO Gene-Phenotype Associations)", "decreased nerve fiber response intensity (MP:0003481 from MPO Gene-Phenotype Associations)", "abnormal nerve fiber response (MP:0003477 from MPO Gene-Phenotype Associations)", "abnormal synaptic acetylcholine release (MP:0004836 from MPO Gene-Phenotype Associations)", "abnormal paired-pulse inhibition (MP:0004807 from MPO Gene-Phenotype Associations)", "deiters cell degeneration (MP:0004628 from MPO Gene-Phenotype Associations)", "abnormal cochlear nerve fiber response (MP:0006324 from MPO Gene-Phenotype Associations)", "abnormal urination pattern (MP:0001761 from MPO Gene-Phenotype Associations)", "increased urination frequency (MP:0011535 from MPO Gene-Phenotype Associations)", "decreased susceptibility to noise-induced hearing loss (MP:0004925 from MPO Gene-Phenotype Associations)", "increased muscle relaxation (MP:0004037 from MPO Gene-Phenotype Associations)", "impaired ability to fire action potentials (MP:0002578 from MPO Gene-Phenotype Associations)", "porphyria (MP:0005654 from MPO Gene-Phenotype Associations)", "erythruria (MP:0011414 from MPO Gene-Phenotype Associations)", "abnormal blinking (MP:0001993 from MPO Gene-Phenotype Associations)", "increased blinking frequency (MP:0001994 from MPO Gene-Phenotype Associations)", "abnormal nerve fiber response threshold (MP:0003478 from MPO Gene-Phenotype Associations)", "decreased nerve fiber response threshold (MP:0003483 from MPO Gene-Phenotype Associations)", "abnormal eye blink conditioning behavior (MP:0002807 from MPO Gene-Phenotype Associations)", "abnormal acid-activated cation-mediated receptor currents (MP:0009244 from MPO Gene-Phenotype Associations)", "phototoxicity (MP:0005653 from MPO Gene-Phenotype Associations)", "abnormal bile color (MP:0000341 from MPO Gene-Phenotype Associations)", "abnormal neuronal stem cell morphology (MP:0012203 from MPO Gene-Phenotype Associations)", "abnormal neuronal stem cell physiology (MP:0012204 from MPO Gene-Phenotype Associations)", "abnormal neuronal stem cell self-renewal (MP:0012205 from MPO Gene-Phenotype Associations)", "decreased neuronal stem cell self-renewal (MP:0012207 from MPO Gene-Phenotype Associations)", "increased neuronal stem cell self-renewal (MP:0012206 from MPO Gene-Phenotype Associations)", "abnormal intestinal smooth muscle morphology (MP:0008802 from MPO Gene-Phenotype Associations)", "decreased susceptibility to age related obesity (MP:0003213 from MPO Gene-Phenotype Associations)", "increased susceptibility to induced choroid neovascularization (MP:0011557 from MPO Gene-Phenotype Associations)", "increased litter size (MP:0001934 from MPO Gene-Phenotype Associations)", "enhanced fertility (MP:0010143 from MPO Gene-Phenotype Associations)", "abnormal tail position or orientation (MP:0013176 from MPO Gene-Phenotype Associations)", "big ears (MP:0000017 from MPO Gene-Phenotype Associations)", "abnormal myoblast differentiation (MP:0011808 from MPO Gene-Phenotype Associations)", "increased acute promyelocytic leukemia incidence (MP:0004049 from MPO Gene-Phenotype Associations)", "increased spleen neoplasm incidence (MP:0005649 from MPO Gene-Phenotype Associations)", "abnormal pancreatic beta cell proliferation (MP:0011818 from MPO Gene-Phenotype Associations)", "increased pancreatic beta cell proliferation (MP:0011819 from MPO Gene-Phenotype Associations)", "decreased pancreatic beta cell proliferation (MP:0011820 from MPO Gene-Phenotype Associations)", "caudal vertebral transformation (MP:0004614 from MPO Gene-Phenotype Associations)", "loss of eyelid cilia (MP:0000425 from MPO Gene-Phenotype Associations)", "bronchial situs inversus (MP:0011251 from MPO Gene-Phenotype Associations)", "abnormal respiratory sounds (MP:0001950 from MPO Gene-Phenotype Associations)", "abnormal collateral sprouting (MP:0010726 from MPO Gene-Phenotype Associations)", "abnormal motor nerve collateral sprouting (MP:0004243 from MPO Gene-Phenotype Associations)", "adipose tissue necrosis (MP:0013249 from MPO Gene-Phenotype Associations)", "decreased interleukin-15 secretion (MP:0008676 from MPO Gene-Phenotype Associations)", "abnormal interleukin-15 secretion (MP:0008674 from MPO Gene-Phenotype Associations)", "abnormal nk cell differentiation (MP:0008053 from MPO Gene-Phenotype Associations)", "failure of zygotic cell division (MP:0003406 from MPO Gene-Phenotype Associations)", "abnormal secondary polar body morphology (MP:0012738 from MPO Gene-Phenotype Associations)", "increased ovary weight (MP:0004855 from MPO Gene-Phenotype Associations)", "diffuse hepatic necrosis (MP:0005151 from MPO Gene-Phenotype Associations)", "suppressed circulating follicle stimulating hormone level (MP:0001749 from MPO Gene-Phenotype Associations)", "abnormal sternebra size (MP:0012280 from MPO Gene-Phenotype Associations)", "decreased sternebra size (MP:0012281 from MPO Gene-Phenotype Associations)", "abnormal endometrial gland development (MP:0013400 from MPO Gene-Phenotype Associations)", "abnormal calcaneum morphology (MP:0009728 from MPO Gene-Phenotype Associations)", "abnormal cumulus expansion (MP:0009373 from MPO Gene-Phenotype Associations)", "absent cumulus expansion (MP:0009374 from MPO Gene-Phenotype Associations)", "decreased skeletal muscle fiber density (MP:0009408 from MPO Gene-Phenotype Associations)", "abnormal scaphoid morphology (MP:0010775 from MPO Gene-Phenotype Associations)", "decreased mean platelet volume (MP:0008935 from MPO Gene-Phenotype Associations)", "upturned snout (MP:0006411 from MPO Gene-Phenotype Associations)", "abnormal water content (MP:0000676 from MPO Gene-Phenotype Associations)", "increased percent water in carcass (MP:0000679 from MPO Gene-Phenotype Associations)", "decreased percent water in carcass (MP:0000683 from MPO Gene-Phenotype Associations)", "abnormal chordamesoderm morphology (MP:0012271 from MPO Gene-Phenotype Associations)", "abnormal miscarriage rate (MP:0004244 from MPO Gene-Phenotype Associations)", "nephrolithiasis (MP:0002708 from MPO Gene-Phenotype Associations)", "abnormal urine sulfate level (MP:0009471 from MPO Gene-Phenotype Associations)", "increased urine sulfate level (MP:0009472 from MPO Gene-Phenotype Associations)", "abnormal circulating sulfate level (MP:0002851 from MPO Gene-Phenotype Associations)", "hyposulfatemia (MP:0002853 from MPO Gene-Phenotype Associations)", "adipsia (MP:0001428 from MPO Gene-Phenotype Associations)", "spleen fibrosis (MP:0011746 from MPO Gene-Phenotype Associations)", "abnormal synaptic norepinephrine release (MP:0005447 from MPO Gene-Phenotype Associations)", "abnormal circadian feeding behavior (MP:0011943 from MPO Gene-Phenotype Associations)", "absent neuronal precursor cells (MP:0004949 from MPO Gene-Phenotype Associations)", "abnormal bitter taste sensitivity (MP:0004210 from MPO Gene-Phenotype Associations)", "abnormal umami taste sensitivity (MP:0004213 from MPO Gene-Phenotype Associations)", "abnormal sweet taste sensitivity (MP:0004209 from MPO Gene-Phenotype Associations)", "abnormal gustatory system physiology (MP:0001985 from MPO Gene-Phenotype Associations)", "abnormal taste sensitivity (MP:0001986 from MPO Gene-Phenotype Associations)", "abnormal salty taste sensitivity (MP:0004212 from MPO Gene-Phenotype Associations)", "abnormal sour taste sensitivity (MP:0004211 from MPO Gene-Phenotype Associations)", "low sweet preference (MP:0012347 from MPO Gene-Phenotype Associations)", "abnormal hippocampus stratum radiatum morphology (MP:0011151 from MPO Gene-Phenotype Associations)", "thick hippocampus stratum radiatum (MP:0011154 from MPO Gene-Phenotype Associations)", "abnormal myofibroblast differentiation (MP:0012196 from MPO Gene-Phenotype Associations)", "impaired myofibroblast differentiation (MP:0012197 from MPO Gene-Phenotype Associations)", "increased chromosomal stability (MP:0010095 from MPO Gene-Phenotype Associations)", "triangular face (MP:0012546 from MPO Gene-Phenotype Associations)", "abnormal cell mass (MP:0003902 from MPO Gene-Phenotype Associations)", "decreased cell mass (MP:0003904 from MPO Gene-Phenotype Associations)", "increased cell mass (MP:0003903 from MPO Gene-Phenotype Associations)", "abnormal perilymph (MP:0004888 from MPO Gene-Phenotype Associations)", "anasarca (MP:0011738 from MPO Gene-Phenotype Associations)", "abnormal circulating apolipoprotein level (MP:0010332 from MPO Gene-Phenotype Associations)", "abnormal circulating apolipoprotein e level (MP:0010333 from MPO Gene-Phenotype Associations)", "abnormal apolipoprotein level (MP:0010331 from MPO Gene-Phenotype Associations)", "eyelid hypoplasia (MP:0013395 from MPO Gene-Phenotype Associations)", "increased nerve conduction velocity (MP:0011994 from MPO Gene-Phenotype Associations)", "abnormal carotid body physiology (MP:0003438 from MPO Gene-Phenotype Associations)", "abnormal pancreas regeneration (MP:0005518 from MPO Gene-Phenotype Associations)", "decreased pancreas regeneration (MP:0005520 from MPO Gene-Phenotype Associations)", "epithelioid cysts (MP:0002015 from MPO Gene-Phenotype Associations)", "supernumerary nipples (MP:0009723 from MPO Gene-Phenotype Associations)", "ectopic nipples (MP:0009724 from MPO Gene-Phenotype Associations)", "supernumerary mammary glands (MP:0009721 from MPO Gene-Phenotype Associations)", "ectopic mammary gland (MP:0009741 from MPO Gene-Phenotype Associations)", "umbilical cord hemorrhage (MP:0012305 from MPO Gene-Phenotype Associations)", "ocular rupture (MP:0006225 from MPO Gene-Phenotype Associations)", "testis inflammation (MP:0001875 from MPO Gene-Phenotype Associations)", "delayed head development (MP:0012177 from MPO Gene-Phenotype Associations)", "oblique facial cleft (MP:0008799 from MPO Gene-Phenotype Associations)", "abnormal pml bodies (MP:0008886 from MPO Gene-Phenotype Associations)", "abnormal insulin clearance (MP:0003839 from MPO Gene-Phenotype Associations)", "nephron necrosis (MP:0011291 from MPO Gene-Phenotype Associations)", "abnormal pp cell physiology (MP:0009195 from MPO Gene-Phenotype Associations)", "increased anterior commissure size (MP:0008228 from MPO Gene-Phenotype Associations)", "lamellar cataracts (MP:0010262 from MPO Gene-Phenotype Associations)", "abnormal intestine regeneration (MP:0003380 from MPO Gene-Phenotype Associations)", "abnormal circulating c-reactive protein level (MP:0010212 from MPO Gene-Phenotype Associations)", "abnormal pineal gland melatonin secretion (MP:0011729 from MPO Gene-Phenotype Associations)", "abnormal pineal gland physiology (MP:0011728 from MPO Gene-Phenotype Associations)", "abnormal galactose homeostasis (MP:0004018 from MPO Gene-Phenotype Associations)", "'de novo' actin filament nucleation (GO:0070060 from GO Biological Process Annotations)", "'de novo' amp biosynthetic process (GO:0044208 from GO Biological Process Annotations)", "'de novo' cotranslational protein folding (GO:0051083 from GO Biological Process Annotations)", "'de novo' ctp biosynthetic process (GO:0044210 from GO Biological Process Annotations)", "'de novo' gdp-l-fucose biosynthetic process (GO:0042351 from GO Biological Process Annotations)", "'de novo' imp biosynthetic process (GO:0006189 from GO Biological Process Annotations)", "'de novo' nad biosynthetic process (GO:0034627 from GO Biological Process Annotations)", "'de novo' nad biosynthetic process from tryptophan (GO:0034354 from GO Biological Process Annotations)", "'de novo' posttranslational protein folding (GO:0051084 from GO Biological Process Annotations)", "'de novo' protein folding (GO:0006458 from GO Biological Process Annotations)", "'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207 from GO Biological Process Annotations)", "'de novo' ump biosynthetic process (GO:0044205 from GO Biological Process Annotations)", "10-formyltetrahydrofolate catabolic process (GO:0009258 from GO Biological Process Annotations)", "10-formyltetrahydrofolate metabolic process (GO:0009256 from GO Biological Process Annotations)", "2'-deoxyribonucleotide biosynthetic process (GO:0009265 from GO Biological Process Annotations)", "2'-deoxyribonucleotide metabolic process (GO:0009394 from GO Biological Process Annotations)", "2-oxobutyrate biosynthetic process (GO:0046360 from GO Biological Process Annotations)", "2-oxobutyrate metabolic process (GO:0046361 from GO Biological Process Annotations)", "2-oxoglutarate metabolic process (GO:0006103 from GO Biological Process Annotations)", "3'-phospho-5'-adenylyl sulfate transmembrane transport (GO:1902559 from GO Biological Process Annotations)", "3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428 from GO Biological Process Annotations)", "3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427 from GO Biological Process Annotations)", "3'-phosphoadenosine 5'-phosphosulfate transport (GO:0046963 from GO Biological Process Annotations)", "3'-utr-mediated mrna destabilization (GO:0061158 from GO Biological Process Annotations)", "3'-utr-mediated mrna stabilization (GO:0070935 from GO Biological Process Annotations)", "3-keto-sphinganine metabolic process (GO:0006666 from GO Biological Process Annotations)", "4-hydroxyproline catabolic process (GO:0019470 from GO Biological Process Annotations)", "4-hydroxyproline metabolic process (GO:0019471 from GO Biological Process Annotations)", "5-methylcytosine catabolic process (GO:0006211 from GO Biological Process Annotations)", "5-methylcytosine metabolic process (GO:0019857 from GO Biological Process Annotations)", "5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015 from GO Biological Process Annotations)", "5-phosphoribose 1-diphosphate metabolic process (GO:0046391 from GO Biological Process Annotations)", "5s class rrna transcription from rna polymerase iii type 1 promoter (GO:0042791 from GO Biological Process Annotations)", "7,8-dihydroneopterin 3'-triphosphate biosynthetic process (GO:0035998 from GO Biological Process Annotations)", "7-methylguanosine cap hypermethylation (GO:0036261 from GO Biological Process Annotations)", "7-methylguanosine mrna capping (GO:0006370 from GO Biological Process Annotations)", "7-methylguanosine rna capping (GO:0009452 from GO Biological Process Annotations)", "9-cis-retinoic acid biosynthetic process (GO:0042904 from GO Biological Process Annotations)", "9-cis-retinoic acid metabolic process (GO:0042905 from GO Biological Process Annotations)", "90s preribosome assembly (GO:0034463 from GO Biological Process Annotations)", "abducens nerve formation (GO:0021599 from GO Biological Process Annotations)", "abortive mitotic cell cycle (GO:0033277 from GO Biological Process Annotations)", "abscission (GO:0009838 from GO Biological Process Annotations)", "acetaldehyde metabolic process (GO:0006117 from GO Biological Process Annotations)", "acetate biosynthetic process (GO:0019413 from GO Biological Process Annotations)", "acetate ester biosynthetic process (GO:1900620 from GO Biological Process Annotations)", "acetate ester metabolic process (GO:1900619 from GO Biological Process Annotations)", "acetate ester transport (GO:1901374 from GO Biological Process Annotations)", "acetate metabolic process (GO:0006083 from GO Biological Process Annotations)", "acetoacetic acid metabolic process (GO:0043438 from GO Biological Process Annotations)", "acetyl-coa biosynthetic process (GO:0006085 from GO Biological Process Annotations)", "acetyl-coa biosynthetic process from acetate (GO:0019427 from GO Biological Process Annotations)", "acetyl-coa biosynthetic process from pyruvate (GO:0006086 from GO Biological Process Annotations)", "acetyl-coa catabolic process (GO:0046356 from GO Biological Process Annotations)", "acetyl-coa metabolic process (GO:0006084 from GO Biological Process Annotations)", "acetyl-coa transport (GO:0015876 from GO Biological Process Annotations)", "acetylcholine biosynthetic process (GO:0008292 from GO Biological Process Annotations)", "acetylcholine catabolic process (GO:0006581 from GO Biological Process Annotations)", "acetylcholine catabolic process in synaptic cleft (GO:0001507 from GO Biological Process Annotations)", "acetylcholine metabolic process (GO:0008291 from GO Biological Process Annotations)", "acetylcholine secretion (GO:0061526 from GO Biological Process Annotations)", "acetylcholine transport (GO:0015870 from GO Biological Process Annotations)", "acid secretion (GO:0046717 from GO Biological Process Annotations)", "acidic amino acid transport (GO:0015800 from GO Biological Process Annotations)", "acinar cell differentiation (GO:0090425 from GO Biological Process Annotations)", "acrosomal vesicle exocytosis (GO:0060478 from GO Biological Process Annotations)", "acrosome assembly (GO:0001675 from GO Biological Process Annotations)", "acrosome matrix dispersal (GO:0002077 from GO Biological Process Annotations)", "acrosome reaction (GO:0007340 from GO Biological Process Annotations)", "actin crosslink formation (GO:0051764 from GO Biological Process Annotations)", "actin cytoskeleton organization (GO:0030036 from GO Biological Process Annotations)", "actin cytoskeleton reorganization (GO:0031532 from GO Biological Process Annotations)", "actin filament branching (GO:0090135 from GO Biological Process Annotations)", "actin filament bundle assembly (GO:0051017 from GO Biological Process Annotations)", "actin filament bundle organization (GO:0061572 from GO Biological Process Annotations)", "actin filament capping (GO:0051693 from GO Biological Process Annotations)", "actin filament depolymerization (GO:0030042 from GO Biological Process Annotations)", "actin filament network formation (GO:0051639 from GO Biological Process Annotations)", "actin filament organization (GO:0007015 from GO Biological Process Annotations)", "actin filament polymerization (GO:0030041 from GO Biological Process Annotations)", "actin filament reorganization (GO:0090527 from GO Biological Process Annotations)", "actin filament reorganization involved in cell cycle (GO:0030037 from GO Biological Process Annotations)", "actin filament severing (GO:0051014 from GO Biological Process Annotations)", "actin filament uncapping (GO:0051695 from GO Biological Process Annotations)", "actin filament-based movement (GO:0030048 from GO Biological Process Annotations)", "actin filament-based process (GO:0030029 from GO Biological Process Annotations)", "actin modification (GO:0030047 from GO Biological Process Annotations)", "actin nucleation (GO:0045010 from GO Biological Process Annotations)", "actin polymerization or depolymerization (GO:0008154 from GO Biological Process Annotations)", "actin polymerization-dependent cell motility (GO:0070358 from GO Biological Process Annotations)", "actin rod assembly (GO:0031247 from GO Biological Process Annotations)", "actin-mediated cell contraction (GO:0070252 from GO Biological Process Annotations)", "actin-myosin filament sliding (GO:0033275 from GO Biological Process Annotations)", "action potential (GO:0001508 from GO Biological Process Annotations)", "activated t cell proliferation (GO:0050798 from GO Biological Process Annotations)", "activation of adenylate cyclase activity (GO:0007190 from GO Biological Process Annotations)", "activation of anaphase-promoting complex activity (GO:0051488 from GO Biological Process Annotations)", "activation of apc-cdc20 complex activity (GO:0007092 from GO Biological Process Annotations)", "activation of blood coagulation via clotting cascade (GO:0002543 from GO Biological Process Annotations)", "activation of cysteine-type endopeptidase activity (GO:0097202 from GO Biological Process Annotations)", "activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919 from GO Biological Process Annotations)", "activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635 from GO Biological Process Annotations)", "activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296 from GO Biological Process Annotations)", "activation of immune response (GO:0002253 from GO Biological Process Annotations)", "activation of innate immune response (GO:0002218 from GO Biological Process Annotations)", "activation of jak2 kinase activity (GO:0042977 from GO Biological Process Annotations)", "activation of janus kinase activity (GO:0042976 from GO Biological Process Annotations)", "activation of jnkk activity (GO:0007256 from GO Biological Process Annotations)", "activation of jun kinase activity (GO:0007257 from GO Biological Process Annotations)", "activation of mapk activity (GO:0000187 from GO Biological Process Annotations)", "activation of mapk activity by adrenergic receptor signaling pathway (GO:0071883 from GO Biological Process Annotations)", "activation of mapk activity involved in innate immune response (GO:0035419 from GO Biological Process Annotations)", "activation of mapkk activity (GO:0000186 from GO Biological Process Annotations)", "activation of mapkkk activity (GO:0000185 from GO Biological Process Annotations)", "activation of meiosis (GO:0090427 from GO Biological Process Annotations)", "activation of meiosis involved in egg activation (GO:0060466 from GO Biological Process Annotations)", "activation of nf-kappab-inducing kinase activity (GO:0007250 from GO Biological Process Annotations)", "activation of phospholipase a2 activity (GO:0032431 from GO Biological Process Annotations)", "activation of phospholipase a2 activity by calcium-mediated signaling (GO:0043006 from GO Biological Process Annotations)", "activation of phospholipase c activity (GO:0007202 from GO Biological Process Annotations)", "activation of phospholipase d activity (GO:0031584 from GO Biological Process Annotations)", "activation of plasma proteins involved in acute inflammatory response (GO:0002541 from GO Biological Process Annotations)", "activation of protein kinase a activity (GO:0034199 from GO Biological Process Annotations)", "activation of protein kinase activity (GO:0032147 from GO Biological Process Annotations)", "activation of protein kinase b activity (GO:0032148 from GO Biological Process Annotations)", "activation of signaling protein activity involved in unfolded protein response (GO:0006987 from GO Biological Process Annotations)", "activation of store-operated calcium channel activity (GO:0032237 from GO Biological Process Annotations)", "activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171 from GO Biological Process Annotations)", "activation-induced cell death of t cells (GO:0006924 from GO Biological Process Annotations)", "active induction of host immune response by virus (GO:0046732 from GO Biological Process Annotations)", "activin receptor signaling pathway (GO:0032924 from GO Biological Process Annotations)", "actomyosin contractile ring assembly (GO:0000915 from GO Biological Process Annotations)", "actomyosin contractile ring organization (GO:0044837 from GO Biological Process Annotations)", "actomyosin structure organization (GO:0031032 from GO Biological Process Annotations)", "acute inflammatory response (GO:0002526 from GO Biological Process Annotations)", "acute inflammatory response to antigenic stimulus (GO:0002438 from GO Biological Process Annotations)", "acute-phase response (GO:0006953 from GO Biological Process Annotations)", "acyl carnitine transmembrane transport (GO:1902616 from GO Biological Process Annotations)", "acyl carnitine transport (GO:0006844 from GO Biological Process Annotations)", "acyl-coa biosynthetic process (GO:0071616 from GO Biological Process Annotations)", "acyl-coa metabolic process (GO:0006637 from GO Biological Process Annotations)", "acylglycerol acyl-chain remodeling (GO:0036155 from GO Biological Process Annotations)", "acylglycerol biosynthetic process (GO:0046463 from GO Biological Process Annotations)", "acylglycerol catabolic process (GO:0046464 from GO Biological Process Annotations)", "acylglycerol homeostasis (GO:0055090 from GO Biological Process Annotations)", "acylglycerol metabolic process (GO:0006639 from GO Biological Process Annotations)", "acylglycerol transport (GO:0034196 from GO Biological Process Annotations)", "adaptation of rhodopsin mediated signaling (GO:0016062 from GO Biological Process Annotations)", "adaptation of signaling pathway (GO:0023058 from GO Biological Process Annotations)", "adaptive immune response (GO:0002250 from GO Biological Process Annotations)", "adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460 from GO Biological Process Annotations)", "adenine biosynthetic process (GO:0046084 from GO Biological Process Annotations)", "adenine metabolic process (GO:0046083 from GO Biological Process Annotations)", "adenine nucleotide transport (GO:0051503 from GO Biological Process Annotations)", "adenine salvage (GO:0006168 from GO Biological Process Annotations)", "adenine transport (GO:0015853 from GO Biological Process Annotations)", "adenohypophysis development (GO:0021984 from GO Biological Process Annotations)", "adenohypophysis morphogenesis (GO:0048855 from GO Biological Process Annotations)", "adenosine 3',5'-bisphosphate transmembrane transport (GO:0071106 from GO Biological Process Annotations)", "adenosine biosynthetic process (GO:0046086 from GO Biological Process Annotations)", "adenosine catabolic process (GO:0006154 from GO Biological Process Annotations)", "adenosine metabolic process (GO:0046085 from GO Biological Process Annotations)", "adenosine receptor signaling pathway (GO:0001973 from GO Biological Process Annotations)", "adenosine to inosine editing (GO:0006382 from GO Biological Process Annotations)", "adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880 from GO Biological Process Annotations)", "adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191 from GO Biological Process Annotations)", "adenylate cyclase-activating g-protein coupled receptor signaling pathway (GO:0007189 from GO Biological Process Annotations)", "adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071881 from GO Biological Process Annotations)", "adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195 from GO Biological Process Annotations)", "adenylate cyclase-inhibiting g-protein coupled acetylcholine receptor signaling pathway (GO:0007197 from GO Biological Process Annotations)", "adenylate cyclase-inhibiting g-protein coupled glutamate receptor signaling pathway (GO:0007196 from GO Biological Process Annotations)", "adenylate cyclase-inhibiting g-protein coupled receptor signaling pathway (GO:0007193 from GO Biological Process Annotations)", "adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:0031635 from GO Biological Process Annotations)", "adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198 from GO Biological Process Annotations)", "adenylate cyclase-modulating g-protein coupled receptor signaling pathway (GO:0007188 from GO Biological Process Annotations)", "adherens junction assembly (GO:0034333 from GO Biological Process Annotations)", "adherens junction maintenance (GO:0034334 from GO Biological Process Annotations)", "adherens junction organization (GO:0034332 from GO Biological Process Annotations)", "adhesion of symbiont to host (GO:0044406 from GO Biological Process Annotations)", "adhesion of symbiont to host cell (GO:0044650 from GO Biological Process Annotations)", "adiponectin-activated signaling pathway (GO:0033211 from GO Biological Process Annotations)", "adipose tissue development (GO:0060612 from GO Biological Process Annotations)", "adp biosynthetic process (GO:0006172 from GO Biological Process Annotations)", "adp catabolic process (GO:0046032 from GO Biological Process Annotations)", "adp metabolic process (GO:0046031 from GO Biological Process Annotations)", "adp phosphorylation (GO:0006757 from GO Biological Process Annotations)", "adp transport (GO:0015866 from GO Biological Process Annotations)", "adrenal chromaffin cell differentiation (GO:0061104 from GO Biological Process Annotations)", "adrenal cortex formation (GO:0035802 from GO Biological Process Annotations)", "adrenal gland development (GO:0030325 from GO Biological Process Annotations)", "adrenergic receptor signaling pathway (GO:0071875 from GO Biological Process Annotations)", "adrenergic receptor signaling pathway involved in heart process (GO:0086023 from GO Biological Process Annotations)", "adrenergic receptor signaling pathway involved in positive regulation of heart rate (GO:0086024 from GO Biological Process Annotations)", "adult behavior (GO:0030534 from GO Biological Process Annotations)", "adult feeding behavior (GO:0008343 from GO Biological Process Annotations)", "adult heart development (GO:0007512 from GO Biological Process Annotations)", "adult locomotory behavior (GO:0008344 from GO Biological Process Annotations)", "adult somatic muscle development (GO:0007527 from GO Biological Process Annotations)", "adult walking behavior (GO:0007628 from GO Biological Process Annotations)", "aerobic electron transport chain (GO:0019646 from GO Biological Process Annotations)", "aerobic respiration (GO:0009060 from GO Biological Process Annotations)", "aflatoxin b1 metabolic process (GO:0043390 from GO Biological Process Annotations)", "aflatoxin metabolic process (GO:0046222 from GO Biological Process Annotations)", "age-dependent response to oxidative stress (GO:0001306 from GO Biological Process Annotations)", "age-dependent response to reactive oxygen species (GO:0001315 from GO Biological Process Annotations)", "aggrephagy (GO:0035973 from GO Biological Process Annotations)", "aggresome assembly (GO:0070842 from GO Biological Process Annotations)", "aggressive behavior (GO:0002118 from GO Biological Process Annotations)", "aging (GO:0007568 from GO Biological Process Annotations)", "agmatine biosynthetic process (GO:0097055 from GO Biological Process Annotations)", "alanine catabolic process (GO:0006524 from GO Biological Process Annotations)", "alanine metabolic process (GO:0006522 from GO Biological Process Annotations)", "alanine transport (GO:0032328 from GO Biological Process Annotations)", "alanyl-trna aminoacylation (GO:0006419 from GO Biological Process Annotations)", "alcohol biosynthetic process (GO:0046165 from GO Biological Process Annotations)", "alcohol catabolic process (GO:0046164 from GO Biological Process Annotations)", "alcohol metabolic process (GO:0006066 from GO Biological Process Annotations)", "aldehyde biosynthetic process (GO:0046184 from GO Biological Process Annotations)", "aldehyde catabolic process (GO:0046185 from GO Biological Process Annotations)", "alditol biosynthetic process (GO:0019401 from GO Biological Process Annotations)", "alditol catabolic process (GO:0019405 from GO Biological Process Annotations)", "alditol metabolic process (GO:0019400 from GO Biological Process Annotations)", "alditol phosphate metabolic process (GO:0052646 from GO Biological Process Annotations)", "aldonic acid catabolic process (GO:0046176 from GO Biological Process Annotations)", "aldonic acid metabolic process (GO:0019520 from GO Biological Process Annotations)", "aldosterone biosynthetic process (GO:0032342 from GO Biological Process Annotations)", "aldosterone metabolic process (GO:0032341 from GO Biological Process Annotations)", "aldosterone secretion (GO:0035932 from GO Biological Process Annotations)", "alkaloid catabolic process (GO:0009822 from GO Biological Process Annotations)", "alkaloid metabolic process (GO:0009820 from GO Biological Process Annotations)", "alkanesulfonate metabolic process (GO:0019694 from GO Biological Process Annotations)", "allantoin biosynthetic process (GO:0019428 from GO Biological Process Annotations)", "allantoin catabolic process (GO:0000256 from GO Biological Process Annotations)", "allantoin metabolic process (GO:0000255 from GO Biological Process Annotations)", "alpha-amino acid biosynthetic process (GO:1901607 from GO Biological Process Annotations)", "alpha-amino acid catabolic process (GO:1901606 from GO Biological Process Annotations)", "alpha-amino acid metabolic process (GO:1901605 from GO Biological Process Annotations)", "alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor clustering (GO:0097113 from GO Biological Process Annotations)", "alpha-beta t cell activation (GO:0046631 from GO Biological Process Annotations)", "alpha-beta t cell activation involved in immune response (GO:0002287 from GO Biological Process Annotations)", "alpha-beta t cell differentiation (GO:0046632 from GO Biological Process Annotations)", "alpha-beta t cell differentiation involved in immune response (GO:0002293 from GO Biological Process Annotations)", "alpha-beta t cell lineage commitment (GO:0002363 from GO Biological Process Annotations)", "alpha-beta t cell proliferation (GO:0046633 from GO Biological Process Annotations)", "alpha-ketoglutarate transport (GO:0015742 from GO Biological Process Annotations)", "alpha-linolenic acid metabolic process (GO:0036109 from GO Biological Process Annotations)", "alpha-tubulin acetylation (GO:0071929 from GO Biological Process Annotations)", "alternative mrna splicing, via spliceosome (GO:0000380 from GO Biological Process Annotations)", "alveolar primary septum development (GO:0061143 from GO Biological Process Annotations)", "alveolar secondary septum development (GO:0061144 from GO Biological Process Annotations)", "amacrine cell differentiation (GO:0035881 from GO Biological Process Annotations)", "ameboidal-type cell migration (GO:0001667 from GO Biological Process Annotations)", "amelogenesis (GO:0097186 from GO Biological Process Annotations)", "amide biosynthetic process (GO:0043604 from GO Biological Process Annotations)", "amide transport (GO:0042886 from GO Biological Process Annotations)", "amine biosynthetic process (GO:0009309 from GO Biological Process Annotations)", "amine catabolic process (GO:0009310 from GO Biological Process Annotations)", "amine metabolic process (GO:0009308 from GO Biological Process Annotations)", "amine transport (GO:0015837 from GO Biological Process Annotations)", "amino acid activation (GO:0043038 from GO Biological Process Annotations)", "amino acid homeostasis (GO:0080144 from GO Biological Process Annotations)", "amino acid import (GO:0043090 from GO Biological Process Annotations)", "amino acid import across plasma membrane (GO:0089718 from GO Biological Process Annotations)", "amino acid import into cell (GO:1902837 from GO Biological Process Annotations)", "amino acid salvage (GO:0043102 from GO Biological Process Annotations)", "amino acid transmembrane transport (GO:0003333 from GO Biological Process Annotations)", "amino acid transport (GO:0006865 from GO Biological Process Annotations)", "amino acid uptake involved in synaptic transmission (GO:0051933 from GO Biological Process Annotations)", "amino sugar biosynthetic process (GO:0046349 from GO Biological Process Annotations)", "amino sugar catabolic process (GO:0046348 from GO Biological Process Annotations)", "amino sugar metabolic process (GO:0006040 from GO Biological Process Annotations)", "amino-acid betaine biosynthetic process (GO:0006578 from GO Biological Process Annotations)", "amino-acid betaine catabolic process (GO:0006579 from GO Biological Process Annotations)", "amino-acid betaine metabolic process (GO:0006577 from GO Biological Process Annotations)", "amino-acid betaine transport (GO:0015838 from GO Biological Process Annotations)", "aminoglycan biosynthetic process (GO:0006023 from GO Biological Process Annotations)", "aminoglycan catabolic process (GO:0006026 from GO Biological Process Annotations)", "aminoglycan metabolic process (GO:0006022 from GO Biological Process Annotations)", "aminoglycoside antibiotic metabolic process (GO:0030647 from GO Biological Process Annotations)", "aminophospholipid transport (GO:0015917 from GO Biological Process Annotations)", "ammon gyrus development (GO:0021541 from GO Biological Process Annotations)", "ammonia homeostasis (GO:0097272 from GO Biological Process Annotations)", "ammonium ion metabolic process (GO:0097164 from GO Biological Process Annotations)", "ammonium transmembrane transport (GO:0072488 from GO Biological Process Annotations)", "ammonium transport (GO:0015696 from GO Biological Process Annotations)", "amp biosynthetic process (GO:0006167 from GO Biological Process Annotations)", "amp catabolic process (GO:0006196 from GO Biological Process Annotations)", "amp metabolic process (GO:0046033 from GO Biological Process Annotations)", "amp phosphorylation (GO:0006756 from GO Biological Process Annotations)", "amp salvage (GO:0044209 from GO Biological Process Annotations)", "amp transport (GO:0080121 from GO Biological Process Annotations)", "amygdala development (GO:0021764 from GO Biological Process Annotations)", "amyloid fibril formation (GO:1990000 from GO Biological Process Annotations)", "amyloid precursor protein catabolic process (GO:0042987 from GO Biological Process Annotations)", "amyloid precursor protein metabolic process (GO:0042982 from GO Biological Process Annotations)", "amylopectin biosynthetic process (GO:0010021 from GO Biological Process Annotations)", "amylopectin metabolic process (GO:2000896 from GO Biological Process Annotations)", "anagen (GO:0042640 from GO Biological Process Annotations)", "anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031145 from GO Biological Process Annotations)", "anatomical structure arrangement (GO:0048532 from GO Biological Process Annotations)", "anatomical structure development (GO:0048856 from GO Biological Process Annotations)", "anatomical structure formation involved in morphogenesis (GO:0048646 from GO Biological Process Annotations)", "anatomical structure homeostasis (GO:0060249 from GO Biological Process Annotations)", "anatomical structure maturation (GO:0071695 from GO Biological Process Annotations)", "anatomical structure morphogenesis (GO:0009653 from GO Biological Process Annotations)", "anatomical structure regression (GO:0060033 from GO Biological Process Annotations)", "androgen biosynthetic process (GO:0006702 from GO Biological Process Annotations)", "androgen catabolic process (GO:0006710 from GO Biological Process Annotations)", "androgen metabolic process (GO:0008209 from GO Biological Process Annotations)", "androgen receptor signaling pathway (GO:0030521 from GO Biological Process Annotations)", "angiogenesis (GO:0001525 from GO Biological Process Annotations)", "angiogenesis involved in coronary vascular morphogenesis (GO:0060978 from GO Biological Process Annotations)", "angiogenesis involved in wound healing (GO:0060055 from GO Biological Process Annotations)", "angiotensin catabolic process in blood (GO:0002005 from GO Biological Process Annotations)", "angiotensin maturation (GO:0002003 from GO Biological Process Annotations)", "angiotensin mediated vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001998 from GO Biological Process Annotations)", "angiotensin-activated signaling pathway (GO:0038166 from GO Biological Process Annotations)", "angiotensin-activated signaling pathway involved in heart process (GO:0086098 from GO Biological Process Annotations)", "angiotensin-mediated drinking behavior (GO:0003051 from GO Biological Process Annotations)", "anion homeostasis (GO:0055081 from GO Biological Process Annotations)", "anion transmembrane transport (GO:0098656 from GO Biological Process Annotations)", "anion transport (GO:0006820 from GO Biological Process Annotations)", "anoikis (GO:0043276 from GO Biological Process Annotations)", "anterior commissure morphogenesis (GO:0021960 from GO Biological Process Annotations)", "anterior compartment pattern formation (GO:0007387 from GO Biological Process Annotations)", "anterior neuropore closure (GO:0021506 from GO Biological Process Annotations)", "anterior semicircular canal development (GO:0060873 from GO Biological Process Annotations)", "anterior|posterior axis specification (GO:0009948 from GO Biological Process Annotations)", "anterior|posterior axis specification, embryo (GO:0008595 from GO Biological Process Annotations)", "anterior|posterior axon guidance (GO:0033564 from GO Biological Process Annotations)", "anterior|posterior pattern specification (GO:0009952 from GO Biological Process Annotations)", "anterior|posterior pattern specification involved in kidney development (GO:0072098 from GO Biological Process Annotations)", "anterior|posterior pattern specification involved in ureteric bud development (GO:0072099 from GO Biological Process Annotations)", "anterograde axon cargo transport (GO:0008089 from GO Biological Process Annotations)", "anterograde synaptic vesicle transport (GO:0048490 from GO Biological Process Annotations)", "anthranilate metabolic process (GO:0043420 from GO Biological Process Annotations)", "anti-mullerian hormone signaling pathway (GO:1990262 from GO Biological Process Annotations)", "antibacterial humoral response (GO:0019731 from GO Biological Process Annotations)", "antibacterial peptide biosynthetic process (GO:0002780 from GO Biological Process Annotations)", "antibacterial peptide secretion (GO:0002779 from GO Biological Process Annotations)", "antibiotic metabolic process (GO:0016999 from GO Biological Process Annotations)", "antibiotic transport (GO:0042891 from GO Biological Process Annotations)", "antifungal humoral response (GO:0019732 from GO Biological Process Annotations)", "antigen processing and presentation (GO:0019882 from GO Biological Process Annotations)", "antigen processing and presentation of endogenous antigen (GO:0019883 from GO Biological Process Annotations)", "antigen processing and presentation of endogenous peptide antigen (GO:0002483 from GO Biological Process Annotations)", "antigen processing and presentation of endogenous peptide antigen via mhc class i (GO:0019885 from GO Biological Process Annotations)", "antigen processing and presentation of endogenous peptide antigen via mhc class i via er pathway (GO:0002484 from GO Biological Process Annotations)", "antigen processing and presentation of endogenous peptide antigen via mhc class i via er pathway, tap-dependent (GO:0002485 from GO Biological Process Annotations)", "antigen processing and presentation of endogenous peptide antigen via mhc class ib (GO:0002476 from GO Biological Process Annotations)", "antigen processing and presentation of endogenous peptide antigen via mhc class ib via er pathway (GO:0002488 from GO Biological Process Annotations)", "antigen processing and presentation of endogenous peptide antigen via mhc class ib via er pathway, tap-dependent (GO:0002489 from GO Biological Process Annotations)", "antigen processing and presentation of exogenous antigen (GO:0019884 from GO Biological Process Annotations)", "antigen processing and presentation of exogenous peptide antigen (GO:0002478 from GO Biological Process Annotations)", "antigen processing and presentation of exogenous peptide antigen via mhc class i (GO:0042590 from GO Biological Process Annotations)", "antigen processing and presentation of exogenous peptide antigen via mhc class i, tap-dependent (GO:0002479 from GO Biological Process Annotations)", "antigen processing and presentation of exogenous peptide antigen via mhc class i, tap-independent (GO:0002480 from GO Biological Process Annotations)", "antigen processing and presentation of exogenous peptide antigen via mhc class ib (GO:0002477 from GO Biological Process Annotations)", "antigen processing and presentation of exogenous peptide antigen via mhc class ii (GO:0019886 from GO Biological Process Annotations)", "antigen processing and presentation of exogenous protein antigen via mhc class ib, tap-dependent (GO:0002481 from GO Biological Process Annotations)", "antigen processing and presentation of lipid antigen via mhc class ib (GO:0048003 from GO Biological Process Annotations)", "antigen processing and presentation of peptide antigen (GO:0048002 from GO Biological Process Annotations)", "antigen processing and presentation of peptide antigen via mhc class i (GO:0002474 from GO Biological Process Annotations)", "antigen processing and presentation of peptide antigen via mhc class ib (GO:0002428 from GO Biological Process Annotations)", "antigen processing and presentation of peptide antigen via mhc class ii (GO:0002495 from GO Biological Process Annotations)", "antigen processing and presentation of peptide or polysaccharide antigen via mhc class ii (GO:0002504 from GO Biological Process Annotations)", "antigen processing and presentation via mhc class ib (GO:0002475 from GO Biological Process Annotations)", "antigen processing and presentation, endogenous lipid antigen via mhc class ib (GO:0048006 from GO Biological Process Annotations)", "antigen processing and presentation, exogenous lipid antigen via mhc class ib (GO:0048007 from GO Biological Process Annotations)", "antigen receptor-mediated signaling pathway (GO:0050851 from GO Biological Process Annotations)", "antigen transcytosis by m cells in mucosal-associated lymphoid tissue (GO:0002412 from GO Biological Process Annotations)", "antimicrobial humoral response (GO:0019730 from GO Biological Process Annotations)", "antimicrobial peptide biosynthetic process (GO:0002777 from GO Biological Process Annotations)", "antimicrobial peptide secretion (GO:0002776 from GO Biological Process Annotations)", "antral ovarian follicle growth (GO:0001547 from GO Biological Process Annotations)", "aorta development (GO:0035904 from GO Biological Process Annotations)", "aorta morphogenesis (GO:0035909 from GO Biological Process Annotations)", "aorta smooth muscle tissue morphogenesis (GO:0060414 from GO Biological Process Annotations)", "aortic smooth muscle cell differentiation (GO:0035887 from GO Biological Process Annotations)", "aortic valve morphogenesis (GO:0003180 from GO Biological Process Annotations)", "apical constriction (GO:0003383 from GO Biological Process Annotations)", "apical junction assembly (GO:0043297 from GO Biological Process Annotations)", "apical protein localization (GO:0045176 from GO Biological Process Annotations)", "apolipoprotein a-i-mediated signaling pathway (GO:0038027 from GO Biological Process Annotations)", "apoptotic cell clearance (GO:0043277 from GO Biological Process Annotations)", "apoptotic chromosome condensation (GO:0030263 from GO Biological Process Annotations)", "apoptotic dna fragmentation (GO:0006309 from GO Biological Process Annotations)", "apoptotic mitochondrial changes (GO:0008637 from GO Biological Process Annotations)", "apoptotic nuclear changes (GO:0030262 from GO Biological Process Annotations)", "apoptotic process (GO:0006915 from GO Biological Process Annotations)", "apoptotic process in bone marrow (GO:0071839 from GO Biological Process Annotations)", "apoptotic process involved in development (GO:1902742 from GO Biological Process Annotations)", "apoptotic process involved in embryonic digit morphogenesis (GO:1902263 from GO Biological Process Annotations)", "apoptotic process involved in heart morphogenesis (GO:0003278 from GO Biological Process Annotations)", "apoptotic process involved in luteolysis (GO:0061364 from GO Biological Process Annotations)", "apoptotic process involved in morphogenesis (GO:0060561 from GO Biological Process Annotations)", "apoptotic process involved in patterning of blood vessels (GO:1902262 from GO Biological Process Annotations)", "apoptotic signaling pathway (GO:0097190 from GO Biological Process Annotations)", "appendage development (GO:0048736 from GO Biological Process Annotations)", "appendage morphogenesis (GO:0035107 from GO Biological Process Annotations)", "arabinose metabolic process (GO:0019566 from GO Biological Process Annotations)", "arachidonic acid metabolic process (GO:0019369 from GO Biological Process Annotations)", "arachidonic acid metabolite production involved in inflammatory response (GO:0002538 from GO Biological Process Annotations)", "arachidonic acid secretion (GO:0050482 from GO Biological Process Annotations)", "archaeal or bacterial-type flagellum-dependent cell motility (GO:0097588 from GO Biological Process Annotations)", "arf protein signal transduction (GO:0032011 from GO Biological Process Annotations)", "arginine biosynthetic process (GO:0006526 from GO Biological Process Annotations)", "arginine biosynthetic process via ornithine (GO:0042450 from GO Biological Process Annotations)", "arginine catabolic process (GO:0006527 from GO Biological Process Annotations)", "arginine import (GO:0090467 from GO Biological Process Annotations)", "arginine metabolic process (GO:0006525 from GO Biological Process Annotations)", "arginine transmembrane transport (GO:1903826 from GO Biological Process Annotations)", "arginine transport (GO:0015809 from GO Biological Process Annotations)", "argininosuccinate metabolic process (GO:0000053 from GO Biological Process Annotations)", "arginyl-trna aminoacylation (GO:0006420 from GO Biological Process Annotations)", "aromatic amino acid family catabolic process (GO:0009074 from GO Biological Process Annotations)", "aromatic amino acid family metabolic process (GO:0009072 from GO Biological Process Annotations)", "aromatic amino acid transport (GO:0015801 from GO Biological Process Annotations)", "aromatic compound biosynthetic process (GO:0019438 from GO Biological Process Annotations)", "aromatic compound catabolic process (GO:0019439 from GO Biological Process Annotations)", "arp2|3 complex-mediated actin nucleation (GO:0034314 from GO Biological Process Annotations)", "arsenate ion transmembrane transport (GO:1901684 from GO Biological Process Annotations)", "arsonoacetate metabolic process (GO:0018872 from GO Biological Process Annotations)", "arterial endothelial cell differentiation (GO:0060842 from GO Biological Process Annotations)", "arterial endothelial cell fate commitment (GO:0060844 from GO Biological Process Annotations)", "artery development (GO:0060840 from GO Biological Process Annotations)", "artery morphogenesis (GO:0048844 from GO Biological Process Annotations)", "artery smooth muscle contraction (GO:0014824 from GO Biological Process Annotations)", "ascending aorta morphogenesis (GO:0035910 from GO Biological Process Annotations)", "ascending thin limb development (GO:0072021 from GO Biological Process Annotations)", "asparagine biosynthetic process (GO:0006529 from GO Biological Process Annotations)", "asparagine catabolic process (GO:0006530 from GO Biological Process Annotations)", "asparagine catabolic process via l-aspartate (GO:0033345 from GO Biological Process Annotations)", "asparagine metabolic process (GO:0006528 from GO Biological Process Annotations)", "asparagine transport (GO:0006867 from GO Biological Process Annotations)", "asparaginyl-trna aminoacylation (GO:0006421 from GO Biological Process Annotations)", "aspartate biosynthetic process (GO:0006532 from GO Biological Process Annotations)", "aspartate catabolic process (GO:0006533 from GO Biological Process Annotations)", "aspartate family amino acid biosynthetic process (GO:0009067 from GO Biological Process Annotations)", "aspartate family amino acid catabolic process (GO:0009068 from GO Biological Process Annotations)", "aspartate family amino acid metabolic process (GO:0009066 from GO Biological Process Annotations)", "aspartate metabolic process (GO:0006531 from GO Biological Process Annotations)", "aspartate transport (GO:0015810 from GO Biological Process Annotations)", "aspartyl-trna aminoacylation (GO:0006422 from GO Biological Process Annotations)", "assembly of actomyosin apparatus involved in cytokinesis (GO:0000912 from GO Biological Process Annotations)", "associative learning (GO:0008306 from GO Biological Process Annotations)", "astral microtubule organization (GO:0030953 from GO Biological Process Annotations)", "astrocyte activation (GO:0048143 from GO Biological Process Annotations)", "astrocyte cell migration (GO:0043615 from GO Biological Process Annotations)", "astrocyte development (GO:0014002 from GO Biological Process Annotations)", "astrocyte differentiation (GO:0048708 from GO Biological Process Annotations)", "astrocyte fate commitment (GO:0060018 from GO Biological Process Annotations)", "asymmetric cell division (GO:0008356 from GO Biological Process Annotations)", "asymmetric golgi ribbon formation (GO:0090164 from GO Biological Process Annotations)", "asymmetric protein localization (GO:0008105 from GO Biological Process Annotations)", "asymmetric stem cell division (GO:0098722 from GO Biological Process Annotations)", "atp biosynthetic process (GO:0006754 from GO Biological Process Annotations)", "atp hydrolysis coupled proton transport (GO:0015991 from GO Biological Process Annotations)", "atp metabolic process (GO:0046034 from GO Biological Process Annotations)", "atp synthesis coupled electron transport (GO:0042773 from GO Biological Process Annotations)", "atp synthesis coupled proton transport (GO:0015986 from GO Biological Process Annotations)", "atp transport (GO:0015867 from GO Biological Process Annotations)", "atp-dependent chromatin remodeling (GO:0043044 from GO Biological Process Annotations)", "atrial cardiac muscle cell action potential (GO:0086014 from GO Biological Process Annotations)", "atrial cardiac muscle cell development (GO:0055014 from GO Biological Process Annotations)", "atrial cardiac muscle cell to av node cell communication (GO:0086066 from GO Biological Process Annotations)", "atrial cardiac muscle tissue morphogenesis (GO:0055009 from GO Biological Process Annotations)", "atrial septum development (GO:0003283 from GO Biological Process Annotations)", "atrial septum morphogenesis (GO:0060413 from GO Biological Process Annotations)", "atrial septum primum morphogenesis (GO:0003289 from GO Biological Process Annotations)", "atrial septum secundum morphogenesis (GO:0003290 from GO Biological Process Annotations)", "atrial ventricular junction remodeling (GO:0003294 from GO Biological Process Annotations)", "atrioventricular bundle cell differentiation (GO:0003167 from GO Biological Process Annotations)", "atrioventricular canal development (GO:0036302 from GO Biological Process Annotations)", "atrioventricular node cell development (GO:0060928 from GO Biological Process Annotations)", "atrioventricular node cell fate commitment (GO:0060929 from GO Biological Process Annotations)", "atrioventricular node development (GO:0003162 from GO Biological Process Annotations)", "atrioventricular valve development (GO:0003171 from GO Biological Process Annotations)", "atrioventricular valve formation (GO:0003190 from GO Biological Process Annotations)", "atrioventricular valve morphogenesis (GO:0003181 from GO Biological Process Annotations)", "attachment of gpi anchor to protein (GO:0016255 from GO Biological Process Annotations)", "attachment of mitotic spindle microtubules to kinetochore (GO:0051315 from GO Biological Process Annotations)", "attachment of spindle microtubules to kinetochore (GO:0008608 from GO Biological Process Annotations)", "attachment of telomere to nuclear envelope (GO:0070197 from GO Biological Process Annotations)", "auditory behavior (GO:0031223 from GO Biological Process Annotations)", "auditory receptor cell development (GO:0060117 from GO Biological Process Annotations)", "auditory receptor cell differentiation (GO:0042491 from GO Biological Process Annotations)", "auditory receptor cell fate commitment (GO:0009912 from GO Biological Process Annotations)", "auditory receptor cell fate determination (GO:0042668 from GO Biological Process Annotations)", "auditory receptor cell fate specification (GO:0042667 from GO Biological Process Annotations)", "auditory receptor cell morphogenesis (GO:0002093 from GO Biological Process Annotations)", "auditory receptor cell stereocilium organization (GO:0060088 from GO Biological Process Annotations)", "autocrine signaling (GO:0035425 from GO Biological Process Annotations)", "autolysis (GO:0001896 from GO Biological Process Annotations)", "autonomic nervous system development (GO:0048483 from GO Biological Process Annotations)", "autophagic cell death (GO:0048102 from GO Biological Process Annotations)", "autophagic vacuole assembly (GO:0000045 from GO Biological Process Annotations)", "autophagic vacuole fusion (GO:0000046 from GO Biological Process Annotations)", "autophagic vacuole maturation (GO:0097352 from GO Biological Process Annotations)", "autophagy (GO:0006914 from GO Biological Process Annotations)", "autophagy in response to er overload (GO:0034263 from GO Biological Process Annotations)", "av node cell action potential (GO:0086016 from GO Biological Process Annotations)", "av node cell to bundle of his cell communication (GO:0086067 from GO Biological Process Annotations)", "av node cell to bundle of his cell communication by electrical coupling (GO:0086053 from GO Biological Process Annotations)", "avoidance of defenses of other organism involved in symbiotic interaction (GO:0051832 from GO Biological Process Annotations)", "avoidance of host defenses (GO:0044413 from GO Biological Process Annotations)", "axial mesoderm development (GO:0048318 from GO Biological Process Annotations)", "axial mesoderm formation (GO:0048320 from GO Biological Process Annotations)", "axial mesoderm morphogenesis (GO:0048319 from GO Biological Process Annotations)", "axial mesodermal cell fate specification (GO:0048327 from GO Biological Process Annotations)", "axis elongation (GO:0003401 from GO Biological Process Annotations)", "axis elongation involved in somitogenesis (GO:0090245 from GO Biological Process Annotations)", "axis specification (GO:0009798 from GO Biological Process Annotations)", "axon cargo transport (GO:0008088 from GO Biological Process Annotations)", "axon choice point recognition (GO:0016198 from GO Biological Process Annotations)", "axon development (GO:0061564 from GO Biological Process Annotations)", "axon ensheathment (GO:0008366 from GO Biological Process Annotations)", "axon ensheathment in central nervous system (GO:0032291 from GO Biological Process Annotations)", "axon extension (GO:0048675 from GO Biological Process Annotations)", "axon extension involved in axon guidance (GO:0048846 from GO Biological Process Annotations)", "axon extension involved in regeneration (GO:0048677 from GO Biological Process Annotations)", "axon guidance (GO:0007411 from GO Biological Process Annotations)", "axon midline choice point recognition (GO:0016199 from GO Biological Process Annotations)", "axon regeneration (GO:0031103 from GO Biological Process Annotations)", "axon target recognition (GO:0007412 from GO Biological Process Annotations)", "axon transport of mitochondrion (GO:0019896 from GO Biological Process Annotations)", "axonal fasciculation (GO:0007413 from GO Biological Process Annotations)", "axonemal dynein complex assembly (GO:0070286 from GO Biological Process Annotations)", "axonemal microtubule depolymerization (GO:0060404 from GO Biological Process Annotations)", "axoneme assembly (GO:0035082 from GO Biological Process Annotations)", "axonogenesis (GO:0007409 from GO Biological Process Annotations)", "axonogenesis involved in innervation (GO:0060385 from GO Biological Process Annotations)", "azole transport (GO:0045117 from GO Biological Process Annotations)", "b cell activation (GO:0042113 from GO Biological Process Annotations)", "b cell activation involved in immune response (GO:0002312 from GO Biological Process Annotations)", "b cell apoptotic process (GO:0001783 from GO Biological Process Annotations)", "b cell chemotaxis (GO:0035754 from GO Biological Process Annotations)", "b cell chemotaxis across high endothelial venule (GO:0035769 from GO Biological Process Annotations)", "b cell costimulation (GO:0031296 from GO Biological Process Annotations)", "b cell cytokine production (GO:0002368 from GO Biological Process Annotations)", "b cell differentiation (GO:0030183 from GO Biological Process Annotations)", "b cell homeostasis (GO:0001782 from GO Biological Process Annotations)", "b cell homeostatic proliferation (GO:0002358 from GO Biological Process Annotations)", "b cell lineage commitment (GO:0002326 from GO Biological Process Annotations)", "b cell mediated immunity (GO:0019724 from GO Biological Process Annotations)", "b cell negative selection (GO:0002352 from GO Biological Process Annotations)", "b cell proliferation (GO:0042100 from GO Biological Process Annotations)", "b cell proliferation involved in immune response (GO:0002322 from GO Biological Process Annotations)", "b cell receptor apoptotic signaling pathway (GO:1990117 from GO Biological Process Annotations)", "b cell receptor signaling pathway (GO:0050853 from GO Biological Process Annotations)", "b cell receptor transport into membrane raft (GO:0032597 from GO Biological Process Annotations)", "b cell receptor transport within lipid bilayer (GO:0032595 from GO Biological Process Annotations)", "b cell selection (GO:0002339 from GO Biological Process Annotations)", "b-1 b cell differentiation (GO:0001923 from GO Biological Process Annotations)", "b-1 b cell homeostasis (GO:0001922 from GO Biological Process Annotations)", "b-1a b cell differentiation (GO:0002337 from GO Biological Process Annotations)", "bacterial-type flagellum-dependent cell motility (GO:0071973 from GO Biological Process Annotations)", "barbed-end actin filament capping (GO:0051016 from GO Biological Process Annotations)", "barbed-end actin filament uncapping (GO:0051638 from GO Biological Process Annotations)", "barrier septum assembly (GO:0000917 from GO Biological Process Annotations)", "basal protein localization (GO:0045175 from GO Biological Process Annotations)", "base conversion or substitution editing (GO:0016553 from GO Biological Process Annotations)", "base-excision repair (GO:0006284 from GO Biological Process Annotations)", "base-excision repair, ap site formation (GO:0006285 from GO Biological Process Annotations)", "base-excision repair, dna ligation (GO:0006288 from GO Biological Process Annotations)", "base-excision repair, gap-filling (GO:0006287 from GO Biological Process Annotations)", "basement membrane assembly (GO:0070831 from GO Biological Process Annotations)", "basement membrane disassembly (GO:0034769 from GO Biological Process Annotations)", "basement membrane organization (GO:0071711 from GO Biological Process Annotations)", "basic amino acid transport (GO:0015802 from GO Biological Process Annotations)", "basolateral protein localization (GO:0061467 from GO Biological Process Annotations)", "basophil activation (GO:0045575 from GO Biological Process Annotations)", "basophil activation involved in immune response (GO:0002276 from GO Biological Process Annotations)", "basophil degranulation (GO:0002561 from GO Biological Process Annotations)", "basophil differentiation (GO:0030221 from GO Biological Process Annotations)", "behavior (GO:0007610 from GO Biological Process Annotations)", "behavioral defense response (GO:0002209 from GO Biological Process Annotations)", "behavioral fear response (GO:0001662 from GO Biological Process Annotations)", "behavioral response to cocaine (GO:0048148 from GO Biological Process Annotations)", "behavioral response to ethanol (GO:0048149 from GO Biological Process Annotations)", "behavioral response to nicotine (GO:0035095 from GO Biological Process Annotations)", "behavioral response to nutrient (GO:0051780 from GO Biological Process Annotations)", "behavioral response to pain (GO:0048266 from GO Biological Process Annotations)", "behavioral response to starvation (GO:0042595 from GO Biological Process Annotations)", "benzene-containing compound metabolic process (GO:0042537 from GO Biological Process Annotations)", "benzoate metabolic process (GO:0018874 from GO Biological Process Annotations)", "bergmann glial cell differentiation (GO:0060020 from GO Biological Process Annotations)", "beta selection (GO:0043366 from GO Biological Process Annotations)", "beta-alanine biosynthetic process (GO:0019483 from GO Biological Process Annotations)", "beta-alanine metabolic process (GO:0019482 from GO Biological Process Annotations)", "beta-amyloid clearance (GO:0097242 from GO Biological Process Annotations)", "beta-amyloid formation (GO:0034205 from GO Biological Process Annotations)", "beta-amyloid metabolic process (GO:0050435 from GO Biological Process Annotations)", "bicarbonate transport (GO:0015701 from GO Biological Process Annotations)", "bile acid and bile salt transport (GO:0015721 from GO Biological Process Annotations)", "bile acid biosynthetic process (GO:0006699 from GO Biological Process Annotations)", "bile acid catabolic process (GO:0030573 from GO Biological Process Annotations)", "bile acid conjugation (GO:0002152 from GO Biological Process Annotations)", "bile acid metabolic process (GO:0008206 from GO Biological Process Annotations)", "bile acid secretion (GO:0032782 from GO Biological Process Annotations)", "bile acid signaling pathway (GO:0038183 from GO Biological Process Annotations)", "bilirubin conjugation (GO:0006789 from GO Biological Process Annotations)", "binding of sperm to zona pellucida (GO:0007339 from GO Biological Process Annotations)", "biological adhesion (GO:0022610 from GO Biological Process Annotations)", "biological phase (GO:0044848 from GO Biological Process Annotations)", "biological regulation (GO:0065007 from GO Biological Process Annotations)", "biological_process (GO:0008150 from GO Biological Process Annotations)", "biomineral tissue development (GO:0031214 from GO Biological Process Annotations)", "biosynthetic process (GO:0009058 from GO Biological Process Annotations)", "biotin metabolic process (GO:0006768 from GO Biological Process Annotations)", "biotin transport (GO:0015878 from GO Biological Process Annotations)", "biphenyl catabolic process (GO:0070980 from GO Biological Process Annotations)", "biphenyl metabolic process (GO:0018879 from GO Biological Process Annotations)", "blastocyst development (GO:0001824 from GO Biological Process Annotations)", "blastocyst formation (GO:0001825 from GO Biological Process Annotations)", "blastocyst growth (GO:0001832 from GO Biological Process Annotations)", "blastocyst hatching (GO:0001835 from GO Biological Process Annotations)", "bleb assembly (GO:0032060 from GO Biological Process Annotations)", "blood circulation (GO:0008015 from GO Biological Process Annotations)", "blood coagulation (GO:0007596 from GO Biological Process Annotations)", "blood coagulation, common pathway (GO:0072377 from GO Biological Process Annotations)", "blood coagulation, extrinsic pathway (GO:0007598 from GO Biological Process Annotations)", "blood coagulation, intrinsic pathway (GO:0007597 from GO Biological Process Annotations)", "blood vessel development (GO:0001568 from GO Biological Process Annotations)", "blood vessel endothelial cell differentiation (GO:0060837 from GO Biological Process Annotations)", "blood vessel endothelial cell fate commitment (GO:0060846 from GO Biological Process Annotations)", "blood vessel endothelial cell fate specification (GO:0097101 from GO Biological Process Annotations)", "blood vessel endothelial cell migration (GO:0043534 from GO Biological Process Annotations)", "blood vessel endothelial cell migration involved in intussusceptive angiogenesis (GO:0002044 from GO Biological Process Annotations)", "blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043 from GO Biological Process Annotations)", "blood vessel lumenization (GO:0072554 from GO Biological Process Annotations)", "blood vessel maturation (GO:0001955 from GO Biological Process Annotations)", "blood vessel morphogenesis (GO:0048514 from GO Biological Process Annotations)", "blood vessel remodeling (GO:0001974 from GO Biological Process Annotations)", "blue light signaling pathway (GO:0009785 from GO Biological Process Annotations)", "bmp signaling pathway (GO:0030509 from GO Biological Process Annotations)", "bmp signaling pathway involved in heart development (GO:0061312 from GO Biological Process Annotations)", "bmp signaling pathway involved in heart induction (GO:0003130 from GO Biological Process Annotations)", "bmp signaling pathway involved in mesodermal cell fate specification (GO:0060803 from GO Biological Process Annotations)", "bmp signaling pathway involved in nephric duct formation (GO:0071893 from GO Biological Process Annotations)", "bmp signaling pathway involved in renal system segmentation (GO:0061151 from GO Biological Process Annotations)", "bmp signaling pathway involved in spinal cord dorsal|ventral patterning (GO:0021919 from GO Biological Process Annotations)", "bmp signaling pathway involved in ureter morphogenesis (GO:0061149 from GO Biological Process Annotations)", "body fluid secretion (GO:0007589 from GO Biological Process Annotations)", "body morphogenesis (GO:0010171 from GO Biological Process Annotations)", "bombesin receptor signaling pathway (GO:0031989 from GO Biological Process Annotations)", "bone cell development (GO:0098751 from GO Biological Process Annotations)", "bone development (GO:0060348 from GO Biological Process Annotations)", "bone marrow development (GO:0048539 from GO Biological Process Annotations)", "bone maturation (GO:0070977 from GO Biological Process Annotations)", "bone mineralization (GO:0030282 from GO Biological Process Annotations)", "bone mineralization involved in bone maturation (GO:0035630 from GO Biological Process Annotations)", "bone morphogenesis (GO:0060349 from GO Biological Process Annotations)", "bone remodeling (GO:0046849 from GO Biological Process Annotations)", "bone resorption (GO:0045453 from GO Biological Process Annotations)", "bone trabecula formation (GO:0060346 from GO Biological Process Annotations)", "bone trabecula morphogenesis (GO:0061430 from GO Biological Process Annotations)", "borate transmembrane transport (GO:0035445 from GO Biological Process Annotations)", "borate transport (GO:0046713 from GO Biological Process Annotations)", "box c|d snorna 3'-end processing (GO:0000494 from GO Biological Process Annotations)", "box c|d snorna metabolic process (GO:0033967 from GO Biological Process Annotations)", "box c|d snorna processing (GO:0034963 from GO Biological Process Annotations)", "box c|d snornp assembly (GO:0000492 from GO Biological Process Annotations)", "box h|aca snorna 3'-end processing (GO:0000495 from GO Biological Process Annotations)", "box h|aca snorna metabolic process (GO:0033979 from GO Biological Process Annotations)", "box h|aca snorna processing (GO:0034964 from GO Biological Process Annotations)", "bradykinin catabolic process (GO:0010815 from GO Biological Process Annotations)", "brain development (GO:0007420 from GO Biological Process Annotations)", "brain morphogenesis (GO:0048854 from GO Biological Process Annotations)", "brain renin-angiotensin system (GO:0002035 from GO Biological Process Annotations)", "brain segmentation (GO:0035284 from GO Biological Process Annotations)", "brain-derived neurotrophic factor receptor signaling pathway (GO:0031547 from GO Biological Process Annotations)", "brainstem development (GO:0003360 from GO Biological Process Annotations)", "branch elongation involved in mammary gland duct branching (GO:0060751 from GO Biological Process Annotations)", "branch elongation involved in salivary gland morphogenesis (GO:0060667 from GO Biological Process Annotations)", "branch elongation involved in ureteric bud branching (GO:0060681 from GO Biological Process Annotations)", "branch elongation of an epithelium (GO:0060602 from GO Biological Process Annotations)", "branched-chain amino acid biosynthetic process (GO:0009082 from GO Biological Process Annotations)", "branched-chain amino acid catabolic process (GO:0009083 from GO Biological Process Annotations)", "branched-chain amino acid metabolic process (GO:0009081 from GO Biological Process Annotations)", "branched-chain amino acid transport (GO:0015803 from GO Biological Process Annotations)", "branching involved in labyrinthine layer morphogenesis (GO:0060670 from GO Biological Process Annotations)", "branching involved in mammary gland duct morphogenesis (GO:0060444 from GO Biological Process Annotations)", "branching involved in open tracheal system development (GO:0060446 from GO Biological Process Annotations)", "branching involved in pancreas morphogenesis (GO:0061114 from GO Biological Process Annotations)", "branching involved in prostate gland morphogenesis (GO:0060442 from GO Biological Process Annotations)", "branching involved in salivary gland morphogenesis (GO:0060445 from GO Biological Process Annotations)", "branching involved in ureteric bud morphogenesis (GO:0001658 from GO Biological Process Annotations)", "branching morphogenesis of a nerve (GO:0048755 from GO Biological Process Annotations)", "branching morphogenesis of an epithelial tube (GO:0048754 from GO Biological Process Annotations)", "branchiomeric skeletal muscle development (GO:0014707 from GO Biological Process Annotations)", "branchiomotor neuron axon guidance (GO:0021785 from GO Biological Process Annotations)", "bronchiole development (GO:0060435 from GO Biological Process Annotations)", "bronchiole morphogenesis (GO:0060436 from GO Biological Process Annotations)", "bronchus development (GO:0060433 from GO Biological Process Annotations)", "bronchus morphogenesis (GO:0060434 from GO Biological Process Annotations)", "brown fat cell differentiation (GO:0050873 from GO Biological Process Annotations)", "bud dilation involved in lung branching (GO:0060503 from GO Biological Process Annotations)", "bud elongation involved in lung branching (GO:0060449 from GO Biological Process Annotations)", "bud outgrowth involved in lung branching (GO:0060447 from GO Biological Process Annotations)", "bundle of his cell action potential (GO:0086043 from GO Biological Process Annotations)", "bundle of his cell to purkinje myocyte communication (GO:0086069 from GO Biological Process Annotations)", "bundle of his cell to purkinje myocyte communication by electrical coupling (GO:0086054 from GO Biological Process Annotations)", "bundle of his cell-purkinje myocyte adhesion involved in cell communication (GO:0086073 from GO Biological Process Annotations)", "bundle of his development (GO:0003166 from GO Biological Process Annotations)", "butyrate catabolic process (GO:0046359 from GO Biological Process Annotations)", "butyrate metabolic process (GO:0019605 from GO Biological Process Annotations)", "c-5 methylation of cytosine (GO:0090116 from GO Biological Process Annotations)", "c-terminal protein amino acid modification (GO:0018410 from GO Biological Process Annotations)", "c-terminal protein deglutamylation (GO:0035609 from GO Biological Process Annotations)", "c-terminal protein lipidation (GO:0006501 from GO Biological Process Annotations)", "c-terminal protein methylation (GO:0006481 from GO Biological Process Annotations)", "c21-steroid hormone biosynthetic process (GO:0006700 from GO Biological Process Annotations)", "c21-steroid hormone metabolic process (GO:0008207 from GO Biological Process Annotations)", "c4-dicarboxylate transport (GO:0015740 from GO Biological Process Annotations)", "caax-box protein processing (GO:0071586 from GO Biological Process Annotations)", "cadmium ion homeostasis (GO:0055073 from GO Biological Process Annotations)", "cadmium ion transmembrane transport (GO:0070574 from GO Biological Process Annotations)", "cadmium ion transport (GO:0015691 from GO Biological Process Annotations)", "cajal body organization (GO:0030576 from GO Biological Process Annotations)", "cajal-retzius cell differentiation (GO:0021870 from GO Biological Process Annotations)", "calcineurin-nfat signaling cascade (GO:0033173 from GO Biological Process Annotations)", "calcitonin catabolic process (GO:0010816 from GO Biological Process Annotations)", "calcitriol biosynthetic process from calciol (GO:0036378 from GO Biological Process Annotations)", "calcium activated galactosylceramide scrambling (GO:0061591 from GO Biological Process Annotations)", "calcium activated phosphatidylcholine scrambling (GO:0061590 from GO Biological Process Annotations)", "calcium activated phosphatidylserine scrambling (GO:0061589 from GO Biological Process Annotations)", "calcium activated phospholipid scrambling (GO:0061588 from GO Biological Process Annotations)", "calcium ion export (GO:1901660 from GO Biological Process Annotations)", "calcium ion export from cell (GO:1990034 from GO Biological Process Annotations)", "calcium ion homeostasis (GO:0055074 from GO Biological Process Annotations)", "calcium ion import (GO:0070509 from GO Biological Process Annotations)", "calcium ion import across plasma membrane (GO:0098703 from GO Biological Process Annotations)", "calcium ion import into cell (GO:1990035 from GO Biological Process Annotations)", "calcium ion import into cytosol (GO:1902656 from GO Biological Process Annotations)", "calcium ion import into sarcoplasmic reticulum (GO:1990036 from GO Biological Process Annotations)", "calcium ion transmembrane import into cytosol (GO:0097553 from GO Biological Process Annotations)", "calcium ion transmembrane import into mitochondrion (GO:0036444 from GO Biological Process Annotations)", "calcium ion transmembrane transport (GO:0070588 from GO Biological Process Annotations)", "calcium ion transport (GO:0006816 from GO Biological Process Annotations)", "calcium ion transport from cytosol to endoplasmic reticulum (GO:1903515 from GO Biological Process Annotations)", "calcium ion transport from endoplasmic reticulum to cytosol (GO:1903514 from GO Biological Process Annotations)", "calcium ion transport into cytosol (GO:0060402 from GO Biological Process Annotations)", "calcium ion-dependent exocytosis (GO:0017156 from GO Biological Process Annotations)", "calcium ion-dependent exocytosis of neurotransmitter (GO:0048791 from GO Biological Process Annotations)", "calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339 from GO Biological Process Annotations)", "calcium-dependent cell-matrix adhesion (GO:0016340 from GO Biological Process Annotations)", "calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338 from GO Biological Process Annotations)", "calcium-independent cell-matrix adhesion (GO:0007161 from GO Biological Process Annotations)", "calcium-mediated signaling (GO:0019722 from GO Biological Process Annotations)", "calcium-mediated signaling using extracellular calcium source (GO:0035585 from GO Biological Process Annotations)", "calcium-mediated signaling using intracellular calcium source (GO:0035584 from GO Biological Process Annotations)", "camera-type eye development (GO:0043010 from GO Biological Process Annotations)", "camera-type eye morphogenesis (GO:0048593 from GO Biological Process Annotations)", "camera-type eye photoreceptor cell differentiation (GO:0060219 from GO Biological Process Annotations)", "camera-type eye photoreceptor cell fate commitment (GO:0060220 from GO Biological Process Annotations)", "camp biosynthetic process (GO:0006171 from GO Biological Process Annotations)", "camp catabolic process (GO:0006198 from GO Biological Process Annotations)", "camp metabolic process (GO:0046058 from GO Biological Process Annotations)", "camp-mediated signaling (GO:0019933 from GO Biological Process Annotations)", "canalicular bile acid transport (GO:0015722 from GO Biological Process Annotations)", "cannabinoid signaling pathway (GO:0038171 from GO Biological Process Annotations)", "canonical wnt signaling pathway (GO:0060070 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:0061317 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development (GO:0061310 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in heart development (GO:0061316 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in mesenchymal stem cell differentiation (GO:0044338 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in metanephric kidney development (GO:0061290 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in neural crest cell differentiation (GO:0044335 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in neural plate anterior|posterior pattern formation (GO:0060823 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in osteoblast differentiation (GO:0044339 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in positive regulation of apoptotic process (GO:0044337 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation (GO:0061324 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in positive regulation of cell-cell adhesion (GO:0044329 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in positive regulation of endothelial cell migration (GO:0044328 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition (GO:0044334 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in positive regulation of wound healing (GO:0044330 from GO Biological Process Annotations)", "canonical wnt signaling pathway involved in regulation of cell proliferation (GO:0044340 from GO Biological Process Annotations)", "cap mrna methylation (GO:0036451 from GO Biological Process Annotations)", "cap-independent translational initiation (GO:0002190 from GO Biological Process Annotations)", "cap1 mrna methylation (GO:0097309 from GO Biological Process Annotations)", "cap2 mrna methylation (GO:0097310 from GO Biological Process Annotations)", "carbamoyl phosphate biosynthetic process (GO:0070409 from GO Biological Process Annotations)", "carbamoyl phosphate metabolic process (GO:0070408 from GO Biological Process Annotations)", "carbohydrate biosynthetic process (GO:0016051 from GO Biological Process Annotations)", "carbohydrate catabolic process (GO:0016052 from GO Biological Process Annotations)", "carbohydrate derivative biosynthetic process (GO:1901137 from GO Biological Process Annotations)", "carbohydrate derivative catabolic process (GO:1901136 from GO Biological Process Annotations)", "carbohydrate derivative metabolic process (GO:1901135 from GO Biological Process Annotations)", "carbohydrate derivative transport (GO:1901264 from GO Biological Process Annotations)", "carbohydrate homeostasis (GO:0033500 from GO Biological Process Annotations)", "carbohydrate mediated signaling (GO:0009756 from GO Biological Process Annotations)", "carbohydrate metabolic process (GO:0005975 from GO Biological Process Annotations)", "carbohydrate phosphorylation (GO:0046835 from GO Biological Process Annotations)", "carbohydrate transmembrane transport (GO:0034219 from GO Biological Process Annotations)", "carbohydrate transport (GO:0008643 from GO Biological Process Annotations)", "carbon catabolite activation of transcription (GO:0045991 from GO Biological Process Annotations)", "carbon catabolite activation of transcription from rna polymerase ii promoter (GO:0000436 from GO Biological Process Annotations)", "carbon catabolite regulation of transcription (GO:0045990 from GO Biological Process Annotations)", "carbon catabolite regulation of transcription from rna polymerase ii promoter (GO:0000429 from GO Biological Process Annotations)", "carbon catabolite repression of transcription (GO:0045013 from GO Biological Process Annotations)", "carbon catabolite repression of transcription from rna polymerase ii promoter (GO:0000437 from GO Biological Process Annotations)", "carbon dioxide transmembrane transport (GO:0035378 from GO Biological Process Annotations)", "carbon dioxide transport (GO:0015670 from GO Biological Process Annotations)", "carboxylic acid biosynthetic process (GO:0046394 from GO Biological Process Annotations)", "carboxylic acid catabolic process (GO:0046395 from GO Biological Process Annotations)", "carboxylic acid metabolic process (GO:0019752 from GO Biological Process Annotations)", "carboxylic acid transport (GO:0046942 from GO Biological Process Annotations)", "cardiac atrium formation (GO:0003210 from GO Biological Process Annotations)", "cardiac atrium morphogenesis (GO:0003209 from GO Biological Process Annotations)", "cardiac cell development (GO:0055006 from GO Biological Process Annotations)", "cardiac cell fate commitment (GO:0060911 from GO Biological Process Annotations)", "cardiac cell fate determination (GO:0060913 from GO Biological Process Annotations)", "cardiac cell fate specification (GO:0060912 from GO Biological Process Annotations)", "cardiac chamber development (GO:0003205 from GO Biological Process Annotations)", "cardiac chamber formation (GO:0003207 from GO Biological Process Annotations)", "cardiac chamber morphogenesis (GO:0003206 from GO Biological Process Annotations)", "cardiac conduction (GO:0061337 from GO Biological Process Annotations)", "cardiac conduction system development (GO:0003161 from GO Biological Process Annotations)", "cardiac endothelial cell differentiation (GO:0003348 from GO Biological Process Annotations)", "cardiac epithelial to mesenchymal transition (GO:0060317 from GO Biological Process Annotations)", "cardiac left ventricle formation (GO:0003218 from GO Biological Process Annotations)", "cardiac left ventricle morphogenesis (GO:0003214 from GO Biological Process Annotations)", "cardiac muscle adaptation (GO:0014887 from GO Biological Process Annotations)", "cardiac muscle cell action potential (GO:0086001 from GO Biological Process Annotations)", "cardiac muscle cell action potential involved in contraction (GO:0086002 from GO Biological Process Annotations)", "cardiac muscle cell apoptotic process (GO:0010659 from GO Biological Process Annotations)", "cardiac muscle cell contraction (GO:0086003 from GO Biological Process Annotations)", "cardiac muscle cell development (GO:0055013 from GO Biological Process Annotations)", "cardiac muscle cell differentiation (GO:0055007 from GO Biological Process Annotations)", "cardiac muscle cell fate commitment (GO:0060923 from GO Biological Process Annotations)", "cardiac muscle cell myoblast differentiation (GO:0060379 from GO Biological Process Annotations)", "cardiac muscle cell proliferation (GO:0060038 from GO Biological Process Annotations)", "cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042 from GO Biological Process Annotations)", "cardiac muscle contraction (GO:0060048 from GO Biological Process Annotations)", "cardiac muscle fiber development (GO:0048739 from GO Biological Process Annotations)", "cardiac muscle hypertrophy (GO:0003300 from GO Biological Process Annotations)", "cardiac muscle hypertrophy in response to stress (GO:0014898 from GO Biological Process Annotations)", "cardiac muscle thin filament assembly (GO:0071691 from GO Biological Process Annotations)", "cardiac muscle tissue development (GO:0048738 from GO Biological Process Annotations)", "cardiac muscle tissue growth (GO:0055017 from GO Biological Process Annotations)", "cardiac muscle tissue growth involved in heart morphogenesis (GO:0003245 from GO Biological Process Annotations)", "cardiac muscle tissue morphogenesis (GO:0055008 from GO Biological Process Annotations)", "cardiac muscle tissue regeneration (GO:0061026 from GO Biological Process Annotations)", "cardiac myofibril assembly (GO:0055003 from GO Biological Process Annotations)", "cardiac neural crest cell development involved in heart development (GO:0061308 from GO Biological Process Annotations)", "cardiac neural crest cell development involved in outflow tract morphogenesis (GO:0061309 from GO Biological Process Annotations)", "cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:0003253 from GO Biological Process Annotations)", "cardiac pacemaker cell development (GO:0060926 from GO Biological Process Annotations)", "cardiac pacemaker cell differentiation (GO:0060920 from GO Biological Process Annotations)", "cardiac pacemaker cell fate commitment (GO:0060927 from GO Biological Process Annotations)", "cardiac right atrium morphogenesis (GO:0003213 from GO Biological Process Annotations)", "cardiac right ventricle formation (GO:0003219 from GO Biological Process Annotations)", "cardiac right ventricle morphogenesis (GO:0003215 from GO Biological Process Annotations)", "cardiac septum development (GO:0003279 from GO Biological Process Annotations)", "cardiac septum morphogenesis (GO:0060411 from GO Biological Process Annotations)", "cardiac vascular smooth muscle cell development (GO:0060948 from GO Biological Process Annotations)", "cardiac vascular smooth muscle cell differentiation (GO:0060947 from GO Biological Process Annotations)", "cardiac ventricle development (GO:0003231 from GO Biological Process Annotations)", "cardiac ventricle formation (GO:0003211 from GO Biological Process Annotations)", "cardiac ventricle morphogenesis (GO:0003208 from GO Biological Process Annotations)", "cardioblast anterior-lateral migration (GO:0003259 from GO Biological Process Annotations)", "cardioblast differentiation (GO:0010002 from GO Biological Process Annotations)", "cardioblast migration (GO:0003260 from GO Biological Process Annotations)", "cardioblast migration to the midline involved in heart field formation (GO:0060975 from GO Biological Process Annotations)", "cardiocyte differentiation (GO:0035051 from GO Biological Process Annotations)", "cardiogenic plate morphogenesis (GO:0003142 from GO Biological Process Annotations)", "cardiolipin acyl-chain remodeling (GO:0035965 from GO Biological Process Annotations)", "cardiolipin biosynthetic process (GO:0032049 from GO Biological Process Annotations)", "cardiolipin metabolic process (GO:0032048 from GO Biological Process Annotations)", "cardiovascular system development (GO:0072358 from GO Biological Process Annotations)", "cargo loading into copii-coated vesicle (GO:0090110 from GO Biological Process Annotations)", "cargo loading into vesicle (GO:0035459 from GO Biological Process Annotations)", "carnitine biosynthetic process (GO:0045329 from GO Biological Process Annotations)", "carnitine catabolic process (GO:0042413 from GO Biological Process Annotations)", "carnitine metabolic process (GO:0009437 from GO Biological Process Annotations)", "carnitine metabolic process, coa-linked (GO:0019254 from GO Biological Process Annotations)", "carnitine shuttle (GO:0006853 from GO Biological Process Annotations)", "carnitine transmembrane transport (GO:1902603 from GO Biological Process Annotations)", "carnitine transport (GO:0015879 from GO Biological Process Annotations)", "carnosine biosynthetic process (GO:0035499 from GO Biological Process Annotations)", "carnosine metabolic process (GO:0035498 from GO Biological Process Annotations)", "carotene catabolic process (GO:0016121 from GO Biological Process Annotations)", "carotene metabolic process (GO:0016119 from GO Biological Process Annotations)", "carotenoid metabolic process (GO:0016116 from GO Biological Process Annotations)", "carotid body glomus cell differentiation (GO:0061103 from GO Biological Process Annotations)", "cartilage condensation (GO:0001502 from GO Biological Process Annotations)", "cartilage development (GO:0051216 from GO Biological Process Annotations)", "cartilage development involved in endochondral bone morphogenesis (GO:0060351 from GO Biological Process Annotations)", "cartilage homeostasis (GO:1990079 from GO Biological Process Annotations)", "cartilage morphogenesis (GO:0060536 from GO Biological Process Annotations)", "catabolic process (GO:0009056 from GO Biological Process Annotations)", "catagen (GO:0042637 from GO Biological Process Annotations)", "catechol-containing compound biosynthetic process (GO:0009713 from GO Biological Process Annotations)", "catechol-containing compound catabolic process (GO:0019614 from GO Biological Process Annotations)", "catechol-containing compound metabolic process (GO:0009712 from GO Biological Process Annotations)", "catecholamine biosynthetic process (GO:0042423 from GO Biological Process Annotations)", "catecholamine catabolic process (GO:0042424 from GO Biological Process Annotations)", "catecholamine metabolic process (GO:0006584 from GO Biological Process Annotations)", "catecholamine secretion (GO:0050432 from GO Biological Process Annotations)", "catecholamine transport (GO:0051937 from GO Biological Process Annotations)", "catecholamine uptake (GO:0090493 from GO Biological Process Annotations)", "catecholamine uptake involved in synaptic transmission (GO:0051934 from GO Biological Process Annotations)", "catenin import into nucleus (GO:0035411 from GO Biological Process Annotations)", "cation homeostasis (GO:0055080 from GO Biological Process Annotations)", "cation transmembrane transport (GO:0098655 from GO Biological Process Annotations)", "cation transport (GO:0006812 from GO Biological Process Annotations)", "caudate nucleus development (GO:0021757 from GO Biological Process Annotations)", "caveola assembly (GO:0070836 from GO Biological Process Annotations)", "caveolin-mediated endocytosis (GO:0072584 from GO Biological Process Annotations)", "cd4-positive or cd8-positive, alpha-beta t cell lineage commitment (GO:0043369 from GO Biological Process Annotations)", "cd4-positive, alpha-beta t cell activation (GO:0035710 from GO Biological Process Annotations)", "cd4-positive, alpha-beta t cell costimulation (GO:0035783 from GO Biological Process Annotations)", "cd4-positive, alpha-beta t cell cytokine production (GO:0035743 from GO Biological Process Annotations)", "cd4-positive, alpha-beta t cell differentiation (GO:0043367 from GO Biological Process Annotations)", "cd4-positive, alpha-beta t cell differentiation involved in immune response (GO:0002294 from GO Biological Process Annotations)", "cd4-positive, alpha-beta t cell lineage commitment (GO:0043373 from GO Biological Process Annotations)", "cd4-positive, cd25-positive, alpha-beta regulatory t cell differentiation (GO:0002361 from GO Biological Process Annotations)", "cd4-positive, cd25-positive, alpha-beta regulatory t cell lineage commitment (GO:0002362 from GO Biological Process Annotations)", "cd40 signaling pathway (GO:0023035 from GO Biological Process Annotations)", "cd8-positive, alpha-beta t cell activation (GO:0036037 from GO Biological Process Annotations)", "cd8-positive, alpha-beta t cell differentiation (GO:0043374 from GO Biological Process Annotations)", "cd8-positive, alpha-beta t cell differentiation involved in immune response (GO:0002302 from GO Biological Process Annotations)", "cd8-positive, alpha-beta t cell lineage commitment (GO:0043375 from GO Biological Process Annotations)", "cdp biosynthetic process (GO:0046705 from GO Biological Process Annotations)", "cdp metabolic process (GO:0046704 from GO Biological Process Annotations)", "cdp phosphorylation (GO:0061508 from GO Biological Process Annotations)", "cdp-choline pathway (GO:0006657 from GO Biological Process Annotations)", "cdp-diacylglycerol biosynthetic process (GO:0016024 from GO Biological Process Annotations)", "cdp-diacylglycerol metabolic process (GO:0046341 from GO Biological Process Annotations)", "cell activation (GO:0001775 from GO Biological Process Annotations)", "cell activation involved in immune response (GO:0002263 from GO Biological Process Annotations)", "cell adhesion (GO:0007155 from GO Biological Process Annotations)", "cell adhesion mediated by integrin (GO:0033627 from GO Biological Process Annotations)", "cell adhesion molecule production (GO:0060352 from GO Biological Process Annotations)", "cell aggregation (GO:0098743 from GO Biological Process Annotations)", "cell aging (GO:0007569 from GO Biological Process Annotations)", "cell chemotaxis (GO:0060326 from GO Biological Process Annotations)", "cell chemotaxis to fibroblast growth factor (GO:0035766 from GO Biological Process Annotations)", "cell communication (GO:0007154 from GO Biological Process Annotations)", "cell communication by chemical coupling (GO:0010643 from GO Biological Process Annotations)", "cell communication by electrical coupling (GO:0010644 from GO Biological Process Annotations)", "cell communication by electrical coupling involved in cardiac conduction (GO:0086064 from GO Biological Process Annotations)", "cell communication involved in cardiac conduction (GO:0086065 from GO Biological Process Annotations)", "cell competition in a multicellular organism (GO:0035212 from GO Biological Process Annotations)", "cell cycle (GO:0007049 from GO Biological Process Annotations)", "cell cycle arrest (GO:0007050 from GO Biological Process Annotations)", "cell cycle checkpoint (GO:0000075 from GO Biological Process Annotations)", "cell cycle comprising mitosis without cytokinesis (GO:0033301 from GO Biological Process Annotations)", "cell cycle dna replication (GO:0044786 from GO Biological Process Annotations)", "cell cycle g1|s phase transition (GO:0044843 from GO Biological Process Annotations)", "cell cycle g2|m phase transition (GO:0044839 from GO Biological Process Annotations)", "cell cycle phase transition (GO:0044770 from GO Biological Process Annotations)", "cell cycle process (GO:0022402 from GO Biological Process Annotations)", "cell cycle switching (GO:0060184 from GO Biological Process Annotations)", "cell cycle switching, mitotic to meiotic cell cycle (GO:0051728 from GO Biological Process Annotations)", "cell death (GO:0008219 from GO Biological Process Annotations)", "cell dedifferentiation (GO:0043697 from GO Biological Process Annotations)", "cell development (GO:0048468 from GO Biological Process Annotations)", "cell differentiation (GO:0030154 from GO Biological Process Annotations)", "cell differentiation in hindbrain (GO:0021533 from GO Biological Process Annotations)", "cell differentiation in spinal cord (GO:0021515 from GO Biological Process Annotations)", "cell differentiation involved in embryonic placenta development (GO:0060706 from GO Biological Process Annotations)", "cell differentiation involved in kidney development (GO:0061005 from GO Biological Process Annotations)", "cell differentiation involved in metanephros development (GO:0072202 from GO Biological Process Annotations)", "cell differentiation involved in salivary gland development (GO:0060689 from GO Biological Process Annotations)", "cell division (GO:0051301 from GO Biological Process Annotations)", "cell envelope organization (GO:0043163 from GO Biological Process Annotations)", "cell fate commitment (GO:0045165 from GO Biological Process Annotations)", "cell fate commitment involved in formation of primary germ layer (GO:0060795 from GO Biological Process Annotations)", "cell fate commitment involved in pattern specification (GO:0060581 from GO Biological Process Annotations)", "cell fate determination (GO:0001709 from GO Biological Process Annotations)", "cell fate determination involved in pattern specification (GO:0060582 from GO Biological Process Annotations)", "cell fate specification (GO:0001708 from GO Biological Process Annotations)", "cell fate specification involved in pattern specification (GO:0060573 from GO Biological Process Annotations)", "cell gliding (GO:0071976 from GO Biological Process Annotations)", "cell growth (GO:0016049 from GO Biological Process Annotations)", "cell growth involved in cardiac muscle cell development (GO:0061049 from GO Biological Process Annotations)", "cell junction assembly (GO:0034329 from GO Biological Process Annotations)", "cell junction maintenance (GO:0034331 from GO Biological Process Annotations)", "cell junction organization (GO:0034330 from GO Biological Process Annotations)", "cell killing (GO:0001906 from GO Biological Process Annotations)", "cell maturation (GO:0048469 from GO Biological Process Annotations)", "cell migration (GO:0016477 from GO Biological Process Annotations)", "cell migration in diencephalon (GO:0061381 from GO Biological Process Annotations)", "cell migration in hindbrain (GO:0021535 from GO Biological Process Annotations)", "cell migration involved in coronary angiogenesis (GO:0060981 from GO Biological Process Annotations)", "cell migration involved in coronary vasculogenesis (GO:0060980 from GO Biological Process Annotations)", "cell migration involved in endocardial cushion formation (GO:0003273 from GO Biological Process Annotations)", "cell migration involved in gastrulation (GO:0042074 from GO Biological Process Annotations)", "cell migration involved in heart development (GO:0060973 from GO Biological Process Annotations)", "cell migration involved in heart formation (GO:0060974 from GO Biological Process Annotations)", "cell migration involved in kidney development (GO:0035787 from GO Biological Process Annotations)", "cell migration involved in mesendoderm migration (GO:0090134 from GO Biological Process Annotations)", "cell migration involved in metanephros development (GO:0035788 from GO Biological Process Annotations)", "cell migration involved in sprouting angiogenesis (GO:0002042 from GO Biological Process Annotations)", "cell migration involved in vasculogenesis (GO:0035441 from GO Biological Process Annotations)", "cell migration to the midline involved in heart development (GO:0003318 from GO Biological Process Annotations)", "cell morphogenesis (GO:0000902 from GO Biological Process Annotations)", "cell morphogenesis involved in differentiation (GO:0000904 from GO Biological Process Annotations)", "cell morphogenesis involved in neuron differentiation (GO:0048667 from GO Biological Process Annotations)", "cell motility (GO:0048870 from GO Biological Process Annotations)", "cell motility involved in cerebral cortex radial glia guided migration (GO:0021814 from GO Biological Process Annotations)", "cell part morphogenesis (GO:0032990 from GO Biological Process Annotations)", "cell projection assembly (GO:0030031 from GO Biological Process Annotations)", "cell projection morphogenesis (GO:0048858 from GO Biological Process Annotations)", "cell projection organization (GO:0030030 from GO Biological Process Annotations)", "cell proliferation (GO:0008283 from GO Biological Process Annotations)", "cell proliferation in bone marrow (GO:0071838 from GO Biological Process Annotations)", "cell proliferation in external granule layer (GO:0021924 from GO Biological Process Annotations)", "cell proliferation in forebrain (GO:0021846 from GO Biological Process Annotations)", "cell proliferation in hindbrain (GO:0021534 from GO Biological Process Annotations)", "cell proliferation in midbrain (GO:0033278 from GO Biological Process Annotations)", "cell proliferation involved in heart morphogenesis (GO:0061323 from GO Biological Process Annotations)", "cell proliferation involved in heart valve development (GO:2000793 from GO Biological Process Annotations)", "cell proliferation involved in kidney development (GO:0072111 from GO Biological Process Annotations)", "cell proliferation involved in mesonephros development (GO:0061209 from GO Biological Process Annotations)", "cell proliferation involved in metanephros development (GO:0072203 from GO Biological Process Annotations)", "cell proliferation involved in outflow tract morphogenesis (GO:0061325 from GO Biological Process Annotations)", "cell recognition (GO:0008037 from GO Biological Process Annotations)", "cell redox homeostasis (GO:0045454 from GO Biological Process Annotations)", "cell separation after cytokinesis (GO:0000920 from GO Biological Process Annotations)", "cell septum assembly (GO:0090529 from GO Biological Process Annotations)", "cell surface bile acid receptor signaling pathway (GO:0038184 from GO Biological Process Annotations)", "cell surface pattern recognition receptor signaling pathway (GO:0002752 from GO Biological Process Annotations)", "cell surface receptor signaling pathway (GO:0007166 from GO Biological Process Annotations)", "cell surface receptor signaling pathway involved in heart development (GO:0061311 from GO Biological Process Annotations)", "cell volume homeostasis (GO:0006884 from GO Biological Process Annotations)", "cell wall chitin metabolic process (GO:0006037 from GO Biological Process Annotations)", "cell wall macromolecule catabolic process (GO:0016998 from GO Biological Process Annotations)", "cell wall macromolecule metabolic process (GO:0044036 from GO Biological Process Annotations)", "cell wall polysaccharide metabolic process (GO:0010383 from GO Biological Process Annotations)", "cell-cell adhesion (GO:0098609 from GO Biological Process Annotations)", "cell-cell adhesion involved in gastrulation (GO:0070586 from GO Biological Process Annotations)", "cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration (GO:0021813 from GO Biological Process Annotations)", "cell-cell adhesion mediated by cadherin (GO:0044331 from GO Biological Process Annotations)", "cell-cell adhesion mediated by integrin (GO:0033631 from GO Biological Process Annotations)", "cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742 from GO Biological Process Annotations)", "cell-cell junction assembly (GO:0007043 from GO Biological Process Annotations)", "cell-cell junction maintenance (GO:0045217 from GO Biological Process Annotations)", "cell-cell junction organization (GO:0045216 from GO Biological Process Annotations)", "cell-cell recognition (GO:0009988 from GO Biological Process Annotations)", "cell-cell signaling (GO:0007267 from GO Biological Process Annotations)", "cell-cell signaling involved in cardiac conduction (GO:0086019 from GO Biological Process Annotations)", "cell-cell signaling involved in cell fate commitment (GO:0045168 from GO Biological Process Annotations)", "cell-cell signaling involved in cell-cell junction organization (GO:1901350 from GO Biological Process Annotations)", "cell-cell signaling involved in kidney development (GO:0060995 from GO Biological Process Annotations)", "cell-cell signaling involved in lung development (GO:0060495 from GO Biological Process Annotations)", "cell-cell signaling involved in mammary gland development (GO:0060764 from GO Biological Process Annotations)", "cell-cell signaling involved in metanephros development (GO:0072204 from GO Biological Process Annotations)", "cell-matrix adhesion (GO:0007160 from GO Biological Process Annotations)", "cell-matrix adhesion involved in ameboidal cell migration (GO:0003366 from GO Biological Process Annotations)", "cell-substrate adherens junction assembly (GO:0007045 from GO Biological Process Annotations)", "cell-substrate adhesion (GO:0031589 from GO Biological Process Annotations)", "cell-substrate junction assembly (GO:0007044 from GO Biological Process Annotations)", "cell-type specific apoptotic process (GO:0097285 from GO Biological Process Annotations)", "cellular alcohol biosynthetic process (GO:0044108 from GO Biological Process Annotations)", "cellular alcohol metabolic process (GO:0044107 from GO Biological Process Annotations)", "cellular aldehyde metabolic process (GO:0006081 from GO Biological Process Annotations)", "cellular alkene metabolic process (GO:0043449 from GO Biological Process Annotations)", "cellular amide catabolic process (GO:0043605 from GO Biological Process Annotations)", "cellular amide metabolic process (GO:0043603 from GO Biological Process Annotations)", "cellular amine metabolic process (GO:0044106 from GO Biological Process Annotations)", "cellular amino acid biosynthetic process (GO:0008652 from GO Biological Process Annotations)", "cellular amino acid catabolic process (GO:0009063 from GO Biological Process Annotations)", "cellular amino acid metabolic process (GO:0006520 from GO Biological Process Annotations)", "cellular ammonia homeostasis (GO:0097275 from GO Biological Process Annotations)", "cellular anion homeostasis (GO:0030002 from GO Biological Process Annotations)", "cellular aromatic compound metabolic process (GO:0006725 from GO Biological Process Annotations)", "cellular biogenic amine biosynthetic process (GO:0042401 from GO Biological Process Annotations)", "cellular biogenic amine catabolic process (GO:0042402 from GO Biological Process Annotations)", "cellular biogenic amine metabolic process (GO:0006576 from GO Biological Process Annotations)", "cellular biosynthetic process (GO:0044249 from GO Biological Process Annotations)", "cellular cadmium ion homeostasis (GO:0006876 from GO Biological Process Annotations)", "cellular calcium ion homeostasis (GO:0006874 from GO Biological Process Annotations)", "cellular carbohydrate biosynthetic process (GO:0034637 from GO Biological Process Annotations)", "cellular carbohydrate catabolic process (GO:0044275 from GO Biological Process Annotations)", "cellular carbohydrate metabolic process (GO:0044262 from GO Biological Process Annotations)", "cellular catabolic process (GO:0044248 from GO Biological Process Annotations)", "cellular cation homeostasis (GO:0030003 from GO Biological Process Annotations)", "cellular chemical homeostasis (GO:0055082 from GO Biological Process Annotations)", "cellular chloride ion homeostasis (GO:0030644 from GO Biological Process Annotations)", "cellular component assembly (GO:0022607 from GO Biological Process Annotations)", "cellular component assembly involved in morphogenesis (GO:0010927 from GO Biological Process Annotations)", "cellular component biogenesis (GO:0044085 from GO Biological Process Annotations)", "cellular component disassembly (GO:0022411 from GO Biological Process Annotations)", "cellular component disassembly involved in execution phase of apoptosis (GO:0006921 from GO Biological Process Annotations)", "cellular component maintenance (GO:0043954 from GO Biological Process Annotations)", "cellular component morphogenesis (GO:0032989 from GO Biological Process Annotations)", "cellular component organization (GO:0016043 from GO Biological Process Annotations)", "cellular component organization or biogenesis (GO:0071840 from GO Biological Process Annotations)", "cellular copper ion homeostasis (GO:0006878 from GO Biological Process Annotations)", "cellular creatinine homeostasis (GO:0097276 from GO Biological Process Annotations)", "cellular defense response (GO:0006968 from GO Biological Process Annotations)", "cellular detoxification of nitrogen compound (GO:0070458 from GO Biological Process Annotations)", "cellular developmental process (GO:0048869 from GO Biological Process Annotations)", "cellular divalent inorganic anion homeostasis (GO:0072501 from GO Biological Process Annotations)", "cellular divalent inorganic cation homeostasis (GO:0072503 from GO Biological Process Annotations)", "cellular extravasation (GO:0045123 from GO Biological Process Annotations)", "cellular glucan metabolic process (GO:0006073 from GO Biological Process Annotations)", "cellular glucose homeostasis (GO:0001678 from GO Biological Process Annotations)", "cellular glucuronidation (GO:0052695 from GO Biological Process Annotations)", "cellular heat acclimation (GO:0070370 from GO Biological Process Annotations)", "cellular homeostasis (GO:0019725 from GO Biological Process Annotations)", "cellular hormone metabolic process (GO:0034754 from GO Biological Process Annotations)", "cellular hyperosmotic response (GO:0071474 from GO Biological Process Annotations)", "cellular hyperosmotic salinity response (GO:0071475 from GO Biological Process Annotations)", "cellular hypotonic response (GO:0071476 from GO Biological Process Annotations)", "cellular hypotonic salinity response (GO:0071477 from GO Biological Process Annotations)", "cellular ion homeostasis (GO:0006873 from GO Biological Process Annotations)", "cellular iron ion homeostasis (GO:0006879 from GO Biological Process Annotations)", "cellular ketone body metabolic process (GO:0046950 from GO Biological Process Annotations)", "cellular ketone metabolic process (GO:0042180 from GO Biological Process Annotations)", "cellular lactam catabolic process (GO:0072340 from GO Biological Process Annotations)", "cellular lactam metabolic process (GO:0072338 from GO Biological Process Annotations)", "cellular lipid biosynthetic process (GO:0097384 from GO Biological Process Annotations)", "cellular lipid catabolic process (GO:0044242 from GO Biological Process Annotations)", "cellular lipid metabolic process (GO:0044255 from GO Biological Process Annotations)", "cellular localization (GO:0051641 from GO Biological Process Annotations)", "cellular macromolecular complex assembly (GO:0034622 from GO Biological Process Annotations)", "cellular macromolecule biosynthetic process (GO:0034645 from GO Biological Process Annotations)", "cellular macromolecule catabolic process (GO:0044265 from GO Biological Process Annotations)", "cellular macromolecule localization (GO:0070727 from GO Biological Process Annotations)", "cellular macromolecule metabolic process (GO:0044260 from GO Biological Process Annotations)", "cellular magnesium ion homeostasis (GO:0010961 from GO Biological Process Annotations)", "cellular metabolic compound salvage (GO:0043094 from GO Biological Process Annotations)", "cellular metabolic process (GO:0044237 from GO Biological Process Annotations)", "cellular metal ion homeostasis (GO:0006875 from GO Biological Process Annotations)", "cellular modified amino acid biosynthetic process (GO:0042398 from GO Biological Process Annotations)", "cellular modified amino acid catabolic process (GO:0042219 from GO Biological Process Annotations)", "cellular modified amino acid metabolic process (GO:0006575 from GO Biological Process Annotations)", "cellular monovalent inorganic anion homeostasis (GO:0030320 from GO Biological Process Annotations)", "cellular monovalent inorganic cation homeostasis (GO:0030004 from GO Biological Process Annotations)", "cellular nitrogen compound biosynthetic process (GO:0044271 from GO Biological Process Annotations)", "cellular nitrogen compound catabolic process (GO:0044270 from GO Biological Process Annotations)", "cellular nitrogen compound metabolic process (GO:0034641 from GO Biological Process Annotations)", "cellular oligosaccharide metabolic process (GO:0051691 from GO Biological Process Annotations)", "cellular organofluorine metabolic process (GO:0090346 from GO Biological Process Annotations)", "cellular organohalogen metabolic process (GO:0090345 from GO Biological Process Annotations)", "cellular phosphate ion homeostasis (GO:0030643 from GO Biological Process Annotations)", "cellular pigment accumulation (GO:0043482 from GO Biological Process Annotations)", "cellular pigmentation (GO:0033059 from GO Biological Process Annotations)", "cellular polysaccharide biosynthetic process (GO:0033692 from GO Biological Process Annotations)", "cellular polysaccharide catabolic process (GO:0044247 from GO Biological Process Annotations)", "cellular polysaccharide metabolic process (GO:0044264 from GO Biological Process Annotations)", "cellular potassium ion homeostasis (GO:0030007 from GO Biological Process Annotations)", "cellular potassium ion transport (GO:0071804 from GO Biological Process Annotations)", "cellular process (GO:0009987 from GO Biological Process Annotations)", "cellular process involved in reproduction in multicellular organism (GO:0022412 from GO Biological Process Annotations)", "cellular process regulating host cell cycle in response to virus (GO:0060154 from GO Biological Process Annotations)", "cellular protein catabolic process (GO:0044257 from GO Biological Process Annotations)", "cellular protein complex assembly (GO:0043623 from GO Biological Process Annotations)", "cellular protein complex disassembly (GO:0043624 from GO Biological Process Annotations)", "cellular protein complex localization (GO:0034629 from GO Biological Process Annotations)", "cellular protein localization (GO:0034613 from GO Biological Process Annotations)", "cellular protein metabolic process (GO:0044267 from GO Biological Process Annotations)", "cellular protein modification process (GO:0006464 from GO Biological Process Annotations)", "cellular respiration (GO:0045333 from GO Biological Process Annotations)", "cellular response to abiotic stimulus (GO:0071214 from GO Biological Process Annotations)", "cellular response to acid chemical (GO:0071229 from GO Biological Process Annotations)", "cellular response to acidic ph (GO:0071468 from GO Biological Process Annotations)", "cellular response to alcohol (GO:0097306 from GO Biological Process Annotations)", "cellular response to alkaline ph (GO:0071469 from GO Biological Process Annotations)", "cellular response to alkaloid (GO:0071312 from GO Biological Process Annotations)", "cellular response to aluminum ion (GO:0071275 from GO Biological Process Annotations)", "cellular response to amine stimulus (GO:0071418 from GO Biological Process Annotations)", "cellular response to amino acid starvation (GO:0034198 from GO Biological Process Annotations)", "cellular response to amino acid stimulus (GO:0071230 from GO Biological Process Annotations)", "cellular response to ammonium ion (GO:0071242 from GO Biological Process Annotations)", "cellular response to antibiotic (GO:0071236 from GO Biological Process Annotations)", "cellular response to arsenic-containing substance (GO:0071243 from GO Biological Process Annotations)", "cellular response to atp (GO:0071318 from GO Biological Process Annotations)", "cellular response to azide (GO:0097185 from GO Biological Process Annotations)", "cellular response to bacterial lipopeptide (GO:0071221 from GO Biological Process Annotations)", "cellular response to bacterial lipoprotein (GO:0071220 from GO Biological Process Annotations)", "cellular response to bile acid (GO:1903413 from GO Biological Process Annotations)", "cellular response to biotic stimulus (GO:0071216 from GO Biological Process Annotations)", "cellular response to blue light (GO:0071483 from GO Biological Process Annotations)", "cellular response to bmp stimulus (GO:0071773 from GO Biological Process Annotations)", "cellular response to brefeldin a (GO:0071238 from GO Biological Process Annotations)", "cellular response to cadmium ion (GO:0071276 from GO Biological Process Annotations)", "cellular response to caffeine (GO:0071313 from GO Biological Process Annotations)", "cellular response to calcium ion (GO:0071277 from GO Biological Process Annotations)", "cellular response to caloric restriction (GO:0061433 from GO Biological Process Annotations)", "cellular response to camp (GO:0071320 from GO Biological Process Annotations)", "cellular response to camptothecin (GO:0072757 from GO Biological Process Annotations)", "cellular response to carbohydrate stimulus (GO:0071322 from GO Biological Process Annotations)", "cellular response to catecholamine stimulus (GO:0071870 from GO Biological Process Annotations)", "cellular response to cell-matrix adhesion (GO:0071460 from GO Biological Process Annotations)", "cellular response to cgmp (GO:0071321 from GO Biological Process Annotations)", "cellular response to chemical stimulus (GO:0070887 from GO Biological Process Annotations)", "cellular response to cholesterol (GO:0071397 from GO Biological Process Annotations)", "cellular response to chromate (GO:0071247 from GO Biological Process Annotations)", "cellular response to cisplatin (GO:0072719 from GO Biological Process Annotations)", "cellular response to cobalt ion (GO:0071279 from GO Biological Process Annotations)", "cellular response to cocaine (GO:0071314 from GO Biological Process Annotations)", "cellular response to cold (GO:0070417 from GO Biological Process Annotations)", "cellular response to copper ion (GO:0071280 from GO Biological Process Annotations)", "cellular response to copper ion starvation (GO:0035874 from GO Biological Process Annotations)", "cellular response to corticosteroid stimulus (GO:0071384 from GO Biological Process Annotations)", "cellular response to corticotropin-releasing hormone stimulus (GO:0071376 from GO Biological Process Annotations)", "cellular response to cortisol stimulus (GO:0071387 from GO Biological Process Annotations)", "cellular response to cycloheximide (GO:0071409 from GO Biological Process Annotations)", "cellular response to cytokine stimulus (GO:0071345 from GO Biological Process Annotations)", "cellular response to decreased oxygen levels (GO:0036294 from GO Biological Process Annotations)", "cellular response to dexamethasone stimulus (GO:0071549 from GO Biological Process Annotations)", "cellular response to diacyl bacterial lipopeptide (GO:0071726 from GO Biological Process Annotations)", "cellular response to disaccharide stimulus (GO:0071324 from GO Biological Process Annotations)", "cellular response to dithiothreitol (GO:0072721 from GO Biological Process Annotations)", "cellular response to dna damage stimulus (GO:0006974 from GO Biological Process Annotations)", "cellular response to dopamine (GO:1903351 from GO Biological Process Annotations)", "cellular response to drug (GO:0035690 from GO Biological Process Annotations)", "cellular response to dsrna (GO:0071359 from GO Biological Process Annotations)", "cellular response to electrical stimulus (GO:0071257 from GO Biological Process Annotations)", "cellular response to endogenous stimulus (GO:0071495 from GO Biological Process Annotations)", "cellular response to epidermal growth factor stimulus (GO:0071364 from GO Biological Process Annotations)", "cellular response to epinephrine stimulus (GO:0071872 from GO Biological Process Annotations)", "cellular response to ergosterol (GO:1901625 from GO Biological Process Annotations)", "cellular response to erythropoietin (GO:0036018 from GO Biological Process Annotations)", "cellular response to estradiol stimulus (GO:0071392 from GO Biological Process Annotations)", "cellular response to estrogen stimulus (GO:0071391 from GO Biological Process Annotations)", "cellular response to ethanol (GO:0071361 from GO Biological Process Annotations)", "cellular response to exogenous dsrna (GO:0071360 from GO Biological Process Annotations)", "cellular response to external stimulus (GO:0071496 from GO Biological Process Annotations)", "cellular response to extracellular stimulus (GO:0031668 from GO Biological Process Annotations)", "cellular response to fatty acid (GO:0071398 from GO Biological Process Annotations)", "cellular response to fibroblast growth factor stimulus (GO:0044344 from GO Biological Process Annotations)", "cellular response to fluid shear stress (GO:0071498 from GO Biological Process Annotations)", "cellular response to fluoride (GO:1902618 from GO Biological Process Annotations)", "cellular response to follicle-stimulating hormone stimulus (GO:0071372 from GO Biological Process Annotations)", "cellular response to freezing (GO:0071497 from GO Biological Process Annotations)", "cellular response to fructose stimulus (GO:0071332 from GO Biological Process Annotations)", "cellular response to gamma radiation (GO:0071480 from GO Biological Process Annotations)", "cellular response to genistein (GO:0071412 from GO Biological Process Annotations)", "cellular response to glucagon stimulus (GO:0071377 from GO Biological Process Annotations)", "cellular response to glucocorticoid stimulus (GO:0071385 from GO Biological Process Annotations)", "cellular response to glucose starvation (GO:0042149 from GO Biological Process Annotations)", "cellular response to glucose stimulus (GO:0071333 from GO Biological Process Annotations)", "cellular response to glyoxal (GO:0036471 from GO Biological Process Annotations)", "cellular response to gonadotropin stimulus (GO:0071371 from GO Biological Process Annotations)", "cellular response to gonadotropin-releasing hormone (GO:0097211 from GO Biological Process Annotations)", "cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011 from GO Biological Process Annotations)", "cellular response to growth factor stimulus (GO:0071363 from GO Biological Process Annotations)", "cellular response to growth hormone stimulus (GO:0071378 from GO Biological Process Annotations)", "cellular response to heat (GO:0034605 from GO Biological Process Annotations)", "cellular response to heparin (GO:0071504 from GO Biological Process Annotations)", "cellular response to hepatocyte growth factor stimulus (GO:0035729 from GO Biological Process Annotations)", "cellular response to hexose stimulus (GO:0071331 from GO Biological Process Annotations)", "cellular response to high density lipoprotein particle stimulus (GO:0071403 from GO Biological Process Annotations)", "cellular response to histamine (GO:0071420 from GO Biological Process Annotations)", "cellular response to hormone stimulus (GO:0032870 from GO Biological Process Annotations)", "cellular response to hydrogen peroxide (GO:0070301 from GO Biological Process Annotations)", "cellular response to hydroperoxide (GO:0071447 from GO Biological Process Annotations)", "cellular response to hydrostatic pressure (GO:0071464 from GO Biological Process Annotations)", "cellular response to hydroxyisoflavone (GO:0071413 from GO Biological Process Annotations)", "cellular response to hydroxyurea (GO:0072711 from GO Biological Process Annotations)", "cellular response to hyperoxia (GO:0071455 from GO Biological Process Annotations)", "cellular response to hypoxia (GO:0071456 from GO Biological Process Annotations)", "cellular response to increased oxygen levels (GO:0036295 from GO Biological Process Annotations)", "cellular response to indole-3-methanol (GO:0071681 from GO Biological Process Annotations)", "cellular response to inorganic substance (GO:0071241 from GO Biological Process Annotations)", "cellular response to insulin stimulus (GO:0032869 from GO Biological Process Annotations)", "cellular response to insulin-like growth factor stimulus (GO:1990314 from GO Biological Process Annotations)", "cellular response to interferon-alpha (GO:0035457 from GO Biological Process Annotations)", "cellular response to interferon-beta (GO:0035458 from GO Biological Process Annotations)", "cellular response to interferon-gamma (GO:0071346 from GO Biological Process Annotations)", "cellular response to interleukin-1 (GO:0071347 from GO Biological Process Annotations)", "cellular response to interleukin-13 (GO:0035963 from GO Biological Process Annotations)", "cellular response to interleukin-18 (GO:0071351 from GO Biological Process Annotations)", "cellular response to interleukin-3 (GO:0036016 from GO Biological Process Annotations)", "cellular response to interleukin-4 (GO:0071353 from GO Biological Process Annotations)", "cellular response to interleukin-6 (GO:0071354 from GO Biological Process Annotations)", "cellular response to ionizing radiation (GO:0071479 from GO Biological Process Annotations)", "cellular response to iron ion (GO:0071281 from GO Biological Process Annotations)", "cellular response to iron ion starvation (GO:0010106 from GO Biological Process Annotations)", "cellular response to iron(iii) ion (GO:0071283 from GO Biological Process Annotations)", "cellular response to isoquinoline alkaloid (GO:0071317 from GO Biological Process Annotations)", "cellular response to jasmonic acid stimulus (GO:0071395 from GO Biological Process Annotations)", "cellular response to ketone (GO:1901655 from GO Biological Process Annotations)", "cellular response to l-ascorbic acid (GO:0071298 from GO Biological Process Annotations)", "cellular response to laminar fluid shear stress (GO:0071499 from GO Biological Process Annotations)", "cellular response to leptin stimulus (GO:0044320 from GO Biological Process Annotations)", "cellular response to leucine (GO:0071233 from GO Biological Process Annotations)", "cellular response to light stimulus (GO:0071482 from GO Biological Process Annotations)", "cellular response to lipid (GO:0071396 from GO Biological Process Annotations)", "cellular response to lipid hydroperoxide (GO:0071449 from GO Biological Process Annotations)", "cellular response to lipopolysaccharide (GO:0071222 from GO Biological Process Annotations)", "cellular response to lipoprotein particle stimulus (GO:0071402 from GO Biological Process Annotations)", "cellular response to lipoteichoic acid (GO:0071223 from GO Biological Process Annotations)", "cellular response to lithium ion (GO:0071285 from GO Biological Process Annotations)", "cellular response to low-density lipoprotein particle stimulus (GO:0071404 from GO Biological Process Annotations)", "cellular response to luteinizing hormone stimulus (GO:0071373 from GO Biological Process Annotations)", "cellular response to macrophage colony-stimulating factor stimulus (GO:0036006 from GO Biological Process Annotations)", "cellular response to magnesium ion (GO:0071286 from GO Biological Process Annotations)", "cellular response to magnetism (GO:0071259 from GO Biological Process Annotations)", "cellular response to manganese ion (GO:0071287 from GO Biological Process Annotations)", "cellular response to mechanical stimulus (GO:0071260 from GO Biological Process Annotations)", "cellular response to menadione (GO:0036245 from GO Biological Process Annotations)", "cellular response to mercury ion (GO:0071288 from GO Biological Process Annotations)", "cellular response to metal ion (GO:0071248 from GO Biological Process Annotations)", "cellular response to methyl methanesulfonate (GO:0072703 from GO Biological Process Annotations)", "cellular response to mineralocorticoid stimulus (GO:0071389 from GO Biological Process Annotations)", "cellular response to misfolded protein (GO:0071218 from GO Biological Process Annotations)", "cellular response to molecule of bacterial origin (GO:0071219 from GO Biological Process Annotations)", "cellular response to molecule of fungal origin (GO:0071226 from GO Biological Process Annotations)", "cellular response to monoamine stimulus (GO:0071868 from GO Biological Process Annotations)", "cellular response to monosaccharide stimulus (GO:0071326 from GO Biological Process Annotations)", "cellular response to morphine (GO:0071315 from GO Biological Process Annotations)", "cellular response to muramyl dipeptide (GO:0071225 from GO Biological Process Annotations)", "cellular response to mycophenolic acid (GO:0071506 from GO Biological Process Annotations)", "cellular response to mycotoxin (GO:0036146 from GO Biological Process Annotations)", "cellular response to nerve growth factor stimulus (GO:1990090 from GO Biological Process Annotations)", "cellular response to nicotine (GO:0071316 from GO Biological Process Annotations)", "cellular response to nitric oxide (GO:0071732 from GO Biological Process Annotations)", "cellular response to nitrite (GO:0071250 from GO Biological Process Annotations)", "cellular response to nitrogen compound (GO:1901699 from GO Biological Process Annotations)", "cellular response to nitrogen dioxide (GO:0035714 from GO Biological Process Annotations)", "cellular response to nitrogen levels (GO:0043562 from GO Biological Process Annotations)", "cellular response to nitrogen starvation (GO:0006995 from GO Biological Process Annotations)", "cellular response to norepinephrine stimulus (GO:0071874 from GO Biological Process Annotations)", "cellular response to nutrient (GO:0031670 from GO Biological Process Annotations)", "cellular response to nutrient levels (GO:0031669 from GO Biological Process Annotations)", "cellular response to oleic acid (GO:0071400 from GO Biological Process Annotations)", "cellular response to organic cyclic compound (GO:0071407 from GO Biological Process Annotations)", "cellular response to organic substance (GO:0071310 from GO Biological Process Annotations)", "cellular response to organonitrogen compound (GO:0071417 from GO Biological Process Annotations)", "cellular response to osmotic stress (GO:0071470 from GO Biological Process Annotations)", "cellular response to oxidative stress (GO:0034599 from GO Biological Process Annotations)", "cellular response to oxygen levels (GO:0071453 from GO Biological Process Annotations)", "cellular response to oxygen radical (GO:0071450 from GO Biological Process Annotations)", "cellular response to oxygen-containing compound (GO:1901701 from GO Biological Process Annotations)", "cellular response to parathyroid hormone stimulus (GO:0071374 from GO Biological Process Annotations)", "cellular response to peptide (GO:1901653 from GO Biological Process Annotations)", "cellular response to peptide hormone stimulus (GO:0071375 from GO Biological Process Annotations)", "cellular response to peptidoglycan (GO:0071224 from GO Biological Process Annotations)", "cellular response to ph (GO:0071467 from GO Biological Process Annotations)", "cellular response to phosphate starvation (GO:0016036 from GO Biological Process Annotations)", "cellular response to platelet-derived growth factor stimulus (GO:0036120 from GO Biological Process Annotations)", "cellular response to potassium ion (GO:0035865 from GO Biological Process Annotations)", "cellular response to potassium ion starvation (GO:0051365 from GO Biological Process Annotations)", "cellular response to progesterone stimulus (GO:0071393 from GO Biological Process Annotations)", "cellular response to prostaglandin d stimulus (GO:0071799 from GO Biological Process Annotations)", "cellular response to prostaglandin e stimulus (GO:0071380 from GO Biological Process Annotations)", "cellular response to prostaglandin stimulus (GO:0071379 from GO Biological Process Annotations)", "cellular response to purine-containing compound (GO:0071415 from GO Biological Process Annotations)", "cellular response to radiation (GO:0071478 from GO Biological Process Annotations)", "cellular response to reactive nitrogen species (GO:1902170 from GO Biological Process Annotations)", "cellular response to reactive oxygen species (GO:0034614 from GO Biological Process Annotations)", "cellular response to redox state (GO:0071461 from GO Biological Process Annotations)", "cellular response to retinoic acid (GO:0071300 from GO Biological Process Annotations)", "cellular response to salt stress (GO:0071472 from GO Biological Process Annotations)", "cellular response to sodium dodecyl sulfate (GO:0072707 from GO Biological Process Annotations)", "cellular response to sorbitol (GO:0072709 from GO Biological Process Annotations)", "cellular response to starvation (GO:0009267 from GO Biological Process Annotations)", "cellular response to staurosporine (GO:0072734 from GO Biological Process Annotations)", "cellular response to steroid hormone stimulus (GO:0071383 from GO Biological Process Annotations)", "cellular response to sterol (GO:0036315 from GO Biological Process Annotations)", "cellular response to sterol depletion (GO:0071501 from GO Biological Process Annotations)", "cellular response to stimulus (GO:0051716 from GO Biological Process Annotations)", "cellular response to stress (GO:0033554 from GO Biological Process Annotations)", "cellular response to sucrose stimulus (GO:0071329 from GO Biological Process Annotations)", "cellular response to superoxide (GO:0071451 from GO Biological Process Annotations)", "cellular response to temperature stimulus (GO:0071502 from GO Biological Process Annotations)", "cellular response to testosterone stimulus (GO:0071394 from GO Biological Process Annotations)", "cellular response to thyroid hormone stimulus (GO:0097067 from GO Biological Process Annotations)", "cellular response to topologically incorrect protein (GO:0035967 from GO Biological Process Annotations)", "cellular response to toxic substance (GO:0097237 from GO Biological Process Annotations)", "cellular response to transforming growth factor beta stimulus (GO:0071560 from GO Biological Process Annotations)", "cellular response to triacyl bacterial lipopeptide (GO:0071727 from GO Biological Process Annotations)", "cellular response to trichostatin a (GO:0035984 from GO Biological Process Annotations)", "cellular response to triglyceride (GO:0071401 from GO Biological Process Annotations)", "cellular response to tumor cell (GO:0071228 from GO Biological Process Annotations)", "cellular response to tumor necrosis factor (GO:0071356 from GO Biological Process Annotations)", "cellular response to type i interferon (GO:0071357 from GO Biological Process Annotations)", "cellular response to unfolded protein (GO:0034620 from GO Biological Process Annotations)", "cellular response to uv (GO:0034644 from GO Biological Process Annotations)", "cellular response to uv-a (GO:0071492 from GO Biological Process Annotations)", "cellular response to uv-b (GO:0071493 from GO Biological Process Annotations)", "cellular response to uv-c (GO:0071494 from GO Biological Process Annotations)", "cellular response to vascular endothelial growth factor stimulus (GO:0035924 from GO Biological Process Annotations)", "cellular response to virus (GO:0098586 from GO Biological Process Annotations)", "cellular response to vitamin (GO:0071295 from GO Biological Process Annotations)", "cellular response to vitamin b1 (GO:0071301 from GO Biological Process Annotations)", "cellular response to vitamin d (GO:0071305 from GO Biological Process Annotations)", "cellular response to vitamin e (GO:0071306 from GO Biological Process Annotations)", "cellular response to vitamin k (GO:0071307 from GO Biological Process Annotations)", "cellular response to water deprivation (GO:0042631 from GO Biological Process Annotations)", "cellular response to water stimulus (GO:0071462 from GO Biological Process Annotations)", "cellular response to x-ray (GO:0071481 from GO Biological Process Annotations)", "cellular response to zinc ion (GO:0071294 from GO Biological Process Annotations)", "cellular response to zinc ion starvation (GO:0034224 from GO Biological Process Annotations)", "cellular senescence (GO:0090398 from GO Biological Process Annotations)", "cellular sodium ion homeostasis (GO:0006883 from GO Biological Process Annotations)", "cellular sphingolipid homeostasis (GO:0090156 from GO Biological Process Annotations)", "cellular stress response to acidic ph (GO:1990451 from GO Biological Process Annotations)", "cellular transition metal ion homeostasis (GO:0046916 from GO Biological Process Annotations)", "cellular triglyceride homeostasis (GO:0035356 from GO Biological Process Annotations)", "cellular trivalent inorganic anion homeostasis (GO:0072502 from GO Biological Process Annotations)", "cellular urea homeostasis (GO:0097277 from GO Biological Process Annotations)", "cellular water homeostasis (GO:0009992 from GO Biological Process Annotations)", "cellular zinc ion homeostasis (GO:0006882 from GO Biological Process Annotations)", "cellularization (GO:0007349 from GO Biological Process Annotations)", "cementum mineralization (GO:0071529 from GO Biological Process Annotations)", "cenp-a containing nucleosome assembly (GO:0034080 from GO Biological Process Annotations)", "central nervous system development (GO:0007417 from GO Biological Process Annotations)", "central nervous system interneuron axonogenesis (GO:0021956 from GO Biological Process Annotations)", "central nervous system morphogenesis (GO:0021551 from GO Biological Process Annotations)", "central nervous system myelin formation (GO:0032289 from GO Biological Process Annotations)", "central nervous system myelin maintenance (GO:0032286 from GO Biological Process Annotations)", "central nervous system myelination (GO:0022010 from GO Biological Process Annotations)", "central nervous system neuron axonogenesis (GO:0021955 from GO Biological Process Annotations)", "central nervous system neuron development (GO:0021954 from GO Biological Process Annotations)", "central nervous system neuron differentiation (GO:0021953 from GO Biological Process Annotations)", "central nervous system projection neuron axonogenesis (GO:0021952 from GO Biological Process Annotations)", "central nervous system vasculogenesis (GO:0022009 from GO Biological Process Annotations)", "central tolerance induction (GO:0002508 from GO Biological Process Annotations)", "centriole assembly (GO:0098534 from GO Biological Process Annotations)", "centriole elongation (GO:0061511 from GO Biological Process Annotations)", "centriole replication (GO:0007099 from GO Biological Process Annotations)", "centriole-centriole cohesion (GO:0010457 from GO Biological Process Annotations)", "centromere complex assembly (GO:0034508 from GO Biological Process Annotations)", "centromeric sister chromatid cohesion (GO:0070601 from GO Biological Process Annotations)", "centrosome cycle (GO:0007098 from GO Biological Process Annotations)", "centrosome duplication (GO:0051298 from GO Biological Process Annotations)", "centrosome localization (GO:0051642 from GO Biological Process Annotations)", "centrosome organization (GO:0051297 from GO Biological Process Annotations)", "centrosome separation (GO:0051299 from GO Biological Process Annotations)", "centrosome-templated microtubule nucleation (GO:0090222 from GO Biological Process Annotations)", "ceramide 1-phosphate transport (GO:1902389 from GO Biological Process Annotations)", "ceramide biosynthetic process (GO:0046513 from GO Biological Process Annotations)", "ceramide catabolic process (GO:0046514 from GO Biological Process Annotations)", "ceramide metabolic process (GO:0006672 from GO Biological Process Annotations)", "ceramide transport (GO:0035627 from GO Biological Process Annotations)", "cerebellar cortex development (GO:0021695 from GO Biological Process Annotations)", "cerebellar cortex formation (GO:0021697 from GO Biological Process Annotations)", "cerebellar cortex morphogenesis (GO:0021696 from GO Biological Process Annotations)", "cerebellar cortex structural organization (GO:0021698 from GO Biological Process Annotations)", "cerebellar granular layer development (GO:0021681 from GO Biological Process Annotations)", "cerebellar granular layer maturation (GO:0021686 from GO Biological Process Annotations)", "cerebellar granular layer morphogenesis (GO:0021683 from GO Biological Process Annotations)", "cerebellar granular layer structural organization (GO:0021685 from GO Biological Process Annotations)", "cerebellar granule cell differentiation (GO:0021707 from GO Biological Process Annotations)", "cerebellar granule cell precursor proliferation (GO:0021930 from GO Biological Process Annotations)", "cerebellar granule cell precursor tangential migration (GO:0021935 from GO Biological Process Annotations)", "cerebellar molecular layer development (GO:0021679 from GO Biological Process Annotations)", "cerebellar purkinje cell differentiation (GO:0021702 from GO Biological Process Annotations)", "cerebellar purkinje cell layer development (GO:0021680 from GO Biological Process Annotations)", "cerebellar purkinje cell layer maturation (GO:0021691 from GO Biological Process Annotations)", "cerebellar purkinje cell layer morphogenesis (GO:0021692 from GO Biological Process Annotations)", "cerebellar purkinje cell layer structural organization (GO:0021693 from GO Biological Process Annotations)", "cerebellar purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation (GO:0021937 from GO Biological Process Annotations)", "cerebellum development (GO:0021549 from GO Biological Process Annotations)", "cerebellum formation (GO:0021588 from GO Biological Process Annotations)", "cerebellum maturation (GO:0021590 from GO Biological Process Annotations)", "cerebellum morphogenesis (GO:0021587 from GO Biological Process Annotations)", "cerebellum structural organization (GO:0021589 from GO Biological Process Annotations)", "cerebellum vasculature morphogenesis (GO:0061301 from GO Biological Process Annotations)", "cerebral cortex cell migration (GO:0021795 from GO Biological Process Annotations)", "cerebral cortex development (GO:0021987 from GO Biological Process Annotations)", "cerebral cortex gabaergic interneuron differentiation (GO:0021892 from GO Biological Process Annotations)", "cerebral cortex gabaergic interneuron fate commitment (GO:0021893 from GO Biological Process Annotations)", "cerebral cortex gabaergic interneuron migration (GO:0021853 from GO Biological Process Annotations)", "cerebral cortex neuron differentiation (GO:0021895 from GO Biological Process Annotations)", "cerebral cortex radial glia guided migration (GO:0021801 from GO Biological Process Annotations)", "cerebral cortex radially oriented cell migration (GO:0021799 from GO Biological Process Annotations)", "cerebral cortex regionalization (GO:0021796 from GO Biological Process Annotations)", "cerebral cortex tangential migration (GO:0021800 from GO Biological Process Annotations)", "cerebral cortex tangential migration using cell-axon interactions (GO:0021824 from GO Biological Process Annotations)", "cerebrospinal fluid secretion (GO:0033326 from GO Biological Process Annotations)", "cervix development (GO:0060067 from GO Biological Process Annotations)", "cgmp biosynthetic process (GO:0006182 from GO Biological Process Annotations)", "cgmp catabolic process (GO:0046069 from GO Biological Process Annotations)", "cgmp metabolic process (GO:0046068 from GO Biological Process Annotations)", "cgmp-mediated signaling (GO:0019934 from GO Biological Process Annotations)", "changes to dna methylation involved in embryo development (GO:1901538 from GO Biological Process Annotations)", "chaperone cofactor-dependent protein refolding (GO:0070389 from GO Biological Process Annotations)", "chaperone mediated protein folding requiring cofactor (GO:0051085 from GO Biological Process Annotations)", "chaperone-mediated protein complex assembly (GO:0051131 from GO Biological Process Annotations)", "chaperone-mediated protein folding (GO:0061077 from GO Biological Process Annotations)", "chaperone-mediated protein transport (GO:0072321 from GO Biological Process Annotations)", "charged-trna amino acid modification (GO:0019988 from GO Biological Process Annotations)", "chemical homeostasis (GO:0048878 from GO Biological Process Annotations)", "chemical homeostasis within a tissue (GO:0048875 from GO Biological Process Annotations)", "chemokine (c-c motif) ligand 11 production (GO:0071954 from GO Biological Process Annotations)", "chemokine (c-c motif) ligand 19 signaling pathway (GO:0038115 from GO Biological Process Annotations)", "chemokine (c-c motif) ligand 2 secretion (GO:0035926 from GO Biological Process Annotations)", "chemokine (c-c motif) ligand 21 signaling pathway (GO:0038116 from GO Biological Process Annotations)", "chemokine (c-c motif) ligand 5 production (GO:0071609 from GO Biological Process Annotations)", "chemokine biosynthetic process (GO:0042033 from GO Biological Process Annotations)", "chemokine metabolic process (GO:0050755 from GO Biological Process Annotations)", "chemokine production (GO:0032602 from GO Biological Process Annotations)", "chemokine receptor transport out of membrane raft (GO:0032600 from GO Biological Process Annotations)", "chemokine receptor transport within lipid bilayer (GO:0033606 from GO Biological Process Annotations)", "chemokine secretion (GO:0090195 from GO Biological Process Annotations)", "chemokine-mediated signaling pathway (GO:0070098 from GO Biological Process Annotations)", "chemorepulsion involved in embryonic olfactory bulb interneuron precursor migration (GO:0021834 from GO Biological Process Annotations)", "chemorepulsion involved in postnatal olfactory bulb interneuron migration (GO:0021836 from GO Biological Process Annotations)", "chemorepulsion of axon (GO:0061643 from GO Biological Process Annotations)", "chemorepulsion of branchiomotor axon (GO:0021793 from GO Biological Process Annotations)", "chemosensory behavior (GO:0007635 from GO Biological Process Annotations)", "chemotaxis (GO:0006935 from GO Biological Process Annotations)", "chiasma assembly (GO:0051026 from GO Biological Process Annotations)", "chitin catabolic process (GO:0006032 from GO Biological Process Annotations)", "chitin metabolic process (GO:0006030 from GO Biological Process Annotations)", "chloramphenicol transport (GO:0042892 from GO Biological Process Annotations)", "chloride ion homeostasis (GO:0055064 from GO Biological Process Annotations)", "chloride transmembrane transport (GO:1902476 from GO Biological Process Annotations)", "chloride transport (GO:0006821 from GO Biological Process Annotations)", "chlorinated hydrocarbon metabolic process (GO:0042196 from GO Biological Process Annotations)", "cholecystokinin signaling pathway (GO:0038188 from GO Biological Process Annotations)", "cholesterol biosynthetic process (GO:0006695 from GO Biological Process Annotations)", "cholesterol biosynthetic process via 24,25-dihydrolanosterol (GO:0033488 from GO Biological Process Annotations)", "cholesterol biosynthetic process via lathosterol (GO:0033490 from GO Biological Process Annotations)", "cholesterol catabolic process (GO:0006707 from GO Biological Process Annotations)", "cholesterol efflux (GO:0033344 from GO Biological Process Annotations)", "cholesterol esterification (GO:0034435 from GO Biological Process Annotations)", "cholesterol homeostasis (GO:0042632 from GO Biological Process Annotations)", "cholesterol import (GO:0070508 from GO Biological Process Annotations)", "cholesterol metabolic process (GO:0008203 from GO Biological Process Annotations)", "cholesterol storage (GO:0010878 from GO Biological Process Annotations)", "cholesterol transport (GO:0030301 from GO Biological Process Annotations)", "choline metabolic process (GO:0019695 from GO Biological Process Annotations)", "choline transport (GO:0015871 from GO Biological Process Annotations)", "chondroblast differentiation (GO:0060591 from GO Biological Process Annotations)", "chondrocyte development (GO:0002063 from GO Biological Process Annotations)", "chondrocyte development involved in endochondral bone morphogenesis (GO:0003433 from GO Biological Process Annotations)", "chondrocyte differentiation (GO:0002062 from GO Biological Process Annotations)", "chondrocyte differentiation involved in endochondral bone morphogenesis (GO:0003413 from GO Biological Process Annotations)", "chondrocyte hypertrophy (GO:0003415 from GO Biological Process Annotations)", "chondrocyte morphogenesis (GO:0090171 from GO Biological Process Annotations)", "chondrocyte morphogenesis involved in endochondral bone morphogenesis (GO:0003414 from GO Biological Process Annotations)", "chondrocyte proliferation (GO:0035988 from GO Biological Process Annotations)", "chondroitin sulfate biosynthetic process (GO:0030206 from GO Biological Process Annotations)", "chondroitin sulfate catabolic process (GO:0030207 from GO Biological Process Annotations)", "chondroitin sulfate metabolic process (GO:0030204 from GO Biological Process Annotations)", "chondroitin sulfate proteoglycan biosynthetic process (GO:0050650 from GO Biological Process Annotations)", "chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050653 from GO Biological Process Annotations)", "chondroitin sulfate proteoglycan metabolic process (GO:0050654 from GO Biological Process Annotations)", "chordate embryonic development (GO:0043009 from GO Biological Process Annotations)", "chorio-allantoic fusion (GO:0060710 from GO Biological Process Annotations)", "chorion development (GO:0060717 from GO Biological Process Annotations)", "chorionic trophoblast cell differentiation (GO:0060718 from GO Biological Process Annotations)", "chromatin assembly (GO:0031497 from GO Biological Process Annotations)", "chromatin assembly or disassembly (GO:0006333 from GO Biological Process Annotations)", "chromatin maintenance (GO:0070827 from GO Biological Process Annotations)", "chromatin modification (GO:0016568 from GO Biological Process Annotations)", "chromatin organization (GO:0006325 from GO Biological Process Annotations)", "chromatin organization involved in negative regulation of transcription (GO:0097549 from GO Biological Process Annotations)", "chromatin organization involved in regulation of transcription (GO:0034401 from GO Biological Process Annotations)", "chromatin remodeling (GO:0006338 from GO Biological Process Annotations)", "chromatin remodeling at centromere (GO:0031055 from GO Biological Process Annotations)", "chromatin silencing (GO:0006342 from GO Biological Process Annotations)", "chromatin silencing at rdna (GO:0000183 from GO Biological Process Annotations)", "chromatin silencing at telomere (GO:0006348 from GO Biological Process Annotations)", "chromatin-mediated maintenance of transcription (GO:0048096 from GO Biological Process Annotations)", "chromosome attachment to the nuclear envelope (GO:0097240 from GO Biological Process Annotations)", "chromosome breakage (GO:0031052 from GO Biological Process Annotations)", "chromosome condensation (GO:0030261 from GO Biological Process Annotations)", "chromosome localization (GO:0050000 from GO Biological Process Annotations)", "chromosome localization to nuclear envelope involved in synapsis (GO:0090220 from GO Biological Process Annotations)", "chromosome movement towards spindle pole (GO:0051305 from GO Biological Process Annotations)", "chromosome organization (GO:0051276 from GO Biological Process Annotations)", "chromosome organization involved in meiosis (GO:0070192 from GO Biological Process Annotations)", "chromosome passenger complex localization to kinetochore (GO:0072356 from GO Biological Process Annotations)", "chromosome passenger complex localization to spindle midzone (GO:0035853 from GO Biological Process Annotations)", "chromosome segregation (GO:0007059 from GO Biological Process Annotations)", "chromosome separation (GO:0051304 from GO Biological Process Annotations)", "chronic inflammatory response (GO:0002544 from GO Biological Process Annotations)", "chronic inflammatory response to antigenic stimulus (GO:0002439 from GO Biological Process Annotations)", "chronological cell aging (GO:0001300 from GO Biological Process Annotations)", "chylomicron assembly (GO:0034378 from GO Biological Process Annotations)", "chylomicron remnant clearance (GO:0034382 from GO Biological Process Annotations)", "chylomicron remodeling (GO:0034371 from GO Biological Process Annotations)", "ciliary basal body organization (GO:0032053 from GO Biological Process Annotations)", "ciliary body morphogenesis (GO:0061073 from GO Biological Process Annotations)", "ciliary neurotrophic factor-mediated signaling pathway (GO:0070120 from GO Biological Process Annotations)", "ciliary receptor clustering involved in smoothened signaling pathway (GO:0060830 from GO Biological Process Annotations)", "cilium assembly (GO:0042384 from GO Biological Process Annotations)", "cilium morphogenesis (GO:0060271 from GO Biological Process Annotations)", "cilium movement (GO:0003341 from GO Biological Process Annotations)", "cilium or flagellum-dependent cell motility (GO:0001539 from GO Biological Process Annotations)", "cilium organization (GO:0044782 from GO Biological Process Annotations)", "cilium-dependent cell motility (GO:0060285 from GO Biological Process Annotations)", "circadian behavior (GO:0048512 from GO Biological Process Annotations)", "circadian regulation of gene expression (GO:0032922 from GO Biological Process Annotations)", "circadian regulation of translation (GO:0097167 from GO Biological Process Annotations)", "circadian rhythm (GO:0007623 from GO Biological Process Annotations)", "circadian sleep|wake cycle (GO:0042745 from GO Biological Process Annotations)", "circadian sleep|wake cycle process (GO:0022410 from GO Biological Process Annotations)", "circadian sleep|wake cycle, non-rem sleep (GO:0042748 from GO Biological Process Annotations)", "circadian sleep|wake cycle, rem sleep (GO:0042747 from GO Biological Process Annotations)", "circadian temperature homeostasis (GO:0060086 from GO Biological Process Annotations)", "circulatory system process (GO:0003013 from GO Biological Process Annotations)", "cis assembly of pre-catalytic spliceosome (GO:0000354 from GO Biological Process Annotations)", "citrate metabolic process (GO:0006101 from GO Biological Process Annotations)", "citrate transport (GO:0015746 from GO Biological Process Annotations)", "citrulline biosynthetic process (GO:0019240 from GO Biological Process Annotations)", "citrulline metabolic process (GO:0000052 from GO Biological Process Annotations)", "clara cell differentiation (GO:0060486 from GO Biological Process Annotations)", "clathrin coat assembly (GO:0048268 from GO Biological Process Annotations)", "clathrin coat disassembly (GO:0072318 from GO Biological Process Annotations)", "clathrin-mediated endocytosis (GO:0072583 from GO Biological Process Annotations)", "cleavage furrow formation (GO:0036089 from GO Biological Process Annotations)", "cleavage furrow ingression (GO:0036090 from GO Biological Process Annotations)", "cleavage in its2 between 5.8s rrna and lsu-rrna of tricistronic rrna transcript (ssu-rrna, 5.8s rrna, lsu-rrna) (GO:0000448 from GO Biological Process Annotations)", "cleavage involved in rrna processing (GO:0000469 from GO Biological Process Annotations)", "cloaca development (GO:0035844 from GO Biological Process Annotations)", "cloacal septation (GO:0060197 from GO Biological Process Annotations)", "closure of optic fissure (GO:0061386 from GO Biological Process Annotations)", "clustering of voltage-gated potassium channels (GO:0045163 from GO Biological Process Annotations)", "clustering of voltage-gated sodium channels (GO:0045162 from GO Biological Process Annotations)", "cmp biosynthetic process (GO:0009224 from GO Biological Process Annotations)", "cmp metabolic process (GO:0046035 from GO Biological Process Annotations)", "cmp phosphorylation (GO:0061566 from GO Biological Process Annotations)", "cmp salvage (GO:0006238 from GO Biological Process Annotations)", "cmp-n-acetylneuraminate transport (GO:0015782 from GO Biological Process Annotations)", "co-translational protein modification (GO:0043686 from GO Biological Process Annotations)", "coagulation (GO:0050817 from GO Biological Process Annotations)", "cobalamin biosynthetic process (GO:0009236 from GO Biological Process Annotations)", "cobalamin metabolic process (GO:0009235 from GO Biological Process Annotations)", "cobalamin transport (GO:0015889 from GO Biological Process Annotations)", "cobalt ion transport (GO:0006824 from GO Biological Process Annotations)", "cocaine metabolic process (GO:0050783 from GO Biological Process Annotations)", "cochlea development (GO:0090102 from GO Biological Process Annotations)", "cochlea morphogenesis (GO:0090103 from GO Biological Process Annotations)", "cochlear nucleus development (GO:0021747 from GO Biological Process Annotations)", "coenzyme a biosynthetic process (GO:0015937 from GO Biological Process Annotations)", "coenzyme a catabolic process (GO:0015938 from GO Biological Process Annotations)", "coenzyme a metabolic process (GO:0015936 from GO Biological Process Annotations)", "coenzyme a transmembrane transport (GO:0035349 from GO Biological Process Annotations)", "coenzyme a transport (GO:0015880 from GO Biological Process Annotations)", "coenzyme biosynthetic process (GO:0009108 from GO Biological Process Annotations)", "coenzyme catabolic process (GO:0009109 from GO Biological Process Annotations)", "coenzyme metabolic process (GO:0006732 from GO Biological Process Annotations)", "coenzyme transport (GO:0051182 from GO Biological Process Annotations)", "cofactor biosynthetic process (GO:0051188 from GO Biological Process Annotations)", "cofactor catabolic process (GO:0051187 from GO Biological Process Annotations)", "cofactor metabolic process (GO:0051186 from GO Biological Process Annotations)", "cofactor transport (GO:0051181 from GO Biological Process Annotations)", "cognition (GO:0050890 from GO Biological Process Annotations)", "cold acclimation (GO:0009631 from GO Biological Process Annotations)", "collagen biosynthetic process (GO:0032964 from GO Biological Process Annotations)", "collagen catabolic process (GO:0030574 from GO Biological Process Annotations)", "collagen fibril organization (GO:0030199 from GO Biological Process Annotations)", "collagen metabolic process (GO:0032963 from GO Biological Process Annotations)", "collagen-activated signaling pathway (GO:0038065 from GO Biological Process Annotations)", "collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063 from GO Biological Process Annotations)", "collateral sprouting (GO:0048668 from GO Biological Process Annotations)", "collateral sprouting in absence of injury (GO:0048669 from GO Biological Process Annotations)", "collecting duct development (GO:0072044 from GO Biological Process Annotations)", "colon epithelial cell migration (GO:0061580 from GO Biological Process Annotations)", "columnar|cuboidal epithelial cell development (GO:0002066 from GO Biological Process Annotations)", "columnar|cuboidal epithelial cell differentiation (GO:0002065 from GO Biological Process Annotations)", "columnar|cuboidal epithelial cell maturation (GO:0002069 from GO Biological Process Annotations)", "comma-shaped body morphogenesis (GO:0072049 from GO Biological Process Annotations)", "commissural neuron axon guidance (GO:0071679 from GO Biological Process Annotations)", "commissural neuron differentiation in spinal cord (GO:0021528 from GO Biological Process Annotations)", "commitment of neuronal cell to specific neuron type in forebrain (GO:0021902 from GO Biological Process Annotations)", "common bile duct development (GO:0061009 from GO Biological Process Annotations)", "common myeloid progenitor cell proliferation (GO:0035726 from GO Biological Process Annotations)", "common-partner smad protein phosphorylation (GO:0007182 from GO Biological Process Annotations)", "compartment pattern specification (GO:0007386 from GO Biological Process Annotations)", "complement activation (GO:0006956 from GO Biological Process Annotations)", "complement activation, alternative pathway (GO:0006957 from GO Biological Process Annotations)", "complement activation, classical pathway (GO:0006958 from GO Biological Process Annotations)", "complement activation, lectin pathway (GO:0001867 from GO Biological Process Annotations)", "complement component c5a signaling pathway (GO:0038178 from GO Biological Process Annotations)", "complement receptor mediated signaling pathway (GO:0002430 from GO Biological Process Annotations)", "complement-dependent cytotoxicity (GO:0097278 from GO Biological Process Annotations)", "compound eye corneal lens development (GO:0048058 from GO Biological Process Annotations)", "compound eye development (GO:0048749 from GO Biological Process Annotations)", "conditioned taste aversion (GO:0001661 from GO Biological Process Annotations)", "connecting tubule development (GO:0072027 from GO Biological Process Annotations)", "connective tissue development (GO:0061448 from GO Biological Process Annotations)", "connective tissue growth factor biosynthetic process (GO:0045189 from GO Biological Process Annotations)", "connective tissue replacement involved in inflammatory response wound healing (GO:0002248 from GO Biological Process Annotations)", "constitutive protein ectodomain proteolysis (GO:0051089 from GO Biological Process Annotations)", "constitutive secretory pathway (GO:0045054 from GO Biological Process Annotations)", "contact inhibition (GO:0060242 from GO Biological Process Annotations)", "contractile actin filament bundle assembly (GO:0030038 from GO Biological Process Annotations)", "convergent extension (GO:0060026 from GO Biological Process Annotations)", "convergent extension involved in axis elongation (GO:0060028 from GO Biological Process Annotations)", "convergent extension involved in gastrulation (GO:0060027 from GO Biological Process Annotations)", "convergent extension involved in neural plate elongation (GO:0022007 from GO Biological Process Annotations)", "convergent extension involved in organogenesis (GO:0060029 from GO Biological Process Annotations)", "convergent extension involved in somitogenesis (GO:0090246 from GO Biological Process Annotations)", "conversion of ds sirna to ss sirna (GO:0036404 from GO Biological Process Annotations)", "conversion of ds sirna to ss sirna involved in rna interference (GO:0033168 from GO Biological Process Annotations)", "conversion of methionyl-trna to n-formyl-methionyl-trna (GO:0071951 from GO Biological Process Annotations)", "cop9 signalosome assembly (GO:0010387 from GO Biological Process Annotations)", "copi coating of golgi vesicle (GO:0048205 from GO Biological Process Annotations)", "copi-coated vesicle budding (GO:0035964 from GO Biological Process Annotations)", "copii vesicle coating (GO:0048208 from GO Biological Process Annotations)", "copii-coated vesicle budding (GO:0090114 from GO Biological Process Annotations)", "copper ion export (GO:0060003 from GO Biological Process Annotations)", "copper ion homeostasis (GO:0055070 from GO Biological Process Annotations)", "copper ion import (GO:0015677 from GO Biological Process Annotations)", "copper ion import into cell (GO:1902861 from GO Biological Process Annotations)", "copper ion transmembrane transport (GO:0035434 from GO Biological Process Annotations)", "copper ion transport (GO:0006825 from GO Biological Process Annotations)", "copulation (GO:0007620 from GO Biological Process Annotations)", "coreceptor-mediated virion attachment to host cell (GO:0046814 from GO Biological Process Annotations)", "cornea development in camera-type eye (GO:0061303 from GO Biological Process Annotations)", "corneocyte development (GO:0003335 from GO Biological Process Annotations)", "cornification (GO:0070268 from GO Biological Process Annotations)", "coronal suture morphogenesis (GO:0060365 from GO Biological Process Annotations)", "coronary artery morphogenesis (GO:0060982 from GO Biological Process Annotations)", "coronary vasculature development (GO:0060976 from GO Biological Process Annotations)", "coronary vasculature morphogenesis (GO:0060977 from GO Biological Process Annotations)", "coronary vein morphogenesis (GO:0003169 from GO Biological Process Annotations)", "corpus callosum development (GO:0022038 from GO Biological Process Annotations)", "corpus callosum morphogenesis (GO:0021540 from GO Biological Process Annotations)", "cortical actin cytoskeleton organization (GO:0030866 from GO Biological Process Annotations)", "cortical collecting duct development (GO:0072059 from GO Biological Process Annotations)", "cortical cytoskeleton organization (GO:0030865 from GO Biological Process Annotations)", "cortical microtubule organization (GO:0043622 from GO Biological Process Annotations)", "corticospinal neuron axon guidance (GO:0021966 from GO Biological Process Annotations)", "corticospinal neuron axon guidance through spinal cord (GO:0021972 from GO Biological Process Annotations)", "corticospinal tract morphogenesis (GO:0021957 from GO Biological Process Annotations)", "corticosteroid hormone secretion (GO:0035930 from GO Biological Process Annotations)", "corticosteroid receptor signaling pathway (GO:0031958 from GO Biological Process Annotations)", "corticotropin hormone secreting cell differentiation (GO:0060128 from GO Biological Process Annotations)", "corticotropin secretion (GO:0051458 from GO Biological Process Annotations)", "cortisol biosynthetic process (GO:0034651 from GO Biological Process Annotations)", "cortisol metabolic process (GO:0034650 from GO Biological Process Annotations)", "cortisol secretion (GO:0043400 from GO Biological Process Annotations)", "cotranslational protein targeting to membrane (GO:0006613 from GO Biological Process Annotations)", "coumarin catabolic process (GO:0046226 from GO Biological Process Annotations)", "coumarin metabolic process (GO:0009804 from GO Biological Process Annotations)", "covalent chromatin modification (GO:0016569 from GO Biological Process Annotations)", "cranial ganglion development (GO:0061550 from GO Biological Process Annotations)", "cranial nerve development (GO:0021545 from GO Biological Process Annotations)", "cranial nerve formation (GO:0021603 from GO Biological Process Annotations)", "cranial nerve morphogenesis (GO:0021602 from GO Biological Process Annotations)", "cranial nerve structural organization (GO:0021604 from GO Biological Process Annotations)", "cranial suture morphogenesis (GO:0060363 from GO Biological Process Annotations)", "craniofacial suture morphogenesis (GO:0097094 from GO Biological Process Annotations)", "crd-mediated mrna stabilization (GO:0070934 from GO Biological Process Annotations)", "creatine biosynthetic process (GO:0006601 from GO Biological Process Annotations)", "creatine metabolic process (GO:0006600 from GO Biological Process Annotations)", "creatine transmembrane transport (GO:1902598 from GO Biological Process Annotations)", "creatine transport (GO:0015881 from GO Biological Process Annotations)", "creatinine homeostasis (GO:0097273 from GO Biological Process Annotations)", "creatinine metabolic process (GO:0046449 from GO Biological Process Annotations)", "cristae formation (GO:0042407 from GO Biological Process Annotations)", "ctp biosynthetic process (GO:0006241 from GO Biological Process Annotations)", "ctp metabolic process (GO:0046036 from GO Biological Process Annotations)", "ctp salvage (GO:0044211 from GO Biological Process Annotations)", "cullin deneddylation (GO:0010388 from GO Biological Process Annotations)", "cut catabolic process (GO:0071034 from GO Biological Process Annotations)", "cut metabolic process (GO:0071043 from GO Biological Process Annotations)", "cuticle development (GO:0042335 from GO Biological Process Annotations)", "cvt pathway (GO:0032258 from GO Biological Process Annotations)", "cyanate catabolic process (GO:0009440 from GO Biological Process Annotations)", "cyanate metabolic process (GO:0009439 from GO Biological Process Annotations)", "cyclic nucleotide biosynthetic process (GO:0009190 from GO Biological Process Annotations)", "cyclic nucleotide catabolic process (GO:0009214 from GO Biological Process Annotations)", "cyclic nucleotide metabolic process (GO:0009187 from GO Biological Process Annotations)", "cyclic purine nucleotide metabolic process (GO:0052652 from GO Biological Process Annotations)", "cyclic-nucleotide-mediated signaling (GO:0019935 from GO Biological Process Annotations)", "cyclooxygenase pathway (GO:0019371 from GO Biological Process Annotations)", "cysteine biosynthetic process (GO:0019344 from GO Biological Process Annotations)", "cysteine catabolic process (GO:0009093 from GO Biological Process Annotations)", "cysteine metabolic process (GO:0006534 from GO Biological Process Annotations)", "cysteine transmembrane transport (GO:1903712 from GO Biological Process Annotations)", "cysteine transport (GO:0042883 from GO Biological Process Annotations)", "cysteinyl-trna aminoacylation (GO:0006423 from GO Biological Process Annotations)", "cytidine catabolic process (GO:0006216 from GO Biological Process Annotations)", "cytidine deamination (GO:0009972 from GO Biological Process Annotations)", "cytidine metabolic process (GO:0046087 from GO Biological Process Annotations)", "cytidine to uridine editing (GO:0016554 from GO Biological Process Annotations)", "cytochrome complex assembly (GO:0017004 from GO Biological Process Annotations)", "cytokine biosynthetic process (GO:0042089 from GO Biological Process Annotations)", "cytokine metabolic process (GO:0042107 from GO Biological Process Annotations)", "cytokine production (GO:0001816 from GO Biological Process Annotations)", "cytokine production involved in immune response (GO:0002367 from GO Biological Process Annotations)", "cytokine production involved in inflammatory response (GO:0002534 from GO Biological Process Annotations)", "cytokine secretion (GO:0050663 from GO Biological Process Annotations)", "cytokine secretion involved in immune response (GO:0002374 from GO Biological Process Annotations)", "cytokine-mediated signaling pathway (GO:0019221 from GO Biological Process Annotations)", "cytokinesis (GO:0000910 from GO Biological Process Annotations)", "cytokinetic process (GO:0032506 from GO Biological Process Annotations)", "cytolysis (GO:0019835 from GO Biological Process Annotations)", "cytolysis by symbiont of host cells (GO:0001897 from GO Biological Process Annotations)", "cytolysis in other organism (GO:0051715 from GO Biological Process Annotations)", "cytolysis in other organism involved in symbiotic interaction (GO:0051801 from GO Biological Process Annotations)", "cytoplasm organization (GO:0007028 from GO Biological Process Annotations)", "cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process (GO:0071629 from GO Biological Process Annotations)", "cytoplasmic actin-based contraction involved in cell motility (GO:0060327 from GO Biological Process Annotations)", "cytoplasmic microtubule depolymerization (GO:0010938 from GO Biological Process Annotations)", "cytoplasmic microtubule organization (GO:0031122 from GO Biological Process Annotations)", "cytoplasmic mrna processing body assembly (GO:0033962 from GO Biological Process Annotations)", "cytoplasmic pattern recognition receptor signaling pathway (GO:0002753 from GO Biological Process Annotations)", "cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528 from GO Biological Process Annotations)", "cytoplasmic rna surveillance (GO:0071026 from GO Biological Process Annotations)", "cytoplasmic sequestering of cftr protein (GO:0043004 from GO Biological Process Annotations)", "cytoplasmic sequestering of nf-kappab (GO:0007253 from GO Biological Process Annotations)", "cytoplasmic sequestering of protein (GO:0051220 from GO Biological Process Annotations)", "cytoplasmic sequestering of transcription factor (GO:0042994 from GO Biological Process Annotations)", "cytoplasmic translation (GO:0002181 from GO Biological Process Annotations)", "cytoplasmic translational initiation (GO:0002183 from GO Biological Process Annotations)", "cytoplasmic transport (GO:0016482 from GO Biological Process Annotations)", "cytosine metabolic process (GO:0019858 from GO Biological Process Annotations)", "cytoskeletal anchoring at nuclear membrane (GO:0090286 from GO Biological Process Annotations)", "cytoskeletal anchoring at plasma membrane (GO:0007016 from GO Biological Process Annotations)", "cytoskeletal matrix organization at active zone (GO:0048789 from GO Biological Process Annotations)", "cytoskeleton organization (GO:0007010 from GO Biological Process Annotations)", "cytoskeleton-dependent cytokinesis (GO:0061640 from GO Biological Process Annotations)", "cytoskeleton-dependent intracellular transport (GO:0030705 from GO Biological Process Annotations)", "cytosol to er transport (GO:0046967 from GO Biological Process Annotations)", "cytosolic calcium ion homeostasis (GO:0051480 from GO Biological Process Annotations)", "cytosolic calcium ion transport (GO:0060401 from GO Biological Process Annotations)", "cytotoxic t cell degranulation (GO:0043316 from GO Biological Process Annotations)", "cytotoxic t cell differentiation (GO:0045065 from GO Biological Process Annotations)", "d-alanine catabolic process (GO:0055130 from GO Biological Process Annotations)", "d-alanine family amino acid metabolic process (GO:0046144 from GO Biological Process Annotations)", "d-alanine metabolic process (GO:0046436 from GO Biological Process Annotations)", "d-alanine transport (GO:0042941 from GO Biological Process Annotations)", "d-amino acid biosynthetic process (GO:0046437 from GO Biological Process Annotations)", "d-amino acid catabolic process (GO:0019478 from GO Biological Process Annotations)", "d-amino acid metabolic process (GO:0046416 from GO Biological Process Annotations)", "d-amino acid transport (GO:0042940 from GO Biological Process Annotations)", "d-aspartate import (GO:0070779 from GO Biological Process Annotations)", "d-aspartate transport (GO:0070777 from GO Biological Process Annotations)", "d-gluconate catabolic process (GO:0046177 from GO Biological Process Annotations)", "d-gluconate metabolic process (GO:0019521 from GO Biological Process Annotations)", "d-glucuronate catabolic process (GO:0042840 from GO Biological Process Annotations)", "d-glucuronate metabolic process (GO:0042839 from GO Biological Process Annotations)", "d-ribose catabolic process (GO:0019303 from GO Biological Process Annotations)", "d-ribose metabolic process (GO:0006014 from GO Biological Process Annotations)", "d-serine biosynthetic process (GO:0070179 from GO Biological Process Annotations)", "d-serine catabolic process (GO:0036088 from GO Biological Process Annotations)", "d-serine metabolic process (GO:0070178 from GO Biological Process Annotations)", "d-serine transport (GO:0042942 from GO Biological Process Annotations)", "d-xylose catabolic process (GO:0042843 from GO Biological Process Annotations)", "d-xylose metabolic process (GO:0042732 from GO Biological Process Annotations)", "dadp biosynthetic process (GO:0006173 from GO Biological Process Annotations)", "dadp catabolic process (GO:0046057 from GO Biological Process Annotations)", "dadp metabolic process (GO:0046056 from GO Biological Process Annotations)", "dadp phosphorylation (GO:0006174 from GO Biological Process Annotations)", "damp phosphorylation (GO:0061565 from GO Biological Process Annotations)", "datp biosynthetic process (GO:0006175 from GO Biological Process Annotations)", "datp catabolic process (GO:0046061 from GO Biological Process Annotations)", "datp metabolic process (GO:0046060 from GO Biological Process Annotations)", "daunorubicin metabolic process (GO:0044597 from GO Biological Process Annotations)", "dcdp biosynthetic process (GO:0006240 from GO Biological Process Annotations)", "dcdp metabolic process (GO:0046062 from GO Biological Process Annotations)", "dcdp phosphorylation (GO:0061570 from GO Biological Process Annotations)", "dcmp phosphorylation (GO:0061567 from GO Biological Process Annotations)", "dct cell differentiation (GO:0072069 from GO Biological Process Annotations)", "de novo centriole assembly (GO:0098535 from GO Biological Process Annotations)", "deadenylation-dependent decapping of nuclear-transcribed mrna (GO:0000290 from GO Biological Process Annotations)", "deadenylation-independent decapping of nuclear-transcribed mrna (GO:0031087 from GO Biological Process Annotations)", "death (GO:0016265 from GO Biological Process Annotations)", "death-inducing signaling complex assembly (GO:0071550 from GO Biological Process Annotations)", "decidualization (GO:0046697 from GO Biological Process Annotations)", "dedifferentiation (GO:0043696 from GO Biological Process Annotations)", "defecation (GO:0030421 from GO Biological Process Annotations)", "defense response (GO:0006952 from GO Biological Process Annotations)", "defense response to bacterium (GO:0042742 from GO Biological Process Annotations)", "defense response to fungus (GO:0050832 from GO Biological Process Annotations)", "defense response to fungus, incompatible interaction (GO:0009817 from GO Biological Process Annotations)", "defense response to gram-negative bacterium (GO:0050829 from GO Biological Process Annotations)", "defense response to gram-positive bacterium (GO:0050830 from GO Biological Process Annotations)", "defense response to nematode (GO:0002215 from GO Biological Process Annotations)", "defense response to other organism (GO:0098542 from GO Biological Process Annotations)", "defense response to protozoan (GO:0042832 from GO Biological Process Annotations)", "defense response to tumor cell (GO:0002357 from GO Biological Process Annotations)", "defense response to virus (GO:0051607 from GO Biological Process Annotations)", "defense response, incompatible interaction (GO:0009814 from GO Biological Process Annotations)", "definitive erythrocyte differentiation (GO:0060318 from GO Biological Process Annotations)", "definitive hemopoiesis (GO:0060216 from GO Biological Process Annotations)", "dehydroascorbic acid transport (GO:0070837 from GO Biological Process Annotations)", "deltoid tuberosity development (GO:0035993 from GO Biological Process Annotations)", "demethylation (GO:0070988 from GO Biological Process Annotations)", "dendrite development (GO:0016358 from GO Biological Process Annotations)", "dendrite extension (GO:0097484 from GO Biological Process Annotations)", "dendrite morphogenesis (GO:0048813 from GO Biological Process Annotations)", "dendrite regeneration (GO:0031104 from GO Biological Process Annotations)", "dendrite self-avoidance (GO:0070593 from GO Biological Process Annotations)", "dendritic cell chemotaxis (GO:0002407 from GO Biological Process Annotations)", "dendritic cell cytokine production (GO:0002371 from GO Biological Process Annotations)", "dendritic cell dendrite assembly (GO:0097026 from GO Biological Process Annotations)", "dendritic cell differentiation (GO:0097028 from GO Biological Process Annotations)", "dendritic cell migration (GO:0036336 from GO Biological Process Annotations)", "dendritic cell proliferation (GO:0044565 from GO Biological Process Annotations)", "dendritic spine development (GO:0060996 from GO Biological Process Annotations)", "dendritic spine maintenance (GO:0097062 from GO Biological Process Annotations)", "dendritic spine morphogenesis (GO:0060997 from GO Biological Process Annotations)", "dendritic spine organization (GO:0097061 from GO Biological Process Annotations)", "dense core granule maturation (GO:1990502 from GO Biological Process Annotations)", "dentate gyrus development (GO:0021542 from GO Biological Process Annotations)", "dentinogenesis (GO:0097187 from GO Biological Process Annotations)", "deoxyadenosine catabolic process (GO:0006157 from GO Biological Process Annotations)", "deoxyadenosine metabolic process (GO:0046090 from GO Biological Process Annotations)", "deoxycytidine metabolic process (GO:0046092 from GO Biological Process Annotations)", "deoxyhypusine biosynthetic process from spermidine (GO:0050983 from GO Biological Process Annotations)", "deoxynucleotide transport (GO:0030302 from GO Biological Process Annotations)", "deoxyribonucleoside biosynthetic process (GO:0046120 from GO Biological Process Annotations)", "deoxyribonucleoside catabolic process (GO:0046121 from GO Biological Process Annotations)", "deoxyribonucleoside diphosphate biosynthetic process (GO:0009189 from GO Biological Process Annotations)", "deoxyribonucleoside diphosphate catabolic process (GO:0009192 from GO Biological Process Annotations)", "deoxyribonucleoside diphosphate metabolic process (GO:0009186 from GO Biological Process Annotations)", "deoxyribonucleoside metabolic process (GO:0009120 from GO Biological Process Annotations)", "deoxyribonucleoside monophosphate biosynthetic process (GO:0009157 from GO Biological Process Annotations)", "deoxyribonucleoside monophosphate catabolic process (GO:0009159 from GO Biological Process Annotations)", "deoxyribonucleoside monophosphate metabolic process (GO:0009162 from GO Biological Process Annotations)", "deoxyribonucleoside triphosphate biosynthetic process (GO:0009202 from GO Biological Process Annotations)", "deoxyribonucleoside triphosphate catabolic process (GO:0009204 from GO Biological Process Annotations)", "deoxyribonucleoside triphosphate metabolic process (GO:0009200 from GO Biological Process Annotations)", "deoxyribonucleotide biosynthetic process (GO:0009263 from GO Biological Process Annotations)", "deoxyribonucleotide catabolic process (GO:0009264 from GO Biological Process Annotations)", "deoxyribonucleotide metabolic process (GO:0009262 from GO Biological Process Annotations)", "deoxyribose phosphate biosynthetic process (GO:0046385 from GO Biological Process Annotations)", "deoxyribose phosphate catabolic process (GO:0046386 from GO Biological Process Annotations)", "deoxyribose phosphate metabolic process (GO:0019692 from GO Biological Process Annotations)", "dephosphorylation (GO:0016311 from GO Biological Process Annotations)", "dephosphorylation of rna polymerase ii c-terminal domain (GO:0070940 from GO Biological Process Annotations)", "depurination (GO:0045007 from GO Biological Process Annotations)", "depyrimidination (GO:0045008 from GO Biological Process Annotations)", "dermatan sulfate biosynthetic process (GO:0030208 from GO Biological Process Annotations)", "dermatan sulfate catabolic process (GO:0030209 from GO Biological Process Annotations)", "dermatan sulfate metabolic process (GO:0030205 from GO Biological Process Annotations)", "dermatan sulfate proteoglycan biosynthetic process (GO:0050651 from GO Biological Process Annotations)", "dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050652 from GO Biological Process Annotations)", "dermatan sulfate proteoglycan metabolic process (GO:0050655 from GO Biological Process Annotations)", "descending thin limb development (GO:0072022 from GO Biological Process Annotations)", "desensitization of g-protein coupled receptor protein signaling pathway (GO:0002029 from GO Biological Process Annotations)", "desensitization of g-protein coupled receptor protein signaling pathway by arrestin (GO:0002032 from GO Biological Process Annotations)", "desmosome assembly (GO:0002159 from GO Biological Process Annotations)", "desmosome disassembly (GO:0035921 from GO Biological Process Annotations)", "desmosome organization (GO:0002934 from GO Biological Process Annotations)", "detection of abiotic stimulus (GO:0009582 from GO Biological Process Annotations)", "detection of bacterial lipopeptide (GO:0070340 from GO Biological Process Annotations)", "detection of bacterial lipoprotein (GO:0042494 from GO Biological Process Annotations)", "detection of bacterium (GO:0016045 from GO Biological Process Annotations)", "detection of biotic stimulus (GO:0009595 from GO Biological Process Annotations)", "detection of calcium ion (GO:0005513 from GO Biological Process Annotations)", "detection of carbohydrate stimulus (GO:0009730 from GO Biological Process Annotations)", "detection of cell density (GO:0060245 from GO Biological Process Annotations)", "detection of cell density by contact stimulus (GO:0060246 from GO Biological Process Annotations)", "detection of cell density by contact stimulus involved in contact inhibition (GO:0060248 from GO Biological Process Annotations)", "detection of chemical stimulus (GO:0009593 from GO Biological Process Annotations)", "detection of chemical stimulus involved in sensory perception (GO:0050907 from GO Biological Process Annotations)", "detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580 from GO Biological Process Annotations)", "detection of chemical stimulus involved in sensory perception of pain (GO:0050968 from GO Biological Process Annotations)", "detection of chemical stimulus involved in sensory perception of smell (GO:0050911 from GO Biological Process Annotations)", "detection of chemical stimulus involved in sensory perception of sour taste (GO:0001581 from GO Biological Process Annotations)", "detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582 from GO Biological Process Annotations)", "detection of chemical stimulus involved in sensory perception of taste (GO:0050912 from GO Biological Process Annotations)", "detection of diacyl bacterial lipopeptide (GO:0042496 from GO Biological Process Annotations)", "detection of endogenous stimulus (GO:0009726 from GO Biological Process Annotations)", "detection of external biotic stimulus (GO:0098581 from GO Biological Process Annotations)", "detection of external stimulus (GO:0009581 from GO Biological Process Annotations)", "detection of fungus (GO:0016046 from GO Biological Process Annotations)", "detection of glucose (GO:0051594 from GO Biological Process Annotations)", "detection of gravity (GO:0009590 from GO Biological Process Annotations)", "detection of hexose stimulus (GO:0009732 from GO Biological Process Annotations)", "detection of hormone stimulus (GO:0009720 from GO Biological Process Annotations)", "detection of hypoxia (GO:0070483 from GO Biological Process Annotations)", "detection of hypoxic conditions in blood by carotid body chemoreceptor signaling (GO:0003029 from GO Biological Process Annotations)", "detection of hypoxic conditions in blood by chemoreceptor signaling (GO:0002007 from GO Biological Process Annotations)", "detection of light stimulus (GO:0009583 from GO Biological Process Annotations)", "detection of light stimulus involved in sensory perception (GO:0050962 from GO Biological Process Annotations)", "detection of light stimulus involved in visual perception (GO:0050908 from GO Biological Process Annotations)", "detection of lipopolysaccharide (GO:0032497 from GO Biological Process Annotations)", "detection of lipoteichoic acid (GO:0070392 from GO Biological Process Annotations)", "detection of mechanical stimulus (GO:0050982 from GO Biological Process Annotations)", "detection of mechanical stimulus involved in equilibrioception (GO:0050973 from GO Biological Process Annotations)", "detection of mechanical stimulus involved in sensory perception (GO:0050974 from GO Biological Process Annotations)", "detection of mechanical stimulus involved in sensory perception of pain (GO:0050966 from GO Biological Process Annotations)", "detection of mechanical stimulus involved in sensory perception of sound (GO:0050910 from GO Biological Process Annotations)", "detection of mechanical stimulus involved in sensory perception of touch (GO:0050976 from GO Biological Process Annotations)", "detection of molecule of bacterial origin (GO:0032490 from GO Biological Process Annotations)", "detection of monosaccharide stimulus (GO:0034287 from GO Biological Process Annotations)", "detection of muramyl dipeptide (GO:0032498 from GO Biological Process Annotations)", "detection of muscle stretch (GO:0035995 from GO Biological Process Annotations)", "detection of nodal flow (GO:0003127 from GO Biological Process Annotations)", "detection of other organism (GO:0098543 from GO Biological Process Annotations)", "detection of oxidative stress (GO:0070994 from GO Biological Process Annotations)", "detection of oxygen (GO:0003032 from GO Biological Process Annotations)", "detection of peptidoglycan (GO:0032499 from GO Biological Process Annotations)", "detection of stimulus (GO:0051606 from GO Biological Process Annotations)", "detection of stimulus involved in sensory perception (GO:0050906 from GO Biological Process Annotations)", "detection of temperature stimulus (GO:0016048 from GO Biological Process Annotations)", "detection of temperature stimulus involved in sensory perception (GO:0050961 from GO Biological Process Annotations)", "detection of temperature stimulus involved in sensory perception of pain (GO:0050965 from GO Biological Process Annotations)", "detection of triacyl bacterial lipopeptide (GO:0042495 from GO Biological Process Annotations)", "detection of tumor cell (GO:0002355 from GO Biological Process Annotations)", "detection of uv (GO:0009589 from GO Biological Process Annotations)", "detection of virus (GO:0009597 from GO Biological Process Annotations)", "detection of visible light (GO:0009584 from GO Biological Process Annotations)", "detection of wounding (GO:0014822 from GO Biological Process Annotations)", "determination of adult lifespan (GO:0008340 from GO Biological Process Annotations)", "determination of affect (GO:0050894 from GO Biological Process Annotations)", "determination of bilateral symmetry (GO:0009855 from GO Biological Process Annotations)", "determination of digestive tract left|right asymmetry (GO:0071907 from GO Biological Process Annotations)", "determination of dorsal identity (GO:0048263 from GO Biological Process Annotations)", "determination of heart left|right asymmetry (GO:0061371 from GO Biological Process Annotations)", "determination of intestine left|right asymmetry (GO:0071908 from GO Biological Process Annotations)", "determination of left|right asymmetry in lateral mesoderm (GO:0003140 from GO Biological Process Annotations)", "determination of left|right asymmetry in nervous system (GO:0035545 from GO Biological Process Annotations)", "determination of left|right symmetry (GO:0007368 from GO Biological Process Annotations)", "determination of liver left|right asymmetry (GO:0071910 from GO Biological Process Annotations)", "determination of pancreatic left|right asymmetry (GO:0035469 from GO Biological Process Annotations)", "determination of stomach left|right asymmetry (GO:0071909 from GO Biological Process Annotations)", "detoxification (GO:0098754 from GO Biological Process Annotations)", "detoxification of cadmium ion (GO:0071585 from GO Biological Process Annotations)", "detoxification of copper ion (GO:0010273 from GO Biological Process Annotations)", "detoxification of mercury ion (GO:0050787 from GO Biological Process Annotations)", "detoxification of nitrogen compound (GO:0051410 from GO Biological Process Annotations)", "development involved in symbiotic interaction (GO:0044111 from GO Biological Process Annotations)", "development of primary female sexual characteristics (GO:0046545 from GO Biological Process Annotations)", "development of primary sexual characteristics (GO:0045137 from GO Biological Process Annotations)", "development of secondary female sexual characteristics (GO:0046543 from GO Biological Process Annotations)", "development of secondary male sexual characteristics (GO:0046544 from GO Biological Process Annotations)", "development of secondary sexual characteristics (GO:0045136 from GO Biological Process Annotations)", "developmental cell growth (GO:0048588 from GO Biological Process Annotations)", "developmental growth (GO:0048589 from GO Biological Process Annotations)", "developmental growth involved in morphogenesis (GO:0060560 from GO Biological Process Annotations)", "developmental induction (GO:0031128 from GO Biological Process Annotations)", "developmental maturation (GO:0021700 from GO Biological Process Annotations)", "developmental pigmentation (GO:0048066 from GO Biological Process Annotations)", "developmental process (GO:0032502 from GO Biological Process Annotations)", "developmental process involved in reproduction (GO:0003006 from GO Biological Process Annotations)", "developmental programmed cell death (GO:0010623 from GO Biological Process Annotations)", "dgdp biosynthetic process (GO:0006185 from GO Biological Process Annotations)", "dgdp catabolic process (GO:0046067 from GO Biological Process Annotations)", "dgdp metabolic process (GO:0046066 from GO Biological Process Annotations)", "dgdp phosphorylation (GO:0006186 from GO Biological Process Annotations)", "dgmp metabolic process (GO:0046054 from GO Biological Process Annotations)", "dgtp catabolic process (GO:0006203 from GO Biological Process Annotations)", "dgtp metabolic process (GO:0046070 from GO Biological Process Annotations)", "diacylglycerol biosynthetic process (GO:0006651 from GO Biological Process Annotations)", "diacylglycerol catabolic process (GO:0046340 from GO Biological Process Annotations)", "diacylglycerol metabolic process (GO:0046339 from GO Biological Process Annotations)", "diadenosine polyphosphate biosynthetic process (GO:0015960 from GO Biological Process Annotations)", "diadenosine polyphosphate catabolic process (GO:0015961 from GO Biological Process Annotations)", "diadenosine polyphosphate metabolic process (GO:0015959 from GO Biological Process Annotations)", "diadenosine tetraphosphate biosynthetic process (GO:0015966 from GO Biological Process Annotations)", "diadenosine tetraphosphate metabolic process (GO:0015965 from GO Biological Process Annotations)", "diapedesis (GO:0050904 from GO Biological Process Annotations)", "diaphragm contraction (GO:0002086 from GO Biological Process Annotations)", "diaphragm development (GO:0060539 from GO Biological Process Annotations)", "dibenzo-p-dioxin catabolic process (GO:0019341 from GO Biological Process Annotations)", "dibenzo-p-dioxin metabolic process (GO:0018894 from GO Biological Process Annotations)", "dicarboxylic acid biosynthetic process (GO:0043650 from GO Biological Process Annotations)", "dicarboxylic acid catabolic process (GO:0043649 from GO Biological Process Annotations)", "dicarboxylic acid metabolic process (GO:0043648 from GO Biological Process Annotations)", "dicarboxylic acid transport (GO:0006835 from GO Biological Process Annotations)", "dichotomous subdivision of an epithelial terminal unit (GO:0060600 from GO Biological Process Annotations)", "dichotomous subdivision of terminal units involved in lung branching (GO:0060448 from GO Biological Process Annotations)", "dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis (GO:0060598 from GO Biological Process Annotations)", "dichotomous subdivision of terminal units involved in salivary gland branching (GO:0060666 from GO Biological Process Annotations)", "dichotomous subdivision of terminal units involved in ureteric bud branching (GO:0060678 from GO Biological Process Annotations)", "diencephalon development (GO:0021536 from GO Biological Process Annotations)", "diencephalon morphogenesis (GO:0048852 from GO Biological Process Annotations)", "diet induced thermogenesis (GO:0002024 from GO Biological Process Annotations)", "digestion (GO:0007586 from GO Biological Process Annotations)", "digestive system development (GO:0055123 from GO Biological Process Annotations)", "digestive system process (GO:0022600 from GO Biological Process Annotations)", "digestive tract development (GO:0048565 from GO Biological Process Annotations)", "digestive tract morphogenesis (GO:0048546 from GO Biological Process Annotations)", "dihydrobiopterin metabolic process (GO:0051066 from GO Biological Process Annotations)", "dihydrofolate metabolic process (GO:0046452 from GO Biological Process Annotations)", "dimeric g-protein coupled receptor signaling pathway (GO:0038042 from GO Biological Process Annotations)", "dimethylallyl diphosphate biosynthetic process (GO:0050992 from GO Biological Process Annotations)", "dimethylallyl diphosphate metabolic process (GO:0050993 from GO Biological Process Annotations)", "diol biosynthetic process (GO:0034312 from GO Biological Process Annotations)", "diol metabolic process (GO:0034311 from GO Biological Process Annotations)", "dipeptide transport (GO:0042938 from GO Biological Process Annotations)", "diphosphate metabolic process (GO:0071344 from GO Biological Process Annotations)", "diphosphoinositol polyphosphate catabolic process (GO:0071544 from GO Biological Process Annotations)", "diphosphoinositol polyphosphate metabolic process (GO:0071543 from GO Biological Process Annotations)", "direct ossification (GO:0036072 from GO Biological Process Annotations)", "directional locomotion (GO:0033058 from GO Biological Process Annotations)", "disaccharide biosynthetic process (GO:0046351 from GO Biological Process Annotations)", "disaccharide catabolic process (GO:0046352 from GO Biological Process Annotations)", "disaccharide metabolic process (GO:0005984 from GO Biological Process Annotations)", "disruption by host of symbiont cells (GO:0051852 from GO Biological Process Annotations)", "disruption by symbiont of host cell (GO:0044004 from GO Biological Process Annotations)", "disruption of cells of other organism (GO:0044364 from GO Biological Process Annotations)", "disruption of cells of other organism involved in symbiotic interaction (GO:0051818 from GO Biological Process Annotations)", "dissemination or transmission of organism from other organism involved in symbiotic interaction (GO:0051821 from GO Biological Process Annotations)", "dissemination or transmission of symbiont from host (GO:0044007 from GO Biological Process Annotations)", "distal convoluted tubule development (GO:0072025 from GO Biological Process Annotations)", "distal tubule development (GO:0072017 from GO Biological Process Annotations)", "distal tubule morphogenesis (GO:0072156 from GO Biological Process Annotations)", "diterpenoid biosynthetic process (GO:0016102 from GO Biological Process Annotations)", "diterpenoid catabolic process (GO:0016103 from GO Biological Process Annotations)", "diterpenoid metabolic process (GO:0016101 from GO Biological Process Annotations)", "ditp catabolic process (GO:0035863 from GO Biological Process Annotations)", "ditp metabolic process (GO:0035862 from GO Biological Process Annotations)", "divalent inorganic anion homeostasis (GO:0072505 from GO Biological Process Annotations)", "divalent inorganic cation homeostasis (GO:0072507 from GO Biological Process Annotations)", "divalent inorganic cation transport (GO:0072511 from GO Biological Process Annotations)", "divalent metal ion export (GO:0070839 from GO Biological Process Annotations)", "divalent metal ion transport (GO:0070838 from GO Biological Process Annotations)", "dna alkylation (GO:0006305 from GO Biological Process Annotations)", "dna biosynthetic process (GO:0071897 from GO Biological Process Annotations)", "dna catabolic process (GO:0006308 from GO Biological Process Annotations)", "dna catabolic process, endonucleolytic (GO:0000737 from GO Biological Process Annotations)", "dna catabolic process, exonucleolytic (GO:0000738 from GO Biological Process Annotations)", "dna conformation change (GO:0071103 from GO Biological Process Annotations)", "dna cytosine deamination (GO:0070383 from GO Biological Process Annotations)", "dna damage checkpoint (GO:0000077 from GO Biological Process Annotations)", "dna damage induced protein phosphorylation (GO:0006975 from GO Biological Process Annotations)", "dna damage response, detection of dna damage (GO:0042769 from GO Biological Process Annotations)", "dna damage response, signal transduction by p53 class mediator (GO:0030330 from GO Biological Process Annotations)", "dna damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977 from GO Biological Process Annotations)", "dna damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978 from GO Biological Process Annotations)", "dna damage response, signal transduction resulting in transcription (GO:0042772 from GO Biological Process Annotations)", "dna dealkylation (GO:0035510 from GO Biological Process Annotations)", "dna dealkylation involved in dna repair (GO:0006307 from GO Biological Process Annotations)", "dna deamination (GO:0045006 from GO Biological Process Annotations)", "dna demethylation (GO:0080111 from GO Biological Process Annotations)", "dna demethylation of male pronucleus (GO:0044727 from GO Biological Process Annotations)", "dna double-strand break processing (GO:0000729 from GO Biological Process Annotations)", "dna double-strand break processing involved in repair via single-strand annealing (GO:0010792 from GO Biological Process Annotations)", "dna duplex unwinding (GO:0032508 from GO Biological Process Annotations)", "dna endoreduplication (GO:0042023 from GO Biological Process Annotations)", "dna excision (GO:0044349 from GO Biological Process Annotations)", "dna geometric change (GO:0032392 from GO Biological Process Annotations)", "dna hypermethylation (GO:0044026 from GO Biological Process Annotations)", "dna hypomethylation (GO:0044028 from GO Biological Process Annotations)", "dna integration (GO:0015074 from GO Biological Process Annotations)", "dna integrity checkpoint (GO:0031570 from GO Biological Process Annotations)", "dna ligation (GO:0006266 from GO Biological Process Annotations)", "dna ligation involved in dna recombination (GO:0051102 from GO Biological Process Annotations)", "dna ligation involved in dna repair (GO:0051103 from GO Biological Process Annotations)", "dna metabolic process (GO:0006259 from GO Biological Process Annotations)", "dna methylation (GO:0006306 from GO Biological Process Annotations)", "dna methylation involved in embryo development (GO:0043045 from GO Biological Process Annotations)", "dna methylation involved in gamete generation (GO:0043046 from GO Biological Process Annotations)", "dna methylation on cytosine (GO:0032776 from GO Biological Process Annotations)", "dna methylation on cytosine within a cg sequence (GO:0010424 from GO Biological Process Annotations)", "dna methylation or demethylation (GO:0044728 from GO Biological Process Annotations)", "dna modification (GO:0006304 from GO Biological Process Annotations)", "dna packaging (GO:0006323 from GO Biological Process Annotations)", "dna protection (GO:0042262 from GO Biological Process Annotations)", "dna recombinase assembly (GO:0000730 from GO Biological Process Annotations)", "dna recombination (GO:0006310 from GO Biological Process Annotations)", "dna repair (GO:0006281 from GO Biological Process Annotations)", "dna replication (GO:0006260 from GO Biological Process Annotations)", "dna replication checkpoint (GO:0000076 from GO Biological Process Annotations)", "dna replication initiation (GO:0006270 from GO Biological Process Annotations)", "dna replication preinitiation complex assembly (GO:0071163 from GO Biological Process Annotations)", "dna replication proofreading (GO:0045004 from GO Biological Process Annotations)", "dna replication, okazaki fragment processing (GO:0033567 from GO Biological Process Annotations)", "dna replication, removal of rna primer (GO:0043137 from GO Biological Process Annotations)", "dna replication, synthesis of rna primer (GO:0006269 from GO Biological Process Annotations)", "dna replication-dependent nucleosome assembly (GO:0006335 from GO Biological Process Annotations)", "dna replication-dependent nucleosome organization (GO:0034723 from GO Biological Process Annotations)", "dna replication-independent nucleosome assembly (GO:0006336 from GO Biological Process Annotations)", "dna replication-independent nucleosome organization (GO:0034724 from GO Biological Process Annotations)", "dna rewinding (GO:0036292 from GO Biological Process Annotations)", "dna strand elongation (GO:0022616 from GO Biological Process Annotations)", "dna strand elongation involved in dna replication (GO:0006271 from GO Biological Process Annotations)", "dna strand renaturation (GO:0000733 from GO Biological Process Annotations)", "dna synthesis involved in dna repair (GO:0000731 from GO Biological Process Annotations)", "dna topological change (GO:0006265 from GO Biological Process Annotations)", "dna unwinding involved in dna replication (GO:0006268 from GO Biological Process Annotations)", "dna-dependent dna replication (GO:0006261 from GO Biological Process Annotations)", "dna-dependent dna replication maintenance of fidelity (GO:0045005 from GO Biological Process Annotations)", "dna-templated transcription, elongation (GO:0006354 from GO Biological Process Annotations)", "dna-templated transcription, initiation (GO:0006352 from GO Biological Process Annotations)", "dna-templated transcription, termination (GO:0006353 from GO Biological Process Annotations)", "dna-templated transcriptional preinitiation complex assembly (GO:0070897 from GO Biological Process Annotations)", "dolichol biosynthetic process (GO:0019408 from GO Biological Process Annotations)", "dolichol metabolic process (GO:0019348 from GO Biological Process Annotations)", "dolichol-linked oligosaccharide biosynthetic process (GO:0006488 from GO Biological Process Annotations)", "dolichyl diphosphate biosynthetic process (GO:0006489 from GO Biological Process Annotations)", "dolichyl diphosphate metabolic process (GO:0046465 from GO Biological Process Annotations)", "dolichyl monophosphate biosynthetic process (GO:0043048 from GO Biological Process Annotations)", "dopamine biosynthetic process (GO:0042416 from GO Biological Process Annotations)", "dopamine biosynthetic process from tyrosine (GO:0006585 from GO Biological Process Annotations)", "dopamine catabolic process (GO:0042420 from GO Biological Process Annotations)", "dopamine metabolic process (GO:0042417 from GO Biological Process Annotations)", "dopamine receptor signaling pathway (GO:0007212 from GO Biological Process Annotations)", "dopamine transport (GO:0015872 from GO Biological Process Annotations)", "dopamine uptake (GO:0090494 from GO Biological Process Annotations)", "dopamine uptake involved in synaptic transmission (GO:0051583 from GO Biological Process Annotations)", "dopaminergic neuron differentiation (GO:0071542 from GO Biological Process Annotations)", "dorsal aorta development (GO:0035907 from GO Biological Process Annotations)", "dorsal aorta morphogenesis (GO:0035912 from GO Biological Process Annotations)", "dorsal spinal cord development (GO:0021516 from GO Biological Process Annotations)", "dorsal|ventral axis specification (GO:0009950 from GO Biological Process Annotations)", "dorsal|ventral axon guidance (GO:0033563 from GO Biological Process Annotations)", "dorsal|ventral neural tube patterning (GO:0021904 from GO Biological Process Annotations)", "dorsal|ventral pattern formation (GO:0009953 from GO Biological Process Annotations)", "dosage compensation (GO:0007549 from GO Biological Process Annotations)", "dosage compensation by inactivation of x chromosome (GO:0009048 from GO Biological Process Annotations)", "double-strand break repair (GO:0006302 from GO Biological Process Annotations)", "double-strand break repair via alternative nonhomologous end joining (GO:0097681 from GO Biological Process Annotations)", "double-strand break repair via break-induced replication (GO:0000727 from GO Biological Process Annotations)", "double-strand break repair via classical nonhomologous end joining (GO:0097680 from GO Biological Process Annotations)", "double-strand break repair via homologous recombination (GO:0000724 from GO Biological Process Annotations)", "double-strand break repair via nonhomologous end joining (GO:0006303 from GO Biological Process Annotations)", "doxorubicin metabolic process (GO:0044598 from GO Biological Process Annotations)", "drinking behavior (GO:0042756 from GO Biological Process Annotations)", "drug catabolic process (GO:0042737 from GO Biological Process Annotations)", "drug export (GO:0046618 from GO Biological Process Annotations)", "drug metabolic process (GO:0017144 from GO Biological Process Annotations)", "drug transmembrane transport (GO:0006855 from GO Biological Process Annotations)", "drug transport (GO:0015893 from GO Biological Process Annotations)", "dsdna loop formation (GO:0090579 from GO Biological Process Annotations)", "dsrna fragmentation (GO:0031050 from GO Biological Process Annotations)", "dsrna transport (GO:0033227 from GO Biological Process Annotations)", "dtdp biosynthetic process (GO:0006233 from GO Biological Process Annotations)", "dtdp metabolic process (GO:0046072 from GO Biological Process Annotations)", "dtmp biosynthetic process (GO:0006231 from GO Biological Process Annotations)", "dtmp metabolic process (GO:0046073 from GO Biological Process Annotations)", "dttp biosynthetic process (GO:0006235 from GO Biological Process Annotations)", "dttp metabolic process (GO:0046075 from GO Biological Process Annotations)", "ductus arteriosus closure (GO:0097070 from GO Biological Process Annotations)", "dudp biosynthetic process (GO:0006227 from GO Biological Process Annotations)", "dudp metabolic process (GO:0046077 from GO Biological Process Annotations)", "dump biosynthetic process (GO:0006226 from GO Biological Process Annotations)", "dump catabolic process (GO:0046079 from GO Biological Process Annotations)", "dump metabolic process (GO:0046078 from GO Biological Process Annotations)", "dutp catabolic process (GO:0046081 from GO Biological Process Annotations)", "dutp metabolic process (GO:0046080 from GO Biological Process Annotations)", "dynamin polymerization involved in membrane fission (GO:0003373 from GO Biological Process Annotations)", "dynamin polymerization involved in mitochondrial fission (GO:0003374 from GO Biological Process Annotations)", "ear development (GO:0043583 from GO Biological Process Annotations)", "ear morphogenesis (GO:0042471 from GO Biological Process Annotations)", "early endosome to golgi transport (GO:0034498 from GO Biological Process Annotations)", "early endosome to late endosome transport (GO:0045022 from GO Biological Process Annotations)", "early endosome to recycling endosome transport (GO:0061502 from GO Biological Process Annotations)", "eating behavior (GO:0042755 from GO Biological Process Annotations)", "ectoderm and mesoderm interaction (GO:0007499 from GO Biological Process Annotations)", "ectoderm development (GO:0007398 from GO Biological Process Annotations)", "ectoderm formation (GO:0001705 from GO Biological Process Annotations)", "ectodermal cell differentiation (GO:0010668 from GO Biological Process Annotations)", "ectodermal placode formation (GO:0060788 from GO Biological Process Annotations)", "ectopic germ cell programmed cell death (GO:0035234 from GO Biological Process Annotations)", "efferent axon development in a lateral line nerve (GO:0048894 from GO Biological Process Annotations)", "egg activation (GO:0007343 from GO Biological Process Annotations)", "egg coat formation (GO:0035803 from GO Biological Process Annotations)", "elastic fiber assembly (GO:0048251 from GO Biological Process Annotations)", "elastin biosynthetic process (GO:0051542 from GO Biological Process Annotations)", "elastin metabolic process (GO:0051541 from GO Biological Process Annotations)", "electron transport chain (GO:0022900 from GO Biological Process Annotations)", "embryo development (GO:0009790 from GO Biological Process Annotations)", "embryo development ending in birth or egg hatching (GO:0009792 from GO Biological Process Annotations)", "embryo implantation (GO:0007566 from GO Biological Process Annotations)", "embryonic appendage morphogenesis (GO:0035113 from GO Biological Process Annotations)", "embryonic axis specification (GO:0000578 from GO Biological Process Annotations)", "embryonic body morphogenesis (GO:0010172 from GO Biological Process Annotations)", "embryonic camera-type eye development (GO:0031076 from GO Biological Process Annotations)", "embryonic camera-type eye formation (GO:0060900 from GO Biological Process Annotations)", "embryonic camera-type eye morphogenesis (GO:0048596 from GO Biological Process Annotations)", "embryonic cleavage (GO:0040016 from GO Biological Process Annotations)", "embryonic cranial skeleton morphogenesis (GO:0048701 from GO Biological Process Annotations)", "embryonic digestive tract development (GO:0048566 from GO Biological Process Annotations)", "embryonic digestive tract morphogenesis (GO:0048557 from GO Biological Process Annotations)", "embryonic digit morphogenesis (GO:0042733 from GO Biological Process Annotations)", "embryonic ectodermal digestive tract development (GO:0048611 from GO Biological Process Annotations)", "embryonic ectodermal digestive tract morphogenesis (GO:0048613 from GO Biological Process Annotations)", "embryonic epithelial tube formation (GO:0001838 from GO Biological Process Annotations)", "embryonic eye morphogenesis (GO:0048048 from GO Biological Process Annotations)", "embryonic foregut morphogenesis (GO:0048617 from GO Biological Process Annotations)", "embryonic forelimb morphogenesis (GO:0035115 from GO Biological Process Annotations)", "embryonic genitalia morphogenesis (GO:0030538 from GO Biological Process Annotations)", "embryonic heart tube anterior|posterior pattern specification (GO:0035054 from GO Biological Process Annotations)", "embryonic heart tube development (GO:0035050 from GO Biological Process Annotations)", "embryonic heart tube elongation (GO:0036306 from GO Biological Process Annotations)", "embryonic heart tube formation (GO:0003144 from GO Biological Process Annotations)", "embryonic heart tube left|right pattern formation (GO:0060971 from GO Biological Process Annotations)", "embryonic heart tube morphogenesis (GO:0003143 from GO Biological Process Annotations)", "embryonic hemopoiesis (GO:0035162 from GO Biological Process Annotations)", "embryonic hindgut morphogenesis (GO:0048619 from GO Biological Process Annotations)", "embryonic hindlimb morphogenesis (GO:0035116 from GO Biological Process Annotations)", "embryonic limb morphogenesis (GO:0030326 from GO Biological Process Annotations)", "embryonic lung development (GO:1990401 from GO Biological Process Annotations)", "embryonic morphogenesis (GO:0048598 from GO Biological Process Annotations)", "embryonic nail plate morphogenesis (GO:0035880 from GO Biological Process Annotations)", "embryonic neurocranium morphogenesis (GO:0048702 from GO Biological Process Annotations)", "embryonic olfactory bulb interneuron precursor migration (GO:0021831 from GO Biological Process Annotations)", "embryonic organ development (GO:0048568 from GO Biological Process Annotations)", "embryonic organ morphogenesis (GO:0048562 from GO Biological Process Annotations)", "embryonic pattern specification (GO:0009880 from GO Biological Process Annotations)", "embryonic placenta development (GO:0001892 from GO Biological Process Annotations)", "embryonic placenta morphogenesis (GO:0060669 from GO Biological Process Annotations)", "embryonic process involved in female pregnancy (GO:0060136 from GO Biological Process Annotations)", "embryonic retina morphogenesis in camera-type eye (GO:0060059 from GO Biological Process Annotations)", "embryonic skeletal joint development (GO:0072498 from GO Biological Process Annotations)", "embryonic skeletal joint morphogenesis (GO:0060272 from GO Biological Process Annotations)", "embryonic skeletal limb joint morphogenesis (GO:0036023 from GO Biological Process Annotations)", "embryonic skeletal system development (GO:0048706 from GO Biological Process Annotations)", "embryonic skeletal system morphogenesis (GO:0048704 from GO Biological Process Annotations)", "embryonic viscerocranium morphogenesis (GO:0048703 from GO Biological Process Annotations)", "enamel mineralization (GO:0070166 from GO Biological Process Annotations)", "endocannabinoid signaling pathway (GO:0071926 from GO Biological Process Annotations)", "endocardial cell differentiation (GO:0060956 from GO Biological Process Annotations)", "endocardial cell fate commitment (GO:0060957 from GO Biological Process Annotations)", "endocardial cushion cell development (GO:0061444 from GO Biological Process Annotations)", "endocardial cushion cell fate commitment (GO:0061445 from GO Biological Process Annotations)", "endocardial cushion development (GO:0003197 from GO Biological Process Annotations)", "endocardial cushion formation (GO:0003272 from GO Biological Process Annotations)", "endocardial cushion morphogenesis (GO:0003203 from GO Biological Process Annotations)", "endocardial cushion to mesenchymal transition (GO:0090500 from GO Biological Process Annotations)", "endocardial cushion to mesenchymal transition involved in heart valve formation (GO:0003199 from GO Biological Process Annotations)", "endocardium development (GO:0003157 from GO Biological Process Annotations)", "endocardium formation (GO:0060214 from GO Biological Process Annotations)", "endocardium morphogenesis (GO:0003160 from GO Biological Process Annotations)", "endochondral bone growth (GO:0003416 from GO Biological Process Annotations)", "endochondral bone morphogenesis (GO:0060350 from GO Biological Process Annotations)", "endochondral ossification (GO:0001958 from GO Biological Process Annotations)", "endocrine hormone secretion (GO:0060986 from GO Biological Process Annotations)", "endocrine pancreas development (GO:0031018 from GO Biological Process Annotations)", "endocrine process (GO:0050886 from GO Biological Process Annotations)", "endocytic recycling (GO:0032456 from GO Biological Process Annotations)", "endocytosis (GO:0006897 from GO Biological Process Annotations)", "endocytosis involved in viral entry into host cell (GO:0075509 from GO Biological Process Annotations)", "endoderm development (GO:0007492 from GO Biological Process Annotations)", "endoderm formation (GO:0001706 from GO Biological Process Annotations)", "endodermal cell differentiation (GO:0035987 from GO Biological Process Annotations)", "endodermal cell fate commitment (GO:0001711 from GO Biological Process Annotations)", "endodermal cell fate determination (GO:0007493 from GO Biological Process Annotations)", "endodermal cell fate specification (GO:0001714 from GO Biological Process Annotations)", "endodermal digestive tract morphogenesis (GO:0061031 from GO Biological Process Annotations)", "endomembrane system organization (GO:0010256 from GO Biological Process Annotations)", "endomitotic cell cycle (GO:0007113 from GO Biological Process Annotations)", "endonucleolytic cleavage in 5'-ets of tricistronic rrna transcript (ssu-rrna, 5.8s rrna, lsu-rrna) (GO:0000480 from GO Biological Process Annotations)", "endonucleolytic cleavage in its1 to separate ssu-rrna from 5.8s rrna and lsu-rrna from tricistronic rrna transcript (ssu-rrna, 5.8s rrna, lsu-rrna) (GO:0000447 from GO Biological Process Annotations)", "endonucleolytic cleavage involved in rrna processing (GO:0000478 from GO Biological Process Annotations)", "endonucleolytic cleavage of tricistronic rrna transcript (ssu-rrna, 5.8s rrna, lsu-rrna) (GO:0000479 from GO Biological Process Annotations)", "endonucleolytic cleavage to generate mature 3'-end of ssu-rrna from (ssu-rrna, 5.8s rrna, lsu-rrna) (GO:0000461 from GO Biological Process Annotations)", "endonucleolytic cleavage to generate mature 5'-end of ssu-rrna from (ssu-rrna, 5.8s rrna, lsu-rrna) (GO:0000472 from GO Biological Process Annotations)", "endoplasmic reticulum calcium ion homeostasis (GO:0032469 from GO Biological Process Annotations)", "endoplasmic reticulum localization (GO:0051643 from GO Biological Process Annotations)", "endoplasmic reticulum membrane fusion (GO:0016320 from GO Biological Process Annotations)", "endoplasmic reticulum membrane organization (GO:0090158 from GO Biological Process Annotations)", "endoplasmic reticulum organization (GO:0007029 from GO Biological Process Annotations)", "endoplasmic reticulum to cytosol transport (GO:1903513 from GO Biological Process Annotations)", "endoplasmic reticulum tubular network organization (GO:0071786 from GO Biological Process Annotations)", "endoplasmic reticulum unfolded protein response (GO:0030968 from GO Biological Process Annotations)", "endoplasmic reticulum-golgi intermediate compartment organization (GO:0097111 from GO Biological Process Annotations)", "endosomal lumen acidification (GO:0048388 from GO Biological Process Annotations)", "endosomal transport (GO:0016197 from GO Biological Process Annotations)", "endosomal vesicle fusion (GO:0034058 from GO Biological Process Annotations)", "endosome localization (GO:0032439 from GO Biological Process Annotations)", "endosome organization (GO:0007032 from GO Biological Process Annotations)", "endosome to lysosome transport (GO:0008333 from GO Biological Process Annotations)", "endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510 from GO Biological Process Annotations)", "endosome to melanosome transport (GO:0035646 from GO Biological Process Annotations)", "endosome to pigment granule transport (GO:0043485 from GO Biological Process Annotations)", "endosome transport via multivesicular body sorting pathway (GO:0032509 from GO Biological Process Annotations)", "endothelial cell activation (GO:0042118 from GO Biological Process Annotations)", "endothelial cell apoptotic process (GO:0072577 from GO Biological Process Annotations)", "endothelial cell chemotaxis (GO:0035767 from GO Biological Process Annotations)", "endothelial cell chemotaxis to fibroblast growth factor (GO:0035768 from GO Biological Process Annotations)", "endothelial cell development (GO:0001885 from GO Biological Process Annotations)", "endothelial cell differentiation (GO:0045446 from GO Biological Process Annotations)", "endothelial cell fate commitment (GO:0060839 from GO Biological Process Annotations)", "endothelial cell fate specification (GO:0060847 from GO Biological Process Annotations)", "endothelial cell migration (GO:0043542 from GO Biological Process Annotations)", "endothelial cell morphogenesis (GO:0001886 from GO Biological Process Annotations)", "endothelial cell proliferation (GO:0001935 from GO Biological Process Annotations)", "endothelial cell-cell adhesion (GO:0071603 from GO Biological Process Annotations)", "endothelial tip cell fate specification (GO:0097102 from GO Biological Process Annotations)", "endothelial tube morphogenesis (GO:0061154 from GO Biological Process Annotations)", "endothelin maturation (GO:0034959 from GO Biological Process Annotations)", "endothelin receptor signaling pathway (GO:0086100 from GO Biological Process Annotations)", "endothelium development (GO:0003158 from GO Biological Process Annotations)", "energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988 from GO Biological Process Annotations)", "energy coupled proton transport, down electrochemical gradient (GO:0015985 from GO Biological Process Annotations)", "energy derivation by oxidation of organic compounds (GO:0015980 from GO Biological Process Annotations)", "energy homeostasis (GO:0097009 from GO Biological Process Annotations)", "energy reserve metabolic process (GO:0006112 from GO Biological Process Annotations)", "engulfment of apoptotic cell (GO:0043652 from GO Biological Process Annotations)", "enkephalin processing (GO:0034230 from GO Biological Process Annotations)", "ensheathment of neurons (GO:0007272 from GO Biological Process Annotations)", "enteric nervous system development (GO:0048484 from GO Biological Process Annotations)", "enteric smooth muscle cell differentiation (GO:0035645 from GO Biological Process Annotations)", "enterobactin transport (GO:0042930 from GO Biological Process Annotations)", "enteroendocrine cell differentiation (GO:0035883 from GO Biological Process Annotations)", "entrainment of circadian clock (GO:0009649 from GO Biological Process Annotations)", "entrainment of circadian clock by photoperiod (GO:0043153 from GO Biological Process Annotations)", "entry into cell of other organism involved in symbiotic interaction (GO:0051806 from GO Biological Process Annotations)", "entry into host (GO:0044409 from GO Biological Process Annotations)", "entry into host cell (GO:0030260 from GO Biological Process Annotations)", "entry into other organism involved in symbiotic interaction (GO:0051828 from GO Biological Process Annotations)", "entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction (GO:0052370 from GO Biological Process Annotations)", "entry of symbiont into host cell by promotion of host phagocytosis (GO:0052066 from GO Biological Process Annotations)", "enucleate erythrocyte development (GO:0048822 from GO Biological Process Annotations)", "enucleate erythrocyte differentiation (GO:0043353 from GO Biological Process Annotations)", "enzyme active site formation (GO:0018307 from GO Biological Process Annotations)", "enzyme active site formation via l-cysteine persulfide (GO:0018192 from GO Biological Process Annotations)", "enzyme active site formation via l-cysteine sulfinic acid (GO:0018323 from GO Biological Process Annotations)", "enzyme linked receptor protein signaling pathway (GO:0007167 from GO Biological Process Annotations)", "enzyme-directed rrna 2'-o-methylation (GO:0000453 from GO Biological Process Annotations)", "eosinophil activation (GO:0043307 from GO Biological Process Annotations)", "eosinophil activation involved in immune response (GO:0002278 from GO Biological Process Annotations)", "eosinophil chemotaxis (GO:0048245 from GO Biological Process Annotations)", "eosinophil degranulation (GO:0043308 from GO Biological Process Annotations)", "eosinophil differentiation (GO:0030222 from GO Biological Process Annotations)", "eosinophil fate commitment (GO:0035854 from GO Biological Process Annotations)", "eosinophil migration (GO:0072677 from GO Biological Process Annotations)", "ephrin receptor signaling pathway (GO:0048013 from GO Biological Process Annotations)", "epiblast cell-extraembryonic ectoderm cell signaling involved in anterior|posterior axis specification (GO:0060802 from GO Biological Process Annotations)", "epiboly (GO:0090504 from GO Biological Process Annotations)", "epiboly involved in gastrulation with mouth forming second (GO:0055113 from GO Biological Process Annotations)", "epidermal cell differentiation (GO:0009913 from GO Biological Process Annotations)", "epidermal cell division (GO:0010481 from GO Biological Process Annotations)", "epidermal cell fate specification (GO:0009957 from GO Biological Process Annotations)", "epidermal growth factor catabolic process (GO:0007174 from GO Biological Process Annotations)", "epidermal growth factor receptor signaling pathway (GO:0007173 from GO Biological Process Annotations)", "epidermal growth factor receptor signaling pathway via i-kappab kinase|nf-kappab cascade (GO:0038168 from GO Biological Process Annotations)", "epidermal growth factor receptor signaling pathway via positive regulation of nf-kappab transcription factor activity (GO:0038167 from GO Biological Process Annotations)", "epidermal growth factor-activated receptor transactivation by g-protein coupled receptor signaling pathway (GO:0035625 from GO Biological Process Annotations)", "epidermal stem cell homeostasis (GO:0036334 from GO Biological Process Annotations)", "epidermis development (GO:0008544 from GO Biological Process Annotations)", "epidermis morphogenesis (GO:0048730 from GO Biological Process Annotations)", "epinephrine biosynthetic process (GO:0042418 from GO Biological Process Annotations)", "epinephrine metabolic process (GO:0042414 from GO Biological Process Annotations)", "epinephrine secretion (GO:0048242 from GO Biological Process Annotations)", "epinephrine transport (GO:0048241 from GO Biological Process Annotations)", "epithelial cell apoptotic process involved in palatal shelf morphogenesis (GO:1990134 from GO Biological Process Annotations)", "epithelial cell development (GO:0002064 from GO Biological Process Annotations)", "epithelial cell differentiation (GO:0030855 from GO Biological Process Annotations)", "epithelial cell differentiation involved in kidney development (GO:0035850 from GO Biological Process Annotations)", "epithelial cell differentiation involved in mammary gland alveolus development (GO:0061030 from GO Biological Process Annotations)", "epithelial cell differentiation involved in prostate gland development (GO:0060742 from GO Biological Process Annotations)", "epithelial cell fate commitment (GO:0072148 from GO Biological Process Annotations)", "epithelial cell maturation (GO:0002070 from GO Biological Process Annotations)", "epithelial cell maturation involved in prostate gland development (GO:0060743 from GO Biological Process Annotations)", "epithelial cell maturation involved in salivary gland development (GO:0060691 from GO Biological Process Annotations)", "epithelial cell migration (GO:0010631 from GO Biological Process Annotations)", "epithelial cell morphogenesis (GO:0003382 from GO Biological Process Annotations)", "epithelial cell proliferation (GO:0050673 from GO Biological Process Annotations)", "epithelial cell proliferation involved in liver morphogenesis (GO:0072575 from GO Biological Process Annotations)", "epithelial cell proliferation involved in lung morphogenesis (GO:0060502 from GO Biological Process Annotations)", "epithelial cell proliferation involved in mammary gland duct elongation (GO:0060750 from GO Biological Process Annotations)", "epithelial cell proliferation involved in prostate gland development (GO:0060767 from GO Biological Process Annotations)", "epithelial cell proliferation involved in prostatic bud elongation (GO:0060517 from GO Biological Process Annotations)", "epithelial cell proliferation involved in renal tubule morphogenesis (GO:2001013 from GO Biological Process Annotations)", "epithelial cell proliferation involved in salivary gland morphogenesis (GO:0060664 from GO Biological Process Annotations)", "epithelial cell-cell adhesion (GO:0090136 from GO Biological Process Annotations)", "epithelial cilium movement (GO:0003351 from GO Biological Process Annotations)", "epithelial cilium movement involved in determination of left|right asymmetry (GO:0060287 from GO Biological Process Annotations)", "epithelial fluid transport (GO:0042045 from GO Biological Process Annotations)", "epithelial structure maintenance (GO:0010669 from GO Biological Process Annotations)", "epithelial to mesenchymal transition (GO:0001837 from GO Biological Process Annotations)", "epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198 from GO Biological Process Annotations)", "epithelial tube branching involved in lung morphogenesis (GO:0060441 from GO Biological Process Annotations)", "epithelial tube formation (GO:0072175 from GO Biological Process Annotations)", "epithelial tube morphogenesis (GO:0060562 from GO Biological Process Annotations)", "epithelial-mesenchymal cell signaling (GO:0060684 from GO Biological Process Annotations)", "epithelial-mesenchymal signaling involved in prostate gland development (GO:0060738 from GO Biological Process Annotations)", "epithelium development (GO:0060429 from GO Biological Process Annotations)", "epithelium migration (GO:0090132 from GO Biological Process Annotations)", "epoxygenase p450 pathway (GO:0019373 from GO Biological Process Annotations)", "equilibrioception (GO:0050957 from GO Biological Process Annotations)", "er overload response (GO:0006983 from GO Biological Process Annotations)", "er to golgi ceramide transport (GO:0035621 from GO Biological Process Annotations)", "er to golgi vesicle-mediated transport (GO:0006888 from GO Biological Process Annotations)", "er-associated misfolded protein catabolic process (GO:0071712 from GO Biological Process Annotations)", "er-associated ubiquitin-dependent protein catabolic process (GO:0030433 from GO Biological Process Annotations)", "er-dependent peroxisome organization (GO:0032581 from GO Biological Process Annotations)", "er-nucleus signaling pathway (GO:0006984 from GO Biological Process Annotations)", "erbb signaling pathway (GO:0038127 from GO Biological Process Annotations)", "erbb2 signaling pathway (GO:0038128 from GO Biological Process Annotations)", "erbb2-erbb3 signaling pathway (GO:0038133 from GO Biological Process Annotations)", "erbb3 signaling pathway (GO:0038129 from GO Biological Process Annotations)", "erk1 and erk2 cascade (GO:0070371 from GO Biological Process Annotations)", "erk5 cascade (GO:0070375 from GO Biological Process Annotations)", "error-prone translesion synthesis (GO:0042276 from GO Biological Process Annotations)", "erythrocyte development (GO:0048821 from GO Biological Process Annotations)", "erythrocyte differentiation (GO:0030218 from GO Biological Process Annotations)", "erythrocyte homeostasis (GO:0034101 from GO Biological Process Annotations)", "erythrocyte maturation (GO:0043249 from GO Biological Process Annotations)", "erythrophore differentiation (GO:0048773 from GO Biological Process Annotations)", "erythropoietin-mediated signaling pathway (GO:0038162 from GO Biological Process Annotations)", "erythrose 4-phosphate|phosphoenolpyruvate family amino acid catabolic process (GO:1902222 from GO Biological Process Annotations)", "erythrose 4-phosphate|phosphoenolpyruvate family amino acid metabolic process (GO:1902221 from GO Biological Process Annotations)", "esophagus smooth muscle contraction (GO:0014846 from GO Biological Process Annotations)", "establishment of anatomical structure orientation (GO:0048560 from GO Biological Process Annotations)", "establishment of apical|basal cell polarity (GO:0035089 from GO Biological Process Annotations)", "establishment of blood-brain barrier (GO:0060856 from GO Biological Process Annotations)", "establishment of blood-nerve barrier (GO:0008065 from GO Biological Process Annotations)", "establishment of body hair or bristle planar orientation (GO:0048104 from GO Biological Process Annotations)", "establishment of body hair planar orientation (GO:0048105 from GO Biological Process Annotations)", "establishment of cell polarity (GO:0030010 from GO Biological Process Annotations)", "establishment of cell polarity involved in ameboidal cell migration (GO:0003365 from GO Biological Process Annotations)", "establishment of centrosome localization (GO:0051660 from GO Biological Process Annotations)", "establishment of chromatin silencing (GO:0006343 from GO Biological Process Annotations)", "establishment of chromosome localization (GO:0051303 from GO Biological Process Annotations)", "establishment of endothelial barrier (GO:0061028 from GO Biological Process Annotations)", "establishment of endothelial intestinal barrier (GO:0090557 from GO Biological Process Annotations)", "establishment of epithelial cell apical|basal polarity (GO:0045198 from GO Biological Process Annotations)", "establishment of epithelial cell polarity (GO:0090162 from GO Biological Process Annotations)", "establishment of glial blood-brain barrier (GO:0060857 from GO Biological Process Annotations)", "establishment of golgi localization (GO:0051683 from GO Biological Process Annotations)", "establishment of integrated proviral latency (GO:0075713 from GO Biological Process Annotations)", "establishment of localization (GO:0051234 from GO Biological Process Annotations)", "establishment of localization in cell (GO:0051649 from GO Biological Process Annotations)", "establishment of lymphocyte polarity (GO:0001767 from GO Biological Process Annotations)", "establishment of meiotic spindle localization (GO:0051295 from GO Biological Process Annotations)", "establishment of meiotic spindle orientation (GO:0051296 from GO Biological Process Annotations)", "establishment of melanosome localization (GO:0032401 from GO Biological Process Annotations)", "establishment of mitochondrion localization (GO:0051654 from GO Biological Process Annotations)", "establishment of mitochondrion localization, microtubule-mediated (GO:0034643 from GO Biological Process Annotations)", "establishment of mitotic spindle localization (GO:0040001 from GO Biological Process Annotations)", "establishment of mitotic spindle orientation (GO:0000132 from GO Biological Process Annotations)", "establishment of monopolar cell polarity (GO:0061162 from GO Biological Process Annotations)", "establishment of natural killer cell polarity (GO:0001770 from GO Biological Process Annotations)", "establishment of neuroblast polarity (GO:0045200 from GO Biological Process Annotations)", "establishment of nucleus localization (GO:0040023 from GO Biological Process Annotations)", "establishment of organ orientation (GO:0048561 from GO Biological Process Annotations)", "establishment of organelle localization (GO:0051656 from GO Biological Process Annotations)", "establishment of pigment granule localization (GO:0051905 from GO Biological Process Annotations)", "establishment of planar polarity (GO:0001736 from GO Biological Process Annotations)", "establishment of planar polarity involved in nephron morphogenesis (GO:0072046 from GO Biological Process Annotations)", "establishment of planar polarity involved in neural tube closure (GO:0090177 from GO Biological Process Annotations)", "establishment of planar polarity of embryonic epithelium (GO:0042249 from GO Biological Process Annotations)", "establishment of protein localization (GO:0045184 from GO Biological Process Annotations)", "establishment of protein localization to chromatin (GO:0071169 from GO Biological Process Annotations)", "establishment of protein localization to chromosome (GO:0070199 from GO Biological Process Annotations)", "establishment of protein localization to endoplasmic reticulum (GO:0072599 from GO Biological Process Annotations)", "establishment of protein localization to endoplasmic reticulum membrane (GO:0097051 from GO Biological Process Annotations)", "establishment of protein localization to golgi (GO:0072600 from GO Biological Process Annotations)", "establishment of protein localization to juxtaparanode region of axon (GO:0071206 from GO Biological Process Annotations)", "establishment of protein localization to membrane (GO:0090150 from GO Biological Process Annotations)", "establishment of protein localization to mitochondrial membrane (GO:0090151 from GO Biological Process Annotations)", "establishment of protein localization to mitochondrion (GO:0072655 from GO Biological Process Annotations)", "establishment of protein localization to organelle (GO:0072594 from GO Biological Process Annotations)", "establishment of protein localization to peroxisome (GO:0072663 from GO Biological Process Annotations)", "establishment of protein localization to plasma membrane (GO:0090002 from GO Biological Process Annotations)", "establishment of protein localization to vacuole (GO:0072666 from GO Biological Process Annotations)", "establishment of ribosome localization (GO:0033753 from GO Biological Process Annotations)", "establishment of rna localization (GO:0051236 from GO Biological Process Annotations)", "establishment of sertoli cell barrier (GO:0097368 from GO Biological Process Annotations)", "establishment of skin barrier (GO:0061436 from GO Biological Process Annotations)", "establishment of spindle localization (GO:0051293 from GO Biological Process Annotations)", "establishment of spindle orientation (GO:0051294 from GO Biological Process Annotations)", "establishment of synaptic specificity at neuromuscular junction (GO:0007529 from GO Biological Process Annotations)", "establishment of synaptic vesicle localization (GO:0097480 from GO Biological Process Annotations)", "establishment of t cell polarity (GO:0001768 from GO Biological Process Annotations)", "establishment of tissue polarity (GO:0007164 from GO Biological Process Annotations)", "establishment of vesicle localization (GO:0051650 from GO Biological Process Annotations)", "establishment of viral latency (GO:0019043 from GO Biological Process Annotations)", "establishment or maintenance of actin cytoskeleton polarity (GO:0030950 from GO Biological Process Annotations)", "establishment or maintenance of apical|basal cell polarity (GO:0035088 from GO Biological Process Annotations)", "establishment or maintenance of bipolar cell polarity (GO:0061245 from GO Biological Process Annotations)", "establishment or maintenance of cell polarity (GO:0007163 from GO Biological Process Annotations)", "establishment or maintenance of cell polarity regulating cell shape (GO:0071963 from GO Biological Process Annotations)", "establishment or maintenance of cytoskeleton polarity (GO:0030952 from GO Biological Process Annotations)", "establishment or maintenance of epithelial cell apical|basal polarity (GO:0045197 from GO Biological Process Annotations)", "establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951 from GO Biological Process Annotations)", "establishment or maintenance of monopolar cell polarity (GO:0061339 from GO Biological Process Annotations)", "establishment or maintenance of neuroblast polarity (GO:0045196 from GO Biological Process Annotations)", "establishment or maintenance of polarity of embryonic epithelium (GO:0016332 from GO Biological Process Annotations)", "establishment or maintenance of transmembrane electrochemical gradient (GO:0010248 from GO Biological Process Annotations)", "estrogen biosynthetic process (GO:0006703 from GO Biological Process Annotations)", "estrogen catabolic process (GO:0006711 from GO Biological Process Annotations)", "estrogen metabolic process (GO:0008210 from GO Biological Process Annotations)", "ethanol catabolic process (GO:0006068 from GO Biological Process Annotations)", "ethanol metabolic process (GO:0006067 from GO Biological Process Annotations)", "ethanol oxidation (GO:0006069 from GO Biological Process Annotations)", "ethanolamine-containing compound metabolic process (GO:0042439 from GO Biological Process Annotations)", "ether biosynthetic process (GO:1901503 from GO Biological Process Annotations)", "ether lipid biosynthetic process (GO:0008611 from GO Biological Process Annotations)", "ether lipid metabolic process (GO:0046485 from GO Biological Process Annotations)", "ether metabolic process (GO:0018904 from GO Biological Process Annotations)", "evasion or tolerance by virus of host immune response (GO:0030683 from GO Biological Process Annotations)", "evasion or tolerance of defense response of other organism involved in symbiotic interaction (GO:0051807 from GO Biological Process Annotations)", "evasion or tolerance of defenses of other organism involved in symbiotic interaction (GO:0051834 from GO Biological Process Annotations)", "evasion or tolerance of host defense response (GO:0030682 from GO Biological Process Annotations)", "evasion or tolerance of host defenses (GO:0044415 from GO Biological Process Annotations)", "evasion or tolerance of host defenses by virus (GO:0019049 from GO Biological Process Annotations)", "evasion or tolerance of host immune response (GO:0020012 from GO Biological Process Annotations)", "evasion or tolerance of immune response of other organism involved in symbiotic interaction (GO:0051805 from GO Biological Process Annotations)", "excretion (GO:0007588 from GO Biological Process Annotations)", "execution phase of apoptosis (GO:0097194 from GO Biological Process Annotations)", "exit from mitosis (GO:0010458 from GO Biological Process Annotations)", "exocrine pancreas development (GO:0031017 from GO Biological Process Annotations)", "exocrine system development (GO:0035272 from GO Biological Process Annotations)", "exocyst assembly (GO:0001927 from GO Biological Process Annotations)", "exocyst localization (GO:0051601 from GO Biological Process Annotations)", "exocytosis (GO:0006887 from GO Biological Process Annotations)", "exogenous drug catabolic process (GO:0042738 from GO Biological Process Annotations)", "exonucleolytic nuclear-transcribed mrna catabolic process involved in deadenylation-dependent decay (GO:0043928 from GO Biological Process Annotations)", "exonucleolytic trimming involved in rrna processing (GO:0000459 from GO Biological Process Annotations)", "exonucleolytic trimming to generate mature 3'-end of 5.8s rrna from tricistronic rrna transcript (ssu-rrna, 5.8s rrna, lsu-rrna) (GO:0000467 from GO Biological Process Annotations)", "exosomal secretion (GO:1990182 from GO Biological Process Annotations)", "exploration behavior (GO:0035640 from GO Biological Process Annotations)", "extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration (GO:0021816 from GO Biological Process Annotations)", "external encapsulating structure organization (GO:0045229 from GO Biological Process Annotations)", "external genitalia morphogenesis (GO:0035261 from GO Biological Process Annotations)", "extracellular amino acid transport (GO:0006860 from GO Biological Process Annotations)", "extracellular fibril organization (GO:0043206 from GO Biological Process Annotations)", "extracellular matrix assembly (GO:0085029 from GO Biological Process Annotations)", "extracellular matrix constituent secretion (GO:0070278 from GO Biological Process Annotations)", "extracellular matrix disassembly (GO:0022617 from GO Biological Process Annotations)", "extracellular matrix organization (GO:0030198 from GO Biological Process Annotations)", "extracellular matrix-cell signaling (GO:0035426 from GO Biological Process Annotations)", "extracellular negative regulation of signal transduction (GO:1900116 from GO Biological Process Annotations)", "extracellular polysaccharide biosynthetic process (GO:0045226 from GO Biological Process Annotations)", "extracellular polysaccharide metabolic process (GO:0046379 from GO Biological Process Annotations)", "extracellular regulation of signal transduction (GO:1900115 from GO Biological Process Annotations)", "extracellular structure organization (GO:0043062 from GO Biological Process Annotations)", "extracellular transport (GO:0006858 from GO Biological Process Annotations)", "extracellular vesicular exosome assembly (GO:0071971 from GO Biological Process Annotations)", "extraocular skeletal muscle development (GO:0002074 from GO Biological Process Annotations)", "extrathymic t cell selection (GO:0045062 from GO Biological Process Annotations)", "extrinsic apoptotic signaling pathway (GO:0097191 from GO Biological Process Annotations)", "extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192 from GO Biological Process Annotations)", "extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625 from GO Biological Process Annotations)", "eye development (GO:0001654 from GO Biological Process Annotations)", "eye morphogenesis (GO:0048592 from GO Biological Process Annotations)", "eye photoreceptor cell development (GO:0042462 from GO Biological Process Annotations)", "eye photoreceptor cell differentiation (GO:0001754 from GO Biological Process Annotations)", "eye photoreceptor cell fate commitment (GO:0042706 from GO Biological Process Annotations)", "eye pigment biosynthetic process (GO:0006726 from GO Biological Process Annotations)", "eye pigment granule organization (GO:0008057 from GO Biological Process Annotations)", "eye pigment metabolic process (GO:0042441 from GO Biological Process Annotations)", "eye pigmentation (GO:0048069 from GO Biological Process Annotations)", "eyelid development in camera-type eye (GO:0061029 from GO Biological Process Annotations)", "face development (GO:0060324 from GO Biological Process Annotations)", "face morphogenesis (GO:0060325 from GO Biological Process Annotations)", "facial nerve morphogenesis (GO:0021610 from GO Biological Process Annotations)", "facial nerve structural organization (GO:0021612 from GO Biological Process Annotations)", "facial nucleus development (GO:0021754 from GO Biological Process Annotations)", "facioacoustic ganglion development (GO:1903375 from GO Biological Process Annotations)", "factor xii activation (GO:0002542 from GO Biological Process Annotations)", "fad biosynthetic process (GO:0006747 from GO Biological Process Annotations)", "fad metabolic process (GO:0046443 from GO Biological Process Annotations)", "fad transmembrane transport (GO:0035350 from GO Biological Process Annotations)", "fad transport (GO:0015883 from GO Biological Process Annotations)", "farnesol catabolic process (GO:0016488 from GO Biological Process Annotations)", "farnesol metabolic process (GO:0016487 from GO Biological Process Annotations)", "farnesyl diphosphate biosynthetic process (GO:0045337 from GO Biological Process Annotations)", "farnesyl diphosphate metabolic process (GO:0045338 from GO Biological Process Annotations)", "fas signaling pathway (GO:0036337 from GO Biological Process Annotations)", "fasciculation of motor neuron axon (GO:0097156 from GO Biological Process Annotations)", "fasciculation of sensory neuron axon (GO:0097155 from GO Biological Process Annotations)", "fasl biosynthetic process (GO:0045210 from GO Biological Process Annotations)", "fast, calcium ion-dependent exocytosis of neurotransmitter (GO:0098746 from GO Biological Process Annotations)", "fat cell differentiation (GO:0045444 from GO Biological Process Annotations)", "fat pad development (GO:0060613 from GO Biological Process Annotations)", "fat-soluble vitamin biosynthetic process (GO:0042362 from GO Biological Process Annotations)", "fat-soluble vitamin catabolic process (GO:0042363 from GO Biological Process Annotations)", "fat-soluble vitamin metabolic process (GO:0006775 from GO Biological Process Annotations)", "fatty acid alpha-oxidation (GO:0001561 from GO Biological Process Annotations)", "fatty acid beta-oxidation (GO:0006635 from GO Biological Process Annotations)", "fatty acid beta-oxidation using acyl-coa dehydrogenase (GO:0033539 from GO Biological Process Annotations)", "fatty acid beta-oxidation using acyl-coa oxidase (GO:0033540 from GO Biological Process Annotations)", "fatty acid biosynthetic process (GO:0006633 from GO Biological Process Annotations)", "fatty acid catabolic process (GO:0009062 from GO Biological Process Annotations)", "fatty acid derivative biosynthetic process (GO:1901570 from GO Biological Process Annotations)", "fatty acid derivative catabolic process (GO:1901569 from GO Biological Process Annotations)", "fatty acid derivative metabolic process (GO:1901568 from GO Biological Process Annotations)", "fatty acid derivative transport (GO:1901571 from GO Biological Process Annotations)", "fatty acid elongation (GO:0030497 from GO Biological Process Annotations)", "fatty acid elongation, monounsaturated fatty acid (GO:0034625 from GO Biological Process Annotations)", "fatty acid elongation, polyunsaturated fatty acid (GO:0034626 from GO Biological Process Annotations)", "fatty acid elongation, saturated fatty acid (GO:0019367 from GO Biological Process Annotations)", "fatty acid elongation, unsaturated fatty acid (GO:0019368 from GO Biological Process Annotations)", "fatty acid homeostasis (GO:0055089 from GO Biological Process Annotations)", "fatty acid metabolic process (GO:0006631 from GO Biological Process Annotations)", "fatty acid omega-oxidation (GO:0010430 from GO Biological Process Annotations)", "fatty acid oxidation (GO:0019395 from GO Biological Process Annotations)", "fatty acid transmembrane transport (GO:1902001 from GO Biological Process Annotations)", "fatty acid transport (GO:0015908 from GO Biological Process Annotations)", "fatty alcohol metabolic process (GO:1903173 from GO Biological Process Annotations)", "fatty-acyl-coa biosynthetic process (GO:0046949 from GO Biological Process Annotations)", "fatty-acyl-coa catabolic process (GO:0036115 from GO Biological Process Annotations)", "fatty-acyl-coa metabolic process (GO:0035337 from GO Biological Process Annotations)", "fatty-acyl-coa transport (GO:0015916 from GO Biological Process Annotations)", "fc receptor mediated inhibitory signaling pathway (GO:0002774 from GO Biological Process Annotations)", "fc receptor mediated stimulatory signaling pathway (GO:0002431 from GO Biological Process Annotations)", "fc receptor signaling pathway (GO:0038093 from GO Biological Process Annotations)", "fc-epsilon receptor signaling pathway (GO:0038095 from GO Biological Process Annotations)", "fc-gamma receptor signaling pathway (GO:0038094 from GO Biological Process Annotations)", "fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096 from GO Biological Process Annotations)", "fear response (GO:0042596 from GO Biological Process Annotations)", "feeding behavior (GO:0007631 from GO Biological Process Annotations)", "female courtship behavior (GO:0008050 from GO Biological Process Annotations)", "female gamete generation (GO:0007292 from GO Biological Process Annotations)", "female genitalia development (GO:0030540 from GO Biological Process Annotations)", "female genitalia morphogenesis (GO:0048807 from GO Biological Process Annotations)", "female gonad development (GO:0008585 from GO Biological Process Annotations)", "female mating behavior (GO:0060180 from GO Biological Process Annotations)", "female meiosis i (GO:0007144 from GO Biological Process Annotations)", "female meiosis ii (GO:0007147 from GO Biological Process Annotations)", "female meiosis sister chromatid cohesion (GO:0007066 from GO Biological Process Annotations)", "female meiotic division (GO:0007143 from GO Biological Process Annotations)", "female pregnancy (GO:0007565 from GO Biological Process Annotations)", "female pronucleus assembly (GO:0035038 from GO Biological Process Annotations)", "female sex determination (GO:0030237 from GO Biological Process Annotations)", "female somatic sex determination (GO:0019101 from GO Biological Process Annotations)", "ferric iron import (GO:0033216 from GO Biological Process Annotations)", "ferric iron import into cell (GO:0097461 from GO Biological Process Annotations)", "ferric iron transport (GO:0015682 from GO Biological Process Annotations)", "ferrous iron import (GO:0070627 from GO Biological Process Annotations)", "ferrous iron transport (GO:0015684 from GO Biological Process Annotations)", "fertilization (GO:0009566 from GO Biological Process Annotations)", "fertilization, exchange of chromosomal proteins (GO:0035042 from GO Biological Process Annotations)", "fetal process involved in parturition (GO:0060138 from GO Biological Process Annotations)", "fever generation (GO:0001660 from GO Biological Process Annotations)", "fibril organization (GO:0097435 from GO Biological Process Annotations)", "fibrinolysis (GO:0042730 from GO Biological Process Annotations)", "fibroblast activation (GO:0072537 from GO Biological Process Annotations)", "fibroblast apoptotic process (GO:0044346 from GO Biological Process Annotations)", "fibroblast growth factor receptor apoptotic signaling pathway (GO:1902178 from GO Biological Process Annotations)", "fibroblast growth factor receptor signaling pathway (GO:0008543 from GO Biological Process Annotations)", "fibroblast growth factor receptor signaling pathway involved in hemopoiesis (GO:0035603 from GO Biological Process Annotations)", "fibroblast growth factor receptor signaling pathway involved in mammary gland specification (GO:0060595 from GO Biological Process Annotations)", "fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow (GO:0035602 from GO Biological Process Annotations)", "fibroblast growth factor receptor signaling pathway involved in neural plate anterior|posterior pattern formation (GO:0060825 from GO Biological Process Annotations)", "fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development (GO:0035607 from GO Biological Process Annotations)", "fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow (GO:0035604 from GO Biological Process Annotations)", "fibroblast migration (GO:0010761 from GO Biological Process Annotations)", "fibroblast proliferation (GO:0048144 from GO Biological Process Annotations)", "filopodium assembly (GO:0046847 from GO Biological Process Annotations)", "filtration diaphragm assembly (GO:0036058 from GO Biological Process Annotations)", "flavin adenine dinucleotide biosynthetic process (GO:0072388 from GO Biological Process Annotations)", "flavin adenine dinucleotide metabolic process (GO:0072387 from GO Biological Process Annotations)", "flavin-containing compound biosynthetic process (GO:0042727 from GO Biological Process Annotations)", "flavin-containing compound metabolic process (GO:0042726 from GO Biological Process Annotations)", "flavone metabolic process (GO:0051552 from GO Biological Process Annotations)", "flavonoid biosynthetic process (GO:0009813 from GO Biological Process Annotations)", "flavonoid glucuronidation (GO:0052696 from GO Biological Process Annotations)", "flavonoid metabolic process (GO:0009812 from GO Biological Process Annotations)", "floor plate development (GO:0033504 from GO Biological Process Annotations)", "floor plate formation (GO:0021508 from GO Biological Process Annotations)", "floor plate morphogenesis (GO:0033505 from GO Biological Process Annotations)", "fluid transport (GO:0042044 from GO Biological Process Annotations)", "fluorene metabolic process (GO:0018917 from GO Biological Process Annotations)", "fmn biosynthetic process (GO:0009398 from GO Biological Process Annotations)", "fmn metabolic process (GO:0046444 from GO Biological Process Annotations)", "foam cell differentiation (GO:0090077 from GO Biological Process Annotations)", "focal adhesion assembly (GO:0048041 from GO Biological Process Annotations)", "folic acid metabolic process (GO:0046655 from GO Biological Process Annotations)", "folic acid transport (GO:0015884 from GO Biological Process Annotations)", "folic acid-containing compound biosynthetic process (GO:0009396 from GO Biological Process Annotations)", "folic acid-containing compound catabolic process (GO:0009397 from GO Biological Process Annotations)", "folic acid-containing compound metabolic process (GO:0006760 from GO Biological Process Annotations)", "follicle-stimulating hormone secretion (GO:0046884 from GO Biological Process Annotations)", "follicle-stimulating hormone signaling pathway (GO:0042699 from GO Biological Process Annotations)", "follicular b cell differentiation (GO:0002316 from GO Biological Process Annotations)", "follicular dendritic cell activation (GO:0002266 from GO Biological Process Annotations)", "follicular dendritic cell differentiation (GO:0002268 from GO Biological Process Annotations)", "foramen ovale closure (GO:0035922 from GO Biological Process Annotations)", "forebrain anterior|posterior pattern specification (GO:0021797 from GO Biological Process Annotations)", "forebrain astrocyte development (GO:0021897 from GO Biological Process Annotations)", "forebrain cell migration (GO:0021885 from GO Biological Process Annotations)", "forebrain development (GO:0030900 from GO Biological Process Annotations)", "forebrain dorsal|ventral pattern formation (GO:0021798 from GO Biological Process Annotations)", "forebrain generation of neurons (GO:0021872 from GO Biological Process Annotations)", "forebrain morphogenesis (GO:0048853 from GO Biological Process Annotations)", "forebrain neuroblast division (GO:0021873 from GO Biological Process Annotations)", "forebrain neuron development (GO:0021884 from GO Biological Process Annotations)", "forebrain neuron differentiation (GO:0021879 from GO Biological Process Annotations)", "forebrain neuron fate commitment (GO:0021877 from GO Biological Process Annotations)", "forebrain radial glial cell differentiation (GO:0021861 from GO Biological Process Annotations)", "forebrain regionalization (GO:0021871 from GO Biological Process Annotations)", "forebrain ventricular zone progenitor cell division (GO:0021869 from GO Biological Process Annotations)", "forebrain-midbrain boundary formation (GO:0021905 from GO Biological Process Annotations)", "foregut morphogenesis (GO:0007440 from GO Biological Process Annotations)", "forelimb morphogenesis (GO:0035136 from GO Biological Process Annotations)", "formaldehyde biosynthetic process (GO:0046293 from GO Biological Process Annotations)", "formaldehyde catabolic process (GO:0046294 from GO Biological Process Annotations)", "formaldehyde metabolic process (GO:0046292 from GO Biological Process Annotations)", "formamide metabolic process (GO:0043606 from GO Biological Process Annotations)", "formate metabolic process (GO:0015942 from GO Biological Process Annotations)", "formate transport (GO:0015724 from GO Biological Process Annotations)", "formation of anatomical boundary (GO:0048859 from GO Biological Process Annotations)", "formation of cytoplasmic translation initiation complex (GO:0001732 from GO Biological Process Annotations)", "formation of organ boundary (GO:0010160 from GO Biological Process Annotations)", "formation of primary germ layer (GO:0001704 from GO Biological Process Annotations)", "formation of radial glial scaffolds (GO:0021943 from GO Biological Process Annotations)", "formation of translation preinitiation complex (GO:0001731 from GO Biological Process Annotations)", "formin-nucleated actin cable assembly (GO:0070649 from GO Biological Process Annotations)", "fourth ventricle development (GO:0021592 from GO Biological Process Annotations)", "fractalkine metabolic process (GO:0050756 from GO Biological Process Annotations)", "free ubiquitin chain polymerization (GO:0010994 from GO Biological Process Annotations)", "frontal suture morphogenesis (GO:0060364 from GO Biological Process Annotations)", "fructosamine metabolic process (GO:0030389 from GO Biological Process Annotations)", "fructose 1,6-bisphosphate metabolic process (GO:0030388 from GO Biological Process Annotations)", "fructose 2,6-bisphosphate metabolic process (GO:0006003 from GO Biological Process Annotations)", "fructose 6-phosphate metabolic process (GO:0006002 from GO Biological Process Annotations)", "fructose biosynthetic process (GO:0046370 from GO Biological Process Annotations)", "fructose catabolic process (GO:0006001 from GO Biological Process Annotations)", "fructose metabolic process (GO:0006000 from GO Biological Process Annotations)", "fructose transport (GO:0015755 from GO Biological Process Annotations)", "fructoselysine metabolic process (GO:0030393 from GO Biological Process Annotations)", "fucose catabolic process (GO:0019317 from GO Biological Process Annotations)", "fucose metabolic process (GO:0006004 from GO Biological Process Annotations)", "fucosylation (GO:0036065 from GO Biological Process Annotations)", "fumarate metabolic process (GO:0006106 from GO Biological Process Annotations)", "fungiform papilla development (GO:0061196 from GO Biological Process Annotations)", "fungiform papilla formation (GO:0061198 from GO Biological Process Annotations)", "fungiform papilla morphogenesis (GO:0061197 from GO Biological Process Annotations)", "fusion of sperm to egg plasma membrane (GO:0007342 from GO Biological Process Annotations)", "fusion of virus membrane with host plasma membrane (GO:0019064 from GO Biological Process Annotations)", "g-protein coupled acetylcholine receptor signaling pathway (GO:0007213 from GO Biological Process Annotations)", "g-protein coupled glutamate receptor signaling pathway (GO:0007216 from GO Biological Process Annotations)", "g-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589 from GO Biological Process Annotations)", "g-protein coupled purinergic receptor signaling pathway (GO:0035588 from GO Biological Process Annotations)", "g-protein coupled receptor catabolic process (GO:1990172 from GO Biological Process Annotations)", "g-protein coupled receptor internalization (GO:0002031 from GO Biological Process Annotations)", "g-protein coupled receptor signaling pathway (GO:0007186 from GO Biological Process Annotations)", "g-protein coupled receptor signaling pathway coupled to cgmp nucleotide second messenger (GO:0007199 from GO Biological Process Annotations)", "g-protein coupled receptor signaling pathway involved in heart process (GO:0086103 from GO Biological Process Annotations)", "g-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187 from GO Biological Process Annotations)", "g0 to g1 transition (GO:0045023 from GO Biological Process Annotations)", "g1 dna damage checkpoint (GO:0044783 from GO Biological Process Annotations)", "g1 to g0 transition (GO:0070314 from GO Biological Process Annotations)", "g1 to g0 transition involved in cell differentiation (GO:0070315 from GO Biological Process Annotations)", "g1|s transition of mitotic cell cycle (GO:0000082 from GO Biological Process Annotations)", "g2 dna damage checkpoint (GO:0031572 from GO Biological Process Annotations)", "g2|m transition of mitotic cell cycle (GO:0000086 from GO Biological Process Annotations)", "gabaergic neuron differentiation (GO:0097154 from GO Biological Process Annotations)", "gabaergic neuron differentiation in basal ganglia (GO:0021858 from GO Biological Process Annotations)", "galactitol metabolic process (GO:0019402 from GO Biological Process Annotations)", "galactolipid biosynthetic process (GO:0019375 from GO Biological Process Annotations)", "galactolipid catabolic process (GO:0019376 from GO Biological Process Annotations)", "galactolipid metabolic process (GO:0019374 from GO Biological Process Annotations)", "galactose catabolic process (GO:0019388 from GO Biological Process Annotations)", "galactose metabolic process (GO:0006012 from GO Biological Process Annotations)", "galactosylceramide biosynthetic process (GO:0006682 from GO Biological Process Annotations)", "galactosylceramide catabolic process (GO:0006683 from GO Biological Process Annotations)", "galactosylceramide metabolic process (GO:0006681 from GO Biological Process Annotations)", "gall bladder development (GO:0061010 from GO Biological Process Annotations)", "gamete generation (GO:0007276 from GO Biological Process Annotations)", "gamma-aminobutyric acid biosynthetic process (GO:0009449 from GO Biological Process Annotations)", "gamma-aminobutyric acid catabolic process (GO:0009450 from GO Biological Process Annotations)", "gamma-aminobutyric acid import (GO:0051939 from GO Biological Process Annotations)", "gamma-aminobutyric acid metabolic process (GO:0009448 from GO Biological Process Annotations)", "gamma-aminobutyric acid secretion (GO:0014051 from GO Biological Process Annotations)", "gamma-aminobutyric acid signaling pathway (GO:0007214 from GO Biological Process Annotations)", "gamma-aminobutyric acid transport (GO:0015812 from GO Biological Process Annotations)", "gamma-delta t cell activation (GO:0046629 from GO Biological Process Annotations)", "gamma-delta t cell differentiation (GO:0042492 from GO Biological Process Annotations)", "gamma-tubulin complex localization (GO:0033566 from GO Biological Process Annotations)", "ganglion development (GO:0061548 from GO Biological Process Annotations)", "ganglion morphogenesis (GO:0061552 from GO Biological Process Annotations)", "ganglion mother cell fate determination (GO:0007402 from GO Biological Process Annotations)", "ganglioside biosynthetic process (GO:0001574 from GO Biological Process Annotations)", "ganglioside catabolic process (GO:0006689 from GO Biological Process Annotations)", "ganglioside metabolic process (GO:0001573 from GO Biological Process Annotations)", "gap junction assembly (GO:0016264 from GO Biological Process Annotations)", "gas homeostasis (GO:0033483 from GO Biological Process Annotations)", "gas transport (GO:0015669 from GO Biological Process Annotations)", "gastric acid secretion (GO:0001696 from GO Biological Process Annotations)", "gastric emptying (GO:0035483 from GO Biological Process Annotations)", "gastric inhibitory peptide signaling pathway (GO:0038192 from GO Biological Process Annotations)", "gastric motility (GO:0035482 from GO Biological Process Annotations)", "gastrin-induced gastric acid secretion (GO:0001698 from GO Biological Process Annotations)", "gastro-intestinal system smooth muscle contraction (GO:0014831 from GO Biological Process Annotations)", "gastrulation (GO:0007369 from GO Biological Process Annotations)", "gastrulation with mouth forming second (GO:0001702 from GO Biological Process Annotations)", "gdp biosynthetic process (GO:0046711 from GO Biological Process Annotations)", "gdp catabolic process (GO:0046712 from GO Biological Process Annotations)", "gdp metabolic process (GO:0046710 from GO Biological Process Annotations)", "gdp phosphorylation (GO:0061568 from GO Biological Process Annotations)", "gdp-l-fucose biosynthetic process (GO:0042350 from GO Biological Process Annotations)", "gdp-l-fucose metabolic process (GO:0046368 from GO Biological Process Annotations)", "gdp-mannose biosynthetic process (GO:0009298 from GO Biological Process Annotations)", "gdp-mannose metabolic process (GO:0019673 from GO Biological Process Annotations)", "gene conversion (GO:0035822 from GO Biological Process Annotations)", "gene expression (GO:0010467 from GO Biological Process Annotations)", "gene looping (GO:0090202 from GO Biological Process Annotations)", "gene silencing (GO:0016458 from GO Biological Process Annotations)", "gene silencing by mirna (GO:0035195 from GO Biological Process Annotations)", "gene silencing by rna (GO:0031047 from GO Biological Process Annotations)", "general adaptation syndrome (GO:0051866 from GO Biological Process Annotations)", "general adaptation syndrome, behavioral process (GO:0051867 from GO Biological Process Annotations)", "generation of catalytic spliceosome for first transesterification step (GO:0000349 from GO Biological Process Annotations)", "generation of neurons (GO:0048699 from GO Biological Process Annotations)", "generation of ovulation cycle rhythm (GO:0060112 from GO Biological Process Annotations)", "generation of precursor metabolites and energy (GO:0006091 from GO Biological Process Annotations)", "genetic imprinting (GO:0071514 from GO Biological Process Annotations)", "genitalia development (GO:0048806 from GO Biological Process Annotations)", "genitalia morphogenesis (GO:0035112 from GO Biological Process Annotations)", "gentamycin metabolic process (GO:1901128 from GO Biological Process Annotations)", "gephyrin clustering (GO:0097116 from GO Biological Process Annotations)", "geranyl diphosphate biosynthetic process (GO:0033384 from GO Biological Process Annotations)", "geranyl diphosphate metabolic process (GO:0033383 from GO Biological Process Annotations)", "geranylgeranyl diphosphate biosynthetic process (GO:0033386 from GO Biological Process Annotations)", "geranylgeranyl diphosphate metabolic process (GO:0033385 from GO Biological Process Annotations)", "germ cell development (GO:0007281 from GO Biological Process Annotations)", "germ cell migration (GO:0008354 from GO Biological Process Annotations)", "germ cell proliferation (GO:0036093 from GO Biological Process Annotations)", "germ-line sex determination (GO:0018992 from GO Biological Process Annotations)", "germ-line stem cell division (GO:0042078 from GO Biological Process Annotations)", "germ-line stem cell maintenance (GO:0030718 from GO Biological Process Annotations)", "germinal center b cell differentiation (GO:0002314 from GO Biological Process Annotations)", "germinal center formation (GO:0002467 from GO Biological Process Annotations)", "germline cell cycle switching, mitotic to meiotic cell cycle (GO:0051729 from GO Biological Process Annotations)", "germline stem cell asymmetric division (GO:0098728 from GO Biological Process Annotations)", "gland development (GO:0048732 from GO Biological Process Annotations)", "gland morphogenesis (GO:0022612 from GO Biological Process Annotations)", "glandular epithelial cell development (GO:0002068 from GO Biological Process Annotations)", "glandular epithelial cell differentiation (GO:0002067 from GO Biological Process Annotations)", "glandular epithelial cell maturation (GO:0002071 from GO Biological Process Annotations)", "glial cell apoptotic process (GO:0034349 from GO Biological Process Annotations)", "glial cell development (GO:0021782 from GO Biological Process Annotations)", "glial cell differentiation (GO:0010001 from GO Biological Process Annotations)", "glial cell fate commitment (GO:0021781 from GO Biological Process Annotations)", "glial cell fate determination (GO:0007403 from GO Biological Process Annotations)", "glial cell fate specification (GO:0021780 from GO Biological Process Annotations)", "glial cell migration (GO:0008347 from GO Biological Process Annotations)", "glial cell proliferation (GO:0014009 from GO Biological Process Annotations)", "glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860 from GO Biological Process Annotations)", "gliogenesis (GO:0042063 from GO Biological Process Annotations)", "globoside biosynthetic process (GO:0001576 from GO Biological Process Annotations)", "globoside metabolic process (GO:0001575 from GO Biological Process Annotations)", "globus pallidus development (GO:0021759 from GO Biological Process Annotations)", "glomerular basement membrane development (GO:0032836 from GO Biological Process Annotations)", "glomerular capillary formation (GO:0072104 from GO Biological Process Annotations)", "glomerular endothelium development (GO:0072011 from GO Biological Process Annotations)", "glomerular epithelial cell development (GO:0072310 from GO Biological Process Annotations)", "glomerular epithelial cell differentiation (GO:0072311 from GO Biological Process Annotations)", "glomerular epithelium development (GO:0072010 from GO Biological Process Annotations)", "glomerular filtration (GO:0003094 from GO Biological Process Annotations)", "glomerular mesangial cell development (GO:0072144 from GO Biological Process Annotations)", "glomerular mesangial cell differentiation (GO:0072008 from GO Biological Process Annotations)", "glomerular mesangial cell proliferation (GO:0072110 from GO Biological Process Annotations)", "glomerular parietal epithelial cell development (GO:0072016 from GO Biological Process Annotations)", "glomerular parietal epithelial cell differentiation (GO:0072139 from GO Biological Process Annotations)", "glomerular visceral epithelial cell development (GO:0072015 from GO Biological Process Annotations)", "glomerular visceral epithelial cell differentiation (GO:0072112 from GO Biological Process Annotations)", "glomerular visceral epithelial cell migration (GO:0090521 from GO Biological Process Annotations)", "glomerulus development (GO:0032835 from GO Biological Process Annotations)", "glomerulus morphogenesis (GO:0072102 from GO Biological Process Annotations)", "glomerulus vasculature development (GO:0072012 from GO Biological Process Annotations)", "glossopharyngeal nerve development (GO:0021563 from GO Biological Process Annotations)", "glossopharyngeal nerve morphogenesis (GO:0021615 from GO Biological Process Annotations)", "glucagon secretion (GO:0070091 from GO Biological Process Annotations)", "glucan biosynthetic process (GO:0009250 from GO Biological Process Annotations)", "glucan catabolic process (GO:0009251 from GO Biological Process Annotations)", "glucan metabolic process (GO:0044042 from GO Biological Process Annotations)", "glucocorticoid biosynthetic process (GO:0006704 from GO Biological Process Annotations)", "glucocorticoid catabolic process (GO:0006713 from GO Biological Process Annotations)", "glucocorticoid mediated signaling pathway (GO:0043402 from GO Biological Process Annotations)", "glucocorticoid metabolic process (GO:0008211 from GO Biological Process Annotations)", "glucocorticoid receptor signaling pathway (GO:0042921 from GO Biological Process Annotations)", "glucocorticoid secretion (GO:0035933 from GO Biological Process Annotations)", "gluconeogenesis (GO:0006094 from GO Biological Process Annotations)", "glucosamine biosynthetic process (GO:0006042 from GO Biological Process Annotations)", "glucosamine catabolic process (GO:0006043 from GO Biological Process Annotations)", "glucosamine metabolic process (GO:0006041 from GO Biological Process Annotations)", "glucosamine-containing compound biosynthetic process (GO:1901073 from GO Biological Process Annotations)", "glucosamine-containing compound catabolic process (GO:1901072 from GO Biological Process Annotations)", "glucosamine-containing compound metabolic process (GO:1901071 from GO Biological Process Annotations)", "glucose 1-phosphate metabolic process (GO:0019255 from GO Biological Process Annotations)", "glucose 6-phosphate metabolic process (GO:0051156 from GO Biological Process Annotations)", "glucose catabolic process (GO:0006007 from GO Biological Process Annotations)", "glucose homeostasis (GO:0042593 from GO Biological Process Annotations)", "glucose import (GO:0046323 from GO Biological Process Annotations)", "glucose mediated signaling pathway (GO:0010255 from GO Biological Process Annotations)", "glucose metabolic process (GO:0006006 from GO Biological Process Annotations)", "glucose transport (GO:0015758 from GO Biological Process Annotations)", "glucose-6-phosphate transport (GO:0015760 from GO Biological Process Annotations)", "glucoside transport (GO:0042946 from GO Biological Process Annotations)", "glucosylceramide biosynthetic process (GO:0006679 from GO Biological Process Annotations)", "glucosylceramide catabolic process (GO:0006680 from GO Biological Process Annotations)", "glucosylceramide metabolic process (GO:0006678 from GO Biological Process Annotations)", "glucuronate catabolic process (GO:0006064 from GO Biological Process Annotations)", "glucuronate metabolic process (GO:0019585 from GO Biological Process Annotations)", "glucuronoside catabolic process (GO:0019391 from GO Biological Process Annotations)", "glucuronoside metabolic process (GO:0019389 from GO Biological Process Annotations)", "glutamate biosynthetic process (GO:0006537 from GO Biological Process Annotations)", "glutamate catabolic process (GO:0006538 from GO Biological Process Annotations)", "glutamate catabolic process to 2-oxoglutarate (GO:0019551 from GO Biological Process Annotations)", "glutamate catabolic process to aspartate (GO:0019550 from GO Biological Process Annotations)", "glutamate decarboxylation to succinate (GO:0006540 from GO Biological Process Annotations)", "glutamate metabolic process (GO:0006536 from GO Biological Process Annotations)", "glutamate receptor signaling pathway (GO:0007215 from GO Biological Process Annotations)", "glutamate secretion (GO:0014047 from GO Biological Process Annotations)", "glutamine biosynthetic process (GO:0006542 from GO Biological Process Annotations)", "glutamine catabolic process (GO:0006543 from GO Biological Process Annotations)", "glutamine family amino acid biosynthetic process (GO:0009084 from GO Biological Process Annotations)", "glutamine family amino acid catabolic process (GO:0009065 from GO Biological Process Annotations)", "glutamine family amino acid metabolic process (GO:0009064 from GO Biological Process Annotations)", "glutamine metabolic process (GO:0006541 from GO Biological Process Annotations)", "glutamine transport (GO:0006868 from GO Biological Process Annotations)", "glutaminyl-trna aminoacylation (GO:0006425 from GO Biological Process Annotations)", "glutaminyl-trnagln biosynthesis via transamidation (GO:0070681 from GO Biological Process Annotations)", "glutamyl-trna aminoacylation (GO:0006424 from GO Biological Process Annotations)", "glutathione biosynthetic process (GO:0006750 from GO Biological Process Annotations)", "glutathione catabolic process (GO:0006751 from GO Biological Process Annotations)", "glutathione derivative biosynthetic process (GO:1901687 from GO Biological Process Annotations)", "glutathione derivative metabolic process (GO:1901685 from GO Biological Process Annotations)", "glutathione metabolic process (GO:0006749 from GO Biological Process Annotations)", "glutathione transport (GO:0034635 from GO Biological Process Annotations)", "glyceraldehyde-3-phosphate biosynthetic process (GO:0046166 from GO Biological Process Annotations)", "glyceraldehyde-3-phosphate metabolic process (GO:0019682 from GO Biological Process Annotations)", "glycerol biosynthetic process (GO:0006114 from GO Biological Process Annotations)", "glycerol biosynthetic process from pyruvate (GO:0046327 from GO Biological Process Annotations)", "glycerol catabolic process (GO:0019563 from GO Biological Process Annotations)", "glycerol ether biosynthetic process (GO:0046504 from GO Biological Process Annotations)", "glycerol ether metabolic process (GO:0006662 from GO Biological Process Annotations)", "glycerol metabolic process (GO:0006071 from GO Biological Process Annotations)", "glycerol transport (GO:0015793 from GO Biological Process Annotations)", "glycerol-3-phosphate biosynthetic process (GO:0046167 from GO Biological Process Annotations)", "glycerol-3-phosphate catabolic process (GO:0046168 from GO Biological Process Annotations)", "glycerol-3-phosphate metabolic process (GO:0006072 from GO Biological Process Annotations)", "glycerolipid biosynthetic process (GO:0045017 from GO Biological Process Annotations)", "glycerolipid catabolic process (GO:0046503 from GO Biological Process Annotations)", "glycerolipid metabolic process (GO:0046486 from GO Biological Process Annotations)", "glycerophosphate shuttle (GO:0006127 from GO Biological Process Annotations)", "glycerophospholipid biosynthetic process (GO:0046474 from GO Biological Process Annotations)", "glycerophospholipid catabolic process (GO:0046475 from GO Biological Process Annotations)", "glycerophospholipid metabolic process (GO:0006650 from GO Biological Process Annotations)", "glycine betaine biosynthetic process (GO:0031456 from GO Biological Process Annotations)", "glycine betaine biosynthetic process from choline (GO:0019285 from GO Biological Process Annotations)", "glycine betaine metabolic process (GO:0031455 from GO Biological Process Annotations)", "glycine biosynthetic process (GO:0006545 from GO Biological Process Annotations)", "glycine biosynthetic process from serine (GO:0019264 from GO Biological Process Annotations)", "glycine biosynthetic process, by transamination of glyoxylate (GO:0019265 from GO Biological Process Annotations)", "glycine catabolic process (GO:0006546 from GO Biological Process Annotations)", "glycine decarboxylation via glycine cleavage system (GO:0019464 from GO Biological Process Annotations)", "glycine import (GO:0036233 from GO Biological Process Annotations)", "glycine metabolic process (GO:0006544 from GO Biological Process Annotations)", "glycine receptor clustering (GO:0072579 from GO Biological Process Annotations)", "glycine transport (GO:0015816 from GO Biological Process Annotations)", "glycogen biosynthetic process (GO:0005978 from GO Biological Process Annotations)", "glycogen catabolic process (GO:0005980 from GO Biological Process Annotations)", "glycogen cell differentiation involved in embryonic placenta development (GO:0060709 from GO Biological Process Annotations)", "glycogen metabolic process (GO:0005977 from GO Biological Process Annotations)", "glycolate biosynthetic process (GO:0046295 from GO Biological Process Annotations)", "glycolate catabolic process (GO:0046296 from GO Biological Process Annotations)", "glycolate metabolic process (GO:0009441 from GO Biological Process Annotations)", "glycolipid biosynthetic process (GO:0009247 from GO Biological Process Annotations)", "glycolipid catabolic process (GO:0019377 from GO Biological Process Annotations)", "glycolipid metabolic process (GO:0006664 from GO Biological Process Annotations)", "glycolipid translocation (GO:0034203 from GO Biological Process Annotations)", "glycolipid transport (GO:0046836 from GO Biological Process Annotations)", "glycolytic process (GO:0006096 from GO Biological Process Annotations)", "glycoprotein biosynthetic process (GO:0009101 from GO Biological Process Annotations)", "glycoprotein catabolic process (GO:0006516 from GO Biological Process Annotations)", "glycoprotein metabolic process (GO:0009100 from GO Biological Process Annotations)", "glycoprotein transport (GO:0034436 from GO Biological Process Annotations)", "glycosaminoglycan biosynthetic process (GO:0006024 from GO Biological Process Annotations)", "glycosaminoglycan catabolic process (GO:0006027 from GO Biological Process Annotations)", "glycosaminoglycan metabolic process (GO:0030203 from GO Biological Process Annotations)", "glycoside catabolic process (GO:0016139 from GO Biological Process Annotations)", "glycoside metabolic process (GO:0016137 from GO Biological Process Annotations)", "glycoside transport (GO:1901656 from GO Biological Process Annotations)", "glycosphingolipid biosynthetic process (GO:0006688 from GO Biological Process Annotations)", "glycosphingolipid catabolic process (GO:0046479 from GO Biological Process Annotations)", "glycosphingolipid metabolic process (GO:0006687 from GO Biological Process Annotations)", "glycosyl compound biosynthetic process (GO:1901659 from GO Biological Process Annotations)", "glycosyl compound catabolic process (GO:1901658 from GO Biological Process Annotations)", "glycosyl compound metabolic process (GO:1901657 from GO Biological Process Annotations)", "glycosylation (GO:0070085 from GO Biological Process Annotations)", "glycosylceramide biosynthetic process (GO:0046476 from GO Biological Process Annotations)", "glycosylceramide catabolic process (GO:0046477 from GO Biological Process Annotations)", "glycosylceramide metabolic process (GO:0006677 from GO Biological Process Annotations)", "glycyl-trna aminoacylation (GO:0006426 from GO Biological Process Annotations)", "glyoxal catabolic process (GO:1903190 from GO Biological Process Annotations)", "glyoxal metabolic process (GO:1903189 from GO Biological Process Annotations)", "glyoxylate catabolic process (GO:0009436 from GO Biological Process Annotations)", "glyoxylate cycle (GO:0006097 from GO Biological Process Annotations)", "glyoxylate metabolic process (GO:0046487 from GO Biological Process Annotations)", "gmp biosynthetic process (GO:0006177 from GO Biological Process Annotations)", "gmp catabolic process (GO:0046038 from GO Biological Process Annotations)", "gmp metabolic process (GO:0046037 from GO Biological Process Annotations)", "gmp salvage (GO:0032263 from GO Biological Process Annotations)", "golgi calcium ion homeostasis (GO:0032468 from GO Biological Process Annotations)", "golgi calcium ion transport (GO:0032472 from GO Biological Process Annotations)", "golgi disassembly (GO:0090166 from GO Biological Process Annotations)", "golgi inheritance (GO:0048313 from GO Biological Process Annotations)", "golgi localization (GO:0051645 from GO Biological Process Annotations)", "golgi organization (GO:0007030 from GO Biological Process Annotations)", "golgi reassembly (GO:0090168 from GO Biological Process Annotations)", "golgi ribbon formation (GO:0090161 from GO Biological Process Annotations)", "golgi to endosome transport (GO:0006895 from GO Biological Process Annotations)", "golgi to lysosome transport (GO:0090160 from GO Biological Process Annotations)", "golgi to plasma membrane cftr protein transport (GO:0043000 from GO Biological Process Annotations)", "golgi to plasma membrane protein transport (GO:0043001 from GO Biological Process Annotations)", "golgi to plasma membrane transport (GO:0006893 from GO Biological Process Annotations)", "golgi to secretory granule transport (GO:0055107 from GO Biological Process Annotations)", "golgi to vacuole transport (GO:0006896 from GO Biological Process Annotations)", "golgi transport vesicle coating (GO:0048200 from GO Biological Process Annotations)", "golgi vesicle budding (GO:0048194 from GO Biological Process Annotations)", "golgi vesicle docking (GO:0048211 from GO Biological Process Annotations)", "golgi vesicle fusion to target membrane (GO:0048210 from GO Biological Process Annotations)", "golgi vesicle prefusion complex stabilization (GO:0048213 from GO Biological Process Annotations)", "golgi vesicle transport (GO:0048193 from GO Biological Process Annotations)", "gonad development (GO:0008406 from GO Biological Process Annotations)", "gonad morphogenesis (GO:0035262 from GO Biological Process Annotations)", "gonadal mesoderm development (GO:0007506 from GO Biological Process Annotations)", "gonadotrophin-releasing hormone neuronal migration to the hypothalamus (GO:0021828 from GO Biological Process Annotations)", "gonadotropin secretion (GO:0032274 from GO Biological Process Annotations)", "gpi anchor biosynthetic process (GO:0006506 from GO Biological Process Annotations)", "gpi anchor metabolic process (GO:0006505 from GO Biological Process Annotations)", "gpi anchor release (GO:0006507 from GO Biological Process Annotations)", "granulocyte activation (GO:0036230 from GO Biological Process Annotations)", "granulocyte chemotaxis (GO:0071621 from GO Biological Process Annotations)", "granulocyte colony-stimulating factor signaling pathway (GO:0038158 from GO Biological Process Annotations)", "granulocyte differentiation (GO:0030851 from GO Biological Process Annotations)", "granulocyte macrophage colony-stimulating factor biosynthetic process (GO:0042253 from GO Biological Process Annotations)", "granulocyte migration (GO:0097530 from GO Biological Process Annotations)", "granuloma formation (GO:0002432 from GO Biological Process Annotations)", "granulosa cell development (GO:0060016 from GO Biological Process Annotations)", "granulosa cell differentiation (GO:0060014 from GO Biological Process Annotations)", "granzyme-mediated apoptotic signaling pathway (GO:0008626 from GO Biological Process Annotations)", "grooming behavior (GO:0007625 from GO Biological Process Annotations)", "growth (GO:0040007 from GO Biological Process Annotations)", "growth factor dependent regulation of skeletal muscle satellite cell proliferation (GO:0014843 from GO Biological Process Annotations)", "growth hormone receptor signaling pathway (GO:0060396 from GO Biological Process Annotations)", "growth hormone secretion (GO:0030252 from GO Biological Process Annotations)", "growth involved in heart morphogenesis (GO:0003241 from GO Biological Process Annotations)", "growth involved in symbiotic interaction (GO:0044110 from GO Biological Process Annotations)", "growth of symbiont in host (GO:0044117 from GO Biological Process Annotations)", "growth of symbiont involved in interaction with host (GO:0044116 from GO Biological Process Annotations)", "growth plate cartilage axis specification (GO:0003421 from GO Biological Process Annotations)", "growth plate cartilage chondrocyte development (GO:0003431 from GO Biological Process Annotations)", "growth plate cartilage chondrocyte differentiation (GO:0003418 from GO Biological Process Annotations)", "growth plate cartilage chondrocyte growth (GO:0003430 from GO Biological Process Annotations)", "growth plate cartilage chondrocyte morphogenesis (GO:0003429 from GO Biological Process Annotations)", "growth plate cartilage chondrocyte proliferation (GO:0003419 from GO Biological Process Annotations)", "growth plate cartilage development (GO:0003417 from GO Biological Process Annotations)", "growth plate cartilage morphogenesis (GO:0003422 from GO Biological Process Annotations)", "gtp biosynthetic process (GO:0006183 from GO Biological Process Annotations)", "gtp metabolic process (GO:0046039 from GO Biological Process Annotations)", "guanine biosynthetic process (GO:0046099 from GO Biological Process Annotations)", "guanine catabolic process (GO:0006147 from GO Biological Process Annotations)", "guanine metabolic process (GO:0046098 from GO Biological Process Annotations)", "guanine salvage (GO:0006178 from GO Biological Process Annotations)", "guanosine metabolic process (GO:0008617 from GO Biological Process Annotations)", "guanosine-containing compound biosynthetic process (GO:1901070 from GO Biological Process Annotations)", "guanosine-containing compound catabolic process (GO:1901069 from GO Biological Process Annotations)", "guanosine-containing compound metabolic process (GO:1901068 from GO Biological Process Annotations)", "guanylate kinase-associated protein clustering (GO:0097117 from GO Biological Process Annotations)", "habenula development (GO:0021986 from GO Biological Process Annotations)", "habituation (GO:0046959 from GO Biological Process Annotations)", "hac1-type intron splice site recognition and cleavage (GO:0070055 from GO Biological Process Annotations)", "hair cell differentiation (GO:0035315 from GO Biological Process Annotations)", "hair cycle (GO:0042633 from GO Biological Process Annotations)", "hair cycle phase (GO:0044851 from GO Biological Process Annotations)", "hair cycle process (GO:0022405 from GO Biological Process Annotations)", "hair follicle cell proliferation (GO:0071335 from GO Biological Process Annotations)", "hair follicle development (GO:0001942 from GO Biological Process Annotations)", "hair follicle maturation (GO:0048820 from GO Biological Process Annotations)", "hair follicle morphogenesis (GO:0031069 from GO Biological Process Annotations)", "hair follicle placode formation (GO:0060789 from GO Biological Process Annotations)", "halogenated hydrocarbon metabolic process (GO:0042197 from GO Biological Process Annotations)", "hard palate development (GO:0060022 from GO Biological Process Annotations)", "harderian gland development (GO:0070384 from GO Biological Process Annotations)", "hatching (GO:0035188 from GO Biological Process Annotations)", "head development (GO:0060322 from GO Biological Process Annotations)", "head morphogenesis (GO:0060323 from GO Biological Process Annotations)", "heart contraction (GO:0060047 from GO Biological Process Annotations)", "heart development (GO:0007507 from GO Biological Process Annotations)", "heart field specification (GO:0003128 from GO Biological Process Annotations)", "heart formation (GO:0060914 from GO Biological Process Annotations)", "heart looping (GO:0001947 from GO Biological Process Annotations)", "heart morphogenesis (GO:0003007 from GO Biological Process Annotations)", "heart process (GO:0003015 from GO Biological Process Annotations)", "heart trabecula formation (GO:0060347 from GO Biological Process Annotations)", "heart trabecula morphogenesis (GO:0061384 from GO Biological Process Annotations)", "heart valve development (GO:0003170 from GO Biological Process Annotations)", "heart valve formation (GO:0003188 from GO Biological Process Annotations)", "heart valve morphogenesis (GO:0003179 from GO Biological Process Annotations)", "heat acclimation (GO:0010286 from GO Biological Process Annotations)", "heat generation (GO:0031649 from GO Biological Process Annotations)", "helper t cell chemotaxis (GO:0035704 from GO Biological Process Annotations)", "helper t cell enhancement of adaptive immune response (GO:0035397 from GO Biological Process Annotations)", "helper t cell extravasation (GO:0035684 from GO Biological Process Annotations)", "hemangioblast cell differentiation (GO:0060217 from GO Biological Process Annotations)", "hematopoietic or lymphoid organ development (GO:0048534 from GO Biological Process Annotations)", "hematopoietic progenitor cell differentiation (GO:0002244 from GO Biological Process Annotations)", "hematopoietic stem cell differentiation (GO:0060218 from GO Biological Process Annotations)", "hematopoietic stem cell homeostasis (GO:0061484 from GO Biological Process Annotations)", "hematopoietic stem cell migration (GO:0035701 from GO Biological Process Annotations)", "hematopoietic stem cell migration to bone marrow (GO:0097241 from GO Biological Process Annotations)", "hematopoietic stem cell proliferation (GO:0071425 from GO Biological Process Annotations)", "heme a biosynthetic process (GO:0006784 from GO Biological Process Annotations)", "heme a metabolic process (GO:0046160 from GO Biological Process Annotations)", "heme biosynthetic process (GO:0006783 from GO Biological Process Annotations)", "heme catabolic process (GO:0042167 from GO Biological Process Annotations)", "heme export (GO:0097037 from GO Biological Process Annotations)", "heme metabolic process (GO:0042168 from GO Biological Process Annotations)", "heme o biosynthetic process (GO:0048034 from GO Biological Process Annotations)", "heme o metabolic process (GO:0048033 from GO Biological Process Annotations)", "heme oxidation (GO:0006788 from GO Biological Process Annotations)", "heme transport (GO:0015886 from GO Biological Process Annotations)", "hemidesmosome assembly (GO:0031581 from GO Biological Process Annotations)", "hemoglobin biosynthetic process (GO:0042541 from GO Biological Process Annotations)", "hemoglobin metabolic process (GO:0020027 from GO Biological Process Annotations)", "hemolysis by symbiont of host erythrocytes (GO:0019836 from GO Biological Process Annotations)", "hemolysis in other organism (GO:0044179 from GO Biological Process Annotations)", "hemolysis in other organism involved in symbiotic interaction (GO:0052331 from GO Biological Process Annotations)", "hemopoiesis (GO:0030097 from GO Biological Process Annotations)", "hemostasis (GO:0007599 from GO Biological Process Annotations)", "heparan sulfate proteoglycan biosynthetic process (GO:0015012 from GO Biological Process Annotations)", "heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015 from GO Biological Process Annotations)", "heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014 from GO Biological Process Annotations)", "heparan sulfate proteoglycan catabolic process (GO:0030200 from GO Biological Process Annotations)", "heparan sulfate proteoglycan metabolic process (GO:0030201 from GO Biological Process Annotations)", "heparin biosynthetic process (GO:0030210 from GO Biological Process Annotations)", "heparin metabolic process (GO:0030202 from GO Biological Process Annotations)", "hepatic duct development (GO:0061011 from GO Biological Process Annotations)", "hepatic immune response (GO:0002384 from GO Biological Process Annotations)", "hepatic stellate cell activation (GO:0035733 from GO Biological Process Annotations)", "hepatoblast differentiation (GO:0061017 from GO Biological Process Annotations)", "hepatocyte apoptotic process (GO:0097284 from GO Biological Process Annotations)", "hepatocyte cell migration (GO:0002194 from GO Biological Process Annotations)", "hepatocyte differentiation (GO:0070365 from GO Biological Process Annotations)", "hepatocyte growth factor receptor signaling pathway (GO:0048012 from GO Biological Process Annotations)", "hepatocyte proliferation (GO:0072574 from GO Biological Process Annotations)", "hepoxilin biosynthetic process (GO:0051122 from GO Biological Process Annotations)", "hepoxilin metabolic process (GO:0051121 from GO Biological Process Annotations)", "heterochromatin assembly (GO:0031507 from GO Biological Process Annotations)", "heterochromatin assembly involved in chromatin silencing (GO:0070869 from GO Biological Process Annotations)", "heterochromatin maintenance (GO:0070829 from GO Biological Process Annotations)", "heterochromatin organization (GO:0070828 from GO Biological Process Annotations)", "heterochromatin organization involved in chromatin silencing (GO:0070868 from GO Biological Process Annotations)", "heterocycle biosynthetic process (GO:0018130 from GO Biological Process Annotations)", "heterocycle catabolic process (GO:0046700 from GO Biological Process Annotations)", "heterocycle metabolic process (GO:0046483 from GO Biological Process Annotations)", "heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157 from GO Biological Process Annotations)", "heterotrimeric g-protein complex assembly (GO:1902605 from GO Biological Process Annotations)", "heterotypic cell-cell adhesion (GO:0034113 from GO Biological Process Annotations)", "hexitol catabolic process (GO:0019407 from GO Biological Process Annotations)", "hexitol metabolic process (GO:0006059 from GO Biological Process Annotations)", "hexose biosynthetic process (GO:0019319 from GO Biological Process Annotations)", "hexose catabolic process (GO:0019320 from GO Biological Process Annotations)", "hexose mediated signaling (GO:0009757 from GO Biological Process Annotations)", "hexose metabolic process (GO:0019318 from GO Biological Process Annotations)", "hexose phosphate transport (GO:0015712 from GO Biological Process Annotations)", "hexose transmembrane transport (GO:0035428 from GO Biological Process Annotations)", "hexose transport (GO:0008645 from GO Biological Process Annotations)", "high-density lipoprotein particle assembly (GO:0034380 from GO Biological Process Annotations)", "high-density lipoprotein particle clearance (GO:0034384 from GO Biological Process Annotations)", "high-density lipoprotein particle remodeling (GO:0034375 from GO Biological Process Annotations)", "hindbrain development (GO:0030902 from GO Biological Process Annotations)", "hindbrain morphogenesis (GO:0021575 from GO Biological Process Annotations)", "hindbrain radial glia guided cell migration (GO:0021932 from GO Biological Process Annotations)", "hindbrain tangential cell migration (GO:0021934 from GO Biological Process Annotations)", "hindgut development (GO:0061525 from GO Biological Process Annotations)", "hindgut morphogenesis (GO:0007442 from GO Biological Process Annotations)", "hindlimb morphogenesis (GO:0035137 from GO Biological Process Annotations)", "hippo signaling (GO:0035329 from GO Biological Process Annotations)", "hippocampus development (GO:0021766 from GO Biological Process Annotations)", "his-purkinje system cell differentiation (GO:0060932 from GO Biological Process Annotations)", "histamine biosynthetic process (GO:0001694 from GO Biological Process Annotations)", "histamine metabolic process (GO:0001692 from GO Biological Process Annotations)", "histamine secretion (GO:0001821 from GO Biological Process Annotations)", "histamine secretion by mast cell (GO:0002553 from GO Biological Process Annotations)", "histamine secretion involved in inflammatory response (GO:0002441 from GO Biological Process Annotations)", "histamine transport (GO:0051608 from GO Biological Process Annotations)", "histamine uptake (GO:0051615 from GO Biological Process Annotations)", "histamine-induced gastric acid secretion (GO:0001697 from GO Biological Process Annotations)", "histidine biosynthetic process (GO:0000105 from GO Biological Process Annotations)", "histidine catabolic process (GO:0006548 from GO Biological Process Annotations)", "histidine catabolic process to glutamate and formamide (GO:0019556 from GO Biological Process Annotations)", "histidine catabolic process to glutamate and formate (GO:0019557 from GO Biological Process Annotations)", "histidine metabolic process (GO:0006547 from GO Biological Process Annotations)", "histidine transport (GO:0015817 from GO Biological Process Annotations)", "histidyl-trna aminoacylation (GO:0006427 from GO Biological Process Annotations)", "histone acetylation (GO:0016573 from GO Biological Process Annotations)", "histone arginine demethylation (GO:0070077 from GO Biological Process Annotations)", "histone arginine methylation (GO:0034969 from GO Biological Process Annotations)", "histone biotinylation (GO:0071110 from GO Biological Process Annotations)", "histone citrullination (GO:0036414 from GO Biological Process Annotations)", "histone deacetylation (GO:0016575 from GO Biological Process Annotations)", "histone demethylation (GO:0016577 from GO Biological Process Annotations)", "histone dephosphorylation (GO:0016576 from GO Biological Process Annotations)", "histone deubiquitination (GO:0016578 from GO Biological Process Annotations)", "histone displacement (GO:0001207 from GO Biological Process Annotations)", "histone exchange (GO:0043486 from GO Biological Process Annotations)", "histone glutamine methylation (GO:1990258 from GO Biological Process Annotations)", "histone h2a acetylation (GO:0043968 from GO Biological Process Annotations)", "histone h2a k63-linked deubiquitination (GO:0070537 from GO Biological Process Annotations)", "histone h2a k63-linked ubiquitination (GO:0070535 from GO Biological Process Annotations)", "histone h2a monoubiquitination (GO:0035518 from GO Biological Process Annotations)", "histone h2a phosphorylation (GO:1990164 from GO Biological Process Annotations)", "histone h2a ubiquitination (GO:0033522 from GO Biological Process Annotations)", "histone h2a-k119 monoubiquitination (GO:0036353 from GO Biological Process Annotations)", "histone h2a-k13 ubiquitination (GO:0036351 from GO Biological Process Annotations)", "histone h2a-k15 ubiquitination (GO:0036352 from GO Biological Process Annotations)", "histone h2a-s1 phosphorylation (GO:0043990 from GO Biological Process Annotations)", "histone h2a-s139 phosphorylation (GO:0035978 from GO Biological Process Annotations)", "histone h2a-t120 phosphorylation (GO:1990245 from GO Biological Process Annotations)", "histone h2b acetylation (GO:0043969 from GO Biological Process Annotations)", "histone h2b conserved c-terminal lysine deubiquitination (GO:0035616 from GO Biological Process Annotations)", "histone h2b conserved c-terminal lysine ubiquitination (GO:0071894 from GO Biological Process Annotations)", "histone h2b ubiquitination (GO:0033523 from GO Biological Process Annotations)", "histone h3 acetylation (GO:0043966 from GO Biological Process Annotations)", "histone h3 deacetylation (GO:0070932 from GO Biological Process Annotations)", "histone h3-k14 acetylation (GO:0044154 from GO Biological Process Annotations)", "histone h3-k27 demethylation (GO:0071557 from GO Biological Process Annotations)", "histone h3-k27 methylation (GO:0070734 from GO Biological Process Annotations)", "histone h3-k27 trimethylation (GO:0098532 from GO Biological Process Annotations)", "histone h3-k36 demethylation (GO:0070544 from GO Biological Process Annotations)", "histone h3-k36 dimethylation (GO:0097676 from GO Biological Process Annotations)", "histone h3-k36 methylation (GO:0010452 from GO Biological Process Annotations)", "histone h3-k36 trimethylation (GO:0097198 from GO Biological Process Annotations)", "histone h3-k4 acetylation (GO:0043973 from GO Biological Process Annotations)", "histone h3-k4 demethylation (GO:0034720 from GO Biological Process Annotations)", "histone h3-k4 demethylation, trimethyl-h3-k4-specific (GO:0034721 from GO Biological Process Annotations)", "histone h3-k4 methylation (GO:0051568 from GO Biological Process Annotations)", "histone h3-k4 trimethylation (GO:0080182 from GO Biological Process Annotations)", "histone h3-k79 methylation (GO:0034729 from GO Biological Process Annotations)", "histone h3-k9 acetylation (GO:0043970 from GO Biological Process Annotations)", "histone h3-k9 demethylation (GO:0033169 from GO Biological Process Annotations)", "histone h3-k9 dimethylation (GO:0036123 from GO Biological Process Annotations)", "histone h3-k9 methylation (GO:0051567 from GO Biological Process Annotations)", "histone h3-k9 modification (GO:0061647 from GO Biological Process Annotations)", "histone h3-k9 trimethylation (GO:0036124 from GO Biological Process Annotations)", "histone h3-r17 methylation (GO:0034971 from GO Biological Process Annotations)", "histone h3-r2 demethylation (GO:0070078 from GO Biological Process Annotations)", "histone h3-r2 methylation (GO:0034970 from GO Biological Process Annotations)", "histone h3-r26 citrullination (GO:0036413 from GO Biological Process Annotations)", "histone h3-r26 methylation (GO:0034972 from GO Biological Process Annotations)", "histone h3-s10 phosphorylation (GO:0043987 from GO Biological Process Annotations)", "histone h3-s10 phosphorylation involved in chromosome condensation (GO:2000775 from GO Biological Process Annotations)", "histone h3-s28 phosphorylation (GO:0043988 from GO Biological Process Annotations)", "histone h3-t11 phosphorylation (GO:0035407 from GO Biological Process Annotations)", "histone h3-t3 phosphorylation (GO:0072355 from GO Biological Process Annotations)", "histone h3-t3 phosphorylation involved in chromosome passenger complex localization to kinetochore (GO:2000751 from GO Biological Process Annotations)", "histone h3-t6 phosphorylation (GO:0035408 from GO Biological Process Annotations)", "histone h3-y41 phosphorylation (GO:0035409 from GO Biological Process Annotations)", "histone h4 acetylation (GO:0043967 from GO Biological Process Annotations)", "histone h4 deacetylation (GO:0070933 from GO Biological Process Annotations)", "histone h4-k12 acetylation (GO:0043983 from GO Biological Process Annotations)", "histone h4-k16 acetylation (GO:0043984 from GO Biological Process Annotations)", "histone h4-k20 demethylation (GO:0035574 from GO Biological Process Annotations)", "histone h4-k20 methylation (GO:0034770 from GO Biological Process Annotations)", "histone h4-k20 trimethylation (GO:0034773 from GO Biological Process Annotations)", "histone h4-k5 acetylation (GO:0043981 from GO Biological Process Annotations)", "histone h4-k8 acetylation (GO:0043982 from GO Biological Process Annotations)", "histone h4-r3 demethylation (GO:0070079 from GO Biological Process Annotations)", "histone h4-r3 methylation (GO:0043985 from GO Biological Process Annotations)", "histone lysine demethylation (GO:0070076 from GO Biological Process Annotations)", "histone lysine methylation (GO:0034968 from GO Biological Process Annotations)", "histone methylation (GO:0016571 from GO Biological Process Annotations)", "histone modification (GO:0016570 from GO Biological Process Annotations)", "histone monoubiquitination (GO:0010390 from GO Biological Process Annotations)", "histone mrna 3'-end processing (GO:0006398 from GO Biological Process Annotations)", "histone mrna catabolic process (GO:0071044 from GO Biological Process Annotations)", "histone mrna metabolic process (GO:0008334 from GO Biological Process Annotations)", "histone phosphorylation (GO:0016572 from GO Biological Process Annotations)", "histone ubiquitination (GO:0016574 from GO Biological Process Annotations)", "histone-serine phosphorylation (GO:0035404 from GO Biological Process Annotations)", "histone-threonine phosphorylation (GO:0035405 from GO Biological Process Annotations)", "histone-tyrosine phosphorylation (GO:0035406 from GO Biological Process Annotations)", "homeostasis of number of cells (GO:0048872 from GO Biological Process Annotations)", "homeostasis of number of cells in a free-living population (GO:0048874 from GO Biological Process Annotations)", "homeostasis of number of cells within a tissue (GO:0048873 from GO Biological Process Annotations)", "homeostatic process (GO:0042592 from GO Biological Process Annotations)", "homocysteine biosynthetic process (GO:0071268 from GO Biological Process Annotations)", "homocysteine catabolic process (GO:0043418 from GO Biological Process Annotations)", "homocysteine metabolic process (GO:0050667 from GO Biological Process Annotations)", "homoiothermy (GO:0042309 from GO Biological Process Annotations)", "homologous chromosome movement towards spindle pole involved in homologous chromosome segregation (GO:0051758 from GO Biological Process Annotations)", "homologous chromosome segregation (GO:0045143 from GO Biological Process Annotations)", "homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156 from GO Biological Process Annotations)", "homoserine metabolic process (GO:0009092 from GO Biological Process Annotations)", "homotypic cell-cell adhesion (GO:0034109 from GO Biological Process Annotations)", "horizontal cell localization (GO:0035852 from GO Biological Process Annotations)", "hormonal regulation of the force of heart contraction (GO:0003058 from GO Biological Process Annotations)", "hormone biosynthetic process (GO:0042446 from GO Biological Process Annotations)", "hormone catabolic process (GO:0042447 from GO Biological Process Annotations)", "hormone metabolic process (GO:0042445 from GO Biological Process Annotations)", "hormone secretion (GO:0046879 from GO Biological Process Annotations)", "hormone transport (GO:0009914 from GO Biological Process Annotations)", "hormone-mediated apoptotic signaling pathway (GO:0008628 from GO Biological Process Annotations)", "hormone-mediated signaling pathway (GO:0009755 from GO Biological Process Annotations)", "host programmed cell death induced by symbiont (GO:0034050 from GO Biological Process Annotations)", "hsp90 deacetylation (GO:0070846 from GO Biological Process Annotations)", "humoral immune response (GO:0006959 from GO Biological Process Annotations)", "humoral immune response mediated by circulating immunoglobulin (GO:0002455 from GO Biological Process Annotations)", "hyaloid vascular plexus regression (GO:1990384 from GO Biological Process Annotations)", "hyaluronan biosynthetic process (GO:0030213 from GO Biological Process Annotations)", "hyaluronan catabolic process (GO:0030214 from GO Biological Process Annotations)", "hyaluronan metabolic process (GO:0030212 from GO Biological Process Annotations)", "hydrogen ion transmembrane transport (GO:1902600 from GO Biological Process Annotations)", "hydrogen peroxide biosynthetic process (GO:0050665 from GO Biological Process Annotations)", "hydrogen peroxide catabolic process (GO:0042744 from GO Biological Process Annotations)", "hydrogen peroxide metabolic process (GO:0042743 from GO Biological Process Annotations)", "hydrogen sulfide biosynthetic process (GO:0070814 from GO Biological Process Annotations)", "hydrogen sulfide metabolic process (GO:0070813 from GO Biological Process Annotations)", "hydrogen transport (GO:0006818 from GO Biological Process Annotations)", "hydroxylysine biosynthetic process (GO:0046947 from GO Biological Process Annotations)", "hydroxylysine metabolic process (GO:0046946 from GO Biological Process Annotations)", "hydroxyproline transport (GO:0034589 from GO Biological Process Annotations)", "hypermethylation of cpg island (GO:0044027 from GO Biological Process Annotations)", "hyperosmotic response (GO:0006972 from GO Biological Process Annotations)", "hyperosmotic salinity response (GO:0042538 from GO Biological Process Annotations)", "hypersensitivity (GO:0002524 from GO Biological Process Annotations)", "hypochlorous acid biosynthetic process (GO:0002149 from GO Biological Process Annotations)", "hypochlorous acid metabolic process (GO:0002148 from GO Biological Process Annotations)", "hypomethylation of cpg island (GO:0044029 from GO Biological Process Annotations)", "hypophysis morphogenesis (GO:0048850 from GO Biological Process Annotations)", "hypothalamic tangential migration using cell-axon interactions (GO:0021856 from GO Biological Process Annotations)", "hypothalamus cell differentiation (GO:0021979 from GO Biological Process Annotations)", "hypothalamus cell migration (GO:0021855 from GO Biological Process Annotations)", "hypothalamus development (GO:0021854 from GO Biological Process Annotations)", "hypotonic response (GO:0006971 from GO Biological Process Annotations)", "hypotonic salinity response (GO:0042539 from GO Biological Process Annotations)", "hypoxanthine biosynthetic process (GO:0046101 from GO Biological Process Annotations)", "hypoxanthine metabolic process (GO:0046100 from GO Biological Process Annotations)", "hypoxanthine salvage (GO:0043103 from GO Biological Process Annotations)", "hypoxia-inducible factor-1alpha signaling pathway (GO:0097411 from GO Biological Process Annotations)", "i-kappab kinase|nf-kappab signaling (GO:0007249 from GO Biological Process Annotations)", "i-kappab phosphorylation (GO:0007252 from GO Biological Process Annotations)", "icosanoid biosynthetic process (GO:0046456 from GO Biological Process Annotations)", "icosanoid catabolic process (GO:1901523 from GO Biological Process Annotations)", "icosanoid metabolic process (GO:0006690 from GO Biological Process Annotations)", "icosanoid secretion (GO:0032309 from GO Biological Process Annotations)", "icosanoid transport (GO:0071715 from GO Biological Process Annotations)", "idp catabolic process (GO:0046709 from GO Biological Process Annotations)", "idp metabolic process (GO:0046707 from GO Biological Process Annotations)", "igg immunoglobulin transcytosis in epithelial cells mediated by fcrn immunoglobulin receptor (GO:0002416 from GO Biological Process Annotations)", "imidazole-containing compound catabolic process (GO:0052805 from GO Biological Process Annotations)", "imidazole-containing compound metabolic process (GO:0052803 from GO Biological Process Annotations)", "imitative learning (GO:0098596 from GO Biological Process Annotations)", "immature b cell differentiation (GO:0002327 from GO Biological Process Annotations)", "immature t cell proliferation (GO:0033079 from GO Biological Process Annotations)", "immature t cell proliferation in thymus (GO:0033080 from GO Biological Process Annotations)", "immortalization of host cell (GO:0020021 from GO Biological Process Annotations)", "immortalization of host cell by virus (GO:0019088 from GO Biological Process Annotations)", "immune effector process (GO:0002252 from GO Biological Process Annotations)", "immune response (GO:0006955 from GO Biological Process Annotations)", "immune response to tumor cell (GO:0002418 from GO Biological Process Annotations)", "immune response-activating cell surface receptor signaling pathway (GO:0002429 from GO Biological Process Annotations)", "immune response-activating signal transduction (GO:0002757 from GO Biological Process Annotations)", "immune response-inhibiting cell surface receptor signaling pathway (GO:0002767 from GO Biological Process Annotations)", "immune response-inhibiting signal transduction (GO:0002765 from GO Biological Process Annotations)", "immune response-regulating cell surface receptor signaling pathway (GO:0002768 from GO Biological Process Annotations)", "immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002433 from GO Biological Process Annotations)", "immune response-regulating signaling pathway (GO:0002764 from GO Biological Process Annotations)", "immune system development (GO:0002520 from GO Biological Process Annotations)", "immune system process (GO:0002376 from GO Biological Process Annotations)", "immunoglobulin biosynthetic process (GO:0002378 from GO Biological Process Annotations)", "immunoglobulin mediated immune response (GO:0016064 from GO Biological Process Annotations)", "immunoglobulin production (GO:0002377 from GO Biological Process Annotations)", "immunoglobulin production in mucosal tissue (GO:0002426 from GO Biological Process Annotations)", "immunoglobulin production involved in immunoglobulin mediated immune response (GO:0002381 from GO Biological Process Annotations)", "immunoglobulin secretion (GO:0048305 from GO Biological Process Annotations)", "immunoglobulin secretion involved in immune response (GO:0002380 from GO Biological Process Annotations)", "immunoglobulin transcytosis in epithelial cells (GO:0002414 from GO Biological Process Annotations)", "immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor (GO:0002415 from GO Biological Process Annotations)", "immunoglobulin v(d)j recombination (GO:0033152 from GO Biological Process Annotations)", "immunological synapse formation (GO:0001771 from GO Biological Process Annotations)", "imp biosynthetic process (GO:0006188 from GO Biological Process Annotations)", "imp metabolic process (GO:0046040 from GO Biological Process Annotations)", "imp salvage (GO:0032264 from GO Biological Process Annotations)", "import across plasma membrane (GO:0098739 from GO Biological Process Annotations)", "import into cell (GO:0098657 from GO Biological Process Annotations)", "in utero embryonic development (GO:0001701 from GO Biological Process Annotations)", "inactivation of mapk activity (GO:0000188 from GO Biological Process Annotations)", "inactivation of mapk activity involved in osmosensory signaling pathway (GO:0000173 from GO Biological Process Annotations)", "inactivation of mapkk activity (GO:0051389 from GO Biological Process Annotations)", "inactivation of x chromosome by dna methylation (GO:0060821 from GO Biological Process Annotations)", "inclusion body assembly (GO:0070841 from GO Biological Process Annotations)", "indolalkylamine biosynthetic process (GO:0046219 from GO Biological Process Annotations)", "indolalkylamine catabolic process (GO:0046218 from GO Biological Process Annotations)", "indolalkylamine metabolic process (GO:0006586 from GO Biological Process Annotations)", "indole metabolic process (GO:0042431 from GO Biological Process Annotations)", "indole-containing compound biosynthetic process (GO:0042435 from GO Biological Process Annotations)", "indole-containing compound catabolic process (GO:0042436 from GO Biological Process Annotations)", "indole-containing compound metabolic process (GO:0042430 from GO Biological Process Annotations)", "induction by organism of defense response of other organism involved in symbiotic interaction (GO:0052251 from GO Biological Process Annotations)", "induction by organism of defense-related nitric oxide production in other organism involved in symbiotic interaction (GO:0052263 from GO Biological Process Annotations)", "induction by organism of immune response of other organism involved in symbiotic interaction (GO:0052558 from GO Biological Process Annotations)", "induction by symbiont of defense-related host nitric oxide production (GO:0052063 from GO Biological Process Annotations)", "induction by symbiont of host defense response (GO:0044416 from GO Biological Process Annotations)", "induction by symbiont of host immune response (GO:0052559 from GO Biological Process Annotations)", "induction by virus of host cell-cell fusion (GO:0006948 from GO Biological Process Annotations)", "induction of bacterial agglutination (GO:0043152 from GO Biological Process Annotations)", "induction of host immune response by virus (GO:0046730 from GO Biological Process Annotations)", "induction of negative chemotaxis (GO:0050929 from GO Biological Process Annotations)", "induction of positive chemotaxis (GO:0050930 from GO Biological Process Annotations)", "induction of programmed cell death (GO:0012502 from GO Biological Process Annotations)", "inductive cell-cell signaling (GO:0031129 from GO Biological Process Annotations)", "inferior colliculus development (GO:0061379 from GO Biological Process Annotations)", "inflammatory cell apoptotic process (GO:0006925 from GO Biological Process Annotations)", "inflammatory response (GO:0006954 from GO Biological Process Annotations)", "inflammatory response to antigenic stimulus (GO:0002437 from GO Biological Process Annotations)", "inhibition of apc-cdc20 complex activity (GO:0060565 from GO Biological Process Annotations)", "inhibition of cysteine-type endopeptidase activity (GO:0097340 from GO Biological Process Annotations)", "inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001 from GO Biological Process Annotations)", "inhibition of neuroepithelial cell differentiation (GO:0002085 from GO Biological Process Annotations)", "inhibitory g-protein coupled receptor phosphorylation (GO:0002030 from GO Biological Process Annotations)", "initiation of neural tube closure (GO:0021993 from GO Biological Process Annotations)", "initiation of primordial ovarian follicle growth (GO:0001544 from GO Biological Process Annotations)", "innate immune response (GO:0045087 from GO Biological Process Annotations)", "innate immune response activating cell surface receptor signaling pathway (GO:0002220 from GO Biological Process Annotations)", "innate immune response in mucosa (GO:0002227 from GO Biological Process Annotations)", "innate immune response-activating signal transduction (GO:0002758 from GO Biological Process Annotations)", "inner cell mass cell differentiation (GO:0001826 from GO Biological Process Annotations)", "inner cell mass cell fate commitment (GO:0001827 from GO Biological Process Annotations)", "inner cell mass cell proliferation (GO:0001833 from GO Biological Process Annotations)", "inner cell mass cellular morphogenesis (GO:0001828 from GO Biological Process Annotations)", "inner dynein arm assembly (GO:0036159 from GO Biological Process Annotations)", "inner ear development (GO:0048839 from GO Biological Process Annotations)", "inner ear morphogenesis (GO:0042472 from GO Biological Process Annotations)", "inner ear receptor cell development (GO:0060119 from GO Biological Process Annotations)", "inner ear receptor cell differentiation (GO:0060113 from GO Biological Process Annotations)", "inner ear receptor cell fate commitment (GO:0060120 from GO Biological Process Annotations)", "inner ear receptor stereocilium organization (GO:0060122 from GO Biological Process Annotations)", "inner medullary collecting duct development (GO:0072061 from GO Biological Process Annotations)", "inner mitochondrial membrane organization (GO:0007007 from GO Biological Process Annotations)", "innervation (GO:0060384 from GO Biological Process Annotations)", "inorganic anion transmembrane transport (GO:0098661 from GO Biological Process Annotations)", "inorganic anion transport (GO:0015698 from GO Biological Process Annotations)", "inorganic cation import into cell (GO:0098659 from GO Biological Process Annotations)", "inorganic cation transmembrane transport (GO:0098662 from GO Biological Process Annotations)", "inorganic diphosphate transport (GO:0030505 from GO Biological Process Annotations)", "inorganic ion homeostasis (GO:0098771 from GO Biological Process Annotations)", "inorganic ion import into cell (GO:0099587 from GO Biological Process Annotations)", "inorganic ion transmembrane transport (GO:0098660 from GO Biological Process Annotations)", "inosine biosynthetic process (GO:0046103 from GO Biological Process Annotations)", "inosine catabolic process (GO:0006148 from GO Biological Process Annotations)", "inosine metabolic process (GO:0046102 from GO Biological Process Annotations)", "inositol biosynthetic process (GO:0006021 from GO Biological Process Annotations)", "inositol catabolic process (GO:0019310 from GO Biological Process Annotations)", "inositol lipid-mediated signaling (GO:0048017 from GO Biological Process Annotations)", "inositol metabolic process (GO:0006020 from GO Biological Process Annotations)", "inositol phosphate biosynthetic process (GO:0032958 from GO Biological Process Annotations)", "inositol phosphate catabolic process (GO:0071545 from GO Biological Process Annotations)", "inositol phosphate dephosphorylation (GO:0046855 from GO Biological Process Annotations)", "inositol phosphate metabolic process (GO:0043647 from GO Biological Process Annotations)", "inositol phosphate-mediated signaling (GO:0048016 from GO Biological Process Annotations)", "inositol phosphorylation (GO:0052746 from GO Biological Process Annotations)", "inositol trisphosphate biosynthetic process (GO:0032959 from GO Biological Process Annotations)", "inositol trisphosphate metabolic process (GO:0032957 from GO Biological Process Annotations)", "insecticide metabolic process (GO:0017143 from GO Biological Process Annotations)", "insemination (GO:0007320 from GO Biological Process Annotations)", "insulin catabolic process (GO:1901143 from GO Biological Process Annotations)", "insulin metabolic process (GO:1901142 from GO Biological Process Annotations)", "insulin processing (GO:0030070 from GO Biological Process Annotations)", "insulin receptor internalization (GO:0038016 from GO Biological Process Annotations)", "insulin receptor signaling pathway (GO:0008286 from GO Biological Process Annotations)", "insulin receptor signaling pathway via phosphatidylinositol 3-kinase (GO:0038028 from GO Biological Process Annotations)", "insulin secretion (GO:0030073 from GO Biological Process Annotations)", "insulin secretion involved in cellular response to glucose stimulus (GO:0035773 from GO Biological Process Annotations)", "insulin-like growth factor receptor signaling pathway (GO:0048009 from GO Biological Process Annotations)", "integrin activation (GO:0033622 from GO Biological Process Annotations)", "integrin biosynthetic process (GO:0045112 from GO Biological Process Annotations)", "integrin-mediated signaling pathway (GO:0007229 from GO Biological Process Annotations)", "intein-mediated protein splicing (GO:0016539 from GO Biological Process Annotations)", "inter-male aggressive behavior (GO:0002121 from GO Biological Process Annotations)", "interaction with host (GO:0051701 from GO Biological Process Annotations)", "interaction with symbiont (GO:0051702 from GO Biological Process Annotations)", "intercellular bridge organization (GO:0043063 from GO Biological Process Annotations)", "interferon-alpha production (GO:0032607 from GO Biological Process Annotations)", "interferon-beta production (GO:0032608 from GO Biological Process Annotations)", "interferon-gamma biosynthetic process (GO:0042095 from GO Biological Process Annotations)", "interferon-gamma production (GO:0032609 from GO Biological Process Annotations)", "interferon-gamma secretion (GO:0072643 from GO Biological Process Annotations)", "interferon-gamma-mediated signaling pathway (GO:0060333 from GO Biological Process Annotations)", "interkinetic nuclear migration (GO:0022027 from GO Biological Process Annotations)", "interleukin-1 alpha secretion (GO:0050703 from GO Biological Process Annotations)", "interleukin-1 beta biosynthetic process (GO:0050720 from GO Biological Process Annotations)", "interleukin-1 beta production (GO:0032611 from GO Biological Process Annotations)", "interleukin-1 beta secretion (GO:0050702 from GO Biological Process Annotations)", "interleukin-1 biosynthetic process (GO:0042222 from GO Biological Process Annotations)", "interleukin-1 production (GO:0032612 from GO Biological Process Annotations)", "interleukin-1 secretion (GO:0050701 from GO Biological Process Annotations)", "interleukin-1-mediated signaling pathway (GO:0070498 from GO Biological Process Annotations)", "interleukin-10 production (GO:0032613 from GO Biological Process Annotations)", "interleukin-10 secretion (GO:0072608 from GO Biological Process Annotations)", "interleukin-11-mediated signaling pathway (GO:0038154 from GO Biological Process Annotations)", "interleukin-12 production (GO:0032615 from GO Biological Process Annotations)", "interleukin-12 secretion (GO:0072610 from GO Biological Process Annotations)", "interleukin-12-mediated signaling pathway (GO:0035722 from GO Biological Process Annotations)", "interleukin-13 biosynthetic process (GO:0042231 from GO Biological Process Annotations)", "interleukin-13-mediated signaling pathway (GO:0035772 from GO Biological Process Annotations)", "interleukin-15 production (GO:0032618 from GO Biological Process Annotations)", "interleukin-15-mediated signaling pathway (GO:0035723 from GO Biological Process Annotations)", "interleukin-17 production (GO:0032620 from GO Biological Process Annotations)", "interleukin-18 production (GO:0032621 from GO Biological Process Annotations)", "interleukin-18-mediated signaling pathway (GO:0035655 from GO Biological Process Annotations)", "interleukin-2 biosynthetic process (GO:0042094 from GO Biological Process Annotations)", "interleukin-2 production (GO:0032623 from GO Biological Process Annotations)", "interleukin-2 secretion (GO:0070970 from GO Biological Process Annotations)", "interleukin-2-mediated signaling pathway (GO:0038110 from GO Biological Process Annotations)", "interleukin-21 secretion (GO:0072619 from GO Biological Process Annotations)", "interleukin-21-mediated signaling pathway (GO:0038114 from GO Biological Process Annotations)", "interleukin-23-mediated signaling pathway (GO:0038155 from GO Biological Process Annotations)", "interleukin-27-mediated signaling pathway (GO:0070106 from GO Biological Process Annotations)", "interleukin-3 production (GO:0032632 from GO Biological Process Annotations)", "interleukin-3-mediated signaling pathway (GO:0038156 from GO Biological Process Annotations)", "interleukin-33-mediated signaling pathway (GO:0038172 from GO Biological Process Annotations)", "interleukin-4 production (GO:0032633 from GO Biological Process Annotations)", "interleukin-4 secretion (GO:0072602 from GO Biological Process Annotations)", "interleukin-4-mediated signaling pathway (GO:0035771 from GO Biological Process Annotations)", "interleukin-5-mediated signaling pathway (GO:0038043 from GO Biological Process Annotations)", "interleukin-6 biosynthetic process (GO:0042226 from GO Biological Process Annotations)", "interleukin-6 production (GO:0032635 from GO Biological Process Annotations)", "interleukin-6-mediated signaling pathway (GO:0070102 from GO Biological Process Annotations)", "interleukin-7-mediated signaling pathway (GO:0038111 from GO Biological Process Annotations)", "interleukin-8 biosynthetic process (GO:0042228 from GO Biological Process Annotations)", "interleukin-8 production (GO:0032637 from GO Biological Process Annotations)", "interleukin-8 secretion (GO:0072606 from GO Biological Process Annotations)", "interleukin-8-mediated signaling pathway (GO:0038112 from GO Biological Process Annotations)", "interleukin-9-mediated signaling pathway (GO:0038113 from GO Biological Process Annotations)", "intermediate filament bundle assembly (GO:0045110 from GO Biological Process Annotations)", "intermediate filament cytoskeleton organization (GO:0045104 from GO Biological Process Annotations)", "intermediate filament organization (GO:0045109 from GO Biological Process Annotations)", "intermediate filament-based process (GO:0045103 from GO Biological Process Annotations)", "intermediate mesoderm development (GO:0048389 from GO Biological Process Annotations)", "intermediate mesodermal cell differentiation (GO:0048392 from GO Biological Process Annotations)", "intermediate-density lipoprotein particle remodeling (GO:0034373 from GO Biological Process Annotations)", "intermembrane transport (GO:0046909 from GO Biological Process Annotations)", "internal peptidyl-lysine acetylation (GO:0018393 from GO Biological Process Annotations)", "internal protein amino acid acetylation (GO:0006475 from GO Biological Process Annotations)", "interneuron migration from the subpallium to the cortex (GO:0021830 from GO Biological Process Annotations)", "interspecies interaction between organisms (GO:0044419 from GO Biological Process Annotations)", "interspecies quorum sensing (GO:0052097 from GO Biological Process Annotations)", "interstrand cross-link repair (GO:0036297 from GO Biological Process Annotations)", "intestinal absorption (GO:0050892 from GO Biological Process Annotations)", "intestinal cholesterol absorption (GO:0030299 from GO Biological Process Annotations)", "intestinal epithelial cell development (GO:0060576 from GO Biological Process Annotations)", "intestinal epithelial cell differentiation (GO:0060575 from GO Biological Process Annotations)", "intestinal epithelial cell maturation (GO:0060574 from GO Biological Process Annotations)", "intestinal epithelial cell migration (GO:0061582 from GO Biological Process Annotations)", "intestinal epithelial structure maintenance (GO:0060729 from GO Biological Process Annotations)", "intestine smooth muscle contraction (GO:0014827 from GO Biological Process Annotations)", "intra-golgi vesicle-mediated transport (GO:0006891 from GO Biological Process Annotations)", "intra-s dna damage checkpoint (GO:0031573 from GO Biological Process Annotations)", "intracellular bile acid receptor signaling pathway (GO:0038185 from GO Biological Process Annotations)", "intracellular cholesterol transport (GO:0032367 from GO Biological Process Annotations)", "intracellular copper ion transport (GO:0015680 from GO Biological Process Annotations)", "intracellular distribution of mitochondria (GO:0048312 from GO Biological Process Annotations)", "intracellular estrogen receptor signaling pathway (GO:0030520 from GO Biological Process Annotations)", "intracellular lipid transport (GO:0032365 from GO Biological Process Annotations)", "intracellular mrna localization (GO:0008298 from GO Biological Process Annotations)", "intracellular ph elevation (GO:0051454 from GO Biological Process Annotations)", "intracellular ph reduction (GO:0051452 from GO Biological Process Annotations)", "intracellular protein transmembrane import (GO:0044743 from GO Biological Process Annotations)", "intracellular protein transmembrane transport (GO:0065002 from GO Biological Process Annotations)", "intracellular protein transport (GO:0006886 from GO Biological Process Annotations)", "intracellular protein transport in other organism involved in symbiotic interaction (GO:0051708 from GO Biological Process Annotations)", "intracellular receptor signaling pathway (GO:0030522 from GO Biological Process Annotations)", "intracellular sequestering of iron ion (GO:0006880 from GO Biological Process Annotations)", "intracellular signal transduction (GO:0035556 from GO Biological Process Annotations)", "intracellular signal transduction involved in g1 dna damage checkpoint (GO:1902400 from GO Biological Process Annotations)", "intracellular steroid hormone receptor signaling pathway (GO:0030518 from GO Biological Process Annotations)", "intracellular sterol transport (GO:0032366 from GO Biological Process Annotations)", "intracellular transport (GO:0046907 from GO Biological Process Annotations)", "intracellular transport of viral protein in host cell (GO:0019060 from GO Biological Process Annotations)", "intracellular transport of virus (GO:0075733 from GO Biological Process Annotations)", "intraciliary anterograde transport (GO:0035720 from GO Biological Process Annotations)", "intraciliary retrograde transport (GO:0035721 from GO Biological Process Annotations)", "intraciliary transport (GO:0042073 from GO Biological Process Annotations)", "intraciliary transport involved in cilium morphogenesis (GO:0035735 from GO Biological Process Annotations)", "intrahepatic bile duct development (GO:0035622 from GO Biological Process Annotations)", "intralumenal vesicle formation (GO:0070676 from GO Biological Process Annotations)", "intramembranous ossification (GO:0001957 from GO Biological Process Annotations)", "intraspecies interaction between organisms (GO:0051703 from GO Biological Process Annotations)", "intrinsic apoptotic signaling pathway (GO:0097193 from GO Biological Process Annotations)", "intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332 from GO Biological Process Annotations)", "intrinsic apoptotic signaling pathway in response to dna damage (GO:0008630 from GO Biological Process Annotations)", "intrinsic apoptotic signaling pathway in response to dna damage by p53 class mediator (GO:0042771 from GO Biological Process Annotations)", "intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059 from GO Biological Process Annotations)", "intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:0036481 from GO Biological Process Annotations)", "intrinsic apoptotic signaling pathway in response to hypoxia (GO:1990144 from GO Biological Process Annotations)", "intrinsic apoptotic signaling pathway in response to osmotic stress (GO:0008627 from GO Biological Process Annotations)", "intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631 from GO Biological Process Annotations)", "intussusceptive angiogenesis (GO:0002041 from GO Biological Process Annotations)", "involuntary skeletal muscle contraction (GO:0003011 from GO Biological Process Annotations)", "iodide transport (GO:0015705 from GO Biological Process Annotations)", "ion homeostasis (GO:0050801 from GO Biological Process Annotations)", "ion transmembrane transport (GO:0034220 from GO Biological Process Annotations)", "ion transport (GO:0006811 from GO Biological Process Annotations)", "ionotropic glutamate receptor signaling pathway (GO:0035235 from GO Biological Process Annotations)", "ires-dependent translational initiation (GO:0002192 from GO Biological Process Annotations)", "iris morphogenesis (GO:0061072 from GO Biological Process Annotations)", "iron assimilation (GO:0033212 from GO Biological Process Annotations)", "iron assimilation by chelation and transport (GO:0033214 from GO Biological Process Annotations)", "iron chelate transport (GO:0015688 from GO Biological Process Annotations)", "iron coordination entity transport (GO:1901678 from GO Biological Process Annotations)", "iron incorporation into metallo-sulfur cluster (GO:0018283 from GO Biological Process Annotations)", "iron ion homeostasis (GO:0055072 from GO Biological Process Annotations)", "iron ion import (GO:0097286 from GO Biological Process Annotations)", "iron ion import into cell (GO:0097459 from GO Biological Process Annotations)", "iron ion transmembrane transport (GO:0034755 from GO Biological Process Annotations)", "iron ion transport (GO:0006826 from GO Biological Process Annotations)", "iron-sulfur cluster assembly (GO:0016226 from GO Biological Process Annotations)", "isg15-protein conjugation (GO:0032020 from GO Biological Process Annotations)", "islet amyloid polypeptide processing (GO:0034231 from GO Biological Process Annotations)", "isocitrate metabolic process (GO:0006102 from GO Biological Process Annotations)", "isoleucine catabolic process (GO:0006550 from GO Biological Process Annotations)", "isoleucine metabolic process (GO:0006549 from GO Biological Process Annotations)", "isoleucyl-trna aminoacylation (GO:0006428 from GO Biological Process Annotations)", "isopentenyl diphosphate biosynthetic process (GO:0009240 from GO Biological Process Annotations)", "isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287 from GO Biological Process Annotations)", "isopentenyl diphosphate metabolic process (GO:0046490 from GO Biological Process Annotations)", "isopeptide cross-linking (GO:0018262 from GO Biological Process Annotations)", "isopeptide cross-linking via n6-(l-isoglutamyl)-l-lysine (GO:0018153 from GO Biological Process Annotations)", "isoprenoid biosynthetic process (GO:0008299 from GO Biological Process Annotations)", "isoprenoid catabolic process (GO:0008300 from GO Biological Process Annotations)", "isoprenoid metabolic process (GO:0006720 from GO Biological Process Annotations)", "isoprenoid transport (GO:0046864 from GO Biological Process Annotations)", "isoquinoline alkaloid metabolic process (GO:0033076 from GO Biological Process Annotations)", "isotype switching (GO:0045190 from GO Biological Process Annotations)", "isotype switching to igg isotypes (GO:0048291 from GO Biological Process Annotations)", "itp catabolic process (GO:0006193 from GO Biological Process Annotations)", "itp metabolic process (GO:0046041 from GO Biological Process Annotations)", "jak-stat cascade (GO:0007259 from GO Biological Process Annotations)", "jak-stat cascade involved in growth hormone signaling pathway (GO:0060397 from GO Biological Process Annotations)", "jnk cascade (GO:0007254 from GO Biological Process Annotations)", "jun phosphorylation (GO:0007258 from GO Biological Process Annotations)", "karyogamy (GO:0000741 from GO Biological Process Annotations)", "keratan sulfate biosynthetic process (GO:0018146 from GO Biological Process Annotations)", "keratan sulfate catabolic process (GO:0042340 from GO Biological Process Annotations)", "keratan sulfate metabolic process (GO:0042339 from GO Biological Process Annotations)", "keratinization (GO:0031424 from GO Biological Process Annotations)", "keratinocyte activation (GO:0032980 from GO Biological Process Annotations)", "keratinocyte development (GO:0003334 from GO Biological Process Annotations)", "keratinocyte differentiation (GO:0030216 from GO Biological Process Annotations)", "keratinocyte migration (GO:0051546 from GO Biological Process Annotations)", "keratinocyte proliferation (GO:0043616 from GO Biological Process Annotations)", "ketone biosynthetic process (GO:0042181 from GO Biological Process Annotations)", "ketone body biosynthetic process (GO:0046951 from GO Biological Process Annotations)", "ketone body catabolic process (GO:0046952 from GO Biological Process Annotations)", "ketone body metabolic process (GO:1902224 from GO Biological Process Annotations)", "ketone catabolic process (GO:0042182 from GO Biological Process Annotations)", "kidney development (GO:0001822 from GO Biological Process Annotations)", "kidney epithelium development (GO:0072073 from GO Biological Process Annotations)", "kidney field specification (GO:0072004 from GO Biological Process Annotations)", "kidney interstitial fibroblast differentiation (GO:0072071 from GO Biological Process Annotations)", "kidney mesenchymal cell proliferation (GO:0072135 from GO Biological Process Annotations)", "kidney mesenchyme development (GO:0072074 from GO Biological Process Annotations)", "kidney mesenchyme morphogenesis (GO:0072131 from GO Biological Process Annotations)", "kidney morphogenesis (GO:0060993 from GO Biological Process Annotations)", "kidney rudiment formation (GO:0072003 from GO Biological Process Annotations)", "kidney smooth muscle cell differentiation (GO:0072195 from GO Biological Process Annotations)", "kidney smooth muscle tissue development (GO:0072194 from GO Biological Process Annotations)", "kidney vasculature development (GO:0061440 from GO Biological Process Annotations)", "killing by host of symbiont cells (GO:0051873 from GO Biological Process Annotations)", "killing by symbiont of host cells (GO:0001907 from GO Biological Process Annotations)", "killing of cells in other organism involved in symbiotic interaction (GO:0051883 from GO Biological Process Annotations)", "killing of cells of other organism (GO:0031640 from GO Biological Process Annotations)", "kinetochore assembly (GO:0051382 from GO Biological Process Annotations)", "kinetochore organization (GO:0051383 from GO Biological Process Annotations)", "kinin cascade (GO:0002254 from GO Biological Process Annotations)", "kit signaling pathway (GO:0038109 from GO Biological Process Annotations)", "kupffer's vesicle development (GO:0070121 from GO Biological Process Annotations)", "kynurenic acid biosynthetic process (GO:0034276 from GO Biological Process Annotations)", "kynurenic acid metabolic process (GO:0034275 from GO Biological Process Annotations)", "kynurenine metabolic process (GO:0070189 from GO Biological Process Annotations)", "l-alanine catabolic process (GO:0042853 from GO Biological Process Annotations)", "l-alanine catabolic process, by transamination (GO:0019481 from GO Biological Process Annotations)", "l-alanine metabolic process (GO:0042851 from GO Biological Process Annotations)", "l-alanine transport (GO:0015808 from GO Biological Process Annotations)", "l-alpha-amino acid transmembrane transport (GO:1902475 from GO Biological Process Annotations)", "l-amino acid import (GO:0043092 from GO Biological Process Annotations)", "l-amino acid transport (GO:0015807 from GO Biological Process Annotations)", "l-arabinose metabolic process (GO:0046373 from GO Biological Process Annotations)", "l-arginine import (GO:0043091 from GO Biological Process Annotations)", "l-arginine import across plasma membrane (GO:0097638 from GO Biological Process Annotations)", "l-arginine import into cell (GO:1902765 from GO Biological Process Annotations)", "l-arginine transmembrane transport (GO:1903400 from GO Biological Process Annotations)", "l-arginine transport (GO:1902023 from GO Biological Process Annotations)", "l-ascorbic acid biosynthetic process (GO:0019853 from GO Biological Process Annotations)", "l-ascorbic acid metabolic process (GO:0019852 from GO Biological Process Annotations)", "l-ascorbic acid transport (GO:0015882 from GO Biological Process Annotations)", "l-asparagine biosynthetic process (GO:0070981 from GO Biological Process Annotations)", "l-asparagine metabolic process (GO:0070982 from GO Biological Process Annotations)", "l-aspartate transmembrane transport (GO:0089712 from GO Biological Process Annotations)", "l-aspartate transport (GO:0070778 from GO Biological Process Annotations)", "l-cysteine catabolic process (GO:0019448 from GO Biological Process Annotations)", "l-cysteine metabolic process (GO:0046439 from GO Biological Process Annotations)", "l-cystine transport (GO:0015811 from GO Biological Process Annotations)", "l-fucose catabolic process (GO:0042355 from GO Biological Process Annotations)", "l-fucose metabolic process (GO:0042354 from GO Biological Process Annotations)", "l-glutamate import (GO:0051938 from GO Biological Process Annotations)", "l-glutamate import into cell (GO:1990123 from GO Biological Process Annotations)", "l-glutamate transmembrane transport (GO:0089711 from GO Biological Process Annotations)", "l-glutamate transport (GO:0015813 from GO Biological Process Annotations)", "l-glutamate uptake involved in synaptic transmission (GO:0051935 from GO Biological Process Annotations)", "l-glutamate(1-) import into cell (GO:1903802 from GO Biological Process Annotations)", "l-histidine transmembrane transport (GO:0089709 from GO Biological Process Annotations)", "l-histidine transport (GO:1902024 from GO Biological Process Annotations)", "l-kynurenine catabolic process (GO:0097053 from GO Biological Process Annotations)", "l-kynurenine metabolic process (GO:0097052 from GO Biological Process Annotations)", "l-lysine catabolic process (GO:0019477 from GO Biological Process Annotations)", "l-lysine catabolic process to acetyl-coa (GO:0019474 from GO Biological Process Annotations)", "l-lysine catabolic process to acetyl-coa via l-pipecolate (GO:0033514 from GO Biological Process Annotations)", "l-lysine catabolic process to acetyl-coa via saccharopine (GO:0033512 from GO Biological Process Annotations)", "l-lysine import (GO:0061461 from GO Biological Process Annotations)", "l-lysine import across plasma membrane (GO:0097639 from GO Biological Process Annotations)", "l-lysine import into cell (GO:1903410 from GO Biological Process Annotations)", "l-lysine metabolic process (GO:0046440 from GO Biological Process Annotations)", "l-lysine transmembrane transport (GO:1903401 from GO Biological Process Annotations)", "l-lysine transport (GO:1902022 from GO Biological Process Annotations)", "l-methionine biosynthetic process (GO:0071265 from GO Biological Process Annotations)", "l-methionine biosynthetic process from methylthioadenosine (GO:0019509 from GO Biological Process Annotations)", "l-methionine biosynthetic process from s-adenosylmethionine (GO:0019284 from GO Biological Process Annotations)", "l-methionine salvage (GO:0071267 from GO Biological Process Annotations)", "l-methylmalonyl-coa metabolic process (GO:0046491 from GO Biological Process Annotations)", "l-ornithine import across plasma membrane (GO:0097640 from GO Biological Process Annotations)", "l-ornithine import into cell (GO:1903411 from GO Biological Process Annotations)", "l-ornithine transmembrane transport (GO:1903352 from GO Biological Process Annotations)", "l-phenylalanine catabolic process (GO:0006559 from GO Biological Process Annotations)", "l-phenylalanine metabolic process (GO:0006558 from GO Biological Process Annotations)", "l-proline biosynthetic process (GO:0055129 from GO Biological Process Annotations)", "l-serine biosynthetic process (GO:0006564 from GO Biological Process Annotations)", "l-serine catabolic process (GO:0006565 from GO Biological Process Annotations)", "l-serine metabolic process (GO:0006563 from GO Biological Process Annotations)", "l-serine transport (GO:0015825 from GO Biological Process Annotations)", "l-threonine catabolic process to glycine (GO:0019518 from GO Biological Process Annotations)", "l-xylitol catabolic process (GO:0051160 from GO Biological Process Annotations)", "l-xylitol metabolic process (GO:0051164 from GO Biological Process Annotations)", "labyrinthine layer blood vessel development (GO:0060716 from GO Biological Process Annotations)", "labyrinthine layer development (GO:0060711 from GO Biological Process Annotations)", "labyrinthine layer morphogenesis (GO:0060713 from GO Biological Process Annotations)", "lacrimal gland development (GO:0032808 from GO Biological Process Annotations)", "lactate biosynthetic process (GO:0019249 from GO Biological Process Annotations)", "lactate biosynthetic process from pyruvate (GO:0019244 from GO Biological Process Annotations)", "lactate metabolic process (GO:0006089 from GO Biological Process Annotations)", "lactate oxidation (GO:0019516 from GO Biological Process Annotations)", "lactate transmembrane transport (GO:0035873 from GO Biological Process Annotations)", "lactate transport (GO:0015727 from GO Biological Process Annotations)", "lactation (GO:0007595 from GO Biological Process Annotations)", "lactose biosynthetic process (GO:0005989 from GO Biological Process Annotations)", "lactose metabolic process (GO:0005988 from GO Biological Process Annotations)", "lagging strand elongation (GO:0006273 from GO Biological Process Annotations)", "lambdoid suture morphogenesis (GO:0060366 from GO Biological Process Annotations)", "lamellipodium assembly (GO:0030032 from GO Biological Process Annotations)", "lamellipodium assembly involved in ameboidal cell migration (GO:0003363 from GO Biological Process Annotations)", "lamellipodium morphogenesis (GO:0072673 from GO Biological Process Annotations)", "lamellipodium organization (GO:0097581 from GO Biological Process Annotations)", "late endosome to golgi transport (GO:0034499 from GO Biological Process Annotations)", "late endosome to vacuole transport (GO:0045324 from GO Biological Process Annotations)", "late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511 from GO Biological Process Annotations)", "late nucleophagy (GO:0044805 from GO Biological Process Annotations)", "late viral transcription (GO:0019086 from GO Biological Process Annotations)", "lateral element assembly (GO:0051878 from GO Biological Process Annotations)", "lateral ganglionic eminence cell proliferation (GO:0022018 from GO Biological Process Annotations)", "lateral geniculate nucleus development (GO:0021771 from GO Biological Process Annotations)", "lateral inhibition (GO:0046331 from GO Biological Process Annotations)", "lateral mesoderm development (GO:0048368 from GO Biological Process Annotations)", "lateral mesoderm formation (GO:0048370 from GO Biological Process Annotations)", "lateral mesodermal cell differentiation (GO:0048371 from GO Biological Process Annotations)", "lateral motor column neuron migration (GO:0097477 from GO Biological Process Annotations)", "lateral semicircular canal development (GO:0060875 from GO Biological Process Annotations)", "lateral sprouting from an epithelium (GO:0060601 from GO Biological Process Annotations)", "lateral sprouting involved in lung morphogenesis (GO:0060490 from GO Biological Process Annotations)", "lateral sprouting involved in mammary gland duct morphogenesis (GO:0060599 from GO Biological Process Annotations)", "lateral ventricle development (GO:0021670 from GO Biological Process Annotations)", "layer formation in cerebral cortex (GO:0021819 from GO Biological Process Annotations)", "lead ion transport (GO:0015692 from GO Biological Process Annotations)", "leading edge cell differentiation (GO:0035026 from GO Biological Process Annotations)", "leading strand elongation (GO:0006272 from GO Biological Process Annotations)", "learned vocalization behavior or vocal learning (GO:0098598 from GO Biological Process Annotations)", "learning (GO:0007612 from GO Biological Process Annotations)", "learning or memory (GO:0007611 from GO Biological Process Annotations)", "left lung development (GO:0060459 from GO Biological Process Annotations)", "left lung morphogenesis (GO:0060460 from GO Biological Process Annotations)", "left ventricular cardiac muscle tissue morphogenesis (GO:0003220 from GO Biological Process Annotations)", "left|right axis specification (GO:0070986 from GO Biological Process Annotations)", "left|right pattern formation (GO:0060972 from GO Biological Process Annotations)", "lens development in camera-type eye (GO:0002088 from GO Biological Process Annotations)", "lens fiber cell apoptotic process (GO:1990086 from GO Biological Process Annotations)", "lens fiber cell development (GO:0070307 from GO Biological Process Annotations)", "lens fiber cell differentiation (GO:0070306 from GO Biological Process Annotations)", "lens fiber cell morphogenesis (GO:0070309 from GO Biological Process Annotations)", "lens induction in camera-type eye (GO:0060235 from GO Biological Process Annotations)", "lens morphogenesis in camera-type eye (GO:0002089 from GO Biological Process Annotations)", "leptin-mediated signaling pathway (GO:0033210 from GO Biological Process Annotations)", "leucine catabolic process (GO:0006552 from GO Biological Process Annotations)", "leucine import (GO:0060356 from GO Biological Process Annotations)", "leucine metabolic process (GO:0006551 from GO Biological Process Annotations)", "leucine transport (GO:0015820 from GO Biological Process Annotations)", "leucyl-trna aminoacylation (GO:0006429 from GO Biological Process Annotations)", "leukemia inhibitory factor signaling pathway (GO:0048861 from GO Biological Process Annotations)", "leukocyte activation (GO:0045321 from GO Biological Process Annotations)", "leukocyte activation involved in immune response (GO:0002366 from GO Biological Process Annotations)", "leukocyte adhesive activation (GO:0050902 from GO Biological Process Annotations)", "leukocyte aggregation (GO:0070486 from GO Biological Process Annotations)", "leukocyte apoptotic process (GO:0071887 from GO Biological Process Annotations)", "leukocyte cell-cell adhesion (GO:0007159 from GO Biological Process Annotations)", "leukocyte chemotaxis (GO:0030595 from GO Biological Process Annotations)", "leukocyte chemotaxis involved in inflammatory response (GO:0002232 from GO Biological Process Annotations)", "leukocyte degranulation (GO:0043299 from GO Biological Process Annotations)", "leukocyte differentiation (GO:0002521 from GO Biological Process Annotations)", "leukocyte homeostasis (GO:0001776 from GO Biological Process Annotations)", "leukocyte mediated cytotoxicity (GO:0001909 from GO Biological Process Annotations)", "leukocyte mediated immunity (GO:0002443 from GO Biological Process Annotations)", "leukocyte migration (GO:0050900 from GO Biological Process Annotations)", "leukocyte migration involved in immune response (GO:0002522 from GO Biological Process Annotations)", "leukocyte migration involved in inflammatory response (GO:0002523 from GO Biological Process Annotations)", "leukocyte proliferation (GO:0070661 from GO Biological Process Annotations)", "leukocyte tethering or rolling (GO:0050901 from GO Biological Process Annotations)", "leukotriene a4 metabolic process (GO:1901751 from GO Biological Process Annotations)", "leukotriene b4 catabolic process (GO:0036101 from GO Biological Process Annotations)", "leukotriene b4 metabolic process (GO:0036102 from GO Biological Process Annotations)", "leukotriene biosynthetic process (GO:0019370 from GO Biological Process Annotations)", "leukotriene catabolic process (GO:0036100 from GO Biological Process Annotations)", "leukotriene metabolic process (GO:0006691 from GO Biological Process Annotations)", "leukotriene production involved in inflammatory response (GO:0002540 from GO Biological Process Annotations)", "leydig cell differentiation (GO:0033327 from GO Biological Process Annotations)", "limb bud formation (GO:0060174 from GO Biological Process Annotations)", "limb development (GO:0060173 from GO Biological Process Annotations)", "limb epidermis development (GO:0060887 from GO Biological Process Annotations)", "limb joint morphogenesis (GO:0036022 from GO Biological Process Annotations)", "limb morphogenesis (GO:0035108 from GO Biological Process Annotations)", "limbic system development (GO:0021761 from GO Biological Process Annotations)", "linear element assembly (GO:0030999 from GO Biological Process Annotations)", "linear vestibuloocular reflex (GO:0060007 from GO Biological Process Annotations)", "linoleic acid metabolic process (GO:0043651 from GO Biological Process Annotations)", "lipid biosynthetic process (GO:0008610 from GO Biological Process Annotations)", "lipid catabolic process (GO:0016042 from GO Biological Process Annotations)", "lipid digestion (GO:0044241 from GO Biological Process Annotations)", "lipid glycosylation (GO:0030259 from GO Biological Process Annotations)", "lipid homeostasis (GO:0055088 from GO Biological Process Annotations)", "lipid hydroperoxide transport (GO:1901373 from GO Biological Process Annotations)", "lipid localization (GO:0010876 from GO Biological Process Annotations)", "lipid metabolic process (GO:0006629 from GO Biological Process Annotations)", "lipid modification (GO:0030258 from GO Biological Process Annotations)", "lipid oxidation (GO:0034440 from GO Biological Process Annotations)", "lipid particle organization (GO:0034389 from GO Biological Process Annotations)", "lipid phosphorylation (GO:0046834 from GO Biological Process Annotations)", "lipid storage (GO:0019915 from GO Biological Process Annotations)", "lipid translocation (GO:0034204 from GO Biological Process Annotations)", "lipid transport (GO:0006869 from GO Biological Process Annotations)", "lipid transport across blood brain barrier (GO:1990379 from GO Biological Process Annotations)", "lipid tube assembly (GO:0060988 from GO Biological Process Annotations)", "lipoate biosynthetic process (GO:0009107 from GO Biological Process Annotations)", "lipoate metabolic process (GO:0009106 from GO Biological Process Annotations)", "lipopolysaccharide biosynthetic process (GO:0009103 from GO Biological Process Annotations)", "lipopolysaccharide metabolic process (GO:0008653 from GO Biological Process Annotations)", "lipopolysaccharide transport (GO:0015920 from GO Biological Process Annotations)", "lipopolysaccharide-mediated signaling pathway (GO:0031663 from GO Biological Process Annotations)", "lipoprotein biosynthetic process (GO:0042158 from GO Biological Process Annotations)", "lipoprotein catabolic process (GO:0042159 from GO Biological Process Annotations)", "lipoprotein localization (GO:0044872 from GO Biological Process Annotations)", "lipoprotein metabolic process (GO:0042157 from GO Biological Process Annotations)", "lipoprotein modification (GO:0042160 from GO Biological Process Annotations)", "lipoprotein oxidation (GO:0042161 from GO Biological Process Annotations)", "lipoprotein particle mediated signaling (GO:0055095 from GO Biological Process Annotations)", "lipoprotein transport (GO:0042953 from GO Biological Process Annotations)", "liposaccharide metabolic process (GO:1903509 from GO Biological Process Annotations)", "lipoxin a4 biosynthetic process (GO:2001303 from GO Biological Process Annotations)", "lipoxin a4 metabolic process (GO:2001302 from GO Biological Process Annotations)", "lipoxin b4 biosynthetic process (GO:2001306 from GO Biological Process Annotations)", "lipoxin b4 metabolic process (GO:2001304 from GO Biological Process Annotations)", "lipoxin biosynthetic process (GO:2001301 from GO Biological Process Annotations)", "lipoxin metabolic process (GO:2001300 from GO Biological Process Annotations)", "lipoxygenase pathway (GO:0019372 from GO Biological Process Annotations)", "liver development (GO:0001889 from GO Biological Process Annotations)", "liver morphogenesis (GO:0072576 from GO Biological Process Annotations)", "liver regeneration (GO:0097421 from GO Biological Process Annotations)", "lobar bronchus development (GO:0060482 from GO Biological Process Annotations)", "localization (GO:0051179 from GO Biological Process Annotations)", "localization of cell (GO:0051674 from GO Biological Process Annotations)", "localization within membrane (GO:0051668 from GO Biological Process Annotations)", "locomotion (GO:0040011 from GO Biological Process Annotations)", "locomotion involved in locomotory behavior (GO:0031987 from GO Biological Process Annotations)", "locomotor rhythm (GO:0045475 from GO Biological Process Annotations)", "locomotory behavior (GO:0007626 from GO Biological Process Annotations)", "locomotory exploration behavior (GO:0035641 from GO Biological Process Annotations)", "locus ceruleus development (GO:0021703 from GO Biological Process Annotations)", "long term synaptic depression (GO:0060292 from GO Biological Process Annotations)", "long-chain fatty acid biosynthetic process (GO:0042759 from GO Biological Process Annotations)", "long-chain fatty acid catabolic process (GO:0042758 from GO Biological Process Annotations)", "long-chain fatty acid import (GO:0044539 from GO Biological Process Annotations)", "long-chain fatty acid metabolic process (GO:0001676 from GO Biological Process Annotations)", "long-chain fatty acid transport (GO:0015909 from GO Biological Process Annotations)", "long-chain fatty-acyl-coa biosynthetic process (GO:0035338 from GO Biological Process Annotations)", "long-chain fatty-acyl-coa catabolic process (GO:0036116 from GO Biological Process Annotations)", "long-chain fatty-acyl-coa metabolic process (GO:0035336 from GO Biological Process Annotations)", "long-term memory (GO:0007616 from GO Biological Process Annotations)", "long-term synaptic potentiation (GO:0060291 from GO Biological Process Annotations)", "loop of henle development (GO:0072070 from GO Biological Process Annotations)", "low-density lipoprotein particle clearance (GO:0034383 from GO Biological Process Annotations)", "low-density lipoprotein particle mediated signaling (GO:0055096 from GO Biological Process Annotations)", "low-density lipoprotein particle receptor biosynthetic process (GO:0045713 from GO Biological Process Annotations)", "low-density lipoprotein particle receptor catabolic process (GO:0032802 from GO Biological Process Annotations)", "low-density lipoprotein particle remodeling (GO:0034374 from GO Biological Process Annotations)", "low-density lipoprotein receptor particle metabolic process (GO:0032799 from GO Biological Process Annotations)", "lung alveolus development (GO:0048286 from GO Biological Process Annotations)", "lung cell differentiation (GO:0060479 from GO Biological Process Annotations)", "lung ciliated cell differentiation (GO:0061141 from GO Biological Process Annotations)", "lung development (GO:0030324 from GO Biological Process Annotations)", "lung epithelial cell differentiation (GO:0060487 from GO Biological Process Annotations)", "lung epithelium development (GO:0060428 from GO Biological Process Annotations)", "lung goblet cell differentiation (GO:0060480 from GO Biological Process Annotations)", "lung growth (GO:0060437 from GO Biological Process Annotations)", "lung induction (GO:0060492 from GO Biological Process Annotations)", "lung lobe formation (GO:0060464 from GO Biological Process Annotations)", "lung lobe morphogenesis (GO:0060463 from GO Biological Process Annotations)", "lung morphogenesis (GO:0060425 from GO Biological Process Annotations)", "lung neuroendocrine cell differentiation (GO:0061100 from GO Biological Process Annotations)", "lung pattern specification process (GO:0060432 from GO Biological Process Annotations)", "lung proximal|distal axis specification (GO:0061115 from GO Biological Process Annotations)", "lung saccule development (GO:0060430 from GO Biological Process Annotations)", "lung secretory cell differentiation (GO:0061140 from GO Biological Process Annotations)", "lung vasculature development (GO:0060426 from GO Biological Process Annotations)", "lung-associated mesenchyme development (GO:0060484 from GO Biological Process Annotations)", "luteinization (GO:0001553 from GO Biological Process Annotations)", "luteinizing hormone secretion (GO:0032275 from GO Biological Process Annotations)", "luteinizing hormone signaling pathway (GO:0042700 from GO Biological Process Annotations)", "luteolysis (GO:0001554 from GO Biological Process Annotations)", "lymph circulation (GO:0003017 from GO Biological Process Annotations)", "lymph node development (GO:0048535 from GO Biological Process Annotations)", "lymph vessel development (GO:0001945 from GO Biological Process Annotations)", "lymph vessel morphogenesis (GO:0036303 from GO Biological Process Annotations)", "lymphangiogenesis (GO:0001946 from GO Biological Process Annotations)", "lymphatic endothelial cell differentiation (GO:0060836 from GO Biological Process Annotations)", "lymphocyte activation (GO:0046649 from GO Biological Process Annotations)", "lymphocyte activation involved in immune response (GO:0002285 from GO Biological Process Annotations)", "lymphocyte aggregation (GO:0071593 from GO Biological Process Annotations)", "lymphocyte apoptotic process (GO:0070227 from GO Biological Process Annotations)", "lymphocyte chemotaxis (GO:0048247 from GO Biological Process Annotations)", "lymphocyte chemotaxis across high endothelial venule (GO:0002518 from GO Biological Process Annotations)", "lymphocyte costimulation (GO:0031294 from GO Biological Process Annotations)", "lymphocyte differentiation (GO:0030098 from GO Biological Process Annotations)", "lymphocyte homeostasis (GO:0002260 from GO Biological Process Annotations)", "lymphocyte mediated immunity (GO:0002449 from GO Biological Process Annotations)", "lymphocyte migration (GO:0072676 from GO Biological Process Annotations)", "lymphocyte migration into lymph node (GO:0097022 from GO Biological Process Annotations)", "lymphocyte migration into lymphoid organs (GO:0097021 from GO Biological Process Annotations)", "lymphocyte proliferation (GO:0046651 from GO Biological Process Annotations)", "lymphoid progenitor cell differentiation (GO:0002320 from GO Biological Process Annotations)", "lymphotoxin a biosynthetic process (GO:0042109 from GO Biological Process Annotations)", "lysine catabolic process (GO:0006554 from GO Biological Process Annotations)", "lysine import (GO:0034226 from GO Biological Process Annotations)", "lysine metabolic process (GO:0006553 from GO Biological Process Annotations)", "lysine transport (GO:0015819 from GO Biological Process Annotations)", "lysobisphosphatidic acid metabolic process (GO:2001311 from GO Biological Process Annotations)", "lysophospholipid transport (GO:0051977 from GO Biological Process Annotations)", "lysosomal lumen acidification (GO:0007042 from GO Biological Process Annotations)", "lysosomal lumen ph elevation (GO:0035752 from GO Biological Process Annotations)", "lysosomal membrane organization (GO:0097212 from GO Biological Process Annotations)", "lysosomal transport (GO:0007041 from GO Biological Process Annotations)", "lysosome localization (GO:0032418 from GO Biological Process Annotations)", "lysosome organization (GO:0007040 from GO Biological Process Annotations)", "lysyl-trna aminoacylation (GO:0006430 from GO Biological Process Annotations)", "lytic vacuole organization (GO:0080171 from GO Biological Process Annotations)", "macroautophagy (GO:0016236 from GO Biological Process Annotations)", "macromolecular complex assembly (GO:0065003 from GO Biological Process Annotations)", "macromolecular complex disassembly (GO:0032984 from GO Biological Process Annotations)", "macromolecular complex remodeling (GO:0034367 from GO Biological Process Annotations)", "macromolecular complex subunit organization (GO:0043933 from GO Biological Process Annotations)", "macromolecule biosynthetic process (GO:0009059 from GO Biological Process Annotations)", "macromolecule catabolic process (GO:0009057 from GO Biological Process Annotations)", "macromolecule deacylation (GO:0098732 from GO Biological Process Annotations)", "macromolecule depalmitoylation (GO:0098734 from GO Biological Process Annotations)", "macromolecule glycosylation (GO:0043413 from GO Biological Process Annotations)", "macromolecule localization (GO:0033036 from GO Biological Process Annotations)", "macromolecule metabolic process (GO:0043170 from GO Biological Process Annotations)", "macromolecule methylation (GO:0043414 from GO Biological Process Annotations)", "macromolecule modification (GO:0043412 from GO Biological Process Annotations)", "macrophage activation (GO:0042116 from GO Biological Process Annotations)", "macrophage activation involved in immune response (GO:0002281 from GO Biological Process Annotations)", "macrophage apoptotic process (GO:0071888 from GO Biological Process Annotations)", "macrophage chemotaxis (GO:0048246 from GO Biological Process Annotations)", "macrophage colony-stimulating factor signaling pathway (GO:0038145 from GO Biological Process Annotations)", "macrophage cytokine production (GO:0010934 from GO Biological Process Annotations)", "macrophage derived foam cell differentiation (GO:0010742 from GO Biological Process Annotations)", "macrophage differentiation (GO:0030225 from GO Biological Process Annotations)", "macrophage inflammatory protein-1 alpha production (GO:0071608 from GO Biological Process Annotations)", "macrophage migration inhibitory factor signaling pathway (GO:0035691 from GO Biological Process Annotations)", "macrophage proliferation (GO:0061517 from GO Biological Process Annotations)", "macropinocytosis (GO:0044351 from GO Biological Process Annotations)", "macula densa development (GO:0072024 from GO Biological Process Annotations)", "magnesium ion homeostasis (GO:0010960 from GO Biological Process Annotations)", "magnesium ion transport (GO:0015693 from GO Biological Process Annotations)", "maintenance of apical|basal cell polarity (GO:0035090 from GO Biological Process Annotations)", "maintenance of blood-brain barrier (GO:0035633 from GO Biological Process Annotations)", "maintenance of cell number (GO:0098727 from GO Biological Process Annotations)", "maintenance of cell polarity (GO:0030011 from GO Biological Process Annotations)", "maintenance of centrosome location (GO:0051661 from GO Biological Process Annotations)", "maintenance of chromatin silencing (GO:0006344 from GO Biological Process Annotations)", "maintenance of dna methylation (GO:0010216 from GO Biological Process Annotations)", "maintenance of dna repeat elements (GO:0043570 from GO Biological Process Annotations)", "maintenance of epithelial cell apical|basal polarity (GO:0045199 from GO Biological Process Annotations)", "maintenance of er location (GO:0051685 from GO Biological Process Annotations)", "maintenance of gastrointestinal epithelium (GO:0030277 from GO Biological Process Annotations)", "maintenance of golgi location (GO:0051684 from GO Biological Process Annotations)", "maintenance of granzyme b location in t cell secretory granule (GO:0033382 from GO Biological Process Annotations)", "maintenance of lens transparency (GO:0036438 from GO Biological Process Annotations)", "maintenance of location (GO:0051235 from GO Biological Process Annotations)", "maintenance of location in cell (GO:0051651 from GO Biological Process Annotations)", "maintenance of mitochondrion location (GO:0051659 from GO Biological Process Annotations)", "maintenance of mitotic sister chromatid cohesion (GO:0034088 from GO Biological Process Annotations)", "maintenance of organ identity (GO:0048496 from GO Biological Process Annotations)", "maintenance of organelle location (GO:0051657 from GO Biological Process Annotations)", "maintenance of presynaptic active zone structure (GO:0048790 from GO Biological Process Annotations)", "maintenance of protease location in mast cell secretory granule (GO:0033373 from GO Biological Process Annotations)", "maintenance of protease location in t cell secretory granule (GO:0033379 from GO Biological Process Annotations)", "maintenance of protein localization in endoplasmic reticulum (GO:0035437 from GO Biological Process Annotations)", "maintenance of protein localization in organelle (GO:0072595 from GO Biological Process Annotations)", "maintenance of protein location (GO:0045185 from GO Biological Process Annotations)", "maintenance of protein location in cell (GO:0032507 from GO Biological Process Annotations)", "maintenance of protein location in extracellular region (GO:0071694 from GO Biological Process Annotations)", "maintenance of protein location in mast cell secretory granule (GO:0033370 from GO Biological Process Annotations)", "maintenance of protein location in membrane (GO:0072658 from GO Biological Process Annotations)", "maintenance of protein location in nucleus (GO:0051457 from GO Biological Process Annotations)", "maintenance of protein location in plasma membrane (GO:0072660 from GO Biological Process Annotations)", "maintenance of protein location in t cell secretory granule (GO:0033377 from GO Biological Process Annotations)", "maintenance of sister chromatid cohesion (GO:0034086 from GO Biological Process Annotations)", "maintenance of symbiont-containing vacuole by host (GO:0085018 from GO Biological Process Annotations)", "maintenance of transcriptional fidelity during dna-templated transcription elongation (GO:0001192 from GO Biological Process Annotations)", "maintenance of transcriptional fidelity during dna-templated transcription elongation from rna polymerase ii promoter (GO:0001193 from GO Biological Process Annotations)", "maintenance of translational fidelity (GO:1990145 from GO Biological Process Annotations)", "malate metabolic process (GO:0006108 from GO Biological Process Annotations)", "malate-aspartate shuttle (GO:0043490 from GO Biological Process Annotations)", "male anatomical structure morphogenesis (GO:0090598 from GO Biological Process Annotations)", "male courtship behavior (GO:0008049 from GO Biological Process Annotations)", "male gamete generation (GO:0048232 from GO Biological Process Annotations)", "male genitalia development (GO:0030539 from GO Biological Process Annotations)", "male genitalia morphogenesis (GO:0048808 from GO Biological Process Annotations)", "male germ cell proliferation (GO:0002176 from GO Biological Process Annotations)", "male germ-line sex determination (GO:0019100 from GO Biological Process Annotations)", "male germ-line stem cell asymmetric division (GO:0048133 from GO Biological Process Annotations)", "male gonad development (GO:0008584 from GO Biological Process Annotations)", "male mating behavior (GO:0060179 from GO Biological Process Annotations)", "male meiosis (GO:0007140 from GO Biological Process Annotations)", "male meiosis chromosome segregation (GO:0007060 from GO Biological Process Annotations)", "male meiosis chromosome separation (GO:0051308 from GO Biological Process Annotations)", "male meiosis i (GO:0007141 from GO Biological Process Annotations)", "male pronucleus assembly (GO:0035039 from GO Biological Process Annotations)", "male sex determination (GO:0030238 from GO Biological Process Annotations)", "male sex differentiation (GO:0046661 from GO Biological Process Annotations)", "malonate catabolic process (GO:0090410 from GO Biological Process Annotations)", "malonyl-coa biosynthetic process (GO:2001295 from GO Biological Process Annotations)", "malonyl-coa catabolic process (GO:2001294 from GO Biological Process Annotations)", "malonyl-coa metabolic process (GO:2001293 from GO Biological Process Annotations)", "maltose metabolic process (GO:0000023 from GO Biological Process Annotations)", "mammary duct terminal end bud growth (GO:0060763 from GO Biological Process Annotations)", "mammary gland alveolus development (GO:0060749 from GO Biological Process Annotations)", "mammary gland branching involved in pregnancy (GO:0060745 from GO Biological Process Annotations)", "mammary gland branching involved in thelarche (GO:0060744 from GO Biological Process Annotations)", "mammary gland bud elongation (GO:0060649 from GO Biological Process Annotations)", "mammary gland bud formation (GO:0060615 from GO Biological Process Annotations)", "mammary gland bud morphogenesis (GO:0060648 from GO Biological Process Annotations)", "mammary gland development (GO:0030879 from GO Biological Process Annotations)", "mammary gland duct morphogenesis (GO:0060603 from GO Biological Process Annotations)", "mammary gland epithelial cell differentiation (GO:0060644 from GO Biological Process Annotations)", "mammary gland epithelial cell proliferation (GO:0033598 from GO Biological Process Annotations)", "mammary gland epithelium development (GO:0061180 from GO Biological Process Annotations)", "mammary gland fat development (GO:0060611 from GO Biological Process Annotations)", "mammary gland formation (GO:0060592 from GO Biological Process Annotations)", "mammary gland involution (GO:0060056 from GO Biological Process Annotations)", "mammary gland lobule development (GO:0061377 from GO Biological Process Annotations)", "mammary gland morphogenesis (GO:0060443 from GO Biological Process Annotations)", "mammary gland specification (GO:0060594 from GO Biological Process Annotations)", "mammary placode formation (GO:0060596 from GO Biological Process Annotations)", "mammillary body development (GO:0021767 from GO Biological Process Annotations)", "mammillothalamic axonal tract development (GO:0061374 from GO Biological Process Annotations)", "mandelate metabolic process (GO:0018924 from GO Biological Process Annotations)", "manganese ion transmembrane transport (GO:0071421 from GO Biological Process Annotations)", "manganese ion transport (GO:0006828 from GO Biological Process Annotations)", "mannan catabolic process (GO:0046355 from GO Biological Process Annotations)", "mannan metabolic process (GO:0010412 from GO Biological Process Annotations)", "mannitol transport (GO:0015797 from GO Biological Process Annotations)", "mannosamine metabolic process (GO:0006050 from GO Biological Process Annotations)", "mannose biosynthetic process (GO:0019307 from GO Biological Process Annotations)", "mannose metabolic process (GO:0006013 from GO Biological Process Annotations)", "mannose transport (GO:0015761 from GO Biological Process Annotations)", "mannosylation (GO:0097502 from GO Biological Process Annotations)", "mapk cascade (GO:0000165 from GO Biological Process Annotations)", "mapk export from nucleus (GO:0045204 from GO Biological Process Annotations)", "mapk import into nucleus (GO:0000189 from GO Biological Process Annotations)", "mapk phosphatase export from nucleus (GO:0045208 from GO Biological Process Annotations)", "mapk phosphatase export from nucleus, leptomycin b sensitive (GO:0045209 from GO Biological Process Annotations)", "marginal zone b cell differentiation (GO:0002315 from GO Biological Process Annotations)", "mast cell activation (GO:0045576 from GO Biological Process Annotations)", "mast cell activation involved in immune response (GO:0002279 from GO Biological Process Annotations)", "mast cell chemotaxis (GO:0002551 from GO Biological Process Annotations)", "mast cell cytokine production (GO:0032762 from GO Biological Process Annotations)", "mast cell degranulation (GO:0043303 from GO Biological Process Annotations)", "mast cell differentiation (GO:0060374 from GO Biological Process Annotations)", "mast cell mediated immunity (GO:0002448 from GO Biological Process Annotations)", "mast cell migration (GO:0097531 from GO Biological Process Annotations)", "mast cell proliferation (GO:0070662 from GO Biological Process Annotations)", "mast cell secretory granule organization (GO:0033364 from GO Biological Process Annotations)", "maternal aggressive behavior (GO:0002125 from GO Biological Process Annotations)", "maternal behavior (GO:0042711 from GO Biological Process Annotations)", "maternal placenta development (GO:0001893 from GO Biological Process Annotations)", "maternal process involved in female pregnancy (GO:0060135 from GO Biological Process Annotations)", "maternal process involved in parturition (GO:0060137 from GO Biological Process Annotations)", "mating (GO:0007618 from GO Biological Process Annotations)", "mating behavior (GO:0007617 from GO Biological Process Annotations)", "mating plug formation (GO:0042628 from GO Biological Process Annotations)", "maturation of 5.8s rrna (GO:0000460 from GO Biological Process Annotations)", "maturation of 5.8s rrna from tricistronic rrna transcript (ssu-rrna, 5.8s rrna, lsu-rrna) (GO:0000466 from GO Biological Process Annotations)", "maturation of 5s rrna (GO:0000481 from GO Biological Process Annotations)", "maturation of lsu-rrna (GO:0000470 from GO Biological Process Annotations)", "maturation of lsu-rrna from tricistronic rrna transcript (ssu-rrna, 5.8s rrna, lsu-rrna) (GO:0000463 from GO Biological Process Annotations)", "maturation of ssu-rrna (GO:0030490 from GO Biological Process Annotations)", "maturation of ssu-rrna from tricistronic rrna transcript (ssu-rrna, 5.8s rrna, lsu-rrna) (GO:0000462 from GO Biological Process Annotations)", "mature b cell differentiation (GO:0002335 from GO Biological Process Annotations)", "mature b cell differentiation involved in immune response (GO:0002313 from GO Biological Process Annotations)", "mature conventional dendritic cell differentiation (GO:0097029 from GO Biological Process Annotations)", "mature natural killer cell chemotaxis (GO:0035782 from GO Biological Process Annotations)", "mature ribosome assembly (GO:0042256 from GO Biological Process Annotations)", "mda-5 signaling pathway (GO:0039530 from GO Biological Process Annotations)", "mechanoreceptor differentiation (GO:0042490 from GO Biological Process Annotations)", "mechanosensory behavior (GO:0007638 from GO Biological Process Annotations)", "medial motor column neuron differentiation (GO:0021526 from GO Biological Process Annotations)", "medium-chain fatty acid biosynthetic process (GO:0051792 from GO Biological Process Annotations)", "medium-chain fatty acid catabolic process (GO:0051793 from GO Biological Process Annotations)", "medium-chain fatty acid metabolic process (GO:0051791 from GO Biological Process Annotations)", "medium-chain fatty acid transport (GO:0001579 from GO Biological Process Annotations)", "medium-chain fatty-acyl-coa catabolic process (GO:0036114 from GO Biological Process Annotations)", "medium-chain fatty-acyl-coa metabolic process (GO:0036112 from GO Biological Process Annotations)", "medullary reticular formation development (GO:0021723 from GO Biological Process Annotations)", "megakaryocyte development (GO:0035855 from GO Biological Process Annotations)", "megakaryocyte differentiation (GO:0030219 from GO Biological Process Annotations)", "meiosis i (GO:0007127 from GO Biological Process Annotations)", "meiosis ii (GO:0007135 from GO Biological Process Annotations)", "meiotic cell cycle (GO:0051321 from GO Biological Process Annotations)", "meiotic cell cycle checkpoint (GO:0033313 from GO Biological Process Annotations)", "meiotic cell cycle process (GO:1903046 from GO Biological Process Annotations)", "meiotic chromosome condensation (GO:0010032 from GO Biological Process Annotations)", "meiotic chromosome movement towards spindle pole (GO:0016344 from GO Biological Process Annotations)", "meiotic chromosome segregation (GO:0045132 from GO Biological Process Annotations)", "meiotic chromosome separation (GO:0051307 from GO Biological Process Annotations)", "meiotic cytokinesis (GO:0033206 from GO Biological Process Annotations)", "meiotic dna double-strand break formation (GO:0042138 from GO Biological Process Annotations)", "meiotic dna integrity checkpoint (GO:0044778 from GO Biological Process Annotations)", "meiotic dna repair synthesis (GO:0000711 from GO Biological Process Annotations)", "meiotic dna replication checkpoint (GO:0033315 from GO Biological Process Annotations)", "meiotic gene conversion (GO:0006311 from GO Biological Process Annotations)", "meiotic metaphase i plate congression (GO:0043060 from GO Biological Process Annotations)", "meiotic metaphase plate congression (GO:0051311 from GO Biological Process Annotations)", "meiotic mismatch repair (GO:0000710 from GO Biological Process Annotations)", "meiotic nuclear division (GO:0007126 from GO Biological Process Annotations)", "meiotic recombination checkpoint (GO:0051598 from GO Biological Process Annotations)", "meiotic sister chromatid cohesion (GO:0051177 from GO Biological Process Annotations)", "meiotic sister chromatid cohesion, centromeric (GO:0051754 from GO Biological Process Annotations)", "meiotic spindle midzone assembly (GO:0051257 from GO Biological Process Annotations)", "meiotic spindle organization (GO:0000212 from GO Biological Process Annotations)", "meiotic telomere clustering (GO:0045141 from GO Biological Process Annotations)", "melanin biosynthetic process (GO:0042438 from GO Biological Process Annotations)", "melanin biosynthetic process from tyrosine (GO:0006583 from GO Biological Process Annotations)", "melanin metabolic process (GO:0006582 from GO Biological Process Annotations)", "melanocyte adhesion (GO:0097326 from GO Biological Process Annotations)", "melanocyte apoptotic process (GO:1902362 from GO Biological Process Annotations)", "melanocyte differentiation (GO:0030318 from GO Biological Process Annotations)", "melanocyte migration (GO:0097324 from GO Biological Process Annotations)", "melanocyte proliferation (GO:0097325 from GO Biological Process Annotations)", "melanosome assembly (GO:1903232 from GO Biological Process Annotations)", "melanosome localization (GO:0032400 from GO Biological Process Annotations)", "melanosome organization (GO:0032438 from GO Biological Process Annotations)", "melanosome transport (GO:0032402 from GO Biological Process Annotations)", "melatonin biosynthetic process (GO:0030187 from GO Biological Process Annotations)", "melatonin metabolic process (GO:0030186 from GO Biological Process Annotations)", "membrane assembly (GO:0071709 from GO Biological Process Annotations)", "membrane biogenesis (GO:0044091 from GO Biological Process Annotations)", "membrane budding (GO:0006900 from GO Biological Process Annotations)", "membrane depolarization (GO:0051899 from GO Biological Process Annotations)", "membrane depolarization during action potential (GO:0086010 from GO Biological Process Annotations)", "membrane depolarization during av node cell action potential (GO:0086045 from GO Biological Process Annotations)", "membrane depolarization during bundle of his cell action potential (GO:0086048 from GO Biological Process Annotations)", "membrane depolarization during cardiac muscle cell action potential (GO:0086012 from GO Biological Process Annotations)", "membrane depolarization during purkinje myocyte cell action potential (GO:0086047 from GO Biological Process Annotations)", "membrane depolarization during sa node cell action potential (GO:0086046 from GO Biological Process Annotations)", "membrane disassembly (GO:0030397 from GO Biological Process Annotations)", "membrane disruption in other organism (GO:0051673 from GO Biological Process Annotations)", "membrane docking (GO:0022406 from GO Biological Process Annotations)", "membrane fission (GO:0090148 from GO Biological Process Annotations)", "membrane fusion (GO:0061025 from GO Biological Process Annotations)", "membrane fusion involved in viral entry into host cell (GO:0039663 from GO Biological Process Annotations)", "membrane hyperpolarization (GO:0060081 from GO Biological Process Annotations)", "membrane invagination (GO:0010324 from GO Biological Process Annotations)", "membrane lipid biosynthetic process (GO:0046467 from GO Biological Process Annotations)", "membrane lipid catabolic process (GO:0046466 from GO Biological Process Annotations)", "membrane lipid metabolic process (GO:0006643 from GO Biological Process Annotations)", "membrane organization (GO:0061024 from GO Biological Process Annotations)", "membrane protein ectodomain proteolysis (GO:0006509 from GO Biological Process Annotations)", "membrane protein intracellular domain proteolysis (GO:0031293 from GO Biological Process Annotations)", "membrane protein proteolysis (GO:0033619 from GO Biological Process Annotations)", "membrane raft assembly (GO:0001765 from GO Biological Process Annotations)", "membrane raft distribution (GO:0031580 from GO Biological Process Annotations)", "membrane raft localization (GO:0051665 from GO Biological Process Annotations)", "membrane raft organization (GO:0031579 from GO Biological Process Annotations)", "membrane raft polarization (GO:0001766 from GO Biological Process Annotations)", "membrane repolarization (GO:0086009 from GO Biological Process Annotations)", "membrane repolarization during action potential (GO:0086011 from GO Biological Process Annotations)", "membrane repolarization during bundle of his cell action potential (GO:0086050 from GO Biological Process Annotations)", "membrane repolarization during cardiac muscle cell action potential (GO:0086013 from GO Biological Process Annotations)", "membrane repolarization during sa node cell action potential (GO:0086052 from GO Biological Process Annotations)", "membrane to membrane docking (GO:0022614 from GO Biological Process Annotations)", "membrane tubulation (GO:0097320 from GO Biological Process Annotations)", "membranous septum morphogenesis (GO:0003149 from GO Biological Process Annotations)", "memory (GO:0007613 from GO Biological Process Annotations)", "memory t cell activation (GO:0035709 from GO Biological Process Annotations)", "memory t cell proliferation (GO:0061485 from GO Biological Process Annotations)", "menaquinone biosynthetic process (GO:0009234 from GO Biological Process Annotations)", "menaquinone catabolic process (GO:0042361 from GO Biological Process Annotations)", "menaquinone metabolic process (GO:0009233 from GO Biological Process Annotations)", "menstrual cycle phase (GO:0022601 from GO Biological Process Annotations)", "menstruation (GO:0042703 from GO Biological Process Annotations)", "mesangial cell development (GO:0072143 from GO Biological Process Annotations)", "mesangial cell differentiation (GO:0072007 from GO Biological Process Annotations)", "mesangial cell-matrix adhesion (GO:0035759 from GO Biological Process Annotations)", "mesenchymal cell apoptotic process (GO:0097152 from GO Biological Process Annotations)", "mesenchymal cell development (GO:0014031 from GO Biological Process Annotations)", "mesenchymal cell differentiation (GO:0048762 from GO Biological Process Annotations)", "mesenchymal cell differentiation involved in kidney development (GO:0072161 from GO Biological Process Annotations)", "mesenchymal cell differentiation involved in lung development (GO:0060915 from GO Biological Process Annotations)", "mesenchymal cell differentiation involved in renal system development (GO:2001012 from GO Biological Process Annotations)", "mesenchymal cell proliferation (GO:0010463 from GO Biological Process Annotations)", "mesenchymal cell proliferation involved in lung development (GO:0060916 from GO Biological Process Annotations)", "mesenchymal cell proliferation involved in ureter development (GO:0072198 from GO Biological Process Annotations)", "mesenchymal cell proliferation involved in ureteric bud development (GO:0072138 from GO Biological Process Annotations)", "mesenchymal smoothened signaling pathway involved in prostate gland development (GO:0060783 from GO Biological Process Annotations)", "mesenchymal stem cell maintenance involved in nephron morphogenesis (GO:0072038 from GO Biological Process Annotations)", "mesenchymal stem cell proliferation (GO:0097168 from GO Biological Process Annotations)", "mesenchymal to epithelial transition (GO:0060231 from GO Biological Process Annotations)", "mesenchymal to epithelial transition involved in metanephric renal vesicle formation (GO:0072285 from GO Biological Process Annotations)", "mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337 from GO Biological Process Annotations)", "mesenchymal to epithelial transition involved in renal vesicle formation (GO:0072036 from GO Biological Process Annotations)", "mesenchymal-epithelial cell signaling (GO:0060638 from GO Biological Process Annotations)", "mesenchymal-epithelial cell signaling involved in lung development (GO:0060496 from GO Biological Process Annotations)", "mesenchymal-epithelial cell signaling involved in prostate gland development (GO:0060739 from GO Biological Process Annotations)", "mesenchyme development (GO:0060485 from GO Biological Process Annotations)", "mesenchyme migration (GO:0090131 from GO Biological Process Annotations)", "mesenchyme morphogenesis (GO:0072132 from GO Biological Process Annotations)", "mesendoderm development (GO:0048382 from GO Biological Process Annotations)", "mesoderm development (GO:0007498 from GO Biological Process Annotations)", "mesoderm formation (GO:0001707 from GO Biological Process Annotations)", "mesoderm migration involved in gastrulation (GO:0007509 from GO Biological Process Annotations)", "mesoderm morphogenesis (GO:0048332 from GO Biological Process Annotations)", "mesoderm structural organization (GO:0048338 from GO Biological Process Annotations)", "mesodermal cell differentiation (GO:0048333 from GO Biological Process Annotations)", "mesodermal cell fate commitment (GO:0001710 from GO Biological Process Annotations)", "mesodermal cell fate determination (GO:0007500 from GO Biological Process Annotations)", "mesodermal cell fate specification (GO:0007501 from GO Biological Process Annotations)", "mesodermal cell migration (GO:0008078 from GO Biological Process Annotations)", "mesodermal to mesenchymal transition involved in gastrulation (GO:0060809 from GO Biological Process Annotations)", "mesodermal-endodermal cell signaling (GO:0003131 from GO Biological Process Annotations)", "mesonephric duct development (GO:0072177 from GO Biological Process Annotations)", "mesonephric duct formation (GO:0072181 from GO Biological Process Annotations)", "mesonephric duct morphogenesis (GO:0072180 from GO Biological Process Annotations)", "mesonephric epithelium development (GO:0072163 from GO Biological Process Annotations)", "mesonephric tubule development (GO:0072164 from GO Biological Process Annotations)", "mesonephric tubule formation (GO:0072172 from GO Biological Process Annotations)", "mesonephric tubule morphogenesis (GO:0072171 from GO Biological Process Annotations)", "mesonephros development (GO:0001823 from GO Biological Process Annotations)", "metabolic process (GO:0008152 from GO Biological Process Annotations)", "metal incorporation into metallo-molybdopterin complex (GO:0042040 from GO Biological Process Annotations)", "metal incorporation into metallo-sulfur cluster (GO:0018282 from GO Biological Process Annotations)", "metal ion homeostasis (GO:0055065 from GO Biological Process Annotations)", "metal ion transport (GO:0030001 from GO Biological Process Annotations)", "metallo-sulfur cluster assembly (GO:0031163 from GO Biological Process Annotations)", "metanephric ascending thin limb development (GO:0072218 from GO Biological Process Annotations)", "metanephric cap mesenchymal cell proliferation involved in metanephros development (GO:0090094 from GO Biological Process Annotations)", "metanephric capsule development (GO:0072213 from GO Biological Process Annotations)", "metanephric capsule specification (GO:0072267 from GO Biological Process Annotations)", "metanephric collecting duct development (GO:0072205 from GO Biological Process Annotations)", "metanephric comma-shaped body morphogenesis (GO:0072278 from GO Biological Process Annotations)", "metanephric connecting tubule development (GO:0072286 from GO Biological Process Annotations)", "metanephric cortex development (GO:0072214 from GO Biological Process Annotations)", "metanephric cortical collecting duct development (GO:0072219 from GO Biological Process Annotations)", "metanephric dct cell differentiation (GO:0072240 from GO Biological Process Annotations)", "metanephric descending thin limb development (GO:0072220 from GO Biological Process Annotations)", "metanephric distal convoluted tubule development (GO:0072221 from GO Biological Process Annotations)", "metanephric distal tubule development (GO:0072235 from GO Biological Process Annotations)", "metanephric distal tubule morphogenesis (GO:0072287 from GO Biological Process Annotations)", "metanephric epithelium development (GO:0072207 from GO Biological Process Annotations)", "metanephric glomerular basement membrane development (GO:0072274 from GO Biological Process Annotations)", "metanephric glomerular capillary formation (GO:0072277 from GO Biological Process Annotations)", "metanephric glomerular endothelium development (GO:0072264 from GO Biological Process Annotations)", "metanephric glomerular epithelial cell development (GO:0072313 from GO Biological Process Annotations)", "metanephric glomerular epithelium development (GO:0072244 from GO Biological Process Annotations)", "metanephric glomerular mesangial cell development (GO:0072255 from GO Biological Process Annotations)", "metanephric glomerular mesangial cell differentiation (GO:0072254 from GO Biological Process Annotations)", "metanephric glomerular mesangial cell proliferation involved in metanephros development (GO:0072262 from GO Biological Process Annotations)", "metanephric glomerular visceral epithelial cell development (GO:0072249 from GO Biological Process Annotations)", "metanephric glomerulus development (GO:0072224 from GO Biological Process Annotations)", "metanephric glomerulus vasculature development (GO:0072239 from GO Biological Process Annotations)", "metanephric interstitial fibroblast development (GO:0072259 from GO Biological Process Annotations)", "metanephric loop of henle development (GO:0072236 from GO Biological Process Annotations)", "metanephric macula densa development (GO:0072227 from GO Biological Process Annotations)", "metanephric mesangial cell differentiation (GO:0072209 from GO Biological Process Annotations)", "metanephric mesenchymal cell differentiation (GO:0072162 from GO Biological Process Annotations)", "metanephric mesenchymal cell migration (GO:0035789 from GO Biological Process Annotations)", "metanephric mesenchymal cell proliferation involved in metanephros development (GO:0072136 from GO Biological Process Annotations)", "metanephric mesenchyme development (GO:0072075 from GO Biological Process Annotations)", "metanephric mesenchyme morphogenesis (GO:0072133 from GO Biological Process Annotations)", "metanephric nephron development (GO:0072210 from GO Biological Process Annotations)", "metanephric nephron epithelium development (GO:0072243 from GO Biological Process Annotations)", "metanephric nephron morphogenesis (GO:0072273 from GO Biological Process Annotations)", "metanephric nephron tubule development (GO:0072234 from GO Biological Process Annotations)", "metanephric nephron tubule formation (GO:0072289 from GO Biological Process Annotations)", "metanephric nephron tubule morphogenesis (GO:0072282 from GO Biological Process Annotations)", "metanephric part of ureteric bud development (GO:0035502 from GO Biological Process Annotations)", "metanephric proximal convoluted tubule development (GO:0072229 from GO Biological Process Annotations)", "metanephric proximal convoluted tubule segment 2 development (GO:0072232 from GO Biological Process Annotations)", "metanephric proximal straight tubule development (GO:0072230 from GO Biological Process Annotations)", "metanephric proximal tubule development (GO:0072237 from GO Biological Process Annotations)", "metanephric renal vesicle morphogenesis (GO:0072283 from GO Biological Process Annotations)", "metanephric s-shaped body morphogenesis (GO:0072284 from GO Biological Process Annotations)", "metanephric smooth muscle tissue development (GO:0072208 from GO Biological Process Annotations)", "metanephric thick ascending limb development (GO:0072233 from GO Biological Process Annotations)", "metanephric tubule development (GO:0072170 from GO Biological Process Annotations)", "metanephric tubule formation (GO:0072174 from GO Biological Process Annotations)", "metanephric tubule morphogenesis (GO:0072173 from GO Biological Process Annotations)", "metanephros development (GO:0001656 from GO Biological Process Annotations)", "metanephros morphogenesis (GO:0003338 from GO Biological Process Annotations)", "metaphase plate congression (GO:0051310 from GO Biological Process Annotations)", "metaphase|anaphase transition of cell cycle (GO:0044784 from GO Biological Process Annotations)", "metaphase|anaphase transition of mitotic cell cycle (GO:0007091 from GO Biological Process Annotations)", "metencephalon development (GO:0022037 from GO Biological Process Annotations)", "methionine biosynthetic process (GO:0009086 from GO Biological Process Annotations)", "methionine metabolic process (GO:0006555 from GO Biological Process Annotations)", "methionine transport (GO:0015821 from GO Biological Process Annotations)", "methionyl-trna aminoacylation (GO:0006431 from GO Biological Process Annotations)", "methotrexate transport (GO:0051958 from GO Biological Process Annotations)", "methyl-branched fatty acid metabolic process (GO:0097089 from GO Biological Process Annotations)", "methylation (GO:0032259 from GO Biological Process Annotations)", "methylation-dependent chromatin silencing (GO:0006346 from GO Biological Process Annotations)", "methylglyoxal biosynthetic process (GO:0019242 from GO Biological Process Annotations)", "methylglyoxal catabolic process (GO:0051596 from GO Biological Process Annotations)", "methylglyoxal catabolic process to d-lactate (GO:0019243 from GO Biological Process Annotations)", "methylglyoxal metabolic process (GO:0009438 from GO Biological Process Annotations)", "mevalonate transport (GO:0015728 from GO Biological Process Annotations)", "mhc class ii biosynthetic process (GO:0045342 from GO Biological Process Annotations)", "mhc class ii protein complex assembly (GO:0002399 from GO Biological Process Annotations)", "mhc protein complex assembly (GO:0002396 from GO Biological Process Annotations)", "microautophagy (GO:0016237 from GO Biological Process Annotations)", "microglia development (GO:0014005 from GO Biological Process Annotations)", "microglial cell activation (GO:0001774 from GO Biological Process Annotations)", "microglial cell activation involved in immune response (GO:0002282 from GO Biological Process Annotations)", "microglial cell proliferation (GO:0061518 from GO Biological Process Annotations)", "microspike assembly (GO:0030035 from GO Biological Process Annotations)", "microtubule anchoring (GO:0034453 from GO Biological Process Annotations)", "microtubule anchoring at centrosome (GO:0034454 from GO Biological Process Annotations)", "microtubule anchoring at microtubule organizing center (GO:0072393 from GO Biological Process Annotations)", "microtubule bundle formation (GO:0001578 from GO Biological Process Annotations)", "microtubule cytoskeleton organization (GO:0000226 from GO Biological Process Annotations)", "microtubule cytoskeleton organization involved in mitosis (GO:1902850 from GO Biological Process Annotations)", "microtubule depolymerization (GO:0007019 from GO Biological Process Annotations)", "microtubule nucleation (GO:0007020 from GO Biological Process Annotations)", "microtubule organizing center organization (GO:0031023 from GO Biological Process Annotations)", "microtubule polymerization (GO:0046785 from GO Biological Process Annotations)", "microtubule polymerization or depolymerization (GO:0031109 from GO Biological Process Annotations)", "microtubule severing (GO:0051013 from GO Biological Process Annotations)", "microtubule sliding (GO:0051012 from GO Biological Process Annotations)", "microtubule-based movement (GO:0007018 from GO Biological Process Annotations)", "microtubule-based peroxisome localization (GO:0060152 from GO Biological Process Annotations)", "microtubule-based process (GO:0007017 from GO Biological Process Annotations)", "microtubule-based transport (GO:0010970 from GO Biological Process Annotations)", "microtubule-dependent intracellular transport of viral material (GO:0075519 from GO Biological Process Annotations)", "microtubule-dependent intracellular transport of viral material towards nucleus (GO:0075521 from GO Biological Process Annotations)", "microvillus assembly (GO:0030033 from GO Biological Process Annotations)", "microvillus organization (GO:0032528 from GO Biological Process Annotations)", "micturition (GO:0060073 from GO Biological Process Annotations)", "midbrain development (GO:0030901 from GO Biological Process Annotations)", "midbrain-hindbrain boundary development (GO:0030917 from GO Biological Process Annotations)", "midbrain-hindbrain boundary initiation (GO:0021547 from GO Biological Process Annotations)", "midbrain-hindbrain boundary maturation during brain development (GO:0022004 from GO Biological Process Annotations)", "midbrain-hindbrain boundary morphogenesis (GO:0021555 from GO Biological Process Annotations)", "middle ear morphogenesis (GO:0042474 from GO Biological Process Annotations)", "midgut development (GO:0007494 from GO Biological Process Annotations)", "milk ejection (GO:0060156 from GO Biological Process Annotations)", "mineralocorticoid biosynthetic process (GO:0006705 from GO Biological Process Annotations)", "mineralocorticoid metabolic process (GO:0008212 from GO Biological Process Annotations)", "mineralocorticoid receptor signaling pathway (GO:0031959 from GO Biological Process Annotations)", "mineralocorticoid secretion (GO:0035931 from GO Biological Process Annotations)", "minus-end-directed organelle transport along microtubule (GO:0072385 from GO Biological Process Annotations)", "mirna catabolic process (GO:0010587 from GO Biological Process Annotations)", "mirna loading onto risc involved in gene silencing by mirna (GO:0035280 from GO Biological Process Annotations)", "mirna metabolic process (GO:0010586 from GO Biological Process Annotations)", "misfolded or incompletely synthesized protein catabolic process (GO:0006515 from GO Biological Process Annotations)", "misfolded protein transport (GO:0070843 from GO Biological Process Annotations)", "mismatch repair (GO:0006298 from GO Biological Process Annotations)", "mitochondria-nucleus signaling pathway (GO:0031930 from GO Biological Process Annotations)", "mitochondrial alanyl-trna aminoacylation (GO:0070143 from GO Biological Process Annotations)", "mitochondrial asparaginyl-trna aminoacylation (GO:0070145 from GO Biological Process Annotations)", "mitochondrial atp synthesis coupled electron transport (GO:0042775 from GO Biological Process Annotations)", "mitochondrial atp synthesis coupled proton transport (GO:0042776 from GO Biological Process Annotations)", "mitochondrial calcium ion homeostasis (GO:0051560 from GO Biological Process Annotations)", "mitochondrial calcium ion transport (GO:0006851 from GO Biological Process Annotations)", "mitochondrial depolarization (GO:0051882 from GO Biological Process Annotations)", "mitochondrial dna metabolic process (GO:0032042 from GO Biological Process Annotations)", "mitochondrial dna repair (GO:0043504 from GO Biological Process Annotations)", "mitochondrial dna replication (GO:0006264 from GO Biological Process Annotations)", "mitochondrial electron transport, cytochrome c to oxygen (GO:0006123 from GO Biological Process Annotations)", "mitochondrial electron transport, nadh to ubiquinone (GO:0006120 from GO Biological Process Annotations)", "mitochondrial electron transport, succinate to ubiquinone (GO:0006121 from GO Biological Process Annotations)", "mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122 from GO Biological Process Annotations)", "mitochondrial fission (GO:0000266 from GO Biological Process Annotations)", "mitochondrial fragmentation involved in apoptotic process (GO:0043653 from GO Biological Process Annotations)", "mitochondrial fusion (GO:0008053 from GO Biological Process Annotations)", "mitochondrial genome maintenance (GO:0000002 from GO Biological Process Annotations)", "mitochondrial iron ion transport (GO:0048250 from GO Biological Process Annotations)", "mitochondrial membrane fission (GO:0090149 from GO Biological Process Annotations)", "mitochondrial membrane organization (GO:0007006 from GO Biological Process Annotations)", "mitochondrial mrna catabolic process (GO:0000958 from GO Biological Process Annotations)", "mitochondrial mrna polyadenylation (GO:0097222 from GO Biological Process Annotations)", "mitochondrial mrna surveillance (GO:0035946 from GO Biological Process Annotations)", "mitochondrial ncrna surveillance (GO:0035945 from GO Biological Process Annotations)", "mitochondrial ornithine transport (GO:0000066 from GO Biological Process Annotations)", "mitochondrial outer membrane permeabilization (GO:0097345 from GO Biological Process Annotations)", "mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686 from GO Biological Process Annotations)", "mitochondrial protein catabolic process (GO:0035694 from GO Biological Process Annotations)", "mitochondrial protein processing (GO:0034982 from GO Biological Process Annotations)", "mitochondrial proton-transporting atp synthase complex assembly (GO:0033615 from GO Biological Process Annotations)", "mitochondrial pyrimidine nucleotide import (GO:1990519 from GO Biological Process Annotations)", "mitochondrial pyruvate transport (GO:0006850 from GO Biological Process Annotations)", "mitochondrial respiratory chain complex assembly (GO:0033108 from GO Biological Process Annotations)", "mitochondrial respiratory chain complex i assembly (GO:0032981 from GO Biological Process Annotations)", "mitochondrial respiratory chain complex i biogenesis (GO:0097031 from GO Biological Process Annotations)", "mitochondrial respiratory chain complex ii assembly (GO:0034553 from GO Biological Process Annotations)", "mitochondrial respiratory chain complex ii biogenesis (GO:0097032 from GO Biological Process Annotations)", "mitochondrial respiratory chain complex iii assembly (GO:0034551 from GO Biological Process Annotations)", "mitochondrial respiratory chain complex iii biogenesis (GO:0097033 from GO Biological Process Annotations)", "mitochondrial respiratory chain complex iv assembly (GO:0033617 from GO Biological Process Annotations)", "mitochondrial respiratory chain complex iv biogenesis (GO:0097034 from GO Biological Process Annotations)", "mitochondrial ribosome assembly (GO:0061668 from GO Biological Process Annotations)", "mitochondrial rna 3'-end processing (GO:0000965 from GO Biological Process Annotations)", "mitochondrial rna 5'-end processing (GO:0000964 from GO Biological Process Annotations)", "mitochondrial rna catabolic process (GO:0000957 from GO Biological Process Annotations)", "mitochondrial rna metabolic process (GO:0000959 from GO Biological Process Annotations)", "mitochondrial rna modification (GO:1900864 from GO Biological Process Annotations)", "mitochondrial rna processing (GO:0000963 from GO Biological Process Annotations)", "mitochondrial rna surveillance (GO:2000827 from GO Biological Process Annotations)", "mitochondrial threonyl-trna aminoacylation (GO:0070159 from GO Biological Process Annotations)", "mitochondrial translation (GO:0032543 from GO Biological Process Annotations)", "mitochondrial translational elongation (GO:0070125 from GO Biological Process Annotations)", "mitochondrial translational initiation (GO:0070124 from GO Biological Process Annotations)", "mitochondrial translational termination (GO:0070126 from GO Biological Process Annotations)", "mitochondrial transmembrane transport (GO:1990542 from GO Biological Process Annotations)", "mitochondrial transport (GO:0006839 from GO Biological Process Annotations)", "mitochondrial trna 3'-end processing (GO:1990180 from GO Biological Process Annotations)", "mitochondrial trna 3'-trailer cleavage, endonucleolytic (GO:0072684 from GO Biological Process Annotations)", "mitochondrial trna methylation (GO:0070901 from GO Biological Process Annotations)", "mitochondrial trna modification (GO:0070900 from GO Biological Process Annotations)", "mitochondrial trna wobble uridine modification (GO:0070899 from GO Biological Process Annotations)", "mitochondrial tyrosyl-trna aminoacylation (GO:0070184 from GO Biological Process Annotations)", "mitochondrion degradation (GO:0000422 from GO Biological Process Annotations)", "mitochondrion degradation by induced vacuole formation (GO:0035695 from GO Biological Process Annotations)", "mitochondrion distribution (GO:0048311 from GO Biological Process Annotations)", "mitochondrion localization (GO:0051646 from GO Biological Process Annotations)", "mitochondrion morphogenesis (GO:0070584 from GO Biological Process Annotations)", "mitochondrion organization (GO:0007005 from GO Biological Process Annotations)", "mitochondrion transport along microtubule (GO:0047497 from GO Biological Process Annotations)", "mitotic cell cycle (GO:0000278 from GO Biological Process Annotations)", "mitotic cell cycle arrest (GO:0071850 from GO Biological Process Annotations)", "mitotic cell cycle checkpoint (GO:0007093 from GO Biological Process Annotations)", "mitotic cell cycle phase transition (GO:0044772 from GO Biological Process Annotations)", "mitotic cell cycle process (GO:1903047 from GO Biological Process Annotations)", "mitotic centrosome separation (GO:0007100 from GO Biological Process Annotations)", "mitotic chromosome condensation (GO:0007076 from GO Biological Process Annotations)", "mitotic chromosome movement towards spindle pole (GO:0007079 from GO Biological Process Annotations)", "mitotic cytokinesis (GO:0000281 from GO Biological Process Annotations)", "mitotic cytokinetic process (GO:1902410 from GO Biological Process Annotations)", "mitotic dna damage checkpoint (GO:0044773 from GO Biological Process Annotations)", "mitotic dna integrity checkpoint (GO:0044774 from GO Biological Process Annotations)", "mitotic dna replication checkpoint (GO:0033314 from GO Biological Process Annotations)", "mitotic dna replication preinitiation complex assembly (GO:1902977 from GO Biological Process Annotations)", "mitotic g1 dna damage checkpoint (GO:0031571 from GO Biological Process Annotations)", "mitotic g1|s transition checkpoint (GO:0044819 from GO Biological Process Annotations)", "mitotic g2 dna damage checkpoint (GO:0007095 from GO Biological Process Annotations)", "mitotic g2|m transition checkpoint (GO:0044818 from GO Biological Process Annotations)", "mitotic metaphase plate congression (GO:0007080 from GO Biological Process Annotations)", "mitotic nuclear division (GO:0007067 from GO Biological Process Annotations)", "mitotic nuclear envelope disassembly (GO:0007077 from GO Biological Process Annotations)", "mitotic nuclear envelope reassembly (GO:0007084 from GO Biological Process Annotations)", "mitotic recombination (GO:0006312 from GO Biological Process Annotations)", "mitotic sister chromatid cohesion (GO:0007064 from GO Biological Process Annotations)", "mitotic sister chromatid cohesion, centromeric (GO:0071962 from GO Biological Process Annotations)", "mitotic sister chromatid segregation (GO:0000070 from GO Biological Process Annotations)", "mitotic sister chromatid separation (GO:0051306 from GO Biological Process Annotations)", "mitotic spindle assembly (GO:0090307 from GO Biological Process Annotations)", "mitotic spindle assembly checkpoint (GO:0007094 from GO Biological Process Annotations)", "mitotic spindle checkpoint (GO:0071174 from GO Biological Process Annotations)", "mitotic spindle elongation (GO:0000022 from GO Biological Process Annotations)", "mitotic spindle midzone assembly (GO:0051256 from GO Biological Process Annotations)", "mitotic spindle organization (GO:0007052 from GO Biological Process Annotations)", "mitotic spindle organization in nucleus (GO:0030472 from GO Biological Process Annotations)", "mitotic spindle stabilization (GO:0043148 from GO Biological Process Annotations)", "mitral valve development (GO:0003174 from GO Biological Process Annotations)", "mitral valve formation (GO:0003192 from GO Biological Process Annotations)", "mitral valve morphogenesis (GO:0003183 from GO Biological Process Annotations)", "mo-molybdopterin cofactor biosynthetic process (GO:0006777 from GO Biological Process Annotations)", "mo-molybdopterin cofactor metabolic process (GO:0019720 from GO Biological Process Annotations)", "modification by host of symbiont molecular function (GO:0052428 from GO Biological Process Annotations)", "modification by host of symbiont morphology or physiology (GO:0051851 from GO Biological Process Annotations)", "modification by symbiont of host morphology or physiology (GO:0044003 from GO Biological Process Annotations)", "modification by virus of host mrna processing (GO:0046778 from GO Biological Process Annotations)", "modification of morphology or physiology of other organism (GO:0035821 from GO Biological Process Annotations)", "modification of morphology or physiology of other organism involved in symbiotic interaction (GO:0051817 from GO Biological Process Annotations)", "modification-dependent macromolecule catabolic process (GO:0043632 from GO Biological Process Annotations)", "modification-dependent protein catabolic process (GO:0019941 from GO Biological Process Annotations)", "modified amino acid transport (GO:0072337 from GO Biological Process Annotations)", "modulation by host of symbiont catalytic activity (GO:0052422 from GO Biological Process Annotations)", "modulation by host of symbiont transcription (GO:0052472 from GO Biological Process Annotations)", "modulation by host of viral catalytic activity (GO:0044867 from GO Biological Process Annotations)", "modulation by host of viral exo-alpha-sialidase activity (GO:0044866 from GO Biological Process Annotations)", "modulation by host of viral genome replication (GO:0044827 from GO Biological Process Annotations)", "modulation by host of viral glycoprotein metabolic process (GO:0044870 from GO Biological Process Annotations)", "modulation by host of viral molecular function (GO:0044868 from GO Biological Process Annotations)", "modulation by host of viral process (GO:0044788 from GO Biological Process Annotations)", "modulation by host of viral release from host cell (GO:0044789 from GO Biological Process Annotations)", "modulation by host of viral transcription (GO:0043921 from GO Biological Process Annotations)", "modulation by organism of apoptotic process in other organism involved in symbiotic interaction (GO:0052433 from GO Biological Process Annotations)", "modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0052255 from GO Biological Process Annotations)", "modulation by organism of defense-related nitric oxide production in other organism involved in symbiotic interaction (GO:0052302 from GO Biological Process Annotations)", "modulation by organism of immune response of other organism involved in symbiotic interaction (GO:0052552 from GO Biological Process Annotations)", "modulation by symbiont of defense-related host nitric oxide production (GO:0052163 from GO Biological Process Annotations)", "modulation by symbiont of host apoptotic process (GO:0052150 from GO Biological Process Annotations)", "modulation by symbiont of host cellular process (GO:0044068 from GO Biological Process Annotations)", "modulation by symbiont of host defense response (GO:0052031 from GO Biological Process Annotations)", "modulation by symbiont of host i-kappab kinase|nf-kappab cascade (GO:0085032 from GO Biological Process Annotations)", "modulation by symbiont of host immune response (GO:0052553 from GO Biological Process Annotations)", "modulation by symbiont of host phagocytosis (GO:0052190 from GO Biological Process Annotations)", "modulation by symbiont of host programmed cell death (GO:0052040 from GO Biological Process Annotations)", "modulation by symbiont of host signal transduction pathway (GO:0052027 from GO Biological Process Annotations)", "modulation by symbiont of host transcription (GO:0052026 from GO Biological Process Annotations)", "modulation by virus of host apoptotic process (GO:0039526 from GO Biological Process Annotations)", "modulation by virus of host autophagy (GO:0039519 from GO Biological Process Annotations)", "modulation by virus of host gene expression (GO:0039656 from GO Biological Process Annotations)", "modulation by virus of host immune response (GO:0075528 from GO Biological Process Annotations)", "modulation by virus of host morphology or physiology (GO:0019048 from GO Biological Process Annotations)", "modulation by virus of host process (GO:0019054 from GO Biological Process Annotations)", "modulation by virus of host transcription (GO:0019056 from GO Biological Process Annotations)", "modulation of apoptotic process in other organism (GO:0044532 from GO Biological Process Annotations)", "modulation of catalytic activity in other organism involved in symbiotic interaction (GO:0052203 from GO Biological Process Annotations)", "modulation of growth of symbiont involved in interaction with host (GO:0044144 from GO Biological Process Annotations)", "modulation of growth of symbiont on or near host (GO:0044139 from GO Biological Process Annotations)", "modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration (GO:0021815 from GO Biological Process Annotations)", "modulation of molecular function in other organism (GO:0044359 from GO Biological Process Annotations)", "modulation of molecular function in other organism involved in symbiotic interaction (GO:0052205 from GO Biological Process Annotations)", "modulation of phagocytosis in other organism involved in symbiotic interaction (GO:0052231 from GO Biological Process Annotations)", "modulation of programmed cell death in other organism (GO:0044531 from GO Biological Process Annotations)", "modulation of programmed cell death in other organism involved in symbiotic interaction (GO:0052248 from GO Biological Process Annotations)", "modulation of signal transduction in other organism (GO:0044501 from GO Biological Process Annotations)", "modulation of signal transduction in other organism involved in symbiotic interaction (GO:0052250 from GO Biological Process Annotations)", "modulation of transcription in other organism involved in symbiotic interaction (GO:0052312 from GO Biological Process Annotations)", "molecular hydrogen transport (GO:0015993 from GO Biological Process Annotations)", "molting cycle (GO:0042303 from GO Biological Process Annotations)", "molting cycle process (GO:0022404 from GO Biological Process Annotations)", "molybdate ion transport (GO:0015689 from GO Biological Process Annotations)", "molybdenum incorporation into molybdenum-molybdopterin complex (GO:0018315 from GO Biological Process Annotations)", "molybdopterin cofactor biosynthetic process (GO:0032324 from GO Biological Process Annotations)", "molybdopterin cofactor metabolic process (GO:0043545 from GO Biological Process Annotations)", "monoamine transport (GO:0015844 from GO Biological Process Annotations)", "monocarboxylic acid biosynthetic process (GO:0072330 from GO Biological Process Annotations)", "monocarboxylic acid catabolic process (GO:0072329 from GO Biological Process Annotations)", "monocarboxylic acid metabolic process (GO:0032787 from GO Biological Process Annotations)", "monocarboxylic acid transport (GO:0015718 from GO Biological Process Annotations)", "monocyte activation (GO:0042117 from GO Biological Process Annotations)", "monocyte aggregation (GO:0070487 from GO Biological Process Annotations)", "monocyte chemotaxis (GO:0002548 from GO Biological Process Annotations)", "monocyte differentiation (GO:0030224 from GO Biological Process Annotations)", "monocyte extravasation (GO:0035696 from GO Biological Process Annotations)", "mononuclear cell migration (GO:0071674 from GO Biological Process Annotations)", "mononuclear cell proliferation (GO:0032943 from GO Biological Process Annotations)", "monosaccharide biosynthetic process (GO:0046364 from GO Biological Process Annotations)", "monosaccharide catabolic process (GO:0046365 from GO Biological Process Annotations)", "monosaccharide metabolic process (GO:0005996 from GO Biological Process Annotations)", "monosaccharide transport (GO:0015749 from GO Biological Process Annotations)", "monoterpenoid metabolic process (GO:0016098 from GO Biological Process Annotations)", "monoubiquitinated histone deubiquitination (GO:0035521 from GO Biological Process Annotations)", "monoubiquitinated histone h2a deubiquitination (GO:0035522 from GO Biological Process Annotations)", "monoubiquitinated protein deubiquitination (GO:0035520 from GO Biological Process Annotations)", "monovalent inorganic anion homeostasis (GO:0055083 from GO Biological Process Annotations)", "monovalent inorganic cation homeostasis (GO:0055067 from GO Biological Process Annotations)", "monovalent inorganic cation transport (GO:0015672 from GO Biological Process Annotations)", "morphogenesis of a branching epithelium (GO:0061138 from GO Biological Process Annotations)", "morphogenesis of a branching structure (GO:0001763 from GO Biological Process Annotations)", "morphogenesis of a polarized epithelium (GO:0001738 from GO Biological Process Annotations)", "morphogenesis of an endothelium (GO:0003159 from GO Biological Process Annotations)", "morphogenesis of an epithelial bud (GO:0060572 from GO Biological Process Annotations)", "morphogenesis of an epithelial fold (GO:0060571 from GO Biological Process Annotations)", "morphogenesis of an epithelial sheet (GO:0002011 from GO Biological Process Annotations)", "morphogenesis of an epithelium (GO:0002009 from GO Biological Process Annotations)", "morphogenesis of embryonic epithelium (GO:0016331 from GO Biological Process Annotations)", "motile cilium assembly (GO:0044458 from GO Biological Process Annotations)", "motor neuron apoptotic process (GO:0097049 from GO Biological Process Annotations)", "motor neuron axon guidance (GO:0008045 from GO Biological Process Annotations)", "motor neuron migration (GO:0097475 from GO Biological Process Annotations)", "movement in environment of other organism involved in symbiotic interaction (GO:0052192 from GO Biological Process Annotations)", "movement in host environment (GO:0052126 from GO Biological Process Annotations)", "movement of cell or subcellular component (GO:0006928 from GO Biological Process Annotations)", "mrna 3'-end processing (GO:0031124 from GO Biological Process Annotations)", "mrna 3'-splice site recognition (GO:0000389 from GO Biological Process Annotations)", "mrna 5'-splice site recognition (GO:0000395 from GO Biological Process Annotations)", "mrna catabolic process (GO:0006402 from GO Biological Process Annotations)", "mrna cis splicing, via spliceosome (GO:0045292 from GO Biological Process Annotations)", "mrna cleavage (GO:0006379 from GO Biological Process Annotations)", "mrna cleavage involved in gene silencing by mirna (GO:0035279 from GO Biological Process Annotations)", "mrna cleavage involved in gene silencing by sirna (GO:0090625 from GO Biological Process Annotations)", "mrna destabilization (GO:0061157 from GO Biological Process Annotations)", "mrna export from nucleus (GO:0006406 from GO Biological Process Annotations)", "mrna export from nucleus in response to heat stress (GO:0031990 from GO Biological Process Annotations)", "mrna localization resulting in posttranscriptional regulation of gene expression (GO:0010609 from GO Biological Process Annotations)", "mrna metabolic process (GO:0016071 from GO Biological Process Annotations)", "mrna methylation (GO:0080009 from GO Biological Process Annotations)", "mrna modification (GO:0016556 from GO Biological Process Annotations)", "mrna polyadenylation (GO:0006378 from GO Biological Process Annotations)", "mrna processing (GO:0006397 from GO Biological Process Annotations)", "mrna pseudouridine synthesis (GO:1990481 from GO Biological Process Annotations)", "mrna splice site selection (GO:0006376 from GO Biological Process Annotations)", "mrna splicing, via endonucleolytic cleavage and ligation (GO:0070054 from GO Biological Process Annotations)", "mrna splicing, via spliceosome (GO:0000398 from GO Biological Process Annotations)", "mrna stabilization (GO:0048255 from GO Biological Process Annotations)", "mrna transcription (GO:0009299 from GO Biological Process Annotations)", "mrna transcription from rna polymerase ii promoter (GO:0042789 from GO Biological Process Annotations)", "mrna transport (GO:0051028 from GO Biological Process Annotations)", "mucopolysaccharide metabolic process (GO:1903510 from GO Biological Process Annotations)", "mucosal immune response (GO:0002385 from GO Biological Process Annotations)", "mucosal-associated lymphoid tissue development (GO:0048537 from GO Biological Process Annotations)", "mucus secretion (GO:0070254 from GO Biological Process Annotations)", "mullerian duct regression (GO:0001880 from GO Biological Process Annotations)", "multi-ciliated epithelial cell differentiation (GO:1903251 from GO Biological Process Annotations)", "multi-multicellular organism process (GO:0044706 from GO Biological Process Annotations)", "multi-organism behavior (GO:0051705 from GO Biological Process Annotations)", "multi-organism biosynthetic process (GO:0044034 from GO Biological Process Annotations)", "multi-organism cellular process (GO:0044764 from GO Biological Process Annotations)", "multi-organism intracellular transport (GO:1902583 from GO Biological Process Annotations)", "multi-organism localization (GO:1902579 from GO Biological Process Annotations)", "multi-organism membrane budding (GO:1902592 from GO Biological Process Annotations)", "multi-organism membrane fusion (GO:0044800 from GO Biological Process Annotations)", "multi-organism membrane organization (GO:0044803 from GO Biological Process Annotations)", "multi-organism metabolic process (GO:0044033 from GO Biological Process Annotations)", "multi-organism nuclear import (GO:1902594 from GO Biological Process Annotations)", "multi-organism organelle organization (GO:1902590 from GO Biological Process Annotations)", "multi-organism process (GO:0051704 from GO Biological Process Annotations)", "multi-organism reproductive behavior (GO:0044705 from GO Biological Process Annotations)", "multi-organism reproductive process (GO:0044703 from GO Biological Process Annotations)", "multi-organism transport (GO:0044766 from GO Biological Process Annotations)", "multicellular organism growth (GO:0035264 from GO Biological Process Annotations)", "multicellular organism reproduction (GO:0032504 from GO Biological Process Annotations)", "multicellular organismal aging (GO:0010259 from GO Biological Process Annotations)", "multicellular organismal catabolic process (GO:0044243 from GO Biological Process Annotations)", "multicellular organismal development (GO:0007275 from GO Biological Process Annotations)", "multicellular organismal homeostasis (GO:0048871 from GO Biological Process Annotations)", "multicellular organismal iron ion homeostasis (GO:0060586 from GO Biological Process Annotations)", "multicellular organismal lipid catabolic process (GO:0044240 from GO Biological Process Annotations)", "multicellular organismal macromolecule catabolic process (GO:0044266 from GO Biological Process Annotations)", "multicellular organismal macromolecule metabolic process (GO:0044259 from GO Biological Process Annotations)", "multicellular organismal metabolic process (GO:0044236 from GO Biological Process Annotations)", "multicellular organismal movement (GO:0050879 from GO Biological Process Annotations)", "multicellular organismal process (GO:0032501 from GO Biological Process Annotations)", "multicellular organismal protein catabolic process (GO:0044254 from GO Biological Process Annotations)", "multicellular organismal protein metabolic process (GO:0044268 from GO Biological Process Annotations)", "multicellular organismal reproductive behavior (GO:0033057 from GO Biological Process Annotations)", "multicellular organismal reproductive process (GO:0048609 from GO Biological Process Annotations)", "multicellular organismal response to stress (GO:0033555 from GO Biological Process Annotations)", "multicellular organismal signaling (GO:0035637 from GO Biological Process Annotations)", "multicellular organismal water homeostasis (GO:0050891 from GO Biological Process Annotations)", "multicellular structure septum development (GO:0080125 from GO Biological Process Annotations)", "multinuclear osteoclast differentiation (GO:0072674 from GO Biological Process Annotations)", "multivesicular body assembly (GO:0036258 from GO Biological Process Annotations)", "multivesicular body organization (GO:0036257 from GO Biological Process Annotations)", "multivesicular body sorting pathway (GO:0071985 from GO Biological Process Annotations)", "muscle adaptation (GO:0043500 from GO Biological Process Annotations)", "muscle atrophy (GO:0014889 from GO Biological Process Annotations)", "muscle cell apoptotic process (GO:0010657 from GO Biological Process Annotations)", "muscle cell cellular homeostasis (GO:0046716 from GO Biological Process Annotations)", "muscle cell development (GO:0055001 from GO Biological Process Annotations)", "muscle cell differentiation (GO:0042692 from GO Biological Process Annotations)", "muscle cell fate commitment (GO:0042693 from GO Biological Process Annotations)", "muscle cell fate determination (GO:0007521 from GO Biological Process Annotations)", "muscle cell fate specification (GO:0042694 from GO Biological Process Annotations)", "muscle cell migration (GO:0014812 from GO Biological Process Annotations)", "muscle cell proliferation (GO:0033002 from GO Biological Process Annotations)", "muscle contraction (GO:0006936 from GO Biological Process Annotations)", "muscle fiber development (GO:0048747 from GO Biological Process Annotations)", "muscle filament sliding (GO:0030049 from GO Biological Process Annotations)", "muscle hypertrophy (GO:0014896 from GO Biological Process Annotations)", "muscle hypertrophy in response to stress (GO:0003299 from GO Biological Process Annotations)", "muscle organ development (GO:0007517 from GO Biological Process Annotations)", "muscle organ morphogenesis (GO:0048644 from GO Biological Process Annotations)", "muscle structure development (GO:0061061 from GO Biological Process Annotations)", "muscle system process (GO:0003012 from GO Biological Process Annotations)", "muscle tissue development (GO:0060537 from GO Biological Process Annotations)", "muscle tissue morphogenesis (GO:0060415 from GO Biological Process Annotations)", "muscular septum morphogenesis (GO:0003150 from GO Biological Process Annotations)", "musculoskeletal movement (GO:0050881 from GO Biological Process Annotations)", "musculoskeletal movement, spinal reflex action (GO:0050883 from GO Biological Process Annotations)", "mycotoxin metabolic process (GO:0043385 from GO Biological Process Annotations)", "myd88-dependent toll-like receptor signaling pathway (GO:0002755 from GO Biological Process Annotations)", "myd88-independent toll-like receptor signaling pathway (GO:0002756 from GO Biological Process Annotations)", "myelin assembly (GO:0032288 from GO Biological Process Annotations)", "myelin maintenance (GO:0043217 from GO Biological Process Annotations)", "myelination (GO:0042552 from GO Biological Process Annotations)", "myelination in peripheral nervous system (GO:0022011 from GO Biological Process Annotations)", "myeloid cell activation involved in immune response (GO:0002275 from GO Biological Process Annotations)", "myeloid cell apoptotic process (GO:0033028 from GO Biological Process Annotations)", "myeloid cell development (GO:0061515 from GO Biological Process Annotations)", "myeloid cell differentiation (GO:0030099 from GO Biological Process Annotations)", "myeloid cell homeostasis (GO:0002262 from GO Biological Process Annotations)", "myeloid dendritic cell activation (GO:0001773 from GO Biological Process Annotations)", "myeloid dendritic cell activation involved in immune response (GO:0002277 from GO Biological Process Annotations)", "myeloid dendritic cell chemotaxis (GO:0002408 from GO Biological Process Annotations)", "myeloid dendritic cell cytokine production (GO:0002372 from GO Biological Process Annotations)", "myeloid dendritic cell differentiation (GO:0043011 from GO Biological Process Annotations)", "myeloid leukocyte activation (GO:0002274 from GO Biological Process Annotations)", "myeloid leukocyte cytokine production (GO:0061082 from GO Biological Process Annotations)", "myeloid leukocyte differentiation (GO:0002573 from GO Biological Process Annotations)", "myeloid leukocyte mediated immunity (GO:0002444 from GO Biological Process Annotations)", "myeloid leukocyte migration (GO:0097529 from GO Biological Process Annotations)", "myeloid progenitor cell differentiation (GO:0002318 from GO Biological Process Annotations)", "myo-inositol transport (GO:0015798 from GO Biological Process Annotations)", "myoblast development (GO:0048627 from GO Biological Process Annotations)", "myoblast differentiation (GO:0045445 from GO Biological Process Annotations)", "myoblast differentiation involved in skeletal muscle regeneration (GO:0014835 from GO Biological Process Annotations)", "myoblast fate commitment (GO:0048625 from GO Biological Process Annotations)", "myoblast fate determination (GO:0007518 from GO Biological Process Annotations)", "myoblast fusion (GO:0007520 from GO Biological Process Annotations)", "myoblast migration (GO:0051451 from GO Biological Process Annotations)", "myoblast migration involved in skeletal muscle regeneration (GO:0014839 from GO Biological Process Annotations)", "myoblast proliferation (GO:0051450 from GO Biological Process Annotations)", "myofibril assembly (GO:0030239 from GO Biological Process Annotations)", "myosin filament assembly (GO:0031034 from GO Biological Process Annotations)", "myosin filament organization (GO:0031033 from GO Biological Process Annotations)", "myotome development (GO:0061055 from GO Biological Process Annotations)", "myotube cell development (GO:0014904 from GO Biological Process Annotations)", "myotube differentiation (GO:0014902 from GO Biological Process Annotations)", "myotube differentiation involved in skeletal muscle regeneration (GO:0014908 from GO Biological Process Annotations)", "n-acetylglucosamine biosynthetic process (GO:0006045 from GO Biological Process Annotations)", "n-acetylglucosamine metabolic process (GO:0006044 from GO Biological Process Annotations)", "n-acetylmannosamine metabolic process (GO:0006051 from GO Biological Process Annotations)", "n-acetylneuraminate biosynthetic process (GO:0046380 from GO Biological Process Annotations)", "n-acetylneuraminate catabolic process (GO:0019262 from GO Biological Process Annotations)", "n-acetylneuraminate metabolic process (GO:0006054 from GO Biological Process Annotations)", "n-glycan fucosylation (GO:0036071 from GO Biological Process Annotations)", "n-glycan processing (GO:0006491 from GO Biological Process Annotations)", "n-glycan processing to lysosome (GO:0016256 from GO Biological Process Annotations)", "n-methyl-d-aspartate receptor clustering (GO:0097114 from GO Biological Process Annotations)", "n-terminal peptidyl-alanine methylation (GO:0018011 from GO Biological Process Annotations)", "n-terminal peptidyl-alanine trimethylation (GO:0018012 from GO Biological Process Annotations)", "n-terminal peptidyl-glutamic acid acetylation (GO:0018002 from GO Biological Process Annotations)", "n-terminal peptidyl-glycine n-myristoylation (GO:0018008 from GO Biological Process Annotations)", "n-terminal peptidyl-l-cysteine n-palmitoylation (GO:0018009 from GO Biological Process Annotations)", "n-terminal peptidyl-lysine acetylation (GO:0018076 from GO Biological Process Annotations)", "n-terminal peptidyl-methionine acetylation (GO:0017196 from GO Biological Process Annotations)", "n-terminal peptidyl-proline dimethylation (GO:0018016 from GO Biological Process Annotations)", "n-terminal peptidyl-proline methylation (GO:0035568 from GO Biological Process Annotations)", "n-terminal peptidyl-serine acetylation (GO:0017198 from GO Biological Process Annotations)", "n-terminal peptidyl-serine dimethylation (GO:0035572 from GO Biological Process Annotations)", "n-terminal peptidyl-serine methylation (GO:0035570 from GO Biological Process Annotations)", "n-terminal peptidyl-serine trimethylation (GO:0035573 from GO Biological Process Annotations)", "n-terminal protein amino acid acetylation (GO:0006474 from GO Biological Process Annotations)", "n-terminal protein amino acid methylation (GO:0006480 from GO Biological Process Annotations)", "n-terminal protein amino acid modification (GO:0031365 from GO Biological Process Annotations)", "n-terminal protein lipidation (GO:0006498 from GO Biological Process Annotations)", "n-terminal protein myristoylation (GO:0006499 from GO Biological Process Annotations)", "n-terminal protein palmitoylation (GO:0006500 from GO Biological Process Annotations)", "nad biosynthesis via nicotinamide riboside salvage pathway (GO:0034356 from GO Biological Process Annotations)", "nad biosynthetic process (GO:0009435 from GO Biological Process Annotations)", "nad catabolic process (GO:0019677 from GO Biological Process Annotations)", "nad metabolic process (GO:0019674 from GO Biological Process Annotations)", "nad transport (GO:0043132 from GO Biological Process Annotations)", "nadh dehydrogenase complex assembly (GO:0010257 from GO Biological Process Annotations)", "nadh metabolic process (GO:0006734 from GO Biological Process Annotations)", "nadh oxidation (GO:0006116 from GO Biological Process Annotations)", "nadp biosynthetic process (GO:0006741 from GO Biological Process Annotations)", "nadp catabolic process (GO:0006742 from GO Biological Process Annotations)", "nadp metabolic process (GO:0006739 from GO Biological Process Annotations)", "nadph oxidation (GO:0070995 from GO Biological Process Annotations)", "nadph regeneration (GO:0006740 from GO Biological Process Annotations)", "nail development (GO:0035878 from GO Biological Process Annotations)", "naphthalene metabolic process (GO:0018931 from GO Biological Process Annotations)", "naphthalene-containing compound metabolic process (GO:0090420 from GO Biological Process Annotations)", "natural killer cell activation (GO:0030101 from GO Biological Process Annotations)", "natural killer cell activation involved in immune response (GO:0002323 from GO Biological Process Annotations)", "natural killer cell chemotaxis (GO:0035747 from GO Biological Process Annotations)", "natural killer cell degranulation (GO:0043320 from GO Biological Process Annotations)", "natural killer cell differentiation (GO:0001779 from GO Biological Process Annotations)", "natural killer cell inhibitory signaling pathway (GO:0002769 from GO Biological Process Annotations)", "natural killer cell mediated cytotoxicity (GO:0042267 from GO Biological Process Annotations)", "natural killer cell mediated immunity (GO:0002228 from GO Biological Process Annotations)", "natural killer cell proliferation (GO:0001787 from GO Biological Process Annotations)", "ncrna 3'-end processing (GO:0043628 from GO Biological Process Annotations)", "ncrna 5'-end processing (GO:0034471 from GO Biological Process Annotations)", "ncrna catabolic process (GO:0034661 from GO Biological Process Annotations)", "ncrna metabolic process (GO:0034660 from GO Biological Process Annotations)", "ncrna processing (GO:0034470 from GO Biological Process Annotations)", "necroptotic process (GO:0070266 from GO Biological Process Annotations)", "necroptotic signaling pathway (GO:0097527 from GO Biological Process Annotations)", "necrotic cell death (GO:0070265 from GO Biological Process Annotations)", "negative adaptation of signaling pathway (GO:0022401 from GO Biological Process Annotations)", "negative chemotaxis (GO:0050919 from GO Biological Process Annotations)", "negative regulation by host of symbiont catalytic activity (GO:0052403 from GO Biological Process Annotations)", "negative regulation by host of symbiont molecular function (GO:0052405 from GO Biological Process Annotations)", "negative regulation by host of viral exo-alpha-sialidase activity (GO:0044869 from GO Biological Process Annotations)", "negative regulation by host of viral genome replication (GO:0044828 from GO Biological Process Annotations)", "negative regulation by host of viral glycoprotein metabolic process (GO:0044871 from GO Biological Process Annotations)", "negative regulation by host of viral process (GO:0044793 from GO Biological Process Annotations)", "negative regulation by host of viral transcription (GO:0043922 from GO Biological Process Annotations)", "negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction (GO:0052490 from GO Biological Process Annotations)", "negative regulation by symbiont of host apoptotic process (GO:0033668 from GO Biological Process Annotations)", "negative regulation by symbiont of host programmed cell death (GO:0052041 from GO Biological Process Annotations)", "negative regulation by virus of viral protein levels in host cell (GO:0046725 from GO Biological Process Annotations)", "negative regulation of acetylcholine secretion, neurotransmission (GO:0014058 from GO Biological Process Annotations)", "negative regulation of acrosome reaction (GO:1902225 from GO Biological Process Annotations)", "negative regulation of actin filament bundle assembly (GO:0032232 from GO Biological Process Annotations)", "negative regulation of actin filament depolymerization (GO:0030835 from GO Biological Process Annotations)", "negative regulation of actin filament polymerization (GO:0030837 from GO Biological Process Annotations)", "negative regulation of actin nucleation (GO:0051126 from GO Biological Process Annotations)", "negative regulation of action potential (GO:0045759 from GO Biological Process Annotations)", "negative regulation of activated t cell proliferation (GO:0046007 from GO Biological Process Annotations)", "negative regulation of activation of jak2 kinase activity (GO:1902569 from GO Biological Process Annotations)", "negative regulation of activation of membrane attack complex (GO:0001971 from GO Biological Process Annotations)", "negative regulation of activation-induced cell death of t cells (GO:0070236 from GO Biological Process Annotations)", "negative regulation of activin receptor signaling pathway (GO:0032926 from GO Biological Process Annotations)", "negative regulation of acute inflammatory response (GO:0002674 from GO Biological Process Annotations)", "negative regulation of acute inflammatory response to antigenic stimulus (GO:0002865 from GO Biological Process Annotations)", "negative regulation of acute inflammatory response to non-antigenic stimulus (GO:0002878 from GO Biological Process Annotations)", "negative regulation of adaptive immune response (GO:0002820 from GO Biological Process Annotations)", "negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002823 from GO Biological Process Annotations)", "negative regulation of adenosine receptor signaling pathway (GO:0060169 from GO Biological Process Annotations)", "negative regulation of adenylate cyclase activity (GO:0007194 from GO Biological Process Annotations)", "negative regulation of adherens junction organization (GO:1903392 from GO Biological Process Annotations)", "negative regulation of adiponectin secretion (GO:0070164 from GO Biological Process Annotations)", "negative regulation of adrenergic receptor signaling pathway (GO:0071878 from GO Biological Process Annotations)", "negative regulation of adrenergic receptor signaling pathway involved in heart process (GO:1901205 from GO Biological Process Annotations)", "negative regulation of alcohol biosynthetic process (GO:1902931 from GO Biological Process Annotations)", "negative regulation of aldosterone biosynthetic process (GO:0032348 from GO Biological Process Annotations)", "negative regulation of aldosterone metabolic process (GO:0032345 from GO Biological Process Annotations)", "negative regulation of alkaline phosphatase activity (GO:0010693 from GO Biological Process Annotations)", "negative regulation of alpha-beta t cell activation (GO:0046636 from GO Biological Process Annotations)", "negative regulation of alpha-beta t cell differentiation (GO:0046639 from GO Biological Process Annotations)", "negative regulation of alpha-beta t cell proliferation (GO:0046642 from GO Biological Process Annotations)", "negative regulation of amine transport (GO:0051953 from GO Biological Process Annotations)", "negative regulation of amino acid transport (GO:0051956 from GO Biological Process Annotations)", "negative regulation of amniotic stem cell differentiation (GO:2000798 from GO Biological Process Annotations)", "negative regulation of amyloid precursor protein biosynthetic process (GO:0042985 from GO Biological Process Annotations)", "negative regulation of amyloid precursor protein catabolic process (GO:1902992 from GO Biological Process Annotations)", "negative regulation of androgen biosynthetic process (GO:2000180 from GO Biological Process Annotations)", "negative regulation of androgen receptor activity (GO:2000824 from GO Biological Process Annotations)", "negative regulation of androgen receptor signaling pathway (GO:0060766 from GO Biological Process Annotations)", "negative regulation of angiogenesis (GO:0016525 from GO Biological Process Annotations)", "negative regulation of anion channel activity (GO:0010360 from GO Biological Process Annotations)", "negative regulation of anion transport (GO:1903792 from GO Biological Process Annotations)", "negative regulation of anoikis (GO:2000811 from GO Biological Process Annotations)", "negative regulation of anti-mullerian hormone signaling pathway (GO:1902613 from GO Biological Process Annotations)", "negative regulation of antigen processing and presentation (GO:0002578 from GO Biological Process Annotations)", "negative regulation of antigen processing and presentation of peptide antigen (GO:0002584 from GO Biological Process Annotations)", "negative regulation of antigen processing and presentation of peptide antigen via mhc class i (GO:0002590 from GO Biological Process Annotations)", "negative regulation of antigen processing and presentation of peptide antigen via mhc class ii (GO:0002587 from GO Biological Process Annotations)", "negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via mhc class ii (GO:0002581 from GO Biological Process Annotations)", "negative regulation of antigen receptor-mediated signaling pathway (GO:0050858 from GO Biological Process Annotations)", "negative regulation of apc-cdc20 complex activity (GO:0060564 from GO Biological Process Annotations)", "negative regulation of apolipoprotein binding (GO:2000657 from GO Biological Process Annotations)", "negative regulation of apoptotic cell clearance (GO:2000426 from GO Biological Process Annotations)", "negative regulation of apoptotic dna fragmentation (GO:1902511 from GO Biological Process Annotations)", "negative regulation of apoptotic process (GO:0043066 from GO Biological Process Annotations)", "negative regulation of apoptotic process in bone marrow (GO:0071866 from GO Biological Process Annotations)", "negative regulation of apoptotic process involved in metanephric collecting duct development (GO:1900215 from GO Biological Process Annotations)", "negative regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900218 from GO Biological Process Annotations)", "negative regulation of apoptotic process involved in morphogenesis (GO:1902338 from GO Biological Process Annotations)", "negative regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902257 from GO Biological Process Annotations)", "negative regulation of apoptotic signaling pathway (GO:2001234 from GO Biological Process Annotations)", "negative regulation of appetite (GO:0032099 from GO Biological Process Annotations)", "negative regulation of appetite by leptin-mediated signaling pathway (GO:0038108 from GO Biological Process Annotations)", "negative regulation of arachidonic acid secretion (GO:1900139 from GO Biological Process Annotations)", "negative regulation of arginine catabolic process (GO:1900082 from GO Biological Process Annotations)", "negative regulation of arp2|3 complex-mediated actin nucleation (GO:0034316 from GO Biological Process Annotations)", "negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902960 from GO Biological Process Annotations)", "negative regulation of astrocyte differentiation (GO:0048712 from GO Biological Process Annotations)", "negative regulation of asymmetric cell division (GO:0045769 from GO Biological Process Annotations)", "negative regulation of atp biosynthetic process (GO:2001170 from GO Biological Process Annotations)", "negative regulation of atp citrate synthase activity (GO:2000984 from GO Biological Process Annotations)", "negative regulation of atp metabolic process (GO:1903579 from GO Biological Process Annotations)", "negative regulation of atpase activity (GO:0032780 from GO Biological Process Annotations)", "negative regulation of auditory receptor cell differentiation (GO:0045608 from GO Biological Process Annotations)", "negative regulation of autophagic vacuole assembly (GO:1902902 from GO Biological Process Annotations)", "negative regulation of autophagy (GO:0010507 from GO Biological Process Annotations)", "negative regulation of axon extension (GO:0030517 from GO Biological Process Annotations)", "negative regulation of axon extension involved in axon guidance (GO:0048843 from GO Biological Process Annotations)", "negative regulation of axon extension involved in regeneration (GO:0048692 from GO Biological Process Annotations)", "negative regulation of axon guidance (GO:1902668 from GO Biological Process Annotations)", "negative regulation of axon regeneration (GO:0048681 from GO Biological Process Annotations)", "negative regulation of axonogenesis (GO:0050771 from GO Biological Process Annotations)", "negative regulation of b cell activation (GO:0050869 from GO Biological Process Annotations)", "negative regulation of b cell apoptotic process (GO:0002903 from GO Biological Process Annotations)", "negative regulation of b cell differentiation (GO:0045578 from GO Biological Process Annotations)", "negative regulation of b cell mediated immunity (GO:0002713 from GO Biological Process Annotations)", "negative regulation of b cell proliferation (GO:0030889 from GO Biological Process Annotations)", "negative regulation of b cell receptor signaling pathway (GO:0050859 from GO Biological Process Annotations)", "negative regulation of barbed-end actin filament capping (GO:2000813 from GO Biological Process Annotations)", "negative regulation of behavior (GO:0048521 from GO Biological Process Annotations)", "negative regulation of beta-amyloid clearance (GO:1900222 from GO Biological Process Annotations)", "negative regulation of beta-amyloid formation (GO:1902430 from GO Biological Process Annotations)", "negative regulation of beta-galactosidase activity (GO:1903770 from GO Biological Process Annotations)", "negative regulation of bile acid biosynthetic process (GO:0070858 from GO Biological Process Annotations)", "negative regulation of binding (GO:0051100 from GO Biological Process Annotations)", "negative regulation of binding of sperm to zona pellucida (GO:2000360 from GO Biological Process Annotations)", "negative regulation of biological process (GO:0048519 from GO Biological Process Annotations)", "negative regulation of biomineral tissue development (GO:0070168 from GO Biological Process Annotations)", "negative regulation of biosynthetic process (GO:0009890 from GO Biological Process Annotations)", "negative regulation of blood circulation (GO:1903523 from GO Biological Process Annotations)", "negative regulation of blood coagulation (GO:0030195 from GO Biological Process Annotations)", "negative regulation of blood pressure (GO:0045776 from GO Biological Process Annotations)", "negative regulation of blood vessel endothelial cell migration (GO:0043537 from GO Biological Process Annotations)", "negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588 from GO Biological Process Annotations)", "negative regulation of blood vessel morphogenesis (GO:2000181 from GO Biological Process Annotations)", "negative regulation of blood vessel remodeling (GO:0060313 from GO Biological Process Annotations)", "negative regulation of bmp signaling pathway (GO:0030514 from GO Biological Process Annotations)", "negative regulation of bone development (GO:1903011 from GO Biological Process Annotations)", "negative regulation of bone mineralization (GO:0030502 from GO Biological Process Annotations)", "negative regulation of bone mineralization involved in bone maturation (GO:1900158 from GO Biological Process Annotations)", "negative regulation of bone remodeling (GO:0046851 from GO Biological Process Annotations)", "negative regulation of bone resorption (GO:0045779 from GO Biological Process Annotations)", "negative regulation of bone trabecula formation (GO:1900155 from GO Biological Process Annotations)", "negative regulation of branch elongation involved in ureteric bud branching (GO:0072096 from GO Biological Process Annotations)", "negative regulation of branch elongation involved in ureteric bud branching by bmp signaling pathway (GO:0072097 from GO Biological Process Annotations)", "negative regulation of branching involved in lung morphogenesis (GO:0061048 from GO Biological Process Annotations)", "negative regulation of branching involved in ureteric bud morphogenesis (GO:0090191 from GO Biological Process Annotations)", "negative regulation of c-c chemokine binding (GO:2001264 from GO Biological Process Annotations)", "negative regulation of calcidiol 1-monooxygenase activity (GO:0010956 from GO Biological Process Annotations)", "negative regulation of calcineurin-nfat signaling cascade (GO:0070885 from GO Biological Process Annotations)", "negative regulation of calcium ion binding (GO:1901877 from GO Biological Process Annotations)", "negative regulation of calcium ion import (GO:0090281 from GO Biological Process Annotations)", "negative regulation of calcium ion import into sarcoplasmic reticulum (GO:1902081 from GO Biological Process Annotations)", "negative regulation of calcium ion transmembrane transport (GO:1903170 from GO Biological Process Annotations)", "negative regulation of calcium ion transmembrane transporter activity (GO:1901020 from GO Biological Process Annotations)", "negative regulation of calcium ion transport (GO:0051926 from GO Biological Process Annotations)", "negative regulation of calcium ion transport into cytosol (GO:0010523 from GO Biological Process Annotations)", "negative regulation of calcium ion-dependent exocytosis (GO:0045955 from GO Biological Process Annotations)", "negative regulation of calcium-dependent cell-cell adhesion (GO:0046588 from GO Biological Process Annotations)", "negative regulation of calcium-independent cell-cell adhesion (GO:0051042 from GO Biological Process Annotations)", "negative regulation of calcium-mediated signaling (GO:0050849 from GO Biological Process Annotations)", "negative regulation of calcium-transporting atpase activity (GO:1901895 from GO Biological Process Annotations)", "negative regulation of calcium:sodium antiporter activity (GO:1903280 from GO Biological Process Annotations)", "negative regulation of camp biosynthetic process (GO:0030818 from GO Biological Process Annotations)", "negative regulation of camp catabolic process (GO:0030821 from GO Biological Process Annotations)", "negative regulation of camp metabolic process (GO:0030815 from GO Biological Process Annotations)", "negative regulation of camp-dependent protein kinase activity (GO:2000480 from GO Biological Process Annotations)", "negative regulation of camp-mediated signaling (GO:0043951 from GO Biological Process Annotations)", "negative regulation of canonical wnt signaling pathway (GO:0090090 from GO Biological Process Annotations)", "negative regulation of canonical wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901296 from GO Biological Process Annotations)", "negative regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation (GO:2000080 from GO Biological Process Annotations)", "negative regulation of canonical wnt signaling pathway involved in neural plate anterior|posterior pattern formation (GO:0060829 from GO Biological Process Annotations)", "negative regulation of carbohydrate metabolic process (GO:0045912 from GO Biological Process Annotations)", "negative regulation of cardiac cell fate specification (GO:2000044 from GO Biological Process Annotations)", "negative regulation of cardiac chamber formation (GO:1901211 from GO Biological Process Annotations)", "negative regulation of cardiac chamber morphogenesis (GO:1901220 from GO Biological Process Annotations)", "negative regulation of cardiac muscle adaptation (GO:0010616 from GO Biological Process Annotations)", "negative regulation of cardiac muscle cell apoptotic process (GO:0010667 from GO Biological Process Annotations)", "negative regulation of cardiac muscle cell differentiation (GO:2000726 from GO Biological Process Annotations)", "negative regulation of cardiac muscle cell myoblast differentiation (GO:2000691 from GO Biological Process Annotations)", "negative regulation of cardiac muscle cell proliferation (GO:0060044 from GO Biological Process Annotations)", "negative regulation of cardiac muscle contraction (GO:0055118 from GO Biological Process Annotations)", "negative regulation of cardiac muscle hypertrophy (GO:0010614 from GO Biological Process Annotations)", "negative regulation of cardiac muscle hypertrophy in response to stress (GO:1903243 from GO Biological Process Annotations)", "negative regulation of cardiac muscle tissue development (GO:0055026 from GO Biological Process Annotations)", "negative regulation of cardiac muscle tissue growth (GO:0055022 from GO Biological Process Annotations)", "negative regulation of cardiac vascular smooth muscle cell differentiation (GO:2000723 from GO Biological Process Annotations)", "negative regulation of cardioblast cell fate specification (GO:0009997 from GO Biological Process Annotations)", "negative regulation of cardioblast differentiation (GO:0051892 from GO Biological Process Annotations)", "negative regulation of cargo loading into copii-coated vesicle (GO:1901303 from GO Biological Process Annotations)", "negative regulation of cartilage development (GO:0061037 from GO Biological Process Annotations)", "negative regulation of catabolic process (GO:0009895 from GO Biological Process Annotations)", "negative regulation of catagen (GO:0051796 from GO Biological Process Annotations)", "negative regulation of catalytic activity (GO:0043086 from GO Biological Process Annotations)", "negative regulation of catalytic activity in other organism involved in symbiotic interaction (GO:0052199 from GO Biological Process Annotations)", "negative regulation of catecholamine metabolic process (GO:0045914 from GO Biological Process Annotations)", "negative regulation of catecholamine secretion (GO:0033604 from GO Biological Process Annotations)", "negative regulation of catecholamine uptake involved in synaptic transmission (GO:0051945 from GO Biological Process Annotations)", "negative regulation of catenin import into nucleus (GO:0035414 from GO Biological Process Annotations)", "negative regulation of cation channel activity (GO:2001258 from GO Biological Process Annotations)", "negative regulation of caveolin-mediated endocytosis (GO:2001287 from GO Biological Process Annotations)", "negative regulation of cd4-positive, alpha-beta t cell activation (GO:2000515 from GO Biological Process Annotations)", "negative regulation of cd4-positive, alpha-beta t cell differentiation (GO:0043371 from GO Biological Process Annotations)", "negative regulation of cd4-positive, alpha-beta t cell proliferation (GO:2000562 from GO Biological Process Annotations)", "negative regulation of cd40 signaling pathway (GO:2000349 from GO Biological Process Annotations)", "negative regulation of cd8-positive, alpha-beta t cell activation (GO:2001186 from GO Biological Process Annotations)", "negative regulation of cell activation (GO:0050866 from GO Biological Process Annotations)", "negative regulation of cell adhesion (GO:0007162 from GO Biological Process Annotations)", "negative regulation of cell adhesion involved in substrate-bound cell migration (GO:0006933 from GO Biological Process Annotations)", "negative regulation of cell adhesion mediated by integrin (GO:0033629 from GO Biological Process Annotations)", "negative regulation of cell adhesion molecule production (GO:0060354 from GO Biological Process Annotations)", "negative regulation of cell aging (GO:0090344 from GO Biological Process Annotations)", "negative regulation of cell communication (GO:0010648 from GO Biological Process Annotations)", "negative regulation of cell communication by electrical coupling (GO:0010651 from GO Biological Process Annotations)", "negative regulation of cell cycle (GO:0045786 from GO Biological Process Annotations)", "negative regulation of cell cycle arrest (GO:0071157 from GO Biological Process Annotations)", "negative regulation of cell cycle checkpoint (GO:1901977 from GO Biological Process Annotations)", "negative regulation of cell cycle g1|s phase transition (GO:1902807 from GO Biological Process Annotations)", "negative regulation of cell cycle g2|m phase transition (GO:1902750 from GO Biological Process Annotations)", "negative regulation of cell cycle phase transition (GO:1901988 from GO Biological Process Annotations)", "negative regulation of cell cycle process (GO:0010948 from GO Biological Process Annotations)", "negative regulation of cell death (GO:0060548 from GO Biological Process Annotations)", "negative regulation of cell development (GO:0010721 from GO Biological Process Annotations)", "negative regulation of cell differentiation (GO:0045596 from GO Biological Process Annotations)", "negative regulation of cell differentiation involved in embryonic placenta development (GO:0060806 from GO Biological Process Annotations)", "negative regulation of cell division (GO:0051782 from GO Biological Process Annotations)", "negative regulation of cell fate commitment (GO:0010454 from GO Biological Process Annotations)", "negative regulation of cell fate specification (GO:0009996 from GO Biological Process Annotations)", "negative regulation of cell growth (GO:0030308 from GO Biological Process Annotations)", "negative regulation of cell growth involved in cardiac muscle cell development (GO:0061052 from GO Biological Process Annotations)", "negative regulation of cell junction assembly (GO:1901889 from GO Biological Process Annotations)", "negative regulation of cell killing (GO:0031342 from GO Biological Process Annotations)", "negative regulation of cell maturation (GO:1903430 from GO Biological Process Annotations)", "negative regulation of cell migration (GO:0030336 from GO Biological Process Annotations)", "negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051 from GO Biological Process Annotations)", "negative regulation of cell morphogenesis involved in differentiation (GO:0010771 from GO Biological Process Annotations)", "negative regulation of cell motility (GO:2000146 from GO Biological Process Annotations)", "negative regulation of cell motility involved in cerebral cortex radial glia guided migration (GO:0021822 from GO Biological Process Annotations)", "negative regulation of cell projection organization (GO:0031345 from GO Biological Process Annotations)", "negative regulation of cell proliferation (GO:0008285 from GO Biological Process Annotations)", "negative regulation of cell proliferation involved in contact inhibition (GO:0060244 from GO Biological Process Annotations)", "negative regulation of cell proliferation involved in heart morphogenesis (GO:2000137 from GO Biological Process Annotations)", "negative regulation of cell proliferation involved in kidney development (GO:1901723 from GO Biological Process Annotations)", "negative regulation of cell proliferation involved in mesonephros development (GO:2000607 from GO Biological Process Annotations)", "negative regulation of cell size (GO:0045792 from GO Biological Process Annotations)", "negative regulation of cell volume (GO:0045794 from GO Biological Process Annotations)", "negative regulation of cell-cell adhesion (GO:0022408 from GO Biological Process Annotations)", "negative regulation of cell-cell adhesion by negative regulation of transcription from rna polymerase ii promoter (GO:1900387 from GO Biological Process Annotations)", "negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048 from GO Biological Process Annotations)", "negative regulation of cell-matrix adhesion (GO:0001953 from GO Biological Process Annotations)", "negative regulation of cell-substrate adhesion (GO:0010812 from GO Biological Process Annotations)", "negative regulation of cellular amide metabolic process (GO:0034249 from GO Biological Process Annotations)", "negative regulation of cellular amine catabolic process (GO:0033242 from GO Biological Process Annotations)", "negative regulation of cellular amine metabolic process (GO:0033239 from GO Biological Process Annotations)", "negative regulation of cellular amino acid biosynthetic process (GO:2000283 from GO Biological Process Annotations)", "negative regulation of cellular amino acid metabolic process (GO:0045763 from GO Biological Process Annotations)", "negative regulation of cellular biosynthetic process (GO:0031327 from GO Biological Process Annotations)", "negative regulation of cellular carbohydrate metabolic process (GO:0010677 from GO Biological Process Annotations)", "negative regulation of cellular catabolic process (GO:0031330 from GO Biological Process Annotations)", "negative regulation of cellular component movement (GO:0051271 from GO Biological Process Annotations)", "negative regulation of cellular component organization (GO:0051129 from GO Biological Process Annotations)", "negative regulation of cellular extravasation (GO:0002692 from GO Biological Process Annotations)", "negative regulation of cellular macromolecule biosynthetic process (GO:2000113 from GO Biological Process Annotations)", "negative regulation of cellular metabolic process (GO:0031324 from GO Biological Process Annotations)", "negative regulation of cellular organofluorine metabolic process (GO:0090350 from GO Biological Process Annotations)", "negative regulation of cellular organohalogen metabolic process (GO:0090349 from GO Biological Process Annotations)", "negative regulation of cellular ph reduction (GO:0032848 from GO Biological Process Annotations)", "negative regulation of cellular process (GO:0048523 from GO Biological Process Annotations)", "negative regulation of cellular protein catabolic process (GO:1903363 from GO Biological Process Annotations)", "negative regulation of cellular protein localization (GO:1903828 from GO Biological Process Annotations)", "negative regulation of cellular protein metabolic process (GO:0032269 from GO Biological Process Annotations)", "negative regulation of cellular respiration (GO:1901856 from GO Biological Process Annotations)", "negative regulation of cellular response to growth factor stimulus (GO:0090288 from GO Biological Process Annotations)", "negative regulation of cellular response to heat (GO:1900035 from GO Biological Process Annotations)", "negative regulation of cellular response to hepatocyte growth factor stimulus (GO:2001113 from GO Biological Process Annotations)", "negative regulation of cellular response to hypoxia (GO:1900038 from GO Biological Process Annotations)", "negative regulation of cellular response to insulin stimulus (GO:1900077 from GO Biological Process Annotations)", "negative regulation of cellular response to oxidative stress (GO:1900408 from GO Biological Process Annotations)", "negative regulation of cellular response to testosterone stimulus (GO:2000655 from GO Biological Process Annotations)", "negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845 from GO Biological Process Annotations)", "negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548 from GO Biological Process Annotations)", "negative regulation of cellular senescence (GO:2000773 from GO Biological Process Annotations)", "negative regulation of centriole elongation (GO:1903723 from GO Biological Process Annotations)", "negative regulation of centriole replication (GO:0046600 from GO Biological Process Annotations)", "negative regulation of centriole-centriole cohesion (GO:1903126 from GO Biological Process Annotations)", "negative regulation of centrosome cycle (GO:0046606 from GO Biological Process Annotations)", "negative regulation of centrosome duplication (GO:0010826 from GO Biological Process Annotations)", "negative regulation of ceramide biosynthetic process (GO:1900060 from GO Biological Process Annotations)", "negative regulation of cerebellar granule cell precursor proliferation (GO:0021941 from GO Biological Process Annotations)", "negative regulation of cgmp biosynthetic process (GO:0030827 from GO Biological Process Annotations)", "negative regulation of cgmp metabolic process (GO:0030824 from GO Biological Process Annotations)", "negative regulation of cgmp-mediated signaling (GO:0010754 from GO Biological Process Annotations)", "negative regulation of chaperone-mediated protein folding (GO:1903645 from GO Biological Process Annotations)", "negative regulation of chemokine (c-c motif) ligand 5 production (GO:0071650 from GO Biological Process Annotations)", "negative regulation of chemokine (c-x-c motif) ligand 2 production (GO:2000342 from GO Biological Process Annotations)", "negative regulation of chemokine biosynthetic process (GO:0045079 from GO Biological Process Annotations)", "negative regulation of chemokine production (GO:0032682 from GO Biological Process Annotations)", "negative regulation of chemokine secretion (GO:0090198 from GO Biological Process Annotations)", "negative regulation of chemokine-mediated signaling pathway (GO:0070100 from GO Biological Process Annotations)", "negative regulation of chemotaxis (GO:0050922 from GO Biological Process Annotations)", "negative regulation of chloride transport (GO:2001226 from GO Biological Process Annotations)", "negative regulation of cholesterol biosynthetic process (GO:0045541 from GO Biological Process Annotations)", "negative regulation of cholesterol efflux (GO:0090370 from GO Biological Process Annotations)", "negative regulation of cholesterol import (GO:0060621 from GO Biological Process Annotations)", "negative regulation of cholesterol metabolic process (GO:0090206 from GO Biological Process Annotations)", "negative regulation of cholesterol storage (GO:0010887 from GO Biological Process Annotations)", "negative regulation of cholesterol transport (GO:0032375 from GO Biological Process Annotations)", "negative regulation of cholesterol transporter activity (GO:0060695 from GO Biological Process Annotations)", "negative regulation of chondrocyte differentiation (GO:0032331 from GO Biological Process Annotations)", "negative regulation of chondrocyte proliferation (GO:1902731 from GO Biological Process Annotations)", "negative regulation of chorionic trophoblast cell proliferation (GO:1901383 from GO Biological Process Annotations)", "negative regulation of chromatin binding (GO:0035562 from GO Biological Process Annotations)", "negative regulation of chromatin modification (GO:1903309 from GO Biological Process Annotations)", "negative regulation of chromatin silencing (GO:0031936 from GO Biological Process Annotations)", "negative regulation of chromatin silencing at rdna (GO:0061188 from GO Biological Process Annotations)", "negative regulation of chromosome organization (GO:2001251 from GO Biological Process Annotations)", "negative regulation of chromosome segregation (GO:0051985 from GO Biological Process Annotations)", "negative regulation of chronic inflammatory response (GO:0002677 from GO Biological Process Annotations)", "negative regulation of chronic inflammatory response to antigenic stimulus (GO:0002875 from GO Biological Process Annotations)", "negative regulation of cilium assembly (GO:1902018 from GO Biological Process Annotations)", "negative regulation of circadian rhythm (GO:0042754 from GO Biological Process Annotations)", "negative regulation of circadian sleep|wake cycle, non-rem sleep (GO:0042323 from GO Biological Process Annotations)", "negative regulation of circadian sleep|wake cycle, rem sleep (GO:0042322 from GO Biological Process Annotations)", "negative regulation of circadian sleep|wake cycle, sleep (GO:0042321 from GO Biological Process Annotations)", "negative regulation of citrulline biosynthetic process (GO:1903249 from GO Biological Process Annotations)", "negative regulation of clathrin-mediated endocytosis (GO:1900186 from GO Biological Process Annotations)", "negative regulation of coagulation (GO:0050819 from GO Biological Process Annotations)", "negative regulation of collagen binding (GO:0033342 from GO Biological Process Annotations)", "negative regulation of collagen biosynthetic process (GO:0032966 from GO Biological Process Annotations)", "negative regulation of collagen catabolic process (GO:0010711 from GO Biological Process Annotations)", "negative regulation of collagen metabolic process (GO:0010713 from GO Biological Process Annotations)", "negative regulation of collateral sprouting (GO:0048671 from GO Biological Process Annotations)", "negative regulation of collateral sprouting in absence of injury (GO:0048698 from GO Biological Process Annotations)", "negative regulation of collateral sprouting of intact axon in response to injury (GO:0048685 from GO Biological Process Annotations)", "negative regulation of complement activation (GO:0045916 from GO Biological Process Annotations)", "negative regulation of complement activation, alternative pathway (GO:0045957 from GO Biological Process Annotations)", "negative regulation of complement activation, classical pathway (GO:0045959 from GO Biological Process Annotations)", "negative regulation of complement activation, lectin pathway (GO:0001869 from GO Biological Process Annotations)", "negative regulation of complement-dependent cytotoxicity (GO:1903660 from GO Biological Process Annotations)", "negative regulation of constitutive secretory pathway (GO:1903434 from GO Biological Process Annotations)", "negative regulation of convergent extension involved in axis elongation (GO:1901233 from GO Biological Process Annotations)", "negative regulation of corticosteroid hormone secretion (GO:2000847 from GO Biological Process Annotations)", "negative regulation of corticotropin secretion (GO:0051460 from GO Biological Process Annotations)", "negative regulation of corticotropin-releasing hormone receptor activity (GO:1900011 from GO Biological Process Annotations)", "negative regulation of cortisol biosynthetic process (GO:2000065 from GO Biological Process Annotations)", "negative regulation of cortisol secretion (GO:0051463 from GO Biological Process Annotations)", "negative regulation of creb transcription factor activity (GO:0032792 from GO Biological Process Annotations)", "negative regulation of cyclase activity (GO:0031280 from GO Biological Process Annotations)", "negative regulation of cyclic nucleotide biosynthetic process (GO:0030803 from GO Biological Process Annotations)", "negative regulation of cyclic nucleotide catabolic process (GO:0030806 from GO Biological Process Annotations)", "negative regulation of cyclic nucleotide metabolic process (GO:0030800 from GO Biological Process Annotations)", "negative regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051344 from GO Biological Process Annotations)", "negative regulation of cyclin catabolic process (GO:2000599 from GO Biological Process Annotations)", "negative regulation of cyclin-dependent protein serine|threonine kinase activity (GO:0045736 from GO Biological Process Annotations)", "negative regulation of cyclin-dependent protein serine|threonine kinase activity involved in g1|s transition of mitotic cell cycle (GO:0031658 from GO Biological Process Annotations)", "negative regulation of cyclin-dependent protein serine|threonine kinase by cyclin degradation (GO:0008054 from GO Biological Process Annotations)", "negative regulation of cysteine-type endopeptidase activity (GO:2000117 from GO Biological Process Annotations)", "negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154 from GO Biological Process Annotations)", "negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268 from GO Biological Process Annotations)", "negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001271 from GO Biological Process Annotations)", "negative regulation of cytokine activity (GO:0060302 from GO Biological Process Annotations)", "negative regulation of cytokine biosynthetic process (GO:0042036 from GO Biological Process Annotations)", "negative regulation of cytokine production (GO:0001818 from GO Biological Process Annotations)", "negative regulation of cytokine production involved in immune response (GO:0002719 from GO Biological Process Annotations)", "negative regulation of cytokine production involved in inflammatory response (GO:1900016 from GO Biological Process Annotations)", "negative regulation of cytokine secretion (GO:0050710 from GO Biological Process Annotations)", "negative regulation of cytokine secretion involved in immune response (GO:0002740 from GO Biological Process Annotations)", "negative regulation of cytokine-mediated signaling pathway (GO:0001960 from GO Biological Process Annotations)", "negative regulation of cytokinesis (GO:0032466 from GO Biological Process Annotations)", "negative regulation of cytolysis (GO:0045918 from GO Biological Process Annotations)", "negative regulation of cytoplasmic mrna processing body assembly (GO:0010607 from GO Biological Process Annotations)", "negative regulation of cytoplasmic translation (GO:2000766 from GO Biological Process Annotations)", "negative regulation of cytoplasmic translational elongation (GO:1900248 from GO Biological Process Annotations)", "negative regulation of cytoplasmic transport (GO:1903650 from GO Biological Process Annotations)", "negative regulation of cytoskeleton organization (GO:0051494 from GO Biological Process Annotations)", "negative regulation of cytosolic calcium ion concentration (GO:0051481 from GO Biological Process Annotations)", "negative regulation of d-amino-acid oxidase activity (GO:1900758 from GO Biological Process Annotations)", "negative regulation of death-inducing signaling complex assembly (GO:1903073 from GO Biological Process Annotations)", "negative regulation of defense response (GO:0031348 from GO Biological Process Annotations)", "negative regulation of defense response to bacterium (GO:1900425 from GO Biological Process Annotations)", "negative regulation of defense response to virus (GO:0050687 from GO Biological Process Annotations)", "negative regulation of defense response to virus by host (GO:0050689 from GO Biological Process Annotations)", "negative regulation of delayed rectifier potassium channel activity (GO:1902260 from GO Biological Process Annotations)", "negative regulation of dendrite development (GO:2000171 from GO Biological Process Annotations)", "negative regulation of dendrite morphogenesis (GO:0050774 from GO Biological Process Annotations)", "negative regulation of dendritic cell antigen processing and presentation (GO:0002605 from GO Biological Process Annotations)", "negative regulation of dendritic cell apoptotic process (GO:2000669 from GO Biological Process Annotations)", "negative regulation of dendritic cell cytokine production (GO:0002731 from GO Biological Process Annotations)", "negative regulation of dendritic cell dendrite assembly (GO:2000548 from GO Biological Process Annotations)", "negative regulation of dendritic cell differentiation (GO:2001199 from GO Biological Process Annotations)", "negative regulation of dendritic spine development (GO:0061000 from GO Biological Process Annotations)", "negative regulation of dendritic spine morphogenesis (GO:0061002 from GO Biological Process Annotations)", "negative regulation of dense core granule biogenesis (GO:2000706 from GO Biological Process Annotations)", "negative regulation of deoxyribonuclease activity (GO:0032076 from GO Biological Process Annotations)", "negative regulation of dephosphorylation (GO:0035305 from GO Biological Process Annotations)", "negative regulation of dermatome development (GO:0061185 from GO Biological Process Annotations)", "negative regulation of detection of glucose (GO:2000971 from GO Biological Process Annotations)", "negative regulation of determination of dorsal identity (GO:2000016 from GO Biological Process Annotations)", "negative regulation of developmental growth (GO:0048640 from GO Biological Process Annotations)", "negative regulation of developmental pigmentation (GO:0048086 from GO Biological Process Annotations)", "negative regulation of developmental process (GO:0051093 from GO Biological Process Annotations)", "negative regulation of digestive system process (GO:0060457 from GO Biological Process Annotations)", "negative regulation of dna binding (GO:0043392 from GO Biological Process Annotations)", "negative regulation of dna biosynthetic process (GO:2000279 from GO Biological Process Annotations)", "negative regulation of dna catabolic process (GO:1903625 from GO Biological Process Annotations)", "negative regulation of dna damage checkpoint (GO:2000002 from GO Biological Process Annotations)", "negative regulation of dna damage response, signal transduction by p53 class mediator (GO:0043518 from GO Biological Process Annotations)", "negative regulation of dna demethylation (GO:1901536 from GO Biological Process Annotations)", "negative regulation of dna endoreduplication (GO:0032876 from GO Biological Process Annotations)", "negative regulation of dna metabolic process (GO:0051053 from GO Biological Process Annotations)", "negative regulation of dna recombination (GO:0045910 from GO Biological Process Annotations)", "negative regulation of dna recombination at telomere (GO:0048239 from GO Biological Process Annotations)", "negative regulation of dna repair (GO:0045738 from GO Biological Process Annotations)", "negative regulation of dna replication (GO:0008156 from GO Biological Process Annotations)", "negative regulation of dna-dependent dna replication (GO:2000104 from GO Biological Process Annotations)", "negative regulation of dna-templated transcription, elongation (GO:0032785 from GO Biological Process Annotations)", "negative regulation of dna-templated transcription, initiation (GO:2000143 from GO Biological Process Annotations)", "negative regulation of dna-templated transcription, termination (GO:0060567 from GO Biological Process Annotations)", "negative regulation of dopamine metabolic process (GO:0045963 from GO Biological Process Annotations)", "negative regulation of dopamine receptor signaling pathway (GO:0060160 from GO Biological Process Annotations)", "negative regulation of dopamine secretion (GO:0033602 from GO Biological Process Annotations)", "negative regulation of dopamine uptake involved in synaptic transmission (GO:0051585 from GO Biological Process Annotations)", "negative regulation of double-strand break repair (GO:2000780 from GO Biological Process Annotations)", "negative regulation of double-strand break repair via homologous recombination (GO:2000042 from GO Biological Process Annotations)", "negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033 from GO Biological Process Annotations)", "negative regulation of early endosome to late endosome transport (GO:2000642 from GO Biological Process Annotations)", "negative regulation of ectoderm development (GO:2000384 from GO Biological Process Annotations)", "negative regulation of ectodermal cell fate specification (GO:0042666 from GO Biological Process Annotations)", "negative regulation of elastin biosynthetic process (GO:0051545 from GO Biological Process Annotations)", "negative regulation of elastin catabolic process (GO:0060311 from GO Biological Process Annotations)", "negative regulation of embryonic development (GO:0045992 from GO Biological Process Annotations)", "negative regulation of endocytosis (GO:0045806 from GO Biological Process Annotations)", "negative regulation of endodeoxyribonuclease activity (GO:0032078 from GO Biological Process Annotations)", "negative regulation of endodermal cell differentiation (GO:1903225 from GO Biological Process Annotations)", "negative regulation of endodermal cell fate specification (GO:0042664 from GO Biological Process Annotations)", "negative regulation of endopeptidase activity (GO:0010951 from GO Biological Process Annotations)", "negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471 from GO Biological Process Annotations)", "negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236 from GO Biological Process Annotations)", "negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903382 from GO Biological Process Annotations)", "negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102 from GO Biological Process Annotations)", "negative regulation of endoribonuclease activity (GO:0060702 from GO Biological Process Annotations)", "negative regulation of endothelial cell apoptotic process (GO:2000352 from GO Biological Process Annotations)", "negative regulation of endothelial cell chemotaxis (GO:2001027 from GO Biological Process Annotations)", "negative regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000545 from GO Biological Process Annotations)", "negative regulation of endothelial cell development (GO:1901551 from GO Biological Process Annotations)", "negative regulation of endothelial cell differentiation (GO:0045602 from GO Biological Process Annotations)", "negative regulation of endothelial cell migration (GO:0010596 from GO Biological Process Annotations)", "negative regulation of endothelial cell proliferation (GO:0001937 from GO Biological Process Annotations)", "negative regulation of energy homeostasis (GO:2000506 from GO Biological Process Annotations)", "negative regulation of entry of bacterium into host cell (GO:2000536 from GO Biological Process Annotations)", "negative regulation of eosinophil activation (GO:1902567 from GO Biological Process Annotations)", "negative regulation of eosinophil degranulation (GO:0043310 from GO Biological Process Annotations)", "negative regulation of eosinophil extravasation (GO:2000420 from GO Biological Process Annotations)", "negative regulation of eosinophil migration (GO:2000417 from GO Biological Process Annotations)", "negative regulation of epidermal cell differentiation (GO:0045605 from GO Biological Process Annotations)", "negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059 from GO Biological Process Annotations)", "negative regulation of epidermal growth factor-activated receptor activity (GO:0007175 from GO Biological Process Annotations)", "negative regulation of epidermis development (GO:0045683 from GO Biological Process Annotations)", "negative regulation of epinephrine secretion (GO:0032811 from GO Biological Process Annotations)", "negative regulation of epithelial cell differentiation (GO:0030857 from GO Biological Process Annotations)", "negative regulation of epithelial cell differentiation involved in kidney development (GO:2000697 from GO Biological Process Annotations)", "negative regulation of epithelial cell migration (GO:0010633 from GO Biological Process Annotations)", "negative regulation of epithelial cell proliferation (GO:0050680 from GO Biological Process Annotations)", "negative regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000795 from GO Biological Process Annotations)", "negative regulation of epithelial cell proliferation involved in prostate gland development (GO:0060770 from GO Biological Process Annotations)", "negative regulation of epithelial to mesenchymal transition (GO:0010719 from GO Biological Process Annotations)", "negative regulation of er-associated ubiquitin-dependent protein catabolic process (GO:1903070 from GO Biological Process Annotations)", "negative regulation of erbb signaling pathway (GO:1901185 from GO Biological Process Annotations)", "negative regulation of erk1 and erk2 cascade (GO:0070373 from GO Biological Process Annotations)", "negative regulation of erythrocyte apoptotic process (GO:1902251 from GO Biological Process Annotations)", "negative regulation of erythrocyte differentiation (GO:0045647 from GO Biological Process Annotations)", "negative regulation of establishment of blood-brain barrier (GO:0090212 from GO Biological Process Annotations)", "negative regulation of establishment of endothelial barrier (GO:1903141 from GO Biological Process Annotations)", "negative regulation of establishment of protein localization to mitochondrion (GO:1903748 from GO Biological Process Annotations)", "negative regulation of establishment of protein localization to plasma membrane (GO:0090005 from GO Biological Process Annotations)", "negative regulation of estrogen receptor binding (GO:0071899 from GO Biological Process Annotations)", "negative regulation of excitatory postsynaptic membrane potential (GO:0090394 from GO Biological Process Annotations)", "negative regulation of execution phase of apoptosis (GO:1900118 from GO Biological Process Annotations)", "negative regulation of exit from mitosis (GO:0001100 from GO Biological Process Annotations)", "negative regulation of exo-alpha-sialidase activity (GO:1903016 from GO Biological Process Annotations)", "negative regulation of exocytosis (GO:0045920 from GO Biological Process Annotations)", "negative regulation of exosomal secretion (GO:1903542 from GO Biological Process Annotations)", "negative regulation of extracellular matrix disassembly (GO:0010716 from GO Biological Process Annotations)", "negative regulation of extracellular matrix organization (GO:1903054 from GO Biological Process Annotations)", "negative regulation of extrinsic apoptotic signaling pathway (GO:2001237 from GO Biological Process Annotations)", "negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240 from GO Biological Process Annotations)", "negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042 from GO Biological Process Annotations)", "negative regulation of eye pigmentation (GO:0048074 from GO Biological Process Annotations)", "negative regulation of fas signaling pathway (GO:1902045 from GO Biological Process Annotations)", "negative regulation of fasl biosynthetic process (GO:0045221 from GO Biological Process Annotations)", "negative regulation of fat cell differentiation (GO:0045599 from GO Biological Process Annotations)", "negative regulation of fat cell proliferation (GO:0070345 from GO Biological Process Annotations)", "negative regulation of fatty acid beta-oxidation (GO:0031999 from GO Biological Process Annotations)", "negative regulation of fatty acid biosynthetic process (GO:0045717 from GO Biological Process Annotations)", "negative regulation of fatty acid metabolic process (GO:0045922 from GO Biological Process Annotations)", "negative regulation of fatty acid oxidation (GO:0046322 from GO Biological Process Annotations)", "negative regulation of fatty acid transport (GO:2000192 from GO Biological Process Annotations)", "negative regulation of feeding behavior (GO:2000252 from GO Biological Process Annotations)", "negative regulation of female gonad development (GO:2000195 from GO Biological Process Annotations)", "negative regulation of female receptivity (GO:0007621 from GO Biological Process Annotations)", "negative regulation of fermentation (GO:1901003 from GO Biological Process Annotations)", "negative regulation of fertilization (GO:0060467 from GO Biological Process Annotations)", "negative regulation of fibril organization (GO:1902904 from GO Biological Process Annotations)", "negative regulation of fibrinolysis (GO:0051918 from GO Biological Process Annotations)", "negative regulation of fibroblast apoptotic process (GO:2000270 from GO Biological Process Annotations)", "negative regulation of fibroblast growth factor production (GO:0090272 from GO Biological Process Annotations)", "negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037 from GO Biological Process Annotations)", "negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior|posterior pattern formation (GO:2000314 from GO Biological Process Annotations)", "negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000703 from GO Biological Process Annotations)", "negative regulation of fibroblast migration (GO:0010764 from GO Biological Process Annotations)", "negative regulation of fibroblast proliferation (GO:0048147 from GO Biological Process Annotations)", "negative regulation of filopodium assembly (GO:0051490 from GO Biological Process Annotations)", "negative regulation of focal adhesion assembly (GO:0051895 from GO Biological Process Annotations)", "negative regulation of follicle-stimulating hormone secretion (GO:0046882 from GO Biological Process Annotations)", "negative regulation of forebrain neuron differentiation (GO:2000978 from GO Biological Process Annotations)", "negative regulation of formation of translation preinitiation complex (GO:1901194 from GO Biological Process Annotations)", "negative regulation of g-protein coupled receptor protein signaling pathway (GO:0045744 from GO Biological Process Annotations)", "negative regulation of g0 to g1 transition (GO:0070317 from GO Biological Process Annotations)", "negative regulation of g1|s transition of mitotic cell cycle (GO:2000134 from GO Biological Process Annotations)", "negative regulation of g1|s transition of mitotic cell cycle by negative regulation of transcription from rna polymerase ii promoter (GO:1900477 from GO Biological Process Annotations)", "negative regulation of g2|m transition of mitotic cell cycle (GO:0010972 from GO Biological Process Annotations)", "negative regulation of gamma-aminobutyric acid secretion (GO:0014053 from GO Biological Process Annotations)", "negative regulation of gap junction assembly (GO:1903597 from GO Biological Process Annotations)", "negative regulation of gastric acid secretion (GO:0060455 from GO Biological Process Annotations)", "negative regulation of gastrulation (GO:2000542 from GO Biological Process Annotations)", "negative regulation of gene expression (GO:0010629 from GO Biological Process Annotations)", "negative regulation of gene expression, epigenetic (GO:0045814 from GO Biological Process Annotations)", "negative regulation of gene silencing (GO:0060969 from GO Biological Process Annotations)", "negative regulation of gene silencing by mirna (GO:0060965 from GO Biological Process Annotations)", "negative regulation of gene silencing by rna (GO:0060967 from GO Biological Process Annotations)", "negative regulation of germinal center formation (GO:0002635 from GO Biological Process Annotations)", "negative regulation of glial cell apoptotic process (GO:0034351 from GO Biological Process Annotations)", "negative regulation of glial cell differentiation (GO:0045686 from GO Biological Process Annotations)", "negative regulation of glial cell proliferation (GO:0060253 from GO Biological Process Annotations)", "negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000734 from GO Biological Process Annotations)", "negative regulation of gliogenesis (GO:0014014 from GO Biological Process Annotations)", "negative regulation of glomerular filtration (GO:0003105 from GO Biological Process Annotations)", "negative regulation of glomerular filtration by angiotensin (GO:0003106 from GO Biological Process Annotations)", "negative regulation of glomerular mesangial cell proliferation (GO:0072125 from GO Biological Process Annotations)", "negative regulation of glomerulus development (GO:0090194 from GO Biological Process Annotations)", "negative regulation of glucagon secretion (GO:0070093 from GO Biological Process Annotations)", "negative regulation of glucocorticoid biosynthetic process (GO:0031947 from GO Biological Process Annotations)", "negative regulation of glucocorticoid mediated signaling pathway (GO:1900170 from GO Biological Process Annotations)", "negative regulation of glucocorticoid metabolic process (GO:0031944 from GO Biological Process Annotations)", "negative regulation of glucocorticoid receptor signaling pathway (GO:2000323 from GO Biological Process Annotations)", "negative regulation of glucocorticoid secretion (GO:2000850 from GO Biological Process Annotations)", "negative regulation of glucokinase activity (GO:0033132 from GO Biological Process Annotations)", "negative regulation of gluconeogenesis (GO:0045721 from GO Biological Process Annotations)", "negative regulation of glucose import (GO:0046325 from GO Biological Process Annotations)", "negative regulation of glucose import in response to insulin stimulus (GO:2001274 from GO Biological Process Annotations)", "negative regulation of glucose transport (GO:0010829 from GO Biological Process Annotations)", "negative regulation of glucosylceramide biosynthetic process (GO:0046318 from GO Biological Process Annotations)", "negative regulation of glutamate metabolic process (GO:2000212 from GO Biological Process Annotations)", "negative regulation of glutamate secretion (GO:0014050 from GO Biological Process Annotations)", "negative regulation of glutamine transport (GO:2000486 from GO Biological Process Annotations)", "negative regulation of glycogen (starch) synthase activity (GO:2000466 from GO Biological Process Annotations)", "negative regulation of glycogen biosynthetic process (GO:0045719 from GO Biological Process Annotations)", "negative regulation of glycogen catabolic process (GO:0045818 from GO Biological Process Annotations)", "negative regulation of glycogen metabolic process (GO:0070874 from GO Biological Process Annotations)", "negative regulation of glycolytic process (GO:0045820 from GO Biological Process Annotations)", "negative regulation of glycoprotein biosynthetic process (GO:0010561 from GO Biological Process Annotations)", "negative regulation of glycoprotein metabolic process (GO:1903019 from GO Biological Process Annotations)", "negative regulation of golgi to plasma membrane cftr protein transport (GO:0043002 from GO Biological Process Annotations)", "negative regulation of golgi to plasma membrane protein transport (GO:0042997 from GO Biological Process Annotations)", "negative regulation of gonadotropin secretion (GO:0032277 from GO Biological Process Annotations)", "negative regulation of granulocyte chemotaxis (GO:0071623 from GO Biological Process Annotations)", "negative regulation of granulocyte differentiation (GO:0030853 from GO Biological Process Annotations)", "negative regulation of growth (GO:0045926 from GO Biological Process Annotations)", "negative regulation of growth hormone receptor signaling pathway (GO:0060400 from GO Biological Process Annotations)", "negative regulation of growth hormone secretion (GO:0060125 from GO Biological Process Annotations)", "negative regulation of growth of symbiont in host (GO:0044130 from GO Biological Process Annotations)", "negative regulation of growth of symbiont involved in interaction with host (GO:0044146 from GO Biological Process Annotations)", "negative regulation of growth of symbiont on or near host surface (GO:0044140 from GO Biological Process Annotations)", "negative regulation of gtp cyclohydrolase i activity (GO:0043105 from GO Biological Process Annotations)", "negative regulation of gtpase activity (GO:0034260 from GO Biological Process Annotations)", "negative regulation of guanylate cyclase activity (GO:0031283 from GO Biological Process Annotations)", "negative regulation of hair cycle (GO:0042636 from GO Biological Process Annotations)", "negative regulation of hair follicle development (GO:0051799 from GO Biological Process Annotations)", "negative regulation of hair follicle maturation (GO:0048817 from GO Biological Process Annotations)", "negative regulation of heart contraction (GO:0045822 from GO Biological Process Annotations)", "negative regulation of heart growth (GO:0061117 from GO Biological Process Annotations)", "negative regulation of heart induction (GO:1901320 from GO Biological Process Annotations)", "negative regulation of heart induction by canonical wnt signaling pathway (GO:0003136 from GO Biological Process Annotations)", "negative regulation of heart looping (GO:1901208 from GO Biological Process Annotations)", "negative regulation of heart rate (GO:0010459 from GO Biological Process Annotations)", "negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001985 from GO Biological Process Annotations)", "negative regulation of heat generation (GO:0031651 from GO Biological Process Annotations)", "negative regulation of helicase activity (GO:0051097 from GO Biological Process Annotations)", "negative regulation of hematopoietic progenitor cell differentiation (GO:1901533 from GO Biological Process Annotations)", "negative regulation of hematopoietic stem cell differentiation (GO:1902037 from GO Biological Process Annotations)", "negative regulation of hemoglobin biosynthetic process (GO:0046986 from GO Biological Process Annotations)", "negative regulation of hemopoiesis (GO:1903707 from GO Biological Process Annotations)", "negative regulation of hemostasis (GO:1900047 from GO Biological Process Annotations)", "negative regulation of hepatocyte differentiation (GO:0070367 from GO Biological Process Annotations)", "negative regulation of hepatocyte growth factor biosynthetic process (GO:0048178 from GO Biological Process Annotations)", "negative regulation of hepatocyte growth factor production (GO:0032686 from GO Biological Process Annotations)", "negative regulation of hepatocyte growth factor receptor signaling pathway (GO:1902203 from GO Biological Process Annotations)", "negative regulation of hepatocyte proliferation (GO:2000346 from GO Biological Process Annotations)", "negative regulation of heterotypic cell-cell adhesion (GO:0034115 from GO Biological Process Annotations)", "negative regulation of hexokinase activity (GO:1903300 from GO Biological Process Annotations)", "negative regulation of high-density lipoprotein particle clearance (GO:0010987 from GO Biological Process Annotations)", "negative regulation of hippo signaling (GO:0035331 from GO Biological Process Annotations)", "negative regulation of histone acetylation (GO:0035067 from GO Biological Process Annotations)", "negative regulation of histone deacetylase activity (GO:1901726 from GO Biological Process Annotations)", "negative regulation of histone deacetylation (GO:0031064 from GO Biological Process Annotations)", "negative regulation of histone h2a k63-linked ubiquitination (GO:1901315 from GO Biological Process Annotations)", "negative regulation of histone h3-k14 acetylation (GO:0071441 from GO Biological Process Annotations)", "negative regulation of histone h3-k27 acetylation (GO:1901675 from GO Biological Process Annotations)", "negative regulation of histone h3-k27 methylation (GO:0061086 from GO Biological Process Annotations)", "negative regulation of histone h3-k36 methylation (GO:0000415 from GO Biological Process Annotations)", "negative regulation of histone h3-k4 methylation (GO:0051572 from GO Biological Process Annotations)", "negative regulation of histone h3-k9 methylation (GO:0051573 from GO Biological Process Annotations)", "negative regulation of histone h4 acetylation (GO:0090241 from GO Biological Process Annotations)", "negative regulation of histone h4-k16 acetylation (GO:2000619 from GO Biological Process Annotations)", "negative regulation of histone methylation (GO:0031061 from GO Biological Process Annotations)", "negative regulation of histone modification (GO:0031057 from GO Biological Process Annotations)", "negative regulation of histone phosphorylation (GO:0033128 from GO Biological Process Annotations)", "negative regulation of histone ubiquitination (GO:0033183 from GO Biological Process Annotations)", "negative regulation of homeostatic process (GO:0032845 from GO Biological Process Annotations)", "negative regulation of homotypic cell-cell adhesion (GO:0034111 from GO Biological Process Annotations)", "negative regulation of hormone biosynthetic process (GO:0032353 from GO Biological Process Annotations)", "negative regulation of hormone metabolic process (GO:0032351 from GO Biological Process Annotations)", "negative regulation of hormone secretion (GO:0046888 from GO Biological Process Annotations)", "negative regulation of humoral immune response (GO:0002921 from GO Biological Process Annotations)", "negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924 from GO Biological Process Annotations)", "negative regulation of hyaluronan biosynthetic process (GO:1900126 from GO Biological Process Annotations)", "negative regulation of hydrogen peroxide biosynthetic process (GO:0010730 from GO Biological Process Annotations)", "negative regulation of hydrogen peroxide catabolic process (GO:2000296 from GO Biological Process Annotations)", "negative regulation of hydrogen peroxide metabolic process (GO:0010727 from GO Biological Process Annotations)", "negative regulation of hydrogen peroxide-induced cell death (GO:1903206 from GO Biological Process Annotations)", "negative regulation of hydrogen peroxide-induced neuron death (GO:1903208 from GO Biological Process Annotations)", "negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384 from GO Biological Process Annotations)", "negative regulation of hydrogen peroxide-mediated programmed cell death (GO:1901299 from GO Biological Process Annotations)", "negative regulation of hydrolase activity (GO:0051346 from GO Biological Process Annotations)", "negative regulation of hypersensitivity (GO:0002884 from GO Biological Process Annotations)", "negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903298 from GO Biological Process Annotations)", "negative regulation of i-kappab kinase|nf-kappab signaling (GO:0043124 from GO Biological Process Annotations)", "negative regulation of icosanoid secretion (GO:0032304 from GO Biological Process Annotations)", "negative regulation of immature t cell proliferation (GO:0033087 from GO Biological Process Annotations)", "negative regulation of immature t cell proliferation in thymus (GO:0033088 from GO Biological Process Annotations)", "negative regulation of immune effector process (GO:0002698 from GO Biological Process Annotations)", "negative regulation of immune response (GO:0050777 from GO Biological Process Annotations)", "negative regulation of immune system process (GO:0002683 from GO Biological Process Annotations)", "negative regulation of immunoglobulin mediated immune response (GO:0002890 from GO Biological Process Annotations)", "negative regulation of immunoglobulin production (GO:0002638 from GO Biological Process Annotations)", "negative regulation of immunoglobulin secretion (GO:0051025 from GO Biological Process Annotations)", "negative regulation of immunological synapse formation (GO:2000521 from GO Biological Process Annotations)", "negative regulation of inclusion body assembly (GO:0090084 from GO Biological Process Annotations)", "negative regulation of inflammatory response (GO:0050728 from GO Biological Process Annotations)", "negative regulation of inflammatory response to antigenic stimulus (GO:0002862 from GO Biological Process Annotations)", "negative regulation of innate immune response (GO:0045824 from GO Biological Process Annotations)", "negative regulation of inner ear receptor cell differentiation (GO:2000981 from GO Biological Process Annotations)", "negative regulation of inorganic anion transmembrane transport (GO:1903796 from GO Biological Process Annotations)", "negative regulation of inositol phosphate biosynthetic process (GO:0010920 from GO Biological Process Annotations)", "negative regulation of insulin receptor signaling pathway (GO:0046627 from GO Biological Process Annotations)", "negative regulation of insulin secretion (GO:0046676 from GO Biological Process Annotations)", "negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179 from GO Biological Process Annotations)", "negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569 from GO Biological Process Annotations)", "negative regulation of integrin activation (GO:0033624 from GO Biological Process Annotations)", "negative regulation of integrin biosynthetic process (GO:0045720 from GO Biological Process Annotations)", "negative regulation of integrin-mediated signaling pathway (GO:2001045 from GO Biological Process Annotations)", "negative regulation of interferon-alpha biosynthetic process (GO:0045355 from GO Biological Process Annotations)", "negative regulation of interferon-alpha production (GO:0032687 from GO Biological Process Annotations)", "negative regulation of interferon-beta biosynthetic process (GO:0045358 from GO Biological Process Annotations)", "negative regulation of interferon-beta production (GO:0032688 from GO Biological Process Annotations)", "negative regulation of interferon-beta secretion (GO:0035548 from GO Biological Process Annotations)", "negative regulation of interferon-gamma biosynthetic process (GO:0045077 from GO Biological Process Annotations)", "negative regulation of interferon-gamma production (GO:0032689 from GO Biological Process Annotations)", "negative regulation of interferon-gamma secretion (GO:1902714 from GO Biological Process Annotations)", "negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336 from GO Biological Process Annotations)", "negative regulation of interleukin-1 beta production (GO:0032691 from GO Biological Process Annotations)", "negative regulation of interleukin-1 beta secretion (GO:0050713 from GO Biological Process Annotations)", "negative regulation of interleukin-1 production (GO:0032692 from GO Biological Process Annotations)", "negative regulation of interleukin-1 secretion (GO:0050711 from GO Biological Process Annotations)", "negative regulation of interleukin-1-mediated signaling pathway (GO:2000660 from GO Biological Process Annotations)", "negative regulation of interleukin-10 biosynthetic process (GO:0045081 from GO Biological Process Annotations)", "negative regulation of interleukin-10 production (GO:0032693 from GO Biological Process Annotations)", "negative regulation of interleukin-10 secretion (GO:2001180 from GO Biological Process Annotations)", "negative regulation of interleukin-12 biosynthetic process (GO:0045083 from GO Biological Process Annotations)", "negative regulation of interleukin-12 production (GO:0032695 from GO Biological Process Annotations)", "negative regulation of interleukin-12 secretion (GO:2001183 from GO Biological Process Annotations)", "negative regulation of interleukin-13 production (GO:0032696 from GO Biological Process Annotations)", "negative regulation of interleukin-13 secretion (GO:2000666 from GO Biological Process Annotations)", "negative regulation of interleukin-17 production (GO:0032700 from GO Biological Process Annotations)", "negative regulation of interleukin-18 production (GO:0032701 from GO Biological Process Annotations)", "negative regulation of interleukin-2 biosynthetic process (GO:0045085 from GO Biological Process Annotations)", "negative regulation of interleukin-2 production (GO:0032703 from GO Biological Process Annotations)", "negative regulation of interleukin-2 secretion (GO:1900041 from GO Biological Process Annotations)", "negative regulation of interleukin-2-mediated signaling pathway (GO:1902206 from GO Biological Process Annotations)", "negative regulation of interleukin-23 production (GO:0032707 from GO Biological Process Annotations)", "negative regulation of interleukin-4 biosynthetic process (GO:0045403 from GO Biological Process Annotations)", "negative regulation of interleukin-4 production (GO:0032713 from GO Biological Process Annotations)", "negative regulation of interleukin-4-mediated signaling pathway (GO:1902215 from GO Biological Process Annotations)", "negative regulation of interleukin-5 production (GO:0032714 from GO Biological Process Annotations)", "negative regulation of interleukin-5 secretion (GO:2000663 from GO Biological Process Annotations)", "negative regulation of interleukin-6 biosynthetic process (GO:0045409 from GO Biological Process Annotations)", "negative regulation of interleukin-6 production (GO:0032715 from GO Biological Process Annotations)", "negative regulation of interleukin-6 secretion (GO:1900165 from GO Biological Process Annotations)", "negative regulation of interleukin-6-mediated signaling pathway (GO:0070104 from GO Biological Process Annotations)", "negative regulation of interleukin-8 biosynthetic process (GO:0045415 from GO Biological Process Annotations)", "negative regulation of interleukin-8 production (GO:0032717 from GO Biological Process Annotations)", "negative regulation of interleukin-8 secretion (GO:2000483 from GO Biological Process Annotations)", "negative regulation of intestinal cholesterol absorption (GO:0045796 from GO Biological Process Annotations)", "negative regulation of intestinal phytosterol absorption (GO:0010949 from GO Biological Process Annotations)", "negative regulation of intracellular calcium activated chloride channel activity (GO:1902939 from GO Biological Process Annotations)", "negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147 from GO Biological Process Annotations)", "negative regulation of intracellular protein transport (GO:0090317 from GO Biological Process Annotations)", "negative regulation of intracellular signal transduction (GO:1902532 from GO Biological Process Annotations)", "negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144 from GO Biological Process Annotations)", "negative regulation of intracellular transport (GO:0032387 from GO Biological Process Annotations)", "negative regulation of intracellular transport of viral material (GO:1901253 from GO Biological Process Annotations)", "negative regulation of intrinsic apoptotic signaling pathway (GO:2001243 from GO Biological Process Annotations)", "negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254 from GO Biological Process Annotations)", "negative regulation of intrinsic apoptotic signaling pathway in response to dna damage (GO:1902230 from GO Biological Process Annotations)", "negative regulation of intrinsic apoptotic signaling pathway in response to dna damage by p53 class mediator (GO:1902166 from GO Biological Process Annotations)", "negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903751 from GO Biological Process Annotations)", "negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902219 from GO Biological Process Annotations)", "negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902239 from GO Biological Process Annotations)", "negative regulation of ion transmembrane transport (GO:0034766 from GO Biological Process Annotations)", "negative regulation of ion transmembrane transporter activity (GO:0032413 from GO Biological Process Annotations)", "negative regulation of ion transport (GO:0043271 from GO Biological Process Annotations)", "negative regulation of isoprenoid metabolic process (GO:0045827 from GO Biological Process Annotations)", "negative regulation of isotype switching (GO:0045829 from GO Biological Process Annotations)", "negative regulation of isotype switching to iga isotypes (GO:0048297 from GO Biological Process Annotations)", "negative regulation of isotype switching to ige isotypes (GO:0048294 from GO Biological Process Annotations)", "negative regulation of jak-stat cascade (GO:0046426 from GO Biological Process Annotations)", "negative regulation of jnk cascade (GO:0046329 from GO Biological Process Annotations)", "negative regulation of jun kinase activity (GO:0043508 from GO Biological Process Annotations)", "negative regulation of keratinocyte apoptotic process (GO:1902173 from GO Biological Process Annotations)", "negative regulation of keratinocyte differentiation (GO:0045617 from GO Biological Process Annotations)", "negative regulation of keratinocyte proliferation (GO:0010839 from GO Biological Process Annotations)", "negative regulation of kidney development (GO:0090185 from GO Biological Process Annotations)", "negative regulation of kidney smooth muscle cell differentiation (GO:2000357 from GO Biological Process Annotations)", "negative regulation of kinase activity (GO:0033673 from GO Biological Process Annotations)", "negative regulation of kit signaling pathway (GO:1900235 from GO Biological Process Annotations)", "negative regulation of l-glutamate transport (GO:0002037 from GO Biological Process Annotations)", "negative regulation of lactation (GO:1903488 from GO Biological Process Annotations)", "negative regulation of lamellipodium assembly (GO:0010593 from GO Biological Process Annotations)", "negative regulation of lamellipodium morphogenesis (GO:2000393 from GO Biological Process Annotations)", "negative regulation of lamellipodium organization (GO:1902744 from GO Biological Process Annotations)", "negative regulation of late endosome to lysosome transport (GO:1902823 from GO Biological Process Annotations)", "negative regulation of leukocyte activation (GO:0002695 from GO Biological Process Annotations)", "negative regulation of leukocyte apoptotic process (GO:2000107 from GO Biological Process Annotations)", "negative regulation of leukocyte cell-cell adhesion (GO:1903038 from GO Biological Process Annotations)", "negative regulation of leukocyte chemotaxis (GO:0002689 from GO Biological Process Annotations)", "negative regulation of leukocyte degranulation (GO:0043301 from GO Biological Process Annotations)", "negative regulation of leukocyte differentiation (GO:1902106 from GO Biological Process Annotations)", "negative regulation of leukocyte mediated cytotoxicity (GO:0001911 from GO Biological Process Annotations)", "negative regulation of leukocyte mediated immunity (GO:0002704 from GO Biological Process Annotations)", "negative regulation of leukocyte migration (GO:0002686 from GO Biological Process Annotations)", "negative regulation of leukocyte proliferation (GO:0070664 from GO Biological Process Annotations)", "negative regulation of leukocyte tethering or rolling (GO:1903237 from GO Biological Process Annotations)", "negative regulation of ligase activity (GO:0051352 from GO Biological Process Annotations)", "negative regulation of lipase activity (GO:0060192 from GO Biological Process Annotations)", "negative regulation of lipid binding (GO:1900131 from GO Biological Process Annotations)", "negative regulation of lipid biosynthetic process (GO:0051055 from GO Biological Process Annotations)", "negative regulation of lipid catabolic process (GO:0050995 from GO Biological Process Annotations)", "negative regulation of lipid kinase activity (GO:0090219 from GO Biological Process Annotations)", "negative regulation of lipid metabolic process (GO:0045833 from GO Biological Process Annotations)", "negative regulation of lipid storage (GO:0010888 from GO Biological Process Annotations)", "negative regulation of lipid transport (GO:0032369 from GO Biological Process Annotations)", "negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665 from GO Biological Process Annotations)", "negative regulation of lipoprotein lipase activity (GO:0051005 from GO Biological Process Annotations)", "negative regulation of lipoprotein lipid oxidation (GO:0060588 from GO Biological Process Annotations)", "negative regulation of lipoprotein metabolic process (GO:0050748 from GO Biological Process Annotations)", "negative regulation of lipoprotein oxidation (GO:0034443 from GO Biological Process Annotations)", "negative regulation of lipoprotein particle clearance (GO:0010985 from GO Biological Process Annotations)", "negative regulation of locomotion (GO:0040013 from GO Biological Process Annotations)", "negative regulation of locomotion involved in locomotory behavior (GO:0090327 from GO Biological Process Annotations)", "negative regulation of long term synaptic depression (GO:1900453 from GO Biological Process Annotations)", "negative regulation of low-density lipoprotein particle clearance (GO:0010989 from GO Biological Process Annotations)", "negative regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045715 from GO Biological Process Annotations)", "negative regulation of low-density lipoprotein particle receptor catabolic process (GO:0032804 from GO Biological Process Annotations)", "negative regulation of lung ciliated cell differentiation (GO:1901247 from GO Biological Process Annotations)", "negative regulation of lung goblet cell differentiation (GO:1901250 from GO Biological Process Annotations)", "negative regulation of luteinizing hormone secretion (GO:0033685 from GO Biological Process Annotations)", "negative regulation of lyase activity (GO:0051350 from GO Biological Process Annotations)", "negative regulation of lymphangiogenesis (GO:1901491 from GO Biological Process Annotations)", "negative regulation of lymphocyte activation (GO:0051250 from GO Biological Process Annotations)", "negative regulation of lymphocyte anergy (GO:0002912 from GO Biological Process Annotations)", "negative regulation of lymphocyte apoptotic process (GO:0070229 from GO Biological Process Annotations)", "negative regulation of lymphocyte chemotaxis (GO:1901624 from GO Biological Process Annotations)", "negative regulation of lymphocyte differentiation (GO:0045620 from GO Biological Process Annotations)", "negative regulation of lymphocyte mediated immunity (GO:0002707 from GO Biological Process Annotations)", "negative regulation of lymphocyte migration (GO:2000402 from GO Biological Process Annotations)", "negative regulation of lymphocyte proliferation (GO:0050672 from GO Biological Process Annotations)", "negative regulation of macroautophagy (GO:0016242 from GO Biological Process Annotations)", "negative regulation of macromitophagy (GO:1901525 from GO Biological Process Annotations)", "negative regulation of macromolecule biosynthetic process (GO:0010558 from GO Biological Process Annotations)", "negative regulation of macromolecule metabolic process (GO:0010605 from GO Biological Process Annotations)", "negative regulation of macrophage activation (GO:0043031 from GO Biological Process Annotations)", "negative regulation of macrophage apoptotic process (GO:2000110 from GO Biological Process Annotations)", "negative regulation of macrophage chemotaxis (GO:0010760 from GO Biological Process Annotations)", "negative regulation of macrophage colony-stimulating factor signaling pathway (GO:1902227 from GO Biological Process Annotations)", "negative regulation of macrophage cytokine production (GO:0010936 from GO Biological Process Annotations)", "negative regulation of macrophage derived foam cell differentiation (GO:0010745 from GO Biological Process Annotations)", "negative regulation of macrophage differentiation (GO:0045650 from GO Biological Process Annotations)", "negative regulation of macrophage fusion (GO:0034240 from GO Biological Process Annotations)", "negative regulation of macrophage inflammatory protein 1 alpha production (GO:0071641 from GO Biological Process Annotations)", "negative regulation of male germ cell proliferation (GO:2000255 from GO Biological Process Annotations)", "negative regulation of male gonad development (GO:2000019 from GO Biological Process Annotations)", "negative regulation of mammary gland epithelial cell proliferation (GO:0033600 from GO Biological Process Annotations)", "negative regulation of map kinase activity (GO:0043407 from GO Biological Process Annotations)", "negative regulation of mapk cascade (GO:0043409 from GO Biological Process Annotations)", "negative regulation of mast cell activation (GO:0033004 from GO Biological Process Annotations)", "negative regulation of mast cell activation involved in immune response (GO:0033007 from GO Biological Process Annotations)", "negative regulation of mast cell apoptotic process (GO:0033026 from GO Biological Process Annotations)", "negative regulation of mast cell cytokine production (GO:0032764 from GO Biological Process Annotations)", "negative regulation of mast cell degranulation (GO:0043305 from GO Biological Process Annotations)", "negative regulation of mast cell differentiation (GO:0060377 from GO Biological Process Annotations)", "negative regulation of mast cell proliferation (GO:0070667 from GO Biological Process Annotations)", "negative regulation of mature b cell apoptotic process (GO:0002906 from GO Biological Process Annotations)", "negative regulation of mda-5 signaling pathway (GO:0039534 from GO Biological Process Annotations)", "negative regulation of mechanoreceptor differentiation (GO:0045632 from GO Biological Process Annotations)", "negative regulation of megakaryocyte differentiation (GO:0045653 from GO Biological Process Annotations)", "negative regulation of meiotic cell cycle (GO:0051447 from GO Biological Process Annotations)", "negative regulation of meiotic cell cycle phase transition (GO:1901994 from GO Biological Process Annotations)", "negative regulation of meiotic nuclear division (GO:0045835 from GO Biological Process Annotations)", "negative regulation of melanin biosynthetic process (GO:0048022 from GO Biological Process Annotations)", "negative regulation of membrane potential (GO:0045837 from GO Biological Process Annotations)", "negative regulation of membrane protein ectodomain proteolysis (GO:0051045 from GO Biological Process Annotations)", "negative regulation of membrane tubulation (GO:1903526 from GO Biological Process Annotations)", "negative regulation of memory t cell differentiation (GO:0043381 from GO Biological Process Annotations)", "negative regulation of mesenchymal cell apoptotic process (GO:2001054 from GO Biological Process Annotations)", "negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061296 from GO Biological Process Annotations)", "negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072305 from GO Biological Process Annotations)", "negative regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900212 from GO Biological Process Annotations)", "negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072040 from GO Biological Process Annotations)", "negative regulation of mesenchymal cell proliferation (GO:0072201 from GO Biological Process Annotations)", "negative regulation of mesenchymal cell proliferation involved in lung development (GO:2000791 from GO Biological Process Annotations)", "negative regulation of mesenchymal cell proliferation involved in ureter development (GO:0072200 from GO Biological Process Annotations)", "negative regulation of mesenchymal stem cell differentiation (GO:2000740 from GO Biological Process Annotations)", "negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003340 from GO Biological Process Annotations)", "negative regulation of mesoderm development (GO:2000381 from GO Biological Process Annotations)", "negative regulation of mesodermal cell fate specification (GO:0042662 from GO Biological Process Annotations)", "negative regulation of mesonephros development (GO:0061218 from GO Biological Process Annotations)", "negative regulation of metabolic process (GO:0009892 from GO Biological Process Annotations)", "negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902963 from GO Biological Process Annotations)", "negative regulation of metalloenzyme activity (GO:0048553 from GO Biological Process Annotations)", "negative regulation of metanephric comma-shaped body morphogenesis (GO:2000007 from GO Biological Process Annotations)", "negative regulation of metanephric glomerular mesangial cell proliferation (GO:0072302 from GO Biological Process Annotations)", "negative regulation of metanephric glomerulus development (GO:0072299 from GO Biological Process Annotations)", "negative regulation of metanephric mesenchymal cell migration (GO:2000590 from GO Biological Process Annotations)", "negative regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072308 from GO Biological Process Annotations)", "negative regulation of metanephric s-shaped body morphogenesis (GO:2000005 from GO Biological Process Annotations)", "negative regulation of metanephros development (GO:0072217 from GO Biological Process Annotations)", "negative regulation of metaphase|anaphase transition of cell cycle (GO:1902100 from GO Biological Process Annotations)", "negative regulation of metaphase|anaphase transition of meiotic cell cycle (GO:1902103 from GO Biological Process Annotations)", "negative regulation of methylation-dependent chromatin silencing (GO:0090310 from GO Biological Process Annotations)", "negative regulation of mhc class ii biosynthetic process (GO:0045347 from GO Biological Process Annotations)", "negative regulation of microtubule depolymerization (GO:0007026 from GO Biological Process Annotations)", "negative regulation of microtubule polymerization (GO:0031115 from GO Biological Process Annotations)", "negative regulation of microtubule polymerization or depolymerization (GO:0031111 from GO Biological Process Annotations)", "negative regulation of microvillus assembly (GO:1903697 from GO Biological Process Annotations)", "negative regulation of mitochondrial calcium ion concentration (GO:0051562 from GO Biological Process Annotations)", "negative regulation of mitochondrial depolarization (GO:0051902 from GO Biological Process Annotations)", "negative regulation of mitochondrial dna metabolic process (GO:1901859 from GO Biological Process Annotations)", "negative regulation of mitochondrial dna replication (GO:0090298 from GO Biological Process Annotations)", "negative regulation of mitochondrial electron transport, nadh to ubiquinone (GO:1902957 from GO Biological Process Annotations)", "negative regulation of mitochondrial fission (GO:0090258 from GO Biological Process Annotations)", "negative regulation of mitochondrial fusion (GO:0010637 from GO Biological Process Annotations)", "negative regulation of mitochondrial membrane permeability (GO:0035795 from GO Biological Process Annotations)", "negative regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902109 from GO Biological Process Annotations)", "negative regulation of mitochondrial membrane potential (GO:0010917 from GO Biological Process Annotations)", "negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029 from GO Biological Process Annotations)", "negative regulation of mitochondrial rna catabolic process (GO:0000961 from GO Biological Process Annotations)", "negative regulation of mitochondrial translation (GO:0070130 from GO Biological Process Annotations)", "negative regulation of mitochondrion degradation (GO:1903147 from GO Biological Process Annotations)", "negative regulation of mitochondrion organization (GO:0010823 from GO Biological Process Annotations)", "negative regulation of mitotic cell cycle (GO:0045930 from GO Biological Process Annotations)", "negative regulation of mitotic cell cycle dna replication (GO:1903464 from GO Biological Process Annotations)", "negative regulation of mitotic cell cycle phase transition (GO:1901991 from GO Biological Process Annotations)", "negative regulation of mitotic cell cycle, embryonic (GO:0045976 from GO Biological Process Annotations)", "negative regulation of mitotic metaphase|anaphase transition (GO:0045841 from GO Biological Process Annotations)", "negative regulation of mitotic nuclear division (GO:0045839 from GO Biological Process Annotations)", "negative regulation of mitotic recombination (GO:0045950 from GO Biological Process Annotations)", "negative regulation of mitotic sister chromatid segregation (GO:0033048 from GO Biological Process Annotations)", "negative regulation of mitotic sister chromatid separation (GO:2000816 from GO Biological Process Annotations)", "negative regulation of molecular function (GO:0044092 from GO Biological Process Annotations)", "negative regulation of molecular function in other organism (GO:0044362 from GO Biological Process Annotations)", "negative regulation of molecular function in other organism involved in symbiotic interaction (GO:0052204 from GO Biological Process Annotations)", "negative regulation of monocyte chemotactic protein-1 production (GO:0071638 from GO Biological Process Annotations)", "negative regulation of monocyte chemotaxis (GO:0090027 from GO Biological Process Annotations)", "negative regulation of monocyte differentiation (GO:0045656 from GO Biological Process Annotations)", "negative regulation of monocyte extravasation (GO:2000438 from GO Biological Process Annotations)", "negative regulation of mononuclear cell migration (GO:0071676 from GO Biological Process Annotations)", "negative regulation of mononuclear cell proliferation (GO:0032945 from GO Biological Process Annotations)", "negative regulation of monooxygenase activity (GO:0032769 from GO Biological Process Annotations)", "negative regulation of motor neuron apoptotic process (GO:2000672 from GO Biological Process Annotations)", "negative regulation of mrna 3'-end processing (GO:0031441 from GO Biological Process Annotations)", "negative regulation of mrna catabolic process (GO:1902373 from GO Biological Process Annotations)", "negative regulation of mrna cleavage (GO:0031438 from GO Biological Process Annotations)", "negative regulation of mrna metabolic process (GO:1903312 from GO Biological Process Annotations)", "negative regulation of mrna modification (GO:0090367 from GO Biological Process Annotations)", "negative regulation of mrna polyadenylation (GO:1900364 from GO Biological Process Annotations)", "negative regulation of mrna processing (GO:0050686 from GO Biological Process Annotations)", "negative regulation of mrna splicing, via spliceosome (GO:0048025 from GO Biological Process Annotations)", "negative regulation of mucus secretion (GO:0070256 from GO Biological Process Annotations)", "negative regulation of multi-organism process (GO:0043901 from GO Biological Process Annotations)", "negative regulation of multicellular organism growth (GO:0040015 from GO Biological Process Annotations)", "negative regulation of multicellular organismal metabolic process (GO:0044252 from GO Biological Process Annotations)", "negative regulation of multicellular organismal process (GO:0051241 from GO Biological Process Annotations)", "negative regulation of muscle adaptation (GO:0014745 from GO Biological Process Annotations)", "negative regulation of muscle cell apoptotic process (GO:0010656 from GO Biological Process Annotations)", "negative regulation of muscle cell differentiation (GO:0051148 from GO Biological Process Annotations)", "negative regulation of muscle contraction (GO:0045932 from GO Biological Process Annotations)", "negative regulation of muscle hyperplasia (GO:0014740 from GO Biological Process Annotations)", "negative regulation of muscle hypertrophy (GO:0014741 from GO Biological Process Annotations)", "negative regulation of muscle organ development (GO:0048635 from GO Biological Process Annotations)", "negative regulation of muscle tissue development (GO:1901862 from GO Biological Process Annotations)", "negative regulation of myelination (GO:0031642 from GO Biological Process Annotations)", "negative regulation of myeloid cell apoptotic process (GO:0033033 from GO Biological Process Annotations)", "negative regulation of myeloid cell differentiation (GO:0045638 from GO Biological Process Annotations)", "negative regulation of myeloid dendritic cell activation (GO:0030886 from GO Biological Process Annotations)", "negative regulation of myeloid leukocyte differentiation (GO:0002762 from GO Biological Process Annotations)", "negative regulation of myeloid leukocyte mediated immunity (GO:0002887 from GO Biological Process Annotations)", "negative regulation of myoblast differentiation (GO:0045662 from GO Biological Process Annotations)", "negative regulation of myoblast fusion (GO:1901740 from GO Biological Process Annotations)", "negative regulation of myoblast proliferation (GO:2000818 from GO Biological Process Annotations)", "negative regulation of myosin-light-chain-phosphatase activity (GO:0035509 from GO Biological Process Annotations)", "negative regulation of myotube differentiation (GO:0010832 from GO Biological Process Annotations)", "negative regulation of n-terminal protein palmitoylation (GO:0060262 from GO Biological Process Annotations)", "negative regulation of nad(p)h oxidase activity (GO:0033861 from GO Biological Process Annotations)", "negative regulation of natural killer cell activation (GO:0032815 from GO Biological Process Annotations)", "negative regulation of natural killer cell chemotaxis (GO:2000502 from GO Biological Process Annotations)", "negative regulation of natural killer cell differentiation (GO:0032824 from GO Biological Process Annotations)", "negative regulation of natural killer cell differentiation involved in immune response (GO:0032827 from GO Biological Process Annotations)", "negative regulation of natural killer cell mediated cytotoxicity (GO:0045953 from GO Biological Process Annotations)", "negative regulation of natural killer cell mediated immunity (GO:0002716 from GO Biological Process Annotations)", "negative regulation of necroptotic process (GO:0060546 from GO Biological Process Annotations)", "negative regulation of necrotic cell death (GO:0060547 from GO Biological Process Annotations)", "negative regulation of negative chemotaxis (GO:0050925 from GO Biological Process Annotations)", "negative regulation of nephron tubule epithelial cell differentiation (GO:0072183 from GO Biological Process Annotations)", "negative regulation of nerve growth factor production (GO:0032904 from GO Biological Process Annotations)", "negative regulation of nervous system development (GO:0051961 from GO Biological Process Annotations)", "negative regulation of neural crest formation (GO:0090301 from GO Biological Process Annotations)", "negative regulation of neural precursor cell proliferation (GO:2000178 from GO Biological Process Annotations)", "negative regulation of neuroblast proliferation (GO:0007406 from GO Biological Process Annotations)", "negative regulation of neurofibrillary tangle assembly (GO:1902997 from GO Biological Process Annotations)", "negative regulation of neurogenesis (GO:0050768 from GO Biological Process Annotations)", "negative regulation of neurological system process (GO:0031645 from GO Biological Process Annotations)", "negative regulation of neuron apoptotic process (GO:0043524 from GO Biological Process Annotations)", "negative regulation of neuron death (GO:1901215 from GO Biological Process Annotations)", "negative regulation of neuron differentiation (GO:0045665 from GO Biological Process Annotations)", "negative regulation of neuron maturation (GO:0014043 from GO Biological Process Annotations)", "negative regulation of neuron migration (GO:2001223 from GO Biological Process Annotations)", "negative regulation of neuron projection development (GO:0010977 from GO Biological Process Annotations)", "negative regulation of neuron projection regeneration (GO:0070571 from GO Biological Process Annotations)", "negative regulation of neurotransmitter secretion (GO:0046929 from GO Biological Process Annotations)", "negative regulation of neurotransmitter transport (GO:0051589 from GO Biological Process Annotations)", "negative regulation of neurotransmitter uptake (GO:0051581 from GO Biological Process Annotations)", "negative regulation of neurotrophin production (GO:0032900 from GO Biological Process Annotations)", "negative regulation of neurotrophin trk receptor signaling pathway (GO:0051387 from GO Biological Process Annotations)", "negative regulation of neutrophil activation (GO:1902564 from GO Biological Process Annotations)", "negative regulation of neutrophil apoptotic process (GO:0033030 from GO Biological Process Annotations)", "negative regulation of neutrophil chemotaxis (GO:0090024 from GO Biological Process Annotations)", "negative regulation of neutrophil degranulation (GO:0043314 from GO Biological Process Annotations)", "negative regulation of neutrophil migration (GO:1902623 from GO Biological Process Annotations)", "negative regulation of nf-kappab import into nucleus (GO:0042347 from GO Biological Process Annotations)", "negative regulation of nf-kappab transcription factor activity (GO:0032088 from GO Biological Process Annotations)", "negative regulation of nfat protein import into nucleus (GO:0051534 from GO Biological Process Annotations)", "negative regulation of nik|nf-kappab signaling (GO:1901223 from GO Biological Process Annotations)", "negative regulation of nitric oxide biosynthetic process (GO:0045019 from GO Biological Process Annotations)", "negative regulation of nitric oxide mediated signal transduction (GO:0010751 from GO Biological Process Annotations)", "negative regulation of nitric-oxide synthase activity (GO:0051001 from GO Biological Process Annotations)", "negative regulation of nitric-oxide synthase biosynthetic process (GO:0051771 from GO Biological Process Annotations)", "negative regulation of nitrogen compound metabolic process (GO:0051172 from GO Biological Process Annotations)", "negative regulation of nk t cell activation (GO:0051134 from GO Biological Process Annotations)", "negative regulation of nlrp3 inflammasome complex assembly (GO:1900226 from GO Biological Process Annotations)", "negative regulation of nodal signaling pathway (GO:1900108 from GO Biological Process Annotations)", "negative regulation of non-canonical wnt signaling pathway (GO:2000051 from GO Biological Process Annotations)", "negative regulation of norepinephrine secretion (GO:0010700 from GO Biological Process Annotations)", "negative regulation of norepinephrine uptake (GO:0051622 from GO Biological Process Annotations)", "negative regulation of notch signaling pathway (GO:0045746 from GO Biological Process Annotations)", "negative regulation of notch signaling pathway involved in somitogenesis (GO:1902367 from GO Biological Process Annotations)", "negative regulation of nuclear cell cycle dna replication (GO:1902576 from GO Biological Process Annotations)", "negative regulation of nuclear division (GO:0051784 from GO Biological Process Annotations)", "negative regulation of nuclear-transcribed mrna catabolic process, deadenylation-dependent decay (GO:1900152 from GO Biological Process Annotations)", "negative regulation of nuclear-transcribed mrna catabolic process, nonsense-mediated decay (GO:2000623 from GO Biological Process Annotations)", "negative regulation of nuclear-transcribed mrna poly(a) tail shortening (GO:0060212 from GO Biological Process Annotations)", "negative regulation of nuclease activity (GO:0032074 from GO Biological Process Annotations)", "negative regulation of nucleic acid-templated transcription (GO:1903507 from GO Biological Process Annotations)", "negative regulation of nucleobase-containing compound metabolic process (GO:0045934 from GO Biological Process Annotations)", "negative regulation of nucleobase-containing compound transport (GO:0032240 from GO Biological Process Annotations)", "negative regulation of nucleocytoplasmic transport (GO:0046823 from GO Biological Process Annotations)", "negative regulation of nucleoside metabolic process (GO:0045978 from GO Biological Process Annotations)", "negative regulation of nucleotide biosynthetic process (GO:0030809 from GO Biological Process Annotations)", "negative regulation of nucleotide catabolic process (GO:0030812 from GO Biological Process Annotations)", "negative regulation of nucleotide metabolic process (GO:0045980 from GO Biological Process Annotations)", "negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070429 from GO Biological Process Annotations)", "negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070433 from GO Biological Process Annotations)", "negative regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070425 from GO Biological Process Annotations)", "negative regulation of odontogenesis (GO:0042483 from GO Biological Process Annotations)", "negative regulation of odontogenesis of dentin-containing tooth (GO:0042489 from GO Biological Process Annotations)", "negative regulation of oligodendrocyte apoptotic process (GO:1900142 from GO Biological Process Annotations)", "negative regulation of oligodendrocyte differentiation (GO:0048715 from GO Biological Process Annotations)", "negative regulation of oligodendrocyte progenitor proliferation (GO:0070446 from GO Biological Process Annotations)", "negative regulation of oocyte development (GO:0060283 from GO Biological Process Annotations)", "negative regulation of oocyte maturation (GO:1900194 from GO Biological Process Annotations)", "negative regulation of organ growth (GO:0046621 from GO Biological Process Annotations)", "negative regulation of organelle assembly (GO:1902116 from GO Biological Process Annotations)", "negative regulation of organelle organization (GO:0010639 from GO Biological Process Annotations)", "negative regulation of organic acid transport (GO:0032891 from GO Biological Process Annotations)", "negative regulation of ossification (GO:0030279 from GO Biological Process Annotations)", "negative regulation of osteoblast differentiation (GO:0045668 from GO Biological Process Annotations)", "negative regulation of osteoblast proliferation (GO:0033689 from GO Biological Process Annotations)", "negative regulation of osteoclast development (GO:2001205 from GO Biological Process Annotations)", "negative regulation of osteoclast differentiation (GO:0045671 from GO Biological Process Annotations)", "negative regulation of osteoclast proliferation (GO:0090291 from GO Biological Process Annotations)", "negative regulation of ovulation (GO:0060280 from GO Biological Process Annotations)", "negative regulation of oxidative phosphorylation (GO:0090324 from GO Biological Process Annotations)", "negative regulation of oxidative phosphorylation uncoupler activity (GO:2000276 from GO Biological Process Annotations)", "negative regulation of oxidative stress-induced cell death (GO:1903202 from GO Biological Process Annotations)", "negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176 from GO Biological Process Annotations)", "negative regulation of oxidative stress-induced neuron death (GO:1903204 from GO Biological Process Annotations)", "negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377 from GO Biological Process Annotations)", "negative regulation of oxidoreductase activity (GO:0051354 from GO Biological Process Annotations)", "negative regulation of pancreatic a cell differentiation (GO:2000227 from GO Biological Process Annotations)", "negative regulation of pancreatic juice secretion (GO:0090188 from GO Biological Process Annotations)", "negative regulation of pancreatic stellate cell proliferation (GO:2000230 from GO Biological Process Annotations)", "negative regulation of pathway-restricted smad protein phosphorylation (GO:0060394 from GO Biological Process Annotations)", "negative regulation of penile erection (GO:0060407 from GO Biological Process Annotations)", "negative regulation of peptidase activity (GO:0010466 from GO Biological Process Annotations)", "negative regulation of peptide hormone secretion (GO:0090278 from GO Biological Process Annotations)", "negative regulation of peptide secretion (GO:0002792 from GO Biological Process Annotations)", "negative regulation of peptidyl-cysteine s-nitrosylation (GO:1902083 from GO Biological Process Annotations)", "negative regulation of peptidyl-lysine acetylation (GO:2000757 from GO Biological Process Annotations)", "negative regulation of peptidyl-serine dephosphorylation (GO:1902309 from GO Biological Process Annotations)", "negative regulation of peptidyl-serine phosphorylation (GO:0033137 from GO Biological Process Annotations)", "negative regulation of peptidyl-threonine phosphorylation (GO:0010801 from GO Biological Process Annotations)", "negative regulation of peptidyl-tyrosine autophosphorylation (GO:1900085 from GO Biological Process Annotations)", "negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732 from GO Biological Process Annotations)", "negative regulation of peroxidase activity (GO:2000469 from GO Biological Process Annotations)", "negative regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035359 from GO Biological Process Annotations)", "negative regulation of phagocytosis (GO:0050765 from GO Biological Process Annotations)", "negative regulation of phagocytosis, engulfment (GO:0060101 from GO Biological Process Annotations)", "negative regulation of phosphatase activity (GO:0010923 from GO Biological Process Annotations)", "negative regulation of phosphate metabolic process (GO:0045936 from GO Biological Process Annotations)", "negative regulation of phosphatidylcholine biosynthetic process (GO:2001246 from GO Biological Process Annotations)", "negative regulation of phosphatidylcholine catabolic process (GO:0010900 from GO Biological Process Annotations)", "negative regulation of phosphatidylinositol 3-kinase activity (GO:0043553 from GO Biological Process Annotations)", "negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067 from GO Biological Process Annotations)", "negative regulation of phosphatidylinositol biosynthetic process (GO:0010512 from GO Biological Process Annotations)", "negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001145 from GO Biological Process Annotations)", "negative regulation of phospholipase a2 activity (GO:1900138 from GO Biological Process Annotations)", "negative regulation of phospholipase activity (GO:0010519 from GO Biological Process Annotations)", "negative regulation of phospholipase c activity (GO:1900275 from GO Biological Process Annotations)", "negative regulation of phospholipase c-activating g-protein coupled receptor signaling pathway (GO:1900737 from GO Biological Process Annotations)", "negative regulation of phospholipid biosynthetic process (GO:0071072 from GO Biological Process Annotations)", "negative regulation of phospholipid metabolic process (GO:1903726 from GO Biological Process Annotations)", "negative regulation of phosphoprotein phosphatase activity (GO:0032515 from GO Biological Process Annotations)", "negative regulation of phosphorus metabolic process (GO:0010563 from GO Biological Process Annotations)", "negative regulation of phosphorylation (GO:0042326 from GO Biological Process Annotations)", "negative regulation of photoreceptor cell differentiation (GO:0046533 from GO Biological Process Annotations)", "negative regulation of pinocytosis (GO:0048550 from GO Biological Process Annotations)", "negative regulation of planar cell polarity pathway involved in axis elongation (GO:2000041 from GO Biological Process Annotations)", "negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:2000151 from GO Biological Process Annotations)", "negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:2000162 from GO Biological Process Annotations)", "negative regulation of planar cell polarity pathway involved in heart morphogenesis (GO:2000160 from GO Biological Process Annotations)", "negative regulation of planar cell polarity pathway involved in neural tube closure (GO:2000168 from GO Biological Process Annotations)", "negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis (GO:2000164 from GO Biological Process Annotations)", "negative regulation of planar cell polarity pathway involved in pericardium morphogenesis (GO:2000166 from GO Biological Process Annotations)", "negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis (GO:2000149 from GO Biological Process Annotations)", "negative regulation of plasma lipoprotein particle oxidation (GO:0034445 from GO Biological Process Annotations)", "negative regulation of plasma membrane long-chain fatty acid transport (GO:0010748 from GO Biological Process Annotations)", "negative regulation of plasmacytoid dendritic cell cytokine production (GO:0002737 from GO Biological Process Annotations)", "negative regulation of plasminogen activation (GO:0010757 from GO Biological Process Annotations)", "negative regulation of platelet activation (GO:0010544 from GO Biological Process Annotations)", "negative regulation of platelet aggregation (GO:0090331 from GO Biological Process Annotations)", "negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642 from GO Biological Process Annotations)", "negative regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000584 from GO Biological Process Annotations)", "negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587 from GO Biological Process Annotations)", "negative regulation of polyamine transmembrane transport (GO:1902268 from GO Biological Process Annotations)", "negative regulation of positive chemotaxis (GO:0050928 from GO Biological Process Annotations)", "negative regulation of positive thymic t cell selection (GO:1902233 from GO Biological Process Annotations)", "negative regulation of post-translational protein modification (GO:1901874 from GO Biological Process Annotations)", "negative regulation of posttranscriptional gene silencing (GO:0060149 from GO Biological Process Annotations)", "negative regulation of potassium ion export (GO:1902303 from GO Biological Process Annotations)", "negative regulation of potassium ion transmembrane transport (GO:1901380 from GO Biological Process Annotations)", "negative regulation of potassium ion transmembrane transporter activity (GO:1901017 from GO Biological Process Annotations)", "negative regulation of potassium ion transport (GO:0043267 from GO Biological Process Annotations)", "negative regulation of pre-mirna processing (GO:2000632 from GO Biological Process Annotations)", "negative regulation of presynaptic membrane organization (GO:1901630 from GO Biological Process Annotations)", "negative regulation of pro-b cell differentiation (GO:2000974 from GO Biological Process Annotations)", "negative regulation of production of mirnas involved in gene silencing by mirna (GO:1903799 from GO Biological Process Annotations)", "negative regulation of production of molecular mediator of immune response (GO:0002701 from GO Biological Process Annotations)", "negative regulation of production of sirna involved in rna interference (GO:1903704 from GO Biological Process Annotations)", "negative regulation of programmed cell death (GO:0043069 from GO Biological Process Annotations)", "negative regulation of prolactin signaling pathway (GO:1902212 from GO Biological Process Annotations)", "negative regulation of prostaglandin biosynthetic process (GO:0031393 from GO Biological Process Annotations)", "negative regulation of prostatic bud formation (GO:0060686 from GO Biological Process Annotations)", "negative regulation of proteasomal protein catabolic process (GO:1901799 from GO Biological Process Annotations)", "negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435 from GO Biological Process Annotations)", "negative regulation of protein acetylation (GO:1901984 from GO Biological Process Annotations)", "negative regulation of protein activation cascade (GO:2000258 from GO Biological Process Annotations)", "negative regulation of protein adp-ribosylation (GO:0010836 from GO Biological Process Annotations)", "negative regulation of protein autophosphorylation (GO:0031953 from GO Biological Process Annotations)", "negative regulation of protein binding (GO:0032091 from GO Biological Process Annotations)", "negative regulation of protein catabolic process (GO:0042177 from GO Biological Process Annotations)", "negative regulation of protein complex assembly (GO:0031333 from GO Biological Process Annotations)", "negative regulation of protein complex disassembly (GO:0043242 from GO Biological Process Annotations)", "negative regulation of protein dephosphorylation (GO:0035308 from GO Biological Process Annotations)", "negative regulation of protein depolymerization (GO:1901880 from GO Biological Process Annotations)", "negative regulation of protein deubiquitination (GO:0090086 from GO Biological Process Annotations)", "negative regulation of protein export from nucleus (GO:0046826 from GO Biological Process Annotations)", "negative regulation of protein folding (GO:1903333 from GO Biological Process Annotations)", "negative regulation of protein glutathionylation (GO:0010734 from GO Biological Process Annotations)", "negative regulation of protein glycosylation (GO:0060051 from GO Biological Process Annotations)", "negative regulation of protein glycosylation in golgi (GO:0090285 from GO Biological Process Annotations)", "negative regulation of protein homodimerization activity (GO:0090074 from GO Biological Process Annotations)", "negative regulation of protein homooligomerization (GO:0032463 from GO Biological Process Annotations)", "negative regulation of protein homotetramerization (GO:1901094 from GO Biological Process Annotations)", "negative regulation of protein import into nucleus (GO:0042308 from GO Biological Process Annotations)", "negative regulation of protein import into nucleus, translocation (GO:0033159 from GO Biological Process Annotations)", "negative regulation of protein k48-linked deubiquitination (GO:1903094 from GO Biological Process Annotations)", "negative regulation of protein k63-linked ubiquitination (GO:1900045 from GO Biological Process Annotations)", "negative regulation of protein kinase activity (GO:0006469 from GO Biological Process Annotations)", "negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387 from GO Biological Process Annotations)", "negative regulation of protein kinase b signaling (GO:0051898 from GO Biological Process Annotations)", "negative regulation of protein kinase c signaling (GO:0090038 from GO Biological Process Annotations)", "negative regulation of protein lipidation (GO:1903060 from GO Biological Process Annotations)", "negative regulation of protein localization to cell surface (GO:2000009 from GO Biological Process Annotations)", "negative regulation of protein localization to ciliary membrane (GO:1903568 from GO Biological Process Annotations)", "negative regulation of protein localization to cilium (GO:1903565 from GO Biological Process Annotations)", "negative regulation of protein localization to nucleus (GO:1900181 from GO Biological Process Annotations)", "negative regulation of protein localization to plasma membrane (GO:1903077 from GO Biological Process Annotations)", "negative regulation of protein metabolic process (GO:0051248 from GO Biological Process Annotations)", "negative regulation of protein modification by small protein conjugation or removal (GO:1903321 from GO Biological Process Annotations)", "negative regulation of protein modification process (GO:0031400 from GO Biological Process Annotations)", "negative regulation of protein oligomerization (GO:0032460 from GO Biological Process Annotations)", "negative regulation of protein phosphatase type 2a activity (GO:0034048 from GO Biological Process Annotations)", "negative regulation of protein phosphatase type 2b activity (GO:0032513 from GO Biological Process Annotations)", "negative regulation of protein phosphorylation (GO:0001933 from GO Biological Process Annotations)", "negative regulation of protein polymerization (GO:0032272 from GO Biological Process Annotations)", "negative regulation of protein polyubiquitination (GO:1902915 from GO Biological Process Annotations)", "negative regulation of protein processing (GO:0010955 from GO Biological Process Annotations)", "negative regulation of protein processing involved in protein targeting to mitochondrion (GO:1903217 from GO Biological Process Annotations)", "negative regulation of protein refolding (GO:0061084 from GO Biological Process Annotations)", "negative regulation of protein secretion (GO:0050709 from GO Biological Process Annotations)", "negative regulation of protein serine|threonine kinase activity (GO:0071901 from GO Biological Process Annotations)", "negative regulation of protein sumoylation (GO:0033234 from GO Biological Process Annotations)", "negative regulation of protein targeting to membrane (GO:0090315 from GO Biological Process Annotations)", "negative regulation of protein targeting to mitochondrion (GO:1903215 from GO Biological Process Annotations)", "negative regulation of protein tetramerization (GO:1901091 from GO Biological Process Annotations)", "negative regulation of protein transport (GO:0051224 from GO Biological Process Annotations)", "negative regulation of protein tyrosine kinase activity (GO:0061099 from GO Biological Process Annotations)", "negative regulation of protein ubiquitination (GO:0031397 from GO Biological Process Annotations)", "negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000059 from GO Biological Process Annotations)", "negative regulation of proteolysis (GO:0045861 from GO Biological Process Annotations)", "negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051 from GO Biological Process Annotations)", "negative regulation of purine nucleotide biosynthetic process (GO:1900372 from GO Biological Process Annotations)", "negative regulation of purine nucleotide catabolic process (GO:0033122 from GO Biological Process Annotations)", "negative regulation of purine nucleotide metabolic process (GO:1900543 from GO Biological Process Annotations)", "negative regulation of rac protein signal transduction (GO:0035021 from GO Biological Process Annotations)", "negative regulation of ras protein signal transduction (GO:0046580 from GO Biological Process Annotations)", "negative regulation of reactive oxygen species biosynthetic process (GO:1903427 from GO Biological Process Annotations)", "negative regulation of reactive oxygen species metabolic process (GO:2000378 from GO Biological Process Annotations)", "negative regulation of receptor activity (GO:2000272 from GO Biological Process Annotations)", "negative regulation of receptor binding (GO:1900121 from GO Biological Process Annotations)", "negative regulation of receptor biosynthetic process (GO:0010871 from GO Biological Process Annotations)", "negative regulation of receptor catabolic process (GO:2000645 from GO Biological Process Annotations)", "negative regulation of receptor internalization (GO:0002091 from GO Biological Process Annotations)", "negative regulation of receptor recycling (GO:0001920 from GO Biological Process Annotations)", "negative regulation of receptor-mediated endocytosis (GO:0048261 from GO Biological Process Annotations)", "negative regulation of reciprocal meiotic recombination (GO:0045128 from GO Biological Process Annotations)", "negative regulation of regulated secretory pathway (GO:1903306 from GO Biological Process Annotations)", "negative regulation of regulatory t cell differentiation (GO:0045590 from GO Biological Process Annotations)", "negative regulation of relaxation of cardiac muscle (GO:1901898 from GO Biological Process Annotations)", "negative regulation of relaxation of muscle (GO:1901078 from GO Biological Process Annotations)", "negative regulation of release of cytochrome c from mitochondria (GO:0090201 from GO Biological Process Annotations)", "negative regulation of release of sequestered calcium ion into cytosol (GO:0051280 from GO Biological Process Annotations)", "negative regulation of renal albumin absorption (GO:2000533 from GO Biological Process Annotations)", "negative regulation of renal output by angiotensin (GO:0003083 from GO Biological Process Annotations)", "negative regulation of renal phosphate excretion (GO:1903403 from GO Biological Process Annotations)", "negative regulation of renal sodium excretion (GO:0035814 from GO Biological Process Annotations)", "negative regulation of renin secretion into blood stream (GO:1900134 from GO Biological Process Annotations)", "negative regulation of reproductive process (GO:2000242 from GO Biological Process Annotations)", "negative regulation of respiratory burst (GO:0060268 from GO Biological Process Annotations)", "negative regulation of respiratory burst involved in inflammatory response (GO:0060266 from GO Biological Process Annotations)", "negative regulation of response to alcohol (GO:1901420 from GO Biological Process Annotations)", "negative regulation of response to biotic stimulus (GO:0002832 from GO Biological Process Annotations)", "negative regulation of response to cytokine stimulus (GO:0060761 from GO Biological Process Annotations)", "negative regulation of response to dna damage stimulus (GO:2001021 from GO Biological Process Annotations)", "negative regulation of response to endoplasmic reticulum stress (GO:1903573 from GO Biological Process Annotations)", "negative regulation of response to external stimulus (GO:0032102 from GO Biological Process Annotations)", "negative regulation of response to extracellular stimulus (GO:0032105 from GO Biological Process Annotations)", "negative regulation of response to food (GO:0032096 from GO Biological Process Annotations)", "negative regulation of response to interferon-gamma (GO:0060331 from GO Biological Process Annotations)", "negative regulation of response to nutrient levels (GO:0032108 from GO Biological Process Annotations)", "negative regulation of response to oxidative stress (GO:1902883 from GO Biological Process Annotations)", "negative regulation of response to reactive oxygen species (GO:1901032 from GO Biological Process Annotations)", "negative regulation of response to stimulus (GO:0048585 from GO Biological Process Annotations)", "negative regulation of response to wounding (GO:1903035 from GO Biological Process Annotations)", "negative regulation of retinal cell programmed cell death (GO:0046671 from GO Biological Process Annotations)", "negative regulation of retinal ganglion cell axon guidance (GO:0090260 from GO Biological Process Annotations)", "negative regulation of retinoic acid biosynthetic process (GO:1900053 from GO Biological Process Annotations)", "negative regulation of retinoic acid receptor signaling pathway (GO:0048387 from GO Biological Process Annotations)", "negative regulation of rho protein signal transduction (GO:0035024 from GO Biological Process Annotations)", "negative regulation of rho-dependent protein serine|threonine kinase activity (GO:2000299 from GO Biological Process Annotations)", "negative regulation of ribonuclease activity (GO:0060701 from GO Biological Process Annotations)", "negative regulation of ribosome biogenesis (GO:0090071 from GO Biological Process Annotations)", "negative regulation of rig-i signaling pathway (GO:0039536 from GO Biological Process Annotations)", "negative regulation of ripoptosome assembly involved in necroptotic process (GO:1902443 from GO Biological Process Annotations)", "negative regulation of rna biosynthetic process (GO:1902679 from GO Biological Process Annotations)", "negative regulation of rna catabolic process (GO:1902369 from GO Biological Process Annotations)", "negative regulation of rna export from nucleus (GO:0046832 from GO Biological Process Annotations)", "negative regulation of rna interference (GO:1900369 from GO Biological Process Annotations)", "negative regulation of rna metabolic process (GO:0051253 from GO Biological Process Annotations)", "negative regulation of rna polymerase ii regulatory region sequence-specific dna binding (GO:1903026 from GO Biological Process Annotations)", "negative regulation of rna polymerase ii transcriptional preinitiation complex assembly (GO:0017055 from GO Biological Process Annotations)", "negative regulation of rna splicing (GO:0033119 from GO Biological Process Annotations)", "negative regulation of rna-directed rna polymerase activity (GO:1900260 from GO Biological Process Annotations)", "negative regulation of root hair elongation (GO:1902891 from GO Biological Process Annotations)", "negative regulation of rrna processing (GO:2000233 from GO Biological Process Annotations)", "negative regulation of rubidium ion transmembrane transporter activity (GO:2000687 from GO Biological Process Annotations)", "negative regulation of rubidium ion transport (GO:2000681 from GO Biological Process Annotations)", "negative regulation of ruffle assembly (GO:1900028 from GO Biological Process Annotations)", "negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315 from GO Biological Process Annotations)", "negative regulation of sarcomere organization (GO:0060299 from GO Biological Process Annotations)", "negative regulation of satellite cell differentiation (GO:1902725 from GO Biological Process Annotations)", "negative regulation of schwann cell proliferation (GO:0010626 from GO Biological Process Annotations)", "negative regulation of secondary metabolite biosynthetic process (GO:1900377 from GO Biological Process Annotations)", "negative regulation of secretion (GO:0051048 from GO Biological Process Annotations)", "negative regulation of secretion by cell (GO:1903531 from GO Biological Process Annotations)", "negative regulation of secretion of lysosomal enzymes (GO:0090341 from GO Biological Process Annotations)", "negative regulation of sequence-specific dna binding transcription factor activity (GO:0043433 from GO Biological Process Annotations)", "negative regulation of sequestering of calcium ion (GO:0051283 from GO Biological Process Annotations)", "negative regulation of sequestering of triglyceride (GO:0010891 from GO Biological Process Annotations)", "negative regulation of serine-type endopeptidase activity (GO:1900004 from GO Biological Process Annotations)", "negative regulation of serine-type peptidase activity (GO:1902572 from GO Biological Process Annotations)", "negative regulation of serotonin secretion (GO:0014063 from GO Biological Process Annotations)", "negative regulation of serotonin uptake (GO:0051612 from GO Biological Process Annotations)", "negative regulation of signal transduction (GO:0009968 from GO Biological Process Annotations)", "negative regulation of signal transduction by p53 class mediator (GO:1901797 from GO Biological Process Annotations)", "negative regulation of signal transduction in absence of ligand (GO:1901099 from GO Biological Process Annotations)", "negative regulation of signaling (GO:0023057 from GO Biological Process Annotations)", "negative regulation of single stranded viral rna replication via double stranded dna intermediate (GO:0045869 from GO Biological Process Annotations)", "negative regulation of single-species biofilm formation (GO:1900191 from GO Biological Process Annotations)", "negative regulation of single-species biofilm formation in or on host organism (GO:1900229 from GO Biological Process Annotations)", "negative regulation of sister chromatid cohesion (GO:0045875 from GO Biological Process Annotations)", "negative regulation of sister chromatid segregation (GO:0033046 from GO Biological Process Annotations)", "negative regulation of skeletal muscle cell differentiation (GO:2001015 from GO Biological Process Annotations)", "negative regulation of skeletal muscle cell proliferation (GO:0014859 from GO Biological Process Annotations)", "negative regulation of skeletal muscle satellite cell proliferation (GO:1902723 from GO Biological Process Annotations)", "negative regulation of skeletal muscle tissue development (GO:0048642 from GO Biological Process Annotations)", "negative regulation of skeletal muscle tissue growth (GO:0048632 from GO Biological Process Annotations)", "negative regulation of smad protein complex assembly (GO:0010991 from GO Biological Process Annotations)", "negative regulation of smad protein import into nucleus (GO:0060392 from GO Biological Process Annotations)", "negative regulation of small gtpase mediated signal transduction (GO:0051058 from GO Biological Process Annotations)", "negative regulation of smooth muscle cell apoptotic process (GO:0034392 from GO Biological Process Annotations)", "negative regulation of smooth muscle cell chemotaxis (GO:0071672 from GO Biological Process Annotations)", "negative regulation of smooth muscle cell differentiation (GO:0051151 from GO Biological Process Annotations)", "negative regulation of smooth muscle cell migration (GO:0014912 from GO Biological Process Annotations)", "negative regulation of smooth muscle cell proliferation (GO:0048662 from GO Biological Process Annotations)", "negative regulation of smooth muscle cell-matrix adhesion (GO:2000098 from GO Biological Process Annotations)", "negative regulation of smooth muscle contraction (GO:0045986 from GO Biological Process Annotations)", "negative regulation of smoothened signaling pathway (GO:0045879 from GO Biological Process Annotations)", "negative regulation of smoothened signaling pathway involved in dorsal|ventral neural tube patterning (GO:1901621 from GO Biological Process Annotations)", "negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021914 from GO Biological Process Annotations)", "negative regulation of snare complex assembly (GO:0035544 from GO Biological Process Annotations)", "negative regulation of sodium ion transmembrane transport (GO:1902306 from GO Biological Process Annotations)", "negative regulation of sodium ion transmembrane transporter activity (GO:2000650 from GO Biological Process Annotations)", "negative regulation of sodium ion transport (GO:0010766 from GO Biological Process Annotations)", "negative regulation of sodium-dependent phosphate transport (GO:2000119 from GO Biological Process Annotations)", "negative regulation of sodium:proton antiporter activity (GO:0032416 from GO Biological Process Annotations)", "negative regulation of sperm motility (GO:1901318 from GO Biological Process Annotations)", "negative regulation of sphingolipid biosynthetic process (GO:0090155 from GO Biological Process Annotations)", "negative regulation of spindle checkpoint (GO:0090233 from GO Biological Process Annotations)", "negative regulation of sprouting angiogenesis (GO:1903671 from GO Biological Process Annotations)", "negative regulation of sprouting of injured axon (GO:0048688 from GO Biological Process Annotations)", "negative regulation of srebp signaling pathway (GO:2000639 from GO Biological Process Annotations)", "negative regulation of stem cell differentiation (GO:2000737 from GO Biological Process Annotations)", "negative regulation of stem cell maintenance (GO:1902455 from GO Biological Process Annotations)", "negative regulation of stem cell proliferation (GO:2000647 from GO Biological Process Annotations)", "negative regulation of steroid biosynthetic process (GO:0010894 from GO Biological Process Annotations)", "negative regulation of steroid hormone biosynthetic process (GO:0090032 from GO Biological Process Annotations)", "negative regulation of steroid hormone secretion (GO:2000832 from GO Biological Process Annotations)", "negative regulation of steroid metabolic process (GO:0045939 from GO Biological Process Annotations)", "negative regulation of sterol import (GO:2000910 from GO Biological Process Annotations)", "negative regulation of sterol transport (GO:0032372 from GO Biological Process Annotations)", "negative regulation of stomach neuroendocrine cell differentiation (GO:0061106 from GO Biological Process Annotations)", "negative regulation of stress fiber assembly (GO:0051497 from GO Biological Process Annotations)", "negative regulation of stress-activated mapk cascade (GO:0032873 from GO Biological Process Annotations)", "negative regulation of stress-activated protein kinase signaling cascade (GO:0070303 from GO Biological Process Annotations)", "negative regulation of striated muscle cell apoptotic process (GO:0010664 from GO Biological Process Annotations)", "negative regulation of striated muscle cell differentiation (GO:0051154 from GO Biological Process Annotations)", "negative regulation of striated muscle contraction (GO:0045988 from GO Biological Process Annotations)", "negative regulation of striated muscle tissue development (GO:0045843 from GO Biological Process Annotations)", "negative regulation of substrate adhesion-dependent cell spreading (GO:1900025 from GO Biological Process Annotations)", "negative regulation of superoxide anion generation (GO:0032929 from GO Biological Process Annotations)", "negative regulation of synapse assembly (GO:0051964 from GO Biological Process Annotations)", "negative regulation of synapse maturation (GO:2000297 from GO Biological Process Annotations)", "negative regulation of synaptic plasticity (GO:0031914 from GO Biological Process Annotations)", "negative regulation of synaptic transmission (GO:0050805 from GO Biological Process Annotations)", "negative regulation of synaptic transmission, cholinergic (GO:0032223 from GO Biological Process Annotations)", "negative regulation of synaptic transmission, dopaminergic (GO:0032227 from GO Biological Process Annotations)", "negative regulation of synaptic transmission, gabaergic (GO:0032229 from GO Biological Process Annotations)", "negative regulation of synaptic transmission, glutamatergic (GO:0051967 from GO Biological Process Annotations)", "negative regulation of synaptic vesicle clustering (GO:2000808 from GO Biological Process Annotations)", "negative regulation of synaptic vesicle exocytosis (GO:2000301 from GO Biological Process Annotations)", "negative regulation of synaptic vesicle transport (GO:1902804 from GO Biological Process Annotations)", "negative regulation of syncytium formation by plasma membrane fusion (GO:0034242 from GO Biological Process Annotations)", "negative regulation of systemic arterial blood pressure (GO:0003085 from GO Biological Process Annotations)", "negative regulation of t cell activation (GO:0050868 from GO Biological Process Annotations)", "negative regulation of t cell activation via t cell receptor contact with antigen bound to mhc molecule on antigen presenting cell (GO:2001189 from GO Biological Process Annotations)", "negative regulation of t cell anergy (GO:0002668 from GO Biological Process Annotations)", "negative regulation of t cell apoptotic process (GO:0070233 from GO Biological Process Annotations)", "negative regulation of t cell cytokine production (GO:0002725 from GO Biological Process Annotations)", "negative regulation of t cell differentiation (GO:0045581 from GO Biological Process Annotations)", "negative regulation of t cell differentiation in thymus (GO:0033085 from GO Biological Process Annotations)", "negative regulation of t cell mediated cytotoxicity (GO:0001915 from GO Biological Process Annotations)", "negative regulation of t cell mediated immunity (GO:0002710 from GO Biological Process Annotations)", "negative regulation of t cell migration (GO:2000405 from GO Biological Process Annotations)", "negative regulation of t cell proliferation (GO:0042130 from GO Biological Process Annotations)", "negative regulation of t cell receptor signaling pathway (GO:0050860 from GO Biological Process Annotations)", "negative regulation of t cell tolerance induction (GO:0002665 from GO Biological Process Annotations)", "negative regulation of t-helper 1 cell activation (GO:2000518 from GO Biological Process Annotations)", "negative regulation of t-helper 1 cell differentiation (GO:0045626 from GO Biological Process Annotations)", "negative regulation of t-helper 1 type immune response (GO:0002826 from GO Biological Process Annotations)", "negative regulation of t-helper 17 cell differentiation (GO:2000320 from GO Biological Process Annotations)", "negative regulation of t-helper 17 type immune response (GO:2000317 from GO Biological Process Annotations)", "negative regulation of t-helper 2 cell cytokine production (GO:2000552 from GO Biological Process Annotations)", "negative regulation of t-helper 2 cell differentiation (GO:0045629 from GO Biological Process Annotations)", "negative regulation of t-helper cell differentiation (GO:0045623 from GO Biological Process Annotations)", "negative regulation of tau-protein kinase activity (GO:1902948 from GO Biological Process Annotations)", "negative regulation of telomerase activity (GO:0051974 from GO Biological Process Annotations)", "negative regulation of telomere maintenance (GO:0032205 from GO Biological Process Annotations)", "negative regulation of telomere maintenance via semi-conservative replication (GO:0032214 from GO Biological Process Annotations)", "negative regulation of telomere maintenance via telomerase (GO:0032211 from GO Biological Process Annotations)", "negative regulation of telomeric rna transcription from rna pol ii promoter (GO:1901581 from GO Biological Process Annotations)", "negative regulation of testicular blood vessel morphogenesis (GO:0061369 from GO Biological Process Annotations)", "negative regulation of testosterone biosynthetic process (GO:2000225 from GO Biological Process Annotations)", "negative regulation of the force of heart contraction (GO:0098736 from GO Biological Process Annotations)", "negative regulation of the force of heart contraction by chemical signal (GO:0003108 from GO Biological Process Annotations)", "negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001986 from GO Biological Process Annotations)", "negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation (GO:1903125 from GO Biological Process Annotations)", "negative regulation of thrombin receptor signaling pathway (GO:0070495 from GO Biological Process Annotations)", "negative regulation of thymidylate synthase biosynthetic process (GO:0050760 from GO Biological Process Annotations)", "negative regulation of thymocyte aggregation (GO:2000399 from GO Biological Process Annotations)", "negative regulation of thymocyte apoptotic process (GO:0070244 from GO Biological Process Annotations)", "negative regulation of tissue remodeling (GO:0034104 from GO Biological Process Annotations)", "negative regulation of tolerance induction (GO:0002644 from GO Biological Process Annotations)", "negative regulation of toll signaling pathway (GO:0045751 from GO Biological Process Annotations)", "negative regulation of toll-like receptor 2 signaling pathway (GO:0034136 from GO Biological Process Annotations)", "negative regulation of toll-like receptor 3 signaling pathway (GO:0034140 from GO Biological Process Annotations)", "negative regulation of toll-like receptor 4 signaling pathway (GO:0034144 from GO Biological Process Annotations)", "negative regulation of toll-like receptor 5 signaling pathway (GO:0034148 from GO Biological Process Annotations)", "negative regulation of toll-like receptor 9 signaling pathway (GO:0034164 from GO Biological Process Annotations)", "negative regulation of toll-like receptor signaling pathway (GO:0034122 from GO Biological Process Annotations)", "negative regulation of tooth mineralization (GO:0070171 from GO Biological Process Annotations)", "negative regulation of tor signaling (GO:0032007 from GO Biological Process Annotations)", "negative regulation of trail-activated apoptotic signaling pathway (GO:1903122 from GO Biological Process Annotations)", "negative regulation of transcription by competitive promoter binding (GO:0010944 from GO Biological Process Annotations)", "negative regulation of transcription by glucose (GO:0045014 from GO Biological Process Annotations)", "negative regulation of transcription by transcription factor localization (GO:0010621 from GO Biological Process Annotations)", "negative regulation of transcription during mitosis (GO:0007068 from GO Biological Process Annotations)", "negative regulation of transcription elongation from rna polymerase ii promoter (GO:0034244 from GO Biological Process Annotations)", "negative regulation of transcription factor import into nucleus (GO:0042992 from GO Biological Process Annotations)", "negative regulation of transcription from rna polymerase i promoter (GO:0016479 from GO Biological Process Annotations)", "negative regulation of transcription from rna polymerase ii promoter (GO:0000122 from GO Biological Process Annotations)", "negative regulation of transcription from rna polymerase ii promoter by glucose (GO:0000433 from GO Biological Process Annotations)", "negative regulation of transcription from rna polymerase ii promoter by histone modification (GO:1903758 from GO Biological Process Annotations)", "negative regulation of transcription from rna polymerase ii promoter during mitosis (GO:0007070 from GO Biological Process Annotations)", "negative regulation of transcription from rna polymerase ii promoter in response to endoplasmic reticulum stress (GO:1990441 from GO Biological Process Annotations)", "negative regulation of transcription from rna polymerase ii promoter in response to hypoxia (GO:0061428 from GO Biological Process Annotations)", "negative regulation of transcription from rna polymerase ii promoter in response to stress (GO:0097201 from GO Biological Process Annotations)", "negative regulation of transcription from rna polymerase ii promoter in response to uv-induced dna damage (GO:0010768 from GO Biological Process Annotations)", "negative regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation (GO:2000820 from GO Biological Process Annotations)", "negative regulation of transcription from rna polymerase iii promoter (GO:0016480 from GO Biological Process Annotations)", "negative regulation of transcription initiation from rna polymerase ii promoter (GO:0060633 from GO Biological Process Annotations)", "negative regulation of transcription involved in g1|s transition of mitotic cell cycle (GO:0071930 from GO Biological Process Annotations)", "negative regulation of transcription of nuclear large rrna transcript from rna polymerase i promoter (GO:1901837 from GO Biological Process Annotations)", "negative regulation of transcription regulatory region dna binding (GO:2000678 from GO Biological Process Annotations)", "negative regulation of transcription, dna-templated (GO:0045892 from GO Biological Process Annotations)", "negative regulation of transferase activity (GO:0051348 from GO Biological Process Annotations)", "negative regulation of transforming growth factor beta production (GO:0071635 from GO Biological Process Annotations)", "negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512 from GO Biological Process Annotations)", "negative regulation of transforming growth factor beta1 production (GO:0032911 from GO Biological Process Annotations)", "negative regulation of transforming growth factor beta2 production (GO:0032912 from GO Biological Process Annotations)", "negative regulation of transforming growth factor beta3 production (GO:0032913 from GO Biological Process Annotations)", "negative regulation of transforming growth factor-beta secretion (GO:2001202 from GO Biological Process Annotations)", "negative regulation of translation (GO:0017148 from GO Biological Process Annotations)", "negative regulation of translation in response to stress (GO:0032055 from GO Biological Process Annotations)", "negative regulation of translation involved in gene silencing by mirna (GO:0035278 from GO Biological Process Annotations)", "negative regulation of translation, ncrna-mediated (GO:0040033 from GO Biological Process Annotations)", "negative regulation of translational elongation (GO:0045900 from GO Biological Process Annotations)", "negative regulation of translational initiation (GO:0045947 from GO Biological Process Annotations)", "negative regulation of translational initiation by iron (GO:0045993 from GO Biological Process Annotations)", "negative regulation of translational initiation in response to stress (GO:0032057 from GO Biological Process Annotations)", "negative regulation of transmembrane receptor protein serine|threonine kinase signaling pathway (GO:0090101 from GO Biological Process Annotations)", "negative regulation of transmembrane transport (GO:0034763 from GO Biological Process Annotations)", "negative regulation of transmission of nerve impulse (GO:0051970 from GO Biological Process Annotations)", "negative regulation of transport (GO:0051051 from GO Biological Process Annotations)", "negative regulation of transporter activity (GO:0032410 from GO Biological Process Annotations)", "negative regulation of transposition (GO:0010529 from GO Biological Process Annotations)", "negative regulation of transposon integration (GO:0070895 from GO Biological Process Annotations)", "negative regulation of triglyceride biosynthetic process (GO:0010868 from GO Biological Process Annotations)", "negative regulation of triglyceride catabolic process (GO:0010897 from GO Biological Process Annotations)", "negative regulation of triglyceride metabolic process (GO:0090209 from GO Biological Process Annotations)", "negative regulation of trophoblast cell migration (GO:1901164 from GO Biological Process Annotations)", "negative regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000308 from GO Biological Process Annotations)", "negative regulation of tumor necrosis factor biosynthetic process (GO:0042536 from GO Biological Process Annotations)", "negative regulation of tumor necrosis factor production (GO:0032720 from GO Biological Process Annotations)", "negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556 from GO Biological Process Annotations)", "negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804 from GO Biological Process Annotations)", "negative regulation of type 2 immune response (GO:0002829 from GO Biological Process Annotations)", "negative regulation of type b pancreatic cell apoptotic process (GO:2000675 from GO Biological Process Annotations)", "negative regulation of type b pancreatic cell development (GO:2000077 from GO Biological Process Annotations)", "negative regulation of type i interferon production (GO:0032480 from GO Biological Process Annotations)", "negative regulation of type i interferon-mediated signaling pathway (GO:0060339 from GO Biological Process Annotations)", "negative regulation of type iv hypersensitivity (GO:0001808 from GO Biological Process Annotations)", "negative regulation of tyrosine phosphorylation of stat protein (GO:0042532 from GO Biological Process Annotations)", "negative regulation of tyrosine phosphorylation of stat1 protein (GO:0042512 from GO Biological Process Annotations)", "negative regulation of tyrosine phosphorylation of stat3 protein (GO:0042518 from GO Biological Process Annotations)", "negative regulation of tyrosine phosphorylation of stat5 protein (GO:0042524 from GO Biological Process Annotations)", "negative regulation of tyrosine phosphorylation of stat6 protein (GO:0042527 from GO Biological Process Annotations)", "negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436 from GO Biological Process Annotations)", "negative regulation of ubiquitin-protein transferase activity (GO:0051444 from GO Biological Process Annotations)", "negative regulation of ubiquitin-specific protease activity (GO:2000157 from GO Biological Process Annotations)", "negative regulation of udp-glucose catabolic process (GO:0010905 from GO Biological Process Annotations)", "negative regulation of ureter smooth muscle cell differentiation (GO:2000062 from GO Biological Process Annotations)", "negative regulation of urine volume (GO:0035811 from GO Biological Process Annotations)", "negative regulation of uterine smooth muscle contraction (GO:0070473 from GO Biological Process Annotations)", "negative regulation of vacuolar transport (GO:1903336 from GO Biological Process Annotations)", "negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948 from GO Biological Process Annotations)", "negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747 from GO Biological Process Annotations)", "negative regulation of vascular permeability (GO:0043116 from GO Biological Process Annotations)", "negative regulation of vascular wound healing (GO:0061044 from GO Biological Process Annotations)", "negative regulation of vasculature development (GO:1901343 from GO Biological Process Annotations)", "negative regulation of vasculogenesis (GO:2001213 from GO Biological Process Annotations)", "negative regulation of vasoconstriction (GO:0045906 from GO Biological Process Annotations)", "negative regulation of vasodilation (GO:0045908 from GO Biological Process Annotations)", "negative regulation of very-low-density lipoprotein particle clearance (GO:0010916 from GO Biological Process Annotations)", "negative regulation of very-low-density lipoprotein particle remodeling (GO:0010903 from GO Biological Process Annotations)", "negative regulation of vesicle fusion (GO:0031339 from GO Biological Process Annotations)", "negative regulation of viral entry into host cell (GO:0046597 from GO Biological Process Annotations)", "negative regulation of viral genome replication (GO:0045071 from GO Biological Process Annotations)", "negative regulation of viral process (GO:0048525 from GO Biological Process Annotations)", "negative regulation of viral release from host cell (GO:1902187 from GO Biological Process Annotations)", "negative regulation of viral transcription (GO:0032897 from GO Biological Process Annotations)", "negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532 from GO Biological Process Annotations)", "negative regulation of vitamin d biosynthetic process (GO:0010957 from GO Biological Process Annotations)", "negative regulation of vitamin d receptor signaling pathway (GO:0070563 from GO Biological Process Annotations)", "negative regulation of vitamin metabolic process (GO:0046137 from GO Biological Process Annotations)", "negative regulation of voltage-gated calcium channel activity (GO:1901386 from GO Biological Process Annotations)", "negative regulation of voltage-gated potassium channel activity (GO:1903817 from GO Biological Process Annotations)", "negative regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903761 from GO Biological Process Annotations)", "negative regulation of wnt protein secretion (GO:0061358 from GO Biological Process Annotations)", "negative regulation of wnt signaling pathway (GO:0030178 from GO Biological Process Annotations)", "negative regulation of wnt signaling pathway involved in digestive tract morphogenesis (GO:2000057 from GO Biological Process Annotations)", "negative regulation of wnt signaling pathway involved in dorsal|ventral axis specification (GO:2000054 from GO Biological Process Annotations)", "negative regulation of wnt signaling pathway involved in heart development (GO:0003308 from GO Biological Process Annotations)", "negative regulation of wound healing (GO:0061045 from GO Biological Process Annotations)", "negative regulation of zinc ion transmembrane import (GO:0071584 from GO Biological Process Annotations)", "negative regulation of zinc ion transmembrane transport (GO:0071583 from GO Biological Process Annotations)", "negative regulation of zinc ion transport (GO:0071582 from GO Biological Process Annotations)", "negative stranded viral rna replication (GO:0039689 from GO Biological Process Annotations)", "negative t cell selection (GO:0043383 from GO Biological Process Annotations)", "negative thymic t cell selection (GO:0045060 from GO Biological Process Annotations)", "nephric duct development (GO:0072176 from GO Biological Process Annotations)", "nephric duct elongation (GO:0035849 from GO Biological Process Annotations)", "nephric duct formation (GO:0072179 from GO Biological Process Annotations)", "nephric duct morphogenesis (GO:0072178 from GO Biological Process Annotations)", "nephrogenic mesenchyme development (GO:0072076 from GO Biological Process Annotations)", "nephrogenic mesenchyme morphogenesis (GO:0072134 from GO Biological Process Annotations)", "nephron development (GO:0072006 from GO Biological Process Annotations)", "nephron epithelium development (GO:0072009 from GO Biological Process Annotations)", "nephron epithelium morphogenesis (GO:0072088 from GO Biological Process Annotations)", "nephron morphogenesis (GO:0072028 from GO Biological Process Annotations)", "nephron tubule development (GO:0072080 from GO Biological Process Annotations)", "nephron tubule epithelial cell differentiation (GO:0072160 from GO Biological Process Annotations)", "nephron tubule formation (GO:0072079 from GO Biological Process Annotations)", "nephron tubule morphogenesis (GO:0072078 from GO Biological Process Annotations)", "nerve development (GO:0021675 from GO Biological Process Annotations)", "nerve growth factor processing (GO:0032455 from GO Biological Process Annotations)", "nerve growth factor production (GO:0032902 from GO Biological Process Annotations)", "nerve growth factor signaling pathway (GO:0038180 from GO Biological Process Annotations)", "nerve maturation (GO:0021682 from GO Biological Process Annotations)", "nervous system development (GO:0007399 from GO Biological Process Annotations)", "netrin-activated signaling pathway (GO:0038007 from GO Biological Process Annotations)", "neural crest cell development (GO:0014032 from GO Biological Process Annotations)", "neural crest cell differentiation (GO:0014033 from GO Biological Process Annotations)", "neural crest cell fate commitment (GO:0014034 from GO Biological Process Annotations)", "neural crest cell fate specification (GO:0014036 from GO Biological Process Annotations)", "neural crest cell migration (GO:0001755 from GO Biological Process Annotations)", "neural crest cell migration involved in autonomic nervous system development (GO:1901166 from GO Biological Process Annotations)", "neural crest cell migration involved in sympathetic nervous system development (GO:1903045 from GO Biological Process Annotations)", "neural crest formation (GO:0014029 from GO Biological Process Annotations)", "neural fold bending (GO:0021503 from GO Biological Process Annotations)", "neural fold elevation formation (GO:0021502 from GO Biological Process Annotations)", "neural fold formation (GO:0001842 from GO Biological Process Annotations)", "neural nucleus development (GO:0048857 from GO Biological Process Annotations)", "neural plate anterior|posterior regionalization (GO:0021999 from GO Biological Process Annotations)", "neural plate axis specification (GO:0021997 from GO Biological Process Annotations)", "neural plate development (GO:0001840 from GO Biological Process Annotations)", "neural plate formation (GO:0021990 from GO Biological Process Annotations)", "neural plate mediolateral regionalization (GO:0021998 from GO Biological Process Annotations)", "neural plate morphogenesis (GO:0001839 from GO Biological Process Annotations)", "neural plate pattern specification (GO:0060896 from GO Biological Process Annotations)", "neural plate regionalization (GO:0060897 from GO Biological Process Annotations)", "neural precursor cell proliferation (GO:0061351 from GO Biological Process Annotations)", "neural retina development (GO:0003407 from GO Biological Process Annotations)", "neural tube closure (GO:0001843 from GO Biological Process Annotations)", "neural tube development (GO:0021915 from GO Biological Process Annotations)", "neural tube formation (GO:0001841 from GO Biological Process Annotations)", "neural tube patterning (GO:0021532 from GO Biological Process Annotations)", "neurexin clustering (GO:0097115 from GO Biological Process Annotations)", "neuroblast differentiation (GO:0014016 from GO Biological Process Annotations)", "neuroblast division (GO:0055057 from GO Biological Process Annotations)", "neuroblast division in subventricular zone (GO:0021849 from GO Biological Process Annotations)", "neuroblast fate determination (GO:0007400 from GO Biological Process Annotations)", "neuroblast migration (GO:0097402 from GO Biological Process Annotations)", "neuroblast proliferation (GO:0007405 from GO Biological Process Annotations)", "neuroendocrine cell differentiation (GO:0061101 from GO Biological Process Annotations)", "neuroepithelial cell differentiation (GO:0060563 from GO Biological Process Annotations)", "neurofilament bundle assembly (GO:0033693 from GO Biological Process Annotations)", "neurofilament cytoskeleton organization (GO:0060052 from GO Biological Process Annotations)", "neurogenesis (GO:0022008 from GO Biological Process Annotations)", "neurohypophysis development (GO:0021985 from GO Biological Process Annotations)", "neuroligin clustering (GO:0097118 from GO Biological Process Annotations)", "neurological system process (GO:0050877 from GO Biological Process Annotations)", "neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976 from GO Biological Process Annotations)", "neuromuscular junction development (GO:0007528 from GO Biological Process Annotations)", "neuromuscular process (GO:0050905 from GO Biological Process Annotations)", "neuromuscular process controlling balance (GO:0050885 from GO Biological Process Annotations)", "neuromuscular process controlling posture (GO:0050884 from GO Biological Process Annotations)", "neuromuscular synaptic transmission (GO:0007274 from GO Biological Process Annotations)", "neuron apoptotic process (GO:0051402 from GO Biological Process Annotations)", "neuron cell-cell adhesion (GO:0007158 from GO Biological Process Annotations)", "neuron cellular homeostasis (GO:0070050 from GO Biological Process Annotations)", "neuron death (GO:0070997 from GO Biological Process Annotations)", "neuron development (GO:0048666 from GO Biological Process Annotations)", "neuron differentiation (GO:0030182 from GO Biological Process Annotations)", "neuron fate commitment (GO:0048663 from GO Biological Process Annotations)", "neuron fate determination (GO:0048664 from GO Biological Process Annotations)", "neuron fate specification (GO:0048665 from GO Biological Process Annotations)", "neuron maturation (GO:0042551 from GO Biological Process Annotations)", "neuron migration (GO:0001764 from GO Biological Process Annotations)", "neuron projection development (GO:0031175 from GO Biological Process Annotations)", "neuron projection extension (GO:1990138 from GO Biological Process Annotations)", "neuron projection extension involved in neuron projection guidance (GO:1902284 from GO Biological Process Annotations)", "neuron projection guidance (GO:0097485 from GO Biological Process Annotations)", "neuron projection morphogenesis (GO:0048812 from GO Biological Process Annotations)", "neuron projection regeneration (GO:0031102 from GO Biological Process Annotations)", "neuron recognition (GO:0008038 from GO Biological Process Annotations)", "neuron remodeling (GO:0016322 from GO Biological Process Annotations)", "neuron-neuron synaptic transmission (GO:0007270 from GO Biological Process Annotations)", "neuronal action potential (GO:0019228 from GO Biological Process Annotations)", "neuronal action potential propagation (GO:0019227 from GO Biological Process Annotations)", "neuronal ion channel clustering (GO:0045161 from GO Biological Process Annotations)", "neuronal signal transduction (GO:0023041 from GO Biological Process Annotations)", "neuronal stem cell division (GO:0036445 from GO Biological Process Annotations)", "neuronal stem cell maintenance (GO:0097150 from GO Biological Process Annotations)", "neuronal-glial interaction involved in cerebral cortex radial glia guided migration (GO:0021812 from GO Biological Process Annotations)", "neuropeptide catabolic process (GO:0010813 from GO Biological Process Annotations)", "neuropeptide signaling pathway (GO:0007218 from GO Biological Process Annotations)", "neuropilin signaling pathway (GO:0038189 from GO Biological Process Annotations)", "neurotransmitter biosynthetic process (GO:0042136 from GO Biological Process Annotations)", "neurotransmitter catabolic process (GO:0042135 from GO Biological Process Annotations)", "neurotransmitter loading into synaptic vesicle (GO:0098700 from GO Biological Process Annotations)", "neurotransmitter metabolic process (GO:0042133 from GO Biological Process Annotations)", "neurotransmitter receptor biosynthetic process (GO:0045212 from GO Biological Process Annotations)", "neurotransmitter receptor metabolic process (GO:0045213 from GO Biological Process Annotations)", "neurotransmitter secretion (GO:0007269 from GO Biological Process Annotations)", "neurotransmitter transport (GO:0006836 from GO Biological Process Annotations)", "neurotransmitter uptake (GO:0001504 from GO Biological Process Annotations)", "neurotransmitter-gated ion channel clustering (GO:0072578 from GO Biological Process Annotations)", "neurotrophin production (GO:0032898 from GO Biological Process Annotations)", "neurotrophin signaling pathway (GO:0038179 from GO Biological Process Annotations)", "neurotrophin trk receptor signaling pathway (GO:0048011 from GO Biological Process Annotations)", "neutral amino acid transport (GO:0015804 from GO Biological Process Annotations)", "neutral lipid biosynthetic process (GO:0046460 from GO Biological Process Annotations)", "neutral lipid catabolic process (GO:0046461 from GO Biological Process Annotations)", "neutral lipid metabolic process (GO:0006638 from GO Biological Process Annotations)", "neutrophil activation (GO:0042119 from GO Biological Process Annotations)", "neutrophil activation involved in immune response (GO:0002283 from GO Biological Process Annotations)", "neutrophil aggregation (GO:0070488 from GO Biological Process Annotations)", "neutrophil apoptotic process (GO:0001781 from GO Biological Process Annotations)", "neutrophil chemotaxis (GO:0030593 from GO Biological Process Annotations)", "neutrophil clearance (GO:0097350 from GO Biological Process Annotations)", "neutrophil degranulation (GO:0043312 from GO Biological Process Annotations)", "neutrophil differentiation (GO:0030223 from GO Biological Process Annotations)", "neutrophil extravasation (GO:0072672 from GO Biological Process Annotations)", "neutrophil homeostasis (GO:0001780 from GO Biological Process Annotations)", "neutrophil mediated cytotoxicity (GO:0070942 from GO Biological Process Annotations)", "neutrophil mediated immunity (GO:0002446 from GO Biological Process Annotations)", "neutrophil mediated killing of bacterium (GO:0070944 from GO Biological Process Annotations)", "neutrophil mediated killing of fungus (GO:0070947 from GO Biological Process Annotations)", "neutrophil mediated killing of gram-negative bacterium (GO:0070945 from GO Biological Process Annotations)", "neutrophil mediated killing of gram-positive bacterium (GO:0070946 from GO Biological Process Annotations)", "neutrophil mediated killing of symbiont cell (GO:0070943 from GO Biological Process Annotations)", "neutrophil migration (GO:1990266 from GO Biological Process Annotations)", "nfat protein import into nucleus (GO:0051531 from GO Biological Process Annotations)", "nickel cation transmembrane transport (GO:0035444 from GO Biological Process Annotations)", "nickel cation transport (GO:0015675 from GO Biological Process Annotations)", "nicotinamide metabolic process (GO:0006769 from GO Biological Process Annotations)", "nicotinamide nucleotide biosynthetic process (GO:0019359 from GO Biological Process Annotations)", "nicotinamide nucleotide metabolic process (GO:0046496 from GO Biological Process Annotations)", "nicotinamide riboside catabolic process (GO:0006738 from GO Biological Process Annotations)", "nicotinamide riboside metabolic process (GO:0046495 from GO Biological Process Annotations)", "nicotinate nucleotide biosynthetic process (GO:0019357 from GO Biological Process Annotations)", "nicotinate nucleotide metabolic process (GO:0046497 from GO Biological Process Annotations)", "nicotinate nucleotide salvage (GO:0019358 from GO Biological Process Annotations)", "nicotinate transport (GO:2001142 from GO Biological Process Annotations)", "nik|nf-kappab signaling (GO:0038061 from GO Biological Process Annotations)", "nipple sheath formation (GO:0060659 from GO Biological Process Annotations)", "nitrate catabolic process (GO:0043602 from GO Biological Process Annotations)", "nitrate metabolic process (GO:0042126 from GO Biological Process Annotations)", "nitrate transport (GO:0015706 from GO Biological Process Annotations)", "nitric oxide biosynthetic process (GO:0006809 from GO Biological Process Annotations)", "nitric oxide catabolic process (GO:0046210 from GO Biological Process Annotations)", "nitric oxide homeostasis (GO:0033484 from GO Biological Process Annotations)", "nitric oxide mediated signal transduction (GO:0007263 from GO Biological Process Annotations)", "nitric oxide metabolic process (GO:0046209 from GO Biological Process Annotations)", "nitric oxide production involved in inflammatory response (GO:0002537 from GO Biological Process Annotations)", "nitric oxide storage (GO:0035732 from GO Biological Process Annotations)", "nitric oxide transport (GO:0030185 from GO Biological Process Annotations)", "nitric oxide-cgmp-mediated signaling pathway (GO:0038060 from GO Biological Process Annotations)", "nitrite transport (GO:0015707 from GO Biological Process Annotations)", "nitrobenzene metabolic process (GO:0018916 from GO Biological Process Annotations)", "nitrogen catabolite activation of transcription (GO:0090294 from GO Biological Process Annotations)", "nitrogen catabolite activation of transcription from rna polymerase ii promoter (GO:0001080 from GO Biological Process Annotations)", "nitrogen catabolite regulation of transcription (GO:0090293 from GO Biological Process Annotations)", "nitrogen catabolite regulation of transcription from rna polymerase ii promoter (GO:0001079 from GO Biological Process Annotations)", "nitrogen compound metabolic process (GO:0006807 from GO Biological Process Annotations)", "nitrogen compound transport (GO:0071705 from GO Biological Process Annotations)", "nitrogen cycle metabolic process (GO:0071941 from GO Biological Process Annotations)", "nitrogen fixation (GO:0009399 from GO Biological Process Annotations)", "nk t cell activation (GO:0051132 from GO Biological Process Annotations)", "nk t cell differentiation (GO:0001865 from GO Biological Process Annotations)", "nk t cell proliferation (GO:0001866 from GO Biological Process Annotations)", "nlrp3 inflammasome complex assembly (GO:0044546 from GO Biological Process Annotations)", "nls-bearing protein import into nucleus (GO:0006607 from GO Biological Process Annotations)", "nodal signaling pathway (GO:0038092 from GO Biological Process Annotations)", "nodal signaling pathway involved in determination of lateral mesoderm left|right asymmetry (GO:1900164 from GO Biological Process Annotations)", "nodal signaling pathway involved in determination of left|right asymmetry (GO:0038107 from GO Biological Process Annotations)", "non-canonical wnt signaling pathway (GO:0035567 from GO Biological Process Annotations)", "non-canonical wnt signaling pathway involved in heart development (GO:0061341 from GO Biological Process Annotations)", "non-canonical wnt signaling pathway via jnk cascade (GO:0038031 from GO Biological Process Annotations)", "non-canonical wnt signaling pathway via mapk cascade (GO:0038030 from GO Biological Process Annotations)", "non-recombinational repair (GO:0000726 from GO Biological Process Annotations)", "nonassociative learning (GO:0046958 from GO Biological Process Annotations)", "nonmotile primary cilium assembly (GO:0035058 from GO Biological Process Annotations)", "nonribosomal peptide biosynthetic process (GO:0019184 from GO Biological Process Annotations)", "nor-spermidine metabolic process (GO:0046204 from GO Biological Process Annotations)", "noradrenergic neuron development (GO:0003358 from GO Biological Process Annotations)", "noradrenergic neuron differentiation (GO:0003357 from GO Biological Process Annotations)", "noradrenergic neuron fate commitment (GO:0003359 from GO Biological Process Annotations)", "norepinephrine biosynthetic process (GO:0042421 from GO Biological Process Annotations)", "norepinephrine metabolic process (GO:0042415 from GO Biological Process Annotations)", "norepinephrine secretion (GO:0048243 from GO Biological Process Annotations)", "norepinephrine transport (GO:0015874 from GO Biological Process Annotations)", "norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001994 from GO Biological Process Annotations)", "nose development (GO:0043584 from GO Biological Process Annotations)", "nose morphogenesis (GO:0043585 from GO Biological Process Annotations)", "notch receptor processing (GO:0007220 from GO Biological Process Annotations)", "notch signaling involved in heart development (GO:0061314 from GO Biological Process Annotations)", "notch signaling pathway (GO:0007219 from GO Biological Process Annotations)", "notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270 from GO Biological Process Annotations)", "notochord cell development (GO:0060035 from GO Biological Process Annotations)", "notochord development (GO:0030903 from GO Biological Process Annotations)", "notochord formation (GO:0014028 from GO Biological Process Annotations)", "notochord morphogenesis (GO:0048570 from GO Biological Process Annotations)", "notochord regression (GO:0060032 from GO Biological Process Annotations)", "nuclear body organization (GO:0030575 from GO Biological Process Annotations)", "nuclear division (GO:0000280 from GO Biological Process Annotations)", "nuclear dna replication (GO:0033260 from GO Biological Process Annotations)", "nuclear envelope disassembly (GO:0051081 from GO Biological Process Annotations)", "nuclear envelope organization (GO:0006998 from GO Biological Process Annotations)", "nuclear envelope reassembly (GO:0031468 from GO Biological Process Annotations)", "nuclear export (GO:0051168 from GO Biological Process Annotations)", "nuclear fragmentation involved in apoptotic nuclear change (GO:0030264 from GO Biological Process Annotations)", "nuclear import (GO:0051170 from GO Biological Process Annotations)", "nuclear inner membrane organization (GO:0071765 from GO Biological Process Annotations)", "nuclear matrix anchoring at nuclear membrane (GO:0090292 from GO Biological Process Annotations)", "nuclear matrix organization (GO:0043578 from GO Biological Process Annotations)", "nuclear membrane organization (GO:0071763 from GO Biological Process Annotations)", "nuclear migration (GO:0007097 from GO Biological Process Annotations)", "nuclear migration along microfilament (GO:0031022 from GO Biological Process Annotations)", "nuclear mrna surveillance (GO:0071028 from GO Biological Process Annotations)", "nuclear ncrna surveillance (GO:0071029 from GO Biological Process Annotations)", "nuclear polyadenylation-dependent mrna catabolic process (GO:0071042 from GO Biological Process Annotations)", "nuclear polyadenylation-dependent ncrna catabolic process (GO:0071046 from GO Biological Process Annotations)", "nuclear polyadenylation-dependent rrna catabolic process (GO:0071035 from GO Biological Process Annotations)", "nuclear polyadenylation-dependent trna catabolic process (GO:0071038 from GO Biological Process Annotations)", "nuclear pore complex assembly (GO:0051292 from GO Biological Process Annotations)", "nuclear pore distribution (GO:0031081 from GO Biological Process Annotations)", "nuclear pore localization (GO:0051664 from GO Biological Process Annotations)", "nuclear pore organization (GO:0006999 from GO Biological Process Annotations)", "nuclear retention of pre-mrna at the site of transcription (GO:0071033 from GO Biological Process Annotations)", "nuclear retention of pre-mrna with aberrant 3'-ends at the site of transcription (GO:0071049 from GO Biological Process Annotations)", "nuclear retention of unspliced pre-mrna at the site of transcription (GO:0071048 from GO Biological Process Annotations)", "nuclear rna surveillance (GO:0071027 from GO Biological Process Annotations)", "nuclear speck organization (GO:0035063 from GO Biological Process Annotations)", "nuclear transport (GO:0051169 from GO Biological Process Annotations)", "nuclear-transcribed mrna catabolic process (GO:0000956 from GO Biological Process Annotations)", "nuclear-transcribed mrna catabolic process, deadenylation-dependent decay (GO:0000288 from GO Biological Process Annotations)", "nuclear-transcribed mrna catabolic process, exonucleolytic (GO:0000291 from GO Biological Process Annotations)", "nuclear-transcribed mrna catabolic process, exonucleolytic, 3'-5' (GO:0034427 from GO Biological Process Annotations)", "nuclear-transcribed mrna catabolic process, no-go decay (GO:0070966 from GO Biological Process Annotations)", "nuclear-transcribed mrna catabolic process, non-stop decay (GO:0070481 from GO Biological Process Annotations)", "nuclear-transcribed mrna catabolic process, nonsense-mediated decay (GO:0000184 from GO Biological Process Annotations)", "nuclear-transcribed mrna poly(a) tail shortening (GO:0000289 from GO Biological Process Annotations)", "nucleic acid metabolic process (GO:0090304 from GO Biological Process Annotations)", "nucleic acid phosphodiester bond hydrolysis (GO:0090305 from GO Biological Process Annotations)", "nucleic acid transport (GO:0050657 from GO Biological Process Annotations)", "nucleic acid-templated transcription (GO:0097659 from GO Biological Process Annotations)", "nucleobase biosynthetic process (GO:0046112 from GO Biological Process Annotations)", "nucleobase catabolic process (GO:0046113 from GO Biological Process Annotations)", "nucleobase metabolic process (GO:0009112 from GO Biological Process Annotations)", "nucleobase transport (GO:0015851 from GO Biological Process Annotations)", "nucleobase-containing compound biosynthetic process (GO:0034654 from GO Biological Process Annotations)", "nucleobase-containing compound catabolic process (GO:0034655 from GO Biological Process Annotations)", "nucleobase-containing compound metabolic process (GO:0006139 from GO Biological Process Annotations)", "nucleobase-containing compound transport (GO:0015931 from GO Biological Process Annotations)", "nucleobase-containing small molecule catabolic process (GO:0034656 from GO Biological Process Annotations)", "nucleobase-containing small molecule interconversion (GO:0015949 from GO Biological Process Annotations)", "nucleobase-containing small molecule metabolic process (GO:0055086 from GO Biological Process Annotations)", "nucleocytoplasmic transport (GO:0006913 from GO Biological Process Annotations)", "nucleologenesis (GO:0017126 from GO Biological Process Annotations)", "nucleolus organization (GO:0007000 from GO Biological Process Annotations)", "nucleolus to nucleoplasm transport (GO:0032066 from GO Biological Process Annotations)", "nucleophagy (GO:0044804 from GO Biological Process Annotations)", "nucleoside biosynthetic process (GO:0009163 from GO Biological Process Annotations)", "nucleoside bisphosphate biosynthetic process (GO:0033866 from GO Biological Process Annotations)", "nucleoside bisphosphate catabolic process (GO:0033869 from GO Biological Process Annotations)", "nucleoside bisphosphate metabolic process (GO:0033865 from GO Biological Process Annotations)", "nucleoside catabolic process (GO:0009164 from GO Biological Process Annotations)", "nucleoside diphosphate biosynthetic process (GO:0009133 from GO Biological Process Annotations)", "nucleoside diphosphate catabolic process (GO:0009134 from GO Biological Process Annotations)", "nucleoside diphosphate metabolic process (GO:0009132 from GO Biological Process Annotations)", "nucleoside diphosphate phosphorylation (GO:0006165 from GO Biological Process Annotations)", "nucleoside metabolic process (GO:0009116 from GO Biological Process Annotations)", "nucleoside monophosphate biosynthetic process (GO:0009124 from GO Biological Process Annotations)", "nucleoside monophosphate catabolic process (GO:0009125 from GO Biological Process Annotations)", "nucleoside monophosphate metabolic process (GO:0009123 from GO Biological Process Annotations)", "nucleoside monophosphate phosphorylation (GO:0046940 from GO Biological Process Annotations)", "nucleoside phosphate biosynthetic process (GO:1901293 from GO Biological Process Annotations)", "nucleoside phosphate catabolic process (GO:1901292 from GO Biological Process Annotations)", "nucleoside phosphate metabolic process (GO:0006753 from GO Biological Process Annotations)", "nucleoside salvage (GO:0043174 from GO Biological Process Annotations)", "nucleoside transmembrane transport (GO:1901642 from GO Biological Process Annotations)", "nucleoside transport (GO:0015858 from GO Biological Process Annotations)", "nucleoside triphosphate biosynthetic process (GO:0009142 from GO Biological Process Annotations)", "nucleoside triphosphate catabolic process (GO:0009143 from GO Biological Process Annotations)", "nucleoside triphosphate metabolic process (GO:0009141 from GO Biological Process Annotations)", "nucleosome assembly (GO:0006334 from GO Biological Process Annotations)", "nucleosome disassembly (GO:0006337 from GO Biological Process Annotations)", "nucleosome mobilization (GO:0042766 from GO Biological Process Annotations)", "nucleosome organization (GO:0034728 from GO Biological Process Annotations)", "nucleosome positioning (GO:0016584 from GO Biological Process Annotations)", "nucleotide biosynthetic process (GO:0009165 from GO Biological Process Annotations)", "nucleotide catabolic process (GO:0009166 from GO Biological Process Annotations)", "nucleotide metabolic process (GO:0009117 from GO Biological Process Annotations)", "nucleotide phosphorylation (GO:0046939 from GO Biological Process Annotations)", "nucleotide salvage (GO:0043173 from GO Biological Process Annotations)", "nucleotide transmembrane transport (GO:1901679 from GO Biological Process Annotations)", "nucleotide transport (GO:0006862 from GO Biological Process Annotations)", "nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872 from GO Biological Process Annotations)", "nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070427 from GO Biological Process Annotations)", "nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431 from GO Biological Process Annotations)", "nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423 from GO Biological Process Annotations)", "nucleotide-excision repair (GO:0006289 from GO Biological Process Annotations)", "nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255 from GO Biological Process Annotations)", "nucleotide-excision repair, dna damage recognition (GO:0000715 from GO Biological Process Annotations)", "nucleotide-excision repair, dna damage removal (GO:0000718 from GO Biological Process Annotations)", "nucleotide-excision repair, dna duplex unwinding (GO:0000717 from GO Biological Process Annotations)", "nucleotide-excision repair, dna gap filling (GO:0006297 from GO Biological Process Annotations)", "nucleotide-excision repair, dna incision (GO:0033683 from GO Biological Process Annotations)", "nucleotide-excision repair, dna incision, 3'-to lesion (GO:0006295 from GO Biological Process Annotations)", "nucleotide-excision repair, dna incision, 5'-to lesion (GO:0006296 from GO Biological Process Annotations)", "nucleotide-excision repair, preincision complex assembly (GO:0006294 from GO Biological Process Annotations)", "nucleotide-sugar biosynthetic process (GO:0009226 from GO Biological Process Annotations)", "nucleotide-sugar catabolic process (GO:0009227 from GO Biological Process Annotations)", "nucleotide-sugar metabolic process (GO:0009225 from GO Biological Process Annotations)", "nucleotide-sugar transport (GO:0015780 from GO Biological Process Annotations)", "nucleus accumbens development (GO:0021768 from GO Biological Process Annotations)", "nucleus localization (GO:0051647 from GO Biological Process Annotations)", "nucleus organization (GO:0006997 from GO Biological Process Annotations)", "o-glycan processing (GO:0016266 from GO Biological Process Annotations)", "o-glycan processing, core 3 (GO:0016269 from GO Biological Process Annotations)", "observational learning (GO:0098597 from GO Biological Process Annotations)", "oculomotor nerve development (GO:0021557 from GO Biological Process Annotations)", "oculomotor nerve formation (GO:0021623 from GO Biological Process Annotations)", "odontoblast differentiation (GO:0071895 from GO Biological Process Annotations)", "odontogenesis (GO:0042476 from GO Biological Process Annotations)", "odontogenesis of dentin-containing tooth (GO:0042475 from GO Biological Process Annotations)", "okazaki fragment processing involved in mitotic dna replication (GO:1903461 from GO Biological Process Annotations)", "olefin metabolic process (GO:1900673 from GO Biological Process Annotations)", "olfactory behavior (GO:0042048 from GO Biological Process Annotations)", "olfactory bulb axon guidance (GO:0071678 from GO Biological Process Annotations)", "olfactory bulb development (GO:0021772 from GO Biological Process Annotations)", "olfactory bulb interneuron development (GO:0021891 from GO Biological Process Annotations)", "olfactory bulb interneuron differentiation (GO:0021889 from GO Biological Process Annotations)", "olfactory bulb mitral cell layer development (GO:0061034 from GO Biological Process Annotations)", "olfactory learning (GO:0008355 from GO Biological Process Annotations)", "olfactory lobe development (GO:0021988 from GO Biological Process Annotations)", "olfactory nerve development (GO:0021553 from GO Biological Process Annotations)", "olfactory pit development (GO:0060166 from GO Biological Process Annotations)", "olfactory placode formation (GO:0030910 from GO Biological Process Annotations)", "oligodendrocyte apoptotic process (GO:0097252 from GO Biological Process Annotations)", "oligodendrocyte cell fate specification (GO:0021778 from GO Biological Process Annotations)", "oligodendrocyte development (GO:0014003 from GO Biological Process Annotations)", "oligodendrocyte differentiation (GO:0048709 from GO Biological Process Annotations)", "oligopeptide transmembrane transport (GO:0035672 from GO Biological Process Annotations)", "oligopeptide transport (GO:0006857 from GO Biological Process Annotations)", "oligosaccharide biosynthetic process (GO:0009312 from GO Biological Process Annotations)", "oligosaccharide catabolic process (GO:0009313 from GO Biological Process Annotations)", "oligosaccharide metabolic process (GO:0009311 from GO Biological Process Annotations)", "oligosaccharide-lipid intermediate biosynthetic process (GO:0006490 from GO Biological Process Annotations)", "omega-hydroxylase p450 pathway (GO:0097267 from GO Biological Process Annotations)", "oncogene-induced cell senescence (GO:0090402 from GO Biological Process Annotations)", "oncosis (GO:0070267 from GO Biological Process Annotations)", "oncostatin-m-mediated signaling pathway (GO:0038165 from GO Biological Process Annotations)", "one-carbon compound transport (GO:0019755 from GO Biological Process Annotations)", "one-carbon metabolic process (GO:0006730 from GO Biological Process Annotations)", "oocyte development (GO:0048599 from GO Biological Process Annotations)", "oocyte differentiation (GO:0009994 from GO Biological Process Annotations)", "oocyte growth (GO:0001555 from GO Biological Process Annotations)", "oocyte maturation (GO:0001556 from GO Biological Process Annotations)", "oogenesis (GO:0048477 from GO Biological Process Annotations)", "oogenesis stage (GO:0022605 from GO Biological Process Annotations)", "operant conditioning (GO:0035106 from GO Biological Process Annotations)", "opioid receptor signaling pathway (GO:0038003 from GO Biological Process Annotations)", "opsin transport (GO:0036372 from GO Biological Process Annotations)", "opsonization (GO:0008228 from GO Biological Process Annotations)", "optic chiasma development (GO:0061360 from GO Biological Process Annotations)", "optic cup formation involved in camera-type eye development (GO:0003408 from GO Biological Process Annotations)", "optic cup morphogenesis involved in camera-type eye development (GO:0002072 from GO Biological Process Annotations)", "optic cup structural organization (GO:0003409 from GO Biological Process Annotations)", "optic nerve development (GO:0021554 from GO Biological Process Annotations)", "optic nerve morphogenesis (GO:0021631 from GO Biological Process Annotations)", "optic nerve structural organization (GO:0021633 from GO Biological Process Annotations)", "optic placode formation (GO:0001743 from GO Biological Process Annotations)", "optic placode formation involved in camera-type eye formation (GO:0046619 from GO Biological Process Annotations)", "optic vesicle morphogenesis (GO:0003404 from GO Biological Process Annotations)", "optokinetic behavior (GO:0007634 from GO Biological Process Annotations)", "orbitofrontal cortex development (GO:0021769 from GO Biological Process Annotations)", "organ development (GO:0048513 from GO Biological Process Annotations)", "organ formation (GO:0048645 from GO Biological Process Annotations)", "organ growth (GO:0035265 from GO Biological Process Annotations)", "organ induction (GO:0001759 from GO Biological Process Annotations)", "organ maturation (GO:0048799 from GO Biological Process Annotations)", "organ morphogenesis (GO:0009887 from GO Biological Process Annotations)", "organ or tissue specific immune response (GO:0002251 from GO Biological Process Annotations)", "organ regeneration (GO:0031100 from GO Biological Process Annotations)", "organ senescence (GO:0010260 from GO Biological Process Annotations)", "organelle assembly (GO:0070925 from GO Biological Process Annotations)", "organelle disassembly (GO:1903008 from GO Biological Process Annotations)", "organelle fission (GO:0048285 from GO Biological Process Annotations)", "organelle fusion (GO:0048284 from GO Biological Process Annotations)", "organelle inheritance (GO:0048308 from GO Biological Process Annotations)", "organelle localization (GO:0051640 from GO Biological Process Annotations)", "organelle membrane fusion (GO:0090174 from GO Biological Process Annotations)", "organelle organization (GO:0006996 from GO Biological Process Annotations)", "organelle transport along microtubule (GO:0072384 from GO Biological Process Annotations)", "organic acid biosynthetic process (GO:0016053 from GO Biological Process Annotations)", "organic acid catabolic process (GO:0016054 from GO Biological Process Annotations)", "organic acid metabolic process (GO:0006082 from GO Biological Process Annotations)", "organic acid transmembrane transport (GO:1903825 from GO Biological Process Annotations)", "organic acid transport (GO:0015849 from GO Biological Process Annotations)", "organic anion transport (GO:0015711 from GO Biological Process Annotations)", "organic cation transport (GO:0015695 from GO Biological Process Annotations)", "organic cyclic compound biosynthetic process (GO:1901362 from GO Biological Process Annotations)", "organic cyclic compound catabolic process (GO:1901361 from GO Biological Process Annotations)", "organic cyclic compound metabolic process (GO:1901360 from GO Biological Process Annotations)", "organic heteropentacyclic compound metabolic process (GO:1901376 from GO Biological Process Annotations)", "organic hydroxy compound biosynthetic process (GO:1901617 from GO Biological Process Annotations)", "organic hydroxy compound catabolic process (GO:1901616 from GO Biological Process Annotations)", "organic hydroxy compound metabolic process (GO:1901615 from GO Biological Process Annotations)", "organic hydroxy compound transport (GO:0015850 from GO Biological Process Annotations)", "organic substance biosynthetic process (GO:1901576 from GO Biological Process Annotations)", "organic substance catabolic process (GO:1901575 from GO Biological Process Annotations)", "organic substance metabolic process (GO:0071704 from GO Biological Process Annotations)", "organic substance transport (GO:0071702 from GO Biological Process Annotations)", "organism emergence from protective structure (GO:0071684 from GO Biological Process Annotations)", "organonitrogen compound biosynthetic process (GO:1901566 from GO Biological Process Annotations)", "organonitrogen compound catabolic process (GO:1901565 from GO Biological Process Annotations)", "organonitrogen compound metabolic process (GO:1901564 from GO Biological Process Annotations)", "organophosphate biosynthetic process (GO:0090407 from GO Biological Process Annotations)", "organophosphate catabolic process (GO:0046434 from GO Biological Process Annotations)", "organophosphate ester transport (GO:0015748 from GO Biological Process Annotations)", "organophosphate metabolic process (GO:0019637 from GO Biological Process Annotations)", "ornithine biosynthetic process (GO:0006592 from GO Biological Process Annotations)", "ornithine catabolic process (GO:0006593 from GO Biological Process Annotations)", "ornithine metabolic process (GO:0006591 from GO Biological Process Annotations)", "ornithine transport (GO:0015822 from GO Biological Process Annotations)", "orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060488 from GO Biological Process Annotations)", "osmosensory signaling pathway (GO:0007231 from GO Biological Process Annotations)", "ossification (GO:0001503 from GO Biological Process Annotations)", "ossification involved in bone maturation (GO:0043931 from GO Biological Process Annotations)", "ossification involved in bone remodeling (GO:0043932 from GO Biological Process Annotations)", "osteoblast development (GO:0002076 from GO Biological Process Annotations)", "osteoblast differentiation (GO:0001649 from GO Biological Process Annotations)", "osteoblast fate commitment (GO:0002051 from GO Biological Process Annotations)", "osteoblast proliferation (GO:0033687 from GO Biological Process Annotations)", "osteoclast development (GO:0036035 from GO Biological Process Annotations)", "osteoclast differentiation (GO:0030316 from GO Biological Process Annotations)", "osteoclast fusion (GO:0072675 from GO Biological Process Annotations)", "osteoclast maturation (GO:0036179 from GO Biological Process Annotations)", "osteoclast proliferation (GO:0002158 from GO Biological Process Annotations)", "otic placode formation (GO:0043049 from GO Biological Process Annotations)", "otic vesicle development (GO:0071599 from GO Biological Process Annotations)", "otic vesicle formation (GO:0030916 from GO Biological Process Annotations)", "otic vesicle morphogenesis (GO:0071600 from GO Biological Process Annotations)", "otolith development (GO:0048840 from GO Biological Process Annotations)", "otolith mineralization (GO:0045299 from GO Biological Process Annotations)", "otolith morphogenesis (GO:0032474 from GO Biological Process Annotations)", "outer dynein arm assembly (GO:0036158 from GO Biological Process Annotations)", "outer ear morphogenesis (GO:0042473 from GO Biological Process Annotations)", "outer medullary collecting duct development (GO:0072060 from GO Biological Process Annotations)", "outer mitochondrial membrane organization (GO:0007008 from GO Biological Process Annotations)", "outflow tract morphogenesis (GO:0003151 from GO Biological Process Annotations)", "outflow tract septum morphogenesis (GO:0003148 from GO Biological Process Annotations)", "ovarian cumulus expansion (GO:0001550 from GO Biological Process Annotations)", "ovarian follicle atresia (GO:0001552 from GO Biological Process Annotations)", "ovarian follicle development (GO:0001541 from GO Biological Process Annotations)", "ovarian follicle rupture (GO:0001543 from GO Biological Process Annotations)", "oviduct development (GO:0060066 from GO Biological Process Annotations)", "oviduct epithelium development (GO:0035846 from GO Biological Process Annotations)", "ovulation (GO:0030728 from GO Biological Process Annotations)", "ovulation cycle (GO:0042698 from GO Biological Process Annotations)", "ovulation cycle process (GO:0022602 from GO Biological Process Annotations)", "ovulation from ovarian follicle (GO:0001542 from GO Biological Process Annotations)", "oxalate metabolic process (GO:0033609 from GO Biological Process Annotations)", "oxalate transport (GO:0019532 from GO Biological Process Annotations)", "oxalic acid secretion (GO:0046724 from GO Biological Process Annotations)", "oxaloacetate metabolic process (GO:0006107 from GO Biological Process Annotations)", "oxidation-dependent protein catabolic process (GO:0070407 from GO Biological Process Annotations)", "oxidation-reduction process (GO:0055114 from GO Biological Process Annotations)", "oxidative deethylation (GO:0071615 from GO Biological Process Annotations)", "oxidative demethylation (GO:0070989 from GO Biological Process Annotations)", "oxidative dna demethylation (GO:0035511 from GO Biological Process Annotations)", "oxidative phosphorylation (GO:0006119 from GO Biological Process Annotations)", "oxidative rna demethylation (GO:0035513 from GO Biological Process Annotations)", "oxidative single-stranded dna demethylation (GO:0035552 from GO Biological Process Annotations)", "oxidative single-stranded rna demethylation (GO:0035553 from GO Biological Process Annotations)", "oxidative stress-induced premature senescence (GO:0090403 from GO Biological Process Annotations)", "oxidoreduction coenzyme metabolic process (GO:0006733 from GO Biological Process Annotations)", "oxoacid metabolic process (GO:0043436 from GO Biological Process Annotations)", "oxygen homeostasis (GO:0032364 from GO Biological Process Annotations)", "oxygen metabolic process (GO:0072592 from GO Biological Process Annotations)", "oxygen transport (GO:0015671 from GO Biological Process Annotations)", "oxylipin metabolic process (GO:0031407 from GO Biological Process Annotations)", "p granule organization (GO:0030719 from GO Biological Process Annotations)", "p38mapk cascade (GO:0038066 from GO Biological Process Annotations)", "palate development (GO:0060021 from GO Biological Process Annotations)", "pallium development (GO:0021543 from GO Biological Process Annotations)", "palmitic acid biosynthetic process (GO:1900535 from GO Biological Process Annotations)", "palmitic acid metabolic process (GO:1900533 from GO Biological Process Annotations)", "pancreas development (GO:0031016 from GO Biological Process Annotations)", "pancreas morphogenesis (GO:0061113 from GO Biological Process Annotations)", "pancreatic a cell development (GO:0003322 from GO Biological Process Annotations)", "pancreatic a cell differentiation (GO:0003310 from GO Biological Process Annotations)", "pancreatic a cell fate commitment (GO:0003326 from GO Biological Process Annotations)", "pancreatic d cell differentiation (GO:0003311 from GO Biological Process Annotations)", "pancreatic epsilon cell differentiation (GO:0090104 from GO Biological Process Annotations)", "pancreatic juice secretion (GO:0030157 from GO Biological Process Annotations)", "pancreatic pp cell fate commitment (GO:0003329 from GO Biological Process Annotations)", "pantothenate metabolic process (GO:0015939 from GO Biological Process Annotations)", "pantothenate transmembrane transport (GO:0015887 from GO Biological Process Annotations)", "paracrine signaling (GO:0038001 from GO Biological Process Annotations)", "parallel actin filament bundle assembly (GO:0030046 from GO Biological Process Annotations)", "paramesonephric duct development (GO:0061205 from GO Biological Process Annotations)", "paranodal junction assembly (GO:0030913 from GO Biological Process Annotations)", "parasympathetic nervous system development (GO:0048486 from GO Biological Process Annotations)", "parathyroid gland development (GO:0060017 from GO Biological Process Annotations)", "parathyroid hormone secretion (GO:0035898 from GO Biological Process Annotations)", "paraxial mesoderm development (GO:0048339 from GO Biological Process Annotations)", "paraxial mesoderm formation (GO:0048341 from GO Biological Process Annotations)", "paraxial mesoderm morphogenesis (GO:0048340 from GO Biological Process Annotations)", "paraxial mesoderm structural organization (GO:0048352 from GO Biological Process Annotations)", "paraxial mesodermal cell fate commitment (GO:0048343 from GO Biological Process Annotations)", "parental behavior (GO:0060746 from GO Biological Process Annotations)", "parturition (GO:0007567 from GO Biological Process Annotations)", "patched ligand maturation (GO:0007225 from GO Biological Process Annotations)", "pathogenesis (GO:0009405 from GO Biological Process Annotations)", "pathway-restricted smad protein phosphorylation (GO:0060389 from GO Biological Process Annotations)", "pattern recognition receptor signaling pathway (GO:0002221 from GO Biological Process Annotations)", "pattern specification involved in kidney development (GO:0061004 from GO Biological Process Annotations)", "pattern specification involved in mesonephros development (GO:0061227 from GO Biological Process Annotations)", "pattern specification involved in metanephros development (GO:0072268 from GO Biological Process Annotations)", "pattern specification involved in pronephros development (GO:0039017 from GO Biological Process Annotations)", "pattern specification process (GO:0007389 from GO Biological Process Annotations)", "patterning of blood vessels (GO:0001569 from GO Biological Process Annotations)", "penetration of zona pellucida (GO:0007341 from GO Biological Process Annotations)", "penile erection (GO:0043084 from GO Biological Process Annotations)", "pentacyclic triterpenoid metabolic process (GO:0019742 from GO Biological Process Annotations)", "pentitol catabolic process (GO:0019527 from GO Biological Process Annotations)", "pentitol metabolic process (GO:0019519 from GO Biological Process Annotations)", "pentose biosynthetic process (GO:0019322 from GO Biological Process Annotations)", "pentose catabolic process (GO:0019323 from GO Biological Process Annotations)", "pentose metabolic process (GO:0019321 from GO Biological Process Annotations)", "pentose-phosphate shunt (GO:0006098 from GO Biological Process Annotations)", "pentose-phosphate shunt, non-oxidative branch (GO:0009052 from GO Biological Process Annotations)", "pentose-phosphate shunt, oxidative branch (GO:0009051 from GO Biological Process Annotations)", "peptide amidation (GO:0001519 from GO Biological Process Annotations)", "peptide antigen assembly with mhc class i protein complex (GO:0002502 from GO Biological Process Annotations)", "peptide antigen assembly with mhc class ii protein complex (GO:0002503 from GO Biological Process Annotations)", "peptide antigen assembly with mhc protein complex (GO:0002501 from GO Biological Process Annotations)", "peptide antigen stabilization (GO:0050823 from GO Biological Process Annotations)", "peptide antigen transport (GO:0046968 from GO Biological Process Annotations)", "peptide biosynthetic process (GO:0043043 from GO Biological Process Annotations)", "peptide catabolic process (GO:0043171 from GO Biological Process Annotations)", "peptide cross-linking (GO:0018149 from GO Biological Process Annotations)", "peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800 from GO Biological Process Annotations)", "peptide hormone processing (GO:0016486 from GO Biological Process Annotations)", "peptide hormone secretion (GO:0030072 from GO Biological Process Annotations)", "peptide metabolic process (GO:0006518 from GO Biological Process Annotations)", "peptide modification (GO:0031179 from GO Biological Process Annotations)", "peptide secretion (GO:0002790 from GO Biological Process Annotations)", "peptide stabilization (GO:0050822 from GO Biological Process Annotations)", "peptide transport (GO:0015833 from GO Biological Process Annotations)", "peptidoglycan catabolic process (GO:0009253 from GO Biological Process Annotations)", "peptidoglycan metabolic process (GO:0000270 from GO Biological Process Annotations)", "peptidyl-alanine modification (GO:0018194 from GO Biological Process Annotations)", "peptidyl-amino acid modification (GO:0018193 from GO Biological Process Annotations)", "peptidyl-arginine methylation (GO:0018216 from GO Biological Process Annotations)", "peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919 from GO Biological Process Annotations)", "peptidyl-arginine methylation, to symmetrical-dimethyl arginine (GO:0019918 from GO Biological Process Annotations)", "peptidyl-arginine modification (GO:0018195 from GO Biological Process Annotations)", "peptidyl-arginine n-methylation (GO:0035246 from GO Biological Process Annotations)", "peptidyl-arginine omega-n-methylation (GO:0035247 from GO Biological Process Annotations)", "peptidyl-asparagine hydroxylation (GO:0042265 from GO Biological Process Annotations)", "peptidyl-asparagine modification (GO:0018196 from GO Biological Process Annotations)", "peptidyl-aspartic acid hydroxylation (GO:0042264 from GO Biological Process Annotations)", "peptidyl-aspartic acid modification (GO:0018197 from GO Biological Process Annotations)", "peptidyl-cysteine methylation (GO:0018125 from GO Biological Process Annotations)", "peptidyl-cysteine modification (GO:0018198 from GO Biological Process Annotations)", "peptidyl-cysteine oxidation (GO:0018171 from GO Biological Process Annotations)", "peptidyl-cysteine s-nitrosylation (GO:0018119 from GO Biological Process Annotations)", "peptidyl-cysteine s-trans-nitrosylation (GO:0035606 from GO Biological Process Annotations)", "peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183 from GO Biological Process Annotations)", "peptidyl-diphthamide metabolic process (GO:0017182 from GO Biological Process Annotations)", "peptidyl-glutamic acid carboxylation (GO:0017187 from GO Biological Process Annotations)", "peptidyl-glutamic acid modification (GO:0018200 from GO Biological Process Annotations)", "peptidyl-glutamine methylation (GO:0018364 from GO Biological Process Annotations)", "peptidyl-glutamine modification (GO:0018199 from GO Biological Process Annotations)", "peptidyl-glycine modification (GO:0018201 from GO Biological Process Annotations)", "peptidyl-histidine dephosphorylation (GO:0035971 from GO Biological Process Annotations)", "peptidyl-histidine hydroxylation (GO:0036138 from GO Biological Process Annotations)", "peptidyl-histidine modification (GO:0018202 from GO Biological Process Annotations)", "peptidyl-l-cysteine s-palmitoylation (GO:0018230 from GO Biological Process Annotations)", "peptidyl-lysine acetylation (GO:0018394 from GO Biological Process Annotations)", "peptidyl-lysine deacetylation (GO:0034983 from GO Biological Process Annotations)", "peptidyl-lysine demalonylation (GO:0036047 from GO Biological Process Annotations)", "peptidyl-lysine desuccinylation (GO:0036049 from GO Biological Process Annotations)", "peptidyl-lysine dimethylation (GO:0018027 from GO Biological Process Annotations)", "peptidyl-lysine hydroxylation (GO:0017185 from GO Biological Process Annotations)", "peptidyl-lysine hydroxylation to 5-hydroxy-l-lysine (GO:0018395 from GO Biological Process Annotations)", "peptidyl-lysine methylation (GO:0018022 from GO Biological Process Annotations)", "peptidyl-lysine modification (GO:0018205 from GO Biological Process Annotations)", "peptidyl-lysine modification to peptidyl-hypusine (GO:0008612 from GO Biological Process Annotations)", "peptidyl-lysine monomethylation (GO:0018026 from GO Biological Process Annotations)", "peptidyl-lysine n6-acetylation (GO:0018003 from GO Biological Process Annotations)", "peptidyl-lysine trimethylation (GO:0018023 from GO Biological Process Annotations)", "peptidyl-methionine modification (GO:0018206 from GO Biological Process Annotations)", "peptidyl-proline hydroxylation (GO:0019511 from GO Biological Process Annotations)", "peptidyl-proline hydroxylation to 3-hydroxy-l-proline (GO:0018400 from GO Biological Process Annotations)", "peptidyl-proline hydroxylation to 4-hydroxy-l-proline (GO:0018401 from GO Biological Process Annotations)", "peptidyl-proline modification (GO:0018208 from GO Biological Process Annotations)", "peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186 from GO Biological Process Annotations)", "peptidyl-pyrromethane cofactor linkage (GO:0018160 from GO Biological Process Annotations)", "peptidyl-s-diacylglycerol-l-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231 from GO Biological Process Annotations)", "peptidyl-serine acetylation (GO:0030920 from GO Biological Process Annotations)", "peptidyl-serine autophosphorylation (GO:0036289 from GO Biological Process Annotations)", "peptidyl-serine dephosphorylation (GO:0070262 from GO Biological Process Annotations)", "peptidyl-serine modification (GO:0018209 from GO Biological Process Annotations)", "peptidyl-serine octanoylation (GO:0018191 from GO Biological Process Annotations)", "peptidyl-serine phosphorylation (GO:0018105 from GO Biological Process Annotations)", "peptidyl-serine trans-autophosphorylation (GO:1990579 from GO Biological Process Annotations)", "peptidyl-threonine dephosphorylation (GO:0035970 from GO Biological Process Annotations)", "peptidyl-threonine modification (GO:0018210 from GO Biological Process Annotations)", "peptidyl-threonine phosphorylation (GO:0018107 from GO Biological Process Annotations)", "peptidyl-tryptophan modification (GO:0018211 from GO Biological Process Annotations)", "peptidyl-tyrosine autophosphorylation (GO:0038083 from GO Biological Process Annotations)", "peptidyl-tyrosine dephosphorylation (GO:0035335 from GO Biological Process Annotations)", "peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264 from GO Biological Process Annotations)", "peptidyl-tyrosine modification (GO:0018212 from GO Biological Process Annotations)", "peptidyl-tyrosine phosphorylation (GO:0018108 from GO Biological Process Annotations)", "peptidyl-tyrosine sulfation (GO:0006478 from GO Biological Process Annotations)", "pericardium development (GO:0060039 from GO Biological Process Annotations)", "pericardium morphogenesis (GO:0003344 from GO Biological Process Annotations)", "pericentric heterochromatin assembly (GO:0031508 from GO Biological Process Annotations)", "peripheral nervous system axon ensheathment (GO:0032292 from GO Biological Process Annotations)", "peripheral nervous system axon regeneration (GO:0014012 from GO Biological Process Annotations)", "peripheral nervous system development (GO:0007422 from GO Biological Process Annotations)", "peripheral nervous system myelin formation (GO:0032290 from GO Biological Process Annotations)", "peripheral nervous system myelin maintenance (GO:0032287 from GO Biological Process Annotations)", "peripheral nervous system neuron axonogenesis (GO:0048936 from GO Biological Process Annotations)", "peripheral nervous system neuron development (GO:0048935 from GO Biological Process Annotations)", "peristalsis (GO:0030432 from GO Biological Process Annotations)", "peroxisomal long-chain fatty acid import (GO:0015910 from GO Biological Process Annotations)", "peroxisomal membrane transport (GO:0015919 from GO Biological Process Annotations)", "peroxisomal transport (GO:0043574 from GO Biological Process Annotations)", "peroxisome degradation (GO:0030242 from GO Biological Process Annotations)", "peroxisome fission (GO:0016559 from GO Biological Process Annotations)", "peroxisome localization (GO:0060151 from GO Biological Process Annotations)", "peroxisome membrane biogenesis (GO:0016557 from GO Biological Process Annotations)", "peroxisome organization (GO:0007031 from GO Biological Process Annotations)", "peroxisome proliferator activated receptor signaling pathway (GO:0035357 from GO Biological Process Annotations)", "peroxisome transport along microtubule (GO:0036250 from GO Biological Process Annotations)", "peyer's patch development (GO:0048541 from GO Biological Process Annotations)", "peyer's patch morphogenesis (GO:0061146 from GO Biological Process Annotations)", "ph elevation (GO:0045852 from GO Biological Process Annotations)", "ph reduction (GO:0045851 from GO Biological Process Annotations)", "phagocytosis (GO:0006909 from GO Biological Process Annotations)", "phagocytosis, engulfment (GO:0006911 from GO Biological Process Annotations)", "phagocytosis, recognition (GO:0006910 from GO Biological Process Annotations)", "phagolysosome assembly (GO:0001845 from GO Biological Process Annotations)", "phagolysosome assembly involved in apoptotic cell clearance (GO:0090387 from GO Biological Process Annotations)", "phagosome acidification (GO:0090383 from GO Biological Process Annotations)", "phagosome maturation (GO:0090382 from GO Biological Process Annotations)", "phagosome-lysosome fusion (GO:0090385 from GO Biological Process Annotations)", "pharyngeal arch artery morphogenesis (GO:0061626 from GO Biological Process Annotations)", "pharyngeal system development (GO:0060037 from GO Biological Process Annotations)", "pharynx development (GO:0060465 from GO Biological Process Annotations)", "phasic smooth muscle contraction (GO:0014821 from GO Biological Process Annotations)", "phenol-containing compound biosynthetic process (GO:0046189 from GO Biological Process Annotations)", "phenol-containing compound catabolic process (GO:0019336 from GO Biological Process Annotations)", "phenol-containing compound metabolic process (GO:0018958 from GO Biological Process Annotations)", "phenylacetate catabolic process (GO:0010124 from GO Biological Process Annotations)", "phenylalanyl-trna aminoacylation (GO:0006432 from GO Biological Process Annotations)", "phenylpropanoid catabolic process (GO:0046271 from GO Biological Process Annotations)", "phenylpropanoid metabolic process (GO:0009698 from GO Biological Process Annotations)", "phosphagen biosynthetic process (GO:0042396 from GO Biological Process Annotations)", "phosphagen metabolic process (GO:0006599 from GO Biological Process Annotations)", "phosphate ion homeostasis (GO:0055062 from GO Biological Process Annotations)", "phosphate ion transmembrane transport (GO:0035435 from GO Biological Process Annotations)", "phosphate ion transport (GO:0006817 from GO Biological Process Annotations)", "phosphate-containing compound metabolic process (GO:0006796 from GO Biological Process Annotations)", "phosphatidic acid biosynthetic process (GO:0006654 from GO Biological Process Annotations)", "phosphatidic acid metabolic process (GO:0046473 from GO Biological Process Annotations)", "phosphatidylcholine acyl-chain remodeling (GO:0036151 from GO Biological Process Annotations)", "phosphatidylcholine biosynthetic process (GO:0006656 from GO Biological Process Annotations)", "phosphatidylcholine catabolic process (GO:0034638 from GO Biological Process Annotations)", "phosphatidylcholine metabolic process (GO:0046470 from GO Biological Process Annotations)", "phosphatidylethanolamine acyl-chain remodeling (GO:0036152 from GO Biological Process Annotations)", "phosphatidylethanolamine biosynthetic process (GO:0006646 from GO Biological Process Annotations)", "phosphatidylethanolamine catabolic process (GO:0046338 from GO Biological Process Annotations)", "phosphatidylethanolamine metabolic process (GO:0046337 from GO Biological Process Annotations)", "phosphatidylglycerol acyl-chain remodeling (GO:0036148 from GO Biological Process Annotations)", "phosphatidylglycerol biosynthetic process (GO:0006655 from GO Biological Process Annotations)", "phosphatidylglycerol metabolic process (GO:0046471 from GO Biological Process Annotations)", "phosphatidylinositol 3-kinase signaling (GO:0014065 from GO Biological Process Annotations)", "phosphatidylinositol acyl-chain remodeling (GO:0036149 from GO Biological Process Annotations)", "phosphatidylinositol biosynthetic process (GO:0006661 from GO Biological Process Annotations)", "phosphatidylinositol catabolic process (GO:0031161 from GO Biological Process Annotations)", "phosphatidylinositol dephosphorylation (GO:0046856 from GO Biological Process Annotations)", "phosphatidylinositol metabolic process (GO:0046488 from GO Biological Process Annotations)", "phosphatidylinositol phosphorylation (GO:0046854 from GO Biological Process Annotations)", "phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092 from GO Biological Process Annotations)", "phosphatidylinositol-mediated signaling (GO:0048015 from GO Biological Process Annotations)", "phosphatidylserine acyl-chain remodeling (GO:0036150 from GO Biological Process Annotations)", "phosphatidylserine biosynthetic process (GO:0006659 from GO Biological Process Annotations)", "phosphatidylserine catabolic process (GO:0006660 from GO Biological Process Annotations)", "phosphatidylserine exposure on apoptotic cell surface (GO:0070782 from GO Biological Process Annotations)", "phosphatidylserine exposure on blood platelet (GO:0097045 from GO Biological Process Annotations)", "phosphatidylserine metabolic process (GO:0006658 from GO Biological Process Annotations)", "phosphoanandamide dephosphorylation (GO:0035644 from GO Biological Process Annotations)", "phosphocreatine biosynthetic process (GO:0046314 from GO Biological Process Annotations)", "phosphocreatine metabolic process (GO:0006603 from GO Biological Process Annotations)", "phospholipase c-activating adrenergic receptor signaling pathway (GO:0071882 from GO Biological Process Annotations)", "phospholipase c-activating angiotensin-activated signaling pathway (GO:0086097 from GO Biological Process Annotations)", "phospholipase c-activating dopamine receptor signaling pathway (GO:0060158 from GO Biological Process Annotations)", "phospholipase c-activating g-protein coupled acetylcholine receptor signaling pathway (GO:0007207 from GO Biological Process Annotations)", "phospholipase c-activating g-protein coupled glutamate receptor signaling pathway (GO:0007206 from GO Biological Process Annotations)", "phospholipase c-activating g-protein coupled receptor signaling pathway (GO:0007200 from GO Biological Process Annotations)", "phospholipase c-activating serotonin receptor signaling pathway (GO:0007208 from GO Biological Process Annotations)", "phospholipase c-inhibiting g-protein coupled receptor signaling pathway (GO:0030845 from GO Biological Process Annotations)", "phospholipase d-activating g-protein coupled receptor signaling pathway (GO:0031583 from GO Biological Process Annotations)", "phospholipid biosynthetic process (GO:0008654 from GO Biological Process Annotations)", "phospholipid catabolic process (GO:0009395 from GO Biological Process Annotations)", "phospholipid dephosphorylation (GO:0046839 from GO Biological Process Annotations)", "phospholipid efflux (GO:0033700 from GO Biological Process Annotations)", "phospholipid homeostasis (GO:0055091 from GO Biological Process Annotations)", "phospholipid metabolic process (GO:0006644 from GO Biological Process Annotations)", "phospholipid scrambling (GO:0017121 from GO Biological Process Annotations)", "phospholipid transfer to membrane (GO:0006649 from GO Biological Process Annotations)", "phospholipid translocation (GO:0045332 from GO Biological Process Annotations)", "phospholipid transport (GO:0015914 from GO Biological Process Annotations)", "phosphorelay signal transduction system (GO:0000160 from GO Biological Process Annotations)", "phosphorus metabolic process (GO:0006793 from GO Biological Process Annotations)", "phosphorylated carbohydrate dephosphorylation (GO:0046838 from GO Biological Process Annotations)", "phosphorylation (GO:0016310 from GO Biological Process Annotations)", "phosphorylation of rna polymerase ii c-terminal domain (GO:0070816 from GO Biological Process Annotations)", "photoperiodism (GO:0009648 from GO Biological Process Annotations)", "photoreactive repair (GO:0000719 from GO Biological Process Annotations)", "photoreceptor cell development (GO:0042461 from GO Biological Process Annotations)", "photoreceptor cell differentiation (GO:0046530 from GO Biological Process Annotations)", "photoreceptor cell fate commitment (GO:0046552 from GO Biological Process Annotations)", "photoreceptor cell maintenance (GO:0045494 from GO Biological Process Annotations)", "photoreceptor cell morphogenesis (GO:0008594 from GO Biological Process Annotations)", "photoreceptor cell outer segment organization (GO:0035845 from GO Biological Process Annotations)", "phototransduction (GO:0007602 from GO Biological Process Annotations)", "phototransduction, visible light (GO:0007603 from GO Biological Process Annotations)", "phthalate metabolic process (GO:0018963 from GO Biological Process Annotations)", "phylloquinone catabolic process (GO:0042376 from GO Biological Process Annotations)", "phylloquinone metabolic process (GO:0042374 from GO Biological Process Annotations)", "phytoalexin metabolic process (GO:0052314 from GO Biological Process Annotations)", "phytol metabolic process (GO:0033306 from GO Biological Process Annotations)", "phytosphingosine biosynthetic process (GO:0071602 from GO Biological Process Annotations)", "phytosphingosine metabolic process (GO:0006671 from GO Biological Process Annotations)", "piecemeal microautophagy of nucleus (GO:0034727 from GO Biological Process Annotations)", "pigment accumulation (GO:0043476 from GO Biological Process Annotations)", "pigment biosynthetic process (GO:0046148 from GO Biological Process Annotations)", "pigment catabolic process (GO:0046149 from GO Biological Process Annotations)", "pigment cell differentiation (GO:0050931 from GO Biological Process Annotations)", "pigment granule aggregation in cell center (GO:0051877 from GO Biological Process Annotations)", "pigment granule localization (GO:0051875 from GO Biological Process Annotations)", "pigment granule maturation (GO:0048757 from GO Biological Process Annotations)", "pigment granule organization (GO:0048753 from GO Biological Process Annotations)", "pigment granule transport (GO:0051904 from GO Biological Process Annotations)", "pigment metabolic process (GO:0042440 from GO Biological Process Annotations)", "pigment metabolic process involved in developmental pigmentation (GO:0043324 from GO Biological Process Annotations)", "pigment metabolic process involved in pigmentation (GO:0043474 from GO Biological Process Annotations)", "pigmentation (GO:0043473 from GO Biological Process Annotations)", "pilomotor reflex (GO:0097195 from GO Biological Process Annotations)", "pinocytosis (GO:0006907 from GO Biological Process Annotations)", "pirna metabolic process (GO:0034587 from GO Biological Process Annotations)", "pituitary gland development (GO:0021983 from GO Biological Process Annotations)", "placenta blood vessel development (GO:0060674 from GO Biological Process Annotations)", "placenta development (GO:0001890 from GO Biological Process Annotations)", "planar cell polarity pathway involved in axis elongation (GO:0003402 from GO Biological Process Annotations)", "planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:0061350 from GO Biological Process Annotations)", "planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:0061349 from GO Biological Process Annotations)", "planar cell polarity pathway involved in heart morphogenesis (GO:0061346 from GO Biological Process Annotations)", "planar cell polarity pathway involved in neural tube closure (GO:0090179 from GO Biological Process Annotations)", "planar cell polarity pathway involved in outflow tract morphogenesis (GO:0061347 from GO Biological Process Annotations)", "planar cell polarity pathway involved in pericardium morphogenesis (GO:0061354 from GO Biological Process Annotations)", "planar cell polarity pathway involved in ventricular septum morphogenesis (GO:0061348 from GO Biological Process Annotations)", "planar dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060489 from GO Biological Process Annotations)", "plasma cell differentiation (GO:0002317 from GO Biological Process Annotations)", "plasma kallikrein-kinin cascade (GO:0002353 from GO Biological Process Annotations)", "plasma lipoprotein particle assembly (GO:0034377 from GO Biological Process Annotations)", "plasma lipoprotein particle clearance (GO:0034381 from GO Biological Process Annotations)", "plasma lipoprotein particle organization (GO:0071827 from GO Biological Process Annotations)", "plasma lipoprotein particle oxidation (GO:0034441 from GO Biological Process Annotations)", "plasma lipoprotein particle remodeling (GO:0034369 from GO Biological Process Annotations)", "plasma membrane copper ion transport (GO:0015679 from GO Biological Process Annotations)", "plasma membrane fusion (GO:0045026 from GO Biological Process Annotations)", "plasma membrane lactate transport (GO:0035879 from GO Biological Process Annotations)", "plasma membrane long-chain fatty acid transport (GO:0015911 from GO Biological Process Annotations)", "plasma membrane organization (GO:0007009 from GO Biological Process Annotations)", "plasma membrane raft assembly (GO:0044854 from GO Biological Process Annotations)", "plasma membrane raft organization (GO:0044857 from GO Biological Process Annotations)", "plasma membrane repair (GO:0001778 from GO Biological Process Annotations)", "plasma membrane to endosome transport (GO:0048227 from GO Biological Process Annotations)", "plasminogen activation (GO:0031639 from GO Biological Process Annotations)", "platelet activating factor biosynthetic process (GO:0006663 from GO Biological Process Annotations)", "platelet activating factor metabolic process (GO:0046469 from GO Biological Process Annotations)", "platelet activation (GO:0030168 from GO Biological Process Annotations)", "platelet aggregation (GO:0070527 from GO Biological Process Annotations)", "platelet alpha granule organization (GO:0070889 from GO Biological Process Annotations)", "platelet degranulation (GO:0002576 from GO Biological Process Annotations)", "platelet dense granule organization (GO:0060155 from GO Biological Process Annotations)", "platelet formation (GO:0030220 from GO Biological Process Annotations)", "platelet morphogenesis (GO:0036344 from GO Biological Process Annotations)", "platelet-derived growth factor receptor signaling pathway (GO:0048008 from GO Biological Process Annotations)", "platelet-derived growth factor receptor-alpha signaling pathway (GO:0035790 from GO Biological Process Annotations)", "platelet-derived growth factor receptor-beta signaling pathway (GO:0035791 from GO Biological Process Annotations)", "plus-end specific microtubule depolymerization (GO:0070462 from GO Biological Process Annotations)", "plus-end-directed organelle transport along microtubule (GO:0072386 from GO Biological Process Annotations)", "plus-end-directed vesicle transport along microtubule (GO:0072383 from GO Biological Process Annotations)", "pma-inducible membrane protein ectodomain proteolysis (GO:0051088 from GO Biological Process Annotations)", "pml body organization (GO:0030578 from GO Biological Process Annotations)", "podosome assembly (GO:0071800 from GO Biological Process Annotations)", "pointed-end actin filament capping (GO:0051694 from GO Biological Process Annotations)", "polar body extrusion after meiotic divisions (GO:0040038 from GO Biological Process Annotations)", "polarity specification of anterior|posterior axis (GO:0009949 from GO Biological Process Annotations)", "polarity specification of proximal|distal axis (GO:0010085 from GO Biological Process Annotations)", "polarized epithelial cell differentiation (GO:0030859 from GO Biological Process Annotations)", "poly(a)+ mrna export from nucleus (GO:0016973 from GO Biological Process Annotations)", "poly-n-acetyllactosamine biosynthetic process (GO:0030311 from GO Biological Process Annotations)", "poly-n-acetyllactosamine metabolic process (GO:0030309 from GO Biological Process Annotations)", "polyadenylation-dependent mrna catabolic process (GO:0071047 from GO Biological Process Annotations)", "polyadenylation-dependent ncrna catabolic process (GO:0043634 from GO Biological Process Annotations)", "polyadenylation-dependent rna catabolic process (GO:0043633 from GO Biological Process Annotations)", "polyadenylation-dependent snorna 3'-end processing (GO:0071051 from GO Biological Process Annotations)", "polyamine acetylation (GO:0032917 from GO Biological Process Annotations)", "polyamine biosynthetic process (GO:0006596 from GO Biological Process Annotations)", "polyamine catabolic process (GO:0006598 from GO Biological Process Annotations)", "polyamine homeostasis (GO:0010509 from GO Biological Process Annotations)", "polyamine metabolic process (GO:0006595 from GO Biological Process Annotations)", "polyamine transport (GO:0015846 from GO Biological Process Annotations)", "polyketide metabolic process (GO:0030638 from GO Biological Process Annotations)", "polynucleotide 3' dephosphorylation (GO:0098506 from GO Biological Process Annotations)", "polynucleotide 5' dephosphorylation (GO:0098507 from GO Biological Process Annotations)", "polynucleotide dephosphorylation (GO:0098501 from GO Biological Process Annotations)", "polyol biosynthetic process (GO:0046173 from GO Biological Process Annotations)", "polyol catabolic process (GO:0046174 from GO Biological Process Annotations)", "polyol metabolic process (GO:0019751 from GO Biological Process Annotations)", "polyol transport (GO:0015791 from GO Biological Process Annotations)", "polyphosphate metabolic process (GO:0006797 from GO Biological Process Annotations)", "polyprenol biosynthetic process (GO:0016094 from GO Biological Process Annotations)", "polyprenol catabolic process (GO:0016095 from GO Biological Process Annotations)", "polyprenol metabolic process (GO:0016093 from GO Biological Process Annotations)", "polysaccharide assembly with mhc class ii protein complex (GO:0002506 from GO Biological Process Annotations)", "polysaccharide biosynthetic process (GO:0000271 from GO Biological Process Annotations)", "polysaccharide catabolic process (GO:0000272 from GO Biological Process Annotations)", "polysaccharide digestion (GO:0044245 from GO Biological Process Annotations)", "polysaccharide localization (GO:0033037 from GO Biological Process Annotations)", "polysaccharide metabolic process (GO:0005976 from GO Biological Process Annotations)", "polyubiquitinated misfolded protein transport (GO:0070845 from GO Biological Process Annotations)", "polyubiquitinated protein transport (GO:0070844 from GO Biological Process Annotations)", "polyuridylation-dependent mrna catabolic process (GO:1990074 from GO Biological Process Annotations)", "pons development (GO:0021548 from GO Biological Process Annotations)", "pons maturation (GO:0021586 from GO Biological Process Annotations)", "pore complex assembly (GO:0046931 from GO Biological Process Annotations)", "porphyrin-containing compound biosynthetic process (GO:0006779 from GO Biological Process Annotations)", "porphyrin-containing compound catabolic process (GO:0006787 from GO Biological Process Annotations)", "porphyrin-containing compound metabolic process (GO:0006778 from GO Biological Process Annotations)", "positive chemotaxis (GO:0050918 from GO Biological Process Annotations)", "positive regulation by host of viral genome replication (GO:0044829 from GO Biological Process Annotations)", "positive regulation by host of viral process (GO:0044794 from GO Biological Process Annotations)", "positive regulation by host of viral release from host cell (GO:0044791 from GO Biological Process Annotations)", "positive regulation by host of viral transcription (GO:0043923 from GO Biological Process Annotations)", "positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction (GO:0052501 from GO Biological Process Annotations)", "positive regulation by organism of defense response of other organism involved in symbiotic interaction (GO:0052510 from GO Biological Process Annotations)", "positive regulation by organism of defense-related nitric oxide production in other organism involved in symbiotic interaction (GO:0052345 from GO Biological Process Annotations)", "positive regulation by organism of immune response of other organism involved in symbiotic interaction (GO:0052555 from GO Biological Process Annotations)", "positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction (GO:0052522 from GO Biological Process Annotations)", "positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction (GO:0052330 from GO Biological Process Annotations)", "positive regulation by symbiont of defense-related host nitric oxide production (GO:0052347 from GO Biological Process Annotations)", "positive regulation by symbiont of host apoptotic process (GO:0052151 from GO Biological Process Annotations)", "positive regulation by symbiont of host defense response (GO:0052509 from GO Biological Process Annotations)", "positive regulation by symbiont of host immune response (GO:0052556 from GO Biological Process Annotations)", "positive regulation by symbiont of host phagocytosis (GO:0052191 from GO Biological Process Annotations)", "positive regulation by symbiont of host programmed cell death (GO:0052042 from GO Biological Process Annotations)", "positive regulation by virus of viral protein levels in host cell (GO:0046726 from GO Biological Process Annotations)", "positive regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043128 from GO Biological Process Annotations)", "positive regulation of abscisic acid-activated signaling pathway (GO:0009789 from GO Biological Process Annotations)", "positive regulation of acetylcholine secretion, neurotransmission (GO:0014057 from GO Biological Process Annotations)", "positive regulation of acrosomal vesicle exocytosis (GO:2000368 from GO Biological Process Annotations)", "positive regulation of acrosome reaction (GO:2000344 from GO Biological Process Annotations)", "positive regulation of actin cytoskeleton reorganization (GO:2000251 from GO Biological Process Annotations)", "positive regulation of actin filament bundle assembly (GO:0032233 from GO Biological Process Annotations)", "positive regulation of actin filament depolymerization (GO:0030836 from GO Biological Process Annotations)", "positive regulation of actin filament polymerization (GO:0030838 from GO Biological Process Annotations)", "positive regulation of actin nucleation (GO:0051127 from GO Biological Process Annotations)", "positive regulation of action potential (GO:0045760 from GO Biological Process Annotations)", "positive regulation of activated t cell proliferation (GO:0042104 from GO Biological Process Annotations)", "positive regulation of activation of jak2 kinase activity (GO:0010535 from GO Biological Process Annotations)", "positive regulation of activation of janus kinase activity (GO:0010536 from GO Biological Process Annotations)", "positive regulation of activation of membrane attack complex (GO:0001970 from GO Biological Process Annotations)", "positive regulation of activation-induced cell death of t cells (GO:0070237 from GO Biological Process Annotations)", "positive regulation of activin receptor signaling pathway (GO:0032927 from GO Biological Process Annotations)", "positive regulation of acute inflammatory response (GO:0002675 from GO Biological Process Annotations)", "positive regulation of acute inflammatory response to antigenic stimulus (GO:0002866 from GO Biological Process Annotations)", "positive regulation of acute inflammatory response to non-antigenic stimulus (GO:0002879 from GO Biological Process Annotations)", "positive regulation of adaptive immune response (GO:0002821 from GO Biological Process Annotations)", "positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824 from GO Biological Process Annotations)", "positive regulation of adenosine receptor signaling pathway (GO:0060168 from GO Biological Process Annotations)", "positive regulation of adenylate cyclase activity (GO:0045762 from GO Biological Process Annotations)", "positive regulation of adenylate cyclase activity involved in g-protein coupled receptor signaling pathway (GO:0010579 from GO Biological Process Annotations)", "positive regulation of adherens junction organization (GO:1903393 from GO Biological Process Annotations)", "positive regulation of adiponectin secretion (GO:0070165 from GO Biological Process Annotations)", "positive regulation of adrenergic receptor signaling pathway (GO:0071879 from GO Biological Process Annotations)", "positive regulation of adrenergic receptor signaling pathway involved in heart process (GO:1901206 from GO Biological Process Annotations)", "positive regulation of alcohol biosynthetic process (GO:1902932 from GO Biological Process Annotations)", "positive regulation of aldosterone biosynthetic process (GO:0032349 from GO Biological Process Annotations)", "positive regulation of aldosterone metabolic process (GO:0032346 from GO Biological Process Annotations)", "positive regulation of aldosterone secretion (GO:2000860 from GO Biological Process Annotations)", "positive regulation of alkaline phosphatase activity (GO:0010694 from GO Biological Process Annotations)", "positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity (GO:2000969 from GO Biological Process Annotations)", "positive regulation of alpha-beta t cell activation (GO:0046635 from GO Biological Process Annotations)", "positive regulation of alpha-beta t cell differentiation (GO:0046638 from GO Biological Process Annotations)", "positive regulation of alpha-beta t cell proliferation (GO:0046641 from GO Biological Process Annotations)", "positive regulation of amine transport (GO:0051954 from GO Biological Process Annotations)", "positive regulation of amino acid transport (GO:0051957 from GO Biological Process Annotations)", "positive regulation of ammonia assimilation cycle (GO:2001250 from GO Biological Process Annotations)", "positive regulation of amyloid precursor protein biosynthetic process (GO:0042986 from GO Biological Process Annotations)", "positive regulation of amyloid precursor protein catabolic process (GO:1902993 from GO Biological Process Annotations)", "positive regulation of anagen (GO:0051885 from GO Biological Process Annotations)", "positive regulation of androgen receptor activity (GO:2000825 from GO Biological Process Annotations)", "positive regulation of androgen secretion (GO:2000836 from GO Biological Process Annotations)", "positive regulation of angiogenesis (GO:0045766 from GO Biological Process Annotations)", "positive regulation of anion channel activity (GO:1901529 from GO Biological Process Annotations)", "positive regulation of anion transport (GO:1903793 from GO Biological Process Annotations)", "positive regulation of anoikis (GO:2000210 from GO Biological Process Annotations)", "positive regulation of anterior head development (GO:2000744 from GO Biological Process Annotations)", "positive regulation of antibacterial peptide biosynthetic process (GO:0006963 from GO Biological Process Annotations)", "positive regulation of antibacterial peptide production (GO:0002803 from GO Biological Process Annotations)", "positive regulation of antigen processing and presentation (GO:0002579 from GO Biological Process Annotations)", "positive regulation of antigen processing and presentation of peptide antigen (GO:0002585 from GO Biological Process Annotations)", "positive regulation of antigen processing and presentation of peptide antigen via mhc class i (GO:0002591 from GO Biological Process Annotations)", "positive regulation of antigen processing and presentation of peptide antigen via mhc class ii (GO:0002588 from GO Biological Process Annotations)", "positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via mhc class ii (GO:0002582 from GO Biological Process Annotations)", "positive regulation of antigen receptor-mediated signaling pathway (GO:0050857 from GO Biological Process Annotations)", "positive regulation of antimicrobial humoral response (GO:0002760 from GO Biological Process Annotations)", "positive regulation of antimicrobial peptide biosynthetic process (GO:0002807 from GO Biological Process Annotations)", "positive regulation of antimicrobial peptide production (GO:0002225 from GO Biological Process Annotations)", "positive regulation of antral ovarian follicle growth (GO:2000388 from GO Biological Process Annotations)", "positive regulation of apoptotic cell clearance (GO:2000427 from GO Biological Process Annotations)", "positive regulation of apoptotic dna fragmentation (GO:1902512 from GO Biological Process Annotations)", "positive regulation of apoptotic process (GO:0043065 from GO Biological Process Annotations)", "positive regulation of apoptotic process by virus (GO:0060139 from GO Biological Process Annotations)", "positive regulation of apoptotic process in other organism (GO:0044533 from GO Biological Process Annotations)", "positive regulation of apoptotic process involved in mammary gland involution (GO:0060058 from GO Biological Process Annotations)", "positive regulation of apoptotic process involved in morphogenesis (GO:1902339 from GO Biological Process Annotations)", "positive regulation of apoptotic signaling pathway (GO:2001235 from GO Biological Process Annotations)", "positive regulation of appetite (GO:0032100 from GO Biological Process Annotations)", "positive regulation of arachidonic acid secretion (GO:0090238 from GO Biological Process Annotations)", "positive regulation of arp2|3 complex-mediated actin nucleation (GO:2000601 from GO Biological Process Annotations)", "positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961 from GO Biological Process Annotations)", "positive regulation of astrocyte chemotaxis (GO:2000464 from GO Biological Process Annotations)", "positive regulation of astrocyte differentiation (GO:0048711 from GO Biological Process Annotations)", "positive regulation of atp biosynthetic process (GO:2001171 from GO Biological Process Annotations)", "positive regulation of atp metabolic process (GO:1903580 from GO Biological Process Annotations)", "positive regulation of atpase activity (GO:0032781 from GO Biological Process Annotations)", "positive regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902425 from GO Biological Process Annotations)", "positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987 from GO Biological Process Annotations)", "positive regulation of auditory receptor cell differentiation (GO:0045609 from GO Biological Process Annotations)", "positive regulation of autophagic vacuole assembly (GO:2000786 from GO Biological Process Annotations)", "positive regulation of autophagy (GO:0010508 from GO Biological Process Annotations)", "positive regulation of axon extension (GO:0045773 from GO Biological Process Annotations)", "positive regulation of axon extension involved in axon guidance (GO:0048842 from GO Biological Process Annotations)", "positive regulation of axon extension involved in regeneration (GO:0048691 from GO Biological Process Annotations)", "positive regulation of axon guidance (GO:1902669 from GO Biological Process Annotations)", "positive regulation of axon regeneration (GO:0048680 from GO Biological Process Annotations)", "positive regulation of axonogenesis (GO:0050772 from GO Biological Process Annotations)", "positive regulation of b cell activation (GO:0050871 from GO Biological Process Annotations)", "positive regulation of b cell apoptotic process (GO:0002904 from GO Biological Process Annotations)", "positive regulation of b cell chemotaxis (GO:2000538 from GO Biological Process Annotations)", "positive regulation of b cell differentiation (GO:0045579 from GO Biological Process Annotations)", "positive regulation of b cell mediated immunity (GO:0002714 from GO Biological Process Annotations)", "positive regulation of b cell proliferation (GO:0030890 from GO Biological Process Annotations)", "positive regulation of b cell receptor signaling pathway (GO:0050861 from GO Biological Process Annotations)", "positive regulation of b cell tolerance induction (GO:0002663 from GO Biological Process Annotations)", "positive regulation of behavior (GO:0048520 from GO Biological Process Annotations)", "positive regulation of behavioral fear response (GO:2000987 from GO Biological Process Annotations)", "positive regulation of beta-amyloid clearance (GO:1900223 from GO Biological Process Annotations)", "positive regulation of beta-amyloid formation (GO:1902004 from GO Biological Process Annotations)", "positive regulation of bile acid biosynthetic process (GO:0070859 from GO Biological Process Annotations)", "positive regulation of binding (GO:0051099 from GO Biological Process Annotations)", "positive regulation of biological process (GO:0048518 from GO Biological Process Annotations)", "positive regulation of biomineral tissue development (GO:0070169 from GO Biological Process Annotations)", "positive regulation of biosynthetic process (GO:0009891 from GO Biological Process Annotations)", "positive regulation of biosynthetic process of antibacterial peptides active against gram-positive bacteria (GO:0006965 from GO Biological Process Annotations)", "positive regulation of blood circulation (GO:1903524 from GO Biological Process Annotations)", "positive regulation of blood coagulation (GO:0030194 from GO Biological Process Annotations)", "positive regulation of blood microparticle formation (GO:2000334 from GO Biological Process Annotations)", "positive regulation of blood pressure (GO:0045777 from GO Biological Process Annotations)", "positive regulation of blood vessel endothelial cell migration (GO:0043536 from GO Biological Process Annotations)", "positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589 from GO Biological Process Annotations)", "positive regulation of blood vessel remodeling (GO:2000504 from GO Biological Process Annotations)", "positive regulation of bmp signaling pathway (GO:0030513 from GO Biological Process Annotations)", "positive regulation of bone development (GO:1903012 from GO Biological Process Annotations)", "positive regulation of bone mineralization (GO:0030501 from GO Biological Process Annotations)", "positive regulation of bone mineralization involved in bone maturation (GO:1900159 from GO Biological Process Annotations)", "positive regulation of bone remodeling (GO:0046852 from GO Biological Process Annotations)", "positive regulation of bone resorption (GO:0045780 from GO Biological Process Annotations)", "positive regulation of branching involved in lung morphogenesis (GO:0061047 from GO Biological Process Annotations)", "positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190 from GO Biological Process Annotations)", "positive regulation of brown fat cell differentiation (GO:0090336 from GO Biological Process Annotations)", "positive regulation of brown fat cell proliferation (GO:0070349 from GO Biological Process Annotations)", "positive regulation of c-c chemokine receptor ccr7 signaling pathway (GO:1903082 from GO Biological Process Annotations)", "positive regulation of calcidiol 1-monooxygenase activity (GO:0060559 from GO Biological Process Annotations)", "positive regulation of calcineurin-nfat signaling cascade (GO:0070886 from GO Biological Process Annotations)", "positive regulation of calcium ion import (GO:0090280 from GO Biological Process Annotations)", "positive regulation of calcium ion transmembrane transporter activity (GO:1901021 from GO Biological Process Annotations)", "positive regulation of calcium ion transport (GO:0051928 from GO Biological Process Annotations)", "positive regulation of calcium ion transport into cytosol (GO:0010524 from GO Biological Process Annotations)", "positive regulation of calcium ion-dependent exocytosis (GO:0045956 from GO Biological Process Annotations)", "positive regulation of calcium-dependent cell-cell adhesion (GO:0046587 from GO Biological Process Annotations)", "positive regulation of calcium-independent cell-cell adhesion (GO:0051041 from GO Biological Process Annotations)", "positive regulation of calcium-mediated signaling (GO:0050850 from GO Biological Process Annotations)", "positive regulation of calcium-transporting atpase activity (GO:1901896 from GO Biological Process Annotations)", "positive regulation of calcium:sodium antiporter activity (GO:1903281 from GO Biological Process Annotations)", "positive regulation of camp biosynthetic process (GO:0030819 from GO Biological Process Annotations)", "positive regulation of camp catabolic process (GO:0030822 from GO Biological Process Annotations)", "positive regulation of camp metabolic process (GO:0030816 from GO Biological Process Annotations)", "positive regulation of camp-dependent protein kinase activity (GO:2000481 from GO Biological Process Annotations)", "positive regulation of camp-mediated signaling (GO:0043950 from GO Biological Process Annotations)", "positive regulation of canonical wnt signaling pathway (GO:0090263 from GO Biological Process Annotations)", "positive regulation of canonical wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901297 from GO Biological Process Annotations)", "positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation (GO:2000081 from GO Biological Process Annotations)", "positive regulation of cap-dependent translational initiation (GO:1903676 from GO Biological Process Annotations)", "positive regulation of cap-independent translational initiation (GO:1903679 from GO Biological Process Annotations)", "positive regulation of carbohydrate metabolic process (GO:0045913 from GO Biological Process Annotations)", "positive regulation of cardiac conduction (GO:1903781 from GO Biological Process Annotations)", "positive regulation of cardiac muscle adaptation (GO:0010615 from GO Biological Process Annotations)", "positive regulation of cardiac muscle cell apoptotic process (GO:0010666 from GO Biological Process Annotations)", "positive regulation of cardiac muscle cell differentiation (GO:2000727 from GO Biological Process Annotations)", "positive regulation of cardiac muscle cell proliferation (GO:0060045 from GO Biological Process Annotations)", "positive regulation of cardiac muscle contraction (GO:0060452 from GO Biological Process Annotations)", "positive regulation of cardiac muscle fiber development (GO:0055020 from GO Biological Process Annotations)", "positive regulation of cardiac muscle hypertrophy (GO:0010613 from GO Biological Process Annotations)", "positive regulation of cardiac muscle hypertrophy in response to stress (GO:1903244 from GO Biological Process Annotations)", "positive regulation of cardiac muscle tissue development (GO:0055025 from GO Biological Process Annotations)", "positive regulation of cardiac muscle tissue growth (GO:0055023 from GO Biological Process Annotations)", "positive regulation of cardiac vascular smooth muscle cell differentiation (GO:2000724 from GO Biological Process Annotations)", "positive regulation of cardioblast differentiation (GO:0051891 from GO Biological Process Annotations)", "positive regulation of cardiolipin metabolic process (GO:1900210 from GO Biological Process Annotations)", "positive regulation of cartilage development (GO:0061036 from GO Biological Process Annotations)", "positive regulation of catabolic process (GO:0009896 from GO Biological Process Annotations)", "positive regulation of catagen (GO:0051795 from GO Biological Process Annotations)", "positive regulation of catalytic activity (GO:0043085 from GO Biological Process Annotations)", "positive regulation of catecholamine metabolic process (GO:0045915 from GO Biological Process Annotations)", "positive regulation of catecholamine secretion (GO:0033605 from GO Biological Process Annotations)", "positive regulation of catecholamine uptake involved in synaptic transmission (GO:0051944 from GO Biological Process Annotations)", "positive regulation of catenin import into nucleus (GO:0035413 from GO Biological Process Annotations)", "positive regulation of cation channel activity (GO:2001259 from GO Biological Process Annotations)", "positive regulation of caveolin-mediated endocytosis (GO:2001288 from GO Biological Process Annotations)", "positive regulation of cd24 biosynthetic process (GO:2000560 from GO Biological Process Annotations)", "positive regulation of cd4-positive, alpha-beta t cell activation (GO:2000516 from GO Biological Process Annotations)", "positive regulation of cd4-positive, alpha-beta t cell costimulation (GO:1900281 from GO Biological Process Annotations)", "positive regulation of cd4-positive, alpha-beta t cell differentiation (GO:0043372 from GO Biological Process Annotations)", "positive regulation of cd4-positive, alpha-beta t cell proliferation (GO:2000563 from GO Biological Process Annotations)", "positive regulation of cd4-positive, cd25-positive, alpha-beta regulatory t cell differentiation (GO:0032831 from GO Biological Process Annotations)", "positive regulation of cd40 signaling pathway (GO:2000350 from GO Biological Process Annotations)", "positive regulation of cd8-positive, alpha-beta cytotoxic t cell extravasation (GO:2000454 from GO Biological Process Annotations)", "positive regulation of cd8-positive, alpha-beta t cell activation (GO:2001187 from GO Biological Process Annotations)", "positive regulation of cd8-positive, alpha-beta t cell differentiation (GO:0043378 from GO Biological Process Annotations)", "positive regulation of cd8-positive, alpha-beta t cell extravasation (GO:2000451 from GO Biological Process Annotations)", "positive regulation of cd8-positive, alpha-beta t cell proliferation (GO:2000566 from GO Biological Process Annotations)", "positive regulation of cell activation (GO:0050867 from GO Biological Process Annotations)", "positive regulation of cell adhesion (GO:0045785 from GO Biological Process Annotations)", "positive regulation of cell adhesion mediated by integrin (GO:0033630 from GO Biological Process Annotations)", "positive regulation of cell adhesion molecule production (GO:0060355 from GO Biological Process Annotations)", "positive regulation of cell aging (GO:0090343 from GO Biological Process Annotations)", "positive regulation of cell communication (GO:0010647 from GO Biological Process Annotations)", "positive regulation of cell communication by chemical coupling (GO:0010652 from GO Biological Process Annotations)", "positive regulation of cell communication by electrical coupling (GO:0010650 from GO Biological Process Annotations)", "positive regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901846 from GO Biological Process Annotations)", "positive regulation of cell cycle (GO:0045787 from GO Biological Process Annotations)", "positive regulation of cell cycle arrest (GO:0071158 from GO Biological Process Annotations)", "positive regulation of cell cycle checkpoint (GO:1901978 from GO Biological Process Annotations)", "positive regulation of cell cycle g1|s phase transition (GO:1902808 from GO Biological Process Annotations)", "positive regulation of cell cycle g2|m phase transition (GO:1902751 from GO Biological Process Annotations)", "positive regulation of cell cycle phase transition (GO:1901989 from GO Biological Process Annotations)", "positive regulation of cell cycle process (GO:0090068 from GO Biological Process Annotations)", "positive regulation of cell death (GO:0010942 from GO Biological Process Annotations)", "positive regulation of cell development (GO:0010720 from GO Biological Process Annotations)", "positive regulation of cell differentiation (GO:0045597 from GO Biological Process Annotations)", "positive regulation of cell division (GO:0051781 from GO Biological Process Annotations)", "positive regulation of cell fate commitment (GO:0010455 from GO Biological Process Annotations)", "positive regulation of cell fate specification (GO:0042660 from GO Biological Process Annotations)", "positive regulation of cell growth (GO:0030307 from GO Biological Process Annotations)", "positive regulation of cell growth involved in cardiac muscle cell development (GO:0061051 from GO Biological Process Annotations)", "positive regulation of cell junction assembly (GO:1901890 from GO Biological Process Annotations)", "positive regulation of cell killing (GO:0031343 from GO Biological Process Annotations)", "positive regulation of cell maturation (GO:1903431 from GO Biological Process Annotations)", "positive regulation of cell migration (GO:0030335 from GO Biological Process Annotations)", "positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089 from GO Biological Process Annotations)", "positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050 from GO Biological Process Annotations)", "positive regulation of cell morphogenesis involved in differentiation (GO:0010770 from GO Biological Process Annotations)", "positive regulation of cell motility (GO:2000147 from GO Biological Process Annotations)", "positive regulation of cell projection organization (GO:0031346 from GO Biological Process Annotations)", "positive regulation of cell proliferation (GO:0008284 from GO Biological Process Annotations)", "positive regulation of cell proliferation by vegf-activated platelet derived growth factor receptor signaling pathway (GO:0038091 from GO Biological Process Annotations)", "positive regulation of cell proliferation in bone marrow (GO:0071864 from GO Biological Process Annotations)", "positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138 from GO Biological Process Annotations)", "positive regulation of cell proliferation involved in heart valve morphogenesis (GO:0003251 from GO Biological Process Annotations)", "positive regulation of cell proliferation involved in kidney development (GO:1901724 from GO Biological Process Annotations)", "positive regulation of cell size (GO:0045793 from GO Biological Process Annotations)", "positive regulation of cell volume (GO:0045795 from GO Biological Process Annotations)", "positive regulation of cell-cell adhesion (GO:0022409 from GO Biological Process Annotations)", "positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049 from GO Biological Process Annotations)", "positive regulation of cell-cell adhesion mediated by integrin (GO:0033634 from GO Biological Process Annotations)", "positive regulation of cell-matrix adhesion (GO:0001954 from GO Biological Process Annotations)", "positive regulation of cell-substrate adhesion (GO:0010811 from GO Biological Process Annotations)", "positive regulation of cellular amide metabolic process (GO:0034250 from GO Biological Process Annotations)", "positive regulation of cellular amine metabolic process (GO:0033240 from GO Biological Process Annotations)", "positive regulation of cellular amino acid biosynthetic process (GO:2000284 from GO Biological Process Annotations)", "positive regulation of cellular amino acid metabolic process (GO:0045764 from GO Biological Process Annotations)", "positive regulation of cellular biosynthetic process (GO:0031328 from GO Biological Process Annotations)", "positive regulation of cellular carbohydrate metabolic process (GO:0010676 from GO Biological Process Annotations)", "positive regulation of cellular catabolic process (GO:0031331 from GO Biological Process Annotations)", "positive regulation of cellular component biogenesis (GO:0044089 from GO Biological Process Annotations)", "positive regulation of cellular component movement (GO:0051272 from GO Biological Process Annotations)", "positive regulation of cellular component organization (GO:0051130 from GO Biological Process Annotations)", "positive regulation of cellular extravasation (GO:0002693 from GO Biological Process Annotations)", "positive regulation of cellular glucuronidation (GO:2001031 from GO Biological Process Annotations)", "positive regulation of cellular metabolic process (GO:0031325 from GO Biological Process Annotations)", "positive regulation of cellular ph reduction (GO:0032849 from GO Biological Process Annotations)", "positive regulation of cellular process (GO:0048522 from GO Biological Process Annotations)", "positive regulation of cellular protein catabolic process (GO:1903364 from GO Biological Process Annotations)", "positive regulation of cellular protein localization (GO:1903829 from GO Biological Process Annotations)", "positive regulation of cellular protein metabolic process (GO:0032270 from GO Biological Process Annotations)", "positive regulation of cellular respiration (GO:1901857 from GO Biological Process Annotations)", "positive regulation of cellular response to drug (GO:2001040 from GO Biological Process Annotations)", "positive regulation of cellular response to hypoxia (GO:1900039 from GO Biological Process Annotations)", "positive regulation of cellular response to insulin stimulus (GO:1900078 from GO Biological Process Annotations)", "positive regulation of cellular response to oxidative stress (GO:1900409 from GO Biological Process Annotations)", "positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846 from GO Biological Process Annotations)", "positive regulation of cellular response to x-ray (GO:2000685 from GO Biological Process Annotations)", "positive regulation of cellular senescence (GO:2000774 from GO Biological Process Annotations)", "positive regulation of central b cell tolerance induction (GO:0002897 from GO Biological Process Annotations)", "positive regulation of central tolerance induction (GO:0002648 from GO Biological Process Annotations)", "positive regulation of centriole elongation (GO:1903724 from GO Biological Process Annotations)", "positive regulation of centriole replication (GO:0046601 from GO Biological Process Annotations)", "positive regulation of centrosome cycle (GO:0046607 from GO Biological Process Annotations)", "positive regulation of centrosome duplication (GO:0010825 from GO Biological Process Annotations)", "positive regulation of ceramide biosynthetic process (GO:2000304 from GO Biological Process Annotations)", "positive regulation of cerebellar granule cell precursor proliferation (GO:0021940 from GO Biological Process Annotations)", "positive regulation of cgmp biosynthetic process (GO:0030828 from GO Biological Process Annotations)", "positive regulation of cgmp metabolic process (GO:0030825 from GO Biological Process Annotations)", "positive regulation of chaperone-mediated protein complex assembly (GO:0090035 from GO Biological Process Annotations)", "positive regulation of chemokine (c-c motif) ligand 5 production (GO:0071651 from GO Biological Process Annotations)", "positive regulation of chemokine (c-x-c motif) ligand 1 production (GO:2000340 from GO Biological Process Annotations)", "positive regulation of chemokine (c-x-c motif) ligand 2 production (GO:2000343 from GO Biological Process Annotations)", "positive regulation of chemokine biosynthetic process (GO:0045080 from GO Biological Process Annotations)", "positive regulation of chemokine production (GO:0032722 from GO Biological Process Annotations)", "positive regulation of chemokine secretion (GO:0090197 from GO Biological Process Annotations)", "positive regulation of chemokine-mediated signaling pathway (GO:0070101 from GO Biological Process Annotations)", "positive regulation of chemotaxis (GO:0050921 from GO Biological Process Annotations)", "positive regulation of cholesterol biosynthetic process (GO:0045542 from GO Biological Process Annotations)", "positive regulation of cholesterol efflux (GO:0010875 from GO Biological Process Annotations)", "positive regulation of cholesterol esterification (GO:0010873 from GO Biological Process Annotations)", "positive regulation of cholesterol homeostasis (GO:2000189 from GO Biological Process Annotations)", "positive regulation of cholesterol metabolic process (GO:0090205 from GO Biological Process Annotations)", "positive regulation of cholesterol storage (GO:0010886 from GO Biological Process Annotations)", "positive regulation of cholesterol transport (GO:0032376 from GO Biological Process Annotations)", "positive regulation of choline o-acetyltransferase activity (GO:1902771 from GO Biological Process Annotations)", "positive regulation of chondrocyte differentiation (GO:0032332 from GO Biological Process Annotations)", "positive regulation of chondrocyte proliferation (GO:1902732 from GO Biological Process Annotations)", "positive regulation of chromatin assembly or disassembly (GO:0045799 from GO Biological Process Annotations)", "positive regulation of chromatin binding (GO:0035563 from GO Biological Process Annotations)", "positive regulation of chromatin modification (GO:1903310 from GO Biological Process Annotations)", "positive regulation of chromatin silencing (GO:0031937 from GO Biological Process Annotations)", "positive regulation of chromosome organization (GO:2001252 from GO Biological Process Annotations)", "positive regulation of chromosome segregation (GO:0051984 from GO Biological Process Annotations)", "positive regulation of chronic inflammatory response (GO:0002678 from GO Biological Process Annotations)", "positive regulation of chronic inflammatory response to antigenic stimulus (GO:0002876 from GO Biological Process Annotations)", "positive regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002882 from GO Biological Process Annotations)", "positive regulation of chylomicron remnant clearance (GO:0090321 from GO Biological Process Annotations)", "positive regulation of cilium assembly (GO:0045724 from GO Biological Process Annotations)", "positive regulation of cilium movement (GO:0003353 from GO Biological Process Annotations)", "positive regulation of circadian rhythm (GO:0042753 from GO Biological Process Annotations)", "positive regulation of circadian sleep|wake cycle, non-rem sleep (GO:0046010 from GO Biological Process Annotations)", "positive regulation of circadian sleep|wake cycle, rem sleep (GO:0046005 from GO Biological Process Annotations)", "positive regulation of circadian sleep|wake cycle, sleep (GO:0045938 from GO Biological Process Annotations)", "positive regulation of circadian sleep|wake cycle, wakefulness (GO:0010841 from GO Biological Process Annotations)", "positive regulation of clathrin-mediated endocytosis (GO:2000370 from GO Biological Process Annotations)", "positive regulation of coagulation (GO:0050820 from GO Biological Process Annotations)", "positive regulation of collagen binding (GO:0033343 from GO Biological Process Annotations)", "positive regulation of collagen biosynthetic process (GO:0032967 from GO Biological Process Annotations)", "positive regulation of collagen metabolic process (GO:0010714 from GO Biological Process Annotations)", "positive regulation of collateral sprouting (GO:0048672 from GO Biological Process Annotations)", "positive regulation of collateral sprouting in absence of injury (GO:0048697 from GO Biological Process Annotations)", "positive regulation of complement activation (GO:0045917 from GO Biological Process Annotations)", "positive regulation of connective tissue growth factor production (GO:0032723 from GO Biological Process Annotations)", "positive regulation of constitutive secretory pathway (GO:1903435 from GO Biological Process Annotations)", "positive regulation of corticosteroid hormone secretion (GO:2000848 from GO Biological Process Annotations)", "positive regulation of corticosterone secretion (GO:2000854 from GO Biological Process Annotations)", "positive regulation of corticotropin secretion (GO:0051461 from GO Biological Process Annotations)", "positive regulation of corticotropin-releasing hormone secretion (GO:0051466 from GO Biological Process Annotations)", "positive regulation of cortisol biosynthetic process (GO:2000066 from GO Biological Process Annotations)", "positive regulation of cortisol secretion (GO:0051464 from GO Biological Process Annotations)", "positive regulation of creb transcription factor activity (GO:0032793 from GO Biological Process Annotations)", "positive regulation of cristae formation (GO:1903852 from GO Biological Process Annotations)", "positive regulation of cyclase activity (GO:0031281 from GO Biological Process Annotations)", "positive regulation of cyclic nucleotide biosynthetic process (GO:0030804 from GO Biological Process Annotations)", "positive regulation of cyclic nucleotide catabolic process (GO:0030807 from GO Biological Process Annotations)", "positive regulation of cyclic nucleotide metabolic process (GO:0030801 from GO Biological Process Annotations)", "positive regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051343 from GO Biological Process Annotations)", "positive regulation of cyclin-dependent protein serine|threonine kinase activity (GO:0045737 from GO Biological Process Annotations)", "positive regulation of cyclin-dependent protein serine|threonine kinase activity involved in g1|s transition of mitotic cell cycle (GO:0031659 from GO Biological Process Annotations)", "positive regulation of cyclin-dependent protein serine|threonine kinase activity involved in g2|m transition of mitotic cell cycle (GO:0031662 from GO Biological Process Annotations)", "positive regulation of cysteine-type endopeptidase activity (GO:2001056 from GO Biological Process Annotations)", "positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280 from GO Biological Process Annotations)", "positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269 from GO Biological Process Annotations)", "positive regulation of cytokine activity (GO:0060301 from GO Biological Process Annotations)", "positive regulation of cytokine biosynthetic process (GO:0042108 from GO Biological Process Annotations)", "positive regulation of cytokine production (GO:0001819 from GO Biological Process Annotations)", "positive regulation of cytokine production involved in immune response (GO:0002720 from GO Biological Process Annotations)", "positive regulation of cytokine production involved in inflammatory response (GO:1900017 from GO Biological Process Annotations)", "positive regulation of cytokine secretion (GO:0050715 from GO Biological Process Annotations)", "positive regulation of cytokine secretion involved in immune response (GO:0002741 from GO Biological Process Annotations)", "positive regulation of cytokine-mediated signaling pathway (GO:0001961 from GO Biological Process Annotations)", "positive regulation of cytokinesis (GO:0032467 from GO Biological Process Annotations)", "positive regulation of cytolysis (GO:0045919 from GO Biological Process Annotations)", "positive regulation of cytoplasmic mrna processing body assembly (GO:0010606 from GO Biological Process Annotations)", "positive regulation of cytoplasmic translation (GO:2000767 from GO Biological Process Annotations)", "positive regulation of cytoplasmic transport (GO:1903651 from GO Biological Process Annotations)", "positive regulation of cytoskeleton organization (GO:0051495 from GO Biological Process Annotations)", "positive regulation of cytosolic calcium ion concentration (GO:0007204 from GO Biological Process Annotations)", "positive regulation of cytosolic calcium ion concentration involved in phospholipase c-activating g-protein coupled signaling pathway (GO:0051482 from GO Biological Process Annotations)", "positive regulation of cytotoxic t cell differentiation (GO:0045585 from GO Biological Process Annotations)", "positive regulation of deacetylase activity (GO:0090045 from GO Biological Process Annotations)", "positive regulation of defense response (GO:0031349 from GO Biological Process Annotations)", "positive regulation of defense response to bacterium (GO:1900426 from GO Biological Process Annotations)", "positive regulation of defense response to virus by host (GO:0002230 from GO Biological Process Annotations)", "positive regulation of delayed rectifier potassium channel activity (GO:1902261 from GO Biological Process Annotations)", "positive regulation of dendrite development (GO:1900006 from GO Biological Process Annotations)", "positive regulation of dendrite morphogenesis (GO:0050775 from GO Biological Process Annotations)", "positive regulation of dendritic cell antigen processing and presentation (GO:0002606 from GO Biological Process Annotations)", "positive regulation of dendritic cell apoptotic process (GO:2000670 from GO Biological Process Annotations)", "positive regulation of dendritic cell chemotaxis (GO:2000510 from GO Biological Process Annotations)", "positive regulation of dendritic cell cytokine production (GO:0002732 from GO Biological Process Annotations)", "positive regulation of dendritic cell dendrite assembly (GO:2000549 from GO Biological Process Annotations)", "positive regulation of dendritic cell differentiation (GO:2001200 from GO Biological Process Annotations)", "positive regulation of dendritic spine development (GO:0060999 from GO Biological Process Annotations)", "positive regulation of dendritic spine maintenance (GO:1902952 from GO Biological Process Annotations)", "positive regulation of dendritic spine morphogenesis (GO:0061003 from GO Biological Process Annotations)", "positive regulation of dense core granule biogenesis (GO:2000707 from GO Biological Process Annotations)", "positive regulation of deoxyribonuclease activity (GO:0032077 from GO Biological Process Annotations)", "positive regulation of dephosphorylation (GO:0035306 from GO Biological Process Annotations)", "positive regulation of dermatome development (GO:0061184 from GO Biological Process Annotations)", "positive regulation of determination of dorsal identity (GO:2000017 from GO Biological Process Annotations)", "positive regulation of developmental growth (GO:0048639 from GO Biological Process Annotations)", "positive regulation of developmental pigmentation (GO:0048087 from GO Biological Process Annotations)", "positive regulation of developmental process (GO:0051094 from GO Biological Process Annotations)", "positive regulation of digestive system process (GO:0060456 from GO Biological Process Annotations)", "positive regulation of dipeptide transmembrane transport (GO:2001150 from GO Biological Process Annotations)", "positive regulation of dipeptide transport (GO:2000880 from GO Biological Process Annotations)", "positive regulation of dna binding (GO:0043388 from GO Biological Process Annotations)", "positive regulation of dna biosynthetic process (GO:2000573 from GO Biological Process Annotations)", "positive regulation of dna catabolic process (GO:1903626 from GO Biological Process Annotations)", "positive regulation of dna damage checkpoint (GO:2000003 from GO Biological Process Annotations)", "positive regulation of dna damage response, signal transduction by p53 class mediator (GO:0043517 from GO Biological Process Annotations)", "positive regulation of dna damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902164 from GO Biological Process Annotations)", "positive regulation of dna endoreduplication (GO:0032877 from GO Biological Process Annotations)", "positive regulation of dna ligation (GO:0051106 from GO Biological Process Annotations)", "positive regulation of dna metabolic process (GO:0051054 from GO Biological Process Annotations)", "positive regulation of dna n-glycosylase activity (GO:1902546 from GO Biological Process Annotations)", "positive regulation of dna recombination (GO:0045911 from GO Biological Process Annotations)", "positive regulation of dna repair (GO:0045739 from GO Biological Process Annotations)", "positive regulation of dna replication (GO:0045740 from GO Biological Process Annotations)", "positive regulation of dna strand elongation (GO:0060383 from GO Biological Process Annotations)", "positive regulation of dna topoisomerase (atp-hydrolyzing) activity (GO:2000373 from GO Biological Process Annotations)", "positive regulation of dna-dependent dna replication (GO:2000105 from GO Biological Process Annotations)", "positive regulation of dna-dependent dna replication initiation (GO:0032298 from GO Biological Process Annotations)", "positive regulation of dna-templated transcription, elongation (GO:0032786 from GO Biological Process Annotations)", "positive regulation of dna-templated transcription, initiation (GO:2000144 from GO Biological Process Annotations)", "positive regulation of dna-templated transcription, termination (GO:0060566 from GO Biological Process Annotations)", "positive regulation of dopamine biosynthetic process (GO:1903181 from GO Biological Process Annotations)", "positive regulation of dopamine metabolic process (GO:0045964 from GO Biological Process Annotations)", "positive regulation of dopamine receptor signaling pathway (GO:0060161 from GO Biological Process Annotations)", "positive regulation of dopamine secretion (GO:0033603 from GO Biological Process Annotations)", "positive regulation of dopamine uptake involved in synaptic transmission (GO:0051586 from GO Biological Process Annotations)", "positive regulation of double-strand break repair (GO:2000781 from GO Biological Process Annotations)", "positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034 from GO Biological Process Annotations)", "positive regulation of early endosome to late endosome transport (GO:2000643 from GO Biological Process Annotations)", "positive regulation of early endosome to recycling endosome transport (GO:1902955 from GO Biological Process Annotations)", "positive regulation of embryonic development (GO:0040019 from GO Biological Process Annotations)", "positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000802 from GO Biological Process Annotations)", "positive regulation of endocytic recycling (GO:2001137 from GO Biological Process Annotations)", "positive regulation of endocytosis (GO:0045807 from GO Biological Process Annotations)", "positive regulation of endopeptidase activity (GO:0010950 from GO Biological Process Annotations)", "positive regulation of endoplasmic reticulum calcium ion concentration (GO:0032470 from GO Biological Process Annotations)", "positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237 from GO Biological Process Annotations)", "positive regulation of endoplasmic reticulum tubular network organization (GO:1903373 from GO Biological Process Annotations)", "positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103 from GO Biological Process Annotations)", "positive regulation of endothelial cell apoptotic process (GO:2000353 from GO Biological Process Annotations)", "positive regulation of endothelial cell chemotaxis (GO:2001028 from GO Biological Process Annotations)", "positive regulation of endothelial cell chemotaxis by vegf-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033 from GO Biological Process Annotations)", "positive regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000546 from GO Biological Process Annotations)", "positive regulation of endothelial cell development (GO:1901552 from GO Biological Process Annotations)", "positive regulation of endothelial cell differentiation (GO:0045603 from GO Biological Process Annotations)", "positive regulation of endothelial cell migration (GO:0010595 from GO Biological Process Annotations)", "positive regulation of endothelial cell proliferation (GO:0001938 from GO Biological Process Annotations)", "positive regulation of energy homeostasis (GO:2000507 from GO Biological Process Annotations)", "positive regulation of engulfment of apoptotic cell (GO:1901076 from GO Biological Process Annotations)", "positive regulation of eosinophil activation (GO:1902568 from GO Biological Process Annotations)", "positive regulation of eosinophil chemotaxis (GO:2000424 from GO Biological Process Annotations)", "positive regulation of eosinophil degranulation (GO:0043311 from GO Biological Process Annotations)", "positive regulation of eosinophil differentiation (GO:0045645 from GO Biological Process Annotations)", "positive regulation of eosinophil migration (GO:2000418 from GO Biological Process Annotations)", "positive regulation of ephrin receptor signaling pathway (GO:1901189 from GO Biological Process Annotations)", "positive regulation of epidermal cell differentiation (GO:0045606 from GO Biological Process Annotations)", "positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742 from GO Biological Process Annotations)", "positive regulation of epidermal growth factor-activated receptor activity (GO:0045741 from GO Biological Process Annotations)", "positive regulation of epidermis development (GO:0045684 from GO Biological Process Annotations)", "positive regulation of epinephrine secretion (GO:0032812 from GO Biological Process Annotations)", "positive regulation of epithelial cell differentiation (GO:0030858 from GO Biological Process Annotations)", "positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698 from GO Biological Process Annotations)", "positive regulation of epithelial cell migration (GO:0010634 from GO Biological Process Annotations)", "positive regulation of epithelial cell proliferation (GO:0050679 from GO Biological Process Annotations)", "positive regulation of epithelial cell proliferation involved in lung morphogenesis (GO:0060501 from GO Biological Process Annotations)", "positive regulation of epithelial cell proliferation involved in prostate gland development (GO:0060769 from GO Biological Process Annotations)", "positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054 from GO Biological Process Annotations)", "positive regulation of epithelial to mesenchymal transition (GO:0010718 from GO Biological Process Annotations)", "positive regulation of er to golgi vesicle-mediated transport (GO:1902953 from GO Biological Process Annotations)", "positive regulation of er-associated ubiquitin-dependent protein catabolic process (GO:1903071 from GO Biological Process Annotations)", "positive regulation of erbb signaling pathway (GO:1901186 from GO Biological Process Annotations)", "positive regulation of erk1 and erk2 cascade (GO:0070374 from GO Biological Process Annotations)", "positive regulation of erk1 and erk2 cascade via tnfsf11-mediated signaling (GO:0071848 from GO Biological Process Annotations)", "positive regulation of erythrocyte aggregation (GO:0034120 from GO Biological Process Annotations)", "positive regulation of erythrocyte differentiation (GO:0045648 from GO Biological Process Annotations)", "positive regulation of establishment of endothelial barrier (GO:1903142 from GO Biological Process Annotations)", "positive regulation of establishment of protein localization to mitochondrion (GO:1903749 from GO Biological Process Annotations)", "positive regulation of establishment of protein localization to plasma membrane (GO:0090004 from GO Biological Process Annotations)", "positive regulation of excitatory postsynaptic membrane potential (GO:2000463 from GO Biological Process Annotations)", "positive regulation of execution phase of apoptosis (GO:1900119 from GO Biological Process Annotations)", "positive regulation of exit from mitosis (GO:0031536 from GO Biological Process Annotations)", "positive regulation of exocytosis (GO:0045921 from GO Biological Process Annotations)", "positive regulation of exosomal secretion (GO:1903543 from GO Biological Process Annotations)", "positive regulation of extracellular matrix assembly (GO:1901203 from GO Biological Process Annotations)", "positive regulation of extracellular matrix constituent secretion (GO:0003331 from GO Biological Process Annotations)", "positive regulation of extracellular matrix disassembly (GO:0090091 from GO Biological Process Annotations)", "positive regulation of extracellular matrix organization (GO:1903055 from GO Biological Process Annotations)", "positive regulation of extracellular vesicular exosome assembly (GO:1903553 from GO Biological Process Annotations)", "positive regulation of extrinsic apoptotic signaling pathway (GO:2001238 from GO Biological Process Annotations)", "positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241 from GO Biological Process Annotations)", "positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043 from GO Biological Process Annotations)", "positive regulation of eye pigmentation (GO:0048075 from GO Biological Process Annotations)", "positive regulation of fast-twitch skeletal muscle fiber contraction (GO:0031448 from GO Biological Process Annotations)", "positive regulation of fat cell differentiation (GO:0045600 from GO Biological Process Annotations)", "positive regulation of fat cell proliferation (GO:0070346 from GO Biological Process Annotations)", "positive regulation of fatty acid beta-oxidation (GO:0032000 from GO Biological Process Annotations)", "positive regulation of fatty acid biosynthetic process (GO:0045723 from GO Biological Process Annotations)", "positive regulation of fatty acid metabolic process (GO:0045923 from GO Biological Process Annotations)", "positive regulation of fatty acid oxidation (GO:0046321 from GO Biological Process Annotations)", "positive regulation of fatty acid transport (GO:2000193 from GO Biological Process Annotations)", "positive regulation of fc receptor mediated stimulatory signaling pathway (GO:0060369 from GO Biological Process Annotations)", "positive regulation of fear response (GO:1903367 from GO Biological Process Annotations)", "positive regulation of feeding behavior (GO:2000253 from GO Biological Process Annotations)", "positive regulation of female gonad development (GO:2000196 from GO Biological Process Annotations)", "positive regulation of female receptivity (GO:0045925 from GO Biological Process Annotations)", "positive regulation of fever generation (GO:0031622 from GO Biological Process Annotations)", "positive regulation of fever generation by positive regulation of prostaglandin secretion (GO:0071812 from GO Biological Process Annotations)", "positive regulation of fibril organization (GO:1902905 from GO Biological Process Annotations)", "positive regulation of fibrinolysis (GO:0051919 from GO Biological Process Annotations)", "positive regulation of fibroblast apoptotic process (GO:2000271 from GO Biological Process Annotations)", "positive regulation of fibroblast growth factor production (GO:0090271 from GO Biological Process Annotations)", "positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743 from GO Biological Process Annotations)", "positive regulation of fibroblast migration (GO:0010763 from GO Biological Process Annotations)", "positive regulation of fibroblast proliferation (GO:0048146 from GO Biological Process Annotations)", "positive regulation of fibronectin-dependent thymocyte migration (GO:2000415 from GO Biological Process Annotations)", "positive regulation of filopodium assembly (GO:0051491 from GO Biological Process Annotations)", "positive regulation of focal adhesion assembly (GO:0051894 from GO Biological Process Annotations)", "positive regulation of follicle-stimulating hormone secretion (GO:0046881 from GO Biological Process Annotations)", "positive regulation of forebrain neuron differentiation (GO:2000979 from GO Biological Process Annotations)", "positive regulation of fractalkine biosynthetic process (GO:0050754 from GO Biological Process Annotations)", "positive regulation of fractalkine production (GO:0032724 from GO Biological Process Annotations)", "positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060550 from GO Biological Process Annotations)", "positive regulation of fructose 1,6-bisphosphate metabolic process (GO:0060552 from GO Biological Process Annotations)", "positive regulation of g-protein coupled receptor protein signaling pathway (GO:0045745 from GO Biological Process Annotations)", "positive regulation of g0 to g1 transition (GO:0070318 from GO Biological Process Annotations)", "positive regulation of g1|s transition of mitotic cell cycle (GO:1900087 from GO Biological Process Annotations)", "positive regulation of g2|m transition of mitotic cell cycle (GO:0010971 from GO Biological Process Annotations)", "positive regulation of gamma-aminobutyric acid secretion (GO:0014054 from GO Biological Process Annotations)", "positive regulation of gamma-delta t cell activation (GO:0046645 from GO Biological Process Annotations)", "positive regulation of gamma-delta t cell activation involved in immune response (GO:2001193 from GO Biological Process Annotations)", "positive regulation of gamma-delta t cell differentiation (GO:0045588 from GO Biological Process Annotations)", "positive regulation of gap junction assembly (GO:1903598 from GO Biological Process Annotations)", "positive regulation of gastrulation (GO:2000543 from GO Biological Process Annotations)", "positive regulation of gene expression (GO:0010628 from GO Biological Process Annotations)", "positive regulation of gene expression, epigenetic (GO:0045815 from GO Biological Process Annotations)", "positive regulation of gene silencing by mirna (GO:2000637 from GO Biological Process Annotations)", "positive regulation of germinal center formation (GO:0002636 from GO Biological Process Annotations)", "positive regulation of glial cell differentiation (GO:0045687 from GO Biological Process Annotations)", "positive regulation of glial cell line-derived neurotrophic factor secretion (GO:1900168 from GO Biological Process Annotations)", "positive regulation of glial cell proliferation (GO:0060252 from GO Biological Process Annotations)", "positive regulation of gliogenesis (GO:0014015 from GO Biological Process Annotations)", "positive regulation of glomerular filtration (GO:0003104 from GO Biological Process Annotations)", "positive regulation of glomerular mesangial cell proliferation (GO:0072126 from GO Biological Process Annotations)", "positive regulation of glomerular metanephric mesangial cell proliferation (GO:0072303 from GO Biological Process Annotations)", "positive regulation of glomerulus development (GO:0090193 from GO Biological Process Annotations)", "positive regulation of glucagon secretion (GO:0070094 from GO Biological Process Annotations)", "positive regulation of glucocorticoid biosynthetic process (GO:0031948 from GO Biological Process Annotations)", "positive regulation of glucocorticoid metabolic process (GO:0031945 from GO Biological Process Annotations)", "positive regulation of glucocorticoid receptor signaling pathway (GO:2000324 from GO Biological Process Annotations)", "positive regulation of glucocorticoid secretion (GO:2000851 from GO Biological Process Annotations)", "positive regulation of glucokinase activity (GO:0033133 from GO Biological Process Annotations)", "positive regulation of gluconeogenesis (GO:0045722 from GO Biological Process Annotations)", "positive regulation of gluconeogenesis by positive regulation of transcription from rna polymerase ii promoter (GO:0035948 from GO Biological Process Annotations)", "positive regulation of glucose import (GO:0046326 from GO Biological Process Annotations)", "positive regulation of glucose import in response to insulin stimulus (GO:2001275 from GO Biological Process Annotations)", "positive regulation of glucose metabolic process (GO:0010907 from GO Biological Process Annotations)", "positive regulation of glucose transport (GO:0010828 from GO Biological Process Annotations)", "positive regulation of glucosylceramide catabolic process (GO:2000753 from GO Biological Process Annotations)", "positive regulation of glutamate metabolic process (GO:2000213 from GO Biological Process Annotations)", "positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization (GO:0061646 from GO Biological Process Annotations)", "positive regulation of glutamate receptor signaling pathway (GO:1900451 from GO Biological Process Annotations)", "positive regulation of glutamate secretion (GO:0014049 from GO Biological Process Annotations)", "positive regulation of glutamate secretion, neurotransmission (GO:1903296 from GO Biological Process Annotations)", "positive regulation of glutamate-cysteine ligase activity (GO:0035229 from GO Biological Process Annotations)", "positive regulation of glutathione peroxidase activity (GO:1903284 from GO Biological Process Annotations)", "positive regulation of glycogen (starch) synthase activity (GO:2000467 from GO Biological Process Annotations)", "positive regulation of glycogen biosynthetic process (GO:0045725 from GO Biological Process Annotations)", "positive regulation of glycogen catabolic process (GO:0045819 from GO Biological Process Annotations)", "positive regulation of glycogen metabolic process (GO:0070875 from GO Biological Process Annotations)", "positive regulation of glycolytic process (GO:0045821 from GO Biological Process Annotations)", "positive regulation of glycoprotein biosynthetic process (GO:0010560 from GO Biological Process Annotations)", "positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation (GO:2000526 from GO Biological Process Annotations)", "positive regulation of glycoprotein metabolic process (GO:1903020 from GO Biological Process Annotations)", "positive regulation of golgi to plasma membrane protein transport (GO:0042998 from GO Biological Process Annotations)", "positive regulation of gonadotropin secretion (GO:0032278 from GO Biological Process Annotations)", "positive regulation of granulocyte chemotaxis (GO:0071624 from GO Biological Process Annotations)", "positive regulation of granulocyte colony-stimulating factor production (GO:0071657 from GO Biological Process Annotations)", "positive regulation of granulocyte differentiation (GO:0030854 from GO Biological Process Annotations)", "positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process (GO:0045425 from GO Biological Process Annotations)", "positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725 from GO Biological Process Annotations)", "positive regulation of granzyme a production (GO:2000513 from GO Biological Process Annotations)", "positive regulation of granzyme b production (GO:0071663 from GO Biological Process Annotations)", "positive regulation of growth (GO:0045927 from GO Biological Process Annotations)", "positive regulation of growth hormone receptor signaling pathway (GO:0060399 from GO Biological Process Annotations)", "positive regulation of growth hormone secretion (GO:0060124 from GO Biological Process Annotations)", "positive regulation of gtpase activity (GO:0043547 from GO Biological Process Annotations)", "positive regulation of guanylate cyclase activity (GO:0031284 from GO Biological Process Annotations)", "positive regulation of hair cycle (GO:0042635 from GO Biological Process Annotations)", "positive regulation of hair follicle cell proliferation (GO:0071338 from GO Biological Process Annotations)", "positive regulation of hair follicle development (GO:0051798 from GO Biological Process Annotations)", "positive regulation of hair follicle maturation (GO:0048818 from GO Biological Process Annotations)", "positive regulation of heart contraction (GO:0045823 from GO Biological Process Annotations)", "positive regulation of heart growth (GO:0060421 from GO Biological Process Annotations)", "positive regulation of heart induction (GO:1901321 from GO Biological Process Annotations)", "positive regulation of heart induction by negative regulation of canonical wnt signaling pathway (GO:0090082 from GO Biological Process Annotations)", "positive regulation of heart rate (GO:0010460 from GO Biological Process Annotations)", "positive regulation of heart rate by epinephrine (GO:0003065 from GO Biological Process Annotations)", "positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996 from GO Biological Process Annotations)", "positive regulation of heat generation (GO:0031652 from GO Biological Process Annotations)", "positive regulation of helicase activity (GO:0051096 from GO Biological Process Annotations)", "positive regulation of hematopoietic progenitor cell differentiation (GO:1901534 from GO Biological Process Annotations)", "positive regulation of hematopoietic stem cell differentiation (GO:1902038 from GO Biological Process Annotations)", "positive regulation of hematopoietic stem cell migration (GO:2000473 from GO Biological Process Annotations)", "positive regulation of hematopoietic stem cell proliferation (GO:1902035 from GO Biological Process Annotations)", "positive regulation of hemoglobin biosynthetic process (GO:0046985 from GO Biological Process Annotations)", "positive regulation of hemopoiesis (GO:1903708 from GO Biological Process Annotations)", "positive regulation of hemostasis (GO:1900048 from GO Biological Process Annotations)", "positive regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010909 from GO Biological Process Annotations)", "positive regulation of hepatic stellate cell activation (GO:2000491 from GO Biological Process Annotations)", "positive regulation of hepatocyte differentiation (GO:0070368 from GO Biological Process Annotations)", "positive regulation of hepatocyte growth factor receptor signaling pathway (GO:1902204 from GO Biological Process Annotations)", "positive regulation of hepatocyte proliferation (GO:2000347 from GO Biological Process Annotations)", "positive regulation of heterochromatin assembly (GO:0031453 from GO Biological Process Annotations)", "positive regulation of heterotypic cell-cell adhesion (GO:0034116 from GO Biological Process Annotations)", "positive regulation of hexokinase activity (GO:1903301 from GO Biological Process Annotations)", "positive regulation of hh target transcription factor activity (GO:0007228 from GO Biological Process Annotations)", "positive regulation of high-density lipoprotein particle assembly (GO:0090108 from GO Biological Process Annotations)", "positive regulation of high-density lipoprotein particle clearance (GO:0010983 from GO Biological Process Annotations)", "positive regulation of hindgut contraction (GO:0060450 from GO Biological Process Annotations)", "positive regulation of hippo signaling (GO:0035332 from GO Biological Process Annotations)", "positive regulation of histamine secretion by mast cell (GO:1903595 from GO Biological Process Annotations)", "positive regulation of histone acetylation (GO:0035066 from GO Biological Process Annotations)", "positive regulation of histone deacetylase activity (GO:1901727 from GO Biological Process Annotations)", "positive regulation of histone deacetylation (GO:0031065 from GO Biological Process Annotations)", "positive regulation of histone deubiquitination (GO:1903586 from GO Biological Process Annotations)", "positive regulation of histone h2b ubiquitination (GO:2001168 from GO Biological Process Annotations)", "positive regulation of histone h3-k14 acetylation (GO:0071442 from GO Biological Process Annotations)", "positive regulation of histone h3-k27 acetylation (GO:1901676 from GO Biological Process Annotations)", "positive regulation of histone h3-k27 methylation (GO:0061087 from GO Biological Process Annotations)", "positive regulation of histone h3-k27 trimethylation (GO:1902466 from GO Biological Process Annotations)", "positive regulation of histone h3-k36 methylation (GO:0000416 from GO Biological Process Annotations)", "positive regulation of histone h3-k4 methylation (GO:0051571 from GO Biological Process Annotations)", "positive regulation of histone h3-k79 methylation (GO:2001162 from GO Biological Process Annotations)", "positive regulation of histone h3-k9 acetylation (GO:2000617 from GO Biological Process Annotations)", "positive regulation of histone h3-k9 dimethylation (GO:1900111 from GO Biological Process Annotations)", "positive regulation of histone h3-k9 methylation (GO:0051574 from GO Biological Process Annotations)", "positive regulation of histone h3-k9 trimethylation (GO:1900114 from GO Biological Process Annotations)", "positive regulation of histone h4 acetylation (GO:0090240 from GO Biological Process Annotations)", "positive regulation of histone h4-k16 acetylation (GO:2000620 from GO Biological Process Annotations)", "positive regulation of histone h4-k20 methylation (GO:0070512 from GO Biological Process Annotations)", "positive regulation of histone methylation (GO:0031062 from GO Biological Process Annotations)", "positive regulation of histone modification (GO:0031058 from GO Biological Process Annotations)", "positive regulation of histone phosphorylation (GO:0033129 from GO Biological Process Annotations)", "positive regulation of histone ubiquitination (GO:0033184 from GO Biological Process Annotations)", "positive regulation of homeostatic process (GO:0032846 from GO Biological Process Annotations)", "positive regulation of homocysteine metabolic process (GO:0050668 from GO Biological Process Annotations)", "positive regulation of homophilic cell adhesion (GO:1903387 from GO Biological Process Annotations)", "positive regulation of homotypic cell-cell adhesion (GO:0034112 from GO Biological Process Annotations)", "positive regulation of hormone biosynthetic process (GO:0046886 from GO Biological Process Annotations)", "positive regulation of hormone metabolic process (GO:0032352 from GO Biological Process Annotations)", "positive regulation of hormone secretion (GO:0046887 from GO Biological Process Annotations)", "positive regulation of humoral immune response (GO:0002922 from GO Biological Process Annotations)", "positive regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002925 from GO Biological Process Annotations)", "positive regulation of hyaluranon cable assembly (GO:1900106 from GO Biological Process Annotations)", "positive regulation of hyaluronan biosynthetic process (GO:1900127 from GO Biological Process Annotations)", "positive regulation of hydrogen peroxide biosynthetic process (GO:0010729 from GO Biological Process Annotations)", "positive regulation of hydrogen peroxide catabolic process (GO:1903285 from GO Biological Process Annotations)", "positive regulation of hydrogen peroxide metabolic process (GO:0010726 from GO Biological Process Annotations)", "positive regulation of hydrogen peroxide-mediated programmed cell death (GO:1901300 from GO Biological Process Annotations)", "positive regulation of hydrolase activity (GO:0051345 from GO Biological Process Annotations)", "positive regulation of hypersensitivity (GO:0002885 from GO Biological Process Annotations)", "positive regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902073 from GO Biological Process Annotations)", "positive regulation of i-kappab kinase|nf-kappab signaling (GO:0043123 from GO Biological Process Annotations)", "positive regulation of i-kappab phosphorylation (GO:1903721 from GO Biological Process Annotations)", "positive regulation of icosanoid secretion (GO:0032305 from GO Biological Process Annotations)", "positive regulation of immature t cell proliferation (GO:0033091 from GO Biological Process Annotations)", "positive regulation of immature t cell proliferation in thymus (GO:0033092 from GO Biological Process Annotations)", "positive regulation of immune complex clearance by monocytes and macrophages (GO:0090265 from GO Biological Process Annotations)", "positive regulation of immune effector process (GO:0002699 from GO Biological Process Annotations)", "positive regulation of immune response (GO:0050778 from GO Biological Process Annotations)", "positive regulation of immune response to tumor cell (GO:0002839 from GO Biological Process Annotations)", "positive regulation of immune system process (GO:0002684 from GO Biological Process Annotations)", "positive regulation of immunoglobulin biosynthetic process (GO:0002642 from GO Biological Process Annotations)", "positive regulation of immunoglobulin mediated immune response (GO:0002891 from GO Biological Process Annotations)", "positive regulation of immunoglobulin production (GO:0002639 from GO Biological Process Annotations)", "positive regulation of immunoglobulin production in mucosal tissue (GO:2000558 from GO Biological Process Annotations)", "positive regulation of immunoglobulin secretion (GO:0051024 from GO Biological Process Annotations)", "positive regulation of immunological synapse formation (GO:2000522 from GO Biological Process Annotations)", "positive regulation of inclusion body assembly (GO:0090261 from GO Biological Process Annotations)", "positive regulation of inflammatory response (GO:0050729 from GO Biological Process Annotations)", "positive regulation of inflammatory response to antigenic stimulus (GO:0002863 from GO Biological Process Annotations)", "positive regulation of inhibitory postsynaptic membrane potential (GO:0097151 from GO Biological Process Annotations)", "positive regulation of innate immune response (GO:0045089 from GO Biological Process Annotations)", "positive regulation of inner ear receptor cell differentiation (GO:2000982 from GO Biological Process Annotations)", "positive regulation of inorganic anion transmembrane transport (GO:1903797 from GO Biological Process Annotations)", "positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031587 from GO Biological Process Annotations)", "positive regulation of inositol phosphate biosynthetic process (GO:0060732 from GO Biological Process Annotations)", "positive regulation of inositol trisphosphate biosynthetic process (GO:0032962 from GO Biological Process Annotations)", "positive regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010925 from GO Biological Process Annotations)", "positive regulation of insulin receptor signaling pathway (GO:0046628 from GO Biological Process Annotations)", "positive regulation of insulin secretion (GO:0032024 from GO Biological Process Annotations)", "positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774 from GO Biological Process Annotations)", "positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568 from GO Biological Process Annotations)", "positive regulation of integrin activation (GO:0033625 from GO Biological Process Annotations)", "positive regulation of integrin biosynthetic process (GO:0045726 from GO Biological Process Annotations)", "positive regulation of integrin-mediated signaling pathway (GO:2001046 from GO Biological Process Annotations)", "positive regulation of interferon-alpha biosynthetic process (GO:0045356 from GO Biological Process Annotations)", "positive regulation of interferon-alpha production (GO:0032727 from GO Biological Process Annotations)", "positive regulation of interferon-beta biosynthetic process (GO:0045359 from GO Biological Process Annotations)", "positive regulation of interferon-beta production (GO:0032728 from GO Biological Process Annotations)", "positive regulation of interferon-gamma biosynthetic process (GO:0045078 from GO Biological Process Annotations)", "positive regulation of interferon-gamma production (GO:0032729 from GO Biological Process Annotations)", "positive regulation of interferon-gamma secretion (GO:1902715 from GO Biological Process Annotations)", "positive regulation of interferon-gamma-mediated signaling pathway (GO:0060335 from GO Biological Process Annotations)", "positive regulation of interleukin-1 alpha biosynthetic process (GO:0050726 from GO Biological Process Annotations)", "positive regulation of interleukin-1 alpha production (GO:0032730 from GO Biological Process Annotations)", "positive regulation of interleukin-1 alpha secretion (GO:0050717 from GO Biological Process Annotations)", "positive regulation of interleukin-1 beta biosynthetic process (GO:0050725 from GO Biological Process Annotations)", "positive regulation of interleukin-1 beta production (GO:0032731 from GO Biological Process Annotations)", "positive regulation of interleukin-1 beta secretion (GO:0050718 from GO Biological Process Annotations)", "positive regulation of interleukin-1 biosynthetic process (GO:0045362 from GO Biological Process Annotations)", "positive regulation of interleukin-1 production (GO:0032732 from GO Biological Process Annotations)", "positive regulation of interleukin-1 secretion (GO:0050716 from GO Biological Process Annotations)", "positive regulation of interleukin-10 biosynthetic process (GO:0045082 from GO Biological Process Annotations)", "positive regulation of interleukin-10 production (GO:0032733 from GO Biological Process Annotations)", "positive regulation of interleukin-10 secretion (GO:2001181 from GO Biological Process Annotations)", "positive regulation of interleukin-12 biosynthetic process (GO:0045084 from GO Biological Process Annotations)", "positive regulation of interleukin-12 production (GO:0032735 from GO Biological Process Annotations)", "positive regulation of interleukin-13 biosynthetic process (GO:0045368 from GO Biological Process Annotations)", "positive regulation of interleukin-13 production (GO:0032736 from GO Biological Process Annotations)", "positive regulation of interleukin-13 secretion (GO:2000667 from GO Biological Process Annotations)", "positive regulation of interleukin-15 production (GO:0032738 from GO Biological Process Annotations)", "positive regulation of interleukin-17 production (GO:0032740 from GO Biological Process Annotations)", "positive regulation of interleukin-18 production (GO:0032741 from GO Biological Process Annotations)", "positive regulation of interleukin-2 biosynthetic process (GO:0045086 from GO Biological Process Annotations)", "positive regulation of interleukin-2 production (GO:0032743 from GO Biological Process Annotations)", "positive regulation of interleukin-2 secretion (GO:1900042 from GO Biological Process Annotations)", "positive regulation of interleukin-23 production (GO:0032747 from GO Biological Process Annotations)", "positive regulation of interleukin-3 biosynthetic process (GO:0045401 from GO Biological Process Annotations)", "positive regulation of interleukin-3 production (GO:0032752 from GO Biological Process Annotations)", "positive regulation of interleukin-4 biosynthetic process (GO:0045404 from GO Biological Process Annotations)", "positive regulation of interleukin-4 production (GO:0032753 from GO Biological Process Annotations)", "positive regulation of interleukin-4-dependent isotype switching to ige isotypes (GO:2000572 from GO Biological Process Annotations)", "positive regulation of interleukin-5 biosynthetic process (GO:0045407 from GO Biological Process Annotations)", "positive regulation of interleukin-5 production (GO:0032754 from GO Biological Process Annotations)", "positive regulation of interleukin-5 secretion (GO:2000664 from GO Biological Process Annotations)", "positive regulation of interleukin-6 biosynthetic process (GO:0045410 from GO Biological Process Annotations)", "positive regulation of interleukin-6 production (GO:0032755 from GO Biological Process Annotations)", "positive regulation of interleukin-6 secretion (GO:2000778 from GO Biological Process Annotations)", "positive regulation of interleukin-6-mediated signaling pathway (GO:0070105 from GO Biological Process Annotations)", "positive regulation of interleukin-8 biosynthetic process (GO:0045416 from GO Biological Process Annotations)", "positive regulation of interleukin-8 production (GO:0032757 from GO Biological Process Annotations)", "positive regulation of interleukin-8 secretion (GO:2000484 from GO Biological Process Annotations)", "positive regulation of intermediate filament depolymerization (GO:0030844 from GO Biological Process Annotations)", "positive regulation of intestinal epithelial structure maintenance (GO:0060731 from GO Biological Process Annotations)", "positive regulation of intracellular cholesterol transport (GO:0032385 from GO Biological Process Annotations)", "positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148 from GO Biological Process Annotations)", "positive regulation of intracellular lipid transport (GO:0032379 from GO Biological Process Annotations)", "positive regulation of intracellular protein transport (GO:0090316 from GO Biological Process Annotations)", "positive regulation of intracellular signal transduction (GO:1902533 from GO Biological Process Annotations)", "positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145 from GO Biological Process Annotations)", "positive regulation of intracellular sterol transport (GO:0032382 from GO Biological Process Annotations)", "positive regulation of intracellular transport (GO:0032388 from GO Biological Process Annotations)", "positive regulation of intrinsic apoptotic signaling pathway (GO:2001244 from GO Biological Process Annotations)", "positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255 from GO Biological Process Annotations)", "positive regulation of intrinsic apoptotic signaling pathway in response to dna damage (GO:1902231 from GO Biological Process Annotations)", "positive regulation of intrinsic apoptotic signaling pathway in response to dna damage by p53 class mediator (GO:1902167 from GO Biological Process Annotations)", "positive regulation of ion transmembrane transport (GO:0034767 from GO Biological Process Annotations)", "positive regulation of ion transmembrane transporter activity (GO:0032414 from GO Biological Process Annotations)", "positive regulation of ion transport (GO:0043270 from GO Biological Process Annotations)", "positive regulation of ip-10 production (GO:0071660 from GO Biological Process Annotations)", "positive regulation of isomerase activity (GO:0010912 from GO Biological Process Annotations)", "positive regulation of isotype switching (GO:0045830 from GO Biological Process Annotations)", "positive regulation of isotype switching to iga isotypes (GO:0048298 from GO Biological Process Annotations)", "positive regulation of isotype switching to ige isotypes (GO:0048295 from GO Biological Process Annotations)", "positive regulation of isotype switching to igg isotypes (GO:0048304 from GO Biological Process Annotations)", "positive regulation of jak-stat cascade (GO:0046427 from GO Biological Process Annotations)", "positive regulation of jnk cascade (GO:0046330 from GO Biological Process Annotations)", "positive regulation of jun kinase activity (GO:0043507 from GO Biological Process Annotations)", "positive regulation of keratinocyte apoptotic process (GO:1902174 from GO Biological Process Annotations)", "positive regulation of keratinocyte differentiation (GO:0045618 from GO Biological Process Annotations)", "positive regulation of keratinocyte migration (GO:0051549 from GO Biological Process Annotations)", "positive regulation of keratinocyte proliferation (GO:0010838 from GO Biological Process Annotations)", "positive regulation of kidney development (GO:0090184 from GO Biological Process Annotations)", "positive regulation of kidney smooth muscle cell differentiation (GO:2000358 from GO Biological Process Annotations)", "positive regulation of killing of cells of other organism (GO:0051712 from GO Biological Process Annotations)", "positive regulation of kinase activity (GO:0033674 from GO Biological Process Annotations)", "positive regulation of l-dopa biosynthetic process (GO:1903197 from GO Biological Process Annotations)", "positive regulation of l-dopa decarboxylase activity (GO:1903200 from GO Biological Process Annotations)", "positive regulation of lactation (GO:1903489 from GO Biological Process Annotations)", "positive regulation of lamellipodium assembly (GO:0010592 from GO Biological Process Annotations)", "positive regulation of lamellipodium morphogenesis (GO:2000394 from GO Biological Process Annotations)", "positive regulation of lamellipodium organization (GO:1902745 from GO Biological Process Annotations)", "positive regulation of large conductance calcium-activated potassium channel activity (GO:1902608 from GO Biological Process Annotations)", "positive regulation of late endosome to lysosome transport (GO:1902824 from GO Biological Process Annotations)", "positive regulation of lateral motor column neuron migration (GO:1902078 from GO Biological Process Annotations)", "positive regulation of lens epithelial cell proliferation (GO:2001111 from GO Biological Process Annotations)", "positive regulation of leukocyte activation (GO:0002696 from GO Biological Process Annotations)", "positive regulation of leukocyte apoptotic process (GO:2000108 from GO Biological Process Annotations)", "positive regulation of leukocyte cell-cell adhesion (GO:1903039 from GO Biological Process Annotations)", "positive regulation of leukocyte chemotaxis (GO:0002690 from GO Biological Process Annotations)", "positive regulation of leukocyte degranulation (GO:0043302 from GO Biological Process Annotations)", "positive regulation of leukocyte differentiation (GO:1902107 from GO Biological Process Annotations)", "positive regulation of leukocyte mediated cytotoxicity (GO:0001912 from GO Biological Process Annotations)", "positive regulation of leukocyte mediated immunity (GO:0002705 from GO Biological Process Annotations)", "positive regulation of leukocyte migration (GO:0002687 from GO Biological Process Annotations)", "positive regulation of leukocyte proliferation (GO:0070665 from GO Biological Process Annotations)", "positive regulation of leukotriene production involved in inflammatory response (GO:0035491 from GO Biological Process Annotations)", "positive regulation of ligand-dependent nuclear receptor transcription coactivator activity (GO:2000327 from GO Biological Process Annotations)", "positive regulation of ligase activity (GO:0051351 from GO Biological Process Annotations)", "positive regulation of lipase activity (GO:0060193 from GO Biological Process Annotations)", "positive regulation of lipid biosynthetic process (GO:0046889 from GO Biological Process Annotations)", "positive regulation of lipid catabolic process (GO:0050996 from GO Biological Process Annotations)", "positive regulation of lipid kinase activity (GO:0090218 from GO Biological Process Annotations)", "positive regulation of lipid metabolic process (GO:0045834 from GO Biological Process Annotations)", "positive regulation of lipid storage (GO:0010884 from GO Biological Process Annotations)", "positive regulation of lipid transport (GO:0032370 from GO Biological Process Annotations)", "positive regulation of lipid transport across blood brain barrier (GO:1903002 from GO Biological Process Annotations)", "positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666 from GO Biological Process Annotations)", "positive regulation of lipoprotein lipase activity (GO:0051006 from GO Biological Process Annotations)", "positive regulation of lipoprotein metabolic process (GO:0050747 from GO Biological Process Annotations)", "positive regulation of lipoprotein particle clearance (GO:0010986 from GO Biological Process Annotations)", "positive regulation of locomotion (GO:0040017 from GO Biological Process Annotations)", "positive regulation of long-term neuronal synaptic plasticity (GO:0048170 from GO Biological Process Annotations)", "positive regulation of long-term synaptic potentiation (GO:1900273 from GO Biological Process Annotations)", "positive regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045716 from GO Biological Process Annotations)", "positive regulation of low-density lipoprotein particle receptor catabolic process (GO:0032805 from GO Biological Process Annotations)", "positive regulation of lung ciliated cell differentiation (GO:1901248 from GO Biological Process Annotations)", "positive regulation of lung goblet cell differentiation (GO:1901251 from GO Biological Process Annotations)", "positive regulation of luteinizing hormone secretion (GO:0033686 from GO Biological Process Annotations)", "positive regulation of lyase activity (GO:0051349 from GO Biological Process Annotations)", "positive regulation of lymphangiogenesis (GO:1901492 from GO Biological Process Annotations)", "positive regulation of lymphocyte activation (GO:0051251 from GO Biological Process Annotations)", "positive regulation of lymphocyte anergy (GO:0002913 from GO Biological Process Annotations)", "positive regulation of lymphocyte apoptotic process (GO:0070230 from GO Biological Process Annotations)", "positive regulation of lymphocyte differentiation (GO:0045621 from GO Biological Process Annotations)", "positive regulation of lymphocyte mediated immunity (GO:0002708 from GO Biological Process Annotations)", "positive regulation of lymphocyte migration (GO:2000403 from GO Biological Process Annotations)", "positive regulation of lymphocyte proliferation (GO:0050671 from GO Biological Process Annotations)", "positive regulation of lymphotoxin a biosynthetic process (GO:0043017 from GO Biological Process Annotations)", "positive regulation of lymphotoxin a production (GO:0032761 from GO Biological Process Annotations)", "positive regulation of lys63-specific deubiquitinase activity (GO:1903007 from GO Biological Process Annotations)", "positive regulation of lysosomal membrane permeability (GO:0097214 from GO Biological Process Annotations)", "positive regulation of macroautophagy (GO:0016239 from GO Biological Process Annotations)", "positive regulation of macromolecule biosynthetic process (GO:0010557 from GO Biological Process Annotations)", "positive regulation of macromolecule metabolic process (GO:0010604 from GO Biological Process Annotations)", "positive regulation of macrophage activation (GO:0043032 from GO Biological Process Annotations)", "positive regulation of macrophage apoptotic process (GO:2000111 from GO Biological Process Annotations)", "positive regulation of macrophage chemotaxis (GO:0010759 from GO Biological Process Annotations)", "positive regulation of macrophage colony-stimulating factor production (GO:1901258 from GO Biological Process Annotations)", "positive regulation of macrophage cytokine production (GO:0060907 from GO Biological Process Annotations)", "positive regulation of macrophage derived foam cell differentiation (GO:0010744 from GO Biological Process Annotations)", "positive regulation of macrophage differentiation (GO:0045651 from GO Biological Process Annotations)", "positive regulation of macrophage fusion (GO:0034241 from GO Biological Process Annotations)", "positive regulation of macrophage tolerance induction (GO:0010933 from GO Biological Process Annotations)", "positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184 from GO Biological Process Annotations)", "positive regulation of maintenance of sister chromatid cohesion (GO:0034093 from GO Biological Process Annotations)", "positive regulation of male germ cell proliferation (GO:2000256 from GO Biological Process Annotations)", "positive regulation of male gonad development (GO:2000020 from GO Biological Process Annotations)", "positive regulation of mammary gland epithelial cell proliferation (GO:0033601 from GO Biological Process Annotations)", "positive regulation of mammary gland involution (GO:1903521 from GO Biological Process Annotations)", "positive regulation of map kinase activity (GO:0043406 from GO Biological Process Annotations)", "positive regulation of mapk cascade (GO:0043410 from GO Biological Process Annotations)", "positive regulation of mapkkk cascade by fibroblast growth factor receptor signaling pathway (GO:0090080 from GO Biological Process Annotations)", "positive regulation of mast cell activation (GO:0033005 from GO Biological Process Annotations)", "positive regulation of mast cell activation involved in immune response (GO:0033008 from GO Biological Process Annotations)", "positive regulation of mast cell chemotaxis (GO:0060754 from GO Biological Process Annotations)", "positive regulation of mast cell cytokine production (GO:0032765 from GO Biological Process Annotations)", "positive regulation of mast cell degranulation (GO:0043306 from GO Biological Process Annotations)", "positive regulation of mast cell differentiation (GO:0060376 from GO Biological Process Annotations)", "positive regulation of mast cell proliferation (GO:0070668 from GO Biological Process Annotations)", "positive regulation of mda-5 signaling pathway (GO:1900245 from GO Biological Process Annotations)", "positive regulation of mechanoreceptor differentiation (GO:0045633 from GO Biological Process Annotations)", "positive regulation of mediator complex assembly (GO:2001178 from GO Biological Process Annotations)", "positive regulation of megakaryocyte differentiation (GO:0045654 from GO Biological Process Annotations)", "positive regulation of meiosis i (GO:0060903 from GO Biological Process Annotations)", "positive regulation of meiotic cell cycle (GO:0051446 from GO Biological Process Annotations)", "positive regulation of meiotic nuclear division (GO:0045836 from GO Biological Process Annotations)", "positive regulation of melanin biosynthetic process (GO:0048023 from GO Biological Process Annotations)", "positive regulation of melanocyte differentiation (GO:0045636 from GO Biological Process Annotations)", "positive regulation of melanosome transport (GO:1902910 from GO Biological Process Annotations)", "positive regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900827 from GO Biological Process Annotations)", "positive regulation of membrane potential (GO:0045838 from GO Biological Process Annotations)", "positive regulation of membrane protein ectodomain proteolysis (GO:0051044 from GO Biological Process Annotations)", "positive regulation of memory t cell activation (GO:2000568 from GO Biological Process Annotations)", "positive regulation of memory t cell differentiation (GO:0043382 from GO Biological Process Annotations)", "positive regulation of mesenchymal cell apoptotic process (GO:2001055 from GO Biological Process Annotations)", "positive regulation of mesenchymal cell proliferation (GO:0002053 from GO Biological Process Annotations)", "positive regulation of mesenchymal cell proliferation involved in ureter development (GO:2000729 from GO Biological Process Annotations)", "positive regulation of mesenchymal stem cell differentiation (GO:2000741 from GO Biological Process Annotations)", "positive regulation of mesenchymal stem cell proliferation (GO:1902462 from GO Biological Process Annotations)", "positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0072108 from GO Biological Process Annotations)", "positive regulation of mesoderm development (GO:2000382 from GO Biological Process Annotations)", "positive regulation of mesodermal cell fate specification (GO:0048337 from GO Biological Process Annotations)", "positive regulation of mesonephros development (GO:0061213 from GO Biological Process Annotations)", "positive regulation of metabolic process (GO:0009893 from GO Biological Process Annotations)", "positive regulation of metalloenzyme activity (GO:0048554 from GO Biological Process Annotations)", "positive regulation of metanephric cap mesenchymal cell proliferation (GO:0090096 from GO Biological Process Annotations)", "positive regulation of metanephric dct cell differentiation (GO:2000594 from GO Biological Process Annotations)", "positive regulation of metanephric glomerular visceral epithelial cell development (GO:2000478 from GO Biological Process Annotations)", "positive regulation of metanephric glomerulus development (GO:0072300 from GO Biological Process Annotations)", "positive regulation of metanephric mesenchymal cell migration (GO:2000591 from GO Biological Process Annotations)", "positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:0035793 from GO Biological Process Annotations)", "positive regulation of metanephric ureteric bud development (GO:2001076 from GO Biological Process Annotations)", "positive regulation of metanephros development (GO:0072216 from GO Biological Process Annotations)", "positive regulation of metaphase|anaphase transition of cell cycle (GO:1902101 from GO Biological Process Annotations)", "positive regulation of mhc class i biosynthetic process (GO:0045345 from GO Biological Process Annotations)", "positive regulation of mhc class ii biosynthetic process (GO:0045348 from GO Biological Process Annotations)", "positive regulation of microtubule depolymerization (GO:0031117 from GO Biological Process Annotations)", "positive regulation of microtubule motor activity (GO:2000576 from GO Biological Process Annotations)", "positive regulation of microtubule plus-end binding (GO:1903033 from GO Biological Process Annotations)", "positive regulation of microtubule polymerization (GO:0031116 from GO Biological Process Annotations)", "positive regulation of microtubule polymerization or depolymerization (GO:0031112 from GO Biological Process Annotations)", "positive regulation of mineralocorticoid secretion (GO:2000857 from GO Biological Process Annotations)", "positive regulation of mirna catabolic process (GO:2000627 from GO Biological Process Annotations)", "positive regulation of mirna metabolic process (GO:2000630 from GO Biological Process Annotations)", "positive regulation of mismatch repair (GO:0032425 from GO Biological Process Annotations)", "positive regulation of mitochondrial calcium ion concentration (GO:0051561 from GO Biological Process Annotations)", "positive regulation of mitochondrial depolarization (GO:0051901 from GO Biological Process Annotations)", "positive regulation of mitochondrial dna metabolic process (GO:1901860 from GO Biological Process Annotations)", "positive regulation of mitochondrial dna replication (GO:0090297 from GO Biological Process Annotations)", "positive regulation of mitochondrial electron transport, nadh to ubiquinone (GO:1902958 from GO Biological Process Annotations)", "positive regulation of mitochondrial fission (GO:0090141 from GO Biological Process Annotations)", "positive regulation of mitochondrial fusion (GO:0010636 from GO Biological Process Annotations)", "positive regulation of mitochondrial membrane permeability (GO:0035794 from GO Biological Process Annotations)", "positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 from GO Biological Process Annotations)", "positive regulation of mitochondrial membrane potential (GO:0010918 from GO Biological Process Annotations)", "positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030 from GO Biological Process Annotations)", "positive regulation of mitochondrial rna catabolic process (GO:0000962 from GO Biological Process Annotations)", "positive regulation of mitochondrial translation (GO:0070131 from GO Biological Process Annotations)", "positive regulation of mitochondrion degradation (GO:1903599 from GO Biological Process Annotations)", "positive regulation of mitochondrion organization (GO:0010822 from GO Biological Process Annotations)", "positive regulation of mitotic cell cycle (GO:0045931 from GO Biological Process Annotations)", "positive regulation of mitotic cell cycle phase transition (GO:1901992 from GO Biological Process Annotations)", "positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267 from GO Biological Process Annotations)", "positive regulation of mitotic cell cycle, embryonic (GO:0045977 from GO Biological Process Annotations)", "positive regulation of mitotic metaphase|anaphase transition (GO:0045842 from GO Biological Process Annotations)", "positive regulation of mitotic nuclear division (GO:0045840 from GO Biological Process Annotations)", "positive regulation of mitotic sister chromatid separation (GO:1901970 from GO Biological Process Annotations)", "positive regulation of molecular function (GO:0044093 from GO Biological Process Annotations)", "positive regulation of monocyte aggregation (GO:1900625 from GO Biological Process Annotations)", "positive regulation of monocyte chemotactic protein-1 production (GO:0071639 from GO Biological Process Annotations)", "positive regulation of monocyte chemotaxis (GO:0090026 from GO Biological Process Annotations)", "positive regulation of monocyte differentiation (GO:0045657 from GO Biological Process Annotations)", "positive regulation of monocyte extravasation (GO:2000439 from GO Biological Process Annotations)", "positive regulation of mononuclear cell migration (GO:0071677 from GO Biological Process Annotations)", "positive regulation of mononuclear cell proliferation (GO:0032946 from GO Biological Process Annotations)", "positive regulation of monooxygenase activity (GO:0032770 from GO Biological Process Annotations)", "positive regulation of monophenol monooxygenase activity (GO:0032773 from GO Biological Process Annotations)", "positive regulation of mrna 3'-end processing (GO:0031442 from GO Biological Process Annotations)", "positive regulation of mrna 3'-utr binding (GO:1903839 from GO Biological Process Annotations)", "positive regulation of mrna binding (GO:1902416 from GO Biological Process Annotations)", "positive regulation of mrna catabolic process (GO:0061014 from GO Biological Process Annotations)", "positive regulation of mrna metabolic process (GO:1903313 from GO Biological Process Annotations)", "positive regulation of mrna polyadenylation (GO:1900365 from GO Biological Process Annotations)", "positive regulation of mrna processing (GO:0050685 from GO Biological Process Annotations)", "positive regulation of mrna splicing, via spliceosome (GO:0048026 from GO Biological Process Annotations)", "positive regulation of mucus secretion (GO:0070257 from GO Biological Process Annotations)", "positive regulation of multi-organism process (GO:0043902 from GO Biological Process Annotations)", "positive regulation of multicellular organism growth (GO:0040018 from GO Biological Process Annotations)", "positive regulation of multicellular organismal metabolic process (GO:0044253 from GO Biological Process Annotations)", "positive regulation of multicellular organismal process (GO:0051240 from GO Biological Process Annotations)", "positive regulation of muscle adaptation (GO:0014744 from GO Biological Process Annotations)", "positive regulation of muscle atrophy (GO:0014737 from GO Biological Process Annotations)", "positive regulation of muscle cell apoptotic process (GO:0010661 from GO Biological Process Annotations)", "positive regulation of muscle cell differentiation (GO:0051149 from GO Biological Process Annotations)", "positive regulation of muscle contraction (GO:0045933 from GO Biological Process Annotations)", "positive regulation of muscle hyperplasia (GO:0014739 from GO Biological Process Annotations)", "positive regulation of muscle hypertrophy (GO:0014742 from GO Biological Process Annotations)", "positive regulation of muscle organ development (GO:0048636 from GO Biological Process Annotations)", "positive regulation of muscle tissue development (GO:1901863 from GO Biological Process Annotations)", "positive regulation of myd88-dependent toll-like receptor signaling pathway (GO:0034126 from GO Biological Process Annotations)", "positive regulation of myelination (GO:0031643 from GO Biological Process Annotations)", "positive regulation of myeloid cell apoptotic process (GO:0033034 from GO Biological Process Annotations)", "positive regulation of myeloid cell differentiation (GO:0045639 from GO Biological Process Annotations)", "positive regulation of myeloid dendritic cell activation (GO:0030887 from GO Biological Process Annotations)", "positive regulation of myeloid dendritic cell chemotaxis (GO:2000529 from GO Biological Process Annotations)", "positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 from GO Biological Process Annotations)", "positive regulation of myeloid leukocyte differentiation (GO:0002763 from GO Biological Process Annotations)", "positive regulation of myeloid leukocyte mediated immunity (GO:0002888 from GO Biological Process Annotations)", "positive regulation of myoblast differentiation (GO:0045663 from GO Biological Process Annotations)", "positive regulation of myoblast fusion (GO:1901741 from GO Biological Process Annotations)", "positive regulation of myoblast proliferation (GO:2000288 from GO Biological Process Annotations)", "positive regulation of myosin light chain kinase activity (GO:0035505 from GO Biological Process Annotations)", "positive regulation of myotome development (GO:2000287 from GO Biological Process Annotations)", "positive regulation of myotube differentiation (GO:0010831 from GO Biological Process Annotations)", "positive regulation of n-terminal peptidyl-lysine acetylation (GO:2000761 from GO Biological Process Annotations)", "positive regulation of nad(p)h oxidase activity (GO:0033864 from GO Biological Process Annotations)", "positive regulation of nad+ adp-ribosyltransferase activity (GO:1901666 from GO Biological Process Annotations)", "positive regulation of natural killer cell activation (GO:0032816 from GO Biological Process Annotations)", "positive regulation of natural killer cell chemotaxis (GO:2000503 from GO Biological Process Annotations)", "positive regulation of natural killer cell cytokine production (GO:0002729 from GO Biological Process Annotations)", "positive regulation of natural killer cell degranulation (GO:0043323 from GO Biological Process Annotations)", "positive regulation of natural killer cell differentiation (GO:0032825 from GO Biological Process Annotations)", "positive regulation of natural killer cell mediated cytotoxicity (GO:0045954 from GO Biological Process Annotations)", "positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860 from GO Biological Process Annotations)", "positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857 from GO Biological Process Annotations)", "positive regulation of natural killer cell mediated immunity (GO:0002717 from GO Biological Process Annotations)", "positive regulation of natural killer cell proliferation (GO:0032819 from GO Biological Process Annotations)", "positive regulation of necroptotic process (GO:0060545 from GO Biological Process Annotations)", "positive regulation of necrotic cell death (GO:0010940 from GO Biological Process Annotations)", "positive regulation of negative chemotaxis (GO:0050924 from GO Biological Process Annotations)", "positive regulation of nephron tubule epithelial cell differentiation (GO:2000768 from GO Biological Process Annotations)", "positive regulation of nervous system development (GO:0051962 from GO Biological Process Annotations)", "positive regulation of neural precursor cell proliferation (GO:2000179 from GO Biological Process Annotations)", "positive regulation of neuroblast proliferation (GO:0002052 from GO Biological Process Annotations)", "positive regulation of neuroepithelial cell differentiation (GO:1902913 from GO Biological Process Annotations)", "positive regulation of neurofibrillary tangle assembly (GO:1902998 from GO Biological Process Annotations)", "positive regulation of neurogenesis (GO:0050769 from GO Biological Process Annotations)", "positive regulation of neurological system process (GO:0031646 from GO Biological Process Annotations)", "positive regulation of neuromuscular synaptic transmission (GO:1900075 from GO Biological Process Annotations)", "positive regulation of neuron apoptotic process (GO:0043525 from GO Biological Process Annotations)", "positive regulation of neuron death (GO:1901216 from GO Biological Process Annotations)", "positive regulation of neuron differentiation (GO:0045666 from GO Biological Process Annotations)", "positive regulation of neuron maturation (GO:0014042 from GO Biological Process Annotations)", "positive regulation of neuron migration (GO:2001224 from GO Biological Process Annotations)", "positive regulation of neuron projection development (GO:0010976 from GO Biological Process Annotations)", "positive regulation of neuron projection regeneration (GO:0070572 from GO Biological Process Annotations)", "positive regulation of neurotransmitter secretion (GO:0001956 from GO Biological Process Annotations)", "positive regulation of neurotransmitter transport (GO:0051590 from GO Biological Process Annotations)", "positive regulation of neurotransmitter uptake (GO:0051582 from GO Biological Process Annotations)", "positive regulation of neurotrophin production (GO:0032901 from GO Biological Process Annotations)", "positive regulation of neurotrophin trk receptor signaling pathway (GO:0051388 from GO Biological Process Annotations)", "positive regulation of neutrophil apoptotic process (GO:0033031 from GO Biological Process Annotations)", "positive regulation of neutrophil chemotaxis (GO:0090023 from GO Biological Process Annotations)", "positive regulation of neutrophil differentiation (GO:0045660 from GO Biological Process Annotations)", "positive regulation of neutrophil extravasation (GO:2000391 from GO Biological Process Annotations)", "positive regulation of neutrophil mediated cytotoxicity (GO:0070960 from GO Biological Process Annotations)", "positive regulation of neutrophil mediated killing of bacterium (GO:0070962 from GO Biological Process Annotations)", "positive regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070963 from GO Biological Process Annotations)", "positive regulation of neutrophil mediated killing of symbiont cell (GO:0070961 from GO Biological Process Annotations)", "positive regulation of neutrophil migration (GO:1902624 from GO Biological Process Annotations)", "positive regulation of nf-kappab import into nucleus (GO:0042346 from GO Biological Process Annotations)", "positive regulation of nf-kappab transcription factor activity (GO:0051092 from GO Biological Process Annotations)", "positive regulation of nfat protein import into nucleus (GO:0051533 from GO Biological Process Annotations)", "positive regulation of nik|nf-kappab signaling (GO:1901224 from GO Biological Process Annotations)", "positive regulation of nitric oxide biosynthetic process (GO:0045429 from GO Biological Process Annotations)", "positive regulation of nitric oxide mediated signal transduction (GO:0010750 from GO Biological Process Annotations)", "positive regulation of nitric-oxide synthase activity (GO:0051000 from GO Biological Process Annotations)", "positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770 from GO Biological Process Annotations)", "positive regulation of nitrogen compound metabolic process (GO:0051173 from GO Biological Process Annotations)", "positive regulation of nk t cell activation (GO:0051135 from GO Biological Process Annotations)", "positive regulation of nk t cell differentiation (GO:0051138 from GO Biological Process Annotations)", "positive regulation of nk t cell proliferation (GO:0051142 from GO Biological Process Annotations)", "positive regulation of nlrp3 inflammasome complex assembly (GO:1900227 from GO Biological Process Annotations)", "positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left|right asymmetry (GO:1900224 from GO Biological Process Annotations)", "positive regulation of non-canonical wnt signaling pathway (GO:2000052 from GO Biological Process Annotations)", "positive regulation of non-canonical wnt signaling pathway via jnk cascade (GO:1901231 from GO Biological Process Annotations)", "positive regulation of nonmotile primary cilium assembly (GO:1902857 from GO Biological Process Annotations)", "positive regulation of norepinephrine secretion (GO:0010701 from GO Biological Process Annotations)", "positive regulation of notch signaling pathway (GO:0045747 from GO Biological Process Annotations)", "positive regulation of notch signaling pathway involved in heart induction (GO:0035481 from GO Biological Process Annotations)", "positive regulation of nuclear cell cycle dna replication (GO:0010571 from GO Biological Process Annotations)", "positive regulation of nuclear division (GO:0051785 from GO Biological Process Annotations)", "positive regulation of nuclear-transcribed mrna catabolic process, deadenylation-dependent decay (GO:1900153 from GO Biological Process Annotations)", "positive regulation of nuclear-transcribed mrna poly(a) tail shortening (GO:0060213 from GO Biological Process Annotations)", "positive regulation of nuclease activity (GO:0032075 from GO Biological Process Annotations)", "positive regulation of nucleic acid-templated transcription (GO:1903508 from GO Biological Process Annotations)", "positive regulation of nucleobase-containing compound metabolic process (GO:0045935 from GO Biological Process Annotations)", "positive regulation of nucleobase-containing compound transport (GO:0032241 from GO Biological Process Annotations)", "positive regulation of nucleocytoplasmic transport (GO:0046824 from GO Biological Process Annotations)", "positive regulation of nucleoside metabolic process (GO:0045979 from GO Biological Process Annotations)", "positive regulation of nucleoside transport (GO:0032244 from GO Biological Process Annotations)", "positive regulation of nucleotide biosynthetic process (GO:0030810 from GO Biological Process Annotations)", "positive regulation of nucleotide catabolic process (GO:0030813 from GO Biological Process Annotations)", "positive regulation of nucleotide metabolic process (GO:0045981 from GO Biological Process Annotations)", "positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070430 from GO Biological Process Annotations)", "positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070434 from GO Biological Process Annotations)", "positive regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070426 from GO Biological Process Annotations)", "positive regulation of odontogenesis (GO:0042482 from GO Biological Process Annotations)", "positive regulation of odontogenesis of dentin-containing tooth (GO:0042488 from GO Biological Process Annotations)", "positive regulation of oligodendrocyte differentiation (GO:0048714 from GO Biological Process Annotations)", "positive regulation of oligodendrocyte progenitor proliferation (GO:0070447 from GO Biological Process Annotations)", "positive regulation of oligopeptide transport (GO:2000878 from GO Biological Process Annotations)", "positive regulation of oocyte development (GO:0060282 from GO Biological Process Annotations)", "positive regulation of oocyte maturation (GO:1900195 from GO Biological Process Annotations)", "positive regulation of optic nerve formation (GO:2000597 from GO Biological Process Annotations)", "positive regulation of organ growth (GO:0046622 from GO Biological Process Annotations)", "positive regulation of organelle assembly (GO:1902117 from GO Biological Process Annotations)", "positive regulation of organelle organization (GO:0010638 from GO Biological Process Annotations)", "positive regulation of organic acid transport (GO:0032892 from GO Biological Process Annotations)", "positive regulation of ossification (GO:0045778 from GO Biological Process Annotations)", "positive regulation of osteoblast differentiation (GO:0045669 from GO Biological Process Annotations)", "positive regulation of osteoblast proliferation (GO:0033690 from GO Biological Process Annotations)", "positive regulation of osteoclast development (GO:2001206 from GO Biological Process Annotations)", "positive regulation of osteoclast differentiation (GO:0045672 from GO Biological Process Annotations)", "positive regulation of osteoclast proliferation (GO:0090290 from GO Biological Process Annotations)", "positive regulation of ovarian follicle development (GO:2000386 from GO Biological Process Annotations)", "positive regulation of ovulation (GO:0060279 from GO Biological Process Annotations)", "positive regulation of oxidative phosphorylation uncoupler activity (GO:2000277 from GO Biological Process Annotations)", "positive regulation of oxidative stress-induced cell death (GO:1903209 from GO Biological Process Annotations)", "positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902177 from GO Biological Process Annotations)", "positive regulation of oxidative stress-induced neuron death (GO:1903223 from GO Biological Process Annotations)", "positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903378 from GO Biological Process Annotations)", "positive regulation of oxidoreductase activity (GO:0051353 from GO Biological Process Annotations)", "positive regulation of oxygen metabolic process (GO:2000376 from GO Biological Process Annotations)", "positive regulation of p38mapk cascade (GO:1900745 from GO Biological Process Annotations)", "positive regulation of pancreatic juice secretion (GO:0090187 from GO Biological Process Annotations)", "positive regulation of pancreatic stellate cell proliferation (GO:2000231 from GO Biological Process Annotations)", "positive regulation of pathway-restricted smad protein phosphorylation (GO:0010862 from GO Biological Process Annotations)", "positive regulation of penile erection (GO:0060406 from GO Biological Process Annotations)", "positive regulation of peptidase activity (GO:0010952 from GO Biological Process Annotations)", "positive regulation of peptide hormone secretion (GO:0090277 from GO Biological Process Annotations)", "positive regulation of peptide secretion (GO:0002793 from GO Biological Process Annotations)", "positive regulation of peptidyl-cysteine s-nitrosylation (GO:2000170 from GO Biological Process Annotations)", "positive regulation of peptidyl-lysine acetylation (GO:2000758 from GO Biological Process Annotations)", "positive regulation of peptidyl-serine dephosphorylation (GO:1902310 from GO Biological Process Annotations)", "positive regulation of peptidyl-serine phosphorylation (GO:0033138 from GO Biological Process Annotations)", "positive regulation of peptidyl-serine phosphorylation of stat protein (GO:0033141 from GO Biological Process Annotations)", "positive regulation of peptidyl-threonine phosphorylation (GO:0010800 from GO Biological Process Annotations)", "positive regulation of peptidyl-tyrosine autophosphorylation (GO:1900086 from GO Biological Process Annotations)", "positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731 from GO Biological Process Annotations)", "positive regulation of peripheral t cell tolerance induction (GO:0002851 from GO Biological Process Annotations)", "positive regulation of peripheral tolerance induction (GO:0002660 from GO Biological Process Annotations)", "positive regulation of peroxidase activity (GO:2000470 from GO Biological Process Annotations)", "positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360 from GO Biological Process Annotations)", "positive regulation of phagocytosis (GO:0050766 from GO Biological Process Annotations)", "positive regulation of phagocytosis, engulfment (GO:0060100 from GO Biological Process Annotations)", "positive regulation of phosphatase activity (GO:0010922 from GO Biological Process Annotations)", "positive regulation of phosphate metabolic process (GO:0045937 from GO Biological Process Annotations)", "positive regulation of phosphate transmembrane transport (GO:2000187 from GO Biological Process Annotations)", "positive regulation of phosphatidylcholine biosynthetic process (GO:2001247 from GO Biological Process Annotations)", "positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552 from GO Biological Process Annotations)", "positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068 from GO Biological Process Annotations)", "positive regulation of phosphatidylinositol biosynthetic process (GO:0010513 from GO Biological Process Annotations)", "positive regulation of phospholipase a2 activity (GO:0032430 from GO Biological Process Annotations)", "positive regulation of phospholipase activity (GO:0010518 from GO Biological Process Annotations)", "positive regulation of phospholipase c activity (GO:0010863 from GO Biological Process Annotations)", "positive regulation of phospholipase c-activating g-protein coupled receptor signaling pathway (GO:1900738 from GO Biological Process Annotations)", "positive regulation of phospholipid biosynthetic process (GO:0071073 from GO Biological Process Annotations)", "positive regulation of phospholipid catabolic process (GO:0060697 from GO Biological Process Annotations)", "positive regulation of phospholipid efflux (GO:1902995 from GO Biological Process Annotations)", "positive regulation of phospholipid metabolic process (GO:1903727 from GO Biological Process Annotations)", "positive regulation of phospholipid scramblase activity (GO:1900163 from GO Biological Process Annotations)", "positive regulation of phospholipid translocation (GO:0061092 from GO Biological Process Annotations)", "positive regulation of phospholipid transport (GO:2001140 from GO Biological Process Annotations)", "positive regulation of phosphoprotein phosphatase activity (GO:0032516 from GO Biological Process Annotations)", "positive regulation of phosphorus metabolic process (GO:0010562 from GO Biological Process Annotations)", "positive regulation of phosphorylation (GO:0042327 from GO Biological Process Annotations)", "positive regulation of phosphorylation of rna polymerase ii c-terminal domain (GO:1901409 from GO Biological Process Annotations)", "positive regulation of phosphorylation of rna polymerase ii c-terminal domain serine 2 residues (GO:2001165 from GO Biological Process Annotations)", "positive regulation of photoreceptor cell differentiation (GO:0046534 from GO Biological Process Annotations)", "positive regulation of pigment cell differentiation (GO:0050942 from GO Biological Process Annotations)", "positive regulation of pinocytosis (GO:0048549 from GO Biological Process Annotations)", "positive regulation of plasma cell differentiation (GO:1900100 from GO Biological Process Annotations)", "positive regulation of plasma membrane long-chain fatty acid transport (GO:0010747 from GO Biological Process Annotations)", "positive regulation of plasminogen activation (GO:0010756 from GO Biological Process Annotations)", "positive regulation of platelet activation (GO:0010572 from GO Biological Process Annotations)", "positive regulation of platelet aggregation (GO:1901731 from GO Biological Process Annotations)", "positive regulation of platelet-derived growth factor production (GO:0090362 from GO Biological Process Annotations)", "positive regulation of platelet-derived growth factor receptor signaling pathway (GO:0010641 from GO Biological Process Annotations)", "positive regulation of podosome assembly (GO:0071803 from GO Biological Process Annotations)", "positive regulation of polarized epithelial cell differentiation (GO:0030862 from GO Biological Process Annotations)", "positive regulation of polyamine transmembrane transport (GO:1902269 from GO Biological Process Annotations)", "positive regulation of positive chemotaxis (GO:0050927 from GO Biological Process Annotations)", "positive regulation of postsynaptic membrane organization (GO:1901628 from GO Biological Process Annotations)", "positive regulation of posttranscriptional gene silencing (GO:0060148 from GO Biological Process Annotations)", "positive regulation of potassium ion export (GO:1902304 from GO Biological Process Annotations)", "positive regulation of potassium ion export across plasma membrane (GO:1903766 from GO Biological Process Annotations)", "positive regulation of potassium ion import (GO:1903288 from GO Biological Process Annotations)", "positive regulation of potassium ion transmembrane transport (GO:1901381 from GO Biological Process Annotations)", "positive regulation of potassium ion transmembrane transporter activity (GO:1901018 from GO Biological Process Annotations)", "positive regulation of potassium ion transport (GO:0043268 from GO Biological Process Annotations)", "positive regulation of presynaptic membrane organization (GO:1901631 from GO Biological Process Annotations)", "positive regulation of pri-mirna transcription from rna polymerase ii promoter (GO:1902895 from GO Biological Process Annotations)", "positive regulation of pro-t cell differentiation (GO:2000176 from GO Biological Process Annotations)", "positive regulation of production of molecular mediator of immune response (GO:0002702 from GO Biological Process Annotations)", "positive regulation of progesterone secretion (GO:2000872 from GO Biological Process Annotations)", "positive regulation of programmed cell death (GO:0043068 from GO Biological Process Annotations)", "positive regulation of prolactin signaling pathway (GO:1902213 from GO Biological Process Annotations)", "positive regulation of prostaglandin biosynthetic process (GO:0031394 from GO Biological Process Annotations)", "positive regulation of prostaglandin secretion (GO:0032308 from GO Biological Process Annotations)", "positive regulation of prostaglandin secretion involved in immune response (GO:0061078 from GO Biological Process Annotations)", "positive regulation of prostaglandin-e synthase activity (GO:2000363 from GO Biological Process Annotations)", "positive regulation of prostaglandin-endoperoxide synthase activity (GO:0060585 from GO Biological Process Annotations)", "positive regulation of proteasomal protein catabolic process (GO:1901800 from GO Biological Process Annotations)", "positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436 from GO Biological Process Annotations)", "positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia (GO:2000777 from GO Biological Process Annotations)", "positive regulation of protein acetylation (GO:1901985 from GO Biological Process Annotations)", "positive regulation of protein activation cascade (GO:2000259 from GO Biological Process Annotations)", "positive regulation of protein autophosphorylation (GO:0031954 from GO Biological Process Annotations)", "positive regulation of protein autoubiquitination (GO:1902499 from GO Biological Process Annotations)", "positive regulation of protein binding (GO:0032092 from GO Biological Process Annotations)", "positive regulation of protein catabolic process (GO:0045732 from GO Biological Process Annotations)", "positive regulation of protein complex assembly (GO:0031334 from GO Biological Process Annotations)", "positive regulation of protein complex disassembly (GO:0043243 from GO Biological Process Annotations)", "positive regulation of protein deacetylation (GO:0090312 from GO Biological Process Annotations)", "positive regulation of protein dephosphorylation (GO:0035307 from GO Biological Process Annotations)", "positive regulation of protein depolymerization (GO:1901881 from GO Biological Process Annotations)", "positive regulation of protein deubiquitination (GO:1903003 from GO Biological Process Annotations)", "positive regulation of protein exit from endoplasmic reticulum (GO:0070863 from GO Biological Process Annotations)", "positive regulation of protein export from nucleus (GO:0046827 from GO Biological Process Annotations)", "positive regulation of protein geranylgeranylation (GO:2000541 from GO Biological Process Annotations)", "positive regulation of protein glycosylation (GO:0060050 from GO Biological Process Annotations)", "positive regulation of protein glycosylation in golgi (GO:0090284 from GO Biological Process Annotations)", "positive regulation of protein homodimerization activity (GO:0090073 from GO Biological Process Annotations)", "positive regulation of protein homooligomerization (GO:0032464 from GO Biological Process Annotations)", "positive regulation of protein import into mitochondrial outer membrane (GO:1903638 from GO Biological Process Annotations)", "positive regulation of protein import into nucleus (GO:0042307 from GO Biological Process Annotations)", "positive regulation of protein import into nucleus, translocation (GO:0033160 from GO Biological Process Annotations)", "positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740 from GO Biological Process Annotations)", "positive regulation of protein k48-linked ubiquitination (GO:1902524 from GO Biological Process Annotations)", "positive regulation of protein k63-linked deubiquitination (GO:1903006 from GO Biological Process Annotations)", "positive regulation of protein k63-linked ubiquitination (GO:1902523 from GO Biological Process Annotations)", "positive regulation of protein kinase a signaling (GO:0010739 from GO Biological Process Annotations)", "positive regulation of protein kinase activity (GO:0045860 from GO Biological Process Annotations)", "positive regulation of protein kinase b signaling (GO:0051897 from GO Biological Process Annotations)", "positive regulation of protein kinase c activity (GO:1900020 from GO Biological Process Annotations)", "positive regulation of protein kinase c signaling (GO:0090037 from GO Biological Process Annotations)", "positive regulation of protein kinase d signaling (GO:1903572 from GO Biological Process Annotations)", "positive regulation of protein linear polyubiquitination (GO:1902530 from GO Biological Process Annotations)", "positive regulation of protein lipidation (GO:1903061 from GO Biological Process Annotations)", "positive regulation of protein localization to cell surface (GO:2000010 from GO Biological Process Annotations)", "positive regulation of protein localization to early endosome (GO:1902966 from GO Biological Process Annotations)", "positive regulation of protein localization to nucleus (GO:1900182 from GO Biological Process Annotations)", "positive regulation of protein localization to plasma membrane (GO:1903078 from GO Biological Process Annotations)", "positive regulation of protein localization to synapse (GO:1902474 from GO Biological Process Annotations)", "positive regulation of protein metabolic process (GO:0051247 from GO Biological Process Annotations)", "positive regulation of protein modification by small protein conjugation or removal (GO:1903322 from GO Biological Process Annotations)", "positive regulation of protein modification process (GO:0031401 from GO Biological Process Annotations)", "positive regulation of protein monoubiquitination (GO:1902527 from GO Biological Process Annotations)", "positive regulation of protein oligomerization (GO:0032461 from GO Biological Process Annotations)", "positive regulation of protein phosphatase type 2b activity (GO:0032514 from GO Biological Process Annotations)", "positive regulation of protein phosphorylation (GO:0001934 from GO Biological Process Annotations)", "positive regulation of protein polymerization (GO:0032273 from GO Biological Process Annotations)", "positive regulation of protein polyubiquitination (GO:1902916 from GO Biological Process Annotations)", "positive regulation of protein processing (GO:0010954 from GO Biological Process Annotations)", "positive regulation of protein secretion (GO:0050714 from GO Biological Process Annotations)", "positive regulation of protein serine|threonine kinase activity (GO:0071902 from GO Biological Process Annotations)", "positive regulation of protein sumoylation (GO:0033235 from GO Biological Process Annotations)", "positive regulation of protein targeting to membrane (GO:0090314 from GO Biological Process Annotations)", "positive regulation of protein transport (GO:0051222 from GO Biological Process Annotations)", "positive regulation of protein tyrosine kinase activity (GO:0061098 from GO Biological Process Annotations)", "positive regulation of protein ubiquitination (GO:0031398 from GO Biological Process Annotations)", "positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000060 from GO Biological Process Annotations)", "positive regulation of proteoglycan biosynthetic process (GO:1902730 from GO Biological Process Annotations)", "positive regulation of proteolysis (GO:0045862 from GO Biological Process Annotations)", "positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052 from GO Biological Process Annotations)", "positive regulation of pseudopodium assembly (GO:0031274 from GO Biological Process Annotations)", "positive regulation of purine nucleotide biosynthetic process (GO:1900373 from GO Biological Process Annotations)", "positive regulation of purine nucleotide catabolic process (GO:0033123 from GO Biological Process Annotations)", "positive regulation of purine nucleotide metabolic process (GO:1900544 from GO Biological Process Annotations)", "positive regulation of pyrroline-5-carboxylate reductase activity (GO:1903168 from GO Biological Process Annotations)", "positive regulation of rac protein signal transduction (GO:0035022 from GO Biological Process Annotations)", "positive regulation of ras protein signal transduction (GO:0046579 from GO Biological Process Annotations)", "positive regulation of reactive oxygen species biosynthetic process (GO:1903428 from GO Biological Process Annotations)", "positive regulation of reactive oxygen species metabolic process (GO:2000379 from GO Biological Process Annotations)", "positive regulation of receptor activity (GO:2000273 from GO Biological Process Annotations)", "positive regulation of receptor binding (GO:1900122 from GO Biological Process Annotations)", "positive regulation of receptor biosynthetic process (GO:0010870 from GO Biological Process Annotations)", "positive regulation of receptor catabolic process (GO:2000646 from GO Biological Process Annotations)", "positive regulation of receptor internalization (GO:0002092 from GO Biological Process Annotations)", "positive regulation of receptor localization to synapse (GO:1902685 from GO Biological Process Annotations)", "positive regulation of receptor recycling (GO:0001921 from GO Biological Process Annotations)", "positive regulation of receptor-mediated endocytosis (GO:0048260 from GO Biological Process Annotations)", "positive regulation of reciprocal meiotic recombination (GO:0010845 from GO Biological Process Annotations)", "positive regulation of regulated secretory pathway (GO:1903307 from GO Biological Process Annotations)", "positive regulation of regulatory t cell differentiation (GO:0045591 from GO Biological Process Annotations)", "positive regulation of relaxation of cardiac muscle (GO:1901899 from GO Biological Process Annotations)", "positive regulation of relaxation of muscle (GO:1901079 from GO Biological Process Annotations)", "positive regulation of release of cytochrome c from mitochondria (GO:0090200 from GO Biological Process Annotations)", "positive regulation of release of sequestered calcium ion into cytosol (GO:0051281 from GO Biological Process Annotations)", "positive regulation of renal albumin absorption (GO:2000534 from GO Biological Process Annotations)", "positive regulation of renal sodium excretion (GO:0035815 from GO Biological Process Annotations)", "positive regulation of renal water transport (GO:2001153 from GO Biological Process Annotations)", "positive regulation of renin secretion into blood stream (GO:1900135 from GO Biological Process Annotations)", "positive regulation of reproductive process (GO:2000243 from GO Biological Process Annotations)", "positive regulation of respiratory burst (GO:0060267 from GO Biological Process Annotations)", "positive regulation of respiratory burst involved in inflammatory response (GO:0060265 from GO Biological Process Annotations)", "positive regulation of response to alcohol (GO:1901421 from GO Biological Process Annotations)", "positive regulation of response to biotic stimulus (GO:0002833 from GO Biological Process Annotations)", "positive regulation of response to cytokine stimulus (GO:0060760 from GO Biological Process Annotations)", "positive regulation of response to dna damage stimulus (GO:2001022 from GO Biological Process Annotations)", "positive regulation of response to drug (GO:2001025 from GO Biological Process Annotations)", "positive regulation of response to external stimulus (GO:0032103 from GO Biological Process Annotations)", "positive regulation of response to extracellular stimulus (GO:0032106 from GO Biological Process Annotations)", "positive regulation of response to food (GO:0032097 from GO Biological Process Annotations)", "positive regulation of response to interferon-gamma (GO:0060332 from GO Biological Process Annotations)", "positive regulation of response to nutrient levels (GO:0032109 from GO Biological Process Annotations)", "positive regulation of response to oxidative stress (GO:1902884 from GO Biological Process Annotations)", "positive regulation of response to reactive oxygen species (GO:1901033 from GO Biological Process Annotations)", "positive regulation of response to stimulus (GO:0048584 from GO Biological Process Annotations)", "positive regulation of response to tumor cell (GO:0002836 from GO Biological Process Annotations)", "positive regulation of response to wounding (GO:1903036 from GO Biological Process Annotations)", "positive regulation of retinal ganglion cell axon guidance (GO:1902336 from GO Biological Process Annotations)", "positive regulation of retinoic acid receptor signaling pathway (GO:0048386 from GO Biological Process Annotations)", "positive regulation of rho guanyl-nucleotide exchange factor activity (GO:2001108 from GO Biological Process Annotations)", "positive regulation of rho protein signal transduction (GO:0035025 from GO Biological Process Annotations)", "positive regulation of rhodopsin gene expression (GO:0045872 from GO Biological Process Annotations)", "positive regulation of rig-i signaling pathway (GO:1900246 from GO Biological Process Annotations)", "positive regulation of rna biosynthetic process (GO:1902680 from GO Biological Process Annotations)", "positive regulation of rna export from nucleus (GO:0046833 from GO Biological Process Annotations)", "positive regulation of rna interference (GO:1900370 from GO Biological Process Annotations)", "positive regulation of rna metabolic process (GO:0051254 from GO Biological Process Annotations)", "positive regulation of rna polymerase ii transcriptional preinitiation complex assembly (GO:0045899 from GO Biological Process Annotations)", "positive regulation of rna splicing (GO:0033120 from GO Biological Process Annotations)", "positive regulation of rubidium ion transmembrane transporter activity (GO:2000688 from GO Biological Process Annotations)", "positive regulation of rubidium ion transport (GO:2000682 from GO Biological Process Annotations)", "positive regulation of ruffle assembly (GO:1900029 from GO Biological Process Annotations)", "positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316 from GO Biological Process Annotations)", "positive regulation of ryanodine-sensitive calcium-release channel activity by adrenergic receptor signaling pathway involved in positive regulation of cardiac muscle contraction (GO:0086094 from GO Biological Process Annotations)", "positive regulation of saliva secretion (GO:0046878 from GO Biological Process Annotations)", "positive regulation of sarcomere organization (GO:0060298 from GO Biological Process Annotations)", "positive regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014718 from GO Biological Process Annotations)", "positive regulation of schwann cell differentiation (GO:0014040 from GO Biological Process Annotations)", "positive regulation of schwann cell proliferation (GO:0010625 from GO Biological Process Annotations)", "positive regulation of sclerotome development (GO:0061189 from GO Biological Process Annotations)", "positive regulation of secondary heart field cardioblast proliferation (GO:0072513 from GO Biological Process Annotations)", "positive regulation of secondary metabolite biosynthetic process (GO:1900378 from GO Biological Process Annotations)", "positive regulation of secretion (GO:0051047 from GO Biological Process Annotations)", "positive regulation of secretion by cell (GO:1903532 from GO Biological Process Annotations)", "positive regulation of secretion of lysosomal enzymes (GO:0090340 from GO Biological Process Annotations)", "positive regulation of semaphorin-plexin signaling pathway (GO:2001262 from GO Biological Process Annotations)", "positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis (GO:2000764 from GO Biological Process Annotations)", "positive regulation of sequence-specific dna binding transcription factor activity (GO:0051091 from GO Biological Process Annotations)", "positive regulation of sequestering of calcium ion (GO:0051284 from GO Biological Process Annotations)", "positive regulation of sequestering of triglyceride (GO:0010890 from GO Biological Process Annotations)", "positive regulation of sequestering of zinc ion (GO:0061090 from GO Biological Process Annotations)", "positive regulation of serine-type endopeptidase activity (GO:1900005 from GO Biological Process Annotations)", "positive regulation of serine-type peptidase activity (GO:1902573 from GO Biological Process Annotations)", "positive regulation of signal transduction (GO:0009967 from GO Biological Process Annotations)", "positive regulation of signal transduction by p53 class mediator (GO:1901798 from GO Biological Process Annotations)", "positive regulation of signaling (GO:0023056 from GO Biological Process Annotations)", "positive regulation of single stranded viral rna replication via double stranded dna intermediate (GO:0045870 from GO Biological Process Annotations)", "positive regulation of single-stranded telomeric dna binding (GO:0060381 from GO Biological Process Annotations)", "positive regulation of sister chromatid cohesion (GO:0045876 from GO Biological Process Annotations)", "positive regulation of skeletal muscle cell differentiation (GO:2001016 from GO Biological Process Annotations)", "positive regulation of skeletal muscle cell proliferation (GO:0014858 from GO Biological Process Annotations)", "positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014810 from GO Biological Process Annotations)", "positive regulation of skeletal muscle fiber development (GO:0048743 from GO Biological Process Annotations)", "positive regulation of skeletal muscle fiber differentiation (GO:1902811 from GO Biological Process Annotations)", "positive regulation of skeletal muscle tissue development (GO:0048643 from GO Biological Process Annotations)", "positive regulation of skeletal muscle tissue growth (GO:0048633 from GO Biological Process Annotations)", "positive regulation of skeletal muscle tissue regeneration (GO:0043415 from GO Biological Process Annotations)", "positive regulation of smad protein import into nucleus (GO:0060391 from GO Biological Process Annotations)", "positive regulation of small gtpase mediated signal transduction (GO:0051057 from GO Biological Process Annotations)", "positive regulation of smooth muscle cell apoptotic process (GO:0034393 from GO Biological Process Annotations)", "positive regulation of smooth muscle cell chemotaxis (GO:0071673 from GO Biological Process Annotations)", "positive regulation of smooth muscle cell differentiation (GO:0051152 from GO Biological Process Annotations)", "positive regulation of smooth muscle cell migration (GO:0014911 from GO Biological Process Annotations)", "positive regulation of smooth muscle cell proliferation (GO:0048661 from GO Biological Process Annotations)", "positive regulation of smooth muscle contraction (GO:0045987 from GO Biological Process Annotations)", "positive regulation of smoothened signaling pathway (GO:0045880 from GO Biological Process Annotations)", "positive regulation of snare complex assembly (GO:0035543 from GO Biological Process Annotations)", "positive regulation of sodium ion export (GO:1903275 from GO Biological Process Annotations)", "positive regulation of sodium ion export from cell (GO:1903278 from GO Biological Process Annotations)", "positive regulation of sodium ion transmembrane transport (GO:1902307 from GO Biological Process Annotations)", "positive regulation of sodium ion transmembrane transporter activity (GO:2000651 from GO Biological Process Annotations)", "positive regulation of sodium ion transport (GO:0010765 from GO Biological Process Annotations)", "positive regulation of sodium-dependent phosphate transport (GO:2000120 from GO Biological Process Annotations)", "positive regulation of sodium:proton antiporter activity (GO:0032417 from GO Biological Process Annotations)", "positive regulation of somatostatin secretion (GO:0090274 from GO Biological Process Annotations)", "positive regulation of sperm motility (GO:1902093 from GO Biological Process Annotations)", "positive regulation of spermidine biosynthetic process (GO:1901307 from GO Biological Process Annotations)", "positive regulation of sphingolipid biosynthetic process (GO:0090154 from GO Biological Process Annotations)", "positive regulation of sphingomyelin catabolic process (GO:2000755 from GO Biological Process Annotations)", "positive regulation of spindle checkpoint (GO:0090232 from GO Biological Process Annotations)", "positive regulation of sprouting angiogenesis (GO:1903672 from GO Biological Process Annotations)", "positive regulation of sprouting of injured axon (GO:0048687 from GO Biological Process Annotations)", "positive regulation of stat protein import into nucleus (GO:2000366 from GO Biological Process Annotations)", "positive regulation of stem cell differentiation (GO:2000738 from GO Biological Process Annotations)", "positive regulation of stem cell maintenance (GO:1902459 from GO Biological Process Annotations)", "positive regulation of stem cell proliferation (GO:2000648 from GO Biological Process Annotations)", "positive regulation of steroid biosynthetic process (GO:0010893 from GO Biological Process Annotations)", "positive regulation of steroid hormone biosynthetic process (GO:0090031 from GO Biological Process Annotations)", "positive regulation of steroid hormone secretion (GO:2000833 from GO Biological Process Annotations)", "positive regulation of steroid metabolic process (GO:0045940 from GO Biological Process Annotations)", "positive regulation of sterol transport (GO:0032373 from GO Biological Process Annotations)", "positive regulation of store-operated calcium channel activity (GO:1901341 from GO Biological Process Annotations)", "positive regulation of stress fiber assembly (GO:0051496 from GO Biological Process Annotations)", "positive regulation of stress-activated mapk cascade (GO:0032874 from GO Biological Process Annotations)", "positive regulation of stress-activated protein kinase signaling cascade (GO:0070304 from GO Biological Process Annotations)", "positive regulation of striated muscle cell apoptotic process (GO:0010663 from GO Biological Process Annotations)", "positive regulation of striated muscle cell differentiation (GO:0051155 from GO Biological Process Annotations)", "positive regulation of striated muscle contraction (GO:0045989 from GO Biological Process Annotations)", "positive regulation of striated muscle tissue development (GO:0045844 from GO Biological Process Annotations)", "positive regulation of substrate adhesion-dependent cell spreading (GO:1900026 from GO Biological Process Annotations)", "positive regulation of sulfur amino acid metabolic process (GO:0031337 from GO Biological Process Annotations)", "positive regulation of sulfur metabolic process (GO:0051176 from GO Biological Process Annotations)", "positive regulation of sumo transferase activity (GO:1903755 from GO Biological Process Annotations)", "positive regulation of superoxide anion generation (GO:0032930 from GO Biological Process Annotations)", "positive regulation of superoxide dismutase activity (GO:1901671 from GO Biological Process Annotations)", "positive regulation of synapse assembly (GO:0051965 from GO Biological Process Annotations)", "positive regulation of synapse maturation (GO:0090129 from GO Biological Process Annotations)", "positive regulation of synapse structural plasticity (GO:0051835 from GO Biological Process Annotations)", "positive regulation of synaptic growth at neuromuscular junction (GO:0045887 from GO Biological Process Annotations)", "positive regulation of synaptic plasticity (GO:0031915 from GO Biological Process Annotations)", "positive regulation of synaptic transmission (GO:0050806 from GO Biological Process Annotations)", "positive regulation of synaptic transmission, cholinergic (GO:0032224 from GO Biological Process Annotations)", "positive regulation of synaptic transmission, dopaminergic (GO:0032226 from GO Biological Process Annotations)", "positive regulation of synaptic transmission, gabaergic (GO:0032230 from GO Biological Process Annotations)", "positive regulation of synaptic transmission, glutamatergic (GO:0051968 from GO Biological Process Annotations)", "positive regulation of synaptic vesicle endocytosis (GO:1900244 from GO Biological Process Annotations)", "positive regulation of synaptic vesicle exocytosis (GO:2000302 from GO Biological Process Annotations)", "positive regulation of synaptic vesicle priming (GO:0010808 from GO Biological Process Annotations)", "positive regulation of synaptic vesicle recycling (GO:1903423 from GO Biological Process Annotations)", "positive regulation of synaptic vesicle transport (GO:1902805 from GO Biological Process Annotations)", "positive regulation of synaptic vesicle uncoating (GO:1903390 from GO Biological Process Annotations)", "positive regulation of syncytium formation by plasma membrane fusion (GO:0060143 from GO Biological Process Annotations)", "positive regulation of systemic arterial blood pressure (GO:0003084 from GO Biological Process Annotations)", "positive regulation of t cell activation (GO:0050870 from GO Biological Process Annotations)", "positive regulation of t cell activation via t cell receptor contact with antigen bound to mhc molecule on antigen presenting cell (GO:2001190 from GO Biological Process Annotations)", "positive regulation of t cell anergy (GO:0002669 from GO Biological Process Annotations)", "positive regulation of t cell apoptotic process (GO:0070234 from GO Biological Process Annotations)", "positive regulation of t cell chemotaxis (GO:0010820 from GO Biological Process Annotations)", "positive regulation of t cell costimulation (GO:2000525 from GO Biological Process Annotations)", "positive regulation of t cell cytokine production (GO:0002726 from GO Biological Process Annotations)", "positive regulation of t cell differentiation (GO:0045582 from GO Biological Process Annotations)", "positive regulation of t cell differentiation in thymus (GO:0033089 from GO Biological Process Annotations)", "positive regulation of t cell extravasation (GO:2000409 from GO Biological Process Annotations)", "positive regulation of t cell mediated cytotoxicity (GO:0001916 from GO Biological Process Annotations)", "positive regulation of t cell mediated immune response to tumor cell (GO:0002842 from GO Biological Process Annotations)", "positive regulation of t cell mediated immunity (GO:0002711 from GO Biological Process Annotations)", "positive regulation of t cell migration (GO:2000406 from GO Biological Process Annotations)", "positive regulation of t cell proliferation (GO:0042102 from GO Biological Process Annotations)", "positive regulation of t cell receptor signaling pathway (GO:0050862 from GO Biological Process Annotations)", "positive regulation of t cell tolerance induction (GO:0002666 from GO Biological Process Annotations)", "positive regulation of t-helper 1 cell cytokine production (GO:2000556 from GO Biological Process Annotations)", "positive regulation of t-helper 1 cell differentiation (GO:0045627 from GO Biological Process Annotations)", "positive regulation of t-helper 1 type immune response (GO:0002827 from GO Biological Process Annotations)", "positive regulation of t-helper 17 cell differentiation (GO:2000321 from GO Biological Process Annotations)", "positive regulation of t-helper 17 cell lineage commitment (GO:2000330 from GO Biological Process Annotations)", "positive regulation of t-helper 17 type immune response (GO:2000318 from GO Biological Process Annotations)", "positive regulation of t-helper 2 cell activation (GO:2000570 from GO Biological Process Annotations)", "positive regulation of t-helper 2 cell cytokine production (GO:2000553 from GO Biological Process Annotations)", "positive regulation of t-helper 2 cell differentiation (GO:0045630 from GO Biological Process Annotations)", "positive regulation of t-helper cell differentiation (GO:0045624 from GO Biological Process Annotations)", "positive regulation of tau-protein kinase activity (GO:1902949 from GO Biological Process Annotations)", "positive regulation of telomerase activity (GO:0051973 from GO Biological Process Annotations)", "positive regulation of telomere maintenance (GO:0032206 from GO Biological Process Annotations)", "positive regulation of telomere maintenance via telomerase (GO:0032212 from GO Biological Process Annotations)", "positive regulation of tendon cell differentiation (GO:2001051 from GO Biological Process Annotations)", "positive regulation of termination of rna polymerase ii transcription, poly(a)-coupled (GO:2000806 from GO Biological Process Annotations)", "positive regulation of testosterone secretion (GO:2000845 from GO Biological Process Annotations)", "positive regulation of the force of heart contraction (GO:0098735 from GO Biological Process Annotations)", "positive regulation of the force of heart contraction by chemical signal (GO:0003099 from GO Biological Process Annotations)", "positive regulation of the force of heart contraction by epinephrine-norepinephrine (GO:0001997 from GO Biological Process Annotations)", "positive regulation of the force of heart contraction by norepinephrine (GO:0003061 from GO Biological Process Annotations)", "positive regulation of thymocyte aggregation (GO:2000400 from GO Biological Process Annotations)", "positive regulation of thymocyte apoptotic process (GO:0070245 from GO Biological Process Annotations)", "positive regulation of thymocyte migration (GO:2000412 from GO Biological Process Annotations)", "positive regulation of thyroid hormone generation (GO:2000611 from GO Biological Process Annotations)", "positive regulation of tissue remodeling (GO:0034105 from GO Biological Process Annotations)", "positive regulation of tolerance induction (GO:0002645 from GO Biological Process Annotations)", "positive regulation of tolerance induction dependent upon immune response (GO:0002654 from GO Biological Process Annotations)", "positive regulation of tolerance induction to self antigen (GO:0002651 from GO Biological Process Annotations)", "positive regulation of toll-like receptor 2 signaling pathway (GO:0034137 from GO Biological Process Annotations)", "positive regulation of toll-like receptor 3 signaling pathway (GO:0034141 from GO Biological Process Annotations)", "positive regulation of toll-like receptor 4 signaling pathway (GO:0034145 from GO Biological Process Annotations)", "positive regulation of toll-like receptor 7 signaling pathway (GO:0034157 from GO Biological Process Annotations)", "positive regulation of toll-like receptor 9 signaling pathway (GO:0034165 from GO Biological Process Annotations)", "positive regulation of toll-like receptor signaling pathway (GO:0034123 from GO Biological Process Annotations)", "positive regulation of tongue muscle cell differentiation (GO:2001037 from GO Biological Process Annotations)", "positive regulation of tooth mineralization (GO:0070172 from GO Biological Process Annotations)", "positive regulation of tor signaling (GO:0032008 from GO Biological Process Annotations)", "positive regulation of trail biosynthetic process (GO:0045556 from GO Biological Process Annotations)", "positive regulation of trail production (GO:0032759 from GO Biological Process Annotations)", "positive regulation of transcription by galactose (GO:0000411 from GO Biological Process Annotations)", "positive regulation of transcription by glucose (GO:0046016 from GO Biological Process Annotations)", "positive regulation of transcription during meiosis (GO:0051039 from GO Biological Process Annotations)", "positive regulation of transcription during mitosis (GO:0045897 from GO Biological Process Annotations)", "positive regulation of transcription elongation from rna polymerase ii promoter (GO:0032968 from GO Biological Process Annotations)", "positive regulation of transcription factor import into nucleus (GO:0042993 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase i promoter (GO:0045943 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter (GO:0045944 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter by galactose (GO:0000435 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter by glucose (GO:0000432 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter during mitosis (GO:0046022 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter in response to arsenic-containing substance (GO:0061395 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter in response to calcium ion (GO:0061400 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter in response to endoplasmic reticulum stress (GO:1990440 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter in response to hypoxia (GO:0061419 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter in response to oxidative stress (GO:0036091 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter in response to stress (GO:0036003 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter involved in cellular response to chemical stimulus (GO:1901522 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter involved in heart development (GO:1901228 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation (GO:0003257 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process (GO:2000763 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter involved in smooth muscle cell differentiation (GO:2000721 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase ii promoter involved in unfolded protein response (GO:0006990 from GO Biological Process Annotations)", "positive regulation of transcription from rna polymerase iii promoter (GO:0045945 from GO Biological Process Annotations)", "positive regulation of transcription initiation from rna polymerase ii promoter (GO:0060261 from GO Biological Process Annotations)", "positive regulation of transcription involved in g1|s transition of mitotic cell cycle (GO:0071931 from GO Biological Process Annotations)", "positive regulation of transcription of notch receptor target (GO:0007221 from GO Biological Process Annotations)", "positive regulation of transcription of nuclear large rrna transcript from rna polymerase i promoter (GO:1901838 from GO Biological Process Annotations)", "positive regulation of transcription on exit from mitosis (GO:0007072 from GO Biological Process Annotations)", "positive regulation of transcription regulatory region dna binding (GO:2000679 from GO Biological Process Annotations)", "positive regulation of transcription via serum response element binding (GO:0010735 from GO Biological Process Annotations)", "positive regulation of transcription, dna-templated (GO:0045893 from GO Biological Process Annotations)", "positive regulation of transferase activity (GO:0051347 from GO Biological Process Annotations)", "positive regulation of transforming growth factor beta production (GO:0071636 from GO Biological Process Annotations)", "positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511 from GO Biological Process Annotations)", "positive regulation of transforming growth factor beta1 production (GO:0032914 from GO Biological Process Annotations)", "positive regulation of transforming growth factor beta2 production (GO:0032915 from GO Biological Process Annotations)", "positive regulation of transforming growth factor beta3 production (GO:0032916 from GO Biological Process Annotations)", "positive regulation of translation (GO:0045727 from GO Biological Process Annotations)", "positive regulation of translation in response to stress (GO:0032056 from GO Biological Process Annotations)", "positive regulation of translational elongation (GO:0045901 from GO Biological Process Annotations)", "positive regulation of translational fidelity (GO:0045903 from GO Biological Process Annotations)", "positive regulation of translational initiation (GO:0045948 from GO Biological Process Annotations)", "positive regulation of translational initiation by iron (GO:0045994 from GO Biological Process Annotations)", "positive regulation of translational initiation in response to stress (GO:0032058 from GO Biological Process Annotations)", "positive regulation of translational termination (GO:0045905 from GO Biological Process Annotations)", "positive regulation of transmembrane receptor protein serine|threonine kinase signaling pathway (GO:0090100 from GO Biological Process Annotations)", "positive regulation of transmembrane transport (GO:0034764 from GO Biological Process Annotations)", "positive regulation of transmission of nerve impulse (GO:0051971 from GO Biological Process Annotations)", "positive regulation of transport (GO:0051050 from GO Biological Process Annotations)", "positive regulation of transporter activity (GO:0032411 from GO Biological Process Annotations)", "positive regulation of triglyceride biosynthetic process (GO:0010867 from GO Biological Process Annotations)", "positive regulation of triglyceride catabolic process (GO:0010898 from GO Biological Process Annotations)", "positive regulation of triglyceride lipase activity (GO:0061365 from GO Biological Process Annotations)", "positive regulation of triglyceride metabolic process (GO:0090208 from GO Biological Process Annotations)", "positive regulation of trophoblast cell migration (GO:1901165 from GO Biological Process Annotations)", "positive regulation of tubulin deacetylation (GO:0090044 from GO Biological Process Annotations)", "positive regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000309 from GO Biological Process Annotations)", "positive regulation of tumor necrosis factor biosynthetic process (GO:0042535 from GO Biological Process Annotations)", "positive regulation of tumor necrosis factor production (GO:0032760 from GO Biological Process Annotations)", "positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557 from GO Biological Process Annotations)", "positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265 from GO Biological Process Annotations)", "positive regulation of type 2 immune response (GO:0002830 from GO Biological Process Annotations)", "positive regulation of type b pancreatic cell apoptotic process (GO:2000676 from GO Biological Process Annotations)", "positive regulation of type b pancreatic cell development (GO:2000078 from GO Biological Process Annotations)", "positive regulation of type i hypersensitivity (GO:0001812 from GO Biological Process Annotations)", "positive regulation of type i interferon production (GO:0032481 from GO Biological Process Annotations)", "positive regulation of type i interferon-mediated signaling pathway (GO:0060340 from GO Biological Process Annotations)", "positive regulation of type ii hypersensitivity (GO:0002894 from GO Biological Process Annotations)", "positive regulation of type iia hypersensitivity (GO:0001798 from GO Biological Process Annotations)", "positive regulation of type iii hypersensitivity (GO:0001805 from GO Biological Process Annotations)", "positive regulation of type iii interferon production (GO:0034346 from GO Biological Process Annotations)", "positive regulation of type iv hypersensitivity (GO:0001809 from GO Biological Process Annotations)", "positive regulation of tyrosine 3-monooxygenase activity (GO:1903178 from GO Biological Process Annotations)", "positive regulation of tyrosine phosphorylation of stat protein (GO:0042531 from GO Biological Process Annotations)", "positive regulation of tyrosine phosphorylation of stat1 protein (GO:0042511 from GO Biological Process Annotations)", "positive regulation of tyrosine phosphorylation of stat3 protein (GO:0042517 from GO Biological Process Annotations)", "positive regulation of tyrosine phosphorylation of stat4 protein (GO:0042520 from GO Biological Process Annotations)", "positive regulation of tyrosine phosphorylation of stat5 protein (GO:0042523 from GO Biological Process Annotations)", "positive regulation of tyrosine phosphorylation of stat6 protein (GO:0042526 from GO Biological Process Annotations)", "positive regulation of ubiquitin-dependent endocytosis (GO:2000397 from GO Biological Process Annotations)", "positive regulation of ubiquitin-protein ligase activity involved in regulation of mitotic cell cycle transition (GO:0051437 from GO Biological Process Annotations)", "positive regulation of ubiquitin-protein transferase activity (GO:0051443 from GO Biological Process Annotations)", "positive regulation of ubiquitin-specific protease activity (GO:2000158 from GO Biological Process Annotations)", "positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280 from GO Biological Process Annotations)", "positive regulation of ureter smooth muscle cell differentiation (GO:2000063 from GO Biological Process Annotations)", "positive regulation of ureteric bud formation (GO:0072107 from GO Biological Process Annotations)", "positive regulation of urine volume (GO:0035810 from GO Biological Process Annotations)", "positive regulation of urothelial cell proliferation (GO:0050677 from GO Biological Process Annotations)", "positive regulation of uterine smooth muscle contraction (GO:0070474 from GO Biological Process Annotations)", "positive regulation of vacuolar transport (GO:1903337 from GO Biological Process Annotations)", "positive regulation of vacuole organization (GO:0044090 from GO Biological Process Annotations)", "positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949 from GO Biological Process Annotations)", "positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748 from GO Biological Process Annotations)", "positive regulation of vascular permeability (GO:0043117 from GO Biological Process Annotations)", "positive regulation of vascular wound healing (GO:0035470 from GO Biological Process Annotations)", "positive regulation of vasculogenesis (GO:2001214 from GO Biological Process Annotations)", "positive regulation of vasoconstriction (GO:0045907 from GO Biological Process Annotations)", "positive regulation of vasodilation (GO:0045909 from GO Biological Process Annotations)", "positive regulation of very-low-density lipoprotein particle remodeling (GO:0010902 from GO Biological Process Annotations)", "positive regulation of vesicle fusion (GO:0031340 from GO Biological Process Annotations)", "positive regulation of viral budding via host escrt complex (GO:1903774 from GO Biological Process Annotations)", "positive regulation of viral entry into host cell (GO:0046598 from GO Biological Process Annotations)", "positive regulation of viral genome replication (GO:0045070 from GO Biological Process Annotations)", "positive regulation of viral process (GO:0048524 from GO Biological Process Annotations)", "positive regulation of viral release from host cell (GO:1902188 from GO Biological Process Annotations)", "positive regulation of viral transcription (GO:0050434 from GO Biological Process Annotations)", "positive regulation of vitamin d 24-hydroxylase activity (GO:0010980 from GO Biological Process Annotations)", "positive regulation of vitamin d biosynthetic process (GO:0060557 from GO Biological Process Annotations)", "positive regulation of vitamin d receptor signaling pathway (GO:0070564 from GO Biological Process Annotations)", "positive regulation of vitamin metabolic process (GO:0046136 from GO Biological Process Annotations)", "positive regulation of voltage-gated calcium channel activity (GO:1901387 from GO Biological Process Annotations)", "positive regulation of voltage-gated chloride channel activity (GO:1902943 from GO Biological Process Annotations)", "positive regulation of voltage-gated potassium channel activity (GO:1903818 from GO Biological Process Annotations)", "positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903762 from GO Biological Process Annotations)", "positive regulation of white fat cell proliferation (GO:0070352 from GO Biological Process Annotations)", "positive regulation of wnt signaling pathway (GO:0030177 from GO Biological Process Annotations)", "positive regulation of wnt signaling pathway by bmp signaling pathway (GO:0060804 from GO Biological Process Annotations)", "positive regulation of wnt signaling pathway involved in dorsal|ventral axis specification (GO:2000055 from GO Biological Process Annotations)", "positive regulation of wnt signaling pathway, planar cell polarity pathway (GO:2000096 from GO Biological Process Annotations)", "positive regulation of wound healing (GO:0090303 from GO Biological Process Annotations)", "positive regulation of wound healing, spreading of epidermal cells (GO:1903691 from GO Biological Process Annotations)", "positive regulation vascular endothelial growth factor production (GO:0010575 from GO Biological Process Annotations)", "positive t cell selection (GO:0043368 from GO Biological Process Annotations)", "positive thymic t cell selection (GO:0045059 from GO Biological Process Annotations)", "post-anal tail morphogenesis (GO:0036342 from GO Biological Process Annotations)", "post-chaperonin tubulin folding pathway (GO:0007023 from GO Biological Process Annotations)", "post-embryonic body morphogenesis (GO:0040032 from GO Biological Process Annotations)", "post-embryonic camera-type eye development (GO:0031077 from GO Biological Process Annotations)", "post-embryonic camera-type eye morphogenesis (GO:0048597 from GO Biological Process Annotations)", "post-embryonic development (GO:0009791 from GO Biological Process Annotations)", "post-embryonic digestive tract morphogenesis (GO:0048621 from GO Biological Process Annotations)", "post-embryonic eye morphogenesis (GO:0048050 from GO Biological Process Annotations)", "post-embryonic hemopoiesis (GO:0035166 from GO Biological Process Annotations)", "post-embryonic morphogenesis (GO:0009886 from GO Biological Process Annotations)", "post-embryonic organ development (GO:0048569 from GO Biological Process Annotations)", "post-embryonic organ morphogenesis (GO:0048563 from GO Biological Process Annotations)", "post-embryonic retina morphogenesis in camera-type eye (GO:0060060 from GO Biological Process Annotations)", "post-golgi vesicle-mediated transport (GO:0006892 from GO Biological Process Annotations)", "post-mating behavior (GO:0045297 from GO Biological Process Annotations)", "post-translational protein acetylation (GO:0034421 from GO Biological Process Annotations)", "post-translational protein modification (GO:0043687 from GO Biological Process Annotations)", "posterior compartment specification (GO:0007388 from GO Biological Process Annotations)", "posterior mesonephric tubule development (GO:0072166 from GO Biological Process Annotations)", "posterior midgut development (GO:0007497 from GO Biological Process Annotations)", "postganglionic parasympathetic fiber development (GO:0021784 from GO Biological Process Annotations)", "postreplication repair (GO:0006301 from GO Biological Process Annotations)", "postsynaptic density assembly (GO:0097107 from GO Biological Process Annotations)", "postsynaptic density organization (GO:0097106 from GO Biological Process Annotations)", "postsynaptic density protein 95 clustering (GO:0097119 from GO Biological Process Annotations)", "postsynaptic membrane assembly (GO:0097104 from GO Biological Process Annotations)", "postsynaptic membrane organization (GO:0001941 from GO Biological Process Annotations)", "posttranscriptional gene silencing (GO:0016441 from GO Biological Process Annotations)", "posttranscriptional gene silencing by rna (GO:0035194 from GO Biological Process Annotations)", "posttranscriptional regulation of gene expression (GO:0010608 from GO Biological Process Annotations)", "posttranslational protein targeting to membrane (GO:0006620 from GO Biological Process Annotations)", "posttranslational protein targeting to membrane, translocation (GO:0031204 from GO Biological Process Annotations)", "potassium ion export (GO:0071435 from GO Biological Process Annotations)", "potassium ion export across plasma membrane (GO:0097623 from GO Biological Process Annotations)", "potassium ion homeostasis (GO:0055075 from GO Biological Process Annotations)", "potassium ion import (GO:0010107 from GO Biological Process Annotations)", "potassium ion import across plasma membrane (GO:1990573 from GO Biological Process Annotations)", "potassium ion transmembrane transport (GO:0071805 from GO Biological Process Annotations)", "potassium ion transport (GO:0006813 from GO Biological Process Annotations)", "pre-b cell allelic exclusion (GO:0002331 from GO Biological Process Annotations)", "pre-b cell differentiation (GO:0002329 from GO Biological Process Annotations)", "pre-mirna export from nucleus (GO:0035281 from GO Biological Process Annotations)", "pre-mirna processing (GO:0031054 from GO Biological Process Annotations)", "pre-mrna catabolic process (GO:1990261 from GO Biological Process Annotations)", "pre-replicative complex assembly (GO:0036388 from GO Biological Process Annotations)", "pre-replicative complex assembly involved in cell cycle dna replication (GO:1902299 from GO Biological Process Annotations)", "pre-replicative complex assembly involved in nuclear cell cycle dna replication (GO:0006267 from GO Biological Process Annotations)", "preantral ovarian follicle growth (GO:0001546 from GO Biological Process Annotations)", "preassembly of gpi anchor in er membrane (GO:0016254 from GO Biological Process Annotations)", "prechordal plate formation (GO:0021501 from GO Biological Process Annotations)", "prenylated protein catabolic process (GO:0030327 from GO Biological Process Annotations)", "prenylation (GO:0097354 from GO Biological Process Annotations)", "prenylcysteine catabolic process (GO:0030328 from GO Biological Process Annotations)", "prenylcysteine metabolic process (GO:0030329 from GO Biological Process Annotations)", "prepulse inhibition (GO:0060134 from GO Biological Process Annotations)", "pressure natriuresis (GO:0003095 from GO Biological Process Annotations)", "presynaptic membrane assembly (GO:0097105 from GO Biological Process Annotations)", "presynaptic membrane organization (GO:0097090 from GO Biological Process Annotations)", "prevention of polyspermy (GO:0060468 from GO Biological Process Annotations)", "primary alcohol biosynthetic process (GO:0034309 from GO Biological Process Annotations)", "primary alcohol catabolic process (GO:0034310 from GO Biological Process Annotations)", "primary alcohol metabolic process (GO:0034308 from GO Biological Process Annotations)", "primary amino compound biosynthetic process (GO:1901162 from GO Biological Process Annotations)", "primary amino compound metabolic process (GO:1901160 from GO Biological Process Annotations)", "primary follicle stage (GO:0048160 from GO Biological Process Annotations)", "primary heart field specification (GO:0003138 from GO Biological Process Annotations)", "primary lung bud formation (GO:0060431 from GO Biological Process Annotations)", "primary metabolic process (GO:0044238 from GO Biological Process Annotations)", "primary mirna processing (GO:0031053 from GO Biological Process Annotations)", "primary ovarian follicle growth (GO:0001545 from GO Biological Process Annotations)", "primary prostatic bud elongation (GO:0060516 from GO Biological Process Annotations)", "primary sex determination (GO:0007538 from GO Biological Process Annotations)", "primary sex determination, germ-line (GO:0007542 from GO Biological Process Annotations)", "primary spermatocyte growth (GO:0007285 from GO Biological Process Annotations)", "primitive erythrocyte differentiation (GO:0060319 from GO Biological Process Annotations)", "primitive hemopoiesis (GO:0060215 from GO Biological Process Annotations)", "primitive streak formation (GO:0090009 from GO Biological Process Annotations)", "principal sensory nucleus of trigeminal nerve development (GO:0021740 from GO Biological Process Annotations)", "pro-b cell differentiation (GO:0002328 from GO Biological Process Annotations)", "pro-t cell differentiation (GO:0002572 from GO Biological Process Annotations)", "production of mirnas involved in gene silencing by mirna (GO:0035196 from GO Biological Process Annotations)", "production of molecular mediator involved in inflammatory response (GO:0002532 from GO Biological Process Annotations)", "production of molecular mediator of immune response (GO:0002440 from GO Biological Process Annotations)", "production of sirna involved in rna interference (GO:0030422 from GO Biological Process Annotations)", "production of small rna involved in gene silencing by rna (GO:0070918 from GO Biological Process Annotations)", "proepicardium development (GO:0003342 from GO Biological Process Annotations)", "progesterone biosynthetic process (GO:0006701 from GO Biological Process Annotations)", "progesterone metabolic process (GO:0042448 from GO Biological Process Annotations)", "progesterone receptor signaling pathway (GO:0050847 from GO Biological Process Annotations)", "progesterone secretion (GO:0042701 from GO Biological Process Annotations)", "programmed cell death (GO:0012501 from GO Biological Process Annotations)", "programmed necrotic cell death (GO:0097300 from GO Biological Process Annotations)", "prolactin secreting cell differentiation (GO:0060127 from GO Biological Process Annotations)", "prolactin secretion (GO:0070459 from GO Biological Process Annotations)", "prolactin signaling pathway (GO:0038161 from GO Biological Process Annotations)", "proline biosynthetic process (GO:0006561 from GO Biological Process Annotations)", "proline catabolic process (GO:0006562 from GO Biological Process Annotations)", "proline catabolic process to glutamate (GO:0010133 from GO Biological Process Annotations)", "proline metabolic process (GO:0006560 from GO Biological Process Annotations)", "proline transmembrane transport (GO:0035524 from GO Biological Process Annotations)", "proline transport (GO:0015824 from GO Biological Process Annotations)", "prolyl-trna aminoacylation (GO:0006433 from GO Biological Process Annotations)", "pronephric duct morphogenesis (GO:0039023 from GO Biological Process Annotations)", "pronephric field specification (GO:0039003 from GO Biological Process Annotations)", "pronephric nephron tubule development (GO:0039020 from GO Biological Process Annotations)", "pronephric nephron tubule morphogenesis (GO:0039008 from GO Biological Process Annotations)", "pronephros development (GO:0048793 from GO Biological Process Annotations)", "pronuclear fusion (GO:0007344 from GO Biological Process Annotations)", "propionate biosynthetic process (GO:0019542 from GO Biological Process Annotations)", "propionate catabolic process (GO:0019543 from GO Biological Process Annotations)", "propionate metabolic process (GO:0019541 from GO Biological Process Annotations)", "proprioception (GO:0019230 from GO Biological Process Annotations)", "proprioception involved in equilibrioception (GO:0051355 from GO Biological Process Annotations)", "propylene metabolic process (GO:0018964 from GO Biological Process Annotations)", "prostaglandin biosynthetic process (GO:0001516 from GO Biological Process Annotations)", "prostaglandin metabolic process (GO:0006693 from GO Biological Process Annotations)", "prostaglandin transport (GO:0015732 from GO Biological Process Annotations)", "prostanoid biosynthetic process (GO:0046457 from GO Biological Process Annotations)", "prostanoid metabolic process (GO:0006692 from GO Biological Process Annotations)", "prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:0060527 from GO Biological Process Annotations)", "prostate epithelial cord elongation (GO:0060523 from GO Biological Process Annotations)", "prostate gland development (GO:0030850 from GO Biological Process Annotations)", "prostate gland epithelium morphogenesis (GO:0060740 from GO Biological Process Annotations)", "prostate gland growth (GO:0060736 from GO Biological Process Annotations)", "prostate gland morphogenesis (GO:0060512 from GO Biological Process Annotations)", "prostate gland morphogenetic growth (GO:0060737 from GO Biological Process Annotations)", "prostate gland stromal morphogenesis (GO:0060741 from GO Biological Process Annotations)", "prostatic bud formation (GO:0060513 from GO Biological Process Annotations)", "prosthetic group metabolic process (GO:0051189 from GO Biological Process Annotations)", "proteasomal protein catabolic process (GO:0010498 from GO Biological Process Annotations)", "proteasomal ubiquitin-independent protein catabolic process (GO:0010499 from GO Biological Process Annotations)", "proteasome assembly (GO:0043248 from GO Biological Process Annotations)", "proteasome core complex assembly (GO:0080129 from GO Biological Process Annotations)", "proteasome regulatory particle assembly (GO:0070682 from GO Biological Process Annotations)", "proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161 from GO Biological Process Annotations)", "protection from natural killer cell mediated cytotoxicity (GO:0042270 from GO Biological Process Annotations)", "protection from non-homologous end joining at telomere (GO:0031848 from GO Biological Process Annotations)", "protection of dna demethylation of female pronucleus (GO:0044726 from GO Biological Process Annotations)", "protein acetylation (GO:0006473 from GO Biological Process Annotations)", "protein activation cascade (GO:0072376 from GO Biological Process Annotations)", "protein acylation (GO:0043543 from GO Biological Process Annotations)", "protein adenylylation (GO:0018117 from GO Biological Process Annotations)", "protein adp-ribosylation (GO:0006471 from GO Biological Process Annotations)", "protein alkylation (GO:0008213 from GO Biological Process Annotations)", "protein arginylation (GO:0016598 from GO Biological Process Annotations)", "protein auto-adp-ribosylation (GO:0070213 from GO Biological Process Annotations)", "protein autophosphorylation (GO:0046777 from GO Biological Process Annotations)", "protein autoprocessing (GO:0016540 from GO Biological Process Annotations)", "protein autoubiquitination (GO:0051865 from GO Biological Process Annotations)", "protein biotinylation (GO:0009305 from GO Biological Process Annotations)", "protein branching point deglutamylation (GO:0035611 from GO Biological Process Annotations)", "protein c-linked glycosylation (GO:0018103 from GO Biological Process Annotations)", "protein c-linked glycosylation via 2'-alpha-mannosyl-l-tryptophan (GO:0018406 from GO Biological Process Annotations)", "protein c-linked glycosylation via tryptophan (GO:0018317 from GO Biological Process Annotations)", "protein carboxylation (GO:0018214 from GO Biological Process Annotations)", "protein catabolic process (GO:0030163 from GO Biological Process Annotations)", "protein catabolic process in the vacuole (GO:0007039 from GO Biological Process Annotations)", "protein citrullination (GO:0018101 from GO Biological Process Annotations)", "protein complex assembly (GO:0006461 from GO Biological Process Annotations)", "protein complex biogenesis (GO:0070271 from GO Biological Process Annotations)", "protein complex disassembly (GO:0043241 from GO Biological Process Annotations)", "protein complex localization (GO:0031503 from GO Biological Process Annotations)", "protein complex oligomerization (GO:0035786 from GO Biological Process Annotations)", "protein complex subunit organization (GO:0071822 from GO Biological Process Annotations)", "protein de-adp-ribosylation (GO:0051725 from GO Biological Process Annotations)", "protein deacetylation (GO:0006476 from GO Biological Process Annotations)", "protein deacylation (GO:0035601 from GO Biological Process Annotations)", "protein dealkylation (GO:0008214 from GO Biological Process Annotations)", "protein deamination (GO:0018277 from GO Biological Process Annotations)", "protein deglutamylation (GO:0035608 from GO Biological Process Annotations)", "protein deglutathionylation (GO:0080058 from GO Biological Process Annotations)", "protein deglycosylation (GO:0006517 from GO Biological Process Annotations)", "protein delipidation (GO:0051697 from GO Biological Process Annotations)", "protein demalonylation (GO:0036046 from GO Biological Process Annotations)", "protein demethylation (GO:0006482 from GO Biological Process Annotations)", "protein deneddylation (GO:0000338 from GO Biological Process Annotations)", "protein depalmitoylation (GO:0002084 from GO Biological Process Annotations)", "protein dephosphorylation (GO:0006470 from GO Biological Process Annotations)", "protein depolymerization (GO:0051261 from GO Biological Process Annotations)", "protein destabilization (GO:0031648 from GO Biological Process Annotations)", "protein desuccinylation (GO:0036048 from GO Biological Process Annotations)", "protein desumoylation (GO:0016926 from GO Biological Process Annotations)", "protein deubiquitination (GO:0016579 from GO Biological Process Annotations)", "protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947 from GO Biological Process Annotations)", "protein exit from endoplasmic reticulum (GO:0032527 from GO Biological Process Annotations)", "protein export from nucleus (GO:0006611 from GO Biological Process Annotations)", "protein farnesylation (GO:0018343 from GO Biological Process Annotations)", "protein folding (GO:0006457 from GO Biological Process Annotations)", "protein folding in endoplasmic reticulum (GO:0034975 from GO Biological Process Annotations)", "protein geranylgeranylation (GO:0018344 from GO Biological Process Annotations)", "protein glycosylation (GO:0006486 from GO Biological Process Annotations)", "protein glycosylation in endoplasmic reticulum (GO:0033577 from GO Biological Process Annotations)", "protein glycosylation in golgi (GO:0033578 from GO Biological Process Annotations)", "protein heterooligomerization (GO:0051291 from GO Biological Process Annotations)", "protein heterotetramerization (GO:0051290 from GO Biological Process Annotations)", "protein heterotrimerization (GO:0070208 from GO Biological Process Annotations)", "protein hexamerization (GO:0034214 from GO Biological Process Annotations)", "protein homooligomerization (GO:0051260 from GO Biological Process Annotations)", "protein homotetramerization (GO:0051289 from GO Biological Process Annotations)", "protein homotrimerization (GO:0070207 from GO Biological Process Annotations)", "protein hydroxylation (GO:0018126 from GO Biological Process Annotations)", "protein import (GO:0017038 from GO Biological Process Annotations)", "protein import into mitochondrial inner membrane (GO:0045039 from GO Biological Process Annotations)", "protein import into mitochondrial intermembrane space (GO:0045041 from GO Biological Process Annotations)", "protein import into mitochondrial matrix (GO:0030150 from GO Biological Process Annotations)", "protein import into mitochondrial outer membrane (GO:0045040 from GO Biological Process Annotations)", "protein import into nucleus (GO:0006606 from GO Biological Process Annotations)", "protein import into nucleus, docking (GO:0000059 from GO Biological Process Annotations)", "protein import into nucleus, translocation (GO:0000060 from GO Biological Process Annotations)", "protein import into peroxisome matrix (GO:0016558 from GO Biological Process Annotations)", "protein import into peroxisome matrix, docking (GO:0016560 from GO Biological Process Annotations)", "protein import into peroxisome matrix, substrate release (GO:0044721 from GO Biological Process Annotations)", "protein import into peroxisome matrix, translocation (GO:0016561 from GO Biological Process Annotations)", "protein import into peroxisome membrane (GO:0045046 from GO Biological Process Annotations)", "protein initiator methionine removal (GO:0070084 from GO Biological Process Annotations)", "protein insertion into er membrane (GO:0045048 from GO Biological Process Annotations)", "protein insertion into membrane (GO:0051205 from GO Biological Process Annotations)", "protein insertion into mitochondrial membrane (GO:0051204 from GO Biological Process Annotations)", "protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844 from GO Biological Process Annotations)", "protein k11-linked deubiquitination (GO:0035871 from GO Biological Process Annotations)", "protein k11-linked ubiquitination (GO:0070979 from GO Biological Process Annotations)", "protein k27-linked deubiquitination (GO:1990167 from GO Biological Process Annotations)", "protein k27-linked ubiquitination (GO:0044314 from GO Biological Process Annotations)", "protein k29-linked deubiquitination (GO:0035523 from GO Biological Process Annotations)", "protein k29-linked ubiquitination (GO:0035519 from GO Biological Process Annotations)", "protein k33-linked deubiquitination (GO:1990168 from GO Biological Process Annotations)", "protein k33-linked ubiquitination (GO:1990390 from GO Biological Process Annotations)", "protein k48-linked deubiquitination (GO:0071108 from GO Biological Process Annotations)", "protein k48-linked ubiquitination (GO:0070936 from GO Biological Process Annotations)", "protein k6-linked deubiquitination (GO:0044313 from GO Biological Process Annotations)", "protein k6-linked ubiquitination (GO:0085020 from GO Biological Process Annotations)", "protein k63-linked deubiquitination (GO:0070536 from GO Biological Process Annotations)", "protein k63-linked ubiquitination (GO:0070534 from GO Biological Process Annotations)", "protein kinase a signaling (GO:0010737 from GO Biological Process Annotations)", "protein kinase b signaling (GO:0043491 from GO Biological Process Annotations)", "protein kinase c deactivation (GO:0042313 from GO Biological Process Annotations)", "protein kinase c signaling (GO:0070528 from GO Biological Process Annotations)", "protein kinase c-activating g-protein coupled receptor signaling pathway (GO:0007205 from GO Biological Process Annotations)", "protein kinase d signaling (GO:0089700 from GO Biological Process Annotations)", "protein linear deubiquitination (GO:1990108 from GO Biological Process Annotations)", "protein linear polyubiquitination (GO:0097039 from GO Biological Process Annotations)", "protein lipidation (GO:0006497 from GO Biological Process Annotations)", "protein lipoylation (GO:0009249 from GO Biological Process Annotations)", "protein localization (GO:0008104 from GO Biological Process Annotations)", "protein localization involved in establishment of planar polarity (GO:0090251 from GO Biological Process Annotations)", "protein localization to adherens junction (GO:0071896 from GO Biological Process Annotations)", "protein localization to basolateral plasma membrane (GO:1903361 from GO Biological Process Annotations)", "protein localization to cell cortex (GO:0072697 from GO Biological Process Annotations)", "protein localization to cell junction (GO:1902414 from GO Biological Process Annotations)", "protein localization to cell leading edge (GO:1902463 from GO Biological Process Annotations)", "protein localization to cell surface (GO:0034394 from GO Biological Process Annotations)", "protein localization to centrosome (GO:0071539 from GO Biological Process Annotations)", "protein localization to chromatin (GO:0071168 from GO Biological Process Annotations)", "protein localization to chromosome (GO:0034502 from GO Biological Process Annotations)", "protein localization to chromosome, centromeric region (GO:0071459 from GO Biological Process Annotations)", "protein localization to chromosome, telomeric region (GO:0070198 from GO Biological Process Annotations)", "protein localization to ciliary membrane (GO:1903441 from GO Biological Process Annotations)", "protein localization to cilium (GO:0061512 from GO Biological Process Annotations)", "protein localization to cytoskeleton (GO:0044380 from GO Biological Process Annotations)", "protein localization to early endosome (GO:1902946 from GO Biological Process Annotations)", "protein localization to endoplasmic reticulum (GO:0070972 from GO Biological Process Annotations)", "protein localization to endoplasmic reticulum exit site (GO:0070973 from GO Biological Process Annotations)", "protein localization to endoplasmic reticulum tubular network (GO:1903420 from GO Biological Process Annotations)", "protein localization to endosome (GO:0036010 from GO Biological Process Annotations)", "protein localization to golgi apparatus (GO:0034067 from GO Biological Process Annotations)", "protein localization to juxtaparanode region of axon (GO:0071205 from GO Biological Process Annotations)", "protein localization to kinetochore (GO:0034501 from GO Biological Process Annotations)", "protein localization to lysosome (GO:0061462 from GO Biological Process Annotations)", "protein localization to m-band (GO:0036309 from GO Biological Process Annotations)", "protein localization to membrane (GO:0072657 from GO Biological Process Annotations)", "protein localization to membrane raft (GO:1903044 from GO Biological Process Annotations)", "protein localization to microtubule (GO:0035372 from GO Biological Process Annotations)", "protein localization to microtubule cytoskeleton (GO:0072698 from GO Biological Process Annotations)", "protein localization to mitochondrion (GO:0070585 from GO Biological Process Annotations)", "protein localization to myelin sheath abaxonal region (GO:0035750 from GO Biological Process Annotations)", "protein localization to nonmotile primary cilium (GO:0097499 from GO Biological Process Annotations)", "protein localization to nuclear envelope (GO:0090435 from GO Biological Process Annotations)", "protein localization to nuclear pore (GO:0090204 from GO Biological Process Annotations)", "protein localization to nucleolus (GO:1902570 from GO Biological Process Annotations)", "protein localization to nucleus (GO:0034504 from GO Biological Process Annotations)", "protein localization to organelle (GO:0033365 from GO Biological Process Annotations)", "protein localization to paranode region of axon (GO:0002175 from GO Biological Process Annotations)", "protein localization to peroxisome (GO:0072662 from GO Biological Process Annotations)", "protein localization to photoreceptor connecting cilium (GO:1903621 from GO Biological Process Annotations)", "protein localization to photoreceptor outer segment (GO:1903546 from GO Biological Process Annotations)", "protein localization to plasma membrane (GO:0072659 from GO Biological Process Annotations)", "protein localization to plasma membrane raft (GO:0044860 from GO Biological Process Annotations)", "protein localization to pre-autophagosomal structure (GO:0034497 from GO Biological Process Annotations)", "protein localization to site of double-strand break (GO:1990166 from GO Biological Process Annotations)", "protein localization to synapse (GO:0035418 from GO Biological Process Annotations)", "protein localization to t-tubule (GO:0036371 from GO Biological Process Annotations)", "protein localization to tight junction (GO:1902396 from GO Biological Process Annotations)", "protein localization to vacuole (GO:0072665 from GO Biological Process Annotations)", "protein mannosylation (GO:0035268 from GO Biological Process Annotations)", "protein maturation (GO:0051604 from GO Biological Process Annotations)", "protein maturation by protein folding (GO:0022417 from GO Biological Process Annotations)", "protein metabolic process (GO:0019538 from GO Biological Process Annotations)", "protein methylation (GO:0006479 from GO Biological Process Annotations)", "protein modification by small protein conjugation (GO:0032446 from GO Biological Process Annotations)", "protein modification by small protein conjugation or removal (GO:0070647 from GO Biological Process Annotations)", "protein modification by small protein removal (GO:0070646 from GO Biological Process Annotations)", "protein modification process (GO:0036211 from GO Biological Process Annotations)", "protein monoubiquitination (GO:0006513 from GO Biological Process Annotations)", "protein myristoylation (GO:0018377 from GO Biological Process Annotations)", "protein n-linked glycosylation (GO:0006487 from GO Biological Process Annotations)", "protein n-linked glycosylation via asparagine (GO:0018279 from GO Biological Process Annotations)", "protein neddylation (GO:0045116 from GO Biological Process Annotations)", "protein nitrosylation (GO:0017014 from GO Biological Process Annotations)", "protein nucleotidylation (GO:0018175 from GO Biological Process Annotations)", "protein o-linked fucosylation (GO:0036066 from GO Biological Process Annotations)", "protein o-linked glycosylation (GO:0006493 from GO Biological Process Annotations)", "protein o-linked glycosylation via serine (GO:0018242 from GO Biological Process Annotations)", "protein o-linked glycosylation via threonine (GO:0018243 from GO Biological Process Annotations)", "protein o-linked mannosylation (GO:0035269 from GO Biological Process Annotations)", "protein octanoylation (GO:0018190 from GO Biological Process Annotations)", "protein oligomerization (GO:0051259 from GO Biological Process Annotations)", "protein oxidation (GO:0018158 from GO Biological Process Annotations)", "protein palmitoleylation (GO:0045234 from GO Biological Process Annotations)", "protein palmitoylation (GO:0018345 from GO Biological Process Annotations)", "protein peptidyl-prolyl isomerization (GO:0000413 from GO Biological Process Annotations)", "protein phosphorylation (GO:0006468 from GO Biological Process Annotations)", "protein poly-adp-ribosylation (GO:0070212 from GO Biological Process Annotations)", "protein polyglutamylation (GO:0018095 from GO Biological Process Annotations)", "protein polyglycylation (GO:0018094 from GO Biological Process Annotations)", "protein polymerization (GO:0051258 from GO Biological Process Annotations)", "protein polyubiquitination (GO:0000209 from GO Biological Process Annotations)", "protein polyufmylation (GO:1990564 from GO Biological Process Annotations)", "protein prenylation (GO:0018342 from GO Biological Process Annotations)", "protein processing (GO:0016485 from GO Biological Process Annotations)", "protein processing involved in protein targeting to mitochondrion (GO:0006627 from GO Biological Process Annotations)", "protein refolding (GO:0042026 from GO Biological Process Annotations)", "protein repair (GO:0030091 from GO Biological Process Annotations)", "protein retention in er lumen (GO:0006621 from GO Biological Process Annotations)", "protein retention in golgi apparatus (GO:0045053 from GO Biological Process Annotations)", "protein secretion (GO:0009306 from GO Biological Process Annotations)", "protein secretion by platelet (GO:0070560 from GO Biological Process Annotations)", "protein side chain deglutamylation (GO:0035610 from GO Biological Process Annotations)", "protein splicing (GO:0030908 from GO Biological Process Annotations)", "protein stabilization (GO:0050821 from GO Biological Process Annotations)", "protein sulfation (GO:0006477 from GO Biological Process Annotations)", "protein sulfhydration (GO:0044524 from GO Biological Process Annotations)", "protein sumoylation (GO:0016925 from GO Biological Process Annotations)", "protein targeting (GO:0006605 from GO Biological Process Annotations)", "protein targeting to er (GO:0045047 from GO Biological Process Annotations)", "protein targeting to golgi (GO:0000042 from GO Biological Process Annotations)", "protein targeting to lysosome (GO:0006622 from GO Biological Process Annotations)", "protein targeting to membrane (GO:0006612 from GO Biological Process Annotations)", "protein targeting to mitochondrion (GO:0006626 from GO Biological Process Annotations)", "protein targeting to peroxisome (GO:0006625 from GO Biological Process Annotations)", "protein targeting to plasma membrane (GO:0072661 from GO Biological Process Annotations)", "protein targeting to vacuole (GO:0006623 from GO Biological Process Annotations)", "protein targeting to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328 from GO Biological Process Annotations)", "protein tetramerization (GO:0051262 from GO Biological Process Annotations)", "protein to membrane docking (GO:0022615 from GO Biological Process Annotations)", "protein trans-autophosphorylation (GO:0036290 from GO Biological Process Annotations)", "protein transmembrane transport (GO:0071806 from GO Biological Process Annotations)", "protein transport (GO:0015031 from GO Biological Process Annotations)", "protein transport into membrane raft (GO:0032596 from GO Biological Process Annotations)", "protein transport into plasma membrane raft (GO:0044861 from GO Biological Process Annotations)", "protein transport out of membrane raft (GO:0032599 from GO Biological Process Annotations)", "protein transport within lipid bilayer (GO:0032594 from GO Biological Process Annotations)", "protein trimerization (GO:0070206 from GO Biological Process Annotations)", "protein ubiquitination (GO:0016567 from GO Biological Process Annotations)", "protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0042787 from GO Biological Process Annotations)", "protein ufmylation (GO:0071569 from GO Biological Process Annotations)", "protein unfolding (GO:0043335 from GO Biological Process Annotations)", "protein urmylation (GO:0032447 from GO Biological Process Annotations)", "protein-carbohydrate complex assembly (GO:0065006 from GO Biological Process Annotations)", "protein-carbohydrate complex subunit organization (GO:0071823 from GO Biological Process Annotations)", "protein-chromophore linkage (GO:0018298 from GO Biological Process Annotations)", "protein-cofactor linkage (GO:0018065 from GO Biological Process Annotations)", "protein-dna complex assembly (GO:0065004 from GO Biological Process Annotations)", "protein-dna complex disassembly (GO:0032986 from GO Biological Process Annotations)", "protein-dna complex subunit organization (GO:0071824 from GO Biological Process Annotations)", "protein-fad linkage (GO:0018293 from GO Biological Process Annotations)", "protein-lipid complex assembly (GO:0065005 from GO Biological Process Annotations)", "protein-lipid complex remodeling (GO:0034368 from GO Biological Process Annotations)", "protein-lipid complex subunit organization (GO:0071825 from GO Biological Process Annotations)", "protein-pyridoxal-5-phosphate linkage (GO:0018352 from GO Biological Process Annotations)", "protein-pyridoxal-5-phosphate linkage via peptidyl-n6-pyridoxal phosphate-l-lysine (GO:0018272 from GO Biological Process Annotations)", "proteoglycan biosynthetic process (GO:0030166 from GO Biological Process Annotations)", "proteoglycan catabolic process (GO:0030167 from GO Biological Process Annotations)", "proteoglycan metabolic process (GO:0006029 from GO Biological Process Annotations)", "proteolysis (GO:0006508 from GO Biological Process Annotations)", "proteolysis involved in cellular protein catabolic process (GO:0051603 from GO Biological Process Annotations)", "proton transport (GO:0015992 from GO Biological Process Annotations)", "proton-transporting atp synthase complex assembly (GO:0043461 from GO Biological Process Annotations)", "proton-transporting two-sector atpase complex assembly (GO:0070071 from GO Biological Process Annotations)", "proton-transporting v-type atpase complex assembly (GO:0070070 from GO Biological Process Annotations)", "protoporphyrinogen ix biosynthetic process (GO:0006782 from GO Biological Process Annotations)", "protoporphyrinogen ix metabolic process (GO:0046501 from GO Biological Process Annotations)", "proximal convoluted tubule development (GO:0072019 from GO Biological Process Annotations)", "proximal convoluted tubule segment 2 development (GO:0072032 from GO Biological Process Annotations)", "proximal straight tubule development (GO:0072020 from GO Biological Process Annotations)", "proximal tubule development (GO:0072014 from GO Biological Process Annotations)", "proximal|distal axis specification (GO:0009946 from GO Biological Process Annotations)", "proximal|distal pattern formation (GO:0009954 from GO Biological Process Annotations)", "proximal|distal pattern formation involved in metanephric nephron development (GO:0072272 from GO Biological Process Annotations)", "proximal|distal pattern formation involved in nephron development (GO:0072047 from GO Biological Process Annotations)", "pseudopodium assembly (GO:0031269 from GO Biological Process Annotations)", "pseudopodium organization (GO:0031268 from GO Biological Process Annotations)", "pseudouridine synthesis (GO:0001522 from GO Biological Process Annotations)", "pteridine metabolic process (GO:0019889 from GO Biological Process Annotations)", "pteridine-containing compound biosynthetic process (GO:0042559 from GO Biological Process Annotations)", "pteridine-containing compound catabolic process (GO:0042560 from GO Biological Process Annotations)", "pteridine-containing compound metabolic process (GO:0042558 from GO Biological Process Annotations)", "pulmonary artery endothelial tube morphogenesis (GO:0061155 from GO Biological Process Annotations)", "pulmonary artery morphogenesis (GO:0061156 from GO Biological Process Annotations)", "pulmonary myocardium development (GO:0003350 from GO Biological Process Annotations)", "pulmonary valve formation (GO:0003193 from GO Biological Process Annotations)", "pulmonary valve morphogenesis (GO:0003184 from GO Biological Process Annotations)", "pulmonary vein morphogenesis (GO:0060577 from GO Biological Process Annotations)", "purine deoxyribonucleoside catabolic process (GO:0046124 from GO Biological Process Annotations)", "purine deoxyribonucleoside diphosphate biosynthetic process (GO:0009183 from GO Biological Process Annotations)", "purine deoxyribonucleoside diphosphate catabolic process (GO:0009184 from GO Biological Process Annotations)", "purine deoxyribonucleoside diphosphate metabolic process (GO:0009182 from GO Biological Process Annotations)", "purine deoxyribonucleoside metabolic process (GO:0046122 from GO Biological Process Annotations)", "purine deoxyribonucleoside monophosphate metabolic process (GO:0009170 from GO Biological Process Annotations)", "purine deoxyribonucleoside triphosphate biosynthetic process (GO:0009216 from GO Biological Process Annotations)", "purine deoxyribonucleoside triphosphate catabolic process (GO:0009217 from GO Biological Process Annotations)", "purine deoxyribonucleoside triphosphate metabolic process (GO:0009215 from GO Biological Process Annotations)", "purine deoxyribonucleotide biosynthetic process (GO:0009153 from GO Biological Process Annotations)", "purine deoxyribonucleotide catabolic process (GO:0009155 from GO Biological Process Annotations)", "purine deoxyribonucleotide metabolic process (GO:0009151 from GO Biological Process Annotations)", "purine nucleobase biosynthetic process (GO:0009113 from GO Biological Process Annotations)", "purine nucleobase catabolic process (GO:0006145 from GO Biological Process Annotations)", "purine nucleobase metabolic process (GO:0006144 from GO Biological Process Annotations)", "purine nucleobase salvage (GO:0043096 from GO Biological Process Annotations)", "purine nucleobase transport (GO:0006863 from GO Biological Process Annotations)", "purine nucleoside biosynthetic process (GO:0042451 from GO Biological Process Annotations)", "purine nucleoside bisphosphate biosynthetic process (GO:0034033 from GO Biological Process Annotations)", "purine nucleoside bisphosphate catabolic process (GO:0034034 from GO Biological Process Annotations)", "purine nucleoside bisphosphate metabolic process (GO:0034032 from GO Biological Process Annotations)", "purine nucleoside catabolic process (GO:0006152 from GO Biological Process Annotations)", "purine nucleoside diphosphate biosynthetic process (GO:0009136 from GO Biological Process Annotations)", "purine nucleoside diphosphate catabolic process (GO:0009137 from GO Biological Process Annotations)", "purine nucleoside diphosphate metabolic process (GO:0009135 from GO Biological Process Annotations)", "purine nucleoside metabolic process (GO:0042278 from GO Biological Process Annotations)", "purine nucleoside monophosphate biosynthetic process (GO:0009127 from GO Biological Process Annotations)", "purine nucleoside monophosphate catabolic process (GO:0009128 from GO Biological Process Annotations)", "purine nucleoside monophosphate metabolic process (GO:0009126 from GO Biological Process Annotations)", "purine nucleoside transmembrane transport (GO:0015860 from GO Biological Process Annotations)", "purine nucleoside triphosphate biosynthetic process (GO:0009145 from GO Biological Process Annotations)", "purine nucleoside triphosphate catabolic process (GO:0009146 from GO Biological Process Annotations)", "purine nucleoside triphosphate metabolic process (GO:0009144 from GO Biological Process Annotations)", "purine nucleotide biosynthetic process (GO:0006164 from GO Biological Process Annotations)", "purine nucleotide catabolic process (GO:0006195 from GO Biological Process Annotations)", "purine nucleotide metabolic process (GO:0006163 from GO Biological Process Annotations)", "purine nucleotide salvage (GO:0032261 from GO Biological Process Annotations)", "purine nucleotide transport (GO:0015865 from GO Biological Process Annotations)", "purine ribonucleoside biosynthetic process (GO:0046129 from GO Biological Process Annotations)", "purine ribonucleoside bisphosphate biosynthetic process (GO:0034036 from GO Biological Process Annotations)", "purine ribonucleoside bisphosphate metabolic process (GO:0034035 from GO Biological Process Annotations)", "purine ribonucleoside catabolic process (GO:0046130 from GO Biological Process Annotations)", "purine ribonucleoside diphosphate biosynthetic process (GO:0009180 from GO Biological Process Annotations)", "purine ribonucleoside diphosphate catabolic process (GO:0009181 from GO Biological Process Annotations)", "purine ribonucleoside diphosphate metabolic process (GO:0009179 from GO Biological Process Annotations)", "purine ribonucleoside metabolic process (GO:0046128 from GO Biological Process Annotations)", "purine ribonucleoside monophosphate biosynthetic process (GO:0009168 from GO Biological Process Annotations)", "purine ribonucleoside monophosphate catabolic process (GO:0009169 from GO Biological Process Annotations)", "purine ribonucleoside monophosphate metabolic process (GO:0009167 from GO Biological Process Annotations)", "purine ribonucleoside salvage (GO:0006166 from GO Biological Process Annotations)", "purine ribonucleoside triphosphate biosynthetic process (GO:0009206 from GO Biological Process Annotations)", "purine ribonucleoside triphosphate catabolic process (GO:0009207 from GO Biological Process Annotations)", "purine ribonucleoside triphosphate metabolic process (GO:0009205 from GO Biological Process Annotations)", "purine ribonucleotide biosynthetic process (GO:0009152 from GO Biological Process Annotations)", "purine ribonucleotide catabolic process (GO:0009154 from GO Biological Process Annotations)", "purine ribonucleotide metabolic process (GO:0009150 from GO Biological Process Annotations)", "purine ribonucleotide transport (GO:0015868 from GO Biological Process Annotations)", "purine-containing compound biosynthetic process (GO:0072522 from GO Biological Process Annotations)", "purine-containing compound catabolic process (GO:0072523 from GO Biological Process Annotations)", "purine-containing compound metabolic process (GO:0072521 from GO Biological Process Annotations)", "purine-containing compound salvage (GO:0043101 from GO Biological Process Annotations)", "purine-containing compound transmembrane transport (GO:0072530 from GO Biological Process Annotations)", "purinergic nucleotide receptor signaling pathway (GO:0035590 from GO Biological Process Annotations)", "purinergic receptor signaling pathway (GO:0035587 from GO Biological Process Annotations)", "purkinje myocyte development (GO:0003165 from GO Biological Process Annotations)", "purkinje myocyte differentiation (GO:0003168 from GO Biological Process Annotations)", "purkinje myocyte to ventricular cardiac muscle cell communication (GO:0086068 from GO Biological Process Annotations)", "purkinje myocyte to ventricular cardiac muscle cell signaling (GO:0086029 from GO Biological Process Annotations)", "putamen development (GO:0021758 from GO Biological Process Annotations)", "putrescine acetylation (GO:0032920 from GO Biological Process Annotations)", "putrescine biosynthetic process (GO:0009446 from GO Biological Process Annotations)", "putrescine biosynthetic process from arginine (GO:0033388 from GO Biological Process Annotations)", "putrescine biosynthetic process from ornithine (GO:0033387 from GO Biological Process Annotations)", "putrescine catabolic process (GO:0009447 from GO Biological Process Annotations)", "putrescine metabolic process (GO:0009445 from GO Biological Process Annotations)", "putrescine transport (GO:0015847 from GO Biological Process Annotations)", "pyramidal neuron development (GO:0021860 from GO Biological Process Annotations)", "pyramidal neuron differentiation (GO:0021859 from GO Biological Process Annotations)", "pyridine nucleoside catabolic process (GO:0070638 from GO Biological Process Annotations)", "pyridine nucleoside metabolic process (GO:0070637 from GO Biological Process Annotations)", "pyridine nucleotide biosynthetic process (GO:0019363 from GO Biological Process Annotations)", "pyridine nucleotide catabolic process (GO:0019364 from GO Biological Process Annotations)", "pyridine nucleotide metabolic process (GO:0019362 from GO Biological Process Annotations)", "pyridine nucleotide salvage (GO:0019365 from GO Biological Process Annotations)", "pyridine-containing compound biosynthetic process (GO:0072525 from GO Biological Process Annotations)", "pyridine-containing compound catabolic process (GO:0072526 from GO Biological Process Annotations)", "pyridine-containing compound metabolic process (GO:0072524 from GO Biological Process Annotations)", "pyridoxal 5'-phosphate salvage (GO:0009443 from GO Biological Process Annotations)", "pyridoxal phosphate biosynthetic process (GO:0042823 from GO Biological Process Annotations)", "pyridoxal phosphate catabolic process (GO:0032361 from GO Biological Process Annotations)", "pyridoxal phosphate metabolic process (GO:0042822 from GO Biological Process Annotations)", "pyridoxine biosynthetic process (GO:0008615 from GO Biological Process Annotations)", "pyridoxine metabolic process (GO:0008614 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleoside biosynthetic process (GO:0046126 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleoside catabolic process (GO:0046127 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleoside diphosphate biosynthetic process (GO:0009197 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleoside diphosphate metabolic process (GO:0009196 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleoside metabolic process (GO:0046125 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleoside monophosphate catabolic process (GO:0009178 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleoside triphosphate biosynthetic process (GO:0009212 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleotide catabolic process (GO:0009223 from GO Biological Process Annotations)", "pyrimidine deoxyribonucleotide metabolic process (GO:0009219 from GO Biological Process Annotations)", "pyrimidine dimer repair (GO:0006290 from GO Biological Process Annotations)", "pyrimidine dimer repair by nucleotide-excision repair (GO:0000720 from GO Biological Process Annotations)", "pyrimidine nucleobase biosynthetic process (GO:0019856 from GO Biological Process Annotations)", "pyrimidine nucleobase catabolic process (GO:0006208 from GO Biological Process Annotations)", "pyrimidine nucleobase metabolic process (GO:0006206 from GO Biological Process Annotations)", "pyrimidine nucleobase transport (GO:0015855 from GO Biological Process Annotations)", "pyrimidine nucleoside biosynthetic process (GO:0046134 from GO Biological Process Annotations)", "pyrimidine nucleoside catabolic process (GO:0046135 from GO Biological Process Annotations)", "pyrimidine nucleoside diphosphate biosynthetic process (GO:0009139 from GO Biological Process Annotations)", "pyrimidine nucleoside diphosphate catabolic process (GO:0009140 from GO Biological Process Annotations)", "pyrimidine nucleoside diphosphate metabolic process (GO:0009138 from GO Biological Process Annotations)", "pyrimidine nucleoside metabolic process (GO:0006213 from GO Biological Process Annotations)", "pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130 from GO Biological Process Annotations)", "pyrimidine nucleoside monophosphate catabolic process (GO:0009131 from GO Biological Process Annotations)", "pyrimidine nucleoside monophosphate metabolic process (GO:0009129 from GO Biological Process Annotations)", "pyrimidine nucleoside salvage (GO:0043097 from GO Biological Process Annotations)", "pyrimidine nucleoside transport (GO:0015864 from GO Biological Process Annotations)", "pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148 from GO Biological Process Annotations)", "pyrimidine nucleoside triphosphate catabolic process (GO:0009149 from GO Biological Process Annotations)", "pyrimidine nucleoside triphosphate metabolic process (GO:0009147 from GO Biological Process Annotations)", "pyrimidine nucleotide biosynthetic process (GO:0006221 from GO Biological Process Annotations)", "pyrimidine nucleotide catabolic process (GO:0006244 from GO Biological Process Annotations)", "pyrimidine nucleotide metabolic process (GO:0006220 from GO Biological Process Annotations)", "pyrimidine nucleotide salvage (GO:0032262 from GO Biological Process Annotations)", "pyrimidine nucleotide transport (GO:0006864 from GO Biological Process Annotations)", "pyrimidine nucleotide-sugar transmembrane transport (GO:0090481 from GO Biological Process Annotations)", "pyrimidine nucleotide-sugar transport (GO:0015781 from GO Biological Process Annotations)", "pyrimidine ribonucleoside biosynthetic process (GO:0046132 from GO Biological Process Annotations)", "pyrimidine ribonucleoside catabolic process (GO:0046133 from GO Biological Process Annotations)", "pyrimidine ribonucleoside diphosphate biosynthetic process (GO:0009194 from GO Biological Process Annotations)", "pyrimidine ribonucleoside diphosphate catabolic process (GO:0009195 from GO Biological Process Annotations)", "pyrimidine ribonucleoside diphosphate metabolic process (GO:0009193 from GO Biological Process Annotations)", "pyrimidine ribonucleoside metabolic process (GO:0046131 from GO Biological Process Annotations)", "pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174 from GO Biological Process Annotations)", "pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173 from GO Biological Process Annotations)", "pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209 from GO Biological Process Annotations)", "pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208 from GO Biological Process Annotations)", "pyrimidine ribonucleotide biosynthetic process (GO:0009220 from GO Biological Process Annotations)", "pyrimidine ribonucleotide catabolic process (GO:0009222 from GO Biological Process Annotations)", "pyrimidine ribonucleotide metabolic process (GO:0009218 from GO Biological Process Annotations)", "pyrimidine ribonucleotide salvage (GO:0010138 from GO Biological Process Annotations)", "pyrimidine-containing compound biosynthetic process (GO:0072528 from GO Biological Process Annotations)", "pyrimidine-containing compound catabolic process (GO:0072529 from GO Biological Process Annotations)", "pyrimidine-containing compound metabolic process (GO:0072527 from GO Biological Process Annotations)", "pyrimidine-containing compound salvage (GO:0008655 from GO Biological Process Annotations)", "pyrimidine-containing compound transmembrane transport (GO:0072531 from GO Biological Process Annotations)", "pyroptosis (GO:0070269 from GO Biological Process Annotations)", "pyruvate biosynthetic process (GO:0042866 from GO Biological Process Annotations)", "pyruvate family amino acid catabolic process (GO:0009080 from GO Biological Process Annotations)", "pyruvate family amino acid metabolic process (GO:0009078 from GO Biological Process Annotations)", "pyruvate metabolic process (GO:0006090 from GO Biological Process Annotations)", "pyruvate transmembrane transport (GO:1901475 from GO Biological Process Annotations)", "pyruvate transport (GO:0006848 from GO Biological Process Annotations)", "quaternary ammonium group transport (GO:0015697 from GO Biological Process Annotations)", "queuosine biosynthetic process (GO:0008616 from GO Biological Process Annotations)", "queuosine metabolic process (GO:0046116 from GO Biological Process Annotations)", "quinolinate biosynthetic process (GO:0019805 from GO Biological Process Annotations)", "quinolinate catabolic process (GO:0034213 from GO Biological Process Annotations)", "quinolinate metabolic process (GO:0046874 from GO Biological Process Annotations)", "quinone biosynthetic process (GO:1901663 from GO Biological Process Annotations)", "quinone catabolic process (GO:1901662 from GO Biological Process Annotations)", "quinone metabolic process (GO:1901661 from GO Biological Process Annotations)", "quorum sensing (GO:0009372 from GO Biological Process Annotations)", "quorum sensing involved in interaction with host (GO:0052106 from GO Biological Process Annotations)", "rab protein signal transduction (GO:0032482 from GO Biological Process Annotations)", "rac protein signal transduction (GO:0016601 from GO Biological Process Annotations)", "radial glia guided migration of cerebellar granule cell (GO:0021933 from GO Biological Process Annotations)", "radial glia guided migration of purkinje cell (GO:0021942 from GO Biological Process Annotations)", "radial glial cell differentiation (GO:0060019 from GO Biological Process Annotations)", "radial pattern formation (GO:0009956 from GO Biological Process Annotations)", "ral protein signal transduction (GO:0032484 from GO Biological Process Annotations)", "random inactivation of x chromosome (GO:0060816 from GO Biological Process Annotations)", "rap protein signal transduction (GO:0032486 from GO Biological Process Annotations)", "ras protein signal transduction (GO:0007265 from GO Biological Process Annotations)", "re-entry into mitotic cell cycle (GO:0000320 from GO Biological Process Annotations)", "reactive nitrogen species metabolic process (GO:2001057 from GO Biological Process Annotations)", "reactive oxygen species biosynthetic process (GO:1903409 from GO Biological Process Annotations)", "reactive oxygen species metabolic process (GO:0072593 from GO Biological Process Annotations)", "receptor biosynthetic process (GO:0032800 from GO Biological Process Annotations)", "receptor catabolic process (GO:0032801 from GO Biological Process Annotations)", "receptor clustering (GO:0043113 from GO Biological Process Annotations)", "receptor guanylyl cyclase signaling pathway (GO:0007168 from GO Biological Process Annotations)", "receptor internalization (GO:0031623 from GO Biological Process Annotations)", "receptor internalization involved in canonical wnt signaling pathway (GO:2000286 from GO Biological Process Annotations)", "receptor localization to nonmotile primary cilium (GO:0097500 from GO Biological Process Annotations)", "receptor localization to synapse (GO:0097120 from GO Biological Process Annotations)", "receptor metabolic process (GO:0043112 from GO Biological Process Annotations)", "receptor recycling (GO:0001881 from GO Biological Process Annotations)", "receptor transactivation (GO:0035624 from GO Biological Process Annotations)", "receptor-mediated endocytosis (GO:0006898 from GO Biological Process Annotations)", "receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport (GO:0090118 from GO Biological Process Annotations)", "receptor-mediated endocytosis of virus by host cell (GO:0019065 from GO Biological Process Annotations)", "receptor-mediated virion attachment to host cell (GO:0046813 from GO Biological Process Annotations)", "reciprocal dna recombination (GO:0035825 from GO Biological Process Annotations)", "reciprocal meiotic recombination (GO:0007131 from GO Biological Process Annotations)", "recognition of apoptotic cell (GO:0043654 from GO Biological Process Annotations)", "recombinational repair (GO:0000725 from GO Biological Process Annotations)", "recruitment of 3'-end processing factors to rna polymerase ii holoenzyme complex (GO:0034402 from GO Biological Process Annotations)", "recruitment of mrna capping enzyme to rna polymerase ii holoenzyme complex (GO:0036031 from GO Biological Process Annotations)", "recycling endosome to golgi transport (GO:0071955 from GO Biological Process Annotations)", "red, far-red light phototransduction (GO:0009585 from GO Biological Process Annotations)", "reduction of food intake in response to dietary excess (GO:0002023 from GO Biological Process Annotations)", "reelin-mediated signaling pathway (GO:0038026 from GO Biological Process Annotations)", "reflex (GO:0060004 from GO Biological Process Annotations)", "regeneration (GO:0031099 from GO Biological Process Annotations)", "regionalization (GO:0003002 from GO Biological Process Annotations)", "regulated secretory pathway (GO:0045055 from GO Biological Process Annotations)", "regulation by virus of viral protein levels in host cell (GO:0046719 from GO Biological Process Annotations)", "regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043126 from GO Biological Process Annotations)", "regulation of abscisic acid-activated signaling pathway (GO:0009787 from GO Biological Process Annotations)", "regulation of acetyl-coa biosynthetic process from pyruvate (GO:0010510 from GO Biological Process Annotations)", "regulation of acetylcholine secretion, neurotransmission (GO:0014056 from GO Biological Process Annotations)", "regulation of acid-sensing ion channel activity (GO:1901585 from GO Biological Process Annotations)", "regulation of acrosomal vesicle exocytosis (GO:2000367 from GO Biological Process Annotations)", "regulation of acrosome reaction (GO:0060046 from GO Biological Process Annotations)", "regulation of actin cytoskeleton organization (GO:0032956 from GO Biological Process Annotations)", "regulation of actin cytoskeleton organization by cell-cell adhesion (GO:0090138 from GO Biological Process Annotations)", "regulation of actin cytoskeleton reorganization (GO:2000249 from GO Biological Process Annotations)", "regulation of actin filament bundle assembly (GO:0032231 from GO Biological Process Annotations)", "regulation of actin filament depolymerization (GO:0030834 from GO Biological Process Annotations)", "regulation of actin filament length (GO:0030832 from GO Biological Process Annotations)", "regulation of actin filament polymerization (GO:0030833 from GO Biological Process Annotations)", "regulation of actin filament-based movement (GO:1903115 from GO Biological Process Annotations)", "regulation of actin filament-based process (GO:0032970 from GO Biological Process Annotations)", "regulation of actin nucleation (GO:0051125 from GO Biological Process Annotations)", "regulation of actin phosphorylation (GO:0043538 from GO Biological Process Annotations)", "regulation of actin polymerization or depolymerization (GO:0008064 from GO Biological Process Annotations)", "regulation of action potential (GO:0098900 from GO Biological Process Annotations)", "regulation of activated t cell proliferation (GO:0046006 from GO Biological Process Annotations)", "regulation of activation of jak2 kinase activity (GO:0010534 from GO Biological Process Annotations)", "regulation of activation of janus kinase activity (GO:0010533 from GO Biological Process Annotations)", "regulation of activation of membrane attack complex (GO:0001969 from GO Biological Process Annotations)", "regulation of activation-induced cell death of t cells (GO:0070235 from GO Biological Process Annotations)", "regulation of activin receptor signaling pathway (GO:0032925 from GO Biological Process Annotations)", "regulation of acute inflammatory response (GO:0002673 from GO Biological Process Annotations)", "regulation of acute inflammatory response to antigenic stimulus (GO:0002864 from GO Biological Process Annotations)", "regulation of acute inflammatory response to non-antigenic stimulus (GO:0002877 from GO Biological Process Annotations)", "regulation of acyl-coa biosynthetic process (GO:0050812 from GO Biological Process Annotations)", "regulation of adaptive immune response (GO:0002819 from GO Biological Process Annotations)", "regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822 from GO Biological Process Annotations)", "regulation of adenosine receptor signaling pathway (GO:0060167 from GO Biological Process Annotations)", "regulation of adenylate cyclase activity (GO:0045761 from GO Biological Process Annotations)", "regulation of adenylate cyclase activity involved in g-protein coupled receptor signaling pathway (GO:0010578 from GO Biological Process Annotations)", "regulation of adherens junction organization (GO:1903391 from GO Biological Process Annotations)", "regulation of adiponectin secretion (GO:0070163 from GO Biological Process Annotations)", "regulation of adrenergic receptor signaling pathway (GO:0071877 from GO Biological Process Annotations)", "regulation of adrenergic receptor signaling pathway involved in heart process (GO:1901204 from GO Biological Process Annotations)", "regulation of alcohol biosynthetic process (GO:1902930 from GO Biological Process Annotations)", "regulation of aldosterone biosynthetic process (GO:0032347 from GO Biological Process Annotations)", "regulation of aldosterone metabolic process (GO:0032344 from GO Biological Process Annotations)", "regulation of aldosterone secretion (GO:2000858 from GO Biological Process Annotations)", "regulation of alkaline phosphatase activity (GO:0010692 from GO Biological Process Annotations)", "regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity (GO:2000311 from GO Biological Process Annotations)", "regulation of alpha-beta t cell activation (GO:0046634 from GO Biological Process Annotations)", "regulation of alpha-beta t cell differentiation (GO:0046637 from GO Biological Process Annotations)", "regulation of alpha-beta t cell proliferation (GO:0046640 from GO Biological Process Annotations)", "regulation of alternative mrna splicing, via spliceosome (GO:0000381 from GO Biological Process Annotations)", "regulation of amine transport (GO:0051952 from GO Biological Process Annotations)", "regulation of amino acid import (GO:0010958 from GO Biological Process Annotations)", "regulation of amino acid transport (GO:0051955 from GO Biological Process Annotations)", "regulation of amino acid uptake involved in synaptic transmission (GO:0051941 from GO Biological Process Annotations)", "regulation of ammonia assimilation cycle (GO:2001248 from GO Biological Process Annotations)", "regulation of amniotic stem cell differentiation (GO:2000797 from GO Biological Process Annotations)", "regulation of amyloid precursor protein biosynthetic process (GO:0042984 from GO Biological Process Annotations)", "regulation of amyloid precursor protein catabolic process (GO:1902991 from GO Biological Process Annotations)", "regulation of anagen (GO:0051884 from GO Biological Process Annotations)", "regulation of anatomical structure morphogenesis (GO:0022603 from GO Biological Process Annotations)", "regulation of anatomical structure size (GO:0090066 from GO Biological Process Annotations)", "regulation of androgen receptor activity (GO:2000823 from GO Biological Process Annotations)", "regulation of androgen receptor signaling pathway (GO:0060765 from GO Biological Process Annotations)", "regulation of androgen secretion (GO:2000834 from GO Biological Process Annotations)", "regulation of angiogenesis (GO:0045765 from GO Biological Process Annotations)", "regulation of angiotensin metabolic process (GO:0060177 from GO Biological Process Annotations)", "regulation of anion channel activity (GO:0010359 from GO Biological Process Annotations)", "regulation of anion transport (GO:0044070 from GO Biological Process Annotations)", "regulation of anoikis (GO:2000209 from GO Biological Process Annotations)", "regulation of anterior head development (GO:2000742 from GO Biological Process Annotations)", "regulation of anti-mullerian hormone signaling pathway (GO:1902612 from GO Biological Process Annotations)", "regulation of antibacterial peptide biosynthetic process (GO:0002808 from GO Biological Process Annotations)", "regulation of antibacterial peptide production (GO:0002786 from GO Biological Process Annotations)", "regulation of antigen processing and presentation (GO:0002577 from GO Biological Process Annotations)", "regulation of antigen processing and presentation of peptide antigen (GO:0002583 from GO Biological Process Annotations)", "regulation of antigen processing and presentation of peptide antigen via mhc class i (GO:0002589 from GO Biological Process Annotations)", "regulation of antigen processing and presentation of peptide antigen via mhc class ii (GO:0002586 from GO Biological Process Annotations)", "regulation of antigen processing and presentation of peptide or polysaccharide antigen via mhc class ii (GO:0002580 from GO Biological Process Annotations)", "regulation of antigen receptor-mediated signaling pathway (GO:0050854 from GO Biological Process Annotations)", "regulation of antimicrobial humoral response (GO:0002759 from GO Biological Process Annotations)", "regulation of antimicrobial peptide biosynthetic process (GO:0002805 from GO Biological Process Annotations)", "regulation of antimicrobial peptide production (GO:0002784 from GO Biological Process Annotations)", "regulation of antral ovarian follicle growth (GO:2000387 from GO Biological Process Annotations)", "regulation of apolipoprotein binding (GO:2000656 from GO Biological Process Annotations)", "regulation of apoptotic cell clearance (GO:2000425 from GO Biological Process Annotations)", "regulation of apoptotic dna fragmentation (GO:1902510 from GO Biological Process Annotations)", "regulation of apoptotic process (GO:0042981 from GO Biological Process Annotations)", "regulation of apoptotic process in bone marrow (GO:0071865 from GO Biological Process Annotations)", "regulation of apoptotic process involved in metanephric collecting duct development (GO:1900214 from GO Biological Process Annotations)", "regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900217 from GO Biological Process Annotations)", "regulation of apoptotic process involved in morphogenesis (GO:1902337 from GO Biological Process Annotations)", "regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902256 from GO Biological Process Annotations)", "regulation of apoptotic signaling pathway (GO:2001233 from GO Biological Process Annotations)", "regulation of appetite (GO:0032098 from GO Biological Process Annotations)", "regulation of arachidonic acid secretion (GO:0090237 from GO Biological Process Annotations)", "regulation of arginine catabolic process (GO:1900081 from GO Biological Process Annotations)", "regulation of arginine metabolic process (GO:0000821 from GO Biological Process Annotations)", "regulation of arp2|3 complex-mediated actin nucleation (GO:0034315 from GO Biological Process Annotations)", "regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959 from GO Biological Process Annotations)", "regulation of astrocyte chemotaxis (GO:2000458 from GO Biological Process Annotations)", "regulation of astrocyte differentiation (GO:0048710 from GO Biological Process Annotations)", "regulation of asymmetric cell division (GO:0009786 from GO Biological Process Annotations)", "regulation of atp biosynthetic process (GO:2001169 from GO Biological Process Annotations)", "regulation of atp citrate synthase activity (GO:2000983 from GO Biological Process Annotations)", "regulation of atp metabolic process (GO:1903578 from GO Biological Process Annotations)", "regulation of atp:adp antiporter activity (GO:0070926 from GO Biological Process Annotations)", "regulation of atpase activity (GO:0043462 from GO Biological Process Annotations)", "regulation of atrial cardiac muscle cell action potential (GO:0098910 from GO Biological Process Annotations)", "regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371 from GO Biological Process Annotations)", "regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372 from GO Biological Process Annotations)", "regulation of attachment of spindle microtubules to kinetochore (GO:0051988 from GO Biological Process Annotations)", "regulation of auditory receptor cell differentiation (GO:0045607 from GO Biological Process Annotations)", "regulation of autophagic vacuole assembly (GO:2000785 from GO Biological Process Annotations)", "regulation of autophagic vacuole fusion (GO:1902452 from GO Biological Process Annotations)", "regulation of autophagic vacuole maturation (GO:1901096 from GO Biological Process Annotations)", "regulation of autophagy (GO:0010506 from GO Biological Process Annotations)", "regulation of av node cell action potential (GO:0098904 from GO Biological Process Annotations)", "regulation of axon diameter (GO:0031133 from GO Biological Process Annotations)", "regulation of axon extension (GO:0030516 from GO Biological Process Annotations)", "regulation of axon extension involved in axon guidance (GO:0048841 from GO Biological Process Annotations)", "regulation of axon extension involved in regeneration (GO:0048690 from GO Biological Process Annotations)", "regulation of axon guidance (GO:1902667 from GO Biological Process Annotations)", "regulation of axon regeneration (GO:0048679 from GO Biological Process Annotations)", "regulation of axonogenesis (GO:0050770 from GO Biological Process Annotations)", "regulation of b cell activation (GO:0050864 from GO Biological Process Annotations)", "regulation of b cell apoptotic process (GO:0002902 from GO Biological Process Annotations)", "regulation of b cell chemotaxis (GO:2000537 from GO Biological Process Annotations)", "regulation of b cell cytokine production (GO:0002721 from GO Biological Process Annotations)", "regulation of b cell differentiation (GO:0045577 from GO Biological Process Annotations)", "regulation of b cell mediated immunity (GO:0002712 from GO Biological Process Annotations)", "regulation of b cell proliferation (GO:0030888 from GO Biological Process Annotations)", "regulation of b cell receptor signaling pathway (GO:0050855 from GO Biological Process Annotations)", "regulation of b cell tolerance induction (GO:0002661 from GO Biological Process Annotations)", "regulation of barbed-end actin filament capping (GO:2000812 from GO Biological Process Annotations)", "regulation of behavior (GO:0050795 from GO Biological Process Annotations)", "regulation of behavioral fear response (GO:2000822 from GO Biological Process Annotations)", "regulation of beta-amyloid clearance (GO:1900221 from GO Biological Process Annotations)", "regulation of beta-amyloid formation (GO:1902003 from GO Biological Process Annotations)", "regulation of bile acid biosynthetic process (GO:0070857 from GO Biological Process Annotations)", "regulation of binding (GO:0051098 from GO Biological Process Annotations)", "regulation of binding of sperm to zona pellucida (GO:2000359 from GO Biological Process Annotations)", "regulation of biological process (GO:0050789 from GO Biological Process Annotations)", "regulation of biological quality (GO:0065008 from GO Biological Process Annotations)", "regulation of biomineral tissue development (GO:0070167 from GO Biological Process Annotations)", "regulation of biosynthetic process (GO:0009889 from GO Biological Process Annotations)", "regulation of biosynthetic process of antibacterial peptides active against gram-positive bacteria (GO:0002816 from GO Biological Process Annotations)", "regulation of blood circulation (GO:1903522 from GO Biological Process Annotations)", "regulation of blood coagulation (GO:0030193 from GO Biological Process Annotations)", "regulation of blood coagulation, intrinsic pathway (GO:2000266 from GO Biological Process Annotations)", "regulation of blood microparticle formation (GO:2000332 from GO Biological Process Annotations)", "regulation of blood pressure (GO:0008217 from GO Biological Process Annotations)", "regulation of blood vessel endothelial cell migration (GO:0043535 from GO Biological Process Annotations)", "regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587 from GO Biological Process Annotations)", "regulation of blood vessel remodeling (GO:0060312 from GO Biological Process Annotations)", "regulation of blood vessel size (GO:0050880 from GO Biological Process Annotations)", "regulation of blood vessel size by renin-angiotensin (GO:0002034 from GO Biological Process Annotations)", "regulation of blood volume by renal aldosterone (GO:0002017 from GO Biological Process Annotations)", "regulation of blood volume by renin-angiotensin (GO:0002016 from GO Biological Process Annotations)", "regulation of bmp signaling pathway (GO:0030510 from GO Biological Process Annotations)", "regulation of body fluid levels (GO:0050878 from GO Biological Process Annotations)", "regulation of bone development (GO:1903010 from GO Biological Process Annotations)", "regulation of bone mineralization (GO:0030500 from GO Biological Process Annotations)", "regulation of bone mineralization involved in bone maturation (GO:1900157 from GO Biological Process Annotations)", "regulation of bone remodeling (GO:0046850 from GO Biological Process Annotations)", "regulation of bone resorption (GO:0045124 from GO Biological Process Annotations)", "regulation of bone trabecula formation (GO:1900154 from GO Biological Process Annotations)", "regulation of branch elongation involved in ureteric bud branching (GO:0072095 from GO Biological Process Annotations)", "regulation of branching involved in lung morphogenesis (GO:0061046 from GO Biological Process Annotations)", "regulation of branching involved in mammary gland duct morphogenesis (GO:0060762 from GO Biological Process Annotations)", "regulation of branching involved in prostate gland morphogenesis (GO:0060687 from GO Biological Process Annotations)", "regulation of branching involved in salivary gland morphogenesis (GO:0060693 from GO Biological Process Annotations)", "regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling (GO:0060683 from GO Biological Process Annotations)", "regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling (GO:0060668 from GO Biological Process Annotations)", "regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling (GO:0060665 from GO Biological Process Annotations)", "regulation of branching involved in ureteric bud morphogenesis (GO:0090189 from GO Biological Process Annotations)", "regulation of branching morphogenesis of a nerve (GO:2000172 from GO Biological Process Annotations)", "regulation of brown fat cell differentiation (GO:0090335 from GO Biological Process Annotations)", "regulation of brown fat cell proliferation (GO:0070347 from GO Biological Process Annotations)", "regulation of bundle of his cell action potential (GO:0098905 from GO Biological Process Annotations)", "regulation of c-c chemokine binding (GO:2001263 from GO Biological Process Annotations)", "regulation of c-c chemokine receptor ccr7 signaling pathway (GO:1903080 from GO Biological Process Annotations)", "regulation of calcidiol 1-monooxygenase activity (GO:0060558 from GO Biological Process Annotations)", "regulation of calcineurin-nfat signaling cascade (GO:0070884 from GO Biological Process Annotations)", "regulation of calcium ion binding (GO:1901876 from GO Biological Process Annotations)", "regulation of calcium ion import (GO:0090279 from GO Biological Process Annotations)", "regulation of calcium ion import into sarcoplasmic reticulum (GO:1902080 from GO Biological Process Annotations)", "regulation of calcium ion transmembrane transport (GO:1903169 from GO Biological Process Annotations)", "regulation of calcium ion transmembrane transporter activity (GO:1901019 from GO Biological Process Annotations)", "regulation of calcium ion transport (GO:0051924 from GO Biological Process Annotations)", "regulation of calcium ion transport into cytosol (GO:0010522 from GO Biological Process Annotations)", "regulation of calcium ion-dependent exocytosis (GO:0017158 from GO Biological Process Annotations)", "regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903233 from GO Biological Process Annotations)", "regulation of calcium-dependent cell-cell adhesion (GO:0046586 from GO Biological Process Annotations)", "regulation of calcium-independent cell-cell adhesion (GO:0051040 from GO Biological Process Annotations)", "regulation of calcium-mediated signaling (GO:0050848 from GO Biological Process Annotations)", "regulation of calcium-transporting atpase activity (GO:1901894 from GO Biological Process Annotations)", "regulation of calcium:sodium antiporter activity (GO:1903279 from GO Biological Process Annotations)", "regulation of camp biosynthetic process (GO:0030817 from GO Biological Process Annotations)", "regulation of camp catabolic process (GO:0030820 from GO Biological Process Annotations)", "regulation of camp metabolic process (GO:0030814 from GO Biological Process Annotations)", "regulation of camp-dependent protein kinase activity (GO:2000479 from GO Biological Process Annotations)", "regulation of camp-mediated signaling (GO:0043949 from GO Biological Process Annotations)", "regulation of canonical wnt signaling pathway (GO:0060828 from GO Biological Process Annotations)", "regulation of canonical wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901295 from GO Biological Process Annotations)", "regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation (GO:2000079 from GO Biological Process Annotations)", "regulation of canonical wnt signaling pathway involved in neural plate anterior|posterior pattern formation (GO:0060827 from GO Biological Process Annotations)", "regulation of cap-dependent translational initiation (GO:1903674 from GO Biological Process Annotations)", "regulation of cap-independent translational initiation (GO:1903677 from GO Biological Process Annotations)", "regulation of carbohydrate biosynthetic process (GO:0043255 from GO Biological Process Annotations)", "regulation of carbohydrate catabolic process (GO:0043470 from GO Biological Process Annotations)", "regulation of carbohydrate metabolic process (GO:0006109 from GO Biological Process Annotations)", "regulation of carbohydrate metabolic process by regulation of transcription from rna polymerase ii promoter (GO:1900402 from GO Biological Process Annotations)", "regulation of carbohydrate phosphatase activity (GO:0032113 from GO Biological Process Annotations)", "regulation of carbohydrate utilization (GO:0043610 from GO Biological Process Annotations)", "regulation of cardiac cell fate specification (GO:2000043 from GO Biological Process Annotations)", "regulation of cardiac chamber formation (GO:1901210 from GO Biological Process Annotations)", "regulation of cardiac chamber morphogenesis (GO:1901219 from GO Biological Process Annotations)", "regulation of cardiac conduction (GO:1903779 from GO Biological Process Annotations)", "regulation of cardiac muscle adaptation (GO:0010612 from GO Biological Process Annotations)", "regulation of cardiac muscle cell action potential (GO:0098901 from GO Biological Process Annotations)", "regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909 from GO Biological Process Annotations)", "regulation of cardiac muscle cell apoptotic process (GO:0010665 from GO Biological Process Annotations)", "regulation of cardiac muscle cell contraction (GO:0086004 from GO Biological Process Annotations)", "regulation of cardiac muscle cell differentiation (GO:2000725 from GO Biological Process Annotations)", "regulation of cardiac muscle cell membrane potential (GO:0086036 from GO Biological Process Annotations)", "regulation of cardiac muscle cell myoblast differentiation (GO:2000690 from GO Biological Process Annotations)", "regulation of cardiac muscle cell proliferation (GO:0060043 from GO Biological Process Annotations)", "regulation of cardiac muscle contraction (GO:0055117 from GO Biological Process Annotations)", "regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882 from GO Biological Process Annotations)", "regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881 from GO Biological Process Annotations)", "regulation of cardiac muscle fiber development (GO:0055018 from GO Biological Process Annotations)", "regulation of cardiac muscle hypertrophy (GO:0010611 from GO Biological Process Annotations)", "regulation of cardiac muscle hypertrophy in response to stress (GO:1903242 from GO Biological Process Annotations)", "regulation of cardiac muscle tissue development (GO:0055024 from GO Biological Process Annotations)", "regulation of cardiac muscle tissue growth (GO:0055021 from GO Biological Process Annotations)", "regulation of cardiac vascular smooth muscle cell differentiation (GO:2000722 from GO Biological Process Annotations)", "regulation of cardioblast cell fate specification (GO:0042686 from GO Biological Process Annotations)", "regulation of cardioblast differentiation (GO:0051890 from GO Biological Process Annotations)", "regulation of cardioblast proliferation (GO:0003264 from GO Biological Process Annotations)", "regulation of cardiolipin metabolic process (GO:1900208 from GO Biological Process Annotations)", "regulation of cargo loading into copii-coated vesicle (GO:1901301 from GO Biological Process Annotations)", "regulation of cartilage development (GO:0061035 from GO Biological Process Annotations)", "regulation of catabolic process (GO:0009894 from GO Biological Process Annotations)", "regulation of catagen (GO:0051794 from GO Biological Process Annotations)", "regulation of catalytic activity (GO:0050790 from GO Biological Process Annotations)", "regulation of catecholamine metabolic process (GO:0042069 from GO Biological Process Annotations)", "regulation of catecholamine secretion (GO:0050433 from GO Biological Process Annotations)", "regulation of catecholamine uptake involved in synaptic transmission (GO:0051940 from GO Biological Process Annotations)", "regulation of catenin import into nucleus (GO:0035412 from GO Biological Process Annotations)", "regulation of cation channel activity (GO:2001257 from GO Biological Process Annotations)", "regulation of caveolin-mediated endocytosis (GO:2001286 from GO Biological Process Annotations)", "regulation of cd24 biosynthetic process (GO:2000559 from GO Biological Process Annotations)", "regulation of cd4-positive, alpha-beta t cell activation (GO:2000514 from GO Biological Process Annotations)", "regulation of cd4-positive, alpha-beta t cell costimulation (GO:1900279 from GO Biological Process Annotations)", "regulation of cd4-positive, alpha-beta t cell differentiation (GO:0043370 from GO Biological Process Annotations)", "regulation of cd4-positive, alpha-beta t cell proliferation (GO:2000561 from GO Biological Process Annotations)", "regulation of cd4-positive, cd25-positive, alpha-beta regulatory t cell differentiation (GO:0032829 from GO Biological Process Annotations)", "regulation of cd40 signaling pathway (GO:2000348 from GO Biological Process Annotations)", "regulation of cd8-positive, alpha-beta cytotoxic t cell extravasation (GO:2000452 from GO Biological Process Annotations)", "regulation of cd8-positive, alpha-beta t cell activation (GO:2001185 from GO Biological Process Annotations)", "regulation of cd8-positive, alpha-beta t cell differentiation (GO:0043376 from GO Biological Process Annotations)", "regulation of cd8-positive, alpha-beta t cell extravasation (GO:2000449 from GO Biological Process Annotations)", "regulation of cd8-positive, alpha-beta t cell proliferation (GO:2000564 from GO Biological Process Annotations)", "regulation of cdc42 protein signal transduction (GO:0032489 from GO Biological Process Annotations)", "regulation of cell activation (GO:0050865 from GO Biological Process Annotations)", "regulation of cell adhesion (GO:0030155 from GO Biological Process Annotations)", "regulation of cell adhesion mediated by integrin (GO:0033628 from GO Biological Process Annotations)", "regulation of cell adhesion molecule production (GO:0060353 from GO Biological Process Annotations)", "regulation of cell aging (GO:0090342 from GO Biological Process Annotations)", "regulation of cell communication (GO:0010646 from GO Biological Process Annotations)", "regulation of cell communication by chemical coupling (GO:0010645 from GO Biological Process Annotations)", "regulation of cell communication by electrical coupling (GO:0010649 from GO Biological Process Annotations)", "regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844 from GO Biological Process Annotations)", "regulation of cell cycle (GO:0051726 from GO Biological Process Annotations)", "regulation of cell cycle arrest (GO:0071156 from GO Biological Process Annotations)", "regulation of cell cycle checkpoint (GO:1901976 from GO Biological Process Annotations)", "regulation of cell cycle g1|s phase transition (GO:1902806 from GO Biological Process Annotations)", "regulation of cell cycle g2|m phase transition (GO:1902749 from GO Biological Process Annotations)", "regulation of cell cycle phase transition (GO:1901987 from GO Biological Process Annotations)", "regulation of cell cycle process (GO:0010564 from GO Biological Process Annotations)", "regulation of cell death (GO:0010941 from GO Biological Process Annotations)", "regulation of cell development (GO:0060284 from GO Biological Process Annotations)", "regulation of cell diameter (GO:0060305 from GO Biological Process Annotations)", "regulation of cell differentiation (GO:0045595 from GO Biological Process Annotations)", "regulation of cell differentiation involved in embryonic placenta development (GO:0060800 from GO Biological Process Annotations)", "regulation of cell division (GO:0051302 from GO Biological Process Annotations)", "regulation of cell fate commitment (GO:0010453 from GO Biological Process Annotations)", "regulation of cell fate specification (GO:0042659 from GO Biological Process Annotations)", "regulation of cell growth (GO:0001558 from GO Biological Process Annotations)", "regulation of cell growth by extracellular stimulus (GO:0001560 from GO Biological Process Annotations)", "regulation of cell growth involved in cardiac muscle cell development (GO:0061050 from GO Biological Process Annotations)", "regulation of cell junction assembly (GO:1901888 from GO Biological Process Annotations)", "regulation of cell killing (GO:0031341 from GO Biological Process Annotations)", "regulation of cell maturation (GO:1903429 from GO Biological Process Annotations)", "regulation of cell migration (GO:0030334 from GO Biological Process Annotations)", "regulation of cell migration involved in sprouting angiogenesis (GO:0090049 from GO Biological Process Annotations)", "regulation of cell morphogenesis (GO:0022604 from GO Biological Process Annotations)", "regulation of cell morphogenesis involved in differentiation (GO:0010769 from GO Biological Process Annotations)", "regulation of cell motility (GO:2000145 from GO Biological Process Annotations)", "regulation of cell motility involved in somitogenic axis elongation (GO:0090249 from GO Biological Process Annotations)", "regulation of cell projection assembly (GO:0060491 from GO Biological Process Annotations)", "regulation of cell projection organization (GO:0031344 from GO Biological Process Annotations)", "regulation of cell projection size (GO:0032536 from GO Biological Process Annotations)", "regulation of cell proliferation (GO:0042127 from GO Biological Process Annotations)", "regulation of cell proliferation in bone marrow (GO:0071863 from GO Biological Process Annotations)", "regulation of cell proliferation involved in embryonic placenta development (GO:0060723 from GO Biological Process Annotations)", "regulation of cell proliferation involved in heart morphogenesis (GO:2000136 from GO Biological Process Annotations)", "regulation of cell proliferation involved in heart valve morphogenesis (GO:0003250 from GO Biological Process Annotations)", "regulation of cell proliferation involved in kidney development (GO:1901722 from GO Biological Process Annotations)", "regulation of cell proliferation involved in mesonephros development (GO:2000606 from GO Biological Process Annotations)", "regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901963 from GO Biological Process Annotations)", "regulation of cell proliferation involved in tissue homeostasis (GO:0060784 from GO Biological Process Annotations)", "regulation of cell shape (GO:0008360 from GO Biological Process Annotations)", "regulation of cell size (GO:0008361 from GO Biological Process Annotations)", "regulation of cell-cell adhesion (GO:0022407 from GO Biological Process Annotations)", "regulation of cell-cell adhesion involved in gastrulation (GO:0070587 from GO Biological Process Annotations)", "regulation of cell-cell adhesion mediated by cadherin (GO:2000047 from GO Biological Process Annotations)", "regulation of cell-cell adhesion mediated by integrin (GO:0033632 from GO Biological Process Annotations)", "regulation of cell-matrix adhesion (GO:0001952 from GO Biological Process Annotations)", "regulation of cell-substrate adhesion (GO:0010810 from GO Biological Process Annotations)", "regulation of cell-substrate junction assembly (GO:0090109 from GO Biological Process Annotations)", "regulation of cellular amide metabolic process (GO:0034248 from GO Biological Process Annotations)", "regulation of cellular amine catabolic process (GO:0033241 from GO Biological Process Annotations)", "regulation of cellular amine metabolic process (GO:0033238 from GO Biological Process Annotations)", "regulation of cellular amino acid biosynthetic process (GO:2000282 from GO Biological Process Annotations)", "regulation of cellular amino acid metabolic process (GO:0006521 from GO Biological Process Annotations)", "regulation of cellular biosynthetic process (GO:0031326 from GO Biological Process Annotations)", "regulation of cellular carbohydrate catabolic process (GO:0043471 from GO Biological Process Annotations)", "regulation of cellular carbohydrate metabolic process (GO:0010675 from GO Biological Process Annotations)", "regulation of cellular catabolic process (GO:0031329 from GO Biological Process Annotations)", "regulation of cellular component biogenesis (GO:0044087 from GO Biological Process Annotations)", "regulation of cellular component movement (GO:0051270 from GO Biological Process Annotations)", "regulation of cellular component organization (GO:0051128 from GO Biological Process Annotations)", "regulation of cellular component size (GO:0032535 from GO Biological Process Annotations)", "regulation of cellular extravasation (GO:0002691 from GO Biological Process Annotations)", "regulation of cellular glucuronidation (GO:2001029 from GO Biological Process Annotations)", "regulation of cellular ketone metabolic process (GO:0010565 from GO Biological Process Annotations)", "regulation of cellular ketone metabolic process by negative regulation of transcription from rna polymerase ii promoter (GO:0072365 from GO Biological Process Annotations)", "regulation of cellular ketone metabolic process by positive regulation of transcription from rna polymerase ii promoter (GO:0072366 from GO Biological Process Annotations)", "regulation of cellular ketone metabolic process by regulation of transcription from rna polymerase ii promoter (GO:0072364 from GO Biological Process Annotations)", "regulation of cellular localization (GO:0060341 from GO Biological Process Annotations)", "regulation of cellular macromolecule biosynthetic process (GO:2000112 from GO Biological Process Annotations)", "regulation of cellular metabolic process (GO:0031323 from GO Biological Process Annotations)", "regulation of cellular organofluorine metabolic process (GO:0090348 from GO Biological Process Annotations)", "regulation of cellular organohalogen metabolic process (GO:0090347 from GO Biological Process Annotations)", "regulation of cellular ph (GO:0030641 from GO Biological Process Annotations)", "regulation of cellular ph reduction (GO:0032847 from GO Biological Process Annotations)", "regulation of cellular process (GO:0050794 from GO Biological Process Annotations)", "regulation of cellular protein catabolic process (GO:1903362 from GO Biological Process Annotations)", "regulation of cellular protein localization (GO:1903827 from GO Biological Process Annotations)", "regulation of cellular protein metabolic process (GO:0032268 from GO Biological Process Annotations)", "regulation of cellular respiration (GO:0043457 from GO Biological Process Annotations)", "regulation of cellular response to drug (GO:2001038 from GO Biological Process Annotations)", "regulation of cellular response to growth factor stimulus (GO:0090287 from GO Biological Process Annotations)", "regulation of cellular response to heat (GO:1900034 from GO Biological Process Annotations)", "regulation of cellular response to hepatocyte growth factor stimulus (GO:2001112 from GO Biological Process Annotations)", "regulation of cellular response to hypoxia (GO:1900037 from GO Biological Process Annotations)", "regulation of cellular response to insulin stimulus (GO:1900076 from GO Biological Process Annotations)", "regulation of cellular response to oxidative stress (GO:1900407 from GO Biological Process Annotations)", "regulation of cellular response to stress (GO:0080135 from GO Biological Process Annotations)", "regulation of cellular response to testosterone stimulus (GO:2000654 from GO Biological Process Annotations)", "regulation of cellular response to transforming growth factor beta stimulus (GO:1903844 from GO Biological Process Annotations)", "regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547 from GO Biological Process Annotations)", "regulation of cellular response to x-ray (GO:2000683 from GO Biological Process Annotations)", "regulation of cellular senescence (GO:2000772 from GO Biological Process Annotations)", "regulation of central b cell tolerance induction (GO:0002895 from GO Biological Process Annotations)", "regulation of central tolerance induction (GO:0002646 from GO Biological Process Annotations)", "regulation of centriole elongation (GO:1903722 from GO Biological Process Annotations)", "regulation of centriole replication (GO:0046599 from GO Biological Process Annotations)", "regulation of centriole-centriole cohesion (GO:0030997 from GO Biological Process Annotations)", "regulation of centromere complex assembly (GO:0090230 from GO Biological Process Annotations)", "regulation of centromeric sister chromatid cohesion (GO:0070602 from GO Biological Process Annotations)", "regulation of centrosome cycle (GO:0046605 from GO Biological Process Annotations)", "regulation of centrosome duplication (GO:0010824 from GO Biological Process Annotations)", "regulation of ceramide biosynthetic process (GO:2000303 from GO Biological Process Annotations)", "regulation of cerebellar granule cell precursor proliferation (GO:0021936 from GO Biological Process Annotations)", "regulation of cgmp biosynthetic process (GO:0030826 from GO Biological Process Annotations)", "regulation of cgmp metabolic process (GO:0030823 from GO Biological Process Annotations)", "regulation of cgmp-mediated signaling (GO:0010752 from GO Biological Process Annotations)", "regulation of chaperone-mediated protein complex assembly (GO:0090034 from GO Biological Process Annotations)", "regulation of chaperone-mediated protein folding (GO:1903644 from GO Biological Process Annotations)", "regulation of chemokine (c-c motif) ligand 5 production (GO:0071649 from GO Biological Process Annotations)", "regulation of chemokine (c-x-c motif) ligand 1 production (GO:2000338 from GO Biological Process Annotations)", "regulation of chemokine (c-x-c motif) ligand 2 production (GO:2000341 from GO Biological Process Annotations)", "regulation of chemokine biosynthetic process (GO:0045073 from GO Biological Process Annotations)", "regulation of chemokine production (GO:0032642 from GO Biological Process Annotations)", "regulation of chemokine secretion (GO:0090196 from GO Biological Process Annotations)", "regulation of chemokine-mediated signaling pathway (GO:0070099 from GO Biological Process Annotations)", "regulation of chemotaxis (GO:0050920 from GO Biological Process Annotations)", "regulation of chloride transport (GO:2001225 from GO Biological Process Annotations)", "regulation of cholesterol biosynthetic process (GO:0045540 from GO Biological Process Annotations)", "regulation of cholesterol efflux (GO:0010874 from GO Biological Process Annotations)", "regulation of cholesterol esterification (GO:0010872 from GO Biological Process Annotations)", "regulation of cholesterol homeostasis (GO:2000188 from GO Biological Process Annotations)", "regulation of cholesterol import (GO:0060620 from GO Biological Process Annotations)", "regulation of cholesterol metabolic process (GO:0090181 from GO Biological Process Annotations)", "regulation of cholesterol storage (GO:0010885 from GO Biological Process Annotations)", "regulation of cholesterol transport (GO:0032374 from GO Biological Process Annotations)", "regulation of cholesterol transporter activity (GO:0060694 from GO Biological Process Annotations)", "regulation of choline o-acetyltransferase activity (GO:1902769 from GO Biological Process Annotations)", "regulation of chondrocyte development (GO:0061181 from GO Biological Process Annotations)", "regulation of chondrocyte differentiation (GO:0032330 from GO Biological Process Annotations)", "regulation of chorionic trophoblast cell proliferation (GO:1901382 from GO Biological Process Annotations)", "regulation of chromatin assembly (GO:0010847 from GO Biological Process Annotations)", "regulation of chromatin assembly or disassembly (GO:0001672 from GO Biological Process Annotations)", "regulation of chromatin binding (GO:0035561 from GO Biological Process Annotations)", "regulation of chromatin disassembly (GO:0010848 from GO Biological Process Annotations)", "regulation of chromatin modification (GO:1903308 from GO Biological Process Annotations)", "regulation of chromatin organization (GO:1902275 from GO Biological Process Annotations)", "regulation of chromatin silencing (GO:0031935 from GO Biological Process Annotations)", "regulation of chromatin silencing at rdna (GO:0061187 from GO Biological Process Annotations)", "regulation of chromatin silencing at telomere (GO:0031938 from GO Biological Process Annotations)", "regulation of chromosome condensation (GO:0060623 from GO Biological Process Annotations)", "regulation of chromosome organization (GO:0033044 from GO Biological Process Annotations)", "regulation of chromosome segregation (GO:0051983 from GO Biological Process Annotations)", "regulation of chronic inflammatory response (GO:0002676 from GO Biological Process Annotations)", "regulation of chronic inflammatory response to antigenic stimulus (GO:0002874 from GO Biological Process Annotations)", "regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002880 from GO Biological Process Annotations)", "regulation of chylomicron remnant clearance (GO:0090320 from GO Biological Process Annotations)", "regulation of cilium assembly (GO:1902017 from GO Biological Process Annotations)", "regulation of cilium beat frequency (GO:0003356 from GO Biological Process Annotations)", "regulation of cilium beat frequency involved in ciliary motility (GO:0060296 from GO Biological Process Annotations)", "regulation of cilium movement (GO:0003352 from GO Biological Process Annotations)", "regulation of cilium movement involved in cell motility (GO:0060295 from GO Biological Process Annotations)", "regulation of cilium-dependent cell motility (GO:1902019 from GO Biological Process Annotations)", "regulation of circadian rhythm (GO:0042752 from GO Biological Process Annotations)", "regulation of circadian sleep|wake cycle (GO:0042749 from GO Biological Process Annotations)", "regulation of circadian sleep|wake cycle, non-rem sleep (GO:0045188 from GO Biological Process Annotations)", "regulation of circadian sleep|wake cycle, rem sleep (GO:0042320 from GO Biological Process Annotations)", "regulation of circadian sleep|wake cycle, sleep (GO:0045187 from GO Biological Process Annotations)", "regulation of circadian sleep|wake cycle, wakefulness (GO:0010840 from GO Biological Process Annotations)", "regulation of citrulline biosynthetic process (GO:1903248 from GO Biological Process Annotations)", "regulation of clathrin-mediated endocytosis (GO:2000369 from GO Biological Process Annotations)", "regulation of coagulation (GO:0050818 from GO Biological Process Annotations)", "regulation of coenzyme metabolic process (GO:0051196 from GO Biological Process Annotations)", "regulation of cofactor metabolic process (GO:0051193 from GO Biological Process Annotations)", "regulation of cohesin localization to chromatin (GO:0071922 from GO Biological Process Annotations)", "regulation of collagen binding (GO:0033341 from GO Biological Process Annotations)", "regulation of collagen biosynthetic process (GO:0032965 from GO Biological Process Annotations)", "regulation of collagen catabolic process (GO:0010710 from GO Biological Process Annotations)", "regulation of collagen metabolic process (GO:0010712 from GO Biological Process Annotations)", "regulation of collateral sprouting (GO:0048670 from GO Biological Process Annotations)", "regulation of collateral sprouting in absence of injury (GO:0048696 from GO Biological Process Annotations)", "regulation of collateral sprouting of intact axon in response to injury (GO:0048683 from GO Biological Process Annotations)", "regulation of complement activation (GO:0030449 from GO Biological Process Annotations)", "regulation of complement activation, alternative pathway (GO:0030451 from GO Biological Process Annotations)", "regulation of complement activation, classical pathway (GO:0030450 from GO Biological Process Annotations)", "regulation of complement activation, lectin pathway (GO:0001868 from GO Biological Process Annotations)", "regulation of complement-dependent cytotoxicity (GO:1903659 from GO Biological Process Annotations)", "regulation of connective tissue growth factor production (GO:0032643 from GO Biological Process Annotations)", "regulation of constitutive secretory pathway (GO:1903433 from GO Biological Process Annotations)", "regulation of convergent extension involved in axis elongation (GO:1901232 from GO Biological Process Annotations)", "regulation of copper ion transmembrane transport (GO:1902311 from GO Biological Process Annotations)", "regulation of corticosteroid hormone secretion (GO:2000846 from GO Biological Process Annotations)", "regulation of corticosterone secretion (GO:2000852 from GO Biological Process Annotations)", "regulation of corticotropin secretion (GO:0051459 from GO Biological Process Annotations)", "regulation of corticotropin-releasing hormone receptor activity (GO:1900010 from GO Biological Process Annotations)", "regulation of corticotropin-releasing hormone secretion (GO:0043397 from GO Biological Process Annotations)", "regulation of cortisol biosynthetic process (GO:2000064 from GO Biological Process Annotations)", "regulation of cortisol secretion (GO:0051462 from GO Biological Process Annotations)", "regulation of cristae formation (GO:1903850 from GO Biological Process Annotations)", "regulation of cyclase activity (GO:0031279 from GO Biological Process Annotations)", "regulation of cyclic nucleotide biosynthetic process (GO:0030802 from GO Biological Process Annotations)", "regulation of cyclic nucleotide catabolic process (GO:0030805 from GO Biological Process Annotations)", "regulation of cyclic nucleotide metabolic process (GO:0030799 from GO Biological Process Annotations)", "regulation of cyclic nucleotide-gated ion channel activity (GO:1902159 from GO Biological Process Annotations)", "regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342 from GO Biological Process Annotations)", "regulation of cyclin catabolic process (GO:2000598 from GO Biological Process Annotations)", "regulation of cyclin-dependent protein serine|threonine kinase activity (GO:0000079 from GO Biological Process Annotations)", "regulation of cyclin-dependent protein serine|threonine kinase activity involved in g1|s transition of mitotic cell cycle (GO:0031657 from GO Biological Process Annotations)", "regulation of cyclin-dependent protein serine|threonine kinase activity involved in g2|m transition of mitotic cell cycle (GO:0031660 from GO Biological Process Annotations)", "regulation of cysteine-type endopeptidase activity (GO:2000116 from GO Biological Process Annotations)", "regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281 from GO Biological Process Annotations)", "regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267 from GO Biological Process Annotations)", "regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270 from GO Biological Process Annotations)", "regulation of cytokine activity (GO:0060300 from GO Biological Process Annotations)", "regulation of cytokine biosynthetic process (GO:0042035 from GO Biological Process Annotations)", "regulation of cytokine production (GO:0001817 from GO Biological Process Annotations)", "regulation of cytokine production involved in immune response (GO:0002718 from GO Biological Process Annotations)", "regulation of cytokine production involved in inflammatory response (GO:1900015 from GO Biological Process Annotations)", "regulation of cytokine secretion (GO:0050707 from GO Biological Process Annotations)", "regulation of cytokine secretion involved in immune response (GO:0002739 from GO Biological Process Annotations)", "regulation of cytokine-mediated signaling pathway (GO:0001959 from GO Biological Process Annotations)", "regulation of cytokinesis (GO:0032465 from GO Biological Process Annotations)", "regulation of cytolysis (GO:0042268 from GO Biological Process Annotations)", "regulation of cytoplasmic mrna processing body assembly (GO:0010603 from GO Biological Process Annotations)", "regulation of cytoplasmic translation (GO:2000765 from GO Biological Process Annotations)", "regulation of cytoplasmic translational elongation (GO:1900247 from GO Biological Process Annotations)", "regulation of cytoplasmic transport (GO:1903649 from GO Biological Process Annotations)", "regulation of cytoskeleton organization (GO:0051493 from GO Biological Process Annotations)", "regulation of cytotoxic t cell differentiation (GO:0045583 from GO Biological Process Annotations)", "regulation of d-amino-acid oxidase activity (GO:1900757 from GO Biological Process Annotations)", "regulation of death-inducing signaling complex assembly (GO:1903072 from GO Biological Process Annotations)", "regulation of defense response (GO:0031347 from GO Biological Process Annotations)", "regulation of defense response to bacterium (GO:1900424 from GO Biological Process Annotations)", "regulation of defense response to virus (GO:0050688 from GO Biological Process Annotations)", "regulation of defense response to virus by host (GO:0050691 from GO Biological Process Annotations)", "regulation of defense response to virus by virus (GO:0050690 from GO Biological Process Annotations)", "regulation of definitive erythrocyte differentiation (GO:0010724 from GO Biological Process Annotations)", "regulation of delayed rectifier potassium channel activity (GO:1902259 from GO Biological Process Annotations)", "regulation of dendrite development (GO:0050773 from GO Biological Process Annotations)", "regulation of dendrite morphogenesis (GO:0048814 from GO Biological Process Annotations)", "regulation of dendritic cell antigen processing and presentation (GO:0002604 from GO Biological Process Annotations)", "regulation of dendritic cell apoptotic process (GO:2000668 from GO Biological Process Annotations)", "regulation of dendritic cell chemotaxis (GO:2000508 from GO Biological Process Annotations)", "regulation of dendritic cell cytokine production (GO:0002730 from GO Biological Process Annotations)", "regulation of dendritic cell dendrite assembly (GO:2000547 from GO Biological Process Annotations)", "regulation of dendritic cell differentiation (GO:2001198 from GO Biological Process Annotations)", "regulation of dendritic spine development (GO:0060998 from GO Biological Process Annotations)", "regulation of dendritic spine maintenance (GO:1902950 from GO Biological Process Annotations)", "regulation of dendritic spine morphogenesis (GO:0061001 from GO Biological Process Annotations)", "regulation of dense core granule biogenesis (GO:2000705 from GO Biological Process Annotations)", "regulation of deoxyribonuclease activity (GO:0032070 from GO Biological Process Annotations)", "regulation of dephosphorylation (GO:0035303 from GO Biological Process Annotations)", "regulation of dermatome development (GO:0061183 from GO Biological Process Annotations)", "regulation of detection of glucose (GO:2000970 from GO Biological Process Annotations)", "regulation of determination of dorsal identity (GO:2000015 from GO Biological Process Annotations)", "regulation of development, heterochronic (GO:0040034 from GO Biological Process Annotations)", "regulation of developmental growth (GO:0048638 from GO Biological Process Annotations)", "regulation of developmental pigmentation (GO:0048070 from GO Biological Process Annotations)", "regulation of developmental process (GO:0050793 from GO Biological Process Annotations)", "regulation of digestive system process (GO:0044058 from GO Biological Process Annotations)", "regulation of dipeptide transmembrane transport (GO:2001148 from GO Biological Process Annotations)", "regulation of dipeptide transport (GO:0090089 from GO Biological Process Annotations)", "regulation of dna binding (GO:0051101 from GO Biological Process Annotations)", "regulation of dna biosynthetic process (GO:2000278 from GO Biological Process Annotations)", "regulation of dna catabolic process (GO:1903624 from GO Biological Process Annotations)", "regulation of dna damage checkpoint (GO:2000001 from GO Biological Process Annotations)", "regulation of dna damage response, signal transduction by p53 class mediator (GO:0043516 from GO Biological Process Annotations)", "regulation of dna damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902162 from GO Biological Process Annotations)", "regulation of dna demethylation (GO:1901535 from GO Biological Process Annotations)", "regulation of dna endoreduplication (GO:0032875 from GO Biological Process Annotations)", "regulation of dna ligation (GO:0051105 from GO Biological Process Annotations)", "regulation of dna metabolic process (GO:0051052 from GO Biological Process Annotations)", "regulation of dna methylation (GO:0044030 from GO Biological Process Annotations)", "regulation of dna n-glycosylase activity (GO:1902544 from GO Biological Process Annotations)", "regulation of dna recombination (GO:0000018 from GO Biological Process Annotations)", "regulation of dna recombination at telomere (GO:0072695 from GO Biological Process Annotations)", "regulation of dna repair (GO:0006282 from GO Biological Process Annotations)", "regulation of dna replication (GO:0006275 from GO Biological Process Annotations)", "regulation of dna strand elongation (GO:0060382 from GO Biological Process Annotations)", "regulation of dna topoisomerase (atp-hydrolyzing) activity (GO:2000371 from GO Biological Process Annotations)", "regulation of dna-dependent dna replication (GO:0090329 from GO Biological Process Annotations)", "regulation of dna-dependent dna replication initiation (GO:0030174 from GO Biological Process Annotations)", "regulation of dna-templated transcription in response to stress (GO:0043620 from GO Biological Process Annotations)", "regulation of dna-templated transcription, elongation (GO:0032784 from GO Biological Process Annotations)", "regulation of dna-templated transcription, initiation (GO:2000142 from GO Biological Process Annotations)", "regulation of dna-templated transcription, termination (GO:0031554 from GO Biological Process Annotations)", "regulation of dopamine biosynthetic process (GO:1903179 from GO Biological Process Annotations)", "regulation of dopamine metabolic process (GO:0042053 from GO Biological Process Annotations)", "regulation of dopamine receptor signaling pathway (GO:0060159 from GO Biological Process Annotations)", "regulation of dopamine secretion (GO:0014059 from GO Biological Process Annotations)", "regulation of dopamine uptake involved in synaptic transmission (GO:0051584 from GO Biological Process Annotations)", "regulation of double-strand break repair (GO:2000779 from GO Biological Process Annotations)", "regulation of double-strand break repair via homologous recombination (GO:0010569 from GO Biological Process Annotations)", "regulation of double-strand break repair via nonhomologous end joining (GO:2001032 from GO Biological Process Annotations)", "regulation of early endosome to late endosome transport (GO:2000641 from GO Biological Process Annotations)", "regulation of early endosome to recycling endosome transport (GO:1902954 from GO Biological Process Annotations)", "regulation of ectoderm development (GO:2000383 from GO Biological Process Annotations)", "regulation of ectodermal cell fate specification (GO:0042665 from GO Biological Process Annotations)", "regulation of eif2 alpha phosphorylation by dsrna (GO:0060735 from GO Biological Process Annotations)", "regulation of eif2 alpha phosphorylation by heme (GO:0010999 from GO Biological Process Annotations)", "regulation of elastin biosynthetic process (GO:0051543 from GO Biological Process Annotations)", "regulation of elastin catabolic process (GO:0060310 from GO Biological Process Annotations)", "regulation of embryonic cell shape (GO:0016476 from GO Biological Process Annotations)", "regulation of embryonic development (GO:0045995 from GO Biological Process Annotations)", "regulation of enamel mineralization (GO:0070173 from GO Biological Process Annotations)", "regulation of endocannabinoid signaling pathway (GO:2000124 from GO Biological Process Annotations)", "regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000800 from GO Biological Process Annotations)", "regulation of endocrine process (GO:0044060 from GO Biological Process Annotations)", "regulation of endocytic recycling (GO:2001135 from GO Biological Process Annotations)", "regulation of endocytosis (GO:0030100 from GO Biological Process Annotations)", "regulation of endodeoxyribonuclease activity (GO:0032071 from GO Biological Process Annotations)", "regulation of endodermal cell differentiation (GO:1903224 from GO Biological Process Annotations)", "regulation of endodermal cell fate specification (GO:0042663 from GO Biological Process Annotations)", "regulation of endopeptidase activity (GO:0052548 from GO Biological Process Annotations)", "regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 from GO Biological Process Annotations)", "regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903381 from GO Biological Process Annotations)", "regulation of endoplasmic reticulum tubular network organization (GO:1903371 from GO Biological Process Annotations)", "regulation of endoplasmic reticulum unfolded protein response (GO:1900101 from GO Biological Process Annotations)", "regulation of endoribonuclease activity (GO:0060699 from GO Biological Process Annotations)", "regulation of endosome size (GO:0051036 from GO Biological Process Annotations)", "regulation of endothelial cell apoptotic process (GO:2000351 from GO Biological Process Annotations)", "regulation of endothelial cell chemotaxis (GO:2001026 from GO Biological Process Annotations)", "regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544 from GO Biological Process Annotations)", "regulation of endothelial cell development (GO:1901550 from GO Biological Process Annotations)", "regulation of endothelial cell differentiation (GO:0045601 from GO Biological Process Annotations)", "regulation of endothelial cell migration (GO:0010594 from GO Biological Process Annotations)", "regulation of endothelial cell proliferation (GO:0001936 from GO Biological Process Annotations)", "regulation of endothelial tube morphogenesis (GO:1901509 from GO Biological Process Annotations)", "regulation of energy homeostasis (GO:2000505 from GO Biological Process Annotations)", "regulation of engulfment of apoptotic cell (GO:1901074 from GO Biological Process Annotations)", "regulation of entry of bacterium into host cell (GO:2000535 from GO Biological Process Annotations)", "regulation of eosinophil activation (GO:1902566 from GO Biological Process Annotations)", "regulation of eosinophil chemotaxis (GO:2000422 from GO Biological Process Annotations)", "regulation of eosinophil degranulation (GO:0043309 from GO Biological Process Annotations)", "regulation of eosinophil differentiation (GO:0045643 from GO Biological Process Annotations)", "regulation of eosinophil extravasation (GO:2000419 from GO Biological Process Annotations)", "regulation of eosinophil migration (GO:2000416 from GO Biological Process Annotations)", "regulation of ephrin receptor signaling pathway (GO:1901187 from GO Biological Process Annotations)", "regulation of epidermal cell differentiation (GO:0045604 from GO Biological Process Annotations)", "regulation of epidermal cell division (GO:0010482 from GO Biological Process Annotations)", "regulation of epidermal growth factor receptor signaling pathway (GO:0042058 from GO Biological Process Annotations)", "regulation of epidermal growth factor-activated receptor activity (GO:0007176 from GO Biological Process Annotations)", "regulation of epidermis development (GO:0045682 from GO Biological Process Annotations)", "regulation of epinephrine secretion (GO:0014060 from GO Biological Process Annotations)", "regulation of epithelial cell differentiation (GO:0030856 from GO Biological Process Annotations)", "regulation of epithelial cell differentiation involved in kidney development (GO:2000696 from GO Biological Process Annotations)", "regulation of epithelial cell migration (GO:0010632 from GO Biological Process Annotations)", "regulation of epithelial cell proliferation (GO:0050678 from GO Biological Process Annotations)", "regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000794 from GO Biological Process Annotations)", "regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768 from GO Biological Process Annotations)", "regulation of epithelial to mesenchymal transition (GO:0010717 from GO Biological Process Annotations)", "regulation of er to golgi vesicle-mediated transport (GO:0060628 from GO Biological Process Annotations)", "regulation of er-associated ubiquitin-dependent protein catabolic process (GO:1903069 from GO Biological Process Annotations)", "regulation of erbb signaling pathway (GO:1901184 from GO Biological Process Annotations)", "regulation of erk1 and erk2 cascade (GO:0070372 from GO Biological Process Annotations)", "regulation of erythrocyte aggregation (GO:0034118 from GO Biological Process Annotations)", "regulation of erythrocyte apoptotic process (GO:1902250 from GO Biological Process Annotations)", "regulation of erythrocyte differentiation (GO:0045646 from GO Biological Process Annotations)", "regulation of establishment of blood-brain barrier (GO:0090210 from GO Biological Process Annotations)", "regulation of establishment of cell polarity (GO:2000114 from GO Biological Process Annotations)", "regulation of establishment of endothelial barrier (GO:1903140 from GO Biological Process Annotations)", "regulation of establishment of planar polarity (GO:0090175 from GO Biological Process Annotations)", "regulation of establishment of planar polarity involved in neural tube closure (GO:0090178 from GO Biological Process Annotations)", "regulation of establishment of protein localization (GO:0070201 from GO Biological Process Annotations)", "regulation of establishment of protein localization to chromosome (GO:0070202 from GO Biological Process Annotations)", "regulation of establishment of protein localization to mitochondrion (GO:1903747 from GO Biological Process Annotations)", "regulation of establishment of protein localization to plasma membrane (GO:0090003 from GO Biological Process Annotations)", "regulation of establishment or maintenance of cell polarity (GO:0032878 from GO Biological Process Annotations)", "regulation of estrogen receptor binding (GO:0071898 from GO Biological Process Annotations)", "regulation of excitatory postsynaptic membrane potential (GO:0060079 from GO Biological Process Annotations)", "regulation of excretion (GO:0044062 from GO Biological Process Annotations)", "regulation of execution phase of apoptosis (GO:1900117 from GO Biological Process Annotations)", "regulation of exit from mitosis (GO:0007096 from GO Biological Process Annotations)", "regulation of exo-alpha-sialidase activity (GO:1903015 from GO Biological Process Annotations)", "regulation of exocyst assembly (GO:0001928 from GO Biological Process Annotations)", "regulation of exocyst localization (GO:0060178 from GO Biological Process Annotations)", "regulation of exocytosis (GO:0017157 from GO Biological Process Annotations)", "regulation of exosomal secretion (GO:1903541 from GO Biological Process Annotations)", "regulation of extent of cell growth (GO:0061387 from GO Biological Process Annotations)", "regulation of extracellular matrix assembly (GO:1901201 from GO Biological Process Annotations)", "regulation of extracellular matrix constituent secretion (GO:0003330 from GO Biological Process Annotations)", "regulation of extracellular matrix disassembly (GO:0010715 from GO Biological Process Annotations)", "regulation of extracellular matrix organization (GO:1903053 from GO Biological Process Annotations)", "regulation of extracellular vesicular exosome assembly (GO:1903551 from GO Biological Process Annotations)", "regulation of extrinsic apoptotic signaling pathway (GO:2001236 from GO Biological Process Annotations)", "regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239 from GO Biological Process Annotations)", "regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041 from GO Biological Process Annotations)", "regulation of eye pigmentation (GO:0048073 from GO Biological Process Annotations)", "regulation of fas signaling pathway (GO:1902044 from GO Biological Process Annotations)", "regulation of fasl biosynthetic process (GO:0045219 from GO Biological Process Annotations)", "regulation of fast-twitch skeletal muscle fiber contraction (GO:0031446 from GO Biological Process Annotations)", "regulation of fat cell differentiation (GO:0045598 from GO Biological Process Annotations)", "regulation of fat cell proliferation (GO:0070344 from GO Biological Process Annotations)", "regulation of fatty acid beta-oxidation (GO:0031998 from GO Biological Process Annotations)", "regulation of fatty acid biosynthetic process (GO:0042304 from GO Biological Process Annotations)", "regulation of fatty acid metabolic process (GO:0019217 from GO Biological Process Annotations)", "regulation of fatty acid oxidation (GO:0046320 from GO Biological Process Annotations)", "regulation of fatty acid transport (GO:2000191 from GO Biological Process Annotations)", "regulation of fc receptor mediated stimulatory signaling pathway (GO:0060368 from GO Biological Process Annotations)", "regulation of fear response (GO:1903365 from GO Biological Process Annotations)", "regulation of feeding behavior (GO:0060259 from GO Biological Process Annotations)", "regulation of female gonad development (GO:2000194 from GO Biological Process Annotations)", "regulation of female receptivity (GO:0045924 from GO Biological Process Annotations)", "regulation of fermentation (GO:0043465 from GO Biological Process Annotations)", "regulation of ferrochelatase activity (GO:0010722 from GO Biological Process Annotations)", "regulation of fertilization (GO:0080154 from GO Biological Process Annotations)", "regulation of fever generation (GO:0031620 from GO Biological Process Annotations)", "regulation of fever generation by regulation of prostaglandin secretion (GO:0071810 from GO Biological Process Annotations)", "regulation of fibril organization (GO:1902903 from GO Biological Process Annotations)", "regulation of fibrinolysis (GO:0051917 from GO Biological Process Annotations)", "regulation of fibroblast apoptotic process (GO:2000269 from GO Biological Process Annotations)", "regulation of fibroblast growth factor production (GO:0090270 from GO Biological Process Annotations)", "regulation of fibroblast growth factor receptor signaling pathway (GO:0040036 from GO Biological Process Annotations)", "regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior|posterior pattern formation (GO:2000313 from GO Biological Process Annotations)", "regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000702 from GO Biological Process Annotations)", "regulation of fibroblast migration (GO:0010762 from GO Biological Process Annotations)", "regulation of fibroblast proliferation (GO:0048145 from GO Biological Process Annotations)", "regulation of fibronectin-dependent thymocyte migration (GO:2000413 from GO Biological Process Annotations)", "regulation of filopodium assembly (GO:0051489 from GO Biological Process Annotations)", "regulation of focal adhesion assembly (GO:0051893 from GO Biological Process Annotations)", "regulation of follicle-stimulating hormone secretion (GO:0046880 from GO Biological Process Annotations)", "regulation of forebrain neuron differentiation (GO:2000977 from GO Biological Process Annotations)", "regulation of formation of translation preinitiation complex (GO:1901193 from GO Biological Process Annotations)", "regulation of fractalkine biosynthetic process (GO:0050752 from GO Biological Process Annotations)", "regulation of fractalkine production (GO:0032644 from GO Biological Process Annotations)", "regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060549 from GO Biological Process Annotations)", "regulation of fructose 1,6-bisphosphate metabolic process (GO:0060551 from GO Biological Process Annotations)", "regulation of fusion of sperm to egg plasma membrane (GO:0043012 from GO Biological Process Annotations)", "regulation of g-protein activated inward rectifier potassium channel activity (GO:1900128 from GO Biological Process Annotations)", "regulation of g-protein coupled receptor protein signaling pathway (GO:0008277 from GO Biological Process Annotations)", "regulation of g0 to g1 transition (GO:0070316 from GO Biological Process Annotations)", "regulation of g1|s transition of mitotic cell cycle (GO:2000045 from GO Biological Process Annotations)", "regulation of g2|m transition of mitotic cell cycle (GO:0010389 from GO Biological Process Annotations)", "regulation of gamma-aminobutyric acid secretion (GO:0014052 from GO Biological Process Annotations)", "regulation of gamma-delta t cell activation (GO:0046643 from GO Biological Process Annotations)", "regulation of gamma-delta t cell activation involved in immune response (GO:2001191 from GO Biological Process Annotations)", "regulation of gamma-delta t cell differentiation (GO:0045586 from GO Biological Process Annotations)", "regulation of gap junction assembly (GO:1903596 from GO Biological Process Annotations)", "regulation of gastric acid secretion (GO:0060453 from GO Biological Process Annotations)", "regulation of gastrulation (GO:0010470 from GO Biological Process Annotations)", "regulation of gene expression (GO:0010468 from GO Biological Process Annotations)", "regulation of gene expression by genetic imprinting (GO:0006349 from GO Biological Process Annotations)", "regulation of gene expression, epigenetic (GO:0040029 from GO Biological Process Annotations)", "regulation of gene silencing (GO:0060968 from GO Biological Process Annotations)", "regulation of gene silencing by mirna (GO:0060964 from GO Biological Process Annotations)", "regulation of gene silencing by rna (GO:0060966 from GO Biological Process Annotations)", "regulation of generation of l-type calcium current (GO:1902514 from GO Biological Process Annotations)", "regulation of generation of precursor metabolites and energy (GO:0043467 from GO Biological Process Annotations)", "regulation of genetic imprinting (GO:2000653 from GO Biological Process Annotations)", "regulation of germinal center formation (GO:0002634 from GO Biological Process Annotations)", "regulation of glial cell apoptotic process (GO:0034350 from GO Biological Process Annotations)", "regulation of glial cell differentiation (GO:0045685 from GO Biological Process Annotations)", "regulation of glial cell line-derived neurotrophic factor secretion (GO:1900166 from GO Biological Process Annotations)", "regulation of glial cell proliferation (GO:0060251 from GO Biological Process Annotations)", "regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000733 from GO Biological Process Annotations)", "regulation of gliogenesis (GO:0014013 from GO Biological Process Annotations)", "regulation of glomerular filtration (GO:0003093 from GO Biological Process Annotations)", "regulation of glomerular mesangial cell proliferation (GO:0072124 from GO Biological Process Annotations)", "regulation of glomerulus development (GO:0090192 from GO Biological Process Annotations)", "regulation of glucagon secretion (GO:0070092 from GO Biological Process Annotations)", "regulation of glucan biosynthetic process (GO:0010962 from GO Biological Process Annotations)", "regulation of glucocorticoid biosynthetic process (GO:0031946 from GO Biological Process Annotations)", "regulation of glucocorticoid mediated signaling pathway (GO:1900169 from GO Biological Process Annotations)", "regulation of glucocorticoid metabolic process (GO:0031943 from GO Biological Process Annotations)", "regulation of glucocorticoid receptor signaling pathway (GO:2000322 from GO Biological Process Annotations)", "regulation of glucocorticoid secretion (GO:2000849 from GO Biological Process Annotations)", "regulation of glucokinase activity (GO:0033131 from GO Biological Process Annotations)", "regulation of gluconeogenesis (GO:0006111 from GO Biological Process Annotations)", "regulation of gluconeogenesis by regulation of transcription from rna polymerase ii promoter (GO:0035947 from GO Biological Process Annotations)", "regulation of gluconeogenesis involved in cellular glucose homeostasis (GO:0090526 from GO Biological Process Annotations)", "regulation of glucose import (GO:0046324 from GO Biological Process Annotations)", "regulation of glucose import in response to insulin stimulus (GO:2001273 from GO Biological Process Annotations)", "regulation of glucose metabolic process (GO:0010906 from GO Biological Process Annotations)", "regulation of glucose transport (GO:0010827 from GO Biological Process Annotations)", "regulation of glucosylceramide biosynthetic process (GO:0046317 from GO Biological Process Annotations)", "regulation of glucosylceramide catabolic process (GO:2000752 from GO Biological Process Annotations)", "regulation of glutamate metabolic process (GO:2000211 from GO Biological Process Annotations)", "regulation of glutamate receptor signaling pathway (GO:1900449 from GO Biological Process Annotations)", "regulation of glutamate secretion (GO:0014048 from GO Biological Process Annotations)", "regulation of glutamate secretion, neurotransmission (GO:1903294 from GO Biological Process Annotations)", "regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051946 from GO Biological Process Annotations)", "regulation of glutamate-cysteine ligase activity (GO:0035227 from GO Biological Process Annotations)", "regulation of glutamine family amino acid metabolic process (GO:0000820 from GO Biological Process Annotations)", "regulation of glutamine transport (GO:2000485 from GO Biological Process Annotations)", "regulation of glutathione peroxidase activity (GO:1903282 from GO Biological Process Annotations)", "regulation of glycogen (starch) synthase activity (GO:2000465 from GO Biological Process Annotations)", "regulation of glycogen biosynthetic process (GO:0005979 from GO Biological Process Annotations)", "regulation of glycogen catabolic process (GO:0005981 from GO Biological Process Annotations)", "regulation of glycogen metabolic process (GO:0070873 from GO Biological Process Annotations)", "regulation of glycolytic by positive regulation of transcription from rna polymerase ii promoter (GO:0072363 from GO Biological Process Annotations)", "regulation of glycolytic process (GO:0006110 from GO Biological Process Annotations)", "regulation of glycolytic process by negative regulation of transcription from rna polymerase ii promoter (GO:0072362 from GO Biological Process Annotations)", "regulation of glycolytic process by regulation of transcription from rna polymerase ii promoter (GO:0072361 from GO Biological Process Annotations)", "regulation of glycoprotein biosynthetic process (GO:0010559 from GO Biological Process Annotations)", "regulation of glycoprotein metabolic process (GO:1903018 from GO Biological Process Annotations)", "regulation of golgi inheritance (GO:0090170 from GO Biological Process Annotations)", "regulation of golgi organization (GO:1903358 from GO Biological Process Annotations)", "regulation of golgi to plasma membrane cftr protein transport (GO:0042999 from GO Biological Process Annotations)", "regulation of golgi to plasma membrane protein transport (GO:0042996 from GO Biological Process Annotations)", "regulation of gonadotropin secretion (GO:0032276 from GO Biological Process Annotations)", "regulation of granulocyte chemotaxis (GO:0071622 from GO Biological Process Annotations)", "regulation of granulocyte colony-stimulating factor production (GO:0071655 from GO Biological Process Annotations)", "regulation of granulocyte differentiation (GO:0030852 from GO Biological Process Annotations)", "regulation of granulocyte macrophage colony-stimulating factor biosynthetic process (GO:0045423 from GO Biological Process Annotations)", "regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645 from GO Biological Process Annotations)", "regulation of granzyme a production (GO:2000511 from GO Biological Process Annotations)", "regulation of granzyme b production (GO:0071661 from GO Biological Process Annotations)", "regulation of grooming behavior (GO:2000821 from GO Biological Process Annotations)", "regulation of growth (GO:0040008 from GO Biological Process Annotations)", "regulation of growth hormone receptor signaling pathway (GO:0060398 from GO Biological Process Annotations)", "regulation of growth hormone secretion (GO:0060123 from GO Biological Process Annotations)", "regulation of growth of symbiont in host (GO:0044126 from GO Biological Process Annotations)", "regulation of growth plate cartilage chondrocyte proliferation (GO:0003420 from GO Biological Process Annotations)", "regulation of growth rate (GO:0040009 from GO Biological Process Annotations)", "regulation of gtp cyclohydrolase i activity (GO:0043095 from GO Biological Process Annotations)", "regulation of gtpase activity (GO:0043087 from GO Biological Process Annotations)", "regulation of guanylate cyclase activity (GO:0031282 from GO Biological Process Annotations)", "regulation of hair cycle (GO:0042634 from GO Biological Process Annotations)", "regulation of hair cycle by canonical wnt signaling pathway (GO:0060901 from GO Biological Process Annotations)", "regulation of hair follicle cell proliferation (GO:0071336 from GO Biological Process Annotations)", "regulation of hair follicle development (GO:0051797 from GO Biological Process Annotations)", "regulation of hair follicle maturation (GO:0048819 from GO Biological Process Annotations)", "regulation of heart contraction (GO:0008016 from GO Biological Process Annotations)", "regulation of heart growth (GO:0060420 from GO Biological Process Annotations)", "regulation of heart induction (GO:0090381 from GO Biological Process Annotations)", "regulation of heart induction by regulation of canonical wnt signaling pathway (GO:0090081 from GO Biological Process Annotations)", "regulation of heart looping (GO:1901207 from GO Biological Process Annotations)", "regulation of heart morphogenesis (GO:2000826 from GO Biological Process Annotations)", "regulation of heart rate (GO:0002027 from GO Biological Process Annotations)", "regulation of heart rate by cardiac conduction (GO:0086091 from GO Biological Process Annotations)", "regulation of heart rate by chemical signal (GO:0003062 from GO Biological Process Annotations)", "regulation of heart rate by hormone (GO:0003064 from GO Biological Process Annotations)", "regulation of heat generation (GO:0031650 from GO Biological Process Annotations)", "regulation of helicase activity (GO:0051095 from GO Biological Process Annotations)", "regulation of hematopoietic progenitor cell differentiation (GO:1901532 from GO Biological Process Annotations)", "regulation of hematopoietic stem cell differentiation (GO:1902036 from GO Biological Process Annotations)", "regulation of hematopoietic stem cell migration (GO:2000471 from GO Biological Process Annotations)", "regulation of hematopoietic stem cell proliferation (GO:1902033 from GO Biological Process Annotations)", "regulation of hemoglobin biosynthetic process (GO:0046984 from GO Biological Process Annotations)", "regulation of hemopoiesis (GO:1903706 from GO Biological Process Annotations)", "regulation of hemostasis (GO:1900046 from GO Biological Process Annotations)", "regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010908 from GO Biological Process Annotations)", "regulation of hepatic stellate cell activation (GO:2000489 from GO Biological Process Annotations)", "regulation of hepatocyte differentiation (GO:0070366 from GO Biological Process Annotations)", "regulation of hepatocyte growth factor biosynthetic process (GO:0048176 from GO Biological Process Annotations)", "regulation of hepatocyte growth factor production (GO:0032646 from GO Biological Process Annotations)", "regulation of hepatocyte growth factor receptor signaling pathway (GO:1902202 from GO Biological Process Annotations)", "regulation of hepatocyte proliferation (GO:2000345 from GO Biological Process Annotations)", "regulation of heterochromatin assembly (GO:0031445 from GO Biological Process Annotations)", "regulation of heterotypic cell-cell adhesion (GO:0034114 from GO Biological Process Annotations)", "regulation of hexokinase activity (GO:1903299 from GO Biological Process Annotations)", "regulation of high voltage-gated calcium channel activity (GO:1901841 from GO Biological Process Annotations)", "regulation of high-density lipoprotein particle assembly (GO:0090107 from GO Biological Process Annotations)", "regulation of high-density lipoprotein particle clearance (GO:0010982 from GO Biological Process Annotations)", "regulation of hindgut contraction (GO:0043134 from GO Biological Process Annotations)", "regulation of hippo signaling (GO:0035330 from GO Biological Process Annotations)", "regulation of histamine secretion by mast cell (GO:1903593 from GO Biological Process Annotations)", "regulation of histone acetylation (GO:0035065 from GO Biological Process Annotations)", "regulation of histone deacetylase activity (GO:1901725 from GO Biological Process Annotations)", "regulation of histone deacetylation (GO:0031063 from GO Biological Process Annotations)", "regulation of histone deubiquitination (GO:1903584 from GO Biological Process Annotations)", "regulation of histone h2a k63-linked ubiquitination (GO:1901314 from GO Biological Process Annotations)", "regulation of histone h2b ubiquitination (GO:2001166 from GO Biological Process Annotations)", "regulation of histone h3-k14 acetylation (GO:0071440 from GO Biological Process Annotations)", "regulation of histone h3-k27 acetylation (GO:1901674 from GO Biological Process Annotations)", "regulation of histone h3-k27 methylation (GO:0061085 from GO Biological Process Annotations)", "regulation of histone h3-k27 trimethylation (GO:1902464 from GO Biological Process Annotations)", "regulation of histone h3-k36 methylation (GO:0000414 from GO Biological Process Annotations)", "regulation of histone h3-k36 trimethylation (GO:2001253 from GO Biological Process Annotations)", "regulation of histone h3-k4 methylation (GO:0051569 from GO Biological Process Annotations)", "regulation of histone h3-k79 methylation (GO:2001160 from GO Biological Process Annotations)", "regulation of histone h3-k9 acetylation (GO:2000615 from GO Biological Process Annotations)", "regulation of histone h3-k9 dimethylation (GO:1900109 from GO Biological Process Annotations)", "regulation of histone h3-k9 methylation (GO:0051570 from GO Biological Process Annotations)", "regulation of histone h3-k9 trimethylation (GO:1900112 from GO Biological Process Annotations)", "regulation of histone h4 acetylation (GO:0090239 from GO Biological Process Annotations)", "regulation of histone h4-k16 acetylation (GO:2000618 from GO Biological Process Annotations)", "regulation of histone h4-k20 methylation (GO:0070510 from GO Biological Process Annotations)", "regulation of histone methylation (GO:0031060 from GO Biological Process Annotations)", "regulation of histone modification (GO:0031056 from GO Biological Process Annotations)", "regulation of histone phosphorylation (GO:0033127 from GO Biological Process Annotations)", "regulation of histone ubiquitination (GO:0033182 from GO Biological Process Annotations)", "regulation of homeostatic process (GO:0032844 from GO Biological Process Annotations)", "regulation of homocysteine metabolic process (GO:0050666 from GO Biological Process Annotations)", "regulation of homologous chromosome segregation (GO:0060629 from GO Biological Process Annotations)", "regulation of homophilic cell adhesion (GO:1903385 from GO Biological Process Annotations)", "regulation of homotypic cell-cell adhesion (GO:0034110 from GO Biological Process Annotations)", "regulation of hormone biosynthetic process (GO:0046885 from GO Biological Process Annotations)", "regulation of hormone levels (GO:0010817 from GO Biological Process Annotations)", "regulation of hormone metabolic process (GO:0032350 from GO Biological Process Annotations)", "regulation of hormone secretion (GO:0046883 from GO Biological Process Annotations)", "regulation of humoral immune response (GO:0002920 from GO Biological Process Annotations)", "regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923 from GO Biological Process Annotations)", "regulation of hyaluranon cable assembly (GO:1900104 from GO Biological Process Annotations)", "regulation of hyaluronan biosynthetic process (GO:1900125 from GO Biological Process Annotations)", "regulation of hydrogen peroxide biosynthetic process (GO:0010728 from GO Biological Process Annotations)", "regulation of hydrogen peroxide catabolic process (GO:2000295 from GO Biological Process Annotations)", "regulation of hydrogen peroxide metabolic process (GO:0010310 from GO Biological Process Annotations)", "regulation of hydrogen peroxide-induced cell death (GO:1903205 from GO Biological Process Annotations)", "regulation of hydrogen peroxide-induced neuron death (GO:1903207 from GO Biological Process Annotations)", "regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903383 from GO Biological Process Annotations)", "regulation of hydrogen peroxide-mediated programmed cell death (GO:1901298 from GO Biological Process Annotations)", "regulation of hydrolase activity (GO:0051336 from GO Biological Process Annotations)", "regulation of hypersensitivity (GO:0002883 from GO Biological Process Annotations)", "regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903297 from GO Biological Process Annotations)", "regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902071 from GO Biological Process Annotations)", "regulation of i-kappab kinase|nf-kappab signaling (GO:0043122 from GO Biological Process Annotations)", "regulation of i-kappab phosphorylation (GO:1903719 from GO Biological Process Annotations)", "regulation of icosanoid secretion (GO:0032303 from GO Biological Process Annotations)", "regulation of immature t cell proliferation (GO:0033083 from GO Biological Process Annotations)", "regulation of immature t cell proliferation in thymus (GO:0033084 from GO Biological Process Annotations)", "regulation of immune complex clearance by monocytes and macrophages (GO:0090264 from GO Biological Process Annotations)", "regulation of immune effector process (GO:0002697 from GO Biological Process Annotations)", "regulation of immune response (GO:0050776 from GO Biological Process Annotations)", "regulation of immune response to tumor cell (GO:0002837 from GO Biological Process Annotations)", "regulation of immune system process (GO:0002682 from GO Biological Process Annotations)", "regulation of immunoglobulin biosynthetic process (GO:0002640 from GO Biological Process Annotations)", "regulation of immunoglobulin mediated immune response (GO:0002889 from GO Biological Process Annotations)", "regulation of immunoglobulin production (GO:0002637 from GO Biological Process Annotations)", "regulation of immunoglobulin production in mucosal tissue (GO:2000557 from GO Biological Process Annotations)", "regulation of immunoglobulin secretion (GO:0051023 from GO Biological Process Annotations)", "regulation of immunological synapse formation (GO:2000520 from GO Biological Process Annotations)", "regulation of inclusion body assembly (GO:0090083 from GO Biological Process Annotations)", "regulation of inflammatory response (GO:0050727 from GO Biological Process Annotations)", "regulation of inflammatory response to antigenic stimulus (GO:0002861 from GO Biological Process Annotations)", "regulation of inhibitory postsynaptic membrane potential (GO:0060080 from GO Biological Process Annotations)", "regulation of innate immune response (GO:0045088 from GO Biological Process Annotations)", "regulation of inner ear receptor cell differentiation (GO:2000980 from GO Biological Process Annotations)", "regulation of inorganic anion transmembrane transport (GO:1903795 from GO Biological Process Annotations)", "regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031585 from GO Biological Process Annotations)", "regulation of inositol phosphate biosynthetic process (GO:0010919 from GO Biological Process Annotations)", "regulation of inositol trisphosphate biosynthetic process (GO:0032960 from GO Biological Process Annotations)", "regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010924 from GO Biological Process Annotations)", "regulation of insulin receptor signaling pathway (GO:0046626 from GO Biological Process Annotations)", "regulation of insulin secretion (GO:0050796 from GO Biological Process Annotations)", "regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178 from GO Biological Process Annotations)", "regulation of insulin-like growth factor receptor signaling pathway (GO:0043567 from GO Biological Process Annotations)", "regulation of integrin activation (GO:0033623 from GO Biological Process Annotations)", "regulation of integrin biosynthetic process (GO:0045113 from GO Biological Process Annotations)", "regulation of integrin-mediated signaling pathway (GO:2001044 from GO Biological Process Annotations)", "regulation of interferon-alpha biosynthetic process (GO:0045354 from GO Biological Process Annotations)", "regulation of interferon-alpha production (GO:0032647 from GO Biological Process Annotations)", "regulation of interferon-beta biosynthetic process (GO:0045357 from GO Biological Process Annotations)", "regulation of interferon-beta production (GO:0032648 from GO Biological Process Annotations)", "regulation of interferon-beta secretion (GO:0035547 from GO Biological Process Annotations)", "regulation of interferon-gamma biosynthetic process (GO:0045072 from GO Biological Process Annotations)", "regulation of interferon-gamma production (GO:0032649 from GO Biological Process Annotations)", "regulation of interferon-gamma secretion (GO:1902713 from GO Biological Process Annotations)", "regulation of interferon-gamma-mediated signaling pathway (GO:0060334 from GO Biological Process Annotations)", "regulation of interleukin-1 alpha biosynthetic process (GO:0050721 from GO Biological Process Annotations)", "regulation of interleukin-1 alpha production (GO:0032650 from GO Biological Process Annotations)", "regulation of interleukin-1 alpha secretion (GO:0050705 from GO Biological Process Annotations)", "regulation of interleukin-1 beta biosynthetic process (GO:0050722 from GO Biological Process Annotations)", "regulation of interleukin-1 beta production (GO:0032651 from GO Biological Process Annotations)", "regulation of interleukin-1 beta secretion (GO:0050706 from GO Biological Process Annotations)", "regulation of interleukin-1 biosynthetic process (GO:0045360 from GO Biological Process Annotations)", "regulation of interleukin-1 production (GO:0032652 from GO Biological Process Annotations)", "regulation of interleukin-1 secretion (GO:0050704 from GO Biological Process Annotations)", "regulation of interleukin-1-mediated signaling pathway (GO:2000659 from GO Biological Process Annotations)", "regulation of interleukin-10 biosynthetic process (GO:0045074 from GO Biological Process Annotations)", "regulation of interleukin-10 production (GO:0032653 from GO Biological Process Annotations)", "regulation of interleukin-10 secretion (GO:2001179 from GO Biological Process Annotations)", "regulation of interleukin-12 biosynthetic process (GO:0045075 from GO Biological Process Annotations)", "regulation of interleukin-12 production (GO:0032655 from GO Biological Process Annotations)", "regulation of interleukin-12 secretion (GO:2001182 from GO Biological Process Annotations)", "regulation of interleukin-13 biosynthetic process (GO:0045366 from GO Biological Process Annotations)", "regulation of interleukin-13 production (GO:0032656 from GO Biological Process Annotations)", "regulation of interleukin-13 secretion (GO:2000665 from GO Biological Process Annotations)", "regulation of interleukin-15 production (GO:0032658 from GO Biological Process Annotations)", "regulation of interleukin-17 production (GO:0032660 from GO Biological Process Annotations)", "regulation of interleukin-18 biosynthetic process (GO:0045381 from GO Biological Process Annotations)", "regulation of interleukin-18 production (GO:0032661 from GO Biological Process Annotations)", "regulation of interleukin-2 biosynthetic process (GO:0045076 from GO Biological Process Annotations)", "regulation of interleukin-2 production (GO:0032663 from GO Biological Process Annotations)", "regulation of interleukin-2 secretion (GO:1900040 from GO Biological Process Annotations)", "regulation of interleukin-2-mediated signaling pathway (GO:1902205 from GO Biological Process Annotations)", "regulation of interleukin-23 production (GO:0032667 from GO Biological Process Annotations)", "regulation of interleukin-3 biosynthetic process (GO:0045399 from GO Biological Process Annotations)", "regulation of interleukin-3 production (GO:0032672 from GO Biological Process Annotations)", "regulation of interleukin-4 biosynthetic process (GO:0045402 from GO Biological Process Annotations)", "regulation of interleukin-4 production (GO:0032673 from GO Biological Process Annotations)", "regulation of interleukin-4-dependent isotype switching to ige isotypes (GO:2000571 from GO Biological Process Annotations)", "regulation of interleukin-4-mediated signaling pathway (GO:1902214 from GO Biological Process Annotations)", "regulation of interleukin-5 biosynthetic process (GO:0045405 from GO Biological Process Annotations)", "regulation of interleukin-5 production (GO:0032674 from GO Biological Process Annotations)", "regulation of interleukin-5 secretion (GO:2000662 from GO Biological Process Annotations)", "regulation of interleukin-6 biosynthetic process (GO:0045408 from GO Biological Process Annotations)", "regulation of interleukin-6 production (GO:0032675 from GO Biological Process Annotations)", "regulation of interleukin-6-mediated signaling pathway (GO:0070103 from GO Biological Process Annotations)", "regulation of interleukin-8 biosynthetic process (GO:0045414 from GO Biological Process Annotations)", "regulation of interleukin-8 production (GO:0032677 from GO Biological Process Annotations)", "regulation of interleukin-8 secretion (GO:2000482 from GO Biological Process Annotations)", "regulation of intermediate filament depolymerization (GO:0030842 from GO Biological Process Annotations)", "regulation of intermediate filament polymerization or depolymerization (GO:0045108 from GO Biological Process Annotations)", "regulation of intestinal cholesterol absorption (GO:0030300 from GO Biological Process Annotations)", "regulation of intestinal epithelial structure maintenance (GO:0060730 from GO Biological Process Annotations)", "regulation of intracellular calcium activated chloride channel activity (GO:1902938 from GO Biological Process Annotations)", "regulation of intracellular cholesterol transport (GO:0032383 from GO Biological Process Annotations)", "regulation of intracellular estrogen receptor signaling pathway (GO:0033146 from GO Biological Process Annotations)", "regulation of intracellular lipid transport (GO:0032377 from GO Biological Process Annotations)", "regulation of intracellular ph (GO:0051453 from GO Biological Process Annotations)", "regulation of intracellular protein transport (GO:0033157 from GO Biological Process Annotations)", "regulation of intracellular signal transduction (GO:1902531 from GO Biological Process Annotations)", "regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143 from GO Biological Process Annotations)", "regulation of intracellular sterol transport (GO:0032380 from GO Biological Process Annotations)", "regulation of intracellular transport (GO:0032386 from GO Biological Process Annotations)", "regulation of intracellular transport of viral material (GO:1901252 from GO Biological Process Annotations)", "regulation of intrinsic apoptotic signaling pathway (GO:2001242 from GO Biological Process Annotations)", "regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253 from GO Biological Process Annotations)", "regulation of intrinsic apoptotic signaling pathway in response to dna damage (GO:1902229 from GO Biological Process Annotations)", "regulation of intrinsic apoptotic signaling pathway in response to dna damage by p53 class mediator (GO:1902165 from GO Biological Process Annotations)", "regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903750 from GO Biological Process Annotations)", "regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902218 from GO Biological Process Annotations)", "regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902238 from GO Biological Process Annotations)", "regulation of inward rectifier potassium channel activity (GO:1901979 from GO Biological Process Annotations)", "regulation of ion homeostasis (GO:2000021 from GO Biological Process Annotations)", "regulation of ion transmembrane transport (GO:0034765 from GO Biological Process Annotations)", "regulation of ion transmembrane transporter activity (GO:0032412 from GO Biological Process Annotations)", "regulation of ion transport (GO:0043269 from GO Biological Process Annotations)", "regulation of ip-10 production (GO:0071658 from GO Biological Process Annotations)", "regulation of isomerase activity (GO:0010911 from GO Biological Process Annotations)", "regulation of isoprenoid metabolic process (GO:0019747 from GO Biological Process Annotations)", "regulation of isotype switching (GO:0045191 from GO Biological Process Annotations)", "regulation of isotype switching to iga isotypes (GO:0048296 from GO Biological Process Annotations)", "regulation of isotype switching to ige isotypes (GO:0048293 from GO Biological Process Annotations)", "regulation of isotype switching to igg isotypes (GO:0048302 from GO Biological Process Annotations)", "regulation of jak-stat cascade (GO:0046425 from GO Biological Process Annotations)", "regulation of jnk cascade (GO:0046328 from GO Biological Process Annotations)", "regulation of jun kinase activity (GO:0043506 from GO Biological Process Annotations)", "regulation of kainate selective glutamate receptor activity (GO:2000312 from GO Biological Process Annotations)", "regulation of keratinocyte apoptotic process (GO:1902172 from GO Biological Process Annotations)", "regulation of keratinocyte differentiation (GO:0045616 from GO Biological Process Annotations)", "regulation of keratinocyte migration (GO:0051547 from GO Biological Process Annotations)", "regulation of keratinocyte proliferation (GO:0010837 from GO Biological Process Annotations)", "regulation of ketone biosynthetic process (GO:0010566 from GO Biological Process Annotations)", "regulation of kidney development (GO:0090183 from GO Biological Process Annotations)", "regulation of kidney size (GO:0035564 from GO Biological Process Annotations)", "regulation of kidney smooth muscle cell differentiation (GO:2000356 from GO Biological Process Annotations)", "regulation of killing of cells of other organism (GO:0051709 from GO Biological Process Annotations)", "regulation of kinase activity (GO:0043549 from GO Biological Process Annotations)", "regulation of kinetochore assembly (GO:0090234 from GO Biological Process Annotations)", "regulation of kit signaling pathway (GO:1900234 from GO Biological Process Annotations)", "regulation of l-arginine import (GO:0010963 from GO Biological Process Annotations)", "regulation of l-dopa biosynthetic process (GO:1903195 from GO Biological Process Annotations)", "regulation of l-dopa decarboxylase activity (GO:1903198 from GO Biological Process Annotations)", "regulation of l-glutamate import (GO:1900920 from GO Biological Process Annotations)", "regulation of l-glutamate transport (GO:0002036 from GO Biological Process Annotations)", "regulation of lactation (GO:1903487 from GO Biological Process Annotations)", "regulation of lamellipodium assembly (GO:0010591 from GO Biological Process Annotations)", "regulation of lamellipodium morphogenesis (GO:2000392 from GO Biological Process Annotations)", "regulation of lamellipodium organization (GO:1902743 from GO Biological Process Annotations)", "regulation of large conductance calcium-activated potassium channel activity (GO:1902606 from GO Biological Process Annotations)", "regulation of late endosome to lysosome transport (GO:1902822 from GO Biological Process Annotations)", "regulation of lateral mesodermal cell fate specification (GO:0048378 from GO Biological Process Annotations)", "regulation of lateral motor column neuron migration (GO:1902076 from GO Biological Process Annotations)", "regulation of lateral pseudopodium assembly (GO:0031275 from GO Biological Process Annotations)", "regulation of lens epithelial cell proliferation (GO:2001109 from GO Biological Process Annotations)", "regulation of leukocyte activation (GO:0002694 from GO Biological Process Annotations)", "regulation of leukocyte apoptotic process (GO:2000106 from GO Biological Process Annotations)", "regulation of leukocyte cell-cell adhesion (GO:1903037 from GO Biological Process Annotations)", "regulation of leukocyte chemotaxis (GO:0002688 from GO Biological Process Annotations)", "regulation of leukocyte degranulation (GO:0043300 from GO Biological Process Annotations)", "regulation of leukocyte differentiation (GO:1902105 from GO Biological Process Annotations)", "regulation of leukocyte mediated cytotoxicity (GO:0001910 from GO Biological Process Annotations)", "regulation of leukocyte mediated immunity (GO:0002703 from GO Biological Process Annotations)", "regulation of leukocyte migration (GO:0002685 from GO Biological Process Annotations)", "regulation of leukocyte proliferation (GO:0070663 from GO Biological Process Annotations)", "regulation of leukocyte tethering or rolling (GO:1903236 from GO Biological Process Annotations)", "regulation of leukotriene production involved in inflammatory response (GO:0035490 from GO Biological Process Annotations)", "regulation of ligand-dependent nuclear receptor transcription coactivator activity (GO:2000325 from GO Biological Process Annotations)", "regulation of ligase activity (GO:0051340 from GO Biological Process Annotations)", "regulation of lipase activity (GO:0060191 from GO Biological Process Annotations)", "regulation of lipid binding (GO:1900130 from GO Biological Process Annotations)", "regulation of lipid biosynthetic process (GO:0046890 from GO Biological Process Annotations)", "regulation of lipid catabolic process (GO:0050994 from GO Biological Process Annotations)", "regulation of lipid kinase activity (GO:0043550 from GO Biological Process Annotations)", "regulation of lipid metabolic process (GO:0019216 from GO Biological Process Annotations)", "regulation of lipid storage (GO:0010883 from GO Biological Process Annotations)", "regulation of lipid transport (GO:0032368 from GO Biological Process Annotations)", "regulation of lipid transport across blood brain barrier (GO:1903000 from GO Biological Process Annotations)", "regulation of lipid transport by negative regulation of transcription from rna polymerase ii promoter (GO:0072368 from GO Biological Process Annotations)", "regulation of lipid transport by positive regulation of transcription from rna polymerase ii promoter (GO:0072369 from GO Biological Process Annotations)", "regulation of lipid transport by regulation of transcription from rna polymerase ii promoter (GO:0072367 from GO Biological Process Annotations)", "regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664 from GO Biological Process Annotations)", "regulation of lipoprotein lipase activity (GO:0051004 from GO Biological Process Annotations)", "regulation of lipoprotein lipid oxidation (GO:0060587 from GO Biological Process Annotations)", "regulation of lipoprotein metabolic process (GO:0050746 from GO Biological Process Annotations)", "regulation of lipoprotein oxidation (GO:0034442 from GO Biological Process Annotations)", "regulation of lipoprotein particle clearance (GO:0010984 from GO Biological Process Annotations)", "regulation of liquid surface tension (GO:0050828 from GO Biological Process Annotations)", "regulation of localization (GO:0032879 from GO Biological Process Annotations)", "regulation of locomotion (GO:0040012 from GO Biological Process Annotations)", "regulation of locomotion involved in locomotory behavior (GO:0090325 from GO Biological Process Annotations)", "regulation of long term synaptic depression (GO:1900452 from GO Biological Process Annotations)", "regulation of long-term neuronal synaptic plasticity (GO:0048169 from GO Biological Process Annotations)", "regulation of long-term synaptic potentiation (GO:1900271 from GO Biological Process Annotations)", "regulation of low-density lipoprotein particle clearance (GO:0010988 from GO Biological Process Annotations)", "regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714 from GO Biological Process Annotations)", "regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803 from GO Biological Process Annotations)", "regulation of lung blood pressure (GO:0014916 from GO Biological Process Annotations)", "regulation of lung ciliated cell differentiation (GO:1901246 from GO Biological Process Annotations)", "regulation of lung goblet cell differentiation (GO:1901249 from GO Biological Process Annotations)", "regulation of luteinizing hormone secretion (GO:0033684 from GO Biological Process Annotations)", "regulation of lyase activity (GO:0051339 from GO Biological Process Annotations)", "regulation of lymphangiogenesis (GO:1901490 from GO Biological Process Annotations)", "regulation of lymphocyte activation (GO:0051249 from GO Biological Process Annotations)", "regulation of lymphocyte anergy (GO:0002911 from GO Biological Process Annotations)", "regulation of lymphocyte apoptotic process (GO:0070228 from GO Biological Process Annotations)", "regulation of lymphocyte chemotaxis (GO:1901623 from GO Biological Process Annotations)", "regulation of lymphocyte differentiation (GO:0045619 from GO Biological Process Annotations)", "regulation of lymphocyte mediated immunity (GO:0002706 from GO Biological Process Annotations)", "regulation of lymphocyte migration (GO:2000401 from GO Biological Process Annotations)", "regulation of lymphocyte proliferation (GO:0050670 from GO Biological Process Annotations)", "regulation of lymphotoxin a biosynthetic process (GO:0043016 from GO Biological Process Annotations)", "regulation of lymphotoxin a production (GO:0032681 from GO Biological Process Annotations)", "regulation of lysosomal lumen ph (GO:0035751 from GO Biological Process Annotations)", "regulation of lysosomal membrane permeability (GO:0097213 from GO Biological Process Annotations)", "regulation of macroautophagy (GO:0016241 from GO Biological Process Annotations)", "regulation of macromitophagy (GO:1901524 from GO Biological Process Annotations)", "regulation of macromolecule biosynthetic process (GO:0010556 from GO Biological Process Annotations)", "regulation of macromolecule metabolic process (GO:0060255 from GO Biological Process Annotations)", "regulation of macrophage activation (GO:0043030 from GO Biological Process Annotations)", "regulation of macrophage apoptotic process (GO:2000109 from GO Biological Process Annotations)", "regulation of macrophage chemotaxis (GO:0010758 from GO Biological Process Annotations)", "regulation of macrophage colony-stimulating factor production (GO:1901256 from GO Biological Process Annotations)", "regulation of macrophage colony-stimulating factor signaling pathway (GO:1902226 from GO Biological Process Annotations)", "regulation of macrophage cytokine production (GO:0010935 from GO Biological Process Annotations)", "regulation of macrophage derived foam cell differentiation (GO:0010743 from GO Biological Process Annotations)", "regulation of macrophage differentiation (GO:0045649 from GO Biological Process Annotations)", "regulation of macrophage fusion (GO:0034239 from GO Biological Process Annotations)", "regulation of macrophage inflammatory protein 1 alpha production (GO:0071640 from GO Biological Process Annotations)", "regulation of macrophage migration inhibitory factor signaling pathway (GO:2000446 from GO Biological Process Annotations)", "regulation of macrophage tolerance induction (GO:0010932 from GO Biological Process Annotations)", "regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182 from GO Biological Process Annotations)", "regulation of maintenance of sister chromatid cohesion (GO:0034091 from GO Biological Process Annotations)", "regulation of male germ cell proliferation (GO:2000254 from GO Biological Process Annotations)", "regulation of male gonad development (GO:2000018 from GO Biological Process Annotations)", "regulation of mammary gland epithelial cell proliferation (GO:0033599 from GO Biological Process Annotations)", "regulation of mammary gland involution (GO:1903519 from GO Biological Process Annotations)", "regulation of map kinase activity (GO:0043405 from GO Biological Process Annotations)", "regulation of mapk cascade (GO:0043408 from GO Biological Process Annotations)", "regulation of mapk export from nucleus (GO:0071701 from GO Biological Process Annotations)", "regulation of mast cell activation (GO:0033003 from GO Biological Process Annotations)", "regulation of mast cell activation involved in immune response (GO:0033006 from GO Biological Process Annotations)", "regulation of mast cell apoptotic process (GO:0033025 from GO Biological Process Annotations)", "regulation of mast cell chemotaxis (GO:0060753 from GO Biological Process Annotations)", "regulation of mast cell cytokine production (GO:0032763 from GO Biological Process Annotations)", "regulation of mast cell degranulation (GO:0043304 from GO Biological Process Annotations)", "regulation of mast cell differentiation (GO:0060375 from GO Biological Process Annotations)", "regulation of mast cell proliferation (GO:0070666 from GO Biological Process Annotations)", "regulation of mature b cell apoptotic process (GO:0002905 from GO Biological Process Annotations)", "regulation of mda-5 signaling pathway (GO:0039533 from GO Biological Process Annotations)", "regulation of mechanoreceptor differentiation (GO:0045631 from GO Biological Process Annotations)", "regulation of mediator complex assembly (GO:2001176 from GO Biological Process Annotations)", "regulation of megakaryocyte differentiation (GO:0045652 from GO Biological Process Annotations)", "regulation of meiosis (GO:0040020 from GO Biological Process Annotations)", "regulation of meiosis i (GO:0060631 from GO Biological Process Annotations)", "regulation of meiotic cell cycle (GO:0051445 from GO Biological Process Annotations)", "regulation of meiotic cell cycle phase transition (GO:1901993 from GO Biological Process Annotations)", "regulation of melanin biosynthetic process (GO:0048021 from GO Biological Process Annotations)", "regulation of melanocyte differentiation (GO:0045634 from GO Biological Process Annotations)", "regulation of melanosome organization (GO:1903056 from GO Biological Process Annotations)", "regulation of melanosome transport (GO:1902908 from GO Biological Process Annotations)", "regulation of membrane depolarization (GO:0003254 from GO Biological Process Annotations)", "regulation of membrane depolarization during action potential (GO:0098902 from GO Biological Process Annotations)", "regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900825 from GO Biological Process Annotations)", "regulation of membrane lipid distribution (GO:0097035 from GO Biological Process Annotations)", "regulation of membrane permeability (GO:0090559 from GO Biological Process Annotations)", "regulation of membrane potential (GO:0042391 from GO Biological Process Annotations)", "regulation of membrane protein ectodomain proteolysis (GO:0051043 from GO Biological Process Annotations)", "regulation of membrane repolarization (GO:0060306 from GO Biological Process Annotations)", "regulation of membrane repolarization during action potential (GO:0098903 from GO Biological Process Annotations)", "regulation of membrane tubulation (GO:1903525 from GO Biological Process Annotations)", "regulation of memory t cell activation (GO:2000567 from GO Biological Process Annotations)", "regulation of memory t cell differentiation (GO:0043380 from GO Biological Process Annotations)", "regulation of mesenchymal cell apoptotic process (GO:2001053 from GO Biological Process Annotations)", "regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061295 from GO Biological Process Annotations)", "regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072304 from GO Biological Process Annotations)", "regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900211 from GO Biological Process Annotations)", "regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072039 from GO Biological Process Annotations)", "regulation of mesenchymal cell proliferation (GO:0010464 from GO Biological Process Annotations)", "regulation of mesenchymal cell proliferation involved in lung development (GO:2000790 from GO Biological Process Annotations)", "regulation of mesenchymal cell proliferation involved in prostate gland development (GO:0060782 from GO Biological Process Annotations)", "regulation of mesenchymal cell proliferation involved in ureter development (GO:0072199 from GO Biological Process Annotations)", "regulation of mesenchymal stem cell differentiation (GO:2000739 from GO Biological Process Annotations)", "regulation of mesenchymal stem cell proliferation (GO:1902460 from GO Biological Process Annotations)", "regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 from GO Biological Process Annotations)", "regulation of mesoderm development (GO:2000380 from GO Biological Process Annotations)", "regulation of mesodermal cell fate specification (GO:0042661 from GO Biological Process Annotations)", "regulation of mesonephros development (GO:0061217 from GO Biological Process Annotations)", "regulation of metabolic process (GO:0019222 from GO Biological Process Annotations)", "regulation of metal ion transport (GO:0010959 from GO Biological Process Annotations)", "regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902962 from GO Biological Process Annotations)", "regulation of metalloenzyme activity (GO:0048552 from GO Biological Process Annotations)", "regulation of metanephric cap mesenchymal cell proliferation (GO:0090095 from GO Biological Process Annotations)", "regulation of metanephric comma-shaped body morphogenesis (GO:2000006 from GO Biological Process Annotations)", "regulation of metanephric dct cell differentiation (GO:2000592 from GO Biological Process Annotations)", "regulation of metanephric glomerular mesangial cell proliferation (GO:0072301 from GO Biological Process Annotations)", "regulation of metanephric glomerular visceral epithelial cell development (GO:2000477 from GO Biological Process Annotations)", "regulation of metanephric glomerulus development (GO:0072298 from GO Biological Process Annotations)", "regulation of metanephric mesenchymal cell migration (GO:2000589 from GO Biological Process Annotations)", "regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:1900238 from GO Biological Process Annotations)", "regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307 from GO Biological Process Annotations)", "regulation of metanephric s-shaped body morphogenesis (GO:2000004 from GO Biological Process Annotations)", "regulation of metanephric ureteric bud development (GO:2001074 from GO Biological Process Annotations)", "regulation of metanephros development (GO:0072215 from GO Biological Process Annotations)", "regulation of metanephros size (GO:0035566 from GO Biological Process Annotations)", "regulation of metaphase plate congression (GO:0090235 from GO Biological Process Annotations)", "regulation of metaphase|anaphase transition of cell cycle (GO:1902099 from GO Biological Process Annotations)", "regulation of metaphase|anaphase transition of meiotic cell cycle (GO:1902102 from GO Biological Process Annotations)", "regulation of methylation-dependent chromatin silencing (GO:0090308 from GO Biological Process Annotations)", "regulation of mhc class i biosynthetic process (GO:0045343 from GO Biological Process Annotations)", "regulation of mhc class ii biosynthetic process (GO:0045346 from GO Biological Process Annotations)", "regulation of microtubule cytoskeleton organization (GO:0070507 from GO Biological Process Annotations)", "regulation of microtubule depolymerization (GO:0031114 from GO Biological Process Annotations)", "regulation of microtubule motor activity (GO:2000574 from GO Biological Process Annotations)", "regulation of microtubule nucleation (GO:0010968 from GO Biological Process Annotations)", "regulation of microtubule plus-end binding (GO:1903031 from GO Biological Process Annotations)", "regulation of microtubule polymerization (GO:0031113 from GO Biological Process Annotations)", "regulation of microtubule polymerization or depolymerization (GO:0031110 from GO Biological Process Annotations)", "regulation of microtubule-based movement (GO:0060632 from GO Biological Process Annotations)", "regulation of microtubule-based process (GO:0032886 from GO Biological Process Annotations)", "regulation of microvillus assembly (GO:0032534 from GO Biological Process Annotations)", "regulation of microvillus length (GO:0032532 from GO Biological Process Annotations)", "regulation of microvillus organization (GO:0032530 from GO Biological Process Annotations)", "regulation of mineralocorticoid secretion (GO:2000855 from GO Biological Process Annotations)", "regulation of mirna catabolic process (GO:2000625 from GO Biological Process Annotations)", "regulation of mirna metabolic process (GO:2000628 from GO Biological Process Annotations)", "regulation of mismatch repair (GO:0032423 from GO Biological Process Annotations)", "regulation of mitochondrial depolarization (GO:0051900 from GO Biological Process Annotations)", "regulation of mitochondrial dna metabolic process (GO:1901858 from GO Biological Process Annotations)", "regulation of mitochondrial dna replication (GO:0090296 from GO Biological Process Annotations)", "regulation of mitochondrial electron transport, nadh to ubiquinone (GO:1902956 from GO Biological Process Annotations)", "regulation of mitochondrial fission (GO:0090140 from GO Biological Process Annotations)", "regulation of mitochondrial fusion (GO:0010635 from GO Biological Process Annotations)", "regulation of mitochondrial membrane permeability (GO:0046902 from GO Biological Process Annotations)", "regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108 from GO Biological Process Annotations)", "regulation of mitochondrial membrane permeability involved in programmed necrotic cell death (GO:1902445 from GO Biological Process Annotations)", "regulation of mitochondrial membrane potential (GO:0051881 from GO Biological Process Annotations)", "regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028 from GO Biological Process Annotations)", "regulation of mitochondrial rna catabolic process (GO:0000960 from GO Biological Process Annotations)", "regulation of mitochondrial translation (GO:0070129 from GO Biological Process Annotations)", "regulation of mitochondrion degradation (GO:1903146 from GO Biological Process Annotations)", "regulation of mitochondrion organization (GO:0010821 from GO Biological Process Annotations)", "regulation of mitotic attachment of spindle microtubules to kinetochore (GO:1902423 from GO Biological Process Annotations)", "regulation of mitotic cell cycle (GO:0007346 from GO Biological Process Annotations)", "regulation of mitotic cell cycle dna replication (GO:1903463 from GO Biological Process Annotations)", "regulation of mitotic cell cycle phase transition (GO:1901990 from GO Biological Process Annotations)", "regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266 from GO Biological Process Annotations)", "regulation of mitotic cell cycle, embryonic (GO:0009794 from GO Biological Process Annotations)", "regulation of mitotic centrosome separation (GO:0046602 from GO Biological Process Annotations)", "regulation of mitotic metaphase|anaphase transition (GO:0030071 from GO Biological Process Annotations)", "regulation of mitotic nuclear division (GO:0007088 from GO Biological Process Annotations)", "regulation of mitotic recombination (GO:0000019 from GO Biological Process Annotations)", "regulation of mitotic sister chromatid segregation (GO:0033047 from GO Biological Process Annotations)", "regulation of mitotic sister chromatid separation (GO:0010965 from GO Biological Process Annotations)", "regulation of mitotic spindle assembly (GO:1901673 from GO Biological Process Annotations)", "regulation of mitotic spindle checkpoint (GO:1903504 from GO Biological Process Annotations)", "regulation of mitotic spindle organization (GO:0060236 from GO Biological Process Annotations)", "regulation of molecular function (GO:0065009 from GO Biological Process Annotations)", "regulation of molecular function, epigenetic (GO:0040030 from GO Biological Process Annotations)", "regulation of monocyte aggregation (GO:1900623 from GO Biological Process Annotations)", "regulation of monocyte chemotactic protein-1 production (GO:0071637 from GO Biological Process Annotations)", "regulation of monocyte chemotaxis (GO:0090025 from GO Biological Process Annotations)", "regulation of monocyte differentiation (GO:0045655 from GO Biological Process Annotations)", "regulation of monocyte extravasation (GO:2000437 from GO Biological Process Annotations)", "regulation of mononuclear cell migration (GO:0071675 from GO Biological Process Annotations)", "regulation of mononuclear cell proliferation (GO:0032944 from GO Biological Process Annotations)", "regulation of monooxygenase activity (GO:0032768 from GO Biological Process Annotations)", "regulation of monophenol monooxygenase activity (GO:0032771 from GO Biological Process Annotations)", "regulation of morphogenesis of a branching structure (GO:0060688 from GO Biological Process Annotations)", "regulation of motor neuron apoptotic process (GO:2000671 from GO Biological Process Annotations)", "regulation of mrna 3'-end processing (GO:0031440 from GO Biological Process Annotations)", "regulation of mrna 3'-utr binding (GO:1903837 from GO Biological Process Annotations)", "regulation of mrna binding (GO:1902415 from GO Biological Process Annotations)", "regulation of mrna catabolic process (GO:0061013 from GO Biological Process Annotations)", "regulation of mrna cleavage (GO:0031437 from GO Biological Process Annotations)", "regulation of mrna export from nucleus (GO:0010793 from GO Biological Process Annotations)", "regulation of mrna metabolic process (GO:1903311 from GO Biological Process Annotations)", "regulation of mrna modification (GO:0090365 from GO Biological Process Annotations)", "regulation of mrna polyadenylation (GO:1900363 from GO Biological Process Annotations)", "regulation of mrna processing (GO:0050684 from GO Biological Process Annotations)", "regulation of mrna splicing, via spliceosome (GO:0048024 from GO Biological Process Annotations)", "regulation of mrna stability (GO:0043488 from GO Biological Process Annotations)", "regulation of mrna stability involved in response to stress (GO:0010610 from GO Biological Process Annotations)", "regulation of mucus secretion (GO:0070255 from GO Biological Process Annotations)", "regulation of multi-organism process (GO:0043900 from GO Biological Process Annotations)", "regulation of multicellular organism growth (GO:0040014 from GO Biological Process Annotations)", "regulation of multicellular organismal development (GO:2000026 from GO Biological Process Annotations)", "regulation of multicellular organismal metabolic process (GO:0044246 from GO Biological Process Annotations)", "regulation of multicellular organismal process (GO:0051239 from GO Biological Process Annotations)", "regulation of multivesicular body size (GO:0010796 from GO Biological Process Annotations)", "regulation of multivesicular body size involved in endosome transport (GO:0010797 from GO Biological Process Annotations)", "regulation of muscle adaptation (GO:0043502 from GO Biological Process Annotations)", "regulation of muscle atrophy (GO:0014735 from GO Biological Process Annotations)", "regulation of muscle cell apoptotic process (GO:0010660 from GO Biological Process Annotations)", "regulation of muscle cell differentiation (GO:0051147 from GO Biological Process Annotations)", "regulation of muscle contraction (GO:0006937 from GO Biological Process Annotations)", "regulation of muscle filament sliding (GO:0032971 from GO Biological Process Annotations)", "regulation of muscle filament sliding speed (GO:0032972 from GO Biological Process Annotations)", "regulation of muscle hyperplasia (GO:0014738 from GO Biological Process Annotations)", "regulation of muscle hypertrophy (GO:0014743 from GO Biological Process Annotations)", "regulation of muscle organ development (GO:0048634 from GO Biological Process Annotations)", "regulation of muscle system process (GO:0090257 from GO Biological Process Annotations)", "regulation of muscle tissue development (GO:1901861 from GO Biological Process Annotations)", "regulation of myd88-dependent toll-like receptor signaling pathway (GO:0034124 from GO Biological Process Annotations)", "regulation of myd88-independent toll-like receptor signaling pathway (GO:0034127 from GO Biological Process Annotations)", "regulation of myelination (GO:0031641 from GO Biological Process Annotations)", "regulation of myeloid cell apoptotic process (GO:0033032 from GO Biological Process Annotations)", "regulation of myeloid cell differentiation (GO:0045637 from GO Biological Process Annotations)", "regulation of myeloid dendritic cell activation (GO:0030885 from GO Biological Process Annotations)", "regulation of myeloid dendritic cell chemotaxis (GO:2000527 from GO Biological Process Annotations)", "regulation of myeloid leukocyte differentiation (GO:0002761 from GO Biological Process Annotations)", "regulation of myeloid leukocyte mediated immunity (GO:0002886 from GO Biological Process Annotations)", "regulation of myoblast differentiation (GO:0045661 from GO Biological Process Annotations)", "regulation of myoblast fusion (GO:1901739 from GO Biological Process Annotations)", "regulation of myoblast proliferation (GO:2000291 from GO Biological Process Annotations)", "regulation of myosin ii filament organization (GO:0043519 from GO Biological Process Annotations)", "regulation of myosin light chain kinase activity (GO:0035504 from GO Biological Process Annotations)", "regulation of myosin-light-chain-phosphatase activity (GO:0035507 from GO Biological Process Annotations)", "regulation of myotome development (GO:2000290 from GO Biological Process Annotations)", "regulation of myotube differentiation (GO:0010830 from GO Biological Process Annotations)", "regulation of n-methyl-d-aspartate selective glutamate receptor activity (GO:2000310 from GO Biological Process Annotations)", "regulation of n-terminal peptidyl-lysine acetylation (GO:2000759 from GO Biological Process Annotations)", "regulation of n-terminal protein palmitoylation (GO:0060254 from GO Biological Process Annotations)", "regulation of nad(p)h oxidase activity (GO:0033860 from GO Biological Process Annotations)", "regulation of nad+ adp-ribosyltransferase activity (GO:1901664 from GO Biological Process Annotations)", "regulation of nadp metabolic process (GO:1902031 from GO Biological Process Annotations)", "regulation of natural killer cell activation (GO:0032814 from GO Biological Process Annotations)", "regulation of natural killer cell apoptotic process (GO:0070247 from GO Biological Process Annotations)", "regulation of natural killer cell chemotaxis (GO:2000501 from GO Biological Process Annotations)", "regulation of natural killer cell cytokine production (GO:0002727 from GO Biological Process Annotations)", "regulation of natural killer cell degranulation (GO:0043321 from GO Biological Process Annotations)", "regulation of natural killer cell differentiation (GO:0032823 from GO Biological Process Annotations)", "regulation of natural killer cell differentiation involved in immune response (GO:0032826 from GO Biological Process Annotations)", "regulation of natural killer cell mediated cytotoxicity (GO:0042269 from GO Biological Process Annotations)", "regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858 from GO Biological Process Annotations)", "regulation of natural killer cell mediated immune response to tumor cell (GO:0002855 from GO Biological Process Annotations)", "regulation of natural killer cell mediated immunity (GO:0002715 from GO Biological Process Annotations)", "regulation of natural killer cell proliferation (GO:0032817 from GO Biological Process Annotations)", "regulation of necroptotic process (GO:0060544 from GO Biological Process Annotations)", "regulation of necrotic cell death (GO:0010939 from GO Biological Process Annotations)", "regulation of negative chemotaxis (GO:0050923 from GO Biological Process Annotations)", "regulation of nephron tubule epithelial cell differentiation (GO:0072182 from GO Biological Process Annotations)", "regulation of nerve growth factor production (GO:0032903 from GO Biological Process Annotations)", "regulation of nerve growth factor receptor activity (GO:0051394 from GO Biological Process Annotations)", "regulation of nervous system development (GO:0051960 from GO Biological Process Annotations)", "regulation of neural crest formation (GO:0090299 from GO Biological Process Annotations)", "regulation of neural precursor cell proliferation (GO:2000177 from GO Biological Process Annotations)", "regulation of neural retina development (GO:0061074 from GO Biological Process Annotations)", "regulation of neuroblast proliferation (GO:1902692 from GO Biological Process Annotations)", "regulation of neurofibrillary tangle assembly (GO:1902996 from GO Biological Process Annotations)", "regulation of neurogenesis (GO:0050767 from GO Biological Process Annotations)", "regulation of neurological system process (GO:0031644 from GO Biological Process Annotations)", "regulation of neuromuscular synaptic transmission (GO:1900073 from GO Biological Process Annotations)", "regulation of neuron apoptotic process (GO:0043523 from GO Biological Process Annotations)", "regulation of neuron death (GO:1901214 from GO Biological Process Annotations)", "regulation of neuron differentiation (GO:0045664 from GO Biological Process Annotations)", "regulation of neuron maturation (GO:0014041 from GO Biological Process Annotations)", "regulation of neuron migration (GO:2001222 from GO Biological Process Annotations)", "regulation of neuron projection development (GO:0010975 from GO Biological Process Annotations)", "regulation of neuron projection regeneration (GO:0070570 from GO Biological Process Annotations)", "regulation of neuronal action potential (GO:0098908 from GO Biological Process Annotations)", "regulation of neuronal signal transduction (GO:1902847 from GO Biological Process Annotations)", "regulation of neuronal synaptic plasticity (GO:0048168 from GO Biological Process Annotations)", "regulation of neurotransmitter levels (GO:0001505 from GO Biological Process Annotations)", "regulation of neurotransmitter secretion (GO:0046928 from GO Biological Process Annotations)", "regulation of neurotransmitter transport (GO:0051588 from GO Biological Process Annotations)", "regulation of neurotransmitter uptake (GO:0051580 from GO Biological Process Annotations)", "regulation of neurotrophin production (GO:0032899 from GO Biological Process Annotations)", "regulation of neurotrophin trk receptor signaling pathway (GO:0051386 from GO Biological Process Annotations)", "regulation of neutrophil activation (GO:1902563 from GO Biological Process Annotations)", "regulation of neutrophil apoptotic process (GO:0033029 from GO Biological Process Annotations)", "regulation of neutrophil chemotaxis (GO:0090022 from GO Biological Process Annotations)", "regulation of neutrophil degranulation (GO:0043313 from GO Biological Process Annotations)", "regulation of neutrophil differentiation (GO:0045658 from GO Biological Process Annotations)", "regulation of neutrophil extravasation (GO:2000389 from GO Biological Process Annotations)", "regulation of neutrophil mediated cytotoxicity (GO:0070948 from GO Biological Process Annotations)", "regulation of neutrophil mediated killing of bacterium (GO:0070950 from GO Biological Process Annotations)", "regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070951 from GO Biological Process Annotations)", "regulation of neutrophil mediated killing of symbiont cell (GO:0070949 from GO Biological Process Annotations)", "regulation of neutrophil migration (GO:1902622 from GO Biological Process Annotations)", "regulation of nf-kappab import into nucleus (GO:0042345 from GO Biological Process Annotations)", "regulation of nfat protein import into nucleus (GO:0051532 from GO Biological Process Annotations)", "regulation of nik|nf-kappab signaling (GO:1901222 from GO Biological Process Annotations)", "regulation of nitric oxide biosynthetic process (GO:0045428 from GO Biological Process Annotations)", "regulation of nitric oxide mediated signal transduction (GO:0010749 from GO Biological Process Annotations)", "regulation of nitric oxide metabolic process (GO:0080164 from GO Biological Process Annotations)", "regulation of nitric-oxide synthase activity (GO:0050999 from GO Biological Process Annotations)", "regulation of nitric-oxide synthase biosynthetic process (GO:0051769 from GO Biological Process Annotations)", "regulation of nitrogen compound metabolic process (GO:0051171 from GO Biological Process Annotations)", "regulation of nitrogen cycle metabolic process (GO:1903314 from GO Biological Process Annotations)", "regulation of nitrogen utilization (GO:0006808 from GO Biological Process Annotations)", "regulation of nk t cell activation (GO:0051133 from GO Biological Process Annotations)", "regulation of nk t cell differentiation (GO:0051136 from GO Biological Process Annotations)", "regulation of nk t cell proliferation (GO:0051140 from GO Biological Process Annotations)", "regulation of nlrp3 inflammasome complex assembly (GO:1900225 from GO Biological Process Annotations)", "regulation of nodal signaling pathway (GO:1900107 from GO Biological Process Annotations)", "regulation of nodal signaling pathway involved in determination of lateral mesoderm left|right asymmetry (GO:1900175 from GO Biological Process Annotations)", "regulation of nodal signaling pathway involved in determination of left|right asymmetry (GO:1900145 from GO Biological Process Annotations)", "regulation of non-canonical wnt signaling pathway (GO:2000050 from GO Biological Process Annotations)", "regulation of non-canonical wnt signaling pathway via jnk cascade (GO:1901229 from GO Biological Process Annotations)", "regulation of nonmotile primary cilium assembly (GO:1902855 from GO Biological Process Annotations)", "regulation of norepinephrine secretion (GO:0014061 from GO Biological Process Annotations)", "regulation of norepinephrine uptake (GO:0051621 from GO Biological Process Annotations)", "regulation of notch signaling pathway (GO:0008593 from GO Biological Process Annotations)", "regulation of notch signaling pathway involved in heart induction (GO:0035480 from GO Biological Process Annotations)", "regulation of notch signaling pathway involved in somitogenesis (GO:1902366 from GO Biological Process Annotations)", "regulation of nuclear cell cycle dna replication (GO:0033262 from GO Biological Process Annotations)", "regulation of nuclear division (GO:0051783 from GO Biological Process Annotations)", "regulation of nuclear-transcribed mrna catabolic process, deadenylation-dependent decay (GO:1900151 from GO Biological Process Annotations)", "regulation of nuclear-transcribed mrna catabolic process, nonsense-mediated decay (GO:2000622 from GO Biological Process Annotations)", "regulation of nuclear-transcribed mrna poly(a) tail shortening (GO:0060211 from GO Biological Process Annotations)", "regulation of nuclease activity (GO:0032069 from GO Biological Process Annotations)", "regulation of nucleic acid-templated transcription (GO:1903506 from GO Biological Process Annotations)", "regulation of nucleobase-containing compound metabolic process (GO:0019219 from GO Biological Process Annotations)", "regulation of nucleobase-containing compound transport (GO:0032239 from GO Biological Process Annotations)", "regulation of nucleocytoplasmic transport (GO:0046822 from GO Biological Process Annotations)", "regulation of nucleoside metabolic process (GO:0009118 from GO Biological Process Annotations)", "regulation of nucleoside transport (GO:0032242 from GO Biological Process Annotations)", "regulation of nucleotide biosynthetic process (GO:0030808 from GO Biological Process Annotations)", "regulation of nucleotide catabolic process (GO:0030811 from GO Biological Process Annotations)", "regulation of nucleotide metabolic process (GO:0006140 from GO Biological Process Annotations)", "regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070428 from GO Biological Process Annotations)", "regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432 from GO Biological Process Annotations)", "regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424 from GO Biological Process Annotations)", "regulation of nucleotide-excision repair (GO:2000819 from GO Biological Process Annotations)", "regulation of nucleus size (GO:0097298 from GO Biological Process Annotations)", "regulation of odontogenesis (GO:0042481 from GO Biological Process Annotations)", "regulation of odontogenesis of dentin-containing tooth (GO:0042487 from GO Biological Process Annotations)", "regulation of oligodendrocyte apoptotic process (GO:1900141 from GO Biological Process Annotations)", "regulation of oligodendrocyte differentiation (GO:0048713 from GO Biological Process Annotations)", "regulation of oligodendrocyte progenitor proliferation (GO:0070445 from GO Biological Process Annotations)", "regulation of oligopeptide transport (GO:0090088 from GO Biological Process Annotations)", "regulation of oocyte development (GO:0060281 from GO Biological Process Annotations)", "regulation of oocyte maturation (GO:1900193 from GO Biological Process Annotations)", "regulation of opioid receptor signaling pathway (GO:2000474 from GO Biological Process Annotations)", "regulation of opsonization (GO:1903027 from GO Biological Process Annotations)", "regulation of optic nerve formation (GO:2000595 from GO Biological Process Annotations)", "regulation of organ formation (GO:0003156 from GO Biological Process Annotations)", "regulation of organ growth (GO:0046620 from GO Biological Process Annotations)", "regulation of organ morphogenesis (GO:2000027 from GO Biological Process Annotations)", "regulation of organelle assembly (GO:1902115 from GO Biological Process Annotations)", "regulation of organelle organization (GO:0033043 from GO Biological Process Annotations)", "regulation of organelle transport along microtubule (GO:1902513 from GO Biological Process Annotations)", "regulation of organic acid transport (GO:0032890 from GO Biological Process Annotations)", "regulation of ossification (GO:0030278 from GO Biological Process Annotations)", "regulation of osteoblast differentiation (GO:0045667 from GO Biological Process Annotations)", "regulation of osteoblast proliferation (GO:0033688 from GO Biological Process Annotations)", "regulation of osteoclast development (GO:2001204 from GO Biological Process Annotations)", "regulation of osteoclast differentiation (GO:0045670 from GO Biological Process Annotations)", "regulation of osteoclast proliferation (GO:0090289 from GO Biological Process Annotations)", "regulation of ovarian follicle development (GO:2000354 from GO Biological Process Annotations)", "regulation of ovulation (GO:0060278 from GO Biological Process Annotations)", "regulation of oxidative phosphorylation (GO:0002082 from GO Biological Process Annotations)", "regulation of oxidative phosphorylation uncoupler activity (GO:2000275 from GO Biological Process Annotations)", "regulation of oxidative stress-induced cell death (GO:1903201 from GO Biological Process Annotations)", "regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175 from GO Biological Process Annotations)", "regulation of oxidative stress-induced neuron death (GO:1903203 from GO Biological Process Annotations)", "regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376 from GO Biological Process Annotations)", "regulation of oxidoreductase activity (GO:0051341 from GO Biological Process Annotations)", "regulation of oxygen metabolic process (GO:2000374 from GO Biological Process Annotations)", "regulation of p38mapk cascade (GO:1900744 from GO Biological Process Annotations)", "regulation of pancreatic a cell differentiation (GO:2000226 from GO Biological Process Annotations)", "regulation of pancreatic juice secretion (GO:0090186 from GO Biological Process Annotations)", "regulation of pancreatic stellate cell proliferation (GO:2000229 from GO Biological Process Annotations)", "regulation of pathway-restricted smad protein phosphorylation (GO:0060393 from GO Biological Process Annotations)", "regulation of penile erection (GO:0060405 from GO Biological Process Annotations)", "regulation of pentose-phosphate shunt (GO:0043456 from GO Biological Process Annotations)", "regulation of peptidase activity (GO:0052547 from GO Biological Process Annotations)", "regulation of peptide hormone secretion (GO:0090276 from GO Biological Process Annotations)", "regulation of peptide secretion (GO:0002791 from GO Biological Process Annotations)", "regulation of peptide transport (GO:0090087 from GO Biological Process Annotations)", "regulation of peptidyl-cysteine s-nitrosylation (GO:2000169 from GO Biological Process Annotations)", "regulation of peptidyl-lysine acetylation (GO:2000756 from GO Biological Process Annotations)", "regulation of peptidyl-serine dephosphorylation (GO:1902308 from GO Biological Process Annotations)", "regulation of peptidyl-serine phosphorylation (GO:0033135 from GO Biological Process Annotations)", "regulation of peptidyl-serine phosphorylation of stat protein (GO:0033139 from GO Biological Process Annotations)", "regulation of peptidyl-threonine phosphorylation (GO:0010799 from GO Biological Process Annotations)", "regulation of peptidyl-tyrosine autophosphorylation (GO:1900084 from GO Biological Process Annotations)", "regulation of peptidyl-tyrosine phosphorylation (GO:0050730 from GO Biological Process Annotations)", "regulation of peripheral t cell tolerance induction (GO:0002849 from GO Biological Process Annotations)", "regulation of peripheral tolerance induction (GO:0002658 from GO Biological Process Annotations)", "regulation of peroxidase activity (GO:2000468 from GO Biological Process Annotations)", "regulation of peroxisome organization (GO:1900063 from GO Biological Process Annotations)", "regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358 from GO Biological Process Annotations)", "regulation of peroxisome size (GO:0044375 from GO Biological Process Annotations)", "regulation of ph (GO:0006885 from GO Biological Process Annotations)", "regulation of phagocytosis (GO:0050764 from GO Biological Process Annotations)", "regulation of phagocytosis, engulfment (GO:0060099 from GO Biological Process Annotations)", "regulation of phosphatase activity (GO:0010921 from GO Biological Process Annotations)", "regulation of phosphate metabolic process (GO:0019220 from GO Biological Process Annotations)", "regulation of phosphate transmembrane transport (GO:2000185 from GO Biological Process Annotations)", "regulation of phosphate transport (GO:0010966 from GO Biological Process Annotations)", "regulation of phosphatidylcholine biosynthetic process (GO:2001245 from GO Biological Process Annotations)", "regulation of phosphatidylcholine catabolic process (GO:0010899 from GO Biological Process Annotations)", "regulation of phosphatidylinositol 3-kinase activity (GO:0043551 from GO Biological Process Annotations)", "regulation of phosphatidylinositol 3-kinase signaling (GO:0014066 from GO Biological Process Annotations)", "regulation of phosphatidylinositol biosynthetic process (GO:0010511 from GO Biological Process Annotations)", "regulation of phosphatidylinositol dephosphorylation (GO:0060304 from GO Biological Process Annotations)", "regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001144 from GO Biological Process Annotations)", "regulation of phospholipase a2 activity (GO:0032429 from GO Biological Process Annotations)", "regulation of phospholipase activity (GO:0010517 from GO Biological Process Annotations)", "regulation of phospholipase c activity (GO:1900274 from GO Biological Process Annotations)", "regulation of phospholipase c-activating g-protein coupled receptor signaling pathway (GO:1900736 from GO Biological Process Annotations)", "regulation of phospholipid biosynthetic process (GO:0071071 from GO Biological Process Annotations)", "regulation of phospholipid catabolic process (GO:0060696 from GO Biological Process Annotations)", "regulation of phospholipid efflux (GO:1902994 from GO Biological Process Annotations)", "regulation of phospholipid metabolic process (GO:1903725 from GO Biological Process Annotations)", "regulation of phospholipid scramblase activity (GO:1900161 from GO Biological Process Annotations)", "regulation of phospholipid translocation (GO:0061091 from GO Biological Process Annotations)", "regulation of phospholipid transport (GO:2001138 from GO Biological Process Annotations)", "regulation of phosphoprotein phosphatase activity (GO:0043666 from GO Biological Process Annotations)", "regulation of phosphorus metabolic process (GO:0051174 from GO Biological Process Annotations)", "regulation of phosphorylation (GO:0042325 from GO Biological Process Annotations)", "regulation of phosphorylation of rna polymerase ii c-terminal domain (GO:1901407 from GO Biological Process Annotations)", "regulation of phosphorylation of rna polymerase ii c-terminal domain serine 2 residues (GO:2001163 from GO Biological Process Annotations)", "regulation of photoreceptor cell differentiation (GO:0046532 from GO Biological Process Annotations)", "regulation of pigment cell differentiation (GO:0050932 from GO Biological Process Annotations)", "regulation of pinocytosis (GO:0048548 from GO Biological Process Annotations)", "regulation of planar cell polarity pathway involved in axis elongation (GO:2000040 from GO Biological Process Annotations)", "regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:2000150 from GO Biological Process Annotations)", "regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:2000161 from GO Biological Process Annotations)", "regulation of planar cell polarity pathway involved in heart morphogenesis (GO:2000159 from GO Biological Process Annotations)", "regulation of planar cell polarity pathway involved in neural tube closure (GO:2000167 from GO Biological Process Annotations)", "regulation of planar cell polarity pathway involved in outflow tract morphogenesis (GO:2000163 from GO Biological Process Annotations)", "regulation of planar cell polarity pathway involved in pericardium morphogenesis (GO:2000165 from GO Biological Process Annotations)", "regulation of planar cell polarity pathway involved in ventricular septum morphogenesis (GO:2000148 from GO Biological Process Annotations)", "regulation of plasma cell differentiation (GO:1900098 from GO Biological Process Annotations)", "regulation of plasma lipoprotein particle levels (GO:0097006 from GO Biological Process Annotations)", "regulation of plasma lipoprotein particle oxidation (GO:0034444 from GO Biological Process Annotations)", "regulation of plasma membrane long-chain fatty acid transport (GO:0010746 from GO Biological Process Annotations)", "regulation of plasma membrane organization (GO:1903729 from GO Biological Process Annotations)", "regulation of plasmacytoid dendritic cell cytokine production (GO:0002736 from GO Biological Process Annotations)", "regulation of plasminogen activation (GO:0010755 from GO Biological Process Annotations)", "regulation of platelet activation (GO:0010543 from GO Biological Process Annotations)", "regulation of platelet aggregation (GO:0090330 from GO Biological Process Annotations)", "regulation of platelet-derived growth factor production (GO:0090361 from GO Biological Process Annotations)", "regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640 from GO Biological Process Annotations)", "regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000583 from GO Biological Process Annotations)", "regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586 from GO Biological Process Annotations)", "regulation of podosome assembly (GO:0071801 from GO Biological Process Annotations)", "regulation of polarized epithelial cell differentiation (GO:0030860 from GO Biological Process Annotations)", "regulation of polyamine biosynthetic process (GO:0010967 from GO Biological Process Annotations)", "regulation of polyamine transmembrane transport (GO:1902267 from GO Biological Process Annotations)", "regulation of polysaccharide biosynthetic process (GO:0032885 from GO Biological Process Annotations)", "regulation of polysaccharide metabolic process (GO:0032881 from GO Biological Process Annotations)", "regulation of positive chemotaxis (GO:0050926 from GO Biological Process Annotations)", "regulation of positive thymic t cell selection (GO:1902232 from GO Biological Process Annotations)", "regulation of post-translational protein modification (GO:1901873 from GO Biological Process Annotations)", "regulation of postsynaptic density protein 95 clustering (GO:1902897 from GO Biological Process Annotations)", "regulation of postsynaptic membrane organization (GO:1901626 from GO Biological Process Annotations)", "regulation of postsynaptic membrane potential (GO:0060078 from GO Biological Process Annotations)", "regulation of posttranscriptional gene silencing (GO:0060147 from GO Biological Process Annotations)", "regulation of potassium ion export (GO:1902302 from GO Biological Process Annotations)", "regulation of potassium ion export across plasma membrane (GO:1903764 from GO Biological Process Annotations)", "regulation of potassium ion import (GO:1903286 from GO Biological Process Annotations)", "regulation of potassium ion transmembrane transport (GO:1901379 from GO Biological Process Annotations)", "regulation of potassium ion transmembrane transporter activity (GO:1901016 from GO Biological Process Annotations)", "regulation of potassium ion transport (GO:0043266 from GO Biological Process Annotations)", "regulation of pre-mirna processing (GO:2000631 from GO Biological Process Annotations)", "regulation of presynaptic membrane organization (GO:1901629 from GO Biological Process Annotations)", "regulation of pri-mirna transcription from rna polymerase ii promoter (GO:1902893 from GO Biological Process Annotations)", "regulation of primary metabolic process (GO:0080090 from GO Biological Process Annotations)", "regulation of primitive erythrocyte differentiation (GO:0010725 from GO Biological Process Annotations)", "regulation of pro-b cell differentiation (GO:2000973 from GO Biological Process Annotations)", "regulation of pro-t cell differentiation (GO:2000174 from GO Biological Process Annotations)", "regulation of production of mirnas involved in gene silencing by mirna (GO:1903798 from GO Biological Process Annotations)", "regulation of production of molecular mediator of immune response (GO:0002700 from GO Biological Process Annotations)", "regulation of production of sirna involved in rna interference (GO:0090065 from GO Biological Process Annotations)", "regulation of production of small rna involved in gene silencing by rna (GO:0070920 from GO Biological Process Annotations)", "regulation of progesterone secretion (GO:2000870 from GO Biological Process Annotations)", "regulation of programmed cell death (GO:0043067 from GO Biological Process Annotations)", "regulation of prolactin signaling pathway (GO:1902211 from GO Biological Process Annotations)", "regulation of pronephros size (GO:0035565 from GO Biological Process Annotations)", "regulation of prostaglandin biosynthetic process (GO:0031392 from GO Biological Process Annotations)", "regulation of prostaglandin secretion (GO:0032306 from GO Biological Process Annotations)", "regulation of prostaglandin-e synthase activity (GO:2000361 from GO Biological Process Annotations)", "regulation of prostaglandin-endoperoxide synthase activity (GO:0060584 from GO Biological Process Annotations)", "regulation of prostatic bud formation (GO:0060685 from GO Biological Process Annotations)", "regulation of proteasomal protein catabolic process (GO:0061136 from GO Biological Process Annotations)", "regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434 from GO Biological Process Annotations)", "regulation of protein acetylation (GO:1901983 from GO Biological Process Annotations)", "regulation of protein activation cascade (GO:2000257 from GO Biological Process Annotations)", "regulation of protein adp-ribosylation (GO:0010835 from GO Biological Process Annotations)", "regulation of protein autophosphorylation (GO:0031952 from GO Biological Process Annotations)", "regulation of protein autoubiquitination (GO:1902498 from GO Biological Process Annotations)", "regulation of protein binding (GO:0043393 from GO Biological Process Annotations)", "regulation of protein catabolic process (GO:0042176 from GO Biological Process Annotations)", "regulation of protein complex assembly (GO:0043254 from GO Biological Process Annotations)", "regulation of protein complex disassembly (GO:0043244 from GO Biological Process Annotations)", "regulation of protein complex stability (GO:0061635 from GO Biological Process Annotations)", "regulation of protein deacetylation (GO:0090311 from GO Biological Process Annotations)", "regulation of protein dephosphorylation (GO:0035304 from GO Biological Process Annotations)", "regulation of protein depolymerization (GO:1901879 from GO Biological Process Annotations)", "regulation of protein deubiquitination (GO:0090085 from GO Biological Process Annotations)", "regulation of protein exit from endoplasmic reticulum (GO:0070861 from GO Biological Process Annotations)", "regulation of protein export from nucleus (GO:0046825 from GO Biological Process Annotations)", "regulation of protein folding (GO:1903332 from GO Biological Process Annotations)", "regulation of protein folding in endoplasmic reticulum (GO:0060904 from GO Biological Process Annotations)", "regulation of protein geranylgeranylation (GO:2000539 from GO Biological Process Annotations)", "regulation of protein glutathionylation (GO:0010732 from GO Biological Process Annotations)", "regulation of protein glycosylation (GO:0060049 from GO Biological Process Annotations)", "regulation of protein glycosylation in golgi (GO:0090283 from GO Biological Process Annotations)", "regulation of protein heterodimerization activity (GO:0043497 from GO Biological Process Annotations)", "regulation of protein homodimerization activity (GO:0043496 from GO Biological Process Annotations)", "regulation of protein homooligomerization (GO:0032462 from GO Biological Process Annotations)", "regulation of protein homotetramerization (GO:1901093 from GO Biological Process Annotations)", "regulation of protein import into mitochondrial outer membrane (GO:1903636 from GO Biological Process Annotations)", "regulation of protein import into nucleus (GO:0042306 from GO Biological Process Annotations)", "regulation of protein import into nucleus, translocation (GO:0033158 from GO Biological Process Annotations)", "regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739 from GO Biological Process Annotations)", "regulation of protein k48-linked deubiquitination (GO:1903093 from GO Biological Process Annotations)", "regulation of protein k63-linked deubiquitination (GO:1903004 from GO Biological Process Annotations)", "regulation of protein k63-linked ubiquitination (GO:1900044 from GO Biological Process Annotations)", "regulation of protein kinase a signaling (GO:0010738 from GO Biological Process Annotations)", "regulation of protein kinase activity (GO:0045859 from GO Biological Process Annotations)", "regulation of protein kinase b signaling (GO:0051896 from GO Biological Process Annotations)", "regulation of protein kinase c activity (GO:1900019 from GO Biological Process Annotations)", "regulation of protein kinase c signaling (GO:0090036 from GO Biological Process Annotations)", "regulation of protein kinase d signaling (GO:1903570 from GO Biological Process Annotations)", "regulation of protein linear polyubiquitination (GO:1902528 from GO Biological Process Annotations)", "regulation of protein lipidation (GO:1903059 from GO Biological Process Annotations)", "regulation of protein localization (GO:0032880 from GO Biological Process Annotations)", "regulation of protein localization to cell surface (GO:2000008 from GO Biological Process Annotations)", "regulation of protein localization to ciliary membrane (GO:1903567 from GO Biological Process Annotations)", "regulation of protein localization to cilium (GO:1903564 from GO Biological Process Annotations)", "regulation of protein localization to early endosome (GO:1902965 from GO Biological Process Annotations)", "regulation of protein localization to nucleus (GO:1900180 from GO Biological Process Annotations)", "regulation of protein localization to plasma membrane (GO:1903076 from GO Biological Process Annotations)", "regulation of protein localization to synapse (GO:1902473 from GO Biological Process Annotations)", "regulation of protein metabolic process (GO:0051246 from GO Biological Process Annotations)", "regulation of protein modification by small protein conjugation or removal (GO:1903320 from GO Biological Process Annotations)", "regulation of protein modification process (GO:0031399 from GO Biological Process Annotations)", "regulation of protein monoubiquitination (GO:1902525 from GO Biological Process Annotations)", "regulation of protein oligomerization (GO:0032459 from GO Biological Process Annotations)", "regulation of protein phosphatase type 2a activity (GO:0034047 from GO Biological Process Annotations)", "regulation of protein phosphatase type 2b activity (GO:0032512 from GO Biological Process Annotations)", "regulation of protein phosphorylation (GO:0001932 from GO Biological Process Annotations)", "regulation of protein polymerization (GO:0032271 from GO Biological Process Annotations)", "regulation of protein polyubiquitination (GO:1902914 from GO Biological Process Annotations)", "regulation of protein processing (GO:0070613 from GO Biological Process Annotations)", "regulation of protein processing involved in protein targeting to mitochondrion (GO:1903216 from GO Biological Process Annotations)", "regulation of protein refolding (GO:0061083 from GO Biological Process Annotations)", "regulation of protein secretion (GO:0050708 from GO Biological Process Annotations)", "regulation of protein serine|threonine kinase activity (GO:0071900 from GO Biological Process Annotations)", "regulation of protein serine|threonine phosphatase activity (GO:0080163 from GO Biological Process Annotations)", "regulation of protein stability (GO:0031647 from GO Biological Process Annotations)", "regulation of protein sumoylation (GO:0033233 from GO Biological Process Annotations)", "regulation of protein targeting (GO:1903533 from GO Biological Process Annotations)", "regulation of protein targeting to membrane (GO:0090313 from GO Biological Process Annotations)", "regulation of protein targeting to mitochondrion (GO:1903214 from GO Biological Process Annotations)", "regulation of protein targeting to vacuolar membrane (GO:1900483 from GO Biological Process Annotations)", "regulation of protein tetramerization (GO:1901090 from GO Biological Process Annotations)", "regulation of protein transport (GO:0051223 from GO Biological Process Annotations)", "regulation of protein tyrosine kinase activity (GO:0061097 from GO Biological Process Annotations)", "regulation of protein ubiquitination (GO:0031396 from GO Biological Process Annotations)", "regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2000058 from GO Biological Process Annotations)", "regulation of proteinase activated receptor activity (GO:1900276 from GO Biological Process Annotations)", "regulation of proteolysis (GO:0030162 from GO Biological Process Annotations)", "regulation of proteolysis involved in cellular protein catabolic process (GO:1903050 from GO Biological Process Annotations)", "regulation of proton transport (GO:0010155 from GO Biological Process Annotations)", "regulation of proton-transporting atpase activity, rotational mechanism (GO:0010849 from GO Biological Process Annotations)", "regulation of pseudopodium assembly (GO:0031272 from GO Biological Process Annotations)", "regulation of purine nucleotide biosynthetic process (GO:1900371 from GO Biological Process Annotations)", "regulation of purine nucleotide catabolic process (GO:0033121 from GO Biological Process Annotations)", "regulation of purine nucleotide metabolic process (GO:1900542 from GO Biological Process Annotations)", "regulation of purkinje myocyte action potential (GO:0098906 from GO Biological Process Annotations)", "regulation of pyrroline-5-carboxylate reductase activity (GO:1903167 from GO Biological Process Annotations)", "regulation of rab protein signal transduction (GO:0032483 from GO Biological Process Annotations)", "regulation of rac protein signal transduction (GO:0035020 from GO Biological Process Annotations)", "regulation of ral protein signal transduction (GO:0032485 from GO Biological Process Annotations)", "regulation of rap protein signal transduction (GO:0032487 from GO Biological Process Annotations)", "regulation of ras protein signal transduction (GO:0046578 from GO Biological Process Annotations)", "regulation of reactive oxygen species biosynthetic process (GO:1903426 from GO Biological Process Annotations)", "regulation of reactive oxygen species metabolic process (GO:2000377 from GO Biological Process Annotations)", "regulation of receptor activity (GO:0010469 from GO Biological Process Annotations)", "regulation of receptor binding (GO:1900120 from GO Biological Process Annotations)", "regulation of receptor biosynthetic process (GO:0010869 from GO Biological Process Annotations)", "regulation of receptor catabolic process (GO:2000644 from GO Biological Process Annotations)", "regulation of receptor internalization (GO:0002090 from GO Biological Process Annotations)", "regulation of receptor localization to synapse (GO:1902683 from GO Biological Process Annotations)", "regulation of receptor recycling (GO:0001919 from GO Biological Process Annotations)", "regulation of receptor-mediated endocytosis (GO:0048259 from GO Biological Process Annotations)", "regulation of reciprocal meiotic recombination (GO:0010520 from GO Biological Process Annotations)", "regulation of regulated secretory pathway (GO:1903305 from GO Biological Process Annotations)", "regulation of regulatory t cell differentiation (GO:0045589 from GO Biological Process Annotations)", "regulation of relaxation of cardiac muscle (GO:1901897 from GO Biological Process Annotations)", "regulation of relaxation of muscle (GO:1901077 from GO Biological Process Annotations)", "regulation of release of cytochrome c from mitochondria (GO:0090199 from GO Biological Process Annotations)", "regulation of release of sequestered calcium ion into cytosol (GO:0051279 from GO Biological Process Annotations)", "regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880 from GO Biological Process Annotations)", "regulation of removal of superoxide radicals (GO:2000121 from GO Biological Process Annotations)", "regulation of renal albumin absorption (GO:2000532 from GO Biological Process Annotations)", "regulation of renal output by angiotensin (GO:0002019 from GO Biological Process Annotations)", "regulation of renal phosphate excretion (GO:1903402 from GO Biological Process Annotations)", "regulation of renal sodium excretion (GO:0035813 from GO Biological Process Annotations)", "regulation of renal system process (GO:0098801 from GO Biological Process Annotations)", "regulation of renal water transport (GO:2001151 from GO Biological Process Annotations)", "regulation of renin secretion into blood stream (GO:1900133 from GO Biological Process Annotations)", "regulation of replicative cell aging (GO:1900062 from GO Biological Process Annotations)", "regulation of reproductive process (GO:2000241 from GO Biological Process Annotations)", "regulation of respiratory burst (GO:0060263 from GO Biological Process Annotations)", "regulation of respiratory burst involved in inflammatory response (GO:0060264 from GO Biological Process Annotations)", "regulation of respiratory gaseous exchange (GO:0043576 from GO Biological Process Annotations)", "regulation of respiratory gaseous exchange by neurological system process (GO:0002087 from GO Biological Process Annotations)", "regulation of respiratory system process (GO:0044065 from GO Biological Process Annotations)", "regulation of response to alcohol (GO:1901419 from GO Biological Process Annotations)", "regulation of response to biotic stimulus (GO:0002831 from GO Biological Process Annotations)", "regulation of response to cytokine stimulus (GO:0060759 from GO Biological Process Annotations)", "regulation of response to dna damage stimulus (GO:2001020 from GO Biological Process Annotations)", "regulation of response to drug (GO:2001023 from GO Biological Process Annotations)", "regulation of response to external stimulus (GO:0032101 from GO Biological Process Annotations)", "regulation of response to extracellular stimulus (GO:0032104 from GO Biological Process Annotations)", "regulation of response to food (GO:0032095 from GO Biological Process Annotations)", "regulation of response to interferon-gamma (GO:0060330 from GO Biological Process Annotations)", "regulation of response to nutrient levels (GO:0032107 from GO Biological Process Annotations)", "regulation of response to osmotic stress (GO:0047484 from GO Biological Process Annotations)", "regulation of response to oxidative stress (GO:1902882 from GO Biological Process Annotations)", "regulation of response to reactive oxygen species (GO:1901031 from GO Biological Process Annotations)", "regulation of response to stimulus (GO:0048583 from GO Biological Process Annotations)", "regulation of response to stress (GO:0080134 from GO Biological Process Annotations)", "regulation of response to tumor cell (GO:0002834 from GO Biological Process Annotations)", "regulation of response to wounding (GO:1903034 from GO Biological Process Annotations)", "regulation of resting membrane potential (GO:0060075 from GO Biological Process Annotations)", "regulation of retina development in camera-type eye (GO:1902866 from GO Biological Process Annotations)", "regulation of retinal cell programmed cell death (GO:0046668 from GO Biological Process Annotations)", "regulation of retinal ganglion cell axon guidance (GO:0090259 from GO Biological Process Annotations)", "regulation of retinoic acid biosynthetic process (GO:1900052 from GO Biological Process Annotations)", "regulation of retinoic acid receptor signaling pathway (GO:0048385 from GO Biological Process Annotations)", "regulation of retrograde vesicle-mediated transport, golgi to er (GO:2000156 from GO Biological Process Annotations)", "regulation of rho guanyl-nucleotide exchange factor activity (GO:2001106 from GO Biological Process Annotations)", "regulation of rho protein signal transduction (GO:0035023 from GO Biological Process Annotations)", "regulation of rho-dependent protein serine|threonine kinase activity (GO:2000298 from GO Biological Process Annotations)", "regulation of rhodopsin gene expression (GO:0007468 from GO Biological Process Annotations)", "regulation of rhodopsin mediated signaling pathway (GO:0022400 from GO Biological Process Annotations)", "regulation of ribonuclease activity (GO:0060700 from GO Biological Process Annotations)", "regulation of ribosome biogenesis (GO:0090069 from GO Biological Process Annotations)", "regulation of rig-i signaling pathway (GO:0039535 from GO Biological Process Annotations)", "regulation of ripoptosome assembly involved in necroptotic process (GO:1902442 from GO Biological Process Annotations)", "regulation of rna biosynthetic process (GO:2001141 from GO Biological Process Annotations)", "regulation of rna export from nucleus (GO:0046831 from GO Biological Process Annotations)", "regulation of rna interference (GO:1900368 from GO Biological Process Annotations)", "regulation of rna metabolic process (GO:0051252 from GO Biological Process Annotations)", "regulation of rna polymerase ii regulatory region sequence-specific dna binding (GO:1903025 from GO Biological Process Annotations)", "regulation of rna polymerase ii transcriptional preinitiation complex assembly (GO:0045898 from GO Biological Process Annotations)", "regulation of rna splicing (GO:0043484 from GO Biological Process Annotations)", "regulation of rna stability (GO:0043487 from GO Biological Process Annotations)", "regulation of rna-directed rna polymerase activity (GO:1900259 from GO Biological Process Annotations)", "regulation of root development (GO:2000280 from GO Biological Process Annotations)", "regulation of root hair elongation (GO:1902890 from GO Biological Process Annotations)", "regulation of root morphogenesis (GO:2000067 from GO Biological Process Annotations)", "regulation of rrna processing (GO:2000232 from GO Biological Process Annotations)", "regulation of rubidium ion transmembrane transporter activity (GO:2000686 from GO Biological Process Annotations)", "regulation of rubidium ion transport (GO:2000680 from GO Biological Process Annotations)", "regulation of ruffle assembly (GO:1900027 from GO Biological Process Annotations)", "regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314 from GO Biological Process Annotations)", "regulation of sa node cell action potential (GO:0098907 from GO Biological Process Annotations)", "regulation of saliva secretion (GO:0046877 from GO Biological Process Annotations)", "regulation of sarcomere organization (GO:0060297 from GO Biological Process Annotations)", "regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014717 from GO Biological Process Annotations)", "regulation of satellite cell proliferation (GO:0014842 from GO Biological Process Annotations)", "regulation of schwann cell differentiation (GO:0014038 from GO Biological Process Annotations)", "regulation of schwann cell proliferation (GO:0010624 from GO Biological Process Annotations)", "regulation of sclerotome development (GO:0061190 from GO Biological Process Annotations)", "regulation of secondary heart field cardioblast proliferation (GO:0003266 from GO Biological Process Annotations)", "regulation of secondary metabolic process (GO:0043455 from GO Biological Process Annotations)", "regulation of secondary metabolite biosynthetic process (GO:1900376 from GO Biological Process Annotations)", "regulation of secretion (GO:0051046 from GO Biological Process Annotations)", "regulation of secretion by cell (GO:1903530 from GO Biological Process Annotations)", "regulation of secretion of lysosomal enzymes (GO:0090182 from GO Biological Process Annotations)", "regulation of semaphorin-plexin signaling pathway (GO:2001260 from GO Biological Process Annotations)", "regulation of sensory perception (GO:0051931 from GO Biological Process Annotations)", "regulation of sensory perception of pain (GO:0051930 from GO Biological Process Annotations)", "regulation of sequence-specific dna binding transcription factor activity (GO:0051090 from GO Biological Process Annotations)", "regulation of sequestering of calcium ion (GO:0051282 from GO Biological Process Annotations)", "regulation of sequestering of triglyceride (GO:0010889 from GO Biological Process Annotations)", "regulation of sequestering of zinc ion (GO:0061088 from GO Biological Process Annotations)", "regulation of serine-type endopeptidase activity (GO:1900003 from GO Biological Process Annotations)", "regulation of serine-type peptidase activity (GO:1902571 from GO Biological Process Annotations)", "regulation of serotonin secretion (GO:0014062 from GO Biological Process Annotations)", "regulation of serotonin uptake (GO:0051611 from GO Biological Process Annotations)", "regulation of short-term neuronal synaptic plasticity (GO:0048172 from GO Biological Process Annotations)", "regulation of signal transduction (GO:0009966 from GO Biological Process Annotations)", "regulation of signal transduction by p53 class mediator (GO:1901796 from GO Biological Process Annotations)", "regulation of signal transduction by receptor internalization (GO:0038009 from GO Biological Process Annotations)", "regulation of signal transduction involved in mitotic g2 dna damage checkpoint (GO:1902504 from GO Biological Process Annotations)", "regulation of signaling (GO:0023051 from GO Biological Process Annotations)", "regulation of single stranded viral rna replication via double stranded dna intermediate (GO:0045091 from GO Biological Process Annotations)", "regulation of single-species biofilm formation (GO:1900190 from GO Biological Process Annotations)", "regulation of single-species biofilm formation in or on host organism (GO:1900228 from GO Biological Process Annotations)", "regulation of single-stranded telomeric dna binding (GO:0060380 from GO Biological Process Annotations)", "regulation of sister chromatid cohesion (GO:0007063 from GO Biological Process Annotations)", "regulation of sister chromatid segregation (GO:0033045 from GO Biological Process Annotations)", "regulation of skeletal muscle adaptation (GO:0014733 from GO Biological Process Annotations)", "regulation of skeletal muscle cell differentiation (GO:2001014 from GO Biological Process Annotations)", "regulation of skeletal muscle cell proliferation (GO:0014857 from GO Biological Process Annotations)", "regulation of skeletal muscle contraction (GO:0014819 from GO Biological Process Annotations)", "regulation of skeletal muscle contraction by calcium ion signaling (GO:0014722 from GO Biological Process Annotations)", "regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014809 from GO Biological Process Annotations)", "regulation of skeletal muscle contraction via regulation of action potential (GO:0014861 from GO Biological Process Annotations)", "regulation of skeletal muscle fiber development (GO:0048742 from GO Biological Process Annotations)", "regulation of skeletal muscle fiber differentiation (GO:1902809 from GO Biological Process Annotations)", "regulation of skeletal muscle tissue development (GO:0048641 from GO Biological Process Annotations)", "regulation of skeletal muscle tissue growth (GO:0048631 from GO Biological Process Annotations)", "regulation of skeletal muscle tissue regeneration (GO:0043416 from GO Biological Process Annotations)", "regulation of smad protein complex assembly (GO:0010990 from GO Biological Process Annotations)", "regulation of smad protein import into nucleus (GO:0060390 from GO Biological Process Annotations)", "regulation of small gtpase mediated signal transduction (GO:0051056 from GO Biological Process Annotations)", "regulation of smooth muscle cell apoptotic process (GO:0034391 from GO Biological Process Annotations)", "regulation of smooth muscle cell chemotaxis (GO:0071671 from GO Biological Process Annotations)", "regulation of smooth muscle cell differentiation (GO:0051150 from GO Biological Process Annotations)", "regulation of smooth muscle cell migration (GO:0014910 from GO Biological Process Annotations)", "regulation of smooth muscle cell proliferation (GO:0048660 from GO Biological Process Annotations)", "regulation of smooth muscle cell-matrix adhesion (GO:2000097 from GO Biological Process Annotations)", "regulation of smooth muscle contraction (GO:0006940 from GO Biological Process Annotations)", "regulation of smoothened signaling pathway (GO:0008589 from GO Biological Process Annotations)", "regulation of smoothened signaling pathway involved in dorsal|ventral neural tube patterning (GO:1901620 from GO Biological Process Annotations)", "regulation of snare complex assembly (GO:0035542 from GO Biological Process Annotations)", "regulation of sodium ion export (GO:1903273 from GO Biological Process Annotations)", "regulation of sodium ion export from cell (GO:1903276 from GO Biological Process Annotations)", "regulation of sodium ion transmembrane transport (GO:1902305 from GO Biological Process Annotations)", "regulation of sodium ion transmembrane transporter activity (GO:2000649 from GO Biological Process Annotations)", "regulation of sodium ion transport (GO:0002028 from GO Biological Process Annotations)", "regulation of sodium-dependent phosphate transport (GO:2000118 from GO Biological Process Annotations)", "regulation of sodium:proton antiporter activity (GO:0032415 from GO Biological Process Annotations)", "regulation of somatostatin secretion (GO:0090273 from GO Biological Process Annotations)", "regulation of somitogenesis (GO:0014807 from GO Biological Process Annotations)", "regulation of sperm motility (GO:1901317 from GO Biological Process Annotations)", "regulation of spermidine biosynthetic process (GO:1901304 from GO Biological Process Annotations)", "regulation of sphingolipid biosynthetic process (GO:0090153 from GO Biological Process Annotations)", "regulation of sphingolipid mediated signaling pathway (GO:1902068 from GO Biological Process Annotations)", "regulation of sphingomyelin catabolic process (GO:2000754 from GO Biological Process Annotations)", "regulation of spindle assembly (GO:0090169 from GO Biological Process Annotations)", "regulation of spindle checkpoint (GO:0090231 from GO Biological Process Annotations)", "regulation of spindle organization (GO:0090224 from GO Biological Process Annotations)", "regulation of spongiotrophoblast cell proliferation (GO:0060721 from GO Biological Process Annotations)", "regulation of sprouting angiogenesis (GO:1903670 from GO Biological Process Annotations)", "regulation of sprouting of injured axon (GO:0048686 from GO Biological Process Annotations)", "regulation of srebp signaling pathway (GO:2000638 from GO Biological Process Annotations)", "regulation of stat protein import into nucleus (GO:2000364 from GO Biological Process Annotations)", "regulation of stem cell differentiation (GO:2000736 from GO Biological Process Annotations)", "regulation of stem cell division (GO:2000035 from GO Biological Process Annotations)", "regulation of stem cell maintenance (GO:2000036 from GO Biological Process Annotations)", "regulation of stem cell proliferation (GO:0072091 from GO Biological Process Annotations)", "regulation of steroid biosynthetic process (GO:0050810 from GO Biological Process Annotations)", "regulation of steroid hormone biosynthetic process (GO:0090030 from GO Biological Process Annotations)", "regulation of steroid hormone secretion (GO:2000831 from GO Biological Process Annotations)", "regulation of steroid metabolic process (GO:0019218 from GO Biological Process Annotations)", "regulation of sterol import (GO:2000909 from GO Biological Process Annotations)", "regulation of sterol transport (GO:0032371 from GO Biological Process Annotations)", "regulation of stomach neuroendocrine cell differentiation (GO:0061105 from GO Biological Process Annotations)", "regulation of store-operated calcium channel activity (GO:1901339 from GO Biological Process Annotations)", "regulation of store-operated calcium entry (GO:2001256 from GO Biological Process Annotations)", "regulation of stress fiber assembly (GO:0051492 from GO Biological Process Annotations)", "regulation of stress-activated mapk cascade (GO:0032872 from GO Biological Process Annotations)", "regulation of stress-activated protein kinase signaling cascade (GO:0070302 from GO Biological Process Annotations)", "regulation of striated muscle cell apoptotic process (GO:0010662 from GO Biological Process Annotations)", "regulation of striated muscle cell differentiation (GO:0051153 from GO Biological Process Annotations)", "regulation of striated muscle contraction (GO:0006942 from GO Biological Process Annotations)", "regulation of striated muscle tissue development (GO:0016202 from GO Biological Process Annotations)", "regulation of substrate adhesion-dependent cell spreading (GO:1900024 from GO Biological Process Annotations)", "regulation of sulfur amino acid metabolic process (GO:0031335 from GO Biological Process Annotations)", "regulation of sulfur metabolic process (GO:0042762 from GO Biological Process Annotations)", "regulation of sumo transferase activity (GO:1903182 from GO Biological Process Annotations)", "regulation of superoxide anion generation (GO:0032928 from GO Biological Process Annotations)", "regulation of superoxide dismutase activity (GO:1901668 from GO Biological Process Annotations)", "regulation of superoxide metabolic process (GO:0090322 from GO Biological Process Annotations)", "regulation of symbiosis, encompassing mutualism through parasitism (GO:0043903 from GO Biological Process Annotations)", "regulation of synapse assembly (GO:0051963 from GO Biological Process Annotations)", "regulation of synapse maturation (GO:0090128 from GO Biological Process Annotations)", "regulation of synapse organization (GO:0050807 from GO Biological Process Annotations)", "regulation of synapse structural plasticity (GO:0051823 from GO Biological Process Annotations)", "regulation of synapse structure or activity (GO:0050803 from GO Biological Process Annotations)", "regulation of synaptic activity (GO:0060025 from GO Biological Process Annotations)", "regulation of synaptic growth at neuromuscular junction (GO:0008582 from GO Biological Process Annotations)", "regulation of synaptic plasticity (GO:0048167 from GO Biological Process Annotations)", "regulation of synaptic transmission (GO:0050804 from GO Biological Process Annotations)", "regulation of synaptic transmission, cholinergic (GO:0032222 from GO Biological Process Annotations)", "regulation of synaptic transmission, dopaminergic (GO:0032225 from GO Biological Process Annotations)", "regulation of synaptic transmission, gabaergic (GO:0032228 from GO Biological Process Annotations)", "regulation of synaptic transmission, glutamatergic (GO:0051966 from GO Biological Process Annotations)", "regulation of synaptic vesicle clustering (GO:2000807 from GO Biological Process Annotations)", "regulation of synaptic vesicle endocytosis (GO:1900242 from GO Biological Process Annotations)", "regulation of synaptic vesicle exocytosis (GO:2000300 from GO Biological Process Annotations)", "regulation of synaptic vesicle fusion to presynaptic membrane (GO:0031630 from GO Biological Process Annotations)", "regulation of synaptic vesicle membrane organization (GO:1901632 from GO Biological Process Annotations)", "regulation of synaptic vesicle priming (GO:0010807 from GO Biological Process Annotations)", "regulation of synaptic vesicle recycling (GO:1903421 from GO Biological Process Annotations)", "regulation of synaptic vesicle transport (GO:1902803 from GO Biological Process Annotations)", "regulation of synaptic vesicle uncoating (GO:1903388 from GO Biological Process Annotations)", "regulation of syncytium formation by plasma membrane fusion (GO:0060142 from GO Biological Process Annotations)", "regulation of system process (GO:0044057 from GO Biological Process Annotations)", "regulation of systemic arterial blood pressure (GO:0003073 from GO Biological Process Annotations)", "regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback (GO:0003026 from GO Biological Process Annotations)", "regulation of systemic arterial blood pressure by atrial natriuretic peptide (GO:0003050 from GO Biological Process Annotations)", "regulation of systemic arterial blood pressure by baroreceptor feedback (GO:0003025 from GO Biological Process Annotations)", "regulation of systemic arterial blood pressure by circulatory renin-angiotensin (GO:0001991 from GO Biological Process Annotations)", "regulation of systemic arterial blood pressure by endothelin (GO:0003100 from GO Biological Process Annotations)", "regulation of systemic arterial blood pressure by hormone (GO:0001990 from GO Biological Process Annotations)", "regulation of systemic arterial blood pressure by ischemic conditions (GO:0001980 from GO Biological Process Annotations)", "regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081 from GO Biological Process Annotations)", "regulation of systemic arterial blood pressure by vasopressin (GO:0001992 from GO Biological Process Annotations)", "regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044 from GO Biological Process Annotations)", "regulation of t cell activation (GO:0050863 from GO Biological Process Annotations)", "regulation of t cell activation via t cell receptor contact with antigen bound to mhc molecule on antigen presenting cell (GO:2001188 from GO Biological Process Annotations)", "regulation of t cell anergy (GO:0002667 from GO Biological Process Annotations)", "regulation of t cell antigen processing and presentation (GO:0002625 from GO Biological Process Annotations)", "regulation of t cell apoptotic process (GO:0070232 from GO Biological Process Annotations)", "regulation of t cell chemotaxis (GO:0010819 from GO Biological Process Annotations)", "regulation of t cell costimulation (GO:2000523 from GO Biological Process Annotations)", "regulation of t cell cytokine production (GO:0002724 from GO Biological Process Annotations)", "regulation of t cell differentiation (GO:0045580 from GO Biological Process Annotations)", "regulation of t cell differentiation in thymus (GO:0033081 from GO Biological Process Annotations)", "regulation of t cell extravasation (GO:2000407 from GO Biological Process Annotations)", "regulation of t cell homeostatic proliferation (GO:0046013 from GO Biological Process Annotations)", "regulation of t cell mediated cytotoxicity (GO:0001914 from GO Biological Process Annotations)", "regulation of t cell mediated immune response to tumor cell (GO:0002840 from GO Biological Process Annotations)", "regulation of t cell mediated immunity (GO:0002709 from GO Biological Process Annotations)", "regulation of t cell migration (GO:2000404 from GO Biological Process Annotations)", "regulation of t cell proliferation (GO:0042129 from GO Biological Process Annotations)", "regulation of t cell receptor signaling pathway (GO:0050856 from GO Biological Process Annotations)", "regulation of t cell tolerance induction (GO:0002664 from GO Biological Process Annotations)", "regulation of t-helper 1 cell activation (GO:2000517 from GO Biological Process Annotations)", "regulation of t-helper 1 cell cytokine production (GO:2000554 from GO Biological Process Annotations)", "regulation of t-helper 1 cell differentiation (GO:0045625 from GO Biological Process Annotations)", "regulation of t-helper 1 type immune response (GO:0002825 from GO Biological Process Annotations)", "regulation of t-helper 17 cell differentiation (GO:2000319 from GO Biological Process Annotations)", "regulation of t-helper 17 cell lineage commitment (GO:2000328 from GO Biological Process Annotations)", "regulation of t-helper 17 type immune response (GO:2000316 from GO Biological Process Annotations)", "regulation of t-helper 2 cell activation (GO:2000569 from GO Biological Process Annotations)", "regulation of t-helper 2 cell cytokine production (GO:2000551 from GO Biological Process Annotations)", "regulation of t-helper 2 cell differentiation (GO:0045628 from GO Biological Process Annotations)", "regulation of t-helper cell differentiation (GO:0045622 from GO Biological Process Annotations)", "regulation of tau-protein kinase activity (GO:1902947 from GO Biological Process Annotations)", "regulation of telomerase activity (GO:0051972 from GO Biological Process Annotations)", "regulation of telomere maintenance (GO:0032204 from GO Biological Process Annotations)", "regulation of telomere maintenance via semi-conservative replication (GO:0032213 from GO Biological Process Annotations)", "regulation of telomere maintenance via telomerase (GO:0032210 from GO Biological Process Annotations)", "regulation of telomeric rna transcription from rna pol ii promoter (GO:1901580 from GO Biological Process Annotations)", "regulation of tendon cell differentiation (GO:2001049 from GO Biological Process Annotations)", "regulation of terminal button organization (GO:2000331 from GO Biological Process Annotations)", "regulation of termination of rna polymerase ii transcription, poly(a)-coupled (GO:2000804 from GO Biological Process Annotations)", "regulation of testosterone biosynthetic process (GO:2000224 from GO Biological Process Annotations)", "regulation of testosterone secretion (GO:2000843 from GO Biological Process Annotations)", "regulation of the force of heart contraction (GO:0002026 from GO Biological Process Annotations)", "regulation of the force of heart contraction by cardiac conduction (GO:0086092 from GO Biological Process Annotations)", "regulation of the force of heart contraction by chemical signal (GO:0003057 from GO Biological Process Annotations)", "regulation of thrombin receptor signaling pathway (GO:0070494 from GO Biological Process Annotations)", "regulation of thymidylate synthase biosynthetic process (GO:0050758 from GO Biological Process Annotations)", "regulation of thymocyte aggregation (GO:2000398 from GO Biological Process Annotations)", "regulation of thymocyte apoptotic process (GO:0070243 from GO Biological Process Annotations)", "regulation of thymocyte migration (GO:2000410 from GO Biological Process Annotations)", "regulation of thyroid hormone generation (GO:2000609 from GO Biological Process Annotations)", "regulation of thyroid hormone mediated signaling pathway (GO:0002155 from GO Biological Process Annotations)", "regulation of thyroid-stimulating hormone secretion (GO:2000612 from GO Biological Process Annotations)", "regulation of tight junction assembly (GO:2000810 from GO Biological Process Annotations)", "regulation of timing of cell differentiation (GO:0048505 from GO Biological Process Annotations)", "regulation of timing of neuron differentiation (GO:0060164 from GO Biological Process Annotations)", "regulation of timing of subpallium neuron differentiation (GO:0060165 from GO Biological Process Annotations)", "regulation of tissue remodeling (GO:0034103 from GO Biological Process Annotations)", "regulation of tolerance induction (GO:0002643 from GO Biological Process Annotations)", "regulation of tolerance induction dependent upon immune response (GO:0002652 from GO Biological Process Annotations)", "regulation of tolerance induction to self antigen (GO:0002649 from GO Biological Process Annotations)", "regulation of toll signaling pathway (GO:0008592 from GO Biological Process Annotations)", "regulation of toll-like receptor 2 signaling pathway (GO:0034135 from GO Biological Process Annotations)", "regulation of toll-like receptor 3 signaling pathway (GO:0034139 from GO Biological Process Annotations)", "regulation of toll-like receptor 4 signaling pathway (GO:0034143 from GO Biological Process Annotations)", "regulation of toll-like receptor 5 signaling pathway (GO:0034147 from GO Biological Process Annotations)", "regulation of toll-like receptor 7 signaling pathway (GO:0034155 from GO Biological Process Annotations)", "regulation of toll-like receptor 9 signaling pathway (GO:0034163 from GO Biological Process Annotations)", "regulation of toll-like receptor signaling pathway (GO:0034121 from GO Biological Process Annotations)", "regulation of tongue muscle cell differentiation (GO:2001035 from GO Biological Process Annotations)", "regulation of tooth mineralization (GO:0070170 from GO Biological Process Annotations)", "regulation of tor signaling (GO:0032006 from GO Biological Process Annotations)", "regulation of trail biosynthetic process (GO:0045554 from GO Biological Process Annotations)", "regulation of trail production (GO:0032679 from GO Biological Process Annotations)", "regulation of trail receptor biosynthetic process (GO:0045560 from GO Biological Process Annotations)", "regulation of trail-activated apoptotic signaling pathway (GO:1903121 from GO Biological Process Annotations)", "regulation of transcription by galactose (GO:0000409 from GO Biological Process Annotations)", "regulation of transcription by glucose (GO:0046015 from GO Biological Process Annotations)", "regulation of transcription during meiosis (GO:0051037 from GO Biological Process Annotations)", "regulation of transcription during mitosis (GO:0045896 from GO Biological Process Annotations)", "regulation of transcription elongation from rna polymerase ii promoter (GO:0034243 from GO Biological Process Annotations)", "regulation of transcription factor import into nucleus (GO:0042990 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase i promoter (GO:0006356 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter (GO:0006357 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter by galactose (GO:0000431 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter by glucose (GO:0000430 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter by histone modification (GO:1903756 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter in response to arsenic-containing substance (GO:0061394 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter in response to hypoxia (GO:0061418 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter in response to iron (GO:0034395 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter in response to oxidative stress (GO:0043619 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter in response to stress (GO:0043618 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter in response to uv-induced dna damage (GO:0010767 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter involved in definitive endodermal cell fate specification (GO:0060807 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter involved in determination of left|right symmetry (GO:1900094 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter involved in forebrain neuron fate commitment (GO:0021882 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter involved in heart development (GO:1901213 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter involved in kidney development (GO:0060994 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter involved in mesonephros development (GO:0061216 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter involved in myocardial precursor cell differentiation (GO:0003256 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter involved in somatic motor neuron fate commitment (GO:0021918 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter involved in spinal cord association neuron specification (GO:0021920 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter involved in spinal cord motor neuron fate specification (GO:0021912 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter involved in ventral spinal cord interneuron specification (GO:0021913 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase ii promoter, mitotic (GO:0046021 from GO Biological Process Annotations)", "regulation of transcription from rna polymerase iii promoter (GO:0006359 from GO Biological Process Annotations)", "regulation of transcription initiation from rna polymerase ii promoter (GO:0060260 from GO Biological Process Annotations)", "regulation of transcription involved in anterior|posterior axis specification (GO:0044324 from GO Biological Process Annotations)", "regulation of transcription involved in cell fate commitment (GO:0060850 from GO Biological Process Annotations)", "regulation of transcription involved in g1|s transition of mitotic cell cycle (GO:0000083 from GO Biological Process Annotations)", "regulation of transcription involved in g2|m transition of mitotic cell cycle (GO:0000117 from GO Biological Process Annotations)", "regulation of transcription involved in lymphatic endothelial cell fate commitment (GO:0060849 from GO Biological Process Annotations)", "regulation of transcription involved in primary germ layer cell fate commitment (GO:0060796 from GO Biological Process Annotations)", "regulation of transcription of nuclear large rrna transcript from rna polymerase i promoter (GO:1901836 from GO Biological Process Annotations)", "regulation of transcription regulatory region dna binding (GO:2000677 from GO Biological Process Annotations)", "regulation of transcription, dna-templated (GO:0006355 from GO Biological Process Annotations)", "regulation of transferase activity (GO:0051338 from GO Biological Process Annotations)", "regulation of transforming growth factor beta production (GO:0071634 from GO Biological Process Annotations)", "regulation of transforming growth factor beta receptor signaling pathway (GO:0017015 from GO Biological Process Annotations)", "regulation of transforming growth factor beta1 production (GO:0032908 from GO Biological Process Annotations)", "regulation of transforming growth factor beta2 production (GO:0032909 from GO Biological Process Annotations)", "regulation of transforming growth factor beta3 production (GO:0032910 from GO Biological Process Annotations)", "regulation of transforming growth factor-beta secretion (GO:2001201 from GO Biological Process Annotations)", "regulation of translation (GO:0006417 from GO Biological Process Annotations)", "regulation of translation by machinery localization (GO:0043143 from GO Biological Process Annotations)", "regulation of translation in response to stress (GO:0043555 from GO Biological Process Annotations)", "regulation of translation, ncrna-mediated (GO:0045974 from GO Biological Process Annotations)", "regulation of translational elongation (GO:0006448 from GO Biological Process Annotations)", "regulation of translational fidelity (GO:0006450 from GO Biological Process Annotations)", "regulation of translational initiation (GO:0006446 from GO Biological Process Annotations)", "regulation of translational initiation by eif2 alpha phosphorylation (GO:0010998 from GO Biological Process Annotations)", "regulation of translational initiation by iron (GO:0006447 from GO Biological Process Annotations)", "regulation of translational initiation in response to stress (GO:0043558 from GO Biological Process Annotations)", "regulation of translational termination (GO:0006449 from GO Biological Process Annotations)", "regulation of transmembrane receptor protein serine|threonine kinase signaling pathway (GO:0090092 from GO Biological Process Annotations)", "regulation of transmembrane transport (GO:0034762 from GO Biological Process Annotations)", "regulation of transmembrane transporter activity (GO:0022898 from GO Biological Process Annotations)", "regulation of transmission of nerve impulse (GO:0051969 from GO Biological Process Annotations)", "regulation of transport (GO:0051049 from GO Biological Process Annotations)", "regulation of transporter activity (GO:0032409 from GO Biological Process Annotations)", "regulation of transposition (GO:0010528 from GO Biological Process Annotations)", "regulation of transposon integration (GO:0070894 from GO Biological Process Annotations)", "regulation of triglyceride biosynthetic process (GO:0010866 from GO Biological Process Annotations)", "regulation of triglyceride catabolic process (GO:0010896 from GO Biological Process Annotations)", "regulation of triglyceride metabolic process (GO:0090207 from GO Biological Process Annotations)", "regulation of trophoblast cell migration (GO:1901163 from GO Biological Process Annotations)", "regulation of tube size (GO:0035150 from GO Biological Process Annotations)", "regulation of tubulin deacetylation (GO:0090043 from GO Biological Process Annotations)", "regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000307 from GO Biological Process Annotations)", "regulation of tumor necrosis factor biosynthetic process (GO:0042534 from GO Biological Process Annotations)", "regulation of tumor necrosis factor production (GO:0032680 from GO Biological Process Annotations)", "regulation of tumor necrosis factor superfamily cytokine production (GO:1903555 from GO Biological Process Annotations)", "regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803 from GO Biological Process Annotations)", "regulation of twitch skeletal muscle contraction (GO:0014724 from GO Biological Process Annotations)", "regulation of type 2 immune response (GO:0002828 from GO Biological Process Annotations)", "regulation of type b pancreatic cell apoptotic process (GO:2000674 from GO Biological Process Annotations)", "regulation of type b pancreatic cell development (GO:2000074 from GO Biological Process Annotations)", "regulation of type b pancreatic cell proliferation (GO:0061469 from GO Biological Process Annotations)", "regulation of type i hypersensitivity (GO:0001810 from GO Biological Process Annotations)", "regulation of type i interferon production (GO:0032479 from GO Biological Process Annotations)", "regulation of type i interferon-mediated signaling pathway (GO:0060338 from GO Biological Process Annotations)", "regulation of type ii hypersensitivity (GO:0002892 from GO Biological Process Annotations)", "regulation of type iia hypersensitivity (GO:0001796 from GO Biological Process Annotations)", "regulation of type iii hypersensitivity (GO:0001803 from GO Biological Process Annotations)", "regulation of type iii interferon production (GO:0034344 from GO Biological Process Annotations)", "regulation of type iv hypersensitivity (GO:0001807 from GO Biological Process Annotations)", "regulation of tyrosine 3-monooxygenase activity (GO:1903176 from GO Biological Process Annotations)", "regulation of tyrosine phosphorylation of stat protein (GO:0042509 from GO Biological Process Annotations)", "regulation of tyrosine phosphorylation of stat1 protein (GO:0042510 from GO Biological Process Annotations)", "regulation of tyrosine phosphorylation of stat3 protein (GO:0042516 from GO Biological Process Annotations)", "regulation of tyrosine phosphorylation of stat4 protein (GO:0042519 from GO Biological Process Annotations)", "regulation of tyrosine phosphorylation of stat5 protein (GO:0042522 from GO Biological Process Annotations)", "regulation of tyrosine phosphorylation of stat6 protein (GO:0042525 from GO Biological Process Annotations)", "regulation of ubiquitin-dependent endocytosis (GO:2000395 from GO Biological Process Annotations)", "regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439 from GO Biological Process Annotations)", "regulation of ubiquitin-protein transferase activity (GO:0051438 from GO Biological Process Annotations)", "regulation of ubiquitin-specific protease activity (GO:2000152 from GO Biological Process Annotations)", "regulation of udp-glucose catabolic process (GO:0010904 from GO Biological Process Annotations)", "regulation of unsaturated fatty acid biosynthetic process (GO:2001279 from GO Biological Process Annotations)", "regulation of urea metabolic process (GO:0034255 from GO Biological Process Annotations)", "regulation of ureter smooth muscle cell differentiation (GO:2000061 from GO Biological Process Annotations)", "regulation of ureteric bud formation (GO:0072106 from GO Biological Process Annotations)", "regulation of urine volume (GO:0035809 from GO Biological Process Annotations)", "regulation of urothelial cell proliferation (GO:0050675 from GO Biological Process Annotations)", "regulation of uterine smooth muscle contraction (GO:0070472 from GO Biological Process Annotations)", "regulation of vacuolar transport (GO:1903335 from GO Biological Process Annotations)", "regulation of vacuole fusion, non-autophagic (GO:0032889 from GO Biological Process Annotations)", "regulation of vacuole organization (GO:0044088 from GO Biological Process Annotations)", "regulation of vascular endothelial growth factor production (GO:0010574 from GO Biological Process Annotations)", "regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947 from GO Biological Process Annotations)", "regulation of vascular endothelial growth factor signaling pathway (GO:1900746 from GO Biological Process Annotations)", "regulation of vascular permeability (GO:0043114 from GO Biological Process Annotations)", "regulation of vascular permeability involved in acute inflammatory response (GO:0002528 from GO Biological Process Annotations)", "regulation of vascular smooth muscle contraction (GO:0003056 from GO Biological Process Annotations)", "regulation of vascular wound healing (GO:0061043 from GO Biological Process Annotations)", "regulation of vasculature development (GO:1901342 from GO Biological Process Annotations)", "regulation of vasculogenesis (GO:2001212 from GO Biological Process Annotations)", "regulation of vasoconstriction (GO:0019229 from GO Biological Process Annotations)", "regulation of vasoconstriction by circulating norepinephrine (GO:0003117 from GO Biological Process Annotations)", "regulation of vasoconstriction by norepinephrine (GO:0003116 from GO Biological Process Annotations)", "regulation of vasodilation (GO:0042312 from GO Biological Process Annotations)", "regulation of ventricular cardiac muscle cell action potential (GO:0098911 from GO Biological Process Annotations)", "regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373 from GO Biological Process Annotations)", "regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307 from GO Biological Process Annotations)", "regulation of very-low-density lipoprotein particle clearance (GO:0010915 from GO Biological Process Annotations)", "regulation of very-low-density lipoprotein particle remodeling (GO:0010901 from GO Biological Process Annotations)", "regulation of vesicle fusion (GO:0031338 from GO Biological Process Annotations)", "regulation of vesicle size (GO:0097494 from GO Biological Process Annotations)", "regulation of vesicle-mediated transport (GO:0060627 from GO Biological Process Annotations)", "regulation of viral budding via host escrt complex (GO:1903772 from GO Biological Process Annotations)", "regulation of viral entry into host cell (GO:0046596 from GO Biological Process Annotations)", "regulation of viral genome replication (GO:0045069 from GO Biological Process Annotations)", "regulation of viral process (GO:0050792 from GO Biological Process Annotations)", "regulation of viral release from host cell (GO:1902186 from GO Biological Process Annotations)", "regulation of viral transcription (GO:0046782 from GO Biological Process Annotations)", "regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531 from GO Biological Process Annotations)", "regulation of vitamin a metabolic process (GO:1901738 from GO Biological Process Annotations)", "regulation of vitamin d 24-hydroxylase activity (GO:0010979 from GO Biological Process Annotations)", "regulation of vitamin d biosynthetic process (GO:0060556 from GO Biological Process Annotations)", "regulation of vitamin d receptor signaling pathway (GO:0070562 from GO Biological Process Annotations)", "regulation of vitamin metabolic process (GO:0030656 from GO Biological Process Annotations)", "regulation of voltage-gated calcium channel activity (GO:1901385 from GO Biological Process Annotations)", "regulation of voltage-gated chloride channel activity (GO:1902941 from GO Biological Process Annotations)", "regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903760 from GO Biological Process Annotations)", "regulation of water loss via skin (GO:0033561 from GO Biological Process Annotations)", "regulation of white fat cell proliferation (GO:0070350 from GO Biological Process Annotations)", "regulation of wnt protein secretion (GO:0061356 from GO Biological Process Annotations)", "regulation of wnt signaling pathway (GO:0030111 from GO Biological Process Annotations)", "regulation of wnt signaling pathway involved in digestive tract morphogenesis (GO:2000056 from GO Biological Process Annotations)", "regulation of wnt signaling pathway involved in dorsal|ventral axis specification (GO:2000053 from GO Biological Process Annotations)", "regulation of wnt signaling pathway involved in heart development (GO:0003307 from GO Biological Process Annotations)", "regulation of wnt signaling pathway, planar cell polarity pathway (GO:2000095 from GO Biological Process Annotations)", "regulation of wound healing (GO:0061041 from GO Biological Process Annotations)", "regulation of wound healing, spreading of epidermal cells (GO:1903689 from GO Biological Process Annotations)", "regulation of zinc ion transmembrane import (GO:0071581 from GO Biological Process Annotations)", "regulation of zinc ion transmembrane transport (GO:0071580 from GO Biological Process Annotations)", "regulation of zinc ion transport (GO:0071579 from GO Biological Process Annotations)", "regulatory t cell differentiation (GO:0045066 from GO Biological Process Annotations)", "relaxation of cardiac muscle (GO:0055119 from GO Biological Process Annotations)", "relaxation of muscle (GO:0090075 from GO Biological Process Annotations)", "relaxation of skeletal muscle (GO:0090076 from GO Biological Process Annotations)", "relaxation of smooth muscle (GO:0044557 from GO Biological Process Annotations)", "relaxation of vascular smooth muscle (GO:0060087 from GO Biological Process Annotations)", "release from viral latency (GO:0019046 from GO Biological Process Annotations)", "release of cytochrome c from mitochondria (GO:0001836 from GO Biological Process Annotations)", "release of cytoplasmic sequestered nf-kappab (GO:0008588 from GO Biological Process Annotations)", "release of matrix enzymes from mitochondria (GO:0032976 from GO Biological Process Annotations)", "release of sequestered calcium ion into cytosol (GO:0051209 from GO Biological Process Annotations)", "release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808 from GO Biological Process Annotations)", "removal of rna primer involved in mitotic dna replication (GO:1903469 from GO Biological Process Annotations)", "removal of superoxide radicals (GO:0019430 from GO Biological Process Annotations)", "renal absorption (GO:0070293 from GO Biological Process Annotations)", "renal artery morphogenesis (GO:0061441 from GO Biological Process Annotations)", "renal capsule development (GO:0072127 from GO Biological Process Annotations)", "renal capsule specification (GO:0072130 from GO Biological Process Annotations)", "renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure (GO:0003072 from GO Biological Process Annotations)", "renal cortex development (GO:0072055 from GO Biological Process Annotations)", "renal filtration (GO:0097205 from GO Biological Process Annotations)", "renal filtration cell differentiation (GO:0061318 from GO Biological Process Annotations)", "renal glucose absorption (GO:0035623 from GO Biological Process Annotations)", "renal inner medulla development (GO:0072053 from GO Biological Process Annotations)", "renal interstitial fibroblast development (GO:0072141 from GO Biological Process Annotations)", "renal outer medulla development (GO:0072054 from GO Biological Process Annotations)", "renal phosphate ion absorption (GO:0097291 from GO Biological Process Annotations)", "renal protein absorption (GO:0097017 from GO Biological Process Annotations)", "renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure (GO:0001999 from GO Biological Process Annotations)", "renal sodium ion absorption (GO:0070294 from GO Biological Process Annotations)", "renal sodium ion transport (GO:0003096 from GO Biological Process Annotations)", "renal system development (GO:0072001 from GO Biological Process Annotations)", "renal system process (GO:0003014 from GO Biological Process Annotations)", "renal system process involved in regulation of blood volume (GO:0001977 from GO Biological Process Annotations)", "renal system process involved in regulation of systemic arterial blood pressure (GO:0003071 from GO Biological Process Annotations)", "renal system vasculature development (GO:0061437 from GO Biological Process Annotations)", "renal tubular secretion (GO:0097254 from GO Biological Process Annotations)", "renal tubule development (GO:0061326 from GO Biological Process Annotations)", "renal tubule morphogenesis (GO:0061333 from GO Biological Process Annotations)", "renal vesicle formation (GO:0072033 from GO Biological Process Annotations)", "renal vesicle induction (GO:0072034 from GO Biological Process Annotations)", "renal vesicle morphogenesis (GO:0072077 from GO Biological Process Annotations)", "renal vesicle progenitor cell differentiation (GO:0072184 from GO Biological Process Annotations)", "renal water absorption (GO:0070295 from GO Biological Process Annotations)", "renal water homeostasis (GO:0003091 from GO Biological Process Annotations)", "renal water transport (GO:0003097 from GO Biological Process Annotations)", "renin secretion into blood stream (GO:0002001 from GO Biological Process Annotations)", "renin-angiotensin regulation of aldosterone production (GO:0002018 from GO Biological Process Annotations)", "replacement ossification (GO:0036075 from GO Biological Process Annotations)", "replication fork arrest (GO:0043111 from GO Biological Process Annotations)", "replication fork processing (GO:0031297 from GO Biological Process Annotations)", "replication fork protection (GO:0048478 from GO Biological Process Annotations)", "replicative cell aging (GO:0001302 from GO Biological Process Annotations)", "replicative senescence (GO:0090399 from GO Biological Process Annotations)", "reproduction (GO:0000003 from GO Biological Process Annotations)", "reproductive behavior (GO:0019098 from GO Biological Process Annotations)", "reproductive process (GO:0022414 from GO Biological Process Annotations)", "reproductive structure development (GO:0048608 from GO Biological Process Annotations)", "reproductive system development (GO:0061458 from GO Biological Process Annotations)", "resolution of meiotic recombination intermediates (GO:0000712 from GO Biological Process Annotations)", "resolution of mitotic recombination intermediates (GO:0071140 from GO Biological Process Annotations)", "resolution of recombination intermediates (GO:0071139 from GO Biological Process Annotations)", "respiratory burst (GO:0045730 from GO Biological Process Annotations)", "respiratory burst after phagocytosis (GO:0045728 from GO Biological Process Annotations)", "respiratory burst involved in defense response (GO:0002679 from GO Biological Process Annotations)", "respiratory chain complex ii assembly (GO:0034552 from GO Biological Process Annotations)", "respiratory chain complex iii assembly (GO:0017062 from GO Biological Process Annotations)", "respiratory chain complex iv assembly (GO:0008535 from GO Biological Process Annotations)", "respiratory electron transport chain (GO:0022904 from GO Biological Process Annotations)", "respiratory gaseous exchange (GO:0007585 from GO Biological Process Annotations)", "respiratory system development (GO:0060541 from GO Biological Process Annotations)", "respiratory system process (GO:0003016 from GO Biological Process Annotations)", "respiratory tube development (GO:0030323 from GO Biological Process Annotations)", "response to abiotic stimulus (GO:0009628 from GO Biological Process Annotations)", "response to acetate (GO:0010034 from GO Biological Process Annotations)", "response to acid chemical (GO:0001101 from GO Biological Process Annotations)", "response to acidic ph (GO:0010447 from GO Biological Process Annotations)", "response to activity (GO:0014823 from GO Biological Process Annotations)", "response to alcohol (GO:0097305 from GO Biological Process Annotations)", "response to alkaline ph (GO:0010446 from GO Biological Process Annotations)", "response to alkaloid (GO:0043279 from GO Biological Process Annotations)", "response to aluminum ion (GO:0010044 from GO Biological Process Annotations)", "response to amine (GO:0014075 from GO Biological Process Annotations)", "response to amino acid (GO:0043200 from GO Biological Process Annotations)", "response to ammonium ion (GO:0060359 from GO Biological Process Annotations)", "response to amphetamine (GO:0001975 from GO Biological Process Annotations)", "response to anesthetic (GO:0072347 from GO Biological Process Annotations)", "response to anoxia (GO:0034059 from GO Biological Process Annotations)", "response to antibiotic (GO:0046677 from GO Biological Process Annotations)", "response to antipsychotic drug (GO:0097332 from GO Biological Process Annotations)", "response to arsenic-containing substance (GO:0046685 from GO Biological Process Annotations)", "response to atp (GO:0033198 from GO Biological Process Annotations)", "response to auditory stimulus (GO:0010996 from GO Biological Process Annotations)", "response to axon injury (GO:0048678 from GO Biological Process Annotations)", "response to azide (GO:0097184 from GO Biological Process Annotations)", "response to bacterial lipopeptide (GO:0070339 from GO Biological Process Annotations)", "response to bacterial lipoprotein (GO:0032493 from GO Biological Process Annotations)", "response to bacterium (GO:0009617 from GO Biological Process Annotations)", "response to bile acid (GO:1903412 from GO Biological Process Annotations)", "response to biotic stimulus (GO:0009607 from GO Biological Process Annotations)", "response to biotin (GO:0070781 from GO Biological Process Annotations)", "response to blue light (GO:0009637 from GO Biological Process Annotations)", "response to bmp (GO:0071772 from GO Biological Process Annotations)", "response to brefeldin a (GO:0031001 from GO Biological Process Annotations)", "response to cadmium ion (GO:0046686 from GO Biological Process Annotations)", "response to caffeine (GO:0031000 from GO Biological Process Annotations)", "response to calcium ion (GO:0051592 from GO Biological Process Annotations)", "response to camp (GO:0051591 from GO Biological Process Annotations)", "response to camptothecin (GO:1901563 from GO Biological Process Annotations)", "response to carbohydrate (GO:0009743 from GO Biological Process Annotations)", "response to carbon monoxide (GO:0034465 from GO Biological Process Annotations)", "response to catecholamine (GO:0071869 from GO Biological Process Annotations)", "response to cell cycle checkpoint signaling (GO:0072396 from GO Biological Process Annotations)", "response to cgmp (GO:0070305 from GO Biological Process Annotations)", "response to chemical (GO:0042221 from GO Biological Process Annotations)", "response to chlorate (GO:0010157 from GO Biological Process Annotations)", "response to cholesterol (GO:0070723 from GO Biological Process Annotations)", "response to chromate (GO:0046687 from GO Biological Process Annotations)", "response to cisplatin (GO:0072718 from GO Biological Process Annotations)", "response to clozapine (GO:0097338 from GO Biological Process Annotations)", "response to cobalamin (GO:0033590 from GO Biological Process Annotations)", "response to cobalt ion (GO:0032025 from GO Biological Process Annotations)", "response to cocaine (GO:0042220 from GO Biological Process Annotations)", "response to cold (GO:0009409 from GO Biological Process Annotations)", "response to copper ion (GO:0046688 from GO Biological Process Annotations)", "response to corticosteroid (GO:0031960 from GO Biological Process Annotations)", "response to corticosterone (GO:0051412 from GO Biological Process Annotations)", "response to corticotropin-releasing hormone (GO:0043435 from GO Biological Process Annotations)", "response to cortisol (GO:0051414 from GO Biological Process Annotations)", "response to cycloheximide (GO:0046898 from GO Biological Process Annotations)", "response to cytokine (GO:0034097 from GO Biological Process Annotations)", "response to ddt (GO:0046680 from GO Biological Process Annotations)", "response to decreased oxygen levels (GO:0036293 from GO Biological Process Annotations)", "response to defense-related host nitric oxide production (GO:0052565 from GO Biological Process Annotations)", "response to defense-related host reactive oxygen species production (GO:0052567 from GO Biological Process Annotations)", "response to defense-related nitric oxide production by other organism involved in symbiotic interaction (GO:0052551 from GO Biological Process Annotations)", "response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction (GO:0052550 from GO Biological Process Annotations)", "response to defenses of other organism involved in symbiotic interaction (GO:0052173 from GO Biological Process Annotations)", "response to denervation involved in regulation of muscle adaptation (GO:0014894 from GO Biological Process Annotations)", "response to dexamethasone (GO:0071548 from GO Biological Process Annotations)", "response to diacyl bacterial lipopeptide (GO:0071724 from GO Biological Process Annotations)", "response to dietary excess (GO:0002021 from GO Biological Process Annotations)", "response to disaccharide (GO:0034285 from GO Biological Process Annotations)", "response to dithiothreitol (GO:0072720 from GO Biological Process Annotations)", "response to diuretic (GO:0036270 from GO Biological Process Annotations)", "response to dna damage checkpoint signaling (GO:0072423 from GO Biological Process Annotations)", "response to dna integrity checkpoint signaling (GO:0072402 from GO Biological Process Annotations)", "response to docetaxel trihydrate (GO:1902519 from GO Biological Process Annotations)", "response to dopamine (GO:1903350 from GO Biological Process Annotations)", "response to drug (GO:0042493 from GO Biological Process Annotations)", "response to dsrna (GO:0043331 from GO Biological Process Annotations)", "response to electrical stimulus (GO:0051602 from GO Biological Process Annotations)", "response to electrical stimulus involved in regulation of muscle adaptation (GO:0014878 from GO Biological Process Annotations)", "response to endogenous stimulus (GO:0009719 from GO Biological Process Annotations)", "response to endoplasmic reticulum stress (GO:0034976 from GO Biological Process Annotations)", "response to epidermal growth factor (GO:0070849 from GO Biological Process Annotations)", "response to epinephrine (GO:0071871 from GO Biological Process Annotations)", "response to erythropoietin (GO:0036017 from GO Biological Process Annotations)", "response to estradiol (GO:0032355 from GO Biological Process Annotations)", "response to estrogen (GO:0043627 from GO Biological Process Annotations)", "response to ethanol (GO:0045471 from GO Biological Process Annotations)", "response to ether (GO:0045472 from GO Biological Process Annotations)", "response to exogenous dsrna (GO:0043330 from GO Biological Process Annotations)", "response to external biotic stimulus (GO:0043207 from GO Biological Process Annotations)", "response to external stimulus (GO:0009605 from GO Biological Process Annotations)", "response to extracellular stimulus (GO:0009991 from GO Biological Process Annotations)", "response to fatty acid (GO:0070542 from GO Biological Process Annotations)", "response to fibroblast growth factor (GO:0071774 from GO Biological Process Annotations)", "response to fluid shear stress (GO:0034405 from GO Biological Process Annotations)", "response to fluoride (GO:1902617 from GO Biological Process Annotations)", "response to fluoxetine (GO:0014076 from GO Biological Process Annotations)", "response to folic acid (GO:0051593 from GO Biological Process Annotations)", "response to follicle-stimulating hormone (GO:0032354 from GO Biological Process Annotations)", "response to food (GO:0032094 from GO Biological Process Annotations)", "response to freezing (GO:0050826 from GO Biological Process Annotations)", "response to fructose (GO:0009750 from GO Biological Process Annotations)", "response to fungicide (GO:0060992 from GO Biological Process Annotations)", "response to fungus (GO:0009620 from GO Biological Process Annotations)", "response to g1 dna damage checkpoint signaling (GO:0072432 from GO Biological Process Annotations)", "response to gamma radiation (GO:0010332 from GO Biological Process Annotations)", "response to genistein (GO:0033595 from GO Biological Process Annotations)", "response to glucagon (GO:0033762 from GO Biological Process Annotations)", "response to glucocorticoid (GO:0051384 from GO Biological Process Annotations)", "response to glucose (GO:0009749 from GO Biological Process Annotations)", "response to glycoside (GO:1903416 from GO Biological Process Annotations)", "response to gold nanoparticle (GO:1990268 from GO Biological Process Annotations)", "response to gonadotropin (GO:0034698 from GO Biological Process Annotations)", "response to gonadotropin-releasing hormone (GO:0097210 from GO Biological Process Annotations)", "response to granulocyte macrophage colony-stimulating factor (GO:0097012 from GO Biological Process Annotations)", "response to gravity (GO:0009629 from GO Biological Process Annotations)", "response to growth factor (GO:0070848 from GO Biological Process Annotations)", "response to growth hormone (GO:0060416 from GO Biological Process Annotations)", "response to heat (GO:0009408 from GO Biological Process Annotations)", "response to heparin (GO:0071503 from GO Biological Process Annotations)", "response to hepatocyte growth factor (GO:0035728 from GO Biological Process Annotations)", "response to herbicide (GO:0009635 from GO Biological Process Annotations)", "response to hexose (GO:0009746 from GO Biological Process Annotations)", "response to high density lipoprotein particle (GO:0055099 from GO Biological Process Annotations)", "response to high light intensity (GO:0009644 from GO Biological Process Annotations)", "response to histamine (GO:0034776 from GO Biological Process Annotations)", "response to hormone (GO:0009725 from GO Biological Process Annotations)", "response to host (GO:0075136 from GO Biological Process Annotations)", "response to host defenses (GO:0052200 from GO Biological Process Annotations)", "response to host immune response (GO:0052572 from GO Biological Process Annotations)", "response to human chorionic gonadotropin (GO:0044752 from GO Biological Process Annotations)", "response to hydrogen peroxide (GO:0042542 from GO Biological Process Annotations)", "response to hydroperoxide (GO:0033194 from GO Biological Process Annotations)", "response to hydrostatic pressure (GO:0051599 from GO Biological Process Annotations)", "response to hydroxyisoflavone (GO:0033594 from GO Biological Process Annotations)", "response to hydroxyurea (GO:0072710 from GO Biological Process Annotations)", "response to hyperoxia (GO:0055093 from GO Biological Process Annotations)", "response to hypoxia (GO:0001666 from GO Biological Process Annotations)", "response to immobilization stress (GO:0035902 from GO Biological Process Annotations)", "response to immune response of other organism involved in symbiotic interaction (GO:0052564 from GO Biological Process Annotations)", "response to inactivity (GO:0014854 from GO Biological Process Annotations)", "response to increased oxygen levels (GO:0036296 from GO Biological Process Annotations)", "response to indole-3-methanol (GO:0071680 from GO Biological Process Annotations)", "response to injury involved in regulation of muscle adaptation (GO:0014876 from GO Biological Process Annotations)", "response to inorganic substance (GO:0010035 from GO Biological Process Annotations)", "response to insecticide (GO:0017085 from GO Biological Process Annotations)", "response to insulin (GO:0032868 from GO Biological Process Annotations)", "response to insulin-like growth factor stimulus (GO:1990418 from GO Biological Process Annotations)", "response to interferon-alpha (GO:0035455 from GO Biological Process Annotations)", "response to interferon-beta (GO:0035456 from GO Biological Process Annotations)", "response to interferon-gamma (GO:0034341 from GO Biological Process Annotations)", "response to interleukin-1 (GO:0070555 from GO Biological Process Annotations)", "response to interleukin-11 (GO:0071105 from GO Biological Process Annotations)", "response to interleukin-12 (GO:0070671 from GO Biological Process Annotations)", "response to interleukin-13 (GO:0035962 from GO Biological Process Annotations)", "response to interleukin-15 (GO:0070672 from GO Biological Process Annotations)", "response to interleukin-18 (GO:0070673 from GO Biological Process Annotations)", "response to interleukin-2 (GO:0070669 from GO Biological Process Annotations)", "response to interleukin-3 (GO:0036015 from GO Biological Process Annotations)", "response to interleukin-4 (GO:0070670 from GO Biological Process Annotations)", "response to interleukin-6 (GO:0070741 from GO Biological Process Annotations)", "response to interleukin-9 (GO:0071104 from GO Biological Process Annotations)", "response to intra-s dna damage checkpoint signaling (GO:0072429 from GO Biological Process Annotations)", "response to ionizing radiation (GO:0010212 from GO Biological Process Annotations)", "response to iron ion (GO:0010039 from GO Biological Process Annotations)", "response to iron(ii) ion (GO:0010040 from GO Biological Process Annotations)", "response to iron(iii) ion (GO:0010041 from GO Biological Process Annotations)", "response to ischemia (GO:0002931 from GO Biological Process Annotations)", "response to isolation stress (GO:0035900 from GO Biological Process Annotations)", "response to isoquinoline alkaloid (GO:0014072 from GO Biological Process Annotations)", "response to jasmonic acid (GO:0009753 from GO Biological Process Annotations)", "response to ketone (GO:1901654 from GO Biological Process Annotations)", "response to l-ascorbic acid (GO:0033591 from GO Biological Process Annotations)", "response to l-glutamate (GO:1902065 from GO Biological Process Annotations)", "response to laminar fluid shear stress (GO:0034616 from GO Biological Process Annotations)", "response to lead ion (GO:0010288 from GO Biological Process Annotations)", "response to leptin (GO:0044321 from GO Biological Process Annotations)", "response to leucine (GO:0043201 from GO Biological Process Annotations)", "response to light intensity (GO:0009642 from GO Biological Process Annotations)", "response to light stimulus (GO:0009416 from GO Biological Process Annotations)", "response to linoleic acid (GO:0070543 from GO Biological Process Annotations)", "response to lipid (GO:0033993 from GO Biological Process Annotations)", "response to lipid hydroperoxide (GO:0006982 from GO Biological Process Annotations)", "response to lipopolysaccharide (GO:0032496 from GO Biological Process Annotations)", "response to lipoprotein particle (GO:0055094 from GO Biological Process Annotations)", "response to lipoteichoic acid (GO:0070391 from GO Biological Process Annotations)", "response to lithium ion (GO:0010226 from GO Biological Process Annotations)", "response to low light intensity stimulus (GO:0009645 from GO Biological Process Annotations)", "response to low-density lipoprotein particle (GO:0055098 from GO Biological Process Annotations)", "response to luteinizing hormone (GO:0034699 from GO Biological Process Annotations)", "response to macrophage colony-stimulating factor (GO:0036005 from GO Biological Process Annotations)", "response to magnesium ion (GO:0032026 from GO Biological Process Annotations)", "response to magnetism (GO:0071000 from GO Biological Process Annotations)", "response to manganese ion (GO:0010042 from GO Biological Process Annotations)", "response to mechanical stimulus (GO:0009612 from GO Biological Process Annotations)", "response to mercury ion (GO:0046689 from GO Biological Process Annotations)", "response to metal ion (GO:0010038 from GO Biological Process Annotations)", "response to metformin (GO:1901558 from GO Biological Process Annotations)", "response to methanol (GO:0033986 from GO Biological Process Annotations)", "response to methotrexate (GO:0031427 from GO Biological Process Annotations)", "response to methyl methanesulfonate (GO:0072702 from GO Biological Process Annotations)", "response to methylglyoxal (GO:0051595 from GO Biological Process Annotations)", "response to methylmercury (GO:0051597 from GO Biological Process Annotations)", "response to mineralocorticoid (GO:0051385 from GO Biological Process Annotations)", "response to misfolded protein (GO:0051788 from GO Biological Process Annotations)", "response to mitotic cell cycle checkpoint signaling (GO:0072414 from GO Biological Process Annotations)", "response to molecule of bacterial origin (GO:0002237 from GO Biological Process Annotations)", "response to molecule of fungal origin (GO:0002238 from GO Biological Process Annotations)", "response to monoamine (GO:0071867 from GO Biological Process Annotations)", "response to monosaccharide (GO:0034284 from GO Biological Process Annotations)", "response to morphine (GO:0043278 from GO Biological Process Annotations)", "response to muramyl dipeptide (GO:0032495 from GO Biological Process Annotations)", "response to muscle activity (GO:0014850 from GO Biological Process Annotations)", "response to muscle activity involved in regulation of muscle adaptation (GO:0014873 from GO Biological Process Annotations)", "response to muscle inactivity (GO:0014870 from GO Biological Process Annotations)", "response to muscle inactivity involved in regulation of muscle adaptation (GO:0014877 from GO Biological Process Annotations)", "response to muscle stretch (GO:0035994 from GO Biological Process Annotations)", "response to mycophenolic acid (GO:0071505 from GO Biological Process Annotations)", "response to mycotoxin (GO:0010046 from GO Biological Process Annotations)", "response to nematode (GO:0009624 from GO Biological Process Annotations)", "response to nerve growth factor (GO:1990089 from GO Biological Process Annotations)", "response to nickel cation (GO:0010045 from GO Biological Process Annotations)", "response to nicotine (GO:0035094 from GO Biological Process Annotations)", "response to nitric oxide (GO:0071731 from GO Biological Process Annotations)", "response to nitrite (GO:0080033 from GO Biological Process Annotations)", "response to nitrogen compound (GO:1901698 from GO Biological Process Annotations)", "response to nitrogen dioxide (GO:0035713 from GO Biological Process Annotations)", "response to nitrosative stress (GO:0051409 from GO Biological Process Annotations)", "response to norepinephrine (GO:0071873 from GO Biological Process Annotations)", "response to nutrient (GO:0007584 from GO Biological Process Annotations)", "response to nutrient levels (GO:0031667 from GO Biological Process Annotations)", "response to oleic acid (GO:0034201 from GO Biological Process Annotations)", "response to organic cyclic compound (GO:0014070 from GO Biological Process Annotations)", "response to organic substance (GO:0010033 from GO Biological Process Annotations)", "response to organonitrogen compound (GO:0010243 from GO Biological Process Annotations)", "response to organophosphorus (GO:0046683 from GO Biological Process Annotations)", "response to osmotic stress (GO:0006970 from GO Biological Process Annotations)", "response to other organism (GO:0051707 from GO Biological Process Annotations)", "response to oxidative stress (GO:0006979 from GO Biological Process Annotations)", "response to oxygen levels (GO:0070482 from GO Biological Process Annotations)", "response to oxygen radical (GO:0000305 from GO Biological Process Annotations)", "response to oxygen-containing compound (GO:1901700 from GO Biological Process Annotations)", "response to ozone (GO:0010193 from GO Biological Process Annotations)", "response to pain (GO:0048265 from GO Biological Process Annotations)", "response to parathyroid hormone (GO:0071107 from GO Biological Process Annotations)", "response to peptide (GO:1901652 from GO Biological Process Annotations)", "response to peptide hormone (GO:0043434 from GO Biological Process Annotations)", "response to peptidoglycan (GO:0032494 from GO Biological Process Annotations)", "response to ph (GO:0009268 from GO Biological Process Annotations)", "response to phenylpropanoid (GO:0080184 from GO Biological Process Annotations)", "response to pheromone (GO:0019236 from GO Biological Process Annotations)", "response to platelet-derived growth factor (GO:0036119 from GO Biological Process Annotations)", "response to platinum ion (GO:0070541 from GO Biological Process Annotations)", "response to potassium ion (GO:0035864 from GO Biological Process Annotations)", "response to progesterone (GO:0032570 from GO Biological Process Annotations)", "response to prostaglandin (GO:0034694 from GO Biological Process Annotations)", "response to prostaglandin d (GO:0071798 from GO Biological Process Annotations)", "response to prostaglandin e (GO:0034695 from GO Biological Process Annotations)", "response to prostaglandin f (GO:0034696 from GO Biological Process Annotations)", "response to protozoan (GO:0001562 from GO Biological Process Annotations)", "response to purine-containing compound (GO:0014074 from GO Biological Process Annotations)", "response to pyrethroid (GO:0046684 from GO Biological Process Annotations)", "response to radiation (GO:0009314 from GO Biological Process Annotations)", "response to reactive oxygen species (GO:0000302 from GO Biological Process Annotations)", "response to redox state (GO:0051775 from GO Biological Process Annotations)", "response to retinoic acid (GO:0032526 from GO Biological Process Annotations)", "response to salt (GO:1902074 from GO Biological Process Annotations)", "response to salt stress (GO:0009651 from GO Biological Process Annotations)", "response to selenium ion (GO:0010269 from GO Biological Process Annotations)", "response to silicon dioxide (GO:0034021 from GO Biological Process Annotations)", "response to sodium dodecyl sulfate (GO:0072706 from GO Biological Process Annotations)", "response to sorbitol (GO:0072708 from GO Biological Process Annotations)", "response to starvation (GO:0042594 from GO Biological Process Annotations)", "response to statin (GO:0036273 from GO Biological Process Annotations)", "response to staurosporine (GO:0072733 from GO Biological Process Annotations)", "response to steroid hormone (GO:0048545 from GO Biological Process Annotations)", "response to sterol (GO:0036314 from GO Biological Process Annotations)", "response to sterol depletion (GO:0006991 from GO Biological Process Annotations)", "response to stilbenoid (GO:0035634 from GO Biological Process Annotations)", "response to stimulus (GO:0050896 from GO Biological Process Annotations)", "response to stimulus involved in regulation of muscle adaptation (GO:0014874 from GO Biological Process Annotations)", "response to stress (GO:0006950 from GO Biological Process Annotations)", "response to sucrose (GO:0009744 from GO Biological Process Annotations)", "response to sulfur dioxide (GO:0010477 from GO Biological Process Annotations)", "response to superoxide (GO:0000303 from GO Biological Process Annotations)", "response to symbiont (GO:0009608 from GO Biological Process Annotations)", "response to symbiotic bacterium (GO:0009609 from GO Biological Process Annotations)", "response to tellurium ion (GO:0046690 from GO Biological Process Annotations)", "response to temperature stimulus (GO:0009266 from GO Biological Process Annotations)", "response to testosterone (GO:0033574 from GO Biological Process Annotations)", "response to thyroid hormone (GO:0097066 from GO Biological Process Annotations)", "response to topologically incorrect protein (GO:0035966 from GO Biological Process Annotations)", "response to toxic substance (GO:0009636 from GO Biological Process Annotations)", "response to transforming growth factor beta (GO:0071559 from GO Biological Process Annotations)", "response to transition metal nanoparticle (GO:1990267 from GO Biological Process Annotations)", "response to triacyl bacterial lipopeptide (GO:0071725 from GO Biological Process Annotations)", "response to trichostatin a (GO:0035983 from GO Biological Process Annotations)", "response to triglyceride (GO:0034014 from GO Biological Process Annotations)", "response to tumor cell (GO:0002347 from GO Biological Process Annotations)", "response to tumor necrosis factor (GO:0034612 from GO Biological Process Annotations)", "response to type i interferon (GO:0034340 from GO Biological Process Annotations)", "response to type iii interferon (GO:0034342 from GO Biological Process Annotations)", "response to unfolded protein (GO:0006986 from GO Biological Process Annotations)", "response to uv (GO:0009411 from GO Biological Process Annotations)", "response to uv-a (GO:0070141 from GO Biological Process Annotations)", "response to uv-b (GO:0010224 from GO Biological Process Annotations)", "response to uv-c (GO:0010225 from GO Biological Process Annotations)", "response to virus (GO:0009615 from GO Biological Process Annotations)", "response to vitamin (GO:0033273 from GO Biological Process Annotations)", "response to vitamin a (GO:0033189 from GO Biological Process Annotations)", "response to vitamin b1 (GO:0010266 from GO Biological Process Annotations)", "response to vitamin b2 (GO:0033274 from GO Biological Process Annotations)", "response to vitamin b3 (GO:0033552 from GO Biological Process Annotations)", "response to vitamin b6 (GO:0034516 from GO Biological Process Annotations)", "response to vitamin d (GO:0033280 from GO Biological Process Annotations)", "response to vitamin e (GO:0033197 from GO Biological Process Annotations)", "response to vitamin k (GO:0032571 from GO Biological Process Annotations)", "response to water (GO:0009415 from GO Biological Process Annotations)", "response to water deprivation (GO:0009414 from GO Biological Process Annotations)", "response to wounding (GO:0009611 from GO Biological Process Annotations)", "response to x-ray (GO:0010165 from GO Biological Process Annotations)", "response to xenobiotic stimulus (GO:0009410 from GO Biological Process Annotations)", "response to yeast (GO:0001878 from GO Biological Process Annotations)", "response to zinc ion (GO:0010043 from GO Biological Process Annotations)", "retina development in camera-type eye (GO:0060041 from GO Biological Process Annotations)", "retina homeostasis (GO:0001895 from GO Biological Process Annotations)", "retina layer formation (GO:0010842 from GO Biological Process Annotations)", "retina morphogenesis in camera-type eye (GO:0060042 from GO Biological Process Annotations)", "retina vasculature development in camera-type eye (GO:0061298 from GO Biological Process Annotations)", "retina vasculature morphogenesis in camera-type eye (GO:0061299 from GO Biological Process Annotations)", "retinal bipolar neuron differentiation (GO:0060040 from GO Biological Process Annotations)", "retinal blood vessel morphogenesis (GO:0061304 from GO Biological Process Annotations)", "retinal cell apoptotic process (GO:1990009 from GO Biological Process Annotations)", "retinal cell programmed cell death (GO:0046666 from GO Biological Process Annotations)", "retinal cone cell development (GO:0046549 from GO Biological Process Annotations)", "retinal ganglion cell axon guidance (GO:0031290 from GO Biological Process Annotations)", "retinal metabolic process (GO:0042574 from GO Biological Process Annotations)", "retinal pigment epithelium development (GO:0003406 from GO Biological Process Annotations)", "retinal rod cell development (GO:0046548 from GO Biological Process Annotations)", "retinal rod cell differentiation (GO:0060221 from GO Biological Process Annotations)", "retinoic acid biosynthetic process (GO:0002138 from GO Biological Process Annotations)", "retinoic acid catabolic process (GO:0034653 from GO Biological Process Annotations)", "retinoic acid metabolic process (GO:0042573 from GO Biological Process Annotations)", "retinoic acid receptor signaling pathway (GO:0048384 from GO Biological Process Annotations)", "retinoid metabolic process (GO:0001523 from GO Biological Process Annotations)", "retinol metabolic process (GO:0042572 from GO Biological Process Annotations)", "retinol transport (GO:0034633 from GO Biological Process Annotations)", "retrograde axon cargo transport (GO:0008090 from GO Biological Process Annotations)", "retrograde protein transport, er to cytosol (GO:0030970 from GO Biological Process Annotations)", "retrograde transport, endosome to golgi (GO:0042147 from GO Biological Process Annotations)", "retrograde transport, endosome to plasma membrane (GO:1990126 from GO Biological Process Annotations)", "retrograde transport, plasma membrane to golgi (GO:0035526 from GO Biological Process Annotations)", "retrograde transport, vesicle recycling within golgi (GO:0000301 from GO Biological Process Annotations)", "retrograde vesicle-mediated transport, golgi to er (GO:0006890 from GO Biological Process Annotations)", "retrotrapezoid nucleus neuron differentiation (GO:0061452 from GO Biological Process Annotations)", "reverse cholesterol transport (GO:0043691 from GO Biological Process Annotations)", "rho protein signal transduction (GO:0007266 from GO Biological Process Annotations)", "rhodopsin mediated signaling pathway (GO:0016056 from GO Biological Process Annotations)", "rhombomere 2 development (GO:0021568 from GO Biological Process Annotations)", "rhombomere 3 development (GO:0021569 from GO Biological Process Annotations)", "rhombomere 3 formation (GO:0021660 from GO Biological Process Annotations)", "rhombomere 3 morphogenesis (GO:0021658 from GO Biological Process Annotations)", "rhombomere 4 development (GO:0021570 from GO Biological Process Annotations)", "rhombomere 5 development (GO:0021571 from GO Biological Process Annotations)", "rhombomere 5 formation (GO:0021666 from GO Biological Process Annotations)", "rhombomere 6 development (GO:0021572 from GO Biological Process Annotations)", "rhombomere development (GO:0021546 from GO Biological Process Annotations)", "rhombomere formation (GO:0021594 from GO Biological Process Annotations)", "rhombomere morphogenesis (GO:0021593 from GO Biological Process Annotations)", "rhythmic behavior (GO:0007622 from GO Biological Process Annotations)", "rhythmic excitation (GO:0043179 from GO Biological Process Annotations)", "rhythmic process (GO:0048511 from GO Biological Process Annotations)", "rhythmic synaptic transmission (GO:0060024 from GO Biological Process Annotations)", "riboflavin biosynthetic process (GO:0009231 from GO Biological Process Annotations)", "riboflavin metabolic process (GO:0006771 from GO Biological Process Annotations)", "riboflavin transport (GO:0032218 from GO Biological Process Annotations)", "ribonucleoprotein complex assembly (GO:0022618 from GO Biological Process Annotations)", "ribonucleoprotein complex biogenesis (GO:0022613 from GO Biological Process Annotations)", "ribonucleoprotein complex disassembly (GO:0032988 from GO Biological Process Annotations)", "ribonucleoprotein complex export from nucleus (GO:0071426 from GO Biological Process Annotations)", "ribonucleoprotein complex import into nucleus (GO:0071167 from GO Biological Process Annotations)", "ribonucleoprotein complex subunit organization (GO:0071826 from GO Biological Process Annotations)", "ribonucleoside biosynthetic process (GO:0042455 from GO Biological Process Annotations)", "ribonucleoside bisphosphate biosynthetic process (GO:0034030 from GO Biological Process Annotations)", "ribonucleoside bisphosphate catabolic process (GO:0034031 from GO Biological Process Annotations)", "ribonucleoside bisphosphate metabolic process (GO:0033875 from GO Biological Process Annotations)", "ribonucleoside catabolic process (GO:0042454 from GO Biological Process Annotations)", "ribonucleoside diphosphate biosynthetic process (GO:0009188 from GO Biological Process Annotations)", "ribonucleoside diphosphate catabolic process (GO:0009191 from GO Biological Process Annotations)", "ribonucleoside diphosphate metabolic process (GO:0009185 from GO Biological Process Annotations)", "ribonucleoside metabolic process (GO:0009119 from GO Biological Process Annotations)", "ribonucleoside monophosphate biosynthetic process (GO:0009156 from GO Biological Process Annotations)", "ribonucleoside monophosphate catabolic process (GO:0009158 from GO Biological Process Annotations)", "ribonucleoside monophosphate metabolic process (GO:0009161 from GO Biological Process Annotations)", "ribonucleoside triphosphate biosynthetic process (GO:0009201 from GO Biological Process Annotations)", "ribonucleoside triphosphate catabolic process (GO:0009203 from GO Biological Process Annotations)", "ribonucleoside triphosphate metabolic process (GO:0009199 from GO Biological Process Annotations)", "ribonucleotide biosynthetic process (GO:0009260 from GO Biological Process Annotations)", "ribonucleotide catabolic process (GO:0009261 from GO Biological Process Annotations)", "ribonucleotide metabolic process (GO:0009259 from GO Biological Process Annotations)", "ribose phosphate biosynthetic process (GO:0046390 from GO Biological Process Annotations)", "ribose phosphate metabolic process (GO:0019693 from GO Biological Process Annotations)", "ribosomal large subunit assembly (GO:0000027 from GO Biological Process Annotations)", "ribosomal large subunit biogenesis (GO:0042273 from GO Biological Process Annotations)", "ribosomal large subunit export from nucleus (GO:0000055 from GO Biological Process Annotations)", "ribosomal protein import into nucleus (GO:0006610 from GO Biological Process Annotations)", "ribosomal small subunit assembly (GO:0000028 from GO Biological Process Annotations)", "ribosomal small subunit biogenesis (GO:0042274 from GO Biological Process Annotations)", "ribosomal small subunit export from nucleus (GO:0000056 from GO Biological Process Annotations)", "ribosomal subunit export from nucleus (GO:0000054 from GO Biological Process Annotations)", "ribosome assembly (GO:0042255 from GO Biological Process Annotations)", "ribosome biogenesis (GO:0042254 from GO Biological Process Annotations)", "ribosome disassembly (GO:0032790 from GO Biological Process Annotations)", "rig-i signaling pathway (GO:0039529 from GO Biological Process Annotations)", "right lung development (GO:0060458 from GO Biological Process Annotations)", "right lung morphogenesis (GO:0060461 from GO Biological Process Annotations)", "right ventricular cardiac muscle tissue morphogenesis (GO:0003221 from GO Biological Process Annotations)", "righting reflex (GO:0060013 from GO Biological Process Annotations)", "ripoptosome assembly (GO:0097343 from GO Biological Process Annotations)", "ripoptosome assembly involved in necroptotic process (GO:1901026 from GO Biological Process Annotations)", "rna (guanine-n7)-methylation (GO:0036265 from GO Biological Process Annotations)", "rna 3'-end processing (GO:0031123 from GO Biological Process Annotations)", "rna 5'-end processing (GO:0000966 from GO Biological Process Annotations)", "rna biosynthetic process (GO:0032774 from GO Biological Process Annotations)", "rna capping (GO:0036260 from GO Biological Process Annotations)", "rna catabolic process (GO:0006401 from GO Biological Process Annotations)", "rna destabilization (GO:0050779 from GO Biological Process Annotations)", "rna export from nucleus (GO:0006405 from GO Biological Process Annotations)", "rna import into mitochondrion (GO:0035927 from GO Biological Process Annotations)", "rna import into nucleus (GO:0006404 from GO Biological Process Annotations)", "rna interference (GO:0016246 from GO Biological Process Annotations)", "rna localization (GO:0006403 from GO Biological Process Annotations)", "rna metabolic process (GO:0016070 from GO Biological Process Annotations)", "rna methylation (GO:0001510 from GO Biological Process Annotations)", "rna modification (GO:0009451 from GO Biological Process Annotations)", "rna phosphodiester bond hydrolysis (GO:0090501 from GO Biological Process Annotations)", "rna phosphodiester bond hydrolysis, endonucleolytic (GO:0090502 from GO Biological Process Annotations)", "rna phosphodiester bond hydrolysis, exonucleolytic (GO:0090503 from GO Biological Process Annotations)", "rna polyadenylation (GO:0043631 from GO Biological Process Annotations)", "rna polymerase i transcriptional preinitiation complex assembly (GO:0001188 from GO Biological Process Annotations)", "rna polymerase i transcriptional preinitiation complex assembly at the promoter for the nuclear large rrna transcript (GO:0001189 from GO Biological Process Annotations)", "rna polymerase ii transcriptional preinitiation complex assembly (GO:0051123 from GO Biological Process Annotations)", "rna processing (GO:0006396 from GO Biological Process Annotations)", "rna repair (GO:0042245 from GO Biological Process Annotations)", "rna replication (GO:0039703 from GO Biological Process Annotations)", "rna secondary structure unwinding (GO:0010501 from GO Biological Process Annotations)", "rna splicing (GO:0008380 from GO Biological Process Annotations)", "rna splicing, via endonucleolytic cleavage and ligation (GO:0000394 from GO Biological Process Annotations)", "rna splicing, via transesterification reactions (GO:0000375 from GO Biological Process Annotations)", "rna splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377 from GO Biological Process Annotations)", "rna stabilization (GO:0043489 from GO Biological Process Annotations)", "rna surveillance (GO:0071025 from GO Biological Process Annotations)", "rna transport (GO:0050658 from GO Biological Process Annotations)", "rna-dependent dna replication (GO:0006278 from GO Biological Process Annotations)", "roof plate formation (GO:0021509 from GO Biological Process Annotations)", "rostrocaudal neural tube patterning (GO:0021903 from GO Biological Process Annotations)", "roundabout signaling pathway (GO:0035385 from GO Biological Process Annotations)", "rrna 2'-o-methylation (GO:0000451 from GO Biological Process Annotations)", "rrna 3'-end processing (GO:0031125 from GO Biological Process Annotations)", "rrna 5'-end processing (GO:0000967 from GO Biological Process Annotations)", "rrna base methylation (GO:0070475 from GO Biological Process Annotations)", "rrna catabolic process (GO:0016075 from GO Biological Process Annotations)", "rrna export from nucleus (GO:0006407 from GO Biological Process Annotations)", "rrna import into mitochondrion (GO:0035928 from GO Biological Process Annotations)", "rrna metabolic process (GO:0016072 from GO Biological Process Annotations)", "rrna methylation (GO:0031167 from GO Biological Process Annotations)", "rrna modification (GO:0000154 from GO Biological Process Annotations)", "rrna processing (GO:0006364 from GO Biological Process Annotations)", "rrna pseudouridine synthesis (GO:0031118 from GO Biological Process Annotations)", "rrna transcription (GO:0009303 from GO Biological Process Annotations)", "rrna transport (GO:0051029 from GO Biological Process Annotations)", "rrna-containing ribonucleoprotein complex export from nucleus (GO:0071428 from GO Biological Process Annotations)", "ruffle assembly (GO:0097178 from GO Biological Process Annotations)", "ruffle organization (GO:0031529 from GO Biological Process Annotations)", "s-adenosyl-l-methionine transmembrane transport (GO:1901962 from GO Biological Process Annotations)", "s-adenosyl-l-methionine transport (GO:0015805 from GO Biological Process Annotations)", "s-adenosylhomocysteine catabolic process (GO:0019510 from GO Biological Process Annotations)", "s-adenosylhomocysteine metabolic process (GO:0046498 from GO Biological Process Annotations)", "s-adenosylmethioninamine biosynthetic process (GO:0006557 from GO Biological Process Annotations)", "s-adenosylmethioninamine metabolic process (GO:0046499 from GO Biological Process Annotations)", "s-adenosylmethionine biosynthetic process (GO:0006556 from GO Biological Process Annotations)", "s-adenosylmethionine cycle (GO:0033353 from GO Biological Process Annotations)", "s-adenosylmethionine metabolic process (GO:0046500 from GO Biological Process Annotations)", "s-methylmethionine cycle (GO:0033528 from GO Biological Process Annotations)", "s-methylmethionine metabolic process (GO:0033477 from GO Biological Process Annotations)", "s-shaped body morphogenesis (GO:0072050 from GO Biological Process Annotations)", "sa node cell action potential (GO:0086015 from GO Biological Process Annotations)", "sa node cell to atrial cardiac muscle cell communication (GO:0086070 from GO Biological Process Annotations)", "sagittal suture morphogenesis (GO:0060367 from GO Biological Process Annotations)", "saliva secretion (GO:0046541 from GO Biological Process Annotations)", "salivary gland cavitation (GO:0060662 from GO Biological Process Annotations)", "salivary gland development (GO:0007431 from GO Biological Process Annotations)", "salivary gland morphogenesis (GO:0007435 from GO Biological Process Annotations)", "sarcomere organization (GO:0045214 from GO Biological Process Annotations)", "sarcomerogenesis (GO:0048769 from GO Biological Process Annotations)", "sarcoplasmic reticulum calcium ion transport (GO:0070296 from GO Biological Process Annotations)", "saturated monocarboxylic acid metabolic process (GO:0032788 from GO Biological Process Annotations)", "scf complex assembly (GO:0010265 from GO Biological Process Annotations)", "scf-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146 from GO Biological Process Annotations)", "schwann cell development (GO:0014044 from GO Biological Process Annotations)", "schwann cell differentiation (GO:0014037 from GO Biological Process Annotations)", "schwann cell proliferation (GO:0014010 from GO Biological Process Annotations)", "sclerotome development (GO:0061056 from GO Biological Process Annotations)", "sebaceous gland cell differentiation (GO:0001949 from GO Biological Process Annotations)", "sebaceous gland development (GO:0048733 from GO Biological Process Annotations)", "second-messenger-mediated signaling (GO:0019932 from GO Biological Process Annotations)", "secondary alcohol metabolic process (GO:1902652 from GO Biological Process Annotations)", "secondary heart field specification (GO:0003139 from GO Biological Process Annotations)", "secondary metabolic process (GO:0019748 from GO Biological Process Annotations)", "secondary metabolite biosynthetic process (GO:0044550 from GO Biological Process Annotations)", "secretion (GO:0046903 from GO Biological Process Annotations)", "secretion by cell (GO:0032940 from GO Biological Process Annotations)", "secretion by lung epithelial cell involved in lung growth (GO:0061033 from GO Biological Process Annotations)", "secretion by tissue (GO:0032941 from GO Biological Process Annotations)", "secretion of lysosomal enzymes (GO:0033299 from GO Biological Process Annotations)", "secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528 from GO Biological Process Annotations)", "secretory granule localization (GO:0032252 from GO Biological Process Annotations)", "secretory granule organization (GO:0033363 from GO Biological Process Annotations)", "segment specification (GO:0007379 from GO Biological Process Annotations)", "segmentation (GO:0035282 from GO Biological Process Annotations)", "selenium compound metabolic process (GO:0001887 from GO Biological Process Annotations)", "selenocysteine biosynthetic process (GO:0016260 from GO Biological Process Annotations)", "selenocysteine incorporation (GO:0001514 from GO Biological Process Annotations)", "selenocysteine metabolic process (GO:0016259 from GO Biological Process Annotations)", "selenocysteinyl-trna(sec) biosynthetic process (GO:0097056 from GO Biological Process Annotations)", "self proteolysis (GO:0097264 from GO Biological Process Annotations)", "semaphorin-plexin signaling pathway (GO:0071526 from GO Biological Process Annotations)", "semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287 from GO Biological Process Annotations)", "semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis (GO:1900220 from GO Biological Process Annotations)", "semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285 from GO Biological Process Annotations)", "semicircular canal development (GO:0060872 from GO Biological Process Annotations)", "semicircular canal formation (GO:0060876 from GO Biological Process Annotations)", "semicircular canal fusion (GO:0060879 from GO Biological Process Annotations)", "semicircular canal morphogenesis (GO:0048752 from GO Biological Process Annotations)", "seminal clot liquefaction (GO:0070684 from GO Biological Process Annotations)", "seminal vesicle epithelium development (GO:0061108 from GO Biological Process Annotations)", "seminiferous tubule development (GO:0072520 from GO Biological Process Annotations)", "senescence-associated heterochromatin focus assembly (GO:0035986 from GO Biological Process Annotations)", "sensitization (GO:0046960 from GO Biological Process Annotations)", "sensory neuron axon guidance (GO:0097374 from GO Biological Process Annotations)", "sensory organ boundary specification (GO:0008052 from GO Biological Process Annotations)", "sensory organ development (GO:0007423 from GO Biological Process Annotations)", "sensory organ morphogenesis (GO:0090596 from GO Biological Process Annotations)", "sensory perception (GO:0007600 from GO Biological Process Annotations)", "sensory perception of bitter taste (GO:0050913 from GO Biological Process Annotations)", "sensory perception of chemical stimulus (GO:0007606 from GO Biological Process Annotations)", "sensory perception of light stimulus (GO:0050953 from GO Biological Process Annotations)", "sensory perception of mechanical stimulus (GO:0050954 from GO Biological Process Annotations)", "sensory perception of pain (GO:0019233 from GO Biological Process Annotations)", "sensory perception of smell (GO:0007608 from GO Biological Process Annotations)", "sensory perception of sound (GO:0007605 from GO Biological Process Annotations)", "sensory perception of sour taste (GO:0050915 from GO Biological Process Annotations)", "sensory perception of sweet taste (GO:0050916 from GO Biological Process Annotations)", "sensory perception of taste (GO:0050909 from GO Biological Process Annotations)", "sensory perception of temperature stimulus (GO:0050951 from GO Biological Process Annotations)", "sensory perception of touch (GO:0050975 from GO Biological Process Annotations)", "sensory perception of umami taste (GO:0050917 from GO Biological Process Annotations)", "sensory processing (GO:0050893 from GO Biological Process Annotations)", "sensory system development (GO:0048880 from GO Biological Process Annotations)", "septin cytoskeleton organization (GO:0032185 from GO Biological Process Annotations)", "septin ring assembly (GO:0000921 from GO Biological Process Annotations)", "septin ring organization (GO:0031106 from GO Biological Process Annotations)", "septum primum development (GO:0003284 from GO Biological Process Annotations)", "septum secundum development (GO:0003285 from GO Biological Process Annotations)", "sequestering of actin monomers (GO:0042989 from GO Biological Process Annotations)", "sequestering of bmp from receptor via bmp binding (GO:0038098 from GO Biological Process Annotations)", "sequestering of bmp in extracellular matrix (GO:0035582 from GO Biological Process Annotations)", "sequestering of calcium ion (GO:0051208 from GO Biological Process Annotations)", "sequestering of extracellular ligand from receptor (GO:0035581 from GO Biological Process Annotations)", "sequestering of iron ion (GO:0097577 from GO Biological Process Annotations)", "sequestering of metal ion (GO:0051238 from GO Biological Process Annotations)", "sequestering of neurotransmitter (GO:0042137 from GO Biological Process Annotations)", "sequestering of nodal from receptor via nodal binding (GO:0038101 from GO Biological Process Annotations)", "sequestering of tgfbeta in extracellular matrix (GO:0035583 from GO Biological Process Annotations)", "sequestering of triglyceride (GO:0030730 from GO Biological Process Annotations)", "sequestering of zinc ion (GO:0032119 from GO Biological Process Annotations)", "serine family amino acid biosynthetic process (GO:0009070 from GO Biological Process Annotations)", "serine family amino acid catabolic process (GO:0009071 from GO Biological Process Annotations)", "serine family amino acid metabolic process (GO:0009069 from GO Biological Process Annotations)", "serine phosphorylation of stat protein (GO:0042501 from GO Biological Process Annotations)", "serine phosphorylation of stat3 protein (GO:0033136 from GO Biological Process Annotations)", "serine transport (GO:0032329 from GO Biological Process Annotations)", "serotonin biosynthetic process (GO:0042427 from GO Biological Process Annotations)", "serotonin metabolic process (GO:0042428 from GO Biological Process Annotations)", "serotonin receptor signaling pathway (GO:0007210 from GO Biological Process Annotations)", "serotonin secretion (GO:0001820 from GO Biological Process Annotations)", "serotonin secretion by platelet (GO:0002554 from GO Biological Process Annotations)", "serotonin secretion involved in inflammatory response (GO:0002442 from GO Biological Process Annotations)", "serotonin secretion, neurotransmission (GO:0060096 from GO Biological Process Annotations)", "serotonin transport (GO:0006837 from GO Biological Process Annotations)", "serotonin uptake (GO:0051610 from GO Biological Process Annotations)", "sertoli cell development (GO:0060009 from GO Biological Process Annotations)", "sertoli cell differentiation (GO:0060008 from GO Biological Process Annotations)", "sertoli cell fate commitment (GO:0060010 from GO Biological Process Annotations)", "sertoli cell proliferation (GO:0060011 from GO Biological Process Annotations)", "seryl-trna aminoacylation (GO:0006434 from GO Biological Process Annotations)", "sesquiterpenoid catabolic process (GO:0016107 from GO Biological Process Annotations)", "sesquiterpenoid metabolic process (GO:0006714 from GO Biological Process Annotations)", "sex determination (GO:0007530 from GO Biological Process Annotations)", "sex differentiation (GO:0007548 from GO Biological Process Annotations)", "sexual reproduction (GO:0019953 from GO Biological Process Annotations)", "short-chain fatty acid biosynthetic process (GO:0051790 from GO Biological Process Annotations)", "short-chain fatty acid catabolic process (GO:0019626 from GO Biological Process Annotations)", "short-chain fatty acid import (GO:0015913 from GO Biological Process Annotations)", "short-chain fatty acid metabolic process (GO:0046459 from GO Biological Process Annotations)", "short-chain fatty acid transport (GO:0015912 from GO Biological Process Annotations)", "short-term memory (GO:0007614 from GO Biological Process Annotations)", "sialic acid transport (GO:0015739 from GO Biological Process Annotations)", "sialylation (GO:0097503 from GO Biological Process Annotations)", "siderophore biosynthetic process (GO:0019290 from GO Biological Process Annotations)", "siderophore metabolic process (GO:0009237 from GO Biological Process Annotations)", "siderophore transport (GO:0015891 from GO Biological Process Annotations)", "signal clustering (GO:1990256 from GO Biological Process Annotations)", "signal complex assembly (GO:0007172 from GO Biological Process Annotations)", "signal maturation (GO:0035638 from GO Biological Process Annotations)", "signal peptide processing (GO:0006465 from GO Biological Process Annotations)", "signal release (GO:0023061 from GO Biological Process Annotations)", "signal transduction (GO:0007165 from GO Biological Process Annotations)", "signal transduction by p53 class mediator (GO:0072331 from GO Biological Process Annotations)", "signal transduction by phosphorylation (GO:0023014 from GO Biological Process Annotations)", "signal transduction downstream of smoothened (GO:0007227 from GO Biological Process Annotations)", "signal transduction in absence of ligand (GO:0038034 from GO Biological Process Annotations)", "signal transduction in response to dna damage (GO:0042770 from GO Biological Process Annotations)", "signal transduction involved in cell cycle checkpoint (GO:0072395 from GO Biological Process Annotations)", "signal transduction involved in dna damage checkpoint (GO:0072422 from GO Biological Process Annotations)", "signal transduction involved in dna integrity checkpoint (GO:0072401 from GO Biological Process Annotations)", "signal transduction involved in g2 dna damage checkpoint (GO:0072425 from GO Biological Process Annotations)", "signal transduction involved in intra-s dna damage checkpoint (GO:0072428 from GO Biological Process Annotations)", "signal transduction involved in mitotic cell cycle checkpoint (GO:0072413 from GO Biological Process Annotations)", "signal transduction involved in mitotic dna damage checkpoint (GO:1902402 from GO Biological Process Annotations)", "signal transduction involved in mitotic dna integrity checkpoint (GO:1902403 from GO Biological Process Annotations)", "signal transduction involved in mitotic g1 dna damage checkpoint (GO:0072431 from GO Biological Process Annotations)", "signal transduction involved in mitotic g2 dna damage checkpoint (GO:0072434 from GO Biological Process Annotations)", "signal transduction involved in regulation of gene expression (GO:0023019 from GO Biological Process Annotations)", "signaling (GO:0023052 from GO Biological Process Annotations)", "single fertilization (GO:0007338 from GO Biological Process Annotations)", "single organism cell adhesion (GO:0098602 from GO Biological Process Annotations)", "single organism reproductive process (GO:0044702 from GO Biological Process Annotations)", "single organism signaling (GO:0044700 from GO Biological Process Annotations)", "single organismal cell-cell adhesion (GO:0016337 from GO Biological Process Annotations)", "single strand break repair (GO:0000012 from GO Biological Process Annotations)", "single stranded viral rna replication via double stranded dna intermediate (GO:0039692 from GO Biological Process Annotations)", "single-multicellular organism process (GO:0044707 from GO Biological Process Annotations)", "single-organism behavior (GO:0044708 from GO Biological Process Annotations)", "single-organism biosynthetic process (GO:0044711 from GO Biological Process Annotations)", "single-organism carbohydrate catabolic process (GO:0044724 from GO Biological Process Annotations)", "single-organism carbohydrate metabolic process (GO:0044723 from GO Biological Process Annotations)", "single-organism catabolic process (GO:0044712 from GO Biological Process Annotations)", "single-organism cellular localization (GO:1902580 from GO Biological Process Annotations)", "single-organism cellular process (GO:0044763 from GO Biological Process Annotations)", "single-organism developmental process (GO:0044767 from GO Biological Process Annotations)", "single-organism intracellular transport (GO:1902582 from GO Biological Process Annotations)", "single-organism localization (GO:1902578 from GO Biological Process Annotations)", "single-organism membrane budding (GO:1902591 from GO Biological Process Annotations)", "single-organism membrane fusion (GO:0044801 from GO Biological Process Annotations)", "single-organism membrane invagination (GO:1902534 from GO Biological Process Annotations)", "single-organism membrane organization (GO:0044802 from GO Biological Process Annotations)", "single-organism metabolic process (GO:0044710 from GO Biological Process Annotations)", "single-organism nuclear import (GO:1902593 from GO Biological Process Annotations)", "single-organism organelle organization (GO:1902589 from GO Biological Process Annotations)", "single-organism process (GO:0044699 from GO Biological Process Annotations)", "single-organism reproductive behavior (GO:0044704 from GO Biological Process Annotations)", "single-organism transport (GO:0044765 from GO Biological Process Annotations)", "sinoatrial node cell development (GO:0060931 from GO Biological Process Annotations)", "sinoatrial node cell differentiation (GO:0060921 from GO Biological Process Annotations)", "sinoatrial node development (GO:0003163 from GO Biological Process Annotations)", "sinoatrial valve morphogenesis (GO:0003185 from GO Biological Process Annotations)", "sinus venosus morphogenesis (GO:0003236 from GO Biological Process Annotations)", "sirna loading onto risc involved in rna interference (GO:0035087 from GO Biological Process Annotations)", "sister chromatid biorientation (GO:0031134 from GO Biological Process Annotations)", "sister chromatid cohesion (GO:0007062 from GO Biological Process Annotations)", "sister chromatid segregation (GO:0000819 from GO Biological Process Annotations)", "skeletal muscle acetylcholine-gated channel clustering (GO:0071340 from GO Biological Process Annotations)", "skeletal muscle adaptation (GO:0043501 from GO Biological Process Annotations)", "skeletal muscle atrophy (GO:0014732 from GO Biological Process Annotations)", "skeletal muscle cell differentiation (GO:0035914 from GO Biological Process Annotations)", "skeletal muscle cell proliferation (GO:0014856 from GO Biological Process Annotations)", "skeletal muscle contraction (GO:0003009 from GO Biological Process Annotations)", "skeletal muscle fiber adaptation (GO:0043503 from GO Biological Process Annotations)", "skeletal muscle fiber development (GO:0048741 from GO Biological Process Annotations)", "skeletal muscle fiber differentiation (GO:0098528 from GO Biological Process Annotations)", "skeletal muscle hypertrophy (GO:0014734 from GO Biological Process Annotations)", "skeletal muscle myosin thick filament assembly (GO:0030241 from GO Biological Process Annotations)", "skeletal muscle organ development (GO:0060538 from GO Biological Process Annotations)", "skeletal muscle satellite cell activation (GO:0014719 from GO Biological Process Annotations)", "skeletal muscle satellite cell commitment (GO:0014813 from GO Biological Process Annotations)", "skeletal muscle satellite cell differentiation (GO:0014816 from GO Biological Process Annotations)", "skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration (GO:0014834 from GO Biological Process Annotations)", "skeletal muscle satellite cell migration (GO:1902766 from GO Biological Process Annotations)", "skeletal muscle satellite cell proliferation (GO:0014841 from GO Biological Process Annotations)", "skeletal muscle thin filament assembly (GO:0030240 from GO Biological Process Annotations)", "skeletal muscle tissue development (GO:0007519 from GO Biological Process Annotations)", "skeletal muscle tissue growth (GO:0048630 from GO Biological Process Annotations)", "skeletal muscle tissue regeneration (GO:0043403 from GO Biological Process Annotations)", "skeletal myofibril assembly (GO:0014866 from GO Biological Process Annotations)", "skeletal system development (GO:0001501 from GO Biological Process Annotations)", "skeletal system morphogenesis (GO:0048705 from GO Biological Process Annotations)", "skin development (GO:0043588 from GO Biological Process Annotations)", "skin epidermis development (GO:0098773 from GO Biological Process Annotations)", "skin morphogenesis (GO:0043589 from GO Biological Process Annotations)", "sleep (GO:0030431 from GO Biological Process Annotations)", "slit diaphragm assembly (GO:0036060 from GO Biological Process Annotations)", "slow endocytic recycling (GO:0032458 from GO Biological Process Annotations)", "slow-twitch skeletal muscle fiber contraction (GO:0031444 from GO Biological Process Annotations)", "smad protein complex assembly (GO:0007183 from GO Biological Process Annotations)", "smad protein import into nucleus (GO:0007184 from GO Biological Process Annotations)", "smad protein signal transduction (GO:0060395 from GO Biological Process Annotations)", "small gtpase mediated signal transduction (GO:0007264 from GO Biological Process Annotations)", "small molecule biosynthetic process (GO:0044283 from GO Biological Process Annotations)", "small molecule catabolic process (GO:0044282 from GO Biological Process Annotations)", "small molecule metabolic process (GO:0044281 from GO Biological Process Annotations)", "small nucleolar ribonucleoprotein complex assembly (GO:0000491 from GO Biological Process Annotations)", "small rna loading onto risc (GO:0070922 from GO Biological Process Annotations)", "smooth endoplasmic reticulum calcium ion homeostasis (GO:0051563 from GO Biological Process Annotations)", "smooth muscle adaptation (GO:0014805 from GO Biological Process Annotations)", "smooth muscle cell chemotaxis (GO:0071670 from GO Biological Process Annotations)", "smooth muscle cell differentiation (GO:0051145 from GO Biological Process Annotations)", "smooth muscle cell migration (GO:0014909 from GO Biological Process Annotations)", "smooth muscle cell proliferation (GO:0048659 from GO Biological Process Annotations)", "smooth muscle cell-matrix adhesion (GO:0061302 from GO Biological Process Annotations)", "smooth muscle contraction (GO:0006939 from GO Biological Process Annotations)", "smooth muscle contraction involved in micturition (GO:0060083 from GO Biological Process Annotations)", "smooth muscle hyperplasia (GO:0014806 from GO Biological Process Annotations)", "smooth muscle hypertrophy (GO:0014895 from GO Biological Process Annotations)", "smooth muscle tissue development (GO:0048745 from GO Biological Process Annotations)", "smoothened signaling pathway (GO:0007224 from GO Biological Process Annotations)", "smoothened signaling pathway involved in dorsal|ventral neural tube patterning (GO:0060831 from GO Biological Process Annotations)", "smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation (GO:0021938 from GO Biological Process Annotations)", "smoothened signaling pathway involved in spinal cord motor neuron cell fate specification (GO:0021776 from GO Biological Process Annotations)", "smoothened signaling pathway involved in ventral spinal cord interneuron specification (GO:0021775 from GO Biological Process Annotations)", "smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021910 from GO Biological Process Annotations)", "snare complex assembly (GO:0035493 from GO Biological Process Annotations)", "snare complex disassembly (GO:0035494 from GO Biological Process Annotations)", "snorna 3'-end processing (GO:0031126 from GO Biological Process Annotations)", "snorna catabolic process (GO:0016077 from GO Biological Process Annotations)", "snorna metabolic process (GO:0016074 from GO Biological Process Annotations)", "snorna processing (GO:0043144 from GO Biological Process Annotations)", "snrna 3'-end processing (GO:0034472 from GO Biological Process Annotations)", "snrna export from nucleus (GO:0006408 from GO Biological Process Annotations)", "snrna import into nucleus (GO:0061015 from GO Biological Process Annotations)", "snrna metabolic process (GO:0016073 from GO Biological Process Annotations)", "snrna modification (GO:0040031 from GO Biological Process Annotations)", "snrna processing (GO:0016180 from GO Biological Process Annotations)", "snrna pseudouridine synthesis (GO:0031120 from GO Biological Process Annotations)", "snrna transcription (GO:0009301 from GO Biological Process Annotations)", "snrna transcription from rna polymerase ii promoter (GO:0042795 from GO Biological Process Annotations)", "snrna transcription from rna polymerase iii promoter (GO:0042796 from GO Biological Process Annotations)", "snrna transport (GO:0051030 from GO Biological Process Annotations)", "snrnp protein import into nucleus (GO:0006608 from GO Biological Process Annotations)", "social behavior (GO:0035176 from GO Biological Process Annotations)", "sodium ion export (GO:0071436 from GO Biological Process Annotations)", "sodium ion export from cell (GO:0036376 from GO Biological Process Annotations)", "sodium ion homeostasis (GO:0055078 from GO Biological Process Annotations)", "sodium ion import (GO:0097369 from GO Biological Process Annotations)", "sodium ion import across plasma membrane (GO:0098719 from GO Biological Process Annotations)", "sodium ion import into cell (GO:1990118 from GO Biological Process Annotations)", "sodium ion transmembrane transport (GO:0035725 from GO Biological Process Annotations)", "sodium ion transport (GO:0006814 from GO Biological Process Annotations)", "sodium-dependent organic anion transport (GO:0043251 from GO Biological Process Annotations)", "sodium-dependent organic cation transport (GO:0070715 from GO Biological Process Annotations)", "sodium-dependent phosphate transport (GO:0044341 from GO Biological Process Annotations)", "sodium-independent organic anion transport (GO:0043252 from GO Biological Process Annotations)", "soft palate development (GO:0060023 from GO Biological Process Annotations)", "somatic cell dna recombination (GO:0016444 from GO Biological Process Annotations)", "somatic diversification of immune receptors (GO:0002200 from GO Biological Process Annotations)", "somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562 from GO Biological Process Annotations)", "somatic diversification of immune receptors via somatic mutation (GO:0002566 from GO Biological Process Annotations)", "somatic diversification of immunoglobulins (GO:0016445 from GO Biological Process Annotations)", "somatic diversification of immunoglobulins involved in immune response (GO:0002208 from GO Biological Process Annotations)", "somatic diversification of t cell receptor genes (GO:0002568 from GO Biological Process Annotations)", "somatic hypermutation of immunoglobulin genes (GO:0016446 from GO Biological Process Annotations)", "somatic motor neuron differentiation (GO:0021523 from GO Biological Process Annotations)", "somatic muscle development (GO:0007525 from GO Biological Process Annotations)", "somatic recombination of immunoglobulin gene segments (GO:0016447 from GO Biological Process Annotations)", "somatic recombination of immunoglobulin genes involved in immune response (GO:0002204 from GO Biological Process Annotations)", "somatic recombination of t cell receptor gene segments (GO:0002681 from GO Biological Process Annotations)", "somatic sex determination (GO:0018993 from GO Biological Process Annotations)", "somatic stem cell division (GO:0048103 from GO Biological Process Annotations)", "somatic stem cell maintenance (GO:0035019 from GO Biological Process Annotations)", "somatostatin receptor signaling pathway (GO:0038169 from GO Biological Process Annotations)", "somatostatin secretion (GO:0070253 from GO Biological Process Annotations)", "somatostatin signaling pathway (GO:0038170 from GO Biological Process Annotations)", "somatotropin secreting cell development (GO:0060133 from GO Biological Process Annotations)", "somatotropin secreting cell differentiation (GO:0060126 from GO Biological Process Annotations)", "somite development (GO:0061053 from GO Biological Process Annotations)", "somite rostral|caudal axis specification (GO:0032525 from GO Biological Process Annotations)", "somite specification (GO:0001757 from GO Biological Process Annotations)", "somitogenesis (GO:0001756 from GO Biological Process Annotations)", "sorbitol catabolic process (GO:0006062 from GO Biological Process Annotations)", "sorbitol metabolic process (GO:0006060 from GO Biological Process Annotations)", "specification of anterior mesonephric tubule identity (GO:0072168 from GO Biological Process Annotations)", "specification of axis polarity (GO:0065001 from GO Biological Process Annotations)", "specification of loop of henle identity (GO:0072086 from GO Biological Process Annotations)", "specification of mesonephric tubule identity (GO:0072167 from GO Biological Process Annotations)", "specification of nephron tubule identity (GO:0072081 from GO Biological Process Annotations)", "specification of organ identity (GO:0010092 from GO Biological Process Annotations)", "specification of organ position (GO:0010159 from GO Biological Process Annotations)", "specification of posterior mesonephric tubule identity (GO:0072169 from GO Biological Process Annotations)", "specification of symmetry (GO:0009799 from GO Biological Process Annotations)", "specification of ureteric bud anterior|posterior symmetry (GO:0072100 from GO Biological Process Annotations)", "specification of ureteric bud anterior|posterior symmetry by bmp signaling pathway (GO:0072101 from GO Biological Process Annotations)", "spemann organizer formation (GO:0060061 from GO Biological Process Annotations)", "spemann organizer formation at the anterior end of the primitive streak (GO:0060064 from GO Biological Process Annotations)", "sperm axoneme assembly (GO:0007288 from GO Biological Process Annotations)", "sperm capacitation (GO:0048240 from GO Biological Process Annotations)", "sperm chromatin condensation (GO:0035092 from GO Biological Process Annotations)", "sperm competition (GO:0046692 from GO Biological Process Annotations)", "sperm displacement (GO:0007321 from GO Biological Process Annotations)", "sperm ejaculation (GO:0042713 from GO Biological Process Annotations)", "sperm entry (GO:0035037 from GO Biological Process Annotations)", "sperm individualization (GO:0007291 from GO Biological Process Annotations)", "sperm mitochondrion organization (GO:0030382 from GO Biological Process Annotations)", "sperm motility (GO:0030317 from GO Biological Process Annotations)", "sperm-egg recognition (GO:0035036 from GO Biological Process Annotations)", "spermatid development (GO:0007286 from GO Biological Process Annotations)", "spermatid differentiation (GO:0048515 from GO Biological Process Annotations)", "spermatid nucleus differentiation (GO:0007289 from GO Biological Process Annotations)", "spermatid nucleus elongation (GO:0007290 from GO Biological Process Annotations)", "spermatogenesis (GO:0007283 from GO Biological Process Annotations)", "spermatogenesis, exchange of chromosomal proteins (GO:0035093 from GO Biological Process Annotations)", "spermidine acetylation (GO:0032918 from GO Biological Process Annotations)", "spermidine biosynthetic process (GO:0008295 from GO Biological Process Annotations)", "spermidine catabolic process (GO:0046203 from GO Biological Process Annotations)", "spermidine metabolic process (GO:0008216 from GO Biological Process Annotations)", "spermine acetylation (GO:0032919 from GO Biological Process Annotations)", "spermine biosynthetic process (GO:0006597 from GO Biological Process Annotations)", "spermine catabolic process (GO:0046208 from GO Biological Process Annotations)", "spermine metabolic process (GO:0008215 from GO Biological Process Annotations)", "spermine transport (GO:0000296 from GO Biological Process Annotations)", "sphinganine biosynthetic process (GO:0046511 from GO Biological Process Annotations)", "sphinganine metabolic process (GO:0006667 from GO Biological Process Annotations)", "sphinganine-1-phosphate biosynthetic process (GO:0006669 from GO Biological Process Annotations)", "sphinganine-1-phosphate metabolic process (GO:0006668 from GO Biological Process Annotations)", "sphingoid biosynthetic process (GO:0046520 from GO Biological Process Annotations)", "sphingoid catabolic process (GO:0046521 from GO Biological Process Annotations)", "sphingoid metabolic process (GO:0046519 from GO Biological Process Annotations)", "sphingolipid biosynthetic process (GO:0030148 from GO Biological Process Annotations)", "sphingolipid catabolic process (GO:0030149 from GO Biological Process Annotations)", "sphingolipid mediated signaling pathway (GO:0090520 from GO Biological Process Annotations)", "sphingolipid metabolic process (GO:0006665 from GO Biological Process Annotations)", "sphingomyelin biosynthetic process (GO:0006686 from GO Biological Process Annotations)", "sphingomyelin catabolic process (GO:0006685 from GO Biological Process Annotations)", "sphingomyelin metabolic process (GO:0006684 from GO Biological Process Annotations)", "sphingosine biosynthetic process (GO:0046512 from GO Biological Process Annotations)", "sphingosine metabolic process (GO:0006670 from GO Biological Process Annotations)", "sphingosine-1-phosphate signaling pathway (GO:0003376 from GO Biological Process Annotations)", "spinal cord anterior|posterior patterning (GO:0021512 from GO Biological Process Annotations)", "spinal cord association neuron differentiation (GO:0021527 from GO Biological Process Annotations)", "spinal cord development (GO:0021510 from GO Biological Process Annotations)", "spinal cord dorsal|ventral patterning (GO:0021513 from GO Biological Process Annotations)", "spinal cord motor neuron cell fate specification (GO:0021520 from GO Biological Process Annotations)", "spinal cord motor neuron differentiation (GO:0021522 from GO Biological Process Annotations)", "spinal cord motor neuron migration (GO:0097476 from GO Biological Process Annotations)", "spinal cord oligodendrocyte cell fate specification (GO:0021530 from GO Biological Process Annotations)", "spinal cord patterning (GO:0021511 from GO Biological Process Annotations)", "spinal cord ventral commissure morphogenesis (GO:0021965 from GO Biological Process Annotations)", "spindle assembly (GO:0051225 from GO Biological Process Annotations)", "spindle assembly checkpoint (GO:0071173 from GO Biological Process Annotations)", "spindle assembly involved in female meiosis (GO:0007056 from GO Biological Process Annotations)", "spindle assembly involved in female meiosis i (GO:0007057 from GO Biological Process Annotations)", "spindle assembly involved in meiosis (GO:0090306 from GO Biological Process Annotations)", "spindle checkpoint (GO:0031577 from GO Biological Process Annotations)", "spindle elongation (GO:0051231 from GO Biological Process Annotations)", "spindle localization (GO:0051653 from GO Biological Process Annotations)", "spindle midzone assembly (GO:0051255 from GO Biological Process Annotations)", "spindle organization (GO:0007051 from GO Biological Process Annotations)", "spindle stabilization (GO:0043146 from GO Biological Process Annotations)", "spleen development (GO:0048536 from GO Biological Process Annotations)", "spleen trabecula formation (GO:0060345 from GO Biological Process Annotations)", "spliceosomal complex assembly (GO:0000245 from GO Biological Process Annotations)", "spliceosomal complex disassembly (GO:0000390 from GO Biological Process Annotations)", "spliceosomal snrnp assembly (GO:0000387 from GO Biological Process Annotations)", "spliceosomal tri-snrnp complex assembly (GO:0000244 from GO Biological Process Annotations)", "splicing factor protein import into nucleus (GO:0035048 from GO Biological Process Annotations)", "spongiotrophoblast differentiation (GO:0060708 from GO Biological Process Annotations)", "spongiotrophoblast layer development (GO:0060712 from GO Biological Process Annotations)", "spongiotrophoblast layer developmental growth (GO:0090214 from GO Biological Process Annotations)", "sprouting angiogenesis (GO:0002040 from GO Biological Process Annotations)", "sprouting of injured axon (GO:0048682 from GO Biological Process Annotations)", "squamous basal epithelial stem cell differentiation involved in prostate gland acinus development (GO:0060529 from GO Biological Process Annotations)", "srebp signaling pathway (GO:0032933 from GO Biological Process Annotations)", "srp-dependent cotranslational protein targeting to membrane (GO:0006614 from GO Biological Process Annotations)", "srp-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617 from GO Biological Process Annotations)", "srp-dependent cotranslational protein targeting to membrane, translocation (GO:0006616 from GO Biological Process Annotations)", "stabilization of membrane potential (GO:0030322 from GO Biological Process Annotations)", "starch catabolic process (GO:0005983 from GO Biological Process Annotations)", "starch metabolic process (GO:0005982 from GO Biological Process Annotations)", "startle response (GO:0001964 from GO Biological Process Annotations)", "stat protein import into nucleus (GO:0007262 from GO Biological Process Annotations)", "stem cell development (GO:0048864 from GO Biological Process Annotations)", "stem cell differentiation (GO:0048863 from GO Biological Process Annotations)", "stem cell division (GO:0017145 from GO Biological Process Annotations)", "stem cell fate determination (GO:0048867 from GO Biological Process Annotations)", "stem cell fate specification (GO:0048866 from GO Biological Process Annotations)", "stem cell maintenance (GO:0019827 from GO Biological Process Annotations)", "stem cell proliferation (GO:0072089 from GO Biological Process Annotations)", "steroid biosynthetic process (GO:0006694 from GO Biological Process Annotations)", "steroid catabolic process (GO:0006706 from GO Biological Process Annotations)", "steroid esterification (GO:0034433 from GO Biological Process Annotations)", "steroid hormone mediated signaling pathway (GO:0043401 from GO Biological Process Annotations)", "steroid hormone receptor complex assembly (GO:0006463 from GO Biological Process Annotations)", "steroid hormone secretion (GO:0035929 from GO Biological Process Annotations)", "steroid metabolic process (GO:0008202 from GO Biological Process Annotations)", "sterol biosynthetic process (GO:0016126 from GO Biological Process Annotations)", "sterol catabolic process (GO:0016127 from GO Biological Process Annotations)", "sterol esterification (GO:0034434 from GO Biological Process Annotations)", "sterol homeostasis (GO:0055092 from GO Biological Process Annotations)", "sterol import (GO:0035376 from GO Biological Process Annotations)", "sterol metabolic process (GO:0016125 from GO Biological Process Annotations)", "sterol regulatory element binding protein import into nucleus (GO:0035105 from GO Biological Process Annotations)", "sterol transmembrane transport (GO:0035382 from GO Biological Process Annotations)", "sterol transport (GO:0015918 from GO Biological Process Annotations)", "stilbene catabolic process (GO:0046272 from GO Biological Process Annotations)", "stilbene metabolic process (GO:0009810 from GO Biological Process Annotations)", "stomach neuroendocrine cell differentiation (GO:0061102 from GO Biological Process Annotations)", "store-operated calcium entry (GO:0002115 from GO Biological Process Annotations)", "strand invasion (GO:0042148 from GO Biological Process Annotations)", "stress fiber assembly (GO:0043149 from GO Biological Process Annotations)", "stress granule assembly (GO:0034063 from GO Biological Process Annotations)", "stress granule disassembly (GO:0035617 from GO Biological Process Annotations)", "stress-activated mapk cascade (GO:0051403 from GO Biological Process Annotations)", "stress-activated protein kinase signaling cascade (GO:0031098 from GO Biological Process Annotations)", "stress-induced mitochondrial fusion (GO:1990046 from GO Biological Process Annotations)", "stress-induced premature senescence (GO:0090400 from GO Biological Process Annotations)", "striatal medium spiny neuron differentiation (GO:0021773 from GO Biological Process Annotations)", "striated muscle adaptation (GO:0014888 from GO Biological Process Annotations)", "striated muscle atrophy (GO:0014891 from GO Biological Process Annotations)", "striated muscle cell apoptotic process (GO:0010658 from GO Biological Process Annotations)", "striated muscle cell development (GO:0055002 from GO Biological Process Annotations)", "striated muscle cell differentiation (GO:0051146 from GO Biological Process Annotations)", "striated muscle cell proliferation (GO:0014855 from GO Biological Process Annotations)", "striated muscle contraction (GO:0006941 from GO Biological Process Annotations)", "striated muscle hypertrophy (GO:0014897 from GO Biological Process Annotations)", "striated muscle myosin thick filament assembly (GO:0071688 from GO Biological Process Annotations)", "striated muscle tissue development (GO:0014706 from GO Biological Process Annotations)", "striatum development (GO:0021756 from GO Biological Process Annotations)", "stromal-epithelial cell signaling involved in prostate gland development (GO:0044345 from GO Biological Process Annotations)", "submandibular salivary gland formation (GO:0060661 from GO Biological Process Annotations)", "subpallium cell proliferation in forebrain (GO:0022012 from GO Biological Process Annotations)", "subpallium development (GO:0021544 from GO Biological Process Annotations)", "subpallium neuron fate commitment (GO:0060163 from GO Biological Process Annotations)", "substance p catabolic process (GO:0010814 from GO Biological Process Annotations)", "substantia nigra development (GO:0021762 from GO Biological Process Annotations)", "substrate adhesion-dependent cell spreading (GO:0034446 from GO Biological Process Annotations)", "substrate-dependent cell migration (GO:0006929 from GO Biological Process Annotations)", "substrate-dependent cell migration, cell attachment to substrate (GO:0006931 from GO Biological Process Annotations)", "substrate-dependent cell migration, cell extension (GO:0006930 from GO Biological Process Annotations)", "substrate-dependent cerebral cortex tangential migration (GO:0021825 from GO Biological Process Annotations)", "substrate-independent telencephalic tangential interneuron migration (GO:0021843 from GO Biological Process Annotations)", "substrate-independent telencephalic tangential migration (GO:0021826 from GO Biological Process Annotations)", "subthalamic nucleus development (GO:0021763 from GO Biological Process Annotations)", "subthalamus development (GO:0021539 from GO Biological Process Annotations)", "succinate metabolic process (GO:0006105 from GO Biological Process Annotations)", "succinate transmembrane transport (GO:0071422 from GO Biological Process Annotations)", "succinate transport (GO:0015744 from GO Biological Process Annotations)", "succinyl-coa metabolic process (GO:0006104 from GO Biological Process Annotations)", "succinyl-coa pathway (GO:0006781 from GO Biological Process Annotations)", "suckling behavior (GO:0001967 from GO Biological Process Annotations)", "sucrose metabolic process (GO:0005985 from GO Biological Process Annotations)", "sugar mediated signaling pathway (GO:0010182 from GO Biological Process Annotations)", "sulfate assimilation (GO:0000103 from GO Biological Process Annotations)", "sulfate transmembrane transport (GO:1902358 from GO Biological Process Annotations)", "sulfate transport (GO:0008272 from GO Biological Process Annotations)", "sulfation (GO:0051923 from GO Biological Process Annotations)", "sulfide oxidation (GO:0019418 from GO Biological Process Annotations)", "sulfide oxidation, using sulfide:quinone oxidoreductase (GO:0070221 from GO Biological Process Annotations)", "sulfur amino acid biosynthetic process (GO:0000097 from GO Biological Process Annotations)", "sulfur amino acid catabolic process (GO:0000098 from GO Biological Process Annotations)", "sulfur amino acid metabolic process (GO:0000096 from GO Biological Process Annotations)", "sulfur amino acid transport (GO:0000101 from GO Biological Process Annotations)", "sulfur compound biosynthetic process (GO:0044272 from GO Biological Process Annotations)", "sulfur compound catabolic process (GO:0044273 from GO Biological Process Annotations)", "sulfur compound metabolic process (GO:0006790 from GO Biological Process Annotations)", "sulfur compound transport (GO:0072348 from GO Biological Process Annotations)", "sulfur oxidation (GO:0019417 from GO Biological Process Annotations)", "superior olivary nucleus maturation (GO:0021722 from GO Biological Process Annotations)", "superior temporal gyrus development (GO:0071109 from GO Biological Process Annotations)", "superior vena cava morphogenesis (GO:0060578 from GO Biological Process Annotations)", "superoxide anion generation (GO:0042554 from GO Biological Process Annotations)", "superoxide metabolic process (GO:0006801 from GO Biological Process Annotations)", "suppression by virus of host apoptotic process (GO:0019050 from GO Biological Process Annotations)", "suppression by virus of host autophagy (GO:0039521 from GO Biological Process Annotations)", "surfactant homeostasis (GO:0043129 from GO Biological Process Annotations)", "susceptibility to natural killer cell mediated cytotoxicity (GO:0042271 from GO Biological Process Annotations)", "susceptibility to t cell mediated cytotoxicity (GO:0060370 from GO Biological Process Annotations)", "swimming behavior (GO:0036269 from GO Biological Process Annotations)", "symbiont intracellular protein transport in host (GO:0030581 from GO Biological Process Annotations)", "symbiosis, encompassing mutualism through parasitism (GO:0044403 from GO Biological Process Annotations)", "sympathetic ganglion development (GO:0061549 from GO Biological Process Annotations)", "sympathetic nervous system development (GO:0048485 from GO Biological Process Annotations)", "sympathetic neuron projection extension (GO:0097490 from GO Biological Process Annotations)", "sympathetic neuron projection guidance (GO:0097491 from GO Biological Process Annotations)", "synapse assembly (GO:0007416 from GO Biological Process Annotations)", "synapse assembly involved in innervation (GO:0060386 from GO Biological Process Annotations)", "synapse maturation (GO:0060074 from GO Biological Process Annotations)", "synapse organization (GO:0050808 from GO Biological Process Annotations)", "synapsis (GO:0007129 from GO Biological Process Annotations)", "synaptic growth at neuromuscular junction (GO:0051124 from GO Biological Process Annotations)", "synaptic target recognition (GO:0008039 from GO Biological Process Annotations)", "synaptic transmission (GO:0007268 from GO Biological Process Annotations)", "synaptic transmission involved in micturition (GO:0060084 from GO Biological Process Annotations)", "synaptic transmission, cholinergic (GO:0007271 from GO Biological Process Annotations)", "synaptic transmission, dopaminergic (GO:0001963 from GO Biological Process Annotations)", "synaptic transmission, gabaergic (GO:0051932 from GO Biological Process Annotations)", "synaptic transmission, glutamatergic (GO:0035249 from GO Biological Process Annotations)", "synaptic transmission, glycinergic (GO:0060012 from GO Biological Process Annotations)", "synaptic vesicle amine transport (GO:0015842 from GO Biological Process Annotations)", "synaptic vesicle clustering (GO:0097091 from GO Biological Process Annotations)", "synaptic vesicle docking (GO:0016081 from GO Biological Process Annotations)", "synaptic vesicle endocytosis (GO:0048488 from GO Biological Process Annotations)", "synaptic vesicle exocytosis (GO:0016079 from GO Biological Process Annotations)", "synaptic vesicle fusion to presynaptic membrane (GO:0031629 from GO Biological Process Annotations)", "synaptic vesicle localization (GO:0097479 from GO Biological Process Annotations)", "synaptic vesicle maturation (GO:0016188 from GO Biological Process Annotations)", "synaptic vesicle membrane organization (GO:0048499 from GO Biological Process Annotations)", "synaptic vesicle priming (GO:0016082 from GO Biological Process Annotations)", "synaptic vesicle recycling (GO:0036465 from GO Biological Process Annotations)", "synaptic vesicle targeting (GO:0016080 from GO Biological Process Annotations)", "synaptic vesicle to endosome fusion (GO:0016189 from GO Biological Process Annotations)", "synaptic vesicle transport (GO:0048489 from GO Biological Process Annotations)", "synaptic vesicle uncoating (GO:0016191 from GO Biological Process Annotations)", "synaptonemal complex assembly (GO:0007130 from GO Biological Process Annotations)", "synaptonemal complex disassembly (GO:0070194 from GO Biological Process Annotations)", "synaptonemal complex organization (GO:0070193 from GO Biological Process Annotations)", "syncytiotrophoblast cell differentiation involved in labyrinthine layer development (GO:0060715 from GO Biological Process Annotations)", "syncytium formation (GO:0006949 from GO Biological Process Annotations)", "syncytium formation by plasma membrane fusion (GO:0000768 from GO Biological Process Annotations)", "system development (GO:0048731 from GO Biological Process Annotations)", "system process (GO:0003008 from GO Biological Process Annotations)", "t cell activation (GO:0042110 from GO Biological Process Annotations)", "t cell activation involved in immune response (GO:0002286 from GO Biological Process Annotations)", "t cell activation via t cell receptor contact with antigen bound to mhc molecule on antigen presenting cell (GO:0002291 from GO Biological Process Annotations)", "t cell aggregation (GO:0070489 from GO Biological Process Annotations)", "t cell antigen processing and presentation (GO:0002457 from GO Biological Process Annotations)", "t cell apoptotic process (GO:0070231 from GO Biological Process Annotations)", "t cell chemotaxis (GO:0010818 from GO Biological Process Annotations)", "t cell costimulation (GO:0031295 from GO Biological Process Annotations)", "t cell cytokine production (GO:0002369 from GO Biological Process Annotations)", "t cell differentiation (GO:0030217 from GO Biological Process Annotations)", "t cell differentiation in thymus (GO:0033077 from GO Biological Process Annotations)", "t cell differentiation involved in immune response (GO:0002292 from GO Biological Process Annotations)", "t cell extravasation (GO:0072683 from GO Biological Process Annotations)", "t cell homeostasis (GO:0043029 from GO Biological Process Annotations)", "t cell homeostatic proliferation (GO:0001777 from GO Biological Process Annotations)", "t cell lineage commitment (GO:0002360 from GO Biological Process Annotations)", "t cell mediated cytotoxicity (GO:0001913 from GO Biological Process Annotations)", "t cell mediated immunity (GO:0002456 from GO Biological Process Annotations)", "t cell migration (GO:0072678 from GO Biological Process Annotations)", "t cell proliferation (GO:0042098 from GO Biological Process Annotations)", "t cell proliferation involved in immune response (GO:0002309 from GO Biological Process Annotations)", "t cell receptor signaling pathway (GO:0050852 from GO Biological Process Annotations)", "t cell receptor v(d)j recombination (GO:0033153 from GO Biological Process Annotations)", "t cell secretory granule organization (GO:0033371 from GO Biological Process Annotations)", "t cell selection (GO:0045058 from GO Biological Process Annotations)", "t cell tolerance induction (GO:0002517 from GO Biological Process Annotations)", "t follicular helper cell differentiation (GO:0061470 from GO Biological Process Annotations)", "t-helper 1 cell differentiation (GO:0045063 from GO Biological Process Annotations)", "t-helper 1 cell lineage commitment (GO:0002296 from GO Biological Process Annotations)", "t-helper 1 type immune response (GO:0042088 from GO Biological Process Annotations)", "t-helper 17 cell chemotaxis (GO:0035705 from GO Biological Process Annotations)", "t-helper 17 cell differentiation (GO:0072539 from GO Biological Process Annotations)", "t-helper 17 cell lineage commitment (GO:0072540 from GO Biological Process Annotations)", "t-helper 2 cell activation (GO:0035712 from GO Biological Process Annotations)", "t-helper 2 cell cytokine production (GO:0035745 from GO Biological Process Annotations)", "t-helper 2 cell differentiation (GO:0045064 from GO Biological Process Annotations)", "t-helper cell differentiation (GO:0042093 from GO Biological Process Annotations)", "t-helper cell lineage commitment (GO:0002295 from GO Biological Process Annotations)", "t-tubule organization (GO:0033292 from GO Biological Process Annotations)", "tachykinin receptor signaling pathway (GO:0007217 from GO Biological Process Annotations)", "tail-anchored membrane protein insertion into er membrane (GO:0071816 from GO Biological Process Annotations)", "tangential migration from the subventricular zone to the olfactory bulb (GO:0022028 from GO Biological Process Annotations)", "targeting of mrna for destruction involved in rna interference (GO:0030423 from GO Biological Process Annotations)", "taste bud development (GO:0061193 from GO Biological Process Annotations)", "taurine biosynthetic process (GO:0042412 from GO Biological Process Annotations)", "taurine metabolic process (GO:0019530 from GO Biological Process Annotations)", "taurine transport (GO:0015734 from GO Biological Process Annotations)", "taxis (GO:0042330 from GO Biological Process Annotations)", "tcr signalosome assembly (GO:0036399 from GO Biological Process Annotations)", "tdp phosphorylation (GO:0061571 from GO Biological Process Annotations)", "tear secretion (GO:0070075 from GO Biological Process Annotations)", "telencephalon cell migration (GO:0022029 from GO Biological Process Annotations)", "telencephalon development (GO:0021537 from GO Biological Process Annotations)", "telencephalon glial cell migration (GO:0022030 from GO Biological Process Annotations)", "telencephalon regionalization (GO:0021978 from GO Biological Process Annotations)", "telomere assembly (GO:0032202 from GO Biological Process Annotations)", "telomere capping (GO:0016233 from GO Biological Process Annotations)", "telomere formation via telomerase (GO:0032203 from GO Biological Process Annotations)", "telomere localization (GO:0034397 from GO Biological Process Annotations)", "telomere maintenance (GO:0000723 from GO Biological Process Annotations)", "telomere maintenance in response to dna damage (GO:0043247 from GO Biological Process Annotations)", "telomere maintenance via recombination (GO:0000722 from GO Biological Process Annotations)", "telomere maintenance via semi-conservative replication (GO:0032201 from GO Biological Process Annotations)", "telomere maintenance via telomerase (GO:0007004 from GO Biological Process Annotations)", "telomere maintenance via telomere lengthening (GO:0010833 from GO Biological Process Annotations)", "telomere organization (GO:0032200 from GO Biological Process Annotations)", "telomeric 3' overhang formation (GO:0031860 from GO Biological Process Annotations)", "telomeric loop formation (GO:0031627 from GO Biological Process Annotations)", "temperature homeostasis (GO:0001659 from GO Biological Process Annotations)", "tendon cell differentiation (GO:0035990 from GO Biological Process Annotations)", "tendon development (GO:0035989 from GO Biological Process Annotations)", "tendon formation (GO:0035992 from GO Biological Process Annotations)", "tendon sheath development (GO:0002932 from GO Biological Process Annotations)", "terminal button organization (GO:0072553 from GO Biological Process Annotations)", "termination of g-protein coupled receptor signaling pathway (GO:0038032 from GO Biological Process Annotations)", "termination of mitochondrial transcription (GO:0006393 from GO Biological Process Annotations)", "termination of rna polymerase i transcription (GO:0006363 from GO Biological Process Annotations)", "termination of rna polymerase ii transcription (GO:0006369 from GO Biological Process Annotations)", "termination of rna polymerase iii transcription (GO:0006386 from GO Biological Process Annotations)", "termination of signal transduction (GO:0023021 from GO Biological Process Annotations)", "terpene catabolic process (GO:0046247 from GO Biological Process Annotations)", "terpene metabolic process (GO:0042214 from GO Biological Process Annotations)", "terpenoid biosynthetic process (GO:0016114 from GO Biological Process Annotations)", "terpenoid catabolic process (GO:0016115 from GO Biological Process Annotations)", "terpenoid metabolic process (GO:0006721 from GO Biological Process Annotations)", "terpenoid transport (GO:0046865 from GO Biological Process Annotations)", "tertiary branching involved in mammary gland duct morphogenesis (GO:0060748 from GO Biological Process Annotations)", "testosterone biosynthetic process (GO:0061370 from GO Biological Process Annotations)", "tetracycline transport (GO:0015904 from GO Biological Process Annotations)", "tetrahydrobiopterin biosynthetic process (GO:0006729 from GO Biological Process Annotations)", "tetrahydrobiopterin metabolic process (GO:0046146 from GO Biological Process Annotations)", "tetrahydrofolate biosynthetic process (GO:0046654 from GO Biological Process Annotations)", "tetrahydrofolate interconversion (GO:0035999 from GO Biological Process Annotations)", "tetrahydrofolate metabolic process (GO:0046653 from GO Biological Process Annotations)", "tetrahydrofolylpolyglutamate biosynthetic process (GO:0046901 from GO Biological Process Annotations)", "tetrahydrofolylpolyglutamate metabolic process (GO:0046900 from GO Biological Process Annotations)", "tetrapyrrole biosynthetic process (GO:0033014 from GO Biological Process Annotations)", "tetrapyrrole catabolic process (GO:0033015 from GO Biological Process Annotations)", "tetrapyrrole metabolic process (GO:0033013 from GO Biological Process Annotations)", "tetraterpenoid metabolic process (GO:0016108 from GO Biological Process Annotations)", "thalamus development (GO:0021794 from GO Biological Process Annotations)", "thermoception (GO:0050955 from GO Biological Process Annotations)", "thermosensory behavior (GO:0040040 from GO Biological Process Annotations)", "thiamine diphosphate biosynthetic process (GO:0009229 from GO Biological Process Annotations)", "thiamine diphosphate metabolic process (GO:0042357 from GO Biological Process Annotations)", "thiamine metabolic process (GO:0006772 from GO Biological Process Annotations)", "thiamine transmembrane transport (GO:0071934 from GO Biological Process Annotations)", "thiamine transport (GO:0015888 from GO Biological Process Annotations)", "thiamine-containing compound metabolic process (GO:0042723 from GO Biological Process Annotations)", "thick ascending limb development (GO:0072023 from GO Biological Process Annotations)", "thiocyanate metabolic process (GO:0018969 from GO Biological Process Annotations)", "thioester biosynthetic process (GO:0035384 from GO Biological Process Annotations)", "thioester metabolic process (GO:0035383 from GO Biological Process Annotations)", "thioester transport (GO:1901337 from GO Biological Process Annotations)", "third ventricle development (GO:0021678 from GO Biological Process Annotations)", "thorax and anterior abdomen determination (GO:0007356 from GO Biological Process Annotations)", "threonine biosynthetic process (GO:0009088 from GO Biological Process Annotations)", "threonine catabolic process (GO:0006567 from GO Biological Process Annotations)", "threonine metabolic process (GO:0006566 from GO Biological Process Annotations)", "threonine transport (GO:0015826 from GO Biological Process Annotations)", "threonyl-trna aminoacylation (GO:0006435 from GO Biological Process Annotations)", "threonylcarbamoyladenosine biosynthetic process (GO:0070526 from GO Biological Process Annotations)", "threonylcarbamoyladenosine metabolic process (GO:0070525 from GO Biological Process Annotations)", "thrombin receptor signaling pathway (GO:0070493 from GO Biological Process Annotations)", "thrombopoietin-mediated signaling pathway (GO:0038163 from GO Biological Process Annotations)", "thromboxane a2 signaling pathway (GO:0038193 from GO Biological Process Annotations)", "thymic t cell selection (GO:0045061 from GO Biological Process Annotations)", "thymidine biosynthetic process (GO:0046105 from GO Biological Process Annotations)", "thymidine catabolic process (GO:0006214 from GO Biological Process Annotations)", "thymidine metabolic process (GO:0046104 from GO Biological Process Annotations)", "thymine catabolic process (GO:0006210 from GO Biological Process Annotations)", "thymine metabolic process (GO:0019859 from GO Biological Process Annotations)", "thymocyte aggregation (GO:0071594 from GO Biological Process Annotations)", "thymocyte apoptotic process (GO:0070242 from GO Biological Process Annotations)", "thymus development (GO:0048538 from GO Biological Process Annotations)", "thyroid gland development (GO:0030878 from GO Biological Process Annotations)", "thyroid hormone catabolic process (GO:0042404 from GO Biological Process Annotations)", "thyroid hormone generation (GO:0006590 from GO Biological Process Annotations)", "thyroid hormone mediated signaling pathway (GO:0002154 from GO Biological Process Annotations)", "thyroid hormone metabolic process (GO:0042403 from GO Biological Process Annotations)", "thyroid hormone transport (GO:0070327 from GO Biological Process Annotations)", "thyroid-stimulating hormone signaling pathway (GO:0038194 from GO Biological Process Annotations)", "thyroid-stimulating hormone-secreting cell differentiation (GO:0060129 from GO Biological Process Annotations)", "tie signaling pathway (GO:0048014 from GO Biological Process Annotations)", "tight junction assembly (GO:0070830 from GO Biological Process Annotations)", "tirap-dependent toll-like receptor 4 signaling pathway (GO:0035665 from GO Biological Process Annotations)", "tirap-dependent toll-like receptor signaling pathway (GO:0035664 from GO Biological Process Annotations)", "tissue development (GO:0009888 from GO Biological Process Annotations)", "tissue homeostasis (GO:0001894 from GO Biological Process Annotations)", "tissue migration (GO:0090130 from GO Biological Process Annotations)", "tissue morphogenesis (GO:0048729 from GO Biological Process Annotations)", "tissue regeneration (GO:0042246 from GO Biological Process Annotations)", "tissue remodeling (GO:0048771 from GO Biological Process Annotations)", "tnfsf11-mediated signaling pathway (GO:0071847 from GO Biological Process Annotations)", "tolerance induction (GO:0002507 from GO Biological Process Annotations)", "tolerance induction to lipopolysaccharide (GO:0072573 from GO Biological Process Annotations)", "tolerance induction to self antigen (GO:0002513 from GO Biological Process Annotations)", "toll signaling pathway (GO:0008063 from GO Biological Process Annotations)", "toll-like receptor 1 signaling pathway (GO:0034130 from GO Biological Process Annotations)", "toll-like receptor 10 signaling pathway (GO:0034166 from GO Biological Process Annotations)", "toll-like receptor 2 signaling pathway (GO:0034134 from GO Biological Process Annotations)", "toll-like receptor 3 signaling pathway (GO:0034138 from GO Biological Process Annotations)", "toll-like receptor 4 signaling pathway (GO:0034142 from GO Biological Process Annotations)", "toll-like receptor 5 signaling pathway (GO:0034146 from GO Biological Process Annotations)", "toll-like receptor 6 signaling pathway (GO:0034150 from GO Biological Process Annotations)", "toll-like receptor 7 signaling pathway (GO:0034154 from GO Biological Process Annotations)", "toll-like receptor 8 signaling pathway (GO:0034158 from GO Biological Process Annotations)", "toll-like receptor 9 signaling pathway (GO:0034162 from GO Biological Process Annotations)", "toll-like receptor signaling pathway (GO:0002224 from GO Biological Process Annotations)", "toll-like receptor tlr1:tlr2 signaling pathway (GO:0038123 from GO Biological Process Annotations)", "toll-like receptor tlr6:tlr2 signaling pathway (GO:0038124 from GO Biological Process Annotations)", "tongue development (GO:0043586 from GO Biological Process Annotations)", "tongue morphogenesis (GO:0043587 from GO Biological Process Annotations)", "tonic smooth muscle contraction (GO:0014820 from GO Biological Process Annotations)", "tooth eruption (GO:0044691 from GO Biological Process Annotations)", "tooth mineralization (GO:0034505 from GO Biological Process Annotations)", "tor signaling (GO:0031929 from GO Biological Process Annotations)", "torc2 signaling (GO:0038203 from GO Biological Process Annotations)", "toxin biosynthetic process (GO:0009403 from GO Biological Process Annotations)", "toxin metabolic process (GO:0009404 from GO Biological Process Annotations)", "toxin transport (GO:1901998 from GO Biological Process Annotations)", "trabecula formation (GO:0060343 from GO Biological Process Annotations)", "trabecula morphogenesis (GO:0061383 from GO Biological Process Annotations)", "trabecular meshwork development (GO:0002930 from GO Biological Process Annotations)", "trachea cartilage development (GO:0060534 from GO Biological Process Annotations)", "trachea cartilage morphogenesis (GO:0060535 from GO Biological Process Annotations)", "trachea development (GO:0060438 from GO Biological Process Annotations)", "trachea formation (GO:0060440 from GO Biological Process Annotations)", "trachea gland development (GO:0061153 from GO Biological Process Annotations)", "trachea morphogenesis (GO:0060439 from GO Biological Process Annotations)", "trail-activated apoptotic signaling pathway (GO:0036462 from GO Biological Process Annotations)", "tram-dependent toll-like receptor 4 signaling pathway (GO:0035669 from GO Biological Process Annotations)", "tram-dependent toll-like receptor signaling pathway (GO:0035668 from GO Biological Process Annotations)", "trans-golgi network membrane organization (GO:0098629 from GO Biological Process Annotations)", "trans-golgi network to recycling endosome transport (GO:0044795 from GO Biological Process Annotations)", "transcription elongation from rna polymerase i promoter (GO:0006362 from GO Biological Process Annotations)", "transcription elongation from rna polymerase ii promoter (GO:0006368 from GO Biological Process Annotations)", "transcription elongation from rna polymerase iii promoter (GO:0006385 from GO Biological Process Annotations)", "transcription factor import into nucleus (GO:0042991 from GO Biological Process Annotations)", "transcription factor tfiiib complex assembly (GO:0070217 from GO Biological Process Annotations)", "transcription from mitochondrial promoter (GO:0006390 from GO Biological Process Annotations)", "transcription from rna polymerase i promoter (GO:0006360 from GO Biological Process Annotations)", "transcription from rna polymerase ii promoter (GO:0006366 from GO Biological Process Annotations)", "transcription from rna polymerase iii promoter (GO:0006383 from GO Biological Process Annotations)", "transcription initiation from mitochondrial promoter (GO:0006391 from GO Biological Process Annotations)", "transcription initiation from rna polymerase i promoter (GO:0006361 from GO Biological Process Annotations)", "transcription initiation from rna polymerase ii promoter (GO:0006367 from GO Biological Process Annotations)", "transcription initiation from rna polymerase iii promoter (GO:0006384 from GO Biological Process Annotations)", "transcription of nuclear large rrna transcript from rna polymerase i promoter (GO:0042790 from GO Biological Process Annotations)", "transcription, dna-templated (GO:0006351 from GO Biological Process Annotations)", "transcription, rna-templated (GO:0001172 from GO Biological Process Annotations)", "transcription-coupled nucleotide-excision repair (GO:0006283 from GO Biological Process Annotations)", "transcription-dependent tethering of rna polymerase ii gene dna at nuclear periphery (GO:0000972 from GO Biological Process Annotations)", "transcriptional activation by promoter-enhancer looping (GO:0071733 from GO Biological Process Annotations)", "transcytosis (GO:0045056 from GO Biological Process Annotations)", "transdifferentiation (GO:0060290 from GO Biological Process Annotations)", "transepithelial ammonium transport (GO:0070634 from GO Biological Process Annotations)", "transepithelial chloride transport (GO:0030321 from GO Biological Process Annotations)", "transepithelial l-ascorbic acid transport (GO:0070904 from GO Biological Process Annotations)", "transepithelial transport (GO:0070633 from GO Biological Process Annotations)", "transepithelial water transport (GO:0035377 from GO Biological Process Annotations)", "transferrin transport (GO:0033572 from GO Biological Process Annotations)", "transformation of host cell by virus (GO:0019087 from GO Biological Process Annotations)", "transformed cell apoptotic process (GO:0006927 from GO Biological Process Annotations)", "transforming growth factor beta activation (GO:0036363 from GO Biological Process Annotations)", "transforming growth factor beta receptor complex assembly (GO:0007181 from GO Biological Process Annotations)", "transforming growth factor beta receptor signaling pathway (GO:0007179 from GO Biological Process Annotations)", "transforming growth factor beta receptor signaling pathway involved in primitive streak formation (GO:0090010 from GO Biological Process Annotations)", "transition between fast and slow fiber (GO:0014883 from GO Biological Process Annotations)", "transition between slow and fast fiber (GO:0014886 from GO Biological Process Annotations)", "transition metal ion homeostasis (GO:0055076 from GO Biological Process Annotations)", "transition metal ion transport (GO:0000041 from GO Biological Process Annotations)", "transitional one stage b cell differentiation (GO:0002333 from GO Biological Process Annotations)", "transitional stage b cell differentiation (GO:0002332 from GO Biological Process Annotations)", "translation (GO:0006412 from GO Biological Process Annotations)", "translational attenuation (GO:0009386 from GO Biological Process Annotations)", "translational elongation (GO:0006414 from GO Biological Process Annotations)", "translational frameshifting (GO:0006452 from GO Biological Process Annotations)", "translational initiation (GO:0006413 from GO Biological Process Annotations)", "translational readthrough (GO:0006451 from GO Biological Process Annotations)", "translational termination (GO:0006415 from GO Biological Process Annotations)", "translesion synthesis (GO:0019985 from GO Biological Process Annotations)", "translocation of molecules into host (GO:0044417 from GO Biological Process Annotations)", "translocation of molecules into other organism involved in symbiotic interaction (GO:0051836 from GO Biological Process Annotations)", "translocation of peptides or proteins into host (GO:0042000 from GO Biological Process Annotations)", "translocation of peptides or proteins into host cell cytoplasm (GO:0044053 from GO Biological Process Annotations)", "translocation of peptides or proteins into other organism involved in symbiotic interaction (GO:0051808 from GO Biological Process Annotations)", "transmembrane receptor protein serine|threonine kinase signaling pathway (GO:0007178 from GO Biological Process Annotations)", "transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169 from GO Biological Process Annotations)", "transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185 from GO Biological Process Annotations)", "transmembrane transport (GO:0055085 from GO Biological Process Annotations)", "transmission of nerve impulse (GO:0019226 from GO Biological Process Annotations)", "transmission of virus (GO:0019089 from GO Biological Process Annotations)", "transport (GO:0006810 from GO Biological Process Annotations)", "transport of viral material towards nucleus (GO:0075606 from GO Biological Process Annotations)", "transport of virus (GO:0046794 from GO Biological Process Annotations)", "transposition (GO:0032196 from GO Biological Process Annotations)", "transposition, dna-mediated (GO:0006313 from GO Biological Process Annotations)", "transsulfuration (GO:0019346 from GO Biological Process Annotations)", "traversing start control point of mitotic cell cycle (GO:0007089 from GO Biological Process Annotations)", "trehalose catabolic process (GO:0005993 from GO Biological Process Annotations)", "trehalose metabolic process (GO:0005991 from GO Biological Process Annotations)", "tricarboxylic acid cycle (GO:0006099 from GO Biological Process Annotations)", "tricarboxylic acid metabolic process (GO:0072350 from GO Biological Process Annotations)", "tricarboxylic acid transmembrane transport (GO:0035674 from GO Biological Process Annotations)", "tricarboxylic acid transport (GO:0006842 from GO Biological Process Annotations)", "trichloroethylene metabolic process (GO:0018979 from GO Biological Process Annotations)", "tricuspid valve development (GO:0003175 from GO Biological Process Annotations)", "tricuspid valve formation (GO:0003195 from GO Biological Process Annotations)", "tricuspid valve morphogenesis (GO:0003186 from GO Biological Process Annotations)", "trif-dependent toll-like receptor signaling pathway (GO:0035666 from GO Biological Process Annotations)", "trigeminal ganglion development (GO:0061551 from GO Biological Process Annotations)", "trigeminal nerve development (GO:0021559 from GO Biological Process Annotations)", "trigeminal nerve structural organization (GO:0021637 from GO Biological Process Annotations)", "trigeminal sensory nucleus development (GO:0021730 from GO Biological Process Annotations)", "triglyceride acyl-chain remodeling (GO:0036153 from GO Biological Process Annotations)", "triglyceride biosynthetic process (GO:0019432 from GO Biological Process Annotations)", "triglyceride catabolic process (GO:0019433 from GO Biological Process Annotations)", "triglyceride homeostasis (GO:0070328 from GO Biological Process Annotations)", "triglyceride metabolic process (GO:0006641 from GO Biological Process Annotations)", "triglyceride mobilization (GO:0006642 from GO Biological Process Annotations)", "triglyceride transport (GO:0034197 from GO Biological Process Annotations)", "triglyceride-rich lipoprotein particle clearance (GO:0071830 from GO Biological Process Annotations)", "triglyceride-rich lipoprotein particle remodeling (GO:0034370 from GO Biological Process Annotations)", "tripeptide transport (GO:0042939 from GO Biological Process Annotations)", "triterpenoid metabolic process (GO:0006722 from GO Biological Process Annotations)", "trivalent inorganic anion homeostasis (GO:0072506 from GO Biological Process Annotations)", "trivalent inorganic cation transport (GO:0072512 from GO Biological Process Annotations)", "trna 3'-end processing (GO:0042780 from GO Biological Process Annotations)", "trna 3'-terminal cca addition (GO:0001680 from GO Biological Process Annotations)", "trna 3'-trailer cleavage (GO:0042779 from GO Biological Process Annotations)", "trna 3'-trailer cleavage, endonucleolytic (GO:0034414 from GO Biological Process Annotations)", "trna 5'-leader removal (GO:0001682 from GO Biological Process Annotations)", "trna aminoacylation (GO:0043039 from GO Biological Process Annotations)", "trna aminoacylation for mitochondrial protein translation (GO:0070127 from GO Biological Process Annotations)", "trna aminoacylation for protein translation (GO:0006418 from GO Biological Process Annotations)", "trna catabolic process (GO:0016078 from GO Biological Process Annotations)", "trna dihydrouridine synthesis (GO:0002943 from GO Biological Process Annotations)", "trna export from nucleus (GO:0006409 from GO Biological Process Annotations)", "trna metabolic process (GO:0006399 from GO Biological Process Annotations)", "trna methylation (GO:0030488 from GO Biological Process Annotations)", "trna methylthiolation (GO:0035600 from GO Biological Process Annotations)", "trna modification (GO:0006400 from GO Biological Process Annotations)", "trna nucleoside ribose methylation (GO:0002128 from GO Biological Process Annotations)", "trna processing (GO:0008033 from GO Biological Process Annotations)", "trna pseudouridine synthesis (GO:0031119 from GO Biological Process Annotations)", "trna splicing, via endonucleolytic cleavage and ligation (GO:0006388 from GO Biological Process Annotations)", "trna thio-modification (GO:0034227 from GO Biological Process Annotations)", "trna transcription (GO:0009304 from GO Biological Process Annotations)", "trna transcription from rna polymerase iii promoter (GO:0042797 from GO Biological Process Annotations)", "trna transport (GO:0051031 from GO Biological Process Annotations)", "trna wobble adenosine to inosine editing (GO:0002100 from GO Biological Process Annotations)", "trna wobble base modification (GO:0002097 from GO Biological Process Annotations)", "trna wobble position uridine thiolation (GO:0002143 from GO Biological Process Annotations)", "trna wobble uridine modification (GO:0002098 from GO Biological Process Annotations)", "trna-type intron splice site recognition and cleavage (GO:0000379 from GO Biological Process Annotations)", "trochlear nerve development (GO:0021558 from GO Biological Process Annotations)", "trochlear nerve formation (GO:0021642 from GO Biological Process Annotations)", "tropane alkaloid metabolic process (GO:0046448 from GO Biological Process Annotations)", "trophectodermal cell differentiation (GO:0001829 from GO Biological Process Annotations)", "trophectodermal cell proliferation (GO:0001834 from GO Biological Process Annotations)", "trophectodermal cellular morphogenesis (GO:0001831 from GO Biological Process Annotations)", "trophoblast giant cell differentiation (GO:0060707 from GO Biological Process Annotations)", "trunk neural crest cell migration (GO:0036484 from GO Biological Process Annotations)", "trypsinogen activation (GO:0032023 from GO Biological Process Annotations)", "tryptophan catabolic process (GO:0006569 from GO Biological Process Annotations)", "tryptophan catabolic process to acetyl-coa (GO:0019442 from GO Biological Process Annotations)", "tryptophan catabolic process to kynurenine (GO:0019441 from GO Biological Process Annotations)", "tryptophan metabolic process (GO:0006568 from GO Biological Process Annotations)", "tryptophan transport (GO:0015827 from GO Biological Process Annotations)", "tryptophanyl-trna aminoacylation (GO:0006436 from GO Biological Process Annotations)", "tube closure (GO:0060606 from GO Biological Process Annotations)", "tube development (GO:0035295 from GO Biological Process Annotations)", "tube formation (GO:0035148 from GO Biological Process Annotations)", "tube lumen cavitation (GO:0060605 from GO Biological Process Annotations)", "tube morphogenesis (GO:0035239 from GO Biological Process Annotations)", "tubulin complex assembly (GO:0007021 from GO Biological Process Annotations)", "tubulin deacetylation (GO:0090042 from GO Biological Process Annotations)", "tumor necrosis factor production (GO:0032640 from GO Biological Process Annotations)", "tumor necrosis factor superfamily cytokine production (GO:0071706 from GO Biological Process Annotations)", "tumor necrosis factor-mediated signaling pathway (GO:0033209 from GO Biological Process Annotations)", "twitch skeletal muscle contraction (GO:0014721 from GO Biological Process Annotations)", "type 2 immune response (GO:0042092 from GO Biological Process Annotations)", "type b pancreatic cell apoptotic process (GO:0097050 from GO Biological Process Annotations)", "type b pancreatic cell development (GO:0003323 from GO Biological Process Annotations)", "type b pancreatic cell differentiation (GO:0003309 from GO Biological Process Annotations)", "type b pancreatic cell fate commitment (GO:0003327 from GO Biological Process Annotations)", "type b pancreatic cell maturation (GO:0072560 from GO Biological Process Annotations)", "type b pancreatic cell proliferation (GO:0044342 from GO Biological Process Annotations)", "type i interferon biosynthetic process (GO:0045351 from GO Biological Process Annotations)", "type i interferon production (GO:0032606 from GO Biological Process Annotations)", "type i interferon signaling pathway (GO:0060337 from GO Biological Process Annotations)", "type i pneumocyte differentiation (GO:0060509 from GO Biological Process Annotations)", "type ii pneumocyte differentiation (GO:0060510 from GO Biological Process Annotations)", "type iv hypersensitivity (GO:0001806 from GO Biological Process Annotations)", "tyrosine catabolic process (GO:0006572 from GO Biological Process Annotations)", "tyrosine metabolic process (GO:0006570 from GO Biological Process Annotations)", "tyrosine phosphorylation of stat protein (GO:0007260 from GO Biological Process Annotations)", "tyrosine phosphorylation of stat1 protein (GO:0042508 from GO Biological Process Annotations)", "tyrosine phosphorylation of stat2 protein (GO:0042502 from GO Biological Process Annotations)", "tyrosine phosphorylation of stat3 protein (GO:0042503 from GO Biological Process Annotations)", "tyrosine phosphorylation of stat5 protein (GO:0042506 from GO Biological Process Annotations)", "tyrosine transport (GO:0015828 from GO Biological Process Annotations)", "tyrosyl-trna aminoacylation (GO:0006437 from GO Biological Process Annotations)", "u2 snrna 3'-end processing (GO:0034474 from GO Biological Process Annotations)", "u4 snrna 3'-end processing (GO:0034475 from GO Biological Process Annotations)", "u6 snrna 3'-end processing (GO:0034477 from GO Biological Process Annotations)", "ubiquinone biosynthetic process (GO:0006744 from GO Biological Process Annotations)", "ubiquinone metabolic process (GO:0006743 from GO Biological Process Annotations)", "ubiquitin homeostasis (GO:0010992 from GO Biological Process Annotations)", "ubiquitin-dependent endocytosis (GO:0070086 from GO Biological Process Annotations)", "ubiquitin-dependent protein catabolic process (GO:0006511 from GO Biological Process Annotations)", "ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162 from GO Biological Process Annotations)", "ubiquitin-dependent smad protein catabolic process (GO:0030579 from GO Biological Process Annotations)", "ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611 from GO Biological Process Annotations)", "udp biosynthetic process (GO:0006225 from GO Biological Process Annotations)", "udp catabolic process (GO:0006256 from GO Biological Process Annotations)", "udp metabolic process (GO:0046048 from GO Biological Process Annotations)", "udp phosphorylation (GO:0061569 from GO Biological Process Annotations)", "udp-d-xylose biosynthetic process (GO:0033320 from GO Biological Process Annotations)", "udp-d-xylose metabolic process (GO:0033319 from GO Biological Process Annotations)", "udp-galactose transmembrane transport (GO:0072334 from GO Biological Process Annotations)", "udp-galactose transport (GO:0015785 from GO Biological Process Annotations)", "udp-glucose catabolic process (GO:0006258 from GO Biological Process Annotations)", "udp-glucose metabolic process (GO:0006011 from GO Biological Process Annotations)", "udp-glucosylation (GO:0097359 from GO Biological Process Annotations)", "udp-glucuronate biosynthetic process (GO:0006065 from GO Biological Process Annotations)", "udp-glucuronate metabolic process (GO:0046398 from GO Biological Process Annotations)", "udp-glucuronic acid transport (GO:0015787 from GO Biological Process Annotations)", "udp-n-acetylgalactosamine metabolic process (GO:0019276 from GO Biological Process Annotations)", "udp-n-acetylglucosamine biosynthetic process (GO:0006048 from GO Biological Process Annotations)", "udp-n-acetylglucosamine catabolic process (GO:0006049 from GO Biological Process Annotations)", "udp-n-acetylglucosamine metabolic process (GO:0006047 from GO Biological Process Annotations)", "udp-n-acetylglucosamine transmembrane transport (GO:1990569 from GO Biological Process Annotations)", "udp-n-acetylglucosamine transport (GO:0015788 from GO Biological Process Annotations)", "udp-xylose transport (GO:0015790 from GO Biological Process Annotations)", "ufp-specific transcription factor mrna processing involved in endoplasmic reticulum unfolded protein response (GO:0030969 from GO Biological Process Annotations)", "ultradian rhythm (GO:0007624 from GO Biological Process Annotations)", "umbilical cord morphogenesis (GO:0036304 from GO Biological Process Annotations)", "ump biosynthetic process (GO:0006222 from GO Biological Process Annotations)", "ump metabolic process (GO:0046049 from GO Biological Process Annotations)", "ump salvage (GO:0044206 from GO Biological Process Annotations)", "uncoating of virus (GO:0019061 from GO Biological Process Annotations)", "unidimensional cell growth (GO:0009826 from GO Biological Process Annotations)", "unsaturated fatty acid biosynthetic process (GO:0006636 from GO Biological Process Annotations)", "unsaturated fatty acid metabolic process (GO:0033559 from GO Biological Process Annotations)", "unsaturated monocarboxylic acid metabolic process (GO:0032789 from GO Biological Process Annotations)", "uracil catabolic process (GO:0006212 from GO Biological Process Annotations)", "uracil metabolic process (GO:0019860 from GO Biological Process Annotations)", "urate biosynthetic process (GO:0034418 from GO Biological Process Annotations)", "urate catabolic process (GO:0019628 from GO Biological Process Annotations)", "urate homeostasis (GO:1903118 from GO Biological Process Annotations)", "urate metabolic process (GO:0046415 from GO Biological Process Annotations)", "urate transport (GO:0015747 from GO Biological Process Annotations)", "urea cycle (GO:0000050 from GO Biological Process Annotations)", "urea homeostasis (GO:0097274 from GO Biological Process Annotations)", "urea metabolic process (GO:0019627 from GO Biological Process Annotations)", "urea transmembrane transport (GO:0071918 from GO Biological Process Annotations)", "urea transport (GO:0015840 from GO Biological Process Annotations)", "ureter development (GO:0072189 from GO Biological Process Annotations)", "ureter epithelial cell differentiation (GO:0072192 from GO Biological Process Annotations)", "ureter maturation (GO:0035799 from GO Biological Process Annotations)", "ureter morphogenesis (GO:0072197 from GO Biological Process Annotations)", "ureter smooth muscle cell differentiation (GO:0072193 from GO Biological Process Annotations)", "ureter smooth muscle contraction (GO:0014849 from GO Biological Process Annotations)", "ureter urothelium development (GO:0072190 from GO Biological Process Annotations)", "ureteric bud development (GO:0001657 from GO Biological Process Annotations)", "ureteric bud elongation (GO:0060677 from GO Biological Process Annotations)", "ureteric bud formation (GO:0060676 from GO Biological Process Annotations)", "ureteric bud invasion (GO:0072092 from GO Biological Process Annotations)", "ureteric bud morphogenesis (GO:0060675 from GO Biological Process Annotations)", "ureteric peristalsis (GO:0072105 from GO Biological Process Annotations)", "uridine metabolic process (GO:0046108 from GO Biological Process Annotations)", "uridine transport (GO:0015862 from GO Biological Process Annotations)", "urinary bladder development (GO:0060157 from GO Biological Process Annotations)", "urinary bladder smooth muscle contraction (GO:0014832 from GO Biological Process Annotations)", "urinary tract smooth muscle contraction (GO:0014848 from GO Biological Process Annotations)", "urogenital system development (GO:0001655 from GO Biological Process Annotations)", "urokinase plasminogen activator signaling pathway (GO:0038195 from GO Biological Process Annotations)", "uronic acid metabolic process (GO:0006063 from GO Biological Process Annotations)", "uropod organization (GO:0032796 from GO Biological Process Annotations)", "uroporphyrinogen iii biosynthetic process (GO:0006780 from GO Biological Process Annotations)", "uroporphyrinogen iii metabolic process (GO:0046502 from GO Biological Process Annotations)", "urothelial cell proliferation (GO:0050674 from GO Biological Process Annotations)", "uterine epithelium development (GO:0035847 from GO Biological Process Annotations)", "uterine smooth muscle contraction (GO:0070471 from GO Biological Process Annotations)", "uterine wall breakdown (GO:0042704 from GO Biological Process Annotations)", "uterus development (GO:0060065 from GO Biological Process Annotations)", "uterus morphogenesis (GO:0061038 from GO Biological Process Annotations)", "utp biosynthetic process (GO:0006228 from GO Biological Process Annotations)", "utp metabolic process (GO:0046051 from GO Biological Process Annotations)", "uv protection (GO:0009650 from GO Biological Process Annotations)", "uv-damage excision repair (GO:0070914 from GO Biological Process Annotations)", "v(d)j recombination (GO:0033151 from GO Biological Process Annotations)", "vacuolar acidification (GO:0007035 from GO Biological Process Annotations)", "vacuolar proton-transporting v-type atpase complex assembly (GO:0070072 from GO Biological Process Annotations)", "vacuolar sequestering (GO:0043181 from GO Biological Process Annotations)", "vacuolar transport (GO:0007034 from GO Biological Process Annotations)", "vacuole fusion (GO:0097576 from GO Biological Process Annotations)", "vacuole fusion, non-autophagic (GO:0042144 from GO Biological Process Annotations)", "vacuole inheritance (GO:0000011 from GO Biological Process Annotations)", "vacuole organization (GO:0007033 from GO Biological Process Annotations)", "vagina development (GO:0060068 from GO Biological Process Annotations)", "vagus nerve development (GO:0021564 from GO Biological Process Annotations)", "vagus nerve morphogenesis (GO:0021644 from GO Biological Process Annotations)", "valine catabolic process (GO:0006574 from GO Biological Process Annotations)", "valine metabolic process (GO:0006573 from GO Biological Process Annotations)", "valyl-trna aminoacylation (GO:0006438 from GO Biological Process Annotations)", "vascular endothelial growth factor production (GO:0010573 from GO Biological Process Annotations)", "vascular endothelial growth factor receptor signaling pathway (GO:0048010 from GO Biological Process Annotations)", "vascular endothelial growth factor receptor-1 signaling pathway (GO:0036323 from GO Biological Process Annotations)", "vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324 from GO Biological Process Annotations)", "vascular endothelial growth factor signaling pathway (GO:0038084 from GO Biological Process Annotations)", "vascular process in circulatory system (GO:0003018 from GO Biological Process Annotations)", "vascular smooth muscle cell development (GO:0097084 from GO Biological Process Annotations)", "vascular smooth muscle cell differentiation (GO:0035886 from GO Biological Process Annotations)", "vascular smooth muscle contraction (GO:0014829 from GO Biological Process Annotations)", "vascular transport (GO:0010232 from GO Biological Process Annotations)", "vascular wound healing (GO:0061042 from GO Biological Process Annotations)", "vasculature development (GO:0001944 from GO Biological Process Annotations)", "vasculogenesis (GO:0001570 from GO Biological Process Annotations)", "vasculogenesis involved in coronary vascular morphogenesis (GO:0060979 from GO Biological Process Annotations)", "vasoconstriction (GO:0042310 from GO Biological Process Annotations)", "vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure (GO:0001987 from GO Biological Process Annotations)", "vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure (GO:0002014 from GO Biological Process Annotations)", "vasodilation (GO:0042311 from GO Biological Process Annotations)", "vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure (GO:0003069 from GO Biological Process Annotations)", "vasodilation by angiotensin involved in regulation of systemic arterial blood pressure (GO:0002033 from GO Biological Process Annotations)", "vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure (GO:0002025 from GO Biological Process Annotations)", "vasodilation of artery involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001984 from GO Biological Process Annotations)", "vasomotion (GO:1990029 from GO Biological Process Annotations)", "vasopressin secretion (GO:0030103 from GO Biological Process Annotations)", "vegf-activated neuropilin signaling pathway (GO:0038190 from GO Biological Process Annotations)", "vegf-activated neuropilin signaling pathway involved in axon guidance (GO:1902378 from GO Biological Process Annotations)", "vegf-activated platelet-derived growth factor receptor signaling pathway (GO:0038086 from GO Biological Process Annotations)", "vein smooth muscle contraction (GO:0014826 from GO Biological Process Annotations)", "venous blood vessel development (GO:0060841 from GO Biological Process Annotations)", "venous blood vessel morphogenesis (GO:0048845 from GO Biological Process Annotations)", "venous endothelial cell differentiation (GO:0060843 from GO Biological Process Annotations)", "ventral midline determination (GO:0007371 from GO Biological Process Annotations)", "ventral midline development (GO:0007418 from GO Biological Process Annotations)", "ventral spinal cord development (GO:0021517 from GO Biological Process Annotations)", "ventral spinal cord interneuron differentiation (GO:0021514 from GO Biological Process Annotations)", "ventral spinal cord interneuron fate commitment (GO:0060579 from GO Biological Process Annotations)", "ventral spinal cord interneuron fate determination (GO:0060580 from GO Biological Process Annotations)", "ventral spinal cord interneuron specification (GO:0021521 from GO Biological Process Annotations)", "ventral trunk neural crest cell migration (GO:0036486 from GO Biological Process Annotations)", "ventricular cardiac muscle cell action potential (GO:0086005 from GO Biological Process Annotations)", "ventricular cardiac muscle cell development (GO:0055015 from GO Biological Process Annotations)", "ventricular cardiac muscle cell differentiation (GO:0055012 from GO Biological Process Annotations)", "ventricular cardiac muscle tissue development (GO:0003229 from GO Biological Process Annotations)", "ventricular cardiac muscle tissue morphogenesis (GO:0055010 from GO Biological Process Annotations)", "ventricular cardiac myofibril assembly (GO:0055005 from GO Biological Process Annotations)", "ventricular compact myocardium morphogenesis (GO:0003223 from GO Biological Process Annotations)", "ventricular septum development (GO:0003281 from GO Biological Process Annotations)", "ventricular septum morphogenesis (GO:0060412 from GO Biological Process Annotations)", "ventricular system development (GO:0021591 from GO Biological Process Annotations)", "ventricular trabecula myocardium morphogenesis (GO:0003222 from GO Biological Process Annotations)", "ventricular zone neuroblast division (GO:0021847 from GO Biological Process Annotations)", "very long-chain fatty acid biosynthetic process (GO:0042761 from GO Biological Process Annotations)", "very long-chain fatty acid catabolic process (GO:0042760 from GO Biological Process Annotations)", "very long-chain fatty acid metabolic process (GO:0000038 from GO Biological Process Annotations)", "very long-chain fatty-acyl-coa metabolic process (GO:0036111 from GO Biological Process Annotations)", "very-low-density lipoprotein particle assembly (GO:0034379 from GO Biological Process Annotations)", "very-low-density lipoprotein particle clearance (GO:0034447 from GO Biological Process Annotations)", "very-low-density lipoprotein particle remodeling (GO:0034372 from GO Biological Process Annotations)", "vesicle coating (GO:0006901 from GO Biological Process Annotations)", "vesicle docking (GO:0048278 from GO Biological Process Annotations)", "vesicle docking involved in exocytosis (GO:0006904 from GO Biological Process Annotations)", "vesicle fusion (GO:0006906 from GO Biological Process Annotations)", "vesicle fusion with golgi apparatus (GO:0048280 from GO Biological Process Annotations)", "vesicle localization (GO:0051648 from GO Biological Process Annotations)", "vesicle organization (GO:0016050 from GO Biological Process Annotations)", "vesicle targeting (GO:0006903 from GO Biological Process Annotations)", "vesicle targeting, to, from or within golgi (GO:0048199 from GO Biological Process Annotations)", "vesicle targeting, trans-golgi to endosome (GO:0048203 from GO Biological Process Annotations)", "vesicle transport along actin filament (GO:0030050 from GO Biological Process Annotations)", "vesicle transport along microtubule (GO:0047496 from GO Biological Process Annotations)", "vesicle uncoating (GO:0072319 from GO Biological Process Annotations)", "vesicle-mediated transport (GO:0016192 from GO Biological Process Annotations)", "vestibular nucleus development (GO:0021750 from GO Biological Process Annotations)", "vestibular receptor cell development (GO:0060118 from GO Biological Process Annotations)", "vestibular reflex (GO:0060005 from GO Biological Process Annotations)", "vestibulocochlear nerve development (GO:0021562 from GO Biological Process Annotations)", "vestibulocochlear nerve formation (GO:0021650 from GO Biological Process Annotations)", "vestibulocochlear nerve structural organization (GO:0021649 from GO Biological Process Annotations)", "viral budding (GO:0046755 from GO Biological Process Annotations)", "viral budding via host escrt complex (GO:0039702 from GO Biological Process Annotations)", "viral capsid secondary envelopment (GO:0046745 from GO Biological Process Annotations)", "viral entry into host cell (GO:0046718 from GO Biological Process Annotations)", "viral genome packaging (GO:0019072 from GO Biological Process Annotations)", "viral genome replication (GO:0019079 from GO Biological Process Annotations)", "viral life cycle (GO:0019058 from GO Biological Process Annotations)", "viral mrna export from host cell nucleus (GO:0046784 from GO Biological Process Annotations)", "viral penetration into host nucleus (GO:0075732 from GO Biological Process Annotations)", "viral process (GO:0016032 from GO Biological Process Annotations)", "viral protein processing (GO:0019082 from GO Biological Process Annotations)", "viral release from host cell (GO:0019076 from GO Biological Process Annotations)", "viral rna genome packaging (GO:0019074 from GO Biological Process Annotations)", "viral rna genome replication (GO:0039694 from GO Biological Process Annotations)", "viral transcription (GO:0019083 from GO Biological Process Annotations)", "virion assembly (GO:0019068 from GO Biological Process Annotations)", "virion attachment to host cell (GO:0019062 from GO Biological Process Annotations)", "virus maturation (GO:0019075 from GO Biological Process Annotations)", "visceral mesoderm-endoderm interaction involved in midgut development (GO:0007495 from GO Biological Process Annotations)", "visceral motor neuron differentiation (GO:0021524 from GO Biological Process Annotations)", "visceral muscle development (GO:0007522 from GO Biological Process Annotations)", "visceral serous pericardium development (GO:0061032 from GO Biological Process Annotations)", "visual behavior (GO:0007632 from GO Biological Process Annotations)", "visual learning (GO:0008542 from GO Biological Process Annotations)", "visual perception (GO:0007601 from GO Biological Process Annotations)", "vitamin a biosynthetic process (GO:0035238 from GO Biological Process Annotations)", "vitamin a import (GO:0071939 from GO Biological Process Annotations)", "vitamin a metabolic process (GO:0006776 from GO Biological Process Annotations)", "vitamin a transport (GO:0071938 from GO Biological Process Annotations)", "vitamin b6 biosynthetic process (GO:0042819 from GO Biological Process Annotations)", "vitamin b6 metabolic process (GO:0042816 from GO Biological Process Annotations)", "vitamin biosynthetic process (GO:0009110 from GO Biological Process Annotations)", "vitamin catabolic process (GO:0009111 from GO Biological Process Annotations)", "vitamin d biosynthetic process (GO:0042368 from GO Biological Process Annotations)", "vitamin d catabolic process (GO:0042369 from GO Biological Process Annotations)", "vitamin d metabolic process (GO:0042359 from GO Biological Process Annotations)", "vitamin d receptor signaling pathway (GO:0070561 from GO Biological Process Annotations)", "vitamin d3 metabolic process (GO:0070640 from GO Biological Process Annotations)", "vitamin e biosynthetic process (GO:0010189 from GO Biological Process Annotations)", "vitamin e metabolic process (GO:0042360 from GO Biological Process Annotations)", "vitamin k biosynthetic process (GO:0042371 from GO Biological Process Annotations)", "vitamin k catabolic process (GO:0042377 from GO Biological Process Annotations)", "vitamin k metabolic process (GO:0042373 from GO Biological Process Annotations)", "vitamin metabolic process (GO:0006766 from GO Biological Process Annotations)", "vitamin transmembrane transport (GO:0035461 from GO Biological Process Annotations)", "vitamin transport (GO:0051180 from GO Biological Process Annotations)", "vitelline membrane formation (GO:0030704 from GO Biological Process Annotations)", "vitellogenesis (GO:0007296 from GO Biological Process Annotations)", "vocal learning (GO:0042297 from GO Biological Process Annotations)", "vocalization behavior (GO:0071625 from GO Biological Process Annotations)", "voluntary musculoskeletal movement (GO:0050882 from GO Biological Process Annotations)", "voluntary skeletal muscle contraction (GO:0003010 from GO Biological Process Annotations)", "water homeostasis (GO:0030104 from GO Biological Process Annotations)", "water transport (GO:0006833 from GO Biological Process Annotations)", "water-soluble vitamin biosynthetic process (GO:0042364 from GO Biological Process Annotations)", "water-soluble vitamin metabolic process (GO:0006767 from GO Biological Process Annotations)", "wax biosynthetic process (GO:0010025 from GO Biological Process Annotations)", "wax metabolic process (GO:0010166 from GO Biological Process Annotations)", "white fat cell differentiation (GO:0050872 from GO Biological Process Annotations)", "wnt receptor catabolic process (GO:0038018 from GO Biological Process Annotations)", "wnt signaling pathway (GO:0016055 from GO Biological Process Annotations)", "wnt signaling pathway involved in dorsal|ventral axis specification (GO:0044332 from GO Biological Process Annotations)", "wnt signaling pathway involved in forebrain neuroblast division (GO:0021874 from GO Biological Process Annotations)", "wnt signaling pathway involved in heart development (GO:0003306 from GO Biological Process Annotations)", "wnt signaling pathway involved in kidney development (GO:0061289 from GO Biological Process Annotations)", "wnt signaling pathway involved in somitogenesis (GO:0090244 from GO Biological Process Annotations)", "wnt signaling pathway involved in wound healing, spreading of epidermal cells (GO:0035659 from GO Biological Process Annotations)", "wnt signaling pathway, calcium modulating pathway (GO:0007223 from GO Biological Process Annotations)", "wnt signaling pathway, planar cell polarity pathway (GO:0060071 from GO Biological Process Annotations)", "wnt-activated signaling pathway involved in forebrain neuron fate commitment (GO:0021881 from GO Biological Process Annotations)", "wound healing (GO:0042060 from GO Biological Process Annotations)", "wound healing involved in inflammatory response (GO:0002246 from GO Biological Process Annotations)", "wound healing, spreading of cells (GO:0044319 from GO Biological Process Annotations)", "wound healing, spreading of epidermal cells (GO:0035313 from GO Biological Process Annotations)", "wybutosine biosynthetic process (GO:0031591 from GO Biological Process Annotations)", "wybutosine metabolic process (GO:0031590 from GO Biological Process Annotations)", "xanthine biosynthetic process (GO:0046111 from GO Biological Process Annotations)", "xanthine catabolic process (GO:0009115 from GO Biological Process Annotations)", "xanthine metabolic process (GO:0046110 from GO Biological Process Annotations)", "xdp catabolic process (GO:1901639 from GO Biological Process Annotations)", "xenobiotic catabolic process (GO:0042178 from GO Biological Process Annotations)", "xenobiotic glucuronidation (GO:0052697 from GO Biological Process Annotations)", "xenobiotic metabolic process (GO:0006805 from GO Biological Process Annotations)", "xenobiotic transport (GO:0042908 from GO Biological Process Annotations)", "xylulose biosynthetic process (GO:0005999 from GO Biological Process Annotations)", "xylulose catabolic process (GO:0005998 from GO Biological Process Annotations)", "xylulose metabolic process (GO:0005997 from GO Biological Process Annotations)", "zinc ion homeostasis (GO:0055069 from GO Biological Process Annotations)", "zinc ion transmembrane import (GO:0071578 from GO Biological Process Annotations)", "zinc ion transmembrane transport (GO:0071577 from GO Biological Process Annotations)", "zinc ion transport (GO:0006829 from GO Biological Process Annotations)", "zonula adherens assembly (GO:0045186 from GO Biological Process Annotations)", "zonula adherens maintenance (GO:0045218 from GO Biological Process Annotations)", "zygote asymmetric cell division (GO:0010070 from GO Biological Process Annotations)", "zygotic determination of anterior|posterior axis, embryo (GO:0007354 from GO Biological Process Annotations)", "zygotic specification of dorsal|ventral axis (GO:0007352 from GO Biological Process Annotations)", "zymogen activation (GO:0031638 from GO Biological Process Annotations)", "zymogen granule exocytosis (GO:0070625 from GO Biological Process Annotations)", "zymogen inhibition (GO:0097341 from GO Biological Process Annotations)"]